Citrus Sinensis ID: 042681

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------34
Protein Sequence
MENESMVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDHMLE
Secondary Structure (PSIPRED)
cccccccccccccccccccEEEEEEcccEEEEcccccccccccccccccEEEEEEEcccccEEEEEccccccccHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEEEEccccHHHHHHHccccccccHHHHHHHHHHHHHccEEcccccccccccccEEEcccccEEccccccccccccccccccccccccccccccccHHHHHHHHHHccccccHHHHcccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccEEEEEEEEccEEEEcccccccEEEEEccccEEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHHHHcccccEccEEEEEccccccccccEEEEEEcccEEHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEcccccccccccHHHHccccccccccccccccHHHHHHHHHHHHccccHHHHcccccHHHHHHHHcccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHccHHHcccccHHHccccccccccccccccccHHHHHHHHHHHHcccccccHcc
Coil and Loop (DISEMBL)
menesmvmkdrgiplyggkyVQYNILGNLFqvsskyvpplqpigrgayGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMThenivkvkdiippmdkekfnDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYihsanvlhrdlkpsnlllnancdlkicdfglarttsetdFMTEYVVTRwdtlfpgkdyVQQLTMITEllgspddsdlgflrsdnARRYVkqlphvpkqpfsqkfpnmspVAIDLAERmlvfdpakritveealnhpylsslheineeptcpypfnfdfeqtsmneEDIKELILREClnfhpdhmle
Flexible Loop (DISEMBL)
menesmvmkdrgiplygGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKitnafdnridaKRILREIKLLchmthenivkvkdiippmdkEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLphvpkqpfsqkfpNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDHMLE
Low Complexity Region (SEG)
MENESMVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDHMLE
Disordered region (IsUnstruct)
**********RGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGS*****LGFL*******YV*******************PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFH******
Disordered Region (DISOPRED)
********************VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH*P*QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLN*HP*****
Disordered Region (DISEMBL)
********KDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDHMLE
Disordered Region (DISPRO)
**********R***LYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPD****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MENESMVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDHMLE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	339	2.2.26 [Sep-21-2011]
Q40531	371	Mitogen-activated protein	N/A	no	0.994	0.908	0.718	1e-156
Q9LQQ9	363	Mitogen-activated protein	yes	no	0.955	0.892	0.713	1e-151
Q39024	376	Mitogen-activated protein	no	no	0.955	0.861	0.699	1e-145
Q40353	371	Mitogen-activated protein	N/A	no	0.988	0.902	0.673	1e-144
Q336X9	376	Mitogen-activated protein	yes	no	0.958	0.864	0.694	1e-144
Q5J4W4	394	Mitogen-activated protein	no	no	0.958	0.824	0.672	1e-141
Q9LMM5	369	Mitogen-activated protein	no	no	0.961	0.883	0.673	1e-138
Q39025	376	Mitogen-activated protein	no	no	0.955	0.861	0.648	1e-134
Q84UI5	398	Mitogen-activated protein	no	no	0.943	0.804	0.640	1e-134
Q07176	387	Mitogen-activated protein	N/A	no	0.943	0.826	0.640	1e-134

>sp|Q40531|NTF6_TOBAC Mitogen-activated protein kinase homolog NTF6 OS=Nicotiana tabacum GN=NTF6 PE=2 SV=1

 Score =  550 bits (1418), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 266/370 (71%), Positives = 302/370 (81%), Gaps = 33/370 (8%)

Query: 1   MENES-MVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSET 59
           MENE+   ++ +GIP + GKYV+YN+LGN F+V+SKY+PP+QP+GRGAYG+VC A NSET
Sbjct: 1   MENETNEKLEIKGIPTHEGKYVEYNVLGNFFEVTSKYIPPIQPVGRGAYGMVCCATNSET 60

Query: 60  KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE 119
           KEEVAIKKI NAF+NRIDAKR LREIKLL HM HENI+K+KDI+ P D+E+FNDVYIVYE
Sbjct: 61  KEEVAIKKIGNAFENRIDAKRTLREIKLLSHMDHENIIKIKDIVRPPDREEFNDVYIVYE 120

Query: 120 LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 179
           LMDTDLHQIIRS QALTDDHCQYFLYQLLRGLKY+HSANVLHRDLKPSNLLLNANCDLKI
Sbjct: 121 LMDTDLHQIIRSSQALTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 180

Query: 180 CDFGLARTTSETDFMTEYVVTRW--------------------------------DTLFP 207
           CDFGLARTTSE DFMTEYVVTRW                                + LFP
Sbjct: 181 CDFGLARTTSEADFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILMELIKREPLFP 240

Query: 208 GKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
           G+DY QQL +I  LLGSP+DSDLGFLRSDNAR+YVK LP VP+ PFSQKFP++SP+A+DL
Sbjct: 241 GRDYAQQLGLIIALLGSPEDSDLGFLRSDNARKYVKHLPRVPRHPFSQKFPDVSPLALDL 300

Query: 268 AERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILR 327
           AERMLVFDPAKRITVE+ALNHP+L SLHEINEEP C  PFNFDFEQ S++E+DIKELI  
Sbjct: 301 AERMLVFDPAKRITVEDALNHPFLISLHEINEEPVCDSPFNFDFEQASLSEDDIKELIWN 360

Query: 328 ECLNFHPDHM 337
           E L F P+ M
Sbjct: 361 EALKFDPNTM 370

Nicotiana tabacum (taxid: 4097)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q9LQQ9|MPK13_ARATH Mitogen-activated protein kinase 13 OS=Arabidopsis thaliana GN=MPK13 PE=1 SV=1

 Score =  535 bits (1379), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 254/356 (71%), Positives = 294/356 (82%), Gaps = 32/356 (8%)

Query: 9   KDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI 68
           +D GI  Y G+YV YN+LGN+F++SSKY+PP++PIGRGAYGIVC A NSET EEVAIKKI
Sbjct: 5   EDGGILTYDGRYVMYNVLGNIFELSSKYIPPIEPIGRGAYGIVCCATNSETNEEVAIKKI 64

Query: 69  TNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQI 128
            NAFDNR+DAKR LREIKLL HM H+N++K+KDII   +KE+F DVYIVYELMDTDLHQI
Sbjct: 65  ANAFDNRVDAKRTLREIKLLSHMDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQI 124

Query: 129 IRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 188
           IRS Q LTDDHCQYFLYQ+LRGLKYIHSANVLHRDLKPSNL+LN NCDLKICDFGLART+
Sbjct: 125 IRSTQTLTDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTS 184

Query: 189 SETDFMTEYVVTRW--------------------------------DTLFPGKDYVQQLT 216
           +ET+ MTEYVVTRW                                +TLFPGKDYVQQL 
Sbjct: 185 NETEIMTEYVVTRWYRAPELLLNSSEYTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLK 244

Query: 217 MITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDP 276
           +ITELLGSPDDSDL FLRSDNAR+YVKQLPHV KQ F +KFPN+SP+A+DLAE+MLVFDP
Sbjct: 245 LITELLGSPDDSDLDFLRSDNARKYVKQLPHVQKQSFREKFPNISPMALDLAEKMLVFDP 304

Query: 277 AKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           +KRITV+EAL  PYL+SLHEINEEPTCP PF+FDFE+T+++E+DIKEL+ RE L+F
Sbjct: 305 SKRITVDEALKQPYLASLHEINEEPTCPTPFSFDFEETALDEQDIKELVWRESLHF 360

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39024|MPK4_ARATH Mitogen-activated protein kinase 4 OS=Arabidopsis thaliana GN=MPK4 PE=1 SV=2

 Score =  515 bits (1326), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 249/356 (69%), Positives = 282/356 (79%), Gaps = 32/356 (8%)

Query: 11  RGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITN 70
           +G+  +GG YVQYN+ GNLF+VS KYVPPL+PIGRGAYGIVC+A NSET EEVAIKKI N
Sbjct: 17  KGVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAATNSETGEEVAIKKIGN 76

Query: 71  AFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIR 130
           AFDN IDAKR LREIKLL HM HEN++ VKDII P  +E FNDVYIVYELMDTDLHQIIR
Sbjct: 77  AFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIR 136

Query: 131 SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
           S Q LTDDHC++FLYQLLRGLKY+HSANVLHRDLKPSNLLLNANCDLK+ DFGLART SE
Sbjct: 137 SNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTKSE 196

Query: 191 TDFMTEYVVTRW--------------------------------DTLFPGKDYVQQLTMI 218
           TDFMTEYVVTRW                                + LFPGKDYV QL +I
Sbjct: 197 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLI 256

Query: 219 TELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAK 278
           TEL+GSPDDS LGFLRSDNARRYV+QLP  P+Q F+ +FPNMS  A+DL E+MLVFDP++
Sbjct: 257 TELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSR 316

Query: 279 RITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           RITV+EAL HPYL+ LH+INEEP C  PFNFDFEQ ++ EE+IKELI RE + F+P
Sbjct: 317 RITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENIKELIYRETVKFNP 372

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Involved in root hair development process. Negative regulator of systemic acquired resistance (SAR) and salicylic acid- (SA) mediated defense response. Required for jasmonic acid- (JA) mediated defense gene expression. May regulate activity of transcription factor controlling pathogenesis-related (PR) gene expression. Seems to act independently of the SAR regulatory protein NPR1 (Nonexpresser of PR1). Phosphorylates MKS1 and transcription factors WRKY25 and WRKY33. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). May act as negative regulator of salt tolerance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40353|MMK2_MEDSA Mitogen-activated protein kinase homolog MMK2 OS=Medicago sativa GN=MMK2 PE=2 SV=1

 Score =  511 bits (1316), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 247/367 (67%), Positives = 286/367 (77%), Gaps = 32/367 (8%)

Query: 1   MENESMVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETK 60
           M  ES     RG+P +GG+Y+QYNI GNLF+VS KYVPP++ +GRGAYGIVC+AVN+ET+
Sbjct: 1   MSVESAENNIRGVPTHGGRYLQYNIYGNLFEVSRKYVPPIRSVGRGAYGIVCAAVNAETR 60

Query: 61  EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYEL 120
           EEVAIKKI NAFDNRIDAKR LREIKLL HM HEN++ +KDII P  KE FN VYIV EL
Sbjct: 61  EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVMSIKDIIRPPQKENFNHVYIVSEL 120

Query: 121 MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 180
           MDTDLHQIIRS Q +TDDHC+YF+YQLLRGLKY+HSANVLHRDLKPSNLLLNANCDLKI 
Sbjct: 121 MDTDLHQIIRSNQPMTDDHCRYFVYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 180

Query: 181 DFGLARTTSETDFMTEYVVTRW--------------------------------DTLFPG 208
           DFGLARTTSETDFMTEYVVTRW                                  LFPG
Sbjct: 181 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSDYTAAIDIWSVGCILGEIVTRQPLFPG 240

Query: 209 KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA 268
           +DYV QL ++TEL+GSPDD+ LGFLRS+NARRYV+QLP  PKQ FS +FPNMSP A+DL 
Sbjct: 241 RDYVHQLRLVTELIGSPDDASLGFLRSENARRYVRQLPQYPKQNFSARFPNMSPGAVDLL 300

Query: 269 ERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRE 328
           E+ML+FDP+KRI V+EAL HPY++ LH+INEEP C  PF+FDFE+    EEDIKELI +E
Sbjct: 301 EKMLIFDPSKRIKVDEALCHPYMAPLHDINEEPVCARPFSFDFEEPMFTEEDIKELIWKE 360

Query: 329 CLNFHPD 335
            + F+PD
Sbjct: 361 SVRFNPD 367

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q336X9|MPK6_ORYSJ Mitogen-activated protein kinase 6 OS=Oryza sativa subsp. japonica GN=MPK6 PE=2 SV=1

 Score =  510 bits (1313), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 248/357 (69%), Positives = 280/357 (78%), Gaps = 32/357 (8%)

Query: 11  RGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITN 70
           +G+  +GG+YV YN+ GN F+VSSKY PP++PIGRGAYGIVC+AVNSE  EEVAIKKI N
Sbjct: 17  KGMGTHGGRYVLYNVYGNFFEVSSKYAPPIRPIGRGAYGIVCAAVNSENGEEVAIKKIGN 76

Query: 71  AFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIR 130
           AFDN IDAKR LREIKLL HM HENI+ +KDII P  ++ FNDVYIV ELMDTDLHQIIR
Sbjct: 77  AFDNHIDAKRTLREIKLLRHMDHENIIAIKDIIRPPRRDNFNDVYIVSELMDTDLHQIIR 136

Query: 131 SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
           S Q LTDDHCQYFLYQLLRGLKY+HSANVLHRDLKPSNL LNANCDLKI DFGLARTT+E
Sbjct: 137 SNQPLTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLFLNANCDLKIADFGLARTTTE 196

Query: 191 TDFMTEYVVTRW--------------------------------DTLFPGKDYVQQLTMI 218
           TD MTEYVVTRW                                  LFPG+DY+QQL +I
Sbjct: 197 TDLMTEYVVTRWYRAPELLLNCSQYTAAIDVWSVGCILGEIVTRQPLFPGRDYIQQLKLI 256

Query: 219 TELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAK 278
           TEL+GSPDDS LGFLRSDNARRY+KQLP  P+Q F  +F NMS  A+DL E+MLVFDP++
Sbjct: 257 TELIGSPDDSSLGFLRSDNARRYMKQLPQYPRQDFRLRFRNMSAGAVDLLEKMLVFDPSR 316

Query: 279 RITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPD 335
           RITV+EAL+HPYL+SLH+INEEPTCP PF+FDFEQ S  EE IKELI RE L F+PD
Sbjct: 317 RITVDEALHHPYLASLHDINEEPTCPAPFSFDFEQPSFTEEHIKELIWRESLAFNPD 373

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q5J4W4|MPK2_ORYSJ Mitogen-activated protein kinase 2 OS=Oryza sativa subsp. japonica GN=MPK2 PE=2 SV=1

 Score =  501 bits (1291), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 240/357 (67%), Positives = 281/357 (78%), Gaps = 32/357 (8%)

Query: 11  RGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITN 70
           +G   +GG+YVQYN+ GNLF+VSSKYVPP++P+GRGA GI+C+ VN++T++EVAIKKI N
Sbjct: 35  KGTLTHGGRYVQYNVYGNLFEVSSKYVPPIRPVGRGACGIICAVVNAQTRQEVAIKKIGN 94

Query: 71  AFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIR 130
           AFDN+IDAKR LREIKLL HM H+N++ +KDII P  +E FNDVYIVYELMDTDLH ++R
Sbjct: 95  AFDNQIDAKRTLREIKLLRHMDHDNVISIKDIIRPPRRENFNDVYIVYELMDTDLHHLLR 154

Query: 131 SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
           S Q LTDDHCQYFLYQ+LRGLKY+HSANVLHRDL+PSNLLLNA CDLKI DFGLARTT+E
Sbjct: 155 SNQPLTDDHCQYFLYQVLRGLKYVHSANVLHRDLRPSNLLLNAKCDLKIGDFGLARTTNE 214

Query: 191 TDFMTEYVVTRW--------------------------------DTLFPGKDYVQQLTMI 218
           TDFM EYVVTRW                                + LFPGKDYV QL +I
Sbjct: 215 TDFMMEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIVTREPLFPGKDYVHQLRLI 274

Query: 219 TELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAK 278
           TEL+GSPDDS LGFLRSDNARRYV+ LP  PKQ F  +FP MS  A+DL ERMLVFDP+K
Sbjct: 275 TELIGSPDDSSLGFLRSDNARRYVRSLPQYPKQQFRARFPTMSSGAMDLLERMLVFDPSK 334

Query: 279 RITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPD 335
           RITV+EAL HPYL+SLHEI +EP CP PF+FDFEQ S+ EEDIKE+I RE L F+P+
Sbjct: 335 RITVDEALCHPYLASLHEIYDEPVCPAPFSFDFEQPSLTEEDIKEIIWREALKFNPE 391

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9LMM5|MPK11_ARATH Mitogen-activated protein kinase 11 OS=Arabidopsis thaliana GN=MPK11 PE=1 SV=1

 Score =  491 bits (1263), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 241/358 (67%), Positives = 277/358 (77%), Gaps = 32/358 (8%)

Query: 9   KDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI 68
            +RG+ + GG+YVQYN+ GNLF+VS KYVPPL+PIGRGA GIVC+A NSET EEVAIKKI
Sbjct: 12  SNRGVSINGGRYVQYNVYGNLFEVSKKYVPPLRPIGRGASGIVCAAWNSETGEEVAIKKI 71

Query: 69  TNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQI 128
            NAF N IDAKR LREIKLL HM H+N++ + DII P   + FNDV+IVYELMDTDLH I
Sbjct: 72  GNAFGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHI 131

Query: 129 IRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 188
           IRS Q LTDDH ++FLYQLLRGLKY+HSANVLHRDLKPSNLLLNANCDLKI DFGLART 
Sbjct: 132 IRSNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTK 191

Query: 189 SETDFMTEYVVTRW--------------------------------DTLFPGKDYVQQLT 216
           SETDFMTEYVVTRW                                + LFPG+DYVQQL 
Sbjct: 192 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLR 251

Query: 217 MITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDP 276
           +ITEL+GSPDDS LGFLRSDNARRYV+QLP  P+Q F+ +FPNMS  A+DL ++MLVFDP
Sbjct: 252 LITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDP 311

Query: 277 AKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
            +RITV+EAL HPYL+ LHE NEEP C  PF+FDFEQ S+ EE+IKELI RE + F+P
Sbjct: 312 NRRITVDEALCHPYLAPLHEYNEEPVCVRPFHFDFEQPSLTEENIKELIYRESVKFNP 369

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39025|MPK5_ARATH Mitogen-activated protein kinase 5 OS=Arabidopsis thaliana GN=MPK5 PE=2 SV=2

 Score =  479 bits (1232), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 231/356 (64%), Positives = 276/356 (77%), Gaps = 32/356 (8%)

Query: 11  RGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITN 70
           +G+ ++GG+Y QYN+ GNLF+VS+KYVPP++PIGRGAYG VC+AV+SET EE+AIKKI  
Sbjct: 17  KGVLVHGGRYFQYNVYGNLFEVSNKYVPPIRPIGRGAYGFVCAAVDSETHEEIAIKKIGK 76

Query: 71  AFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIR 130
           AFDN++DAKR LREIKLL H+ HEN+V +KDII P  KE F DVYIV+ELMDTDLHQIIR
Sbjct: 77  AFDNKVDAKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFVDVYIVFELMDTDLHQIIR 136

Query: 131 SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
           S Q+L DDHCQYFLYQ+LRGLKYIHSANVLHRDLKPSNLLLN+NCDLKI DFGLARTTSE
Sbjct: 137 SNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSNCDLKITDFGLARTTSE 196

Query: 191 TDFMTEYVVTRW--------------------------------DTLFPGKDYVQQLTMI 218
           T++MTEYVVTRW                                + LFPGKDYV QL +I
Sbjct: 197 TEYMTEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTREPLFPGKDYVHQLKLI 256

Query: 219 TELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAK 278
           TEL+GSPD + L FLRS NAR+YVK+LP  P+Q FS +FP+M+  AIDL E+MLVFDP K
Sbjct: 257 TELIGSPDGASLEFLRSANARKYVKELPKFPRQNFSARFPSMNSTAIDLLEKMLVFDPVK 316

Query: 279 RITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           RITVEEAL +PYLS+LH++N+EP C   F+F FE  S  EE+IKEL+  E + F+P
Sbjct: 317 RITVEEALCYPYLSALHDLNDEPVCSNHFSFHFEDPSSTEEEIKELVWLESVKFNP 372

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q84UI5|MPK1_ORYSJ Mitogen-activated protein kinase 1 OS=Oryza sativa subsp. japonica GN=MPK1 PE=1 SV=1

 Score =  478 bits (1231), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 226/353 (64%), Positives = 280/353 (79%), Gaps = 33/353 (9%)

Query: 16  YGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR 75
           +GG+++QYNI GN+F+V++KY PP+ PIG+GAYGIVCSA+NSET E+VAIKKI NAFDN+
Sbjct: 46  HGGRFIQYNIFGNVFEVTAKYKPPILPIGKGAYGIVCSALNSETGEQVAIKKIANAFDNK 105

Query: 76  IDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQAL 135
           IDAKR LREIKLL HM HENIV ++DIIPP  +  FNDVYI YELMDTDLHQIIRS QAL
Sbjct: 106 IDAKRTLREIKLLRHMDHENIVAIRDIIPPPQRNSFNDVYIAYELMDTDLHQIIRSNQAL 165

Query: 136 TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
           +++HCQYFLYQ+LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT
Sbjct: 166 SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 225

Query: 196 EYVVTRW--------------------------------DTLFPGKDYVQQLTMITELLG 223
           EYVVTRW                                  LFPG+D+V QL ++ EL+G
Sbjct: 226 EYVVTRWYRAPELLLNSSEYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIG 285

Query: 224 SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVE 283
           +P+++DL F+ ++NARRY++QLP   +Q F +KFP++ P+AIDL E+ML FDP +RITVE
Sbjct: 286 TPNEADLDFV-NENARRYIRQLPRHARQSFPEKFPHVHPLAIDLVEKMLTFDPRQRITVE 344

Query: 284 EALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
            AL HPYL+SLH+I++EP C  PF+FDFEQ +++EE +K+LI +E L F+PD+
Sbjct: 345 GALAHPYLASLHDISDEPVCSSPFSFDFEQHALSEEQMKDLIYQEGLAFNPDY 397

Involved in sphingolipid elicitor (SE)-dependent defense signaling pathway. Acts downstream of heterotrimeric G protein alpha subunit and small GTPase RAC1. May regulate the expression of various genes involved in biotic and abiotic stress response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q07176|MMK1_MEDSA Mitogen-activated protein kinase homolog MMK1 OS=Medicago sativa GN=MMK1 PE=1 SV=1

 Score =  477 bits (1228), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 226/353 (64%), Positives = 276/353 (78%), Gaps = 33/353 (9%)

Query: 16  YGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR 75
           +GG+++QYNI GN+F+V++KY PP+ PIG+GAYGIVCSA NSET E VA+KKI NAFDN+
Sbjct: 34  HGGRFIQYNIFGNIFEVTAKYKPPIMPIGKGAYGIVCSAHNSETNEHVAVKKIANAFDNK 93

Query: 76  IDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQAL 135
           IDAKR LREIKLL HM HEN+V ++DI+PP  +E FNDVYI YELMDTDLHQIIRS QAL
Sbjct: 94  IDAKRTLREIKLLRHMDHENVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQAL 153

Query: 136 TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
           +++HCQYFLYQ+LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR TSETDFMT
Sbjct: 154 SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT 213

Query: 196 EYVVTRW--------------------------------DTLFPGKDYVQQLTMITELLG 223
           EYVVTRW                                  LFPG+D+V QL ++ EL+G
Sbjct: 214 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIG 273

Query: 224 SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVE 283
           +P + DLGFL ++NA+RY++QLP   +Q F +KFP++ P AIDL E+ML FDP KRITVE
Sbjct: 274 TPSEDDLGFL-NENAKRYIRQLPPYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVE 332

Query: 284 EALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           +AL HPYL+SLH+I++EP C  PF+FDFEQ ++ EE +KELI RE L F+P++
Sbjct: 333 DALAHPYLTSLHDISDEPVCMTPFSFDFEQHALTEEQMKELIYREALAFNPEY 385

May play a role in the mitogenic induction of symbiotic root nodules on Alfalfa by Rhizobium signal molecules.

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	339
255578759	372	big map kinase/bmk, putative [Ricinus co	1.0	0.911	0.784	1e-166
225435169	371	PREDICTED: mitogen-activated protein kin	1.0	0.913	0.768	1e-165
267881838	367	mitogen-activated protein kinase [Malus	0.964	0.891	0.766	1e-160
116789860	372	unknown [Picea sitchensis] gi|148909452|	0.964	0.879	0.749	1e-157
357472479	374	Mitogen-activated protein kinase [Medica	1.0	0.906	0.721	1e-156
4456682	374	MAP kinase [Medicago sativa]	1.0	0.906	0.719	1e-156
187761607	371	MAP kinase [Nicotiana benthamiana]	0.994	0.908	0.721	1e-155
12718824	371	NRK1 MAPK [Nicotiana tabacum]	0.994	0.908	0.716	1e-154
358249014	376	uncharacterized protein LOC100802929 [Gl	0.997	0.898	0.749	1e-154
2499616	371	RecName: Full=Mitogen-activated protein	0.994	0.908	0.718	1e-154

>gi|255578759|ref|XP_002530237.1| big map kinase/bmk, putative [Ricinus communis] gi|223530241|gb|EEF32143.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  590 bits (1521), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 292/372 (78%), Positives = 313/372 (84%), Gaps = 33/372 (8%)

Query: 1   MENES-MVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSET 59
           MEN+S MV+ +RG   Y GKYVQYN+LGNLF+V+SKY PP+QP+GRGAYGIVC A NSET
Sbjct: 1   MENDSSMVIDERGNRTYNGKYVQYNVLGNLFEVTSKYSPPIQPVGRGAYGIVCCARNSET 60

Query: 60  KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE 119
           KEEVAIKKI NAFDNRIDAKR LREIKLLCHM HENIVK+KDIIPP ++  FNDVYIVYE
Sbjct: 61  KEEVAIKKIGNAFDNRIDAKRTLREIKLLCHMDHENIVKIKDIIPPPERATFNDVYIVYE 120

Query: 120 LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 179
           LMDTDLHQIIRS QALTDDH QYFLYQLLRGLKY+HSANVLHRDLKPSNLLLNANCDLKI
Sbjct: 121 LMDTDLHQIIRSTQALTDDHVQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 180

Query: 180 CDFGLARTTSETDFMTEYVVTRW--------------------------------DTLFP 207
           CDFGLARTTSETDFMTEYVVTRW                                + LFP
Sbjct: 181 CDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILMEIIRREPLFP 240

Query: 208 GKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
           GKDYVQQL +ITELLGSPD+SDLGFLRSDNARRYVKQLPHVPKQPFSQKFP++SPVA+DL
Sbjct: 241 GKDYVQQLGLITELLGSPDESDLGFLRSDNARRYVKQLPHVPKQPFSQKFPDVSPVALDL 300

Query: 268 AERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILR 327
           AERMLVFDP KRITVEEALNHP+LSSLHEINEEPTCP PF FDFEQTS+NEEDIKELI  
Sbjct: 301 AERMLVFDPCKRITVEEALNHPFLSSLHEINEEPTCPSPFIFDFEQTSLNEEDIKELIWA 360

Query: 328 ECLNFHPDHMLE 339
           E LNF+ D MLE
Sbjct: 361 ESLNFNSDVMLE 372

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225435169|ref|XP_002284710.1| PREDICTED: mitogen-activated protein kinase homolog NTF6 [Vitis vinifera] gi|297746181|emb|CBI16237.3| unnamed protein product [Vitis vinifera]

 Score =  587 bits (1514), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 285/371 (76%), Positives = 313/371 (84%), Gaps = 32/371 (8%)

Query: 1   MENESMVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETK 60
           MENES  ++ +G+P YGGKYVQYN+LGNLF+VS+KYVPP+QP+GRGAYGIVC A NSET 
Sbjct: 1   MENESAAVEVKGVPSYGGKYVQYNVLGNLFEVSAKYVPPIQPVGRGAYGIVCCATNSETN 60

Query: 61  EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYEL 120
           +EVAIKKI NAFDNRIDAKR LREIKLLCHM HENIVK+KDII P DKEKFNDVYIVYEL
Sbjct: 61  KEVAIKKIGNAFDNRIDAKRTLREIKLLCHMDHENIVKIKDIIRPPDKEKFNDVYIVYEL 120

Query: 121 MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 180
           MDTDLHQIIRS QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA+CDLKIC
Sbjct: 121 MDTDLHQIIRSSQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNADCDLKIC 180

Query: 181 DFGLARTTSETDFMTEYVVTRW--------------------------------DTLFPG 208
           DFGLARTTSETDFMTEYVVTRW                                + LFPG
Sbjct: 181 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILMEILRREPLFPG 240

Query: 209 KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA 268
           KDYVQQL +ITELLGSP+DSDLGFLRSDNAR+YVKQLP VPKQPFS+KFPN+SP+A+DL 
Sbjct: 241 KDYVQQLVLITELLGSPEDSDLGFLRSDNARKYVKQLPCVPKQPFSEKFPNISPIAMDLV 300

Query: 269 ERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRE 328
           E+MLVFDP+KRITVEEALNHP+L  LHEINEEP CP PF FDFEQ+S++E+DIKELI  E
Sbjct: 301 EKMLVFDPSKRITVEEALNHPFLLPLHEINEEPICPSPFIFDFEQSSLSEDDIKELIWNE 360

Query: 329 CLNFHPDHMLE 339
            LNF+PD MLE
Sbjct: 361 SLNFNPDEMLE 371

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|267881838|gb|ACY82514.1| mitogen-activated protein kinase [Malus x domestica]

 Score =  570 bits (1470), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 275/359 (76%), Positives = 303/359 (84%), Gaps = 32/359 (8%)

Query: 12  GIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA 71
           GIPLYGGKY+QYNILGNLF+VS+KY PP+ P+GRGAYGIVC A NSETKEEVAIKKI NA
Sbjct: 8   GIPLYGGKYIQYNILGNLFEVSAKYAPPIHPVGRGAYGIVCCATNSETKEEVAIKKIGNA 67

Query: 72  FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS 131
           FDNRIDAKR LREI+LLCHM H+N++K+KDII P D+EKFNDVYIVYE MDTDL+QII S
Sbjct: 68  FDNRIDAKRTLREIELLCHMDHDNVIKIKDIIRPADREKFNDVYIVYESMDTDLNQIINS 127

Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
            QAL DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL+ANCDLKIC FGLARTTSET
Sbjct: 128 GQALIDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLSANCDLKICGFGLARTTSET 187

Query: 192 DFMTEYVVTRW--------------------------------DTLFPGKDYVQQLTMIT 219
           DFMTEYVVTRW                                + LFPGKDYVQQL++I 
Sbjct: 188 DFMTEYVVTRWYRAPELLLNCSEYTGAIDIWSVGCIVIEILRREPLFPGKDYVQQLSLIN 247

Query: 220 ELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKR 279
           ELLGSPD+SDLGFLRSDNAR+YVKQLPHVPKQPF++KFPN+SP+AID AERMLVFDP+KR
Sbjct: 248 ELLGSPDESDLGFLRSDNARKYVKQLPHVPKQPFAEKFPNVSPLAIDHAERMLVFDPSKR 307

Query: 280 ITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDHML 338
           ITVEEALNHP+LSSLHEINEEP CP PF FDFEQ S++EEDIKELI RE L F+PD+ML
Sbjct: 308 ITVEEALNHPFLSSLHEINEEPICPSPFVFDFEQASLDEEDIKELIWRESLRFNPDNML 366

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116789860|gb|ABK25416.1| unknown [Picea sitchensis] gi|148909452|gb|ABR17824.1| unknown [Picea sitchensis]

 Score =  561 bits (1445), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 269/359 (74%), Positives = 299/359 (83%), Gaps = 32/359 (8%)

Query: 11  RGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITN 70
           +GI  +GG+YVQYNI GNLF+VSSKY+PP++PIGRGAYGIVCSAVN+ET EEVAIKKI N
Sbjct: 13  QGILTHGGQYVQYNIFGNLFEVSSKYIPPIRPIGRGAYGIVCSAVNTETNEEVAIKKIGN 72

Query: 71  AFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIR 130
           AFDNRIDAKR LREIKLLCHM HENI+ +KDII P  +E FNDVYIVYELMDTDL+QIIR
Sbjct: 73  AFDNRIDAKRTLREIKLLCHMEHENIIAIKDIIRPPQRENFNDVYIVYELMDTDLYQIIR 132

Query: 131 SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
           S Q LT+DHCQYFLYQLLRGLKYIHSAN+LHRDLKPSNLLLNANCDLKICDFGLARTTSE
Sbjct: 133 STQPLTEDHCQYFLYQLLRGLKYIHSANILHRDLKPSNLLLNANCDLKICDFGLARTTSE 192

Query: 191 TDFMTEYVVTRW--------------------------------DTLFPGKDYVQQLTMI 218
           TDFMTEYVVTRW                                + LFPGKDYVQQL +I
Sbjct: 193 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIFMEILKREPLFPGKDYVQQLRLI 252

Query: 219 TELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAK 278
           TEL+GSPDDSDLGFLRSDNARRY++QLP  PKQPFSQKFPNM+P A+DL E+MLVFDP+K
Sbjct: 253 TELIGSPDDSDLGFLRSDNARRYIRQLPQFPKQPFSQKFPNMAPAAVDLLEKMLVFDPSK 312

Query: 279 RITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDHM 337
           RITV+EAL+HPYL+SLH+IN+EP+CP PFNFDFEQ S  EE IKELI RE LNF+PD M
Sbjct: 313 RITVQEALSHPYLASLHDINDEPSCPTPFNFDFEQPSFTEEHIKELIWRETLNFNPDMM 371

Source: Picea sitchensis

Species: Picea sitchensis

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357472479|ref|XP_003606524.1| Mitogen-activated protein kinase [Medicago truncatula] gi|355507579|gb|AES88721.1| Mitogen-activated protein kinase [Medicago truncatula]

 Score =  558 bits (1438), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 270/374 (72%), Positives = 306/374 (81%), Gaps = 35/374 (9%)

Query: 1   MEN---ESMVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNS 57
           MEN   ES     +G  ++ GKY+QYN+LGNLF+V S Y+PPLQP+GRGAYGIVC A NS
Sbjct: 1   MENKNPESEKANSKGTLIHDGKYIQYNVLGNLFEVYSNYIPPLQPVGRGAYGIVCCATNS 60

Query: 58  ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV 117
           +T E VAIKKI +AFDNRIDAKR LREIKLLCHM H+N++K+KDII P DKEKFNDVYIV
Sbjct: 61  DTNEGVAIKKIGDAFDNRIDAKRTLREIKLLCHMDHDNVIKIKDIIKPADKEKFNDVYIV 120

Query: 118 YELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL 177
           YELMDTDLHQII+S QALTD+HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL
Sbjct: 121 YELMDTDLHQIIQSNQALTDEHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL 180

Query: 178 KICDFGLARTTSETDFMTEYVVTRW--------------------------------DTL 205
           KICDFGLARTTSETDFMTEYVVTRW                                + L
Sbjct: 181 KICDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDVWSVGCILMEIIRREPL 240

Query: 206 FPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
           FPGKDYVQQL +ITELLGSP++ DLGFLRSDNA++YVKQLPHV KQPF+++FP+MSP+A+
Sbjct: 241 FPGKDYVQQLALITELLGSPNEEDLGFLRSDNAKKYVKQLPHVDKQPFAERFPDMSPLAL 300

Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELI 325
           DLAE+MLVFDP+KRITVEEALNHPY+SSLHEINEEP CP PF FDFEQ ++NE+DIKELI
Sbjct: 301 DLAEKMLVFDPSKRITVEEALNHPYMSSLHEINEEPVCPSPFVFDFEQATLNEDDIKELI 360

Query: 326 LRECLNFHPDHMLE 339
            RE LNF  + +LE
Sbjct: 361 WRESLNFCKEQILE 374

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|4456682|emb|CAB37188.1| MAP kinase [Medicago sativa]

 Score =  555 bits (1431), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 269/374 (71%), Positives = 305/374 (81%), Gaps = 35/374 (9%)

Query: 1   MEN---ESMVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNS 57
           MEN   ES     +G  ++ GKY+QYN+LGNLF+V S Y+PPLQP+GRGAYGIVC A NS
Sbjct: 1   MENKNPESEKANSKGTLIHDGKYIQYNVLGNLFEVYSNYIPPLQPVGRGAYGIVCCATNS 60

Query: 58  ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV 117
           +T E VAIKKI +AFDNRIDAKR LREIKLLCHM H+N++K+KDII P DKEKFNDVYIV
Sbjct: 61  DTNEGVAIKKIGDAFDNRIDAKRTLREIKLLCHMDHDNVIKIKDIIKPADKEKFNDVYIV 120

Query: 118 YELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL 177
           YELMDTDLHQII+S QALTD+HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL ANCDL
Sbjct: 121 YELMDTDLHQIIQSNQALTDEHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLKANCDL 180

Query: 178 KICDFGLARTTSETDFMTEYVVTRW--------------------------------DTL 205
           KICDFGLARTTSETDFMTEYVVTRW                                + L
Sbjct: 181 KICDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDVWSVGCILMEIIRREPL 240

Query: 206 FPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
           FPGKDYVQQL +ITELLGSP++ DLGFLRSDNA++YVKQLPHV KQPF+++FP+MSP+A+
Sbjct: 241 FPGKDYVQQLALITELLGSPNEEDLGFLRSDNAKKYVKQLPHVDKQPFAERFPDMSPLAL 300

Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELI 325
           DLAE+MLVFDP+KRITVEEALNHPY+SSLHEINEEP CP PF FDFEQ ++NE+DIKELI
Sbjct: 301 DLAEKMLVFDPSKRITVEEALNHPYMSSLHEINEEPVCPSPFVFDFEQATLNEDDIKELI 360

Query: 326 LRECLNFHPDHMLE 339
            RE LNF  + +LE
Sbjct: 361 WRESLNFCKEQILE 374

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|187761607|dbj|BAG31942.1| MAP kinase [Nicotiana benthamiana]

 Score =  554 bits (1427), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 267/370 (72%), Positives = 304/370 (82%), Gaps = 33/370 (8%)

Query: 1   MENES-MVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSET 59
           MENE+   ++ +G+P + GKYV+YN+LGN F+V+SKY+PP+QP+GRGAYG+VC A NSET
Sbjct: 1   MENETNEKLEIKGVPTHEGKYVEYNVLGNFFEVTSKYIPPIQPVGRGAYGMVCCATNSET 60

Query: 60  KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE 119
           KEEVAIKKI NAF+NRIDAKR LREIKLL HM HENI+K+KDI+ P D+E+FNDVYIVYE
Sbjct: 61  KEEVAIKKIGNAFENRIDAKRTLREIKLLSHMDHENIIKIKDIVRPPDREEFNDVYIVYE 120

Query: 120 LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 179
           LMDTDLHQIIRS QALTDDHCQYFLYQLLRGLKY+HSANVLHRDLKPSNLLLNANCDLKI
Sbjct: 121 LMDTDLHQIIRSSQALTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 180

Query: 180 CDFGLARTTSETDFMTEYVVTRW--------------------------------DTLFP 207
           CDFGLARTTSETDFMTEYVVTRW                                + LFP
Sbjct: 181 CDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILMELVKREPLFP 240

Query: 208 GKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
           G+DY QQL +I ELLGSP+DSDLGFLRSDNAR+YVK LP VP+QPFSQKF ++SP+A+DL
Sbjct: 241 GRDYAQQLGLIIELLGSPEDSDLGFLRSDNARKYVKHLPRVPRQPFSQKFSDVSPLALDL 300

Query: 268 AERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILR 327
           AERMLVFDPAKRITVE+ALNHP+L SLHEINEEP C  PFNFDFEQ S++E+DIKELI  
Sbjct: 301 AERMLVFDPAKRITVEDALNHPFLISLHEINEEPVCDSPFNFDFEQASLSEDDIKELIWN 360

Query: 328 ECLNFHPDHM 337
           E L F P+ M
Sbjct: 361 EALKFDPNTM 370

Source: Nicotiana benthamiana

Species: Nicotiana benthamiana

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|12718824|dbj|BAB32406.1| NRK1 MAPK [Nicotiana tabacum]

 Score =  551 bits (1419), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 265/370 (71%), Positives = 303/370 (81%), Gaps = 33/370 (8%)

Query: 1   MENES-MVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSET 59
           MENE+   ++ +G+P + GKYV+YN+LGN F+V+SKY+PP+QP+GRGAYG+VC A NSET
Sbjct: 1   MENETNEKLEIKGVPTHEGKYVEYNVLGNFFEVTSKYIPPIQPVGRGAYGMVCCATNSET 60

Query: 60  KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE 119
           KEEVAIKKI NAF+NRIDAKR LREIKLL HM HENI+K+KDI+ P D+E+FNDVYIVYE
Sbjct: 61  KEEVAIKKIGNAFENRIDAKRTLREIKLLSHMDHENIIKIKDIVRPPDREEFNDVYIVYE 120

Query: 120 LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 179
           LMDTDLHQIIRS QALT+DHCQYFLYQLLRGLKY+HSANVLHRDLKPSNLLLNANCDLKI
Sbjct: 121 LMDTDLHQIIRSSQALTEDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 180

Query: 180 CDFGLARTTSETDFMTEYVVTRW--------------------------------DTLFP 207
           CDFGLARTTSE DFMTEYVVTRW                                + LFP
Sbjct: 181 CDFGLARTTSEADFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILMELIKREPLFP 240

Query: 208 GKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
           G+DY QQL +I  LLGSP+DSDLGFLRSDNAR+YVK LP VP+QPFSQKFP++SP+A+DL
Sbjct: 241 GRDYAQQLGLIIALLGSPEDSDLGFLRSDNARKYVKHLPRVPRQPFSQKFPDVSPLALDL 300

Query: 268 AERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILR 327
           AERMLVFDPAKRITVE+ALNHP+L SLHEINEEP C  PFNFDFEQ S++E+DIKELI  
Sbjct: 301 AERMLVFDPAKRITVEDALNHPFLISLHEINEEPVCDSPFNFDFEQASLSEDDIKELIWN 360

Query: 328 ECLNFHPDHM 337
           E L F P+ M
Sbjct: 361 EALKFDPNTM 370

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358249014|ref|NP_001240234.1| uncharacterized protein LOC100802929 [Glycine max] gi|255642592|gb|ACU21591.1| unknown [Glycine max]

 Score =  550 bits (1418), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 278/371 (74%), Positives = 310/371 (83%), Gaps = 33/371 (8%)

Query: 2   ENESMVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKE 61
           E+E+   K +GIP++GGKYV+YNILGN FQV SKY PPLQP+GRGAYGIVC A NSETKE
Sbjct: 6   ESENPKGKGKGIPIHGGKYVRYNILGNHFQVYSKYAPPLQPVGRGAYGIVCCATNSETKE 65

Query: 62  EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM 121
            VAIKKI NAFDNRIDAKR LREIKLLCHM H+NI+K+KDII P ++E FNDVYIVYELM
Sbjct: 66  GVAIKKIGNAFDNRIDAKRTLREIKLLCHMEHDNIIKIKDIIRPAERENFNDVYIVYELM 125

Query: 122 DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 181
           DTDLHQII+S QALTD+HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD
Sbjct: 126 DTDLHQIIQSNQALTDEHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 185

Query: 182 FGLARTTSETDFMTEYVVTRW--------------------------------DTLFPGK 209
           FGLARTTSETDFMTEYVVTRW                                + LFPGK
Sbjct: 186 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTSAIDIWSVGCILMEIIRREPLFPGK 245

Query: 210 DYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAE 269
           DYVQQL +ITEL+GSP+DSDLGFLRSDNA++YVKQLPHV KQ F+++FP++SP+AIDLAE
Sbjct: 246 DYVQQLALITELIGSPNDSDLGFLRSDNAKKYVKQLPHVEKQSFAERFPDVSPLAIDLAE 305

Query: 270 RMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILREC 329
           +MLVFDP+KRITVEEALNHPY++SLHEINEEPTCP PF FDFEQT +NEEDIKELI +E 
Sbjct: 306 KMLVFDPSKRITVEEALNHPYMASLHEINEEPTCPTPFIFDFEQTILNEEDIKELIWKES 365

Query: 330 LNFHPDH-MLE 339
           LNF  DH MLE
Sbjct: 366 LNFSQDHQMLE 376

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|2499616|sp|Q40531.1|NTF6_TOBAC RecName: Full=Mitogen-activated protein kinase homolog NTF6; AltName: Full=P43 gi|634068|emb|CAA58760.1| p43Nft6 serine/threonine protein kinase [Nicotiana tabacum]

 Score =  550 bits (1418), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 266/370 (71%), Positives = 302/370 (81%), Gaps = 33/370 (8%)

Query: 1   MENES-MVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSET 59
           MENE+   ++ +GIP + GKYV+YN+LGN F+V+SKY+PP+QP+GRGAYG+VC A NSET
Sbjct: 1   MENETNEKLEIKGIPTHEGKYVEYNVLGNFFEVTSKYIPPIQPVGRGAYGMVCCATNSET 60

Query: 60  KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE 119
           KEEVAIKKI NAF+NRIDAKR LREIKLL HM HENI+K+KDI+ P D+E+FNDVYIVYE
Sbjct: 61  KEEVAIKKIGNAFENRIDAKRTLREIKLLSHMDHENIIKIKDIVRPPDREEFNDVYIVYE 120

Query: 120 LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 179
           LMDTDLHQIIRS QALTDDHCQYFLYQLLRGLKY+HSANVLHRDLKPSNLLLNANCDLKI
Sbjct: 121 LMDTDLHQIIRSSQALTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 180

Query: 180 CDFGLARTTSETDFMTEYVVTRW--------------------------------DTLFP 207
           CDFGLARTTSE DFMTEYVVTRW                                + LFP
Sbjct: 181 CDFGLARTTSEADFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILMELIKREPLFP 240

Query: 208 GKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
           G+DY QQL +I  LLGSP+DSDLGFLRSDNAR+YVK LP VP+ PFSQKFP++SP+A+DL
Sbjct: 241 GRDYAQQLGLIIALLGSPEDSDLGFLRSDNARKYVKHLPRVPRHPFSQKFPDVSPLALDL 300

Query: 268 AERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILR 327
           AERMLVFDPAKRITVE+ALNHP+L SLHEINEEP C  PFNFDFEQ S++E+DIKELI  
Sbjct: 301 AERMLVFDPAKRITVEDALNHPFLISLHEINEEPVCDSPFNFDFEQASLSEDDIKELIWN 360

Query: 328 ECLNFHPDHM 337
           E L F P+ M
Sbjct: 361 EALKFDPNTM 370

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	339
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.572	0.534	0.788	3.4e-141
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.566	0.510	0.817	9.5e-135
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.569	0.523	0.777	7.9e-129
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.566	0.510	0.776	9.1e-126
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.578	0.496	0.765	7.2e-124
TAIR|locus:2062897	372	MPK12 "mitogen-activated prote	0.560	0.510	0.721	8.4e-121
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.587	0.537	0.684	5.9e-118
TAIR|locus:2080457	393	MPK10 "MAP kinase 10" [Arabido	0.578	0.498	0.645	3.1e-108
TAIR|locus:2012808	370	MPK1 "mitogen-activated protei	0.575	0.527	0.643	1.4e-95
TAIR|locus:2202892	376	MPK2 "mitogen-activated protei	0.539	0.486	0.682	2.1e-94

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 845 (302.5 bits), Expect = 3.4e-141, Sum P(2) = 3.4e-141
 Identities = 153/194 (78%), Positives = 174/194 (89%)

Query:     9 KDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI 68
             +D GI  Y G+YV YN+LGN+F++SSKY+PP++PIGRGAYGIVC A NSET EEVAIKKI
Sbjct:     5 EDGGILTYDGRYVMYNVLGNIFELSSKYIPPIEPIGRGAYGIVCCATNSETNEEVAIKKI 64

Query:    69 TNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQI 128
              NAFDNR+DAKR LREIKLL HM H+N++K+KDII   +KE+F DVYIVYELMDTDLHQI
Sbjct:    65 ANAFDNRVDAKRTLREIKLLSHMDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQI 124

Query:   129 IRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 188
             IRS Q LTDDHCQYFLYQ+LRGLKYIHSANVLHRDLKPSNL+LN NCDLKICDFGLART+
Sbjct:   125 IRSTQTLTDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTS 184

Query:   189 SETDFMTEYVVTRW 202
             +ET+ MTEYVVTRW
Sbjct:   185 NETEIMTEYVVTRW 198

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 838 (300.0 bits), Expect = 9.5e-135, Sum P(2) = 9.5e-135
 Identities = 157/192 (81%), Positives = 171/192 (89%)

Query:    11 RGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITN 70
             +G+  +GG YVQYN+ GNLF+VS KYVPPL+PIGRGAYGIVC+A NSET EEVAIKKI N
Sbjct:    17 KGVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAATNSETGEEVAIKKIGN 76

Query:    71 AFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIR 130
             AFDN IDAKR LREIKLL HM HEN++ VKDII P  +E FNDVYIVYELMDTDLHQIIR
Sbjct:    77 AFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIR 136

Query:   131 SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
             S Q LTDDHC++FLYQLLRGLKY+HSANVLHRDLKPSNLLLNANCDLK+ DFGLART SE
Sbjct:   137 SNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTKSE 196

Query:   191 TDFMTEYVVTRW 202
             TDFMTEYVVTRW
Sbjct:   197 TDFMTEYVVTRW 208

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 788 (282.4 bits), Expect = 7.9e-129, Sum P(2) = 7.9e-129
 Identities = 150/193 (77%), Positives = 167/193 (86%)

Query:    10 DRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKIT 69
             +RG+ + GG+YVQYN+ GNLF+VS KYVPPL+PIGRGA GIVC+A NSET EEVAIKKI 
Sbjct:    13 NRGVSINGGRYVQYNVYGNLFEVSKKYVPPLRPIGRGASGIVCAAWNSETGEEVAIKKIG 72

Query:    70 NAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQII 129
             NAF N IDAKR LREIKLL HM H+N++ + DII P   + FNDV+IVYELMDTDLH II
Sbjct:    73 NAFGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHII 132

Query:   130 RSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
             RS Q LTDDH ++FLYQLLRGLKY+HSANVLHRDLKPSNLLLNANCDLKI DFGLART S
Sbjct:   133 RSNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTKS 192

Query:   190 ETDFMTEYVVTRW 202
             ETDFMTEYVVTRW
Sbjct:   193 ETDFMTEYVVTRW 205

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 815 (292.0 bits), Expect = 9.1e-126, Sum P(2) = 9.1e-126
 Identities = 149/192 (77%), Positives = 173/192 (90%)

Query:    11 RGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITN 70
             +G+ ++GG+Y QYN+ GNLF+VS+KYVPP++PIGRGAYG VC+AV+SET EE+AIKKI  
Sbjct:    17 KGVLVHGGRYFQYNVYGNLFEVSNKYVPPIRPIGRGAYGFVCAAVDSETHEEIAIKKIGK 76

Query:    71 AFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIR 130
             AFDN++DAKR LREIKLL H+ HEN+V +KDII P  KE F DVYIV+ELMDTDLHQIIR
Sbjct:    77 AFDNKVDAKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFVDVYIVFELMDTDLHQIIR 136

Query:   131 SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
             S Q+L DDHCQYFLYQ+LRGLKYIHSANVLHRDLKPSNLLLN+NCDLKI DFGLARTTSE
Sbjct:   137 SNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSNCDLKITDFGLARTTSE 196

Query:   191 TDFMTEYVVTRW 202
             T++MTEYVVTRW
Sbjct:   197 TEYMTEYVVTRW 208

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 825 (295.5 bits), Expect = 7.2e-124, Sum P(2) = 7.2e-124
 Identities = 153/200 (76%), Positives = 174/200 (87%)

Query:    16 YGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR 75
             +GG+++QYNI GN+F+V++KY PP+ PIG+GAYGIVCSA+NSET E VAIKKI NAFDN+
Sbjct:    42 HGGRFIQYNIFGNIFEVTAKYKPPIMPIGKGAYGIVCSAMNSETNESVAIKKIANAFDNK 101

Query:    76 IDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQAL 135
             IDAKR LREIKLL HM HENIV ++DIIPP  +  FNDVYI YELMDTDLHQIIRS QAL
Sbjct:   102 IDAKRTLREIKLLRHMDHENIVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQIIRSNQAL 161

Query:   136 TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
             +++HCQYFLYQ+LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR TSE+DFMT
Sbjct:   162 SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSESDFMT 221

Query:   196 EYVVTRW----DTLFPGKDY 211
             EYVVTRW    + L    DY
Sbjct:   222 EYVVTRWYRAPELLLNSSDY 241

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2062897 MPK12 "mitogen-activated protein kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 744 (267.0 bits), Expect = 8.4e-121, Sum P(2) = 8.4e-121
 Identities = 137/190 (72%), Positives = 164/190 (86%)

Query:    13 IPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF 72
             +P +GG+YVQYN+ G LF+VS KYVPP++PIGRGA GIVC+AVNS T E+VAIKKI NAF
Sbjct:    17 VPTHGGRYVQYNVYGQLFEVSRKYVPPIRPIGRGACGIVCAAVNSVTGEKVAIKKIGNAF 76

Query:    73 DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK 132
             DN IDAKR LREIKLL HM HEN++ +KDI+ P  ++ FNDVYIVYELMDTDL +I+RS 
Sbjct:    77 DNIIDAKRTLREIKLLRHMDHENVITIKDIVRPPQRDIFNDVYIVYELMDTDLQRILRSN 136

Query:   133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
             Q LT D C++ +YQLLRGLKY+HSAN+LHRDL+PSN+LLN+  +LKI DFGLARTTS+TD
Sbjct:   137 QTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNVLLNSKNELKIGDFGLARTTSDTD 196

Query:   193 FMTEYVVTRW 202
             FMTEYVVTRW
Sbjct:   197 FMTEYVVTRW 206

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

GO:0007243 "intracellular protein kinase cascade" evidence=IC

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0080026 "response to indolebutyric acid stimulus" evidence=IMP

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 764 (274.0 bits), Expect = 5.9e-118, Sum P(2) = 5.9e-118
 Identities = 139/203 (68%), Positives = 171/203 (84%)

Query:    13 IPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF 72
             +  +GG+++ Y+I G+LF+++SKY PP+ PIGRGAYGIVCS +++ET E VA+KKI NAF
Sbjct:    14 VETHGGQFISYDIFGSLFEITSKYRPPIIPIGRGAYGIVCSVLDTETNELVAMKKIANAF 73

Query:    73 DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK 132
             DN +DAKR LREIKLL H+ HENI+ ++D++PP  + +F+DVYI  ELMDTDLHQIIRS 
Sbjct:    74 DNHMDAKRTLREIKLLRHLDHENIIAIRDVVPPPLRRQFSDVYISTELMDTDLHQIIRSN 133

Query:   133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
             Q+L+++HCQYFLYQLLRGLKYIHSAN++HRDLKPSNLLLNANCDLKICDFGLAR TSE D
Sbjct:   134 QSLSEEHCQYFLYQLLRGLKYIHSANIIHRDLKPSNLLLNANCDLKICDFGLARPTSEND 193

Query:   193 FMTEYVVTRW----DTLFPGKDY 211
             FMTEYVVTRW    + L    DY
Sbjct:   194 FMTEYVVTRWYRAPELLLNSSDY 216

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2080457 MPK10 "MAP kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 690 (248.0 bits), Expect = 3.1e-108, Sum P(2) = 3.1e-108
 Identities = 129/200 (64%), Positives = 159/200 (79%)

Query:    16 YGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR 75
             + G+Y+QYN+ G++F++ +KY PP++PIGRGA GIVCSAV+SET E+VAIKKIT  FDN 
Sbjct:    39 HDGRYIQYNLFGHIFELPAKYKPPIRPIGRGACGIVCSAVDSETNEKVAIKKITQVFDNT 98

Query:    76 IDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQAL 135
             I+AKR LREIKLL H  HENIV ++D+I P  ++ F DVYIV ELM+ DL++ ++S Q L
Sbjct:    99 IEAKRTLREIKLLRHFDHENIVAIRDVILPPQRDSFEDVYIVNELMEFDLYRTLKSDQEL 158

Query:   136 TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
             T DH  YF+YQ+LRGLKYIHSANVLHRDLKPSNLLL+  CDLKICDFGLAR T E++ MT
Sbjct:   159 TKDHGMYFMYQILRGLKYIHSANVLHRDLKPSNLLLSTQCDLKICDFGLARATPESNLMT 218

Query:   196 EYVVTRW----DTLFPGKDY 211
             EYVVTRW    + L    DY
Sbjct:   219 EYVVTRWYRAPELLLGSSDY 238

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2012808 MPK1 "mitogen-activated protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 686 (246.5 bits), Expect = 1.4e-95, Sum P(2) = 1.4e-95
 Identities = 128/199 (64%), Positives = 163/199 (81%)

Query:     5 SMVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVA 64
             ++V    GI   G  Y  +++   LF++ +KY+P ++PIGRGAYG+VCS+VNS+T E+VA
Sbjct:     3 TLVDPPNGIRNEGKHY--FSMWQTLFEIDTKYMP-IKPIGRGAYGVVCSSVNSDTNEKVA 59

Query:    65 IKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTD 124
             IKKI N ++NRIDA R LRE+KLL H+ HEN++ +KD++ P+ K  F DVY+VYELMDTD
Sbjct:    60 IKKIHNVYENRIDALRTLRELKLLRHLRHENVIALKDVMMPIHKMSFKDVYLVYELMDTD 119

Query:   125 LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 184
             LHQII+S Q L++DHCQYFL+QLLRGLKYIHSAN+LHRDLKP NLL+NANCDLKICDFGL
Sbjct:   120 LHQIIKSSQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKICDFGL 179

Query:   185 ARTTS-ETDFMTEYVVTRW 202
             AR ++ +  FMTEYVVTRW
Sbjct:   180 ARASNTKGQFMTEYVVTRW 198

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006635 "fatty acid beta-oxidation" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0008219 "cell death" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009755 "hormone-mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0016558 "protein import into peroxisome matrix" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0009734 "auxin mediated signaling pathway" evidence=TAS

TAIR|locus:2202892 MPK2 "mitogen-activated protein kinase homolog 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 681 (244.8 bits), Expect = 2.1e-94, Sum P(2) = 2.1e-94
 Identities = 127/186 (68%), Positives = 156/186 (83%)

Query:    18 GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID 77
             GK+  +++   LF++ +KYVP ++PIGRGAYG+VCS+VN E+ E VAIKKI N F+NRID
Sbjct:    15 GKHY-FSMWQTLFEIDTKYVP-IKPIGRGAYGVVCSSVNRESNERVAIKKIHNVFENRID 72

Query:    78 AKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD 137
             A R LRE+KLL H+ HEN+V +KD++    K  F DVY+VYELMDTDLHQII+S Q L++
Sbjct:    73 ALRTLRELKLLRHLRHENVVALKDVMMANHKRSFKDVYLVYELMDTDLHQIIKSSQVLSN 132

Query:   138 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTE 196
             DHCQYFL+QLLRGLKYIHSAN+LHRDLKP NLL+NANCDLKICDFGLART++ +  FMTE
Sbjct:   133 DHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNTKGQFMTE 192

Query:   197 YVVTRW 202
             YVVTRW
Sbjct:   193 YVVTRW 198

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000902 "cell morphogenesis" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0048193 "Golgi vesicle transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q336X9	MPK6_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.6946	0.9587	0.8643	yes	no
Q40884	MAPK_PETHY	2, ., 7, ., 1, 1, ., 2, 4	0.5406	0.9439	0.8333	N/A	no
Q9LQQ9	MPK13_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.7134	0.9557	0.8925	yes	no
P46196	MK01_BOVIN	2, ., 7, ., 1, 1, ., 2, 4	0.4626	0.9115	0.8583	yes	no
Q06060	MAPK_PEA	2, ., 7, ., 1, 1, ., 2, 4	0.6345	0.9439	0.8121	N/A	no
Q40531	NTF6_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7189	0.9941	0.9083	N/A	no
P28482	MK01_HUMAN	2, ., 7, ., 1, 1, ., 2, 4	0.4626	0.9115	0.8583	yes	no
Q40532	NTF4_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.6373	0.9439	0.8142	N/A	no
P0CP68	HOG1_CRYNJ	2, ., 7, ., 1, 1, ., 2, 4	0.4524	0.8997	0.8356	yes	no
Q40517	NTF3_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.5378	0.9439	0.8602	N/A	no
A2XFC8	MPK5_ORYSI	2, ., 7, ., 1, 1, ., 2, 4	0.5795	0.9439	0.8672	N/A	no
P63085	MK01_MOUSE	2, ., 7, ., 1, 1, ., 2, 4	0.4626	0.9115	0.8631	yes	no
Q07176	MMK1_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.6402	0.9439	0.8268	N/A	no
P63086	MK01_RAT	2, ., 7, ., 1, 1, ., 2, 4	0.4626	0.9115	0.8631	yes	no
Q40353	MMK2_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.6730	0.9882	0.9029	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.979
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	GSVIVG00024447001	SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (371 aa)
		(Vitis vinifera)
Predicted Functional Partners:
	GSVIVG00016514001	SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (354 aa)			•			•		•	0.811
	GSVIVG00016645001	SubName- Full=Putative uncharacterized protein (Chromosome chr11 scaffold_13, whole genome shot [...] (354 aa)			•			•		•	0.810

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	339
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.0
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-173
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-142
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-133
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-124
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-124
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-123
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-103
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-101
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-94
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-92
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-92
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-92
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-90
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-89
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-83
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-75
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-71
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-68
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-68
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-64
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-63
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-63
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-63
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-62
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-62
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-62
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-55
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-53
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-52
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-51
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-51
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-49
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-48
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-47
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-46
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-46
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-44
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-43
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-43
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-42
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-42
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-41
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-41
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-41
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-40
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-38
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-37
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-36
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-35
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-34
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-34
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-34
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-33
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-33
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-33
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-30
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-30
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-27
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-25
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-24
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-24
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-09
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	3e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-04
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	4e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	0.001
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.001
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	0.001
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.001
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	0.002

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  580 bits (1497), Expect = 0.0
 Identities = 229/338 (67%), Positives = 264/338 (78%), Gaps = 34/338 (10%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           F+V +KYVP   PIGRGAYGIVCSA NSET E+VAIKKI NAFDNRIDAKR LREIKLL 
Sbjct: 1   FEVDTKYVPIK-PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR 59

Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLR 149
           H+ HEN++ +KDI+PP  +E FNDVYIVYELMDTDLHQIIRS Q L+DDHCQYFLYQLLR
Sbjct: 60  HLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR 119

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET-DFMTEYVVTRW------ 202
           GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  DFMTEYVVTRW      
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179

Query: 203 --------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD 236
                                       LFPGKDYV QL +ITELLGSP + DLGF+R++
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239

Query: 237 NARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
            ARRY++ LP+ P+Q F++ FP+ +P+AIDL E+MLVFDP+KRITVEEAL HPYL+SLH+
Sbjct: 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299

Query: 297 INEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
            ++EP C  PF+FDFE+ ++ EEDIKELI  E L +HP
Sbjct: 300 PSDEPVCQTPFSFDFEEDALTEEDIKELIYNEMLAYHP 337

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  483 bits (1246), Expect = e-173
 Identities = 186/327 (56%), Positives = 228/327 (69%), Gaps = 37/327 (11%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
            L+PIG GAYG+VCSAV+  T  +VAIKKI+N FD+ IDAKRILREIKLL H+ HENI+ 
Sbjct: 4   LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIG 63

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           + DI+ P   E FNDVYIV ELM+TDLH++I+S Q LTDDH QYFLYQ+LRGLKY+HSAN
Sbjct: 64  LLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN 123

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVTRW------------ 202
           V+HRDLKPSN+L+N+NCDLKICDFGLAR       E  F+TEYVVTRW            
Sbjct: 124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR 183

Query: 203 -----D---------------TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV 242
                D                LFPG+DY+ QL +I E+LG+P + DL F+ S+ AR Y+
Sbjct: 184 YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYL 243

Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
           K LP  PK+P S+ FP  SP AIDL E+MLVFDP KRIT +EAL HPYL+ LH+  +EP 
Sbjct: 244 KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPV 303

Query: 303 CPYPFNF-DFEQTSMNEEDIKELILRE 328
              PF+F  F+   + EE++KELI  E
Sbjct: 304 AKPPFDFDFFDDDELTEEELKELIYEE 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  406 bits (1046), Expect = e-142
 Identities = 173/336 (51%), Positives = 214/336 (63%), Gaps = 40/336 (11%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           F V  +Y   L  IG GAYG+VCSA +  T  +VAIKKI+  F+++   +R LREIK+L 
Sbjct: 1   FDVGPRYQN-LSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILR 58

Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLR 149
              HENI+ + DII P   E FNDVYIV ELM+TDL+++I++ Q L++DH QYFLYQ+LR
Sbjct: 59  RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILR 117

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----TDFMTEYVVTRW--- 202
           GLKYIHSANVLHRDLKPSNLLLN NCDLKICDFGLAR        T F+TEYV TRW   
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 203 -----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFL 233
                                          LFPGKDY+ QL +I  +LG+P   DL  +
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237

Query: 234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
            S  AR Y+K LP  PK P+++ FPN  P A+DL ++ML F+P KRITVEEAL HPYL  
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297

Query: 294 LHEINEEPTCPYPFNFDFEQT-SMNEEDIKELILRE 328
            H+ ++EP    PF FDFE    + +E +KELI  E
Sbjct: 298 YHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEE 333

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  381 bits (981), Expect = e-133
 Identities = 166/336 (49%), Positives = 226/336 (67%), Gaps = 39/336 (11%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           F V S+Y  P++ IG GAYG+VCSA+++ + ++VAIKKI +AFD    AKR LRE+K+L 
Sbjct: 1   FDVGSRY-KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILR 59

Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLR 149
           H  H+NI+ ++DI+ P   + F DVY+V +LM++DLH II S Q LT++H +YFLYQLLR
Sbjct: 60  HFKHDNIIAIRDILRPPGAD-FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLR 118

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSETD---FMTEYVVTRW-- 202
           GLKYIHSANV+HRDLKPSNLL+N +C+L+I DFG+AR  ++S T+   FMTEYV TRW  
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 203 ------------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGF 232
                                           LFPGK+YV QL +I  +LGSP +  L  
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238

Query: 233 LRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
           + SD  R+Y++ LP     P+S+ FP  SP A+DL  +ML FDP +RITVE+AL HP+L+
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298

Query: 293 SLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRE 328
             H+ ++EPTCP PF+FDFE   ++ E +KE I++E
Sbjct: 299 QYHDPDDEPTCPPPFDFDFEAIELSREQLKEAIVKE 334

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  360 bits (925), Expect = e-124
 Identities = 151/348 (43%), Positives = 214/348 (61%), Gaps = 38/348 (10%)

Query: 20  YVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK 79
           + +  +   +++V  +Y   L P+G GAYG VCSA +++T  +VAIKK++  F + I AK
Sbjct: 1   FYRQELNKTVWEVPDRYQN-LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK 59

Query: 80  RILREIKLLCHMTHENIVKVKDII-PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDD 138
           R  RE++LL HM HEN++ + D+  P    E F DVY+V  LM  DL+ I++  Q L+DD
Sbjct: 60  RTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDD 118

Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYV 198
           H Q+ +YQ+LRGLKYIHSA ++HRDLKPSN+ +N +C+LKI DFGLAR T +   MT YV
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYV 176

Query: 199 VTRW--------------------------------DTLFPGKDYVQQLTMITELLGSPD 226
            TRW                                 TLFPG D++ QL  I  L+G+PD
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236

Query: 227 DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEAL 286
           +  L  + S++AR Y++ LP +PK+ F + F   +P+AIDL E+MLV DP KRIT  EAL
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296

Query: 287 NHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
            HPYL+  H+  +EP  P P++  FE   +  ++ KEL+ +E +NF P
Sbjct: 297 AHPYLAEYHDPEDEPVAP-PYDQSFESRDLTVDEWKELVYKEIMNFKP 343

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  358 bits (920), Expect = e-124
 Identities = 170/332 (51%), Positives = 218/332 (65%), Gaps = 48/332 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHM-THENI 96
           ++ +G+GAYGIVCSA N+ET EE  VAIKKITN F  +I AKR LRE+KLL H   H+NI
Sbjct: 5   IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI 64

Query: 97  VKV--KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
             +   DI+ P     FN++Y+  ELM+ DLHQIIRS Q LTD H Q F+YQ+L GLKYI
Sbjct: 65  TCLYDMDIVFP---GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-----TDFMTEYVVTRW------- 202
           HSANVLHRDLKP NLL+NA+C+LKICDFGLAR  SE       FMTEYV TRW       
Sbjct: 122 HSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181

Query: 203 -------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN 237
                                      +F GKDYV QL  I ++LG+PD+  L  + S  
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK 241

Query: 238 ARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI 297
           A+ Y++ LP++PK+PF   FPN +P+A+DL E++L FDP KRI+VEEAL HPYL+  H+ 
Sbjct: 242 AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301

Query: 298 NEEPTCPYPFNFDFE-QTSMNEEDIKELILRE 328
           ++EP C  PF+F FE + SM E  ++++I+ E
Sbjct: 302 DDEPVCQKPFDFSFESEDSMEE--LRDMIIEE 331

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  356 bits (915), Expect = e-123
 Identities = 156/334 (46%), Positives = 211/334 (63%), Gaps = 39/334 (11%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+G+YG+VCSA+++ T E+VAIKKI + F++  DA RILREIKLL  + H +IV++
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           K I+ P  + +F D+Y+V+ELM++DLHQ+I++   LT +H Q+FLYQLLR LKYIH+ANV
Sbjct: 65  KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANV 124

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLART----TSETDFMTEYVVTRW------------- 202
            HRDLKP N+L NA+C LKICDFGLAR     T    F T+YV TRW             
Sbjct: 125 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 184

Query: 203 --------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV 242
                                 LFPGK+ V QL +IT+LLG+P    +  +R++ ARRY+
Sbjct: 185 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYL 244

Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
             +      PFSQKFPN  P+A+ L ER+L FDP  R T EEAL  PY   L ++  EP+
Sbjct: 245 SSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPS 304

Query: 303 C-PYP-FNFDFEQTSMNEEDIKELILRECLNFHP 334
             P     F+FE+  + +ED++ELI RE L +HP
Sbjct: 305 AQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  307 bits (787), Expect = e-103
 Identities = 154/337 (45%), Positives = 203/337 (60%), Gaps = 42/337 (12%)

Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           I G +F+++++YV  LQP+G GA+G+VCSA +  T + VAIKKI   F   + AKR  RE
Sbjct: 1   IFGTVFEITNRYVD-LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE 59

Query: 85  IKLLCHMTHENIVKVKDI-IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYF 143
           +KLL H+ HENI+ + DI I P       D+Y V EL+ TDLH+++ S+  L     QYF
Sbjct: 60  LKLLKHLRHENIISLSDIFISP-----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYF 113

Query: 144 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR-- 201
           LYQ+LRGLKY+HSA V+HRDLKPSN+L+N NCDLKICDFGLAR       MT YV TR  
Sbjct: 114 LYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYY 171

Query: 202 ------------------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLG 231
                             W              LFPGKD+V Q ++IT+LLG+P D  + 
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231

Query: 232 FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            + S+N  R+V+ LP     PFS+KF N  P AIDL E+MLVFDP KRI+  EAL HPYL
Sbjct: 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Query: 292 SSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRE 328
           +  H+  +EP     F++ F    +  +  K ++  E
Sbjct: 292 APYHDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  301 bits (774), Expect = e-101
 Identities = 133/315 (42%), Positives = 184/315 (58%), Gaps = 44/315 (13%)

Query: 31  QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCH 90
            +  KY   LQ +G+GAYGIV  A++  TKE VA+KKI +AF N  DA+R  REI  L  
Sbjct: 4   HILRKY-EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE 62

Query: 91  MT-HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLR 149
           +  H NIVK+ ++I   +     D+Y+V+E M+TDLH +IR    L D H +Y +YQLL+
Sbjct: 63  LGDHPNIVKLLNVIKAEND---KDIYLVFEYMETDLHAVIR-ANILEDVHKRYIMYQLLK 118

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD------FMTEYVVTRW- 202
            LKYIHS NV+HRDLKPSN+LLN++C +K+ DFGLAR+ SE +       +T+YV TRW 
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178

Query: 203 ----------------DT---------------LFPGKDYVQQLTMITELLGSPDDSDLG 231
                           D                LFPG   + QL  I E++G P   D+ 
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238

Query: 232 FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            ++S  A   +  LP  P++P  +  P  S  A+DL +++LVF+P KR+T EEAL HPY+
Sbjct: 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298

Query: 292 SSLHEINEEPTCPYP 306
           +  H  ++EP  PYP
Sbjct: 299 AQFHNPSDEPVLPYP 313

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  283 bits (724), Expect = 4e-94
 Identities = 140/328 (42%), Positives = 196/328 (59%), Gaps = 37/328 (11%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L P+G GAYG VCSA ++  +++VA+KK++  F + I A+R  RE++LL HM HEN++ +
Sbjct: 20  LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL 79

Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D+  P    E FN+VY+V  LM  DL+ I++  Q L+D+H Q+ +YQLLRGLKYIHSA 
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG 138

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+ +N +C+L+I DFGLAR     D MT YV TRW                
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEMTGYVATRWYRAPEIMLNWMHYNQT 196

Query: 203 ----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP 246
                             LFPG DY+ QL  I E++G+P    L  + S++AR+Y++ LP
Sbjct: 197 VDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLP 256

Query: 247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYP 306
           H+P+Q   + F   +P+AIDL E+MLV D  KRI+  EAL HPY S  H+  +EP    P
Sbjct: 257 HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAE-P 315

Query: 307 FNFDFEQTSMNEEDIKELILRECLNFHP 334
           ++   E      E+ KEL   E  +F P
Sbjct: 316 YDESPENKERTIEEWKELTYEEVSSFKP 343

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  276 bits (708), Expect = 3e-92
 Identities = 118/286 (41%), Positives = 150/286 (52%), Gaps = 40/286 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  IG G YG+V  A +  T E VAIKKI   F++    K  LREIKLL  + H NI+K+
Sbjct: 4   LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSAN 158
            D+          D+Y+V+E MDTDL+++I+ +Q  L +   + +LYQLL+GL + HS  
Sbjct: 64  LDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW--------------- 202
           +LHRDLKP NLL+N    LK+ DFGLAR+  S     T YVVTRW               
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178

Query: 203 -----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL 245
                              LFPGK  + QL  I   LG+PD        S  AR Y    
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-LARNYKFSF 237

Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           P     P  + FPN SP A+DL  +ML +DP KRIT E+AL HPY 
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  278 bits (712), Expect = 3e-92
 Identities = 142/339 (41%), Positives = 204/339 (60%), Gaps = 38/339 (11%)

Query: 29  LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++LL
Sbjct: 12  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70

Query: 89  CHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQL 147
            HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ+
Sbjct: 71  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 129

Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW----- 202
           LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T +   MT YV TRW     
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPE 187

Query: 203 ---------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS 235
                                       TLFPG D++ QL +I  L+G+P    L  + S
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247

Query: 236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
           ++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  H
Sbjct: 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307

Query: 296 EINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           + ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 308 DPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 345

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  277 bits (711), Expect = 4e-92
 Identities = 136/339 (40%), Positives = 191/339 (56%), Gaps = 39/339 (11%)

Query: 29  LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++++  +Y   L+ +G GAYG VCSA++  T E+VAIKK++  F + I AKR  RE+ LL
Sbjct: 10  VWELPERYTS-LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLL 68

Query: 89  CHMTHENIVKVKDI-IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQL 147
            HM HEN++ + D+    +  ++F D Y+V   M TDL +I+     L++D  QY +YQ+
Sbjct: 69  KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP--LSEDKVQYLVYQM 126

Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW----- 202
           L GLKYIHSA ++HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRW     
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPE 184

Query: 203 ---------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS 235
                                       TLF GKDY+ QLT I ++ G P    +  L  
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244

Query: 236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
             A+ Y+K LP  P++ FS  FP  SP A+DL E+ML  D  KR+T  EAL HPY  S  
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304

Query: 296 EINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           + +EE     P++   E   ++ ++ K+ I +E  +F P
Sbjct: 305 DADEETE-QQPYDDSLENEKLSVDEWKKHIYKEVKSFSP 342

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  274 bits (702), Expect = 3e-90
 Identities = 129/348 (37%), Positives = 186/348 (53%), Gaps = 59/348 (16%)

Query: 37  VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
           V P +PIG GA+G+V S  +    + VA+KK+ N F N +  KR+ RE+K+LC   H+N+
Sbjct: 2   VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           +   DI+ P   + F ++Y+V ELM +DLH+II S Q L+ DH + FLYQ+LRGLKY+HS
Sbjct: 62  LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--ETDFMTEYVVTR------------- 201
           A +LHRD+KP NLL+N+NC LKICDFGLAR     E+  MT+ VVT+             
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH 181

Query: 202 -------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV 242
                  W              LF  +  +QQL +IT+LLG+P    +       AR ++
Sbjct: 182 YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GARAHI 240

Query: 243 KQLPHVPKQPFSQKFPNMSPV---AIDLAERMLVFDPAKRITVEEALNHPYL-------- 291
            + PH P       +   S     A+ L  RMLVFDP KRI+  +AL HPYL        
Sbjct: 241 LRGPHKPPS-LPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYH 299

Query: 292 ------------SSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILR 327
                         ++  + EP+   PF+ ++E+   +   +KE + +
Sbjct: 300 TCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQ 347

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  270 bits (692), Expect = 4e-89
 Identities = 132/348 (37%), Positives = 202/348 (58%), Gaps = 38/348 (10%)

Query: 20  YVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK 79
           Y +  +   +++V  +Y   L+ +G GAYG VCSA++  T  +VAIKK+   F + + AK
Sbjct: 1   YYRQEVNKTIWEVPDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK 59

Query: 80  RILREIKLLCHMTHENIVKVKDIIPP-MDKEKFNDVYIVYELMDTDLHQIIRSKQALTDD 138
           R  RE++LL HM HEN++ + D+  P +  ++F+D Y+V   M TDL ++++ ++ L++D
Sbjct: 60  RAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK-LSED 118

Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYV 198
             Q+ +YQ+L+GLKYIH+A ++HRDLKP NL +N +C+LKI DFGLAR T     MT YV
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYV 176

Query: 199 VTRW--------------------------------DTLFPGKDYVQQLTMITELLGSPD 226
           VTRW                                  LF G D++ QL  I ++ G+P 
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236

Query: 227 DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEAL 286
              +  L+S++A+ YVK+LP   K+ F    PN +P+A+++ E+MLV D   RIT  EAL
Sbjct: 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296

Query: 287 NHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
            HPY    H+  +E   P P++  F++   + E+ K L   E L+F P
Sbjct: 297 AHPYFEEFHDPEDETEAP-PYDDSFDEVDQSLEEWKRLTFTEILSFQP 343

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  256 bits (657), Expect = 1e-83
 Identities = 131/347 (37%), Positives = 187/347 (53%), Gaps = 54/347 (15%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           F V  +Y   L+PIG GA GIVC+A ++ T + VAIKK++  F N   AKR  RE+ L+ 
Sbjct: 12  FTVLKRYQN-LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK 70

Query: 90  HMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL 148
            + H+NI+ + ++  P    E+F DVY+V ELMD +L Q+I  +  L  +   Y LYQ+L
Sbjct: 71  LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQML 128

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR------- 201
            G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR       
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 188

Query: 202 ------------WD------------TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN 237
                       W              LFPG D++ Q   I E LG+P D  +  L+   
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP-T 247

Query: 238 ARRYVKQLPHVPKQPFSQKFP-------------NMSPVAIDLAERMLVFDPAKRITVEE 284
            R YV+  P      F + FP               +  A DL  +MLV DP KRI+V++
Sbjct: 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307

Query: 285 ALNHPYLSSLH---EINEEPTCPYPFNFDFEQTSMNEEDIKELILRE 328
           AL HPY++  +   E+   P  PY  + D  + ++  E+ KELI +E
Sbjct: 308 ALQHPYINVWYDPSEVEAPPPAPYDHSIDEREHTV--EEWKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  232 bits (594), Expect = 5e-75
 Identities = 103/293 (35%), Positives = 144/293 (49%), Gaps = 55/293 (18%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR------ILREIKLLCHMTH 93
           L+ +G G YG+V  A + +T E VA+KKI      R+D +        LREI LL  + H
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKI------RLDNEEEGIPSTALREISLLKELKH 57

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLK 152
            NIVK+ D+I    K     +Y+V+E  D DL + +  +   L+ +  +  +YQLLRGL 
Sbjct: 58  PNIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW--------- 202
           Y HS  +LHRDLKP N+L+N +  LK+ DFGLAR         T  VVT W         
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLG 172

Query: 203 ----DT-------------------LFPGKDYVQQLTMITELLGSPDDSD-LGFLRSDNA 238
                T                   LFPG   + QL  I ++LG+P +    G  +  + 
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD- 231

Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             Y    P  P +   +  P + P  IDL  +ML ++PAKRI+ +EAL HPY 
Sbjct: 232 --YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  222 bits (568), Expect = 2e-71
 Identities = 94/271 (34%), Positives = 142/271 (52%), Gaps = 39/271 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G G++G V  A + +T + VAIK I      + D +RILREIK+L  + H NIV++
Sbjct: 4   LEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK-DRERILREIKILKKLKHPNIVRL 62

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D+      E  + +Y+V E  +  DL  +++ +  L++D  +++L Q+L  L+Y+HS  
Sbjct: 63  YDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMI 218
           ++HRDLKP N+LL+ +  +K+ DFGLAR     + +T +V T          Y     M 
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE--------Y-----MA 164

Query: 219 TE-LLGSPDD--SD---LG------------FLRSDNARRYVKQLPHVPKQPFSQKFPNM 260
            E LLG       D   LG            F   D      K++   PK PF     ++
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK-PKPPFPPPEWDI 223

Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           SP A DL  ++LV DP KR+T EEAL HP+ 
Sbjct: 224 SPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  217 bits (554), Expect = 2e-68
 Identities = 118/347 (34%), Positives = 182/347 (52%), Gaps = 52/347 (14%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           F + S+Y+  L+P+G G+ G+V SAV+S+  + VA+KKI     +    K  LREIK++ 
Sbjct: 1   FDLGSRYMD-LRPLGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIR 57

Query: 90  HMTHENIVKVKDIIPPM---------DKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHC 140
            + H+NIVKV +++ P             + N VYIV E M+TDL  ++  +  L+++H 
Sbjct: 58  RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL-EQGPLSEEHA 116

Query: 141 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARTT----SETDFMT 195
           + F+YQLLRGLKYIHSANVLHRDLKP+N+ +N  +  LKI DFGLAR      S   +++
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 196 EYVVTRW--------------------------------DTLFPGKDYVQQLTMITELLG 223
           E +VT+W                                  LF G   ++Q+ +I E + 
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236

Query: 224 SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVE 283
              + D   L +     +V+     P++P     P ++P A+D  E++L F+P  R+T E
Sbjct: 237 VVREEDRNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295

Query: 284 EALNHPYLSSLHEINEEPTCPYPFNFDFE-QTSMNEEDIKELILREC 329
           EAL HPY+S      +EP   +PF+ + E    +   +I  +I    
Sbjct: 296 EALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSIIYNWD 342

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  215 bits (549), Expect = 3e-68
 Identities = 98/298 (32%), Positives = 148/298 (49%), Gaps = 68/298 (22%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR------ILREIKLLCHMTHENI 96
           IG G YG V  A N +T E VA+KKI      R++ ++       +REIKLL  + H NI
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI------RMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIH 155
           V++K+I   +  +    +Y+V+E MD DL  ++ S +   T+   + ++ QLL GL+Y+H
Sbjct: 61  VRLKEI---VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--ETDFMTEYVVTRW----------- 202
           S  +LHRD+K SN+L+N +  LK+ DFGLAR  +   +   T  V+T W           
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 203 ---------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRY 241
                                  +F G   ++QL  I EL GSP D +            
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW---------PG 228

Query: 242 VKQLPHV----PKQP----FSQKFPN-MSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
           V +LP      PK+P      + F + + P A+DL +++L  DP KRI+ ++AL H Y
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  207 bits (529), Expect = 2e-64
 Identities = 126/359 (35%), Positives = 189/359 (52%), Gaps = 49/359 (13%)

Query: 18  GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID 77
            ++    +  + F V  +Y   L+PIG GA GIVC+A ++     VA+KK++  F N+  
Sbjct: 5   SQFYSVQVADSTFTVLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 63

Query: 78  AKRILREIKLLCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALT 136
           AKR  RE+ LL  + H+NI+ + ++  P    E+F DVY+V ELMD +L Q+I  +  L 
Sbjct: 64  AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME--LD 121

Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE 196
            +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART      MT 
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181

Query: 197 YVVTRW-------------------------------DTLFPGKDYVQQLTMITELLGSP 225
           YVVTR+                                 +F G D++ Q   + E LG+P
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241

Query: 226 DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN------------MSPVAIDLAERMLV 273
               +  L+    R YV+  P  P   F + FP+             +  A DL  +MLV
Sbjct: 242 SAEFMNRLQ-PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLV 300

Query: 274 FDPAKRITVEEALNHPYLSSLHEINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
            DP KRI+V+EAL HPY++  ++  E E   P  ++   E+     E+ KELI +E ++
Sbjct: 301 IDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMD 359

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  205 bits (523), Expect = 1e-63
 Identities = 129/347 (37%), Positives = 189/347 (54%), Gaps = 49/347 (14%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           F V  +Y   L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+ 
Sbjct: 13  FTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 71

Query: 90  HMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL 148
            + H+NI+ + ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L
Sbjct: 72  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQML 129

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW------ 202
            G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR+      
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189

Query: 203 -------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN 237
                                      LFPG+DY+ Q   + E LG+P    +  L+   
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 248

Query: 238 ARRYVKQLPHVPKQPFSQKFPN------------MSPVAIDLAERMLVFDPAKRITVEEA 285
            R YV+  P      F + FP+             +  A DL  +MLV DPAKRI+V+EA
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308

Query: 286 LNHPYLSSLHEINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           L HPY++  ++  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 355

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  202 bits (517), Expect = 3e-63
 Identities = 104/289 (35%), Positives = 142/289 (49%), Gaps = 45/289 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRID--AKRILREIKLLCHMTHENIVKV 99
           +G G Y +V  A + ET   VAIKKI         D      LREIKLL  + H NI+ +
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSAN 158
            D+       K N + +V+E M+TDL ++I+ K   LT    + ++   LRGL+Y+HS  
Sbjct: 68  LDVFG----HKSN-INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTT-SETDFMTEYVVTRW--------------- 202
           +LHRDLKP+NLL+ ++  LK+ DFGLAR+  S    MT  VVTRW               
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGV 182

Query: 203 -----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL 245
                                PG   + QL  I E LG+P + +   + S     YV + 
Sbjct: 183 GVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP--DYV-EF 239

Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
              P  P  Q FP  S  A+DL +R+L  +P KRIT  +AL HPY S+ 
Sbjct: 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  200 bits (510), Expect = 7e-63
 Identities = 81/286 (28%), Positives = 130/286 (45%), Gaps = 63/286 (22%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G G++G V  A +  T + VA+K +    +     +   REI++L  ++H NIV++
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D       E  + +Y+V E  +  DL   +     L++D  +    Q+LRGL+Y+HS  
Sbjct: 64  IDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETD-FMTEYVVTRW--------------- 202
           ++HRDLKP N+LL+ N  +KI DFGLA+   ++   +T +V T W               
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 203 -----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL 245
                               F G++ + QL +I  +LG P + D                
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFD---------------- 222

Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                     K+ + S  A DL ++ L  DP+KR T EE L HP+ 
Sbjct: 223 --------EPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  200 bits (510), Expect = 2e-62
 Identities = 98/285 (34%), Positives = 148/285 (51%), Gaps = 43/285 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG GA+GIV  A + ET E VA+KK+           + LREIK L    H  +VK+ D+
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
            P       +   +V E M +DL +++R  ++ L +   + ++  LL+G+ Y+H+  ++H
Sbjct: 68  FP-----HGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH 122

Query: 162 RDLKPSNLLLNANCDLKICDFGLARTTSETD--FMTEYVVTRW----------------- 202
           RDLKP+NLL++A+  LKI DFGLAR  SE +    +  V TRW                 
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV 182

Query: 203 DT---------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK-QLP 246
           D                LFPG++ ++QL ++   LG+P++     L S     Y K   P
Sbjct: 183 DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS--LPDYNKITFP 240

Query: 247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                P  + FP+ SP A+DL + +LV+DP+KR++  EAL HPY 
Sbjct: 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  199 bits (509), Expect = 2e-62
 Identities = 100/294 (34%), Positives = 141/294 (47%), Gaps = 62/294 (21%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKD 101
           +G G +G V  A N ET E VAIKK+   F +  +    LRE+K L  +  H NIVK+K+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPNIVKLKE 65

Query: 102 IIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANV 159
           +     +E  +++Y V+E M+ +L+Q+++ ++    ++   +  +YQ+L+GL +IH    
Sbjct: 66  VF----REN-DELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------DT------ 204
            HRDLKP NLL++    +KI DFGLAR        T+YV TRW          T      
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPV 180

Query: 205 -----------------LFPGKDYVQQLTMITELLGSPDDSD----------LGFLRSDN 237
                            LFPG   + QL  I  +LG+P   D          LGF     
Sbjct: 181 DIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF----- 235

Query: 238 ARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                 + P        Q  PN SP AIDL + ML +DP KR T  +AL HPY 
Sbjct: 236 ------RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  201 bits (512), Expect = 7e-62
 Identities = 127/358 (35%), Positives = 192/358 (53%), Gaps = 49/358 (13%)

Query: 20  YVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK 79
           +    I  + F V  +Y   L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AK
Sbjct: 10  FYSVEIGDSTFTVLKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK 68

Query: 80  RILREIKLLCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDD 138
           R  RE+ L+  + H+NI+ + ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +
Sbjct: 69  RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHE 126

Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYV 198
              Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YV
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186

Query: 199 VTRW-------------------------------DTLFPGKDYVQQLTMITELLGSPDD 227
           VTR+                                 LFPG D++ Q   + E LG+P  
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246

Query: 228 SDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM------------SPVAIDLAERMLVFD 275
             +  L+    R YV+  P      F + FP++            +  A DL  +MLV D
Sbjct: 247 EFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305

Query: 276 PAKRITVEEALNHPYLSSLHEINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
            +KRI+V+EAL HPY++  ++ +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  182 bits (464), Expect = 2e-55
 Identities = 103/298 (34%), Positives = 142/298 (47%), Gaps = 62/298 (20%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI--LREIKLLCHMTHENIV 97
           L  I  G YG+V  A + +T E VA+KK+    +   +   I  LREI +L  + H NIV
Sbjct: 10  LNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHPNIV 67

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDTDLHQII-RSKQALTDDHCQYFLYQLLRGLKYIHS 156
            VK+++  +     + +Y+V E ++ DL  ++   KQ       +  + QLL G+ ++H 
Sbjct: 68  TVKEVV--VGS-NLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-TDFMTEYVVTRW------------- 202
             +LHRDLK SNLLLN    LKICDFGLAR         T+ VVT W             
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEY 184

Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDL-GFLRSDNARRYV 242
                                LFPGK  + QL  I +LLG+P +    GF          
Sbjct: 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF---------- 234

Query: 243 KQLPHV-----PKQPFSQ---KFPN--MSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
            +LP        K P++Q   KFP   +S    DL  R+L +DPAKRI+ E+AL HPY
Sbjct: 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  177 bits (451), Expect = 1e-53
 Identities = 90/285 (31%), Positives = 138/285 (48%), Gaps = 41/285 (14%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GAYG+V    N  T E VAIKK   + D+    K  LRE+K+L  + HENIV +K+ 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQII-RSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
                +     +Y+V+E ++  L +++  S   L  D  + +++QLL+ + Y HS N++H
Sbjct: 69  FRRKGR-----LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 162 RDLKPSNLLLNANCDLKICDFGLARTTSE--TDFMTEYVVTRW---------DT------ 204
           RD+KP N+L++ +  LK+CDFG AR         +T+YV TRW         DT      
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPV 183

Query: 205 -----------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
                            LFPG   + QL +I + LG    S      S+     V     
Sbjct: 184 DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEP 243

Query: 248 VPKQPFSQKFPN-MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
              +   +++P  +S  A+D  +  L  DP +R+T +E L HPY 
Sbjct: 244 SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  173 bits (442), Expect = 3e-52
 Identities = 88/291 (30%), Positives = 129/291 (44%), Gaps = 52/291 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR------ILREIKLLCHMT---H 93
           IG GAYG V  A +  T   VA+KK+      R+           LREI LL  +    H
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV------RVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIR--SKQALTDDHCQYFLYQLLRGL 151
            NIV++ D+      ++   + +V+E +D DL   +    K  L  +  +  + QLLRG+
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW--------- 202
            ++HS  ++HRDLKP N+L+ ++  +KI DFGLAR  S    +T  VVT W         
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ 180

Query: 203 ----------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARR 240
                                   LF G     QL  I +++G P + +       N   
Sbjct: 181 SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW----PRNVSL 236

Query: 241 YVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                P    + F    P +    +DL ++ML F+P KRI+  EAL HPY 
Sbjct: 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  171 bits (436), Expect = 2e-51
 Identities = 104/300 (34%), Positives = 144/300 (48%), Gaps = 68/300 (22%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR------ILREIKLLCHMTH 93
           ++ IG G YG+V  A +  T E VA+KKI      R++ +        +REI LL  + H
Sbjct: 4   VEKIGEGTYGVVYKARDKLTGEIVALKKI------RLETEDEGVPSTAIREISLLKELNH 57

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS--KQALTDDHCQYFLYQLLRGL 151
            NIV++ D++    + K   +Y+V+E +D DL + + S     L     + +LYQLL+G+
Sbjct: 58  PNIVRLLDVV--HSENK---LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF------MTEYVVTRW--- 202
            Y HS  VLHRDLKP NLL++    LK+ DFGLAR      F       T  VVT W   
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA-----FGVPVRTYTHEVVTLWYRA 167

Query: 203 --------------DT---------------LFPGKDYVQQLTMITELLGSPDDSDLGFL 233
                         D                LFPG   + QL  I   LG+PD+     +
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227

Query: 234 RS--DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            S  D    Y    P   +Q  S+  PN+    +DL  +MLV+DPAKRI+ + AL HPY 
Sbjct: 228 TSLPD----YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  171 bits (435), Expect = 5e-51
 Identities = 101/291 (34%), Positives = 147/291 (50%), Gaps = 50/291 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI--LREIKLLCHMTHENIV 97
           L  IG G YGIV  A ++ + E VA+KK+    DN  D   I  LREI LL ++ H NIV
Sbjct: 12  LNRIGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLRHPNIV 69

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHS 156
           ++K+++     +  + +++V E  + DL  ++ +     ++   +  + QLLRGL+Y+H 
Sbjct: 70  ELKEVVV---GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE 126

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF-MTEYVVTRW------------- 202
             ++HRDLK SNLLL     LKI DFGLART       MT  VVT W             
Sbjct: 127 NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186

Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDL-GFLRSDNARRYV 242
                                L PGK  ++QL +I +LLG+P++S   GF       ++ 
Sbjct: 187 TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF- 245

Query: 243 KQLPHVPKQPFS---QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
                +PKQP++    KFP +S   + L   +L++DP KR T EEAL   Y
Sbjct: 246 ----TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  164 bits (418), Expect = 8e-49
 Identities = 102/294 (34%), Positives = 138/294 (46%), Gaps = 58/294 (19%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG G YG V  A N ET E VA+K++    D+       LREI LL  + H+NIV++
Sbjct: 5   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDH-CQYFLYQLLRGLKYIHSAN 158
            D++    K     + +V+E  D DL +   S     D    + F++QLL+GL + HS N
Sbjct: 65  YDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLART--TSETDFMTEYVVTRW-------------D 203
           VLHRDLKP NLL+N N +LK+ DFGLAR        +  E VVT W              
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYS 178

Query: 204 T--------------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
           T                    LFPG D   QL  I  LLG+P         ++ +   V 
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP---------TEESWPGVS 229

Query: 244 QLPHVPKQP-------FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
           +LP     P            P ++    DL + +LV +P +RI+ EEAL HPY
Sbjct: 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  163 bits (413), Expect = 5e-48
 Identities = 97/293 (33%), Positives = 137/293 (46%), Gaps = 56/293 (19%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR-----ILREIKLLCHMTHE 94
           L+ +G G Y  V    N  T E VA+K+I       +DA+       +REI L+  + HE
Sbjct: 5   LEKLGEGTYATVYKGRNRTTGEIVALKEI------HLDAEEGTPSTAIREISLMKELKHE 58

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS---KQALTDDHCQYFLYQLLRGL 151
           NIV++ D+I   +K     + +V+E MD DL + + +   + AL  +  + F YQLL+G+
Sbjct: 59  NIVRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--TSETDFMTEYVVTRW------- 202
            + H   VLHRDLKP NLL+N   +LK+ DFGLAR        F  E VVT W       
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-VVTLWYRAPDVL 172

Query: 203 -------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN 237
                                      LFPG +   QL  I  ++G+P +S         
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP--GISQ 230

Query: 238 ARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
              Y    P  P Q   Q FP+  P+ IDL  R+L  +P  RI+  +AL HP+
Sbjct: 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  161 bits (408), Expect = 2e-47
 Identities = 98/292 (33%), Positives = 135/292 (46%), Gaps = 54/292 (18%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR------ILREIKLLCHMTH 93
           ++ IG G YG+V  A N  T E VA+KKI      R+D +        +REI LL  + H
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALKKI------RLDTETEGVPSTAIREISLLKELNH 58

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQI--IRSKQALTDDHCQYFLYQLLRGL 151
            NIVK+ D+I   +K     +Y+V+E +  DL +         +     + +L+QLL+GL
Sbjct: 59  PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW-------- 202
            + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W        
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173

Query: 203 ------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNA 238
                                     LFPG   + QL  I   LG+PD+     + S   
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--L 231

Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
             Y    P   +Q FS+  P +     DL  +ML +DP KRI+ + AL HP+
Sbjct: 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  158 bits (403), Expect = 1e-46
 Identities = 84/282 (29%), Positives = 140/282 (49%), Gaps = 41/282 (14%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKD 101
           IG G +  V  A + +T +  AIK +   F + ++    LREI+ L  ++ H NI+++ +
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 102 IIPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           ++   D+ K   + +V+ELMD +L+++I+  K+ L +   + ++YQLL+ L ++H   + 
Sbjct: 66  VL--FDR-KTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF 122

Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW------------------ 202
           HRD+KP N+L+  +  LK+ DFG  R        TEY+ TRW                  
Sbjct: 123 HRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMD 181

Query: 203 --------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHV 248
                           LFPG + + Q+  I ++LG+PD   L   R      Y    P  
Sbjct: 182 IWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY--NFPSK 239

Query: 249 PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
                 +  PN S   +DL +++L +DP +RIT ++AL HPY
Sbjct: 240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  157 bits (400), Expect = 9e-46
 Identities = 89/304 (29%), Positives = 132/304 (43%), Gaps = 57/304 (18%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI--LREIKLLCHMTHENI 96
            L  +G G +G V  A   +T   VA+KKI     N  D   I  LREIK+L  + H N+
Sbjct: 12  ILGKLGEGTFGEVYKARQIKTGRVVALKKILM--HNEKDGFPITALREIKILKKLKHPNV 69

Query: 97  VKVKDII---PPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLK 152
           V + D+    P   K K   VY+V   MD DL  ++ +    LT+   + ++ QLL G+ 
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN 129

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-------------TTSETDFMTEYVV 199
           Y+H  ++LHRD+K +N+L++    LKI DFGLAR                   + T  VV
Sbjct: 130 YLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY-TNLVV 188

Query: 200 TRW--------------------------------DTLFPGKDYVQQLTMITELLGSPDD 227
           TRW                                  +  GK  + QL +I +L G+P +
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248

Query: 228 SDL-GFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEAL 286
               G+              +       ++F  + P  +DL  ++L  DP KR+T  +AL
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRT--LEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306

Query: 287 NHPY 290
            HPY
Sbjct: 307 EHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  154 bits (391), Expect = 2e-44
 Identities = 102/341 (29%), Positives = 156/341 (45%), Gaps = 73/341 (21%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKR-------- 80
           F +S +Y+     +G G YG V  A ++ T + VAIKK+      N +   R        
Sbjct: 4   FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63

Query: 81  ---ILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD 137
               LRE+K++  + HENI+ + D+   ++ +  N   +V ++M +DL +++  K  LT+
Sbjct: 64  HFTTLRELKIMNEIKHENIMGLVDVY--VEGDFIN---LVMDIMASDLKKVVDRKIRLTE 118

Query: 138 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR----------- 186
              +  L Q+L GL  +H    +HRDL P+N+ +N+    KI DFGLAR           
Sbjct: 119 SQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 187 ----TTSETDFMTEYVVTRW--------------------------------DTLFPGKD 210
               T    + MT  VVT W                                  LFPG++
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238

Query: 211 YVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAER 270
            + QL  I ELLG+P++ +  + ++     Y +  P  PK      FPN S  AIDL + 
Sbjct: 239 EIDQLGRIFELLGTPNEDN--WPQAKKLPLYTEFTPRKPKD-LKTIFPNASDDAIDLLQS 295

Query: 271 MLVFDPAKRITVEEALNHPYLSSLHEINEEPTCP--YPFNF 309
           +L  +P +RI+ +EAL H Y  S    +  P  P   PFNF
Sbjct: 296 LLKLNPLERISAKEALKHEYFKS----DPLPCDPSQLPFNF 332

Length = 335

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  151 bits (383), Expect = 2e-43
 Identities = 96/291 (32%), Positives = 138/291 (47%), Gaps = 43/291 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A +  T E +A+KKI    ++       +REI LL  M H NIV++
Sbjct: 7   VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDH--CQYFLYQLLRGLKYIHSA 157
           +D++     EK   +Y+V+E +D DL + + S      +    + +LYQ+LRG+ Y HS 
Sbjct: 67  QDVV---HSEK--RLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121

Query: 158 NVLHRDLKPSNLLLNANCD-LKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
            VLHRDLKP NLL++   + LK+ DFGLAR         T  VVT W             
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181

Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + +L  I  +LG+P++     + S     Y  
Sbjct: 182 STPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS--LPDYKS 239

Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
             P  P +  +   P + P  +DL  +ML  DP+KRIT   AL H Y   L
Sbjct: 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290

Length = 294

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  150 bits (382), Expect = 2e-43
 Identities = 85/285 (29%), Positives = 138/285 (48%), Gaps = 39/285 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  IG G+YG+V    N ET + VAIKK   + D+ +  K  LREI++L  + H N+V +
Sbjct: 6   LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++     K K +   +V+E  D T L+++ ++ + + +   +  ++Q L+ + + H  N
Sbjct: 66  IEVF--RRKRKLH---LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFM-TEYVVTRW---------DT---- 204
            +HRD+KP N+L+     +K+CDFG AR  +      T+YV TRW         DT    
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP 180

Query: 205 -------------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL 245
                              L+PGK  V QL +I + LG           ++   + +   
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240

Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
               ++P   KFPN+S  A+   +  L  DP +R++ EE L HPY
Sbjct: 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  148 bits (375), Expect = 3e-42
 Identities = 102/300 (34%), Positives = 146/300 (48%), Gaps = 63/300 (21%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI--LREIKLLCHMTHENIVKVK 100
           IG G YG V  A + +T E VA+KK+    DN  +   I  +REIK+L  + H NIV +K
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 101 DII----PPMD--KEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKY 153
           +I+      +D  K+K    Y+V+E MD DL  ++ S     ++DH + F+ QLL GL Y
Sbjct: 73  EIVTDKQDALDFKKDKGA-FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNY 131

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSETDFMTEYVVTRW--------- 202
            H  N LHRD+K SN+LLN    +K+ DFGLAR   + E+   T  V+T W         
Sbjct: 132 CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG 191

Query: 203 -----------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNAR 239
                                    +F     + QL +I+ L GSP  +           
Sbjct: 192 EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA---------VW 242

Query: 240 RYVKQLPHV----PKQPFSQK----FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             V +LP+     PK+ + ++    F  +   A+DL + ML  DP+KR T EEALN P+L
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  147 bits (373), Expect = 4e-42
 Identities = 94/292 (32%), Positives = 138/292 (47%), Gaps = 45/292 (15%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN-IVK 98
           L+ IG G YG V  A +  T + VA+KK     D        LREI LL  ++    IV+
Sbjct: 6   LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVR 65

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-----QALTDDHCQYFLYQLLRGLKY 153
           + D+    +K     +Y+V+E +D+DL + + S      + L     + F+YQLL+G+ +
Sbjct: 66  LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 154 IHSANVLHRDLKPSNLLLNANCD-LKICDFGLART-TSETDFMTEYVVTRW--------- 202
            H   V+HRDLKP NLL++     LKI D GL R  +      T  +VT W         
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG 185

Query: 203 -----------------------DTLFPGKDYVQQLTMITELLGSPDDSDL-GFLRSDNA 238
                                    LFPG   +QQL  I +LLG+P +    G  +  + 
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDW 245

Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
             +    P    Q  S+  P++SP  +DL ++ML +DPAKRI+ + AL HPY
Sbjct: 246 HEF----PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  146 bits (370), Expect = 1e-41
 Identities = 90/288 (31%), Positives = 137/288 (47%), Gaps = 43/288 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V    N +T + VA+KKI    +        +REI LL  + H NIV +
Sbjct: 5   IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL 64

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQI---IRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           +D++  M + +   +Y+++E +  DL +    +   Q +  +  + +LYQ+L+G+ + HS
Sbjct: 65  QDVL--MQESR---LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL++    +K+ DFGLAR         T  VVT W             
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LF G   + QL  I  +LG+P +     + S     Y  
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS--LPDYKN 237

Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   K        N+    +DL E+ML++DPAKRI+ ++ALNHPY 
Sbjct: 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 1e-41
 Identities = 95/295 (32%), Positives = 136/295 (46%), Gaps = 56/295 (18%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR-----ILREIKLLCHMTHE 94
           L  +G G+Y  V    +  T + VA+K+I      R++ +       +RE  LL  + H 
Sbjct: 10  LDKLGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHA 63

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDH-CQYFLYQLLRGLKY 153
           NIV + DII    K+      +V+E +DTDL Q +         H  + FL+QLLRGL Y
Sbjct: 64  NIVTLHDII--HTKKTLT---LVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW----DTL--- 205
            H   VLHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT W    D L   
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGS 178

Query: 206 -------------------------FPG-KDYVQQLTMITELLGSP-DDSDLGFLRSDNA 238
                                    FPG  D   QL  I  +LG+P +++  G   +   
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238

Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPV--AIDLAERMLVFDPAKRITVEEALNHPYL 291
           + Y    P  P +P     P +  +    +LA + L ++P KRI+  EA+ HPY 
Sbjct: 239 KPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (364), Expect = 5e-41
 Identities = 72/270 (26%), Positives = 130/270 (48%), Gaps = 38/270 (14%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +GRG++G V  A++ +T E +A+K +  + D+  + + + REI++L  + H NIV+    
Sbjct: 8   LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
                 E+ N + I  E +    L  +++    L +   + +  Q+L GL Y+HS  ++H
Sbjct: 68  ---ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVH 124

Query: 162 RDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLF---P----GKDY--- 211
           RD+K +N+L++++  +K+ DFG A+   + +   E   +   T +   P    G++Y   
Sbjct: 125 RDIKGANILVDSDGVVKLADFGCAKRLGDIE-TGEGTGSVRGTPYWMAPEVIRGEEYGRA 183

Query: 212 ---------VQQLTMITELLGSPDDSDLGFLRSD-NARRYVKQLPHVPKQPFSQKFPNMS 261
                    V  + M T   G P  S+LG   +         + P +P+        ++S
Sbjct: 184 ADIWSLGCTV--IEMAT---GKPPWSELGNPMAALYKIGSSGEPPEIPE--------HLS 230

Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             A D   + L  DP KR T +E L HP+L
Sbjct: 231 EEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  144 bits (364), Expect = 7e-41
 Identities = 87/285 (30%), Positives = 151/285 (52%), Gaps = 45/285 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G+YG+V    + ET + VAIKK   + D+++  K  +REI++L  + HEN+V + ++
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
                K++    Y+V+E +D T L  + +    L +   + +L+Q+LRG+++ HS N++H
Sbjct: 69  F--RRKKRL---YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123

Query: 162 RDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW------------------ 202
           RD+KP N+L++ +  +K+CDFG ART  +  +  T+YV TRW                  
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVD 183

Query: 203 --------------DTLFPGKDYVQQLTMITELLG--SPDDSDLGFLRSDNARRYVKQLP 246
                         + LFPG   + QL  I + LG   P   ++ F +  N      +LP
Sbjct: 184 IWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI-FQK--NPLFAGMRLP 240

Query: 247 HVPK-QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
            V + +P  ++FP +S + +DLA++ L  DP  R +  + L+H +
Sbjct: 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  140 bits (354), Expect = 4e-40
 Identities = 55/162 (33%), Positives = 94/162 (58%), Gaps = 10/162 (6%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G +G V  A + +T ++VAIK I     + +  + +LREI++L  + H NIVK+  +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL-LEELLREIEILKKLNHPNIVKLYGV 59

Query: 103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSANVL 160
                 E  N +Y+V E  +   L  +++  +  L++D     L Q+L GL+Y+HS  ++
Sbjct: 60  F-----EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114

Query: 161 HRDLKPSNLLLNANCD-LKICDFGLART-TSETDFMTEYVVT 200
           HRDLKP N+LL+++   +K+ DFGL++  TS+   +   V T
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  139 bits (353), Expect = 6e-39
 Identities = 96/311 (30%), Positives = 141/311 (45%), Gaps = 67/311 (21%)

Query: 34  SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI--LREIKLLCHM 91
           SKY   L  IG+G +G V  A + +TK+ VA+KK+    +N  +   I  LREIK+L  +
Sbjct: 12  SKYEK-LAKIGQGTFGEVFKARHKKTKQIVALKKVL--MENEKEGFPITALREIKILQLL 68

Query: 92  THENIVKVKDII---PPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQL 147
            HEN+V + +I               Y+V+E  + DL  ++ +K    T    +  +  L
Sbjct: 69  KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML 128

Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET-----DFMTEYVVTRW 202
           L GL YIH   +LHRD+K +N+L+  +  LK+ DFGLAR  S +     +  T  VVT W
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188

Query: 203 ----DTLFPGKDY----------------------------VQQLTMITELLGS------ 224
               + L   +DY                              QLT+I++L GS      
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248

Query: 225 PDDSDLGF-----LRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKR 279
           P    L       L     R+  ++L    K           P A+DL +++LV DPAKR
Sbjct: 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVK----------DPHALDLIDKLLVLDPAKR 298

Query: 280 ITVEEALNHPY 290
           I  + ALNH +
Sbjct: 299 IDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  136 bits (345), Expect = 3e-38
 Identities = 80/269 (29%), Positives = 130/269 (48%), Gaps = 30/269 (11%)

Query: 36  YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
               L+ IG+G +G V  A +  T +EVAIK I    +++   ++I+ EI++L    H N
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPN 58

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKY 153
           IVK           K ++++IV E      L  +++S  Q LT+    Y   +LL+GL+Y
Sbjct: 59  IVKYYGSY-----LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR-WDTLFP----G 208
           +HS  ++HRD+K +N+LL ++ ++K+ DFGL+   S+T      V T  W  + P    G
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYW--MAPEVING 171

Query: 209 KDYVQQ-------LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
           K Y  +       +T I    G P  S+L  ++   A   +         P  +     S
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFKIATNGP----PGLRNPEKWS 224

Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPY 290
               D  ++ L  +P KR T E+ L HP+
Sbjct: 225 DEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  133 bits (337), Expect = 9e-37
 Identities = 84/278 (30%), Positives = 128/278 (46%), Gaps = 52/278 (18%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG GA G V  A +  T +EVAIKK+     N+   + I+ EI ++    H NIV  
Sbjct: 24  LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNIVDY 80

Query: 100 KD--IIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            D  ++        +++++V E MD    TD+  I ++   + +    Y   ++L+GL+Y
Sbjct: 81  YDSYLVG-------DELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEY 131

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTRW 202
           +HS NV+HRD+K  N+LL+ +  +K+ DFG  A+ T E            +M   V+ R 
Sbjct: 132 LHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR- 190

Query: 203 DTLFPGKDYVQQL------TMITELL-GSPDDSDLGFLRSDNARRYV-KQLPHVPKQPFS 254
                 KDY  ++       M  E+  G P       LR   A   +  +     K P  
Sbjct: 191 ------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---ALFLITTKGIPPLKNPEK 241

Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
                 SP   D   + LV DP KR + EE L HP+L 
Sbjct: 242 -----WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  132 bits (333), Expect = 2e-36
 Identities = 87/283 (30%), Positives = 144/283 (50%), Gaps = 42/283 (14%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GAYG+V    + ETKE VAIKK  ++ +N    +  LRE+K+L  +  ENIV++K+ 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
                  +   +Y+V+E ++ ++ +++      +  +  + ++YQL++ + + H  +++H
Sbjct: 69  F-----RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123

Query: 162 RDLKPSNLLLNANCDLKICDFGLARTTSETD--FMTEYVVTRW----------------- 202
           RD+KP NLL++ N  LK+CDFG AR  SE      TEYV TRW                 
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVD 183

Query: 203 --------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHV 248
                           LFPG+  + QL  I ++LG P  ++   L   N R +  + P V
Sbjct: 184 MWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG-PLPAEQMKLFYSNPRFHGLRFPAV 242

Query: 249 PK-QPFSQKFPN-MSPVAIDLAERMLVFDPAKRITVEEALNHP 289
              Q   +++   +S V +DL + +L  +P  R   E+ LNHP
Sbjct: 243 NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  130 bits (327), Expect = 3e-35
 Identities = 96/290 (33%), Positives = 134/290 (46%), Gaps = 43/290 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G G Y  V    +  T+  VA+K+I    +       I RE+ LL  + H NIV +
Sbjct: 11  LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTL 69

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDH-CQYFLYQLLRGLKYIHSAN 158
            DI+   DK     + +V+E +D DL Q +     +   H  + FLYQ+LRGL Y H   
Sbjct: 70  HDIVH-TDKS----LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW--------------- 202
           VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT W               
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Query: 203 -----------------DTLFPGKDYVQQLTMITELLGSP-DDSDLGFLRSDNARRYVKQ 244
                              LFPG     +L +I  LLG+P +++  G   +D  + Y   
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY--N 242

Query: 245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
            P    QP     P +    I+L  + L ++  KRI+ EEA+ H Y  SL
Sbjct: 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  128 bits (322), Expect = 1e-34
 Identities = 96/292 (32%), Positives = 130/292 (44%), Gaps = 43/292 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  +G G Y  V    +  T   VA+K+I    +       I RE+ LL  + H NIV +
Sbjct: 11  LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTL 69

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDH-CQYFLYQLLRGLKYIHSAN 158
            DII     EK   + +V+E +D DL Q +       + H  + FL+QLLRGL Y H   
Sbjct: 70  HDII---HTEK--SLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW--------------- 202
           VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT W               
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Query: 203 -----------------DTLFPGKDYVQQLTMITELLGSPDDSDL-GFLRSDNARRYVKQ 244
                              LFPG    +QL  I  +LG+P +    G L ++  + Y   
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY--N 242

Query: 245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
            P           P +     +L  ++L F+  KRI+ EEA+ HPY   L E
Sbjct: 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  127 bits (321), Expect = 1e-34
 Identities = 93/287 (32%), Positives = 134/287 (46%), Gaps = 43/287 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  +G G Y  V    +  T+  VA+K+I    +       I RE+ LL ++ H NIV +
Sbjct: 10  LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHANIVTL 68

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDH-CQYFLYQLLRGLKYIHSAN 158
            DII          + +V+E +D+DL Q + +   L   H  + F++QLLRGL Y H   
Sbjct: 69  HDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW----DTL-------- 205
           +LHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT W    D L        
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 206 --------------------FPGKDYVQQLTMITELLGSP-DDSDLGFLRSDNARRYVKQ 244
                               FPG    ++L +I  LLG+P +++  G   ++  R Y+  
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL-- 241

Query: 245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            P    QP     P +    IDL   +L+++   RI+ E AL H Y 
Sbjct: 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  127 bits (322), Expect = 2e-34
 Identities = 91/318 (28%), Positives = 132/318 (41%), Gaps = 80/318 (25%)

Query: 43  IGRGAYGIVCSAV--NSETKEEVAIKKI--TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           IGRG YG V  A   N +  +E AIKK          I      REI LL  + HEN+V 
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC-REIALLRELKHENVVS 66

Query: 99  VKDII-PPMDKEKFNDVYIVYELMDTDLHQII---RSKQA--LTDDHCQYFLYQLLRGLK 152
           + ++     DK     VY++++  + DL QII   R  +   +     +  L+Q+L G+ 
Sbjct: 67  LVEVFLEHADKS----VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122

Query: 153 YIHSANVLHRDLKPSNLLLNANCD----LKICDFGLAR-------TTSETDFMTEYVVTR 201
           Y+HS  VLHRDLKP+N+L+         +KI D GLAR         ++ D     VVT 
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---PVVVTI 179

Query: 202 W--------------------------------DTLFPGKD---------YVQQLTMITE 220
           W                                + +F G++            QL  I E
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239

Query: 221 LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS--------QKFPNMSPVAIDLAERML 272
           +LG+P + D   ++      Y   +     + +         +K         DL  ++L
Sbjct: 240 VLGTPTEKDWPDIK--KMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297

Query: 273 VFDPAKRITVEEALNHPY 290
            +DP KRIT EEAL HPY
Sbjct: 298 EYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  124 bits (314), Expect = 1e-33
 Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 50/278 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G+G+ G+V    +  T +  A+KKI +   +    K++LRE+K L       +VK 
Sbjct: 6   VKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKC 64

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-A 157
                     K  ++ IV E MD   L  +++    + +    Y   Q+L+GL Y+H+  
Sbjct: 65  YGAFY-----KEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT-EYVVT-------RWDTLFPGK 209
           +++HRD+KPSNLL+N+  ++KI DFG+++    T      +V T       R      G+
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPER----IQGE 175

Query: 210 DY-----VQQL-TMITELLGSPDDSDLG---FLRSDNAR-----RYV--KQLPHVPKQPF 253
            Y     +  L   + E         LG   FL           + +     P +P + F
Sbjct: 176 SYSYAADIWSLGLTLLECA-------LGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228

Query: 254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           S +F        D     L  DP KR +  E L HP++
Sbjct: 229 SPEF-------RDFISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  126 bits (315), Expect = 5e-33
 Identities = 69/301 (22%), Positives = 130/301 (43%), Gaps = 38/301 (12%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHE-NIV 97
           L+ +G G++G V  A +   ++ VA+K +    +++    +R LREI++L  + H  NIV
Sbjct: 5   LRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRS---KQALTDDHCQYFLYQLLRGLKY 153
           K+ D       +    +Y+V E +D   L  +++    K  L++    + L Q+L  L+Y
Sbjct: 62  KLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 154 IHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTSETD-------FMTEYVVTRWD-- 203
           +HS  ++HRD+KP N+LL+ +   +K+ DFGLA+   +           +  V T     
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 204 ----TLFPGKDYVQQ-------LTMITELLGSPD-DSDLGFLRSDNARRYVKQL--PHVP 249
                                 +T+   L G P  + +     +    + + +L  P + 
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNF 309
                     +S  A DL +++L  DP  R++    L+H  L+ L     + +     + 
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296

Query: 310 D 310
            
Sbjct: 297 S 297

Length = 384

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  123 bits (310), Expect = 6e-33
 Identities = 95/298 (31%), Positives = 139/298 (46%), Gaps = 43/298 (14%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           F  ++ Y+  L+ +G G+Y  V   ++    + VA+K I+   +  +    I RE  LL 
Sbjct: 1   FGAATSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLK 58

Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQ-IIRSKQALTDDHCQYFLYQLL 148
            + H NIV + DII   +   F     V+E M TDL Q +I+    L   + + F++QLL
Sbjct: 59  GLKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL 113

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW----- 202
           RGL YIH  ++LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT W     
Sbjct: 114 RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPD 173

Query: 203 ---------------------------DTLFPG-KDYVQQLTMITELLGSP-DDSDLGFL 233
                                         FPG  D  +QL  I  +LG P +D+  G  
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233

Query: 234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           +  N +          +     K  +  P A DLA +ML+  P  RI+ ++AL HPY 
Sbjct: 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  121 bits (307), Expect = 8e-33
 Identities = 81/270 (30%), Positives = 123/270 (45%), Gaps = 44/270 (16%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IGRGA+G+V   +N ET + VAIK+I+         K I++EI LL ++ H NIVK    
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           I     E  + +YI+ E  +   L QII+      +     ++YQ+L+GL Y+H   V+H
Sbjct: 68  I-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIH 122

Query: 162 RDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY-----VQQLT 216
           RD+K +N+L   +  +K+ DFG+A   ++       VV        G  Y     V +++
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV--------GTPYWMAPEVIEMS 174

Query: 217 MIT-------------ELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM-S 261
             +             ELL G+P   DL       A   + Q  H P        P   S
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLN---PMAALFRIVQDDHPP-------LPEGIS 224

Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           P   D   +    DP  R T ++ L HP++
Sbjct: 225 PELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  116 bits (293), Expect = 1e-30
 Identities = 48/162 (29%), Positives = 83/162 (51%), Gaps = 10/162 (6%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG+G++G V         +   +K+I  +  +  + +  L E+K+L  + H NI+K  + 
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE- 66

Query: 103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQA----LTDDHCQYFLYQLLRGLKYIHSA 157
                 E+   + IV E  D  DL Q I+ ++       ++    +  QL   LKY+HS 
Sbjct: 67  ----SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVV 199
            +LHRD+KP N+ L +N  +K+ DFG+++  S T  + + VV
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  116 bits (293), Expect = 1e-30
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 13/160 (8%)

Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
            + +G GA+G V            + EVA+K +     +    +  LRE +++  + H N
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-ASEQQIEEFLREARIMRKLDHPN 62

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQ--ALTDDHCQYFLYQLLRGLK 152
           IVK+  +    ++E    + IV E M   DL   +R  +   L+      F  Q+ RG++
Sbjct: 63  IVKLLGVC--TEEEP---LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           Y+ S N +HRDL   N L+  N  +KI DFGL+R   + D
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  116 bits (292), Expect = 1e-30
 Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 12/159 (7%)

Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
            + +G GA+G V          + K EVA+K +     +    +  LRE +++  + H N
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED-ASEQQIEEFLREARIMRKLDHPN 62

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIR-SKQALTDDHCQYFLYQLLRGLKY 153
           +VK+  +    ++E    +YIV E M+  DL   +R ++  L+      F  Q+ RG++Y
Sbjct: 63  VVKLLGVC--TEEEP---LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           + S N +HRDL   N L+  N  +KI DFGL+R   + D
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 156

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  115 bits (290), Expect = 4e-30
 Identities = 81/289 (28%), Positives = 123/289 (42%), Gaps = 40/289 (13%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKI---TNAFDNRIDAKRILREIKLLCHMTHEN 95
           P+  IG GAYG V  A +  +   VA+K +   TN     +   R +  +K L    H N
Sbjct: 4   PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA--LTDDHCQYFLYQLLRGLKY 153
           IV++ D+      ++   V +V+E +D DL   +       L  +  +  + Q LRGL +
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW----------- 202
           +H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T  VVT W           
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST 183

Query: 203 --------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV 242
                                 LF G     QL  I +L+G P + D     +     + 
Sbjct: 184 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFS 243

Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            + P    +P     P +      L   ML F+P KRI+   AL HP+ 
Sbjct: 244 PRGP----RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  109 bits (272), Expect = 2e-27
 Identities = 98/300 (32%), Positives = 138/300 (46%), Gaps = 60/300 (20%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G G+Y  V    +    + VA+K I    +       I RE  LL  + H NIV +
Sbjct: 10  LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHANIVLL 68

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQII-RSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            DII    KE      +V+E + TDL Q + +    L  ++ + FL+QLLRGL YIH   
Sbjct: 69  HDII--HTKETLT---LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW----DTL-------- 205
           +LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT W    D L        
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 206 --------------------FPG-KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ 244
                               FPG KD   QL  I  +LG+P+         ++    V  
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN---------EDTWPGVHS 234

Query: 245 LPHVPKQPFS--------QKFPNMSPV--AIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           LPH   + F+        Q +  +S V  A DLA ++L   P  R++ + AL+H Y S L
Sbjct: 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  108 bits (270), Expect = 3e-27
 Identities = 81/293 (27%), Positives = 132/293 (45%), Gaps = 49/293 (16%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEE-VAIKKITNAFDNRIDAKRILREIKLLCHMT---HE 94
            +  IG GAYG V  A + +     VA+K++             +RE+ +L H+    H 
Sbjct: 5   CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS--KQALTDDHCQYFLYQLLRGLK 152
           N+V++ D+      ++   + +V+E +D DL   +    +  +  +  +  ++QLLRGL 
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------- 202
           ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  VVT W          
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 184

Query: 203 ---------------------DTLFPGKDYVQQLTMITELLGSPDDSD----LGFLRSDN 237
                                  LF G   V QL  I +++G P + D    +   R   
Sbjct: 185 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 244

Query: 238 ARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
             +          QP  +   ++  +  DL  + L F+PAKRI+   AL+HPY
Sbjct: 245 HSK--------SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  102 bits (256), Expect = 2e-25
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 16/174 (9%)

Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
            + +G GA+G V           T+ +VA+K +        + +  L E  ++  ++H N
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE-EREEFLEEASIMKKLSHPN 62

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKY 153
           IV++  +      E    +YIV E M   DL   +R   + LT         Q+ +G++Y
Sbjct: 63  IVRLLGVC--TQGEP---LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
           + S N +HRDL   N L+  N  +KI DFGL+R   E D    Y   R     P
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD----YYRKRGGGKLP 167

Length = 258

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  105 bits (263), Expect = 2e-25
 Identities = 86/297 (28%), Positives = 136/297 (45%), Gaps = 54/297 (18%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A+  +T E+VAIKK+        D +   RE+ ++ ++ H NI+ +KD 
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQ------DPQYKNRELLIMKNLNHINIIFLKDY 127

Query: 103 -----IPPMDKEKFNDVYIVYELMDTDLHQII----RSKQALTDDHCQYFLYQLLRGLKY 153
                    +K  F +V  V E +   +H+ +    R+  AL     + + YQL R L Y
Sbjct: 128 YYTECFKKNEKNIFLNV--VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 154 IHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSETDFMTEYVVTR----------- 201
           IHS  + HRDLKP NLL++ N   LK+CDFG A+          Y+ +R           
Sbjct: 186 IHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 202 ---------WD------------TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARR 240
                    W              +F G+  V QL  I ++LG+P +  L  +  + A  
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD- 304

Query: 241 YVKQLPHVPKQPFSQKFPNMSP-VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
              + P V  +   + FP  +P  AI+   + L ++P KR+   EAL  P+   L +
Sbjct: 305 --IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359

Length = 440

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  100 bits (250), Expect = 1e-24
 Identities = 69/267 (25%), Positives = 127/267 (47%), Gaps = 30/267 (11%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN---RIDAKRILREIKLLCHMTHENIV 97
           + +G G++G V   +N +  +  A+K+++ A D    +   K++ +EI LL  + H NIV
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 98  KVKDIIPPMDKEKFND-VYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           +       +  E+  D +YI  EL+    L ++++   +  +   + +  Q+L GL+Y+H
Sbjct: 66  QY------LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH 119

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT-RW---DTLFPGKDY 211
             N +HRD+K +N+L++ N  +K+ DFG+A+   E  F   +  +  W   + +     Y
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179

Query: 212 VQQL-------TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
                      T++    G P  S L  + +       K+LP +P         ++S  A
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPD--------HLSDEA 231

Query: 265 IDLAERMLVFDPAKRITVEEALNHPYL 291
            D   + L  DP+ R T  E L HP++
Sbjct: 232 KDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 98.5 bits (246), Expect = 5e-24
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 51/284 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           I +GAYG V  A    T +  AIK I  A    +    ++L E  +L       +VK+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 102 IIPPMDKEKF---NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    F    ++Y+V E +   DL  ++ +  +L +D  + ++ +++  L+Y+HS 
Sbjct: 60  -------YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN 112

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK-DYV---- 212
            ++HRDLKP N+L+++N  LK+ DFGL++       +      + D    G  DY+    
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 213 ---QQLT----------MITELL-GSP----DDSDLGFLRSDNARRYVKQLPHVPKQPFS 254
              Q  +          ++ E L G P    +  +  F    N      + P        
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF---QNILNGKIEWP-------- 221

Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRI---TVEEALNHPYLSSLH 295
            +   +S  AIDL  ++LV DP KR+   ++EE  NHP+   + 
Sbjct: 222 -EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 97.2 bits (243), Expect = 2e-23
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 19/165 (11%)

Query: 42  PIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
            +G GA+G V             EVA+K +     +  + K  L+E +++  + H N+V+
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRS---------KQALTDDHCQYFLYQLL 148
           +  +    ++E    +Y+V E M+  DL   +R          K  L+      F  Q+ 
Sbjct: 61  LLGVC--TEEEP---LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +G++Y+ S   +HRDL   N L+  +  +KI DFGL+R   + D+
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 75/287 (26%), Positives = 120/287 (41%), Gaps = 51/287 (17%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID-AKRILREIKLLCHMT-HENIVK 98
           + IG G++  V  A   ET +E AIK +      +    K +  E ++L  +  H  I+K
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 99  VKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           +       D+E    +Y V E   + +L Q IR   +L +   +++  ++L  L+Y+HS 
Sbjct: 67  LYYTF--QDEEN---LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLT- 216
            ++HRDLKP N+LL+ +  +KI DFG A+                +     +   ++   
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181

Query: 217 -------MITELLGSPD---DSD---LGFLRSDNARRYVKQLPHVPKQPFSQK------- 256
                  +  ELL        SD   LG +        + Q+    K PF          
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCI--------IYQM-LTGKPPFRGSNEYLTFQ 232

Query: 257 --------FP-NMSPVAIDLAERMLVFDPAKRITV----EEALNHPY 290
                   FP N  P A DL E++LV DP  R+ V    +E   HP+
Sbjct: 233 KILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.2 bits (240), Expect = 3e-23
 Identities = 77/268 (28%), Positives = 120/268 (44%), Gaps = 41/268 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G+YG V  A++ ET + VAIK +    D     + I++EI +L       IVK    
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL----QEIIKEISILKQCDSPYIVKYYGS 66

Query: 103 IPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                  K  D++IV E       +D+ +I      LT++     LYQ L+GL+Y+HS  
Sbjct: 67  Y-----FKNTDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLF---------PGK 209
            +HRD+K  N+LLN     K+ DFG++   ++T      V+    T F          G 
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI---GTPFWMAPEVIQEIGY 176

Query: 210 DYVQQ-----LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP-NMSPV 263
           +         +T I    G P  SD+      +  R +  +P+ P    S   P   SP 
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDI------HPMRAIFMIPNKPPPTLSD--PEKWSPE 228

Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYL 291
             D  ++ LV DP +R +  + L HP++
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 95.9 bits (239), Expect = 5e-23
 Identities = 81/266 (30%), Positives = 124/266 (46%), Gaps = 26/266 (9%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G +G V +AVN +T E +A+K+I    ++    K I  E+K+L  + H N+VK   +
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHC-QYFLYQLLRGLKYIHSANVL 160
              + +EK   VYI  E      L +++   + L D+H  + +  QLL GL Y+HS  ++
Sbjct: 68  --EVHREK---VYIFMEYCSGGTLEELLEHGRIL-DEHVIRVYTLQLLEGLAYLHSHGIV 121

Query: 161 HRDLKPSNLLLNANCDLKICDFGLA-RTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMIT 219
           HRD+KP+N+ L+ N  +K+ DFG A +  + T  M E V +   T       V       
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181

Query: 220 ELLGSPDDSDLG--------------FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
               + D   LG               L ++    +     H P  P S +   +SP   
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ---LSPEGK 238

Query: 266 DLAERMLVFDPAKRITVEEALNHPYL 291
           D  +R L  DP KR T  E L HP++
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 94.5 bits (236), Expect = 1e-22
 Identities = 73/272 (26%), Positives = 126/272 (46%), Gaps = 47/272 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI-------TNAFDNRIDAKRILREIKLLCHMTHEN 95
           +G+G++G V      +T +  A+K +           ++ +  + IL  I       H  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN------HPF 54

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           IVK+        +EK   +Y+V E     +L   +  +   +++  +++  +++  L+Y+
Sbjct: 55  IVKLHYAF--QTEEK---LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYL 109

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRWDTLFP----GK 209
           HS  +++RDLKP N+LL+A+  +K+ DFGLA+  +SE      +  T  + L P    GK
Sbjct: 110 HSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP-EYLAPEVLLGK 168

Query: 210 DYVQQL------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP-NMS 261
            Y + +       ++ E+L G P      F   D    Y K    + K P   +FP  +S
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPP-----FYAEDRKEIYEK----ILKDPL--RFPEFLS 217

Query: 262 PVAIDLAERMLVFDPAKRIT---VEEALNHPY 290
           P A DL   +L  DP KR+     EE   HP+
Sbjct: 218 PEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 66/271 (24%), Positives = 121/271 (44%), Gaps = 36/271 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR----ILREIKLLCHMTHEN 95
           L+ IG+GA+G VC     +TK+  A+K +      +   K     +L E ++L  + H  
Sbjct: 5   LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ---KCVEKGSVRNVLNERRILQELNHPF 61

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           +V +       D+E   ++Y+V +L+   DL   +  K   +++  ++++ +++  L+Y+
Sbjct: 62  LVNLWYSF--QDEE---NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQ 214
           HS  ++HRD+KP N+LL+    + I DF +A   +     T    T          Y+  
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGT--------PGYMAP 168

Query: 215 LTMITELLGSPDDS-DLG-----FLRSD-----NARRYVKQLPHVPKQPFSQKFPNM-SP 262
             +  +      D   LG      LR       ++R    Q+    +      +P   S 
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA-DVLYPATWST 227

Query: 263 VAIDLAERMLVFDPAKRI--TVEEALNHPYL 291
            AID   ++L  DP KR+   +++  NHPY 
Sbjct: 228 EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 50/155 (32%), Positives = 78/155 (50%), Gaps = 18/155 (11%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVK--- 98
           IG G YG V  A + +T + VAIK +    D     + I  E  +L   + H NI     
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE---EEIKEEYNILRKYSNHPNIATFYG 70

Query: 99  --VKDIIPPMDKEKFNDVYIVYELMD----TDLHQ-IIRSKQALTDDHCQYFLYQLLRGL 151
             +K   P  D +    +++V EL      TDL + + +  + L ++   Y L + LRGL
Sbjct: 71  AFIKKNPPGNDDQ----LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            Y+H   V+HRD+K  N+LL  N ++K+ DFG++ 
Sbjct: 127 AYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 88.5 bits (220), Expect = 3e-20
 Identities = 52/169 (30%), Positives = 87/169 (51%), Gaps = 14/169 (8%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG+G++G V         + +  K+I        + ++++ E+ +L  + H NIV+  D 
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQII----RSKQALTDDHCQYFLYQLLRGLKYIH-- 155
           I  +D+     +YIV E  +  DL Q+I    + ++ + ++     L QLL  L   H  
Sbjct: 68  I--IDRSN-QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 156 ---SANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVT 200
                 VLHRDLKP+N+ L+AN ++K+ DFGLA+    ++ F   YV T
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 5e-20
 Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 65/283 (22%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT--NAFDNRIDAKRILREIKLLCHMTHENIV 97
           L+ IG+G++G V  A++  T + VAIK I    A D   D   I +EI+ L       I 
Sbjct: 6   LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED---IQQEIQFLSQCRSPYIT 62

Query: 98  K-----VKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLL 148
           K     +K           + ++I+ E        DL +  +    L + +  + L ++L
Sbjct: 63  KYYGSFLKG----------SKLWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVL 108

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPG 208
            GL+Y+H    +HRD+K +N+LL+   D+K+ DFG++   + T       +++ +T F G
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST-------MSKRNT-FVG 160

Query: 209 KDY------VQQL----------TMIT--ELL-GSPDDSDLGFLRSDNARRYVKQLPHVP 249
             +      ++Q             IT  EL  G P  SDL  +R       V  L  +P
Sbjct: 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFL--IP 211

Query: 250 KQPFSQKFPNM-SPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           K        N  S    D     L  DP +R + +E L H ++
Sbjct: 212 KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 51/280 (18%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
            L  +G G  G+V   ++  T + +A+K I    +  I  K+ILRE+ +L       IV 
Sbjct: 5   YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ-KQILRELDILHKCNSPYIVG 63

Query: 99  VKDIIPPMDKEKF-------NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFL-YQLLR 149
                       F        D+ I  E MD   L +I++  Q    +     +   +L+
Sbjct: 64  ------------FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLK 111

Query: 150 GLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW----DT 204
           GL Y+H    ++HRD+KPSN+L+N+   +K+CDFG++     +   T +V T      + 
Sbjct: 112 GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPER 170

Query: 205 LFPGKDYVQQ------LTMITEL------LGSPDDSDLGFLRSDNARRYVKQ-LPHVPKQ 251
           +      V+       L++I EL          +D   G    +  +  V +  P +P  
Sbjct: 171 IQGNDYSVKSDIWSLGLSLI-ELATGRFPYPPENDPPDGIF--ELLQYIVNEPPPRLPSG 227

Query: 252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            FS  F        D     L+ DP +R + +E L HP++
Sbjct: 228 KFSPDF-------QDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 85.2 bits (211), Expect = 5e-19
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 35/273 (12%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRIL-------REIKLLCHMTHE 94
           IG+G YG V  A+N  T E +A+K++   A        R          EI+ L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVY--ELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
           NIV+       +  E   +   ++   +    +   +R+     +   ++F  Q+L GL 
Sbjct: 69  NIVQY------LGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE------------TDF-MTEYVV 199
           Y+HS  +LHRDLK  NLL++A+   KI DFG+++ + +            + F M   V+
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 200 TRWDTLFPGKDYVQQL-TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF 257
             +   +  K  +  L  ++ E+  G    SD   + +       +  P +P        
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP----PDVS 238

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
            N+SPVA+D        +P  R T  E L HP+
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 85.2 bits (211), Expect = 5e-19
 Identities = 70/266 (26%), Positives = 122/266 (45%), Gaps = 37/266 (13%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRIL--REIKLLCHMTHENIVKVK 100
           IG G+ GIVC A +  T  +VA+KK+    D R   +R L   E+ ++    H NIV++ 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM----DLRKQQRRELLFNEVVIMRDYQHPNIVEMY 82

Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                 D     ++++V E ++      I +   + ++        +L+ L ++H+  V+
Sbjct: 83  SSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVI 137

Query: 161 HRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTRWDTLFPGK 209
           HRD+K  ++LL ++  +K+ DFG  A+ + E            +M   V++R        
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR-LPYGTEV 196

Query: 210 DYVQQLTMITELL-GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
           D      M+ E++ G P   ++  L       A + ++        P  +    +SP   
Sbjct: 197 DIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDNL----PPKLKNLHKVSPRLR 246

Query: 266 DLAERMLVFDPAKRITVEEALNHPYL 291
              +RMLV DPA+R T  E LNHP+L
Sbjct: 247 SFLDRMLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 9e-19
 Identities = 79/276 (28%), Positives = 116/276 (42%), Gaps = 46/276 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +Q IG G YG V  A +  T E VAIK I    +   D + I +EI +L    H NIV  
Sbjct: 8   IQRIGSGTYGDVYKARDIATGELVAIKVI--KLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 100 KDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
                  DK     ++IV E        D++Q+ R    L++    Y   + L+GL Y+H
Sbjct: 66  FGSYLRRDK-----LWIVMEYCGGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLH 118

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET-----DFM-TEYVVTRWDTLFP-- 207
               +HRD+K +N+LL  + D+K+ DFG++   + T      F+ T Y    W  + P  
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY----W--MAPEV 172

Query: 208 -----GKDYVQQ-------LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ 255
                   Y  +       +T I      P   DL      +  R +  +      P   
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDL------HPMRALFLISKSNFPPPKL 226

Query: 256 KFPNM-SPVAIDLAERMLVFDPAKRITVEEALNHPY 290
           K     SPV  D  ++ L  DP KR T  + L HP+
Sbjct: 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 83.7 bits (207), Expect = 1e-18
 Identities = 51/163 (31%), Positives = 87/163 (53%), Gaps = 8/163 (4%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  IG+G++G+V   V    K   A+K+I  +  NR + +  + E ++L  +    I++ 
Sbjct: 5   LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHS 156
            +    +DK K N   IV E  +  DLH++++    + L +D    F  Q+L GL ++HS
Sbjct: 65  YESF--LDKGKLN---IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVV 199
             +LHRD+K  NL L+A  ++KI D G+A+  S+       +V
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV 162

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 83.3 bits (206), Expect = 2e-18
 Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 23/162 (14%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK---RILREIKLLCHMTHENIV 97
           + IG+G + +V  A+       VA+KK+   F+  +DAK     L+EI LL  + H N++
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKV-QIFE-MMDAKARQDCLKEIDLLKQLDHPNVI 65

Query: 98  KVKDIIPPMDKEKF---NDVYIVYELMDT-DLHQIIR--SKQALTDDHCQ---YFLYQLL 148
           K            F   N++ IV EL D  DL ++I+   KQ           YF  QL 
Sbjct: 66  KYLA--------SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLC 116

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
             L+++HS  ++HRD+KP+N+ + A   +K+ D GL R  S 
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 3e-18
 Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 46/279 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PI +GA+G V  A    T +  AIK +  +    + AK  +  +K         I+ +
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKS---DMIAKNQVTNVKA-----ERAIMMI 52

Query: 100 KDIIPPMDKEKF-----NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +   P + K  +     + +Y+V E ++  D   +I++   L +D  + ++ +++ G++ 
Sbjct: 53  QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVED 112

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GK 209
           +H   ++HRD+KP NLL++    LK+ DFGL    S      +  V   D L P    G 
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGL----SRNGLENKKFVGTPDYLAPETILGV 168

Query: 210 DYVQQ-------LTMITELLGSP----DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP 258
              +          +   L G P    +  D  F   DN        P        +   
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF---DNILSRRINWP-------EEVKE 218

Query: 259 NMSPVAIDLAERMLVFDPAKRI---TVEEALNHPYLSSL 294
             SP A+DL  R+L  DPAKR+     +E  +HP+  S+
Sbjct: 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 81.6 bits (202), Expect = 7e-18
 Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 58/285 (20%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK- 98
           ++ IG GA  +V +A+     E+VAIK+I +    +     + +E++ +    H N+VK 
Sbjct: 6   IEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 99  -----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK--QALTDDHC-QYFLYQLLR 149
                V D +           ++V   +    L  I++S   +   D+      L ++L+
Sbjct: 65  YTSFVVGDEL-----------WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK 113

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR------W- 202
           GL+Y+HS   +HRD+K  N+LL  +  +KI DFG++ + ++    T  V         W 
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173

Query: 203 --DTLFPGKDYVQQ-------LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP---- 249
             + +     Y  +       +T I    G+   S    ++       +  L + P    
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-----LMLTLQNDPPSLE 228

Query: 250 ----KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
                + +S+ F  M    I L    L  DP+KR T EE L H +
Sbjct: 229 TGADYKKYSKSFRKM----ISLC---LQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.6 bits (204), Expect = 9e-18
 Identities = 53/155 (34%), Positives = 83/155 (53%), Gaps = 21/155 (13%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--ILREIKLLCHMTHENIVKVK 100
           IG GA G V   ++  T    A+K I   + N  D  R  I REI++L  + H N+VK  
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVVKCH 138

Query: 101 DIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           D+      +   ++ ++ E MD       H  I  +Q L D        Q+L G+ Y+H 
Sbjct: 139 DMF-----DHNGEIQVLLEFMDGGSLEGTH--IADEQFLAD-----VARQILSGIAYLHR 186

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
            +++HRD+KPSNLL+N+  ++KI DFG++R  ++T
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221

Length = 353

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 19/154 (12%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH---ENI 96
           L+ IGRGAYG V    +  T   VA+K I N      D   I RE+ LL  +      NI
Sbjct: 6   LELIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQPPNI 64

Query: 97  VK-----VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            K     +K             ++I+ E  +    + +     + + +    + ++L  L
Sbjct: 65  TKYYGSYLKG----------PRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVAL 114

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           KYIH   V+HRD+K +N+L+    ++K+CDFG+A
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVA 148

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 79.4 bits (196), Expect = 3e-17
 Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 16/155 (10%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G+G+YG V         +  A+K++     ++ + +  + EI++L  + H NI+  
Sbjct: 5   LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64

Query: 100 KDIIPPMDKEKF---NDVYIVYELMD-TDLHQIIRSKQA----LTDDHCQYFLYQLLRGL 151
           K        E F   N + IV E     DL + I  ++     + +        QLLRGL
Sbjct: 65  K--------EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           + +H   +LHRDLK +N+LL AN  +KI D G+++
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISK 151

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 80.1 bits (197), Expect = 4e-17
 Identities = 72/266 (27%), Positives = 125/266 (46%), Gaps = 37/266 (13%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--ILREIKLLCHMTHENIVKVK 100
           IG G+ GIVC A    +  +VA+K +    D R   +R  +  E+ ++    H+N+V+  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM----DLRKQQRRELLFNEVVIMRDYQHQNVVE-- 82

Query: 101 DIIPPMDKEKF--NDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                M K      +++++ E +       I S+  L ++        +L+ L Y+HS  
Sbjct: 83  -----MYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG 137

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSET-----------DFMTEYVVTRWDTLFP 207
           V+HRD+K  ++LL  +  +K+ DFG     S+             +M   V++R  T + 
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR--TPYG 195

Query: 208 GKDYVQQL-TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
            +  +  L  M+ E++ G P         SD+  + +K+L   P  P  +    +SPV  
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP------YFSDSPVQAMKRLRDSPP-PKLKNAHKISPVLR 248

Query: 266 DLAERMLVFDPAKRITVEEALNHPYL 291
           D  ERML  +P +R T +E L+HP+L
Sbjct: 249 DFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.3 bits (193), Expect = 1e-16
 Identities = 43/148 (29%), Positives = 83/148 (56%), Gaps = 9/148 (6%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR---EIKLLCHMTHENIVKV 99
           +G+GA+G V    + +T  E+A+K++    D+    K +     EI+LL ++ HE IV+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
              +   D E    + I  E M    +   +++  ALT+   + +  Q+L G++Y+HS  
Sbjct: 70  YGCL--RDDET---LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM 124

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
           ++HRD+K +N+L ++  ++K+ DFG ++
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 76.3 bits (188), Expect = 7e-16
 Identities = 73/287 (25%), Positives = 130/287 (45%), Gaps = 47/287 (16%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
            ++ +GRGAYG+V    +  T   +A+K+I  A  N  + KR+L ++ +   M   +   
Sbjct: 5   VIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDI--SMRSVDCPY 61

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLH----QIIRSKQALTDDHCQYFLYQLLRGLKYI 154
                  + +E   DV+I  E+MDT L     ++      + +D        +++ L+Y+
Sbjct: 62  TVTFYGALFRE--GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119

Query: 155 HSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQ 213
           HS  +V+HRD+KPSN+L+N N  +K+CDFG+          + Y+V   D++    D   
Sbjct: 120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGI----------SGYLV---DSVAKTIDAGC 166

Query: 214 QLTMITELLGSPDDSDLGF-LRSD-------------------NARRYVKQLPHVPKQPF 253
           +  M  E + +P+ +  G+ ++SD                   + +   +QL  V ++P 
Sbjct: 167 KPYMAPERI-NPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP- 224

Query: 254 SQKFPN--MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN 298
           S + P    SP   D   + L  +  +R    E L HP+       N
Sbjct: 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKN 271

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 76.2 bits (187), Expect = 8e-16
 Identities = 74/286 (25%), Positives = 134/286 (46%), Gaps = 33/286 (11%)

Query: 35  KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--ILREIKLLCHMT 92
           +Y+     IG G+ GIVC A    T ++VA+KK+    D R   +R  +  E+ ++    
Sbjct: 22  EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRDYH 77

Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
           HEN+V + +     D     ++++V E ++      I +   + ++        +LR L 
Sbjct: 78  HENVVDMYNSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALS 132

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTR 201
           Y+H+  V+HRD+K  ++LL ++  +K+ DFG  A+ + E            +M   V++R
Sbjct: 133 YLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR 192

Query: 202 WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
                    +   + +I  + G P   +   L++   RR    LP  P+   S K  ++ 
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--MRRIRDNLP--PRVKDSHKVSSVL 248

Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPF 307
              +DL   MLV +P++R T +E L HP+L    ++   P+C  P 
Sbjct: 249 RGFLDL---MLVREPSQRATAQELLQHPFL----KLAGPPSCIVPL 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 38/150 (25%), Positives = 70/150 (46%), Gaps = 15/150 (10%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNA--FDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +G G +G V            A+K +      +     + I  E ++L    H  IVK+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKLY 59

Query: 101 DIIPPMDKEKFNDVYIVYELMDT----DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
                     F D   +Y LM+     +L  I+R +    +   ++++  ++   +Y+H+
Sbjct: 60  --------RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN 111

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +++RDLKP NLLL++N  +K+ DFG A+
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAK 141

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 25/156 (16%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLL-----CHMTHENIV 97
           IGRGA+G V   ++  +   +A+K+I +  D + + KR+L ++ ++     C      IV
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-EQKRLLMDLDVVMRSSDC----PYIV 66

Query: 98  KVKDIIPPMDKEKFN--DVYIVYELMDTDLHQIIR-----SKQALTDDHCQYFLYQLLRG 150
           K    +       F   D +I  ELMD  L +  +      K  + ++         ++ 
Sbjct: 67  KFYGAL-------FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119

Query: 151 LKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLA 185
           L Y+     ++HRD+KPSN+LL+ N ++K+CDFG++
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 35/279 (12%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--ILREIKLLCHMTHENIVKVK 100
           IG G+ GIVC A    + + VA+KK+    D R   +R  +  E+ ++    HEN+V++ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 83

Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +     D     ++++V E ++      I +   + ++        +L+ L  +H+  V+
Sbjct: 84  NSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVI 138

Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITE 220
           HRD+K  ++LL  +  +K+ DFG     S+        V R  +L  G  Y     +I+ 
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-------VPRRKSLV-GTPYWMAPELISR 190

Query: 221 LLGSP--DDSDLGFL---RSDNARRYVKQLPHVPKQPFSQKFP-------NMSPVAIDLA 268
           L   P  D   LG +     D    Y  + P    +      P        +SP      
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFL 250

Query: 269 ERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPF 307
           +R+LV DPA+R T  E L HP+L+        P+C  P 
Sbjct: 251 DRLLVRDPAQRATAAELLKHPFLAKAG----PPSCIVPL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.5 bits (184), Expect = 4e-15
 Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 76/290 (26%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIK-----KI--TNAFDNRIDAKRILREIKLLCHMTHEN 95
           +G G++G V    +  + +  A+K     KI      ++ ++ KRIL+ I+      H  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR------HPF 62

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +V +           F D   +Y +M+     +L   +R      +   +++  Q++  L
Sbjct: 63  LVNLYG--------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLAL 114

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTL------ 205
           +Y+HS ++++RDLKP NLLL+++  +KI DFG A+           V  R  TL      
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK----------RVKGRTYTLCGTPEY 164

Query: 206 -----FPGKDYVQQLT------MITELL-GSP---DDSDLGFLRSDNARRYVKQLPHVPK 250
                   K Y + +       +I E+L G P   DD+ +         +          
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV--------- 215

Query: 251 QPFSQKFP-NMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSL 294
                +FP   SP A DL   +L  D  KR+      V +  NHP+ + +
Sbjct: 216 -----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 83/317 (26%), Positives = 128/317 (40%), Gaps = 76/317 (23%)

Query: 43  IGRGAYGIVCSAVNSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +GRG YG V  A   + K+E   A+K+I    +    +    REI LL  + H N++ ++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64

Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA---------LTDDHCQYFLYQLLRGL 151
            +       K   V+++++  + DL  II+  +A         L     +  LYQ+L G+
Sbjct: 65  KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 152 KYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARTTSET----DFMTEYVVTRW- 202
            Y+H+  VLHRDLKP+N+L+         +KI D G AR  +        +   VVT W 
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 203 ---DTLFPGKDYVQ-------------------------------------QLTMITELL 222
              + L   + Y +                                     QL  I  ++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241

Query: 223 GSPDDSDLGFLR--------SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVF 274
           G P D D   +R          + RR       + K     K    S V + L +++L  
Sbjct: 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFL-LLQKLLTM 300

Query: 275 DPAKRITVEEALNHPYL 291
           DP KRIT E+AL  PY 
Sbjct: 301 DPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 78/274 (28%), Positives = 118/274 (43%), Gaps = 42/274 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G GA+G V  A + ET    A K I   + +   D    + EI +L    H NIV + +
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKHPNIVGLYE 69

Query: 102 IIPPMDKEKFND--VYIVYELMDTD-LHQII-RSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    F +  ++I+ E  D   L  I+   ++ LT+   +Y   Q+L  L ++HS 
Sbjct: 70  AY-------FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD-----------FMTEYVV---TRWD 203
            V+HRDLK  N+LL  + D+K+ DFG++     T            +M   VV   T  D
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182

Query: 204 TLFPGKDYVQQL--TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP--FSQKFPN 259
             +  K  +  L  T+I      P   +L  +R     + +K  P    QP  +S  F  
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKILKSEPPTLDQPSKWSSSFN- 239

Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
                 D  +  LV DP  R T  E L HP++S 
Sbjct: 240 ------DFLKSCLVKDPDDRPTAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 14/160 (8%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G YGIV +A +  T+  +AIK+I          + +  EI L  ++ H NIV+    
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQY--- 70

Query: 103 IPPMDKEKFNDVYIVY--ELMDTDLHQIIRSKQALTDDHCQ---YFLYQLLRGLKYIHSA 157
              +  +  N  + ++  ++    L  ++RSK     D+ Q   ++  Q+L GLKY+H  
Sbjct: 71  ---LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127

Query: 158 NVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTE 196
            ++HRD+K  N+L+N     +KI DFG ++  +  +  TE
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 73/280 (26%), Positives = 130/280 (46%), Gaps = 51/280 (18%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKR------ILREIKLLCHMTHEN 95
           IG G++G V   +N+ + E +A+K++   +       ++      + REI LL  + HEN
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           IV+       +D +  N +++ Y +    +  ++ +  A  +   + F+ Q+L+GL Y+H
Sbjct: 68  IVQYLG--SSLDADHLN-IFLEY-VPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSETD---------FMTEYV 198
           +  ++HRD+K +N+L++    +KI DFG+++        T +            +M   V
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Query: 199 VTRWDTLFPGKDYVQQL-TMITELLGS----PDDSDLG--FLRSDNARRYVKQLPHVPKQ 251
           V +  T +  K  +  L  ++ E+L      PD + L   F   +NA       P +P  
Sbjct: 184 VKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS------PEIPS- 234

Query: 252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                  N+S  AID  E+    D  KR T  E L HP+L
Sbjct: 235 -------NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 71.5 bits (175), Expect = 3e-14
 Identities = 67/271 (24%), Positives = 120/271 (44%), Gaps = 37/271 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G+G+YG V    +    ++  IKK+     +R + K   +E +LL  + H NIV  
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHS 156
           ++     D      +YIV    +  DL+  ++ +  + L ++    +  Q+   L+Y+H 
Sbjct: 65  RESWEGEDGL----LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW---DTLFPGKDY- 211
            ++LHRDLK  N+ L     +K+ D G+AR   ++ D  +  + T +     LF  K Y 
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYN 180

Query: 212 -----------VQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM 260
                      V ++  +     + D + L +      R    +LP +PK        + 
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVY------RIIEGKLPPMPK--------DY 226

Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           SP   +L   ML   P KR +V+  L  PY+
Sbjct: 227 SPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 9/149 (6%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  +G GA G V       T    A+K IT    N    K+ILRE+++        IVK 
Sbjct: 6   LSRLGEGAGGSVTKCRLKNTGMIFALKTITTD-PNPDLQKQILRELEINKSCKSPYIVKY 64

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT----DLHQIIRSKQALTDDHCQYFLYQ-LLRGLKYI 154
                 +D E  + + I  E  +      +++ ++ +     +     + + +L+GL Y+
Sbjct: 65  YGAF--LD-ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFG 183
           HS  ++HRD+KPSN+LL     +K+CDFG
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 28/175 (16%)

Query: 40  LQPIGRGAYGIV-----CSAVNSETKEEVAIKKITNAFDNRIDAKR-ILREIKLLCHMTH 93
            + +G GA+G V             KE VA+K +     N  DA++   RE +LL +  H
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQH 67

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS--------------KQALTDD 138
           ENIVK   +    D        +V+E M+  DL++ +RS                 LT  
Sbjct: 68  ENIVKFYGVCTEGDP-----PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                  Q+  G+ Y+ S + +HRDL   N L+  +  +KI DFG++R    TD+
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.0 bits (174), Expect = 4e-14
 Identities = 44/160 (27%), Positives = 86/160 (53%), Gaps = 9/160 (5%)

Query: 35  KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE 94
           KYV  ++ IG G++G      + E  ++  IK+I  +  +  + +   +E+ +L +M H 
Sbjct: 1   KYVK-VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHP 59

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQ--ALTDDHCQYFLYQLLRGL 151
           NIV+ ++       E+  ++YIV +  +  DL++ I +++     +D    +  Q+   L
Sbjct: 60  NIVQYQESF-----EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           K++H   +LHRD+K  N+ L  +  +K+ DFG+AR  + T
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 70.0 bits (171), Expect = 7e-14
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 14/167 (8%)

Query: 40  LQPIGRGAYG--IVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           L+ +G G++G  ++   VNS+ K  +   ++  +     D+++   E  LL  M H NIV
Sbjct: 5   LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIV 61

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLYQLLRGLKYI 154
             K+       E    +YIV E  D  DL Q I+ ++     +D    +  Q+  G+++I
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVT 200
           H   VLHRD+K  N+ L  N  +K+ DFG AR  TS   +   YV T
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 64/265 (24%), Positives = 114/265 (43%), Gaps = 30/265 (11%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G++G V   +++ T++ VAIK I +  +   + + I +EI +L       + K 
Sbjct: 9   LERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                     K   ++I+ E +       +       +      L ++L+GL Y+HS   
Sbjct: 68  YG-----SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK 122

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQ----- 214
           +HRD+K +N+LL+   D+K+ DFG+A   ++T       V     + P  + +QQ     
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP--EVIQQSAYDS 180

Query: 215 --------LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
                   +T I    G P +SD+  +R          L  +PK          S    +
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDMHPMRV---------LFLIPKNNPPTLTGEFSKPFKE 231

Query: 267 LAERMLVFDPAKRITVEEALNHPYL 291
             +  L  DP+ R T +E L H ++
Sbjct: 232 FIDACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 21/171 (12%)

Query: 24  NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR 83
            I G  +      +  L  IG G  G V      +T   +A+K++     N+ + KRIL 
Sbjct: 4   TIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT-GNKEENKRILM 62

Query: 84  EIKLLCHMTHE--NIVK-----VKDIIPPMDKEKFNDVYIVYELMDTDLHQI-IRSKQAL 135
           ++ ++   +H+   IVK     + D           DV+I  ELM T L ++  R +  +
Sbjct: 63  DLDVVL-KSHDCPYIVKCYGYFITDS----------DVFICMELMSTCLDKLLKRIQGPI 111

Query: 136 TDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            +D        +++ L Y+     V+HRD+KPSN+LL+A+ ++K+CDFG++
Sbjct: 112 PEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 71/264 (26%), Positives = 119/264 (45%), Gaps = 27/264 (10%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+GA G V +A++  T +EVAIK++      +   + I+ EI ++    H NIV  
Sbjct: 24  FEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKHPNIVNY 81

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            D     D     ++++V E +       + ++  + +        + L+ L+++HS  V
Sbjct: 82  LDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 136

Query: 160 LHRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTRWDTLFPG 208
           +HRD+K  N+LL  +  +K+ DFG  A+ T E            +M   VVTR     P 
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPK 195

Query: 209 KDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
            D      M  E++ G P   +   LR+     Y+      P+    +K   +S +  D 
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIATNGTPELQNPEK---LSAIFRDF 248

Query: 268 AERMLVFDPAKRITVEEALNHPYL 291
             R L  D  KR + +E L HP+L
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 69/265 (26%), Positives = 119/265 (44%), Gaps = 28/265 (10%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G++G V   +++ TKE VAIK I +  +   + + I +EI +L       I + 
Sbjct: 9   LERIGKGSFGEVYKGIDNRTKEVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 67

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                     K   ++I+ E +       +     L + +    L ++L+GL Y+HS   
Sbjct: 68  YG-----SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK 122

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETD-----------FMTEYVVTRWDTLFPG 208
           +HRD+K +N+LL+   D+K+ DFG+A   ++T            +M   V+ +    F  
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 209 KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQ-PFSQKFPNMSPVAIDL 267
             +   +T I    G P +SDL  +R          L  +PK  P + +     P   + 
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRV---------LFLIPKNSPPTLEGQYSKPFK-EF 232

Query: 268 AERMLVFDPAKRITVEEALNHPYLS 292
            E  L  DP  R T +E L H +++
Sbjct: 233 VEACLNKDPRFRPTAKELLKHKFIT 257

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 68.2 bits (167), Expect = 3e-13
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 8/164 (4%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           P++ +G+GA+G       +E    V  K++     +  + +  L EI +L  + H NI+ 
Sbjct: 4   PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSKQALTDDHCQYFLYQLLRGLKYIH 155
             +          N + I  E  +   L+  I  +  Q   ++   ++L+Q++  + YIH
Sbjct: 64  YYNHF-----MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVV 199
            A +LHRD+K  N+ L     +K+ DFG+++       M E VV
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 82/317 (25%), Positives = 133/317 (41%), Gaps = 76/317 (23%)

Query: 43  IGRGAYGIVCSAVNSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +GRG YG V  A   + K++   A+K+I    +    +    REI LL  + H N++ ++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64

Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA---------LTDDHCQYFLYQLLRGL 151
            +       K   V+++++  + DL  II+  +A         L     +  LYQ+L G+
Sbjct: 65  KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 152 KYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARTTSET----DFMTEYVVTRW- 202
            Y+H+  VLHRDLKP+N+L+         +KI D G AR  +        +   VVT W 
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 203 ---DTLFPGKDYVQQL------TMITELLGS---------------PDDSD--------L 230
              + L   + Y + +       +  ELL S               P   D        +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241

Query: 231 GFLRSDNARRYVKQLPH---VPKQPFSQKFPNMSPV-------------AIDLAERMLVF 274
           GF  +D     +K++P    + K      + N S +             A  L +++L  
Sbjct: 242 GF-PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM 300

Query: 275 DPAKRITVEEALNHPYL 291
           DP KRIT E+A+  PY 
Sbjct: 301 DPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 52/183 (28%), Positives = 76/183 (41%), Gaps = 45/183 (24%)

Query: 58  ETKEEVAIKKITNAFDNRIDA-------KRILREIKLLCHMTHENIVKVKD--IIPPMDK 108
            T  EVAIK +      R DA        R  RE  L   + H NIV + D    PP   
Sbjct: 1   MTGHEVAIKLL------RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP--- 51

Query: 109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPS 167
                ++ V+E +    L +++ +  AL        + Q+L  L   H+  ++HRDLKP 
Sbjct: 52  ---GLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQ 108

Query: 168 NLLLNANCD---LKICDFGLARTTSETDFMTEYVVTRWDTLFPG--KDYVQQLTMITELL 222
           N++++        K+ DFG+                   TL PG     V  LT  TE+L
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIG------------------TLLPGVRDADVATLTRTTEVL 150

Query: 223 GSP 225
           G+P
Sbjct: 151 GTP 153

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           L  IG G++G V  A NS T E VA+KK++ +     +  + I++E+K L  + H N ++
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 99  VKDIIPPMDKEKFNDVYIVYELM---DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
            K         K +  ++V E      +DL ++   K+ L +       +  L+GL Y+H
Sbjct: 86  YKGCY-----LKEHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLH 138

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
           S N++HRD+K  N+LL     +K+ DFG A  +S
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS 172

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 68.2 bits (166), Expect = 5e-13
 Identities = 71/263 (26%), Positives = 121/263 (46%), Gaps = 27/263 (10%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + IG+GA G V +A++  T +EVAIK+I      +   + I+ EI ++  + + NIV   
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPNIVNFL 82

Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           D     D     ++++V E +       + ++  + +        + L+ L+++H+  V+
Sbjct: 83  DSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVI 137

Query: 161 HRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTRWDTLFPGK 209
           HRD+K  N+LL  +  +K+ DFG  A+ T E            +M   VVTR     P  
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKV 196

Query: 210 DYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA 268
           D      M  E++ G P   +   LR+     Y+      P+    +K   +SP+  D  
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIATNGTPELQNPEK---LSPIFRDFL 249

Query: 269 ERMLVFDPAKRITVEEALNHPYL 291
            R L  D  KR + +E L HP+L
Sbjct: 250 NRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.7 bits (165), Expect = 5e-13
 Identities = 50/154 (32%), Positives = 83/154 (53%), Gaps = 15/154 (9%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR---ILREIKLLCHMTHENIV 97
           + IGRG +  V  A     ++ VA+KK+   F+  +DAK     ++EI LL  + H N++
Sbjct: 8   KKIGRGQFSEVYRATCLLDRKPVALKKV-QIFE-MMDAKARQDCVKEIDLLKQLNHPNVI 65

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII----RSKQALTDDHCQYFLYQLLRGLK 152
           K  D        + N++ IV EL D  DL Q+I    + K+ + +     +  QL   ++
Sbjct: 66  KYLDSFI-----EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           ++HS  V+HRD+KP+N+ + A   +K+ D GL R
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 67.8 bits (166), Expect = 5e-13
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 11/157 (7%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G +G V   +       VAIK + +  D+ +  +   +E++ L  + H++++ +  +
Sbjct: 14  LGSGYFGEVWEGLWKNRVR-VAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLISLFAV 70

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANV 159
               +      VYI+ ELM+   L   +RS   Q L          Q+  G+ Y+   N 
Sbjct: 71  CSVGEP-----VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE 196
           +HRDL   N+L+  +   K+ DFGLAR   E  +++ 
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 67.6 bits (165), Expect = 7e-13
 Identities = 42/155 (27%), Positives = 80/155 (51%), Gaps = 19/155 (12%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT----NAFDNRIDAKRILREIKLLCHMTHENI 96
           Q +G GA+     A + +T   +A+K++T     + +     + + +EI+L+  + H +I
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-----DTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +++  +    +   FN   +  E M        L +    K+A+  ++ +    QLLRGL
Sbjct: 66  IRM--LGATCEDSHFN---LFVEWMAGGSVSHLLSKYGAFKEAVIINYTE----QLLRGL 116

Query: 152 KYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLA 185
            Y+H   ++HRD+K +NLL+++    L+I DFG A
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 27/174 (15%)

Query: 32  VSSKYVPPLQPIGRGAYGIVCSA---VNSETKEEVAIK--KITNAFDNRIDAKRILREIK 86
           +   YV   + IG G +G VC     +  + + +VAIK  K  ++   R+D    L E  
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEAS 57

Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLY 145
           ++    H NI++++ ++      K   V I+ E M+   L + +R          ++ + 
Sbjct: 58  IMGQFDHPNIIRLEGVV-----TKSRPVMIITEYMENGSLDKFLRENDG------KFTVG 106

Query: 146 QLLR-------GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           QL+        G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R   +++
Sbjct: 107 QLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 71/259 (27%), Positives = 112/259 (43%), Gaps = 24/259 (9%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +GRGA+GIV        ++ V IK+I      + +      E ++L  ++H NI++  + 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQII--RSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
               DK     + IV E      L + I  R    L +D   +F  Q+L  L ++H+  +
Sbjct: 68  FL-EDKA----LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI 122

Query: 160 LHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDYVQQ 214
           LHRDLK  N+LL+ +   +KI DFG+++  S +      VV     + P    GK Y Q+
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPELCEGKPYNQK 181

Query: 215 LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP----NMSPVAIDLAER 270
             +    LG          R+  A      LP +  +  S  F       SP    L   
Sbjct: 182 SDIWA--LGCVLYELASLKRAFEA----ANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235

Query: 271 MLVFDPAKRITVEEALNHP 289
           ML  DP+KR  + + +  P
Sbjct: 236 MLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 13/174 (7%)

Query: 40  LQPIGRGAYGIVCSA----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G G +G V       +   T E+VA+K + N            REI++L  + HEN
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY--QLLRGLKY 153
           IVK K +    +K     + ++ E + +   +    +     +  +  L+  Q+ +G+ Y
Sbjct: 68  IVKYKGV---CEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
           + S   +HRDL   N+L+ +   +KI DFGLA+   E     +Y   +     P
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK---DYYYVKEPGESP 175

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 65.7 bits (160), Expect = 2e-12
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 9/156 (5%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G++G +  A      E   IK+I        + +   +E+ LL  M H NIV  
Sbjct: 5   IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQAL--TDDHCQYFLYQLLRGLKYIHS 156
                    ++   ++IV E  D  DL + I  ++ +  ++D    +  Q+  GLK+IH 
Sbjct: 65  FASF-----QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 157 ANVLHRDLKPSNLLLNANCDL-KICDFGLARTTSET 191
             +LHRD+K  N+ L+ N  + K+ DFG+AR  +++
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 15/154 (9%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G V  A N ET    A K I    +  ++   +  EI +L    H NIVK+ D 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV--EIDILASCDHPNIVKLLDA 70

Query: 103 IPPMDKEKFNDVYIVYEL-----MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    N+++I+ E      +D  + ++ R    LT+   +    Q L  L Y+H  
Sbjct: 71  F-----YYENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHEN 122

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
            ++HRDLK  N+L   + D+K+ DFG++   + T
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 42/148 (28%), Positives = 89/148 (60%), Gaps = 7/148 (4%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR---EIKLLCHMTHENIVKV 99
           +GRGA+G V    +++T  E+A+K++    D++  +K +     EI+LL ++ H+ IV+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 100 KDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
              +   +++K +   I  E M    +   +++  ALT++  + +  Q+L+G+ Y+HS  
Sbjct: 70  YGCLRDPEEKKLS---IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM 126

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
           ++HRD+K +N+L ++  ++K+ DFG ++
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 43/149 (28%), Positives = 87/149 (58%), Gaps = 9/149 (6%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR---EIKLLCHMTHENIVKV 99
           +G+GA+G V    +++T  E+A+K++    ++   +K +     EI+LL ++ HE IV+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 100 KDII-PPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
              +  PM++     + I  E M    +   ++S  ALT++  + +  Q+L G+ Y+HS 
Sbjct: 70  YGCLRDPMERT----LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            ++HRD+K +N+L ++  ++K+ DFG ++
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 19/153 (12%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G G +G+V        K +VAIK I     +  D    + E K++  ++H N+V++
Sbjct: 9   LKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDD---FIEEAKVMMKLSHPNLVQL 64

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRS-----KQALTDDHCQYFLYQLLRGLKY 153
             +       K   ++IV E M    L   +R            D C      +   ++Y
Sbjct: 65  YGVC-----TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS----DVCEAMEY 115

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           + S   +HRDL   N L+  +  +K+ DFGLAR
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 13/160 (8%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI--TNAFDNRIDAK-RILREIKLLCHMTHENI 96
           ++ IG+G YG V    N +     A+K +   +  D  I+A+  IL+ +       H N+
Sbjct: 27  IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP-----NHPNV 81

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMD----TDLHQ-IIRSKQALTDDHCQYFLYQLLRGL 151
           VK   +    DK     +++V EL +    T+L + ++   Q L +    Y LY  L GL
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           +++H+  ++HRD+K +N+LL     +K+ DFG++   + T
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 50/153 (32%), Positives = 74/153 (48%), Gaps = 8/153 (5%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +Q +G G YG V  A N  T E  A+K I    +   D   I +EI ++    H NIV  
Sbjct: 14  IQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNIVAY 71

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                 + +EK   ++I  E      L  I      L++    Y   + L+GL Y+HS  
Sbjct: 72  --FGSYLSREK---LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
            +HRD+K +N+LL  N D+K+ DFG+A   + T
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 43/148 (29%), Positives = 74/148 (50%), Gaps = 7/148 (4%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           L+ IG G++G V  A +  T E VAIKK++ +     +  + I++E++ L  + H N ++
Sbjct: 20  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSA 157
            K         + +  ++V E        I+   K+ L +       +  L+GL Y+HS 
Sbjct: 80  YKGCYL-----REHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
             +HRD+K  N+LL     +K+ DFG A
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSA 162

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 65.1 bits (158), Expect = 5e-12
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 27/264 (10%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+GA G V +A++  T +EVAIK++      +   + I+ EI ++    + NIV  
Sbjct: 24  FEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPNIVNY 81

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            D     D     ++++V E +       + ++  + +        + L+ L ++HS  V
Sbjct: 82  LDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136

Query: 160 LHRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTRWDTLFPG 208
           +HRD+K  N+LL  +  +K+ DFG  A+ T E            +M   VVTR     P 
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPK 195

Query: 209 KDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
            D      M  E++ G P   +   LR+         L      P  Q    +S V  D 
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIATNGTPELQNPERLSAVFRDF 248

Query: 268 AERMLVFDPAKRITVEEALNHPYL 291
             R L  D  +R + +E L HP+L
Sbjct: 249 LNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 70/269 (26%), Positives = 120/269 (44%), Gaps = 38/269 (14%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI-DAKRILREIKLLCHMTHENIVKVKD 101
           +G G++G V  A +  T E  AIK +      ++   + + +E  +L  ++H  IV +  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM-- 83

Query: 102 IIPPMDKEKFNDVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +    D+ +   VY + E ++  +L   +R      +D  +++  +L+   +Y+HS +++
Sbjct: 84  MCSFQDENR---VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDII 140

Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDF----MTEYV---VTRWDTLFPGKDYVQ 213
           +RDLKP NLLL+    +K+ DFG A+   +  F      EY+   V +        D+  
Sbjct: 141 YRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWT 200

Query: 214 QLTMITELL-GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPVAIDLA 268
              ++ E + G P   DD+          R Y K L          KFPN     A DL 
Sbjct: 201 MGVLLYEFIAGYPPFFDDTPF--------RIYEKILAG------RLKFPNWFDGRARDLV 246

Query: 269 ERMLVFDPAKRI-----TVEEALNHPYLS 292
           + +L  D  KR+      V +  NHPY  
Sbjct: 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFH 275

Length = 329

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 64.3 bits (157), Expect = 6e-12
 Identities = 44/163 (26%), Positives = 80/163 (49%), Gaps = 13/163 (7%)

Query: 32  VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM 91
           ++SK +     IG+G +G V         ++VA+K +    D+   A+  L E  ++  +
Sbjct: 3   INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLK---DDSTAAQAFLAEASVMTTL 57

Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK--QALTDDHCQYFLYQLL 148
            H N+V++  ++  +     N +YIV E M    L   +RS+    +T      F   + 
Sbjct: 58  RHPNLVQLLGVV--LQG---NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
            G++Y+   N +HRDL   N+L++ +   K+ DFGLA+  S+ 
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.8 bits (158), Expect = 6e-12
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 21/177 (11%)

Query: 43  IGRGAYGIVCSAVN-SETKEEVAIK---KITNAFDNRIDAKRILREIKLLCHM-THENIV 97
           +G GA+G V  A     +K +  +K   K+     +  + + ++ E+K++ H+  HENIV
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 98  KVKDIIPPMDKEKFNDVYIVYEL-MDTDLHQIIRSKQA--LTDDHCQYFLYQLLRGLKYI 154
            +              + ++ E     DL   +R K+   LT +    F YQ+ +G+ ++
Sbjct: 103 NLLGAC-----TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE--YVVTRWDTLFPGK 209
            S N +HRDL   N+LL     +KICDFGLAR     D M +  YVV + +   P K
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVV-KGNARLPVK 208

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 8e-12
 Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 13/150 (8%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           + IG+G +G V   V  +   EVA+K  + T   D +    + L+E ++L    H NIVK
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKR---KFLQEAEILKQYDHPNIVK 56

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           +  +   + K+    +YIV EL+     L  + + K  LT             G++Y+ S
Sbjct: 57  LIGVC--VQKQP---IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  LKI DFG++R
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 64.4 bits (157), Expect = 8e-12
 Identities = 68/274 (24%), Positives = 119/274 (43%), Gaps = 38/274 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +  +G G  G V S V       V  KK+ +        K+ILRE++++       IV  
Sbjct: 10  ISDLGAGNGGSV-SKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSF 68

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                       N++ +  E MD   L +I +    +  +        ++ GL Y+++ +
Sbjct: 69  YGAF-----LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 159 -VLHRDLKPSNLLLNANCDLKICDFG----LARTTSETDFMTEYVVTRWDTLFPGKDYVQ 213
            ++HRD+KPSN+L+N+   +K+CDFG    L  + ++T F+        + +  GK  V+
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-FVGTSTYMSPERIQGGKYTVK 182

Query: 214 Q------LTMITELLG------SPDDSD-----LGFLRSDNARRYVKQLPHVPKQPFSQK 256
                  +++I   LG      S  D D     +G L  D  ++ V++ P  P+ P S  
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL--DLLQQIVQEPP--PRLP-SSD 237

Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
           FP       D  +  L+ DP +R T ++    P 
Sbjct: 238 FP---EDLRDFVDACLLKDPTERPTPQQLCAMPP 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 64.3 bits (156), Expect = 9e-12
 Identities = 50/154 (32%), Positives = 80/154 (51%), Gaps = 15/154 (9%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR---ILREIKLLCHMTHENIV 97
           + IGRG +  V  A        VA+KK+   FD  +DAK     ++EI LL  + H N++
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKV-QIFD-LMDAKARADCIKEIDLLKQLNHPNVI 65

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIR----SKQALTDDHCQYFLYQLLRGLK 152
           K           + N++ IV EL D  DL ++I+     K+ + +     +  QL   L+
Sbjct: 66  KYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           ++HS  V+HRD+KP+N+ + A   +K+ D GL R
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 44/150 (29%), Positives = 76/150 (50%), Gaps = 13/150 (8%)

Query: 43  IGRGAYGIV-CSAVNSETKEEVAIKKITNAFDNRIDAKRILR----EIKLLCHMTHENIV 97
           +G+GAYG V C   N    + +A+K++     N + A++       E+ LL  + H NIV
Sbjct: 8   LGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 98  KVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           +   +   +D    N + I  E +    +  I+     L +     +  Q+L G+ Y+H+
Sbjct: 66  QY--LGTCLDD---NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             V+HRD+K +N++L  N  +K+ DFG AR
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 67/281 (23%), Positives = 130/281 (46%), Gaps = 47/281 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR-ILREIKLLCHMTHENIVK 98
           L  +G+G YG V  A   +T E VA+K++  +   +++  R +L E  +L     E +VK
Sbjct: 6   LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           +           F D   +Y  M+     D   ++ +   L++DH ++++ ++   +  +
Sbjct: 66  LL--------YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL 117

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--------TDFMTEYVV--TRWDT 204
           H    +HRDLKP N L++A+  +K+ DFGL++             D+M   V+    +D 
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDF 177

Query: 205 LFPGKDYVQQLTMITELL--------GSPDDSDLGFLRSDNARRYVKQLPHVPKQP-FSQ 255
                DY     M+ E L         +P+++       +N + + + L    ++P +  
Sbjct: 178 ---TVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYWKETL----QRPVYDD 224

Query: 256 KFPNMSPVAIDLAERMLVFDPAKRI-TVEEALNHPYLSSLH 295
              N+S  A DL  +++  DP++R  ++E+  NHP+   + 
Sbjct: 225 PRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 21/154 (13%)

Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAF--DNRIDAKRILREIKLLCHMTHENIV 97
           IG G +G V      +    +  VAIK +   +    R D    L E  ++   +H NI+
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD---FLSEASIMGQFSHHNII 69

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQALTDDHCQYFLYQLLRG----LK 152
           +++ ++      KF    I+ E M+   L + +R       +   Y L  +LRG    +K
Sbjct: 70  RLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMK 121

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Y+   N +HRDL   N+L+N+N + K+ DFGL+R
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 63.6 bits (154), Expect = 2e-11
 Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 11/159 (6%)

Query: 35  KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTH 93
           K    L+ IG G++G V  A +  T E VAIKK++ +     +  + I++E+K L  + H
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELM---DTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
            N ++ K         + +  ++V E      +DL ++   K+ L +       +  L+G
Sbjct: 85  PNSIEYKGCY-----LREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAITHGALQG 137

Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
           L Y+HS N++HRD+K  N+LL     +K+ DFG A   S
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 16/155 (10%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           IG+G  G V  A +      VA+KKI  +  +N +  KR LRE K+   + H  IV V  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 102 IIPPMDKEKFNDVYIVYELMDTDLHQIIRS---KQALTDDHCQ-----YFL---YQLLRG 150
           I    D   +   YI        L  +++S   K++L+ +  +      FL   +++   
Sbjct: 70  ICSDGDPVYYTMPYIEGY----TLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           ++Y+HS  VLHRDLKP N+LL    ++ I D+G A
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160

Length = 932

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 65/291 (22%), Positives = 124/291 (42%), Gaps = 59/291 (20%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVK 98
           L+ +G GAYG V             ++K+      ++ A ++L++  ++    T E+   
Sbjct: 5   LRVLGTGAYGKV-----------FLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT 53

Query: 99  VKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIR------------SKQALTDDHCQYFLY 145
            + ++  + +  F  V + Y    DT LH I+              ++  T+   + ++ 
Sbjct: 54  ERQVLEAVRRCPFL-VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA 112

Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSETD----------F 193
           +++  L ++H   +++RD+K  N+LL++   + + DFGL++     E +          +
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172

Query: 194 MTEYVVTRWDTLFPGKDYV---QQLTMIT-ELL--GSPDDSDLG-FLRSDNARRYVKQLP 246
           M   V+        G D       L ++T ELL   SP   D     +S+ +RR +K  P
Sbjct: 173 MAPEVIRGGS---GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP 229

Query: 247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRI---TVEEALNHPYLSSL 294
             P          MS  A D  +++L  DP KR+     +E  NHP+   +
Sbjct: 230 PFP--------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 44/281 (15%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK--RILREIKLLCHMTHENIV 97
           L  +G+G YG V   ++  T   +A+K+I    D   ++K  +I+ E+ +L       IV
Sbjct: 6   LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD---ESKFNQIIMELDILHKAVSPYIV 62

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDT----DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
              D       E    VY+  E MD      L+    + + + +D  +   Y +++GLK+
Sbjct: 63  ---DFYGAFFIE--GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 154 IHSA-NVLHRDLKPSNLLLNANCDLKICDFG----LARTTSETD-----FMTEYVVTRWD 203
           +    N++HRD+KP+N+L+N N  +K+CDFG    L  + ++T+     +M    +    
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGG 177

Query: 204 TLFPGKDYVQQ------LTMITELLGS----PDDSDLGFLRSDNARRYVKQLPHVPKQPF 253
                   VQ       L+++   LG     P+     F           QL  +     
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF----------AQLSAIVDGDP 227

Query: 254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
                  S  A D   + L   P +R T  + L HP+L   
Sbjct: 228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 43/160 (26%), Positives = 84/160 (52%), Gaps = 13/160 (8%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI--TNAFDNRIDAK-RILREIKLLCHMTHENI 96
           ++ IG+G YG V   +N +   + A+K +   +  D  I+A+  IL+ +       H N+
Sbjct: 23  IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNV 77

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMD----TDLHQ-IIRSKQALTDDHCQYFLYQLLRGL 151
           VK   +    D +  + +++V EL +    TDL +  ++  + + +    Y L++ L GL
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           +++H    +HRD+K +N+LL     +K+ DFG++   + T
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.4 bits (151), Expect = 4e-11
 Identities = 68/264 (25%), Positives = 118/264 (44%), Gaps = 27/264 (10%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+GA G V +A++  T +EVAI+++      +   + I+ EI ++    + NIV  
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            D     D     ++++V E +       + ++  + +        + L+ L+++HS  V
Sbjct: 83  LDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 160 LHRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTRWDTLFPG 208
           +HRD+K  N+LL  +  +K+ DFG  A+ T E            +M   VVTR     P 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPK 196

Query: 209 KDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
            D      M  E++ G P   +   LR+     Y+      P+    +K   +S +  D 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRA----LYLIATNGTPELQNPEK---LSAIFRDF 249

Query: 268 AERMLVFDPAKRITVEEALNHPYL 291
             R L  D  KR + +E L H +L
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 56/285 (19%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK- 98
           ++ +G G YG V    + +T +  AIK +    D   + K  +  +K   H  H NI   
Sbjct: 21  VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSH--HRNIATY 78

Query: 99  ----VKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRG 150
               +K   P  D +    +++V E       TDL +  +   AL +D   Y   ++LRG
Sbjct: 79  YGAFIKKSPPGHDDQ----LWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRG 133

Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFG----LARTTSETD-------FMTEYVV 199
           L ++H+  V+HRD+K  N+LL  N ++K+ DFG    L RT    +       +M   V+
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 200 TRWDTLFPGKDYVQQL-----TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP-- 252
              +      DY   +     T I    G+P   D+  +R+         L  +P+ P  
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---------LFLIPRNPPP 244

Query: 253 ------FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                 +S+KF       ID  E  LV +   R + E+ L HP++
Sbjct: 245 KLKSKKWSKKF-------IDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 6e-11
 Identities = 38/152 (25%), Positives = 66/152 (43%), Gaps = 15/152 (9%)

Query: 43  IGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G V   V         EVA+K +          K  LRE  ++  + H  IV++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE-HIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 100 KDII--PPMDKEKFNDVYIVYELMDTD-LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
             +    P+         +V EL     L + ++ ++ +     +   +Q+  G+ Y+ S
Sbjct: 62  IGVCKGEPL--------MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES 113

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTT 188
            + +HRDL   N+LL      KI DFG++R  
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 71/275 (25%), Positives = 118/275 (42%), Gaps = 42/275 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK---- 98
           +G G YG V    + +T +  AIK +    D   + K+ +  +K   H  H NI      
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATYYGA 71

Query: 99  -VKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            +K   P MD +    +++V E       TDL +  +    L ++   Y   ++LRGL +
Sbjct: 72  FIKKNPPGMDDQ----LWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSH 126

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFG----LARTTSETD-------FMTEYVVTRW 202
           +H   V+HRD+K  N+LL  N ++K+ DFG    L RT    +       +M   V+   
Sbjct: 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 203 DTLFPGKDYVQQL-----TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ-K 256
           +      D+   L     T I    G+P   D+  +R+         L  +P+ P  + K
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---------LFLIPRNPAPRLK 237

Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
               S       E  LV + ++R T E+ + HP++
Sbjct: 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 76/275 (27%), Positives = 121/275 (44%), Gaps = 42/275 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G V  A N ET    A K I    +  ++   +  EI++L    H  IVK+   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV--EIEILATCNHPYIVKLLGA 77

Query: 103 IPPMDKEKFNDVYIVYEL-----MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                K     ++I+ E      +D  + ++ R    LT+   Q    Q+L  L+Y+HS 
Sbjct: 78  FYWDGK-----LWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM 129

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA----RTTSETD-------FMTEYVV---TRWD 203
            ++HRDLK  N+LL  + D+K+ DFG++    +T    D       +M   VV   T  D
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 204 TLFPGKDYVQQL--TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP--FSQKFPN 259
           T +  K  +  L  T+I      P   +L  +R     +  K  P    QP  +S +F +
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSEPPTLSQPSKWSMEFRD 247

Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
               A+D         P  R +  + L HP++SS+
Sbjct: 248 FLKTALDK-------HPETRPSAAQLLEHPFVSSV 275

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 67/301 (22%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD----NRIDAKRILREIKLLCHMTHE 94
            ++ IGRGA+G V    + +T +  A+K +    D    N+I   R  R+I     +   
Sbjct: 5   VIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDI-----LADA 58

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +   +  +      E+   +Y+V E M   DL  ++  K    ++  ++++ +L+  L  
Sbjct: 59  DSPWIVKLYYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYV- 212
           +H    +HRD+KP N+L++A+  +K+ DFGL +  ++      Y+    + LF     V 
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 213 -----QQLTMITELLGSPD--------------DSD---LG------------FLRSDNA 238
                Q+       +G+PD              + D   LG            F      
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236

Query: 239 RRYVK--------QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRIT-VEEALNHP 289
             Y K        + P  P          +SP AIDL  R L+ DP  R+   EE  +HP
Sbjct: 237 ETYNKIINWKESLRFPPDPP---------VSPEAIDLICR-LLCDPEDRLGSFEEIKSHP 286

Query: 290 Y 290
           +
Sbjct: 287 F 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 61.2 bits (148), Expect = 8e-11
 Identities = 49/153 (32%), Positives = 71/153 (46%), Gaps = 8/153 (5%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +Q IG G YG V  A N  T E  AIK I    +   D   + +EI ++    H NIV  
Sbjct: 14  IQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                  DK     ++I  E      L  I      L++    Y   + L+GL Y+HS  
Sbjct: 72  FGSYLRRDK-----LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
            +HRD+K +N+LL  N  +K+ DFG++   + T
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 39/164 (23%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAI--KKITNAFDNRIDAKRILREIKLL-----CHM 91
            ++ IGRGA+G            EV +  KK T      I A + LR+ ++L      H+
Sbjct: 5   SIKVIGRGAFG------------EVRLVQKKDTG----HIYAMKKLRKSEMLEKEQVAHV 48

Query: 92  THENIVKVKDIIPPMD-------KEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHC 140
             E     +DI+   D          F D   +Y +M+     D+  ++  K   T++  
Sbjct: 49  RAE-----RDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET 103

Query: 141 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 184
           ++++ + +  +  IH    +HRD+KP NLLL+A   +K+ DFGL
Sbjct: 104 RFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 28/148 (18%)

Query: 63  VAIKKI-TNAFDN-RIDAKRILREIKLLCHMTHENIVKVKDII---PPMDKEKFNDVYIV 117
           VA+K +  +A DN R D    L+E+K+L  ++  NI ++  +    PP+         ++
Sbjct: 49  VAVKVLRPDASDNARED---FLKEVKILSRLSDPNIARLLGVCTVDPPL--------CMI 97

Query: 118 YELMDT-DLHQIIRSKQALTDDHCQY--------FLY---QLLRGLKYIHSANVLHRDLK 165
            E M+  DL+Q ++   A T               LY   Q+  G++Y+ S N +HRDL 
Sbjct: 98  MEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157

Query: 166 PSNLLLNANCDLKICDFGLARTTSETDF 193
             N L+  N  +KI DFG++R    +D+
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYSSDY 185

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 26/170 (15%)

Query: 43  IGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           +G GA+G V  A        + K  VA+K + +A DN    K   RE +LL ++ HE+IV
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA--RKDFHREAELLTNLQHEHIV 70

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK-------------QALTDDHCQYF 143
           K   +    D      + +V+E M   DL++ +R+                LT     + 
Sbjct: 71  KFYGVCVEGDP-----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 144 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             Q+  G+ Y+ S + +HRDL   N L+  N  +KI DFG++R    TD+
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 175

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 71/269 (26%), Positives = 119/269 (44%), Gaps = 33/269 (12%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKD 101
           IG+G++G V      +T+   A+K I  A   +R +    L E  +L  +    IV +K 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                  EK   +Y+V   ++  +L   ++ +        +++  +LL  L+ +H  NV+
Sbjct: 60  -FSFQSPEK---LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115

Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDYVQQL- 215
           +RDLKP N+LL+    + +CDFGL +   + D  T       + L P    G  Y + + 
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175

Query: 216 -----TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP-NMSPVAIDLA 268
                 ++ E+L G P      F   +    Y K L    ++P   +FP      A DL 
Sbjct: 176 WWTLGVLLYEMLTGLPP-----FYDENVNEMYRKIL----QEPL--RFPDGFDRDAKDLL 224

Query: 269 ERMLVFDPAKRITV---EEALNHPYLSSL 294
             +L  DP +R+     +E  NHP+ S L
Sbjct: 225 IGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 40/162 (24%), Positives = 85/162 (52%), Gaps = 18/162 (11%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG+G +G V      +T+   A+K ++         K+ +   K + H   E  + V+ +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLS---------KKEIVAKKEVAHTIGERNILVRTL 51

Query: 103 I---PPMDKEKFN-----DVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +   P +   KF+     D+Y+V + M   +L   ++ +   ++D  ++++ +L+  L++
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEH 111

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
           +H  ++++RDLKP N+LL+A   + +CDFGL++     +  T
Sbjct: 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 36/136 (26%), Positives = 64/136 (47%), Gaps = 16/136 (11%)

Query: 71  AFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQII 129
           +  + +    I++E      + H NIV+        D+     +YIV +L++   L +  
Sbjct: 51  SIGDIVSEVTIIKE-----QLRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHF 100

Query: 130 RS----KQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNLLLNANCDLKICDFGL 184
            S    KQ  T++       Q++  L+Y+H    ++HRDL P+N++L  +  + I DFGL
Sbjct: 101 NSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160

Query: 185 ARTTSETDFMTEYVVT 200
           A+       +T  V T
Sbjct: 161 AKQKQPESKLTSVVGT 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.5 bits (146), Expect = 2e-10
 Identities = 63/263 (23%), Positives = 115/263 (43%), Gaps = 26/263 (9%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G++G V   +++ T++ VAIK I +  +   + + I +EI +L       + K 
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                     K   ++I+ E +       +     L +      L ++L+GL Y+HS   
Sbjct: 68  YG-----SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETD-----------FMTEYVVTRWDTLFPG 208
           +HRD+K +N+LL+ + ++K+ DFG+A   ++T            +M   V+ +       
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182

Query: 209 KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA 268
             +   +T I    G P  S+L           +K L  +PK        N S    +  
Sbjct: 183 DIWSLGITAIELAKGEPPHSEL---------HPMKVLFLIPKNNPPTLEGNYSKPLKEFV 233

Query: 269 ERMLVFDPAKRITVEEALNHPYL 291
           E  L  +P+ R T +E L H ++
Sbjct: 234 EACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 27/156 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G +G V       T ++VA+K I       + A+  L E  ++  + H+N+V++  +
Sbjct: 14  IGEGEFGAVLQG--EYTGQKVAVKNIKC----DVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSK-QALTDDHCQYFLYQLLR-------GLKY 153
           I        N +YIV ELM   +L   +R++ +AL        + QLL+       G++Y
Sbjct: 68  I------LHNGLYIVMELMSKGNLVNFLRTRGRALVS------VIQLLQFSLDVAEGMEY 115

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
           + S  ++HRDL   N+L++ +   K+ DFGLAR  S
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 40/147 (27%), Positives = 83/147 (56%), Gaps = 5/147 (3%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR---EIKLLCHMTHENIVKV 99
           +G+GA+G V    + +T  E+A K++    ++   +K +     EI+LL ++ HE IV+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
              +     EK   +++ Y +    +   +++  ALT+   + +  Q+L G+ Y+HS  +
Sbjct: 70  YGCLRD-RAEKTLTIFMEY-MPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HRD+K +N+L ++  ++K+ DFG ++
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 23/155 (14%)

Query: 43  IGRGAYGIVCSA-VNSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G VCS  +    K E  VAIK +   +  +   +  L E  ++    H NI+ +
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-QRRDFLSEASIMGQFDHPNIIHL 70

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQL---LRG----L 151
           + ++      K   V IV E M+   L   +R          Q+ + QL   LRG    +
Sbjct: 71  EGVV-----TKSKPVMIVTEYMENGSLDAFLRKHDG------QFTVIQLVGMLRGIASGM 119

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           KY+     +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 42/172 (24%), Positives = 81/172 (47%), Gaps = 26/172 (15%)

Query: 40  LQPIGRGAYGIV-----CSAVNSETKEEVAIKKITNAFDNRIDAKRI--LREIKLLCHMT 92
           ++ +G+G++G+V        V  E +  VAIK +    +N    +RI  L E  ++    
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV---NENASMRERIEFLNEASVMKEFN 67

Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHC-------QYFL 144
             ++V++  ++            +V ELM   DL   +RS++   +++        Q F+
Sbjct: 68  CHHVVRLLGVV-----STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122

Query: 145 Y---QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
               ++  G+ Y+ +   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY 174

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.0 bits (143), Expect = 5e-10
 Identities = 43/171 (25%), Positives = 79/171 (46%), Gaps = 16/171 (9%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEE---VAIKKITNAFDNRIDAKRILREIK 86
           +++  + +   + IG G +G V   V    + E   VA+K   N        ++ L+E  
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS-VREKFLQEAY 59

Query: 87  LLCHMTHENIVKVKDII--PPMDKEKFNDVYIVYELMDT-DLHQII-RSKQALTDDHCQY 142
           ++    H +IVK+  +I   P+        +IV EL    +L   +  +K +L       
Sbjct: 60  IMRQFDHPHIVKLIGVITENPV--------WIVMELAPLGELRSYLQVNKYSLDLASLIL 111

Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           + YQL   L Y+ S   +HRD+   N+L+++   +K+ DFGL+R   +  +
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 59.1 bits (143), Expect = 5e-10
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 23/155 (14%)

Query: 43  IGRGAYGIVCSA-VNSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G VC   +    K E  VAIK + + +  +   +  L E  ++    H NI+ +
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNIIHL 70

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQL---LRG----L 151
           + ++      K   V I+ E M+   L   +R          Q+ + QL   LRG    +
Sbjct: 71  EGVV-----TKSRPVMIITEFMENGALDSFLRQNDG------QFTVIQLVGMLRGIAAGM 119

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           KY+   N +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 11/159 (6%)

Query: 35  KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTH 93
           K    L+ IG G++G V  A +    E VAIKK++ +     +  + I++E++ L  + H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELM---DTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
            N ++ +         + +  ++V E      +DL ++   K+ L +       +  L+G
Sbjct: 75  PNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQG 127

Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
           L Y+HS N++HRD+K  N+LL+    +K+ DFG A   +
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 36/155 (23%), Positives = 73/155 (47%), Gaps = 25/155 (16%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIK--KITNAFDNRI-----DAKRILREIKLLCHMTHEN 95
           +G G +G V    +  ++   A+K   I      +      + KR+L+E+       H  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS------HPF 62

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           I+++            +D   +Y LM+     +L   +R+    ++    ++  +++  L
Sbjct: 63  IIRLF--------WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL 114

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +Y+HS  +++RDLKP N+LL+    +K+ DFG A+
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 14/148 (9%)

Query: 43  IGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G +G V     N  TK  VA+K +       +  +  L+E +++  + H+ +V++  
Sbjct: 14  LGAGQFGEVWMGTWNGTTK--VAVKTLKPG---TMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSAN 158
           +    +      +YIV E M    L   ++S   + L          Q+  G+ Y+ S N
Sbjct: 69  VCSEEEP-----IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN 123

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +HRDL   N+L+  N   KI DFGLAR
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 58.3 bits (141), Expect = 8e-10
 Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 23/164 (14%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 103 I---PPMDKEKFNDVYIVYELMDT-DLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R   +Q +      Y   Q+   ++Y+  
Sbjct: 71  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT 200
            N +HRDL   N L+  N  +K+ DFGL+R       MT    T
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSR------LMTGDTYT 160

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 16/159 (10%)

Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRI----DAKRILREIKLLCHMTHEN 95
           IG+G +G V       +   K   A+K +     NRI    + ++ L+E  ++   +H N
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL-----NRITDLEEVEQFLKEGIIMKDFSHPN 57

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYI 154
           ++ +  I  P   E    V + Y +   DL   IRS+    T      F  Q+ +G++Y+
Sbjct: 58  VLSLLGICLP--SEGSPLVVLPY-MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL 114

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
            S   +HRDL   N +L+ +  +K+ DFGLAR   + ++
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 25/156 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IGRGA+G V           +  KK T      I A +ILR+  +L      +I   
Sbjct: 6   LKVIGRGAFGEV----------RLVQKKDTG----HIYAMKILRKADMLEKEQVAHIRAE 51

Query: 100 KDIIPPMDKE-------KFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLL 148
           +DI+   D          F D   +Y +M+     D+  ++  K  L+++  Q+++ + +
Sbjct: 52  RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV 111

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 184
             +  IH    +HRD+KP NLLL+A   +K+ DFGL
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 25/156 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IGRGA+G V      +T    A+K              ILR+  +L      +I   
Sbjct: 6   LKVIGRGAFGEVRLVQKKDTGHVYAMK--------------ILRKADMLEKEQVGHIRAE 51

Query: 100 KDIIPPMD-----------KEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL 148
           +DI+   D           ++K N   I+  L   D+  ++  K  LT++  Q+++ + +
Sbjct: 52  RDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV 111

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 184
             +  IH    +HRD+KP NLLL++   +K+ DFGL
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 13/155 (8%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           LQ IG+G +G V   +      +VA+K I N       A+  L E  ++  + H N+V++
Sbjct: 11  LQTIGKGEFGDV--MLGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQL 64

Query: 100 KDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHS 156
             +I     E+   +YIV E M    L   +RS+    L  D    F   +   ++Y+ +
Sbjct: 65  LGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
            N +HRDL   N+L++ +   K+ DFGL +  S T
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 63/291 (21%), Positives = 129/291 (44%), Gaps = 55/291 (18%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVK 98
           L+ +G GAYG V             ++K++     ++ A ++L++  ++    T E+   
Sbjct: 5   LKVLGTGAYGKV-----------FLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT 53

Query: 99  VKDIIPPMDKEKFNDVYIVYELM-DTDLHQII------------RSKQALTDDHCQYFLY 145
            + ++  + +  F  V + Y    DT LH I+              ++   +   Q +  
Sbjct: 54  ERQVLEHIRQSPFL-VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG 112

Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--TSET----------DF 193
           +++  L+++H   +++RD+K  N+LL++N  + + DFGL++     E           ++
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 194 MTEYVVTRWDTLF-PGKDYVQQLTMITELL--GSPDDSD-LGFLRSDNARRYVKQLPHVP 249
           M   +V   D       D+     ++ ELL   SP   D     +++ +RR +K  P  P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 232

Query: 250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLH 295
           ++        MS +A D+ +R+L+ DP KR+       +E   HP+   ++
Sbjct: 233 QE--------MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 39/163 (23%)

Query: 43  IGRGAYGIV----CSAVNSETKEEVAIK-----KITNAFDNRIDAKRILREIKLLCHMTH 93
           +G G++G+V     S    +    VA+K     K+++  D+       L+E  ++  + H
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIP-VAVKCLKSDKLSDIMDD------FLKEAAIMHSLDH 55

Query: 94  ENIVKVKDII--PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY------ 145
           EN++++  ++   P+             +M T+L  +      L  D   +FL       
Sbjct: 56  ENLIRLYGVVLTHPL-------------MMVTELAPLGSLLDRLRKDALGHFLISTLCDY 102

Query: 146 --QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             Q+  G++Y+ S   +HRDL   N+LL ++  +KI DFGL R
Sbjct: 103 AVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 39/148 (26%), Positives = 73/148 (49%), Gaps = 11/148 (7%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           Q IG G +G+V      E K +VAIK I     +  D      E +++  ++H  +V++ 
Sbjct: 10  QEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPKLVQLY 65

Query: 101 DIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSAN 158
            +       + + + +V+E M+   L   +R+++   + +        +  G+ Y+ S+N
Sbjct: 66  GVC-----TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
           V+HRDL   N L+  N  +K+ DFG+ R
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 12/162 (7%)

Query: 35  KYVPPLQPIGRGAYGIVC----SAVNSETKEEVAIK--KITNAFDNRIDAKRILREIKLL 88
           +Y+  ++ +G G +G V        N  T E VA+K  K      N    K+   EI +L
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINIL 60

Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL 148
             + HENIVK K       ++    + ++ E +     +    K  L       F  Q+ 
Sbjct: 61  KTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQIC 117

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            G+ Y+HS + +HRDL   N+LL+ +  +KI DFGLA+   E
Sbjct: 118 EGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 17/156 (10%)

Query: 40  LQPIGRGAYGIV--C--SAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           +Q +G+G +G V  C    +   T E VA+KK+ ++    +  +   REI++L  + H+N
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL--RDFEREIEILKSLQHDN 66

Query: 96  IVKVKDIIPPMDKEKFNDV--YIVY-ELMDTDLHQIIRSKQALTDDHCQYFLY--QLLRG 150
           IVK K +     +     V  Y+ Y  L D     + + ++ L  DH +  LY  Q+ +G
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRD----YLQKHRERL--DHRKLLLYASQICKG 120

Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           ++Y+ S   +HRDL   N+L+ +   +KI DFGL +
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK 156

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 8/151 (5%)

Query: 41  QPIGRGAYGIVCSAVNSETKEE---VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           Q +G+G++G V    + +   E     +K+I     N  +  +  +E +LL  + H  IV
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           K       ++++ F  +    E  D D  L ++  + + L+++    +  QLL G+ Y+H
Sbjct: 66  KFHASF--LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
              +LHRDLK  N+ L  N  LKI DFG++R
Sbjct: 124 QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 29/217 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVK 98
           ++ IG GA+G VC     +T    A+K +  A    R  A  +  E  +L    +E +VK
Sbjct: 6   IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVK 65

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           +           F D   +Y +MD     D+  ++       +D  ++++ +L   ++ +
Sbjct: 66  LY--------YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW--DTLFPGK-DY 211
           H    +HRD+KP N+L++ +  +K+ DFGL      T F       RW  D+ +  K D+
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLC-----TGF-------RWTHDSKYYQKGDH 165

Query: 212 VQQLTM-ITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
            +Q +M  +E     D   L  L     R++ + L H
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAH 202

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 30/176 (17%)

Query: 43  IGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G +G V  A  N  TK  VA+K +       +  +  L E  ++  + H+ +VK+  
Sbjct: 14  LGAGQFGEVWMATYNKHTK--VAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHA 68

Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-------LTDDHCQYFLYQLLRGLKY 153
           ++    KE    +YI+ E M    L   ++S +        L D     F  Q+  G+ +
Sbjct: 69  VV---TKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGMAF 117

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK 209
           I   N +HRDL+ +N+L++A+   KI DFGLAR   + ++       R    FP K
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-----TAREGAKFPIK 168

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 67/277 (24%), Positives = 128/277 (46%), Gaps = 18/277 (6%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIK-LLCHMTHENIVKVK 100
           IG+G++G V  A +   ++  A+K +   A   + + K I+ E   LL ++ H  +V + 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 101 DIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                 DK     +Y V + ++  +L   ++ ++   +   +++  ++   L Y+HS N+
Sbjct: 63  FSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 117

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMIT 219
           ++RDLKP N+LL++   + + DFGL +   E +  T       + L P   + Q      
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV 177

Query: 220 E--LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPA 277
           +   LG+     L  L    +R   +   ++  +P   K PN++  A  L E +L  D  
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK-PNITNSARHLLEGLLQKDRT 236

Query: 278 KRITVE----EALNHPYLSSLH--EINEEPTCPYPFN 308
           KR+  +    E  NH + S ++  ++  +   P PFN
Sbjct: 237 KRLGAKDDFMEIKNHIFFSPINWDDLINKKITP-PFN 272

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 56.3 bits (136), Expect = 6e-09
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 26/154 (16%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLL--CHMTHENIVK-- 98
           +G G  G+V   ++  +   +A K I       I   +I+RE+K+L  C+  +  IV   
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAI-RNQIIRELKVLHECNSPY--IVGFY 65

Query: 99  ---VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
                D           ++ I  E MD   L Q+++    + ++        +LRGL Y+
Sbjct: 66  GAFYSD----------GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYL 115

Query: 155 ---HSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
              H   ++HRD+KPSN+L+N+  ++K+CDFG++
Sbjct: 116 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 147

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 7e-09
 Identities = 71/305 (23%), Positives = 118/305 (38%), Gaps = 68/305 (22%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G VC+     T +  A KK+        + KRI +       +  + I+     
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKL--------EKKRIKKRKGEAMALNEKQIL----- 54

Query: 103 IPPMDKEKFNDVYIV-----YE----------LM---DTDLHQIIRSKQALTDDHCQYFL 144
                 EK N  ++V     YE          LM   D   H          ++   ++ 
Sbjct: 55  ------EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA 108

Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD----------FM 194
            ++  GL+ +H   +++RDLKP N+LL+    ++I D GLA    E +          +M
Sbjct: 109 AEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYM 168

Query: 195 TEYVVTRWDTLFPGKDYVQQLTMITELLG--SPDDSDLGFLRSDNARRYVKQLPHVPKQP 252
              VV      F   D+     +I E++   SP       ++ +   R VK+        
Sbjct: 169 APEVVKNERYTF-SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEE---- 223

Query: 253 FSQKFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLH----EIN--EEP 301
           +S+KF   S  A  +  ++L  DP  R+       EE   HP+  + +    E    E P
Sbjct: 224 YSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPP 280

Query: 302 TCPYP 306
            CP P
Sbjct: 281 FCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 23/61 (37%), Positives = 35/61 (57%)

Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           + LT      F YQ+ RG++++ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 193 F 193
           +
Sbjct: 187 Y 187

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 55.1 bits (132), Expect = 1e-08
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 13/154 (8%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 14  LGQGCFGEVWMGTWNGTTR-VAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLYQLLRGLKYIHSANV 159
           +          +YIV E M    L   ++ +    L          Q+  G+ Y+   N 
Sbjct: 70  VSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 63/289 (21%), Positives = 121/289 (41%), Gaps = 54/289 (18%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVK 98
           L+ +G GAYG V             ++K+T     ++ A ++L++  L+    T E+   
Sbjct: 5   LKVLGTGAYGKV-----------FLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRT 53

Query: 99  VKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIR------------SKQALTDDHCQYFLY 145
            ++++  + +  F  V + Y    +  LH I+              +   ++D  +++  
Sbjct: 54  ERNVLEHVRQSPFL-VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG 112

Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---------RTTS---ETDF 193
           +++  L+++H   +++RD+K  N+LL++   + + DFGL+         RT S     ++
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 194 MTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR---SDNARRYVKQLPHVPK 250
           M   ++          D+     +I ELL       L   R   S+ +RR +K  P  P 
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP- 231

Query: 251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSL 294
                    + P A DL  ++L  DP KR+        E   HP+   L
Sbjct: 232 -------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 20/152 (13%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IGRG +G V S         VA+K         + AK  L+E ++L   +H NIV++  +
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 61

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLR-------GLKYI 154
                  +   +YIV EL+   D    +R++        +  + +L++       G++Y+
Sbjct: 62  C-----TQKQPIYIVMELVQGGDFLTFLRTEGP------RLKVKELIQMVENAAAGMEYL 110

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            S + +HRDL   N L+     LKI DFG++R
Sbjct: 111 ESKHCIHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 75/284 (26%), Positives = 131/284 (46%), Gaps = 36/284 (12%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIK-LLCHMTHENIVKVK 100
           IG+G++G V  A +    +  A+K +   A   + + K I+ E   LL ++ H  +V + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 101 DIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                 DK     +Y V + ++  +L   ++ +++  +   +++  ++   L Y+HS N+
Sbjct: 63  YSFQTADK-----LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLAR-------TTSETDFMTEYV---VTRWDTLFPGK 209
           ++RDLKP N+LL++   + + DFGL +       TTS      EY+   V R        
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177

Query: 210 DYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA 268
           D+     ++ E+L G P      F   D A  Y   L     +P   K PN+S  A  L 
Sbjct: 178 DWWCLGAVLYEMLYGLPP-----FYSRDTAEMYDNIL----NKPLRLK-PNISVSARHLL 227

Query: 269 ERMLVFDPAKRI----TVEEALNHPYLSSLHE---INEEPTCPY 305
           E +L  D  KR+       E  NH + SS++    +N++ T P+
Sbjct: 228 EGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPF 271

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 40/151 (26%), Positives = 76/151 (50%), Gaps = 9/151 (5%)

Query: 40  LQPIGRGAYG---IVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
           L+ +G+G++G   +V      +  +  A+K +  A     D  R   E  +L  + H  I
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 97  VKVKDIIPPMDKEKFNDVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           VK+        K     +Y++ + L   DL   +  +   T++  +++L +L   L ++H
Sbjct: 61  VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           S  +++RDLKP N+LL+    +K+ DFGL++
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 31/189 (16%)

Query: 122 DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-LKIC 180
           D DL  +++ +  L++   +  + QL+  L  +H  N++H D+K  N+L +   D + +C
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 181 DFGLAR---TTSETDFMTEY------VVTRWDTLFPGKDYVQQLTMITELL--GSP---- 225
           D+GL +   T S  D   +Y          +D  F   D+     +  ELL    P    
Sbjct: 153 DYGLCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSF---DWWAVGVLTYELLTGKHPFKED 209

Query: 226 DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKR-ITVEE 284
           +D +L        +R  K+LP            N+S  A D  + ML ++   R     E
Sbjct: 210 EDEELDL--ESLLKRQQKKLP---------FIKNVSKNANDFVQSMLKYNINYRLTNYNE 258

Query: 285 ALNHPYLSS 293
            + HP+L  
Sbjct: 259 IIKHPFLKI 267

Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 9/146 (6%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V      + K  VA+K         +  K  L E ++L    H NIVK+  +
Sbjct: 3   LGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60

Query: 103 IPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                  +   +YIV EL+     L  + + K  L       F      G+ Y+ S N +
Sbjct: 61  C-----TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115

Query: 161 HRDLKPSNLLLNANCDLKICDFGLAR 186
           HRDL   N L+  N  LKI DFG++R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 63/277 (22%), Positives = 115/277 (41%), Gaps = 40/277 (14%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR----ILREIKLLCHMTHENIVK 98
           +G+G +G VC+     T +  A KK+      RI  ++     L E ++L  +    +V 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 99  VKDIIPPMDKEKFNDVYIVYELM---DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           +         E  + + +V  LM   D   H     +    +    ++  ++  GL+ +H
Sbjct: 65  LA-----YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----------TDFMTEYVVTRWDTL 205
              +++RDLKP N+LL+ +  ++I D GLA    E            +M   VV      
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 179

Query: 206 FPGKDYVQQLTMITELLG--SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
           F   D+     ++ E++   SP       ++ +   R VK++     + +S+KF   SP 
Sbjct: 180 F-SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ----EEYSEKF---SPD 231

Query: 264 AIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLH 295
           A  L + +L  DP +R+        E   HP    ++
Sbjct: 232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 71/285 (24%), Positives = 130/285 (45%), Gaps = 34/285 (11%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIK-LLCHMTHENIVKVK 100
           IG+G++G V  A      +  A+K +      NR + K I+ E   LL ++ H  +V + 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 101 DIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                 +K     +Y V + ++  +L   ++ +++  +   +++  ++   L Y+HS N+
Sbjct: 63  YSFQTTEK-----LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMT------EYV---VTRWDTLFPGK 209
           ++RDLKP N+LL++   + + DFGL +   +++D  T      EY+   V R        
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177

Query: 210 DYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA 268
           D+     ++ E+L G P      F   D A  Y     ++  +P   + P  S  A  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPP-----FYCRDVAEMY----DNILHKPLVLR-PGASLTAWSIL 227

Query: 269 ERMLVFDPAKRITVEEAL----NHPYLSSLHEIN-EEPTCPYPFN 308
           E +L  D  +R+  +E       HP+  SL   + E+   P PFN
Sbjct: 228 EELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFN 272

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 41/156 (26%), Positives = 81/156 (51%), Gaps = 26/156 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IGRGA+G            EVA+ K+ NA  +++ A +IL + ++L         + 
Sbjct: 6   LKVIGRGAFG------------EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREE 51

Query: 100 KDIIPPMDKE-------KFNDVYIVYELMD----TDLHQII-RSKQALTDDHCQYFLYQL 147
           +D++   D +        F D   +Y +MD     DL  ++ + +  L +D  +++L ++
Sbjct: 52  RDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM 111

Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 183
           +  +  +H  + +HRD+KP N+L++ N  +++ DFG
Sbjct: 112 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 11/149 (7%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G +G+V        + +VAIK I     +  D    + E K++  ++H  +V++
Sbjct: 9   MKELGSGQFGVV-HLGKWRAQIKVAIKAINEGAMSEED---FIEEAKVMMKLSHPKLVQL 64

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
             +       +   +YIV E M+   L   +R +Q  L+ D        +  G++Y+   
Sbjct: 65  YGVC-----TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           + +HRDL   N L+++   +K+ DFG+ R
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 30/173 (17%)

Query: 43  IGRGAYGIV----CSAVNSET-KEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTHENI 96
           +G GA+G V    C  +  E  K  VA+K +  A ++ R D +R   E +LL  + H++I
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQHI 69

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQ---------------ALTDDHC 140
           V+   +           + +V+E M   DL++ +RS                  LT    
Sbjct: 70  VRFYGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124

Query: 141 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                Q+  G+ Y+ S + +HRDL   N L+     +KI DFG++R    TD+
Sbjct: 125 LAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 177

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 32/203 (15%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++PI RGA+G V         +  A+K +  A  + I+            +M H+   + 
Sbjct: 9   VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA--DMINK-----------NMVHQVQAE- 54

Query: 100 KDIIPPMDKEKF-----------NDVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQL 147
           +D +  + K  F           N+VY+V E L+  D+  ++       ++    ++ ++
Sbjct: 55  RDALA-LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEV 113

Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
              L Y+H   ++HRDLKP N+L++    +K+ DFGL++ T   +     ++T      P
Sbjct: 114 ALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173

Query: 208 GKDYV----QQLTMITEL-LGSP 225
             DY     Q L++I+ L   +P
Sbjct: 174 KNDYSRTPGQVLSLISSLGFNTP 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 34/125 (27%), Positives = 61/125 (48%), Gaps = 18/125 (14%)

Query: 82  LREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQI-----IRSKQAL 135
           L+EIK++  + + NI+++  +    D      + ++ E M+  DL+Q      I S    
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 136 TDD-------HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 188
            ++       +  Y   Q+  G+KY+ S N +HRDL   N L+  +  +KI DFG++R  
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Query: 189 SETDF 193
              D+
Sbjct: 180 YSGDY 184

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 34/161 (21%), Positives = 77/161 (47%), Gaps = 15/161 (9%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIV 97
            ++ +G+G  G V       T +  A+K +       R   KR+L E ++L  + H  + 
Sbjct: 5   KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMD----TDLHQII--RSKQALTDDHCQYFLYQLLRGL 151
            +         E +     +  +MD     +L +++  +  + L+++  +++  ++L  L
Sbjct: 65  TLYASF---QTETY-----LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           +Y+H   +++RDLKP N+LL+ +  + + DF L++ +    
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 24/56 (42%), Positives = 37/56 (66%)

Query: 131 SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            K+ LT +    + +Q+ RG++++ S   +HRDL   N+LL+ N  +KICDFGLAR
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 53.4 bits (128), Expect = 3e-08
 Identities = 40/150 (26%), Positives = 74/150 (49%), Gaps = 7/150 (4%)

Query: 43  IGRGAYGIVCSAVNSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +G G +G V   +    K E  VA+K + N  ++      +LRE  ++  + +  IV++ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
            I    + E +  V  + EL    L++ ++  + +T+ +    ++Q+  G+KY+   N +
Sbjct: 63  GIC---EAESWMLVMELAEL--GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117

Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSE 190
           HRDL   N+LL      KI DFGL++    
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGA 147

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 44/173 (25%), Positives = 83/173 (47%), Gaps = 24/173 (13%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           +++  + +  ++ +G G +G V     N+ TK  VA+K +       +  +  L E  L+
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPG---TMSVQAFLEEANLM 55

Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQA-------LTDDHC 140
             + H+ +V++  ++      K   +YI+ E M    L   ++S +        L D   
Sbjct: 56  KTLQHDKLVRLYAVV-----TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID--- 107

Query: 141 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             F  Q+  G+ YI   N +HRDL+ +N+L++ +   KI DFGLAR   + ++
Sbjct: 108 --FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 37/161 (22%), Positives = 73/161 (45%), Gaps = 10/161 (6%)

Query: 43  IGRGAYGIVCSAV--NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +G G +G V        ++  +VA+K +  A   R + +  L E   +    H N++++ 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 101 DI-IPPMDKEKFNDVYIVYELMD-TDLHQII------RSKQALTDDHCQYFLYQLLRGLK 152
            + +  ++ E +    ++   M   DLH  +         Q L       F+  +  G++
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           Y+ S + +HRDL   N +LN N ++ + DFGL++     D+
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY 167

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 23/55 (41%), Positives = 37/55 (67%)

Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           K+ LT +    + +Q+ +G++++ S   +HRDL   N+LL+ N  +KICDFGLAR
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 227

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 48/166 (28%), Positives = 87/166 (52%), Gaps = 15/166 (9%)

Query: 35  KYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIK--KITNAFDNRIDAKRILREIKLL 88
           +++  ++ +G G +G V  C        T E+VA+K  K  +  ++  D K+   EI++L
Sbjct: 4   RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEIL 60

Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII-RSKQALTDDHCQYFLYQ 146
            ++ HENIVK K I     ++  N + ++ E + +  L + + R+K  +       +  Q
Sbjct: 61  RNLYHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ 117

Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           + +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +   ETD
Sbjct: 118 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETD 162

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 54/283 (19%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI---------LREIKLLCHMTH 93
           +G+G +G VC+     T +  A KK+        D KR+         L E K+L  ++ 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKL--------DKKRLKKRKGEQMALNEKKILEKVSS 52

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS--KQALTDDHCQYFLYQLLRG 150
             IV +         E  +D+ +V  LM+  DL   I +  +    +    ++  Q++ G
Sbjct: 53  RFIVSLAYAF-----ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG 107

Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT---------- 200
           L+++H   +++RDLKP N+LL+ + +++I D GLA        +     T          
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167

Query: 201 --RWDTLFPGKDYVQQLTMITELLG--SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK 256
              +D  F   D+      + E++   SP       +  +  +R   ++       +  K
Sbjct: 168 GEVYD--FS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA----VEYPDK 220

Query: 257 FPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSL 294
           F   SP A DL E +L  DP KR+     + +E   HP    L
Sbjct: 221 F---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 36/170 (21%), Positives = 76/170 (44%), Gaps = 21/170 (12%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEE-----VAIKKITNAFDNRIDAKRILREIKLLCHMTH 93
            +  +GRG +G V  A     +EE     V +K +    D  + ++   RE+ +   ++H
Sbjct: 9   EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE-FRRELDMFRKLSH 67

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR---------SKQALTDDHCQYF 143
           +N+V++  +    + E     Y++ E  D  DL Q +R             L+       
Sbjct: 68  KNVVRLLGLC--REAEPH---YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122

Query: 144 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             Q+  G+ ++ +A  +HRDL   N L+++  ++K+    L++    +++
Sbjct: 123 CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 25/156 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G GA+G VC A   +TK   A+K               LR+  +L      ++   
Sbjct: 6   IKTLGIGAFGEVCLARKVDTKALYAMKT--------------LRKKDVLLRNQVAHVKAE 51

Query: 100 KDIIPPMDKE-------KFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLL 148
           +DI+   D E        F D   +Y +MD     D+  ++       +D  ++++ +L 
Sbjct: 52  RDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELT 111

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 184
             ++ +H    +HRD+KP N+L++ +  +K+ DFGL
Sbjct: 112 CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 13/153 (8%)

Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   V      + K  VAIK +          K IL E  ++  + H +
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPH 70

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +V++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 71  VVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 31/174 (17%)

Query: 43  IGRGAYGIV----CSAVNSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
           +G GA+G V    C  + S TK++  VA+K + +        K   RE +LL ++ HE+I
Sbjct: 13  LGEGAFGKVFLAECYNL-SPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHI 69

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR----------------SKQALTDDH 139
           VK   +    D      + +V+E M   DL++ +R                +K  L    
Sbjct: 70  VKFYGVCGDGDP-----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 140 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             +   Q+  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R    TD+
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 40/164 (24%), Positives = 76/164 (46%), Gaps = 28/164 (17%)

Query: 46  GAYG--IVCSAVNSETKEEVAIKKITNAFDNRIDAKRIL---------------REIKLL 88
           GA+G   +C A+ + T+E  A + + +    +   +R++                EI  L
Sbjct: 159 GAFGKIFIC-ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILAL 217

Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDD-----HCQYF 143
             + HENI+K+++I+         + Y++ +  D DL+  +  +     D       +  
Sbjct: 218 GRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272

Query: 144 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
           + QLL  ++YIH   ++HRD+K  N+ LN +  + + DFG A  
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316

Length = 501

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 14/172 (8%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMTHENIVKVK 100
           IGRGA+G V   V  ++ ++V   K+ + F+   R D+     E  +   M   N   V 
Sbjct: 51  IGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDI---MAFANSPWVV 106

Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
            +      +K+  +Y+V E M       + S   + +   +++  +++  L  IHS  ++
Sbjct: 107 QLFCAFQDDKY--LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 164

Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYV 212
           HRD+KP N+LL+ +  LK+ DFG      ET  +      R DT     DY+
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV------RCDTAVGTPDYI 210

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 52.6 bits (126), Expect = 8e-08
 Identities = 19/40 (47%), Positives = 31/40 (77%)

Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +++GL Y+ S  +LHRD+KPSN+L+N    +K+CDFG++ 
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 40/156 (25%), Positives = 79/156 (50%), Gaps = 26/156 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IGRGA+G            EVA+ K+ +    RI A +IL + ++L         + 
Sbjct: 6   IKVIGRGAFG------------EVAVVKMKHT--ERIYAMKILNKWEMLKRAETACFREE 51

Query: 100 KDIIPPMDKE-------KFNDVYIVYELMD----TDLHQII-RSKQALTDDHCQYFLYQL 147
           ++++   D +        F D   +Y +MD     DL  ++ + +  L +D  ++++ ++
Sbjct: 52  RNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEM 111

Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 183
           +  +  IH  + +HRD+KP N+LL+ N  +++ DFG
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 14/87 (16%)

Query: 132 KQALTDDHCQ--------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 183
           K  L+DD  +         F YQ+ RG++++ S N +HRDL   N+LL     +KICDFG
Sbjct: 223 KNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFG 282

Query: 184 LARTTSETDFMTEY-VVTRWDTLFPGK 209
           LAR     D M +   V++  T  P K
Sbjct: 283 LAR-----DIMHDSNYVSKGSTFLPVK 304

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 1/90 (1%)

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           VK  DI    + E   D Y+      T    +I    AL+      F YQ+  G++++ S
Sbjct: 199 VKYADI-ESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS 257

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N+L+     +KICDFGLAR
Sbjct: 258 KNCVHRDLAARNVLICEGKLVKICDFGLAR 287

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 38/148 (25%), Positives = 66/148 (44%), Gaps = 28/148 (18%)

Query: 63  VAIKKITNAFDNRIDAKR-----ILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV 117
           VA+K +      R DA +      L+EIK++  +   NI+++  +    D      + ++
Sbjct: 49  VAVKML------REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDP-----LCMI 97

Query: 118 YELMDT-DLHQIIRSKQALTD-----------DHCQYFLYQLLRGLKYIHSANVLHRDLK 165
            E M+  DL+Q +   +                   +   Q+  G+KY+ S N +HRDL 
Sbjct: 98  TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157

Query: 166 PSNLLLNANCDLKICDFGLARTTSETDF 193
             N L+  N  +KI DFG++R     D+
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 25/170 (14%)

Query: 43  IGRGAYGIVCSAV------NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
           +G GA+G V                 VA+K +     ++ + K  L+E  L+ +  H NI
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-EKKEFLKEAHLMSNFNHPNI 61

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLL------- 148
           VK+  +   +  E     YI+ ELM+  DL   +R  +          L +LL       
Sbjct: 62  VKLLGVC--LLNEP---QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNA---NCD--LKICDFGLARTTSETDF 193
           +G  Y+   + +HRDL   N L++    + D  +KI DFGLAR   ++D+
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 40/277 (14%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G +G VC+     T +  A K++       R      L E ++L  +  + +V +  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA- 66

Query: 102 IIPPMDKEKFNDVYIVYELM---DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                  E  + + +V  +M   D   H          ++   ++  ++L GL+ +H  N
Sbjct: 67  ----YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMI 218
            ++RDLKP N+LL+    ++I D GLA    E + +   V T          Y+    + 
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT--------VGYMAPEVLN 174

Query: 219 TELLG-SPDDSDLGFL-------------RSDNARR-YVKQLPHVPKQPFSQKFPNMSPV 263
            +    SPD   LG L             R +  +R  V +     ++ +S KF   S  
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF---SEE 231

Query: 264 AIDLAERMLVFDPAKRITVE-----EALNHPYLSSLH 295
           A  + + +L  DP +R+  +     E   HP+  +++
Sbjct: 232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 44/147 (29%), Positives = 75/147 (51%), Gaps = 16/147 (10%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMTHENIVKVK 100
           IGRGA+G V   V  ++ ++V   K+ + F+   R D+     E  ++ H   E IV++ 
Sbjct: 51  IGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109

Query: 101 DIIPPMDKEKFND---VYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
                     F D   +Y+V E M   DL  ++ S   + +   +++  +++  L  IHS
Sbjct: 110 --------YAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDAIHS 160

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFG 183
              +HRD+KP N+LL+ +  LK+ DFG
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 42/176 (23%), Positives = 82/176 (46%), Gaps = 16/176 (9%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVK 98
           ++ +G GA+G VC A   +T    A+K +      NR     +  E  +L    +E +VK
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           +           F D   +Y +MD     D+  ++   +   +   ++++ +L   ++ +
Sbjct: 66  LY--------YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLA---RTTSETDFMTEYVVTRWDTLFP 207
           H    +HRD+KP N+L++ +  +K+ DFGL    R T  + +  +    R D++ P
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 11/148 (7%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN---AFDNRIDAKRILREIKLLCHMTHENIVKV 99
           I  GAYG V    + ET++  A+KKI        N+I    + R+I     +T      V
Sbjct: 9   ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI-----LTFAENPFV 63

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
             +    + ++   + +V E ++  D   ++++  AL  D  + +  + +  L+Y+H+  
Sbjct: 64  VSMFCSFETKRH--LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
           ++HRDLKP NLL+ +   +K+ DFGL++
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 22/162 (13%)

Query: 40  LQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G G +G V   + N+ T   VA+K +       +D K  L E +++  + H  +++
Sbjct: 11  LRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPG---TMDPKDFLAEAQIMKKLRHPKLIQ 65

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL-------RGL 151
           +  +    +      +YIV ELM      ++   Q       +  L QL+        G+
Sbjct: 66  LYAVCTLEEP-----IYIVTELMKYG--SLLEYLQGGAGRALK--LPQLIDMAAQVASGM 116

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
            Y+ + N +HRDL   N+L+  N   K+ DFGLAR   E  +
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 26/57 (45%), Positives = 34/57 (59%), Gaps = 3/57 (5%)

Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVV 199
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR     D  + YVV
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR-ND--SNYVV 272

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 24/55 (43%), Positives = 36/55 (65%)

Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           K  LT +    + +Q+ RG++++ S   +HRDL   N+LL+ N  +KICDFGLAR
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 222

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 15/158 (9%)

Query: 40  LQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           ++ +G G +G V     N  TK  VA+K +       +  +  L E +++  + H+ +V+
Sbjct: 11  IKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPG---TMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIH 155
           +  ++          +YIV E M    L   ++    +AL   +      Q+  G+ YI 
Sbjct: 66  LYAVVSE------EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             N +HRDL+ +N+L+      KI DFGLAR   + ++
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 25/75 (33%), Positives = 48/75 (64%), Gaps = 2/75 (2%)

Query: 113 DVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNLL 170
           ++ I  E MD   L Q+++  + + ++        +LRGL Y+   + ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136

Query: 171 LNANCDLKICDFGLA 185
           +N+  ++K+CDFG++
Sbjct: 137 VNSRGEIKLCDFGVS 151

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 69/300 (23%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIK---KITNAFDNRIDAKRILREI-------KLLCHM- 91
           +G+G++G V  A    T E  AIK   K     D+ ++   + R +         L H+ 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 92  ----THENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQ 146
               T E++                  + V E ++  DL   I+S     +   +++  +
Sbjct: 63  CTFQTKEHL------------------FFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE 104

Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLF 206
           ++ GL+++H   +++RDLK  N+LL+ +  +KI DFG+ +     +          D + 
Sbjct: 105 IICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIA 164

Query: 207 P----GKDYVQQL------TMITELL--GSP---DDSDLGF--LRSDNARRYVKQLPHVP 249
           P    G+ Y + +       ++ E+L   SP   +D D  F  + +D         PH P
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--------PHFP 216

Query: 250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEAL-NHPYLSSLH-EINEEPTCPYPF 307
           +         +S  A D   ++   DP KR+ V+  +  HP+   +  E  E+   P PF
Sbjct: 217 RW--------ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPF 268

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 60/277 (21%), Positives = 115/277 (41%), Gaps = 37/277 (13%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G +G V +     T +  A KK+       R   +  + E ++L  +    IV +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 102 IIPPMDKEKFNDVYIVYELMDT-DL----HQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
                  +   D+ +V  +M+  DL    + +        +    ++  Q++ GL+++H 
Sbjct: 61  AF-----QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE-YVVT---RWDTLFPGKDY- 211
             +++RDLKP N+LL+ + +++I D GLA    +    T+ Y  T       L  G++Y 
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 212 --VQQLTM---ITELLGSPDDSDLGFLRSDNARRYVKQLPH-VPKQP--FSQKFPNMSPV 263
             V    +   + E++ +      G  R+   +   K+L   +      +  KF   SP 
Sbjct: 176 FSVDYFALGVTLYEMIAAR-----GPFRARGEKVENKELKQRILNDSVTYPDKF---SPA 227

Query: 264 AIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLH 295
           +    E +L  DP KR+       +    HP    L+
Sbjct: 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 34/164 (20%), Positives = 67/164 (40%), Gaps = 15/164 (9%)

Query: 43  IGRGAYGIVCSAVNSE---TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G V     S+   ++ +VA+K +        + +  L E   +    H N++K+
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 100 KDI-IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLL--------R 149
             +       +K     ++   M   DLH  +   +       +    Q L         
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKFMVDIAL 124

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           G++Y+ + N +HRDL   N +L  +  + + DFGL++     D+
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 38/149 (25%), Positives = 66/149 (44%), Gaps = 11/149 (7%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G G +G+V        + +VAIK I    +  +     + E K++  ++HE +V++
Sbjct: 9   LKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQL 64

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSA 157
             +       K   +YIV E M    L   +R                 +  G+ Y+ S 
Sbjct: 65  YGVC-----TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N L++    +K+ DFGL+R
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 22/49 (44%), Positives = 32/49 (65%)

Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDY 192

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 8/157 (5%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA G V  A      E  A+K +     +  D  R   E+  L +    +IVK  + 
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 103 IPPMDKEKFNDVYIVYELMD----TDLHQIIRSK----QALTDDHCQYFLYQLLRGLKYI 154
               D     +V ++  ++D     DL Q I+S+    +   +        Q+L  + ++
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV 159

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           HS +++HRD+K +N+LL +N  +K+ DFG ++  + T
Sbjct: 160 HSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT 196

Length = 496

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 25/160 (15%)

Query: 43  IGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G +G V     N  TK  VAIK +       +  +  L E  L+  + H  +V++  
Sbjct: 14  LGAGQFGEVWMGYYNGHTK--VAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLL-------RGLKY 153
           ++    +E    +YI+ E M+   L   ++     T +  +  + +L+        G+ +
Sbjct: 69  VV---TQEP---IYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMAAQIAEGMAF 117

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           I   N +HRDL+ +N+L++     KI DFGLAR   + ++
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 37/148 (25%), Positives = 68/148 (45%), Gaps = 7/148 (4%)

Query: 44  GRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI-----VK 98
           GR  YGI+      +  EEV +K + +   + I    +L+E  LL  ++H+NI     V 
Sbjct: 20  GRIFYGILIDEKPGKE-EEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVC 77

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           ++D  PP     + +   +   +         + QAL+     +   Q+  G+ Y+H   
Sbjct: 78  IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG 137

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
           V+H+D+   N +++    +KI D  L+R
Sbjct: 138 VIHKDIAARNCVIDEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 21/49 (42%), Positives = 32/49 (65%)

Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR   + D+
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 61/268 (22%), Positives = 110/268 (41%), Gaps = 70/268 (26%)

Query: 82  LREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY-----IVYELMDTDLHQII-RSKQAL 135
           L E  LL ++ H +++++KD +          V      +V     +DL+  + +  + L
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTL----------VSGAITCMVLPHYSSDLYTYLTKRSRPL 154

Query: 136 TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--------- 186
             D       Q+L GL+Y+H+  ++HRD+K  N+ +N    + I D G A+         
Sbjct: 155 PIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214

Query: 187 ---TTSETDFMTEYVVTRWDT----------LFP---------------GKDYV-----Q 213
               T ET+        ++++          LF                 ++YV      
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274

Query: 214 QLTMITELLGSPDDSDLGFLRSDNAR--RYVKQLPHVPKQPFSQKFPNMSPVAID----- 266
            L +I+ L   P++    F R   +R  R   +   + +QP+++ +P    V +      
Sbjct: 275 LLKIISTLKVHPEE----FPRDPGSRLVRGFIEYASLERQPYTR-YPCFQRVNLPIDGEF 329

Query: 267 LAERMLVFDPAKRITVEEALNHPYLSSL 294
           L  +ML FD A R + EE LN+P  + L
Sbjct: 330 LVHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 18/55 (32%), Positives = 39/55 (70%)

Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           ++  T++  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +
Sbjct: 89  ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.5 bits (118), Expect = 8e-07
 Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 11/162 (6%)

Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G+G +G V  A       + ++VA+K +     +  D +  LRE   +    H N++K+
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 100 KDI-IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ------ALTDDHCQYFLYQLLRGL 151
             + +    K +     ++   M   DLH  +   +       L       F+  +  G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +Y+ S N +HRDL   N +LN N  + + DFGL++     D+
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY 168

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.5 bits (118), Expect = 8e-07
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 26/156 (16%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI---------LREIKLLCHMTH 93
           IGRG +G V     ++T +  A+K +        D KRI         L E  +L  ++ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVST 53

Query: 94  EN---IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLR 149
            +   IV +       DK  F     + +LM+  DLH  +      ++   +++  +++ 
Sbjct: 54  GDCPFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL 108

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           GL+++H+  V++RDLKP+N+LL+ +  ++I D GLA
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 49.4 bits (118), Expect = 8e-07
 Identities = 44/178 (24%), Positives = 76/178 (42%), Gaps = 32/178 (17%)

Query: 40  LQPIGRGAYGIV-----CSAVNSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHMT 92
           L+ +G GA+G V            +   VAIK  K       + + ++   E +L+  + 
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ---EAELMSDLQ 66

Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQY--------- 142
           H NIV    ++    KE+     +++E +   DLH+ +      +D   +          
Sbjct: 67  HPNIVC---LLGVCTKEQ--PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 143 ----FL---YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
               FL    Q+  G++Y+ S + +HRDL   N L+     +KI DFGL+R     D+
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 38/153 (24%), Positives = 77/153 (50%), Gaps = 14/153 (9%)

Query: 40  LQPIGRGAYG-IVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIV 97
           ++ +G G++G ++ +   +E    VAIK+   +    +     +  E K+L ++ H   V
Sbjct: 35  IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94

Query: 98  KVKDIIPPMDKEKFND---VYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            +           F D   +Y+V E ++  +    +R  +   +D   ++  Q++   +Y
Sbjct: 95  NLYG--------SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEY 146

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           + S N+++RDLKP NLLL+ +  +K+ DFG A+
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179

Length = 340

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 49.7 bits (119), Expect = 9e-07
 Identities = 36/140 (25%), Positives = 64/140 (45%), Gaps = 14/140 (10%)

Query: 49  GIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK 108
            IV  A +  T   VA+KKI     ++ D K + +EI     + H NI+        +  
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF--IVD 71

Query: 109 EKFNDVYIVYELMD----TDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHR 162
              +++Y+V  LM      DL   +++   + L +    + L  +L  L YIHS   +HR
Sbjct: 72  ---SELYVVSPLMAYGSCEDL---LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHR 125

Query: 163 DLKPSNLLLNANCDLKICDF 182
            +K S++LL+ +  + +   
Sbjct: 126 SVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.4 bits (118), Expect = 9e-07
 Identities = 19/59 (32%), Positives = 37/59 (62%)

Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
           +D   ++L ++   L+++H   +++RDLKP N+LL+A   +K+ DFGL + +     +T
Sbjct: 99  EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.8 bits (119), Expect = 9e-07
 Identities = 42/171 (24%), Positives = 68/171 (39%), Gaps = 24/171 (14%)

Query: 22  QYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI 81
           QYNIL +L         P    G      VC+    E +++V +K +T         K  
Sbjct: 93  QYNILSSL--------TP----GSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTP 133

Query: 82  LREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQ 141
            REI +L  ++H  I+ +        + K + V +V      DL   +     L  +   
Sbjct: 134 GREIDILKTISHRAIINLIHAY----RWK-STVCMVMPKYKCDLFTYVDRSGPLPLEQAI 188

Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
               +LL  L Y+H   ++HRD+K  N+ L+   +  + DFG A       
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239

Length = 392

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.8 bits (119), Expect = 9e-07
 Identities = 25/59 (42%), Positives = 34/59 (57%), Gaps = 7/59 (11%)

Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE--YVV 199
           F  Q+ +G+ ++ S N +HRD+   N+LL      KICDFGLAR     D M +  YVV
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVV 270

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 33/164 (20%)

Query: 43  IGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G +G V     N  TK  VAIK +       +  +  L+E +++  + H+ +V +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTK--VAIKTLKPG---TMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 102 IIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD-----DHCQYFLYQLLR------- 149
           ++          +YIV E M          K +L D     D     L QL+        
Sbjct: 69  VVSE------EPIYIVTEFM---------GKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           G+ YI   N +HRDL+ +N+L+  N   KI DFGLAR   + ++
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 22/179 (12%)

Query: 31  QVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREI 85
           +V    +  L+ +G GA+G V   +         + +VA+K +  +  +  D    L E 
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEA 60

Query: 86  KLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFL 144
            ++    H+NIV++  +      E+    +I+ ELM   DL   +R  +   +      +
Sbjct: 61  LIMSKFNHQNIVRLIGV----SFER-LPRFILLELMAGGDLKSFLRENRPRPERPSSLTM 115

Query: 145 YQLLR-------GLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARTTSETDF 193
             LL        G KY+   + +HRD+   N LL         KI DFG+AR      +
Sbjct: 116 KDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY 174

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 36/153 (23%), Positives = 75/153 (49%), Gaps = 14/153 (9%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  +G+G++G V  A    T E  AIK +            ++++  + C M  + ++ +
Sbjct: 5   LMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--------VIQDDDVECTMVEKRVLAL 56

Query: 100 KDIIPPMDK-----EKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + +     +  + +Y V E ++  DL   I+      + H  ++  ++  GL +
Sbjct: 57  SGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFF 116

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS  +++RDLK  N++L++   +KI DFG+ +
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 37/132 (28%), Positives = 62/132 (46%), Gaps = 25/132 (18%)

Query: 82  LREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQ------- 133
           L+E+K+L  +   NI+++  +    D      + ++ E M+  DL+Q + S         
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDP-----LCMITEYMENGDLNQFLSSHHLDDKEEN 121

Query: 134 ---ALTDDHC------QYFLY---QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 181
              A+   HC         L+   Q+  G+KY+ S N +HRDL   N L+  N  +KI D
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181

Query: 182 FGLARTTSETDF 193
           FG++R     D+
Sbjct: 182 FGMSRNLYAGDY 193

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 42/151 (27%), Positives = 78/151 (51%), Gaps = 16/151 (10%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR----ILREIKLLCHMTHEN--- 95
           IGRG +G V     ++T +  A+K +      RI  K+     L E  +L  ++  +   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           IV +       DK  F     + +LM+  DLH  +      ++   +++  +++ GL+++
Sbjct: 59  IVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHM 113

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           H+  V++RDLKP+N+LL+ +  ++I D GLA
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 21/49 (42%), Positives = 31/49 (63%)

Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 53/237 (22%), Positives = 98/237 (41%), Gaps = 53/237 (22%)

Query: 113 DVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNLL 170
           ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 136

Query: 171 LNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDYVQQ-------LTMIT 219
           +N+  ++K+CDFG++      D M    V     + P    G  Y  Q       L+++ 
Sbjct: 137 VNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194

Query: 220 ELLGS-----PDDSDLGF-----LRSDNARRYVKQLPHVPKQPFSQKFPN-MSPVAI--- 265
             +G      PD  +L       +  D A       P  P +P S   P+   P+AI   
Sbjct: 195 MAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFEL 254

Query: 266 ----------------------DLAERMLVFDPAKRITVEEALNHPYL--SSLHEIN 298
                                 D   + L+ +PA+R  +++ + H ++  S   E++
Sbjct: 255 LDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAEEVD 311

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 21/49 (42%), Positives = 31/49 (63%)

Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 195

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 19/42 (45%), Positives = 29/42 (69%)

Query: 144 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           + Q+L GL+ +H   ++HRD+KP NLL+  +  +KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 19/58 (32%), Positives = 39/58 (67%)

Query: 129 IRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +  ++  ++D  +++  +++  L Y+HS +V++RDLK  NL+L+ +  +KI DFGL +
Sbjct: 86  LSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 33/152 (21%), Positives = 73/152 (48%), Gaps = 14/152 (9%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + +G+G++G V  A   E+    A+K +            IL++  + C MT + I+ + 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDV--------ILQDDDVECTMTEKRILSLA 52

Query: 101 DIIPPMDK-----EKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
              P + +     +  + ++ V E ++  DL   I+  +   +   +++  ++   L ++
Sbjct: 53  RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFL 112

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           H   +++RDLK  N+LL+     K+ DFG+ +
Sbjct: 113 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 42/180 (23%), Positives = 85/180 (47%), Gaps = 21/180 (11%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
            L  +G+G++G V  A    T E  AIK +            ++++  + C M  + ++ 
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--------VIQDDDVECTMVEKRVLA 55

Query: 99  VKDIIPPMDK-----EKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
           ++D  P + +     +  + +Y V E ++  DL   I+      +    ++  ++  GL 
Sbjct: 56  LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYV 212
           ++H   +++RDLK  N++L++   +KI DFG+ +     + M + V TR  T     DY+
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTR--TFCGTPDYI 168

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 41/175 (23%), Positives = 72/175 (41%), Gaps = 26/175 (14%)

Query: 43  IGRGAYGIVCSAVNSETK-----EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           +G G +G V  A     K       VA+K +     +  + + +L E  LL  + H +++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 98  KVKDII----PPM----------------DKEKFNDVYIVYELMDTDLHQIIRSKQALTD 137
           K+        P +                +  K    Y+  +      +     ++ALT 
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 138 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
                F +Q+ RG++Y+    ++HRDL   N+L+     +KI DFGL+R   E D
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 14/172 (8%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMTHENIVKVK 100
           IGRGA+G V   V  ++  +V   K+ + F+   R D+     E  +   M   N   V 
Sbjct: 51  IGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI---MAFANSPWVV 106

Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
            +      +++  +Y+V E M       + S   + +   +++  +++  L  IHS   +
Sbjct: 107 QLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 164

Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYV 212
           HRD+KP N+LL+ +  LK+ DFG          M +  + R DT     DY+
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMK------MNKEGMVRCDTAVGTPDYI 210

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 41/156 (26%), Positives = 78/156 (50%), Gaps = 26/156 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IGRGA+G            EVA+ K+ N    ++ A +IL + ++L         + 
Sbjct: 6   LKVIGRGAFG------------EVAVVKMKNT--GQVYAMKILNKWEMLKRAETACFREE 51

Query: 100 KDIIPPMDKE-------KFNDVYIVYELMD----TDLHQII-RSKQALTDDHCQYFLYQL 147
           +D++   D+         F D   +Y +MD     DL  ++ + +  L +D  +++L ++
Sbjct: 52  RDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM 111

Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 183
           +  +  +H    +HRD+KP N+LL+ N  +++ DFG
Sbjct: 112 VLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 35/159 (22%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF-------DNRIDAKRIL------REIKLL- 88
           +GRG +G V  A   +T E  AIK +           ++ +  KRI       R   L+ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 89  ---CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY 145
              C  T +++  V +     D            LM   +H  I +    ++    ++  
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGD------------LM---MH--IHTDV-FSEPRAVFYAA 108

Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 184
            ++ GL+Y+H   +++RDLK  NLLL+    +KI DFGL
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 46.6 bits (110), Expect = 8e-06
 Identities = 18/55 (32%), Positives = 37/55 (67%)

Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           ++  ++D  +++  +++  L Y+HS  +++RDLK  NL+L+ +  +KI DFGL +
Sbjct: 89  ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 46.3 bits (110), Expect = 9e-06
 Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 26/159 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  +G+G++G V  A    T E  AIK +            I+++  + C M  + ++ +
Sbjct: 5   LMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--------IIQDDDVECTMVEKRVLAL 56

Query: 100 KDIIPP-----------MDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQL 147
               PP           MD+     +Y V E ++  DL   I+      + H  ++  ++
Sbjct: 57  PGK-PPFLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI 110

Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             GL ++HS  +++RDLK  N++L+A   +KI DFG+ +
Sbjct: 111 AIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 40/180 (22%), Positives = 82/180 (45%), Gaps = 22/180 (12%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V        V  E +  VAIK +  A   R +    L E
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 59

Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYF 143
             ++      ++V++  ++      +     ++ ELM   DL   +RS +   +++    
Sbjct: 60  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114

Query: 144 LYQLLR----------GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
              L +          G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 20/79 (25%), Positives = 44/79 (55%), Gaps = 4/79 (5%)

Query: 111 FNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKP 166
           F D   +Y +M+     DL  ++      ++D  ++++ + +  ++ +H    +HRD+KP
Sbjct: 70  FQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKP 129

Query: 167 SNLLLNANCDLKICDFGLA 185
            N+L++    +K+ DFGL+
Sbjct: 130 DNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 65/294 (22%), Positives = 118/294 (40%), Gaps = 46/294 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR----ILREIKLLCHMTHENIVK 98
           +G+G +G VC+     T +  A KK+      RI  ++     L E ++L  +    +V 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 99  VKDIIPPMDKEKFNDVYIVYELM---DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           +         E  + + +V  +M   D   H          +    ++  +L  GL+ + 
Sbjct: 65  LA-----YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD----------FMTEYVVTRWDTL 205
              +++RDLKP N+LL+    ++I D GLA    E +          +M   V+      
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179

Query: 206 FPGKDYVQQLTMITELL--GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
           F   D+     +I E++   SP       ++ +   R VK+     ++ +S+KF   S  
Sbjct: 180 F-SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE----DQEEYSEKF---SED 231

Query: 264 AIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLH----EIN--EEPTCPYP 306
           A  +   +L  +P +R+            HP   +++    E N  E P CP P
Sbjct: 232 AKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 11/154 (7%)

Query: 43  IGRGAYGIVCSAVNSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +G G +G V   V    K++  VAIK + N  + +     ++RE +++  + +  IV+  
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVR-- 59

Query: 101 DIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSAN 158
            +I   + E    + +V E+     L++ +  K+  +T  +    ++Q+  G+KY+   N
Sbjct: 60  -MIGVCEAE---ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            +HRDL   N+LL      KI DFGL++     D
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 13/150 (8%)

Query: 43  IGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + ++ +
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHVCR 73

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           +  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y+  
Sbjct: 74  LLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             ++HRDL   N+L+     +KI DFGLA+
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 49/195 (25%), Positives = 74/195 (37%), Gaps = 44/195 (22%)

Query: 43  IGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           IG+GA+G V  A     +  E    VA+K +       + A    RE  L+    H NIV
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDHPNIV 71

Query: 98  K---VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS---------------------- 131
           K   V  +  PM         +++E M   DL++ +R                       
Sbjct: 72  KLLGVCAVGKPM--------CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123

Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
              L+         Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183

Query: 192 DFM----TEYVVTRW 202
           D+      + +  RW
Sbjct: 184 DYYKASENDAIPIRW 198

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 37/147 (25%), Positives = 69/147 (46%), Gaps = 9/147 (6%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G +G VC+     T +  A KK+       +   K  L E ++L  +    IV +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 102 IIPPMDKEKFNDVYIVYELM---DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                  E    + +V  LM   D   H     ++ L  +   ++  Q+  G+ ++HS +
Sbjct: 61  AF-----ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLA 185
           +++RD+KP N+LL+   + ++ D GLA
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 43.7 bits (104), Expect = 3e-05
 Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 11/121 (9%)

Query: 71  AFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQII 129
             D RI  +R  RE +++     +  V V   +  +D E F    IV E ++   L  +I
Sbjct: 36  ELDERIRRERTRREARIM-SRARKAGVNVP-AVYFVDPENFI---IVMEYIEGEPLKDLI 90

Query: 130 RSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
            S      +  +     + +    +HSA ++H DL  SN++L+    + + DFGLA  + 
Sbjct: 91  NSNGMEELELSREIGRLVGK----LHSAGIIHGDLTTSNMILSGG-KIYLIDFGLAEFSK 145

Query: 190 E 190
           +
Sbjct: 146 D 146

Length = 211

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 47/183 (25%), Positives = 74/183 (40%), Gaps = 28/183 (15%)

Query: 23  YNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRIL 82
           Y +LG    VS++    L  +G G +G V  A + + KE  A+K + N      DAK   
Sbjct: 117 YVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK--- 173

Query: 83  REIKLLCHMTHENIVKVKDIIPPMDKEKF--ND---VYIVYELMDTDLHQIIRSKQALTD 137
            EI+    M         D  P M  +++  N+   + IV       L   I      + 
Sbjct: 174 IEIQF---MEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH 230

Query: 138 DHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNAN----------------CDLKIC 180
            H    ++Q    L Y H+  +++H DLKP N+L+  +                C ++IC
Sbjct: 231 RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRIC 290

Query: 181 DFG 183
           D G
Sbjct: 291 DLG 293

Length = 467

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 35/141 (24%), Positives = 63/141 (44%), Gaps = 15/141 (10%)

Query: 46  GAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPP 105
           GA G   + ++++T E V IK              ILR I       H +I+++K     
Sbjct: 103 GAEGFAFACIDNKTCEHVVIK--AGQRGGTATEAHILRAI------NHPSIIQLKGTF-- 152

Query: 106 MDKEKFNDVY-IVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDL 164
                +N    ++     TDL+  + +K+ +           +LR ++Y+H   ++HRD+
Sbjct: 153 ----TYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDI 208

Query: 165 KPSNLLLNANCDLKICDFGLA 185
           K  N+ +N   D+ + DFG A
Sbjct: 209 KAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 45.1 bits (106), Expect = 4e-05
 Identities = 48/181 (26%), Positives = 75/181 (41%), Gaps = 42/181 (23%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G +G V    +  T+E    K I+       +  +++ E+ ++  + H+NIV+ 
Sbjct: 18  IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIR---------SKQALTDDHCQYFLYQLLR 149
            D       +K   +YI+ E  D  DL + I+          + A+ D        QLL 
Sbjct: 78  IDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD-----ITRQLLH 129

Query: 150 GLKYIHS-------ANVLHRDLKPSNLL-----------------LNANCDLKICDFGLA 185
            L Y H+         VLHRDLKP N+                  LN     KI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 186 R 186
           +
Sbjct: 190 K 190

Length = 1021

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 26/182 (14%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRI--L 82
           ++VS + +  L+ +G+G++G+V        +  E +  VA+K +  +   R   +RI  L
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR---ERIEFL 57

Query: 83  REIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDD--- 138
            E  ++   T  ++V++  ++      K     +V ELM   DL   +RS +   ++   
Sbjct: 58  NEASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112

Query: 139 ----HCQYFLY---QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
                 Q  +    ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ET
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172

Query: 192 DF 193
           D+
Sbjct: 173 DY 174

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 41/164 (25%), Positives = 71/164 (43%), Gaps = 26/164 (15%)

Query: 43  IGRGAYGIVCSA--VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKV 99
           IG G +G V  A       + + AIK++   + ++ D +    E+++LC +  H NI+ +
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 100 KDIIPPMDKEKFNDVYIVYE---------------LMDTDLHQII--RSKQALTDDHCQY 142
                    E    +Y+  E               +++TD    I   +   L+     +
Sbjct: 74  LGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128

Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 47/204 (23%), Positives = 89/204 (43%), Gaps = 29/204 (14%)

Query: 112 NDVYIVYELM-DTDLHQII-RSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL 169
           +++Y+V E     DL  ++ R +    +D  Q++L +L+  +  +H    +HRD+KP N+
Sbjct: 74  DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133

Query: 170 LLNANCDLKICDFG-LARTTSET-----------DFMTEYVVTRWDTLFPGK-----DYV 212
           L++    +K+ DFG  AR T+             D++   V+T  +    G      D+ 
Sbjct: 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWW 193

Query: 213 QQLTMITELL--GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAER 270
               +  E++   SP      F    +A+ Y   +       F +  P +S   +DL + 
Sbjct: 194 SLGVIAYEMIYGRSP------FHEGTSAKTYNNIMNFQRFLKFPED-PKVSSDFLDLIQS 246

Query: 271 MLVFDPAKRITVEEALNHPYLSSL 294
           +L     +R+  E    HP+ S +
Sbjct: 247 LLC-GQKERLGYEGLCCHPFFSKI 269

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 39/160 (24%), Positives = 76/160 (47%), Gaps = 16/160 (10%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG+G++G V  A         A+K +          K IL++ K   H+  E  V +K++
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQK--------KTILKK-KEQNHIMAERNVLLKNL 53

Query: 103 IPPMD---KEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
             P        F     +Y ++D     +L   ++ ++   +   +++  ++   + Y+H
Sbjct: 54  KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH 113

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
           S N+++RDLKP N+LL++   + + DFGL +   E +  T
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 42/178 (23%), Positives = 76/178 (42%), Gaps = 26/178 (14%)

Query: 41  QPIGRGAYG-IVCSAVNSE-TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           + IG G +G ++   VNS  T  +V +K++     +  +  + L E +    + H N+++
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKEL-RVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59

Query: 99  V----KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHC-----QYFLYQLL 148
                 ++ P +         +V E     DL   +RS +            Q    ++ 
Sbjct: 60  CLGQCTEVTPYL---------LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIA 110

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE----YVVTRW 202
            GL ++H  N +H DL   N LL A+  +KI D+GL+    + D+       +V  RW
Sbjct: 111 LGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 36/150 (24%), Positives = 72/150 (48%), Gaps = 14/150 (9%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G++G V  A    T +  AIK +            +L +  + C M  + ++ +   
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDV--------VLMDDDVECTMVEKRVLSLAWE 54

Query: 103 IPPMD------KEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
            P +       + K N  +++  L   DL   I+S          ++  +++ GL+++HS
Sbjct: 55  HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS 114

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +++RDLK  N+LL+ +  +KI DFG+ +
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 20/161 (12%)

Query: 43  IGRGAYGIVCSA-VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVK 100
           IG G +G V  A +  +  +  A  K+   F +  D +    E+++LC +  H NI+   
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII--- 66

Query: 101 DIIPPMDKEKFNDVYIVY----ELMD-TDLHQIIRSKQALTDDH---CQYFLYQLLR--- 149
           +++   +   +  + I Y     L+D     +++ +  A   +H         QLL+   
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 150 ----GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
               G++Y+     +HRDL   N+L+  N   KI DFGL+R
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 19/74 (25%), Positives = 48/74 (64%), Gaps = 1/74 (1%)

Query: 114 VYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN 172
           +++V E ++  DL   ++ ++ L ++H +++  ++   L ++H   +++RDLK  N+LL+
Sbjct: 71  LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130

Query: 173 ANCDLKICDFGLAR 186
           A+  +K+ D+G+ +
Sbjct: 131 ADGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 20/56 (35%), Positives = 38/56 (67%), Gaps = 1/56 (1%)

Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           ++  ++D  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +
Sbjct: 89  ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 17/63 (26%), Positives = 40/63 (63%)

Query: 124 DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 183
           DL   ++ ++ L ++H +++  ++   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 141

Query: 184 LAR 186
           + +
Sbjct: 142 MCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 35/151 (23%), Positives = 74/151 (49%), Gaps = 16/151 (10%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G++G V  A    T E  A+K +            IL++  + C MT + ++ +   
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDV--------ILQDDDVECTMTEKRVLALAGK 54

Query: 103 IPPMDKEKF------NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
             P   +        + ++ V E ++  DL   I+      +   +++  +++ GL+++H
Sbjct: 55  -HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
              +++RDLK  N+LL++   +KI DFG+ +
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 18/40 (45%), Positives = 26/40 (65%)

Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           QLL  + YIH   ++HRD+K  N+L+N   D+ + DFG A
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA 307

Length = 461

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 41/172 (23%), Positives = 79/172 (45%), Gaps = 34/172 (19%)

Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
           ++  +++ GL+++HS  +++RDLK  N++L+ +  +KI DFG+ +     D         
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159

Query: 202 WDTLFP----GKDYVQQL------TMITELL--GSP---DDSDLGF--LRSDNARRYVKQ 244
            D + P    G  Y   +       ++ E+L   SP   DD D  F  +R D        
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT------- 212

Query: 245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN-HPYLSSLH 295
            PH P+         ++  + D+ E++   DP +R+ V   +  HP+  +++
Sbjct: 213 -PHYPRW--------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 20/161 (12%)

Query: 43  IGRGAYGIVCSA-VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE-NIVKVK 100
           IG G +G V  A +  +     A  K    + ++ D +    E+++LC + H  NI+   
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII--- 59

Query: 101 DIIPPMDKEKFNDVYIVY----ELMD-TDLHQIIRSKQALTDDH---CQYFLYQLLR--- 149
           +++   +   +  + I Y     L+D     +++ +  A    +         QLL    
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 150 ----GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
               G+ Y+     +HRDL   N+L+  N   KI DFGL+R
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 13/150 (8%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIK---KITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G GA+G V   +     E V I    KI N           + E  ++  M H ++V++
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 100 KDI-IPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
             + + P        + +V +LM     L  +   K  +       +  Q+ +G+ Y+  
Sbjct: 75  LGVCLSPT-------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE 127

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             ++HRDL   N+L+ +   +KI DFGLAR
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLAR 157

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 38/150 (25%), Positives = 74/150 (49%), Gaps = 14/150 (9%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G++G V  A    T E  AIK +      + D   IL++  + C MT + I+ +   
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVL------KKDV--ILQDDDVDCTMTEKRILALAAK 54

Query: 103 IPPMDK-----EKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
            P +       +  + ++ V E ++  DL   I+  +   +   +++  ++   L ++H 
Sbjct: 55  HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             V++RDLK  N+LL+A    K+ DFG+ +
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 36/149 (24%), Positives = 59/149 (39%), Gaps = 1/149 (0%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +GR        A      +E  + K     D R  A     E+  L    H  IVK  D 
Sbjct: 75  VGRNPTTAAFVATRGSDPKEKVVAKFVMLNDER-QAAYARSELHCLAACDHFGIVKHFDD 133

Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHR 162
               DK      Y     ++  + Q ++      +       YQ++  L  +HS  ++HR
Sbjct: 134 FKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHR 193

Query: 163 DLKPSNLLLNANCDLKICDFGLARTTSET 191
           DLK +N+ L     +K+ DFG ++  S++
Sbjct: 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDS 222

Length = 478

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 17/41 (41%), Positives = 27/41 (65%)

Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 17/63 (26%), Positives = 40/63 (63%)

Query: 124 DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 183
           DL   ++ ++ L ++H +++  ++   L ++H   +++RDLK  N+LL+A   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 141

Query: 184 LAR 186
           + +
Sbjct: 142 MCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.8 bits (99), Expect = 4e-04
 Identities = 31/168 (18%), Positives = 62/168 (36%), Gaps = 29/168 (17%)

Query: 33  SSKYVPPLQPIGRGAYGIVCSAVNSE----TKEEVA----IKKITNAFDNRIDAKRILRE 84
             +   P   IG+GA   +            KE V       ++    D R+  +R   E
Sbjct: 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPEL----DERLRTERTRAE 386

Query: 85  IKLLCHMTHENIVKVKDIIPPM--DKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQY 142
            +LL      +  +   +  P+  D +      ++  +   DL  ++     L       
Sbjct: 387 ARLL------SEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLEGNPEL------- 433

Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            + ++   +  +H A ++H DL  SN ++  +  L + DFGL + +  
Sbjct: 434 -VRKVGEIVAKLHKAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 43/161 (26%), Positives = 67/161 (41%), Gaps = 16/161 (9%)

Query: 43  IGRGAYGIVCSA-VNSETKEE--VAIKKITNAFDNRIDAKR--ILREIKLLCHMTHENIV 97
           +G G +G +C   +   +K E  VAI  +        D +R   L E   L    H NIV
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLR---AGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIH 155
           +++ +I      + N + IV E M    L   +R  +  L        L  L  G+KY+ 
Sbjct: 70  RLEGVI-----TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFG-LARTTSETDFMT 195
               +H+ L    +L+N++   KI  F  L    SE  + T
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTT 165

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 24/178 (13%)

Query: 41  QPIGRGAYG-IVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV-- 97
             IG G +G ++    +    +   + K   A     +    L+E++    + H N++  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 98  --KVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQ-----LLR 149
             +  + IP +         +V E     DL   +RS + +     Q  + Q     +  
Sbjct: 61  LGQCIESIPYL---------LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
           GL ++H A+ +H DL   N  L A+  +KI D+GLA      D    Y +T+     P
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED----YYITKDCHAVP 165

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 24/154 (15%)

Query: 58  ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV 117
           +  + VAIK + +  +N        +E  L+  + H NIV +  ++      +   V ++
Sbjct: 32  DHAQLVAIKTLKD-INNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQEQPVCML 85

Query: 118 YELMDT-DLHQIIRSKQALTDDHCQY--------------FLY---QLLRGLKYIHSANV 159
           +E ++  DLH+ +  +   +D  C                FL+   Q+  G++Y+ S   
Sbjct: 86  FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFF 145

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +H+DL   N+L+     +KI D GL+R     D+
Sbjct: 146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADY 179

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 39.1 bits (92), Expect = 0.001
 Identities = 13/37 (35%), Positives = 23/37 (62%), Gaps = 1/37 (2%)

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
           +H A ++H DL  SN+++  +  L + DFGL + + E
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSDE 141

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 38.4 bits (90), Expect = 0.002
 Identities = 12/28 (42%), Positives = 15/28 (53%)

Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHP 289
           P   DL  +ML  DP KR + +E L H 
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	339
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.98
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.96
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK10345	210	hypothetical protein; Provisional	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
smart00090	237	RIO RIO-like kinase.	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.69
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.67
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.56
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.52
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.52
KOG1243	690	consensus Protein kinase [General function predict	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.35
KOG3087	229	consensus Serine/threonine protein kinase [General	99.32
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.32
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.27
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.26
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.23
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.14
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.09
PRK09902	216	hypothetical protein; Provisional	99.08
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.9
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.9
COG4248	637	Uncharacterized protein with protein kinase and he	98.82
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.78
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.72
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.64
PF01636	239	APH: Phosphotransferase enzyme family This family	98.54
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.41
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.38
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.37
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.34
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.27
PLN02876	822	acyl-CoA dehydrogenase	98.21
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.12
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.96
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.94
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.87
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.84
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.82
PRK10593	297	hypothetical protein; Provisional	97.8
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.77
PRK05231	319	homoserine kinase; Provisional	97.72
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.7
KOG2270	520	consensus Serine/threonine protein kinase involved	97.66
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.62
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.61
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.54
PLN02756	418	S-methyl-5-thioribose kinase	97.47
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.45
PRK12396	409	5-methylribose kinase; Reviewed	97.28
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.24
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.24
PLN02236	344	choline kinase	97.23
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.05
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.98
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.93
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.85
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.83
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.42
PTZ00384	383	choline kinase; Provisional	96.34
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.26
PRK11768	325	serine/threonine protein kinase; Provisional	95.84
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.43
PTZ00296	442	choline kinase; Provisional	95.39
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.89
PRK10271	188	thiK thiamine kinase; Provisional	94.85
PRK06148	1013	hypothetical protein; Provisional	94.85
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.51

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-54  Score=364.96  Aligned_cols=314  Identities=57%  Similarity=0.958  Sum_probs=280.1

Q ss_pred             eEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeee
Q 042681           20 YVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV   99 (339)
Q Consensus        20 ~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~   99 (339)
                      ++.+..++..+.++.+|.. ++.||+|+||.|..+.++.+|+.||+|++..........++.++|+++|+.++|+||+.+
T Consensus         8 ~~~~~~~~~~~~i~~~y~~-~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l   86 (359)
T KOG0660|consen    8 YYDYEVFGELFEIPRYYVL-IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGL   86 (359)
T ss_pred             ceEEEeeeeEEeccceecc-cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceE
Confidence            6788999999999999999 999999999999999999999999999999888888899999999999999999999999


Q ss_pred             eeecCCCCcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEE
Q 042681          100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI  179 (339)
Q Consensus       100 ~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL  179 (339)
                      .+++..........+|+|+|+++.+|.+.+++++.+++..+...+.|++.||+|+|+.|++||||||.|++++.+..+|+
T Consensus        87 ~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI  166 (359)
T KOG0660|consen   87 LDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKI  166 (359)
T ss_pred             EeecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEe
Confidence            99997755567788999999999999999999888999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCC---C----------Ccccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccc-------------
Q 042681          180 CDFGLARTTSE---T----------DFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGF-------------  232 (339)
Q Consensus       180 ~Dfg~~~~~~~---~----------~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~-------------  232 (339)
                      +|||+|+....   .          .|.+|++...+ .++...|+|+.||++-++++|++.|.+...             
T Consensus       167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt  246 (359)
T KOG0660|consen  167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT  246 (359)
T ss_pred             ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence            99999988752   2          24455554433 477889999999999999999988743322             


Q ss_pred             --------cccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCC
Q 042681          233 --------LRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCP  304 (339)
Q Consensus       233 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~  304 (339)
                              ........++...+..+..++...+++.++.+.+|+.+||..||.+|+|++|+|+||||..++++.++|.|+
T Consensus       247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~  326 (359)
T KOG0660|consen  247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ  326 (359)
T ss_pred             CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC
Confidence                    223445667888899999999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCCChhhccCCHHHHHHHHHHHHHhcCCCC
Q 042681          305 YPFNFDFEQTSMNEEDIKELILRECLNFHPDH  336 (339)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (339)
                      ..+.. +... .+.+++++++.+|.++|+++.
T Consensus       327 ~~~~~-~~~~-~~~~~~r~~i~~e~~~~~~~~  356 (359)
T KOG0660|consen  327 PIFDS-FEHE-LTEEELRELIYKEILDFHPDV  356 (359)
T ss_pred             CCCcc-cccc-ccHHHHHHHHHHHHHhhCccc
Confidence            76554 4444 888999999999999999874

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-53  Score=359.24  Aligned_cols=254  Identities=30%  Similarity=0.459  Sum_probs=212.2

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChH-----hHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI-----DAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      +.+.|.. .+.||+|+||.|-+|..+.||+.||+|++++......     ....+.+|+++|++|+||||++++++|   
T Consensus       170 ~~d~yii-~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---  245 (475)
T KOG0615|consen  170 FNDYYII-SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---  245 (475)
T ss_pred             hcceeEe-eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee---
Confidence            4555655 9999999999999999999999999999987643321     223467999999999999999999999   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC---CCeEEeec
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDF  182 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~---~~ikL~Df  182 (339)
                        +.....|+||||++ |+|.+.+-.++.+.+...+.++.|++.||.|||++||+||||||+|||+..+   ..+||+||
T Consensus       246 --~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  246 --EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             --ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence              77788899999998 7999999999999999999999999999999999999999999999999876   67999999


Q ss_pred             cccccc----------CCCCcccccccccccc---CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCC
Q 042681          183 GLARTT----------SETDFMTEYVVTRWDT---LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP  249 (339)
Q Consensus       183 g~~~~~----------~~~~~~~~~~~~~~~~---~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (339)
                      |+|+..          |++.|.+||+......   ..+.|+|++||++|..++|.+||.+-...+.     ..+++....
T Consensus       324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----l~eQI~~G~  398 (475)
T KOG0615|consen  324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----LKEQILKGR  398 (475)
T ss_pred             chhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----HHHHHhcCc
Confidence            999765          4456777777655433   3456999999999999999999875433321     222333333


Q ss_pred             CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       250 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ....+..|..+|++..+||++||..||++|||+.++|+||||+...-
T Consensus       399 y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  399 YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence            33334455779999999999999999999999999999999997754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-51  Score=346.60  Aligned_cols=254  Identities=23%  Similarity=0.344  Sum_probs=215.5

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC-eE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN-DV  114 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~-~~  114 (339)
                      ....++.||+|..|+||+|+|+.|++.+|+|++.. ..+....+++.+|+++++..+||+|+++||+|     ...+ .+
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF-----~~~~~~i  153 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAF-----YSNGEEI  153 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE-----EeCCceE
Confidence            33348899999999999999999999999999943 34555678899999999999999999999999     5556 59


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEEeecccccc-----
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLART-----  187 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL~Dfg~~~~-----  187 (339)
                      +|+||||+ |+|..+++..++++|.....++.+|++||.|||. .+|+||||||+|||++++|.|||||||.+..     
T Consensus       154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~  233 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI  233 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhh
Confidence            99999998 7999999988999999999999999999999995 9999999999999999999999999999854     


Q ss_pred             ----cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          188 ----TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       188 ----~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                          .|+..|++||......+...+|+|++|+.++++.+|+.|+.... ............+...+.+..+..  .+|++
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv~~ppP~lP~~--~fS~e  310 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIVDEPPPRLPEG--EFSPE  310 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHhcCCCCCCCcc--cCCHH
Confidence                46667999999999999999999999999999999998865531 111222233333333333333322  48999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          264 AIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      +++||.+||++||++||++.|+++|||++......
T Consensus       311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence            99999999999999999999999999999886643

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-51  Score=362.21  Aligned_cols=247  Identities=30%  Similarity=0.499  Sum_probs=215.0

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. .+.||+|||+.||.+++..+|+.||+|++.+. .......+.+.+|+++.++|+||||++++++|     ++...
T Consensus        19 ~Y~~-g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   19 RYKR-GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             eeee-eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            3444 89999999999999999999999999999764 44556678899999999999999999999999     78889


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +|||+|+|. ++|..++++++.++|.+++.++.||+.||.|||+++|+|||||..|+|++.+.++||+|||+|..+    
T Consensus        93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999998 899999999999999999999999999999999999999999999999999999999999999754    


Q ss_pred             -------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          189 -------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                             |++.|.+||+.......+..|+|++||++|.+++|.+||+.-..-  .....+.......+        ..+|
T Consensus       173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk--ety~~Ik~~~Y~~P--------~~ls  242 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK--ETYNKIKLNEYSMP--------SHLS  242 (592)
T ss_pred             cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH--HHHHHHHhcCcccc--------cccC
Confidence                   567899999999999999999999999999999999997653211  11122211111111        2589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      .++++||.+||+.||.+|||++++|.|+||.+..-+
T Consensus       243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p  278 (592)
T KOG0575|consen  243 AEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP  278 (592)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence            999999999999999999999999999999655443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=336.25  Aligned_cols=251  Identities=21%  Similarity=0.374  Sum_probs=216.7

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++.|.. ++.||+|+||+||+|+.+.|++.||+|++++.. ....+.+....|..+|..++||.|++++-.|     ++.
T Consensus        24 ~~dF~~-lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~   97 (357)
T KOG0598|consen   24 PDDFEI-LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTE   97 (357)
T ss_pred             hhheee-eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccC
Confidence            344444 999999999999999999999999999998763 3445678899999999999999999999999     788


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc---
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART---  187 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~---  187 (339)
                      ..+|+|+||+. |.|+.++.+++.+++..++-++.+|+.||.|||++||+||||||+|||+|.+|+++|+|||+|+.   
T Consensus        98 ~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            89999999997 69999999999999999999999999999999999999999999999999999999999999963   


Q ss_pred             --------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          188 --------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       188 --------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                              .|++.|++||+....++..+.|.|++|+++|+|++|.+|+..-      ........+...+...   ....
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~------~~~~~~~~I~~~k~~~---~p~~  248 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE------DVKKMYDKILKGKLPL---PPGY  248 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc------cHHHHHHHHhcCcCCC---CCcc
Confidence                    4667899999999999999999999999999999999997542      2222222222222111   1123


Q ss_pred             CCHHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCccCC
Q 042681          260 MSPVAIDLAERMLVFDPAKRI----TVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rp----s~~ell~hp~f~~~~~~~  298 (339)
                      ++.++++||+++|+.||++|.    .+.++.+||||..+.|..
T Consensus       249 ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  249 LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             CCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence            799999999999999999996    688999999999999854

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=343.31  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=216.0

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMD  107 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~  107 (339)
                      ..-+.+|.. ++.||.|+|++|++|+++.+++.||+|++.+... ...-.+.+..|..+|.+| .||.|++++-.|    
T Consensus        69 kk~~~DF~F-g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF----  143 (604)
T KOG0592|consen   69 KKTPNDFKF-GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF----  143 (604)
T ss_pred             cCChhhcch-hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe----
Confidence            444566777 9999999999999999999999999999977633 233356688999999999 799999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                       .+...+|+|+||++ |+|.+++++.+.+++..++.++.||+.||+|||++|||||||||+|||+|.+|+++|+|||.|+
T Consensus       144 -QD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  144 -QDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             -ecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccc
Confidence             67788999999998 8999999999999999999999999999999999999999999999999999999999999985


Q ss_pred             cc------------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHH
Q 042681          187 TT------------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV  242 (339)
Q Consensus       187 ~~------------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~  242 (339)
                      .+                        |+-.|.+||+..........|+|++||++|.|+.|.+||....  .....+++.
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--eyliFqkI~  300 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--EYLIFQKIQ  300 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--HHHHHHHHH
Confidence            43                        3335777888888889999999999999999999999976432  112223333


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      ......+        +++++.+++||+++|..||++|+|+.+|.+||||.++.|..
T Consensus       301 ~l~y~fp--------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  301 ALDYEFP--------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             HhcccCC--------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            3222222        46789999999999999999999999999999999999864

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.4e-48  Score=338.31  Aligned_cols=257  Identities=24%  Similarity=0.360  Sum_probs=218.1

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      +.-+.+.+++.||+|+||.||+|+.+.||..||+|++++. .....+.+.++.|..+|....+|+||+++-.|     ++
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD  212 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QD  212 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cC
Confidence            3444444599999999999999999999999999999876 44566788999999999999999999999999     77


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc---
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---  186 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~---  186 (339)
                      ...+||||||++ |++.+++.+.+.+++..++-++.+++.|++.||+.|++||||||+|+|||..|++||+|||+|.   
T Consensus       213 ~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  213 KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            889999999998 7999999999999999999999999999999999999999999999999999999999999983   


Q ss_pred             -------------------------------------------------------ccCCCCccccccccccccCCCCccH
Q 042681          187 -------------------------------------------------------TTSETDFMTEYVVTRWDTLFPGKDY  211 (339)
Q Consensus       187 -------------------------------------------------------~~~~~~~~~~~~~~~~~~~~~~d~~  211 (339)
                                                                             .+|++.|++||+.....+....|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence                                                                   1344557888888888889999999


Q ss_pred             HHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcC
Q 042681          212 VQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRI---TVEEALNH  288 (339)
Q Consensus       212 ~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~h  288 (339)
                      ++||++|+++.|.+||..-.  +......+.........+.    -..++++++|||.+||. ||++|.   ++.||.+|
T Consensus       373 SLG~ImyEmLvGyPPF~s~t--p~~T~rkI~nwr~~l~fP~----~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSET--PQETYRKIVNWRETLKFPE----EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhhhccCCC----cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence            99999999999999987542  2233333333322222211    13478999999999999 999999   48999999


Q ss_pred             CCCCCCccCCCC
Q 042681          289 PYLSSLHEINEE  300 (339)
Q Consensus       289 p~f~~~~~~~~~  300 (339)
                      |||+.+.|.+..
T Consensus       446 PfF~~v~W~~l~  457 (550)
T KOG0605|consen  446 PFFKGVDWDHLR  457 (550)
T ss_pred             CccccCCcchhh
Confidence            999999997643

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-47  Score=342.11  Aligned_cols=299  Identities=45%  Similarity=0.795  Sum_probs=239.0

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|+||.||++.+..+|+.||+|++...........++.+|+.+++.++||||+++++++..........+
T Consensus         1 ry~i-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKI-QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEE-EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            3555 889999999999999999999999999987554444455678899999999999999999998854433344568


Q ss_pred             EEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc------
Q 042681          115 YIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT------  188 (339)
Q Consensus       115 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~------  188 (339)
                      ++||||++++|.+.+.....+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...      
T Consensus        80 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          80 YVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             EEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence            99999999999999988888999999999999999999999999999999999999999999999999998642      


Q ss_pred             --------CCCCccccccccc--cccCCCCccHHHHHHHHHHHhCCCCCCccccccc---------------------ch
Q 042681          189 --------SETDFMTEYVVTR--WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS---------------------DN  237 (339)
Q Consensus       189 --------~~~~~~~~~~~~~--~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~---------------------~~  237 (339)
                              +...|.+||....  ..+..+.|+|++|++++++++|.+++........                     ..
T Consensus       160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  239 (338)
T cd07859         160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK  239 (338)
T ss_pred             cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence                    2345778887654  4567789999999999999999988754321100                     00


Q ss_pred             HHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCC--CCCChhhcc
Q 042681          238 ARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYP--FNFDFEQTS  315 (339)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~--~~~~~~~~~  315 (339)
                      ...................++.+++++.++|.+||+.||++|||+.++++||||+........+.....  ..+.+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (338)
T cd07859         240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRR  319 (338)
T ss_pred             HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHh
Confidence            011111222222233334456788999999999999999999999999999999988776544444322  466777889


Q ss_pred             CCHHHHHHHHHHHHHhcCC
Q 042681          316 MNEEDIKELILRECLNFHP  334 (339)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~  334 (339)
                      .+.++++..+.++.++++|
T Consensus       320 ~~~~~~~~~~~~~~~~~~~  338 (338)
T cd07859         320 LTKEDVRELIYREILEYHP  338 (338)
T ss_pred             cCHHHHHHHHHHHHHhcCC
Confidence            9999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=317.42  Aligned_cols=248  Identities=23%  Similarity=0.380  Sum_probs=219.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.+ +++||.|+||.|.+++++.+|..||+|++.+. ...-...+...+|..+|+.+.||.++++++.+     .+..
T Consensus        44 ~dfe~-~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~  117 (355)
T KOG0616|consen   44 QDFER-LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS  117 (355)
T ss_pred             hhhhh-eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence            34555 99999999999999999999999999999875 34455678899999999999999999999999     7788


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .+++||||.+ |.|+.++++.+++++..++-++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||.|++.   
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999998 799999999999999999999999999999999999999999999999999999999999999754   


Q ss_pred             -----CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          189 -----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       189 -----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                           |++.|.+||+....++..+.|.|++|+.+|+|+.|.+||.+...  .....++.......+        +.++++
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~KI~~~~v~fP--------~~fs~~  267 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYEKILEGKVKFP--------SYFSSD  267 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHHHHHhCcccCC--------cccCHH
Confidence                 67789999999999999999999999999999999999876543  333344444333333        347999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          264 AIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      +++||+++|+.|-++|.     ...++..||||+++.|.
T Consensus       268 ~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~  306 (355)
T KOG0616|consen  268 AKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE  306 (355)
T ss_pred             HHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence            99999999999999994     67899999999999874

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6e-48  Score=316.65  Aligned_cols=257  Identities=29%  Similarity=0.512  Sum_probs=213.0

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. +..+|+|+||+||+|+++.||+.||+|++..+..++...+-.++|+++|++|+|+|++.++++|     .....
T Consensus         2 ekYE~-LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrk   75 (396)
T KOG0593|consen    2 EKYEK-LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRK   75 (396)
T ss_pred             cHHhh-hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhcce
Confidence            45666 8889999999999999999999999999987777776777789999999999999999999999     77788


Q ss_pred             EEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC-
Q 042681          114 VYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET-  191 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~-  191 (339)
                      +++|+|||+-++.+.+... ..++++.++.++.|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.+..+ 
T Consensus        76 lhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   76 LHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             eEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            9999999998877777654 67999999999999999999999999999999999999999999999999999987633 


Q ss_pred             ----------Cccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccc------------hHHHHHhhCCCC
Q 042681          192 ----------DFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD------------NARRYVKQLPHV  248 (339)
Q Consensus       192 ----------~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~------------~~~~~~~~~~~~  248 (339)
                                +|.+||.... .++..+.|+|+.||+..++++|.+.+.+-+....-            .-..++...+..
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence                      3666665544 67899999999999999999999887654432110            001111111111


Q ss_pred             ---------CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          249 ---------PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       249 ---------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                               ...+....+++++.-+.||+++||+.||.+|++-+|++.||||.++-+
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE  292 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence                     112333456788899999999999999999999999999999977654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-48  Score=334.45  Aligned_cols=261  Identities=32%  Similarity=0.493  Sum_probs=214.9

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCC
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMD  107 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~  107 (339)
                      ...+-++|.. ++.||.|.||.||+|+...+|..||+|++++.... .+...-++|+..|++|+ ||||+++.+++.   
T Consensus         5 ~~~~m~RY~~-i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~---   79 (538)
T KOG0661|consen    5 QVIFMDRYTV-IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIR---   79 (538)
T ss_pred             ehhHHHHHHH-HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhh---
Confidence            3456788988 99999999999999999999999999999876544 33445578999999998 999999999994   


Q ss_pred             cCCcCeEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          108 KEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                       +....+++||||++.+|.++++.+ +.+++..++.|+.||++||+|+|++|+.|||+||+|||+..+..+||+|||+|+
T Consensus        80 -d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   80 -DNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             -ccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccc
Confidence             333389999999999999999865 679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCC----------Cccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh-----------
Q 042681          187 TTSET----------DFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ-----------  244 (339)
Q Consensus       187 ~~~~~----------~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~-----------  244 (339)
                      .....          .|.+||+..+ ..+..+.|.|++||+++++..-++.|.+....  +...++.+.           
T Consensus       159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~--Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI--DQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH--HHHHHHHHHhCCCccccchh
Confidence            76543          4666766544 45788999999999999999888776543322  111122222           


Q ss_pred             -----------CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          245 -----------LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       245 -----------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                                 .+......+....+.++.++.+||.+||.+||.+||||.|+|+||||+.....
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence                       23333334444557799999999999999999999999999999999987654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.1e-46  Score=302.31  Aligned_cols=265  Identities=34%  Similarity=0.526  Sum_probs=216.1

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      .+|.. .+.||+|.||.||+|++..||+.||+|+++............++|++.|+.++|+||+.++++|     .....
T Consensus         2 ~rY~~-~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~   75 (318)
T KOG0659|consen    2 DRYEK-LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSN   75 (318)
T ss_pred             chhhh-hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCc
Confidence            46777 8999999999999999999999999999987644433345678999999999999999999999     55677


Q ss_pred             EEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC-
Q 042681          114 VYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET-  191 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~-  191 (339)
                      +.+|+||++.+|...++.+ ..++...++.++.++++||+|||++.|.||||||+|+||+++|.+||.|||+++.++.+ 
T Consensus        76 l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   76 LSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9999999999999999875 57999999999999999999999999999999999999999999999999999987754 


Q ss_pred             ----------Cccccccc-cccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh----------------
Q 042681          192 ----------DFMTEYVV-TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ----------------  244 (339)
Q Consensus       192 ----------~~~~~~~~-~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~----------------  244 (339)
                                .|.+||+. +...+....|+|+.||++-+++.+.+.+.+-...  +....++..                
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi--dQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI--DQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH--HHHHHHHHHcCCCCcccCccccccc
Confidence                      35566644 3446788899999999999999887766432211  111111111                


Q ss_pred             ----CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCC
Q 042681          245 ----LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYP  306 (339)
Q Consensus       245 ----~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~  306 (339)
                          +...+..+....++..+.++.||+.+||..||.+|+|+.|+++||||++...+..+...+.|
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p  299 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIP  299 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCC
Confidence                12334444445678889999999999999999999999999999999987665544433333

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.8e-46  Score=330.83  Aligned_cols=304  Identities=65%  Similarity=1.054  Sum_probs=249.6

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      |.+.++|.. .+.||.|++|.||++.+..+++.+|+|.+............+.+|+.+++.++||||+++++++......
T Consensus         1 ~~~~~~y~~-~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   79 (337)
T cd07858           1 FEVDTKYVP-IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE   79 (337)
T ss_pred             CccccceeE-EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence            456788888 9999999999999999999999999999876544444556778999999999999999999988554333


Q ss_pred             CcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          110 KFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ....+++++||++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        80 ~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          80 AFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             ccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            44568999999999999999888899999999999999999999999999999999999999999999999999987543


Q ss_pred             C-----------CCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccccc---------------------ccc
Q 042681          190 E-----------TDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFL---------------------RSD  236 (339)
Q Consensus       190 ~-----------~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~---------------------~~~  236 (339)
                      .           ..|.+|+.... .....++|+|++|++++++++|.+++......                     ...
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            2           24667775543 34677899999999999999999887432110                     001


Q ss_pred             hHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCChhhccC
Q 042681          237 NARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSM  316 (339)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~  316 (339)
                      .....................+.+++++++||++||+.+|++|||+.++++||||..+......+....++++++++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDAL  319 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCCccchhhhhhhc
Confidence            11112222222222333334467899999999999999999999999999999999999888888889999999999999


Q ss_pred             CHHHHHHHHHHHHHhcCC
Q 042681          317 NEEDIKELILRECLNFHP  334 (339)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~  334 (339)
                      ..+++++.+..|-+-|+|
T Consensus       320 ~~~~~~~~~~~~~~~~~~  337 (337)
T cd07858         320 TEEDIKELIYNEMLAYHP  337 (337)
T ss_pred             CHHHHHHHHHHHHhhcCC
Confidence            999999999999988875

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=328.78  Aligned_cols=248  Identities=30%  Similarity=0.428  Sum_probs=207.0

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC---hHhHHHHHHHHHHHhhCC-CCCeeeeeeecCC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN---RIDAKRILREIKLLCHMT-HENIVKVKDIIPP  105 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~  105 (339)
                      ....++|.. .+.||+|+||+|+.+.+..+|+.+|+|++.+....   ....+.+.+|+.+++.++ ||||+++++++  
T Consensus        13 ~~~~g~y~~-~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~--   89 (370)
T KOG0583|consen   13 QLSIGKYEL-GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF--   89 (370)
T ss_pred             ccccCceee-eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE--
Confidence            355677888 99999999999999999999999999977654111   133556778999999998 99999999999  


Q ss_pred             CCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC-CCeEEeecc
Q 042681          106 MDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG  183 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~-~~ikL~Dfg  183 (339)
                         .....+++||||+. |+|++.+.+.++++|..++.+|.|++.||+|||++||+||||||+||+++.+ +++||+|||
T Consensus        90 ---~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   90 ---ATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             ---ecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence               66667999999998 6999999999999999999999999999999999999999999999999999 999999999


Q ss_pred             ccccc-----------CCCCcccccccccc--ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          184 LARTT-----------SETDFMTEYVVTRW--DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       184 ~~~~~-----------~~~~~~~~~~~~~~--~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      ++...           |.+.|.+||+....  +...+.|+|++|+++|.+++|..||.+...  ......+.  ......
T Consensus       167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--~~l~~ki~--~~~~~~  242 (370)
T KOG0583|consen  167 LSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--PNLYRKIR--KGEFKI  242 (370)
T ss_pred             cccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--HHHHHHHh--cCCccC
Confidence            99755           34468889888764  446889999999999999999999876211  11111111  111111


Q ss_pred             CCccccCCCC-CHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          251 QPFSQKFPNM-SPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       251 ~~~~~~~~~~-s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                      +      ..+ |+++++|+.+||..||.+|+|+.+++.||||+.
T Consensus       243 p------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  243 P------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             C------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            1      224 999999999999999999999999999999997

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=305.71  Aligned_cols=254  Identities=29%  Similarity=0.444  Sum_probs=218.0

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ..+.+.|.+ -+.||+|+|+.|+++.+..||+.+|+|.+..........+.+.+|+++-+.|+||||+++++.+     .
T Consensus         7 ~~f~d~y~l-~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~   80 (355)
T KOG0033|consen    7 TKFSDNYDV-KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----Q   80 (355)
T ss_pred             cccchhhhH-HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----c
Confidence            445677777 8899999999999999999999999999977666666788899999999999999999999998     7


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC---CeEEeecccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC---DLKICDFGLA  185 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~---~ikL~Dfg~~  185 (339)
                      ..+..++|+|++. ++|..-+-++--.+|..+..++.||+.||.|+|.+||||||+||.|+++.+..   -+||+|||++
T Consensus        81 ~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA  160 (355)
T KOG0033|consen   81 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLA  160 (355)
T ss_pred             ccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceE
Confidence            7888999999998 58877776667789999999999999999999999999999999999996543   5999999998


Q ss_pred             cc----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          186 RT----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       186 ~~----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                      ..          .|.+.|++|++...-++..+.|+|+.|+++|.++.|.+||++-.      .....+.+......-...
T Consensus       161 i~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~------~~rlye~I~~g~yd~~~~  234 (355)
T KOG0033|consen  161 IEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------QHRLYEQIKAGAYDYPSP  234 (355)
T ss_pred             EEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc------HHHHHHHHhccccCCCCc
Confidence            64          45678999999999999999999999999999999999987521      222233333333333344


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      .++.++++.++||++||..||.+|+|+.|+|+|||+.+-.
T Consensus       235 ~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  235 EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            6688999999999999999999999999999999998653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=313.28  Aligned_cols=254  Identities=29%  Similarity=0.420  Sum_probs=215.6

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      ....-++|.. .+.||+|+|++||+++++.++..+|+|.+.+........+.+..|+.+|+.++||||+++++++     
T Consensus         5 ~~~~~~~y~~-~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----   78 (429)
T KOG0595|consen    5 SMRVVGDYEL-SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----   78 (429)
T ss_pred             ccccccccee-hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----
Confidence            3445677877 7789999999999999999999999999988877787888899999999999999999999999     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC------CCeEEee
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN------CDLKICD  181 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~------~~ikL~D  181 (339)
                      ..++.+|+|||||. |+|.+++++++.+++..++..+.||+.||++||+++|+||||||+||||+.+      -.+||.|
T Consensus        79 ~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   79 EDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             ecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence            77789999999998 8999999999999999999999999999999999999999999999999865      4589999


Q ss_pred             ccccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          182 FGLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       182 fg~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ||+|+.+          |.+-|++||+.....+..+.|.|+.|+++|.+++|..|+........   ..+... .... .
T Consensus       159 FGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL---~~~~~k-~~~~-~  233 (429)
T KOG0595|consen  159 FGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL---LLYIKK-GNEI-V  233 (429)
T ss_pred             cchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH---HHHHhc-cccc-c
Confidence            9999765          45579999999999999999999999999999999999764321111   111111 1111 1


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      +..+  ..++...++|+...|+.+|.+|.+..+-+.||++..-.
T Consensus       234 ~~~~--~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  234 PVLP--AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             Cchh--hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            1111  23677788999999999999999999999999987654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-45  Score=329.26  Aligned_cols=250  Identities=31%  Similarity=0.444  Sum_probs=215.1

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ++.||.|+.|.|.+|++..||+..|+|++.+. .........+-+|+.+|+-+.|||+++++++|     ++..++|+|.
T Consensus        17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~lylvl   91 (786)
T KOG0588|consen   17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHLYLVL   91 (786)
T ss_pred             cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceEEEEE
Confidence            89999999999999999999999999999766 44455567788999999999999999999999     8889999999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc----------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----------  187 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~----------  187 (339)
                      ||++ |.|++++..++++++.++.+++.||+.|+.|+|..+||||||||+|+++|..++|||.|||+|..          
T Consensus        92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS  171 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS  171 (786)
T ss_pred             EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence            9998 89999999999999999999999999999999999999999999999999999999999999853          


Q ss_pred             cCCCCcccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          188 TSETDFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       188 ~~~~~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                      .|.+.|++||+.. ..+.+.++|+|+.|+++|.+++|..||.+      +..+..+........    +....+|+++++
T Consensus       172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNir~LLlKV~~G~f----~MPs~Is~eaQd  241 (786)
T KOG0588|consen  172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNIRVLLLKVQRGVF----EMPSNISSEAQD  241 (786)
T ss_pred             CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccHHHHHHHHHcCcc----cCCCcCCHHHHH
Confidence            4667899999776 45678899999999999999999999763      233322222221111    111468999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCC
Q 042681          267 LAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCP  304 (339)
Q Consensus       267 li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~  304 (339)
                      ||++||..||++|+|.+|+++|||++........++..
T Consensus       242 LLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~  279 (786)
T KOG0588|consen  242 LLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLR  279 (786)
T ss_pred             HHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcC
Confidence            99999999999999999999999999988765553333

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-45  Score=311.74  Aligned_cols=249  Identities=28%  Similarity=0.414  Sum_probs=202.1

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      ++.. .+.||+|+||.||++.+.++|...|+|.+...  +....+.+.+|+.+|.+++||||++++|.....  +. ..+
T Consensus        18 ~~~~-~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~--~~-~~~   91 (313)
T KOG0198|consen   18 NWSK-GKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSR--EN-DEY   91 (313)
T ss_pred             hhhh-hccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccc--cC-eee
Confidence            3444 89999999999999999999999999998755  222267789999999999999999999975221  11 369


Q ss_pred             EEEEecCc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-CCCeEEeecccccccC--
Q 042681          115 YIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARTTS--  189 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-~~~ikL~Dfg~~~~~~--  189 (339)
                      +++|||++ |+|.+++...+ ++++..++.+..||++||.|||++|++||||||+|||++. ++.+||+|||++....  
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999998 79999999876 7999999999999999999999999999999999999999 7999999999876443  


Q ss_pred             ------------CCCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          190 ------------ETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       190 ------------~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                                  .+.|++|+..... ......|+|++||++++|++|.+|+..+    ................   +..
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~~~---P~i  244 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGREDSL---PEI  244 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccCCC---CCC
Confidence                        3457888888752 2334899999999999999999887764    1111111111111111   122


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ...+|.++++||.+|+..||++||||+++|.|||......
T Consensus       245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            3468999999999999999999999999999999987655

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.1e-45  Score=322.18  Aligned_cols=248  Identities=28%  Similarity=0.456  Sum_probs=219.1

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. .+.||+|+||.||+++.+.|.+.||+|.+.+......+.+.+.+|+++++.++||||+.++++|     ++..+
T Consensus         2 e~yhv-~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~   75 (808)
T KOG0597|consen    2 EQYHV-YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAH   75 (808)
T ss_pred             cchhH-HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccce
Confidence            35666 8899999999999999999999999999998888888899999999999999999999999999     88899


Q ss_pred             EEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-----
Q 042681          114 VYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-----  188 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-----  188 (339)
                      +++|.|||.|+|++++.+.+.++|+.+..++.|++.||.|||+.+|.|||+||.||+++.+|.+||||||+|+..     
T Consensus        76 ~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   76 LWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             EEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999753     


Q ss_pred             ------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          189 ------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       189 ------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                            |++-|++||.....++...+|.|++||++|+++.|.+||..-.      .......+...+..+.    ...|.
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~v~~p----~~~S~  225 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDPVKPP----STASS  225 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCCCCCc----ccccH
Confidence                  5567999999999999999999999999999999999975322      1122222222222111    36899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ++++|++.+|.+||.+|+|..+++.|||.+.-.+.
T Consensus       226 ~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~  260 (808)
T KOG0597|consen  226 SFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINI  260 (808)
T ss_pred             HHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhh
Confidence            99999999999999999999999999999865544

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-44  Score=314.87  Aligned_cols=256  Identities=30%  Similarity=0.458  Sum_probs=206.9

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .+.|.. ++.||+|.||+||+|++..||+.||+|+++..........-..+||.+|++|+||||+++.++..+   ...+
T Consensus       116 ~~~fek-i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~---~~~~  191 (560)
T KOG0600|consen  116 ADSFEK-IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS---KLSG  191 (560)
T ss_pred             hHHHHH-HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe---cCCc
Confidence            345666 899999999999999999999999999998776556566777899999999999999999999943   2347


Q ss_pred             eEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC
Q 042681          113 DVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET  191 (339)
Q Consensus       113 ~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~  191 (339)
                      .+|+|+|||+.+|.-++.. .-.+++.++++++.||+.||.|||++|+.|||||.+|||||.+|.+||+|||+|+.+...
T Consensus       192 siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  192 SIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             eEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            8999999999999998877 458999999999999999999999999999999999999999999999999999854322


Q ss_pred             ------------Cccccccc-cccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCC---------
Q 042681          192 ------------DFMTEYVV-TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP---------  249 (339)
Q Consensus       192 ------------~~~~~~~~-~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~---------  249 (339)
                                  .|.+||+. +...+....|.|+.||++.+++.|.+.+..-...  .....++.......         
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv--eQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV--EQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH--HHHHHHHHHhCCCChhccccccC
Confidence                        46677654 4456888999999999999999999887543211  11111111111100         


Q ss_pred             ------------CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          250 ------------KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       250 ------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                                  ...+.+.+..+++...+|+..||..||.+|.||.++|.|+||..-
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence                        011112345578899999999999999999999999999999433

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.9e-44  Score=318.58  Aligned_cols=295  Identities=47%  Similarity=0.824  Sum_probs=238.2

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .+.++|.. .+.||.|++|.||++.+..+|+.||+|++............+.+|+.+++.++||||+++++++.... ..
T Consensus         2 ~~~~~y~~-~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~   79 (334)
T cd07855           2 DVGSRYKP-IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-AD   79 (334)
T ss_pred             chhhceee-eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CC
Confidence            45567777 89999999999999999999999999999765444445677888999999999999999999885432 34


Q ss_pred             cCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          111 FNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       111 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ...+++|+||++++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+...  
T Consensus        80 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          80 FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             CceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            567899999999999999988888999999999999999999999999999999999999999999999999998543  


Q ss_pred             -------------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccccccc-------------------
Q 042681          189 -------------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS-------------------  235 (339)
Q Consensus       189 -------------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~-------------------  235 (339)
                                   +...|.+|+.... .....++|+|++|++++++++|..++........                   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence                         2234666776533 3467789999999999999999998754321100                   


Q ss_pred             --chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCChhh
Q 042681          236 --DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQ  313 (339)
Q Consensus       236 --~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  313 (339)
                        ......................+..+++++++|++||+.+|++||++.+++.||||.........+.+..++++++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEA  319 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCCCCCCChhh
Confidence              000111111111122222223356789999999999999999999999999999999999998888999999999999


Q ss_pred             ccCCHHHHHHHHHH
Q 042681          314 TSMNEEDIKELILR  327 (339)
Q Consensus       314 ~~~~~~~~~~~~~~  327 (339)
                      .+.+.+.+.+.+.+
T Consensus       320 ~~~~~~~~~~~~~~  333 (334)
T cd07855         320 IELSREQLKEAIVK  333 (334)
T ss_pred             hhcChhhHHHHhhc
Confidence            98898988887754

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=311.68  Aligned_cols=261  Identities=26%  Similarity=0.394  Sum_probs=207.4

Q ss_pred             EEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh------------HhHHHHHHHHHHH
Q 042681           21 VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR------------IDAKRILREIKLL   88 (339)
Q Consensus        21 ~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~------------~~~~~~~~e~~~l   88 (339)
                      +.+.....+.+ -++|.+ ++.||+|.||.|.+|++..+++.||+|++.+....+            ...+++++|+.+|
T Consensus        85 ~~~~~~~~~k~-lNqy~l-~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIail  162 (576)
T KOG0585|consen   85 VRYDDDQDRKQ-LNQYEL-IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAIL  162 (576)
T ss_pred             eeecCccccee-hhheeh-hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHH
Confidence            34444444444 467888 999999999999999999999999999996543221            1236899999999


Q ss_pred             hhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 042681           89 CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKP  166 (339)
Q Consensus        89 ~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~givH~dikp  166 (339)
                      +++.||||++++++.-+   .....+|+|+|||. |.+.+.-. .++ +++.+++.|+.+++.||+|||.+||+||||||
T Consensus       163 Kkl~H~nVV~LiEvLDD---P~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKP  238 (576)
T KOG0585|consen  163 KKLHHPNVVKLIEVLDD---PESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKP  238 (576)
T ss_pred             HhcCCcCeeEEEEeecC---cccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccch
Confidence            99999999999999944   45567999999998 55543332 344 99999999999999999999999999999999


Q ss_pred             CCeeeccCCCeEEeecccccc----------------cCCCCccccccccc----cccCCCCccHHHHHHHHHHHhCCCC
Q 042681          167 SNLLLNANCDLKICDFGLART----------------TSETDFMTEYVVTR----WDTLFPGKDYVQQLTMITELLGSPD  226 (339)
Q Consensus       167 ~NIli~~~~~ikL~Dfg~~~~----------------~~~~~~~~~~~~~~----~~~~~~~d~~~~g~~~~~~l~g~~~  226 (339)
                      +|+|++++|++||+|||.+..                .|++.|++||.+..    ....++-|+|++|+++|.++.|..|
T Consensus       239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P  318 (576)
T KOG0585|consen  239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP  318 (576)
T ss_pred             hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence            999999999999999998853                46677889988765    3467789999999999999999999


Q ss_pred             CCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          227 DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      |.+-..  .....+++..-...+      ..+...+.++|||.+||++||++|++..++..|||...--
T Consensus       319 F~~~~~--~~l~~KIvn~pL~fP------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  319 FFDDFE--LELFDKIVNDPLEFP------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             cccchH--HHHHHHHhcCcccCC------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            754321  122222222211111      2245789999999999999999999999999999998663

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-44  Score=302.97  Aligned_cols=289  Identities=29%  Similarity=0.463  Sum_probs=219.5

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.+|+|+||.||++....+++.+|+|++-.+....      -+|+.+|+.+.||||+++.-+|......+.-.+.+|||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle  102 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE  102 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence            889999999999999999999999999986542211      26999999999999999999886654332346789999


Q ss_pred             cCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC-CCeEEeecccccccCCCC--
Q 042681          120 LMDTDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTSETD--  192 (339)
Q Consensus       120 ~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~-~~ikL~Dfg~~~~~~~~~--  192 (339)
                      |++.+|.+.++.    +..++.-.++-+..||+.||.|||+.|||||||||.|+|+|.+ |.+||||||.|+......  
T Consensus       103 ymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn  182 (364)
T KOG0658|consen  103 YMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN  182 (364)
T ss_pred             hchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence            999999999974    5789999999999999999999999999999999999999976 899999999998765432  


Q ss_pred             --------ccccccc-cccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCC--------------
Q 042681          193 --------FMTEYVV-TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP--------------  249 (339)
Q Consensus       193 --------~~~~~~~-~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~--------------  249 (339)
                              |.+||.. +...++..-|+|+.||++.+++.|.+.|.+-...  +....++..++...              
T Consensus       183 iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG~Pt~e~I~~mn~~y~~~  260 (364)
T KOG0658|consen  183 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLGTPTREDIKSMNPNYTEF  260 (364)
T ss_pred             eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence                    5566644 4457899999999999999999999887553211  11122222111111              


Q ss_pred             ------CCCccc-cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCC----CCCChhhccCCH
Q 042681          250 ------KQPFSQ-KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYP----FNFDFEQTSMNE  318 (339)
Q Consensus       250 ------~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~----~~~~~~~~~~~~  318 (339)
                            ...... .....++++.+|+.++|+++|++|.++.|+++||||..++++....+...+    +++.-.......
T Consensus       261 ~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~~~e~~~~~  340 (364)
T KOG0658|consen  261 KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFNFKRAELGISP  340 (364)
T ss_pred             cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccCchHHHhccch
Confidence                  111111 235689999999999999999999999999999999999887543333222    444444445555


Q ss_pred             HHHHHHHHHHHHhcCCCC
Q 042681          319 EDIKELILRECLNFHPDH  336 (339)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~  336 (339)
                      +-...++.+....+..+.
T Consensus       341 ~~~~~l~p~~~~~~~~~~  358 (364)
T KOG0658|consen  341 ELVNVLIPEHLREQEKDK  358 (364)
T ss_pred             HHHHhhccHhhhhhcccc
Confidence            555556665555555443

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-45  Score=295.88  Aligned_cols=253  Identities=29%  Similarity=0.448  Sum_probs=208.8

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc--Ch----HhHHHHHHHHHHHhhC-CCCCeeeeeeecCC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD--NR----IDAKRILREIKLLCHM-THENIVKVKDIIPP  105 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~--~~----~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~  105 (339)
                      -++|.. .+.||+|..++|.++.++.+|+.+|+|++.....  ..    .-.+.-.+|+.+|+++ .||+|+++.+++  
T Consensus        16 y~~y~p-keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--   92 (411)
T KOG0599|consen   16 YAKYEP-KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--   92 (411)
T ss_pred             HhhcCh-HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--
Confidence            356666 8899999999999999999999999999853311  11    1234456899999998 699999999999  


Q ss_pred             CCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          106 MDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                         +.+..+++|+|.++ |.|++++.....+++...++|+.|++.|+.|||.++||||||||+|||++++.+++|+|||+
T Consensus        93 ---es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   93 ---ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             ---cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccce
Confidence               77888999999998 99999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccc----------CCCCccccccccc------cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCC
Q 042681          185 ARTT----------SETDFMTEYVVTR------WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHV  248 (339)
Q Consensus       185 ~~~~----------~~~~~~~~~~~~~------~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~  248 (339)
                      ++.+          |++.|.+|+....      ..++...|.|+.|+++|.++.|.+|||--..+-  -...+    ...
T Consensus       170 a~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml--MLR~I----meG  243 (411)
T KOG0599|consen  170 ACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML--MLRMI----MEG  243 (411)
T ss_pred             eeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH--HHHHH----Hhc
Confidence            9764          5667888876643      346677899999999999999999986321110  01111    222


Q ss_pred             CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          249 PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       249 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ......+.|.++|.+.+|||.+||+.||++|.|++|+|+||||..+--.
T Consensus       244 kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~  292 (411)
T KOG0599|consen  244 KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ  292 (411)
T ss_pred             ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence            2233344567789999999999999999999999999999999766443

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-43  Score=301.86  Aligned_cols=258  Identities=22%  Similarity=0.342  Sum_probs=211.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ++.||.|.-|+||+|+.+.++..+|+|++.+... .+....++..|.+||..++||.++.+|..|     +.....|++|
T Consensus        82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~~~cl~m  156 (459)
T KOG0610|consen   82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDKYSCLVM  156 (459)
T ss_pred             HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccceeEEEE
Confidence            8899999999999999999999999999987633 345567888999999999999999999999     8888999999


Q ss_pred             ecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-------
Q 042681          119 ELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-------  188 (339)
                      |||+ |+|..+++++  +.+++..++-++.+++.||+|||-+|||+|||||+|||+..+|+|.|+||.++.+.       
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~  236 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV  236 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence            9998 7999888764  67999999999999999999999999999999999999999999999999876211       


Q ss_pred             ------------------------------------------------------------CCCCccccccccccccCCCC
Q 042681          189 ------------------------------------------------------------SETDFMTEYVVTRWDTLFPG  208 (339)
Q Consensus       189 ------------------------------------------------------------~~~~~~~~~~~~~~~~~~~~  208 (339)
                                                                                  |+..|.+||+.......++.
T Consensus       237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV  316 (459)
T KOG0610|consen  237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV  316 (459)
T ss_pred             ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence                                                                        11136667777777899999


Q ss_pred             ccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC----HHH
Q 042681          209 KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRIT----VEE  284 (339)
Q Consensus       209 d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps----~~e  284 (339)
                      |+|.+|+.+|+|+.|.-||-...  .......++..-...+.      .+.++..++|||+++|.+||++|+.    |+|
T Consensus       317 DWWtfGIflYEmLyG~TPFKG~~--~~~Tl~NIv~~~l~Fp~------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e  388 (459)
T KOG0610|consen  317 DWWTFGIFLYEMLYGTTPFKGSN--NKETLRNIVGQPLKFPE------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE  388 (459)
T ss_pred             hHHHHHHHHHHHHhCCCCcCCCC--chhhHHHHhcCCCcCCC------CCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence            99999999999999999864321  11222222222222221      2467899999999999999999998    999


Q ss_pred             HhcCCCCCCCccC----CCCCCCCCCCCCC
Q 042681          285 ALNHPYLSSLHEI----NEEPTCPYPFNFD  310 (339)
Q Consensus       285 ll~hp~f~~~~~~----~~~~~~~~~~~~~  310 (339)
                      |.+||||++++|.    ..+|..|.+.+..
T Consensus       389 IK~HpFF~gVnWaLir~~~PP~iP~~~d~~  418 (459)
T KOG0610|consen  389 IKRHPFFEGVNWALIRCARPPEIPKPVDGG  418 (459)
T ss_pred             hhcCccccCCChhheeccCCCcCCCccccC
Confidence            9999999999985    2444445554443

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-43  Score=316.62  Aligned_cols=301  Identities=40%  Similarity=0.718  Sum_probs=226.9

Q ss_pred             ccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCC
Q 042681           26 LGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPP  105 (339)
Q Consensus        26 ~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~  105 (339)
                      .+..+.++++|.. ++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++..
T Consensus         7 ~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07878           7 NKTVWEVPERYQN-LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             hHHHhhhhhhhhh-heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence            3456788999999 999999999999999999999999999997654444455678899999999999999999998843


Q ss_pred             CCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          106 MDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       106 ~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                      ... ......++++++++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          86 ATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cccccccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence            211 22345799999999999887754 6799999999999999999999999999999999999999999999999999


Q ss_pred             cccc--------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccccccc--------------------
Q 042681          185 ARTT--------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS--------------------  235 (339)
Q Consensus       185 ~~~~--------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~--------------------  235 (339)
                      +...        +...|.+||.... .....+.|+|++|++++++++|..++........                    
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         165 ARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             ceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            8653        3345788887654 3567789999999999999999988754221100                    


Q ss_pred             -chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCChhhc
Q 042681          236 -DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQT  314 (339)
Q Consensus       236 -~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  314 (339)
                       .............+.......+...++.+.+||.+||+.||++|||+.++++||||.....+...+.. .+++......
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~-~~~~~~~~~~  323 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEA-EPYDESPENK  323 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcccccc-Cccccchhhh
Confidence             00011111111122222222334567889999999999999999999999999999987665433322 3444444444


Q ss_pred             cCCHHHHHHHHHHHH
Q 042681          315 SMNEEDIKELILREC  329 (339)
Q Consensus       315 ~~~~~~~~~~~~~~~  329 (339)
                      .-+.+++++....+.
T Consensus       324 ~~~~~~~~~~~~~~~  338 (343)
T cd07878         324 ERTIEEWKELTYEEV  338 (343)
T ss_pred             hccHHHHHHHHHHHH
Confidence            455566666555443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.4e-44  Score=295.86  Aligned_cols=258  Identities=31%  Similarity=0.448  Sum_probs=207.1

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +.|.. +..|++|.||.||+|+++.|++.||+|+++.......-.-.-++|+.+|.+.+||||+.+-++..-   .+-+.
T Consensus        76 ~efe~-lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d~  151 (419)
T KOG0663|consen   76 EEFEK-LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMDK  151 (419)
T ss_pred             HHHHH-HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---cccce
Confidence            35555 889999999999999999999999999997654322222345799999999999999999999853   44566


Q ss_pred             EEEEEecCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC-
Q 042681          114 VYIVYELMDTDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET-  191 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~-  191 (339)
                      +|+|||||+.+|..++.+.+ ++.+.+++.++.|++.||+|||.+.|+||||||+|+|++..|.+|++|||+|+.++.+ 
T Consensus       152 iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  152 IYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            99999999999999998764 8999999999999999999999999999999999999999999999999999988876 


Q ss_pred             ----------Ccccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC-------------
Q 042681          192 ----------DFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH-------------  247 (339)
Q Consensus       192 ----------~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~-------------  247 (339)
                                .|.+|++.. ...+..+.|.|+.||++-+++.+.+.+.+-+..  +....++..+..             
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~--dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI--DQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH--HHHHHHHHHhCCCccccCCCccccc
Confidence                      467777554 445788899999999999999998887544322  111222222111             


Q ss_pred             ---------CCCCCccccCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          248 ---------VPKQPFSQKFPN--MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       248 ---------~~~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                               .+...+...++.  +++...+|++.+|..||.+|.||.|+|+|+||.....+
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence                     111112223333  45889999999999999999999999999999986544

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.1e-43  Score=314.65  Aligned_cols=276  Identities=37%  Similarity=0.604  Sum_probs=214.8

Q ss_pred             eEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeee
Q 042681           20 YVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV   99 (339)
Q Consensus        20 ~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~   99 (339)
                      +......+..+.+.++|.. .+.||+|+||.||++.+..+|+.+|+|++............+.+|+.+++.++||||+++
T Consensus         7 ~~~~~~~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   85 (359)
T cd07876           7 FYSVQVADSTFTVLKRYQQ-LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL   85 (359)
T ss_pred             cceecccchhhhhhhceEE-EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeee
Confidence            3444556667788899998 999999999999999999999999999997665555556778899999999999999999


Q ss_pred             eeecCCCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeE
Q 042681          100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK  178 (339)
Q Consensus       100 ~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ik  178 (339)
                      ++++..... .....+++||||++++|.+.+.  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++
T Consensus        86 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~k  163 (359)
T cd07876          86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  163 (359)
T ss_pred             eeeeccCCCccccceeEEEEeCCCcCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEE
Confidence            999843221 1224589999999998887764  3588999999999999999999999999999999999999999999


Q ss_pred             Eeeccccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc-------------
Q 042681          179 ICDFGLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS-------------  235 (339)
Q Consensus       179 L~Dfg~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~-------------  235 (339)
                      |+|||+++..          ++..|++||......+..+.|+|++|++++++++|..++........             
T Consensus       164 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  243 (359)
T cd07876         164 ILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA  243 (359)
T ss_pred             EecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence            9999998643          23458889888777788899999999999999999998764321100             


Q ss_pred             -------chHHHHHhhCCCCCCCCccc------------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          236 -------DNARRYVKQLPHVPKQPFSQ------------KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       236 -------~~~~~~~~~~~~~~~~~~~~------------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                             .............+.....+            .....++++++||.+||+.||++|||+.|+++||||.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence                   00000111111111111111            11124678999999999999999999999999999987655


Q ss_pred             CC
Q 042681          297 IN  298 (339)
Q Consensus       297 ~~  298 (339)
                      +.
T Consensus       324 ~~  325 (359)
T cd07876         324 PA  325 (359)
T ss_pred             cc
Confidence            43

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=310.94  Aligned_cols=247  Identities=19%  Similarity=0.296  Sum_probs=206.4

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. ++.||+|+||.||+|.+..+|+.+|+|++..... .....+.+.+|+.+++.++||||+++++++     .+...
T Consensus         2 ~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   75 (291)
T cd05612           2 DLER-IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF   75 (291)
T ss_pred             Ccee-eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence            4566 8999999999999999999999999999875422 223456788999999999999999999998     66678


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +++||||++ |+|.+++.+.+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++...    
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            999999997 799999998889999999999999999999999999999999999999999999999999998643    


Q ss_pred             ----CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHH
Q 042681          189 ----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       189 ----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  264 (339)
                          +...|.+||.........+.|+|++|+++|++++|..|+.....  ............     .   ....+++.+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~-----~---~~~~~~~~~  225 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--FGIYEKILAGKL-----E---FPRHLDLYA  225 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCc-----C---CCccCCHHH
Confidence                34468889988777788899999999999999999998754321  111111111111     1   113468999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCccC
Q 042681          265 IDLAERMLVFDPAKRIT-----VEEALNHPYLSSLHEI  297 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~~  297 (339)
                      ++||++||+.||.+||+     +.++++||||..+.+.
T Consensus       226 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         226 KDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             HHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence            99999999999999995     9999999999987765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-45  Score=297.34  Aligned_cols=236  Identities=27%  Similarity=0.334  Sum_probs=199.8

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      .|.+ .++||+|.||.||+|+...+|+.+|+|.++-...+....+....|+.+|++|+||||+++++.-.   .++...+
T Consensus        20 ~y~I-l~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~evl   95 (375)
T KOG0591|consen   20 DYQI-LKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEVL   95 (375)
T ss_pred             HHHH-HHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchhh
Confidence            3555 99999999999999999999999999999977778888899999999999999999999998331   1444458


Q ss_pred             EEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccCCCCCCCeeeccCCCeEEeecccc
Q 042681          115 YIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHS--AN--VLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~--~g--ivH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                      +||||||+ |+|.+.++.    ++.++|.++|.++.|++.||.++|+  ..  +.||||||.||+++.+|.+||+|||++
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            99999998 899988853    4689999999999999999999998  44  999999999999999999999999998


Q ss_pred             cc-----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          186 RT-----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       186 ~~-----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      +.           +|++.|++|+.....++.+.+|+|++||++|+|..-.+||..-      ........+.+...++.+
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qgd~~~~p  249 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQGDYPPLP  249 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcCCCCCCc
Confidence            64           5677899999999999999999999999999999999997654      222222222333333332


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITV  282 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~  282 (339)
                      .  ..+|.+++.||..|+..||..||+.
T Consensus       250 ~--~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  250 D--EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             H--HHhhhHHHHHHHHHccCCcccCCCc
Confidence            2  2478999999999999999999985

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1e-42  Score=315.37  Aligned_cols=294  Identities=37%  Similarity=0.603  Sum_probs=224.4

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ++.||+|+||.||++.+..+|+.||+|++...........++.+|+.++..++||||+++++++...........++|+|
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   84 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE   84 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence            88999999999999999999999999998765444455678899999999999999999999995432222237899999


Q ss_pred             cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC----------
Q 042681          120 LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS----------  189 (339)
Q Consensus       120 ~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~----------  189 (339)
                      |++++|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....          
T Consensus        85 ~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  164 (372)
T cd07853          85 LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE  164 (372)
T ss_pred             ccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCC
Confidence            9999999999888899999999999999999999999999999999999999999999999999886422          


Q ss_pred             --CCCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccc--------------------hHHHHHhhCC
Q 042681          190 --ETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD--------------------NARRYVKQLP  246 (339)
Q Consensus       190 --~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~--------------------~~~~~~~~~~  246 (339)
                        ...|.+||..... .+..+.|+|++|++++++++|..++.........                    ..........
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  244 (372)
T cd07853         165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGP  244 (372)
T ss_pred             CcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCC
Confidence              2347777765543 3567899999999999999999987543211000                    0000000001


Q ss_pred             CCCCC--CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC--------------------CCCCCCC
Q 042681          247 HVPKQ--PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI--------------------NEEPTCP  304 (339)
Q Consensus       247 ~~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~--------------------~~~~~~~  304 (339)
                      ..+..  .........++++.+||.+||+.||++|||+.++++||||......                    ..++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (372)
T cd07853         245 HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSAN  324 (372)
T ss_pred             CCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCCcccCCCCC
Confidence            00000  0011223468899999999999999999999999999999875321                    1233344


Q ss_pred             CCCCCChhhccCCHHHHHHHHHHHHHhcC
Q 042681          305 YPFNFDFEQTSMNEEDIKELILRECLNFH  333 (339)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (339)
                      .+++.++.....+..++++.+.+...++.
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (372)
T cd07853         325 PPFDDEYEKNLTSVRQVKEELHQFILEQQ  353 (372)
T ss_pred             CCCCcccccccCCHHHHHHHHHHHHHHhh
Confidence            45666666666677888888877776663

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-43  Score=311.71  Aligned_cols=255  Identities=30%  Similarity=0.434  Sum_probs=216.7

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMD  107 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~  107 (339)
                      -.+...|.. .+.||+|.||.||+++++.||+.+|+|.+.+... .......+.+|+.+|++++ ||||+.+++.|    
T Consensus        31 ~~~~~~Y~l-~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~----  105 (382)
T KOG0032|consen   31 EDIKEKYEL-GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF----  105 (382)
T ss_pred             ccccccEEe-hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence            445566777 8999999999999999999999999999987643 3335678999999999998 99999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC----CCeEEeec
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN----CDLKICDF  182 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~----~~ikL~Df  182 (339)
                       +....+++|||++. |.|++.+... .+++..+..++.|++.|++|||+.|++||||||+|+++...    +.++++||
T Consensus       106 -e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  106 -EDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             -EcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence             77779999999998 7999999876 59999999999999999999999999999999999999643    47999999


Q ss_pred             cccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          183 GLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       183 g~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      |++...          |++.|.+|+.....++....|+|+.|+++|.+++|.+|++......  .    ...........
T Consensus       184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--~----~~~i~~~~~~f  257 (382)
T KOG0032|consen  184 GLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--I----FLAILRGDFDF  257 (382)
T ss_pred             CCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--H----HHHHHcCCCCC
Confidence            999653          5567899999988899999999999999999999999987543211  1    11222222334


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ..+.|+.+|..+++||++||..||.+|+|+.++|+|||++.....
T Consensus       258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~  302 (382)
T KOG0032|consen  258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA  302 (382)
T ss_pred             CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence            445668899999999999999999999999999999999887443

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-43  Score=313.61  Aligned_cols=242  Identities=20%  Similarity=0.315  Sum_probs=203.2

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      +.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.++..++||||+++++++     .....+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            46899999999999999999999999997642 2333456788999999999999999999998     66778999999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----------  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----------  188 (339)
                      |++ |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+++..          
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            998 699999988889999999999999999999999999999999999999999999999999987642          


Q ss_pred             -CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          189 -SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       189 -~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                       +...|++||......+..+.|+|++|++++++++|..|+......  ........  ...   .   ....+++++++|
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~~~--~~~---~---~p~~~~~~~~~l  225 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILM--EEI---R---FPRTLSPEAKSL  225 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHHHc--CCC---C---CCCCCCHHHHHH
Confidence             345688899887777888999999999999999999987542211  11111111  111   1   113578999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          268 AERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       268 i~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      |.+||+.||++||     ++.++++||||..+.+.
T Consensus       226 i~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         226 LAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             HHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999999999     89999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.3e-42  Score=312.28  Aligned_cols=305  Identities=35%  Similarity=0.550  Sum_probs=226.5

Q ss_pred             eEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeee
Q 042681           20 YVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV   99 (339)
Q Consensus        20 ~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~   99 (339)
                      ..........+.+.++|.. .+.||+|+||.||++.+..+++.+|+|++............+.+|+.+++.++||||+++
T Consensus        10 ~~~~~~~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~   88 (364)
T cd07875          10 FYSVEIGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL   88 (364)
T ss_pred             ceeeecCcchhchhcceeE-EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCcccc
Confidence            3444555566778899998 999999999999999999999999999998665555556778899999999999999999


Q ss_pred             eeecCCCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeE
Q 042681          100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK  178 (339)
Q Consensus       100 ~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ik  178 (339)
                      ++++..... .....+++||||++++|.+.+..  .+++..++.++.|++.||+|||++||+||||||+||+++.++.++
T Consensus        89 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k  166 (364)
T cd07875          89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  166 (364)
T ss_pred             ceeecccccccccCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEE
Confidence            998743221 22346899999999998888754  588999999999999999999999999999999999999999999


Q ss_pred             EeecccccccC----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHH------
Q 042681          179 ICDFGLARTTS----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV------  242 (339)
Q Consensus       179 L~Dfg~~~~~~----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~------  242 (339)
                      |+|||+++..+          ...|.+||.........+.|+|++|++++++++|..++......  .......      
T Consensus       167 L~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~  244 (364)
T cd07875         167 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTP  244 (364)
T ss_pred             EEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCC
Confidence            99999986433          34578888887777888999999999999999999887543211  0001111      


Q ss_pred             ----------------hhCCCCCCCC------------ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          243 ----------------KQLPHVPKQP------------FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       243 ----------------~~~~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                                      ...+......            ........+.++++||.+||+.||++|||+.++++||||..+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                            0000000000            001111245679999999999999999999999999999877


Q ss_pred             ccCCCCCCCCCCC-CCChhhccCCHHHHHHHHHHHH
Q 042681          295 HEINEEPTCPYPF-NFDFEQTSMNEEDIKELILREC  329 (339)
Q Consensus       295 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  329 (339)
                      .+.......+... ...........++.++.+..+.
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (364)
T cd07875         325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEV  360 (364)
T ss_pred             cCcccCCCCCCCCCCccchhhhccHHHHHHHHHHHH
Confidence            6654433222211 1222222344455555555544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.2e-43  Score=307.14  Aligned_cols=249  Identities=31%  Similarity=0.496  Sum_probs=198.1

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||.|+||.||++.+..+++.+|+|+++..... .....+.+|+.+++.++||||+++++++     .....
T Consensus         5 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~   77 (288)
T cd07871           5 ETYVK-LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDII-----HTERC   77 (288)
T ss_pred             ccceE-eeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCe
Confidence            45777 89999999999999999999999999998654222 2235677999999999999999999998     55678


Q ss_pred             EEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      .++||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...    
T Consensus        78 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          78 LTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             EEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            9999999999999988764 45899999999999999999999999999999999999999999999999998543    


Q ss_pred             -------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhC---------------
Q 042681          189 -------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL---------------  245 (339)
Q Consensus       189 -------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~---------------  245 (339)
                             +...|++||.... .....+.|+|++|++++++++|..++......  ..........               
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--EELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhccccch
Confidence                   2334778886543 45677899999999999999999887543211  0001110000               


Q ss_pred             -------CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          246 -------PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       246 -------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                             +.....+.....+.+++++++||++||+.||.+|||++|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                   0001111112234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-42  Score=313.36  Aligned_cols=307  Identities=35%  Similarity=0.551  Sum_probs=226.6

Q ss_pred             EEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeee
Q 042681           21 VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK  100 (339)
Q Consensus        21 ~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~  100 (339)
                      .+.......+.+.++|.. ++.||+|+||.||++.+..+++.+|+|++............+.+|+.+++.++||||++++
T Consensus         4 ~~~~~~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   82 (355)
T cd07874           4 YSVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL   82 (355)
T ss_pred             eeeccCchhhhhhhceeE-EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhcee
Confidence            345556667788899988 9999999999999999999999999999986655555667888999999999999999999


Q ss_pred             eecCCCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEE
Q 042681          101 DIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI  179 (339)
Q Consensus       101 ~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL  179 (339)
                      +++..... ......++||||+++++.+.+..  .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl  160 (355)
T cd07874          83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_pred             eeeeccccccccceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEE
Confidence            98843221 22345899999999988887754  5889999999999999999999999999999999999999999999


Q ss_pred             eecccccccC----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc-------------
Q 042681          180 CDFGLARTTS----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD-------------  236 (339)
Q Consensus       180 ~Dfg~~~~~~----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~-------------  236 (339)
                      +|||+++..+          +..|++||.........+.|+|++|++++++++|..++.........             
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             eeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999986533          34578888877777788999999999999999999987543211100             


Q ss_pred             -------hHHHHHhhCCCCCCCC------------ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          237 -------NARRYVKQLPHVPKQP------------FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       237 -------~~~~~~~~~~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                             ....+...........            ........+.++++||.+||+.||++|||+.|+++||||....+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence                   0000100000000000            001112246778999999999999999999999999999876554


Q ss_pred             CCCCCCC-CCCCCChhhccCCHHHHHHHHHHHHH
Q 042681          298 NEEPTCP-YPFNFDFEQTSMNEEDIKELILRECL  330 (339)
Q Consensus       298 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (339)
                      ....... ..+.........+.+..++.++...+
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (355)
T cd07874         321 AEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM  354 (355)
T ss_pred             hhccCCCccccccchhhhhccHHHHHHHHHHHhh
Confidence            3222111 11222222333455556666555543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-44  Score=320.78  Aligned_cols=252  Identities=21%  Similarity=0.343  Sum_probs=212.7

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCc
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDK  108 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~  108 (339)
                      .++-+.+..++.||+|+||+|++++.+.+++.||+|++++. .....+.+..+.|.+++...+ ||.++.++.+|     
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----  438 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----  438 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence            33444444599999999999999999999999999999887 455667888999999988885 99999999999     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ++..++|+||||+. |+ .-.+.+.+.+++..++-|+..|+.||+|||++||+|||||.+|||+|.+|++||+|||+|+.
T Consensus       439 QT~~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  439 QTKEHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             ccCCeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc
Confidence            78899999999998 56 33445568899999999999999999999999999999999999999999999999999964


Q ss_pred             -----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          188 -----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       188 -----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                                 .|++.|++|++.....++.+.|.|++|+.+|+|++|.+||..      +...+....+...... +   
T Consensus       518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g------ddEee~FdsI~~d~~~-y---  587 (694)
T KOG0694|consen  518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG------DDEEEVFDSIVNDEVR-Y---  587 (694)
T ss_pred             cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC------CCHHHHHHHHhcCCCC-C---
Confidence                       356789999999999999999999999999999999999653      2223333322221111 0   


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCccCC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRIT-----VEEALNHPYLSSLHEIN  298 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~~~  298 (339)
                      ...+|.++.++++++|++||++|+.     +.++.+||||+++.|..
T Consensus       588 P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~  634 (694)
T KOG0694|consen  588 PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD  634 (694)
T ss_pred             CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence            0248999999999999999999994     58999999999999853

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.4e-43  Score=312.55  Aligned_cols=248  Identities=23%  Similarity=0.328  Sum_probs=206.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.. .+.||+|+||.||+|.+..+++.+|+|++.+.. ......+.+.+|+.++..++||||+++++++     ....
T Consensus        18 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   91 (329)
T PTZ00263         18 SDFEM-GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN   91 (329)
T ss_pred             hheEE-EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence            45555 899999999999999999999999999997542 2223456788999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .+++||||+. |+|.+.+...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...   
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            8999999997 699999998889999999999999999999999999999999999999999999999999998754   


Q ss_pred             -----CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          189 -----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       189 -----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                           +...|++||.........+.|+|++|+++|++++|..|+.....  ..........  .   ...   ...++..
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~--~---~~~---p~~~~~~  241 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRIYEKILAG--R---LKF---PNWFDGR  241 (329)
T ss_pred             cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HHHHHHHhcC--C---cCC---CCCCCHH
Confidence                 33458889888777788899999999999999999999754321  1111111111  1   111   1237899


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCccC
Q 042681          264 AIDLAERMLVFDPAKRIT-----VEEALNHPYLSSLHEI  297 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~~  297 (339)
                      +++||.+||+.||++||+     +++++.||||+...+.
T Consensus       242 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        242 ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence            999999999999999997     7999999999986543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.2e-43  Score=307.90  Aligned_cols=256  Identities=29%  Similarity=0.417  Sum_probs=200.8

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. ++.||.|+||.||+|.+..+++.+|+|++...... .....+.+|+.+++.++||||+++++++     ....
T Consensus         4 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~   76 (303)
T cd07869           4 ADSYEK-LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDII-----HTKE   76 (303)
T ss_pred             cccceE-eeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCC
Confidence            467777 99999999999999999999999999998754322 2234577899999999999999999999     5667


Q ss_pred             eEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      ..++||||++++|.+++... +.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++...   
T Consensus        77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          77 TLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             eEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            89999999999998888654 67999999999999999999999999999999999999999999999999988542   


Q ss_pred             --------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCC----------
Q 042681          189 --------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP----------  249 (339)
Q Consensus       189 --------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~----------  249 (339)
                              +...|++||.... .....++|+|++|++++++++|..|+........ .............          
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhCCCChhhccchhhc
Confidence                    2234778886543 3456678999999999999999999865422111 1111111000000          


Q ss_pred             ----C--------CCccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          250 ----K--------QPFSQKF--PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       250 ----~--------~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                          .        ......+  ..+++++++||.+||+.||++|||+.++++||||+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence                0        0000000  124678999999999999999999999999999998743

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.6e-43  Score=305.39  Aligned_cols=249  Identities=27%  Similarity=0.449  Sum_probs=199.2

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. ++.||+|+||.||++++..+++.+|+|++..........+.+.+|+.+++.++||||+++++++     .....+
T Consensus         2 ~y~~-~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (287)
T cd07848           2 KFEV-LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL   75 (287)
T ss_pred             CceE-EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence            5666 8999999999999999999999999999976544444567788999999999999999999998     667789


Q ss_pred             EEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-----
Q 042681          115 YIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-----  188 (339)
Q Consensus       115 ~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-----  188 (339)
                      ++||||+++++.+.+.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+...     
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            99999999766665543 467999999999999999999999999999999999999999999999999998643     


Q ss_pred             -------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh--------------CCC
Q 042681          189 -------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ--------------LPH  247 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~--------------~~~  247 (339)
                             +...|.+||.........+.|+|++|++++++++|.+|+.......  ........              ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID--QLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhCCCCHHHHHhhhccch
Confidence                   2335788888776677889999999999999999998876432111  00000000              000


Q ss_pred             C---CCCCc-------cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          248 V---PKQPF-------SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       248 ~---~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      .   .....       ......+|.++++||++||++||++|||++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            0   00000       01112478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-43  Score=318.31  Aligned_cols=251  Identities=18%  Similarity=0.224  Sum_probs=200.8

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||.||+|.+..+++.+|+|...        ...+.+|+.+++.++||||+++++++     .....
T Consensus        92 ~~y~~-~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~  157 (391)
T PHA03212         92 AGFSI-LETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKF  157 (391)
T ss_pred             CCcEE-EEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCe
Confidence            46777 999999999999999999999999999653        23467899999999999999999998     56678


Q ss_pred             EEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc------
Q 042681          114 VYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART------  187 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~------  187 (339)
                      .++++|++.++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..      
T Consensus       158 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        158 TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             eEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999853      


Q ss_pred             ------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc-----chHHHHHhhC-----------
Q 042681          188 ------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS-----DNARRYVKQL-----------  245 (339)
Q Consensus       188 ------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~-----~~~~~~~~~~-----------  245 (339)
                            .++..|.+||......+..+.|+|++|+++|++++|..++........     ..........           
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence                  234457788888777788899999999999999999876543211000     0000000000           


Q ss_pred             ------------CCCCC----CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          246 ------------PHVPK----QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       246 ------------~~~~~----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                                  .....    .+.......++.++.+||.+||+.||++|||+.|+++||||+.+..+.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~  386 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPY  386 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCC
Confidence                        00000    000011123577899999999999999999999999999999876543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-43  Score=311.20  Aligned_cols=255  Identities=22%  Similarity=0.348  Sum_probs=208.8

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC-hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.+ ++.||+|+||.||+|++..+++.||+|++.+.... ......+.+|+.++..++||||+++++++     .....
T Consensus         2 ~y~~-~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~   75 (333)
T cd05600           2 DFQI-LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY   75 (333)
T ss_pred             CcEE-EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence            4556 89999999999999999999999999999765322 23456788999999999999999999999     66778


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      .++||||++ |+|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...    
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~  155 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA  155 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccccc
Confidence            999999997 799999988889999999999999999999999999999999999999999999999999998643    


Q ss_pred             ----CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHH
Q 042681          189 ----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       189 ----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  264 (339)
                          +...|.+||......+..+.|+|++|++++++++|..|+......  ...............+........++.++
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--ETWENLKYWKETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--HHHHHHHhccccccCCCCCccccccCHHH
Confidence                445688999887778889999999999999999999997543211  11111111111111111111113578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          265 IDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      .+||.+||..+|.+||++.++++||||..+.+.
T Consensus       234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~  266 (333)
T cd05600         234 WDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN  266 (333)
T ss_pred             HHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence            999999999999999999999999999987553

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-42  Score=310.59  Aligned_cols=305  Identities=43%  Similarity=0.759  Sum_probs=243.7

Q ss_pred             EccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecC
Q 042681           25 ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIP  104 (339)
Q Consensus        25 ~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~  104 (339)
                      +.+..+.+.++|.. .+.||+|++|.||++.+..+++.+|+|++............+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~~~~y~~-~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07851           6 LNKTVWEVPDRYQN-LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFT   84 (343)
T ss_pred             hccceecccCceEE-EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence            34556778999988 99999999999999999999999999998765444445567889999999999999999999884


Q ss_pred             CCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          105 PMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       105 ~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                      .... ......++|+||++++|.+++.. .++++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          85 PASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccccccccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccc
Confidence            3221 22235899999999999998876 579999999999999999999999999999999999999999999999999


Q ss_pred             cccccC--------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHH-------------
Q 042681          184 LARTTS--------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRY-------------  241 (339)
Q Consensus       184 ~~~~~~--------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~-------------  241 (339)
                      .+....        ...|.+|+.... .....+.|+|++|++++++++|..++......  ......             
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         164 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             ccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCHHHHh
Confidence            987543        234667776533 24667899999999999999999887532211  111111             


Q ss_pred             ----------HhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCCh
Q 042681          242 ----------VKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDF  311 (339)
Q Consensus       242 ----------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~  311 (339)
                                ...........+......+++++.+||.+||+.+|.+|||+.++++||||.........+ ...+++.++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~-~~~~~~~~~  320 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEP-VAPPYDQSF  320 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccc-cccccCcch
Confidence                      111111222222223345789999999999999999999999999999999987775443 377888999


Q ss_pred             hhccCCHHHHHHHHHHHHHhcCC
Q 042681          312 EQTSMNEEDIKELILRECLNFHP  334 (339)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~  334 (339)
                      ...++..+..+.++..+.+||.|
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07851         321 ESRDLTVDEWKELVYKEIMNFKP  343 (343)
T ss_pred             hhhhcCHHHHHHHhHHHHHhccC
Confidence            99999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-42  Score=315.00  Aligned_cols=250  Identities=20%  Similarity=0.352  Sum_probs=202.8

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      |.. ++.||+|+||+||+|++..+++.||+|++.+.. ........+.+|+.++..++||||+++++++     .....+
T Consensus         3 f~~-~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           3 FVK-IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             ceE-EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            444 889999999999999999999999999997642 3344567789999999999999999999999     666789


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc------
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART------  187 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~------  187 (339)
                      ++||||++ |+|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+||+++.+++++|+|||++..      
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            99999997 79999998888999999999999999999999999999999999999999999999999998642      


Q ss_pred             ----------------------------------------------------cCCCCccccccccccccCCCCccHHHHH
Q 042681          188 ----------------------------------------------------TSETDFMTEYVVTRWDTLFPGKDYVQQL  215 (339)
Q Consensus       188 ----------------------------------------------------~~~~~~~~~~~~~~~~~~~~~d~~~~g~  215 (339)
                                                                          .++..|++||......+..+.|+|++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                                2445688888877777888999999999


Q ss_pred             HHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHhcCCCCCC
Q 042681          216 TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV--FDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       216 ~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~--~dP~~Rps~~ell~hp~f~~  293 (339)
                      ++|++++|..|+.....  ..............   . ......+++++++||.+|+.  .+|..|+++.++++||||+.
T Consensus       237 il~elltG~~Pf~~~~~--~~~~~~i~~~~~~~---~-~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         237 ILFEMLVGQPPFLAPTP--TETQLKVINWENTL---H-IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE  310 (381)
T ss_pred             HHHHHHhCCCCCcCCCH--HHHHHHHHcccccc---C-CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence            99999999999754321  11111111101111   1 11123579999999999654  45556999999999999998


Q ss_pred             CccC
Q 042681          294 LHEI  297 (339)
Q Consensus       294 ~~~~  297 (339)
                      +.+.
T Consensus       311 ~~~~  314 (381)
T cd05626         311 VDFS  314 (381)
T ss_pred             CChh
Confidence            7653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-43  Score=315.30  Aligned_cols=250  Identities=23%  Similarity=0.372  Sum_probs=206.4

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. ++.||+|+||.||+|++..+|+.||+|++.+.. ........+.+|+.++..++||||+++++++     .....
T Consensus         2 ~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (364)
T cd05599           2 DFES-IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY   75 (364)
T ss_pred             CceE-EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence            4555 899999999999999999999999999997542 2233456688999999999999999999999     67788


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +++||||++ |+|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++...    
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            999999997 799999988889999999999999999999999999999999999999999999999999987532    


Q ss_pred             ---------------------------------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhC
Q 042681          189 ---------------------------------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLG  223 (339)
Q Consensus       189 ---------------------------------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g  223 (339)
                                                                   ++..|++||+.....+..+.|+|++|++++++++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence                                                         44568888888777788899999999999999999


Q ss_pred             CCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCccC
Q 042681          224 SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRIT---VEEALNHPYLSSLHEI  297 (339)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~~~~~~  297 (339)
                      ..|+......  ............   .... ....+++++++||.+||. +|.+|++   +.++++||||....+.
T Consensus       236 ~~Pf~~~~~~--~~~~~i~~~~~~---~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         236 YPPFCSDNPQ--ETYRKIINWKET---LQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             CCCCCCCCHH--HHHHHHHcCCCc---cCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            9997643211  111111111111   1111 112478999999999997 9999998   9999999999988653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-44  Score=282.90  Aligned_cols=240  Identities=25%  Similarity=0.402  Sum_probs=209.0

Q ss_pred             CccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           39 PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        39 ~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      +.+.||+|.||.||+++.++++-.+|+|++.+... .....+++.+|+++...|+||||+++|++|     -+...+|++
T Consensus        26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~~riyLi  100 (281)
T KOG0580|consen   26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDSKRIYLI  100 (281)
T ss_pred             ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----eccceeEEE
Confidence            39999999999999999999999999999977632 233457789999999999999999999999     566789999


Q ss_pred             EecCc-ccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc------
Q 042681          118 YELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT------  188 (339)
Q Consensus       118 ~e~~~-g~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~------  188 (339)
                      +||++ |+++..++  ..+++++..++.++.|++.||.|+|.++++||||||+|+|++.++.+|+.|||.+...      
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~  180 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRK  180 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCCce
Confidence            99998 89999998  6678999999999999999999999999999999999999999999999999987433      


Q ss_pred             ---CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          189 ---SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       189 ---~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                         ++..|.+||.+.........|.|.+|+..|+.+.|.+||.+..  .....+.+.......+        ..++.+++
T Consensus       181 tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~~~~~p--------~~is~~a~  250 (281)
T KOG0580|consen  181 TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKVDLKFP--------STISGGAA  250 (281)
T ss_pred             eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHccccCC--------cccChhHH
Confidence               4456889999988899999999999999999999999987654  3333344433322222        45899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          266 DLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       266 ~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                      |||.+||.++|.+|.+..|++.|||+..
T Consensus       251 dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  251 DLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHHhccCccccccHHHHhhhHHHHh
Confidence            9999999999999999999999999864

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-42  Score=301.91  Aligned_cols=248  Identities=19%  Similarity=0.288  Sum_probs=202.2

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccC-hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      .+.||+|+||.||++.+..+|+.||+|.+.+.... ......+.+|+.++..++|++|+++++++     ......++||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~lv~   79 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALCLVL   79 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEEEEE
Confidence            78899999999999999999999999998754322 22345678999999999999999999998     6667899999


Q ss_pred             ecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-------
Q 042681          119 ELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-------  188 (339)
                      ||++ |+|.+.+...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...       
T Consensus        80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence            9998 6888777543  46899999999999999999999999999999999999999999999999998643       


Q ss_pred             ---CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          189 ---SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       189 ---~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                         +...|++||......+....|+|++|++++++++|..|+.......  ........... ..   ......+++++.
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~-~~---~~~~~~~s~~~~  233 (285)
T cd05631         160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KREEVDRRVKE-DQ---EEYSEKFSEDAK  233 (285)
T ss_pred             CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hHHHHHHHhhc-cc---ccCCccCCHHHH
Confidence               3346888988877778889999999999999999999976432211  11111111111 11   112245789999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhcCCCCCCCccCC
Q 042681          266 DLAERMLVFDPAKRIT-----VEEALNHPYLSSLHEIN  298 (339)
Q Consensus       266 ~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~~~  298 (339)
                      +|+++||+.||.+||+     ++++++||||..+.+..
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~  271 (285)
T cd05631         234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR  271 (285)
T ss_pred             HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence            9999999999999997     89999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=298.47  Aligned_cols=256  Identities=23%  Similarity=0.307  Sum_probs=211.5

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      |.++.+.+.+.+.||.|..++||+|+...++..||+|++....- ..+.+.+++|+..+..++||||++++..|     .
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc-~~~ld~l~kE~~~msl~~HPNIv~~~~sF-----v   94 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC-NNDLDALRKEVQTMSLIDHPNIVTYHCSF-----V   94 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh-hhhHHHHHHHHHHhhhcCCCCcceEEEEE-----E
Confidence            34444444449999999999999999999999999999975433 33478899999999999999999999999     7


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      ....+++||.|+. |++.++++..  ..++|..+..+++++++||.|||++|.+|||||+.||||+++|.|||+|||.+.
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence            7788999999998 8999999874  569999999999999999999999999999999999999999999999998763


Q ss_pred             ---------------ccCCCCccccccc--cccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCC
Q 042681          187 ---------------TTSETDFMTEYVV--TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP  249 (339)
Q Consensus       187 ---------------~~~~~~~~~~~~~--~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (339)
                                     ..+++.+++||..  ....+.+++|+|++|++.+++..|..|+..++.+.     .....+...+
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-----vLl~tLqn~p  249 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-----VLLLTLQNDP  249 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-----HHHHHhcCCC
Confidence                           2455667888873  34578999999999999999999999988765432     2222222222


Q ss_pred             CC-----CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          250 KQ-----PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       250 ~~-----~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ..     .-.+....++.+++.+|..||++||++||||+++++|+||+....
T Consensus       250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            21     111223457888999999999999999999999999999998764

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.2e-42  Score=312.19  Aligned_cols=251  Identities=22%  Similarity=0.311  Sum_probs=203.1

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. ++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.++..++||+|+++++.+     .....
T Consensus         2 ~y~~-~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~   75 (363)
T cd05628           2 DFES-LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN   75 (363)
T ss_pred             CceE-eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence            4555 899999999999999999999999999997542 2233456788999999999999999999999     66778


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc-----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----  187 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~-----  187 (339)
                      +++||||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||+++.     
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999997 69999999888999999999999999999999999999999999999999999999999998753     


Q ss_pred             -----------------------------------------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCC
Q 042681          188 -----------------------------------------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD  226 (339)
Q Consensus       188 -----------------------------------------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~  226 (339)
                                                               .++..|++||......+..++|+|++|+++|++++|..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                                     234567888887777788899999999999999999999


Q ss_pred             CCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCC---CCCCHHHHhcCCCCCCCccCC
Q 042681          227 DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPA---KRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~---~Rps~~ell~hp~f~~~~~~~  298 (339)
                      +.....  .............   ..... ...+++++++||.+|+. +|.   .||+++++++||||+.+.+..
T Consensus       236 f~~~~~--~~~~~~i~~~~~~---~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         236 FCSETP--QETYKKVMNWKET---LIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             CCCCCH--HHHHHHHHcCcCc---ccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence            754321  1111111111011   11111 12478999999999775 444   468999999999999987643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.3e-42  Score=301.80  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=197.9

Q ss_pred             ccCCCccccccccceEEEEEEeCC-CCceEEEEEecccccChHhHHHHHHHHHHHhhC---CCCCeeeeeeecCCCCcCC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSE-TKEEVAIKKITNAFDNRIDAKRILREIKLLCHM---THENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~I~~~~~~~~~~~~~~  110 (339)
                      +|.. ++.||+|+||.||+|++.. +++.+|+|+++.............+|+.+++.+   +||||+++++++.......
T Consensus         2 ~Y~~-~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYEC-VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             Ccce-eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            5666 8999999999999999865 468899999876543333334556677776665   6999999999885433234


Q ss_pred             cCeEEEEEecCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          111 FNDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       111 ~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ...+++||||++++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+...
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            5679999999999999998653  45899999999999999999999999999999999999999999999999998643


Q ss_pred             C----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC------------
Q 042681          189 S----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP------------  246 (339)
Q Consensus       189 ~----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~------------  246 (339)
                      .          ...|.+||.........++|+|++|++++++++|.+++......  ...........            
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         161 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             cCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhchhhhc
Confidence            2          34578888877667788999999999999999999987653221  11111111100            


Q ss_pred             -------CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          247 -------HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       247 -------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                             .....+.....+.+++.+++|+.+||+.||++|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                   011111222335678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-43  Score=298.15  Aligned_cols=249  Identities=25%  Similarity=0.420  Sum_probs=211.5

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      .-.+..+|.+ .++||+|.||+|-+|.+...|+.||+|.+++. ..+..+.-++.+|+++|..|+||||+.+|++|    
T Consensus        48 khnlkHRyE~-~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF----  122 (668)
T KOG0611|consen   48 KHNLKHRYEI-TETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF----  122 (668)
T ss_pred             ccchhhHHHH-HHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh----
Confidence            3345567888 99999999999999999999999999999876 45566677899999999999999999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                       ++...+.|||||.. |.|.+++..++.+++.+++.+|.||.+|+.|+|+++++|||||.+|||+|.|+++||.|||++.
T Consensus       123 -ENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSN  201 (668)
T KOG0611|consen  123 -ENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSN  201 (668)
T ss_pred             -cCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhh
Confidence             88888999999998 8999999999999999999999999999999999999999999999999999999999999985


Q ss_pred             c----------cCCCCccccccccccc-cCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          187 T----------TSETDFMTEYVVTRWD-TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       187 ~----------~~~~~~~~~~~~~~~~-~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                      .          .|.+-|++|++....+ ..+..|.|++|+.+|.+..|..||.+..      ....+.++.....   .+
T Consensus       202 ly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs~GaY---rE  272 (668)
T KOG0611|consen  202 LYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQISRGAY---RE  272 (668)
T ss_pred             hhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhhcccc---cC
Confidence            3          3556688888776554 5666889999999999999999976532      2222222222211   11


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                        |..+.++..||+.||..||++|-|+.++-.|=|.+-.
T Consensus       273 --P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwg  309 (668)
T KOG0611|consen  273 --PETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWG  309 (668)
T ss_pred             --CCCCchHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence              4467889999999999999999999999999776533

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-42  Score=307.39  Aligned_cols=293  Identities=55%  Similarity=0.892  Sum_probs=234.7

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||.|++|.||+|.+..+++.+++|++..........+.+.+|+.+++.++||||+++++++...........
T Consensus         1 ~y~i-~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYEL-LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             Ccee-eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            3555 889999999999999999999999999997654445556788999999999999999999999854332233478


Q ss_pred             EEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC---
Q 042681          115 YIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET---  191 (339)
Q Consensus       115 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~---  191 (339)
                      +++|||++++|.+.+.+...+++..++.++.||+.||++||+.|++|+||||+||+++.++.++|+|||.+......   
T Consensus        80 ~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~  159 (330)
T cd07834          80 YIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE  159 (330)
T ss_pred             EEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence            99999999999999988789999999999999999999999999999999999999999999999999998754332   


Q ss_pred             -----------Ccccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccc---------------------cchH
Q 042681          192 -----------DFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR---------------------SDNA  238 (339)
Q Consensus       192 -----------~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~---------------------~~~~  238 (339)
                                 .|.+|+..... ....+.|+|++|++++++++|.+++.......                     ....
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (330)
T cd07834         160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA  239 (330)
T ss_pred             cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence                       25677766555 67788999999999999999998875433110                     0011


Q ss_pred             HHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCC-ChhhccCC
Q 042681          239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNF-DFEQTSMN  317 (339)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~-~~~~~~~~  317 (339)
                      ...................+.++.++.++|.+||+++|++||++.++++||||+.+...........+++. .+...+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (330)
T cd07834         240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELT  319 (330)
T ss_pred             hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccccccchhhcC
Confidence            11111112222222233345678999999999999999999999999999999999988777777777766 56777888


Q ss_pred             HHHHHHHHHHH
Q 042681          318 EEDIKELILRE  328 (339)
Q Consensus       318 ~~~~~~~~~~~  328 (339)
                      .++..+++.++
T Consensus       320 ~~~~~~~~~~~  330 (330)
T cd07834         320 EEELKELIYEE  330 (330)
T ss_pred             HHHHhHHhhcC
Confidence            88888887653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=314.70  Aligned_cols=249  Identities=18%  Similarity=0.313  Sum_probs=203.2

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. ++.||+|+||.||++.+..+++.||+|++.+.. ......+.+.+|+.++..++||||+++++++     .....
T Consensus         2 ~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~   75 (377)
T cd05629           2 DFHT-VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY   75 (377)
T ss_pred             CceE-eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence            4555 899999999999999999999999999986542 2233456788999999999999999999999     66778


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc-----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----  187 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~-----  187 (339)
                      +|+||||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||+++.     
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999997 79999998888999999999999999999999999999999999999999999999999998852     


Q ss_pred             -----------------------------------------------------cCCCCccccccccccccCCCCccHHHH
Q 042681          188 -----------------------------------------------------TSETDFMTEYVVTRWDTLFPGKDYVQQ  214 (339)
Q Consensus       188 -----------------------------------------------------~~~~~~~~~~~~~~~~~~~~~d~~~~g  214 (339)
                                                                           .++..|++||......+..+.|+|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence                                                                 244568888887777788899999999


Q ss_pred             HHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCC
Q 042681          215 LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKR---ITVEEALNHPYL  291 (339)
Q Consensus       215 ~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~ell~hp~f  291 (339)
                      ++++++++|..|+.....  ............   ...+ .....++.++++||.+||. +|.+|   +++.+++.||||
T Consensus       236 vil~elltG~~Pf~~~~~--~~~~~~i~~~~~---~~~~-p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~  308 (377)
T cd05629         236 AIMFECLIGWPPFCSENS--HETYRKIINWRE---TLYF-PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFF  308 (377)
T ss_pred             hhhhhhhcCCCCCCCCCH--HHHHHHHHccCC---ccCC-CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCc
Confidence            999999999999754221  111111111101   1111 1113478999999999998 77765   599999999999


Q ss_pred             CCCcc
Q 042681          292 SSLHE  296 (339)
Q Consensus       292 ~~~~~  296 (339)
                      ..+.+
T Consensus       309 ~~~~~  313 (377)
T cd05629         309 RGVDW  313 (377)
T ss_pred             CCCCH
Confidence            98764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-42  Score=290.56  Aligned_cols=262  Identities=33%  Similarity=0.503  Sum_probs=205.7

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCC-eeeeeeecCCCCc-CCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN-IVKVKDIIPPMDK-EKF  111 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-I~~~~~~~~~~~~-~~~  111 (339)
                      ..|.. ++.||+|+||+||+|+.+.+|+.||+|+++.....+-......+|+.+++.|+|+| |+++++++..... ...
T Consensus        11 ~~~~~-~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   11 FDYEK-VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHH-HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            44555 78899999999999999999999999999876443334456789999999999999 9999999943210 112


Q ss_pred             CeEEEEEecCcccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          112 NDVYIVYELMDTDLHQIIRSKQ----ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       112 ~~~~iv~e~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ..+++|+||...+|..++....    .++...++.++.||+.||+|||++||+||||||+||+|+++|.+||+|||+|+.
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence            3789999999999999997644    688899999999999999999999999999999999999999999999999975


Q ss_pred             cCC-----------CCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC-----
Q 042681          188 TSE-----------TDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK-----  250 (339)
Q Consensus       188 ~~~-----------~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  250 (339)
                      .+-           ..|.+|++.... .+....|+|++||++.+++++.+.|.....  ......+.........     
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCccCCCC
Confidence            542           246667655443 688889999999999999998877654332  2222222222222111     


Q ss_pred             -----------------CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          251 -----------------QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       251 -----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                                       ..+....+..+++..+++.+||+.+|.+|.||+.++.||||.......
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence                             111122244556899999999999999999999999999999997654

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.7e-42  Score=305.84  Aligned_cols=242  Identities=19%  Similarity=0.309  Sum_probs=201.9

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      +.||+|+||.||++++..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++     .....+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            468999999999999999999999999976432 233456778899999999999999999999     66678999999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----------  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----------  188 (339)
                      |++ |+|..++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...          
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            998 799988888888999999999999999999999999999999999999999999999999987542          


Q ss_pred             -CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          189 -SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       189 -~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                       +...|++||.........+.|+|++|++++++++|..|+......  .........  ...      ....+++++++|
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~~~~~~--~~~------~p~~~~~~~~~l  225 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILME--EIR------FPRTLSPEAKSL  225 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHhcC--CCC------CCCCCCHHHHHH
Confidence             345688899887777888999999999999999999987543211  111111111  111      113578999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          268 AERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       268 i~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      |.+||+.||.+||     ++.++++||||....+.
T Consensus       226 i~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~  260 (323)
T cd05595         226 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  260 (323)
T ss_pred             HHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999999998     89999999999987754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-43  Score=309.05  Aligned_cols=242  Identities=28%  Similarity=0.435  Sum_probs=203.8

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      .|.. ...||+|+.|.||.|....+++.||+|++......  ..+.+++|+.+|+..+|+||+.+++.|     -..+.+
T Consensus       274 ~y~~-~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sy-----lv~deL  345 (550)
T KOG0578|consen  274 KYTD-FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSY-----LVGDEL  345 (550)
T ss_pred             hhcc-hhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHh-----ccccee
Confidence            3444 78899999999999999999999999999765333  346688999999999999999999999     455789


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc------
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART------  187 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~------  187 (339)
                      ++||||++ |+|-+.+.. ..++|.++..++.++++||+|||.+||+|||||.+||++..+|.+||+|||+|.+      
T Consensus       346 WVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             EEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            99999998 677666654 5699999999999999999999999999999999999999999999999999964      


Q ss_pred             -----cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          188 -----TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       188 -----~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                           +|++.+++||+..+..+.+..|+|++|+.+++|+-|.+|+..      +.....++.+.....+.+ .....+|+
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln------E~PlrAlyLIa~ng~P~l-k~~~klS~  497 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN------ENPLRALYLIATNGTPKL-KNPEKLSP  497 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC------CChHHHHHHHhhcCCCCc-CCccccCH
Confidence                 456779999999999999999999999999999999999642      111122222222222221 12246899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                      .+++|+.+||+.||.+|++|.+||+||||+
T Consensus       498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  498 ELKDFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             HHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence            999999999999999999999999999994

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.5e-42  Score=305.83  Aligned_cols=242  Identities=19%  Similarity=0.313  Sum_probs=202.2

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      +.||+|+||.||++++..+|+.+|+|++.+... .......+.+|+.+++.++||||+++++++     .....+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            368999999999999999999999999976532 334456788999999999999999999998     66778999999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----------  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----------  188 (339)
                      |++ |+|...+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...          
T Consensus        76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            998 689989888888999999999999999999999999999999999999999999999999987642          


Q ss_pred             -CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          189 -SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       189 -~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                       +...|++||.........+.|+|++|++++++++|..|+.....      ........... ..   ....+++++.+|
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~~~-~~---~p~~~~~~~~~l  225 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMED-IK---FPRTLSADAKSL  225 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhccCC-cc---CCCCCCHHHHHH
Confidence             34568888887777778899999999999999999999754321      11111111111 11   113578999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          268 AERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       268 i~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      |++||+.||++|+     ++.++++||||....+.
T Consensus       226 i~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         226 LSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             HHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            9999999999997     89999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.6e-42  Score=313.81  Aligned_cols=250  Identities=20%  Similarity=0.357  Sum_probs=204.0

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. ++.||+|+||.||+|++..+++.+|+|++.+.. ........+.+|+.+++.++||||+++++.+     .....
T Consensus         2 ~f~~-~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~   75 (382)
T cd05625           2 MFVK-IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN   75 (382)
T ss_pred             CcEE-EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCE
Confidence            3445 899999999999999999999999999987542 2334456788999999999999999999999     66678


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc-----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----  187 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~-----  187 (339)
                      +++||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..     
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999997 69999998888899999999999999999999999999999999999999999999999998632     


Q ss_pred             -----------------------------------------------------cCCCCccccccccccccCCCCccHHHH
Q 042681          188 -----------------------------------------------------TSETDFMTEYVVTRWDTLFPGKDYVQQ  214 (339)
Q Consensus       188 -----------------------------------------------------~~~~~~~~~~~~~~~~~~~~~d~~~~g  214 (339)
                                                                           .++..|++||......+..+.|+|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                                 234468888888777788899999999


Q ss_pred             HHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCC
Q 042681          215 LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRIT---VEEALNHPYL  291 (339)
Q Consensus       215 ~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f  291 (339)
                      ++++++++|..|+.....  ...............    ......++++++++|.+|+ .+|.+|++   +.++++||||
T Consensus       236 vil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~----~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f  308 (382)
T cd05625         236 VILYEMLVGQPPFLAQTP--LETQMKVINWQTSLH----IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFF  308 (382)
T ss_pred             HHHHHHHhCCCCCCCCCH--HHHHHHHHccCCCcC----CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCc
Confidence            999999999999764321  111111111111111    1112457999999999986 59999997   9999999999


Q ss_pred             CCCccC
Q 042681          292 SSLHEI  297 (339)
Q Consensus       292 ~~~~~~  297 (339)
                      +.+.+.
T Consensus       309 ~~~~~~  314 (382)
T cd05625         309 KTIDFS  314 (382)
T ss_pred             CCcChH
Confidence            987653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-42  Score=302.89  Aligned_cols=239  Identities=24%  Similarity=0.391  Sum_probs=200.3

Q ss_pred             cccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecC
Q 042681           43 IGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM  121 (339)
Q Consensus        43 lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~  121 (339)
                      ||+|+||.||++.+..+++.+|+|++.... ........+.+|+.++.+++||||+++++++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            699999999999999999999999987542 2334456788999999999999999999998     6667899999999


Q ss_pred             c-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-----------C
Q 042681          122 D-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-----------S  189 (339)
Q Consensus       122 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-----------~  189 (339)
                      + |+|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...           +
T Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            8 799999988889999999999999999999999999999999999999999999999999988642           3


Q ss_pred             CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHH
Q 042681          190 ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAE  269 (339)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  269 (339)
                      ...|++||......+..+.|+|++|++++++++|..|+......  .......    ....    .....+++++++||.
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--~~~~~~~----~~~~----~~~~~~~~~~~~li~  225 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--EMYRKIL----QEPL----RFPDGFDRDAKDLLI  225 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--HHHHHHH----cCCC----CCCCcCCHHHHHHHH
Confidence            45688899887777888999999999999999999997643211  1111111    1111    111357899999999


Q ss_pred             HhcccCCCCCC---CHHHHhcCCCCCCCcc
Q 042681          270 RMLVFDPAKRI---TVEEALNHPYLSSLHE  296 (339)
Q Consensus       270 ~~L~~dP~~Rp---s~~ell~hp~f~~~~~  296 (339)
                      +||+.||.+||   ++.+++.||||....+
T Consensus       226 ~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         226 GLLSRDPTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             HHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence            99999999997   5899999999998754

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.9e-42  Score=299.45  Aligned_cols=254  Identities=27%  Similarity=0.426  Sum_probs=197.7

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC---CCCCeeeeeeecCCCCcCCc
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM---THENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~I~~~~~~~~~~~~~~~  111 (339)
                      +|.. ++.||+|+||.||+|++..+|+.+|+|.++.............+|+.+++.+   +||||+++++++........
T Consensus         1 ~y~~-~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEP-VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceE-eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            3555 8999999999999999999999999999875433322233455677666655   79999999999854333345


Q ss_pred             CeEEEEEecCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          112 NDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       112 ~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ..+++++||++++|.+++...  ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+....
T Consensus        80 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          80 TKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             ceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            568999999999999888653  458999999999999999999999999999999999999999999999999986432


Q ss_pred             ----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC-------------
Q 042681          190 ----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP-------------  246 (339)
Q Consensus       190 ----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~-------------  246 (339)
                                ...|.+||.........++|+|++|++++++++|.+++......  ...........             
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07863         160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIGLPPEDDWPRDVTL  237 (288)
T ss_pred             CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--HHHHHHHHHhCCCChhhCcccccc
Confidence                      33588888877777888999999999999999999887543211  11111111100             


Q ss_pred             ------CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          247 ------HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       247 ------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                            ...........+.++..+++||.+||+.||++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  011111122335678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.7e-42  Score=305.90  Aligned_cols=248  Identities=19%  Similarity=0.339  Sum_probs=201.8

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||++.+..+++.||+|++++... .......+.+|..++..+ +||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            468999999999999999999999999976532 233456688899999998 699999999999     6677899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc----------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----------  187 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~----------  187 (339)
                      ||++ |+|.+++.+.+++++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++..          
T Consensus        76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            9997 69999988888999999999999999999999999999999999999999999999999998853          


Q ss_pred             -cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccc--cchHHHH-HhhCCCCCCCCccccCCCCCHH
Q 042681          188 -TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR--SDNARRY-VKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       188 -~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                       .++..|.+||......+..+.|+|++|+++|++++|..|+.......  ....... ....... ...   ....++.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~p~~~~~~  231 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-QIR---IPRSLSVK  231 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-CCC---CCCCCCHH
Confidence             23446888888877778889999999999999999999986432211  1111111 1111110 011   11357899


Q ss_pred             HHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCccC
Q 042681          264 AIDLAERMLVFDPAKRIT------VEEALNHPYLSSLHEI  297 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps------~~ell~hp~f~~~~~~  297 (339)
                      +.++|++||+.||.+|++      ++++++||||.++.+.
T Consensus       232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~  271 (329)
T cd05588         232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD  271 (329)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence            999999999999999997      7899999999987653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-42  Score=307.90  Aligned_cols=248  Identities=19%  Similarity=0.317  Sum_probs=205.2

Q ss_pred             CccCCCccccccccceEEEEEEeCCCC-ceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETK-EEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~-~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++|.. ++.||+|+||.||+|.+..++ ..+|+|++.+.. ......+.+.+|+.++..++||||+++++++     ...
T Consensus        30 ~~y~~-~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~  103 (340)
T PTZ00426         30 EDFNF-IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE  103 (340)
T ss_pred             hhcEE-EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence            45656 899999999999999876655 689999986542 2233456788999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ..+++||||++ |+|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...  
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            78999999997 799999998889999999999999999999999999999999999999999999999999998653  


Q ss_pred             ------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          189 ------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       189 ------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                            +...|++||...........|+|++|+++|++++|..|+......  ............        ..+.+++
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~i~~~~~~--------~p~~~~~  253 (340)
T PTZ00426        184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LIYQKILEGIIY--------FPKFLDN  253 (340)
T ss_pred             CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HHHHHHhcCCCC--------CCCCCCH
Confidence                  334588898887777788999999999999999999997643211  111111111111        1134789


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          263 VAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      .++++|++||+.||.+|+     ++.++++||||.++.+.
T Consensus       254 ~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        254 NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            999999999999999996     89999999999988654

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=311.14  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=207.0

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. ++.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.++..++||||+++++++     .....
T Consensus         2 ~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (350)
T cd05573           2 DFEV-IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH   75 (350)
T ss_pred             CceE-EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence            5666 8999999999999999999999999999976532 224456788999999999999999999998     66778


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +++||||++ ++|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...    
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999997 799999988889999999999999999999999999999999999999999999999999988643    


Q ss_pred             ------------------------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccc
Q 042681          189 ------------------------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGF  232 (339)
Q Consensus       189 ------------------------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~  232 (339)
                                                          ++..|.+||......+....|+|++|++++++++|..|+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                                23347788887777788899999999999999999999765431


Q ss_pred             cccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCCCccCC
Q 042681          233 LRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRIT-VEEALNHPYLSSLHEIN  298 (339)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-~~ell~hp~f~~~~~~~  298 (339)
                        ...............    ......+++++++||.+||. ||.+||+ +.++++||||+.+.+..
T Consensus       236 --~~~~~~i~~~~~~~~----~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~  295 (350)
T cd05573         236 --QETYNKIINWKESLR----FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWEN  295 (350)
T ss_pred             --HHHHHHHhccCCccc----CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHH
Confidence              111111111101111    11113379999999999998 9999999 99999999999886643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.1e-42  Score=313.93  Aligned_cols=250  Identities=20%  Similarity=0.343  Sum_probs=204.6

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.+ ++.||+|+||.||+|++..+++.||+|++.+.. ........+.+|+.++..++||||+++++.+     ...+.
T Consensus         2 ~y~~-~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (376)
T cd05598           2 MFVK-IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN   75 (376)
T ss_pred             CceE-EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence            4556 999999999999999999999999999986542 2223456788999999999999999999999     66788


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc-----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----  187 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~-----  187 (339)
                      +++||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..     
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999997 79999998888899999999999999999999999999999999999999999999999998631     


Q ss_pred             -------------------------------------------------cCCCCccccccccccccCCCCccHHHHHHHH
Q 042681          188 -------------------------------------------------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMI  218 (339)
Q Consensus       188 -------------------------------------------------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~  218 (339)
                                                                       .+...|++||.........+.|+|++|+++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                             2455688888887777888999999999999


Q ss_pred             HHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCc
Q 042681          219 TELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRI---TVEEALNHPYLSSLH  295 (339)
Q Consensus       219 ~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~~~~  295 (339)
                      ++++|..|+......  .......    .............+++++.++|.+|+ .+|.+|+   ++.++++||||+.+.
T Consensus       236 ell~G~~Pf~~~~~~--~~~~~i~----~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         236 EMLVGQPPFLADTPA--ETQLKVI----NWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             ehhhCCCCCCCCCHH--HHHHHHh----ccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            999999997643211  1111111    11111011112357899999999977 5999999   999999999999875


Q ss_pred             cC
Q 042681          296 EI  297 (339)
Q Consensus       296 ~~  297 (339)
                      ..
T Consensus       309 ~~  310 (376)
T cd05598         309 FA  310 (376)
T ss_pred             HH
Confidence            43

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=304.06  Aligned_cols=297  Identities=50%  Similarity=0.802  Sum_probs=224.6

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .++++|.+ .+.||+|++|.||++.+..+|+.||+|+++.. ........+.+|+.+++.++||||+++++++.......
T Consensus         2 ~~~~~y~i-~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           2 DVGPRYQN-LSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccccceEE-EEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence            45678887 99999999999999999999999999998643 22334566788999999999999999999875543344


Q ss_pred             cCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-
Q 042681          111 FNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-  189 (339)
Q Consensus       111 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-  189 (339)
                      ....++++||++++|.+.+.. +.+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.... 
T Consensus        80 ~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          80 FNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             cceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            456899999999999887754 679999999999999999999999999999999999999999999999999886432 


Q ss_pred             -------------CCCcccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCccccccc-------------chH----
Q 042681          190 -------------ETDFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS-------------DNA----  238 (339)
Q Consensus       190 -------------~~~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~-------------~~~----  238 (339)
                                   ...|.+|+... ........|+|++|++++++++|..++........             ...    
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence                         22366777543 33466789999999999999999988754221100             000    


Q ss_pred             ----HHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCChhhc
Q 042681          239 ----RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQT  314 (339)
Q Consensus       239 ----~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  314 (339)
                          ...................+..++++.++|.+||+.+|++|||+.++++||||..+......+....++-++++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~  318 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF  318 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccc
Confidence                0001111111111111223457889999999999999999999999999999999988765555534433333322


Q ss_pred             -cCCHHHHHHHHHHHHH
Q 042681          315 -SMNEEDIKELILRECL  330 (339)
Q Consensus       315 -~~~~~~~~~~~~~~~~  330 (339)
                       ..--+.+++.+.++++
T Consensus       319 ~~~~~~~~~~~~~~~~~  335 (336)
T cd07849         319 DDLPKEKLKELIFEEIM  335 (336)
T ss_pred             cccCHHHHHHHHHHHhc
Confidence             3445778888877765

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2e-41  Score=295.27  Aligned_cols=245  Identities=21%  Similarity=0.333  Sum_probs=198.3

Q ss_pred             cccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecC
Q 042681           43 IGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM  121 (339)
Q Consensus        43 lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~  121 (339)
                      ||+|+||+||++.+..+|+.+|+|++..... .......+..|+.+++.++||||+++.+++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            6999999999999999999999999875422 222345678899999999999999999998     6667899999999


Q ss_pred             c-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--------
Q 042681          122 D-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--------  188 (339)
Q Consensus       122 ~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--------  188 (339)
                      + |+|.+.+..    ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+...        
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            7 688877642    356999999999999999999999999999999999999999999999999998643        


Q ss_pred             ---CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          189 ---SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       189 ---~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                         +...|.+||.........+.|+|++|+++|++++|..|+........  ............ .   .....++++++
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~-~---~~~~~~~~~~~  229 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILNDS-V---TYPDKFSPASK  229 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcccC-C---CCcccCCHHHH
Confidence               23457888887777778899999999999999999998754321111  111111111111 1   11135789999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccCC
Q 042681          266 DLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       266 ~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~~  298 (339)
                      +++.+||+.||++||     +++++++||||+...+..
T Consensus       230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence            999999999999999     889999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-41  Score=304.40  Aligned_cols=306  Identities=39%  Similarity=0.672  Sum_probs=238.9

Q ss_pred             EccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecC
Q 042681           25 ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIP  104 (339)
Q Consensus        25 ~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~  104 (339)
                      ..+..|.+.++|.. .+.||+|++|.||+|.+..+|+.+|+|++............+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~~~~y~~-~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~   84 (342)
T cd07879           6 VNKTVWELPERYTS-LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT   84 (342)
T ss_pred             hhhhhhccccceEE-EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence            45567888899988 99999999999999999999999999998765444434566889999999999999999999985


Q ss_pred             CCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          105 PMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       105 ~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                      .... .....+++|+||+..+|....  ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          85 SAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             ccccCCCCceEEEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence            3211 122457999999998877665  3468999999999999999999999999999999999999999999999999


Q ss_pred             cccccC--------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccch-----------------
Q 042681          184 LARTTS--------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN-----------------  237 (339)
Q Consensus       184 ~~~~~~--------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~-----------------  237 (339)
                      ++....        ...|.+|+.... .....+.|+|++|++++++++|..++........-.                 
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         163 LARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             CCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            986532        224677776544 346778999999999999999999876432111000                 


Q ss_pred             ----HHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCChhh
Q 042681          238 ----ARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQ  313 (339)
Q Consensus       238 ----~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  313 (339)
                          ...........+.......++..++++++||.+||+.||.+||++.+++.||||+.+.+.. +..++.+++.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~-~~~~~~~~~~~~~~  321 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD-EETEQQPYDDSLEN  321 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc-ccCCCCcccchhhh
Confidence                0000111111122222223456788999999999999999999999999999999998754 33457778888888


Q ss_pred             ccCCHHHHHHHHHHHHHhcCC
Q 042681          314 TSMNEEDIKELILRECLNFHP  334 (339)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~  334 (339)
                      .+.+.++....++++.-.|+|
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~  342 (342)
T cd07879         322 EKLSVDEWKKHIYKEVKSFSP  342 (342)
T ss_pred             hhCCHHHHHHHhhhhhhccCC
Confidence            888889999999888877765

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.7e-41  Score=301.64  Aligned_cols=287  Identities=49%  Similarity=0.819  Sum_probs=225.3

Q ss_pred             ccccccccceEEEEEEeCCC--CceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSET--KEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      .+.||+|+||.||++.+..+  +..+|+|++..........+.+.+|+.+++++ +||||+++++...... .....+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~~~~~   83 (332)
T cd07857           5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFNELYL   83 (332)
T ss_pred             EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCCcEEE
Confidence            78899999999999999888  89999999876544444456788999999999 5999999998753211 23356899


Q ss_pred             EEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--------
Q 042681          117 VYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--------  188 (339)
Q Consensus       117 v~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--------  188 (339)
                      ++++++++|.+.+.....+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+...        
T Consensus        84 ~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (332)
T cd07857          84 YEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA  163 (332)
T ss_pred             EEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999988643        


Q ss_pred             -------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccccccc---------------------chHH
Q 042681          189 -------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS---------------------DNAR  239 (339)
Q Consensus       189 -------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~---------------------~~~~  239 (339)
                             +...|.+|+.... .....+.|+|++|++++++++|.+++........                     ....
T Consensus       164 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
T cd07857         164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQ  243 (332)
T ss_pred             ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHH
Confidence                   2234667775433 3467789999999999999999988754321100                     0000


Q ss_pred             HHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCChhhccCCHH
Q 042681          240 RYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEE  319 (339)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (339)
                      .........+...+....+..+..+++|+.+||+.||++|||+.+++.||||+.++++...+.|..+++++|..+ .+-+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  322 (332)
T cd07857         244 NYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESE-DSME  322 (332)
T ss_pred             HHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCcccc-ccHH
Confidence            111111222222333344567899999999999999999999999999999999999888889999999999884 4445


Q ss_pred             HHHHHHHHH
Q 042681          320 DIKELILRE  328 (339)
Q Consensus       320 ~~~~~~~~~  328 (339)
                      +++..+.++
T Consensus       323 ~~~~~~~~~  331 (332)
T cd07857         323 ELRDMIIEE  331 (332)
T ss_pred             HHHHHHhhc
Confidence            666666543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.8e-42  Score=302.71  Aligned_cols=242  Identities=18%  Similarity=0.286  Sum_probs=200.4

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||+|++..+++.||+|++.+.. ......+.+..|..++..+ +||||+++++++     .....+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            46899999999999999999999999987542 2233456677888888876 699999999999     6677899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ |+|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...         
T Consensus        76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            9998 699999988889999999999999999999999999999999999999999999999999987542         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                        +...|.+||......+..+.|+|++|+++|++++|..|+.....      ............ .   ....+++++++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~-~---~~~~~~~~~~~  225 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEV-V---YPTWLSQDAVD  225 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCC-C---CCCCCCHHHHH
Confidence              34568889888777778889999999999999999999764321      111111111111 0   11347899999


Q ss_pred             HHHHhcccCCCCCCCH------HHHhcCCCCCCCccC
Q 042681          267 LAERMLVFDPAKRITV------EEALNHPYLSSLHEI  297 (339)
Q Consensus       267 li~~~L~~dP~~Rps~------~ell~hp~f~~~~~~  297 (339)
                      ||++||+.||.+||++      +++++||||..+.+.
T Consensus       226 li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~  262 (320)
T cd05590         226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE  262 (320)
T ss_pred             HHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999999999998      999999999988764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.1e-41  Score=301.62  Aligned_cols=248  Identities=19%  Similarity=0.341  Sum_probs=200.9

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||++++..+++.+|+|++.+.. ........+.+|+.++..+ +||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence            46899999999999999999999999997653 2334456678899988877 799999999999     6677899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ |+|..++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...         
T Consensus        76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            9998 689888888889999999999999999999999999999999999999999999999999988542         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc--chHHHHHhhCCCCCCCCccccCCCCCHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS--DNARRYVKQLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  264 (339)
                        +...|.+||.........++|+|++|++++++++|..|+........  .................   ....++..+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---~p~~~~~~~  232 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---IPRSLSVKA  232 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC---CCCCCCHHH
Confidence              34468888888777778899999999999999999999853322111  11111111100001111   113578999


Q ss_pred             HHHHHHhcccCCCCCCC------HHHHhcCCCCCCCcc
Q 042681          265 IDLAERMLVFDPAKRIT------VEEALNHPYLSSLHE  296 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rps------~~ell~hp~f~~~~~  296 (339)
                      .+||++||+.||.+||+      +.++++||||+.+.+
T Consensus       233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            99999999999999998      589999999998865

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.8e-41  Score=300.36  Aligned_cols=254  Identities=19%  Similarity=0.327  Sum_probs=203.8

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||.||++++..+|..+|+|.+.... .......+.+|+.+++.++||||+++++++     ...+.
T Consensus         5 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~   77 (331)
T cd06649           5 DDFER-ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE   77 (331)
T ss_pred             ccceE-EEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence            55666 899999999999999999999999999987542 233456789999999999999999999998     56678


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .++||||++ ++|.+++...+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...   
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999998 69999998888899999999999999999999986 6999999999999999999999999998643   


Q ss_pred             ------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchH------------------------
Q 042681          189 ------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNA------------------------  238 (339)
Q Consensus       189 ------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~------------------------  238 (339)
                            +...|.+||.........++|+|++|++++++++|..|+...........                        
T Consensus       158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence                  34468888888777788899999999999999999998743211000000                        


Q ss_pred             ----------------HHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          239 ----------------RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       239 ----------------~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                                      ..............  .....+++++++||.+||++||++|||+.++++||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                            00000000000000  001247889999999999999999999999999999986543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.1e-41  Score=300.90  Aligned_cols=242  Identities=19%  Similarity=0.299  Sum_probs=200.1

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||+|++..+++.+|+|++.+... .....+.+..|..++..+ +||||+++++++     ...+.+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            468999999999999999999999999976422 233456677888888876 799999999999     6667899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ ++|...+.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...         
T Consensus        76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            9998 699999988889999999999999999999999999999999999999999999999999988642         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                        +...|++||......+..+.|+|++|++++++++|..|+.....  .........    ... .   ....+++++++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--~~~~~~i~~----~~~-~---~p~~~~~~~~~  225 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--DDLFESILH----DDV-L---YPVWLSKEAVS  225 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--HHHHHHHHc----CCC-C---CCCCCCHHHHH
Confidence              34468888888777788899999999999999999999754321  111111111    110 0   01247899999


Q ss_pred             HHHHhcccCCCCCC-------CHHHHhcCCCCCCCccC
Q 042681          267 LAERMLVFDPAKRI-------TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       267 li~~~L~~dP~~Rp-------s~~ell~hp~f~~~~~~  297 (339)
                      ||.+||+.||++||       ++.++++||||..+.+.
T Consensus       226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             HHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence            99999999999999       99999999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-41  Score=301.76  Aligned_cols=309  Identities=40%  Similarity=0.706  Sum_probs=240.6

Q ss_pred             EEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeee
Q 042681           23 YNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI  102 (339)
Q Consensus        23 ~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~  102 (339)
                      .+..+..+.+.++|.. .+.||+|+||.||++.+..+|+.||+|++..........+.+.+|+.++.+++||||++++++
T Consensus         6 ~~~~~~~~~~~~~y~~-~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~   84 (345)
T cd07877           6 QELNKTIWEVPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   84 (345)
T ss_pred             hhHHHHHhhccCceEE-EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence            3455677889999998 999999999999999999999999999997654444445678899999999999999999998


Q ss_pred             cCCCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEee
Q 042681          103 IPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD  181 (339)
Q Consensus       103 ~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~D  181 (339)
                      +..... ......++++++++++|.+++.. +.+++..++.++.|++.||+|||+.|++||||||+||++++++.++|+|
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~d  163 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD  163 (345)
T ss_pred             eeecccccccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEec
Confidence            843221 12345789999998999887765 5699999999999999999999999999999999999999999999999


Q ss_pred             cccccccC--------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccccccc-----------------
Q 042681          182 FGLARTTS--------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS-----------------  235 (339)
Q Consensus       182 fg~~~~~~--------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~-----------------  235 (339)
                      ||.+....        ...|.+|+.... .....+.|+|++|++++++++|..++........                 
T Consensus       164 fg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T cd07877         164 FGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  243 (345)
T ss_pred             ccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            99986532        234667776543 3456789999999999999999988743221100                 


Q ss_pred             ----chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCCh
Q 042681          236 ----DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDF  311 (339)
Q Consensus       236 ----~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~  311 (339)
                          .............+...........++++++||.+||+.||.+||++.+++.||||.....+...+. +.+++..+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~-~~~~~~~~  322 (345)
T cd07877         244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV-ADPYDQSF  322 (345)
T ss_pred             hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcccc-CCCccCcc
Confidence                0001111112222222222223356889999999999999999999999999999999887665543 45788888


Q ss_pred             hhccCCHHHHHHHHHHHHHhcCC
Q 042681          312 EQTSMNEEDIKELILRECLNFHP  334 (339)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~  334 (339)
                      .......++.+...+++.-.|.|
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~  345 (345)
T cd07877         323 ESRDLLIDEWKSLTYDEVISFVP  345 (345)
T ss_pred             hhcccCHHHHHHHHHHHHHhcCC
Confidence            88888888888888888877754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.5e-42  Score=307.73  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=204.6

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      .|.. ++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.++..++||+|+++++.+     .....
T Consensus         2 ~f~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~   75 (360)
T cd05627           2 DFES-LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN   75 (360)
T ss_pred             CceE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            3445 899999999999999999999999999997542 2333456788999999999999999999999     66788


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc-----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----  187 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~-----  187 (339)
                      +++||||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++..     
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999997 69999998888999999999999999999999999999999999999999999999999998753     


Q ss_pred             -----------------------------------------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCC
Q 042681          188 -----------------------------------------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD  226 (339)
Q Consensus       188 -----------------------------------------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~  226 (339)
                                                               .++..|++||......+..+.|+|++|+++|++++|..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence                                                     244568888888777788899999999999999999999


Q ss_pred             CCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCccCC
Q 042681          227 DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRI---TVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~~~~~~~  298 (339)
                      +......  ...........   ...... ...+++++++||.+|+. ||.+|+   ++.++++||||.++.+..
T Consensus       236 f~~~~~~--~~~~~i~~~~~---~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         236 FCSETPQ--ETYRKVMNWKE---TLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             CCCCCHH--HHHHHHHcCCC---ceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence            7543211  11111111000   111111 12378999999999875 999999   489999999999987643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-41  Score=312.24  Aligned_cols=256  Identities=29%  Similarity=0.414  Sum_probs=196.2

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc---C
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK---E  109 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~---~  109 (339)
                      ..+|.. ++.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++.....   .
T Consensus        65 ~~~y~~-~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKL-GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEE-eEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            345666 999999999999999999999999999885431      223479999999999999999987633211   1


Q ss_pred             CcCeEEEEEecCcccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC-CeEEeeccc
Q 042681          110 KFNDVYIVYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGL  184 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~-~ikL~Dfg~  184 (339)
                      ....+++||||++++|.+++.    ....+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+
T Consensus       138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence            223578999999998877764    346799999999999999999999999999999999999999665 699999999


Q ss_pred             cccc----------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC------
Q 042681          185 ARTT----------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH------  247 (339)
Q Consensus       185 ~~~~----------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~------  247 (339)
                      ++..          +...|++||.... ..+..+.|+|++|++++++++|.+|+......  ............      
T Consensus       218 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             chhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHH
Confidence            9643          2345788887543 45778899999999999999999987643211  111111111100      


Q ss_pred             --------------CCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          248 --------------VPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       248 --------------~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                                    .........+ ...++++++||.+||++||.+|||+.|+++||||..+.+.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence                          0000011111 2467899999999999999999999999999999988764

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.1e-41  Score=298.30  Aligned_cols=254  Identities=31%  Similarity=0.487  Sum_probs=201.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||.||++.+..+++.+|+|++...... .....+.+|+.+++.++||||+++++++     ...+.
T Consensus         6 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~   78 (309)
T cd07872           6 ETYIK-LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKS   78 (309)
T ss_pred             CceEE-EEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCe
Confidence            56766 89999999999999999999999999998754322 2234577899999999999999999998     56678


Q ss_pred             EEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          114 VYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      .++||||++++|.+.+... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+....   
T Consensus        79 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          79 LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            9999999999999888654 458999999999999999999999999999999999999999999999999986432   


Q ss_pred             --------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHh-----------------
Q 042681          190 --------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK-----------------  243 (339)
Q Consensus       190 --------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~-----------------  243 (339)
                              ...|.+|+.... .....+.|+|++|++++++++|.+++.......  .......                 
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED--ELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHhhhcchh
Confidence                    234677776543 346778999999999999999998875432110  0000000                 


Q ss_pred             -----hCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          244 -----QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       244 -----~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                           ..............+.+++++++||.+||+.||.+|||+.++++||||+.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence                 00111111111233567899999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.5e-41  Score=302.30  Aligned_cols=242  Identities=20%  Similarity=0.314  Sum_probs=201.0

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      +.||+|+||.||++.+..+|+.+|+|++.+... .......+.+|+.++..++||||+++++++     .....+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            468999999999999999999999999976432 233456778899999999999999999998     66778999999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      |++ |+|..++...+.+++..++.++.||+.||.|||+ +|++||||||+||+++.++.++|+|||++...         
T Consensus        76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            998 6899888888899999999999999999999997 79999999999999999999999999987532         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                        +...|++||......+..+.|+|++|++++++++|..|+.....      ........... ..   ....+++++.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~------~~~~~~i~~~~-~~---~p~~~~~~~~~  225 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEE-IR---FPRTLSPEAKS  225 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH------HHHHHHHhcCC-CC---CCCCCCHHHHH
Confidence              34568889888777788899999999999999999998754321      11111111111 01   11357899999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          267 LAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       267 li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      ||.+||+.||++|+     ++.++++||||..+.+.
T Consensus       226 li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         226 LLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             HHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            99999999999997     89999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.5e-42  Score=304.62  Aligned_cols=251  Identities=19%  Similarity=0.286  Sum_probs=203.0

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. .+.||+|+||.||++.+..+|+.+|+|+++.... .....+.+.+|+.++..++||||+++++++     .....
T Consensus         2 ~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~   75 (330)
T cd05601           2 DFDV-KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN   75 (330)
T ss_pred             CceE-EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence            4555 8899999999999999999999999999976532 233456678999999999999999999998     66678


Q ss_pred             EEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          114 VYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .++||||++ |+|.+++.+. ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...   
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999997 7999999775 78999999999999999999999999999999999999999999999999998643   


Q ss_pred             ---------CCCCcccccccc------ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          189 ---------SETDFMTEYVVT------RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       189 ---------~~~~~~~~~~~~------~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                               +...|.+||...      ...+..+.|+|++|++++++++|..|+......  ......... ...  .. 
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i~~~-~~~--~~-  229 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--KTYNNIMNF-QRF--LK-  229 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--HHHHHHHcC-CCc--cC-
Confidence                     234577888765      334567899999999999999999997543211  111111111 110  11 


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      ....+.+++++++||++||+ +|.+||+++++++||||..+.+..
T Consensus       230 ~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~  273 (330)
T cd05601         230 FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN  273 (330)
T ss_pred             CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence            11124578999999999998 999999999999999999876654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.7e-41  Score=300.74  Aligned_cols=250  Identities=18%  Similarity=0.302  Sum_probs=200.2

Q ss_pred             cCCCccccccccceEEEEEEeC---CCCceEEEEEeccccc--ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcC
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNS---ETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKE  109 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~---~~~~~~avK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~  109 (339)
                      |.+ ++.||+|+||.||++++.   .+++.+|+|++.+...  .....+.+.+|+.++..+ +||+|+++++++     .
T Consensus         2 y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           2 FEL-LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             ceE-EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            444 889999999999999864   4789999999875422  223346678899999999 599999999998     6


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ..+.+++||||++ |+|.+++..++.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            6778999999998 699999988889999999999999999999999999999999999999999999999999988642


Q ss_pred             ------------CCCCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          189 ------------SETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       189 ------------~~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                                  +...|++||..... ....+.|+|++|++++++++|..|+.........  ............ .   
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~-~---  229 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILKCDP-P---  229 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhcCCC-C---
Confidence                        33457788876543 3667899999999999999999997543221111  111111111111 1   


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      ..+.+++.++++|.+||+.||++||     ++.++++||||+...+.
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  276 (332)
T cd05614         230 FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE  276 (332)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            1135789999999999999999999     88899999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.2e-41  Score=299.29  Aligned_cols=246  Identities=20%  Similarity=0.318  Sum_probs=202.3

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCC-CCeeeeeeecCCCCcCCcCe
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~I~~~~~~~~~~~~~~~~~  113 (339)
                      |.. ++.||+|+||.||+|.+..+++.||+|++.+... .....+.+..|..++..++| ++|+++++++     ...+.
T Consensus         2 y~~-~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (324)
T cd05587           2 FNF-LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR   75 (324)
T ss_pred             ceE-EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence            444 8899999999999999999999999999976432 23345678889999999975 5688899988     56678


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +++||||++ |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...    
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999997 799999988888999999999999999999999999999999999999999999999999987532    


Q ss_pred             -------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          189 -------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                             +...|.+||......+..+.|+|++|++++++++|..|+.....  ..........    . ..   ....++
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i~~~----~-~~---~~~~~~  225 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQSIMEH----N-VS---YPKSLS  225 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHcC----C-CC---CCCCCC
Confidence                   44568889988777778889999999999999999999754321  1111111111    1 11   113578


Q ss_pred             HHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCccC
Q 042681          262 PVAIDLAERMLVFDPAKRITV-----EEALNHPYLSSLHEI  297 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~-----~ell~hp~f~~~~~~  297 (339)
                      +++++++.+||+.||.+|+++     .++++||||..+.+.
T Consensus       226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~  266 (324)
T cd05587         226 KEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE  266 (324)
T ss_pred             HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            999999999999999999976     899999999987653

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-40  Score=298.57  Aligned_cols=306  Identities=38%  Similarity=0.686  Sum_probs=237.4

Q ss_pred             ccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCC
Q 042681           26 LGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPP  105 (339)
Q Consensus        26 ~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~  105 (339)
                      .+..|.+.++|.. ++.||+|++|.||++.+..+|+.||+|++............+.+|+.+++.++||||+++++++..
T Consensus         7 ~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07880           7 NKTIWEVPDRYRD-LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             hhhhhccccceEE-EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence            4567788999998 999999999999999999999999999986554444445678899999999999999999999843


Q ss_pred             CCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          106 MDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       106 ~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                      ... .....+++||||++++|.+++.+ ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          86 DLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             CccccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            211 11235799999998888888764 6799999999999999999999999999999999999999999999999999


Q ss_pred             ccccC--------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccccccc--------------------
Q 042681          185 ARTTS--------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS--------------------  235 (339)
Q Consensus       185 ~~~~~--------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~--------------------  235 (339)
                      +....        ...|.+|+.... .......|+|++|++++++++|..|+........                    
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         165 ARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             ccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            86543        234566775543 2356779999999999999999988754321100                    


Q ss_pred             -chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCChhhc
Q 042681          236 -DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQT  314 (339)
Q Consensus       236 -~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  314 (339)
                       ......................+.+++.+.++|.+||+.||++|||+.++++||||+........+ ...++..++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~  323 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET-EAPPYDDSFDEV  323 (343)
T ss_pred             chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccccc-CCCCccccHHhh
Confidence             000011111111111122223356889999999999999999999999999999999997765443 344677777777


Q ss_pred             cCCHHHHHHHHHHHHHhcCC
Q 042681          315 SMNEEDIKELILRECLNFHP  334 (339)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~  334 (339)
                      +-+=++.+.+-.-|++.|.|
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07880         324 DQSLEEWKRLTFTEILSFQP  343 (343)
T ss_pred             ccchHHHHHHHHHHHHhcCC
Confidence            77778888888888888865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=282.16  Aligned_cols=260  Identities=26%  Similarity=0.400  Sum_probs=213.0

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPM  106 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~  106 (339)
                      ..-.+.++|.+.-+.||-|-.|.|..+.++.|++.+|+|++...       ...++|++.-... .||||+.++++|...
T Consensus        55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs  127 (400)
T KOG0604|consen   55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENS  127 (400)
T ss_pred             hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence            34457889999889999999999999999999999999998643       5567888886666 599999999999654


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc---CCCeEEe
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKIC  180 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~---~~~ikL~  180 (339)
                      . .....+.+|||.++ |.|+..+..++  .++|.++..|+.||..|+.|||+.+|+||||||+|+|...   |..+||+
T Consensus       128 ~-~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  128 Y-QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             c-cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence            4 44567899999998 79999998865  4999999999999999999999999999999999999964   5579999


Q ss_pred             ecccccccCC----------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc-hHHHHHhhCCCCC
Q 042681          181 DFGLARTTSE----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD-NARRYVKQLPHVP  249 (339)
Q Consensus       181 Dfg~~~~~~~----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~-~~~~~~~~~~~~~  249 (339)
                      |||+|+....          +-|.+|+..+...+...-|.|++|+++|.+++|.+||.+.....-. ..+..+. ..+. 
T Consensus       207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~-~gqy-  284 (400)
T KOG0604|consen  207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR-TGQY-  284 (400)
T ss_pred             ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh-ccCc-
Confidence            9999986552          3477788888778888899999999999999999999766433221 1221111 1111 


Q ss_pred             CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       250 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                       ..-.+.|..+|++.+|+|+++|..+|++|.|+.+++.|||+.+.....
T Consensus       285 -~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp  332 (400)
T KOG0604|consen  285 -EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP  332 (400)
T ss_pred             -cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence             111234567899999999999999999999999999999999887653

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.9e-41  Score=305.14  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=201.6

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      .++|.. ++.||+|+||.||++++..+++.+|+|++.+.. ......+.+.+|+.+++.++||||+++++++     ...
T Consensus        42 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~  115 (370)
T cd05596          42 AEDFDV-IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD  115 (370)
T ss_pred             HHHcEE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            356666 899999999999999999999999999996542 2233445678899999999999999999998     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ..+++||||++ |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||.+...  
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            78999999997 689888765 56899999999999999999999999999999999999999999999999998543  


Q ss_pred             ----------CCCCcccccccccc----ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 ----------SETDFMTEYVVTRW----DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 ----------~~~~~~~~~~~~~~----~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                                +...|++||.....    ....++|+|++|+++|++++|..|+......  .....+...   ...... 
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~---~~~~~~-  268 (370)
T cd05596         195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMDH---KNSLTF-  268 (370)
T ss_pred             CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--HHHHHHHcC---CCcCCC-
Confidence                      33457788765432    3567899999999999999999997653221  111111111   111111 


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCcc
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAK--RITVEEALNHPYLSSLHE  296 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~--Rps~~ell~hp~f~~~~~  296 (339)
                      .....+|.++++||++||+.+|.+  |++++++++||||++..+
T Consensus       269 ~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         269 PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence            112357999999999999999998  999999999999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.2e-41  Score=299.56  Aligned_cols=248  Identities=17%  Similarity=0.283  Sum_probs=201.7

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||+|.+..+++.+|+|++++... .....+.+.+|+.++.++ +||+|+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            469999999999999999999999999976532 233456788999999888 699999999998     6677899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ |+|..++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...         
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            9997 699999888889999999999999999999999999999999999999999999999999988642         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHH-HHhhCCCCCCCCccccCCCCCHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARR-YVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                        +...|++||......+..++|+|++|++++++++|..|+............. ........ ...   ....++..+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~---~p~~~~~~~~  231 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIR---IPRFLSVKAS  231 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCC---CCCCCCHHHH
Confidence              3446888888877778889999999999999999999985432211111111 11111111 111   1134789999


Q ss_pred             HHHHHhcccCCCCCCC------HHHHhcCCCCCCCccC
Q 042681          266 DLAERMLVFDPAKRIT------VEEALNHPYLSSLHEI  297 (339)
Q Consensus       266 ~li~~~L~~dP~~Rps------~~ell~hp~f~~~~~~  297 (339)
                      ++|.+||+.||.+|++      +.+++.||||+.+.+.
T Consensus       232 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         232 HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence            9999999999999997      5799999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.5e-41  Score=298.28  Aligned_cols=241  Identities=18%  Similarity=0.308  Sum_probs=200.1

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|..+++.+ +||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46899999999999999999999999997653 2233456677899999888 699999999998     6667899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ |+|...+.+.+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...         
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            9997 699999988889999999999999999999999999999999999999999999999999987531         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                        +...|.+||......+..+.|+|++|++++++++|..|+.....  ..........    . ..   ....++.++++
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i~~~----~-~~---~~~~~~~~~~~  225 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSILED----E-VR---YPRWLSKEAKS  225 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcC----C-CC---CCCcCCHHHHH
Confidence              34467888888777788899999999999999999998754321  1111111111    1 01   11347899999


Q ss_pred             HHHHhcccCCCCCCCH-----HHHhcCCCCCCCcc
Q 042681          267 LAERMLVFDPAKRITV-----EEALNHPYLSSLHE  296 (339)
Q Consensus       267 li~~~L~~dP~~Rps~-----~ell~hp~f~~~~~  296 (339)
                      ||++||+.||++||++     .++++||||+.+.+
T Consensus       226 li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             HHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            9999999999999999     99999999999865

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-40  Score=298.49  Aligned_cols=272  Identities=37%  Similarity=0.596  Sum_probs=212.2

Q ss_pred             EEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeee
Q 042681           22 QYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD  101 (339)
Q Consensus        22 ~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~  101 (339)
                      +....+-.+.+.++|.. ++.||+|++|.||++.+..+|+.+|+|.+.+..........+.+|+.+++.++||||+++++
T Consensus         4 ~~~~~~~~~~~~~~y~~-~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   82 (353)
T cd07850           4 SVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLN   82 (353)
T ss_pred             eecccchhhhhhcceEE-EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceee
Confidence            34455666788899998 99999999999999999999999999998765444555567889999999999999999999


Q ss_pred             ecCCCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEe
Q 042681          102 IIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC  180 (339)
Q Consensus       102 ~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~  180 (339)
                      ++..... ......++||||++++|.+.+...  +++..++.++.|++.||+|||++|++||||||+||+++.++.++|+
T Consensus        83 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~  160 (353)
T cd07850          83 VFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  160 (353)
T ss_pred             eeccCCCccccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEc
Confidence            8853221 223468999999999999888653  8999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCC----------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHH----------
Q 042681          181 DFGLARTTSE----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARR----------  240 (339)
Q Consensus       181 Dfg~~~~~~~----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~----------  240 (339)
                      |||.+...+.          ..|.+|+.........+.|+|++|++++++++|..++......  .....          
T Consensus       161 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~  238 (353)
T cd07850         161 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI--DQWNKIIEQLGTPSD  238 (353)
T ss_pred             cCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhcCCCCH
Confidence            9999875432          2477788777777888999999999999999999886432110  00000          


Q ss_pred             ------------HHhhCCCCCCCCcccc-------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          241 ------------YVKQLPHVPKQPFSQK-------------FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       241 ------------~~~~~~~~~~~~~~~~-------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                                  ............+...             ....+..+++||.+||+.||++|||+.++|.||||+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~  318 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY  318 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence                        0000000000000000             113466789999999999999999999999999998766


Q ss_pred             cCC
Q 042681          296 EIN  298 (339)
Q Consensus       296 ~~~  298 (339)
                      ...
T Consensus       319 ~~~  321 (353)
T cd07850         319 DPS  321 (353)
T ss_pred             CCc
Confidence            643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.7e-41  Score=297.26  Aligned_cols=242  Identities=19%  Similarity=0.319  Sum_probs=198.1

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||+|.+..+|+.+|+|++++... ..........|..++... +||+|+++++++     ...+.+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            468999999999999999999999999976422 122345567788887764 899999999999     6677899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||+. |+|..++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...         
T Consensus        76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            9998 699999988888999999999999999999999999999999999999999999999999987532         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                        +...|.+||......+..+.|+|++|++++++++|..|+.....  ..........   .+  .   ....++.++++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~---~~--~---~~~~~~~~~~~  225 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVD---TP--H---YPRWITKESKD  225 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC---CC--C---CCCCCCHHHHH
Confidence              34568889988777788899999999999999999999754321  1111111111   11  1   11247899999


Q ss_pred             HHHHhcccCCCCCCCH-HHHhcCCCCCCCccC
Q 042681          267 LAERMLVFDPAKRITV-EEALNHPYLSSLHEI  297 (339)
Q Consensus       267 li~~~L~~dP~~Rps~-~ell~hp~f~~~~~~  297 (339)
                      ||++||+.||++||++ .++++||||..+.+.
T Consensus       226 li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~  257 (316)
T cd05620         226 ILEKLFERDPTRRLGVVGNIRGHPFFKTINWT  257 (316)
T ss_pred             HHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence            9999999999999997 588899999987643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.6e-41  Score=297.11  Aligned_cols=242  Identities=23%  Similarity=0.373  Sum_probs=199.6

Q ss_pred             ccccccccceEEEEEEeC---CCCceEEEEEeccccc--ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           40 LQPIGRGAYGIVCSAVNS---ETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~---~~~~~~avK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      ++.||+|+||.||+|...   .+++.+|+|++.....  .......+.+|+.+++.++||||+++++++     ...+.+
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence            367999999999999864   5788999999875422  223345678999999999999999999999     666789


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-----
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-----  188 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-----  188 (339)
                      ++||||++ ++|.+.+.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++..     
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999998 699999988889999999999999999999999999999999999999999999999999987532     


Q ss_pred             ------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          189 ------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       189 ------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                            +...|.+||.........+.|+|++|++++++++|..|+......  .......    ....    ...+.+++
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~~~~~~~----~~~~----~~~~~~~~  225 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--KTIDKIL----KGKL----NLPPYLTP  225 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--HHHHHHH----cCCC----CCCCCCCH
Confidence                  344688898887777788999999999999999999997543211  1111111    1111    11145789


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCcc
Q 042681          263 VAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHE  296 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~  296 (339)
                      ++++||.+||+.||++||     ++.+++.||||....+
T Consensus       226 ~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         226 EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             HHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999999999999999     8999999999987654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5e-41  Score=297.64  Aligned_cols=241  Identities=20%  Similarity=0.314  Sum_probs=196.4

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||+|.+..+++.||+|+++.... .....+....|..++..+ +||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            468999999999999999999999999976432 223345556677777654 899999999998     6667899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ |+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...         
T Consensus        76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9997 799999988889999999999999999999999999999999999999999999999999998642         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                        +...|++||......+..+.|+|++|++++++++|..|+.....  .........   ..  ..   ....++.++.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~---~~--~~---~~~~~~~~~~~  225 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DELFDSILN---DR--PH---FPRWISKEAKD  225 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc---CC--CC---CCCCCCHHHHH
Confidence              34468888887777778899999999999999999999764321  111111111   11  11   11347899999


Q ss_pred             HHHHhcccCCCCCCCH-HHHhcCCCCCCCcc
Q 042681          267 LAERMLVFDPAKRITV-EEALNHPYLSSLHE  296 (339)
Q Consensus       267 li~~~L~~dP~~Rps~-~ell~hp~f~~~~~  296 (339)
                      ||.+||+.||++||++ .+++.||||..+.+
T Consensus       226 ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         226 CLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             HHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence            9999999999999986 58889999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.9e-40  Score=288.71  Aligned_cols=246  Identities=20%  Similarity=0.296  Sum_probs=196.2

Q ss_pred             cccccceEEEEEEeCCCCceEEEEEecccccC-hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecC
Q 042681           43 IGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM  121 (339)
Q Consensus        43 lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~  121 (339)
                      ||+|+||.||+++...+|+.||+|++...... .........|+.+++.++||||+++++++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            69999999999999999999999998654222 22234556799999999999999999998     6677899999999


Q ss_pred             c-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----------
Q 042681          122 D-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----------  188 (339)
Q Consensus       122 ~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----------  188 (339)
                      + ++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...          
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  155 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA  155 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence            7 6888887543  35889999999999999999999999999999999999999999999999988643          


Q ss_pred             CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHH
Q 042681          189 SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA  268 (339)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  268 (339)
                      +...|.+|+.........++|+|++|++++++++|..|+........  ...........   ........+++++++||
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~~~li  230 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLED---EVKFEHQNFTEESKDIC  230 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhcc---ccccccccCCHHHHHHH
Confidence            23467888887777788899999999999999999999764321111  11111111110   11111235789999999


Q ss_pred             HHhcccCCCCCCCH----HHHhcCCCCCCCccCC
Q 042681          269 ERMLVFDPAKRITV----EEALNHPYLSSLHEIN  298 (339)
Q Consensus       269 ~~~L~~dP~~Rps~----~ell~hp~f~~~~~~~  298 (339)
                      .+||+.||.+||++    .+++.||||+.+.+..
T Consensus       231 ~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~  264 (277)
T cd05607         231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR  264 (277)
T ss_pred             HHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence            99999999999999    6788999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.4e-41  Score=298.47  Aligned_cols=241  Identities=23%  Similarity=0.362  Sum_probs=197.2

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHH-HHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIK-LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||+||++.+..+|+.+|+|++.+... .......+..|.. +++.++||||+++++.+     ......++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            468999999999999999999999999975422 2223345555655 45778999999999998     6677899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ |+|..++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...         
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            9998 699999988889999999999999999999999999999999999999999999999999987532         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                        +...|++||......+..+.|+|++|++++++++|..|+......  ........   . .    ....+.+++++.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~~---~-~----~~~~~~~~~~~~~  225 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--EMYDNILN---K-P----LRLKPNISVSARH  225 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--HHHHHHHc---C-C----CCCCCCCCHHHHH
Confidence              334688898887777888999999999999999999987543211  11111111   1 1    1112457999999


Q ss_pred             HHHHhcccCCCCCCCH----HHHhcCCCCCCCcc
Q 042681          267 LAERMLVFDPAKRITV----EEALNHPYLSSLHE  296 (339)
Q Consensus       267 li~~~L~~dP~~Rps~----~ell~hp~f~~~~~  296 (339)
                      +|.+||+.||.+||++    .+++.||||..+.+
T Consensus       226 li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             HHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            9999999999999987    69999999998765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.6e-41  Score=292.03  Aligned_cols=250  Identities=32%  Similarity=0.505  Sum_probs=197.7

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. ++.||+|++|.||++.+..+++.+|+|+++...........+.+|+.+++.++||||+++++++     .....++
T Consensus         2 y~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (285)
T cd07861           2 YTK-IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY   75 (285)
T ss_pred             ceE-eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence            444 8899999999999999999999999999876544443456778999999999999999999999     6677899


Q ss_pred             EEEecCcccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          116 IVYELMDTDLHQIIRSK---QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       116 iv~e~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      +||||++++|.+++...   ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++...+   
T Consensus        76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            99999999998888642   569999999999999999999999999999999999999999999999999886432   


Q ss_pred             --------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccc-------------------hHHHH
Q 042681          190 --------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD-------------------NARRY  241 (339)
Q Consensus       190 --------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~-------------------~~~~~  241 (339)
                              ...|.+|+.... .....++|+|++|++++++++|.+++.........                   ....+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence                    334677876543 34567799999999999999999887533211000                   00001


Q ss_pred             HhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          242 VKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ..................++++++++|++||+.||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            11111111111112234588999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-41  Score=299.83  Aligned_cols=243  Identities=25%  Similarity=0.385  Sum_probs=200.0

Q ss_pred             ccccccccceEEEEEEe---CCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVN---SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~---~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      ++.||+|+||.||++.+   ..+|+.+|+|++.+..........+.+|+.++.+++||||+++++++     ...+..++
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~l   75 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYL   75 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEE
Confidence            36799999999999986   35789999999976543334456678899999999999999999999     66778999


Q ss_pred             EEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-------
Q 042681          117 VYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-------  188 (339)
Q Consensus       117 v~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-------  188 (339)
                      ||||++ |+|.+.+.+...+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...       
T Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence            999997 799999988888999999999999999999999999999999999999999999999999988643       


Q ss_pred             ----CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHH
Q 042681          189 ----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       189 ----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  264 (339)
                          +...|++||.........+.|+|++|++++++++|..|+.....  ...........  ..      ....+++++
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~i~~~~--~~------~p~~~~~~~  225 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--KETMTMILKAK--LG------MPQFLSPEA  225 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--HHHHHHHHcCC--CC------CCCCCCHHH
Confidence                23357788887777778899999999999999999998754211  11111111111  10      113578999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCccC
Q 042681          265 IDLAERMLVFDPAKRIT-----VEEALNHPYLSSLHEI  297 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~~  297 (339)
                      ++||++||+.||++||+     +.+++.||||..+.+.
T Consensus       226 ~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~  263 (318)
T cd05582         226 QSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN  263 (318)
T ss_pred             HHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence            99999999999999999     7889999999987653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.8e-41  Score=302.09  Aligned_cols=252  Identities=21%  Similarity=0.289  Sum_probs=201.0

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ..++|.. ++.||+|+||.||++++..+++.+|+|++.+.. ......+.+.+|+.+++.++||||+++++++     ..
T Consensus        41 ~~~~y~~-~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~  114 (370)
T cd05621          41 KAEDYDV-VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QD  114 (370)
T ss_pred             CHHHCeE-EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----Ec
Confidence            3466777 999999999999999999999999999987532 2233445678999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-  188 (339)
                      ...+++||||++ |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++... 
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            788999999997 799998865 46899999999999999999999999999999999999999999999999998643 


Q ss_pred             -----------CCCCcccccccccc----ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          189 -----------SETDFMTEYVVTRW----DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       189 -----------~~~~~~~~~~~~~~----~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                                 ++..|++||.....    ....++|+|++|+++|++++|..|+.....  ......+.....   ....
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--~~~~~~i~~~~~---~~~~  268 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--VGTYSKIMDHKN---SLNF  268 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCc---ccCC
Confidence                       34457888876543    256789999999999999999999764321  111122211111   1111


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCcc
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAK--RITVEEALNHPYLSSLHE  296 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~--Rps~~ell~hp~f~~~~~  296 (339)
                      . ....++..++++|.+||+.+|.+  |+++.++++||||+...+
T Consensus       269 p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         269 P-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             C-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence            1 11347899999999999866654  899999999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3e-40  Score=294.08  Aligned_cols=291  Identities=45%  Similarity=0.770  Sum_probs=225.7

Q ss_pred             ccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCC
Q 042681           26 LGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPP  105 (339)
Q Consensus        26 ~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~  105 (339)
                      +|..+.+.++|.. ++.||.|+||.||++.+..+++.+|+|++.+........+.+.+|+.++..++||||+++++++. 
T Consensus         2 ~~~~~~~~~~y~~-~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-   79 (328)
T cd07856           2 FGTVFEITNRYVD-LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI-   79 (328)
T ss_pred             CcceeccccceEE-EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe-
Confidence            5778889999999 99999999999999999999999999998765444445577889999999999999999999883 


Q ss_pred             CCcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          106 MDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                         ......++++||++++|.+++.. .++++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        80 ---~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          80 ---SPLEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             ---cCCCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccc
Confidence               23456899999999998887764 56889999999999999999999999999999999999999999999999988


Q ss_pred             cccC--------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccccccc---------------------
Q 042681          186 RTTS--------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS---------------------  235 (339)
Q Consensus       186 ~~~~--------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~---------------------  235 (339)
                      ....        ...|.+|+.... .......|+|++|++++++++|..++........                     
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         156 RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            6532        234667775433 4567789999999999999999988753321000                     


Q ss_pred             chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCChhhcc
Q 042681          236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTS  315 (339)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  315 (339)
                      ................+.....+.++++++++|++||+.+|++||++.+++.||||.....+..++....-|++.+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFNDAD  315 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCchhhcCCchhccc
Confidence            00001111111112222223345678999999999999999999999999999999999887666655555555555544


Q ss_pred             CCHHHHH
Q 042681          316 MNEEDIK  322 (339)
Q Consensus       316 ~~~~~~~  322 (339)
                      +--+.-+
T Consensus       316 ~~~~~~~  322 (328)
T cd07856         316 LPVDTWK  322 (328)
T ss_pred             CCHHHHH
Confidence            4444433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.5e-40  Score=294.47  Aligned_cols=242  Identities=19%  Similarity=0.330  Sum_probs=197.9

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||+|++..+++.||+|+++.... ..........|..++..+ +||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            468999999999999999999999999976422 122345566777777764 899999999999     6667899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ |+|.+++.+...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...         
T Consensus        76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            9997 799999988888999999999999999999999999999999999999999999999999987642         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                        ++..|++||.........+.|+|++|++++++++|..|+.....  ....... .. .. +  ..   ...++.++++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i-~~-~~-~--~~---~~~~~~~~~~  225 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSI-RM-DN-P--CY---PRWLTREAKD  225 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHH-Hh-CC-C--CC---CccCCHHHHH
Confidence              34468889887777788899999999999999999998754321  1111111 11 11 1  11   1247899999


Q ss_pred             HHHHhcccCCCCCCCHH-HHhcCCCCCCCccC
Q 042681          267 LAERMLVFDPAKRITVE-EALNHPYLSSLHEI  297 (339)
Q Consensus       267 li~~~L~~dP~~Rps~~-ell~hp~f~~~~~~  297 (339)
                      ||.+||+.||++||++. ++++||||..+.+.
T Consensus       226 li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         226 ILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             HHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence            99999999999999996 89999999998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=289.89  Aligned_cols=250  Identities=21%  Similarity=0.306  Sum_probs=201.1

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      |.. .+.||+|+||.||++.+..+++.+|+|++..... .......+.+|+.+++.++||||+++++.+     .....+
T Consensus         2 y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           2 FRH-YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             ceE-EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            444 7899999999999999999999999999875422 222345677899999999999999999998     566789


Q ss_pred             EEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          115 YIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      ++||||++ |+|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...   
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999997 6888877543  46999999999999999999999999999999999999999999999999988653   


Q ss_pred             -------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          189 -------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                             +...|++|+...........|+|++|+++|++++|..|+......  .............. .   .....++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~-~---~~~~~~~  229 (285)
T cd05605         156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--VKREEVERRVKEDQ-E---EYSEKFS  229 (285)
T ss_pred             CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh--hHHHHHHHHhhhcc-c---ccCcccC
Confidence                   233577888877667778899999999999999999997643211  11111111111111 1   1123578


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          262 PVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      ..+++||.+||..||.+||     ++.++++||||....+.
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence            9999999999999999999     99999999999986554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-40  Score=295.91  Aligned_cols=242  Identities=23%  Similarity=0.313  Sum_probs=196.2

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHH---hhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLL---CHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l---~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      ++.||+|+||.||++.+..+|+.||+|++++.. ......+.+.+|+.++   ..++||||+++++++     ......|
T Consensus         4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~~~~   78 (324)
T cd05589           4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTEDHVC   78 (324)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCCEEE
Confidence            789999999999999999999999999997542 2233345666776655   456799999999999     6677899


Q ss_pred             EEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc------
Q 042681          116 IVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT------  188 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~------  188 (339)
                      +||||++ ++|...+.. +.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++...      
T Consensus        79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence            9999998 588777654 67999999999999999999999999999999999999999999999999987532      


Q ss_pred             -----CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          189 -----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       189 -----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                           +...|++||.........+.|+|++|+++|++++|..|+......  ...........   .     ....++++
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~~---~-----~p~~~~~~  227 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFDSIVNDEV---R-----YPRFLSRE  227 (324)
T ss_pred             ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC---C-----CCCCCCHH
Confidence                 344688888887777788899999999999999999997543211  11111111111   1     11357899


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          264 AIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      +.++|.+||+.||++||     ++.++++||||+++.+.
T Consensus       228 ~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         228 AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             HHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence            99999999999999999     69999999999987643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-41  Score=293.30  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=213.5

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .|.+=|.. .+.||+|.|+.|-+|++..||+.||||++.+...+.....++.+|++.|+.++||||+++|++.     ..
T Consensus        15 kIAGLYDL-ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DT   88 (864)
T KOG4717|consen   15 KIAGLYDL-EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DT   88 (864)
T ss_pred             ceeeeehh-hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cc
Confidence            35666777 9999999999999999999999999999999888888889999999999999999999999999     77


Q ss_pred             cCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee-ccCCCeEEeecccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL-NANCDLKICDFGLART  187 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli-~~~~~ikL~Dfg~~~~  187 (339)
                      ...+|+|+|.-+ |+|++++.+ ...++|+.++.+|.||+.|+.|+|+..+|||||||+||.+ ..-|-+||.|||++-.
T Consensus        89 QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk  168 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK  168 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeecccccc
Confidence            788999999998 799999966 4789999999999999999999999999999999999865 5788999999999966


Q ss_pred             cCC----------CCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          188 TSE----------TDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       188 ~~~----------~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      +..          ..|.+|++...- +.-++.|+|++|+++|.+.||.+||......  .....+.  ......+     
T Consensus       169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--ETLTmIm--DCKYtvP-----  239 (864)
T KOG4717|consen  169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--ETLTMIM--DCKYTVP-----  239 (864)
T ss_pred             CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--hhhhhhh--cccccCc-----
Confidence            533          347788876544 4556789999999999999999998654211  1111111  1222222     


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                       ..+|.++++||.+||..||.+|-+.+++..|+|++.+....
T Consensus       240 -shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  240 -SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             -hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence             35899999999999999999999999999999999997754

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.2e-40  Score=294.48  Aligned_cols=255  Identities=18%  Similarity=0.313  Sum_probs=203.4

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. .+.||.|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++     ...+
T Consensus         4 ~~~y~~-~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~   76 (333)
T cd06650           4 DDDFEK-ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDG   76 (333)
T ss_pred             hhhhhe-eccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEE-----EECC
Confidence            356666 999999999999999999999999999886542 233456788999999999999999999999     6667


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ..++||||+. ++|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...  
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          77 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            8999999997 69999998888899999999999999999999975 7999999999999999999999999988643  


Q ss_pred             -------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccch------------------------
Q 042681          189 -------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN------------------------  237 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~------------------------  237 (339)
                             +...|.+||.........++|+|++|++++++++|..|+..........                        
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (333)
T cd06650         157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR  236 (333)
T ss_pred             hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence                   3346888888877777888999999999999999998865321100000                        


Q ss_pred             --------------HHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          238 --------------ARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       238 --------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                                    ................  ....++.++++||.+||+.||++|||+.++++||||+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  307 (333)
T cd06650         237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA  307 (333)
T ss_pred             hhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence                          0000000000000000  01236788999999999999999999999999999987643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.9e-40  Score=292.17  Aligned_cols=255  Identities=31%  Similarity=0.468  Sum_probs=200.5

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||.|+||.||++.+..+++.+|+|.+...... .....+.+|+.+++.++||||+++++++     .....
T Consensus         6 ~~y~~-~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~   78 (301)
T cd07873           6 ETYIK-LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKS   78 (301)
T ss_pred             cceEE-eeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCe
Confidence            45666 89999999999999999999999999998654222 2234577899999999999999999999     66678


Q ss_pred             EEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          114 VYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      .++||||++++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+....   
T Consensus        79 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          79 LTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             EEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            999999999999988865 3578999999999999999999999999999999999999999999999999886432   


Q ss_pred             --------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC--------------
Q 042681          190 --------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP--------------  246 (339)
Q Consensus       190 --------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~--------------  246 (339)
                              ...|.+|+.... .....++|+|++|++++++++|.+++......  ...........              
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhccc
Confidence                    234667776543 34566789999999999999999887543211  00001100000              


Q ss_pred             --------CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          247 --------HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       247 --------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                              ...........+.+++++++||.+||+.||.+|||+.++++||||+.+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence                    000000111224578899999999999999999999999999999888653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=7e-41  Score=292.47  Aligned_cols=250  Identities=34%  Similarity=0.497  Sum_probs=196.8

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|++|.||+|.+..+|+.+|+|.+............+.+|+.+++.++||||+++++++     ......
T Consensus         1 ~y~~-~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~   74 (284)
T cd07839           1 KYEK-LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKL   74 (284)
T ss_pred             Ccee-EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCce
Confidence            3555 7899999999999999999999999999976533333345677899999999999999999999     566789


Q ss_pred             EEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC----
Q 042681          115 YIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS----  189 (339)
Q Consensus       115 ~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~----  189 (339)
                      ++++||++++|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...+    
T Consensus        75 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          75 TLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            99999999999888865 5679999999999999999999999999999999999999999999999999886543    


Q ss_pred             -------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHh--------------hCCC
Q 042681          190 -------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK--------------QLPH  247 (339)
Q Consensus       190 -------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~--------------~~~~  247 (339)
                             ...|.+||.... .....++|+|++|++++++++|..|+....... ........              ....
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHHHhCCCChHHhHHhhhccc
Confidence                   234677876543 335678999999999999999987753321110 00011000              0000


Q ss_pred             CC-C------CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          248 VP-K------QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       248 ~~-~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      .. .      ....+..+.+++++++||.+||+.||.+|||++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            00 0      00012234678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=289.90  Aligned_cols=233  Identities=26%  Similarity=0.346  Sum_probs=194.6

Q ss_pred             ccccccccceEEEEEEeCCCCce-EEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC-eEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEE-VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN-DVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~-~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~-~~~iv  117 (339)
                      .+.||+|+||+||++.++.  .. +|+|++..........+.+.+|+.+|.+++||||++++|++     .... .++||
T Consensus        46 ~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~-----~~~~~~~~iV  118 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGAC-----TSPPGSLCIV  118 (362)
T ss_pred             hhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCceEEE
Confidence            5669999999999999874  45 99999987655555578999999999999999999999999     4444 79999


Q ss_pred             EecCc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCCeeeccCC-CeEEeeccccccc----
Q 042681          118 YELMD-TDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNLLLNANC-DLKICDFGLARTT----  188 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~g-ivH~dikp~NIli~~~~-~ikL~Dfg~~~~~----  188 (339)
                      |||++ |+|.+++..  .+.++...+..++.||+.|++|||+++ |+||||||+|||++.++ ++||+|||+++..    
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            99998 899999977  688999999999999999999999999 99999999999999998 9999999999543    


Q ss_pred             -------CCCCcccccccc--ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          189 -------SETDFMTEYVVT--RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       189 -------~~~~~~~~~~~~--~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                             |+..+++||+..  ...+..+.|+|++|+++|++++|..|+.....   .............+.  ..   ..
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~Rp~--~p---~~  270 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGLRPP--IP---KE  270 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCCCC--CC---cc
Confidence                   334689999988  55899999999999999999999999876543   111111111121121  11   23


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      +++.+..|+.+||..||++||++.+++.
T Consensus       271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  271 CPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            8899999999999999999999998875

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-40  Score=294.14  Aligned_cols=253  Identities=20%  Similarity=0.327  Sum_probs=200.9

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. ++.||+|+||.||++.+..+++.||+|++.+.. ......+.+.+|+.++..++|+||+++++++     .....
T Consensus         2 ~y~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (331)
T cd05597           2 DFEI-LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN   75 (331)
T ss_pred             CceE-EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence            4666 899999999999999999999999999987532 2333456688899999999999999999999     66788


Q ss_pred             EEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          114 VYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      +++||||++ |+|.+++.+ ...+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...   
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999997 799999876 467999999999999999999999999999999999999999999999999987542   


Q ss_pred             ---------CCCCccccccccc-----cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 ---------SETDFMTEYVVTR-----WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 ---------~~~~~~~~~~~~~-----~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                               +...|++||....     .....+.|+|++|++++++++|..|+......  .........   .......
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--~~~~~i~~~---~~~~~~~  230 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNH---KEHFQFP  230 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--HHHHHHHcC---CCcccCC
Confidence                     3345778877642     34566799999999999999999997543211  111111111   1111222


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCccCC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAK--RITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~--Rps~~ell~hp~f~~~~~~~  298 (339)
                      ...+.+++++++||++||..++++  |+++.++++||||..+.+..
T Consensus       231 ~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~  276 (331)
T cd05597         231 PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN  276 (331)
T ss_pred             CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence            223458999999999999764444  78999999999999886643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-41  Score=295.79  Aligned_cols=247  Identities=24%  Similarity=0.339  Sum_probs=211.2

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.+|+|+||.+++++++.+++.||+|.+..............+|+.++.+++||||+.+.+.|     ...+.
T Consensus         4 ~~Ye~-~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~-----~~~~~   77 (426)
T KOG0589|consen    4 DNYEV-LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSF-----EEDGQ   77 (426)
T ss_pred             chhhh-hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccch-----hcCCc
Confidence            46666 9999999999999999999999999999987766666677889999999999999999999999     55565


Q ss_pred             -EEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-
Q 042681          114 -VYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-  188 (339)
Q Consensus       114 -~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-  188 (339)
                       ++|||+||+ |++.+.+...  ..++++.+..|+.|++.||+|||+++|+|||||+.|||++.++.|+|+|||+|+.. 
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence             999999998 6999998654  57999999999999999999999999999999999999999999999999998654 


Q ss_pred             ----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          189 ----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       189 ----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                |++.|++||++...++..++|+|++||++|++.+-.++|....      ....+..+......+..   .
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------m~~Li~ki~~~~~~Plp---~  228 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------MSELILKINRGLYSPLP---S  228 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------hHHHHHHHhhccCCCCC---c
Confidence                      5567899999999999999999999999999999998865322      22222222222222222   4


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      .++.+++.+|+.||..+|..||++.++|.+|.+....
T Consensus       229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  229 MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            5899999999999999999999999999999887443

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.5e-40  Score=294.20  Aligned_cols=246  Identities=19%  Similarity=0.297  Sum_probs=202.3

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCe
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      |.. ++.||+|+||.||++++..+++.+|+|++.+... ..........|..++..+ .|++|+++++++     .....
T Consensus         2 f~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           2 FNF-LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             ceE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            344 8899999999999999999999999999976532 223345567788888877 589999999998     66678


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +++||||++ |+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...    
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999997 799999988889999999999999999999999999999999999999999999999999988642    


Q ss_pred             -------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          189 -------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                             +...|++||......+..+.|+|++|++++++++|..|+.....  ............     .   ....++
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~~~~-----~---~p~~~s  225 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEHNV-----A---YPKSMS  225 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC-----C---CCCcCC
Confidence                   34568889988877888999999999999999999999764321  111111111111     0   113578


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCccC
Q 042681          262 PVAIDLAERMLVFDPAKRIT-----VEEALNHPYLSSLHEI  297 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~~  297 (339)
                      .++++|+.+||+.||++|++     ..++++||||+.+.+.
T Consensus       226 ~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         226 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            99999999999999999997     4899999999988754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.8e-42  Score=294.11  Aligned_cols=242  Identities=28%  Similarity=0.452  Sum_probs=198.2

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ++.||+|+||.||++.+..+++.+|+|++..............+|+.++++++||||+++++++     ......+++||
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~v~~   78 (260)
T PF00069_consen    4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVF-----QDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEE-----EESSEEEEEEE
T ss_pred             eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccc-----ccccccccccc
Confidence            8899999999999999999999999999987644444444556799999999999999999999     66788999999


Q ss_pred             cCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----------
Q 042681          120 LMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----------  188 (339)
Q Consensus       120 ~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----------  188 (339)
                      |+++ +|.+++.+.+.+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+...          
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9995 99999998889999999999999999999999999999999999999999999999999998631          


Q ss_pred             -CCCCcccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchH-HHHHh-hCCCCCCCCccccCCCCCHHH
Q 042681          189 -SETDFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNA-RRYVK-QLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       189 -~~~~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~s~~~  264 (339)
                       +...|.+|+... ........|+|++|++++++++|..|+........... ..... .......     .....++.+
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l  233 (260)
T PF00069_consen  159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----QSREKSEEL  233 (260)
T ss_dssp             SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----SHTTSHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----ccchhHHHH
Confidence             223578888877 67788899999999999999999988776521111111 10100 0000000     001124889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          265 IDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      +++|.+||+.||++||++.++++||||
T Consensus       234 ~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  234 RDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5e-40  Score=295.75  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=193.2

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||.||++.+..+|+.||+|++.... .......+.+|+.+++.++|+||+++++++     ...+.
T Consensus        74 ~~~~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~  146 (353)
T PLN00034         74 SELER-VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE  146 (353)
T ss_pred             HHHhh-hhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence            34555 889999999999999999999999999986432 233456788999999999999999999998     66778


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +++||||+. ++|..    ....++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++...    
T Consensus       147 ~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        147 IQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            999999998 56643    345678888999999999999999999999999999999999999999999998643    


Q ss_pred             -------CCCCccccccccc-----cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          189 -------SETDFMTEYVVTR-----WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       189 -------~~~~~~~~~~~~~-----~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                             +...|.+||....     .....+.|+|++|++++++++|..++........   ............   ...
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~---~~~  296 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASLMCAICMSQP---PEA  296 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHHhccCC---CCC
Confidence                   2345777876532     2234579999999999999999998762211111   111111111111   111


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ...++.++++||.+||+.||++||++.|+++||||..-..
T Consensus       297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        297 PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence            2457899999999999999999999999999999988643

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-40  Score=296.60  Aligned_cols=241  Identities=22%  Similarity=0.361  Sum_probs=196.5

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHH-HHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIK-LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||+||++.+..+|+.+|+|++.+... .......+..|.. +++.++||||+++++.+     ......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            468999999999999999999999999975422 2233445566655 46778999999999998     6677899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ |+|...+.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...         
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            9998 689999888889999999999999999999999999999999999999999999999999987642         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                        +...|++||......+..+.|+|++|++++++++|..|+......  ........    ...    ...+..+..+.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~~~~----~~~----~~~~~~~~~~~~  225 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--EMYDNILH----KPL----VLRPGASLTAWS  225 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--HHHHHHHc----CCc----cCCCCCCHHHHH
Confidence              334588888877777788999999999999999999997643211  11111111    110    112457899999


Q ss_pred             HHHHhcccCCCCCCCH----HHHhcCCCCCCCcc
Q 042681          267 LAERMLVFDPAKRITV----EEALNHPYLSSLHE  296 (339)
Q Consensus       267 li~~~L~~dP~~Rps~----~ell~hp~f~~~~~  296 (339)
                      +|++||+.+|++||++    .++++||||....+
T Consensus       226 ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         226 ILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             HHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence            9999999999999976    59999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.2e-40  Score=298.47  Aligned_cols=254  Identities=28%  Similarity=0.400  Sum_probs=201.9

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-C-----CCeeeeeeecCCCCc
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-H-----ENIVKVKDIIPPMDK  108 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~I~~~~~~~~~~~~  108 (339)
                      +|.+ .+.||+|+||+|.+|.+.+|++.||+|++++.   ..-..+...|+.+|..|+ |     -|+++++++|     
T Consensus       187 rY~V-~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----  257 (586)
T KOG0667|consen  187 RYEV-LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----  257 (586)
T ss_pred             EEEE-EEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----
Confidence            7888 99999999999999999999999999999765   333456778999999996 3     4999999999     


Q ss_pred             CCcCeEEEEEecCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC--CCeEEeeccc
Q 042681          109 EKFNDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGL  184 (339)
Q Consensus       109 ~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~--~~ikL~Dfg~  184 (339)
                      ...+++|||+|.++-+|.++++.+  .+++...++.++.||+.||.+||+.||+|+||||+|||+..-  ..|||+|||+
T Consensus       258 ~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  258 YFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             ccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence            778999999999999999999886  468999999999999999999999999999999999999643  3799999999


Q ss_pred             ccccCCC--------CccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccc-------------------cch
Q 042681          185 ARTTSET--------DFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR-------------------SDN  237 (339)
Q Consensus       185 ~~~~~~~--------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~-------------------~~~  237 (339)
                      |+..+..        -|.+||+..+.++..+-|.|++||++.++++|.+.+.+.....                   +..
T Consensus       338 Sc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  338 SCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             ccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            9876543        4788999999999999999999999999999987773221110                   000


Q ss_pred             HHHHHhh-----------------------------CCCCCCC----CccccCC-CCCHHHHHHHHHhcccCCCCCCCHH
Q 042681          238 ARRYVKQ-----------------------------LPHVPKQ----PFSQKFP-NMSPVAIDLAERMLVFDPAKRITVE  283 (339)
Q Consensus       238 ~~~~~~~-----------------------------~~~~~~~----~~~~~~~-~~s~~~~~li~~~L~~dP~~Rps~~  283 (339)
                      ...++..                             ......+    ......+ .-...+.|||.+||.+||.+|+|+.
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence            0000000                             0000000    0001111 2234579999999999999999999


Q ss_pred             HHhcCCCCCCCccC
Q 042681          284 EALNHPYLSSLHEI  297 (339)
Q Consensus       284 ell~hp~f~~~~~~  297 (339)
                      ++|+||||......
T Consensus       498 qal~Hpfl~~~~~~  511 (586)
T KOG0667|consen  498 QALNHPFLTGTSLE  511 (586)
T ss_pred             HHhcCccccccccc
Confidence            99999999966544

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-40  Score=301.32  Aligned_cols=254  Identities=20%  Similarity=0.245  Sum_probs=200.6

Q ss_pred             ccCccCCCccccccccceEEEEEEeC--CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNS--ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      +..+|.+ ++.||.|+||.||++...  .+++.+++|.+...       ....+|+.+++.++||||+++++++     .
T Consensus        90 ~~~~y~i-~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~-----~  156 (392)
T PHA03207         90 VRMQYNI-LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAY-----R  156 (392)
T ss_pred             ccCceEE-EEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeE-----e
Confidence            3456777 999999999999999754  35678999987643       2345799999999999999999998     5


Q ss_pred             CcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-
Q 042681          110 KFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-  188 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-  188 (339)
                      ....+|++||++.++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++... 
T Consensus       157 ~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        157 WKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             eCCEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            6678999999999999999977788999999999999999999999999999999999999999999999999998543 


Q ss_pred             ------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc-chHHHHHh------------
Q 042681          189 ------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS-DNARRYVK------------  243 (339)
Q Consensus       189 ------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~-~~~~~~~~------------  243 (339)
                                  +...|.+|+......+..+.|+|++|+++|++++|..|+........ ........            
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence                        33457788887777778889999999999999999998865432110 00111111            


Q ss_pred             ----------hCCCCCCCC--cccc--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          244 ----------QLPHVPKQP--FSQK--FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       244 ----------~~~~~~~~~--~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                                .........  ....  ...++.+++++|.+||+.||.+|||+.+++.||||....+..
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~  385 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL  385 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence                      000000000  0000  023577899999999999999999999999999998766543

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=281.10  Aligned_cols=244  Identities=24%  Similarity=0.351  Sum_probs=200.2

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC---hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN---RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      +.|.. .+.||+|++|.||++.+..+++.+++|.+......   ....+.+.+|+.++++++||||+++++++     ..
T Consensus         2 ~~~~~-~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~   75 (263)
T cd06625           2 TNWRR-GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RD   75 (263)
T ss_pred             Ccccc-cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----cc
Confidence            34555 89999999999999999999999999998654322   22345688999999999999999999999     55


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ....++++||++ ++|.+.+...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            668999999997 6999999888889999999999999999999999999999999999999999999999999885432


Q ss_pred             --------------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          190 --------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       190 --------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                                    ...|.+|+.........++|+|++|++++++++|..|+.....     ..............   .
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~---~  227 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-----MAAIFKIATQPTNP---Q  227 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-----HHHHHHHhccCCCC---C
Confidence                          2347788877766778889999999999999999988654311     11111111111111   1


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ....++.++.++|.+||..+|.+|||+.++++||||
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            113578999999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.4e-40  Score=291.90  Aligned_cols=242  Identities=18%  Similarity=0.306  Sum_probs=199.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      .+.||+|+||.||+|+++.+|+.||+|++.+... .....+.+..|..++..+. |++|+++++++     .....+++|
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv   79 (323)
T cd05615           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDRLYFV   79 (323)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCEEEEE
Confidence            7889999999999999999999999999976422 2334456778889988885 67888899988     666789999


Q ss_pred             EecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--------
Q 042681          118 YELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--------  188 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--------  188 (339)
                      |||++ |+|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...        
T Consensus        80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            99997 799999988889999999999999999999999999999999999999999999999999987642        


Q ss_pred             ---CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          189 ---SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       189 ---~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                         +...|++||.........+.|+|++|++++++++|..|+.....  .............        ....++.+++
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i~~~~~~--------~p~~~~~~~~  229 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQSIMEHNVS--------YPKSLSKEAV  229 (323)
T ss_pred             CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC--------CCccCCHHHH
Confidence               34568889888777778899999999999999999999764321  1111111111111        1135789999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhcCCCCCCCcc
Q 042681          266 DLAERMLVFDPAKRIT-----VEEALNHPYLSSLHE  296 (339)
Q Consensus       266 ~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~  296 (339)
                      +++.+||+.+|.+|++     ..++++||||+.+.+
T Consensus       230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             HHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence            9999999999999997     579999999999865

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-40  Score=295.59  Aligned_cols=248  Identities=23%  Similarity=0.302  Sum_probs=193.6

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ..+|.. ++.||+|+||.||+|.+..+++.+|+|+....        ....|+.+++.++||||+++++++     ....
T Consensus        65 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~  130 (357)
T PHA03209         65 SLGYTV-IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTL-----VSGA  130 (357)
T ss_pred             hcCcEE-EEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheE-----EeCC
Confidence            345777 99999999999999999999999999975432        235689999999999999999998     5667


Q ss_pred             eEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      ..++|+|++.++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||.++..   
T Consensus       131 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        131 ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             eeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            8899999999999998865 467999999999999999999999999999999999999999999999999998632   


Q ss_pred             -------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcc-cccccc-------hHHHHHhhCCC------
Q 042681          189 -------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDL-GFLRSD-------NARRYVKQLPH------  247 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~-~~~~~~-------~~~~~~~~~~~------  247 (339)
                             +...|.+||......+..+.|+|++|+++|+++++..+.... +.....       ...........      
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence                   334578888887777888999999999999999865443221 111000       00000000000      


Q ss_pred             ----------------CCCCCcc----ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          248 ----------------VPKQPFS----QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       248 ----------------~~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                                      ....+..    .....++.++.+||.+||+.||++|||+.|+++||||+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence                            0000000    0012467788999999999999999999999999999864

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.5e-39  Score=283.86  Aligned_cols=259  Identities=24%  Similarity=0.328  Sum_probs=207.4

Q ss_pred             EccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecC
Q 042681           25 ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIP  104 (339)
Q Consensus        25 ~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~  104 (339)
                      ..++.+...+.|.. ++.||.|++|.||++++..+++.+++|.+...  .....+.+.+|+.+++.++||||+++++.+ 
T Consensus         3 ~~~~~~~~~~~y~i-~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   78 (292)
T cd06644           3 HVRRDLDPNEVWEI-IGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAF-   78 (292)
T ss_pred             hhhcccCcchhhhh-hheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEE-
Confidence            45666777788888 99999999999999999999999999998653  344567788999999999999999999998 


Q ss_pred             CCCcCCcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeec
Q 042681          105 PMDKEKFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF  182 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Df  182 (339)
                          ...+..++||||++ ++|..++.+ ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+||
T Consensus        79 ----~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~df  154 (292)
T cd06644          79 ----YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADF  154 (292)
T ss_pred             ----EeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccC
Confidence                55678999999998 577766654 467999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC-----------CCCcccccccc-----ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC
Q 042681          183 GLARTTS-----------ETDFMTEYVVT-----RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP  246 (339)
Q Consensus       183 g~~~~~~-----------~~~~~~~~~~~-----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  246 (339)
                      |.+....           ...|.+||...     ......++|+|++|+++|++++|..|+.....     ....... .
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~-~  228 (292)
T cd06644         155 GVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKI-A  228 (292)
T ss_pred             ccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHH-h
Confidence            9875432           23467777653     23345679999999999999999998754321     1111111 1


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       247 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      ..... .......++.++.++|.+||+.+|++||++.++++||||..+...+
T Consensus       229 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         229 KSEPP-TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             cCCCc-cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence            11111 1111235788999999999999999999999999999999887654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.9e-40  Score=291.70  Aligned_cols=252  Identities=19%  Similarity=0.335  Sum_probs=200.7

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. ++.||+|+||.||++++..+++.+|+|++.+.. ........+.+|+.++..++|++|+++++.+     .....
T Consensus         2 ~y~~-~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (332)
T cd05623           2 DFEI-LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN   75 (332)
T ss_pred             CceE-EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence            4555 899999999999999999999999999986532 2233345578899999999999999999999     66778


Q ss_pred             EEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          114 VYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      +++||||+. |+|.+++.+ ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...   
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999997 799999976 467999999999999999999999999999999999999999999999999987532   


Q ss_pred             ---------CCCCcccccccc-----ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 ---------SETDFMTEYVVT-----RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 ---------~~~~~~~~~~~~-----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                               +...|++||...     ...+..+.|+|++|++++++++|..|+......  .......   .........
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--~~~~~i~---~~~~~~~~p  230 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIM---NHKERFQFP  230 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--HHHHHHh---CCCccccCC
Confidence                     345688888764     234677899999999999999999997543211  1111111   111112222


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCccC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAK--RITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~--Rps~~ell~hp~f~~~~~~  297 (339)
                      .....+++++++||++||..+|.+  |++++++++||||.++.+.
T Consensus       231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~  275 (332)
T cd05623         231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD  275 (332)
T ss_pred             CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence            333468999999999999765554  6899999999999987653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.3e-40  Score=296.44  Aligned_cols=251  Identities=21%  Similarity=0.285  Sum_probs=199.7

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      .++|.. ++.||+|+||.||+|++..+++.+|+|++.+.. ......+.+.+|+.+++.++||||+++++.+     ...
T Consensus        42 ~~~y~i-~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (371)
T cd05622          42 AEDYEV-VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  115 (371)
T ss_pred             hhhcEE-EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence            466777 999999999999999999999999999986532 2233445678899999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ..+++||||++ |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++...  
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            78999999997 689888865 46899999999999999999999999999999999999999999999999998543  


Q ss_pred             ----------CCCCcccccccccc----ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 ----------SETDFMTEYVVTRW----DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 ----------~~~~~~~~~~~~~~----~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                                ++..|++||.....    ....+.|+|++|+++|++++|..|+......  .....+.....   .... 
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~---~~~~-  268 (371)
T cd05622         195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHKN---SLTF-  268 (371)
T ss_pred             CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCC---cccC-
Confidence                      34457888876543    2567899999999999999999997643211  11112211111   1111 


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCcc
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAK--RITVEEALNHPYLSSLHE  296 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~--Rps~~ell~hp~f~~~~~  296 (339)
                      ...+.++..+++||.+||..++.+  |+++.++++||||++..+
T Consensus       269 ~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         269 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence            112468999999999999844443  789999999999988543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-42  Score=293.51  Aligned_cols=247  Identities=27%  Similarity=0.404  Sum_probs=214.2

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ...|.. .+.||+|+||.||++.+..+++.||+|++... ....+...+.+|+.++.+++++||.++|+.+     -.+.
T Consensus        12 ~~~~~~-~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsy-----l~g~   84 (467)
T KOG0201|consen   12 ELLYTK-LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSY-----LKGT   84 (467)
T ss_pred             cccccc-chhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhhe-----eecc
Confidence            445666 78999999999999999999999999999654 3344567788999999999999999999999     7778


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc----
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----  187 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~----  187 (339)
                      .++++||||+ |++.+.++....+.+..+..++.+++.||.|||..+.+|||||+.||++..+|.+||+|||.+..    
T Consensus        85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence            8999999998 79999999877789999999999999999999999999999999999999999999999999843    


Q ss_pred             -------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          188 -------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       188 -------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                             ++++-+++||+.....+..+.|+|++|++.+++..|.+|+.....+      .....++....+.+..   .+
T Consensus       165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------rvlflIpk~~PP~L~~---~~  235 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------RVLFLIPKSAPPRLDG---DF  235 (467)
T ss_pred             hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc------eEEEeccCCCCCcccc---cc
Confidence                   4667789999999889999999999999999999999998765432      2233344444443333   58


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      |+.+++||..||.+||+.||+|.++|+|+|++...
T Consensus       236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  236 SPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            99999999999999999999999999999998743

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.2e-40  Score=293.02  Aligned_cols=241  Identities=22%  Similarity=0.366  Sum_probs=195.9

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHH-HHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIK-LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||+|++..+++.+|+|++.+... .......+..|.. +++.++||||+++++++     ...+.+++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            468999999999999999999999999975422 1222334444444 56778999999999998     6667899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ ++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...         
T Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            9998 699999988888999999999999999999999999999999999999999999999999987532         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                        +...|++||......+..+.|+|++|++++++++|..|+......  ........    ...    ...+.++..+.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~----~~~----~~~~~~~~~~~~  225 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILN----KPL----QLKPNITNSARH  225 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHHHh----CCc----CCCCCCCHHHHH
Confidence              345688899887777888999999999999999999997643211  11111111    111    112468999999


Q ss_pred             HHHHhcccCCCCCCCHH----HHhcCCCCCCCcc
Q 042681          267 LAERMLVFDPAKRITVE----EALNHPYLSSLHE  296 (339)
Q Consensus       267 li~~~L~~dP~~Rps~~----ell~hp~f~~~~~  296 (339)
                      +|.+||+.||.+||++.    ++++||||..+.+
T Consensus       226 li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         226 LLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             HHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence            99999999999999875    8999999988764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.1e-40  Score=290.73  Aligned_cols=242  Identities=21%  Similarity=0.329  Sum_probs=195.7

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHH-HHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIK-LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||+|++..+|+.+|+|++.+... .......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            468999999999999999999999999875422 2223344555554 57888999999999998     6677899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ ++|...+...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++...         
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            9998 689888888888999999999999999999999999999999999999999999999999987642         


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                        +...|.+||......+..+.|+|++|+++|++++|..|+.....      ..........+ .   ...+..+.++.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~-~---~~~~~~~~~~~~  225 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILHKP-L---QLPGGKTVAACD  225 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhcCC-C---CCCCCCCHHHHH
Confidence              33458888887766778899999999999999999999754321      11111111111 1   111457889999


Q ss_pred             HHHHhcccCCCCCCCH----HHHhcCCCCCCCccC
Q 042681          267 LAERMLVFDPAKRITV----EEALNHPYLSSLHEI  297 (339)
Q Consensus       267 li~~~L~~dP~~Rps~----~ell~hp~f~~~~~~  297 (339)
                      +|.+||+.||.+||++    .++++||||..+.+.
T Consensus       226 li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~  260 (321)
T cd05603         226 LLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD  260 (321)
T ss_pred             HHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence            9999999999999975    599999999987653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.5e-39  Score=302.90  Aligned_cols=254  Identities=20%  Similarity=0.290  Sum_probs=193.6

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC------CCCeeeeeeecCCC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT------HENIVKVKDIIPPM  106 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~I~~~~~~~~~~  106 (339)
                      .++|.+ ++.||+|+||.||+|.+..+++.||+|+++...   ........|+.+++.++      |++++++++++.  
T Consensus       128 ~~~y~i-~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~--  201 (467)
T PTZ00284        128 TQRFKI-LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ--  201 (467)
T ss_pred             CCcEEE-EEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE--
Confidence            466777 999999999999999999999999999986431   12233455666666654      456889999883  


Q ss_pred             CcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCC----------
Q 042681          107 DKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANC----------  175 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~----------  175 (339)
                        ....++|+||++++++|.+++.+.+.+++..++.++.||+.||.|||+ .||+||||||+||+++.++          
T Consensus       202 --~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        202 --NETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             --cCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence              334579999999999999999888899999999999999999999997 6999999999999998765          


Q ss_pred             ------CeEEeecccccc--------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHH
Q 042681          176 ------DLKICDFGLART--------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRY  241 (339)
Q Consensus       176 ------~ikL~Dfg~~~~--------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~  241 (339)
                            .+||+|||.+..        .+...|++||......+..+.|+|++|+++|++++|..+|......  ......
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i  357 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL--EHLHLM  357 (467)
T ss_pred             cCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHH
Confidence                  499999998753        3455789999888778888999999999999999999998543211  000000


Q ss_pred             HhhC-----------------------CCCCCCCcc---------ccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          242 VKQL-----------------------PHVPKQPFS---------QKF--PNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       242 ~~~~-----------------------~~~~~~~~~---------~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ....                       .........         ...  ...++.+.+||.+||++||.+|||++|+|+
T Consensus       358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            0000                       000000000         000  012466889999999999999999999999


Q ss_pred             CCCCCCCcc
Q 042681          288 HPYLSSLHE  296 (339)
Q Consensus       288 hp~f~~~~~  296 (339)
                      ||||.....
T Consensus       438 Hp~~~~~~~  446 (467)
T PTZ00284        438 HPYVLKYYP  446 (467)
T ss_pred             CccccccCC
Confidence            999998654

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.5e-39  Score=289.49  Aligned_cols=279  Identities=43%  Similarity=0.712  Sum_probs=215.8

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~  109 (339)
                      .+.++|.. .+.||+|++|.||++.+..+|+.+|+|++............+.+|+.++.++ +||||+++++++..   .
T Consensus         4 ~~~~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~   79 (337)
T cd07852           4 HILRKYEI-LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---E   79 (337)
T ss_pred             hhhhHHHH-hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---C
Confidence            45677777 8999999999999999999999999999865444444456678899999999 99999999998832   3


Q ss_pred             CcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          110 KFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      .....++||||++++|.+++... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 ~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          80 NDKDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             CCceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            34568999999999999988765 88999999999999999999999999999999999999999999999999886432


Q ss_pred             C----------------CCcccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc----------------
Q 042681          190 E----------------TDFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD----------------  236 (339)
Q Consensus       190 ~----------------~~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~----------------  236 (339)
                      .                ..|.+|+... ......++|+|++|++++++++|..++.........                
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            1                2366676543 234567899999999999999999887543211100                


Q ss_pred             -----hHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCCh
Q 042681          237 -----NARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDF  311 (339)
Q Consensus       237 -----~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~  311 (339)
                           .....................+.++.+++++|.+||+.||++|||+.++++||||+........+....++...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~  318 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPL  318 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCc
Confidence                 000011111222222333344568999999999999999999999999999999999877665655555655544


Q ss_pred             hhc
Q 042681          312 EQT  314 (339)
Q Consensus       312 ~~~  314 (339)
                      ...
T Consensus       319 ~~~  321 (337)
T cd07852         319 DDN  321 (337)
T ss_pred             ccc
Confidence            443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-39  Score=284.55  Aligned_cols=248  Identities=32%  Similarity=0.483  Sum_probs=197.1

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. ++.||.|++|.||+|.+..+|+.+|+|++............+.+|++++.+++||||+++++++     ......+
T Consensus         2 y~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           2 FQK-VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             cee-eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            444 8899999999999999999999999999876544443446788999999999999999999998     5667899


Q ss_pred             EEEecCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC----
Q 042681          116 IVYELMDTDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS----  189 (339)
Q Consensus       116 iv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~----  189 (339)
                      ++|||+.++|..++..  ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...+    
T Consensus        76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            9999999889888865  3568999999999999999999999999999999999999999999999999886432    


Q ss_pred             -------CCCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHH-------------------
Q 042681          190 -------ETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV-------------------  242 (339)
Q Consensus       190 -------~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~-------------------  242 (339)
                             ...|.+||..... .....+|+|++|++++++++|..++.......  ......                   
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHH
Confidence                   2236677755432 24667999999999999999998865322110  011111                   


Q ss_pred             --hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          243 --KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       243 --~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                        ...............+.++++++++|.+||+.||++|||++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence              1111111122222235678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.8e-39  Score=288.05  Aligned_cols=245  Identities=26%  Similarity=0.383  Sum_probs=185.1

Q ss_pred             ccccccccceEEEEEEeC--CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNS--ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      .+.||+|+||.||+|.+.  .+++.+|+|.+.....    ...+.+|+.+++.++||||+++++++..   .....++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEE
Confidence            568999999999999965  4678999999865421    2346789999999999999999998843   334568999


Q ss_pred             EecCcccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee----ccCCCeEEeeccc
Q 042681          118 YELMDTDLHQIIRSK---------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGL  184 (339)
Q Consensus       118 ~e~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli----~~~~~ikL~Dfg~  184 (339)
                      +||++++|.+++...         ..+++..++.++.||+.||+|||++|++||||||+||++    +.++.+||+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            999999998887532         258999999999999999999999999999999999999    4567899999999


Q ss_pred             ccccC--------------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccc-------cchHHHHH
Q 042681          185 ARTTS--------------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR-------SDNARRYV  242 (339)
Q Consensus       185 ~~~~~--------------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~-------~~~~~~~~  242 (339)
                      ++...              +..|++||.... ..+..+.|+|++|++++++++|.+++.......       ........
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            86432              234788887654 346778999999999999999998875321100       00000111


Q ss_pred             hhCCCC-----------C---------------CC----CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          243 KQLPHV-----------P---------------KQ----PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       243 ~~~~~~-----------~---------------~~----~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ......           +               ..    .........+.++.+||.+||++||.+|||++|+++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            000000           0               00    0000012245678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.7e-39  Score=283.80  Aligned_cols=246  Identities=23%  Similarity=0.347  Sum_probs=199.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      .+.||+|+||.||++.+..+++.+|+|.+..... .......+.+|+.+++.++|++|+++++.+     ......++||
T Consensus         5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~   79 (285)
T cd05630           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALCLVL   79 (285)
T ss_pred             eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEEEEE
Confidence            7789999999999999999999999999875432 223345678899999999999999999998     5567899999


Q ss_pred             ecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-------
Q 042681          119 ELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-------  188 (339)
                      ||++ ++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...       
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  159 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence            9997 6898887543  36999999999999999999999999999999999999999999999999988542       


Q ss_pred             ---CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc-chHHHHHhhCCCCCCCCccccCCCCCHHH
Q 042681          189 ---SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS-DNARRYVKQLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       189 ---~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  264 (339)
                         +...|++|+.........+.|+|++|++++++++|..|+........ ..........   . .   .....+++++
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~-~---~~~~~~~~~~  232 (285)
T cd05630         160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---Q-E---EYSEKFSPDA  232 (285)
T ss_pred             CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---h-h---hcCccCCHHH
Confidence               23457888887777778889999999999999999999764321111 1111111100   0 0   1124578999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCccC
Q 042681          265 IDLAERMLVFDPAKRIT-----VEEALNHPYLSSLHEI  297 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~~  297 (339)
                      ++|+.+||+.||++|||     +.++++||||..+.+.
T Consensus       233 ~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         233 RSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             HHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence            99999999999999999     9999999999887554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.1e-39  Score=283.41  Aligned_cols=249  Identities=29%  Similarity=0.512  Sum_probs=195.0

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. ++.||+|++|.||++.+..+|+.+|+|++..........+.+.+|+.++..++||||+++++++     ......
T Consensus         2 ~y~~-~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07847           2 KYEK-LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL   75 (286)
T ss_pred             ceee-eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence            5666 8899999999999999999999999999875533333345678999999999999999999999     667789


Q ss_pred             EEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC---
Q 042681          115 YIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE---  190 (339)
Q Consensus       115 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~---  190 (339)
                      ++||||+++ .|..+......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.....   
T Consensus        76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            999999995 5555555566799999999999999999999999999999999999999999999999999875432   


Q ss_pred             --------CCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC---------------
Q 042681          191 --------TDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP---------------  246 (339)
Q Consensus       191 --------~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~---------------  246 (339)
                              ..|.+|+.... .....+.|+|++|++++++++|.+|+.......  ..........               
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhcccccc
Confidence                    23566765433 345678999999999999999998875432111  0000000000               


Q ss_pred             ----CCC----CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          247 ----HVP----KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       247 ----~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                          ..+    ..+.....+.++..+.+||.+||+.+|++||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                000    001111234678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-40  Score=303.27  Aligned_cols=247  Identities=20%  Similarity=0.251  Sum_probs=195.4

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ...|.+ .+.||+|+||.||++.+..+++.+|+|....        ..+.+|+.++++++|+||+++++++     ...+
T Consensus       168 ~~gy~i-~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~-----~~~~  233 (461)
T PHA03211        168 GLGFAI-HRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVR-----VVGG  233 (461)
T ss_pred             cCCeEE-EEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEE-----EECC
Confidence            456777 8999999999999999999999999996421        2356899999999999999999998     5667


Q ss_pred             eEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      ..++|||++.++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..   
T Consensus       234 ~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        234 LTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            88999999999999988764 57999999999999999999999999999999999999999999999999998542   


Q ss_pred             ----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc-----chHHHHHhhCCC----CC
Q 042681          189 ----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS-----DNARRYVKQLPH----VP  249 (339)
Q Consensus       189 ----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~-----~~~~~~~~~~~~----~~  249 (339)
                                +...|++||.........+.|+|++|+++|++++|..+.........     ......+.....    .+
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence                      34467888887777778889999999999999988765433221110     011111111000    00


Q ss_pred             -------------------C----CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          250 -------------------K----QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       250 -------------------~----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                                         .    ......+..++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                               0    0001111245678999999999999999999999999999975

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=264.30  Aligned_cols=247  Identities=19%  Similarity=0.258  Sum_probs=199.2

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++||++ .+.||.|||+-||++++..+++.||+|++....  ..+.+..++|++..++++|||+++++++......+...
T Consensus        20 ~~Ryri-~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRI-QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEE-eeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            567777 999999999999999999999999999998663  45678899999999999999999999987554323344


Q ss_pred             eEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeeeccCCCeEEeecccc
Q 042681          113 DVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                      ..||+++|+. |+|.+.+..    +..+++.++..|+.+|+.||++||+..  ++||||||.||++++.+.++|.|||.+
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence            5899999998 899999864    247999999999999999999999998  999999999999999999999999998


Q ss_pred             cccC--------------------CCCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHH
Q 042681          186 RTTS--------------------ETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV  242 (339)
Q Consensus       186 ~~~~--------------------~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~  242 (339)
                      +...                    +..|.+||...   ......+.|+|++||++|.++.|..||+.... .+...... 
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSlaLA-  254 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLALA-  254 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEEEe-
Confidence            6532                    12466776554   23467789999999999999999999864322 22221111 


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                         ........+.. +.+|+.+.+||++||+.||.+||++.+++.+
T Consensus       255 ---v~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  255 ---VQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             ---eeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence               11222222222 2389999999999999999999999999865

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-41  Score=278.08  Aligned_cols=255  Identities=22%  Similarity=0.317  Sum_probs=217.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ++.||+|.||+|.+++.+.+|+.||+|++++.. ....+.+.-+.|-++|+..+||.+..+.-.|     +....+|+||
T Consensus       173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~drlCFVM  247 (516)
T KOG0690|consen  173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQDRLCFVM  247 (516)
T ss_pred             HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCceEEEEE
Confidence            899999999999999999999999999998873 4555678888999999999999999998888     7778999999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc----------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----------  187 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~----------  187 (339)
                      ||+. |.|+-++.+.+.+++..++-+...|++||.|||+.+||+||||.+|+++|.+|++||.|||+|+.          
T Consensus       248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kT  327 (516)
T KOG0690|consen  248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKT  327 (516)
T ss_pred             EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceecc
Confidence            9997 79999999999999999999999999999999999999999999999999999999999999953          


Q ss_pred             -cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          188 -TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       188 -~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                       .|++.|.+|++.....+..+.|.|.+|+++|+|+||+.|+..-  ........+.......+        ..+|++++.
T Consensus       328 FCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~--dh~kLFeLIl~ed~kFP--------r~ls~eAkt  397 (516)
T KOG0690|consen  328 FCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK--DHEKLFELILMEDLKFP--------RTLSPEAKT  397 (516)
T ss_pred             ccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc--chhHHHHHHHhhhccCC--------ccCCHHHHH
Confidence             4677899999999999999999999999999999999997542  22222233333222222        358999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCCCCCCCccCC-CCCCCCCCCCC
Q 042681          267 LAERMLVFDPAKRI-----TVEEALNHPYLSSLHEIN-EEPTCPYPFNF  309 (339)
Q Consensus       267 li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~~-~~~~~~~~~~~  309 (339)
                      |+..+|.+||.+|.     .|.++.+|+||.++.|.. -.+....||++
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKP  446 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKP  446 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCC
Confidence            99999999999998     478999999999999853 22233444444

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-39  Score=290.51  Aligned_cols=252  Identities=19%  Similarity=0.315  Sum_probs=201.3

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. ++.||+|+||.||++++..+++.||+|++.+.. ........+.+|..++..++|++|+++++++     ...+.
T Consensus         2 ~y~i-~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~   75 (331)
T cd05624           2 DFEI-IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY   75 (331)
T ss_pred             CceE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            5666 899999999999999999999999999987532 2233445678899999999999999999999     66788


Q ss_pred             EEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          114 VYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .++||||+. |+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...   
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999997 799999976 468999999999999999999999999999999999999999999999999987542   


Q ss_pred             ---------CCCCccccccccc-----cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 ---------SETDFMTEYVVTR-----WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 ---------~~~~~~~~~~~~~-----~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                               +...|++||....     .....+.|+|++|+++|++++|..|+......  .......   .......+.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~~i~---~~~~~~~~p  230 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIM---NHEERFQFP  230 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--HHHHHHH---cCCCcccCC
Confidence                     3445778886654     34567899999999999999999997543211  1111111   111112223


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCccC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAK--RITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~--Rps~~ell~hp~f~~~~~~  297 (339)
                      .....++++++++|.+||..++.+  |++++++++||||+.+.+.
T Consensus       231 ~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         231 SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence            333457899999999999976655  5689999999999987653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.8e-39  Score=290.32  Aligned_cols=261  Identities=30%  Similarity=0.411  Sum_probs=206.6

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHh------------HHHHHHHHHHHhhCCCCCee
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID------------AKRILREIKLLCHMTHENIV   97 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~------------~~~~~~e~~~l~~l~h~~I~   97 (339)
                      .++.++|..+.+.||.|++|.||++.+..+++.+|+|+++........            ...+.+|+.++..++||||+
T Consensus         4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   83 (335)
T PTZ00024          4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM   83 (335)
T ss_pred             cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence            467889988678899999999999999999999999998654222100            12467899999999999999


Q ss_pred             eeeeecCCCCcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCe
Q 042681           98 KVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL  177 (339)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~i  177 (339)
                      ++++++     ......+++|||++|+|.+++.....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+
T Consensus        84 ~~~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         84 GLVDVY-----VEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             eeeEEE-----ecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence            999998     566789999999999999999888889999999999999999999999999999999999999999999


Q ss_pred             EEeecccccccC-------------------------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccc
Q 042681          178 KICDFGLARTTS-------------------------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLG  231 (339)
Q Consensus       178 kL~Dfg~~~~~~-------------------------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~  231 (339)
                      +|+|||.+...+                         ...|.+||.... .....+.|+|++|++++++++|.+++....
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999987554                         223566665533 235678999999999999999998875432


Q ss_pred             ccccchHHHHHhhCCCC--------------------CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          232 FLRSDNARRYVKQLPHV--------------------PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       232 ~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ..  .............                    .........+..+.++.++|.+||+.+|++|||+++++.||||
T Consensus       239 ~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        239 EI--DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             HH--HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence            11  1111111111100                    0111112234568899999999999999999999999999999


Q ss_pred             CCCccC
Q 042681          292 SSLHEI  297 (339)
Q Consensus       292 ~~~~~~  297 (339)
                      +.....
T Consensus       317 ~~~~~~  322 (335)
T PTZ00024        317 KSDPLP  322 (335)
T ss_pred             CCCCCC
Confidence            977554

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.8e-39  Score=285.55  Aligned_cols=256  Identities=34%  Similarity=0.490  Sum_probs=201.5

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccC---hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN---RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      |.. .+.||.|++|.||++.+..+|+.+++|.+......   ......+.+|+.+++.++|+||+++++++     ....
T Consensus         2 y~~-~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (298)
T cd07841           2 YEK-GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS   75 (298)
T ss_pred             cee-eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence            445 78899999999999999999999999999765333   22345677899999999999999999999     5567


Q ss_pred             eEEEEEecCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC
Q 042681          113 DVYIVYELMDTDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET  191 (339)
Q Consensus       113 ~~~iv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~  191 (339)
                      ..++||||++++|.+++.... .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            899999999889999998765 8999999999999999999999999999999999999999999999999998765432


Q ss_pred             -----------Ccccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC-------------
Q 042681          192 -----------DFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP-------------  246 (339)
Q Consensus       192 -----------~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~-------------  246 (339)
                                 .|.+|+... ......+.|+|++|++++++++|.+++......  ...........             
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHHHHHHHHcCCCchhhhhhcccc
Confidence                       356666543 234567899999999999999997665432211  11111111100             


Q ss_pred             -------CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCC
Q 042681          247 -------HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE  299 (339)
Q Consensus       247 -------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~  299 (339)
                             .....+....+...+..++++|.+||+++|++|||+.++++||||++...+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~  293 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP  293 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence                   00111111223456889999999999999999999999999999999877653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-39  Score=289.46  Aligned_cols=250  Identities=19%  Similarity=0.235  Sum_probs=194.3

Q ss_pred             ccccccc--cceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRG--AYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      ++.||+|  ++++||++.++.+|+.||+|++............+.+|+.+++.++||||+++++++     ......++|
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-----~~~~~~~lv   77 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IADNELWVV   77 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----EECCEEEEE
Confidence            6789999  678999999999999999999976544454556778899999999999999999999     666789999


Q ss_pred             EecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc------
Q 042681          118 YELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT------  188 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~------  188 (339)
                      |||++ |+|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++++||+.+...      
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            99998 7899988653  46899999999999999999999999999999999999999999999999754221      


Q ss_pred             ------------CCCCccccccccc--cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC-------
Q 042681          189 ------------SETDFMTEYVVTR--WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH-------  247 (339)
Q Consensus       189 ------------~~~~~~~~~~~~~--~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~-------  247 (339)
                                  +...|.+|+....  ..+..+.|+|++|++++++++|..|+......... ..........       
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH-HHHhcCCccccccccch
Confidence                        1123667776543  34677899999999999999999997643211100 0000000000       


Q ss_pred             ------------------------------CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          248 ------------------------------VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       248 ------------------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                                                    ............+++++++||++||+.||++|||++++++||||+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                          000000011123678899999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3e-39  Score=283.11  Aligned_cols=247  Identities=22%  Similarity=0.351  Sum_probs=205.4

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. .+.||+|++|.||++.+..+++.+|+|++.... ........+.+|+.++++++||||+++++++     .....
T Consensus         2 ~y~~-~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   75 (290)
T cd05580           2 DFEF-IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN   75 (290)
T ss_pred             ceEE-EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence            4556 899999999999999999999999999986542 2233456788999999999999999999998     66778


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      .+++|||++ ++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  155 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT  155 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence            999999995 7999999888899999999999999999999999999999999999999999999999999987543   


Q ss_pred             -----CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHH
Q 042681          190 -----ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       190 -----~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  264 (339)
                           ...|.+|+...........|+|++|++++++++|..|+.....  ........  ...   ..   ....++..+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~--~~~---~~---~~~~~~~~l  225 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYEKIL--EGK---VR---FPSFFSPDA  225 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHh--cCC---cc---CCccCCHHH
Confidence                 3357778877666677789999999999999999998754331  11111111  111   11   113468999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          265 IDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      +++|.+||+.||.+|+     +++++++||||+.+.+.
T Consensus       226 ~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         226 KDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             HHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence            9999999999999999     99999999999998864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.4e-39  Score=283.31  Aligned_cols=249  Identities=21%  Similarity=0.346  Sum_probs=200.1

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|+||.||++.+..++..+|+|.+.... ......++.+|++++++++||||+++++++     ...+.+
T Consensus         2 ~~~~-~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   74 (308)
T cd06615           2 DFEK-LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEI   74 (308)
T ss_pred             CceE-EeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEE
Confidence            3555 889999999999999999999999999886542 233456788999999999999999999999     667789


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      ++||||++ ++|.+++.+.+.+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+...    
T Consensus        75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence            99999997 6999999888899999999999999999999997 69999999999999999999999999987643    


Q ss_pred             -----CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh-------------------
Q 042681          189 -----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ-------------------  244 (339)
Q Consensus       189 -----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~-------------------  244 (339)
                           +...|.+|+.........+.|+|++|++++++++|..|+......   ........                   
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccccCCCC
Confidence                 234677888776666778899999999999999999886422100   00000000                   


Q ss_pred             --------------CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          245 --------------LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       245 --------------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                                    ......+..  ....++.++++|+.+||..+|++||++.++++||||....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKL--PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccC--cCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence                          000000000  0113678899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.8e-39  Score=289.63  Aligned_cols=271  Identities=38%  Similarity=0.625  Sum_probs=206.9

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc--
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK--  108 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~--  108 (339)
                      .+.++|.. .+.||.|++|.||+|.+..+|+.+|+|++.....  ...+.+.+|+.+++.++||||+++++++.....  
T Consensus         2 ~~~~~y~~-~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           2 DLGSRYMD-LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             CcCcceEE-EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence            45678888 9999999999999999999999999999865432  345678899999999999999999988743221  


Q ss_pred             -------CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-CCCeEEe
Q 042681          109 -------EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKIC  180 (339)
Q Consensus       109 -------~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-~~~ikL~  180 (339)
                             ......++++||++++|.+.+.. ..+++..++.++.||+.||.|||+.|++||||||+||+++. ++.++|+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                   11235899999999999888764 57999999999999999999999999999999999999985 5578999


Q ss_pred             ecccccccC--------------CCCcccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh-
Q 042681          181 DFGLARTTS--------------ETDFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ-  244 (339)
Q Consensus       181 Dfg~~~~~~--------------~~~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~-  244 (339)
                      |||.+....              ...|.+|+... ......++|+|++|++++++++|..|+.......  ........ 
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~~~~~~  235 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--QMQLILESV  235 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhc
Confidence            999986431              22466777543 2446678999999999999999999875432110  00000000 


Q ss_pred             ---------------------CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCC
Q 042681          245 ---------------------LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTC  303 (339)
Q Consensus       245 ---------------------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~  303 (339)
                                           .......+.....+.++.++++||.+||+.||.+|||+.++++||||+.+..+...+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~  315 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVS  315 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCC
Confidence                                 01111122222345688999999999999999999999999999999987766555444


Q ss_pred             CCCC
Q 042681          304 PYPF  307 (339)
Q Consensus       304 ~~~~  307 (339)
                      ..|+
T Consensus       316 ~~~~  319 (342)
T cd07854         316 LHPF  319 (342)
T ss_pred             CCCc
Confidence            4343

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.9e-39  Score=285.71  Aligned_cols=258  Identities=30%  Similarity=0.451  Sum_probs=200.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. .+.||.|++|.||++.+..+|+.||+|+++.............+|+.+++.++|+||+++++++..   .....
T Consensus         7 ~~y~~-~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~   82 (309)
T cd07845           7 TEFEK-LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS   82 (309)
T ss_pred             cceeE-eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence            45666 899999999999999999999999999987543333223456689999999999999999999842   23356


Q ss_pred             EEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC--
Q 042681          114 VYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--  190 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--  190 (339)
                      +++||||++++|.+++.. ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+.....  
T Consensus        83 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          83 IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            899999999999888875 46799999999999999999999999999999999999999999999999999875432  


Q ss_pred             ---------CCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC-------------
Q 042681          191 ---------TDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH-------------  247 (339)
Q Consensus       191 ---------~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~-------------  247 (339)
                               ..|.+||.... .....+.|+|++|++++++++|.+++......  ............             
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChhhchhhhccc
Confidence                     23677776543 44677899999999999999999887532211  111111110000             


Q ss_pred             ---------CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          248 ---------VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       248 ---------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                               ..........+..++++.+||.+||+.||++|||+.++++||||+....+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence                     00000111123368899999999999999999999999999999877655

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-40  Score=304.20  Aligned_cols=260  Identities=22%  Similarity=0.307  Sum_probs=210.4

Q ss_pred             EEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeee
Q 042681           22 QYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVK  100 (339)
Q Consensus        22 ~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~  100 (339)
                      .-+..|..+.|++.-..+.+.|++|||+.||+|++...|..||+|++-..  +......+.+|+.+|+.|+ |+|||.++
T Consensus        24 ~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yi  101 (738)
T KOG1989|consen   24 ENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYI  101 (738)
T ss_pred             ccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEe
Confidence            44556677777777777799999999999999999998899999998654  6667888999999999996 99999999


Q ss_pred             ee-cCCCCcCC-cCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeeecc
Q 042681          101 DI-IPPMDKEK-FNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNA  173 (339)
Q Consensus       101 ~~-~~~~~~~~-~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dikp~NIli~~  173 (339)
                      +. ........ ...+.|+||||. |+|.+++.++  .++++.++++|+.|+++||.+||...  |+|||||-+||||+.
T Consensus       102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~  181 (738)
T KOG1989|consen  102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA  181 (738)
T ss_pred             ccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC
Confidence            93 32221122 245899999999 7999999853  56999999999999999999999998  999999999999999


Q ss_pred             CCCeEEeecccccc--------------------cCCCCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcc
Q 042681          174 NCDLKICDFGLART--------------------TSETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDL  230 (339)
Q Consensus       174 ~~~ikL~Dfg~~~~--------------------~~~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~  230 (339)
                      +|+.||||||.++.                    ..++.|.+||.+.   .++...+.|+|++||.+|.++....||+.-
T Consensus       182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            99999999999853                    3345688887554   557888999999999999999999998754


Q ss_pred             cccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC--------CCCCCCc
Q 042681          231 GFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH--------PYLSSLH  295 (339)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h--------p~f~~~~  295 (339)
                      +...-        .......++    ++.++..+++||+.||+.||++||++.|++.+        +++.++.
T Consensus       262 g~laI--------lng~Y~~P~----~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  262 GKLAI--------LNGNYSFPP----FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             cceeE--------EeccccCCC----CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence            32211        111122221    25689999999999999999999999999864        5665555

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.6e-39  Score=276.36  Aligned_cols=243  Identities=20%  Similarity=0.337  Sum_probs=199.5

Q ss_pred             cccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecC
Q 042681           43 IGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM  121 (339)
Q Consensus        43 lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~  121 (339)
                      ||.|++|.||++.+..+++.+++|++.+... .....+.+.+|+.+++.++||||+++++.+     ......++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            6999999999999999999999999976432 233457789999999999999999999998     6667899999999


Q ss_pred             c-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC----------
Q 042681          122 D-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----------  190 (339)
Q Consensus       122 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~----------  190 (339)
                      + ++|.+++.+...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....          
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~  155 (262)
T cd05572          76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT  155 (262)
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence            7 79999998888899999999999999999999999999999999999999999999999999875433          


Q ss_pred             CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHH
Q 042681          191 TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAER  270 (339)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  270 (339)
                      ..|.+|+...........|+|++|++++++++|..|+..............   ..........   ...+++++++|.+
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~~i~~  229 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI---LKGNGKLEFP---NYIDKAAKDLIKQ  229 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH---hccCCCCCCC---cccCHHHHHHHHH
Confidence            346777776666677789999999999999999998765432111111111   1101111111   2357899999999


Q ss_pred             hcccCCCCCCC-----HHHHhcCCCCCCCcc
Q 042681          271 MLVFDPAKRIT-----VEEALNHPYLSSLHE  296 (339)
Q Consensus       271 ~L~~dP~~Rps-----~~ell~hp~f~~~~~  296 (339)
                      ||+.+|++||+     ++|+++||||++..+
T Consensus       230 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         230 LLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             HccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence            99999999999     999999999998765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-40  Score=291.42  Aligned_cols=240  Identities=20%  Similarity=0.333  Sum_probs=192.5

Q ss_pred             cccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhC---CCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           43 IGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHM---THENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        43 lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l---~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ||+|+||.||+|++..+|+.+|+|++.+.. ...........|..++...   .||+|+++++++     .....+++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            699999999999999999999999986542 2223344556677777665   699999999999     6677899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...         
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            9997 799999988889999999999999999999999999999999999999999999999999987542         


Q ss_pred             --CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          189 --SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       189 --~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                        +...|++||.... .....+.|+|++|+++|++++|..|+......  ............     ..  ...++++++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~-----~~--~~~~~~~~~  226 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QMYRNIAFGKVR-----FP--KNVLSDEGR  226 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--HHHHHHHcCCCC-----CC--CccCCHHHH
Confidence              3345788886643 34678899999999999999999987542111  111111111111     10  124789999


Q ss_pred             HHHHHhcccCCCCCC----CHHHHhcCCCCCCCcc
Q 042681          266 DLAERMLVFDPAKRI----TVEEALNHPYLSSLHE  296 (339)
Q Consensus       266 ~li~~~L~~dP~~Rp----s~~ell~hp~f~~~~~  296 (339)
                      +||++||+.||.+||    ++.++++||||....+
T Consensus       227 ~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             HHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence            999999999999998    7999999999987653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=292.95  Aligned_cols=288  Identities=23%  Similarity=0.327  Sum_probs=237.5

Q ss_pred             cccCCCccccCCceEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHH
Q 042681            7 VMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREI   85 (339)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~   85 (339)
                      ++.++....|...+++|.+++. +-++.+++..-+.||+||||.|+-++-+.||+-||+|++.+. ...+......++|.
T Consensus       158 pF~~f~~S~yf~rFlQWK~lE~-qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk  236 (591)
T KOG0986|consen  158 PFQEFLESDYFTRFLQWKWLEL-QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEK  236 (591)
T ss_pred             hHhHhHHHHHHHHHHHHHHHHh-hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHH
Confidence            3455556677788888998887 777778777789999999999999999999999999998655 23333456678999


Q ss_pred             HHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 042681           86 KLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHR  162 (339)
Q Consensus        86 ~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~  162 (339)
                      .+|..++.+.|+.+--.|     ++...+|+|+..+. |+|.-++.+.+  .+++..+.-++.+|+.||++||+.+||+|
T Consensus       237 ~iL~kV~s~FiVslaYAf-----eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYR  311 (591)
T KOG0986|consen  237 QILEKVSSPFIVSLAYAF-----ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYR  311 (591)
T ss_pred             HHHHHhccCcEEEEeeee-----cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeec
Confidence            999999999999998888     78889999999997 79988887765  79999999999999999999999999999


Q ss_pred             CCCCCCeeeccCCCeEEeecccccc----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccc
Q 042681          163 DLKPSNLLLNANCDLKICDFGLART----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGF  232 (339)
Q Consensus       163 dikp~NIli~~~~~ikL~Dfg~~~~----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~  232 (339)
                      ||||+|||+|+.|+++|+|+|+|..          .|+..|++|++.....+.+..|.|++||.+|+|+.|..||.....
T Consensus       312 DLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke  391 (591)
T KOG0986|consen  312 DLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE  391 (591)
T ss_pred             cCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence            9999999999999999999999853          566789999999988899999999999999999999999754322


Q ss_pred             cccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccCC------CCC
Q 042681          233 LRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEIN------EEP  301 (339)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~~------~~~  301 (339)
                      ...   .+-+.........   +...++|++++++.+.+|++||++|.     ++.++.+||||++++|..      .+|
T Consensus       392 Kvk---~eEvdrr~~~~~~---ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PP  465 (591)
T KOG0986|consen  392 KVK---REEVDRRTLEDPE---EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPP  465 (591)
T ss_pred             hhh---HHHHHHHHhcchh---hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCC
Confidence            111   1111111111111   22246899999999999999999998     678999999999999854      455


Q ss_pred             CCCCC
Q 042681          302 TCPYP  306 (339)
Q Consensus       302 ~~~~~  306 (339)
                      .+|.|
T Consensus       466 fiPdp  470 (591)
T KOG0986|consen  466 FIPDP  470 (591)
T ss_pred             CCCCc
Confidence            55555

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.3e-39  Score=276.65  Aligned_cols=246  Identities=22%  Similarity=0.317  Sum_probs=197.9

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccC----hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN----RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      |.. .+.||+|++|.||++.+..+++.+|+|++......    ....+.+.+|+.+++.++||||+++++++     ...
T Consensus         2 ~~~-~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           2 WLK-GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             ccc-cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            444 78899999999999999999999999998754321    12356788999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC-CeEEeecccccccC
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTS  189 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~-~ikL~Dfg~~~~~~  189 (339)
                      +..++|+||+. ++|.+++.+.+++++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            78999999998 68999998888899999999999999999999999999999999999998776 59999999986543


Q ss_pred             ---------------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          190 ---------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       190 ---------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                                     ...|.+|+.........+.|+|++|++++++++|..|+........  ..............   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~---  230 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFKIASATTAP---  230 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHHHhccCCCC---
Confidence                           2246677766656677889999999999999999988753322111  11111111111111   


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                      .....+++++++++.+||..+|.+||++.++++||||+
T Consensus       231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            11134789999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.2e-39  Score=278.76  Aligned_cols=249  Identities=19%  Similarity=0.292  Sum_probs=197.2

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. ++.||+|++|.||++.+..+++.+|+|.+.... .......+.+|+.++.+++||||+++++.+     ......+
T Consensus         3 ~~~-~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   75 (279)
T cd06619           3 IQY-QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAF-----FVENRIS   75 (279)
T ss_pred             chh-eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EECCEEE
Confidence            444 889999999999999999999999999986542 233456788999999999999999999999     6667889


Q ss_pred             EEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc------
Q 042681          116 IVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT------  188 (339)
Q Consensus       116 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~------  188 (339)
                      +||||+++ +|..+    ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...      
T Consensus        76 lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~  151 (279)
T cd06619          76 ICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK  151 (279)
T ss_pred             EEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccccc
Confidence            99999985 55433    45789999999999999999999999999999999999999999999999998643      


Q ss_pred             ---CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc-hHHHHHhhCCCCCCCCccccCCCCCHHH
Q 042681          189 ---SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD-NARRYVKQLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       189 ---~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~  264 (339)
                         +...|.+|+.........+.|+|++|++++++++|..|+......... .................  .....++++
T Consensus       152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  229 (279)
T cd06619         152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL--PVGQFSEKF  229 (279)
T ss_pred             CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC--CCCcCCHHH
Confidence               233577888777667788999999999999999999987543211111 00111111111111111  113478899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          265 IDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ++++.+||+.+|.+||++.++++||||......
T Consensus       230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~  262 (279)
T cd06619         230 VHFITQCMRKQPKERPAPENLMDHPFIVQYNDG  262 (279)
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence            999999999999999999999999999887543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.9e-39  Score=301.44  Aligned_cols=254  Identities=21%  Similarity=0.262  Sum_probs=205.8

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc---
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK---  108 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~---  108 (339)
                      ..++|.+ .+.||+|+||.||++.+..+|+.||+|++............+.+|+..+..++|+||+++++.+.....   
T Consensus        30 ~~~rY~i-~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         30 QAKKYWI-SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             cCCCEEE-EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3467777 999999999999999999999999999997765556666778899999999999999999887743211   


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                      .....+++||||++ |+|.+++..    ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence            11124789999998 799998864    3579999999999999999999999999999999999999999999999999


Q ss_pred             ccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          184 LARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       184 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      +++..             ++..|++||......+..+.|+|++|+++|++++|..|+....      .............
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~~~~  262 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLAGRY  262 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhcCCC
Confidence            98543             3345888988877778889999999999999999999875421      1111111111111


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      .   ...+.+++++.+|+.+||+.||.+||++.++++|||++...
T Consensus       263 ~---~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        263 D---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             C---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence            1   12246889999999999999999999999999999987653

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.8e-39  Score=282.18  Aligned_cols=252  Identities=33%  Similarity=0.518  Sum_probs=197.1

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. .+.||.|++|.||+|.+..+++.+++|.++...........+.+|+.++..++||||+++++++..   .....
T Consensus         5 ~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---~~~~~   80 (293)
T cd07843           5 DEYEK-LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG---SNLDK   80 (293)
T ss_pred             hhhhh-hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe---cCCCc
Confidence            45666 899999999999999999999999999997654333334567789999999999999999998832   22378


Q ss_pred             EEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC-
Q 042681          114 VYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET-  191 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~-  191 (339)
                      .++|+||++++|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        81 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          81 IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            9999999999999988764 45999999999999999999999999999999999999999999999999988754432 


Q ss_pred             ----------Ccccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh--------------CC
Q 042681          192 ----------DFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ--------------LP  246 (339)
Q Consensus       192 ----------~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~--------------~~  246 (339)
                                .|.+|+..... ....+.|+|++|++++++++|.+++........  .......              ..
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ--LNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCchHHHHHhhccc
Confidence                      36677765432 346789999999999999999988764332111  0110000              00


Q ss_pred             C--------CCCCCccccCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          247 H--------VPKQPFSQKFPN--MSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       247 ~--------~~~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      .        .........++.  +++.++++|++||+.+|++|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            0        000111122233  48899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.3e-39  Score=277.25  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=203.5

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. .+.||.|++|.||++.+..+++.+++|.+..... ......+.+|+.+++.++||||+++++.+     ......+
T Consensus         3 ~~~-~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (265)
T cd06605           3 LEY-LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDIS   75 (265)
T ss_pred             chH-HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEE
Confidence            444 8899999999999999999999999999876533 34557788999999999999999999998     5568899


Q ss_pred             EEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          116 IVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +++||++ ++|.+++... ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+...    
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            9999998 7999999776 789999999999999999999999 99999999999999999999999999987543    


Q ss_pred             -----CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          189 -----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       189 -----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                           +...|.+|+...........|+|++|++++++++|..|+.......... .................  ..++.+
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~  232 (265)
T cd06605         156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-FELLQYIVNEPPPRLPS--GKFSPD  232 (265)
T ss_pred             hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-HHHHHHHhcCCCCCCCh--hhcCHH
Confidence                 3345788887777778888999999999999999998876442111111 11111111111111111  117889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          264 AIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      ++++|.+||..||++|||+.+++.||||+..+
T Consensus       233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            99999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.2e-39  Score=277.28  Aligned_cols=244  Identities=26%  Similarity=0.319  Sum_probs=196.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. .+.||+|+||.||+|.+..+++.+|+|.++...  ......+.+|+.+++.++||||+++++.+     .....
T Consensus         9 ~~~~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~   80 (267)
T cd06645           9 EDFEL-IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDK   80 (267)
T ss_pred             HHHHH-HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCE
Confidence            35555 899999999999999999999999999986542  23345678899999999999999999998     66678


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      ++++|||++ ++|.+++...+.+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+...    
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            999999998 699999988889999999999999999999999999999999999999999999999999987543    


Q ss_pred             -------CCCCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          189 -------SETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       189 -------~~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                             +...|.+|+...   ......++|+|++|++++++++|..|+......  ....  ............ ....
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--~~~~--~~~~~~~~~~~~-~~~~  235 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--RALF--LMTKSNFQPPKL-KDKM  235 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--hhHH--hhhccCCCCCcc-cccC
Confidence                   233577787643   334667899999999999999999886533211  1111  111111111111 1112


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPY  290 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  290 (339)
                      .++..++++|.+||+.+|++||++.++++|||
T Consensus       236 ~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            47889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.7e-39  Score=281.93  Aligned_cols=255  Identities=33%  Similarity=0.479  Sum_probs=197.1

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. .+.||+|+||.||++.+..+++.||+|++............+.+|+.++..+. ||||+++++++..........
T Consensus         2 ~y~~-~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           2 AYEK-LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CceE-eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4666 88999999999999999999999999998765433334466788999999995 699999999985433222334


Q ss_pred             EEEEEecCcccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-CCCeEEeecccccc
Q 042681          114 VYIVYELMDTDLHQIIRSK-----QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLART  187 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-~~~ikL~Dfg~~~~  187 (339)
                      .+++|||++++|.+++...     ..+++..++.++.||+.||.|||++|++||||+|+||+++. ++.++|+|||.+..
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            8999999999998887542     45899999999999999999999999999999999999998 88999999998865


Q ss_pred             cC-----------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh-----------
Q 042681          188 TS-----------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ-----------  244 (339)
Q Consensus       188 ~~-----------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~-----------  244 (339)
                      ..           ...|.+|+.... .....+.|+|++|++++++++|..++.......  ........           
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCChhhCcc
Confidence            32           224677776543 345778999999999999999998875432111  00111110           


Q ss_pred             ---------CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          245 ---------LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       245 ---------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                               .............+.+++++.+||.+||..||.+||++.+++.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                     011111111222356889999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1e-38  Score=276.21  Aligned_cols=246  Identities=22%  Similarity=0.323  Sum_probs=196.8

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC---hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN---RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ..|.. .+.||+|++|.||++.+..+++.+++|++......   ......+.+|+.+++.++||||+++++++..   ..
T Consensus         2 ~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~   77 (266)
T cd06651           2 INWRR-GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RA   77 (266)
T ss_pred             CCccc-cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CC
Confidence            34555 89999999999999999999999999998654322   2334568899999999999999999998842   23


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ...+++++||++ ++|.+.+...+.+++...+.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          78 EKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            457899999997 6999999887889999999999999999999999999999999999999999999999999875432


Q ss_pred             --------------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          190 --------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       190 --------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                                    ...|.+|+.........+.|+|++|++++++++|..|+.....     ..............   .
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~---~  229 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----MAAIFKIATQPTNP---Q  229 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----HHHHHHHhcCCCCC---C
Confidence                          2246778777666677889999999999999999998764321     11111111111111   1


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                      ....+++.+++++ +||..+|++||+++++++||||+
T Consensus       230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         230 LPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            1134688899999 57778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.5e-39  Score=280.23  Aligned_cols=249  Identities=34%  Similarity=0.490  Sum_probs=198.1

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. .+.||.|++|.||+|.+..+|+.+|+|++............+.+|+.+++.++||||+++++++     ......+
T Consensus         2 y~~-~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           2 YKI-LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             ceE-EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            555 8899999999999999999999999999976544444557788999999999999999999999     5677899


Q ss_pred             EEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC----
Q 042681          116 IVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----  190 (339)
Q Consensus       116 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~----  190 (339)
                      +|+||++++|.+++.. ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....    
T Consensus        76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9999998899998865 46799999999999999999999999999999999999999999999999998865432    


Q ss_pred             --------CCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC---------------
Q 042681          191 --------TDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP---------------  246 (339)
Q Consensus       191 --------~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~---------------  246 (339)
                              ..|.+||.... .....+.|+|++|++++++++|.+++.....  ............               
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCcch
Confidence                    23666776533 3356789999999999999999766543211  111111111100               


Q ss_pred             -------CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          247 -------HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       247 -------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                             ...........+..+.++.+||++||+.+|++|||++++++||||.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                   0011111223356789999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.7e-39  Score=279.07  Aligned_cols=248  Identities=24%  Similarity=0.389  Sum_probs=193.9

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHH-HhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL-LCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.+ ++.||+|+||.||++++..+|+.||+|++....... ....+..|+.. ++.++||||+++++++     .....
T Consensus         2 ~~~~-~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~-----~~~~~   74 (283)
T cd06617           2 DLEV-IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGAL-----FREGD   74 (283)
T ss_pred             CceE-EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEE-----ecCCc
Confidence            4555 889999999999999999999999999987653333 23455556665 5667899999999999     56677


Q ss_pred             EEEEEecCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          114 VYIVYELMDTDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      .+++|||++|+|.+++..    ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||.+...
T Consensus        75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            999999999988877754    35789999999999999999999997 9999999999999999999999999998643


Q ss_pred             C----------CCCccccccccc----cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 S----------ETDFMTEYVVTR----WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 ~----------~~~~~~~~~~~~----~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      .          ...|.+|+....    .....+.|+|++|++++++++|..|+...... .........    ...... 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~----~~~~~~-  228 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVVE----EPSPQL-  228 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHHh----cCCCCC-
Confidence            2          234667775533    23467899999999999999999887543211 111111111    111111 


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                       ....+|.+++++|.+||..+|.+||++.++++||||.....
T Consensus       229 -~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         229 -PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             -CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence             11247899999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=282.73  Aligned_cols=252  Identities=19%  Similarity=0.317  Sum_probs=204.2

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC-hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. .+.||+|++|.||+|.+..+++.+|+|.+...... ....+.+.+|+.++..++||||+++++.+     .....
T Consensus         2 ~y~~-~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   75 (316)
T cd05574           2 HFKK-IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY   75 (316)
T ss_pred             ceEE-eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence            4555 78999999999999999999999999999765333 23556788999999999999999999998     66778


Q ss_pred             EEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          114 VYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      .+++|||+. ++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+...  
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999997 6999988753  57999999999999999999999999999999999999999999999999987542  


Q ss_pred             --------------------------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcc
Q 042681          189 --------------------------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDL  230 (339)
Q Consensus       189 --------------------------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~  230 (339)
                                                            +...|.+|+.........+.|+|++|++++++++|..|+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence                                                  223467777776666777899999999999999999987533


Q ss_pred             cccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCCCCCCCccCCCC
Q 042681          231 GFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRIT----VEEALNHPYLSSLHEINEE  300 (339)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps----~~ell~hp~f~~~~~~~~~  300 (339)
                      ...  .......   ......   ......+++++++|.+||..||++|||    +.+++.||||++..+....
T Consensus       236 ~~~--~~~~~~~---~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~  301 (316)
T cd05574         236 NRD--ETFSNIL---KKEVTF---PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR  301 (316)
T ss_pred             chH--HHHHHHh---cCCccC---CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence            211  1111111   111111   111236899999999999999999999    9999999999998876543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-38  Score=275.06  Aligned_cols=241  Identities=26%  Similarity=0.381  Sum_probs=196.8

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh-------HhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR-------IDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      |.. ...||.|++|.||+|.+..+++.+|+|.+.......       ...+.+.+|+.+++.++||||+++++++     
T Consensus         2 ~~~-~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----   75 (267)
T cd06628           2 WIK-GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS-----   75 (267)
T ss_pred             ccc-cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence            444 788999999999999999999999999886543221       1235678999999999999999999998     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ......++++||++ ++|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||++++++.++|+|||.+..
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            56678899999997 69999998888899999999999999999999999999999999999999999999999998765


Q ss_pred             cC-----------------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          188 TS-----------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       188 ~~-----------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      ..                 ...|.+|+...........|+|++|++++++++|..|+......     ........ ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~  229 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QAIFKIGE-NAS  229 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HHHHHHhc-cCC
Confidence            43                 22366777666666677899999999999999999987643211     11111111 111


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      .   .....++..+.++|++||+.||++||++.++++||||
T Consensus       230 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         230 P---EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             C---cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            1   1113578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=269.25  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=206.9

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      |....+.||+|+|+.|-.+....+|..||||++.+.  ......++.+|++++.+. .|+||++++++|     ++....
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~F  151 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRF  151 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceE
Confidence            444467899999999999999999999999999765  444578899999999998 499999999999     778889


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC---CeEEeecccccc---
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC---DLKICDFGLART---  187 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~---~ikL~Dfg~~~~---  187 (339)
                      |+|||.+. |.|+.++.+++.+++.++.+++.+|+.||.|||.+||+|||+||+|||-.+.+   -+|||||.++..   
T Consensus       152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~  231 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL  231 (463)
T ss_pred             EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence            99999997 79999999999999999999999999999999999999999999999997554   489999977632   


Q ss_pred             ---------------cCCCCcccccccc-----ccccCCCCccHHHHHHHHHHHhCCCCCCcc-----cccccchH----
Q 042681          188 ---------------TSETDFMTEYVVT-----RWDTLFPGKDYVQQLTMITELLGSPDDSDL-----GFLRSDNA----  238 (339)
Q Consensus       188 ---------------~~~~~~~~~~~~~-----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~-----~~~~~~~~----  238 (339)
                                     .|...|++|++..     ...+..+-|.|++|+++|.|+.|.+||...     +...+...    
T Consensus       232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ  311 (463)
T KOG0607|consen  232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ  311 (463)
T ss_pred             CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence                           2233466666543     234666788999999999999999999533     22222211    


Q ss_pred             HHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      ...+..+.......-...|..+|.+.++||..+|..|+.+|.++.+++.|||++.+...+
T Consensus       312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek  371 (463)
T KOG0607|consen  312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK  371 (463)
T ss_pred             HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence            122222222222222345677999999999999999999999999999999999887643

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=310.89  Aligned_cols=252  Identities=23%  Similarity=0.352  Sum_probs=211.2

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.+ ++.||+|+||.|.+++++.|++.||+|++++- ...+.+.+-|..|..+|..-+.+=|+.++-.|     .+..
T Consensus        75 ~Dfei-lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~  148 (1317)
T KOG0612|consen   75 EDFEI-LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER  148 (1317)
T ss_pred             HhhHH-HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence            44444 99999999999999999999999999999763 34456678899999999999999999999999     7788


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc----
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----  187 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~----  187 (339)
                      ++|+||||++ |+|..++.+..+++++.++-|+..|+.||..||+.|+|||||||+|||||..|++||.|||.|.+    
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            9999999997 79999999988999999999999999999999999999999999999999999999999999854    


Q ss_pred             --------cCCCCccccccccc-----cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          188 --------TSETDFMTEYVVTR-----WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       188 --------~~~~~~~~~~~~~~-----~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                              +|+|.|.+|++...     ..++..-|+|++|+++|+|+.|.-||..-...  ..+.++......   ..++
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv--eTY~KIm~hk~~---l~FP  303 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV--ETYGKIMNHKES---LSFP  303 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH--HHHHHHhchhhh---cCCC
Confidence                    56788999987653     34667789999999999999999997543222  122222222111   1122


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCccCC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRIT---VEEALNHPYLSSLHEIN  298 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~~~~~~~  298 (339)
                      . -..+|+++++||++++. +|+.|.+   ++++..||||.++.|..
T Consensus       304 ~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~  348 (1317)
T KOG0612|consen  304 D-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDN  348 (1317)
T ss_pred             c-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhh
Confidence            1 13589999999999887 8889998   99999999999999954

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.2e-39  Score=286.36  Aligned_cols=240  Identities=22%  Similarity=0.342  Sum_probs=187.8

Q ss_pred             CccCCCccccccccceEEEEEEe-----CCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVN-----SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMD  107 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~  107 (339)
                      ++|.+ ++.||+|+||.||+|.+     ..+++.||+|++... ........+.+|+.++..+ +||||+++++++.   
T Consensus         7 ~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---   81 (338)
T cd05102           7 DRLRL-GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACT---   81 (338)
T ss_pred             hHcee-eeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEec---
Confidence            34554 89999999999999975     234578999998643 2233456789999999999 8999999999873   


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhc------------------------------------------------------
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSK------------------------------------------------------  132 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~------------------------------------------------------  132 (339)
                       .....++++|||++ |+|.+++...                                                      
T Consensus        82 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          82 -KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             -CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence             33456899999998 7999888642                                                      


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-------------CC
Q 042681          133 --------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-------------ET  191 (339)
Q Consensus       133 --------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-------------~~  191 (339)
                              .++++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++...             ..
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                    247788899999999999999999999999999999999999999999999986431             12


Q ss_pred             CccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHH
Q 042681          192 DFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAER  270 (339)
Q Consensus       192 ~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  270 (339)
                      .|++||......+..++|+|++|+++|++++ |..|+......  .........   .....   ....+++++++|+.+
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~---~~~~~---~~~~~~~~l~~li~~  312 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQRLKD---GTRMR---APENATPEIYRIMLA  312 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHhc---CCCCC---CCCCCCHHHHHHHHH
Confidence            4778887776677889999999999999996 88886543211  111111111   11111   113578999999999


Q ss_pred             hcccCCCCCCCHHHHhc
Q 042681          271 MLVFDPAKRITVEEALN  287 (339)
Q Consensus       271 ~L~~dP~~Rps~~ell~  287 (339)
                      ||+.||.+|||+.++++
T Consensus       313 cl~~dp~~RPs~~el~~  329 (338)
T cd05102         313 CWQGDPKERPTFSALVE  329 (338)
T ss_pred             HccCChhhCcCHHHHHH
Confidence            99999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.8e-38  Score=271.93  Aligned_cols=242  Identities=23%  Similarity=0.347  Sum_probs=197.5

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. .+.||+|++|.||++.+..+++.+|+|++..........+.+.+|+.+++.++|||++++++.+.    .....++
T Consensus         2 y~~-~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           2 YCF-VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             ceE-EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            445 89999999999999999999999999999765445555667889999999999999999998872    2345689


Q ss_pred             EEEecCc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          116 IVYELMD-TDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +++||++ ++|.+.+..  ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+...    
T Consensus        77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            9999997 689888875  346899999999999999999999999999999999999999999999999988543    


Q ss_pred             -------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          189 -------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                             +...|.+||.........+.|+|++|++++++++|..++.....      ..............   ....++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~---~~~~~~  227 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEGKLPP---MPKDYS  227 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcCCCC---CccccC
Confidence                   23457788887777777889999999999999999988653211      11111111111111   113578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      +++.+++.+||+.||++||++.++++||||
T Consensus       228 ~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         228 PELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.4e-38  Score=278.04  Aligned_cols=247  Identities=20%  Similarity=0.309  Sum_probs=199.3

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccC-hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      .+.||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.++|++|+++++.+     ......+++|
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~   79 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALCLVL   79 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEEEEE
Confidence            67899999999999999999999999998654322 22345678899999999999999999998     5667899999


Q ss_pred             ecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-------
Q 042681          119 ELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-------  188 (339)
                      ||+. ++|.+.+...  .++++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++...       
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR  159 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence            9998 6888777543  46999999999999999999999999999999999999999999999999988542       


Q ss_pred             ---CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          189 ---SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       189 ---~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                         +...|.+|+...........|+|++|++++++++|..|+.......  ............. .   ...+.++.++.
T Consensus       160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~~~~~~~~-~---~~~~~~~~~~~  233 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVDRRVLETE-E---VYSAKFSEEAK  233 (285)
T ss_pred             CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhhccc-c---ccCccCCHHHH
Confidence               2345778888766677888999999999999999999875432110  1111111111111 1   11245789999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhcCCCCCCCccC
Q 042681          266 DLAERMLVFDPAKRIT-----VEEALNHPYLSSLHEI  297 (339)
Q Consensus       266 ~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~~  297 (339)
                      +|+.+||+.||.+||+     +.+++.||||+...+.
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             HHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence            9999999999999999     8999999999998554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.6e-38  Score=271.03  Aligned_cols=238  Identities=24%  Similarity=0.326  Sum_probs=198.0

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||+|++|.||++.+..+++.+++|.+............+.+|+.+++.++||||+++++++     ......++|||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e   79 (256)
T cd08529           5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLNIVME   79 (256)
T ss_pred             eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEEEEEE
Confidence            7889999999999999999999999999876545556677889999999999999999999998     56678999999


Q ss_pred             cCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-------
Q 042681          120 LMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-------  189 (339)
Q Consensus       120 ~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-------  189 (339)
                      |++ ++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....       
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            997 6999988763  679999999999999999999999999999999999999999999999999876532       


Q ss_pred             ----CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          190 ----ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       190 ----~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                          ...|.+|+.........++|+|++|++++++++|..|+....  ........    ........   ...++.++.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~----~~~~~~~~---~~~~~~~~~  230 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGALILKI----IRGVFPPV---SQMYSQQLA  230 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH----HcCCCCCC---ccccCHHHH
Confidence                234677887776677788999999999999999999875432  11111111    11111111   124789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          266 DLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       266 ~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      +++.+||+.+|++||++.++++|||+
T Consensus       231 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         231 QLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHHccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=278.37  Aligned_cols=247  Identities=34%  Similarity=0.534  Sum_probs=197.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||.|++|.||++.+..+|+.+|+|++............+.+|+.+++.++|||++++++++     ......++++|
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~iv~e   78 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYLVFE   78 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEEEEe
Confidence            7889999999999999999999999999876543343446678899999999999999999998     56688999999


Q ss_pred             cCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC--------
Q 042681          120 LMDTDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--------  189 (339)
Q Consensus       120 ~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~--------  189 (339)
                      |++++|.+++....  .+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+...+        
T Consensus        79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            99999999987755  79999999999999999999999999999999999999999999999999986542        


Q ss_pred             ---CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccch-------------------HHHHHhhCC
Q 042681          190 ---ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN-------------------ARRYVKQLP  246 (339)
Q Consensus       190 ---~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~-------------------~~~~~~~~~  246 (339)
                         ...|.+|+.... ......+|+|++|++++++++|.+++..........                   .........
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP  238 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence               223667775533 345677999999999999999998875432110000                   000011111


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       247 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ...........+.++..+.++|.+||+.+|.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            112222223345688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.6e-39  Score=283.72  Aligned_cols=245  Identities=26%  Similarity=0.380  Sum_probs=183.7

Q ss_pred             ccccccccceEEEEEEeCC--CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSE--TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      .+.||+|+||.||+|....  +++.+|+|.+....    ....+.+|+.+++.++||||+++++++..   ......+++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEE
Confidence            5679999999999999653  66889999886532    22456789999999999999999998843   344678999


Q ss_pred             EecCcccHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee----ccCCCeEEeeccc
Q 042681          118 YELMDTDLHQIIRS---------KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGL  184 (339)
Q Consensus       118 ~e~~~g~L~~~l~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli----~~~~~ikL~Dfg~  184 (339)
                      +||++++|.+++..         ...+++..++.++.||+.||.|||+.|++||||||+||++    +.++.++|+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            99999999888752         1358899999999999999999999999999999999999    4567899999999


Q ss_pred             ccccC--------------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccc-------cchHHHHH
Q 042681          185 ARTTS--------------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR-------SDNARRYV  242 (339)
Q Consensus       185 ~~~~~--------------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~-------~~~~~~~~  242 (339)
                      ++...              +..|.+||.... .....++|+|++|++++++++|.+++.......       ........
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            86532              224777886644 345677999999999999999998874321100       00000000


Q ss_pred             hhCCCCC--------------------------CCC----ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          243 KQLPHVP--------------------------KQP----FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       243 ~~~~~~~--------------------------~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      .......                          ...    ........+..+.+||.+||+.||.+|||++|+++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000000                          000    000112345678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.3e-38  Score=274.11  Aligned_cols=244  Identities=26%  Similarity=0.284  Sum_probs=194.1

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||.||++.+..+++.+|+|++....  ......+.+|+.++..++||||+++++.+     .....
T Consensus         9 ~~y~~-~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-----~~~~~   80 (267)
T cd06646           9 HDYEL-IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSY-----LSREK   80 (267)
T ss_pred             hhcch-hheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEE-----EeCCE
Confidence            34666 999999999999999999999999999986442  22345678899999999999999999998     56678


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      +++||||++ ++|.+++...+++++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+....   
T Consensus        81 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          81 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999998 6999998888889999999999999999999999999999999999999999999999999886442   


Q ss_pred             --------CCCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          190 --------ETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       190 --------~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                              ...|.+|+...   ......+.|+|++|++++++++|..|+......  ......  ........ ......
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~--~~~~~~--~~~~~~~~-~~~~~~  235 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--RALFLM--SKSNFQPP-KLKDKT  235 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--hhheee--ecCCCCCC-CCcccc
Confidence                    22466777552   233556799999999999999999886432111  000000  00111111 111123


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPY  290 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  290 (339)
                      .++..+++||++||+.+|++||+++++++|+|
T Consensus       236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            47899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-39  Score=288.98  Aligned_cols=248  Identities=25%  Similarity=0.340  Sum_probs=211.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +.|.+ .++||+|.|+.|.++.+..||..||+|.+.+...+....+.+.+|++++..|+||||++++.+.     .....
T Consensus        56 g~y~i-~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~~~  129 (596)
T KOG0586|consen   56 GLYVI-IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETEAT  129 (596)
T ss_pred             cceee-eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eecce
Confidence            34445 9999999999999999999999999999999888887778899999999999999999999999     77788


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +|+||||+. |.+++++.+.+++.+..+..++.|++.|++|||+++|||||||++||+++.+.++||+|||++..+    
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence            999999997 799999999999999999999999999999999999999999999999999999999999999654    


Q ss_pred             ------CCCCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          189 ------SETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       189 ------~~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                            +.++|++||+.... +..+..|.|++|.++|.++.|..|+.+-.......         ......+. ..-.++
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------rvl~gk~r-Ip~~ms  279 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------RVLRGKYR-IPFYMS  279 (596)
T ss_pred             cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------hheeeeec-ccceee
Confidence                  44568888766544 56778999999999999999999976432111110         00011111 112378


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      .++.++|+++|..+|.+|++.+++.+|+|+....+.
T Consensus       280 ~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  280 CDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             chhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            899999999999999999999999999999988775

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.4e-38  Score=279.30  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=202.8

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. ++.||+|+||.||++.+..+++.+++|.+..... .......+.+|+.+++.++||||+++++.+     .....
T Consensus         2 ~y~~-~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (305)
T cd05609           2 DFET-IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH   75 (305)
T ss_pred             CceE-eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence            4555 8899999999999999999999999999875422 233456788999999999999999999998     66778


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc-----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----  187 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~-----  187 (339)
                      ++++|||++ ++|.+++...+.+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.++.     
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999998 69999998888899999999999999999999999999999999999999999999999998752     


Q ss_pred             ---------------------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC
Q 042681          188 ---------------------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP  246 (339)
Q Consensus       188 ---------------------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  246 (339)
                                           .+...|.+|+.........+.|+|++|++++++++|..|+....  .............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--~~~~~~~~~~~~~  233 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--PEELFGQVISDDI  233 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccc
Confidence                                 12224677777666667888999999999999999998875321  1111111111111


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCccCC
Q 042681          247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRIT---VEEALNHPYLSSLHEIN  298 (339)
Q Consensus       247 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~~~~~~~  298 (339)
                      ..+.     ....++.+++++|.+||+.+|++||+   +.++++||||....+..
T Consensus       234 ~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~  283 (305)
T cd05609         234 EWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG  283 (305)
T ss_pred             CCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence            1111     11257899999999999999999997   79999999998877653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-39  Score=280.25  Aligned_cols=250  Identities=32%  Similarity=0.505  Sum_probs=194.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|++|.||++.++.+++.||+|.+....... ....+.+|+.+++.++||||+++++++     .....
T Consensus         5 ~~y~~-~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~   77 (291)
T cd07844           5 ETYKK-LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDII-----HTKKT   77 (291)
T ss_pred             cceeE-EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCe
Confidence            55666 899999999999999999999999999987543221 224567899999999999999999998     66678


Q ss_pred             EEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          114 VYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      .++||||++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+....   
T Consensus        78 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          78 LTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9999999999999988653 578999999999999999999999999999999999999999999999999886432   


Q ss_pred             --------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC-------------
Q 042681          190 --------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH-------------  247 (339)
Q Consensus       190 --------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~-------------  247 (339)
                              ...|.+|+.... .....++|+|++|++++++++|..++...... .............             
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-EDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHHHhcCCCChhhhhhhhhcc
Confidence                    223666775533 34567899999999999999999887543211 1111111110000             


Q ss_pred             ---------CCCCCccccCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          248 ---------VPKQPFSQKFPNMS--PVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       248 ---------~~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                               ..........+.++  .++.+++.+||+.+|.+|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                     00111111223344  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2e-38  Score=275.96  Aligned_cols=245  Identities=25%  Similarity=0.348  Sum_probs=197.5

Q ss_pred             cccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecC
Q 042681           43 IGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM  121 (339)
Q Consensus        43 lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~  121 (339)
                      ||+|+||+||+|.+..+|+.+++|.+..... .......+.+|+.+++.++||||+++++++     ...+..|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            6999999999999999999999999865422 222345667899999999999999999998     6667899999999


Q ss_pred             c-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---------
Q 042681          122 D-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---------  189 (339)
Q Consensus       122 ~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---------  189 (339)
                      + ++|.+++.+.+  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....         
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA  155 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence            8 69999887655  79999999999999999999999999999999999999999999999999886432         


Q ss_pred             -CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHH
Q 042681          190 -ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA  268 (339)
Q Consensus       190 -~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  268 (339)
                       ...|.+|+...........|+|++|++++++++|..|+........  .......... ..   ....+.++++++++|
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~-~~---~~~~~~~~~~~~~li  229 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEELKRRTLE-MA---VEYPDKFSPEAKDLC  229 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHHHHhcccc-cc---ccCCccCCHHHHHHH
Confidence             2356778776655677789999999999999999998754322111  1111111111 11   111235789999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCCCCCCCccCC
Q 042681          269 ERMLVFDPAKRI-----TVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       269 ~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~~  298 (339)
                      .+||+.||++||     ++.+++.||||....+..
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         230 EALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             HHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence            999999999999     889999999999887754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=284.64  Aligned_cols=242  Identities=21%  Similarity=0.340  Sum_probs=202.5

Q ss_pred             cccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           27 GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        27 ~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      ...|.+..+....++.||+|-||.||.+.+.. ...+|+|.++..   ....+.+.+|+.+|++|+|++|+++++++   
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~---  270 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVC---  270 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEE---
Confidence            45566666666669999999999999999874 347999988754   22346788999999999999999999999   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                        +..+.++|||||+. |+|.++++.  +..++..+...++.|||+|++||+++++|||||...|||++.++.+||+|||
T Consensus       271 --~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  271 --TKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             --ecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccc
Confidence              66668999999998 999999987  5679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC------------ccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          184 LARTTSETD------------FMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       184 ~~~~~~~~~------------~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      +|+..++..            +.+||......++.++|+|++|+.++++++ |..|+..   +......+.+....+.+.
T Consensus       349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~---msn~ev~~~le~GyRlp~  425 (468)
T KOG0197|consen  349 LARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG---MSNEEVLELLERGYRLPR  425 (468)
T ss_pred             cccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC---CCHHHHHHHHhccCcCCC
Confidence            999665543            456888888889999999999999999997 4454332   333344444444444444


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEAL  286 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell  286 (339)
                      +      +.||+++.+++..||+.+|++|||++.+.
T Consensus       426 P------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  426 P------EGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             C------CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            4      56999999999999999999999998665

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-38  Score=277.06  Aligned_cols=250  Identities=23%  Similarity=0.361  Sum_probs=199.2

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. ++.||+|+||.||++.+..+|+.+|+|.+... ........+.+|+.++++++||||+++++.+     ...+..
T Consensus         2 ~~~~-~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   74 (286)
T cd06622           2 EIEV-LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAV   74 (286)
T ss_pred             hhhh-hhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeE
Confidence            4555 89999999999999999999999999988653 2333456788999999999999999999998     667789


Q ss_pred             EEEEecCc-ccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          115 YIVYELMD-TDLHQIIRSK---QALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ++||||++ ++|.+++...   ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999998 5888877653   379999999999999999999996 699999999999999999999999999886542


Q ss_pred             ---------CCCcccccccccc------ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          190 ---------ETDFMTEYVVTRW------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       190 ---------~~~~~~~~~~~~~------~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                               ...|.+|+.....      ....+.|+|++|++++++++|..|+......   ................  
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~--  229 (286)
T cd06622         155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSAIVDGDPPT--  229 (286)
T ss_pred             CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHHHhhcCCCC--
Confidence                     2346677765332      2467899999999999999999987543211   1111111111111111  


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                       ..+.++.++++||.+||+.+|++||++.+++.||||......
T Consensus       230 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         230 -LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             -CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence             123578999999999999999999999999999999888654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-38  Score=280.06  Aligned_cols=254  Identities=33%  Similarity=0.525  Sum_probs=198.7

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|++|.||++.+..+|+.+|+|.+............+.+|+.++++++||||+++++++     ......
T Consensus         3 ~y~~-~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (294)
T PLN00009          3 QYEK-VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL   76 (294)
T ss_pred             ceEE-EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence            4555 8899999999999999999999999999876543333446678999999999999999999999     666789


Q ss_pred             EEEEecCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-CCCeEEeecccccccC--
Q 042681          115 YIVYELMDTDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARTTS--  189 (339)
Q Consensus       115 ~iv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-~~~ikL~Dfg~~~~~~--  189 (339)
                      ++||||++++|.+.+....  .+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.++|+|||++...+  
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9999999999988886543  3588899999999999999999999999999999999985 5579999999986432  


Q ss_pred             ---------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC-------------
Q 042681          190 ---------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP-------------  246 (339)
Q Consensus       190 ---------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~-------------  246 (339)
                               ...|.+||.... .....+.|+|++|++++++++|.+++......  ...........             
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhhccccccc
Confidence                     124667775433 34567899999999999999999887543211  11111111110             


Q ss_pred             --------CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          247 --------HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       247 --------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                              ...........+.++++++++|.+||+.+|++||++.++++||||.++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence                    00111111123567899999999999999999999999999999998865

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-38  Score=274.85  Aligned_cols=243  Identities=24%  Similarity=0.399  Sum_probs=201.3

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      |.. .+.||.|+||.||++.+..+++.+++|++.+... .....+.+.+|+.++++++||||+++++.+     ......
T Consensus         2 y~~-~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           2 FEL-LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             ceE-EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            444 8899999999999999999999999999976432 234567889999999999999999999998     667789


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC---
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE---  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~---  190 (339)
                      ++|+||+. ++|.+++....++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.....   
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence            99999997 69999998777999999999999999999999999999999999999999999999999998865432   


Q ss_pred             -------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          191 -------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       191 -------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                             ..|.+|+.........++|+|++|++++++++|..|+......   ........... ..   ....+.++.+
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~-~~---~~~~~~~~~~  228 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET-AD---VLYPATWSTE  228 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc-cc---ccCcccCcHH
Confidence                   2467788776666788999999999999999999987643321   11111121111 11   1122457899


Q ss_pred             HHHHHHHhcccCCCCCCCH--HHHhcCCCC
Q 042681          264 AIDLAERMLVFDPAKRITV--EEALNHPYL  291 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps~--~ell~hp~f  291 (339)
                      +.++|.+||+.||.+||++  .++++||||
T Consensus       229 ~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         229 AIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.9e-38  Score=275.71  Aligned_cols=244  Identities=24%  Similarity=0.347  Sum_probs=195.0

Q ss_pred             CCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           37 VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        37 ~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      +.+.+.||.|+||.||++.+..++..+++|.+...  .......+.+|+.++..++||||+++++++     ......++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~~   79 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWI   79 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEE-----eeCCEEEE
Confidence            33488999999999999999999999999998643  334456788999999999999999999998     55678999


Q ss_pred             EEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc------
Q 042681          117 VYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT------  188 (339)
Q Consensus       117 v~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~------  188 (339)
                      |+||++ ++|...+.+ ..++++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...      
T Consensus        80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  159 (282)
T cd06643          80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  159 (282)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence            999998 577776654 467999999999999999999999999999999999999999999999999988543      


Q ss_pred             -----CCCCcccccccc-----ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          189 -----SETDFMTEYVVT-----RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       189 -----~~~~~~~~~~~~-----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                           +...|.+|+...     .......+|+|++|++++++++|.+|+....  ...........    .... .....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~----~~~~-~~~~~  232 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKS----EPPT-LAQPS  232 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--HHHHHHHHhhc----CCCC-CCCcc
Confidence                 223477777652     2335568999999999999999998865432  11111111111    1111 11113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      .++.++++||.+||+.||.+||++.++++||||...
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            478999999999999999999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=274.27  Aligned_cols=246  Identities=25%  Similarity=0.363  Sum_probs=202.1

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||.|++|.||++.+..+++.+++|.+.... .......+.+|+.+++.++||||+++++++     ......
T Consensus         2 ~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   74 (274)
T cd06609           2 LFTL-LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSF-----LKGSKL   74 (274)
T ss_pred             hhhh-hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEE-----EECCeE
Confidence            5666 899999999999999999999999999987543 233456678999999999999999999998     556789


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC---
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE---  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~---  190 (339)
                      ++|+||++ ++|.+++... ++++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+.....   
T Consensus        75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            99999998 6899888764 899999999999999999999999999999999999999999999999999865432   


Q ss_pred             --------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          191 --------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       191 --------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                              ..|.+|+.........++|+|++|++++++++|..|+.....  .    ................  ..+++
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--~----~~~~~~~~~~~~~~~~--~~~~~  225 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--M----RVLFLIPKNNPPSLEG--NKFSK  225 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--H----HHHHHhhhcCCCCCcc--cccCH
Confidence                    236778877766688899999999999999999999764321  1    1111111111111111  12788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ++.+++.+||..+|++|||++++++||||.....
T Consensus       226 ~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         226 PFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence            9999999999999999999999999999987644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.5e-38  Score=270.57  Aligned_cols=242  Identities=21%  Similarity=0.330  Sum_probs=198.3

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|+||.+|++.+..+|+.+++|.+............+.+|+.+++.++||||+++++++     ...+..
T Consensus         1 ~y~~-~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   74 (256)
T cd08218           1 KYVK-VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNL   74 (256)
T ss_pred             CceE-EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeE
Confidence            3555 8999999999999999999999999999875544444556788999999999999999999998     667789


Q ss_pred             EEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC--
Q 042681          115 YIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--  189 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~--  189 (339)
                      ++|+||+. ++|.+.+...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....  
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            99999997 6999888654  368999999999999999999999999999999999999999999999999886442  


Q ss_pred             ---------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          190 ---------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       190 ---------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                               ...|.+|+.........++|+|++|++++++++|..++...     .. ..............   ....+
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~-~~~~~~~~~~~~~~---~~~~~  225 (256)
T cd08218         155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NM-KNLVLKIIRGSYPP---VSSHY  225 (256)
T ss_pred             hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CH-HHHHHHHhcCCCCC---CcccC
Confidence                     23477788766666777899999999999999999886432     11 11111111111111   11357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      +.++.++|.+||+.+|++||++.++++||||
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            8999999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-38  Score=308.06  Aligned_cols=252  Identities=21%  Similarity=0.277  Sum_probs=203.3

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.+ ++.||.|+||.||+|.+..++..+|+|.+............+..|+.++..++||||++++++|..   ....
T Consensus        12 l~~YeI-l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~~   87 (1021)
T PTZ00266         12 LNEYEV-IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KANQ   87 (1021)
T ss_pred             cCCEEE-EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCCC
Confidence            457777 999999999999999999999999999997665555566788999999999999999999998843   3345


Q ss_pred             eEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccCCCCCCCeeecc-------
Q 042681          113 DVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSA-------NVLHRDLKPSNLLLNA-------  173 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-------givH~dikp~NIli~~-------  173 (339)
                      .++|||||++ ++|.+++..    .+.+++..++.|+.||+.||.|||+.       +|+||||||+|||++.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            7899999998 799988865    35799999999999999999999985       4999999999999964       


Q ss_pred             ----------CCCeEEeeccccccc----------CCCCcccccccc--ccccCCCCccHHHHHHHHHHHhCCCCCCccc
Q 042681          174 ----------NCDLKICDFGLARTT----------SETDFMTEYVVT--RWDTLFPGKDYVQQLTMITELLGSPDDSDLG  231 (339)
Q Consensus       174 ----------~~~ikL~Dfg~~~~~----------~~~~~~~~~~~~--~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~  231 (339)
                                .+.++|+|||++...          +...|++|++..  ...+..++|+|++|+++|++++|..||....
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                      234899999988643          345688888763  2346678999999999999999999975432


Q ss_pred             ccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          232 FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      .     ...........+..+    .+..+.++.+||.+||+.+|.+||++.|+|.|||+..+..+
T Consensus       248 ~-----~~qli~~lk~~p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        248 N-----FSQLISELKRGPDLP----IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             c-----HHHHHHHHhcCCCCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            1     112222222222111    13578999999999999999999999999999999877543

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-38  Score=278.42  Aligned_cols=249  Identities=30%  Similarity=0.540  Sum_probs=194.6

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. ++.||+|++|.||++.+..+++.+|+|++..........+.+.+|+++++.++||||+++++++     ......
T Consensus         2 ~y~~-~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07846           2 KYEN-LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL   75 (286)
T ss_pred             ceeE-eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence            4555 8999999999999999999999999999876544443456788999999999999999999999     667789


Q ss_pred             EEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC----
Q 042681          115 YIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS----  189 (339)
Q Consensus       115 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~----  189 (339)
                      ++|+||+++ .|..+......+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++....    
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            999999995 555555555679999999999999999999999999999999999999999999999999886432    


Q ss_pred             -------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC---------------
Q 042681          190 -------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP---------------  246 (339)
Q Consensus       190 -------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~---------------  246 (339)
                             ...|.+|+.... .....++|+|++|++++++++|.+++......  ...........               
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI--DQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH--HHHHHHHHHhCCCchhhHHHhccchH
Confidence                   223566765543 33556799999999999999998876432211  00000000000               


Q ss_pred             ----CCC----CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          247 ----HVP----KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       247 ----~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                          ..+    ........+.++..+++|+.+||+.+|++||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                000    011112235678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.4e-39  Score=297.72  Aligned_cols=243  Identities=21%  Similarity=0.243  Sum_probs=198.3

Q ss_pred             cCCCccccccccceEEEEEEeCCC-CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSET-KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      |.. .+.||+|++|.||+|....+ ++.+|+|.+...  .......+.+|+.++..++||||+++++++     ...+.+
T Consensus        69 y~~-~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~  140 (478)
T PTZ00267         69 YVL-TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKL  140 (478)
T ss_pred             EEE-EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEE
Confidence            556 89999999999999998877 778888876433  333456678899999999999999999999     667889


Q ss_pred             EEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-
Q 042681          115 YIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-  188 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-  188 (339)
                      ++||||++ |+|.+++.+    ..++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.. 
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            99999997 799887753    457999999999999999999999999999999999999999999999999998643 


Q ss_pred             ------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          189 ------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       189 ------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                                  ++..|++||.........+.|+|++|++++++++|..|+.....      .............+   .
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~~~---~  291 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGKYDP---F  291 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC---C
Confidence                        33458888887777788889999999999999999998753221      11111111111111   1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      ...++.++++||.+||+.||++||++.+++.|||++...
T Consensus       292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~~  330 (478)
T PTZ00267        292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVA  330 (478)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHHH
Confidence            135789999999999999999999999999999997653

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5e-38  Score=272.73  Aligned_cols=246  Identities=28%  Similarity=0.393  Sum_probs=195.9

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC--------hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN--------RIDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      +|.. .+.||.|++|.||++.+..+|+.+|+|.+......        ....+.+..|+.++..++||||+++++++   
T Consensus         2 ~~~~-~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---   77 (272)
T cd06629           2 KWVK-GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---   77 (272)
T ss_pred             ceee-cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe---
Confidence            3455 88999999999999999999999999988643211        11234677899999999999999999998   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                        ......++||||+. ++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        78 --~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          78 --TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             --ccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence              66678999999997 799999988888999999999999999999999999999999999999999999999999988


Q ss_pred             cccC-------------CCCcccccccccc--ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          186 RTTS-------------ETDFMTEYVVTRW--DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       186 ~~~~-------------~~~~~~~~~~~~~--~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      ....             ...|.+|+.....  ....+.|+|++|++++++++|..|+....     ..............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~  230 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-----AIAAMFKLGNKRSA  230 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-----hHHHHHHhhccccC
Confidence            6532             1235667655433  36778999999999999999998864321     11111111111111


Q ss_pred             CCc-cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          251 QPF-SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       251 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ... ....+.++.+++++|.+||..+|++||+++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            111 12234578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.3e-38  Score=271.08  Aligned_cols=242  Identities=24%  Similarity=0.327  Sum_probs=195.8

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccC----hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN----RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      |.. .+.||+|+||.||++.. .+|+.+|+|.+......    ......+.+|+.+++.++|+||+++++++     ...
T Consensus         2 ~~~-~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   74 (265)
T cd06631           2 WTK-GEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD   74 (265)
T ss_pred             ccc-cceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence            344 88999999999999986 47889999988654222    22346688999999999999999999999     566


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-  189 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-  189 (339)
                      ...++++||++ ++|.+++.+..++++..++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+.... 
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            88999999997 6999999887889999999999999999999999999999999999999999999999999886431 


Q ss_pred             ----------------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          190 ----------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       190 ----------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                                      ...|.+|+..........+|+|++|++++++++|..|+......     ..........  ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~--~~~  227 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-----AAMFYIGAHR--GLM  227 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-----HHHHHhhhcc--CCC
Confidence                            22467777776666778899999999999999999987543211     1111111000  011


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ......++.++.++|++||+.+|++||++.++++||||
T Consensus       228 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         228 PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            11224578999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=272.20  Aligned_cols=244  Identities=29%  Similarity=0.350  Sum_probs=197.5

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. .+.||.|++|.||+|.+..+++.+++|.+.....  ...+.+.+|+.+++.++||||+++++.+     .....
T Consensus         3 ~~~~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~   74 (262)
T cd06613           3 EDYEL-IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDK   74 (262)
T ss_pred             cceEE-EEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCE
Confidence            45555 8899999999999999999999999999875422  2457888999999999999999999998     66678


Q ss_pred             EEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC--
Q 042681          114 VYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--  189 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~--  189 (339)
                      ++++|||++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....  
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            999999998 5888888775 789999999999999999999999999999999999999999999999999886432  


Q ss_pred             ---------CCCcccccccccc---ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          190 ---------ETDFMTEYVVTRW---DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       190 ---------~~~~~~~~~~~~~---~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                               ...|.+|+.....   .....+|+|++|++++++++|..|+......  ......  ........ .....
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--~~~~~~--~~~~~~~~-~~~~~  229 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--RALFLI--SKSNFPPP-KLKDK  229 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH--HhccCCCc-cccch
Confidence                     2246778876554   6677899999999999999999987643211  111111  11111111 11112


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPY  290 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  290 (339)
                      ..++.++++++++||..+|.+|||+.+++.|||
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            346788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.6e-38  Score=270.65  Aligned_cols=245  Identities=29%  Similarity=0.411  Sum_probs=200.4

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|++|.||++.+..+++.+++|.+..........+.+.+|+.+++.++|+||+++++.+     .....+
T Consensus         1 ~y~~-~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~   74 (264)
T cd06626           1 RWQR-GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKV   74 (264)
T ss_pred             Ccee-eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEE
Confidence            3555 8899999999999999999999999999976655455678899999999999999999999988     566789


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC----
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS----  189 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~----  189 (339)
                      ++|+||++ ++|.+++.+...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....    
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999998 7999999887789999999999999999999999999999999999999999999999999886542    


Q ss_pred             -----------CCCccccccccccc---cCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          190 -----------ETDFMTEYVVTRWD---TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       190 -----------~~~~~~~~~~~~~~---~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                                 ...|.+|+......   .....|+|++|++++++++|..|+.....  .   .............. ..
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~---~~~~~~~~~~~~~~-~~  228 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--E---FQIMFHVGAGHKPP-IP  228 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--h---HHHHHHHhcCCCCC-CC
Confidence                       22466677655444   67789999999999999999999754321  1   11111111111111 11


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ....+++.+.++|.+||+.+|.+||++.+++.|||+
T Consensus       229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         229 DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            223468999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9.1e-38  Score=268.65  Aligned_cols=242  Identities=24%  Similarity=0.358  Sum_probs=199.6

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. ++.||.|+||.||.+++..+++.+++|.+............+.+|+.++++++|+||+++++++     ......
T Consensus         1 ~y~~-~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   74 (256)
T cd08221           1 HYIP-IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTL   74 (256)
T ss_pred             CceE-eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeE
Confidence            3555 8999999999999999999999999999876554555667788999999999999999999999     566789


Q ss_pred             EEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          115 YIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      +++|||++ ++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...   
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            99999997 6999998764  56899999999999999999999999999999999999999999999999987643   


Q ss_pred             --------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          189 --------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       189 --------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                              +...|.+|+...........|+|++|++++++++|..++....  .........    ......   ....+
T Consensus       155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--~~~~~~~~~----~~~~~~---~~~~~  225 (256)
T cd08221         155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--PLNLVVKIV----QGNYTP---VVSVY  225 (256)
T ss_pred             cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHH----cCCCCC---Ccccc
Confidence                    2334667776665566778999999999999999998864321  111111111    111111   11457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      +.++.+++.+||..+|.+||++.++++|||+
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         226 SSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            8999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5e-38  Score=273.72  Aligned_cols=245  Identities=21%  Similarity=0.277  Sum_probs=191.7

Q ss_pred             ccccccceEEEEEEeCCCCceEEEEEecccccC-hHhHHHHHHHHHHHh---hCCCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           42 PIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLC---HMTHENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        42 ~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~e~~~l~---~l~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      .||+|+||.||++.+..+++.+|+|.+.+.... ........++..+++   ..+||+|+.+++.+     ...+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence            489999999999999999999999998765332 222233344444333   34799999999998     556789999


Q ss_pred             EecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--------
Q 042681          118 YELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--------  188 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--------  188 (339)
                      |||++ ++|.+++...+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...        
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  155 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS  155 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCc
Confidence            99998 689999888888999999999999999999999999999999999999999999999999988543        


Q ss_pred             -CCCCcccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 -SETDFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 -~~~~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                       +...|.+|+... ......++|+|++|++++++++|..|+..........   ........ .   ....+.++.++++
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~-~---~~~~~~~~~~~~~  228 (279)
T cd05633         156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLTV-N---VELPDSFSPELKS  228 (279)
T ss_pred             CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhhcC-C---cCCccccCHHHHH
Confidence             344577787654 3446678999999999999999999976443211111   11111111 1   1112457899999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCCCCCCCccCC
Q 042681          267 LAERMLVFDPAKRI-----TVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       267 li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~~  298 (339)
                      +|++||..||++||     ++.++++||||+.+.+..
T Consensus       229 li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         229 LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence            99999999999999     699999999999977543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-38  Score=274.36  Aligned_cols=248  Identities=27%  Similarity=0.396  Sum_probs=198.8

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.+ ++.||.|++|.||++.+..++..+|+|.+...  .......+.+|+.+++.++||||+++++.+     .....
T Consensus         5 ~~~~i-~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   76 (280)
T cd06611           5 DIWEI-IGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENK   76 (280)
T ss_pred             hHHHH-HHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCe
Confidence            44556 89999999999999999989999999998643  344456788999999999999999999998     56678


Q ss_pred             EEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC--
Q 042681          114 VYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--  189 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~--  189 (339)
                      .++||||++ ++|.+++.. .+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....  
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            999999998 588888866 4579999999999999999999999999999999999999999999999999875432  


Q ss_pred             ---------CCCcccccccc-----ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          190 ---------ETDFMTEYVVT-----RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       190 ---------~~~~~~~~~~~-----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                               ...|.+|+...     .......+|+|++|++++++++|..|+......     ..... ........ ..
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~~-~~  229 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVLLK-ILKSEPPT-LD  229 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----HHHHH-HhcCCCCC-cC
Confidence                     23466676543     233556799999999999999999987643211     11111 11111111 11


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ....++.++.++|.+||+.+|.+||++.++++||||.+..+
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence            11357899999999999999999999999999999987743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7e-38  Score=269.27  Aligned_cols=241  Identities=30%  Similarity=0.454  Sum_probs=197.5

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. .+.||+|++|.||++.+..+++.+++|.+....    ..+.+.+|+.+++.++||||+++++++     .....
T Consensus         3 ~~y~~-~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~   72 (256)
T cd06612           3 EVFDI-LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSY-----FKNTD   72 (256)
T ss_pred             ccchh-hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCc
Confidence            45666 899999999999999999989999999986542    257889999999999999999999999     56678


Q ss_pred             EEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-
Q 042681          114 VYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-  190 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-  190 (339)
                      .++++||++ ++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+..... 
T Consensus        73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            999999998 689988865 46789999999999999999999999999999999999999999999999998865432 


Q ss_pred             ----------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          191 ----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       191 ----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                                ..|.+|+.........++|+|++|++++++++|..|+......     ... ......... .......+
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~~-~~~~~~~~  225 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-----RAI-FMIPNKPPP-TLSDPEKW  225 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-----hhh-hhhccCCCC-CCCchhhc
Confidence                      3467787776666777899999999999999999886532111     111 111111111 11112346


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      +.++.+++.+||+.||++|||+.++++||||
T Consensus       226 ~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         226 SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             CHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            7899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.6e-38  Score=270.20  Aligned_cols=247  Identities=27%  Similarity=0.403  Sum_probs=204.2

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. .+.||.|++|.||+|.+..+++.+++|++...... .....+.+|+..+..++|+||+++++++     ......+
T Consensus         3 ~~~-~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06623           3 LER-VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEIS   75 (264)
T ss_pred             cee-eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEE
Confidence            444 88999999999999999999999999998765332 4467789999999999999999999998     5668899


Q ss_pred             EEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEEeecccccccC----
Q 042681          116 IVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS----  189 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~----  189 (339)
                      +++||++ ++|.+++.....+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+....    
T Consensus        76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999998 7999999888899999999999999999999999 999999999999999999999999999886543    


Q ss_pred             -------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC-CC
Q 042681          190 -------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MS  261 (339)
Q Consensus       190 -------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s  261 (339)
                             ...|.+|+..........+|+|++|++++++++|..|+.......   ................   ... ++
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~---~~~~~~  229 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAICDGPPPSL---PAEEFS  229 (264)
T ss_pred             cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHhcCCCCCC---CcccCC
Confidence                   234667777666677788999999999999999999876543211   1111111111111111   123 78


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      ..+.++|.+||..+|++||++.++++||||+...
T Consensus       230 ~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            9999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.6e-38  Score=276.43  Aligned_cols=245  Identities=20%  Similarity=0.254  Sum_probs=186.5

Q ss_pred             CccCCCccccccccceEEEEEEeCC----------------CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCee
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSE----------------TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV   97 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~   97 (339)
                      ++|.. .+.||+|+||.||+|.+..                ++..+|+|.+.... .......+.+|+.++..++||||+
T Consensus         5 ~~~~~-~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           5 GHLLF-KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhCee-eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence            45666 8999999999999997532                34579999887542 333456789999999999999999


Q ss_pred             eeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 042681           98 KVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK-------------------QALTDDHCQYFLYQLLRGLKYIHSA  157 (339)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~  157 (339)
                      ++++++     ......+++|||++ |+|.+++...                   ..+++..++.++.||+.||.|||++
T Consensus        83 ~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~  157 (304)
T cd05096          83 RLLGVC-----VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL  157 (304)
T ss_pred             EEEEEE-----ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence            999999     55567899999997 6999888543                   2367788999999999999999999


Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHhC-
Q 042681          158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLG-  223 (339)
Q Consensus       158 givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g-  223 (339)
                      |++||||||+||+++.++.+||+|||+++...             ...|++|+.........++|+|++|+++++++++ 
T Consensus       158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            99999999999999999999999999986432             2247788877666778889999999999999864 


Q ss_pred             -CCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          224 -SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                       ..|+.....  .......................+.+++.+.+|+.+||+.||++|||+.++.+
T Consensus       238 ~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         238 KEQPYGELTD--EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCCcCCH--HHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence             344433221  11111111111111111111122457899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=274.20  Aligned_cols=241  Identities=27%  Similarity=0.421  Sum_probs=209.1

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ++.||.|+||+||++.++.+|..+|+|.+...    .+.+.+.+|+.++++.+.|+++++||.+     -....++||||
T Consensus        38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSY-----FK~sDLWIVME  108 (502)
T KOG0574|consen   38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSY-----FKHSDLWIVME  108 (502)
T ss_pred             HHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhh-----ccCCceEeehh
Confidence            88899999999999999999999999987533    4678899999999999999999999988     55667999999


Q ss_pred             cCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc----------
Q 042681          120 LMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----------  187 (339)
Q Consensus       120 ~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~----------  187 (339)
                      ||+ |++.++++. ++++++.++..++...++||+|||...-+|||||..|||++-+|..||.|||.+..          
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            999 999999864 58999999999999999999999999999999999999999999999999999854          


Q ss_pred             -cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          188 -TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       188 -~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                       .+++.+++|++.....+.+..|+|++|+..++|.-|++|+.+...++.      +..++..+.+.+. ....+|.++-|
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------IFMIPT~PPPTF~-KPE~WS~~F~D  261 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA------IFMIPTKPPPTFK-KPEEWSSEFND  261 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce------eEeccCCCCCCCC-ChHhhhhHHHH
Confidence             466778999999999999999999999999999999999876543322      1223333333322 22347899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          267 LAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       267 li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ||++||-++|++|-||.++++|||+++...
T Consensus       262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  262 FIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             HHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence            999999999999999999999999998754

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.6e-38  Score=270.29  Aligned_cols=246  Identities=25%  Similarity=0.372  Sum_probs=197.4

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||.|++|.||++....++..+++|++....... ..+.+.+|+..++.++|+||+++++.+     ......
T Consensus         2 ~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   74 (267)
T cd06610           2 DYEL-IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDEL   74 (267)
T ss_pred             ccee-eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEE
Confidence            4555 889999999999999999899999999987543333 567889999999999999999999998     667789


Q ss_pred             EEEEecCc-ccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC
Q 042681          115 YIVYELMD-TDLHQIIRSK---QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~  190 (339)
                      ++++|+++ ++|.+++...   ..+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            99999997 6899888764   4589999999999999999999999999999999999999999999999998754332


Q ss_pred             ---------------CCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          191 ---------------TDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       191 ---------------~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                                     ..|.+|+..... ....++|+|++|++++++++|..|+......  .........  ........
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~--~~~~~~~~  230 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQN--DPPSLETG  230 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcC--CCCCcCCc
Confidence                           235566655444 5677899999999999999999987543221  111111111  11111111


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      .....+++.+++++.+||+.||++||++.++++||||
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            1124678999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-38  Score=270.84  Aligned_cols=245  Identities=23%  Similarity=0.352  Sum_probs=193.2

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEecccccC-hHhHHHHHHHHHHH-hhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-RIDAKRILREIKLL-CHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~e~~~l-~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||.|++|.||+|.+..+|+.+|+|.+.+.... ......+..|..++ ...+||||+++++++     ......++++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence            5689999999999999999999999998654221 22223445555544 445899999999999     6667899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-------CC
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-------SE  190 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-------~~  190 (339)
                      ||++ ++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...       +.
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGT  156 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCC
Confidence            9997 699999988888999999999999999999999999999999999999999999999999987643       33


Q ss_pred             CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHH
Q 042681          191 TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAER  270 (339)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  270 (339)
                      ..|.+|+.........++|+|++|++++++++|..|+......  ............    ........+++++.++|.+
T Consensus       157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~  230 (260)
T cd05611         157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--AVFDNILSRRIN----WPEEVKEFCSPEAVDLINR  230 (260)
T ss_pred             cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhcccC----CCCcccccCCHHHHHHHHH
Confidence            4577787766666788899999999999999999987543211  111111111111    1111123578999999999


Q ss_pred             hcccCCCCCCC---HHHHhcCCCCCCCcc
Q 042681          271 MLVFDPAKRIT---VEEALNHPYLSSLHE  296 (339)
Q Consensus       271 ~L~~dP~~Rps---~~ell~hp~f~~~~~  296 (339)
                      ||+.+|++||+   ++|++.||||..+.|
T Consensus       231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         231 LLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             HccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            99999999995   579999999988765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.2e-38  Score=272.60  Aligned_cols=247  Identities=24%  Similarity=0.388  Sum_probs=194.7

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcC-C
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKE-K  110 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~-~  110 (339)
                      .++|.. .+.||+|+||.||++.+..+++.+|+|.+....   .....+.+|+.++..+ +||||+++++++...... .
T Consensus         5 ~~~y~~-~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           5 AGIFEL-VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhH-HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            456767 899999999999999999999999999986542   2235678899999998 699999999998542211 1


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ....+++|||++ ++|.+++...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            346899999998 6999988763  4689999999999999999999999999999999999999999999999999864


Q ss_pred             cC-----------CCCcccccccc-----ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          188 TS-----------ETDFMTEYVVT-----RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       188 ~~-----------~~~~~~~~~~~-----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ..           ...|.+|+...     ...+..++|+|++|++++++++|..|+......     ..... .......
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~~-~~~~~~~  234 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFL-IPRNPAP  234 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHHH-HhcCCCC
Confidence            32           22467777653     224566899999999999999999987543211     11111 1111111


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      .  .....++.++++|+.+||..+|.+|||+.++++||||
T Consensus       235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         235 R--LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             C--CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            1  1113578999999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=276.40  Aligned_cols=249  Identities=33%  Similarity=0.516  Sum_probs=196.1

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|++|.||+|.+..+++.+++|++............+.+|+.+++.++|+||+++++++     ...+..
T Consensus         2 ~y~~-~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   75 (288)
T cd07833           2 KYEV-LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF-----RRKGRL   75 (288)
T ss_pred             ceeE-EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheE-----EECCEE
Confidence            4555 8899999999999999999999999999876544444567889999999999999999999999     556789


Q ss_pred             EEEEecCcccHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC---
Q 042681          115 YIVYELMDTDLHQI-IRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE---  190 (339)
Q Consensus       115 ~iv~e~~~g~L~~~-l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~---  190 (339)
                      ++++||+++++.+. ..+...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....   
T Consensus        76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99999999655554 44556799999999999999999999999999999999999999999999999998765432   


Q ss_pred             ---------CCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC-------------
Q 042681          191 ---------TDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH-------------  247 (339)
Q Consensus       191 ---------~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~-------------  247 (339)
                               ..|.+|+..... ....++|+|++|++++++++|.+++......  ............             
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcccCc
Confidence                     236677766555 6778899999999999999999876533211  000000000000             


Q ss_pred             -CC-----CC----CccccCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          248 -VP-----KQ----PFSQKFP-NMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       248 -~~-----~~----~~~~~~~-~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                       ..     ..    .....++ .++.++++||++||..+|++||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             00     00    0000112 248899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.8e-38  Score=268.88  Aligned_cols=242  Identities=25%  Similarity=0.382  Sum_probs=196.9

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEeccccc---ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD---NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      |.. .+.||+|++|+||++....+++.+++|.+.....   .....+.+.+|+.+++.++||||+++++++     ....
T Consensus         2 ~~~-~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           2 WRK-GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             ccc-cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            454 7889999999999999998999999999865432   233456788999999999999999999998     5667


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC--
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--  189 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~--  189 (339)
                      .+++++||++ ++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....  
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            8999999998 6999999887889999999999999999999999999999999999999999999999999886432  


Q ss_pred             --------CCCccccccccccc-cCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          190 --------ETDFMTEYVVTRWD-TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       190 --------~~~~~~~~~~~~~~-~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                              ...|.+|+...... .....|.|++|++++++++|..|+.....  ........   .....   ....+.+
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~---~~~~~---~~~~~~~  227 (258)
T cd06632         156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAVFKIG---RSKEL---PPIPDHL  227 (258)
T ss_pred             ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHHHHHHH---hcccC---CCcCCCc
Confidence                    22356676655444 67789999999999999999999765431  11111111   10111   1112457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ++++++++.+||+.+|++||++.++++|||+
T Consensus       228 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         228 SDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            8999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-38  Score=281.09  Aligned_cols=256  Identities=24%  Similarity=0.338  Sum_probs=204.0

Q ss_pred             cccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCC
Q 042681           27 GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPP  105 (339)
Q Consensus        27 ~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~  105 (339)
                      .+.+.+.++-+.+++.||+||.+.||+|...+ .+.||+|++.....+.....-+.+|+..|.+|+ |.+|++++++-  
T Consensus       353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE--  429 (677)
T KOG0596|consen  353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE--  429 (677)
T ss_pred             CeeEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee--
Confidence            35677777766669999999999999998654 457777777666667777888999999999995 99999999997  


Q ss_pred             CCcCCcCeEEEEEecCcccHHHHHHhcCCCCH-HHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          106 MDKEKFNDVYIVYELMDTDLHQIIRSKQALTD-DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~-~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                         -..+.+|+||||-+.+|..++++.....+ ..++.+..|+++|+.++|..||||.||||.|+++- .|++||+|||+
T Consensus       430 ---v~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGI  505 (677)
T KOG0596|consen  430 ---VTDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGI  505 (677)
T ss_pred             ---ccCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeech
Confidence               66788999999999999999988765444 58888999999999999999999999999999885 57999999999


Q ss_pred             cc-------------ccCCCCcccccccccc-----------ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHH
Q 042681          185 AR-------------TTSETDFMTEYVVTRW-----------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARR  240 (339)
Q Consensus       185 ~~-------------~~~~~~~~~~~~~~~~-----------~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~  240 (339)
                      |.             +.|+..|++||.....           ....++|+|++||++|.|+.|..|+..+....    .+
T Consensus       506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~----aK  581 (677)
T KOG0596|consen  506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI----AK  581 (677)
T ss_pred             hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH----HH
Confidence            85             3566679998876543           25678999999999999999999987653221    11


Q ss_pred             HHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          241 YVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      ............+++..+  ..++.++++.||.+||.+||++.++|+|||++...
T Consensus       582 l~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  582 LHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             HHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence            111111112222222221  23399999999999999999999999999998754

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.6e-38  Score=279.67  Aligned_cols=256  Identities=31%  Similarity=0.396  Sum_probs=193.7

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc---C
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK---E  109 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~---~  109 (339)
                      -++|.. ++.||+|++|.||+|.+..+++.+|+|.+............+.+|+.++++++||||+++++++.....   .
T Consensus        11 ~~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEK-LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEE-EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            445766 899999999999999999999999999986543333334456789999999999999999998744321   1


Q ss_pred             CcCeEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          110 KFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      .....++||||++++|.+.+... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            23457999999999998888664 37899999999999999999999999999999999999999999999999988643


Q ss_pred             CC---------------CCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC-----
Q 042681          189 SE---------------TDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH-----  247 (339)
Q Consensus       189 ~~---------------~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~-----  247 (339)
                      ..               ..|.+||..... ....++|+|++|++++++++|.+++......  ............     
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCGSITPEV  247 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhh
Confidence            21               236777765432 3567899999999999999998876433211  000000000000     


Q ss_pred             -----------------CCCCCcccc--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          248 -----------------VPKQPFSQK--FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       248 -----------------~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                                       .........  ....+..+++||.+||..||.+|||++++++||||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                             000000000  01135778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.8e-38  Score=270.20  Aligned_cols=246  Identities=22%  Similarity=0.340  Sum_probs=197.2

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc---ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD---NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .+|.. .+.||+|+||.||++.+..+|+.+++|.+.....   .....+.+.+|+.+++.+.||||+++++++.+   ..
T Consensus         2 ~~~~~-~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   77 (265)
T cd06652           2 TNWRL-GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PM   77 (265)
T ss_pred             CcceE-eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CC
Confidence            45555 8999999999999999999999999998864322   22345678899999999999999999998843   22


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ...++++|||++ ++|.+++.+.+.+++..+..++.|++.||+|||++|++|+||+|+||++++++.++|+|||.+....
T Consensus        78 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          78 ERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             CceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            356889999997 6999999887889999999999999999999999999999999999999999999999999886432


Q ss_pred             --------------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          190 --------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       190 --------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                                    ...|.+|+.........++|+|++|++++++++|..|+......     .............   .
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~---~  229 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAIFKIATQPTNP---V  229 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHHHHHhcCCCCC---C
Confidence                          22467788776666778899999999999999999987643211     1111111111111   1


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                      ..+..+..+.++|.+|+. +|++||+++++++|||+.
T Consensus       230 ~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         230 LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            113567889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.8e-38  Score=274.19  Aligned_cols=246  Identities=24%  Similarity=0.397  Sum_probs=194.3

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      .+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++. ||||+++++++     ......+++|
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~-----~~~~~~~~~~   82 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGAL-----FREGDCWICM   82 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEE-----ecCCcEEEEE
Confidence            78899999999999999999999999998754332 44567889999999996 99999999998     5567789999


Q ss_pred             ecCcccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          119 ELMDTDLHQIIR-----SKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       119 e~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      ||+++++.++..     ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++....   
T Consensus        83 e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             ecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            999876655432     24679999999999999999999997 499999999999999999999999999985432   


Q ss_pred             -------CCCcccccccccc---ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCc-cccCC
Q 042681          190 -------ETDFMTEYVVTRW---DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF-SQKFP  258 (339)
Q Consensus       190 -------~~~~~~~~~~~~~---~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  258 (339)
                             ...|.+|+.....   .+..++|+|++|++++++++|..|+....     ................. .....
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd06616         163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDPPILSNSEER  237 (288)
T ss_pred             ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCCCCcCCCcCCC
Confidence                   2357777766544   46778999999999999999999975432     11111111111111111 11113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      .++.++.+|+.+||+.+|++|||++++++||||+....
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence            57899999999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.5e-38  Score=274.31  Aligned_cols=248  Identities=25%  Similarity=0.362  Sum_probs=201.5

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ..+|.. ++.||.|++|.||++.+..+++.+++|.+......  ....+.+|+.+++.+.||||+++++.+     ....
T Consensus        19 ~~~y~~-~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~-----~~~~   90 (296)
T cd06654          19 KKKYTR-FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSY-----LVGD   90 (296)
T ss_pred             ccceee-EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEE-----EeCC
Confidence            456666 89999999999999999999999999998754322  346688999999999999999999998     5567


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      ..++||||++ ++|.+++.+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+...   
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            8999999997 689888764 56899999999999999999999999999999999999999999999999987542   


Q ss_pred             --------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          189 --------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       189 --------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                              +...|.+|+.........+.|+|++|++++++++|..|+......  .  ..........+   .......+
T Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~--~~~~~~~~~~~---~~~~~~~~  242 (296)
T cd06654         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--R--ALYLIATNGTP---ELQNPEKL  242 (296)
T ss_pred             ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--H--hHHHHhcCCCC---CCCCcccc
Confidence                    233577888777666778999999999999999999997543211  1  11111111111   11112357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      +..+.+++.+||..+|.+||++.++++||||.....
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             CHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            889999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.7e-38  Score=275.22  Aligned_cols=249  Identities=26%  Similarity=0.380  Sum_probs=201.2

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. ++.||.|++|.||++.+..+|+.+++|.+.....  .....+.+|+.+++.++||||+++++.+     ......
T Consensus        20 ~y~~-~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~   91 (296)
T cd06655          20 KYTR-YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSF-----LVGDEL   91 (296)
T ss_pred             eEEE-EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceE
Confidence            4555 8899999999999999999999999999865422  2346788999999999999999999998     666789


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-----
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-----  188 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-----  188 (339)
                      ++|+||+. ++|..++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...     
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             EEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            99999997 688777754 57899999999999999999999999999999999999999999999999987543     


Q ss_pred             ------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          189 ------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       189 ------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                            +...|.+|+...........|+|++|++++++++|..|+......  ..... ..... .   ........+++
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--~~~~~-~~~~~-~---~~~~~~~~~~~  243 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYL-IATNG-T---PELQNPEKLSP  243 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HHhcC-C---cccCCcccCCH
Confidence                  223467788776666778899999999999999999887543211  11111 11111 1   11112245789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCC
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE  299 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~  299 (339)
                      .++++|.+||..||++||++.++++||||+.......
T Consensus       244 ~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~  280 (296)
T cd06655         244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSS  280 (296)
T ss_pred             HHHHHHHHHhhcChhhCCCHHHHhhChHhhhcccccc
Confidence            9999999999999999999999999999998776443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.5e-38  Score=276.32  Aligned_cols=247  Identities=34%  Similarity=0.547  Sum_probs=194.4

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. ++.||.|++|.||++.+..+|+.+|+|+++.... ......+.+|+.+++.++||||+++++++     ...+..+
T Consensus         2 y~~-~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   74 (284)
T cd07836           2 FKQ-LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLM   74 (284)
T ss_pred             ceE-eeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEE
Confidence            445 8899999999999999999999999999876532 22345677899999999999999999999     5667889


Q ss_pred             EEEecCcccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          116 IVYELMDTDLHQIIRSK---QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       116 iv~e~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      +||||++++|.+++...   ..+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+....   
T Consensus        75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            99999999999888653   468999999999999999999999999999999999999999999999999886432   


Q ss_pred             --------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhC---------------
Q 042681          190 --------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL---------------  245 (339)
Q Consensus       190 --------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~---------------  245 (339)
                              ...|.+|+.... .....++|+|++|++++++++|..++......  ..........               
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhHHHHhcCc
Confidence                    234667775533 34567899999999999999999886543211  1111111100               


Q ss_pred             ------CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          246 ------PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       246 ------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                            ............+.++..++++|.+||+.||.+||++.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                  0000001111224568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=290.77  Aligned_cols=250  Identities=28%  Similarity=0.386  Sum_probs=205.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +..+.|+..||.|+||.||+|..+.++-..|.|++...  .....+.++-|+++|....||+|+++++.|     ...+.
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ay-----y~enk  103 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAY-----YFENK  103 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHH-----hccCc
Confidence            34455599999999999999999999988999988643  455678899999999999999999999998     66788


Q ss_pred             EEEEEecCcc-cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc-----
Q 042681          114 VYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-----  186 (339)
Q Consensus       114 ~~iv~e~~~g-~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~-----  186 (339)
                      ++|+.|||+| -+..++.. .+.+++.++..++.|++.||.|||+++|+|||||..|||++-+|.|+|.|||.+.     
T Consensus       104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence            9999999985 45444443 5789999999999999999999999999999999999999999999999999984     


Q ss_pred             ------ccCCCCccccccccc-----cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          187 ------TTSETDFMTEYVVTR-----WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       187 ------~~~~~~~~~~~~~~~-----~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                            ..|++.+++|++...     .++.+.+|+|++|+++++|..+.+|......+.     ..+......+.. + .
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-----VllKiaKSePPT-L-l  256 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSEPPT-L-L  256 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-----HHHHHhhcCCCc-c-c
Confidence                  356677788876543     467888999999999999999999977654332     222221111111 1 1


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ....++..++||+.+||.+||..||+++++++|||++++...
T Consensus       257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            124578999999999999999999999999999999988653

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.8e-38  Score=275.35  Aligned_cols=250  Identities=26%  Similarity=0.370  Sum_probs=202.0

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ..+|.. ++.||.|++|.||++.+..+++.+|+|.+.....  ...+.+.+|+.+++.++||||+++++++     ....
T Consensus        18 ~~~y~~-~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   89 (297)
T cd06656          18 KKKYTR-FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSY-----LVGD   89 (297)
T ss_pred             hhhcee-eeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCC
Confidence            456777 8999999999999999999999999999865422  2346678999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      ..++||||++ ++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+...   
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            8999999997 688888754 56899999999999999999999999999999999999999999999999987543   


Q ss_pred             --------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          189 --------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       189 --------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                              +...|.+|+...........|+|++|++++++++|..|+.......     .... ..... .+.......+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-----~~~~-~~~~~-~~~~~~~~~~  241 (297)
T cd06656         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYL-IATNG-TPELQNPERL  241 (297)
T ss_pred             ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-----heee-eccCC-CCCCCCcccc
Confidence                    2234667777666667788999999999999999999875422110     0000 00000 1111112347


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      +..+++|+.+||+.+|++||++.++++||||+......
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence            88899999999999999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.5e-38  Score=272.98  Aligned_cols=245  Identities=27%  Similarity=0.427  Sum_probs=189.5

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ++.||+|++|.||++.+..+++.+|+|+++........ ....+|+..+.++. ||||+++++++.+   ...+..++||
T Consensus         4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~---~~~~~~~lv~   79 (282)
T cd07831           4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFD---RKTGRLALVF   79 (282)
T ss_pred             EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEec---CCCCcEEEEE
Confidence            78899999999999999999999999998765333322 34457888898885 9999999999842   2236789999


Q ss_pred             ecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC--------
Q 042681          119 ELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--------  189 (339)
Q Consensus       119 e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~--------  189 (339)
                      ||++++|.+.+... ..+++..++.++.|++.||+|||+.|++||||+|+||+++. +.++|+|||.+....        
T Consensus        80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~  158 (282)
T cd07831          80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEY  158 (282)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCC
Confidence            99999999888764 57899999999999999999999999999999999999999 999999999986542        


Q ss_pred             --CCCccccccc-cccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHh-----------hCCCCCCC----
Q 042681          190 --ETDFMTEYVV-TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK-----------QLPHVPKQ----  251 (339)
Q Consensus       190 --~~~~~~~~~~-~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~----  251 (339)
                        ...|.+|+.. .......++|+|++|++++++++|.+++.......  .......           ........    
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence              2246677753 33345678999999999999999988875432111  0000000           00000000    


Q ss_pred             ------CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          252 ------PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       252 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                            ......+.++.+++++|.+||+.+|++||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                  0011123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-37  Score=272.91  Aligned_cols=250  Identities=33%  Similarity=0.478  Sum_probs=192.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|++|.||++.+..+|+.+++|.+...... .....+.+|+.+++.++|+||+++++++     .....
T Consensus         5 ~~y~~-~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~   77 (291)
T cd07870           5 TSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDII-----HTKET   77 (291)
T ss_pred             ceeEE-EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence            55666 89999999999999999999999999998654322 2234567899999999999999999998     56678


Q ss_pred             EEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          114 VYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      .++|+||+++++.+.+.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.++...   
T Consensus        78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          78 LTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             EEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            999999999888877754 3568889999999999999999999999999999999999999999999999886432   


Q ss_pred             --------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh--------------CC
Q 042681          190 --------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ--------------LP  246 (339)
Q Consensus       190 --------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~--------------~~  246 (339)
                              ...|.+|+.... ......+|+|++|++++++++|..++...... ..........              ..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-FEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-HHHHHHHHHHcCCCChhhhhhhhhcc
Confidence                    234667776543 33566789999999999999999887543211 0111111000              00


Q ss_pred             CCC--------CCCccccCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          247 HVP--------KQPFSQKFP--NMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       247 ~~~--------~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ...        .......+.  ..+.++.+++.+||+.||++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            000        000000001  136789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-38  Score=274.22  Aligned_cols=245  Identities=39%  Similarity=0.603  Sum_probs=197.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ++.||.|++|.||++.+..+++.+++|.+............+.+|+.+++.++|+||+++++++     ......++++|
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e   78 (283)
T cd05118           4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYLVFE   78 (283)
T ss_pred             ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEEEEe
Confidence            7889999999999999999999999999876654444557788999999999999999999998     55678999999


Q ss_pred             cCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC-------
Q 042681          120 LMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET-------  191 (339)
Q Consensus       120 ~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~-------  191 (339)
                      |++++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......       
T Consensus        79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            9999999888763 68999999999999999999999999999999999999999999999999988654332       


Q ss_pred             ----Ccccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh----------------------
Q 042681          192 ----DFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ----------------------  244 (339)
Q Consensus       192 ----~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~----------------------  244 (339)
                          .|.+|+..... ....++|+|++|++++++++|..++.......  ........                      
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVWPKFTSLARNYKFS  236 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence                36667765544 56778999999999999999988764332110  11111111                      


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       245 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      .............+.++.+++++|.+||+.||.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            11111111122234578999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-37  Score=267.32  Aligned_cols=243  Identities=26%  Similarity=0.352  Sum_probs=198.3

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. .+.||.|++|.||++.+..+++.+|+|.+..........+++.+|+.+++.++||||+++++++..   ......+
T Consensus         2 y~~-~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           2 YEV-LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             cee-eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            444 788999999999999999999999999987655555566788999999999999999999997742   3445689


Q ss_pred             EEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          116 IVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIH-----SANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH-----~~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                      ++|||++ ++|.+++..    ..++++..++.++.||+.||.|||     +.+++|+||+|+||+++.++.++|+|||.+
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            9999997 689888865    367999999999999999999999     899999999999999999999999999988


Q ss_pred             cccC-----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          186 RTTS-----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       186 ~~~~-----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      ....           ...|.+|+...........|+|++|++++.+++|..|+....   ..   ............   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~---~~~~~~~~~~~~---  228 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QL---QLASKIKEGKFR---  228 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HH---HHHHHHhcCCCC---
Confidence            6542           234667777666667778999999999999999998875432   11   111111111111   


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      .....++..+.+++.+||+.+|++||++.++++|||+
T Consensus       229 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            1123578999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-37  Score=270.70  Aligned_cols=255  Identities=24%  Similarity=0.299  Sum_probs=198.2

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. .+.||.|++|.||++.+..+++.+|+|.+..... ......+.+|++++..++||||+++++++..   .....++
T Consensus         3 ~~~-~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~   77 (287)
T cd06621           3 IVE-LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG   77 (287)
T ss_pred             eEE-EEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence            444 7889999999999999999999999999875422 2345778999999999999999999998843   3345789


Q ss_pred             EEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-
Q 042681          116 IVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-  189 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-  189 (339)
                      +||||++ ++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... 
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999997 688877643    3568999999999999999999999999999999999999999999999999875432 


Q ss_pred             --------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc---CC
Q 042681          190 --------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK---FP  258 (339)
Q Consensus       190 --------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  258 (339)
                              ...|.+|+...........|+|++|++++++++|..|+........... .................   ..
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd06621         158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLSYIVNMPNPELKDEPGNGI  236 (287)
T ss_pred             cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HHHHHHhcCCchhhccCCCCCC
Confidence                    2346677776666677889999999999999999988764422101111 11111111111111111   12


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      .+++.++++|.+||+.+|++|||+.|+++||||.+...
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             chHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            35688999999999999999999999999999976654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.2e-37  Score=266.18  Aligned_cols=242  Identities=23%  Similarity=0.284  Sum_probs=198.0

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|++|.||++.+..+++.+|+|.+............+.+|+.+++.++||||+++++.+     ......
T Consensus         1 ~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   74 (256)
T cd08220           1 KYEK-IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKAL   74 (256)
T ss_pred             CceE-EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEE
Confidence            3555 8899999999999999999999999999976544455567889999999999999999999998     666789


Q ss_pred             EEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC-CeEEeecccccccC-
Q 042681          115 YIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTS-  189 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~-~ikL~Dfg~~~~~~-  189 (339)
                      ++||||++ ++|.+++...  ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+.... 
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            99999997 6999998763  4589999999999999999999999999999999999998654 57999999986543 


Q ss_pred             ---------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          190 ---------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       190 ---------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                               ...|.+|+.........+.|+|++|++++++++|..++......  ......    .......   ....+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~----~~~~~~~---~~~~~  225 (256)
T cd08220         155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKI----MSGTFAP---ISDRY  225 (256)
T ss_pred             CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHH----HhcCCCC---CCCCc
Confidence                     23577888777666778899999999999999999886543211  111111    1111111   11347


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ++++++++.+||+.+|++|||+.++++||||
T Consensus       226 ~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         226 SPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-38  Score=273.03  Aligned_cols=245  Identities=34%  Similarity=0.547  Sum_probs=197.3

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||+|++|.||++....+++.+++|.+............+.+|+.+++.++|+||+++++++     ......++|+|
T Consensus         4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~v~e   78 (282)
T cd07829           4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYLVFE   78 (282)
T ss_pred             ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEEEec
Confidence            6789999999999999999999999999986543344456778899999999999999999999     55678999999


Q ss_pred             cCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC--------
Q 042681          120 LMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--------  190 (339)
Q Consensus       120 ~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--------  190 (339)
                      |++++|.+++.+. ..+++..++.++.|++.||++||+.|++||||+|+||+++.++.++|+|||.+.....        
T Consensus        79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            9999999999876 6899999999999999999999999999999999999999999999999999865432        


Q ss_pred             ---CCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHH---------------------hhC
Q 042681          191 ---TDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV---------------------KQL  245 (339)
Q Consensus       191 ---~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~---------------------~~~  245 (339)
                         ..|.+|+..... ....+.|+|++|++++++++|.+++.......  ......                     ...
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID--QLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence               235667765444 56778999999999999999988764432110  000000                     011


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       246 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ...........++..+..+.++|.+||..||++||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            1111112223345568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.9e-39  Score=287.13  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=208.3

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccc--ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA--FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      -.++|......||+|+|-+||+|.+..+|-.||+-.++..  .......+++..|+.+|+.|+||||++++.+|.+.   
T Consensus        37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---  113 (632)
T KOG0584|consen   37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---  113 (632)
T ss_pred             CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC---
Confidence            3566766688899999999999999999999998877644  33445569999999999999999999999999663   


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeeecc-CCCeEEeecccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNA-NCDLKICDFGLA  185 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dikp~NIli~~-~~~ikL~Dfg~~  185 (339)
                      ....+-+|+|.+. |+|..++++.+.++.+.++.|+.||++||.|||++.  |+|||||.+||||+. .|.|||+|+|+|
T Consensus       114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence            3366889999997 999999999999999999999999999999999985  999999999999974 578999999998


Q ss_pred             c---------ccCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          186 R---------TTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       186 ~---------~~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      +         ..|++.|++||.+. ..+....|+|++|+|+++|.++.-|+..+...     ..+........++.....
T Consensus       194 tl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQIYKKV~SGiKP~sl~k  267 (632)
T KOG0584|consen  194 TLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQIYKKVTSGIKPAALSK  267 (632)
T ss_pred             HHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HHHHHHHHcCCCHHHhhc
Confidence            5         36788999999887 56788899999999999999999887655322     222222222222221111


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      .  -.+++++||.+||.. .+.|||+.|+|.||||..-
T Consensus       268 V--~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  268 V--KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             c--CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            1  268899999999999 9999999999999999874

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.8e-37  Score=270.75  Aligned_cols=251  Identities=23%  Similarity=0.350  Sum_probs=196.0

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~  109 (339)
                      ...++|.. .+.||+|++|.||++....+++.+|+|++....   .....+.+|+.+++++ +|||++++++++......
T Consensus        19 ~~~~~y~~-~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          19 DPTDTWEI-IETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             CCCCCeEE-EEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            34677777 899999999999999999999999999986432   2235677899999998 799999999998543323


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                      .....++||||++ ++|.+++..    ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~  174 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV  174 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence            3457899999997 688888753    46789999999999999999999999999999999999999999999999998


Q ss_pred             ccccC-----------CCCcccccccccc-----ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCC
Q 042681          185 ARTTS-----------ETDFMTEYVVTRW-----DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHV  248 (339)
Q Consensus       185 ~~~~~-----------~~~~~~~~~~~~~-----~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~  248 (339)
                      +....           ...|.+|+.....     ....+.|+|++|++++++++|..|+.....     ...... ....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-----~~~~~~-~~~~  248 (291)
T cd06639         175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-----VKTLFK-IPRN  248 (291)
T ss_pred             chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-----HHHHHH-HhcC
Confidence            86432           2246667754322     246789999999999999999988754321     111111 1111


Q ss_pred             CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          249 PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       249 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                      ..... .....++..+.+||.+||+.+|++||++.++++||||+
T Consensus       249 ~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         249 PPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            11111 11134678899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-37  Score=269.35  Aligned_cols=241  Identities=27%  Similarity=0.417  Sum_probs=196.1

Q ss_pred             cccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecC
Q 042681           43 IGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM  121 (339)
Q Consensus        43 lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~  121 (339)
                      ||.|++|.||++.+..+|+.+++|.+..... .....+.+.+|+.++++++||||+++++.+     ......++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            6899999999999999999999999865422 234457788999999999999999999988     6677899999999


Q ss_pred             c-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-----------
Q 042681          122 D-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-----------  189 (339)
Q Consensus       122 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-----------  189 (339)
                      . ++|.+++.+.+.+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....           
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            7 6999999887789999999999999999999999999999999999999999999999999875432           


Q ss_pred             --------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          190 --------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       190 --------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                              ...|.+|+...........|+|++|++++++++|..++.....      ............ .... ...++
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~~~-~~~~~  227 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILNGKI-EWPE-DVEVS  227 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCCc-CCCc-cccCC
Confidence                    2245667766666677789999999999999999988653321      111111111111 1111 11248


Q ss_pred             HHHHHHHHHhcccCCCCCCCH---HHHhcCCCCCCCcc
Q 042681          262 PVAIDLAERMLVFDPAKRITV---EEALNHPYLSSLHE  296 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~---~ell~hp~f~~~~~  296 (339)
                      ..+.+++.+||+.+|.+|||+   .++++||||+++.|
T Consensus       228 ~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         228 DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             HHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            999999999999999999999   99999999998754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3e-37  Score=272.55  Aligned_cols=249  Identities=23%  Similarity=0.306  Sum_probs=199.5

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ..+|.. .+.||+|++|.||++.+..+|+.+|+|++.... ......+.+.+|+.+++.++||||+++++++     ...
T Consensus        14 ~~~y~~-~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~-----~~~   87 (307)
T cd06607          14 EKLFTD-LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY-----LRE   87 (307)
T ss_pred             chhhhh-heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----EeC
Confidence            355666 899999999999999999999999999986542 3334456788999999999999999999999     556


Q ss_pred             CeEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-
Q 042681          112 NDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-  189 (339)
Q Consensus       112 ~~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-  189 (339)
                      ...++|+||+.|++.+.+.. .+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.... 
T Consensus        88 ~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          88 HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            77899999999988888764 4679999999999999999999999999999999999999999999999999886432 


Q ss_pred             ------CCCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          190 ------ETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       190 ------~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                            ...|.+|+...   ......+.|+|++|++++++++|..|+......     ... ............  ...+
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~-~~~~~~~~~~~~--~~~~  239 (307)
T cd06607         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SAL-YHIAQNDSPTLS--SNDW  239 (307)
T ss_pred             CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHH-HHHhcCCCCCCC--chhh
Confidence                  33567777652   234667899999999999999999886533211     111 111111111111  1236


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      +.+++++|.+||+.+|++||++.+++.||||..-.
T Consensus       240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            88999999999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=240.92  Aligned_cols=252  Identities=35%  Similarity=0.506  Sum_probs=198.8

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|.||+||++++..+++.+|+|.++....+.......++|+.+++.++|.||++++++.     -....+
T Consensus         3 ~ydk-mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkkl   76 (292)
T KOG0662|consen    3 KYDK-MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_pred             chHH-HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCcee
Confidence            3445 7889999999999999999999999999988766666667889999999999999999999998     566789


Q ss_pred             EEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCCC-
Q 042681          115 YIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD-  192 (339)
Q Consensus       115 ~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~~-  192 (339)
                      .+|+|||..+|..+... ++.++.+.++..+.|++.||.|+|++++.|||+||.|++|+.||.+||.|||+++-++-+- 
T Consensus        77 tlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   77 TLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             EEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            99999999999998865 6889999999999999999999999999999999999999999999999999998877552 


Q ss_pred             ----------cccccccc-ccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCcc------
Q 042681          193 ----------FMTEYVVT-RWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS------  254 (339)
Q Consensus       193 ----------~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  254 (339)
                                |.+|.+.- ..-+...-|.|+.||+..++.- |.+.+...  ...+....++...........+      
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~--dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC--cHHHHHHHHHHHhCCCccccCCccccCC
Confidence                      22332221 1124555778999998887764 44444332  1223333444333322221111      


Q ss_pred             ---------------ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          255 ---------------QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       255 ---------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                                     +..|.++...+||++++|..+|.+|++|+++++||||...
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                           1224456668999999999999999999999999999864

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.8e-37  Score=264.74  Aligned_cols=243  Identities=27%  Similarity=0.407  Sum_probs=200.6

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc--Ce
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF--ND  113 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~--~~  113 (339)
                      |.. .+.||+|++|.||++.+..+++.+++|++..........+.+.+|+..+++++||||+++++.+     ...  ..
T Consensus         2 ~~~-~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (260)
T cd06606           2 WTR-GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSE-----RDEEKNT   75 (260)
T ss_pred             cee-eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ecCCCCe
Confidence            444 7889999999999999999999999999976654455678889999999999999999999998     444  77


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC-
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET-  191 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~-  191 (339)
                      +++++||++ ++|.+++.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          76 LNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            999999996 799999988779999999999999999999999999999999999999999999999999987654332 


Q ss_pred             ------------CccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          192 ------------DFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       192 ------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                  .|.+|+...........|+|++|++++++++|..|+....    .... .......  ..........
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~-~~~~~~~--~~~~~~~~~~  228 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMA-ALYKIGS--SGEPPEIPEH  228 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHH-HHHhccc--cCCCcCCCcc
Confidence                        4567777666667888999999999999999998876543    1111 1111111  0111112234


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      .+..++++|.+||+.||++||++.++++||||
T Consensus       229 ~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         229 LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             cCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            68999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-37  Score=271.22  Aligned_cols=252  Identities=20%  Similarity=0.295  Sum_probs=201.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|++|.||++.+..+|+.+|+|++.... .......+.+|+.+++.++||||+++++.+     .....
T Consensus         5 ~~~~~-~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~   77 (284)
T cd06620           5 EDLET-ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENN   77 (284)
T ss_pred             HHHHH-HHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCE
Confidence            34555 899999999999999999999999999886542 233457789999999999999999999999     55678


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      +++||||++ ++|.+++...+.+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...   
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999998 6898888887889999999999999999999996 69999999999999999999999999987542   


Q ss_pred             ------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccc-----cchHHHHHhhCCCCCCCCccccC
Q 042681          189 ------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR-----SDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       189 ------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                            +...|.+|+.........+.|+|++|++++++++|..|+.......     ....................  .
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  235 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP--S  235 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC--c
Confidence                  3345777887666677788999999999999999999976543210     00011111111111111110  1


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      ..++.++.+|+.+||+.||++|||+.++++||||..-
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            2367889999999999999999999999999999664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=270.37  Aligned_cols=250  Identities=31%  Similarity=0.467  Sum_probs=193.7

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC---CCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM---THENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      ++.||+|++|.||++.+..+++.+|+|++............+.+|+.++.++   +||||+++++++..........+++
T Consensus         4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   83 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL   83 (287)
T ss_pred             EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence            7889999999999999998999999999976544333345566787777666   5999999999995443223334999


Q ss_pred             EEecCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-----
Q 042681          117 VYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-----  189 (339)
Q Consensus       117 v~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-----  189 (339)
                      +|||++++|.+++...  ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....     
T Consensus        84 ~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~  163 (287)
T cd07838          84 VFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL  163 (287)
T ss_pred             EehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCccc
Confidence            9999999998888664  358999999999999999999999999999999999999999999999999986543     


Q ss_pred             -----CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhC-------------------
Q 042681          190 -----ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL-------------------  245 (339)
Q Consensus       190 -----~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~-------------------  245 (339)
                           ...|.+|+.........+.|+|++|++++++++|.+++.....  ......+....                   
T Consensus       164 ~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (287)
T cd07838         164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE--ADQLDKIFDVIGLPSEEEWPRNVSLPRSSF  241 (287)
T ss_pred             ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh--HHHHHHHHHHcCCCChHhcCCCcccchhhc
Confidence                 2236777777666678889999999999999999887654221  11111111111                   


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       246 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ............+.+++.+.++|.+||+.||++||++.++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         242 PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            0111111122223567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=275.50  Aligned_cols=252  Identities=30%  Similarity=0.421  Sum_probs=192.2

Q ss_pred             cCCCccccccccceEEEEEEeCC--CCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSE--TKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~--~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      |.. .+.||+|++|.||+|.+..  +++.||+|.+.... ........+.+|+.++..++||||+++++++..   ....
T Consensus         2 y~~-~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   77 (316)
T cd07842           2 YEI-EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK   77 (316)
T ss_pred             ceE-EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence            445 7889999999999999988  89999999997643 122234567889999999999999999999943   2236


Q ss_pred             eEEEEEecCcccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc----CCCeEEeecc
Q 042681          113 DVYIVYELMDTDLHQIIRSK-----QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA----NCDLKICDFG  183 (339)
Q Consensus       113 ~~~iv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~----~~~ikL~Dfg  183 (339)
                      .+++||||++++|.+.+...     ..+++..++.++.|++.||.|||+.|++||||||+||+++.    ++.++|+|||
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            79999999998888877532     36899999999999999999999999999999999999999    9999999999


Q ss_pred             cccccCC--------------CCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccc-------cchHHHH
Q 042681          184 LARTTSE--------------TDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR-------SDNARRY  241 (339)
Q Consensus       184 ~~~~~~~--------------~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~-------~~~~~~~  241 (339)
                      ++.....              ..|.+|+.... ......+|+|++|++++++++|.+++.......       .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            8875422              23667775543 345677999999999999999998876433211       0000111


Q ss_pred             HhhCCC---------------------CCCCCcc--------ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          242 VKQLPH---------------------VPKQPFS--------QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       242 ~~~~~~---------------------~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ......                     .......        ......+.++.+++.+||+.||++|||+.++++||||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            110000                     0000000        0001467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.2e-37  Score=266.41  Aligned_cols=238  Identities=26%  Similarity=0.396  Sum_probs=189.2

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ...||+|+||.||++.+..++..+++|.+...  .....+.+.+|+.+++.++|+||+++++++     ......++++|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e   85 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFME   85 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEEe
Confidence            45699999999999999999999999988644  233456788999999999999999999998     56678999999


Q ss_pred             cCc-ccHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-CCCeEEeeccccccc------
Q 042681          120 LMD-TDLHQIIRSK-QAL--TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARTT------  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~-~~~--~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-~~~ikL~Dfg~~~~~------  188 (339)
                      |++ ++|.+++... ..+  ++..+..++.|++.||+|||++|++||||||+||+++. ++.++|+|||.+...      
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence            997 6999988764 455  88889999999999999999999999999999999976 679999999987543      


Q ss_pred             -----CCCCcccccccccc--ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          189 -----SETDFMTEYVVTRW--DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       189 -----~~~~~~~~~~~~~~--~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                           +...|.+|+.....  ....++|+|++|++++++++|..|+..........   ..... .....   .....++
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~-~~~~~---~~~~~~~  238 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGM-FKIHP---EIPESLS  238 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhh-hccCC---CCCcccC
Confidence                 23356677765432  35678999999999999999998875432111110   00000 00011   1113578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      +++++++.+||+.+|++|||+.+++.||||
T Consensus       239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.2e-38  Score=293.30  Aligned_cols=260  Identities=20%  Similarity=0.225  Sum_probs=188.4

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCc-eEEEE--------------Eeccc-ccChHhHHHHHHHHHHHhhCCC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKE-EVAIK--------------KITNA-FDNRIDAKRILREIKLLCHMTH   93 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~-~~avK--------------~~~~~-~~~~~~~~~~~~e~~~l~~l~h   93 (339)
                      -.+.++|.+ ++.||+|+||.||++..+.... ..+.|              .+.+. .........+.+|+.++.+++|
T Consensus       144 ~~~~~~Y~i-i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        144 DEFLAHFRV-IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhhccEE-EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence            345678888 9999999999999987654322 12222              11111 1122234567899999999999


Q ss_pred             CCeeeeeeecCCCCcCCcCeEEEEEecCcccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 042681           94 ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-----QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN  168 (339)
Q Consensus        94 ~~I~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~N  168 (339)
                      |||+++++++     ......++++++++++|.+++...     .......++.++.||+.||+|||++||+||||||+|
T Consensus       223 pnIv~l~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~N  297 (501)
T PHA03210        223 ENILKIEEIL-----RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLEN  297 (501)
T ss_pred             CCcCcEeEEE-----EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            9999999999     666778999999999888887542     234466788899999999999999999999999999


Q ss_pred             eeeccCCCeEEeeccccccc------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCC-ccccccc
Q 042681          169 LLLNANCDLKICDFGLARTT------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDS-DLGFLRS  235 (339)
Q Consensus       169 Ili~~~~~ikL~Dfg~~~~~------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~-~~~~~~~  235 (339)
                      ||++.++.+||+|||++...            +...|.+||......+....|+|++|++++++++|..+.. .......
T Consensus       298 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            99999999999999998643            3345778888777778888999999999999998864332 1111111


Q ss_pred             chHHHHHhhCCCCC----------------------CCCccc--cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          236 DNARRYVKQLPHVP----------------------KQPFSQ--KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       236 ~~~~~~~~~~~~~~----------------------~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ..............                      ......  ....++.++.++|.+||++||.+|||+.|++.||||
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            11111111100000                      000000  012356778899999999999999999999999999


Q ss_pred             CCCc
Q 042681          292 SSLH  295 (339)
Q Consensus       292 ~~~~  295 (339)
                      ....
T Consensus       458 ~~~~  461 (501)
T PHA03210        458 SAEE  461 (501)
T ss_pred             hcCC
Confidence            8754

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.2e-37  Score=266.98  Aligned_cols=242  Identities=19%  Similarity=0.265  Sum_probs=189.8

Q ss_pred             cCccCCCcccc--ccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcC
Q 042681           33 SSKYVPPLQPI--GRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKE  109 (339)
Q Consensus        33 ~~~y~~~~~~l--g~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~  109 (339)
                      .++|.. .+.+  |+|+||.||++.++.+++.+|+|.+........       |+.....+ +||||+++++.+     .
T Consensus        13 ~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~-----~   79 (267)
T PHA03390         13 LKNCEI-VKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSV-----T   79 (267)
T ss_pred             HHhhcc-ccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEE-----e
Confidence            345555 5555  999999999999999999999999865422211       22222222 699999999999     5


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC-CeEEeecccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~-~ikL~Dfg~~~~  187 (339)
                      ..+.+++||||++ ++|.+++.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||.+..
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~  159 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI  159 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence            5678999999997 79999998878999999999999999999999999999999999999999998 999999998865


Q ss_pred             cC-------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          188 TS-------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       188 ~~-------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                      .+       ...|.+|+.........+.|+|++|++++++++|..|+....... .......... ..    .....+.+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~----~~~~~~~~  233 (267)
T PHA03390        160 IGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QK----KLPFIKNV  233 (267)
T ss_pred             cCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cc----cCCccccc
Confidence            43       335778888776677788999999999999999998876322111 0111111111 11    11122358


Q ss_pred             CHHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCC
Q 042681          261 SPVAIDLAERMLVFDPAKRIT-VEEALNHPYLSS  293 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps-~~ell~hp~f~~  293 (339)
                      ++.+++||.+||+.+|.+||+ ++++++||||.+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             CHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            999999999999999999996 599999999975

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2e-37  Score=280.71  Aligned_cols=239  Identities=24%  Similarity=0.325  Sum_probs=188.3

Q ss_pred             ccCCCccccccccceEEEEEEe-----CCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCc
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVN-----SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDK  108 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~  108 (339)
                      +|.. .+.||+|+||.||+|.+     ..++..+|+|+++... .....+.+.+|+.++..+ +||||+++++++     
T Consensus        36 ~~~~-~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----  108 (375)
T cd05104          36 RLSF-GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGAC-----  108 (375)
T ss_pred             Heeh-hheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence            4555 99999999999999974     3467789999986442 233456788999999999 899999999999     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhc-------------------------------------------------------
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSK-------------------------------------------------------  132 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~-------------------------------------------------------  132 (339)
                      ......++||||++ |+|.+++...                                                       
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            66678899999998 7998888542                                                       


Q ss_pred             --------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC--
Q 042681          133 --------------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--  190 (339)
Q Consensus       133 --------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--  190 (339)
                                          ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.....  
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                                1478888999999999999999999999999999999999999999999999864321  


Q ss_pred             -----------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          191 -----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       191 -----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                 ..|++||.........++|+|++|++++++++ |..|+.......  ...........   ..   ...
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~~---~~---~~~  340 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEGYR---ML---SPE  340 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhCcc---CC---CCC
Confidence                       23778888777778889999999999999997 777765432111  11111111111   10   112


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..+.++++|+.+||+.||++|||+.++++.
T Consensus       341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-37  Score=270.47  Aligned_cols=247  Identities=32%  Similarity=0.505  Sum_probs=194.5

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ++.||.|++|.||++.+..+|+.+|+|++............+.+|+.+++.++|||++++++++...   ..+..++|+|
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~lv~e   80 (287)
T cd07840           4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYMVFE   80 (287)
T ss_pred             eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEEEec
Confidence            7889999999999999999999999999986643344456688999999999999999999998321   1378999999


Q ss_pred             cCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC-------
Q 042681          120 LMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET-------  191 (339)
Q Consensus       120 ~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~-------  191 (339)
                      |++++|.+++.+. ..+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||.+......       
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (287)
T cd07840          81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN  160 (287)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence            9999999988765 68999999999999999999999999999999999999999999999999988654332       


Q ss_pred             -----Ccccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC---------------
Q 042681          192 -----DFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK---------------  250 (339)
Q Consensus       192 -----~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------  250 (339)
                           .|.+|+... ......++|+|++|++++++++|..++......  ...............               
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchhhccccccchhhhhc
Confidence                 366677543 234567899999999999999999887543321  111111111000000               


Q ss_pred             -------CCccccCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          251 -------QPFSQKFPN-MSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       251 -------~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                             ......+.. +++.+.+++++||+.+|.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                   000011122 38899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.8e-37  Score=270.15  Aligned_cols=241  Identities=27%  Similarity=0.420  Sum_probs=198.5

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~  112 (339)
                      +|.. .+.||+|++|.||++.+..+|+.+++|++.+... .....+.+.+|+.++++++ ||||+++++++     ....
T Consensus         2 ~y~~-~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~   75 (280)
T cd05581           2 DFKF-GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE   75 (280)
T ss_pred             CceE-eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence            4555 8899999999999999999999999999876422 3334567889999999998 99999999998     6667


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-  190 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-  190 (339)
                      ..+++||+++ ++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..... 
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            8999999995 79999999888999999999999999999999999999999999999999999999999998765432 


Q ss_pred             ------------------------------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHH
Q 042681          191 ------------------------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARR  240 (339)
Q Consensus       191 ------------------------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~  240 (339)
                                                    ..|.+|+...........|+|++|++++++++|..|+......  .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~  233 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--LTFQK  233 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--HHHHH
Confidence                                          2355666655556677899999999999999999987644311  11111


Q ss_pred             HHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCC
Q 042681          241 YVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITV----EEALNHPYL  291 (339)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~----~ell~hp~f  291 (339)
                      ......        .....+++.+.+||.+||+.+|++||++    .++++||||
T Consensus       234 ~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         234 ILKLEY--------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHhcCC--------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            111100        1113568999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.4e-37  Score=263.70  Aligned_cols=241  Identities=23%  Similarity=0.361  Sum_probs=199.8

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. .+.||.|++|.||++.+..++..+++|++............+.+|+++++.++|||++++++.+     ......+
T Consensus         2 y~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-----~~~~~~~   75 (258)
T cd08215           2 YEI-IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-----EEKGKLC   75 (258)
T ss_pred             ceE-EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-----ecCCEEE
Confidence            445 7899999999999999999999999999976655556677889999999999999999999998     5557899


Q ss_pred             EEEecCc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC
Q 042681          116 IVYELMD-TDLHQIIRSK----QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  190 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~  190 (339)
                      +++|+++ ++|.+.+...    ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            9999998 5899988763    7799999999999999999999999999999999999999999999999999865433


Q ss_pred             C-----------CccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          191 T-----------DFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       191 ~-----------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                      .           .|.+|+...........|+|++|++++++++|..++....      ................   ...
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~  226 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKGQYPPI---PSQ  226 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcCCCCCC---CCC
Confidence            2           3667776666667788999999999999999988864322      1111111111111111   135


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ++.++.+++.+||..+|++||++.++++||||
T Consensus       227 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         227 YSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            78999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.2e-37  Score=267.77  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=194.5

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCc-C
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDK-E  109 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~-~  109 (339)
                      -.+.|.. .+.||.|+||.||++.+..+++.+|+|++...   ......+..|+.++..+ +||||+++++++..... .
T Consensus        14 ~~~~~~~-~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          14 PAGIFEL-VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhh-heeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            3466777 89999999999999999999999999988543   22345677899999998 69999999999843211 2


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      ....++++|||++ |+|.+++...  ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            3457899999998 6898888653  458899999999999999999999999999999999999999999999999975


Q ss_pred             ccC-----------CCCcccccccc-----ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          187 TTS-----------ETDFMTEYVVT-----RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       187 ~~~-----------~~~~~~~~~~~-----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      ...           ...|.+||...     .......+|+|++|++++++++|..|+.....     ....... .....
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-----~~~~~~~-~~~~~  243 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-----MRALFLI-PRNPP  243 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-----HhhhhhH-hhCCC
Confidence            432           23477777653     23456679999999999999999988754321     1111111 11111


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ..  .....++.++.+||.+||+.||.+||++.++++||||
T Consensus       244 ~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 PK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            11  1113578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=261.33  Aligned_cols=241  Identities=31%  Similarity=0.452  Sum_probs=201.1

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. .+.||+|++|.||++.+..+++.+++|.+............+.+|++++.+++|||++++++++     ...+..+
T Consensus         2 y~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (254)
T cd06627           2 YQL-GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY   75 (254)
T ss_pred             cee-eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence            455 8899999999999999999999999999987655445667899999999999999999999998     5567899


Q ss_pred             EEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC----
Q 042681          116 IVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----  190 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~----  190 (339)
                      +++||++ ++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....    
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999998 59999998888999999999999999999999999999999999999999999999999998875432    


Q ss_pred             -------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          191 -------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       191 -------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                             ..|.+|+.........+.|+|++|++++++++|..|+......  ......  ...  ...   ...+.++..
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~~~~--~~~--~~~---~~~~~~~~~  226 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AALFRI--VQD--DHP---PLPEGISPE  226 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHHHHH--hcc--CCC---CCCCCCCHH
Confidence                   2366777665555778899999999999999999887643311  111111  111  111   112457899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          264 AIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      +++++.+||..+|++||++.+++.||||
T Consensus       227 ~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         227 LKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-37  Score=272.33  Aligned_cols=244  Identities=25%  Similarity=0.433  Sum_probs=197.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ...||.|+||.||++.+..+++.+|+|++...  .....+.+.+|+.++..++||||+++++.+     ......++|||
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~lv~e   99 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWVVME   99 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEEEEe
Confidence            66799999999999999999999999998643  233456688999999999999999999998     56678999999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----------  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----------  188 (339)
                      |++ ++|.+++. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...          
T Consensus       100 ~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         100 FLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            998 57777664 457999999999999999999999999999999999999999999999999987532          


Q ss_pred             -CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          189 -SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       189 -~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                       +...|.+|+.........++|+|++|++++++++|..|+......  ...........    ... .....++..+.++
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~----~~~-~~~~~~~~~~~~l  251 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDNLP----PRV-KDSHKVSSVLRGF  251 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCC----Ccc-ccccccCHHHHHH
Confidence             233577888777667788899999999999999999986542211  11111111111    111 1113478899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          268 AERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       268 i~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      +.+||..||++|||++++++||||.....+.
T Consensus       252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         252 LDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            9999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.6e-37  Score=279.71  Aligned_cols=246  Identities=22%  Similarity=0.296  Sum_probs=191.6

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCC-----CceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeee
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSET-----KEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDI  102 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~  102 (339)
                      .|.++.+.+.+++.||+|+||.||+|.+..+     +..||+|++..... ......+.+|+.+++.+ +|+||++++++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~  110 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGA  110 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence            3444444444599999999999999986543     35799999875432 23456788999999999 89999999999


Q ss_pred             cCCCCcCCcCeEEEEEecCc-ccHHHHHHhc-------------------------------------------------
Q 042681          103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSK-------------------------------------------------  132 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-------------------------------------------------  132 (339)
                      +     .....+++||||+. |+|.+++...                                                 
T Consensus       111 ~-----~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (374)
T cd05106         111 C-----THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMR  185 (374)
T ss_pred             e-----cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccC
Confidence            8     66678999999998 7999887532                                                 


Q ss_pred             ---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-
Q 042681          133 ---------------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-  190 (339)
Q Consensus       133 ---------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-  190 (339)
                                           .++++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+++.... 
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~  265 (374)
T cd05106         186 PVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND  265 (374)
T ss_pred             CccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence                                 2478888999999999999999999999999999999999999999999999864321 


Q ss_pred             ------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          191 ------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       191 ------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                  ..|++||......+..+.|+|++|++++++++ |..|+......  ...............      .
T Consensus       266 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~~~~~~~~~~~~~~------~  337 (374)
T cd05106         266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SKFYKMVKRGYQMSR------P  337 (374)
T ss_pred             cceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HHHHHHHHcccCccC------C
Confidence                        23788887776778889999999999999996 98887543211  111111111111111      1


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ...++++++++.+||+.||.+|||+.++++.
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~  368 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQL  368 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2368999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.8e-37  Score=271.28  Aligned_cols=256  Identities=32%  Similarity=0.438  Sum_probs=196.7

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC-----
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD-----  107 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-----  107 (339)
                      .++|.+ .+.||.|++|.||++.+..+|+.+|+|+++...........+.+|+.+++.++||||+++++++.+..     
T Consensus         6 ~~~~~~-~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           6 VDKFDI-IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhe-eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            345666 89999999999999999999999999998765333334456778999999999999999999984321     


Q ss_pred             cCCcCeEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          108 KEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      ......+++++||+++++...+.+. ..+++..++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+.
T Consensus        85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~  164 (302)
T cd07864          85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR  164 (302)
T ss_pred             cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence            0123479999999999888887654 479999999999999999999999999999999999999999999999999986


Q ss_pred             ccC------------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC---
Q 042681          187 TTS------------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK---  250 (339)
Q Consensus       187 ~~~------------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~---  250 (339)
                      ...            ...|.+|+.... .....+.|+|++|++++++++|.+++......  ...............   
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQLELISRLCGSPCPAVW  242 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhhc
Confidence            532            223666775432 33567899999999999999999887543211  111111111000000   


Q ss_pred             -------------------CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          251 -------------------QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       251 -------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                                         ......+..++..++++|.+||+.||++||++.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                               01111234578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-37  Score=266.71  Aligned_cols=248  Identities=25%  Similarity=0.374  Sum_probs=194.9

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCc-CC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDK-EK  110 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~-~~  110 (339)
                      .++|.. .+.||.|++|.||+|.+..+++.+++|++....   ...+.+.+|+.+++++ +|+||+++++++..... ..
T Consensus         5 ~~~y~~-~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFEL-VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeh-eeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            467777 899999999999999999999999999986542   2346788999999999 69999999999854321 23


Q ss_pred             cCeEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                      ...+++||||++ ++|.+++..    ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            456899999998 588888754    357999999999999999999999999999999999999999999999999987


Q ss_pred             cccC-----------CCCccccccccc-----cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCC
Q 042681          186 RTTS-----------ETDFMTEYVVTR-----WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP  249 (339)
Q Consensus       186 ~~~~-----------~~~~~~~~~~~~-----~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (339)
                      ....           ...|.+|+....     .....++|+|++|++++++++|..|+.....  .....   .. ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~---~~-~~~~  234 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALF---KI-PRNP  234 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHH---Hh-hccC
Confidence            5432           224667765432     2345679999999999999999998754311  11111   11 1111


Q ss_pred             CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       250 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ..... ....+++++++||.+||..||++|||+.++++|||+
T Consensus       235 ~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         235 PPTLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            11111 112378899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.6e-37  Score=266.17  Aligned_cols=245  Identities=21%  Similarity=0.281  Sum_probs=191.6

Q ss_pred             ccccccceEEEEEEeCCCCceEEEEEecccccC-hHhHHHHHHHH---HHHhhCCCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           42 PIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-RIDAKRILREI---KLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        42 ~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~e~---~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      .||+|+||.||++.+..+++.||+|.+.+.... .........|.   ..+....||+|+++++++     ......++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            479999999999999999999999998754322 11122233343   344445799999999998     666789999


Q ss_pred             EecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--------
Q 042681          118 YELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--------  188 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--------  188 (339)
                      |||+. ++|.+++...+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+...        
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~  155 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS  155 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCc
Confidence            99997 689888888788999999999999999999999999999999999999999999999999987643        


Q ss_pred             -CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 -SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 -~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                       +...|.+||.... .......|+|++|++++++++|..|+............   ..... ....   ....++.++.+
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~-~~~~---~~~~~s~~~~~  228 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLT-MAVE---LPDSFSPELRS  228 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhhc-cCCC---CCCcCCHHHHH
Confidence             3345777887653 34667899999999999999999987654221111111   11111 1111   11346899999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCCCCCCCccCC
Q 042681          267 LAERMLVFDPAKRI-----TVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       267 li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~~  298 (339)
                      ++.+||..+|.+||     ++.++++||||+...+..
T Consensus       229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             HHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence            99999999999999     999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.3e-37  Score=268.22  Aligned_cols=236  Identities=15%  Similarity=0.148  Sum_probs=189.6

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEecccccCh-HhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR-IDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ..||+|+++.||++..  +|+.+|+|+++...... ...+.+.+|+.++.+++||||+++++++.+.. .....+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5689999999999987  68899999997653333 22467889999999999999999999984311 22456899999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEEeeccccccc--------C
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTT--------S  189 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--------~  189 (339)
                      |++ |+|.+++.+.+.+++.....++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...        +
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~  182 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN  182 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccC
Confidence            998 7999999888889999999999999999999998 49999999999999999999999999998642        3


Q ss_pred             CCCccccccccc--cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          190 ETDFMTEYVVTR--WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       190 ~~~~~~~~~~~~--~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                      ...|.+|+....  ..+..++|+|++|+++|++++|..|+......  ...........   ....   ...+++++++|
T Consensus       183 ~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i~~~~~---~~~~---~~~~~~~l~~l  254 (283)
T PHA02988        183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLIINKNN---SLKL---PLDCPLEIKCI  254 (283)
T ss_pred             cccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhcCC---CCCC---CCcCcHHHHHH
Confidence            345788887764  56788999999999999999999997654211  11111111111   1111   12578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 042681          268 AERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       268 i~~~L~~dP~~Rps~~ell~  287 (339)
                      +.+||+.||++|||+.+++.
T Consensus       255 i~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        255 VEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHhcCCcccCcCHHHHHH
Confidence            99999999999999999985

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.5e-37  Score=266.66  Aligned_cols=253  Identities=24%  Similarity=0.353  Sum_probs=195.8

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPM  106 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~  106 (339)
                      ......++|.. .+.||+|++|.||++.+..+++.+|+|++....   .....+.+|+.++..+ +||||+++++++...
T Consensus        12 ~~~~~~~~~~~-~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          12 SFPDPSDTWEI-IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             cCCCcccceee-eeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34455677777 999999999999999999999999999876431   1235577899999999 699999999987543


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEee
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD  181 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~D  181 (339)
                      ........++||||++ ++|.+++..    ...+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence            3345567999999997 688887642    35789999999999999999999999999999999999999999999999


Q ss_pred             cccccccC-----------CCCcccccccc-----ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhC
Q 042681          182 FGLARTTS-----------ETDFMTEYVVT-----RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL  245 (339)
Q Consensus       182 fg~~~~~~-----------~~~~~~~~~~~-----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~  245 (339)
                      ||.+....           ...|.+|+...     ......+.|+|++|++++++++|..|+......     ..... .
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-----~~~~~-~  241 (286)
T cd06638         168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-----RALFK-I  241 (286)
T ss_pred             CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-----HHHhh-c
Confidence            99986432           23466777543     123566899999999999999999887543211     11111 1


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       246 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ........ .....++..+++|+.+||+.||++|||+.++++||||
T Consensus       242 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         242 PRNPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cccCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            11111100 0112367889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-36  Score=266.39  Aligned_cols=243  Identities=25%  Similarity=0.419  Sum_probs=197.9

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||+|++|.||++.+..+++.+++|++...  .....+.+.+|+.++..++||||+++++++     ......++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~v~e   96 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWVVME   96 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEEEEe
Confidence            56899999999999999999999999988543  223345688999999999999999999998     55678899999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----------  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----------  188 (339)
                      |+. ++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+...          
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            997 689888877 67999999999999999999999999999999999999999999999999987532          


Q ss_pred             -CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          189 -SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       189 -~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                       +...|.+|+...........|+|++|++++++++|..|+.....  .........    ... +.......++..+.++
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~~~~~~~~----~~~-~~~~~~~~~~~~l~~l  248 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQAMKRIRD----NLP-PKLKNLHKVSPRLRSF  248 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHh----cCC-CCCcccccCCHHHHHH
Confidence             23357788877666677889999999999999999988653211  111111111    111 1111123478999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          268 AERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       268 i~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      +.+||+.+|++||++.++++||||......
T Consensus       249 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         249 LDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             HHHHcccChhhCcCHHHHccCcccccCCCc
Confidence            999999999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.3e-37  Score=273.73  Aligned_cols=256  Identities=28%  Similarity=0.417  Sum_probs=196.1

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc---C
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK---E  109 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~---~  109 (339)
                      .++|.. .+.||.|++|.||++.+..+++.+|+|++............+.+|+.+++.++||||+++++++.....   .
T Consensus         7 ~~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEI-LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEE-EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            356776 899999999999999999999999999986543333233456789999999999999999998743221   1


Q ss_pred             CcCeEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          110 KFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ....+++++||+++++...+.. ...+++..++.++.|++.||+|||++|++|+||||+||++++++.++|+|||++...
T Consensus        86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            2345899999999888887765 457999999999999999999999999999999999999999999999999998643


Q ss_pred             CC----------------------CCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhC
Q 042681          189 SE----------------------TDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL  245 (339)
Q Consensus       189 ~~----------------------~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~  245 (339)
                      ..                      ..|.+|+.... .....+.|+|++|++++++++|.+++.......  .........
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~--~~~~~~~~~  243 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID--QLHLIFKLC  243 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence            22                      22667775432 346678999999999999999998875432211  011111100


Q ss_pred             CC----------------------CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          246 PH----------------------VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       246 ~~----------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ..                      .........+..+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            00                      00001111234566889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.4e-37  Score=267.56  Aligned_cols=245  Identities=24%  Similarity=0.370  Sum_probs=199.3

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      .|.. ++.||.|++|.||++.+..++..+|+|.+.... .......+.+|+.++..++||||+++++.+     ......
T Consensus         5 ~y~~-~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   77 (277)
T cd06640           5 LFTK-LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKL   77 (277)
T ss_pred             hhhh-hhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEE
Confidence            4555 888999999999999999999999999886542 233457788999999999999999999999     667789


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC---
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE---  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~---  190 (339)
                      ++||||++ ++|.+++.. +++++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....   
T Consensus        78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999998 689888765 6789999999999999999999999999999999999999999999999999854332   


Q ss_pred             --------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          191 --------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       191 --------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                              ..|.+|+.........+.|+|++|++++++++|..|+......      ............   .....++.
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~~~~~~~~---~~~~~~~~  227 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM------RVLFLIPKNNPP---TLTGEFSK  227 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH------hHhhhhhcCCCC---CCchhhhH
Confidence                    2367777766666778899999999999999999886542111      111111111111   11234678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      .+.+++.+||+.+|++||++.++++||||.....
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         228 PFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence            8999999999999999999999999999976644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=255.60  Aligned_cols=247  Identities=21%  Similarity=0.342  Sum_probs=200.2

Q ss_pred             CccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           39 PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        39 ~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      .+..||+|..|+|++++.+.+|..+|||.+... .+..+.++++..++++..- .+|+|++.+|+|     -....++|.
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF-----i~n~dV~Ic  169 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYF-----ITNTDVFIC  169 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE-----eeCchHHHH
Confidence            377899999999999999999999999999764 4555678888888876555 599999999999     556678999


Q ss_pred             EecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCeeeccCCCeEEeecccccc--------
Q 042681          118 YELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIH-SANVLHRDLKPSNLLLNANCDLKICDFGLART--------  187 (339)
Q Consensus       118 ~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH-~~givH~dikp~NIli~~~~~ikL~Dfg~~~~--------  187 (339)
                      ||.++..+..+++. .++++|..+-.+...+++||.||- ++||+|||+||+|||+|..|++||||||++.+        
T Consensus       170 MelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht  249 (391)
T KOG0983|consen  170 MELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT  249 (391)
T ss_pred             HHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence            99998666666544 578999999999999999999997 56899999999999999999999999999854        


Q ss_pred             --cCCCCcccccccccc---ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          188 --TSETDFMTEYVVTRW---DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       188 --~~~~~~~~~~~~~~~---~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                        .|...|++||.....   .+..++|+|++|+.++++.+|..|+..... ............     ++....-.++|+
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-dFe~ltkvln~e-----PP~L~~~~gFSp  323 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-DFEVLTKVLNEE-----PPLLPGHMGFSP  323 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-cHHHHHHHHhcC-----CCCCCcccCcCH
Confidence              345578888877654   467789999999999999999999765421 222222222211     122222235899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ++++|+..||++|+.+||...++|+|||+...+..
T Consensus       324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a  358 (391)
T KOG0983|consen  324 DFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA  358 (391)
T ss_pred             HHHHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence            99999999999999999999999999999887543

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-36  Score=264.44  Aligned_cols=247  Identities=21%  Similarity=0.279  Sum_probs=189.8

Q ss_pred             cCccCCCccccccccceEEEEEE----eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      .+||+..++.||+|+||+||++.    ...++..+|+|.+.... .......+.+|+.+++.++||||+++++++..   
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   77 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSE---   77 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence            46786659999999999998865    34578899999986542 22345678899999999999999999998742   


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .....++++|||++ ++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+..
T Consensus        78 ~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          78 QGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             CCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence            23456899999998 688888865 4699999999999999999999999999999999999999999999999999875


Q ss_pred             cCC--------------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc---------hHHHHHhh
Q 042681          188 TSE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD---------NARRYVKQ  244 (339)
Q Consensus       188 ~~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~---------~~~~~~~~  244 (339)
                      ...              ..|.+|+.........++|+|++|++++++++|..|+...+.....         ........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            432              1256777666666778899999999999999998876433211000         00000000


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       245 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .......   .....++.++.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         237 LERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000111   112357899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.2e-37  Score=271.93  Aligned_cols=246  Identities=20%  Similarity=0.237  Sum_probs=188.9

Q ss_pred             cceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCc-ccH
Q 042681           47 AYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDL  125 (339)
Q Consensus        47 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L  125 (339)
                      +++.||++++..+++.+|+|+++...........+.+|+.++..++||||+++++++     ......+++|||++ ++|
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEEeccCCCCH
Confidence            556677777788999999999987644555678899999999999999999999998     66677999999998 789


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC--------------
Q 042681          126 HQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--------------  189 (339)
Q Consensus       126 ~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~--------------  189 (339)
                      .+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.+....              
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~  166 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK  166 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence            8888753  568999999999999999999999999999999999999999999999999875331              


Q ss_pred             ----CCCccccccccc--cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC-------------CCC-
Q 042681          190 ----ETDFMTEYVVTR--WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP-------------HVP-  249 (339)
Q Consensus       190 ----~~~~~~~~~~~~--~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~-------------~~~-  249 (339)
                          ...|.+|+....  ..+..++|+|++|++++++++|..|+......... .........             ... 
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
T cd08216         167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML-LEKVRGTVPCLLDKSTYPLYEDSMSQ  245 (314)
T ss_pred             cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccCccccccCchhhhcCCcCc
Confidence                123666776543  34567899999999999999999997654311100 000000000             000 


Q ss_pred             -----------CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          250 -----------KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       250 -----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                                 ..........++.++.+|+.+||+.||++|||+.++++||||+.+.+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~  305 (314)
T cd08216         246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRN  305 (314)
T ss_pred             ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccc
Confidence                       0000001122456789999999999999999999999999999887543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-36  Score=263.07  Aligned_cols=243  Identities=23%  Similarity=0.279  Sum_probs=193.8

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.+ .+.||+|+||.||++.+..+++.+|+|.+... .........+.+|+.+++.++||||+++++++     ...+
T Consensus         2 ~~~~i-~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   75 (267)
T cd08228           2 ANFQI-EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF-----IEDN   75 (267)
T ss_pred             cceee-eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeE-----EECC
Confidence            35566 89999999999999999999999999988653 23344456788999999999999999999998     5567


Q ss_pred             eEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          113 DVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ..++++||++ ++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~  155 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF  155 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECcccccee
Confidence            8999999998 688887753    34589999999999999999999999999999999999999999999999998764


Q ss_pred             c-----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          188 T-----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       188 ~-----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      .           +...|.+|+..........+|+|++|++++++++|..|+....... ...........   ..+.  .
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~---~~~~--~  229 (267)
T cd08228         156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIEQCD---YPPL--P  229 (267)
T ss_pred             ccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHhcCC---CCCC--C
Confidence            3           2234677887766667788999999999999999998864322111 11111111111   1111  1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ...++..+++++.+||+.+|++||++.++++.
T Consensus       230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            12467889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.4e-37  Score=270.74  Aligned_cols=245  Identities=27%  Similarity=0.391  Sum_probs=198.6

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      .|.. ++.||+|++|.||++.+..+++.+|+|.+..... ....+.+.+|+.++..++||||+++++.+     ......
T Consensus         5 ~y~~-~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   77 (277)
T cd06642           5 LFTK-LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKL   77 (277)
T ss_pred             HHHH-HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCce
Confidence            3445 7889999999999999999999999998864422 23456788999999999999999999998     566789


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC----
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS----  189 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~----  189 (339)
                      ++|+||++ ++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....    
T Consensus        78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999998 688887754 678999999999999999999999999999999999999999999999999886432    


Q ss_pred             -------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          190 -------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       190 -------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                             ...|.+|+.........++|+|++|++++++++|..|+......      ............   .....++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~~~~~~~~---~~~~~~~~  227 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM------RVLFLIPKNSPP---TLEGQYSK  227 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh------hHHhhhhcCCCC---CCCcccCH
Confidence                   23467788776667778899999999999999999886532111      011111111111   11134688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ++.++|.+||+.+|++||++.++++||||.....
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         228 PFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence            8999999999999999999999999999977654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=280.54  Aligned_cols=243  Identities=24%  Similarity=0.301  Sum_probs=204.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccCh-HhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR-IDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ++.||.|+||.||-|++..+.+.||+|+++.+.... .-.+.+++|+.+|++++|||++.+.|+|     -.....++||
T Consensus        31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy-----Lre~TaWLVM  105 (948)
T KOG0577|consen   31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY-----LREHTAWLVM  105 (948)
T ss_pred             HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee-----eccchHHHHH
Confidence            889999999999999999999999999998664433 3356789999999999999999999999     5566679999


Q ss_pred             ecCcccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc-------ccCC
Q 042681          119 ELMDTDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-------TTSE  190 (339)
Q Consensus       119 e~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~-------~~~~  190 (339)
                      |||-|+-.+++. ..+++.+.++..|+.+.+.||+|||+.+.+|||||..|||++..|.|||.|||.+.       .+|+
T Consensus       106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGT  185 (948)
T KOG0577|consen  106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGT  185 (948)
T ss_pred             HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchhcccCC
Confidence            999887777774 34789999999999999999999999999999999999999999999999999985       4677


Q ss_pred             CCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          191 TDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       191 ~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                      +.+++|++..   ...+..+.|+|++|++.+++.-..+|.....      .-..++.+.++..+.+.  .+.+|..+++|
T Consensus       186 PywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN------AMSALYHIAQNesPtLq--s~eWS~~F~~F  257 (948)
T KOG0577|consen  186 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESPTLQ--SNEWSDYFRNF  257 (948)
T ss_pred             ccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch------HHHHHHHHHhcCCCCCC--CchhHHHHHHH
Confidence            7888888765   3457888999999999999999988865432      22233333343333332  25689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          268 AERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       268 i~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      |.+||++-|.+|||.+++++|+|..--+
T Consensus       258 vd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  258 VDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             HHHHHhhCcccCCcHHHHhhcchhccCC
Confidence            9999999999999999999999987554

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2e-37  Score=276.16  Aligned_cols=250  Identities=18%  Similarity=0.261  Sum_probs=192.5

Q ss_pred             cccccc--cceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRG--AYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ..||+|  +||+||++.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++     ......++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence            456666  999999999999999999999876544455567888999999999999999999999     6667899999


Q ss_pred             ecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-------
Q 042681          119 ELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-------  188 (339)
                      ||+. +++.+++.+.  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++++||+.+...       
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9998 6999888764  45899999999999999999999999999999999999999999999999753211       


Q ss_pred             -----------CCCCccccccccc--cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC--------
Q 042681          189 -----------SETDFMTEYVVTR--WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH--------  247 (339)
Q Consensus       189 -----------~~~~~~~~~~~~~--~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~--------  247 (339)
                                 +...|.+|+....  .....+.|+|++|++++++++|..|+......  ............        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCcccccc
Confidence                       1123667776543  33567899999999999999999987543211  000000000000        


Q ss_pred             ------------------------------CCCCC-ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          248 ------------------------------VPKQP-FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       248 ------------------------------~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                                                    ..... .......+++.+++|+++||+.||++|||+.++++||||..+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                          00000 00011236788999999999999999999999999999988876


Q ss_pred             C
Q 042681          297 I  297 (339)
Q Consensus       297 ~  297 (339)
                      .
T Consensus       317 ~  317 (328)
T cd08226         317 Q  317 (328)
T ss_pred             h
Confidence            4

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.8e-36  Score=259.98  Aligned_cols=232  Identities=22%  Similarity=0.340  Sum_probs=186.6

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEec
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYEL  120 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~  120 (339)
                      +.||+|+||.||++.+..+++.+|+|.+.... .......+.+|+.+++.++||||+++++++     ......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEee
Confidence            36899999999999999999999999876432 333456789999999999999999999998     556779999999


Q ss_pred             Cc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC--------
Q 042681          121 MD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--------  190 (339)
Q Consensus       121 ~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--------  190 (339)
                      ++ ++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.....        
T Consensus        75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            97 6999988654 4689999999999999999999999999999999999999999999999999864321        


Q ss_pred             -----CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHH
Q 042681          191 -----TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       191 -----~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  264 (339)
                           ..|.+|+..........+|+|++|++++++++ |..|+.....   ..........   ....   ....++..+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~~~~~~~~---~~~~---~~~~~~~~~  225 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQTREAIEQG---VRLP---CPELCPDAV  225 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHHHHHHHcC---CCCC---CcccCCHHH
Confidence                 13677777666667778999999999999997 7777643221   1111111111   1111   113468999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 042681          265 IDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .+|+.+||+.+|++|||+.++++
T Consensus       226 ~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         226 YRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=262.14  Aligned_cols=245  Identities=22%  Similarity=0.350  Sum_probs=197.7

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccc---cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .+|.. .+.||+|++|.||++.+..+++.+++|.+....   ........+.+|+.++++++||||+++++++.+   ..
T Consensus         2 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~   77 (264)
T cd06653           2 VNWRL-GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PE   77 (264)
T ss_pred             Cceee-eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CC
Confidence            45666 899999999999999999999999999875431   223345678899999999999999999999843   23


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ...+++++||++ ++|.+.+...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.++...
T Consensus        78 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          78 EKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            456889999997 6899999887889999999999999999999999999999999999999999999999999986432


Q ss_pred             --------------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          190 --------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       190 --------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                                    ...|.+|+.........++|+|++|++++++++|..|+......     .............   .
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~---~  229 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AAIFKIATQPTKP---M  229 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HHHHHHHcCCCCC---C
Confidence                          23467787776666777899999999999999999997643211     1112211111111   1


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ....+++.+.++|.+||+ +|.+||++.+++.|||.
T Consensus       230 ~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         230 LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            224578999999999999 57999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-36  Score=267.25  Aligned_cols=256  Identities=22%  Similarity=0.336  Sum_probs=196.5

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~  109 (339)
                      .+.-..+.+.+.||+|++|.||++.+..+++.+|+|.++..... .....+.+|+.++... .||||+++++++     .
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~   84 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYF-----I   84 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheee-----e
Confidence            33333334499999999999999999999999999998754322 2345566777766666 599999999999     5


Q ss_pred             CcCeEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          110 KFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .....+++|||+++++.+++.. ...+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||.+..
T Consensus        85 ~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          85 TDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             cCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            6678999999999888777765 4679999999999999999999997 6999999999999999999999999999865


Q ss_pred             cC----------CCCcccccccccc----ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          188 TS----------ETDFMTEYVVTRW----DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       188 ~~----------~~~~~~~~~~~~~----~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      ..          ...|.+|+.....    ....+.|+|++|++++++++|..|+...... ...........  ...  .
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~--~~~--~  239 (296)
T cd06618         165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQEE--PPS--L  239 (296)
T ss_pred             ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcCC--CCC--C
Confidence            43          2246667765433    2567899999999999999999987542111 11111111111  111  1


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                       .....++.++++|+.+||+.||++||++.++++||||.......
T Consensus       240 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  283 (296)
T cd06618         240 -PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE  283 (296)
T ss_pred             -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence             11124788999999999999999999999999999999776543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.7e-37  Score=262.29  Aligned_cols=241  Identities=24%  Similarity=0.331  Sum_probs=195.4

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. .+.||+|++|.||++.+..+|..+|+|.+..........+.+.+|+.+++.++|+||+++++.+     ......+
T Consensus         2 ~~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           2 YEI-IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             ceE-EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            444 7889999999999999999999999999876533334456788999999999999999999998     6677899


Q ss_pred             EEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC-eEEeecccccccCC-
Q 042681          116 IVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSE-  190 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~-ikL~Dfg~~~~~~~-  190 (339)
                      +++||++ ++|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||.+..... 
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999997 69999886543  5799999999999999999999999999999999999998864 69999998865432 


Q ss_pred             ----------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          191 ----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       191 ----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                                ..|.+|+.........+.|+|++|++++++++|..|+.....     ....... ....   .....+.+
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~-~~~~---~~~~~~~~  226 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKI-CQGY---FAPISPNF  226 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHH-hccc---CCCCCCCC
Confidence                      246677776666677889999999999999999988643211     1111111 1111   11222467


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      +.+++++|.+||..+|++|||+.++++||||
T Consensus       227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         227 SRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.1e-36  Score=267.83  Aligned_cols=249  Identities=24%  Similarity=0.318  Sum_probs=198.7

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      +.|.. .+.||+|++|.||++.+..+|+.+++|++..... .......+.+|+.+++.++|||++++++++     ....
T Consensus        21 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~   94 (313)
T cd06633          21 EIFVG-LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY-----LKEH   94 (313)
T ss_pred             HHhhc-ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCC
Confidence            33555 7789999999999999999999999999865422 333446788999999999999999999998     5667


Q ss_pred             eEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC--
Q 042681          113 DVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--  189 (339)
Q Consensus       113 ~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~--  189 (339)
                      ..++||||+.+++.+.+.. ..++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....  
T Consensus        95 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~  174 (313)
T cd06633          95 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA  174 (313)
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence            7899999999988888765 4679999999999999999999999999999999999999999999999999886432  


Q ss_pred             -----CCCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          190 -----ETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       190 -----~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                           ...|.+|+...   .......+|+|++|++++++++|..|+......  ........  ...+.    ...+.++
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~--~~~~~----~~~~~~~  246 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQ--NDSPT----LQSNEWT  246 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHh--cCCCC----CCccccC
Confidence                 23477777653   234667789999999999999999886543211  11111111  11111    1123467


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ..+++|+.+||+.+|.+||++.+++.||||+....
T Consensus       247 ~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~  281 (313)
T cd06633         247 DSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP  281 (313)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence            88999999999999999999999999999997653

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=258.27  Aligned_cols=303  Identities=36%  Similarity=0.581  Sum_probs=232.2

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      ..++++.||.- ++.+|.|.- .|-.|.+.-+++++|+|++..+.......++..+|..++..++|+||++++.+|....
T Consensus        11 s~ftv~~Ry~n-L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   11 STFTVPKRYVN-LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK   88 (369)
T ss_pred             cceeeeeeeee-ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence            67889999999 999999988 7888888889999999999887777777788999999999999999999999994332


Q ss_pred             c-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          108 K-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       108 ~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      . +.....|+|||++..+|.+.+.  -.++-+++..++.|++.|++|||+.||+||||||+||++..++.+|+.|||+++
T Consensus        89 ~l~~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             cHHHHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence            1 1224589999999999988887  468888999999999999999999999999999999999999999999999998


Q ss_pred             ccCCC----------CccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccc------------c--------c
Q 042681          187 TTSET----------DFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR------------S--------D  236 (339)
Q Consensus       187 ~~~~~----------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~------------~--------~  236 (339)
                      ..+..          -|.+|++..+..+....|+|+.||++-+++.|...+.+-....            .        .
T Consensus       167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            76544          2556776666678888999999999999999987664211100            0        0


Q ss_pred             hHHHHHhhCCCCCCCCc------------cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCC-CCCC
Q 042681          237 NARRYVKQLPHVPKQPF------------SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE-EPTC  303 (339)
Q Consensus       237 ~~~~~~~~~~~~~~~~~------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~-~~~~  303 (339)
                      ....+....++.....+            .+..+.-+..+++|+.+||..||++|.|+.++|+|||++-+....+ +...
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~  326 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPP  326 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCC
Confidence            00111111111111111            1111223456899999999999999999999999999994432211 1122


Q ss_pred             CCCCCCChhhccCCHHHHHHHHHHHHHhcCC
Q 042681          304 PYPFNFDFEQTSMNEEDIKELILRECLNFHP  334 (339)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (339)
                      +.+++-.+.....+-++.++.+.+|.++|++
T Consensus       327 pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~  357 (369)
T KOG0665|consen  327 PEIYDKQLDEREHTIEEWKELIFKEVQRFEE  357 (369)
T ss_pred             CchhhhhcccccCCHHHHHHHHHHHHHhhcc
Confidence            2245555555566789999999999999998

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=276.79  Aligned_cols=243  Identities=25%  Similarity=0.417  Sum_probs=207.9

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||+|-||+||-+.++++|+.||||++.+.........++++|+.+|+++.||.|+.+-..|     ++...+++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence            5789999999999999999999999999988766666678999999999999999999999999     78889999999


Q ss_pred             cCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC---CCeEEeeccccccc------
Q 042681          120 LMDTDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARTT------  188 (339)
Q Consensus       120 ~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~---~~ikL~Dfg~~~~~------  188 (339)
                      .+.|++++-+..  .+++++...+-++.||+.||+|||-+||+|+||||+|||+.+.   ..+||||||.|+..      
T Consensus       644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            999988887754  4789999999999999999999999999999999999999754   36999999999754      


Q ss_pred             ----CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHH
Q 042681          189 ----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       189 ----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  264 (339)
                          |++.|.+|++.....+...-|.|+.|+++|--+.|..||..-.     .....+   .+-....-...|..+++++
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQI---QNAaFMyPp~PW~eis~~A  795 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQI---QNAAFMYPPNPWSEISPEA  795 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHh---hccccccCCCchhhcCHHH
Confidence                5567888998888888889999999999999999998875432     111111   1111111223346789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          265 IDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      .|||+.+|+..-++|.|.+..+.|||+++..
T Consensus       796 idlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  796 IDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            9999999999999999999999999999774

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-36  Score=267.10  Aligned_cols=249  Identities=26%  Similarity=0.382  Sum_probs=200.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||.||++.+..+++.+++|.+...  .....+.+.+|+.+++.++||||+++++.+     .....
T Consensus        19 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~   90 (293)
T cd06647          19 KKYTR-FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSY-----LVGDE   90 (293)
T ss_pred             hhcee-eeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhhee-----eeCCc
Confidence            56666 89999999999999999889999999998643  222346788999999999999999999998     55677


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      .++|+||++ ++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....   
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            999999997 689888765 468899999999999999999999999999999999999999999999999875432   


Q ss_pred             --------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          190 --------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       190 --------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                              ...|.+|+...........|+|++|++++++++|..|+........      .......... .......++
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~~~~~-~~~~~~~~~  242 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGTP-ELQNPEKLS  242 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhcCCCC-CCCCccccC
Confidence                    2236778777666677889999999999999999988754321110      0000001111 111123467


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      ..++++|++||..+|++||++.+++.||||+..+...
T Consensus       243 ~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~  279 (293)
T cd06647         243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLS  279 (293)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccc
Confidence            8899999999999999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.7e-36  Score=258.39  Aligned_cols=237  Identities=31%  Similarity=0.466  Sum_probs=194.7

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||+|++|.||++.+..+++.+++|++.....  .....+.+|+..++.++||+++++++.+     ......++++|
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~~e   77 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIVME   77 (253)
T ss_pred             eeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEEEe
Confidence            7889999999999999999999999999876533  3457788999999999999999999998     55678999999


Q ss_pred             cCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC------
Q 042681          120 LMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET------  191 (339)
Q Consensus       120 ~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~------  191 (339)
                      |++ ++|.+++... +.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......      
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  157 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM  157 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence            998 7999988775 68999999999999999999999999999999999999999999999999988665432      


Q ss_pred             ----CccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          192 ----DFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       192 ----~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                          .|.+|+.........+.|+|++|++++++++|..|+........   ...... .  ...... ....++..+.++
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~-~--~~~~~~-~~~~~~~~~~~~  230 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LFKIAT-N--GPPGLR-NPEKWSDEFKDF  230 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHHh-c--CCCCcC-cccccCHHHHHH
Confidence                36777776666677889999999999999999988654321111   111111 1  111111 112248899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCC
Q 042681          268 AERMLVFDPAKRITVEEALNHPY  290 (339)
Q Consensus       268 i~~~L~~dP~~Rps~~ell~hp~  290 (339)
                      |.+||+.||++|||+.++++|||
T Consensus       231 i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         231 LKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHccCChhhCCCHHHHhcCCC
Confidence            99999999999999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-36  Score=263.00  Aligned_cols=237  Identities=18%  Similarity=0.224  Sum_probs=188.3

Q ss_pred             ccCCCccccccccceEEEEEEeC---CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNS---ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      +|.+ .+.||+|+||.||++.+.   ..+..+|+|.++.... ......+.+|+..+..++||||+++++++     ...
T Consensus         6 ~~~~-~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   78 (266)
T cd05064           6 SIKI-ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TRG   78 (266)
T ss_pred             HeEE-eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ecC
Confidence            3444 889999999999999765   4567899998875422 33456788999999999999999999998     566


Q ss_pred             CeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          112 NDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ...++||||++ |+|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+....
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            78999999998 6888888763 578999999999999999999999999999999999999999999999999865321


Q ss_pred             ------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          190 ------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       190 ------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                                  ...|.+||.........++|+|++|++++++++ |..|++.....   .........   ...+   .
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~---~~~~---~  229 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVEDG---FRLP---A  229 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCC---CCCC---C
Confidence                        124677887766677888999999999999775 88887643211   111111111   1111   1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .+.++..+.+++.+||+.+|.+||++.++++
T Consensus       230 ~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         230 PRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            2457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.5e-36  Score=263.42  Aligned_cols=248  Identities=20%  Similarity=0.298  Sum_probs=191.9

Q ss_pred             cCccCCCccccccccceEEEEEEeCC-----CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSE-----TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      .++|.+ .+.||+|+||.||++.++.     .+..+|+|.+.... .......+.+|+.+++.++||||+++++++    
T Consensus         5 ~~~~~i-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----   78 (288)
T cd05061           5 REKITL-LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVV----   78 (288)
T ss_pred             HHHcee-eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE----
Confidence            356666 8999999999999997542     34589999876442 223345678999999999999999999998    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSK----------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD  176 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~  176 (339)
                       ......+++|||++ |+|.+++...          ...+...+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus        79 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~  157 (288)
T cd05061          79 -SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             -cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc
Confidence             55567899999997 7999999652          23456788899999999999999999999999999999999999


Q ss_pred             eEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHH
Q 042681          177 LKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYV  242 (339)
Q Consensus       177 ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~  242 (339)
                      ++|+|||+++...             ...|.+|+..........+|+|++|++++++++ |..|+....   ........
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~---~~~~~~~~  234 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---NEQVLKFV  234 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH
Confidence            9999999886432             123677777666667788999999999999998 566654321   11111111


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCCCcc
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSLHE  296 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~------hp~f~~~~~  296 (339)
                      ....   ...   ....+++.+++++.+||+.||++|||+.++++      ||||..+.|
T Consensus       235 ~~~~---~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         235 MDGG---YLD---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             HcCC---CCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence            1111   111   11346789999999999999999999999987      999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=262.47  Aligned_cols=245  Identities=26%  Similarity=0.393  Sum_probs=195.5

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC---CCCeeeeeeecCCCCcCCcC
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT---HENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~~~~~~  112 (339)
                      |.. ++.||.|++|.||++.+..+++.+++|.+.... .....+.+.+|+.+++.++   |||++++++++     ....
T Consensus         3 y~~-~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~   75 (277)
T cd06917           3 YQR-LELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGP   75 (277)
T ss_pred             hhh-hhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCC
Confidence            444 889999999999999999999999999986542 2334567888999999986   99999999998     5667


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-  190 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-  190 (339)
                      ..+++|||+. ++|.+++.. +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..... 
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            8999999997 688888765 5899999999999999999999999999999999999999999999999998865432 


Q ss_pred             ----------CCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          191 ----------TDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       191 ----------~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                ..|.+|+.... ......+|+|++|++++++++|..|+......      ...............  ...
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~~~~~~~~~~~~--~~~  226 (277)
T cd06917         155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMMLIPKSKPPRLE--DNG  226 (277)
T ss_pred             ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhhccccCCCCCCC--ccc
Confidence                      23566765432 34567899999999999999999987543211      111111111111111  113


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ++.++.+++.+||+.||++||++.+++.||||+....
T Consensus       227 ~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         227 YSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence            7889999999999999999999999999999977653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-36  Score=267.54  Aligned_cols=243  Identities=25%  Similarity=0.398  Sum_probs=196.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ...||.|+||.||++.+..+++.+|+|++.....  .....+.+|+.++..++||||+++++.+     ......++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~iv~e   98 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELWVLME   98 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEEEEEe
Confidence            5579999999999999999999999999864322  2345688999999999999999999998     66678999999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----------  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----------  188 (339)
                      |++ ++|..++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...          
T Consensus        99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659          99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence            998 577776644 67899999999999999999999999999999999999999999999999987532          


Q ss_pred             -CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          189 -SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       189 -~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                       +...|.+|+.........+.|+|++|++++++++|..|+.....  ...    ........ .........++..+.++
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~----~~~~~~~~-~~~~~~~~~~~~~l~~~  250 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQA----MKRLRDSP-PPKLKNAHKISPVLRDF  250 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH----HHHHhccC-CCCccccCCCCHHHHHH
Confidence             23357788877666778889999999999999999998653211  111    11111111 11112234578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          268 AERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       268 i~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      |.+||+.+|.+||++.++++||||.....+
T Consensus       251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~  280 (297)
T cd06659         251 LERMLTREPQERATAQELLDHPFLLQTGLP  280 (297)
T ss_pred             HHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence            999999999999999999999999977553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-36  Score=259.04  Aligned_cols=233  Identities=22%  Similarity=0.358  Sum_probs=192.1

Q ss_pred             cccccccceEEEEEEeCCC---CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSET---KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      +.||+|+||.||++.+...   +..+++|.+....... ..+.+.+|+..+..++|+||+++++++     .....++++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVC-----TEEEPLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeee-----cCCCceEEE
Confidence            4689999999999999866   8899999987653333 567889999999999999999999998     557789999


Q ss_pred             EecCc-ccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          118 YELMD-TDLHQIIRSK---------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      |||++ ++|.+++...         ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence            99995 7999999875         7899999999999999999999999999999999999999999999999999875


Q ss_pred             cCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          188 TSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       188 ~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      ...             ..|.+|+.........+.|+|++|++++++++ |..|+....   ..........   ....  
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~---~~~~--  226 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---NEEVLEYLRK---GYRL--  226 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHc---CCCC--
Confidence            543             24677887766677888999999999999998 577765542   1111111111   1111  


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                       .....++.++.+++.+||+.+|++|||+.+++.+
T Consensus       227 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         227 -PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             -CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence             1124578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.1e-36  Score=259.39  Aligned_cols=232  Identities=19%  Similarity=0.300  Sum_probs=186.9

Q ss_pred             ccccccceEEEEEEe--CCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           42 PIGRGAYGIVCSAVN--SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        42 ~lg~G~~~~v~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .||+|+||.||++.+  ..+++.+|+|+++.........+.+.+|+.+++.++||||+++++++     . ....++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~-~~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----E-AESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----c-CCCcEEEEe
Confidence            589999999999964  56788999999876544555567889999999999999999999987     2 235689999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC--------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--------  190 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--------  190 (339)
                      |++ ++|.+++...+.+++..+..++.|++.||+|||++|++||||||.||+++.++.++|+|||.+.....        
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            998 78999998878899999999999999999999999999999999999999999999999999864422        


Q ss_pred             ------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          191 ------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       191 ------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                            ..|.+|+...........|+|++|++++++++ |..|+.....   ........   ......   ....++++
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~---~~~~~~---~~~~~~~~  226 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIE---SGERME---CPQRCPPE  226 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH---CCCCCC---CCCCCCHH
Confidence                  24666776655566778999999999999997 8888654321   11111111   111111   11358899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          264 AIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +.++|.+||+.||++||++.++...
T Consensus       227 l~~li~~~~~~~p~~Rp~~~~i~~~  251 (257)
T cd05116         227 MYDLMKLCWTYGVDERPGFAVVELR  251 (257)
T ss_pred             HHHHHHHHhccCchhCcCHHHHHHH
Confidence            9999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.7e-36  Score=259.27  Aligned_cols=241  Identities=24%  Similarity=0.339  Sum_probs=197.6

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.+ .+.||.|++|.||++.+..+++.+++|.+............+.+|+.+++.++||||+++++++     ......+
T Consensus         2 y~~-~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08530           2 FKV-LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC   75 (256)
T ss_pred             ceE-eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence            444 7889999999999999999999999999876554555567788999999999999999999998     5567899


Q ss_pred             EEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          116 IVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      +|+||++ ++|.+++.+    ...+++..++.++.|++.||+|||+.|++|+||+|.||+++.++.++|+|||.+...  
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            9999997 689888865    367899999999999999999999999999999999999999999999999988644  


Q ss_pred             -------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          189 -------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                             +...|.+|+...........|+|++|++++++++|..|+......   ......   .......   ....++
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~---~~~~~~~---~~~~~~  226 (256)
T cd08530         156 NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKV---QRGKYPP---IPPIYS  226 (256)
T ss_pred             CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---hcCCCCC---CchhhC
Confidence                   233566777766666777899999999999999999887543211   111111   1111111   113578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      .++++++.+||+.+|++||++.++++||++
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         227 QDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.7e-36  Score=259.78  Aligned_cols=232  Identities=19%  Similarity=0.312  Sum_probs=189.2

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||+|++|.||++.+..+++.+++|.+...   ......+.+|+.+++.++||||+++++++     .....++++||
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e   82 (263)
T cd05052          11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYIITE   82 (263)
T ss_pred             eeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEEEEE
Confidence            78899999999999999999999999988643   23356788999999999999999999998     56677899999


Q ss_pred             cCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC------
Q 042681          120 LMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE------  190 (339)
Q Consensus       120 ~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~------  190 (339)
                      |++ ++|.+++...  ..+++..++.++.|++.||+|||++|++||||||+||++++++.++|+|||.+.....      
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~  162 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  162 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence            997 7999988653  4689999999999999999999999999999999999999999999999999865432      


Q ss_pred             ------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          191 ------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       191 ------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                            ..|.+|+...........|+|++|++++++++ |..|+....   ...........   ...   .....++.+
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---~~~~~~~~~~~---~~~---~~~~~~~~~  233 (263)
T cd05052         163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKG---YRM---ERPEGCPPK  233 (263)
T ss_pred             CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCC---CCC---CCCCCCCHH
Confidence                  23677887666667788999999999999998 777754321   11111111111   111   112457899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          264 AIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +.++|.+||+.||++||++.++++.
T Consensus       234 ~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         234 VYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHHHHHccCCcccCCCHHHHHHH
Confidence            9999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.4e-36  Score=261.39  Aligned_cols=241  Identities=23%  Similarity=0.278  Sum_probs=191.7

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. .+.||+|++|.||++.+..+++.+++|.+.... ........+.+|+.+++.++||||+++++++     ...+.
T Consensus         3 ~y~~-~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~   76 (267)
T cd08229           3 NFRI-EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE   76 (267)
T ss_pred             hhhh-hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence            4555 889999999999999999999999999886542 3344456788999999999999999999998     56678


Q ss_pred             EEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          114 VYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      .+++|||++ ++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            999999998 689888763    356899999999999999999999999999999999999999999999999987543


Q ss_pred             -----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          189 -----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       189 -----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                 +...|.+|+..........+|+|++|++++++++|..|+......    ..............+.  ..
T Consensus       157 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~--~~  230 (267)
T cd08229         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQCDYPPL--PS  230 (267)
T ss_pred             ccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhcCCCCCC--Cc
Confidence                       223466777776666778899999999999999999886432111    0111111111111111  11


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ..+++.+++++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         231 DHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            347889999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.9e-36  Score=291.23  Aligned_cols=242  Identities=24%  Similarity=0.323  Sum_probs=192.7

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.. ++.||+|+||.||+|.+..+|+.||+|++..... .....+++.+|+.++..++||||+++++++     ...+
T Consensus         2 grYeI-i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~   75 (932)
T PRK13184          2 QRYDI-IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGD   75 (932)
T ss_pred             CCeEE-EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCC
Confidence            46666 8999999999999999999999999999976433 233456789999999999999999999998     6667


Q ss_pred             eEEEEEecCc-ccHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEe
Q 042681          113 DVYIVYELMD-TDLHQIIRSK-----------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC  180 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~  180 (339)
                      ..+++|||++ ++|.+++.+.           ...+...+..++.||+.||+|||++|++||||||+||+++.++.++|+
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLi  155 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL  155 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEE
Confidence            8999999998 6898888541           235667788999999999999999999999999999999999999999


Q ss_pred             eccccccc-----------------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccc
Q 042681          181 DFGLARTT-----------------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLG  231 (339)
Q Consensus       181 Dfg~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~  231 (339)
                      |||++...                             ++..|++||.........++|+|++|++++++++|..|+....
T Consensus       156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~  235 (932)
T PRK13184        156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK  235 (932)
T ss_pred             ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence            99998643                             3456888888777778889999999999999999999875421


Q ss_pred             ccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          232 FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..     .........  .+........+++.+.+++.+||+.||++||+..+.+.+
T Consensus       236 ~~-----ki~~~~~i~--~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        236 GR-----KISYRDVIL--SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hh-----hhhhhhhcc--ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            11     000011010  111111124578999999999999999999977665543

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-37  Score=256.58  Aligned_cols=262  Identities=29%  Similarity=0.435  Sum_probs=201.0

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCc----eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKE----EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPP  105 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~  105 (339)
                      +..-..|.. ++.||+|.||.||+|..++++.    .||+|+++.............+|+..++.++|||++.+..+|. 
T Consensus        20 ve~l~~ye~-ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl-   97 (438)
T KOG0666|consen   20 VEDLFEYEG-IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL-   97 (438)
T ss_pred             HHHHHHhhc-cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh-
Confidence            344456666 8999999999999997665533    7899999766444444567789999999999999999999994 


Q ss_pred             CCcCCcCeEEEEEecCcccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC----CC
Q 042681          106 MDKEKFNDVYIVYELMDTDLHQIIRS-----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN----CD  176 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~----~~  176 (339)
                         +....+++++||++-+|+++++.     .+.++...++.|+.||+.|+.|||++-+.||||||.||++..+    |+
T Consensus        98 ---~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen   98 ---SHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             ---ccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCe
Confidence               33778999999999999999964     2569999999999999999999999999999999999999887    89


Q ss_pred             eEEeecccccccCCC--------------Ccccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCccc-------ccc
Q 042681          177 LKICDFGLARTTSET--------------DFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLG-------FLR  234 (339)
Q Consensus       177 ikL~Dfg~~~~~~~~--------------~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~-------~~~  234 (339)
                      |||+|||+++.+.++              .|.+||... ...++.+.|+|+.||+.-++++..+.|....       -+.
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq  254 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ  254 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence            999999999876543              366666543 4457888999999999999998777663211       111


Q ss_pred             cchHHHHHhhCCCCCCCCcc-----------------------------ccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 042681          235 SDNARRYVKQLPHVPKQPFS-----------------------------QKFPNMSPVAIDLAERMLVFDPAKRITVEEA  285 (339)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~el  285 (339)
                      .+....++..+........+                             .....-++...+|+.+||+.||.+|.|++++
T Consensus       255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA  334 (438)
T KOG0666|consen  255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA  334 (438)
T ss_pred             HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence            12223333332222111111                             0112234558899999999999999999999


Q ss_pred             hcCCCCCCCcc
Q 042681          286 LNHPYLSSLHE  296 (339)
Q Consensus       286 l~hp~f~~~~~  296 (339)
                      ++|+||+.-.-
T Consensus       335 leh~yF~~d~l  345 (438)
T KOG0666|consen  335 LEHPYFTEDPL  345 (438)
T ss_pred             hcccccccCCC
Confidence            99999987643

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.3e-36  Score=261.37  Aligned_cols=240  Identities=25%  Similarity=0.363  Sum_probs=195.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||+|+||.||++.+..+++.+|+|.+..... ....+.+.+|+.++..++||||+++++.+     ......++|||
T Consensus         9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e   82 (277)
T cd06641           9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWIIME   82 (277)
T ss_pred             heeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEEEEE
Confidence            7889999999999999999999999998764322 23456788999999999999999999999     66678999999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----------  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----------  188 (339)
                      |++ ++|.+++.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++...          
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            998 588877764 57899999999999999999999999999999999999999999999999987543          


Q ss_pred             -CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          189 -SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       189 -~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                       +...|.+|+...........|+|++|++++++++|..|+.....  .    ............   .....++.++.++
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~----~~~~~~~~~~~~---~~~~~~~~~~~~~  232 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--M----KVLFLIPKNNPP---TLEGNYSKPLKEF  232 (277)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--H----HHHHHHhcCCCC---CCCcccCHHHHHH
Confidence             22346777776656667789999999999999999988754321  1    111111111111   1113578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          268 AERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       268 i~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      +.+||+.+|.+||++.++++||||....
T Consensus       233 i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         233 VEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             HHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence            9999999999999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.9e-36  Score=262.93  Aligned_cols=245  Identities=21%  Similarity=0.251  Sum_probs=189.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCC----------------ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCee
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETK----------------EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV   97 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~----------------~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~   97 (339)
                      ++|.. ++.||+|+||.||++.+..++                ..+|+|.+..... ....+.+.+|+.+++.++||||+
T Consensus         5 ~~~~~-~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           5 QPLNF-VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhCcc-cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence            45666 999999999999999876544                4579998875422 34567788999999999999999


Q ss_pred             eeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 042681           98 KVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ-----------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLK  165 (339)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~givH~dik  165 (339)
                      ++++++     ......+++||++. ++|.+++....           .+++..++.++.|++.||.|||++|++|+|||
T Consensus        83 ~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk  157 (296)
T cd05051          83 RLLGVC-----TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA  157 (296)
T ss_pred             EEEEEE-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence            999998     55578999999997 69999987655           78999999999999999999999999999999


Q ss_pred             CCCeeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh--CCCCCCcc
Q 042681          166 PSNLLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL--GSPDDSDL  230 (339)
Q Consensus       166 p~NIli~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~--g~~~~~~~  230 (339)
                      |+||+++.++.++|+|||.+.....             ..|++|+.........++|+|++|++++++++  +..|+...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999999999999999999874321             24777887666677889999999999999987  45554432


Q ss_pred             cccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          231 GFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ...  ......................+.++.++.+++.+||+.||++|||+.++++
T Consensus       238 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         238 TDQ--QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ChH--HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            211  1111111111111111111122456899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.1e-36  Score=262.25  Aligned_cols=238  Identities=19%  Similarity=0.259  Sum_probs=190.2

Q ss_pred             ccCCCccccccccceEEEEEEeCCCC-----ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETK-----EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      +|.. .+.||+|++|.||++.....+     ..+++|.+.... .......+.+|+.++..++||||+++++++     .
T Consensus         6 ~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~   78 (283)
T cd05048           6 AVRF-LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----T   78 (283)
T ss_pred             Hcch-hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEE-----c
Confidence            3444 899999999999999876554     679999886432 333456788999999999999999999998     5


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK----------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN  172 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~  172 (339)
                      .....+++|||++ ++|.+++...                ..+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus        79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~  158 (283)
T cd05048          79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG  158 (283)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence            5667899999998 7999998754                4578899999999999999999999999999999999999


Q ss_pred             cCCCeEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchH
Q 042681          173 ANCDLKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNA  238 (339)
Q Consensus       173 ~~~~ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~  238 (339)
                      +++.++|+|||++....             ...|.+||.........++|+|++|++++++++ |..|+.....  ..  
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~~--  234 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QE--  234 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--HH--
Confidence            99999999999986431             124778887766677888999999999999997 8877654321  11  


Q ss_pred             HHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                        ............   ....+++++.+|+.+||+.||.+||++.+++++
T Consensus       235 --~~~~i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         235 --VIEMIRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             --HHHHHHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              111111111111   124588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3e-37  Score=293.29  Aligned_cols=249  Identities=28%  Similarity=0.376  Sum_probs=190.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC------
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD------  107 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~------  107 (339)
                      +++.+ ++.||+||||.||+|+++-+|+.||+|++.... .......+.+|+..+.+|+||||++++..|....      
T Consensus       479 ~DFEE-L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  479 NDFEE-LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhHH-HHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            34445 889999999999999999999999999997665 5556788999999999999999999996662200      


Q ss_pred             --------------------------------------------------------------------------------
Q 042681          108 --------------------------------------------------------------------------------  107 (339)
Q Consensus       108 --------------------------------------------------------------------------------  107 (339)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------cC--------CcCeEEEEEecCccc-HHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhC
Q 042681          108 --------------------KE--------KFNDVYIVYELMDTD-LHQIIRSKQAL-TDDHCQYFLYQLLRGLKYIHSA  157 (339)
Q Consensus       108 --------------------~~--------~~~~~~iv~e~~~g~-L~~~l~~~~~~-~~~~~~~i~~qi~~aL~~LH~~  157 (339)
                                          +.        ....+||=||||+.+ +.+++..+... ....+|+++.+|+.||.|+|++
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                00        003478999999965 55555554444 5788999999999999999999


Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecccccc-----------------------------cCCCCccccccccccc---cC
Q 042681          158 NVLHRDLKPSNLLLNANCDLKICDFGLART-----------------------------TSETDFMTEYVVTRWD---TL  205 (339)
Q Consensus       158 givH~dikp~NIli~~~~~ikL~Dfg~~~~-----------------------------~~~~~~~~~~~~~~~~---~~  205 (339)
                      |++||||||.|||+++++.|||+|||+++.                             .|+..|.+||+...+.   +.
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            999999999999999999999999999864                             1223488898887766   88


Q ss_pred             CCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 042681          206 FPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEA  285 (339)
Q Consensus       206 ~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el  285 (339)
                      .+.|.|++|+++++|+.-..+        .-.....+..+.....+.....+..--+.-+.+|++||++||++||||.|+
T Consensus       797 ~KiDmYSLGIVlFEM~yPF~T--------sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL  868 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLYPFGT--------SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL  868 (1351)
T ss_pred             chhhhHHHHHHHHHHhccCCc--------hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence            899999999999999854221        111122222222211111111122344567889999999999999999999


Q ss_pred             hcCCCCC
Q 042681          286 LNHPYLS  292 (339)
Q Consensus       286 l~hp~f~  292 (339)
                      |.+-||-
T Consensus       869 L~s~llp  875 (1351)
T KOG1035|consen  869 LNSELLP  875 (1351)
T ss_pred             hhccCCC
Confidence            9999987

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=257.46  Aligned_cols=234  Identities=24%  Similarity=0.392  Sum_probs=194.2

Q ss_pred             cccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecC
Q 042681           43 IGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM  121 (339)
Q Consensus        43 lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~  121 (339)
                      ||.|++|.||++.+..+++.+++|.+..... .......+.+|+.+++.++||||+++++.+     ......+++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            6999999999999998999999999876532 233566788999999999999999999998     6778899999999


Q ss_pred             c-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC----------
Q 042681          122 D-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----------  190 (339)
Q Consensus       122 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~----------  190 (339)
                      + ++|.+++.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....          
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            5 79999998888899999999999999999999999999999999999999999999999998865432          


Q ss_pred             -CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHH
Q 042681          191 -TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAE  269 (339)
Q Consensus       191 -~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  269 (339)
                       ..|.+|+...........|+|++|++++++++|..|+.....      ......... ....   .....+..++++++
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~---~~~~~~~~l~~~i~  225 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-DPLR---FPEFLSPEARDLIS  225 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-CCCC---CCCCCCHHHHHHHH
Confidence             246777776666677789999999999999999988754321      111111111 1111   11345899999999


Q ss_pred             HhcccCCCCCCCH---HHHhcCCCC
Q 042681          270 RMLVFDPAKRITV---EEALNHPYL  291 (339)
Q Consensus       270 ~~L~~dP~~Rps~---~ell~hp~f  291 (339)
                      +||..||++||++   .++++||||
T Consensus       226 ~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         226 GLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHhcCCHhhCCCcccHHHHHhCCCC
Confidence            9999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.2e-36  Score=258.95  Aligned_cols=237  Identities=23%  Similarity=0.302  Sum_probs=193.3

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. .+.||.|+||.||++.+..+++.+|+|.+.... .....+.+.+|+.+++.++||||+++++.+     .....++
T Consensus         2 y~~-~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   74 (255)
T cd08219           2 YNV-LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLY   74 (255)
T ss_pred             ceE-EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEE
Confidence            444 889999999999999999999999999986542 233457788999999999999999999999     6678899


Q ss_pred             EEEecCc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC--
Q 042681          116 IVYELMD-TDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--  190 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--  190 (339)
                      ++|||++ ++|.+++..  ...+++..++.++.|++.||.+||++|++|+||+|+||++++++.++|+|||.+.....  
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            9999997 689888865  34689999999999999999999999999999999999999999999999999865432  


Q ss_pred             ---------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          191 ---------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       191 ---------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                               ..|.+|+.........+.|+|++|++++++++|..|+.....      .............+.   ...++
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~  225 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQGSYKPL---PSHYS  225 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcCCCCCC---CcccC
Confidence                     247778877766778889999999999999999998754211      111111111111111   13478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..+++||.+||+.||.+||++.+++.-
T Consensus       226 ~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         226 YELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-36  Score=261.46  Aligned_cols=244  Identities=33%  Similarity=0.507  Sum_probs=191.7

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      .+.||.|++|.||+|....+++.+++|++...... .......+|+..+.+++ ||||+++++++     ......++||
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~lv~   77 (283)
T cd07830           4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYFVF   77 (283)
T ss_pred             heeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEEEE
Confidence            78899999999999999999999999998754332 23344567999999998 99999999999     5577899999


Q ss_pred             ecCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC------
Q 042681          119 ELMDTDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE------  190 (339)
Q Consensus       119 e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~------  190 (339)
                      ||++|+|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+.....      
T Consensus        78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            999999999987754  789999999999999999999999999999999999999999999999999865432      


Q ss_pred             ----CCccccccc-cccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC-------------------
Q 042681          191 ----TDFMTEYVV-TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP-------------------  246 (339)
Q Consensus       191 ----~~~~~~~~~-~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~-------------------  246 (339)
                          ..|.+|+.. .......+.|+|++|++++++++|.+++.......  ..........                   
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID--QLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH--HHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence                235667654 23345778999999999999999988764332110  0111110000                   


Q ss_pred             ---CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          247 ---HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       247 ---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                         ...........+..+.+++++|++||+.+|++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence               000011112223447889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.1e-36  Score=262.66  Aligned_cols=248  Identities=31%  Similarity=0.409  Sum_probs=203.0

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ...+.|.. .+.||.|++|.||++.+..++..+++|++.....   ....+.+|+..+..++|+||+++++.+     ..
T Consensus        16 ~~~~~~~~-~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~   86 (286)
T cd06614          16 DPRELYKN-LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSY-----LV   86 (286)
T ss_pred             CccccchH-hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEE-----EE
Confidence            44555666 8899999999999999998999999999875432   456788999999999999999999998     55


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ....++++||++ ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            678999999998 79999998866 8999999999999999999999999999999999999999999999999987543


Q ss_pred             C-----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          189 S-----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       189 ~-----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                      .           ...|.+|+...........|+|++|++++++++|..|+......  ...... ....   ... ....
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~-~~~~---~~~-~~~~  239 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLI-TTKG---IPP-LKNP  239 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-HhcC---CCC-Ccch
Confidence            2           23577788776666788899999999999999999886532211  111111 1111   111 1111


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      ..++.+++++|.+||+.+|.+||++.++++||||...
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             hhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            3378999999999999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-36  Score=257.93  Aligned_cols=239  Identities=22%  Similarity=0.304  Sum_probs=191.1

Q ss_pred             CccCCCccccccccceEEEEEEeCCC---CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSET---KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ++|.. .+.||+|+||.||+|.+..+   ...+|+|.+.... .......+.+|+.++..++||||+++++.+     ..
T Consensus         4 ~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   76 (266)
T cd05033           4 SYVTI-EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TK   76 (266)
T ss_pred             HHcee-eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ec
Confidence            34555 89999999999999998654   4578999886542 333456788999999999999999999998     56


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ....+++|||++ ++|.+++... +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            677999999997 6999998663 57899999999999999999999999999999999999999999999999998765


Q ss_pred             CC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 SE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 ~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      ..             ..|.+|+.........++|+|++|++++++++ |..|+......   ............+.    
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~~~----  229 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVEDGYRLPP----  229 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHHcCCCCCC----
Confidence            31             23677777766667788999999999999987 88876543211   11111111111111    


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                        ...+++.+.+++.+||+.+|++||++.+++++
T Consensus       230 --~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         230 --PMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             --CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              13578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.8e-36  Score=262.23  Aligned_cols=247  Identities=20%  Similarity=0.329  Sum_probs=196.1

Q ss_pred             ccccccccceEEEEEEeC---CCCceEEEEEeccccc--ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCe
Q 042681           40 LQPIGRGAYGIVCSAVNS---ETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~---~~~~~~avK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      .+.||.|+||.||+|.+.   .+|+.||+|++.....  .....+.+.+|+.++..+ +|++|+++++++     .....
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~~~~~   79 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----QTDTK   79 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----ecCCe
Confidence            788999999999999875   4789999999865422  223346678899999999 599999999998     66678


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      .++|+||++ ++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....   
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            999999998 6999999888889999999999999999999999999999999999999999999999999886542   


Q ss_pred             ---------CCCccccccccc--cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          190 ---------ETDFMTEYVVTR--WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       190 ---------~~~~~~~~~~~~--~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                               ...|.+|+....  .......|+|++|++++++++|..|+......  ............... +.   ..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~-~~---~~  233 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP-PY---PQ  233 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC-CC---Cc
Confidence                     234666766543  23456799999999999999999887532211  111111111111111 11   13


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      .+++.+.+++++||+.||.+||     ++.+++.||||+...+.
T Consensus       234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence            4788999999999999999997     89999999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.9e-36  Score=259.28  Aligned_cols=240  Identities=19%  Similarity=0.305  Sum_probs=186.9

Q ss_pred             ccccccccceEEEEEEeCCCCc--eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC-cCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKE--EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD-KEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-~~~~~~~~i  116 (339)
                      .+.||+|+||.||++.+..++.  .+|+|.++.........+.+.+|+.+++.++||||+++++++.... .......++
T Consensus         4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   83 (272)
T cd05075           4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV   83 (272)
T ss_pred             ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence            7889999999999999877765  6899988766555556778899999999999999999999763221 112235789


Q ss_pred             EEecCc-ccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          117 VYELMD-TDLHQIIRS------KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       117 v~e~~~-g~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      +|||+. |+|.+++..      ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++...
T Consensus        84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  163 (272)
T cd05075          84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY  163 (272)
T ss_pred             EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccC
Confidence            999998 788887742      2458999999999999999999999999999999999999999999999999987543


Q ss_pred             C-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          190 E-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       190 ~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                      .             ..|.+|+.........+.|+|++|++++++++ |..|+....   .........   .....   .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~~---~~~~~---~  234 (272)
T cd05075         164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYDYLR---QGNRL---K  234 (272)
T ss_pred             cccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHH---cCCCC---C
Confidence            2             13556666666667788999999999999998 677754321   111111111   11111   1


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..+.++..++++|.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            124578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=274.12  Aligned_cols=251  Identities=21%  Similarity=0.229  Sum_probs=205.3

Q ss_pred             EEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeee
Q 042681           22 QYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD  101 (339)
Q Consensus        22 ~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~  101 (339)
                      +.+.-...|.|+-....+...||+|.||+||++++.+   .||||++..........+.|.+|+.++++-+|.||+-+.|
T Consensus       379 ~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG  455 (678)
T KOG0193|consen  379 QASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG  455 (678)
T ss_pred             cCCccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence            3445557788888888889999999999999999975   5999999887777778899999999999999999999999


Q ss_pred             ecCCCCcCCcCeEEEEEecCcc-cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEE
Q 042681          102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI  179 (339)
Q Consensus       102 ~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL  179 (339)
                      ++     .++.. .||+..|+| +|..++.. +..+.....+.|+.||++|+.|||.++|+|+|||..|||+.+++.|||
T Consensus       456 ~~-----~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkI  529 (678)
T KOG0193|consen  456 AC-----MNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKI  529 (678)
T ss_pred             hh-----cCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEE
Confidence            99     55554 999999996 88888854 467999999999999999999999999999999999999999999999


Q ss_pred             eeccccccc---------C----CCCccccccccc---cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHh
Q 042681          180 CDFGLARTT---------S----ETDFMTEYVVTR---WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK  243 (339)
Q Consensus       180 ~Dfg~~~~~---------~----~~~~~~~~~~~~---~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~  243 (339)
                      +|||++..-         .    -.-|++||+...   .++.+.+|+|++|+++|++++|..|+..      .....++.
T Consensus       530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi------~~~dqIif  603 (678)
T KOG0193|consen  530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI------QNRDQIIF  603 (678)
T ss_pred             ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC------CChhheEE
Confidence            999998521         1    123788887654   3688999999999999999999999652      11122222


Q ss_pred             hCCCC-CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          244 QLPHV-PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       244 ~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ...+. ..+.......++++++++|+..||..++++||.+.+++.
T Consensus       604 mVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  604 MVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             EecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            22222 122222333567889999999999999999999999886

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=279.98  Aligned_cols=241  Identities=26%  Similarity=0.395  Sum_probs=201.3

Q ss_pred             ccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecC
Q 042681           42 PIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM  121 (339)
Q Consensus        42 ~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~  121 (339)
                      .||+|.||+||-+++..|...+|+|.+...  +....+.+..|+..-.+|+|.||++++|.+     ..++++-|+||-+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqV  654 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQV  654 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecC
Confidence            479999999999999999999999998533  445567889999999999999999999998     7788999999999


Q ss_pred             c-ccHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec-cCCCeEEeeccccccc--------
Q 042681          122 D-TDLHQIIRSK-QAL--TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTT--------  188 (339)
Q Consensus       122 ~-g~L~~~l~~~-~~~--~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~-~~~~ikL~Dfg~~~~~--------  188 (339)
                      + |+|..+++.. +++  ++.++.-+..||++||.|||.+.|||||||-+||+++ -.|.+||+|||.++++        
T Consensus       655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            7 7999998875 676  8899999999999999999999999999999999996 5789999999999764        


Q ss_pred             ---CCCCccccccccc--cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          189 ---SETDFMTEYVVTR--WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       189 ---~~~~~~~~~~~~~--~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                         |+.+|++|++...  ..+..+.|+|++||++++|.+|++||...+.....-.+.  .-...-     +.....+|.+
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV--GmyKvH-----P~iPeelsae  807 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV--GMYKVH-----PPIPEELSAE  807 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh--cceecC-----CCCcHHHHHH
Confidence               3446899988754  357889999999999999999999987665433222110  011111     1112357889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          264 AIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ++.||.+|+.++|..||+|.++|+.||++.-..
T Consensus       808 ak~FilrcFepd~~~R~sA~~LL~DpFlq~~~k  840 (1226)
T KOG4279|consen  808 AKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNK  840 (1226)
T ss_pred             HHHHHHHHcCCCcccCccHHHhccCcccccCCC
Confidence            999999999999999999999999999987743

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=255.51  Aligned_cols=231  Identities=19%  Similarity=0.290  Sum_probs=186.9

Q ss_pred             cccccccceEEEEEEeCCCC---ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETK---EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      +.||+|+||.||+|....++   ..+|+|.+...... ...+.+.+|+.+++.+.||||+++++++     . ....++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~-~~~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVC-----K-GEPLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEE-----c-CCceEEE
Confidence            46899999999999876554   78999998765333 3456788999999999999999999987     3 3457999


Q ss_pred             EecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC------
Q 042681          118 YELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE------  190 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~------  190 (339)
                      |||+. ++|.+++.+.+.+++..+..++.|++.||+|||..|++|+||||+||+++.++.++|+|||.++....      
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99997 79999998888899999999999999999999999999999999999999999999999999864321      


Q ss_pred             --------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          191 --------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       191 --------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                              ..|.+|+.........++|+|++|++++++++ |..|+....   ..............      .....++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~------~~~~~~~  224 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---GAEVIAMLESGERL------PRPEECP  224 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHHcCCcC------CCCCCCC
Confidence                    13677777766677888999999999999997 888865432   11112222221111      1124578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ..++++|.+||..+|++||++.++++
T Consensus       225 ~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         225 QEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.3e-36  Score=262.84  Aligned_cols=247  Identities=19%  Similarity=0.292  Sum_probs=194.2

Q ss_pred             ccccccccceEEEEEEeC---CCCceEEEEEeccccc--ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCe
Q 042681           40 LQPIGRGAYGIVCSAVNS---ETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~---~~~~~~avK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      .+.||+|++|.||++.+.   .+++.+|+|.+.+...  .......+.+|+.++.++ +||+|+++++.+     .....
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~~~~~   79 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----QTDTK   79 (288)
T ss_pred             EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----ecCCE
Confidence            788999999999999854   4678899999875422  223346678999999999 599999999998     66678


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      .++||||++ ++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...    
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            999999998 699999988788999999999999999999999999999999999999999999999999987643    


Q ss_pred             --------CCCCccccccccccc--cCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          189 --------SETDFMTEYVVTRWD--TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       189 --------~~~~~~~~~~~~~~~--~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                              +...|.+|+......  .....|+|++|++++++++|..|+........  ............ ..   ...
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~-~~---~~~  233 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSK-PP---FPK  233 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccC-CC---CCc
Confidence                    223456666654333  56789999999999999999988753221111  111111111110 11   113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCccC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRIT---VEEALNHPYLSSLHEI  297 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~~~~~~  297 (339)
                      .++.+++++|.+||+.||++|||   +.++++||||+++.+.
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence            47889999999999999999998   5677999999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.6e-36  Score=263.03  Aligned_cols=243  Identities=25%  Similarity=0.418  Sum_probs=195.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ...||+|++|.||++....+|+.+|+|++...  .......+.+|+.++..++|+||+++++.+     ......+++||
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e   97 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVME   97 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEEe
Confidence            45699999999999999999999999988543  223456788999999999999999999999     66778999999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---------  189 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---------  189 (339)
                      |++ ++|.+++. .+.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....         
T Consensus        98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657          98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            998 57777664 4578999999999999999999999999999999999999999999999999875432         


Q ss_pred             --CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          190 --ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       190 --~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                        ...|.+|+.........+.|+|++|++++++++|..|+......  ...........     ........+++.+.++
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~~l~~l  249 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLP-----PKLKNLHKVSPSLKGF  249 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCC-----cccCCcccCCHHHHHH
Confidence              22467787776666778899999999999999999886532111  11111111111     1111224578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          268 AERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       268 i~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      +.+||+.+|.+||++.++++||||.....+
T Consensus       250 i~~~l~~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         250 LDRLLVRDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             HHHHHhCCcccCcCHHHHhcChHHhccCCC
Confidence            999999999999999999999999988753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-35  Score=263.62  Aligned_cols=247  Identities=24%  Similarity=0.304  Sum_probs=197.1

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      |.. .+.||+|+||.||++.+..++..+|+|++..... .......+.+|+.+++.++|||++++++++     ......
T Consensus        27 f~~-~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~  100 (317)
T cd06635          27 FTD-LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-----LREHTA  100 (317)
T ss_pred             hhh-hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCCeE
Confidence            444 8889999999999999999999999999875422 233456788999999999999999999998     556778


Q ss_pred             EEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC----
Q 042681          115 YIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS----  189 (339)
Q Consensus       115 ~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~----  189 (339)
                      ++||||+.|++.+.+.. ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....    
T Consensus       101 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (317)
T cd06635         101 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS  180 (317)
T ss_pred             EEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCccc
Confidence            99999999988888754 5679999999999999999999999999999999999999999999999999876443    


Q ss_pred             ---CCCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          190 ---ETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       190 ---~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                         ...|.+|+...   ......+.|+|++|++++++++|..|+.....  .......... .   ...  .....+++.
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~-~---~~~--~~~~~~~~~  252 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQN-E---SPT--LQSNEWSDY  252 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhc-c---CCC--CCCccccHH
Confidence               23477777652   23466789999999999999999988654211  1111111111 1   010  011346888


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          264 AIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ++++|.+||+.+|.+||++.++++|||+.....
T Consensus       253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            999999999999999999999999999966544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.6e-36  Score=265.53  Aligned_cols=238  Identities=19%  Similarity=0.302  Sum_probs=189.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCce----EEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEE----VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      .+|.. .+.||+|+||.||++.+..+++.    +|+|.+... ......+.+.+|+.+++.++||||+++++++.     
T Consensus         7 ~~f~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~-----   79 (316)
T cd05108           7 TEFKK-IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICL-----   79 (316)
T ss_pred             hhcee-eeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEc-----
Confidence            34555 99999999999999998766654    899988643 23344567889999999999999999999983     


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      . ...+++++|+. |+|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||+++.
T Consensus        80 ~-~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          80 T-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             C-CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence            2 24678999997 7999998764 4689999999999999999999999999999999999999999999999999975


Q ss_pred             cCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          188 TSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       188 ~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      ...             ..|++|+.........++|+|++|+++|++++ |..|+......   ............+.   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~~---  232 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEKGERLPQ---  232 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhCCCCCCC---
Confidence            431             13677777766677888999999999999987 88886543211   11222222111111   


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                         .+.++.++.+++.+||..+|++||++.+++.+
T Consensus       233 ---~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         233 ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               13578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-35  Score=256.94  Aligned_cols=242  Identities=24%  Similarity=0.330  Sum_probs=193.1

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.. .+.||.|++|.||++.+..+|+.+|+|.++.. .......+.+.+|+.++++++|++|+++++.+     ...+
T Consensus         2 ~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-----~~~~   75 (267)
T cd08224           2 GNFKI-EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-----IENN   75 (267)
T ss_pred             Cceee-eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCC
Confidence            45666 89999999999999999999999999998753 23334467889999999999999999999999     5567


Q ss_pred             eEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          113 DVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ..+++|||++ ++|..++..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~  155 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF  155 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeee
Confidence            8899999998 699888854    34589999999999999999999999999999999999999999999999998754


Q ss_pred             cC-----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          188 TS-----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       188 ~~-----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      ..           ...|.+|+.........++|+|++|++++++++|..|+.....    ...............+..  
T Consensus       156 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~--  229 (267)
T cd08224         156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEKCDYPPLP--  229 (267)
T ss_pred             ccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhcCCCCCCC--
Confidence            32           2346677776666677889999999999999999988643221    111111111111111111  


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ...++..++++|.+||..+|++|||+.++++
T Consensus       230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            1257889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.7e-36  Score=267.94  Aligned_cols=241  Identities=23%  Similarity=0.343  Sum_probs=189.1

Q ss_pred             CccCCCccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMD  107 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~  107 (339)
                      ++|.+ ++.||.|+||.||+|...     .+++.||+|++.... .......+.+|+.++.++ +|+||+++++++.   
T Consensus         7 ~~~~i-~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~---   81 (337)
T cd05054           7 DRLKL-GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACT---   81 (337)
T ss_pred             HHhhh-hcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEe---
Confidence            45666 999999999999999754     345789999986542 233456778899999999 7999999999873   


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhc------------------------------------------------------
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSK------------------------------------------------------  132 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~------------------------------------------------------  132 (339)
                       .....++++|||+. ++|.+++...                                                      
T Consensus        82 -~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          82 -KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             -cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence             33457899999998 6898887532                                                      


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-------------CCC
Q 042681          133 -------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-------------ETD  192 (339)
Q Consensus       133 -------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-------------~~~  192 (339)
                             .++++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++....             ...
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                   267899999999999999999999999999999999999999999999999987531             124


Q ss_pred             ccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHh
Q 042681          193 FMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERM  271 (339)
Q Consensus       193 ~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  271 (339)
                      |++|+......+..+.|+|++|++++++++ |..|+.....  ............   ...   .....++++.+++.+|
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~---~~~---~~~~~~~~~~~l~~~c  312 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--DEEFCRRLKEGT---RMR---APEYATPEIYSIMLDC  312 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc--cHHHHHHHhccC---CCC---CCccCCHHHHHHHHHH
Confidence            778887777778889999999999999997 8888654211  111111111111   111   1134688999999999


Q ss_pred             cccCCCCCCCHHHHhcC
Q 042681          272 LVFDPAKRITVEEALNH  288 (339)
Q Consensus       272 L~~dP~~Rps~~ell~h  288 (339)
                      |+.+|++||++.++++|
T Consensus       313 l~~~p~~RPs~~ell~~  329 (337)
T cd05054         313 WHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ccCChhhCcCHHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-36  Score=262.56  Aligned_cols=233  Identities=27%  Similarity=0.409  Sum_probs=182.8

Q ss_pred             ccccccccceEEEEEEeC----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           40 LQPIGRGAYGIVCSAVNS----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      .+.||.|+||.||+|...    ..+..|+||.++. .......+.+.+|+..+.+++||||++++|++     ...+..+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~-----~~~~~~~   77 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFC-----IENEPLF   77 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEE-----ESSSSEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccc-----ccccccc
Confidence            578999999999999987    4567899999854 33444578899999999999999999999999     4555699


Q ss_pred             EEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          116 IVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      +|+||+. |+|.+++...  ..+++...+.|+.||+.||.|||+++++|++|+++||+++.++.+||+|||.+....   
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999998 7999999886  789999999999999999999999999999999999999999999999999987652   


Q ss_pred             ----------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          190 ----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       190 ----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                ...|.+||.........++|+|++|++++++++ |..|+...   ................      ...
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~~~~~~~~------~~~  228 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKLKQGQRLP------IPD  228 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHHHTTEETT------SBT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccce------ecc
Confidence                      123667777766668889999999999999999 66775443   1122122222211111      113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .++..+.++|.+||+.||.+||++.++++
T Consensus       229 ~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  229 NCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             TSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             chhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            57899999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.7e-36  Score=263.05  Aligned_cols=238  Identities=21%  Similarity=0.313  Sum_probs=187.3

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceE--EEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCc
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEV--AIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~--avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~  111 (339)
                      +|.. .+.||+|+||.||+|.+..++..+  ++|.+... ........+.+|+.++.++ +||||+++++++     ...
T Consensus         8 ~~~~-~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~   80 (303)
T cd05088           8 DIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   80 (303)
T ss_pred             hcee-eeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence            4444 889999999999999988777654  66665432 2334456788999999999 899999999998     566


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQ----------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN  174 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~  174 (339)
                      +.+++||||++ ++|.+++...+                .+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            77999999997 79999986532                57899999999999999999999999999999999999999


Q ss_pred             CCeEEeecccccccC----------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHh
Q 042681          175 CDLKICDFGLARTTS----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVK  243 (339)
Q Consensus       175 ~~ikL~Dfg~~~~~~----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~  243 (339)
                      +.++|+|||++....          ...|.+|+.........++|+|++|++++++++ |..|+......      ....
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~  234 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE  234 (303)
T ss_pred             CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHH
Confidence            999999999985321          124677887766667789999999999999997 88876432211      1111


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       244 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ........   .....+++++.+|+.+||+.+|++||++.+++++
T Consensus       235 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         235 KLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHhcCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11111111   1112468899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1e-35  Score=262.94  Aligned_cols=248  Identities=22%  Similarity=0.292  Sum_probs=197.7

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      |.. .+.||.|++|.||++.+..+++.+++|.+... .........+.+|+.+++.++|+|++++++++     ......
T Consensus        17 ~~~-~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   90 (308)
T cd06634          17 FSD-LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHTA   90 (308)
T ss_pred             HHH-HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCee
Confidence            444 78899999999999999999999999998653 22333456788999999999999999999998     556778


Q ss_pred             EEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC----
Q 042681          115 YIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS----  189 (339)
Q Consensus       115 ~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~----  189 (339)
                      ++|+||+.|++.+.+.. ..++++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+....    
T Consensus        91 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  170 (308)
T cd06634          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX  170 (308)
T ss_pred             EEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCccc
Confidence            99999999988887754 4578999999999999999999999999999999999999999999999999886533    


Q ss_pred             ---CCCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          190 ---ETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       190 ---~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                         ...|.+|+...   ......+.|+|++|++++++++|..|+......   ...   ...........  ....++..
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~---~~~~~~~~~~~--~~~~~~~~  242 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SAL---YHIAQNESPAL--QSGHWSEY  242 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---HHH---HHHhhcCCCCc--CcccccHH
Confidence               33577777642   234567899999999999999999886543111   001   11111111111  11357889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          264 AIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      +++||.+||+.+|++||++.+++.|||+......
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~  276 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence            9999999999999999999999999999986443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.3e-35  Score=258.33  Aligned_cols=240  Identities=18%  Similarity=0.289  Sum_probs=186.9

Q ss_pred             cCccCCCccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      .++|.. .+.||+|++|.||++.+.     .++..+|+|++.... .......+.+|+.+++.++||||+++++++    
T Consensus         5 ~~~~~~-~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----   78 (277)
T cd05062           5 REKITM-SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV----   78 (277)
T ss_pred             HHHcee-eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE----
Confidence            344555 899999999999999864     245679999886432 223456688999999999999999999998    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQ----------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD  176 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~  176 (339)
                       ......++||||++ ++|.+++.+.+          .++...+..++.|++.||.|||+.|++|+||||+||++++++.
T Consensus        79 -~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          79 -SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             -cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence             56678999999998 79999886532          3567888999999999999999999999999999999999999


Q ss_pred             eEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHH
Q 042681          177 LKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYV  242 (339)
Q Consensus       177 ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~  242 (339)
                      ++|+|||++....             ...|++|+..........+|+|++|++++++++ |..|+....   ........
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~---~~~~~~~~  234 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---NEQVLRFV  234 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH
Confidence            9999999885431             124778887766667888999999999999998 566654321   11111111


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ....   ...   ....++..+++++.+||+.||++|||+.+++++
T Consensus       235 ~~~~---~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         235 MEGG---LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HcCC---cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1111   111   113578899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-35  Score=256.56  Aligned_cols=235  Identities=19%  Similarity=0.307  Sum_probs=187.0

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +.+.+++.||+|++|.||++... ++..+|+|.+...   ....+.+.+|+.+++.++|+||+++++++     ......
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPI   76 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCc
Confidence            33344899999999999999865 5677999987643   22356789999999999999999999998     566778


Q ss_pred             EEEEecCc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-
Q 042681          115 YIVYELMD-TDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-  190 (339)
                      +++|||++ ++|.+++..  ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..... 
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            99999997 799998865  35688999999999999999999999999999999999999999999999999875432 


Q ss_pred             -----------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          191 -----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       191 -----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                 ..|.+|+...........|+|++|++++++++ |..|+....   ............   ..   ....
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~~---~~---~~~~  227 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSALQRGY---RM---PRME  227 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC---HHHHHHHHHcCC---CC---CCCC
Confidence                       13677776665666778999999999999997 888765321   111111111111   11   1123


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .++.++.+++.+||+.+|++||+++++.+
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         228 NCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            57899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-35  Score=261.30  Aligned_cols=245  Identities=20%  Similarity=0.271  Sum_probs=185.6

Q ss_pred             CccCCCccccccccceEEEEEEeCCCC--------------ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeee
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETK--------------EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV   99 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~--------------~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~   99 (339)
                      ++|.. .+.||+|+||.||++.+..++              ..+|+|.++... .......+.+|++++.+++||||+++
T Consensus         5 ~~~~~-~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           5 QQLRL-KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             HhCee-hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            35555 899999999999999875432              358999887542 33345678899999999999999999


Q ss_pred             eeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 042681          100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKP  166 (339)
Q Consensus       100 ~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp  166 (339)
                      ++++     ......++||||+. ++|.+++....            .+++..++.++.|++.||+|||++|++|+||||
T Consensus        83 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp  157 (295)
T cd05097          83 LGVC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT  157 (295)
T ss_pred             EEEE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence            9999     55677899999998 68988885431            368889999999999999999999999999999


Q ss_pred             CCeeeccCCCeEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh--CCCCCCccc
Q 042681          167 SNLLLNANCDLKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL--GSPDDSDLG  231 (339)
Q Consensus       167 ~NIli~~~~~ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~--g~~~~~~~~  231 (339)
                      +||+++.++.++|+|||++....             ...|.+|+.........++|+|++|++++++++  +..|+....
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            99999999999999999986432             124677776666667889999999999999987  444443221


Q ss_pred             ccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          232 FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .  .......................+.+++.+.+|+.+||+.||++||+++++++
T Consensus       238 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         238 D--EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             h--HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            1  11111111111111111111222457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-35  Score=256.46  Aligned_cols=240  Identities=18%  Similarity=0.264  Sum_probs=188.3

Q ss_pred             ccccccccceEEEEEEeCC---CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc-CCcCeEE
Q 042681           40 LQPIGRGAYGIVCSAVNSE---TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK-EKFNDVY  115 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~-~~~~~~~  115 (339)
                      .+.||+|+||.||+|....   ++..+|+|.++...........+.+|+..++.++||||+++++++..... ......+
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05035           4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM   83 (273)
T ss_pred             ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence            7889999999999998654   34789999987655555556788999999999999999999998743221 1223479


Q ss_pred             EEEecCc-ccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          116 IVYELMD-TDLHQIIRSK------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      +++||+. |+|..++...      ..+++..++.++.|++.||.|||+.|++||||||+||++++++.++|+|||.++..
T Consensus        84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  163 (273)
T cd05035          84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI  163 (273)
T ss_pred             EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeec
Confidence            9999998 7888887432      36899999999999999999999999999999999999999999999999998754


Q ss_pred             CC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 SE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 ~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      ..             ..|.+|+.........++|+|++|++++++++ |..|+.....   .........   ....   
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~~---~~~~---  234 (273)
T cd05035         164 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLRH---GNRL---  234 (273)
T ss_pred             cccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc---CCCC---
Confidence            22             13566776666667788999999999999998 7777644321   111111111   1111   


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .....++.++.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1124578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=254.25  Aligned_cols=237  Identities=22%  Similarity=0.311  Sum_probs=190.3

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ..+.+.+.+.||+|++|.||++...  |+.+|+|.+.....   ..+++.+|+.++..++|+||+++++++     ....
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~   73 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVV-----LQGN   73 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEE-----cCCC
Confidence            3344444899999999999999864  78999999875422   457789999999999999999999998     5567


Q ss_pred             eEEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ..++||||++ ++|.+++....  .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence            7899999998 69999997655  79999999999999999999999999999999999999999999999999987543


Q ss_pred             C--------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          190 E--------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       190 ~--------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                      .        ..|.+|+.........++|+|++|++++++++ |..|+.....   ..........   ...   .....+
T Consensus       154 ~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~---~~~---~~~~~~  224 (256)
T cd05039         154 QGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKG---YRM---EAPEGC  224 (256)
T ss_pred             cccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcC---CCC---CCccCC
Confidence            2        23667776665566778999999999999996 8887654321   1111111111   111   111357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ++.+.++|.+||..+|++||++.++++.
T Consensus       225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~  252 (256)
T cd05039         225 PPEVYKVMKDCWELDPAKRPTFKQLREQ  252 (256)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            8999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-35  Score=259.06  Aligned_cols=233  Identities=23%  Similarity=0.300  Sum_probs=186.2

Q ss_pred             CccccccccceEEEEEEe-----CCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           39 PLQPIGRGAYGIVCSAVN-----SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        39 ~~~~lg~G~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +.+.||.|+||.||++..     ..++..+|+|.+...  .......+.+|+.++.+++||||+++++++     .....
T Consensus         9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   81 (288)
T cd05093           9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEGDP   81 (288)
T ss_pred             eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCc
Confidence            388999999999999985     234567899988643  334456789999999999999999999998     56678


Q ss_pred             EEEEEecCc-ccHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEE
Q 042681          114 VYIVYELMD-TDLHQIIRSKQ-------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI  179 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL  179 (339)
                      ++++|||++ ++|.+++...+             .+++..++.++.|++.||+|||++|++||||||+||++++++.++|
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence            999999998 79999986543             4899999999999999999999999999999999999999999999


Q ss_pred             eecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhC
Q 042681          180 CDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQL  245 (339)
Q Consensus       180 ~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~  245 (339)
                      +|||.+....             ...|.+|+.........++|+|++|++++++++ |..|+.....  ....... .  
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--~~~~~~i-~--  236 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIECI-T--  236 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH-H--
Confidence            9999986432             124778887766677888999999999999998 7877643321  1111111 1  


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       246 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                       ......   ....++.++.+|+.+||+.||.+|||+.+++.
T Consensus       237 -~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         237 -QGRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             -cCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             111111   11347899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.9e-35  Score=268.82  Aligned_cols=246  Identities=22%  Similarity=0.283  Sum_probs=188.5

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCC-----CceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeee
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSET-----KEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDI  102 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~  102 (339)
                      ++.++..-+.+++.||+|+||.||++.+...     +..||+|++... ......+.+.+|+.++.++. ||||++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~  109 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGA  109 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence            3333333333389999999999999986533     346999998654 23334567899999999996 9999999999


Q ss_pred             cCCCCcCCcCeEEEEEecCc-ccHHHHHHhc-------------------------------------------------
Q 042681          103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSK-------------------------------------------------  132 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-------------------------------------------------  132 (339)
                      +     ......++||||++ |+|.+++.+.                                                 
T Consensus       110 ~-----~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (400)
T cd05105         110 C-----TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD  184 (400)
T ss_pred             E-----ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence            9     66678999999998 7998887542                                                 


Q ss_pred             -----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 042681          133 -----------------------------------------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLK  165 (339)
Q Consensus       133 -----------------------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dik  165 (339)
                                                                     ..+++..+..++.|++.||.|||+.|++|+|||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dik  264 (400)
T cd05105         185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA  264 (400)
T ss_pred             ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence                                                           247788889999999999999999999999999


Q ss_pred             CCCeeeccCCCeEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCccc
Q 042681          166 PSNLLLNANCDLKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLG  231 (339)
Q Consensus       166 p~NIli~~~~~ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~  231 (339)
                      |+||+++.++.++|+|||++....             ...|++|+.........+.|+|++|++++++++ |..|+....
T Consensus       265 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             hHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            999999999999999999986432             124778887766667888999999999999986 777764321


Q ss_pred             ccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          232 FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..  ............   ..   ....++.++++++.+||+.||++||++.++.+.
T Consensus       345 ~~--~~~~~~~~~~~~---~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  393 (400)
T cd05105         345 VD--STFYNKIKSGYR---MA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI  393 (400)
T ss_pred             hh--HHHHHHHhcCCC---CC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence            11  111111111111   11   113578999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.6e-36  Score=256.64  Aligned_cols=220  Identities=17%  Similarity=0.223  Sum_probs=179.6

Q ss_pred             ccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCc-cc
Q 042681           46 GAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TD  124 (339)
Q Consensus        46 G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~  124 (339)
                      |.++.||+|++..+++.+|+|++....       ...+|...+....||||+++++++     ......+++|||++ |+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~   71 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGK   71 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCC
Confidence            899999999999999999999997542       123344455556799999999998     56678999999998 69


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC--------CCCcccc
Q 042681          125 LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--------ETDFMTE  196 (339)
Q Consensus       125 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~--------~~~~~~~  196 (339)
                      |.+++.+..++++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+....        ...|.+|
T Consensus        72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aP  151 (237)
T cd05576          72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAP  151 (237)
T ss_pred             HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCC
Confidence            99999887889999999999999999999999999999999999999999999999999865432        2347788


Q ss_pred             ccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCC
Q 042681          197 YVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDP  276 (339)
Q Consensus       197 ~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  276 (339)
                      +...........|+|++|++++++++|..++...+..        .......      ...+.+++.++++|.+||+.||
T Consensus       152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~~~~~~~------~~~~~~~~~~~~li~~~l~~dp  217 (237)
T cd05576         152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------INTHTTL------NIPEWVSEEARSLLQQLLQFNP  217 (237)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------ccccccc------CCcccCCHHHHHHHHHHccCCH
Confidence            8776666777899999999999999998765432110        0000000      1113478999999999999999


Q ss_pred             CCCCCH-----HHHhcCCCC
Q 042681          277 AKRITV-----EEALNHPYL  291 (339)
Q Consensus       277 ~~Rps~-----~ell~hp~f  291 (339)
                      ++||++     +++++||||
T Consensus       218 ~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         218 TERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HHhcCCCccchHHHHcCCCC
Confidence            999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=254.25  Aligned_cols=234  Identities=21%  Similarity=0.254  Sum_probs=186.8

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      |.. .+.||+|++|.||++.+. ++..+|+|.+.....   ....+.+|+.+++.++||||+++++++     ......+
T Consensus         6 ~~~-~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd05059           6 LTF-LKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIF   75 (256)
T ss_pred             cch-hhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceE
Confidence            444 889999999999999876 467899998864422   235678899999999999999999998     5567789


Q ss_pred             EEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC---
Q 042681          116 IVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE---  190 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~---  190 (339)
                      +||||++ ++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.++....   
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            9999997 689999875 35789999999999999999999999999999999999999999999999998864322   


Q ss_pred             ---------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          191 ---------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       191 ---------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                               ..|.+|+.........++|+|++|++++++++ |..|+.....  ...... .....   ...   ....+
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~-~~~~~---~~~---~~~~~  226 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVVES-VSAGY---RLY---RPKLA  226 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHHHHH-HHcCC---cCC---CCCCC
Confidence                     13777877766667778999999999999998 6777654321  111111 11111   111   11347


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +.++.+++.+||..+|++|||+.++++.
T Consensus       227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            8999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-35  Score=258.27  Aligned_cols=248  Identities=22%  Similarity=0.342  Sum_probs=188.9

Q ss_pred             CccCCCccccccccceEEEEEEe----CCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVN----SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ++++.+++.||+|+||.||++..    ..+++.+|+|.++... .......+.+|+.+++.++||||+++++++..   .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~   78 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE---D   78 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---C
Confidence            34445589999999999999973    5678899999986442 33345678999999999999999999998842   2


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .....++||||++ ++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+..
T Consensus        79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence            2356899999997 7999988654 4689999999999999999999999999999999999999999999999998864


Q ss_pred             cCC--------------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccc---------ccchHHHHHhh
Q 042681          188 TSE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFL---------RSDNARRYVKQ  244 (339)
Q Consensus       188 ~~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~---------~~~~~~~~~~~  244 (339)
                      ...              ..|.+|+.........++|+|++|+++++++++..+.......         ...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            322              1366777666666778899999999999999876543211000         00000011111


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       245 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .......   .....++..+.+|+.+||+.+|.+||++.+++++
T Consensus       239 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         239 LEEGKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHcCccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1111111   1124578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.7e-35  Score=254.54  Aligned_cols=234  Identities=19%  Similarity=0.255  Sum_probs=185.5

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|+||.||++.... +..+|+|.+.....   ..+.+.+|+.+++.++||||+++++++     ......
T Consensus         5 ~~~~-~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   74 (256)
T cd05114           5 ELTF-MKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPL   74 (256)
T ss_pred             HcEE-eeEecCCcCceEEEEEecc-CceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCE
Confidence            3444 7889999999999998754 56799998764322   245688999999999999999999998     566779


Q ss_pred             EEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC--
Q 042681          115 YIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--  190 (339)
                      +++|||++ |+|.+++.. .+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.++....  
T Consensus        75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            99999997 799998865 35689999999999999999999999999999999999999999999999998864321  


Q ss_pred             ----------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          191 ----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       191 ----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                ..|.+|+.........+.|+|++|++++++++ |..|+....      ................   ...
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~------~~~~~~~i~~~~~~~~---~~~  225 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS------NYEVVEMISRGFRLYR---PKL  225 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHCCCCCCC---CCC
Confidence                      13667777666667788999999999999999 777754321      1111111111111111   123


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .+..+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         226 ASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            5788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.8e-35  Score=258.18  Aligned_cols=234  Identities=18%  Similarity=0.293  Sum_probs=186.3

Q ss_pred             ccccccccceEEEEEEe----CCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           40 LQPIGRGAYGIVCSAVN----SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      .+.||+|+||.||++..    ..++..+++|.+... ........+.+|+.+++.++||||+++++++     ......+
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~   83 (283)
T cd05090          10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQEQPVC   83 (283)
T ss_pred             eeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecCCceE
Confidence            78999999999999985    345678999988753 2333456788999999999999999999998     5566789


Q ss_pred             EEEecCc-ccHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCe
Q 042681          116 IVYELMD-TDLHQIIRSK-----------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL  177 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~i  177 (339)
                      ++|||++ ++|.+++...                 ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence            9999998 7999988532                 247888999999999999999999999999999999999999999


Q ss_pred             EEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHh
Q 042681          178 KICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVK  243 (339)
Q Consensus       178 kL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~  243 (339)
                      +|+|||+++....             ..|.+|+.........+.|+|++|++++++++ |..|+.....   ........
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~~~  240 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEMVR  240 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence            9999999865422             13777877666667888999999999999998 8777654221   11111111


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       244 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ...   ..+   ....+++.+++++.+||+.||.+||++.+++++
T Consensus       241 ~~~---~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         241 KRQ---LLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             cCC---cCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            111   111   123578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-35  Score=254.63  Aligned_cols=230  Identities=23%  Similarity=0.300  Sum_probs=185.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||+|++|.||++.+. +++.+|+|.++....   ..+.+.+|+.++++++||||+++++++     ...+..+++||
T Consensus        11 ~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e   81 (261)
T cd05068          11 LRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYIVTE   81 (261)
T ss_pred             EEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeeeeee
Confidence            899999999999999875 457899999875422   245688999999999999999999998     66677899999


Q ss_pred             cCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC------
Q 042681          120 LMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE------  190 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~------  190 (339)
                      |++ ++|.+++....  .+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++.....      
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR  161 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence            995 79999997644  789999999999999999999999999999999999999999999999998865432      


Q ss_pred             ------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          191 ------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       191 ------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                            ..|.+|+...........|+|++|++++++++ |..|+....   ..........   ....+   ....++..
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~---~~~~~---~~~~~~~~  232 (261)
T cd05068         162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQVDQ---GYRMP---CPPGCPKE  232 (261)
T ss_pred             CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHc---CCCCC---CCCcCCHH
Confidence                  13677777666667788999999999999998 887764321   1111111111   11111   11357899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 042681          264 AIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      +.+++.+||+.+|++||++.++++
T Consensus       233 ~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         233 LYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.9e-35  Score=254.26  Aligned_cols=235  Identities=20%  Similarity=0.239  Sum_probs=185.8

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|++|.||.+.... +..+|+|.+.....   ....+.+|+.++..++||||+++++++     ......
T Consensus         5 ~~~~-~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   74 (256)
T cd05113           5 DLTF-LKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPI   74 (256)
T ss_pred             HeEE-eeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCc
Confidence            4455 7889999999999998754 45699998864422   235688999999999999999999998     555678


Q ss_pred             EEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC--
Q 042681          115 YIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--  190 (339)
                      +++|||+. ++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.++....  
T Consensus        75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            99999997 6899988764 4789999999999999999999999999999999999999999999999998764322  


Q ss_pred             ----------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          191 ----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       191 ----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                ..|.+|+.........++|+|++|++++++++ |..|+.....   ........   .......   ...
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~---~~~~~~~---~~~  225 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVS---QGLRLYR---PHL  225 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHh---cCCCCCC---CCC
Confidence                      13667776665567778999999999999998 8877653321   11111111   1111111   123


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .+..+++++.+||+.+|.+||++.+++.+
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         226 ASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            68899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-35  Score=258.48  Aligned_cols=237  Identities=24%  Similarity=0.307  Sum_probs=189.8

Q ss_pred             ccCCCccccccccceEEEEEEeCC-----CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSE-----TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      +|.. .+.||+|+||.||++.+..     +++.+|+|.++.... ....+.+.+|+.+++.++||||+++++++     .
T Consensus         6 ~~~~-~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~   78 (280)
T cd05049           6 TIVL-KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVC-----T   78 (280)
T ss_pred             HhhH-HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEE-----e
Confidence            3445 8899999999999998753     467899999865422 33457889999999999999999999999     5


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK--------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN  174 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~  174 (339)
                      .....+++|||++ ++|.+++...              ..+++..+..++.|++.||++||++|++||||||+||+++.+
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~  158 (280)
T cd05049          79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD  158 (280)
T ss_pred             cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence            5678999999997 7999998653              347889999999999999999999999999999999999999


Q ss_pred             CCeEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHH
Q 042681          175 CDLKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARR  240 (339)
Q Consensus       175 ~~ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~  240 (339)
                      +.++|+|||.+....             ...|.+||..........+|+|++|++++++++ |..|+.....   ..   
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~---  232 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EE---  232 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HH---
Confidence            999999999886431             124778887777778888999999999999998 8888654321   11   


Q ss_pred             HHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          241 YVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ...........   .....++..+++++.+||+.||++||++.++++
T Consensus       233 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         233 VIECITQGRLL---QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHHcCCcC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            11111111111   111357899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.1e-35  Score=257.04  Aligned_cols=238  Identities=20%  Similarity=0.270  Sum_probs=188.5

Q ss_pred             ccCCCccccccccceEEEEEEeCC-----CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSE-----TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      +|.+ .+.||+|++|.||+|.+..     ++..+++|.+.... .......+.+|+.+++.++|+||+++++++     .
T Consensus         7 ~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~   79 (277)
T cd05036           7 SITL-LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVS-----F   79 (277)
T ss_pred             HcEe-eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----c
Confidence            3444 8899999999999999877     77889999876432 233346688999999999999999999988     4


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC---CeE
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQ-------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC---DLK  178 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~---~ik  178 (339)
                      .....+++|||+. ++|.+++...+       .+++..+..++.||+.||+|||++|++|+||||+||+++.++   .++
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence            5567899999996 79999986643       589999999999999999999999999999999999998765   599


Q ss_pred             EeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhh
Q 042681          179 ICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQ  244 (339)
Q Consensus       179 L~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~  244 (339)
                      |+|||.++....             ..|++|+.........++|+|++|++++++++ |..|+.....   .........
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~~~~  236 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFVTG  236 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc
Confidence            999999875421             23677887766678889999999999999996 8777653221   111111111


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       245 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..   ...   ....++..+.+++.+||+.+|++||++.++++|
T Consensus       237 ~~---~~~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         237 GG---RLD---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CC---cCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            11   111   124578999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.3e-35  Score=259.36  Aligned_cols=239  Identities=21%  Similarity=0.293  Sum_probs=187.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCc--eEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKE--EVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~  110 (339)
                      ++|.. .+.||+|+||.||++....++.  .+++|.++.. ......+.+.+|+.++.++ +||||+++++++     ..
T Consensus         2 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~   74 (297)
T cd05089           2 EDIKF-EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----EN   74 (297)
T ss_pred             cccee-eeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----cc
Confidence            35555 8899999999999999877765  4678776532 2333456788999999999 799999999998     55


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK----------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA  173 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~  173 (339)
                      .+.+++++||++ ++|.+++...                ..+++..++.++.|++.||+|||+.|++||||||+||+++.
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~  154 (297)
T cd05089          75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE  154 (297)
T ss_pred             CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC
Confidence            667999999997 7999998653                24888999999999999999999999999999999999999


Q ss_pred             CCCeEEeecccccccC----------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHH
Q 042681          174 NCDLKICDFGLARTTS----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYV  242 (339)
Q Consensus       174 ~~~ikL~Dfg~~~~~~----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~  242 (339)
                      ++.++|+|||++....          ...|.+|+.........++|+|++|++++++++ |..|+......   .   ..
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~---~~  228 (297)
T cd05089         155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---E---LY  228 (297)
T ss_pred             CCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---H---HH
Confidence            9999999999875321          123777887766667788999999999999997 88886543211   1   11


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .........   .....++.++++|+.+||+.+|.+||+++++++.
T Consensus       229 ~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         229 EKLPQGYRM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            111111111   1113578999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.5e-35  Score=256.51  Aligned_cols=245  Identities=20%  Similarity=0.276  Sum_probs=187.2

Q ss_pred             ccCCCccccccccceEEEEEE----eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      +|.. ++.||+|+||.||++.    +..+++.+|+|++...  .....+.+.+|+.++..++||||+++++++..   ..
T Consensus         5 ~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~   78 (284)
T cd05081           5 HLKF-IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AG   78 (284)
T ss_pred             ccee-eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CC
Confidence            3444 8999999999999997    4567889999998643  33445678899999999999999999998732   23


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ...+++|+||++ ++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            356899999997 7999998754 56899999999999999999999999999999999999999999999999998754


Q ss_pred             CCC--------------CccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc----------chHHHHHhh
Q 042681          189 SET--------------DFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS----------DNARRYVKQ  244 (339)
Q Consensus       189 ~~~--------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~----------~~~~~~~~~  244 (339)
                      ...              .|.+|+.........+.|+|++|++++++++|..+.........          .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            221              25677776666677889999999999999987654322211000          000000011


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       245 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .......   .....++.++.+|+.+||..+|++|||+.++++.
T Consensus       239 ~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         239 LKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             HhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            1111111   1124578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.5e-35  Score=260.01  Aligned_cols=238  Identities=21%  Similarity=0.350  Sum_probs=188.2

Q ss_pred             ccCCCccccccccceEEEEEEeCCC-----CceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCc
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSET-----KEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDK  108 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~  108 (339)
                      +|.. .+.||+|++|.||++.+...     ...+|+|.+.... .......+.+|+.++..+ +||||+++++++     
T Consensus        13 ~~~~-~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-----   85 (293)
T cd05053          13 RLTL-GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC-----   85 (293)
T ss_pred             HeEE-eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-----
Confidence            3444 88999999999999987643     3689999887542 233456788999999999 799999999998     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRS----------------KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL  171 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~----------------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli  171 (339)
                      ...+.++++|||+. |+|..++..                .+.+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~  165 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV  165 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence            55677999999997 799998854                2468899999999999999999999999999999999999


Q ss_pred             ccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccch
Q 042681          172 NANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDN  237 (339)
Q Consensus       172 ~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~  237 (339)
                      +.++.++|+|||.++....             ..|.+|+.........++|+|++|++++++++ |..|+......   .
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~  242 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---E  242 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---H
Confidence            9999999999999864322             23677887766677888999999999999986 77776433211   1


Q ss_pred             HHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          238 ARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .........   ..   .....++.++.+|+.+||..||++|||+.+++++
T Consensus       243 ~~~~~~~~~---~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGY---RM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCC---cC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            111111111   11   1113568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=272.59  Aligned_cols=239  Identities=26%  Similarity=0.370  Sum_probs=197.6

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCC
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMD  107 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~  107 (339)
                      .....+.|.. ...+|.|+|+.|..+.+..+++.+++|++.+...      ...+|+.++... +||||+++++.+    
T Consensus       317 ~~~~~~~y~~-~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~----  385 (612)
T KOG0603|consen  317 TAPFTESYEF-REELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVY----  385 (612)
T ss_pred             cCCcchhhcc-ccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeeccee----
Confidence            4446677877 7779999999999999999999999999976522      234566555554 799999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee-ccCCCeEEeecccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL-NANCDLKICDFGLA  185 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli-~~~~~ikL~Dfg~~  185 (339)
                       ....+.++|||.+. +.+.+.+....... ..+..|+.+|+.|+.|||++|+|||||||+|||+ ++.++++|+|||.+
T Consensus       386 -~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a  463 (612)
T KOG0603|consen  386 -EDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFW  463 (612)
T ss_pred             -cCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechh
Confidence             77889999999998 56666666655555 7888899999999999999999999999999999 58999999999998


Q ss_pred             cccCC--------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          186 RTTSE--------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       186 ~~~~~--------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                      +....        ..|.+||....+++..+.|+|++|+++|+|++|..++...+..     ..+...+.   .....   
T Consensus       464 ~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~---~~~~s---  532 (612)
T KOG0603|consen  464 SELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQ---MPKFS---  532 (612)
T ss_pred             hhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhc---CCccc---
Confidence            76543        3688999999999999999999999999999999998765533     11111111   11111   


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ..+|.++++||++||+.||.+||++.+++.||||
T Consensus       533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  533 ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            4589999999999999999999999999999999

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.5e-35  Score=255.86  Aligned_cols=237  Identities=19%  Similarity=0.295  Sum_probs=187.7

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCc----eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKE----EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      +|.. ++.||+|+||.||+|.+..+|+    .||+|++... ........+.+|+.++..++||||+++++++.     .
T Consensus         8 ~~~~-~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~   80 (279)
T cd05109           8 ELKK-VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICL-----T   80 (279)
T ss_pred             heee-eeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc-----C
Confidence            3444 8999999999999999877776    4789988654 23334567889999999999999999999983     2


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                       ...+++++|++ |+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++..
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence             33678999997 7999998764 57999999999999999999999999999999999999999999999999998654


Q ss_pred             C-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 S-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 ~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      .             ...|++|+.........+.|+|++|++++++++ |..|+....   ..............+.    
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~----  232 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPDLLEKGERLPQ----  232 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCCcCCC----
Confidence            2             123677877766667788999999999999987 777764322   1111222222111111    


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                        .+.++.++.+++.+||+.||++||++.+++..
T Consensus       233 --~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~  264 (279)
T cd05109         233 --PPICTIDVYMIMVKCWMIDSECRPRFRELVDE  264 (279)
T ss_pred             --CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              13578999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-35  Score=255.40  Aligned_cols=238  Identities=18%  Similarity=0.290  Sum_probs=187.5

Q ss_pred             ccCCCccccccccceEEEEEEeCCC-----CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSET-----KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      +|.. .+.||+|+||.||++.+...     +..+|+|.+.... .......+.+|+.++..++||||+++++++     .
T Consensus         7 ~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~   79 (277)
T cd05032           7 KITL-IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   79 (277)
T ss_pred             HeeE-EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence            4444 89999999999999987643     4789999986442 233446788999999999999999999998     5


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeE
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK----------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK  178 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ik  178 (339)
                      .....++||||++ ++|.+++...          ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence            5678999999997 7999998643          2367889999999999999999999999999999999999999999


Q ss_pred             EeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhh
Q 042681          179 ICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQ  244 (339)
Q Consensus       179 L~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~  244 (339)
                      |+|||.++....             ..|.+|+.........++|+|++|++++++++ |..|+....   ......... 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~~~~-  235 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---NEEVLKFVI-  235 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC---HHHHHHHHh-
Confidence            999998864321             24677887766667888999999999999997 777754321   111111221 


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       245 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                        ......   ....++.++.+++.+||+.+|++|||+.++++.
T Consensus       236 --~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         236 --DGGHLD---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             --cCCCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence              111111   113468999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-35  Score=265.04  Aligned_cols=241  Identities=23%  Similarity=0.366  Sum_probs=186.3

Q ss_pred             CccCCCccccccccceEEEEEEe-----CCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVN-----SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMD  107 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~  107 (339)
                      ++|.. ++.||+|+||.||+|.+     ..+++.||+|+++... .......+.+|+.++.++ +||||+++++++.   
T Consensus         7 ~~~~~-~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---   81 (343)
T cd05103           7 DRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT---   81 (343)
T ss_pred             hHhcc-cccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceee---
Confidence            45666 99999999999999984     3467899999987542 233456788999999999 6899999999873   


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhc------------------------------------------------------
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSK------------------------------------------------------  132 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~------------------------------------------------------  132 (339)
                       .....++++|||++ |+|.+++...                                                      
T Consensus        82 -~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          82 -KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             -cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence             33456899999998 7999888642                                                      


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC----------
Q 042681          133 -------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS----------  189 (339)
Q Consensus       133 -------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~----------  189 (339)
                                   ..++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....          
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                         236778888999999999999999999999999999999999999999999986532          


Q ss_pred             ---CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          190 ---ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       190 ---~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                         ...|.+|+.........+.|+|++|++++++++ |..|+......  .........   .......   ...++++.
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~---~~~~~~~---~~~~~~~~  312 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKE---GTRMRAP---DYTTPEMY  312 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhc---cCCCCCC---CCCCHHHH
Confidence               123677777666667788999999999999996 87776432211  111111111   1111111   23678999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 042681          266 DLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       266 ~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +++.+||+.||.+||++.++++|
T Consensus       313 ~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         313 QTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999987

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-38  Score=298.46  Aligned_cols=244  Identities=27%  Similarity=0.346  Sum_probs=206.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ...||.|.||.||.|.+..+|...|+|.++-..........+.+|..++..++|||+++++|+-     .....++|.||
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE-----vHRekv~IFME 1314 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE-----VHREKVYIFME 1314 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee-----ecHHHHHHHHH
Confidence            6678999999999999999999999999876555555667788999999999999999999987     55667899999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----------  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----------  188 (339)
                      ||+ |+|.+.+...+..++...+.+..|++.|+.|||+.|||||||||+||+++.+|.+|++|||.|.+.          
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            998 799999998888899999999999999999999999999999999999999999999999999653          


Q ss_pred             -----CCCCcccccccccc---ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          189 -----SETDFMTEYVVTRW---DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       189 -----~~~~~~~~~~~~~~---~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                           |++-|++||..+..   +..-+.|+|++||++++|++|+.|+..+.     ....+.........++.++   .+
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-----ne~aIMy~V~~gh~Pq~P~---~l 1466 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-----NEWAIMYHVAAGHKPQIPE---RL 1466 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-----chhHHHhHHhccCCCCCch---hh
Confidence                 45568999988764   46778999999999999999999975442     2222333333333333332   38


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      |++.++||.+||..||.+|.++.|+++|-|=+...+
T Consensus      1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred             hHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence            999999999999999999999999999988776654

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.6e-35  Score=251.51  Aligned_cols=235  Identities=20%  Similarity=0.302  Sum_probs=186.1

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.+ ++.||+|++|.||++.+. ++..+|+|.+......   .+.+.+|+.+++.++||+|+++++++     .. .
T Consensus         5 ~~~~~~-~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~-----~~-~   73 (260)
T cd05070           5 RESLQL-IKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVV-----SE-E   73 (260)
T ss_pred             hHHhhh-hheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEE-----CC-C
Confidence            345555 999999999999999765 5667999998754332   35688999999999999999999987     22 3


Q ss_pred             eEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          113 DVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ..+++|||++ ++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+....
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            4789999997 6999988753  458999999999999999999999999999999999999999999999999986542


Q ss_pred             C------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          190 E------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       190 ~------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      .            ..|.+|+.........++|+|++|++++++++ |..|+.....      .............+   .
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~---~  224 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGYRMP---C  224 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCCC---C
Confidence            2            13777887766677789999999999999998 7777654221      11111111111111   1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ....+..+++|+.+||..+|++|||++++.+
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         225 PQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             CCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            1357889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.5e-35  Score=258.08  Aligned_cols=245  Identities=20%  Similarity=0.259  Sum_probs=183.5

Q ss_pred             CccCCCccccccccceEEEEEEeCC----------------CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCee
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSE----------------TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV   97 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~   97 (339)
                      ++|.. .+.||+|+||.||++.+..                ++..+|+|++... ........+.+|+.++..++|+||+
T Consensus         5 ~~~~~-~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTF-KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhcee-eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            34555 8999999999999986432                3457899988654 2233456788999999999999999


Q ss_pred             eeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 042681           98 KVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ-----------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLK  165 (339)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~givH~dik  165 (339)
                      ++++++     ......+++|||+. ++|.+++....           .+++..+..++.|++.||+|||++|++|+|||
T Consensus        83 ~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk  157 (296)
T cd05095          83 RLLAVC-----ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA  157 (296)
T ss_pred             eEEEEE-----ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence            999998     55567899999997 79999886532           36778899999999999999999999999999


Q ss_pred             CCCeeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh--CCCCCCcc
Q 042681          166 PSNLLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL--GSPDDSDL  230 (339)
Q Consensus       166 p~NIli~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~--g~~~~~~~  230 (339)
                      |+||+++.++.++|+|||.+.....             ..|.+|+.........++|+|++|++++++++  |..|+...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9999999999999999999865321             23555665544556778999999999999997  55565432


Q ss_pred             cccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          231 GFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ....  .....................+.+++.+++|+.+||+.||++||++.++++
T Consensus       238 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQ--VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHH--HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2111  111110100000011111122457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.1e-35  Score=256.66  Aligned_cols=246  Identities=20%  Similarity=0.280  Sum_probs=190.4

Q ss_pred             ccCCCccccccccceEEEEEEeC----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNS----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      +++...+.||+|+||.||++...    .+++.+|+|++...... .....+.+|+.+++.++||||+++++++..   ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~   79 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEK---PG   79 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeec---CC
Confidence            34444899999999999999854    35889999998765333 356788999999999999999999998832   23


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ....+++|||++ ++|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            557899999997 69999987644 6999999999999999999999999999999999999999999999999998765


Q ss_pred             CC--------------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc---------hHHHHHhhC
Q 042681          189 SE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD---------NARRYVKQL  245 (339)
Q Consensus       189 ~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~---------~~~~~~~~~  245 (339)
                      ..              ..|.+|+...........|+|++|++++++++|..++.........         .........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            41              1255676665566778899999999999999998776432211100         011111111


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       246 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .......   ....++.++.+|+.+||+.+|.+|||+.++++
T Consensus       240 ~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KEGERLP---RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HcCCcCC---CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1111111   11346789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.9e-35  Score=259.94  Aligned_cols=239  Identities=20%  Similarity=0.326  Sum_probs=188.5

Q ss_pred             CccCCCccccccccceEEEEEEeCC-------CCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSE-------TKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPP  105 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~  105 (339)
                      ++|.+ .+.||+|+||.||++.+..       +...+|+|.+.... .......+.+|+.+++.+ +||||+++++++  
T Consensus        18 ~~~~i-~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--   93 (307)
T cd05098          18 DRLVL-GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC--   93 (307)
T ss_pred             HHeEE-eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence            45655 8999999999999998643       23469999887542 233456788899999999 799999999998  


Q ss_pred             CCcCCcCeEEEEEecCc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 042681          106 MDKEKFNDVYIVYELMD-TDLHQIIRSKQ----------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN  168 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~N  168 (339)
                         ......++||||++ |+|.+++...+                .+++..++.++.|++.||+|||++|++||||||+|
T Consensus        94 ---~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  170 (307)
T cd05098          94 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN  170 (307)
T ss_pred             ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence               55677999999998 79999997532                47889999999999999999999999999999999


Q ss_pred             eeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccc
Q 042681          169 LLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLR  234 (339)
Q Consensus       169 Ili~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~  234 (339)
                      |+++.++.++|+|||.+.....             ..|++|+.........++|+|++|++++++++ |..|+...+   
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---  247 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---  247 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---
Confidence            9999999999999999864321             24777877666667788999999999999998 777754322   


Q ss_pred             cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ...........   ...   .....++.++.+|+.+||..+|++||++.+++++
T Consensus       248 ~~~~~~~~~~~---~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         248 VEELFKLLKEG---HRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHHcC---CCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            11111111111   111   1123578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.8e-35  Score=253.90  Aligned_cols=235  Identities=19%  Similarity=0.280  Sum_probs=189.5

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. ++.||.|++|.||++.+.. ++.+++|.+...  .......+.+|+.+++.++||||+++++++     ......
T Consensus         7 ~y~~-~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   77 (261)
T cd05148           7 EFTL-ERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPV   77 (261)
T ss_pred             HHHH-hhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCe
Confidence            3445 8999999999999999987 889999998654  222345688999999999999999999998     566779


Q ss_pred             EEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-
Q 042681          115 YIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-  190 (339)
                      ++||||++ ++|.+++...  ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..... 
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            99999998 6999999753  4689999999999999999999999999999999999999999999999999865432 


Q ss_pred             ----------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          191 ----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       191 ----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                ..|.+|+..........+|+|++|++++++++ |..|+.....  ........    .....+   ....
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~----~~~~~~---~~~~  228 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQIT----AGYRMP---CPAK  228 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHH----hCCcCC---CCCC
Confidence                      13667777666667788999999999999998 7877654321  11111111    111111   1245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      +++++.+++.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         229 CPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            7899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.5e-35  Score=258.48  Aligned_cols=238  Identities=21%  Similarity=0.346  Sum_probs=187.3

Q ss_pred             ccCCCccccccccceEEEEEEeCC-------CCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSE-------TKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPM  106 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~  106 (339)
                      +|.+ .+.||+|+||.||++.+..       .+..+|+|.++... .......+.+|+.++..+ +||||+++++++   
T Consensus        13 ~~~~-~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---   87 (314)
T cd05099          13 RLVL-GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVC---   87 (314)
T ss_pred             Heee-eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE---
Confidence            4444 8999999999999998642       34578999886542 334456788999999999 699999999998   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCe
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSK----------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL  169 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NI  169 (339)
                        .....++++|||+. |+|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus        88 --~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          88 --TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             --ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence              55567899999997 7999998653                3488899999999999999999999999999999999


Q ss_pred             eeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCccccccc
Q 042681          170 LLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRS  235 (339)
Q Consensus       170 li~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~  235 (339)
                      +++.++.++|+|||.++....             ..|++||.........++|+|++|++++++++ |..|+...+.   
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---  242 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---  242 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence            999999999999999865421             24778887766677888999999999999998 7776543321   


Q ss_pred             chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..........   ...   .....++.++++++.+||..+|++|||+.++++.
T Consensus       243 ~~~~~~~~~~---~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         243 EELFKLLREG---HRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             HHHHHHHHcC---CCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1111111111   111   1124578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.5e-35  Score=251.47  Aligned_cols=232  Identities=19%  Similarity=0.272  Sum_probs=186.0

Q ss_pred             cccccccceEEEEEEeCC-CCc--eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSE-TKE--EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~-~~~--~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      +.||+|++|.||++.+.. +++  .+|+|.+...... ...+.+.+|+..+.+++||||+++++.+     .. ...+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~-~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVV-----LT-HPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEE-----cC-CeEEEE
Confidence            468999999999999765 333  6899998765443 5567889999999999999999999998     44 778999


Q ss_pred             EecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC----
Q 042681          118 YELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----  190 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~----  190 (339)
                      +||++ ++|.+.+.+..  .+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.....    
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99997 79999997754  689999999999999999999999999999999999999999999999998865433    


Q ss_pred             ----------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          191 ----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       191 ----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                ..|.+|+.........++|+|++|++++++++ |..|+......  ...........   ..   .....
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~---~~---~~~~~  225 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKEGE---RL---ERPEA  225 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhcCC---cC---CCCcc
Confidence                      24677777666677888999999999999998 88886433111  11111111111   11   11134


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ++..+.+++.+||+.+|++||++.+++.
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         226 CPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             CCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            6889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.8e-35  Score=253.12  Aligned_cols=234  Identities=21%  Similarity=0.301  Sum_probs=188.1

Q ss_pred             ccccccccceEEEEEEeCCCCc---eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      .+.||+|+||.||+|....+++   .|++|.+... ........+..|+.+++.++||||+++++++     ......++
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~~l   82 (269)
T cd05065           9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRPVMI   82 (269)
T ss_pred             EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCceEE
Confidence            8899999999999999887665   5999988654 2344567889999999999999999999998     56677899


Q ss_pred             EEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC----
Q 042681          117 VYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----  190 (339)
Q Consensus       117 v~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~----  190 (339)
                      ||||++ ++|.+++.. .+.+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.....    
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~  162 (269)
T cd05065          83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  162 (269)
T ss_pred             EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence            999998 689888875 35689999999999999999999999999999999999999999999999998754321    


Q ss_pred             ------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          191 ------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       191 ------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                  ..|.+|+.........+.|+|++|++++++++ |..|++....   .............+.      .
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~~~~~~~------~  233 (269)
T cd05065         163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQDYRLPP------P  233 (269)
T ss_pred             cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcCCcCCC------c
Confidence                        13667777666667788999999999999885 8888654321   111112211111111      1


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..++..+.+++.+||..+|++||++.++++.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         234 MDCPTALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3578899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.1e-35  Score=253.71  Aligned_cols=234  Identities=22%  Similarity=0.290  Sum_probs=185.5

Q ss_pred             CCccccccccceEEEEEEe-----CCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           38 PPLQPIGRGAYGIVCSAVN-----SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        38 ~~~~~lg~G~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ...+.||+|+||.||++..     ..++..+++|.+...  .......+.+|+.++..++|+||+++++++     ....
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   80 (280)
T cd05092           8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVC-----TEGR   80 (280)
T ss_pred             eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecCC
Confidence            3488999999999999974     335678889987643  334456789999999999999999999998     5566


Q ss_pred             eEEEEEecCc-ccHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQ---------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD  176 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~  176 (339)
                      ..+++|||++ ++|.+++...+               .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence            7899999997 79999986542               4889999999999999999999999999999999999999999


Q ss_pred             eEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHH
Q 042681          177 LKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYV  242 (339)
Q Consensus       177 ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~  242 (339)
                      ++|+|||++....             ...|.+|+.........++|+|++|++++++++ |.+|+.......   .....
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~  237 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AIECI  237 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HHHHH
Confidence            9999999986432             124777877666667788999999999999997 887764432111   11111


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ....   ..   .....+++.+.++|.+||+.||++||++.+++.
T Consensus       238 ~~~~---~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGR---EL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCc---cC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1111   11   111357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.6e-35  Score=250.79  Aligned_cols=237  Identities=20%  Similarity=0.297  Sum_probs=186.8

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++.+.+.+++.||+|+||.||+|... +++.+|+|.+.....   ....+.+|+.+++.++||||+++++++     . .
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~-~   72 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVV-----T-Q   72 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEE-----c-c
Confidence            33344444999999999999999865 578899999875432   245788999999999999999999987     2 2


Q ss_pred             CeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          112 NDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ...+++|||+. ++|.+++.+.  ..+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+...
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            45899999997 7999988653  46899999999999999999999999999999999999999999999999998654


Q ss_pred             CC------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          189 SE------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       189 ~~------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                      ..            ..|.+|+...........|+|++|++++++++ |..|+.....   .........   ....+   
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~---~~~~~---  223 (260)
T cd05067         153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNLER---GYRMP---  223 (260)
T ss_pred             CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHc---CCCCC---
Confidence            31            23677777666667788999999999999998 8888653321   111111111   11111   


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .....+.++.+++.+||+.+|++||++++++.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            11346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8e-35  Score=251.30  Aligned_cols=234  Identities=21%  Similarity=0.294  Sum_probs=184.6

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.+ .+.||+|++|.||+|.+..+ ..+|+|++.....   ..+.+.+|+.+++.++||||+++++.+     .. ..
T Consensus         6 ~~~~~-~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~~-~~   74 (262)
T cd05071           6 ESLRL-EVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVV-----SE-EP   74 (262)
T ss_pred             HHeeE-eeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEE-----CC-CC
Confidence            55666 99999999999999988765 4699999875322   235688999999999999999999987     22 34


Q ss_pred             EEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC
Q 042681          114 VYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  190 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~  190 (339)
                      .++||||++ |+|.+++...  ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            789999998 6999999753  4589999999999999999999999999999999999999999999999999864322


Q ss_pred             ------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          191 ------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       191 ------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                  ..|.+|+.........+.|+|++|++++++++ |..|+....   ..   ............+   ..
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~---~~---~~~~~~~~~~~~~---~~  225 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NR---EVLDQVERGYRMP---CP  225 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---hH---HHHHHHhcCCCCC---Cc
Confidence                        13677777666667888999999999999999 776654321   11   1111111111111   12


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ..++..+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         226 PECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.6e-35  Score=252.51  Aligned_cols=238  Identities=22%  Similarity=0.309  Sum_probs=188.5

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCc---eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ++|.+ .+.||+|+||.||++.+..++.   .+|+|.++... .......+.+|+.++..++||||+++++++     ..
T Consensus         4 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   76 (267)
T cd05066           4 SCIKI-EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TK   76 (267)
T ss_pred             HHeEe-eeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence            34555 8999999999999999865543   68999886543 233456788999999999999999999998     56


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ....+++|||++ ++|.+++... +.+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+...
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            677899999997 6899998764 56899999999999999999999999999999999999999999999999988653


Q ss_pred             CC--------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          189 SE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       189 ~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      ..              ..|.+|+.........+.|+|++|++++++++ |..|+......  . .........   ..+ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~-~~~~~~~~~---~~~-  229 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--D-VIKAIEEGY---RLP-  229 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--H-HHHHHhCCC---cCC-
Confidence            22              13566776665667788999999999999886 88886543211  1 111111111   111 


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                        ....+++.+++++.+||+.+|.+||++.++++
T Consensus       230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         230 --APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             --CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence              11357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=248.79  Aligned_cols=231  Identities=24%  Similarity=0.338  Sum_probs=186.4

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEec
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYEL  120 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~  120 (339)
                      +.||.|++|.||++.+.. ++.+++|.+...... .....+.+|+.++++++||||+++++++     ......++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEc
Confidence            468999999999999887 999999988765333 3557789999999999999999999998     566778999999


Q ss_pred             Cc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC--------
Q 042681          121 MD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--------  190 (339)
Q Consensus       121 ~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--------  190 (339)
                      ++ ++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.....        
T Consensus        74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            97 689998865 45689999999999999999999999999999999999999999999999999864431        


Q ss_pred             -----CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHH
Q 042681          191 -----TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       191 -----~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  264 (339)
                           ..|.+|+..........+|+|++|++++++++ |..|+.....   ...........   ....   ...++.++
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~~~~~~~~---~~~~---~~~~~~~~  224 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTRERIESGY---RMPA---PQLCPEEI  224 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHHHHHhcCC---CCCC---CccCCHHH
Confidence                 13677777666667788999999999999998 7776544321   11111111111   1111   13468899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 042681          265 IDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .+++.+||..+|.+|||+.++++
T Consensus       225 ~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         225 YRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHHHHHhccChhhCcCHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=249.88  Aligned_cols=234  Identities=21%  Similarity=0.301  Sum_probs=187.2

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.+ .+.||+|++|.||++.+. +++.+|+|.+.....   ..+.+.+|+.+++.++||||+++++++     ......
T Consensus         7 ~~~i-~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (261)
T cd05034           7 SLKL-ERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPI   76 (261)
T ss_pred             heee-eeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCce
Confidence            4444 899999999999999875 457899999875432   346788999999999999999999998     555678


Q ss_pred             EEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-
Q 042681          115 YIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-  190 (339)
                      +++|||++ ++|.+++...  ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+..... 
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            99999997 6999998764  4689999999999999999999999999999999999999999999999999875432 


Q ss_pred             -----------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          191 -----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       191 -----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                 ..|.+|+.........+.|+|++|++++++++ |..|+....  ........ .   .....+   ...
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~~-~---~~~~~~---~~~  227 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREVLEQV-E---RGYRMP---RPP  227 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH-H---cCCCCC---CCC
Confidence                       24677877766667888999999999999998 888764321  11111111 1   111111   113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ..+.++.+++.+||+.+|.+||+++++++
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         228 NCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            46889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.8e-35  Score=257.82  Aligned_cols=238  Identities=24%  Similarity=0.358  Sum_probs=187.5

Q ss_pred             ccCCCccccccccceEEEEEEe-----CCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCc
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVN-----SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDK  108 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~  108 (339)
                      +|.. .+.||+|+||.||++.+     ..++..+|+|.++... .....+.+.+|+.+++++ +||||+++++++     
T Consensus        36 ~~~~-~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----  108 (302)
T cd05055          36 NLSF-GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGAC-----  108 (302)
T ss_pred             HeEE-cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEE-----
Confidence            4444 89999999999999975     3345689999886542 233456788999999999 799999999998     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                      ...+..+++|||+. |+|.+++....  .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            55677999999997 79999987543  3899999999999999999999999999999999999999999999999998


Q ss_pred             cccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          186 RTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       186 ~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      .....             ..|.+|+.........++|+|++|++++++++ |..|+......  ...........   ..
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~~~~---~~  263 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIKEGY---RM  263 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHHcCC---cC
Confidence            64321             23677776666667778999999999999997 88876543221  11111111111   11


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .   .....++.+.+++.+||..+|++|||+.++++
T Consensus       264 ~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         264 A---QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             C---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            1   11346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.7e-35  Score=253.03  Aligned_cols=241  Identities=22%  Similarity=0.314  Sum_probs=188.0

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc---cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      +|.+ .+.||+|++|.||++.+..++..+++|.++...   ........+.+|+.++..++||||+++++++     ...
T Consensus         1 ~y~i-~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   74 (260)
T cd08222           1 RYIL-QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LER   74 (260)
T ss_pred             Ccee-eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcC
Confidence            4556 889999999999999998887777777665321   2223345567899999999999999999998     555


Q ss_pred             CeEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          112 NDVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      ...++++||++ ++|.+.+..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+.
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~  153 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSR  153 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCcee
Confidence            67899999998 688877743    467999999999999999999999999999999999999975 579999999876


Q ss_pred             ccC-----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          187 TTS-----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       187 ~~~-----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                      ...           ...|.+|+.........+.|+|++|++++.+++|..++....     ......... .......  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~--  225 (260)
T cd08222         154 LLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIV-EGPTPSL--  225 (260)
T ss_pred             ecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHH-cCCCCCC--
Confidence            432           234666776655556678999999999999999998864321     111111111 1111111  


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                       ...++.++.++|.+||+.+|++||++.++++||||
T Consensus       226 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         226 -PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -cchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence             13578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-34  Score=249.32  Aligned_cols=234  Identities=26%  Similarity=0.366  Sum_probs=188.3

Q ss_pred             CccccccccceEEEEEEeCCCC----ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           39 PLQPIGRGAYGIVCSAVNSETK----EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        39 ~~~~lg~G~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +.+.||.|+||.||++.+..++    ..+|+|.+..... ....+.+.+|+..+..++|+||+++++++     ...+..
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVC-----TEEEPL   76 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEE-----cCCCee
Confidence            3788999999999999998766    8899999865422 22567889999999999999999999998     555789


Q ss_pred             EEEEecCc-ccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-
Q 042681          115 YIVYELMD-TDLHQIIRSKQA--LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-  190 (339)
                      +++|||+. ++|.+++.....  +++..+..++.|++.||++||+.|++|+||+|+||++++++.++|+|||.+..... 
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999997 699999876544  99999999999999999999999999999999999999999999999999865432 


Q ss_pred             -----------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          191 -----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       191 -----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                 ..|.+|+.........++|+|++|++++++++ |..|+...   ..   ..............   ...
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~---~~~~~~~~~~~~~~---~~~  227 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SN---EEVLEYLKKGYRLP---KPE  227 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CH---HHHHHHHhcCCCCC---CCC
Confidence                       24666776655667788999999999999998 66665432   11   11111111111111   113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .++.++.+++.+||..+|++|||+.++++
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      228 NCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             cCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            47899999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-34  Score=248.94  Aligned_cols=231  Identities=19%  Similarity=0.312  Sum_probs=182.3

Q ss_pred             ccccccceEEEEEEeC--CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           42 PIGRGAYGIVCSAVNS--ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        42 ~lg~G~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .||+|+||.||++.+.  .++..+|+|++... ......+.+.+|+.++++++||||+++++++     . ....++|||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-----~-~~~~~lv~e   74 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----E-AEALMLVME   74 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----c-CCCeEEEEE
Confidence            3899999999999765  44567999988654 2334456788999999999999999999987     3 235799999


Q ss_pred             cCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-------
Q 042681          120 LMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-------  190 (339)
Q Consensus       120 ~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-------  190 (339)
                      |++ ++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.....       
T Consensus        75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            997 689988865 46799999999999999999999999999999999999999999999999999864321       


Q ss_pred             -------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          191 -------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       191 -------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                             ..|.+|+.........+.|+|++|++++++++ |..|+.....   ...........   ...   ..+.+++
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~---~~~---~~~~~~~  225 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVMSFIEQGK---RLD---CPAECPP  225 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHHCCC---CCC---CCCCCCH
Confidence                   24667776655567778999999999999996 8888654321   11111111111   111   1145789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ++.+++.+||..+|++||++.++.+.
T Consensus       226 ~l~~li~~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         226 EMYALMKDCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.6e-35  Score=254.97  Aligned_cols=233  Identities=22%  Similarity=0.288  Sum_probs=184.8

Q ss_pred             ccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           40 LQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      .+.||+|+||.||++.+.     .++..+++|.+...  .....+.+.+|+.+++.++||||+++++++     ......
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   82 (291)
T cd05094          10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDGDPL   82 (291)
T ss_pred             eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccCCce
Confidence            788999999999999854     34566888887543  233346788999999999999999999999     556779


Q ss_pred             EEEEecCc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCe
Q 042681          115 YIVYELMD-TDLHQIIRSK----------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL  177 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~i  177 (339)
                      ++||||++ ++|.+++...                +.+++..++.++.||+.||+|||++|++||||||+||+++.++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999997 7999998653                238899999999999999999999999999999999999999999


Q ss_pred             EEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHh
Q 042681          178 KICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVK  243 (339)
Q Consensus       178 kL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~  243 (339)
                      +|+|||.+....             ...|.+|+.........++|+|++|++++++++ |..|+......   ...   .
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~---~  236 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVI---E  236 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---H
Confidence            999999985432             124777887766667788999999999999998 88886543211   111   1


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       244 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ........   .....++..+.+++.+||+.+|++||++.++++.
T Consensus       237 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         237 CITQGRVL---ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             HHhCCCCC---CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            11111111   1113468899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-34  Score=254.14  Aligned_cols=233  Identities=21%  Similarity=0.301  Sum_probs=183.2

Q ss_pred             ccccccccceEEEEEEeCC-----CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           40 LQPIGRGAYGIVCSAVNSE-----TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      .+.||+|+||.||++.+..     ....+++|.+.... .......+.+|+.++..++||||+++++.+     ...+..
T Consensus         5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   78 (290)
T cd05045           5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQDGPL   78 (290)
T ss_pred             cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCCc
Confidence            7899999999999998643     23568888776432 233456788999999999999999999998     556678


Q ss_pred             EEEEecCc-ccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCe
Q 042681          115 YIVYELMD-TDLHQIIRSK------------------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL  169 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NI  169 (339)
                      ++++||+. ++|.+++...                        ..+++..++.++.|++.||.|||+.|++||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            99999998 7898887542                        3478899999999999999999999999999999999


Q ss_pred             eeccCCCeEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCccccccc
Q 042681          170 LLNANCDLKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRS  235 (339)
Q Consensus       170 li~~~~~ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~  235 (339)
                      ++++++.++|+|||.++...             ...|.+|+.........++|+|++|++++++++ |..|+....   .
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~  235 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---P  235 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---H
Confidence            99999999999999986431             124667776666667788999999999999998 887764321   1


Q ss_pred             chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ...........   ...   ....++.++++++.+||+.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~---~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         236 ERLFNLLKTGY---RME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHhCCC---CCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            11111111111   111   11357899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1e-34  Score=249.69  Aligned_cols=230  Identities=23%  Similarity=0.335  Sum_probs=184.5

Q ss_pred             CccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           39 PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        39 ~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.+.||+|++|.||++...  |..+++|.++..    ...+.+.+|+.+++.++|++++++++++.    ......++++
T Consensus        10 ~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~lv~   79 (256)
T cd05082          10 LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVT   79 (256)
T ss_pred             eeeeecccCCCeEEEEEEc--CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEEEE
Confidence            3899999999999999764  778999988643    23457889999999999999999999752    3445689999


Q ss_pred             ecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-----
Q 042681          119 ELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-----  190 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-----  190 (339)
                      ||++ ++|.+++.+.+  .+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.....     
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  159 (256)
T cd05082          80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG  159 (256)
T ss_pred             ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCCCC
Confidence            9998 69999987643  488999999999999999999999999999999999999999999999999875432     


Q ss_pred             ---CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          191 ---TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       191 ---~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                         ..|++|+.........++|+|++|++++++++ |..|+....      ..............   ...+.+++.+++
T Consensus       160 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~~~  230 (256)
T cd05082         160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKGYKM---DAPDGCPPVVYD  230 (256)
T ss_pred             ccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCCCC---CCCCCCCHHHHH
Confidence               24778887776677888999999999999997 877754321      11111111111111   112457899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 042681          267 LAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       267 li~~~L~~dP~~Rps~~ell~  287 (339)
                      ++.+||+.+|++|||+.++++
T Consensus       231 li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         231 VMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.9e-35  Score=254.97  Aligned_cols=237  Identities=17%  Similarity=0.239  Sum_probs=186.8

Q ss_pred             cCCCccccccccceEEEEEEeCCC-----CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSET-----KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      |.. .+.||.|+||.||++.+..+     ++.+|+|+++... .....+.+.+|+.++..++||||+++++++     ..
T Consensus         7 ~~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~   79 (283)
T cd05091           7 VRF-MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK   79 (283)
T ss_pred             HHH-HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence            344 88999999999999987543     5789999987543 233456788999999999999999999999     55


Q ss_pred             cCeEEEEEecCc-ccHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRS----------------KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA  173 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~----------------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~  173 (339)
                      ....++++||+. ++|.+++..                ...+++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence            667899999998 688888753                135788899999999999999999999999999999999999


Q ss_pred             CCCeEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHH
Q 042681          174 NCDLKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNAR  239 (339)
Q Consensus       174 ~~~ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~  239 (339)
                      ++.++|+|||+++...             ...|.+||.........+.|+|++|++++++++ |..++....      ..
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~  233 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------NQ  233 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC------HH
Confidence            9999999999876432             124777887766667888999999999999997 666654321      11


Q ss_pred             HHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          240 RYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ............+.   ...++..+.+|+.+||+.+|.+||+++++++.
T Consensus       234 ~~~~~i~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         234 DVIEMIRNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            11222111111111   14588999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.3e-35  Score=264.85  Aligned_cols=245  Identities=21%  Similarity=0.295  Sum_probs=188.5

Q ss_pred             ccccCccCCCccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeec
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDII  103 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~  103 (339)
                      |.++.+...+.+.||+|+||.||+|.+.     .+++.||+|++..... ....+.+.+|+.++.++. ||||+++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            4455444444899999999999999854     3556899999975422 233457889999999997 99999999999


Q ss_pred             CCCCcCCcCeEEEEEecCc-ccHHHHHHhcC-------------------------------------------------
Q 042681          104 PPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ-------------------------------------------------  133 (339)
Q Consensus       104 ~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-------------------------------------------------  133 (339)
                           ......++||||+. |+|.+++...+                                                 
T Consensus       111 -----~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (401)
T cd05107         111 -----TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE  185 (401)
T ss_pred             -----ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence                 55667999999998 79999885421                                                 


Q ss_pred             -------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 042681          134 -------------------------------------------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDL  164 (339)
Q Consensus       134 -------------------------------------------------~~~~~~~~~i~~qi~~aL~~LH~~givH~di  164 (339)
                                                                       .+++..++.++.|++.||.|||+.|++||||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdl  265 (401)
T cd05107         186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDL  265 (401)
T ss_pred             ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccC
Confidence                                                             3566778889999999999999999999999


Q ss_pred             CCCCeeeccCCCeEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcc
Q 042681          165 KPSNLLLNANCDLKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDL  230 (339)
Q Consensus       165 kp~NIli~~~~~ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~  230 (339)
                      ||+||+++.++.++|+|||+++...             ...|++|+.........+.|+|++|++++++++ |..|+...
T Consensus       266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         266 AARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             CcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999999999999986432             123677777666667778999999999999997 77775433


Q ss_pred             cccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          231 GFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +...  ...........   ..   ....++.++.+|+.+||..+|.+||++.+++..
T Consensus       346 ~~~~--~~~~~~~~~~~---~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         346 PMNE--QFYNAIKRGYR---MA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CchH--HHHHHHHcCCC---CC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2111  11111111111   11   113478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-34  Score=249.62  Aligned_cols=234  Identities=21%  Similarity=0.273  Sum_probs=183.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. .+.||+|++|.||++.+..+ ..+|+|.+.....   ..+.+.+|+.+++.++|||++++++++     .. ..
T Consensus         6 ~~~~~-~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~-~~   74 (260)
T cd05069           6 ESLRL-DVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVV-----SE-EP   74 (260)
T ss_pred             HHeee-eeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEE-----cC-CC
Confidence            45555 88999999999999987654 4689998764322   246688999999999999999999987     22 34


Q ss_pred             EEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC
Q 042681          114 VYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  190 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~  190 (339)
                      .+++|||++ ++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            789999998 6999999764  3588999999999999999999999999999999999999999999999999865422


Q ss_pred             ------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          191 ------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       191 ------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                  ..|.+|+...........|+|++|++++++++ |..|+.....   ..........   ....   ..
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~---~~~~---~~  225 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERG---YRMP---CP  225 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcC---CCCC---CC
Confidence                        13666776665567778999999999999998 7777653211   1111111111   1111   11


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ...+..+++++.+||..||++||+++++++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         226 QGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9.9e-35  Score=259.49  Aligned_cols=245  Identities=20%  Similarity=0.324  Sum_probs=189.4

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCC-------CceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeee
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSET-------KEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVK  100 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~  100 (339)
                      .|.+....+.+++.||+|+||.||+|++...       +..+|+|.+... ......+.+.+|+.++.++ +||||++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            3444444334499999999999999986432       236899987643 2333457788999999999 799999999


Q ss_pred             eecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 042681          101 DIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ----------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRD  163 (339)
Q Consensus       101 ~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~d  163 (339)
                      +++     ......++++||++ |+|.+++....                .++...+..++.|++.||.|||++|++|||
T Consensus        85 ~~~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~d  159 (334)
T cd05100          85 GAC-----TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD  159 (334)
T ss_pred             EEE-----ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence            998     55667899999997 69999987532                477888999999999999999999999999


Q ss_pred             CCCCCeeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCc
Q 042681          164 LKPSNLLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSD  229 (339)
Q Consensus       164 ikp~NIli~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~  229 (339)
                      |||+||+++.++.++|+|||.++....             ..|++|+.........+.|+|++|++++++++ |..++..
T Consensus       160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  239 (334)
T cd05100         160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  239 (334)
T ss_pred             cccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            999999999999999999999864322             13777877766667788999999999999997 7776543


Q ss_pred             ccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          230 LGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ...   ........   .....   .....++.++.+++.+||+.+|++||++.+++++
T Consensus       240 ~~~---~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         240 IPV---EELFKLLK---EGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CCH---HHHHHHHH---cCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            221   11111111   11111   1123578899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-34  Score=250.31  Aligned_cols=237  Identities=21%  Similarity=0.344  Sum_probs=188.3

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCc---eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      +|.. .+.||+|++|.||++....+++   .+++|.+.... .....+.+.+|+.++..++||||+++++++     ...
T Consensus         6 ~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   78 (268)
T cd05063           6 HITK-QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF   78 (268)
T ss_pred             HceE-eeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence            4444 7889999999999999876655   68999886542 233456788999999999999999999999     566


Q ss_pred             CeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          112 NDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ...++||||++ ++|.+++.. .+.+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            77899999998 689888865 3678999999999999999999999999999999999999999999999999986442


Q ss_pred             C--------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          190 E--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       190 ~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      .              ..|.+|+.........+.|+|++|++++++++ |..|+.....  .. .......   ....+. 
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~-~~~~i~~---~~~~~~-  231 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HE-VMKAIND---GFRLPA-  231 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HH-HHHHHhc---CCCCCC-
Confidence            1              13667776665566778999999999999987 8888754321  11 1111111   111111 


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                        ...++.++.+++.+||+.+|++||++.++++
T Consensus       232 --~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         232 --PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             --CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence              1246889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-36  Score=267.34  Aligned_cols=245  Identities=19%  Similarity=0.343  Sum_probs=204.7

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ++.||-|+||.|.+++-..|...||+|.+++. ...+.....+..|..||..-..+-|+++|-.|     .+...+|+||
T Consensus       634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnLYFVM  708 (1034)
T KOG0608|consen  634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNLYFVM  708 (1034)
T ss_pred             EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCceEEEE
Confidence            88999999999999999999999999999765 55666788899999999999999999999999     7778899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc-----------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-----------  186 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~-----------  186 (339)
                      +|++ |++-.++-+.+-+.|+.++-++.++..|+++.|.+|++||||||+|||||.+|+|||+|||+|+           
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence            9997 7999999998999999999999999999999999999999999999999999999999999983           


Q ss_pred             ------------------------------------------ccCCCCccccccccccccCCCCccHHHHHHHHHHHhCC
Q 042681          187 ------------------------------------------TTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGS  224 (339)
Q Consensus       187 ------------------------------------------~~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~  224 (339)
                                                                .+|++.|.+|++.....+...-|.|+.|+++|+|+.|.
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence                                                      13455688888888888888899999999999999999


Q ss_pred             CCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCcc
Q 042681          225 PDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRI---TVEEALNHPYLSSLHE  296 (339)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~~~~~  296 (339)
                      +||-...-.  ....+.    ..+..........++|+++.++|.++. ..++.|+   .++|+..||||+.+.+
T Consensus       869 ~pf~~~tp~--~tq~kv----~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  869 PPFLADTPG--ETQYKV----INWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             CCccCCCCC--cceeee----eehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccch
Confidence            997543211  110000    011111111122468999999999865 4888898   4678999999998875

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-34  Score=251.98  Aligned_cols=240  Identities=18%  Similarity=0.269  Sum_probs=187.8

Q ss_pred             CccCCCccccccccceEEEEEEeCC-----CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSE-----TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      ++|.. ++.||.|+||.||+++.+.     +.+.+++|.+... ......+.+.+|+.++++++||||+++++++     
T Consensus         5 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----   77 (275)
T cd05046           5 SNLQE-ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----   77 (275)
T ss_pred             Hhcee-eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----
Confidence            34555 8999999999999999653     3567889987543 2233456789999999999999999999998     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeE
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQ---------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK  178 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ik  178 (339)
                      ......++||||++ ++|.+++....         .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEE
Confidence            55667899999998 79999997655         689999999999999999999999999999999999999999999


Q ss_pred             EeecccccccC------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhC
Q 042681          179 ICDFGLARTTS------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQL  245 (339)
Q Consensus       179 L~Dfg~~~~~~------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~  245 (339)
                      |+|||++....            ...|.+|+.........++|+|++|++++++++ |..|+.....   ......... 
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~~~-  233 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRLQA-  233 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHHHc-
Confidence            99999875322            123677776665567788999999999999998 6666543211   111111110 


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       246 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .... .   .....++..+.+++.+||+.+|++||++.+++..
T Consensus       234 ~~~~-~---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         234 GKLE-L---PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCcC-C---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            1111 1   1113578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-34  Score=249.82  Aligned_cols=232  Identities=22%  Similarity=0.331  Sum_probs=182.7

Q ss_pred             cccccccceEEEEEEeCCCCce--EEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      +.||+|+||.||++....++..  +++|.++.. ........+.+|+.++.++ +||||+++++++     ...+..+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv   74 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLA   74 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEE
Confidence            3589999999999999887764  577877532 2334456788999999999 799999999999     556678999


Q ss_pred             EecCc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEe
Q 042681          118 YELMD-TDLHQIIRSKQ----------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC  180 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~  180 (339)
                      |||+. |+|.+++...+                .+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+
T Consensus        75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence            99997 79999986532                47899999999999999999999999999999999999999999999


Q ss_pred             ecccccccC----------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCC
Q 042681          181 DFGLARTTS----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVP  249 (339)
Q Consensus       181 Dfg~~~~~~----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (339)
                      |||++....          ...|.+|+.........+.|+|++|++++++++ |..|+.....      ...........
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~  228 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQGY  228 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHHhCCC
Confidence            999984221          123777887766677788999999999999996 8887643211      11111111111


Q ss_pred             CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       250 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ..   .....++.++.+++.+||..||.+|||+.+++.
T Consensus       229 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            11   111346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3e-34  Score=249.97  Aligned_cols=238  Identities=18%  Similarity=0.258  Sum_probs=184.1

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCce----EEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEE----VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ++|.. ++.||.|+||.||++.+..+++.    +++|.+... ........+..|+..+..++||||+++++++     .
T Consensus         7 ~~~~~-~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~-----~   79 (279)
T cd05111           7 TELRK-LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-----P   79 (279)
T ss_pred             hhcee-ccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEE-----C
Confidence            45555 89999999999999998877764    666666432 2233345677888889999999999999987     2


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      . ...++++||+. |+|.+++.. .+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.++.
T Consensus        80 ~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          80 G-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             C-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            2 34678899987 899999975 46799999999999999999999999999999999999999999999999999864


Q ss_pred             cC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          188 TS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       188 ~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      ..             ...|.+|+......+..++|+|++|++++++++ |..|+....   ............   ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---~~~~~~~~~~~~---~~~~  232 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR---PHEVPDLLEKGE---RLAQ  232 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCC---cCCC
Confidence            32             124667776655567788999999999999997 887765431   111122222111   1111


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                         ...++.++.+++.+||..||++|||+.++++.
T Consensus       233 ---~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         233 ---PQICTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             ---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence               12367889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.3e-34  Score=245.60  Aligned_cols=232  Identities=22%  Similarity=0.323  Sum_probs=184.8

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEec
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYEL  120 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~  120 (339)
                      +.||+|++|.||++... +++.+|+|.+.... .......+.+|+.+++.++||||+++++++     ......++||||
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVC-----TQRQPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEE-----ecCCccEEEEEC
Confidence            36899999999999854 68899999886543 233345688999999999999999999998     555678999999


Q ss_pred             Cc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC--------
Q 042681          121 MD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--------  190 (339)
Q Consensus       121 ~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--------  190 (339)
                      ++ ++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....        
T Consensus        74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            97 799988865 35689999999999999999999999999999999999999999999999998864321        


Q ss_pred             ----CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          191 ----TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       191 ----~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                          ..|.+|+.........+.|+|++|++++++++ |..|+.....   ..........   ...   .....++..+.
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~~~~~~~---~~~---~~~~~~~~~~~  224 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQAREQVEKG---YRM---SCPQKCPDDVY  224 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcC---CCC---CCCCCCCHHHH
Confidence                23777887766667788999999999999998 8877653321   1111111111   111   11235789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 042681          266 DLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       266 ~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +++.+||+.+|++||++.++++.
T Consensus       225 ~li~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         225 KVMQRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             HHHHHHcccCcccCCCHHHHHHH
Confidence            99999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=257.56  Aligned_cols=246  Identities=20%  Similarity=0.329  Sum_probs=210.0

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      +..||+|+||+|-++..+.+.+.||+|++++... ...+.+--+.|-++|... +-|.+++++.+|     ++...+|+|
T Consensus       354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTmDRLyFV  428 (683)
T KOG0696|consen  354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTMDRLYFV  428 (683)
T ss_pred             EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhhhheeeE
Confidence            7899999999999999999999999999988743 333455567788888776 588999999999     677889999


Q ss_pred             EecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc---------
Q 042681          118 YELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART---------  187 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~---------  187 (339)
                      |||+. |+|--.+++.+++.+..+.-++.+|+-||-+||++||++||||.+||+++++|++||.|||+++.         
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTk  508 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTK  508 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCccee
Confidence            99997 79999999999999999999999999999999999999999999999999999999999999863         


Q ss_pred             --cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          188 --TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       188 --~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                        .+++.|.+|++....++....|.|+.|+.+|+++.|.+|+..-  ........+.......+        .++|.++.
T Consensus       509 TFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--DE~elF~aI~ehnvsyP--------KslSkEAv  578 (683)
T KOG0696|consen  509 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQAIMEHNVSYP--------KSLSKEAV  578 (683)
T ss_pred             eecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHccCcCc--------ccccHHHH
Confidence              4677899999999999999999999999999999999997642  11222222222222222        46899999


Q ss_pred             HHHHHhcccCCCCCCCH-----HHHhcCCCCCCCccCCCC
Q 042681          266 DLAERMLVFDPAKRITV-----EEALNHPYLSSLHEINEE  300 (339)
Q Consensus       266 ~li~~~L~~dP~~Rps~-----~ell~hp~f~~~~~~~~~  300 (339)
                      ++++.+|.+.|++|...     .++..||||+.+.|.+.+
T Consensus       579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E  618 (683)
T KOG0696|consen  579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLE  618 (683)
T ss_pred             HHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHh
Confidence            99999999999999943     689999999999987533

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=246.43  Aligned_cols=271  Identities=21%  Similarity=0.296  Sum_probs=217.8

Q ss_pred             ccCCceEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhh-CCC
Q 042681           15 LYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCH-MTH   93 (339)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~-l~h   93 (339)
                      .+...++.+.-.++...+......-...||.|+||+|++..++.+|+..|||+++.... ..+.++++.|.+...+ -+.
T Consensus        44 ~~s~g~l~~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~c  122 (361)
T KOG1006|consen   44 SYSTGTLKLPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNC  122 (361)
T ss_pred             HhccCceecCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCC
Confidence            34444667777788888888888888999999999999999999999999999986544 4456788888886554 479


Q ss_pred             CCeeeeeeecCCCCcCCcCeEEEEEecCcccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCC
Q 042681           94 ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIR-----SKQALTDDHCQYFLYQLLRGLKYIH-SANVLHRDLKPS  167 (339)
Q Consensus        94 ~~I~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH-~~givH~dikp~  167 (339)
                      |||+++||..     -..+..+|.||.++-+|..+.+     +...++|..+-.|.-..+.||.||- ...|+|||+||+
T Consensus       123 p~IVkfyGa~-----F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPS  197 (361)
T KOG1006|consen  123 PNIVKFYGAL-----FSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPS  197 (361)
T ss_pred             cHHHHHhhhh-----hcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChh
Confidence            9999999998     5567789999999977766553     3568999999999999999999997 558999999999


Q ss_pred             CeeeccCCCeEEeecccccc----------cCCCCcccccccccc--ccCCCCccHHHHHHHHHHHhCCCCCCccccccc
Q 042681          168 NLLLNANCDLKICDFGLART----------TSETDFMTEYVVTRW--DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS  235 (339)
Q Consensus       168 NIli~~~~~ikL~Dfg~~~~----------~~~~~~~~~~~~~~~--~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~  235 (339)
                      |||++..|.+||||||+|..          .|..+|++||...+.  .+.-++|+|++|+++++..+|..|+..|..   
T Consensus       198 NILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---  274 (361)
T KOG1006|consen  198 NILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---  274 (361)
T ss_pred             heEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---
Confidence            99999999999999999854          345579999877654  366789999999999999999998765532   


Q ss_pred             chHHHHHhhCCCCCCC--CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          236 DNARRYVKQLPHVPKQ--PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       236 ~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                        ..+.+........+  ......-.+|..++.+|.-||.+|-+.||...+++++||++-...
T Consensus       275 --vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  275 --VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             --HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence              22222222222222  222222358899999999999999999999999999999987643

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-36  Score=263.99  Aligned_cols=237  Identities=21%  Similarity=0.259  Sum_probs=195.1

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      ++|.|+=.-+.-++-||+|+-|.||+++.+  ++.||||+++..         --.+|+=|++|+||||+.+.|++    
T Consensus       117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVC----  181 (904)
T KOG4721|consen  117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVC----  181 (904)
T ss_pred             hhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeee----
Confidence            455555444444778999999999999765  689999988522         12467779999999999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                       .....+|||||||. |-|.+.++.+..+.......|..+|+.|++|||.+.|+|||||.-||||+.+..|||+|||.++
T Consensus       182 -tqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  182 -TQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             -cCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchH
Confidence             77889999999998 9999999999999999999999999999999999999999999999999999999999999986


Q ss_pred             cc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          187 TT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       187 ~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      ..          |+-.+++|+.....+...+.|+|++|+++|+|++|..|+-+.....-     +.....+....++   
T Consensus       261 e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----IwGVGsNsL~Lpv---  332 (904)
T KOG4721|consen  261 ELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IWGVGSNSLHLPV---  332 (904)
T ss_pred             hhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EEeccCCcccccC---
Confidence            54          33458899999999999999999999999999999999754321110     0000011111111   


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ...+++.++=||++||+..|..||++.+++.|
T Consensus       333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             cccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            13588899999999999999999999999999

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.9e-34  Score=254.42  Aligned_cols=239  Identities=21%  Similarity=0.334  Sum_probs=186.4

Q ss_pred             CccCCCccccccccceEEEEEEeC-------CCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNS-------ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPP  105 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~  105 (339)
                      ++|.+ .+.||+|+||.||++++.       .++..+|+|.+... ........+.+|+.++..+ +||||+++++.+  
T Consensus        15 ~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--   90 (304)
T cd05101          15 DKLTL-GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--   90 (304)
T ss_pred             HHeee-cceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence            34444 899999999999999753       23457899987643 2234456788999999999 799999999998  


Q ss_pred             CCcCCcCeEEEEEecCc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 042681          106 MDKEKFNDVYIVYELMD-TDLHQIIRSK----------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN  168 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~N  168 (339)
                         ......+++|||+. |+|.+++.+.                ..++...+..++.|++.||+|||++|++||||||+|
T Consensus        91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence               55677899999998 7999998753                247788899999999999999999999999999999


Q ss_pred             eeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccc
Q 042681          169 LLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLR  234 (339)
Q Consensus       169 Ili~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~  234 (339)
                      |+++.++.++|+|||.++....             ..|.+|+......+..++|+|++|++++++++ |..++...+   
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---  244 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---  244 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---
Confidence            9999999999999999865421             23677887666667788999999999999997 666654322   


Q ss_pred             cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..........   ....   .....++.++++|+.+||..+|++||++.++++.
T Consensus       245 ~~~~~~~~~~---~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         245 VEELFKLLKE---GHRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHHc---CCcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            1111111111   1111   1113578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-34  Score=249.88  Aligned_cols=227  Identities=15%  Similarity=0.262  Sum_probs=177.8

Q ss_pred             cccccccceEEEEEEeCCCC----------ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           41 QPIGRGAYGIVCSAVNSETK----------EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~----------~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      +.||+|+||.||++.+..++          ..+++|.+.....   ....+.+|+.+++.++||||+++++++     ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   72 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVC-----VR   72 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEE-----ec
Confidence            46899999999999998776          3477776654321   157788999999999999999999988     33


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC-------CeEEee
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-------DLKICD  181 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~-------~ikL~D  181 (339)
                       ...++||||++ |+|.+++.... .+++..+..++.||+.||+|||++|++|+||||+||+++.++       .++|+|
T Consensus        73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence             55799999998 78999987765 799999999999999999999999999999999999999887       799999


Q ss_pred             ccccccc-------CCCCcccccccccc--ccCCCCccHHHHHHHHHHHhC-CCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          182 FGLARTT-------SETDFMTEYVVTRW--DTLFPGKDYVQQLTMITELLG-SPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       182 fg~~~~~-------~~~~~~~~~~~~~~--~~~~~~d~~~~g~~~~~~l~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ||.+...       +...|.+|+.....  ....+.|+|++|++++++++| ..|+....  . ...........   ..
T Consensus       152 fg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--~-~~~~~~~~~~~---~~  225 (259)
T cd05037         152 PGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--S-SEKERFYQDQH---RL  225 (259)
T ss_pred             CCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--c-hhHHHHHhcCC---CC
Confidence            9998763       23457778776544  567789999999999999985 55544332  1 11111111111   01


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      +     ...+..+.++|.+||..+|++|||+.++++
T Consensus       226 ~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         226 P-----MPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             C-----CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0     112378999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.4e-34  Score=251.74  Aligned_cols=237  Identities=20%  Similarity=0.232  Sum_probs=185.4

Q ss_pred             ccCCCccccccccceEEEEEEeCC-----CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSE-----TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      +|.. ++.||+|+||.||+|.+..     ++..+|+|.+.... .......+.+|+.++..++||||+++++++     .
T Consensus         6 ~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~   78 (288)
T cd05050           6 NIEY-VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVC-----A   78 (288)
T ss_pred             hcee-cccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence            4444 8999999999999998753     67889999886542 233456788999999999999999999998     5


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK----------------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKP  166 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~----------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp  166 (339)
                      .....++++||++ ++|.+++...                      ..+++..++.++.|++.||.|||+.|++||||+|
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p  158 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT  158 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence            5667899999998 6999998643                      2477888999999999999999999999999999


Q ss_pred             CCeeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccc
Q 042681          167 SNLLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGF  232 (339)
Q Consensus       167 ~NIli~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~  232 (339)
                      +||+++.++.++|+|||.+.....             ..|.+|+.........++|+|++|++++++++ |..|+.....
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999864321             13667776666667788999999999999986 6666543211


Q ss_pred             cccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          233 LRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                            ..............   ....++.++.+|+.+||+.+|.+|||+.|+++
T Consensus       239 ------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 ------EEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             ------HHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                  11111111111111   11357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-34  Score=249.70  Aligned_cols=237  Identities=21%  Similarity=0.303  Sum_probs=188.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCc----eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKE----EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ++|.. .+.||+|+||.||++.+..+|+    .+|+|...... .......+.+|+.+++.++||||+++++++     .
T Consensus         7 ~~~~~-~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~   79 (279)
T cd05057           7 TELEK-IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGIC-----L   79 (279)
T ss_pred             HHcEE-cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence            45555 8999999999999999877665    58888876542 234456788999999999999999999998     3


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      . ...++++||++ |+|.+++.+. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.++.
T Consensus        80 ~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          80 S-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             c-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence            3 57899999997 7999998764 5799999999999999999999999999999999999999999999999999865


Q ss_pred             cCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          188 TSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       188 ~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      ...             ..|.+|+.........+.|+|++|++++++++ |..|+.....   .............+.   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~---  232 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPDLLEKGERLPQ---  232 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhCCCCCCC---
Confidence            421             13667776666667788999999999999998 8888654321   111222221111111   


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                         ...++..+.+++.+||..+|++||++.++++
T Consensus       233 ---~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         233 ---PPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence               1346789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-37  Score=246.34  Aligned_cols=263  Identities=29%  Similarity=0.398  Sum_probs=197.5

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc--
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK--  108 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~--  108 (339)
                      ...+.|.. ..+||+|.||.||+|+.+++|+.||+|++.-......-....++|+++|+.|+|+|++.+++++.....  
T Consensus        14 ~~~~~yek-~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   14 DEVSKYEK-LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             ecchHHHH-HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            44566777 889999999999999999999999999775322122222456899999999999999999999855331  


Q ss_pred             -CCcCeEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          109 -EKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       109 -~~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                       .....+++|+++|+.+|.-++.+. .+++..+++.++.++..||.|+|++.|+|||+||+|++|+.+|.++|.|||+++
T Consensus        93 ~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence             122348999999999999999876 789999999999999999999999999999999999999999999999999996


Q ss_pred             ccCCC---------------Cccccccc-cccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc--------------
Q 042681          187 TTSET---------------DFMTEYVV-TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD--------------  236 (339)
Q Consensus       187 ~~~~~---------------~~~~~~~~-~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~--------------  236 (339)
                      .+...               .|.+|+.. +..++..+-|+|..||++-+|+++.+-+........-              
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            54322               35555543 3456888999999999999999988776443211100              


Q ss_pred             -----hHHHHHhh----CCCCCCCCccccCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          237 -----NARRYVKQ----LPHVPKQPFSQKFP--NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       237 -----~~~~~~~~----~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                           ....+...    .+......+.....  .-.++..+|+.+||..||.+|+.+.+++.|.||..-
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence                 00000000    00100111111111  124578899999999999999999999999999754

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-34  Score=248.58  Aligned_cols=230  Identities=16%  Similarity=0.225  Sum_probs=175.4

Q ss_pred             cccccccceEEEEEEeCCC------------CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           41 QPIGRGAYGIVCSAVNSET------------KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~------------~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      +.||+|+||.||++....+            ...+++|.+...  .......+.+|+.++..++||||+++++++     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~-----   73 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVC-----   73 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence            3589999999999975322            235788876543  233345778899999999999999999998     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC-------eEE
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-------LKI  179 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~-------ikL  179 (339)
                      ......+++|||++ ++|..++.. ...+++..++.++.||+.||+|||++|++||||||+||+++.++.       +++
T Consensus        74 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          74 VRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             ecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence            45566799999998 577777654 457999999999999999999999999999999999999987664       899


Q ss_pred             eeccccccc-------CCCCcccccccc-ccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          180 CDFGLARTT-------SETDFMTEYVVT-RWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       180 ~Dfg~~~~~-------~~~~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      +|||.+...       +...|.+||... ......++|+|++|+++|++++ |..|+......   ........  ... 
T Consensus       154 ~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~--~~~-  227 (262)
T cd05077         154 SDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA---EKERFYEG--QCM-  227 (262)
T ss_pred             CCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh---HHHHHHhc--Ccc-
Confidence            999988643       234578888664 3456778999999999999974 66664432111   11111111  000 


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                           .....++++++|+.+||+.||++||++.+++++
T Consensus       228 -----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         228 -----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                 112346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.4e-34  Score=245.38  Aligned_cols=233  Identities=21%  Similarity=0.324  Sum_probs=183.5

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      .+.+.+.||+|+||.||++... .+..+++|.+...   ....+.+.+|+.+++.++|+||+++++.+     .. ...+
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~-~~~~   76 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVV-----TK-EPIY   76 (260)
T ss_pred             ceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEE-----cC-CCeE
Confidence            3334999999999999999855 4567999987643   22356788999999999999999999998     33 5689


Q ss_pred             EEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC--
Q 042681          116 IVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--  190 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--  190 (339)
                      ++|||++ ++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....  
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            9999997 7999998763  4578889999999999999999999999999999999999999999999998865432  


Q ss_pred             ----------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          191 ----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       191 ----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                ..|.+|+.........+.|+|++|++++++++ |..|+....   ...........   ...   .....
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~---~~~---~~~~~  227 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALERG---YRM---PRPEN  227 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHhCC---CCC---CCccc
Confidence                      12667776666667778999999999999998 888765321   11111111111   111   11245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .+.++.+++.+||+.+|++||++.++++
T Consensus       228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         228 CPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            7899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-36  Score=252.83  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=198.0

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCC--C----CeeeeeeecCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH--E----NIVKVKDIIPP  105 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----~I~~~~~~~~~  105 (339)
                      +.++|.+ +.++|+|.||+|-.+-+..++..+|+|+++.-   ..-.+..+-|+.+++++.+  |    -++.+.++|  
T Consensus        87 l~~Ry~i-~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--  160 (415)
T KOG0671|consen   87 LTNRYEI-VDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--  160 (415)
T ss_pred             cccceeh-hhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--
Confidence            3788999 99999999999999999999999999998643   2234566789999999942  2    467788888  


Q ss_pred             CCcCCcCeEEEEEecCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc----------
Q 042681          106 MDKEKFNDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA----------  173 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~----------  173 (339)
                         +-.++.|||+|.++-++++++..+  .+++...++.|..|++.++++||+.+++|.||||+||++.+          
T Consensus       161 ---dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  161 ---DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             ---hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence               778999999999999999999875  57999999999999999999999999999999999999932          


Q ss_pred             ----------CCCeEEeecccccc--------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccc-
Q 042681          174 ----------NCDLKICDFGLART--------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR-  234 (339)
Q Consensus       174 ----------~~~ikL~Dfg~~~~--------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~-  234 (339)
                                +..|+|+|||.|+.        +.+..|.+||+....+...+.|+|+.||+++++.+|...|....... 
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                      23489999999964        34557999999999999999999999999999999987664433110 


Q ss_pred             ------------cch-----HHHHHhhCCCCCCCCc----------------cccCCC---CCHHHHHHHHHhcccCCCC
Q 042681          235 ------------SDN-----ARRYVKQLPHVPKQPF----------------SQKFPN---MSPVAIDLAERMLVFDPAK  278 (339)
Q Consensus       235 ------------~~~-----~~~~~~~~~~~~~~~~----------------~~~~~~---~s~~~~~li~~~L~~dP~~  278 (339)
                                  ...     ..+++... ....+..                ......   -...+.|||++||..||.+
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence                        000     11111111 1110000                000001   1233789999999999999


Q ss_pred             CCCHHHHhcCCCCCCCc
Q 042681          279 RITVEEALNHPYLSSLH  295 (339)
Q Consensus       279 Rps~~ell~hp~f~~~~  295 (339)
                      |+|+.|+|.||||....
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998764

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.1e-34  Score=246.70  Aligned_cols=236  Identities=22%  Similarity=0.273  Sum_probs=176.4

Q ss_pred             cccccccceEEEEEEeCC--CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSE--TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||++....  ....+++|.+... ........+.+|+..++.++||||+++++.+     ......++||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~   74 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVL   74 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEE
Confidence            358999999999996433  3457888876543 2333456788999999999999999999998     5567799999


Q ss_pred             ecCc-ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          119 ELMD-TDLHQIIRSKQ-----ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      ||++ |+|.+++....     ..++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+....   
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence            9998 79999987642     34677889999999999999999999999999999999999999999999985421   


Q ss_pred             ----------CCCcccccccc-------ccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          190 ----------ETDFMTEYVVT-------RWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       190 ----------~~~~~~~~~~~-------~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                                ...|.+|+...       ......+.|+|++|++++++++ |..|+.....  ..........  .....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~--~~~~~  230 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQVLKQVVRE--QDIKL  230 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhhc--cCccC
Confidence                      12367777643       2345668999999999999998 6666543211  1111111111  11111


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      +.......+++.+.+++..|+ .||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         231 PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            111222457889999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=257.72  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=191.3

Q ss_pred             ccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCC
Q 042681           26 LGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPP  105 (339)
Q Consensus        26 ~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~  105 (339)
                      ..+...-++.+.. ...||+|+||.||++.... |+.+|||++.......  ...|.+|+.++.+++|||+++++|+|  
T Consensus        67 ~~el~~AT~~Fs~-~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC--  140 (361)
T KOG1187|consen   67 YDELRKATNNFSE-SNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYC--  140 (361)
T ss_pred             HHHHHHHHhCCch-hcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEE--
Confidence            4455555666666 7899999999999998765 4899999886553332  34599999999999999999999999  


Q ss_pred             CCcCCcC-eEEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCCeeeccCCCeE
Q 042681          106 MDKEKFN-DVYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLK  178 (339)
Q Consensus       106 ~~~~~~~-~~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~dikp~NIli~~~~~ik  178 (339)
                         .+.+ ..++|+||++ |+|.+++....  +++|....+|+.+++.||+|||...   |+||||||+|||+|.+.+.|
T Consensus       141 ---~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  141 ---LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             ---ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence               5555 5999999998 89999997654  8999999999999999999999753   99999999999999999999


Q ss_pred             EeecccccccC------------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHH-hhC
Q 042681          179 ICDFGLARTTS------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV-KQL  245 (339)
Q Consensus       179 L~Dfg~~~~~~------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~-~~~  245 (339)
                      |+|||+|+...            +..|.+|+.......+.++|+|++|++++++++|+.+..............+. ...
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999986443            33578888877777888999999999999999999766543211111111110 000


Q ss_pred             CCCCC-CCccccC--CCCC--HH---HHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          246 PHVPK-QPFSQKF--PNMS--PV---AIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       246 ~~~~~-~~~~~~~--~~~s--~~---~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..... ..+....  ..++  ..   +..+..+|++.+|..||+..|+++.
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence            00000 0000010  1222  22   4577789999999999999997643

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.5e-35  Score=251.73  Aligned_cols=230  Identities=13%  Similarity=0.226  Sum_probs=177.4

Q ss_pred             cccccccceEEEEEEeCCCCc-------eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           41 QPIGRGAYGIVCSAVNSETKE-------EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~-------~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +.||+|+||.||++.+..++.       .+++|.+...  .....+.+.+|+.+++.++||||+++++++     .....
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~   73 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVC-----VCGDE   73 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEE-----EeCCC
Confidence            368999999999999866544       3777776433  233456788899999999999999999998     55567


Q ss_pred             EEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC--------eEEeecc
Q 042681          114 VYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--------LKICDFG  183 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~--------ikL~Dfg  183 (339)
                      .++||||++ |+|.+++..+ ..+++..+..++.||+.||+|||++|++||||||+||+++.++.        ++++|||
T Consensus        74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            899999998 6899998764 45899999999999999999999999999999999999987764        6999999


Q ss_pred             cccccC-------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCC-CCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          184 LARTTS-------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGS-PDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       184 ~~~~~~-------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      .+....       ...|.+|+.... ......+|+|++|++++++++|. .++.....   ............       
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~-------  223 (258)
T cd05078         154 ISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---QKKLQFYEDRHQ-------  223 (258)
T ss_pred             cccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---HHHHHHHHcccc-------
Confidence            886433       335778876654 34577899999999999999985 44332111   111111111111       


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                       .....+.++.+|+.+||+.||++|||++++++.
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         224 -LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             -CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence             112356889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.7e-34  Score=245.48  Aligned_cols=236  Identities=21%  Similarity=0.241  Sum_probs=177.5

Q ss_pred             cccccccceEEEEEEeC--CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNS--ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||++...  .++..+++|.++.... ......+.+|+.+++.++||||+++++++     ......++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~   74 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVM   74 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEE
Confidence            46899999999999754  3556799998865432 23345788899999999999999999998     5556789999


Q ss_pred             ecCc-ccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          119 ELMD-TDLHQIIRSK-----QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       119 e~~~-g~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      ||++ |+|.+++...     ...++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+....   
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9998 7999988643     245677888999999999999999999999999999999999999999999885321   


Q ss_pred             ----------CCCcccccccccc-------ccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          190 ----------ETDFMTEYVVTRW-------DTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       190 ----------~~~~~~~~~~~~~-------~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                                ...|.+||.....       ....+.|+|++|++++++++ |..|+......  . ..... ........
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~-~~~~~-~~~~~~~~  230 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--Q-VLTYT-VREQQLKL  230 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--H-HHHHH-hhcccCCC
Confidence                      2246777765432       24568999999999999996 88886543211  1 11111 11111111


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .........++.+.+++++|+ .+|++|||+++++.
T Consensus       231 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         231 PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            111111246788999999999 68999999999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=264.67  Aligned_cols=247  Identities=20%  Similarity=0.366  Sum_probs=212.0

Q ss_pred             CccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           39 PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        39 ~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      .+-+||-||||.|-++........+|+|.+++. ..+....+++..|..+|...+.|.|+++|..|     .+...+|++
T Consensus       424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~kyvYmL  498 (732)
T KOG0614|consen  424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKYVYML  498 (732)
T ss_pred             hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchhhhhh
Confidence            378899999999999988776667999998765 45566678899999999999999999999999     777889999


Q ss_pred             EecC-cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--------
Q 042681          118 YELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--------  188 (339)
Q Consensus       118 ~e~~-~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--------  188 (339)
                      ||-| +|.|+..++.++.+.+.+++-++..++.|+.|||++||++|||||+|.+++.+|.+||.|||+|++.        
T Consensus       499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT  578 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT  578 (732)
T ss_pred             HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceee
Confidence            9998 4899999999999999999999999999999999999999999999999999999999999999765        


Q ss_pred             --CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHH
Q 042681          189 --SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID  266 (339)
Q Consensus       189 --~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  266 (339)
                        |++.|.+|++........+.|.|++|+.++++++|.+||.....+  .....++..+.   ...++   ..++....+
T Consensus       579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--ktYn~ILkGid---~i~~P---r~I~k~a~~  650 (732)
T KOG0614|consen  579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--KTYNLILKGID---KIEFP---RRITKTATD  650 (732)
T ss_pred             ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--HHHHHHHhhhh---hhhcc---cccchhHHH
Confidence              456789999999889999999999999999999999998765322  22222222222   22221   347888999


Q ss_pred             HHHHhcccCCCCCCC-----HHHHhcCCCCCCCccCC
Q 042681          267 LAERMLVFDPAKRIT-----VEEALNHPYLSSLHEIN  298 (339)
Q Consensus       267 li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~~~  298 (339)
                      ||+++...+|.+|..     +.++.+|.||.+..|..
T Consensus       651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg  687 (732)
T KOG0614|consen  651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG  687 (732)
T ss_pred             HHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence            999999999999995     89999999999998853

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-35  Score=260.55  Aligned_cols=253  Identities=20%  Similarity=0.292  Sum_probs=208.8

Q ss_pred             EEEEEccccccccCccCCCccccccccceEEEEEEeCCCCc---e-EEEEEecc-cccChHhHHHHHHHHHHHhhCCCCC
Q 042681           21 VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKE---E-VAIKKITN-AFDNRIDAKRILREIKLLCHMTHEN   95 (339)
Q Consensus        21 ~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~---~-~avK~~~~-~~~~~~~~~~~~~e~~~l~~l~h~~   95 (339)
                      +...+....|.+......+.+.||+|+||.||++..+..+.   . ||+|..+. ..........+++|.+++++++|||
T Consensus       143 L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~N  222 (474)
T KOG0194|consen  143 LKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPN  222 (474)
T ss_pred             ecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCC
Confidence            66677788899999999989999999999999999765422   3 78998875 3456777889999999999999999


Q ss_pred             eeeeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc
Q 042681           96 IVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA  173 (339)
Q Consensus        96 I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~  173 (339)
                      |++++|+.     .....+++|||+|. |+|.+++++.+ .++..+...++.+.+.||+|||+++++||||..+|+|++.
T Consensus       223 VVr~yGVa-----~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~  297 (474)
T KOG0194|consen  223 VVRFYGVA-----VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK  297 (474)
T ss_pred             EEEEEEEE-----cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC
Confidence            99999998     66678999999998 79999999876 5999999999999999999999999999999999999999


Q ss_pred             CCCeEEeecccccccC-----------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHH
Q 042681          174 NCDLKICDFGLARTTS-----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRY  241 (339)
Q Consensus       174 ~~~ikL~Dfg~~~~~~-----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~  241 (339)
                      ++.+||+|||+++...           ...+.+||.....-+++.+|+|++|+.+|+.+. |..|+...   ........
T Consensus       298 ~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~---~~~~v~~k  374 (474)
T KOG0194|consen  298 KGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM---KNYEVKAK  374 (474)
T ss_pred             CCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC---CHHHHHHH
Confidence            9999999999986542           124677888888888999999999999999987 56565443   22222222


Q ss_pred             H-hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          242 V-KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       242 ~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      + ......+..      ...+.++..++.+|+..+|+.||++.++.+
T Consensus       375 I~~~~~r~~~~------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  375 IVKNGYRMPIP------SKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHhcCccCCCC------CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            2 212212211      256888999999999999999999998875

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.3e-34  Score=252.50  Aligned_cols=247  Identities=15%  Similarity=0.134  Sum_probs=182.0

Q ss_pred             CccCCCccccccccceEEEEEEeCCC---CceEEEEEecccccChHh---------HHHHHHHHHHHhhCCCCCeeeeee
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSET---KEEVAIKKITNAFDNRID---------AKRILREIKLLCHMTHENIVKVKD  101 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~I~~~~~  101 (339)
                      ++|.+ .+.||+|+||.||+|.+..+   +..+|+|+..........         ......+...+..+.|++|+++++
T Consensus        12 ~~y~i-~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         12 KEWKI-DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CceEE-eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            45555 99999999999999998877   667777754322111100         011233445566778999999998


Q ss_pred             ecCCCCcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEee
Q 042681          102 IIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD  181 (339)
Q Consensus       102 ~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~D  181 (339)
                      +..... ......+++++++..++.+.+......++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|
T Consensus        91 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D  169 (294)
T PHA02882         91 CGSFKR-CRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID  169 (294)
T ss_pred             eeeEec-CCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence            763221 1123457889988888887777666678899999999999999999999999999999999999999999999


Q ss_pred             ccccccc------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccch---HHH
Q 042681          182 FGLARTT------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN---ARR  240 (339)
Q Consensus       182 fg~~~~~------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~---~~~  240 (339)
                      ||+|+..                  ++..|++|+......+..+.|+|++|++++++++|..|+..........   ...
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~  249 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD  249 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence            9998643                  3345677777777778889999999999999999999987553221110   011


Q ss_pred             HHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          241 YVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ......... .    ..+.+++.+.++++.|++.+|.+||+..++++
T Consensus       250 ~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        250 FIKRLHEGK-I----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHhhhhh-h----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            111111111 0    12456899999999999999999999999875

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.9e-34  Score=249.41  Aligned_cols=239  Identities=18%  Similarity=0.282  Sum_probs=189.0

Q ss_pred             CccCCCccccccccceEEEEEEeCC----CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSE----TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ++|.. .+.||+|+||.||++.+..    ++..+++|.+... ........+.+|+.+++.++||||+++++++.    .
T Consensus         6 ~~~~~-~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~   79 (280)
T cd05043           6 DRVTL-SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCI----E   79 (280)
T ss_pred             hheEE-eeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----c
Confidence            44555 8899999999999999876    3578888887643 34445677889999999999999999999873    3


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEe
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK--------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC  180 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~  180 (339)
                      .....+++++|++ ++|.+++...        ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence            3456899999997 7999988653        458999999999999999999999999999999999999999999999


Q ss_pred             ecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCC
Q 042681          181 DFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLP  246 (339)
Q Consensus       181 Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~  246 (339)
                      |||+++...             ...|.+|+.........++|+|++|++++++++ |..|+.....   ...........
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~  236 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKDGY  236 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHcCC
Confidence            999987542             123677887766667888999999999999998 8888654321   11111111111


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       247 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .   ..   ....+++++.+++.+||..+|++|||+.++++
T Consensus       237 ~---~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 R---LA---QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             C---CC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1   11   11346899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=245.91  Aligned_cols=270  Identities=19%  Similarity=0.313  Sum_probs=219.5

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMD  107 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~  107 (339)
                      +.++=+.+.+++.||+|+|++|-+++.++|.+.||+|++++.. .+..+...+..|-.++.+- +||.++-++.+|    
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf----  320 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF----  320 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh----
Confidence            3344344444999999999999999999999999999998763 4455677888899988887 799999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                       .+...+++|.||++ |+|--+++++++++++.++-+...|+.||.|||+.||++||||.+|+++|..|++||+|+|+|+
T Consensus       321 -qtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  321 -QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             -cccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh
Confidence             77788999999998 7998888989999999999999999999999999999999999999999999999999999985


Q ss_pred             c-----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc-hHHHHHhhCCCCCCCCcc
Q 042681          187 T-----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD-NARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       187 ~-----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  254 (339)
                      .           .+++.|.+|++.....+.+..|.|++|+.+++|+.|+.|+.-.+....+ ....++.+.....+... 
T Consensus       400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri-  478 (593)
T KOG0695|consen  400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI-  478 (593)
T ss_pred             cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc-
Confidence            3           4567899999999999999999999999999999999998766543322 11222221111111111 


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCC------CHHHHhcCCCCCCCccCC-CCCCCCCCC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRI------TVEEALNHPYLSSLHEIN-EEPTCPYPF  307 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rp------s~~ell~hp~f~~~~~~~-~~~~~~~~~  307 (339)
                        ..++|-.+..+++..|.+||.+|.      ...++..||||+++.|.- +++.+..||
T Consensus       479 --prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf  536 (593)
T KOG0695|consen  479 --PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPF  536 (593)
T ss_pred             --cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCC
Confidence              134677788999999999999998      578999999999998752 334444443

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.2e-34  Score=249.08  Aligned_cols=229  Identities=16%  Similarity=0.210  Sum_probs=174.3

Q ss_pred             ccccccceEEEEEEeCCC------------------------CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCee
Q 042681           42 PIGRGAYGIVCSAVNSET------------------------KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV   97 (339)
Q Consensus        42 ~lg~G~~~~v~~~~~~~~------------------------~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~   97 (339)
                      .||+|+||.||++....+                        ...+++|++...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            589999999999874321                        235788877543  222345678899999999999999


Q ss_pred             eeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC
Q 042681           98 KVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC  175 (339)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~  175 (339)
                      ++++++     ......++||||++ |+|..++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++..+
T Consensus        80 ~~~~~~-----~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          80 FVHGVC-----VRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG  154 (274)
T ss_pred             eEEEEE-----EeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence            999998     55667899999998 688877765 46789999999999999999999999999999999999997644


Q ss_pred             -------CeEEeeccccccc-------CCCCccccccccc-cccCCCCccHHHHHHHHHHH-hCCCCCCcccccccchHH
Q 042681          176 -------DLKICDFGLARTT-------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITEL-LGSPDDSDLGFLRSDNAR  239 (339)
Q Consensus       176 -------~ikL~Dfg~~~~~-------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l-~g~~~~~~~~~~~~~~~~  239 (339)
                             .++++|||.+...       +...|.+|+.... .....+.|+|++|+++++++ .|..|+.....   ....
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~  231 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP---SEKE  231 (274)
T ss_pred             cccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh---HHHH
Confidence                   3899999987532       3345777775543 45677899999999999985 57777643321   1111


Q ss_pred             HHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          240 RYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .........+        ...++.+.++|.+||+.+|++||++.+++++
T Consensus       232 ~~~~~~~~~~--------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         232 RFYEKKHRLP--------EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHhccCCC--------CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            1111111111        2246789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.7e-34  Score=244.57  Aligned_cols=235  Identities=20%  Similarity=0.287  Sum_probs=185.7

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||.|++|.||++.+. ++..+++|.+......   ...+.+|+.+++.++||+|+++++++     ......
T Consensus         5 ~~~~-~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   74 (256)
T cd05112           5 ELTL-VQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPI   74 (256)
T ss_pred             HeEE-EeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCce
Confidence            3444 788999999999999875 4678999988654332   35678899999999999999999998     556678


Q ss_pred             EEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC--
Q 042681          115 YIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--  190 (339)
                      ++++||+. ++|.+++... +.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....  
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            99999998 6888888754 5689999999999999999999999999999999999999999999999998864322  


Q ss_pred             ----------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          191 ----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       191 ----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                ..|.+|+.........++|+|++|++++++++ |..|+....      ................   ...
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~  225 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS------NSEVVETINAGFRLYK---PRL  225 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC------HHHHHHHHhCCCCCCC---CCC
Confidence                      23667776665667778999999999999998 777754321      1111111111111110   123


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .+..+.+|+.+||+.+|++|||+.+++++
T Consensus       226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         226 ASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            57899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-33  Score=245.45  Aligned_cols=233  Identities=24%  Similarity=0.351  Sum_probs=184.7

Q ss_pred             ccccccccceEEEEEEeCCC---CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSET---KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      .+.||.|++|.||+|.+...   ...+++|...... .....+.+.+|+.+++.++||||+++++++.     . ...++
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~-~~~~l   83 (270)
T cd05056          11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-----E-NPVWI   83 (270)
T ss_pred             eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEc-----C-CCcEE
Confidence            88999999999999987544   3468889876442 2345568899999999999999999999883     2 34689


Q ss_pred             EEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC----
Q 042681          117 VYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----  190 (339)
Q Consensus       117 v~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~----  190 (339)
                      ||||++ ++|.+++.+. ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....    
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  163 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY  163 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence            999997 7999999764 4689999999999999999999999999999999999999999999999998864321    


Q ss_pred             --------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          191 --------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       191 --------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                              ..|.+|+...........|+|++|++++++++ |..|+......   .......   ......   ..+.++
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~---~~~~~~---~~~~~~  234 (270)
T cd05056         164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIE---NGERLP---MPPNCP  234 (270)
T ss_pred             ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH---cCCcCC---CCCCCC
Confidence                    24677877666667788999999999999885 88886543211   1111111   111111   124578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..+++++.+||..+|++|||+.+++..
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-33  Score=245.84  Aligned_cols=240  Identities=19%  Similarity=0.272  Sum_probs=183.9

Q ss_pred             ccccccccceEEEEEEeC---CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC-cCeEE
Q 042681           40 LQPIGRGAYGIVCSAVNS---ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK-FNDVY  115 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~-~~~~~  115 (339)
                      .+.||+|+||.||+|...   .+++.+|+|++..........+.+.+|+.+++.++||||+++++++....... ....+
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM   83 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence            788999999999999854   45789999999876555666778899999999999999999999874432111 12357


Q ss_pred             EEEecCc-ccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          116 IVYELMD-TDLHQIIRSK------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ++++|+. |+|.+++...      ..++...++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||.++..
T Consensus        84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~  163 (273)
T cd05074          84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI  163 (273)
T ss_pred             EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccc
Confidence            8999997 7888776432      25788999999999999999999999999999999999999999999999998754


Q ss_pred             CC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 SE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 ~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      ..             ..|.+|+.........++|+|++|++++++++ |.+++.....   ..............     
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~-----  235 (273)
T cd05074         164 YSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIKGNRLK-----  235 (273)
T ss_pred             cCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHcCCcCC-----
Confidence            32             12444555444456778999999999999998 7777543211   11111111111111     


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                       ..+..+..+.+++.+||+.+|++|||+.+++++
T Consensus       236 -~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         236 -QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             113578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-33  Score=244.09  Aligned_cols=234  Identities=21%  Similarity=0.275  Sum_probs=179.5

Q ss_pred             cccccccceEEEEEEeCC---CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSE---TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      +.||+|+||.||+|.+..   ++..+|+|.+... ......+.+.+|+.+++.++||||+++++++.    ...+..+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv   75 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVV   75 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEE
Confidence            468999999999998643   3457899987532 23344677889999999999999999999763    234557899


Q ss_pred             EecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC------
Q 042681          118 YELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS------  189 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~------  189 (339)
                      |||+. ++|.+++... ...++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||+++...      
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99998 7999998764 456778888999999999999999999999999999999999999999999986432      


Q ss_pred             ---------CCCccccccccccccCCCCccHHHHHHHHHHHhC-CCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          190 ---------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLG-SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       190 ---------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                               ...|.+|+.........+.|+|++|++++++++| .+++....   .........   .......   ...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~---~~~  226 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYLL---QGRRLLQ---PEY  226 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHh---cCCCCCC---CCc
Confidence                     1246777776666777889999999999999995 44443211   111111111   1111111   123


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +++.+.+++.+||..+|++||++.++++.
T Consensus       227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         227 CPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            67899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1e-34  Score=268.76  Aligned_cols=248  Identities=22%  Similarity=0.307  Sum_probs=201.0

Q ss_pred             EEccccccccCccCCCccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeee
Q 042681           24 NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK   98 (339)
Q Consensus        24 ~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~   98 (339)
                      +....-..++.......+.||+|+||+||+++..     .....||||.++.. .+....+.|.+|++++..++|||||+
T Consensus       475 ~~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVr  553 (774)
T KOG1026|consen  475 NPDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVR  553 (774)
T ss_pred             CCccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEE
Confidence            3344445566667777899999999999999843     33457999988654 33446788999999999999999999


Q ss_pred             eeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhc----------C----CCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 042681           99 VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK----------Q----ALTDDHCQYFLYQLLRGLKYIHSANVLHRD  163 (339)
Q Consensus        99 ~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------~----~~~~~~~~~i~~qi~~aL~~LH~~givH~d  163 (339)
                      ++|++     ..++.+|+|+||+. |+|.++++.+          .    +++..+.+.|+.||+.|+.||-++.+||||
T Consensus       554 LlGVC-----~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRD  628 (774)
T KOG1026|consen  554 LLGVC-----REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRD  628 (774)
T ss_pred             EEEEE-----ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccc
Confidence            99999     78889999999999 9999999642          2    288999999999999999999999999999


Q ss_pred             CCCCCeeeccCCCeEEeecccccccCCC-------------CccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCc
Q 042681          164 LKPSNLLLNANCDLKICDFGLARTTSET-------------DFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSD  229 (339)
Q Consensus       164 ikp~NIli~~~~~ikL~Dfg~~~~~~~~-------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~  229 (339)
                      |..+|.|+..+..|||+|||+++..-..             .+++||......++..+|+|++|+++|+.++ |..|+.+
T Consensus       629 LATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g  708 (774)
T KOG1026|consen  629 LATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG  708 (774)
T ss_pred             hhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc
Confidence            9999999999999999999999754322             4678888888899999999999999999985 6666554


Q ss_pred             ccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 042681          230 LGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEAL  286 (339)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell  286 (339)
                      +.   ..   +.++........   ....++|.++.+|+..||+.+|.+||++.||-
T Consensus       709 lS---n~---EVIe~i~~g~lL---~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  709 LS---NQ---EVIECIRAGQLL---SCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             cc---hH---HHHHHHHcCCcc---cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            32   22   222222222221   12246999999999999999999999999874

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-33  Score=243.20  Aligned_cols=231  Identities=22%  Similarity=0.338  Sum_probs=183.6

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|+||.||++.  .+++.+|+|.++..    .....+.+|+.++..++||||+++++++.     . ...
T Consensus         7 ~~~~-~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~-~~~   73 (254)
T cd05083           7 KLTL-GEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVIL-----H-NGL   73 (254)
T ss_pred             Hcee-eeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEc-----C-CCc
Confidence            4555 8999999999999986  46888999988643    23457889999999999999999999983     2 236


Q ss_pred             EEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-
Q 042681          115 YIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-  190 (339)
                      +++|||+. ++|.+++....  .+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+..... 
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence            99999997 69999987643  589999999999999999999999999999999999999999999999998865322 


Q ss_pred             -------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          191 -------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       191 -------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                             ..|.+|+...........|+|++|++++++++ |..|+.....   .........   .....   ....++.
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~---~~~~~---~~~~~~~  224 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKECVEK---GYRME---PPEGCPA  224 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHhC---CCCCC---CCCcCCH
Confidence                   24677777666667778999999999999997 8877643321   111111111   11111   1245789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .+++++.+||+.+|.+||++.+++.
T Consensus       225 ~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         225 DVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-33  Score=249.01  Aligned_cols=237  Identities=18%  Similarity=0.286  Sum_probs=184.9

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCc----eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKE----EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      +|.. .+.||+|+||.||++.+..+|.    .+|+|.+.... .......+.+|+.++..++||||+++++++.     .
T Consensus         8 ~~~~-~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~   80 (303)
T cd05110           8 ELKR-VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCL-----S   80 (303)
T ss_pred             hcee-ccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-----C
Confidence            3344 8899999999999999887776    46888775432 2333456889999999999999999999883     2


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                       ...++++||++ |+|.+.+... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++..
T Consensus        81 -~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          81 -PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             -CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence             23578999998 7999998764 46899999999999999999999999999999999999999999999999998643


Q ss_pred             CC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 SE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 ~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      ..             ..|.+|+.........++|+|++|++++++++ |..|+....   ..............+     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~-----  231 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLLEKGERLP-----  231 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHCCCCCC-----
Confidence            21             23666776665667778999999999999986 777765432   111222222211111     


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                       ..+.++.++++++.+||..+|++||++.++++.
T Consensus       232 -~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         232 -QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             113468899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.3e-34  Score=274.78  Aligned_cols=147  Identities=26%  Similarity=0.474  Sum_probs=132.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.+ ++.||.|+||.||+|.+..+++.||+|++... .........+.+|+.++..++||||+++++++     ....
T Consensus         4 ~~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   77 (669)
T cd05610           4 EEFVI-VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN   77 (669)
T ss_pred             CCEEE-EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence            45666 89999999999999999999999999999754 23344457788999999999999999999988     6667


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      .+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            8999999996 7999999888889999999999999999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.3e-33  Score=244.57  Aligned_cols=232  Identities=25%  Similarity=0.318  Sum_probs=182.4

Q ss_pred             cccccccceEEEEEEeCCCC------ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           41 QPIGRGAYGIVCSAVNSETK------EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +.||+|++|.||++.....+      +.+++|.+.... .......+.+|+.+++.++||||+++++++     ......
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   74 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-----LLNEPQ   74 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeee-----cCCCCe
Confidence            36899999999999876433      678999876542 223456788999999999999999999998     555678


Q ss_pred             EEEEecCc-ccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC-----CeEEee
Q 042681          115 YIVYELMD-TDLHQIIRSK-------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-----DLKICD  181 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~-----~ikL~D  181 (339)
                      +++|||++ ++|.+++.+.       ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++     .++|+|
T Consensus        75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999997 7999988642       3478899999999999999999999999999999999999887     899999


Q ss_pred             cccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCC
Q 042681          182 FGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPH  247 (339)
Q Consensus       182 fg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~  247 (339)
                      ||++....             ...|.+|+.........+.|+|++|++++++++ |..|+....   ..........   
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~~~~~~~~~~---  228 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVLQHVTA---  228 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---HHHHHHHHhc---
Confidence            99986432             234677887776677888999999999999997 887764321   1111111111   


Q ss_pred             CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          248 VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       248 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ....   .....++..+.+++.+||..+|.+||++.++++
T Consensus       229 ~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         229 GGRL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             CCcc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            1111   112457899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.2e-33  Score=240.29  Aligned_cols=236  Identities=19%  Similarity=0.212  Sum_probs=173.4

Q ss_pred             cccccccceEEEEEEeCCCC--ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETK--EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||+++...++  ..+++|.+.... .......+.+|+..++.++||||+++++.+     ......++||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~~~~~lv~   74 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQC-----VEAIPYLLVF   74 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEe-----cCCCccEEEE
Confidence            35899999999999754332  346677665432 233456789999999999999999999998     5566789999


Q ss_pred             ecCc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-----
Q 042681          119 ELMD-TDLHQIIRSK----QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-----  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-----  188 (339)
                      ||++ |+|.+++.+.    ...++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+...     
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            9998 7999998753    34677788899999999999999999999999999999999999999999987531     


Q ss_pred             --------CCCCccccccccc-------cccCCCCccHHHHHHHHHHHhC-CCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          189 --------SETDFMTEYVVTR-------WDTLFPGKDYVQQLTMITELLG-SPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       189 --------~~~~~~~~~~~~~-------~~~~~~~d~~~~g~~~~~~l~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                              +...|.+|+....       .....+.|+|++|+++++++++ ..|+.....  ............  ....
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~~--~~~~  230 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNHVIKDQQ--VKLF  230 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHhhcc--cccC
Confidence                    1234677776532       2345679999999999999875 445432211  111111111111  0111


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .......+++.+.+++..|| .+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         231 KPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            11112347889999999999 68999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=9.2e-34  Score=266.87  Aligned_cols=258  Identities=18%  Similarity=0.223  Sum_probs=166.4

Q ss_pred             cCccCCCccccccccceEEEEEEeCCC----CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC-
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSET----KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD-  107 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-  107 (339)
                      .++|.. .+.||+|+||.||+|.+..+    +..+|+|++.....    .+...++  .+....+.++..+...+.... 
T Consensus       131 ~~~y~l-~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        131 KDDFVL-GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             cCCeEE-eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            345666 89999999999999999988    99999998764311    1111111  112222233333322221111 


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQA--------------------LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKP  166 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~aL~~LH~~givH~dikp  166 (339)
                      ......+++|+||++ ++|.+++.....                    .....+..++.||+.||.|||+.||+||||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP  283 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP  283 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence            134567899999998 689888864321                    12345678999999999999999999999999


Q ss_pred             CCeeecc-CCCeEEeeccccccc------------CCCCccccccccccc----------------------cCCCCccH
Q 042681          167 SNLLLNA-NCDLKICDFGLARTT------------SETDFMTEYVVTRWD----------------------TLFPGKDY  211 (339)
Q Consensus       167 ~NIli~~-~~~ikL~Dfg~~~~~------------~~~~~~~~~~~~~~~----------------------~~~~~d~~  211 (339)
                      +|||++. ++.+||+|||+++..            +++.|++||......                      ...+.|+|
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            9999986 579999999999643            234577777432111                      12335999


Q ss_pred             HHHHHHHHHHhCCCCCCcccccc-------cchHHHHHhhCCCCCCCCcc---ccCCCCCHHHHHHHHHhcccCCCCCCC
Q 042681          212 VQQLTMITELLGSPDDSDLGFLR-------SDNARRYVKQLPHVPKQPFS---QKFPNMSPVAIDLAERMLVFDPAKRIT  281 (339)
Q Consensus       212 ~~g~~~~~~l~g~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rps  281 (339)
                      ++|+++++++++..+........       ......+.............   ......+....+||.+||+.||++|||
T Consensus       364 SlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t  443 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS  443 (566)
T ss_pred             HHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence            99999999998765432110000       00000110111100000000   111122445679999999999999999


Q ss_pred             HHHHhcCCCCCCCccC
Q 042681          282 VEEALNHPYLSSLHEI  297 (339)
Q Consensus       282 ~~ell~hp~f~~~~~~  297 (339)
                      +.++|+||||+.....
T Consensus       444 a~e~L~Hpff~~~~~~  459 (566)
T PLN03225        444 AKAALAHPYFDREGLL  459 (566)
T ss_pred             HHHHhCCcCcCCCCcc
Confidence            9999999999987654

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.4e-33  Score=239.90  Aligned_cols=239  Identities=21%  Similarity=0.316  Sum_probs=186.2

Q ss_pred             cCCCccccccccceEEEEEEeCC-CCceEEEEEecccc--------cChHhHHHHHHHHHHHhh-CCCCCeeeeeeecCC
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSE-TKEEVAIKKITNAF--------DNRIDAKRILREIKLLCH-MTHENIVKVKDIIPP  105 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~-~~~~~avK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~~I~~~~~~~~~  105 (339)
                      |.. .+.||+|+||.||++.+.. +++.+|+|.+....        ........+.+|+.++.. ++||||+++++++  
T Consensus         2 y~~-~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--   78 (269)
T cd08528           2 YAV-LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--   78 (269)
T ss_pred             chh-hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence            444 8899999999999999987 67899999885331        223344567788888765 6999999999998  


Q ss_pred             CCcCCcCeEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEE
Q 042681          106 MDKEKFNDVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKI  179 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL  179 (339)
                         ...+..+++|||++ ++|.+++..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||++++++.++|
T Consensus        79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence               66778999999997 588877632    4579999999999999999999996 78999999999999999999999


Q ss_pred             eecccccccC----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCC
Q 042681          180 CDFGLARTTS----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP  249 (339)
Q Consensus       180 ~Dfg~~~~~~----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (339)
                      +|||.+....          ...|.+|+...........|+|++|++++++++|..|+......   .......   ...
T Consensus       156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~---~~~  229 (269)
T cd08528         156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLATKIV---EAV  229 (269)
T ss_pred             ecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHHHHh---hcc
Confidence            9999986433          23467777776666777899999999999999999886432111   1111111   111


Q ss_pred             CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       250 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..+..  ...++++++++|.+||+.||++||++.++..+
T Consensus       230 ~~~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         230 YEPLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CCcCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            11111  12478999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.5e-32  Score=233.61  Aligned_cols=233  Identities=33%  Similarity=0.529  Sum_probs=188.9

Q ss_pred             cceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCcc-cH
Q 042681           47 AYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DL  125 (339)
Q Consensus        47 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L  125 (339)
                      +||.||++.+..+|+.+++|++........ ...+.+|+..++.++|+||+++++.+     ......++++|++++ +|
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVF-----EDEDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhhe-----eeCCEEEEEEeCCCCCCH
Confidence            589999999999999999999875533221 57888999999999999999999998     556789999999985 99


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC----------CCccc
Q 042681          126 HQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----------TDFMT  195 (339)
Q Consensus       126 ~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~----------~~~~~  195 (339)
                      .+++.....+++..++.++.+++.++.+||+.|++|+||+|.||+++.++.++|+|||.+.....          ..|.+
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            99998766699999999999999999999999999999999999999999999999999875543          24667


Q ss_pred             cccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccC
Q 042681          196 EYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFD  275 (339)
Q Consensus       196 ~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  275 (339)
                      |+.........+.|+|++|++++++++|..++....     ............... .......++.++.+++.+||..+
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~  228 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-----QLLELFKKIGKPKPP-FPPPEWKISPEAKDLIRKLLVKD  228 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHhccCCC-CccccccCCHHHHHHHHHHccCC
Confidence            777665666778999999999999999988864321     111111211111111 11111227889999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q 042681          276 PAKRITVEEALNHPYL  291 (339)
Q Consensus       276 P~~Rps~~ell~hp~f  291 (339)
                      |++||++.++++||||
T Consensus       229 p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      229 PEKRLTAEEALQHPFF  244 (244)
T ss_pred             chhccCHHHHhhCCCC
Confidence            9999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=6.5e-34  Score=225.61  Aligned_cols=261  Identities=26%  Similarity=0.447  Sum_probs=195.0

Q ss_pred             cccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCC
Q 042681           27 GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPP  105 (339)
Q Consensus        27 ~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~  105 (339)
                      -..|--.++|.+ ++.+|+|.++.||.+....+++.+++|+++.-     -.+.+.+|+.+|+.|. ||||++++++..+
T Consensus        31 ~i~wg~~ddYei-vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~D  104 (338)
T KOG0668|consen   31 VIDWGNQDDYEI-VRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKD  104 (338)
T ss_pred             eeeccccchHHH-HHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence            334555677888 99999999999999999999999999988642     3467899999999996 9999999999966


Q ss_pred             CCcCCcCeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC-CeEEeecc
Q 042681          106 MDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFG  183 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~-~ikL~Dfg  183 (339)
                      +   ......+++||... +...+..   .++...++.++.+++.||.|+|++||.|||+||.|++||... .++|+|+|
T Consensus       105 p---~SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWG  178 (338)
T KOG0668|consen  105 P---ESKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWG  178 (338)
T ss_pred             c---cccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecc
Confidence            4   34557899999984 6655543   488889999999999999999999999999999999999655 59999999


Q ss_pred             cccccCCC----------Ccccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccch------------HHH
Q 042681          184 LARTTSET----------DFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN------------ARR  240 (339)
Q Consensus       184 ~~~~~~~~----------~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~------------~~~  240 (339)
                      +|...-..          -+..|+... ...+...-|.|++||.+..++....||.--. ...+.            ...
T Consensus       179 LAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLGt~el~~  257 (338)
T KOG0668|consen  179 LAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLGTDELYA  257 (338)
T ss_pred             hHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhChHHHHH
Confidence            99654322          123344333 3345667899999999999998887763211 10000            000


Q ss_pred             HH------------hhCCCCCCCCcc-----ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCC
Q 042681          241 YV------------KQLPHVPKQPFS-----QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE  300 (339)
Q Consensus       241 ~~------------~~~~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~  300 (339)
                      ++            .......+....     +.-.-+++++.||+.++|..|-.+|+||.|++.||||..+.+....
T Consensus       258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~  334 (338)
T KOG0668|consen  258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS  334 (338)
T ss_pred             HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence            00            001111111110     1112267999999999999999999999999999999998876543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-33  Score=248.25  Aligned_cols=263  Identities=20%  Similarity=0.247  Sum_probs=204.3

Q ss_pred             CCceEEEEEcc-----ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC
Q 042681           17 GGKYVQYNILG-----NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM   91 (339)
Q Consensus        17 ~~~~~~~~~~~-----~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l   91 (339)
                      +.+..+|...+     ....++.+-..+++.||+|-||.|.+|+-.. +..+|+|.++.. ........|.+|+++|.++
T Consensus       515 Nss~v~y~~~~~~k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqL  592 (807)
T KOG1094|consen  515 NSSAVPYLPPGVGKGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPD-ATKNARNDFLKEIKILSRL  592 (807)
T ss_pred             ccccccccCcccccCcchhhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcc-cchhHHHHHHHHHHHHhcc
Confidence            34444444443     3455666667779999999999999998643 789999998754 3334467899999999999


Q ss_pred             CCCCeeeeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 042681           92 THENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN  168 (339)
Q Consensus        92 ~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~N  168 (339)
                      +||||++++|++     ..++.+|+++||++ |+|.+++..+.  ........+|+.||++|++||.+.++|||||.+.|
T Consensus       593 khPNIveLvGVC-----~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rN  667 (807)
T KOG1094|consen  593 KHPNIVELLGVC-----VQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRN  667 (807)
T ss_pred             CCCCeeEEEeee-----ecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccc
Confidence            999999999999     77788999999998 99999998763  34556677799999999999999999999999999


Q ss_pred             eeeccCCCeEEeecccccccCCC-------------CccccccccccccCCCCccHHHHHHHHHHH--hCCCCCCccccc
Q 042681          169 LLLNANCDLKICDFGLARTTSET-------------DFMTEYVVTRWDTLFPGKDYVQQLTMITEL--LGSPDDSDLGFL  233 (339)
Q Consensus       169 Ili~~~~~ikL~Dfg~~~~~~~~-------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l--~g~~~~~~~~~~  233 (339)
                      +|++.++++||+|||+++.+-..             .+++.|......++.++|+|.+|+++|+++  +...|+.+....
T Consensus       668 cLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e  747 (807)
T KOG1094|consen  668 CLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE  747 (807)
T ss_pred             eeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence            99999999999999999855433             355566666667999999999999999975  556666544322


Q ss_pred             ccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .  ................+....+-++..+.+++.+||..+-.+|||++++..|
T Consensus       748 ~--vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  748 Q--VVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             H--HHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence            1  1122222222223333333445689999999999999999999999998654

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=249.07  Aligned_cols=243  Identities=21%  Similarity=0.359  Sum_probs=192.1

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCC--CCc--eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecC
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSE--TKE--EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIP  104 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~--~~~--~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~  104 (339)
                      ...+...-..+.++||.|-||.||++....  .|+  .||+|.-++. .+....+.|+.|..+|+.++||||++++|++.
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~  461 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV  461 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence            334444444457899999999999998432  344  4677776553 33445789999999999999999999999983


Q ss_pred             CCCcCCcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeec
Q 042681          105 PMDKEKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF  182 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Df  182 (339)
                            ....+||||.++ |.|..+++.+ ..++......++.||+.||.|||+...|||||..+|||+.+...+||+||
T Consensus       462 ------e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  462 ------EQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             ------ccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeeccc
Confidence                  245799999999 9999999876 46999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCC------------ccccccccccccCCCCccHHHHHHHHHHH-hCCCCCCcccccccchHHHHHhhCCCCC
Q 042681          183 GLARTTSETD------------FMTEYVVTRWDTLFPGKDYVQQLTMITEL-LGSPDDSDLGFLRSDNARRYVKQLPHVP  249 (339)
Q Consensus       183 g~~~~~~~~~------------~~~~~~~~~~~~~~~~d~~~~g~~~~~~l-~g~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (339)
                      |+++-.....            +++|+-..-..++.++|+|.+|+++|+.+ .|..||......      ..+..+.+..
T Consensus       536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs------DVI~~iEnGe  609 (974)
T KOG4257|consen  536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS------DVIGHIENGE  609 (974)
T ss_pred             chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc------ceEEEecCCC
Confidence            9998766543            45666666667889999999999999976 577776543211      1112222233


Q ss_pred             CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       250 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      +.+   ..++|++.+..|+.+||.++|.+||.+.++..
T Consensus       610 RlP---~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  610 RLP---CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             CCC---CCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            322   22679999999999999999999998877654

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=231.10  Aligned_cols=259  Identities=40%  Similarity=0.644  Sum_probs=199.3

Q ss_pred             CCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           37 VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        37 ~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      ..+.+.||-|+||.||.+.+..+|+.+++|++..-...-...+++.+|+++|..++|.|++..+++.....-+-...+|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34478999999999999999999999999998766666667789999999999999999999999986554444456889


Q ss_pred             EEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC-----
Q 042681          117 VYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET-----  191 (339)
Q Consensus       117 v~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~-----  191 (339)
                      ++|.+..+|..++-.-..++.+.++..+.||+.||+|||+.||.||||||.|+++++|..+||||||+++.-...     
T Consensus       135 ~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM  214 (449)
T KOG0664|consen  135 LTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM  214 (449)
T ss_pred             HHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence            999999999999988899999999999999999999999999999999999999999999999999999764322     


Q ss_pred             -------Cccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccccc-------------ccchHH----HHHhh-C
Q 042681          192 -------DFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFL-------------RSDNAR----RYVKQ-L  245 (339)
Q Consensus       192 -------~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~-------------~~~~~~----~~~~~-~  245 (339)
                             -|.+||+... ..++.+.|+|+.||+.-+++..+..|....-.             ..+..+    ..... +
T Consensus       215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L  294 (449)
T KOG0664|consen  215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL  294 (449)
T ss_pred             HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence                   3666776544 35778899999999988777554444221110             000000    00000 1


Q ss_pred             CCCCCCCccc-cC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          246 PHVPKQPFSQ-KF-----PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       246 ~~~~~~~~~~-~~-----~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      ....+.+... .+     ..-..+..+++.+||..||++|.+.++++.|++....+
T Consensus       295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            1111111111 11     11234578999999999999999999999999997665

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=255.10  Aligned_cols=193  Identities=25%  Similarity=0.313  Sum_probs=162.1

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC-cCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD-KEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-~~~~~~~~iv~  118 (339)
                      -+.||+||||.||+++++.+|+.+|+|.+.+.. .....++..+|++++++|+|||||+++++=.... ........+||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            567999999999999999999999999997653 3445688899999999999999999999863211 00123468999


Q ss_pred             ecCc-ccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc--CC--CeEEeeccccccc--
Q 042681          119 ELMD-TDLHQIIRS---KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA--NC--DLKICDFGLARTT--  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~--~~--~ikL~Dfg~~~~~--  188 (339)
                      |||. |+|+..+.+   ...+++.+.+.++.+++.||+|||++|||||||||.||++-.  +|  .-||+|||.|+..  
T Consensus        97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d  176 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDD  176 (732)
T ss_pred             eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCC
Confidence            9997 799999965   357999999999999999999999999999999999999842  23  4899999999765  


Q ss_pred             --------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccccc
Q 042681          189 --------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFL  233 (339)
Q Consensus       189 --------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~  233 (339)
                              |+..|.+|+...+ ..++...|.|++|+++|+..+|..||......
T Consensus       177 ~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  177 NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence                    4456788888774 67788899999999999999999998766544

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-32  Score=261.32  Aligned_cols=241  Identities=22%  Similarity=0.298  Sum_probs=194.0

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCc-----eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKE-----EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      ++..-....+.||+|+||.||.+....-..     .||+|.+.+. .+......|++|..+|..++||||++++|++   
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~---  764 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVC---  764 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEee---
Confidence            444445557889999999999998654333     3788877643 4455678899999999999999999999999   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeE
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSK-------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK  178 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ik  178 (339)
                        -.....+|++||++ |+|..+++..       ..++......++.||++|++||++++.|||||..+|+|++....+|
T Consensus       765 --l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  765 --LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             --cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEE
Confidence              44677899999998 8999999864       4699999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCC-------------CccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhh
Q 042681          179 ICDFGLARTTSET-------------DFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQ  244 (339)
Q Consensus       179 L~Dfg~~~~~~~~-------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~  244 (339)
                      +.|||+|+..-..             .+++||.....-++.++|+|++|+.+|++++ |..|+...   ...........
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~---~n~~v~~~~~~  919 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR---SNFEVLLDVLE  919 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc---chHHHHHHHHh
Confidence            9999999832211             3677887777789999999999999999986 66665432   22222221222


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       245 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      -.+.+.+      +.|+..+.+++.+||+.+|++||++..+++
T Consensus       920 ggRL~~P------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  920 GGRLDPP------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCccCCC------CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            2222222      568999999999999999999999999987

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.7e-33  Score=246.65  Aligned_cols=252  Identities=27%  Similarity=0.421  Sum_probs=198.3

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC------CCCeeeeeeecC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT------HENIVKVKDIIP  104 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~I~~~~~~~~  104 (339)
                      .+-++|.. ....|+|-||.|..|.+..-|..||+|++.+.   ..-.+.-+.|+++|+.|+      --|+++++..| 
T Consensus       429 ~LD~RY~V-~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-  503 (752)
T KOG0670|consen  429 LLDSRYEV-QGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-  503 (752)
T ss_pred             hhcceeEE-EeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-
Confidence            34578888 88999999999999999999999999999764   222345678999999996      24788999888 


Q ss_pred             CCCcCCcCeEEEEEecCcccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-CCCeEEe
Q 042681          105 PMDKEKFNDVYIVYELMDTDLHQIIRSK---QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKIC  180 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-~~~ikL~  180 (339)
                          ...+++|+|+|-..-+|.+.+++.   ..+....+..++.|++.||..|-.+|++|.||||+|||+.. ...+|||
T Consensus       504 ----~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLC  579 (752)
T KOG0670|consen  504 ----KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLC  579 (752)
T ss_pred             ----hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeec
Confidence                778999999999999999999874   46889999999999999999999999999999999999985 4569999


Q ss_pred             ecccccccCCCC---------ccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC-
Q 042681          181 DFGLARTTSETD---------FMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK-  250 (339)
Q Consensus       181 Dfg~~~~~~~~~---------~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-  250 (339)
                      |||.|...+...         |.+|++....++..+-|.|+.||++|++.+|...|.+-..-.  -...........+. 
T Consensus       580 DfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~--MLrl~me~KGk~p~K  657 (752)
T KOG0670|consen  580 DFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ--MLRLFMELKGKFPNK  657 (752)
T ss_pred             cCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH--HHHHHHHhcCCCcHH
Confidence            999998877653         778999999999999999999999999999988774322100  00000000000000 


Q ss_pred             ---------CCccc-----------------------------------cCCCCC-------HHHHHHHHHhcccCCCCC
Q 042681          251 ---------QPFSQ-----------------------------------KFPNMS-------PVAIDLAERMLVFDPAKR  279 (339)
Q Consensus       251 ---------~~~~~-----------------------------------~~~~~s-------~~~~~li~~~L~~dP~~R  279 (339)
                               +.+..                                   ..+.++       ..+++|+.+||..||++|
T Consensus       658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence                     00000                                   001122       347899999999999999


Q ss_pred             CCHHHHhcCCCCCC
Q 042681          280 ITVEEALNHPYLSS  293 (339)
Q Consensus       280 ps~~ell~hp~f~~  293 (339)
                      .|..|+|+||||+.
T Consensus       738 it~nqAL~HpFi~~  751 (752)
T KOG0670|consen  738 ITVNQALKHPFITE  751 (752)
T ss_pred             CCHHHHhcCCcccC
Confidence            99999999999974

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=242.63  Aligned_cols=255  Identities=21%  Similarity=0.312  Sum_probs=200.9

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC-----hHhHHHHHHHHHHHhhCCCCCeeeeeee
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-----RIDAKRILREIKLLCHMTHENIVKVKDI  102 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~I~~~~~~  102 (339)
                      .--.++++|.. +++||+|||+.||+|.+....+.+|||+-......     ..-.+...+|.++-+.|.||.|+++|++
T Consensus       457 DHptLn~RYLl-LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  457 DHPTLNDRYLL-LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             cCcchHHHHHH-HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            34467889999 99999999999999999999999999975432221     2224567899999999999999999999


Q ss_pred             cCCCCcCCcCeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCCeeecc---CCC
Q 042681          103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA--NVLHRDLKPSNLLLNA---NCD  176 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--givH~dikp~NIli~~---~~~  176 (339)
                      |.    -+...+|-|+|||+| +|.-++++++.+++.+++.|+.||+.||.||...  .|+|=||||.|||+-+   -|.
T Consensus       536 fs----lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  536 FS----LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             ee----eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccce
Confidence            94    455678999999996 7888888899999999999999999999999976  5999999999999954   467


Q ss_pred             eEEeecccccccCCC------------------Ccccccccc----ccccCCCCccHHHHHHHHHHHhCCCCCCcccccc
Q 042681          177 LKICDFGLARTTSET------------------DFMTEYVVT----RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR  234 (339)
Q Consensus       177 ikL~Dfg~~~~~~~~------------------~~~~~~~~~----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~  234 (339)
                      +||+|||+++.....                  +|.+|++..    ++....+.|+|+.|++.|..+.|+.||.....- 
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-  690 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-  690 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-
Confidence            999999999765432                  355665443    234677899999999999999999997643211 


Q ss_pred             cchHHHHHhhC--CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          235 SDNARRYVKQL--PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       235 ~~~~~~~~~~~--~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                          ..++...  .......++. -|-++.++++||++||++.-++|....++-.||+|.-
T Consensus       691 ----QdILqeNTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  691 ----QDILQENTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             ----HHHHhhhchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence                1111111  1111111111 1568999999999999999999999999999999964

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.2e-31  Score=245.03  Aligned_cols=257  Identities=17%  Similarity=0.262  Sum_probs=175.8

Q ss_pred             cCccCCCccccccccceEEEEEEeC----------------CCCceEEEEEecccccCh------------HhHHHHHHH
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNS----------------ETKEEVAIKKITNAFDNR------------IDAKRILRE   84 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~----------------~~~~~~avK~~~~~~~~~------------~~~~~~~~e   84 (339)
                      .++|.+ .+.||+|+||.||++...                ..++.||+|++.......            ...+....|
T Consensus       144 ~d~F~i-~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        144 SDDFQL-RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             ccCceE-eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            456666 999999999999998642                345689999986432110            011223456


Q ss_pred             HHHHhhCCCCCe-----eeeeeecCCCCc---CCcCeEEEEEecCc-ccHHHHHHhc-----------------------
Q 042681           85 IKLLCHMTHENI-----VKVKDIIPPMDK---EKFNDVYIVYELMD-TDLHQIIRSK-----------------------  132 (339)
Q Consensus        85 ~~~l~~l~h~~I-----~~~~~~~~~~~~---~~~~~~~iv~e~~~-g~L~~~l~~~-----------------------  132 (339)
                      +.++.+++|.++     +++++++.....   ...+..++|+||++ ++|.+++...                       
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766544     667777632110   12356899999998 6888877531                       


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC------------CCCccccccc
Q 042681          133 -QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS------------ETDFMTEYVV  199 (339)
Q Consensus       133 -~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~------------~~~~~~~~~~  199 (339)
                       ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....            ++.|.+||..
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence             124567788999999999999999999999999999999999999999999985431            2457777765


Q ss_pred             cccc----------------------cCCCCccHHHHHHHHHHHhCCC-CCCcccccccc------hHHHHHhhCCCCCC
Q 042681          200 TRWD----------------------TLFPGKDYVQQLTMITELLGSP-DDSDLGFLRSD------NARRYVKQLPHVPK  250 (339)
Q Consensus       200 ~~~~----------------------~~~~~d~~~~g~~~~~~l~g~~-~~~~~~~~~~~------~~~~~~~~~~~~~~  250 (339)
                      ....                      .....|+|++|+++++++++.. ++.........      ....+...  ....
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~~~~  460 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--KGQK  460 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--cccC
Confidence            3211                      1123599999999999999875 43322111110      00001000  0011


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCCCCCC
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDP---AKRITVEEALNHPYLSS  293 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP---~~Rps~~ell~hp~f~~  293 (339)
                      .. ...+...++..++|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       461 ~~-~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        461 YD-FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CC-cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            11 12345678999999999999876   68999999999999964

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-32  Score=249.58  Aligned_cols=246  Identities=25%  Similarity=0.390  Sum_probs=202.7

Q ss_pred             CCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           38 PPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        38 ~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      ++++.||.|.+|.||++.++.+|+..|+|+........   +....|+.+++.+ .|||++.+++++.-.....++.+++
T Consensus        22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             EEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            33889999999999999999999999999886553333   4455688888888 5999999999997666567788999


Q ss_pred             EEecCc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-----
Q 042681          117 VYELMD-TDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-----  188 (339)
Q Consensus       117 v~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-----  188 (339)
                      |||||+ |+.-++++.  ..++.|..+..|++.++.||.+||...++|||||-.|||++.++.|||+|||.+..+     
T Consensus        99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g  178 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG  178 (953)
T ss_pred             EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccc
Confidence            999998 788888865  467999999999999999999999999999999999999999999999999998643     


Q ss_pred             ------CCCCcccccccccc-----ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          189 ------SETDFMTEYVVTRW-----DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       189 ------~~~~~~~~~~~~~~-----~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                            |++-+++|+++...     .+..+.|.|++|++.+++.-|.+|..+.-     . ...+..++..+.+.+. ..
T Consensus       179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-----P-mraLF~IpRNPPPkLk-rp  251 (953)
T KOG0587|consen  179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-----P-MRALFLIPRNPPPKLK-RP  251 (953)
T ss_pred             cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-----h-hhhhccCCCCCCcccc-ch
Confidence                  44557778776543     46677999999999999999999865432     1 2223344444444332 23


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                      ...++++.+||..||.+|-.+||+..++|+|||+..
T Consensus       252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             hhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            568999999999999999999999999999999983

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-32  Score=246.63  Aligned_cols=242  Identities=19%  Similarity=0.315  Sum_probs=195.4

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCC-Cc--eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSET-KE--EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~-~~--~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      .|+++.....++||+|+||+|+++.|... |+  .||||.++...... ....|++|+.+|.+|+|||++++||+..   
T Consensus       106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl---  181 (1039)
T KOG0199|consen  106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVL---  181 (1039)
T ss_pred             eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeec---
Confidence            34455555578899999999999998753 33  57999987664444 6788999999999999999999999983   


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                        + ....+|+|.++ |+|++.+.+  ...+-......++.||+.|++||.++++|||||...|+++.+...|||+|||+
T Consensus       182 --~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGL  258 (1039)
T KOG0199|consen  182 --D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGL  258 (1039)
T ss_pred             --c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccc
Confidence              2 55789999998 899999976  45688899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC--------------ccccccccccccCCCCccHHHHHHHHHHHhC-CCCCCcccccccchHHHHHhhCCCCC
Q 042681          185 ARTTSETD--------------FMTEYVVTRWDTLFPGKDYVQQLTMITELLG-SPDDSDLGFLRSDNARRYVKQLPHVP  249 (339)
Q Consensus       185 ~~~~~~~~--------------~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g-~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (339)
                      .+.++...              +.+||......+..++|+|..|+++|+|+++ .-|+...   ........+......+
T Consensus       259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~---~g~qIL~~iD~~erLp  335 (1039)
T KOG0199|consen  259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC---RGIQILKNIDAGERLP  335 (1039)
T ss_pred             eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC---CHHHHHHhccccccCC
Confidence            98876542              4567777777899999999999999999975 4443332   2222222222223333


Q ss_pred             CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       250 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ++      +.||+++.++++.||..+|.+|||+..|.+.
T Consensus       336 RP------k~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  336 RP------KYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             CC------CCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            33      5689999999999999999999999998754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.98  E-value=6.1e-33  Score=253.45  Aligned_cols=250  Identities=21%  Similarity=0.327  Sum_probs=207.1

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCc---eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      .|.-.|..+.+.||.|.||.|++++.+..|+   .||+|.++.. ........|+.|..||=++.||||+++-|+.    
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVV----  699 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVV----  699 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEE----
Confidence            3445566668999999999999999887664   6899988654 5556778899999999999999999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                       .....+.||.|||+ |+|..+++++ +.++..+..-+++.|+.|++||-++|+|||||...|||++++-.+|++|||++
T Consensus       700 -Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  700 -TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             -ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence             88889999999998 8999999875 67999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC--------------CccccccccccccCCCCccHHHHHHHHHHH-hCCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          186 RTTSET--------------DFMTEYVVTRWDTLFPGKDYVQQLTMITEL-LGSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       186 ~~~~~~--------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      +.+.+.              .+.+||......++.++|+|+.|+++|+.+ .|..|+|+..   ....-+.+++-.+.+.
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS---NQdVIkaIe~gyRLPp  855 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVIKAIEQGYRLPP  855 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc---hHHHHHHHHhccCCCC
Confidence            876432              245677777677999999999999999965 6899988753   2222333333333333


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC--CCCCCCc
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH--PYLSSLH  295 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h--p~f~~~~  295 (339)
                      +      ..|+..+.+|+..||++|-++||.+.|++.+  ..+++..
T Consensus       856 P------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  856 P------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             C------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence            2      4699999999999999999999999999874  4444443

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=238.35  Aligned_cols=244  Identities=17%  Similarity=0.277  Sum_probs=197.9

Q ss_pred             cccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           27 GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        27 ~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      ..-|....-.+.+-++||.|-||.||.+.|++..-.+|||.++.   +....+.|+.|..+|+.++|||+++++|+|   
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVC---  332 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC---  332 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhh---
Confidence            34455556666668899999999999999999999999998864   355678999999999999999999999999   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                        .....+|||+||+. |+|+++++..  ..++.-....++.||.+|++||..++++||||...|.|+..+..+|+.|||
T Consensus       333 --T~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFG  410 (1157)
T KOG4278|consen  333 --THEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFG  410 (1157)
T ss_pred             --ccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccc
Confidence              67778999999998 9999999753  457777888999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCc------------cccccccccccCCCCccHHHHHHHHHHHhC-CCCCCcccccccchHHHHHhhCCCCCC
Q 042681          184 LARTTSETDF------------MTEYVVTRWDTLFPGKDYVQQLTMITELLG-SPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       184 ~~~~~~~~~~------------~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      +++.+....|            .+|+-.....+..++|+|.+|+.+|++.+. -.|+..   .........++...+...
T Consensus       411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG---idlSqVY~LLEkgyRM~~  487 (1157)
T KOG4278|consen  411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYGLLEKGYRMDG  487 (1157)
T ss_pred             hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC---ccHHHHHHHHhccccccC
Confidence            9988765543            345555556688899999999999998864 444322   222222222222222222


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      +      .+|++.+..|++.||+++|++||+++++-+
T Consensus       488 P------eGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  488 P------EGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             C------CCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence            2      479999999999999999999999987653

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.8e-31  Score=228.42  Aligned_cols=135  Identities=28%  Similarity=0.456  Sum_probs=119.1

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC--------CCCeeeeeeecC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT--------HENIVKVKDIIP  104 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~I~~~~~~~~  104 (339)
                      .+||.. +++||=|.|++||+|-+..+.+.||+|+++..   ..-.+..+.||++|++++        ..+|+++++.|.
T Consensus        77 ~gRY~v-~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   77 GGRYHV-QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             CceEEE-EEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            488888 99999999999999999999999999998643   333456789999999984        248999999997


Q ss_pred             CCCcCCcCeEEEEEecCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCeeec
Q 042681          105 PMDKEKFNDVYIVYELMDTDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIH-SANVLHRDLKPSNLLLN  172 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH-~~givH~dikp~NIli~  172 (339)
                      ... .++.++|+|+|+.+.+|+.++..  .+.++...++.|+.||+.||.||| ++||+|.||||+|||+.
T Consensus       153 hsG-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  153 HSG-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             ecC-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            765 67789999999999999999975  478999999999999999999999 56999999999999993

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-32  Score=250.12  Aligned_cols=236  Identities=26%  Similarity=0.302  Sum_probs=181.0

Q ss_pred             ccccccccce-EEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYG-IVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~-~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      .+.+|.|+.| .||++.-  .|+.||||++-..     ......+|+..|+.- .||||+++++.-     .+....||+
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa  581 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA  581 (903)
T ss_pred             HHHcccCCCCcEEEEEee--CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence            5567899888 5788865  5889999987532     345678999999988 599999999986     777889999


Q ss_pred             EecCcccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc---C--CCeEEeeccccccc
Q 042681          118 YELMDTDLHQIIRSKQA----LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---N--CDLKICDFGLARTT  188 (339)
Q Consensus       118 ~e~~~g~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~---~--~~ikL~Dfg~~~~~  188 (339)
                      .|.|..+|.+++.....    ......+..+.|+++||++||+.+||||||||.||||+.   +  .+++|+|||+|++.
T Consensus       582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            99999999999987411    111345788999999999999999999999999999976   3  36999999999765


Q ss_pred             C--------------CCCccccccccccccCCCCccHHHHHHHHHHHhC-CCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          189 S--------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLG-SPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       189 ~--------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      +              ...+.+||.........+.|++++||+.|+.++| ..||.+.....    ..++.....  ...+
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----~NIl~~~~~--L~~L  735 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----ANILTGNYT--LVHL  735 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh----hhhhcCccc--eeee
Confidence            3              3357788888777778899999999999998887 66665432111    111111111  1111


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      .   +....++++||.+|++++|..||+|.++|.||+|.+...
T Consensus       736 ~---~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ek  775 (903)
T KOG1027|consen  736 E---PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEK  775 (903)
T ss_pred             c---cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHH
Confidence            0   111228999999999999999999999999999987653

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=216.31  Aligned_cols=254  Identities=19%  Similarity=0.300  Sum_probs=200.1

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPM  106 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~  106 (339)
                      ..+++.+.|.+ .+.||.|.||.+-+|+++.+...+|+|.+..+.   ...+.|.+|...--.| .|.||+..|++-.  
T Consensus        18 ~kv~l~d~y~I-~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF--   91 (378)
T KOG1345|consen   18 KKVDLEDVYTI-NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAF--   91 (378)
T ss_pred             cccchhhhhhH-HHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHh--
Confidence            34677788888 999999999999999999999999999987653   3457788998877777 4999999988753  


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec--cCCCeEEeecc
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN--ANCDLKICDFG  183 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~--~~~~ikL~Dfg  183 (339)
                        +..+.+++++||++ |+|..-+.. ..+-|...+.++.|+++|+.|+|++++||||||.+||||-  +..++||||||
T Consensus        92 --qt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   92 --QTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             --hcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecc
Confidence              66678999999999 999877765 5688999999999999999999999999999999999994  33489999999


Q ss_pred             cccccCCC--------Cccccccccc-----cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          184 LARTTSET--------DFMTEYVVTR-----WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       184 ~~~~~~~~--------~~~~~~~~~~-----~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      .+++.+..        .|.+|+.+..     .......|+|.+|++++..++|..|+.......... ..+.... ....
T Consensus       169 ~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y-~~~~~w~-~rk~  246 (378)
T KOG1345|consen  169 LTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY-WEWEQWL-KRKN  246 (378)
T ss_pred             cccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH-HHHHHHh-cccC
Confidence            99887754        3455544432     235667999999999999999999987443333322 2222222 2223


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCCC
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKR---ITVEEALNHPYLS  292 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~ell~hp~f~  292 (339)
                      ...+..+..+|+.+..+.++-|.++|++|   -+++.-...-|..
T Consensus       247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            35556667789999999999999999999   5666666666654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-30  Score=201.39  Aligned_cols=203  Identities=25%  Similarity=0.412  Sum_probs=172.6

Q ss_pred             EEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeee
Q 042681           23 YNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKD  101 (339)
Q Consensus        23 ~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~  101 (339)
                      -++.-+.+.+.......+..||+|++|+|-+.++..+|...|+|.+..... ....++.++|+.+..+- .+|.++.++|
T Consensus        34 i~I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyG  112 (282)
T KOG0984|consen   34 IYIGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYG  112 (282)
T ss_pred             EEEecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeeh
Confidence            344555588888888889999999999999999999999999999987644 44557788888876554 7999999999


Q ss_pred             ecCCCCcCCcCeEEEEEecCcccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeeeccCCC
Q 042681          102 IIPPMDKEKFNDVYIVYELMDTDLHQII----RSKQALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCD  176 (339)
Q Consensus       102 ~~~~~~~~~~~~~~iv~e~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dikp~NIli~~~~~  176 (339)
                      .+     ...+.++|.||.+.-+|..+.    ++.+.++|..+-+|+..++.||.|||++ .++|||+||+||||+.+|+
T Consensus       113 a~-----~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq  187 (282)
T KOG0984|consen  113 AL-----FREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ  187 (282)
T ss_pred             hh-----hccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc
Confidence            88     667889999999998877665    4568899999999999999999999966 8999999999999999999


Q ss_pred             eEEeecccccc----------cCCCCcccccccccc----ccCCCCccHHHHHHHHHHHhCCCCCCccc
Q 042681          177 LKICDFGLART----------TSETDFMTEYVVTRW----DTLFPGKDYVQQLTMITELLGSPDDSDLG  231 (339)
Q Consensus       177 ikL~Dfg~~~~----------~~~~~~~~~~~~~~~----~~~~~~d~~~~g~~~~~~l~g~~~~~~~~  231 (339)
                      +|+||||.+..          .|..+|++||.....    .+.-++|+|++|++++++.+++.|+..+.
T Consensus       188 VKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  188 VKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             EEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            99999999853          344578888876532    57778999999999999999999977654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=1.2e-29  Score=256.40  Aligned_cols=237  Identities=16%  Similarity=0.232  Sum_probs=177.6

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      .+.. .+.||+|+||.||+|.+..+|..||+|++......      ...|++.+++++||||+++++++     ......
T Consensus       691 ~~~~-~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~-----~~~~~~  758 (968)
T PLN00113        691 SLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLC-----RSEKGA  758 (968)
T ss_pred             hCCc-ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEE-----EcCCCC
Confidence            3444 67899999999999999999999999988643211      12457889999999999999999     555678


Q ss_pred             EEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCCCCeeeccCCCeEEeecccccc---
Q 042681          115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART---  187 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~dikp~NIli~~~~~ikL~Dfg~~~~---  187 (339)
                      ++||||++ |+|.+++..   +++..+..++.|++.||+|||   +.+++||||||+||+++.++..++. ++....   
T Consensus       759 ~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            99999998 799999853   889999999999999999999   6699999999999999998887765 444322   


Q ss_pred             ----cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh-CCCCC-----CCCccccC
Q 042681          188 ----TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ-LPHVP-----KQPFSQKF  257 (339)
Q Consensus       188 ----~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~  257 (339)
                          .+...|++||......+..++|+|++|+++|++++|..|+....... .....+... .....     .+......
T Consensus       835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (968)
T PLN00113        835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDMWIDPSIRGDV  913 (968)
T ss_pred             CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC-CcHHHHHHHhcCccchhheeCccccCCC
Confidence                23357899998887788899999999999999999999874321111 111111110 00000     00000000


Q ss_pred             ---CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          258 ---PNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       258 ---~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                         .....++.+++.+||+.||++|||+.++++.
T Consensus       914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence               0112357789999999999999999999976

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-30  Score=222.16  Aligned_cols=239  Identities=22%  Similarity=0.270  Sum_probs=178.1

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC--CCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM--THENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      ++.||+|.||.||++.++  |+.||||++...     +.+.+.+|.++++.+  +|+||+.+++.-.- +......+++|
T Consensus       216 ~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~-~~gs~TQLwLv  287 (513)
T KOG2052|consen  216 QEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNK-DNGSWTQLWLV  287 (513)
T ss_pred             EEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhcccc-CCCceEEEEEe
Confidence            889999999999999997  789999999754     446788899998885  89999999986421 11233459999


Q ss_pred             EecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCeeeccCCCeEEeecccccc-
Q 042681          118 YELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA--------NVLHRDLKPSNLLLNANCDLKICDFGLART-  187 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------givH~dikp~NIli~~~~~ikL~Dfg~~~~-  187 (339)
                      ++|.+ |+|++++.. ..++.+...+++..++.||.+||-.        .|+|||||..|||+.+++.+.|.|+|+|.+ 
T Consensus       288 TdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h  366 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  366 (513)
T ss_pred             eecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence            99999 999999987 7899999999999999999999943        399999999999999999999999999853 


Q ss_pred             --------------cCCCCcccccccccc------ccCCCCccHHHHHHHHHHHhC----------CCCCCccc-ccc-c
Q 042681          188 --------------TSETDFMTEYVVTRW------DTLFPGKDYVQQLTMITELLG----------SPDDSDLG-FLR-S  235 (339)
Q Consensus       188 --------------~~~~~~~~~~~~~~~------~~~~~~d~~~~g~~~~~~l~g----------~~~~~~~~-~~~-~  235 (339)
                                    .|+-.|++||+....      +.....|+|++|+++|+....          .+|+.++- ..+ .
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~  446 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF  446 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence                          445569999988654      345569999999999998732          23333221 111 1


Q ss_pred             chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ....+.+-.....+..+........=..+..+++.||..||..|.||--+.+
T Consensus       447 eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  447 EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            1222222222222222222211111233568899999999999999977664

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=2.8e-30  Score=221.66  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=187.5

Q ss_pred             cCccCCCccccccccceEEEEEEeCC---CCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSE---TKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDK  108 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~  108 (339)
                      .+.|.. +++||.|.|++||++.+..   .++.+|+|.+...    ....++.+|+++|..+ .+.||+++.+++     
T Consensus        35 ~~~~~~-v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~-----  104 (418)
T KOG1167|consen   35 SNAYKV-VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF-----  104 (418)
T ss_pred             hhhhhh-hccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh-----
Confidence            444555 9999999999999999887   7889999998654    2346789999999999 599999999999     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-CCCeEEeeccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLAR  186 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-~~~ikL~Dfg~~~  186 (339)
                      ...+.+++|+||++ ....++...   ++...++.+++.++.||+++|++|||||||||+|++.+. .++-.|+|||++.
T Consensus       105 rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  105 RNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             ccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence            77889999999999 577777655   778999999999999999999999999999999999985 5678999999985


Q ss_pred             cc-------------------------------------------------------CCCCccccccccc-cccCCCCcc
Q 042681          187 TT-------------------------------------------------------SETDFMTEYVVTR-WDTLFPGKD  210 (339)
Q Consensus       187 ~~-------------------------------------------------------~~~~~~~~~~~~~-~~~~~~~d~  210 (339)
                      ..                                                       |++.|.+|++... ...+.+.|+
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            10                                                       1111223332222 235677999


Q ss_pred             HHHHHHHHHHHhCCCCCCccccccc-----------chHHHHH-----------------------------hhCCCCCC
Q 042681          211 YVQQLTMITELLGSPDDSDLGFLRS-----------DNARRYV-----------------------------KQLPHVPK  250 (339)
Q Consensus       211 ~~~g~~~~~~l~g~~~~~~~~~~~~-----------~~~~~~~-----------------------------~~~~~~~~  250 (339)
                      |+.|++++..+.+..||...+....           ....+..                             ........
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            9999999999999888753332110           0000000                             00000011


Q ss_pred             --CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          251 --QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       251 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                        ..........+..+.+|+.+||+.||.+|.||+++|+||||....+.
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~  390 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT  390 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence              01111112345678999999999999999999999999999966554

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-29  Score=237.40  Aligned_cols=245  Identities=23%  Similarity=0.351  Sum_probs=197.5

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCC-------CCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeee
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSE-------TKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVK  100 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~  100 (339)
                      .|.+..+...+.+.||+|+||+|+++....       ....+|||.++..... .+.+.+..|+.+++.+ .|+||+.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            567777777667899999999999997431       1457899988765444 6778899999999999 599999999


Q ss_pred             eecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 042681          101 DIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ----------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRD  163 (339)
Q Consensus       101 ~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~d  163 (339)
                      |++     ...+.+++|+||+. |+|..++++.+                .++......++.||+.|++||++.+++|||
T Consensus       369 G~~-----t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRD  443 (609)
T KOG0200|consen  369 GAC-----TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRD  443 (609)
T ss_pred             eee-----ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchh
Confidence            999     55788999999998 99999998755                388899999999999999999999999999


Q ss_pred             CCCCCeeeccCCCeEEeecccccccCCC--------------CccccccccccccCCCCccHHHHHHHHHHHh-CCCCCC
Q 042681          164 LKPSNLLLNANCDLKICDFGLARTTSET--------------DFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDS  228 (339)
Q Consensus       164 ikp~NIli~~~~~ikL~Dfg~~~~~~~~--------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~  228 (339)
                      |..+||++..+..+|++|||+|+.....              .+++||......++..+|+|++|+++|++++ |..|+.
T Consensus       444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence            9999999999999999999999742211              2667777777788999999999999999885 566654


Q ss_pred             cccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ..+.  .....+.+....+..++      ..+++++.++++.||+.+|++||++.++..
T Consensus       524 ~~~~--~~~l~~~l~~G~r~~~P------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  524 GIPP--TEELLEFLKEGNRMEQP------EHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             CCCc--HHHHHHHHhcCCCCCCC------CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            4221  11112233333333333      357999999999999999999999998875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.6e-28  Score=204.08  Aligned_cols=200  Identities=33%  Similarity=0.536  Sum_probs=174.3

Q ss_pred             cccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCc
Q 042681           43 IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD  122 (339)
Q Consensus        43 lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~  122 (339)
                      ||+|++|.||++....+++.+++|++....... ..+.+.+|+..++.++|++|+++++++     ......++++|+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVF-----EDENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeee-----ecCCeEEEEEecCC
Confidence            689999999999998889999999987553322 356788999999999999999999998     55578999999999


Q ss_pred             -ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-CCCeEEeecccccccCC---------
Q 042681          123 -TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSE---------  190 (339)
Q Consensus       123 -g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-~~~ikL~Dfg~~~~~~~---------  190 (339)
                       ++|.+++... ..++...++.++.+++.+|++||+.|++|+||+|.||+++. ++.++|+|||.+.....         
T Consensus        75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence             7999998775 57999999999999999999999999999999999999999 89999999998875433         


Q ss_pred             --CCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          191 --TDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       191 --~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                        ..|.+|+..... ......|.|++|++++++                                         ..+.++
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------~~~~~~  193 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------PELKDL  193 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------HHHHHH
Confidence              245566655544 666789999999999987                                         569999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCC
Q 042681          268 AERMLVFDPAKRITVEEALNHP  289 (339)
Q Consensus       268 i~~~L~~dP~~Rps~~ell~hp  289 (339)
                      +.+|++.+|++||++.++++|+
T Consensus       194 l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         194 IRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHhhCCcccCcCHHHHhhCC
Confidence            9999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=231.66  Aligned_cols=187  Identities=28%  Similarity=0.410  Sum_probs=161.8

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEeccccc--ChHh----HHHHHHHHHHHhhCC---CCCeeeeeeecCCC
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD--NRID----AKRILREIKLLCHMT---HENIVKVKDIIPPM  106 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~----~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~  106 (339)
                      |.. ++.||.|+||+|++|.++.+...|++|.+.+...  +...    .-.+--|+.+|..|+   |+||++++++|   
T Consensus       563 ytt-lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF---  638 (772)
T KOG1152|consen  563 YTT-LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF---  638 (772)
T ss_pred             cee-eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee---
Confidence            666 8999999999999999999999999999976521  1111    112446999999997   99999999999   


Q ss_pred             CcCCcCeEEEEEecCc-c-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          107 DKEKFNDVYIVYELMD-T-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                        ++.+.+||+||..+ | +|++++..+..++|.+++.|+.|++.|+++||++||||||||-+|++++++|.+||+|||.
T Consensus       639 --Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  639 --EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             --ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence              88899999999997 5 9999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccc---------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCC
Q 042681          185 ARTT---------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDS  228 (339)
Q Consensus       185 ~~~~---------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~  228 (339)
                      +...         |+-.|++|+.... .+...+.|+|++|+.+|..+....|+.
T Consensus       717 aa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            8543         4456888887654 456778999999999999888887754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-30  Score=233.04  Aligned_cols=250  Identities=26%  Similarity=0.325  Sum_probs=202.0

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      -.++|.. +..+|+|.||.||+++++.+++..|+|+++..  ...+.+-+.+|+-+++.-+||||+.+++.+     -..
T Consensus        13 P~ddyel-lqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~   84 (829)
T KOG0576|consen   13 PQDDYEL-LQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRR   84 (829)
T ss_pred             Cccchhh-eeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhh-----hhh
Confidence            3566777 99999999999999999999999999999754  233456677899999999999999999999     566


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ..++|+||||+ |+|.++..-.+++++.++...++..++||+|||++|-+|||||-.||++++.|.+||.|||.+...  
T Consensus        85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence            77899999998 688888877899999999999999999999999999999999999999999999999999998543  


Q ss_pred             ---------CCCCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          189 ---------SETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       189 ---------~~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                               |++.+++|+...   ...+....|+|+.|+..+++---.+|..+.-     ..+..+-.......++....
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-----pmr~l~LmTkS~~qpp~lkD  239 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-----PMRALFLMTKSGFQPPTLKD  239 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-----hHHHHHHhhccCCCCCcccC
Confidence                     455566766543   3357778999999999888776666654332     11111122222233333333


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      -...++.+.+|++.+|.++|.+||+++-+|+|||...-
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            35688999999999999999999999999999998654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8.1e-29  Score=227.65  Aligned_cols=232  Identities=19%  Similarity=0.312  Sum_probs=187.3

Q ss_pred             ccccccccceEEEEEEeCCCCc----eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKE----EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      .+.||+|+||+||++.+...|+    +||+|++... ........++.|+-+|.++.|||++++++++...      .+-
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~~q  773 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------TLQ  773 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------hHH
Confidence            6789999999999999876665    6788877644 3334457899999999999999999999998432      278


Q ss_pred             EEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC--
Q 042681          116 IVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET--  191 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~--  191 (339)
                      ||++|++ |+|.++++. +.++.....+.|+.||++|+.|||.+++|||||..+|||+.+-..+|+.|||+++.....  
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            9999999 899999976 468999999999999999999999999999999999999999999999999999865432  


Q ss_pred             C-----------ccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          192 D-----------FMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       192 ~-----------~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                      .           +++-+......+...+|+|++|+.+|++++ |..|+...+   .......++.-.+...+      +.
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~---~~eI~dlle~geRLsqP------pi  924 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP---AEEIPDLLEKGERLSQP------PI  924 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC---HHHhhHHHhccccCCCC------CC
Confidence            2           223344444568889999999999999885 777766543   22333333333333333      56


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ++.++..++.+||..|+..||+++++..
T Consensus       925 CtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  925 CTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            8999999999999999999999988764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-28  Score=211.32  Aligned_cols=235  Identities=23%  Similarity=0.272  Sum_probs=177.2

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC--CCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM--THENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      .+.||+|+||.||+|+..  ++.||||++..     .+.+.+.+|.+++...  +|+||+++++.-.... .....+.||
T Consensus       215 ~eli~~Grfg~V~KaqL~--~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLV  286 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD--NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLV  286 (534)
T ss_pred             HHHhhcCccceeehhhcc--CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEE
Confidence            778999999999999764  69999999853     3567788888887765  7999999999874433 224579999


Q ss_pred             EecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          118 YELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA---------NVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ++|.+ |+|.++++. ..+++....+++..++.||+|||+-         .|+|||||..|||+.+|+...|+|||+|.+
T Consensus       287 t~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             eeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            99998 999999987 5799999999999999999999963         499999999999999999999999999965


Q ss_pred             c-------------CCCCcccccccccc------ccCCCCccHHHHHHHHHHHhCCCCC-------Cccccc-------c
Q 042681          188 T-------------SETDFMTEYVVTRW------DTLFPGKDYVQQLTMITELLGSPDD-------SDLGFL-------R  234 (339)
Q Consensus       188 ~-------------~~~~~~~~~~~~~~------~~~~~~d~~~~g~~~~~~l~g~~~~-------~~~~~~-------~  234 (339)
                      +             |+..|++||.....      ....+.|+|++|+++++++......       ...++.       .
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            4             44568898876543      2233589999999999998654333       333322       1


Q ss_pred             cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 042681          235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVE  283 (339)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~  283 (339)
                      .+............+..+....-...-.-+++.+..||..||+.|+||.
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence            1222333333333332221111112335578999999999999999984

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=6.3e-28  Score=226.86  Aligned_cols=272  Identities=26%  Similarity=0.305  Sum_probs=205.1

Q ss_pred             EEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecc----cccChHhHHHHHHHHHHHhhCCCCCeee
Q 042681           23 YNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITN----AFDNRIDAKRILREIKLLCHMTHENIVK   98 (339)
Q Consensus        23 ~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~----~~~~~~~~~~~~~e~~~l~~l~h~~I~~   98 (339)
                      -.+.+....+...|....+.+|.|++|.|+.+......+.++.|.+..    ..........+..|+.+-..+.|||++.
T Consensus       306 ~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e  385 (601)
T KOG0590|consen  306 LTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIE  385 (601)
T ss_pred             cccccCccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhh
Confidence            345666677778898889999999999999988887777777776542    2222222233667888888899999998


Q ss_pred             eeeecCCCCcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeE
Q 042681           99 VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK  178 (339)
Q Consensus        99 ~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ik  178 (339)
                      ....+.     ......-.||||+++|+.++...+.+....+-.++.|++.||+|+|++|+.|||+||+|+++..+|.+|
T Consensus       386 ~l~~~~-----~~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lk  460 (601)
T KOG0590|consen  386 TLDIVQ-----EIDGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILK  460 (601)
T ss_pred             hHHHHh-----hcccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceE
Confidence            888873     333333339999999999999888999999999999999999999999999999999999999999999


Q ss_pred             Eeeccccccc---------------CCCCcccccccccccc-CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHH
Q 042681          179 ICDFGLARTT---------------SETDFMTEYVVTRWDT-LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV  242 (339)
Q Consensus       179 L~Dfg~~~~~---------------~~~~~~~~~~~~~~~~-~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~  242 (339)
                      ++|||.+..+               +..+|.+||.+...++ ....|+|+.|++++.|.+|+.++-.. ...........
T Consensus       461 i~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a-~~~~~~~~~~~  539 (601)
T KOG0590|consen  461 IIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVA-KKSDNSFKTNN  539 (601)
T ss_pred             EeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccc-cccccchhhhc
Confidence            9999998532               3446888887776554 45689999999999999997774322 11111111111


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCC
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE  300 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~  300 (339)
                      ..............+..++...+.+|.+||++||.+|.|+++|++.+||+.+..+...
T Consensus       540 ~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v~  597 (601)
T KOG0590|consen  540 YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHVD  597 (601)
T ss_pred             cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEec
Confidence            1111111111122234478889999999999999999999999999999999877643

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=6.7e-27  Score=230.71  Aligned_cols=195  Identities=11%  Similarity=0.169  Sum_probs=142.5

Q ss_pred             hCCC-CCeeeeeeecCCCC--cCCcCeEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 042681           90 HMTH-ENIVKVKDIIPPMD--KEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLK  165 (339)
Q Consensus        90 ~l~h-~~I~~~~~~~~~~~--~~~~~~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dik  165 (339)
                      .++| +||.++++++....  ......++.++|+++++|.+++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            3445 57777777763221  012245788899999999999975 4569999999999999999999999999999999


Q ss_pred             CCCeeecc-------------------CCCeEEeeccccccc---------------------------CCCCccccccc
Q 042681          166 PSNLLLNA-------------------NCDLKICDFGLARTT---------------------------SETDFMTEYVV  199 (339)
Q Consensus       166 p~NIli~~-------------------~~~ikL~Dfg~~~~~---------------------------~~~~~~~~~~~  199 (339)
                      |+|||++.                   ++.+|++|||+++..                           ++..|++||..
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            99999964                   445666777766421                           22348899987


Q ss_pred             cccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCC
Q 042681          200 TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKR  279 (339)
Q Consensus       200 ~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  279 (339)
                      ....+..+.|+|++|+++|++++|.+++....    ..........  .+.     ......+...+++.+||+++|.+|
T Consensus       188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~~--~~~-----~~~~~~~~~~~~~~~~L~~~P~~R  256 (793)
T PLN00181        188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHRV--LPP-----QILLNWPKEASFCLWLLHPEPSCR  256 (793)
T ss_pred             ccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHhh--cCh-----hhhhcCHHHHHHHHHhCCCChhhC
Confidence            77778899999999999999999877643211    1111111110  010     001124567899999999999999


Q ss_pred             CCHHHHhcCCCCCCCc
Q 042681          280 ITVEEALNHPYLSSLH  295 (339)
Q Consensus       280 ps~~ell~hp~f~~~~  295 (339)
                      |++.++++||||....
T Consensus       257 ps~~eil~h~~~~~~~  272 (793)
T PLN00181        257 PSMSELLQSEFINEPR  272 (793)
T ss_pred             cChHHHhhchhhhhhh
Confidence            9999999999998754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=3.2e-25  Score=186.45  Aligned_cols=183  Identities=31%  Similarity=0.482  Sum_probs=158.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||.|++|.||++....+++.+++|.+...... ...+.+.+|+..++.++|+|++++++.+     ......++++|
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v~e   77 (225)
T smart00221        4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVF-----EDPEPLYLVME   77 (225)
T ss_pred             eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeee-----ecCCceEEEEe
Confidence            78899999999999999988999999999765332 2457888999999999999999999998     55577899999


Q ss_pred             cCcc-cHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC------
Q 042681          120 LMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET------  191 (339)
Q Consensus       120 ~~~g-~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~------  191 (339)
                      ++++ +|.+++..... +++..++.++.+++.++.+||+.|++|+||+|.||+++.++.++|+|||.+......      
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            9985 99999987666 899999999999999999999999999999999999999999999999988755432      


Q ss_pred             ------Cccccccc-cccccCCCCccHHHHHHHHHHHhCCCCCC
Q 042681          192 ------DFMTEYVV-TRWDTLFPGKDYVQQLTMITELLGSPDDS  228 (339)
Q Consensus       192 ------~~~~~~~~-~~~~~~~~~d~~~~g~~~~~~l~g~~~~~  228 (339)
                            .+.+|+.. .........|+|++|++++++++|..|+.
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence                  25667665 44555668999999999999999998864

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=3.7e-25  Score=180.43  Aligned_cols=143  Identities=20%  Similarity=0.213  Sum_probs=111.2

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHh------------------------HHHHHHHHHHHhhCCCCC
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID------------------------AKRILREIKLLCHMTHEN   95 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~~   95 (339)
                      .+.||+|++|.||+|.+. +|+.||+|+++........                        .....+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            578999999999999987 8999999999764221111                        122345999999998777


Q ss_pred             eeeeeeecCCCCcCCcCeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCCeeecc
Q 042681           96 IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI-HSANVLHRDLKPSNLLLNA  173 (339)
Q Consensus        96 I~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~givH~dikp~NIli~~  173 (339)
                      +.....+.     ..  ..++||||++| ++.......++++...+..++.|++.+|.++ |+.|++||||||+||+++ 
T Consensus        81 v~~p~~~~-----~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-  152 (190)
T cd05147          81 IPCPEPIL-----LK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCCcEEE-----ec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence            64333222     11  23899999986 4444444557899999999999999999999 799999999999999998 


Q ss_pred             CCCeEEeecccccccCCC
Q 042681          174 NCDLKICDFGLARTTSET  191 (339)
Q Consensus       174 ~~~ikL~Dfg~~~~~~~~  191 (339)
                      ++.++|+|||+|...+.+
T Consensus       153 ~~~v~LiDFG~a~~~~~~  170 (190)
T cd05147         153 DGKLYIIDVSQSVEHDHP  170 (190)
T ss_pred             CCcEEEEEccccccCCCc
Confidence            578999999999876544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.9e-24  Score=191.34  Aligned_cols=140  Identities=21%  Similarity=0.300  Sum_probs=111.3

Q ss_pred             ccCccCCCccccccccceEEEEEEeCC-CCceEEEEEeccccc---ChHhHHHHHHHHHHHhhCCCCCeee-eeeecCCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSE-TKEEVAIKKITNAFD---NRIDAKRILREIKLLCHMTHENIVK-VKDIIPPM  106 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~-~~~~~avK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~I~~-~~~~~~~~  106 (339)
                      +.++|.. .+.||+|+||+||+|.+.. +++.+|+|++.....   .....+.+.+|+.+++.++|+|++. +++ +   
T Consensus        16 ~~~~Y~~-~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~---   90 (365)
T PRK09188         16 LSARFVE-TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T---   90 (365)
T ss_pred             ccCCceE-ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c---
Confidence            4566777 9999999999999999876 677889998753311   2334567899999999999999985 443 2   


Q ss_pred             CcCCcCeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCCeeeccCCCeEEeeccc
Q 042681          107 DKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDL-KPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~di-kp~NIli~~~~~ikL~Dfg~  184 (339)
                           +..++||||++| +|. .+..   ..   ...++.|++.||.|||++||+|||| ||+||+++.++.++|+|||+
T Consensus        91 -----~~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 -----GKDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             -----CCcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence                 246999999985 664 2211   11   1467899999999999999999999 99999999999999999999


Q ss_pred             cccc
Q 042681          185 ARTT  188 (339)
Q Consensus       185 ~~~~  188 (339)
                      |+..
T Consensus       159 A~~~  162 (365)
T PRK09188        159 ASVF  162 (365)
T ss_pred             ceec
Confidence            9754

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=1e-23  Score=172.62  Aligned_cols=143  Identities=18%  Similarity=0.161  Sum_probs=113.0

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChH------------------------hHHHHHHHHHHHhhCCCCC
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI------------------------DAKRILREIKLLCHMTHEN   95 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~   95 (339)
                      .+.||+|++|+||+|.+. +|+.||+|+++.......                        ......+|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            678999999999999987 899999999976522100                        0123457899999999988


Q ss_pred             eeeeeeecCCCCcCCcCeEEEEEecCccc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeecc
Q 042681           96 IVKVKDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNA  173 (339)
Q Consensus        96 I~~~~~~~~~~~~~~~~~~~iv~e~~~g~-L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~  173 (339)
                      +.....+.     ..  ..++||||++|. +........+++...+..++.|++.+|.++|+ .|++||||||+||+++ 
T Consensus        81 i~~p~~~~-----~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-  152 (190)
T cd05145          81 VPVPEPIL-----LK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCCceEEE-----ec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence            75444433     11  138999999863 43333345678899999999999999999999 9999999999999999 


Q ss_pred             CCCeEEeecccccccCCC
Q 042681          174 NCDLKICDFGLARTTSET  191 (339)
Q Consensus       174 ~~~ikL~Dfg~~~~~~~~  191 (339)
                      ++.++|+|||++.....+
T Consensus       153 ~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         153 DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             CCCEEEEEcccceecCCC
Confidence            889999999999877643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-23  Score=168.78  Aligned_cols=243  Identities=18%  Similarity=0.213  Sum_probs=180.6

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPM  106 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~  106 (339)
                      +.+.+.++|.. ++.||+|+||.+|++....+|..||+|+-+.....    -++..|..++..|+ ...|+.+.-+.   
T Consensus         9 ~~~iv~gky~l-vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~---   80 (341)
T KOG1163|consen    9 EELIVGGKYKL-VRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYG---   80 (341)
T ss_pred             hhheeccceEE-EEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhc---
Confidence            45667888988 99999999999999999999999999986544222    24677888888886 56777777666   


Q ss_pred             CcCCcCeEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc---CCCeEEeec
Q 042681          107 DKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDF  182 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~---~~~ikL~Df  182 (339)
                        .+.....+||+..+.+|.+++.- .+.++..+++-++-|++.-++|+|.++.+||||||+|++..-   ...+.|+||
T Consensus        81 --~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDF  158 (341)
T KOG1163|consen   81 --TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDF  158 (341)
T ss_pred             --cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEec
Confidence              66777899999999999988863 478999999999999999999999999999999999999963   346999999


Q ss_pred             ccccccCCCC------------------ccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh
Q 042681          183 GLARTTSETD------------------FMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ  244 (339)
Q Consensus       183 g~~~~~~~~~------------------~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~  244 (339)
                      |+|++..+..                  |++.......+..-+.|.-++|.++.+..-|..|+.+..........+.+.+
T Consensus       159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E  238 (341)
T KOG1163|consen  159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE  238 (341)
T ss_pred             cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence            9998764431                  2222222223345556778999999999999999877644333322222222


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 042681          245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITV  282 (339)
Q Consensus       245 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  282 (339)
                        .-...+......++|.++.-.+.-|=..--.+-|..
T Consensus       239 --kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  239 --KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             --hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence              222233334446678888877777766666666643

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.91  E-value=2.4e-23  Score=177.55  Aligned_cols=235  Identities=16%  Similarity=0.256  Sum_probs=181.9

Q ss_pred             ccccccccceEEEEEEeCCCCc-----eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKE-----EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      ...+.+|.||.||.+.++..+.     .+-+|.++. .-.+.+...++.|--.+..+.|||+.++.++..    ++....
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i----e~~~~P  363 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSI----EDYATP  363 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEe----eccCcc
Confidence            6778899999999997764332     344554432 233445677889999999999999999999884    455668


Q ss_pred             EEEEecCc-ccHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          115 YIVYELMD-TDLHQIIRS--------KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                      ++++.+.+ |+|..++..        .+.++..+...++.|++.|++|||+.|++|.||..+|.+||+.-++||+|=.++
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLS  443 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALS  443 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhc
Confidence            99999999 999999873        145777888899999999999999999999999999999999999999998888


Q ss_pred             cccC--------CC-----CccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          186 RTTS--------ET-----DFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       186 ~~~~--------~~-----~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      +-+-        ++     .++++|......+..++|+|++|+.+|++++ |..|+....   ......++....+..++
T Consensus       444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID---PfEm~~ylkdGyRlaQP  520 (563)
T KOG1024|consen  444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID---PFEMEHYLKDGYRLAQP  520 (563)
T ss_pred             cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC---HHHHHHHHhccceecCC
Confidence            7532        22     2556676677789999999999999999885 566654321   22223333333332222


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                            -+|+.++..++..||...|++||+++|+..+
T Consensus       521 ------~NCPDeLf~vMacCWallpeeRPsf~Qlv~c  551 (563)
T KOG1024|consen  521 ------FNCPDELFTVMACCWALLPEERPSFSQLVIC  551 (563)
T ss_pred             ------CCCcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence                  3699999999999999999999999998753

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=2.6e-22  Score=177.85  Aligned_cols=242  Identities=19%  Similarity=0.198  Sum_probs=176.4

Q ss_pred             ccCCCccccccccceEEEEEEeCCCC-ceEEEEEecccccChHhHHHHHHHHHHHhhCC----CCCeeeeeeecCCCCcC
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETK-EEVAIKKITNAFDNRIDAKRILREIKLLCHMT----HENIVKVKDIIPPMDKE  109 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~I~~~~~~~~~~~~~  109 (339)
                      +|.+ .+.||+|+||.||.|.+..++ ..+|+|..........  ..+..|..++..+.    .+++..+++...    .
T Consensus        19 ~~~i-~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~   91 (322)
T KOG1164|consen   19 RYKL-GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----S   91 (322)
T ss_pred             ceEE-eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc----C
Confidence            6666 999999999999999988775 6788887754322221  15677888888886    368999998872    2


Q ss_pred             CcCeEEEEEecCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC-----CCeEEeec
Q 042681          110 KFNDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-----CDLKICDF  182 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~-----~~ikL~Df  182 (339)
                      .....++||+.++.+|.++....  +.++..++..++.|++.||++||+.|++||||||+|+.+...     ..+.|.||
T Consensus        92 ~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   92 TEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             CCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            45678999999999999988653  689999999999999999999999999999999999999754     35999999


Q ss_pred             cccc--ccC-------------------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHH
Q 042681          183 GLAR--TTS-------------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRY  241 (339)
Q Consensus       183 g~~~--~~~-------------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~  241 (339)
                      |+++  +..                   +..|++..+....+.....|.|++++.+++++.|..|+.........  ...
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~--~~~  249 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK--SKF  249 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH--HHH
Confidence            9998  321                   11233333334445777788999999999999999886544322111  111


Q ss_pred             HhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          242 VKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ...........   .....+.++..+...+-..+...+|....+...
T Consensus       250 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  250 EKDPRKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHHhhhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            11111111000   122356778888888888999999988776654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=4.4e-23  Score=167.08  Aligned_cols=161  Identities=18%  Similarity=0.133  Sum_probs=122.9

Q ss_pred             ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc------cCCCCccc
Q 042681          123 TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART------TSETDFMT  195 (339)
Q Consensus       123 g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~------~~~~~~~~  195 (339)
                      |+|.+++.. .+++++..++.++.|++.||+|||+.+      ||+||+++.++.+++  ||.+..      .++..|++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~y~a   72 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPYFMA   72 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccccCCCcccccC
Confidence            688999976 456999999999999999999999998      999999999999999  998864      34567899


Q ss_pred             cccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH--HHHHHHHHhcc
Q 042681          196 EYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP--VAIDLAERMLV  273 (339)
Q Consensus       196 ~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~li~~~L~  273 (339)
                      ||......+..++|+|++|+++|++++|..|+....... ................ .......++.  +++++|.+||.
T Consensus        73 PE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~cl~  150 (176)
T smart00750       73 PEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPADDPR-DRSNLESVSAARSFADFMRVCAS  150 (176)
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhccCCcc-ccccHHHHHhhhhHHHHHHHHHh
Confidence            998887788889999999999999999999875432211 1111222111111100 0001112333  69999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCC
Q 042681          274 FDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       274 ~dP~~Rps~~ell~hp~f~~  293 (339)
                      .+|.+||++.++++|+|+..
T Consensus       151 ~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      151 RLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             cccccccCHHHHHHHHHHHH
Confidence            99999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=3.9e-23  Score=170.49  Aligned_cols=177  Identities=10%  Similarity=0.077  Sum_probs=131.1

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChH-hHHH------HHHHHHHHhhCCCCCeeeeeeecC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI-DAKR------ILREIKLLCHMTHENIVKVKDIIP  104 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~------~~~e~~~l~~l~h~~I~~~~~~~~  104 (339)
                      +.++|.. ++.||.|+||.||++..  ++..+|+|++........ ..++      +.+|+..+.++.||+|..+.+++.
T Consensus        29 l~~~y~~-~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         29 LSYNIKT-IKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             hhCceEE-EEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            4788888 99999999999999755  467899999976543332 2223      568989999999999999998864


Q ss_pred             CCCcC---CcCeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEe
Q 042681          105 PMDKE---KFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC  180 (339)
Q Consensus       105 ~~~~~---~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~  180 (339)
                      .....   ..+..+++|||++| +|.+..    .+++    ....+++.+|..+|+.|++|||++|+||+++++| ++|+
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence            32111   12458999999996 776652    2333    2456999999999999999999999999999988 9999


Q ss_pred             ecccccccCCCCccccccccccccCCCCccHHHHHHHHHHH
Q 042681          181 DFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITEL  221 (339)
Q Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l  221 (339)
                      |||............. ......+....|+|++|+.++...
T Consensus       177 Dfg~~~~~~e~~a~d~-~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        177 DLSGKRCTAQRKAKDR-IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ECCCcccccchhhHHH-HHHHhHhcccccccceeEeehHHH
Confidence            9999876643322222 222223446899999998876543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.9e-23  Score=187.40  Aligned_cols=235  Identities=20%  Similarity=0.316  Sum_probs=194.8

Q ss_pred             ccccccceEEEEEE---eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           42 PIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        42 ~lg~G~~~~v~~~~---~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      .+|.|++|.|++++   ....|.-|++|+.++..........-..|..++...+ ||.+++++-.+     +..+..+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence            37999999999886   3456788999998766433333335567888888886 99999999999     777889999


Q ss_pred             EecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-------C
Q 042681          118 YELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-------S  189 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-------~  189 (339)
                      +++.. |.|...+.+...+.+.....+...++.|+.++|+.|++|||+|++||+++.+|++++.|||.++..       +
T Consensus        76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cg  155 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACG  155 (612)
T ss_pred             hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhccc
Confidence            99997 699999999999999999999999999999999999999999999999999999999999998643       3


Q ss_pred             CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHH
Q 042681          190 ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAE  269 (339)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  269 (339)
                      +-.|++|++..  ......|.|++|..++++++|..|+..      +....+.......+        ...+..+++++.
T Consensus       156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il~~~~~~p--------~~l~~~a~~~~~  219 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKRILKAELEMP--------RELSAEARSLFR  219 (612)
T ss_pred             chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHHHHhhhccCCc--------hhhhHHHHHHHH
Confidence            55788898887  677889999999999999999999764      22222222111111        246888999999


Q ss_pred             HhcccCCCCCCCH-----HHHhcCCCCCCCccC
Q 042681          270 RMLVFDPAKRITV-----EEALNHPYLSSLHEI  297 (339)
Q Consensus       270 ~~L~~dP~~Rps~-----~ell~hp~f~~~~~~  297 (339)
                      .++..+|..|...     .++++|+||+.+.|.
T Consensus       220 ~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  220 QLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            9999999999954     799999999999887

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=1.2e-21  Score=166.55  Aligned_cols=226  Identities=19%  Similarity=0.220  Sum_probs=142.4

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCC----------CCeeeeeeecCCC--
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTH----------ENIVKVKDIIPPM--  106 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h----------~~I~~~~~~~~~~--  106 (339)
                      .+.||.|+++.||.+.+..||+.+|+|++..... .....+.+.+|.-....+.+          -.++..++.....  
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            6789999999999999999999999999865532 23345666666654444322          1222222222100  


Q ss_pred             -------CcCCcC---eEEEEEecCcccHHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCe
Q 042681          107 -------DKEKFN---DVYIVYELMDTDLHQIIR---SKQA----LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL  169 (339)
Q Consensus       107 -------~~~~~~---~~~iv~e~~~g~L~~~l~---~~~~----~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NI  169 (339)
                             ......   ..+++|+-+.++|.+.+.   ....    ........+..|+++.+++||+.|++|+||+|+|+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nf  176 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENF  176 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGE
T ss_pred             CcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeE
Confidence                   000111   357899999888877763   2211    22223345669999999999999999999999999


Q ss_pred             eeccCCCeEEeecccccccCCC--------Cccccccccc--------cccCCCCccHHHHHHHHHHHhCCCCCCccccc
Q 042681          170 LLNANCDLKICDFGLARTTSET--------DFMTEYVVTR--------WDTLFPGKDYVQQLTMITELLGSPDDSDLGFL  233 (339)
Q Consensus       170 li~~~~~ikL~Dfg~~~~~~~~--------~~~~~~~~~~--------~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~  233 (339)
                      +++.+|.+.|+||+.....+..        .+.+|+....        ...++..|.|.+|+++|.+.|+..|+......
T Consensus       177 ll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~  256 (288)
T PF14531_consen  177 LLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPE  256 (288)
T ss_dssp             EE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGG
T ss_pred             EEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcc
Confidence            9999999999999887554432        3445544432        24567789999999999999999997644322


Q ss_pred             ccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCC
Q 042681          234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKR  279 (339)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  279 (339)
                      .....             .+... ..+++.++.||.+||++||.+|
T Consensus       257 ~~~~~-------------~f~~C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  257 ADPEW-------------DFSRC-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STSGG-------------GGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred             ccccc-------------cchhc-CCcCHHHHHHHHHHccCCcccC
Confidence            22111             11112 2578999999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=2.7e-21  Score=159.10  Aligned_cols=136  Identities=21%  Similarity=0.278  Sum_probs=105.0

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-----CCCCeeeeeeecCCCCcCCcCe-
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-----THENIVKVKDIIPPMDKEKFND-  113 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~I~~~~~~~~~~~~~~~~~-  113 (339)
                      .+.||+|++|.||.  +..++.. ++|++.....  ...+.+.+|+.++..+     .||||+++++++.+.  ...+. 
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~v   79 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGYV   79 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeEE
Confidence            56799999999995  7767665 6898865322  2346789999999999     579999999999532  11234 


Q ss_pred             EEEEEecCc---ccHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCcccCCCCCCCeeecc----CCCeEEeecccc
Q 042681          114 VYIVYELMD---TDLHQIIRSKQALTDDHCQYFLYQLLRGL-KYIHSANVLHRDLKPSNLLLNA----NCDLKICDFGLA  185 (339)
Q Consensus       114 ~~iv~e~~~---g~L~~~l~~~~~~~~~~~~~i~~qi~~aL-~~LH~~givH~dikp~NIli~~----~~~ikL~Dfg~~  185 (339)
                      +.+|+||.+   ++|.+++++ +.+++.  ..++.|++.++ +|||+++|+||||||+||+++.    +++++|+|++-+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            347899954   699999976 356666  35678888887 9999999999999999999974    337999995444

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=5.8e-21  Score=159.99  Aligned_cols=193  Identities=20%  Similarity=0.253  Sum_probs=155.3

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~  109 (339)
                      .++-.|.. .+.||.|+||.++.+.+.-+++.||+|.-. ..   ...-++..|.+.++.| ..++|+.++-+-     .
T Consensus        25 ~VG~hyrV-GkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rk---S~APQLrdEYr~YKlL~g~~GIP~vYYFG-----q   94 (449)
T KOG1165|consen   25 MVGPHYRV-GKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----Q   94 (449)
T ss_pred             Eeccccee-ccccccCcceeeecccccccCceEEEEecc-cc---CCcchHHHHHHHHHHHcCCCCCCceeeec-----c
Confidence            45566766 999999999999999999999999999642 22   2234567788888887 589999988766     6


Q ss_pred             CcCeEEEEEecCcccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC-----CCeEEeecc
Q 042681          110 KFNDVYIVYELMDTDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-----CDLKICDFG  183 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~-----~~ikL~Dfg  183 (339)
                      .+.+-.+|+|..+.+|.+++. ..++++..++..++.|++.-++++|++.+|.|||||+|+||...     ..|.++|||
T Consensus        95 eG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen   95 EGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             ccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence            777889999999998888884 45789999999999999999999999999999999999999643     348999999


Q ss_pred             cccccCCC------------------CccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccc
Q 042681          184 LARTTSET------------------DFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFL  233 (339)
Q Consensus       184 ~~~~~~~~------------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~  233 (339)
                      +|+..-++                  .|++.......+..-+.|.-++|-+.++.+-|..||..+...
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            99765443                  344444444445566677789999999999999998776433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=5.3e-20  Score=163.36  Aligned_cols=252  Identities=28%  Similarity=0.476  Sum_probs=190.2

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChH-hHHHHHHHHHHHhhCCCC-CeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI-DAKRILREIKLLCHMTHE-NIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      .+.||.|+|+.||.+.+.   ..+++|.+........ ....+.+|+..+..+.|+ +|+++.+.+     ......+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~   76 (384)
T COG0515           5 LRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSLYLV   76 (384)
T ss_pred             EEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEEEEE
Confidence            778999999999999987   7889999877644443 567889999999999988 799999998     445558999


Q ss_pred             EecCc-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC-CeEEeecccccccC---
Q 042681          118 YELMD-TDLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTS---  189 (339)
Q Consensus       118 ~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~-~ikL~Dfg~~~~~~---  189 (339)
                      ++++. +++.+.+....   .++...+..++.|++.++.++|+.|++|||+||+||+++..+ .++++|||.+....   
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99998 57776776654   799999999999999999999999999999999999999988 69999999876332   


Q ss_pred             --------------CCCccccccccc---cccCCCCccHHHHHHHHHHHhCCCCCCccccc-ccchHHHHHhhCCCC-CC
Q 042681          190 --------------ETDFMTEYVVTR---WDTLFPGKDYVQQLTMITELLGSPDDSDLGFL-RSDNARRYVKQLPHV-PK  250 (339)
Q Consensus       190 --------------~~~~~~~~~~~~---~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~-~~~~~~~~~~~~~~~-~~  250 (339)
                                    ...|.+|+....   .......|.|++|+.++.++.|..|+...... ............... ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence                          234667776665   46778899999999999999999884332210 011112222222211 01


Q ss_pred             CCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCC
Q 042681          251 QPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE  299 (339)
Q Consensus       251 ~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~  299 (339)
                      ....... ......+.+++.+++..+|..|.+..+...++|.........
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~  286 (384)
T COG0515         237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES  286 (384)
T ss_pred             cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccccc
Confidence            1100000 111257899999999999999999999999877766655443

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=6.8e-21  Score=160.53  Aligned_cols=145  Identities=14%  Similarity=0.090  Sum_probs=112.8

Q ss_pred             cCCCccccccccceEEEEEE-eCCCCceEEEEEecccccCh----------------------HhHHHHHHHHHHHhhCC
Q 042681           36 YVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNR----------------------IDAKRILREIKLLCHMT   92 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~-~~~~~~~~avK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~   92 (339)
                      |.+ .+.||+|++|.||+|. +..+|+.||+|++.......                      .....+.+|+.++.++.
T Consensus        30 ~~i-~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       30 SAI-GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             HHh-CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            444 8999999999999998 67789999999987542110                      01123568999999996


Q ss_pred             C--CCeeeeeeecCCCCcCCcCeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCC
Q 042681           93 H--ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSN  168 (339)
Q Consensus        93 h--~~I~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g-ivH~dikp~N  168 (339)
                      +  ..++++++..         ..++||||++| +|..............+..++.|++.+|++||+.| ++||||||+|
T Consensus       109 ~~~i~~p~~~~~~---------~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAWR---------RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEec---------CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence            5  3344444421         24899999996 55555444556777778899999999999999999 9999999999


Q ss_pred             eeeccCCCeEEeecccccccCCC
Q 042681          169 LLLNANCDLKICDFGLARTTSET  191 (339)
Q Consensus       169 Ili~~~~~ikL~Dfg~~~~~~~~  191 (339)
                      |+++ ++.++|+|||.+...+.+
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccCCc
Confidence            9999 889999999998876654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=4.5e-20  Score=158.18  Aligned_cols=183  Identities=21%  Similarity=0.272  Sum_probs=137.0

Q ss_pred             CCCCeeeeeeecCCCC----------------------cCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHH
Q 042681           92 THENIVKVKDIIPPMD----------------------KEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLR  149 (339)
Q Consensus        92 ~h~~I~~~~~~~~~~~----------------------~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~  149 (339)
                      +||||+++.+.|.+.-                      -..+..+|+||..+..+|.+++.. ...+.....-++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-~~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-RHRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-CCCchHHHHHHHHHHHH
Confidence            5999999998884311                      123356899999999999999987 45677788889999999


Q ss_pred             HHHHHHhCCcccCCCCCCCeeec--cCC--CeEEeecccccc-----------------cCCCCccccccccccc-----
Q 042681          150 GLKYIHSANVLHRDLKPSNLLLN--ANC--DLKICDFGLART-----------------TSETDFMTEYVVTRWD-----  203 (339)
Q Consensus       150 aL~~LH~~givH~dikp~NIli~--~~~--~ikL~Dfg~~~~-----------------~~~~~~~~~~~~~~~~-----  203 (339)
                      |+.|||++|+.|||+|.+||++.  +++  .+.+.|||+|--                 .++...++||+.+..+     
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            99999999999999999999994  444  478899998732                 1223356676665432     


Q ss_pred             -cCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 042681          204 -TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITV  282 (339)
Q Consensus       204 -~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  282 (339)
                       ...+.|.|..|...|+.+....||..-+.+.-+...        .....++.....+++.+++||..+|+.||++|+++
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~--------Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT--------YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchheechhh--------hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence             345688999999999999999998764333222221        11112222234689999999999999999999985


Q ss_pred             H
Q 042681          283 E  283 (339)
Q Consensus       283 ~  283 (339)
                      .
T Consensus       505 ~  505 (598)
T KOG4158|consen  505 N  505 (598)
T ss_pred             c
Confidence            3

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.83  E-value=3.6e-21  Score=182.87  Aligned_cols=233  Identities=19%  Similarity=0.194  Sum_probs=169.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccccc--ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      ++-||++.|=+|.++++.+ | .+++|++-+...  .-....+.+.+++ ....++||.+.+..+.     .....-|+|
T Consensus        28 ~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kAAylv   99 (1431)
T KOG1240|consen   28 VENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKAAYLV   99 (1431)
T ss_pred             ecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHHHHHH
Confidence            7889999999999998875 4 499999865422  2222344445555 5566899999998887     667778999


Q ss_pred             EecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-------
Q 042681          118 YELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-------  190 (339)
Q Consensus       118 ~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-------  190 (339)
                      -+|...+|.+.+..+..+..-+.+=|+.||+.||..+|..||||||||.+||||++=+=+.|+||..-+..--       
T Consensus       100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            9999999999999988888888888999999999999999999999999999999887899999987543211       


Q ss_pred             -----------CCccccccccc-----------cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCC
Q 042681          191 -----------TDFMTEYVVTR-----------WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHV  248 (339)
Q Consensus       191 -----------~~~~~~~~~~~-----------~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~  248 (339)
                                 .-|.+||....           +-...+-|++++||++.++++-..|...+......     ... ...
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aY-----r~~-~~~  253 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAY-----RSG-NAD  253 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhH-----hcc-Ccc
Confidence                       11444543322           11456689999999999999864443332211110     000 011


Q ss_pred             CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          249 PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       249 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ....+.+..+  +..++++|..|++.||++|.+|++.|+.
T Consensus       254 ~~e~~Le~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLEKIE--DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CHHHHHHhCc--CccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1111111111  3469999999999999999999999975

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=9.9e-20  Score=147.17  Aligned_cols=172  Identities=13%  Similarity=0.064  Sum_probs=122.4

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccccc--ChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      +..|++|+||+|+.+..  .+.+++.+.+....-  .......+.+|+++|++|. |+++++++++.         ..++
T Consensus         7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~l   75 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRHL   75 (218)
T ss_pred             ceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEEE
Confidence            77899999999997765  577888777654322  1222346789999999995 58899998852         3599


Q ss_pred             EEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCCeeeccCCCeEEeecccccccCCCCc-
Q 042681          117 VYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDL-KPSNLLLNANCDLKICDFGLARTTSETDF-  193 (339)
Q Consensus       117 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~di-kp~NIli~~~~~ikL~Dfg~~~~~~~~~~-  193 (339)
                      +|||+.| +|.+....       ....++.|++.+|.++|++|++|||| ||+||+++.++.++|+|||++........ 
T Consensus        76 vmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         76 DRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             EEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            9999986 55433211       12357889999999999999999999 79999999999999999999975443221 


Q ss_pred             ----c--------------ccccccc-------cccCCCCccHHHHHHHHHHHhCCCCCCc
Q 042681          194 ----M--------------TEYVVTR-------WDTLFPGKDYVQQLTMITELLGSPDDSD  229 (339)
Q Consensus       194 ----~--------------~~~~~~~-------~~~~~~~d~~~~g~~~~~~l~g~~~~~~  229 (339)
                          .              +++..+.       .......+.+..|.-+|.++++..+.++
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                0              1111110       0112234456778888888888877654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.81  E-value=5.1e-20  Score=174.78  Aligned_cols=213  Identities=25%  Similarity=0.392  Sum_probs=158.0

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ..+-. +++|..|++|.||.++++.+.+.+|+| +.+.       ..+++.           |..+.+           .
T Consensus        83 ~df~~-IklisngAygavylvrh~~trqrfa~k-iNkq-------~lilRn-----------ilt~a~-----------n  131 (1205)
T KOG0606|consen   83 SDFNT-IKLISNGAYGAVYLVRHKETRQRFAMK-INKQ-------NLILRN-----------ILTFAG-----------N  131 (1205)
T ss_pred             cccce-eEeeccCCCCceeeeeccccccchhhc-cccc-------chhhhc-----------cccccC-----------C
Confidence            34444 999999999999999999999999995 4332       111111           222221           2


Q ss_pred             EEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc------
Q 042681          114 VYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART------  187 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~------  187 (339)
                      .++|     |+=...++.-++++...        +.|++|||+.||+|||+||+|.+|..-|++|++|||+++.      
T Consensus       132 pfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  132 PFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence            2333     44455556656666544        7889999999999999999999999999999999998742      


Q ss_pred             --------------------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC
Q 042681          188 --------------------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH  247 (339)
Q Consensus       188 --------------------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  247 (339)
                                          .+.+.|.+|+++.+..+..+.|+|++|+++|+.+.|..++..-  .+.......+.....
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd--tpeelfg~visd~i~  276 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQVISDDIE  276 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC--CHHHHHhhhhhhhcc
Confidence                                3556788999999999999999999999999999999886542  111112222222221


Q ss_pred             CCCCCccccCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCccC
Q 042681          248 VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRI---TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       248 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~~~~~~  297 (339)
                      .+     +.-..+++++++++.++|+.+|..|.   .+.++.+|+||+.+.|.
T Consensus       277 wp-----E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  277 WP-----EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             cc-----ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            11     11245789999999999999999998   57788999999999886

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=4.7e-19  Score=147.79  Aligned_cols=136  Identities=23%  Similarity=0.262  Sum_probs=109.5

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccCh------HhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR------IDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++.||+|++|.||++.+  .|..+++|+........      ....++.+|+.++..+.|++++....++     .....
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~-----~~~~~   73 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYF-----VDPEN   73 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEE-----EeCCC
Confidence            36799999999999987  67789999765432211      1234678899999999998887666655     23345


Q ss_pred             EEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          114 VYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       114 ~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .+++|||++| +|.+.+.....    ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            7899999984 88888765332    7888999999999999999999999999999999 78999999999865

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=2e-19  Score=173.39  Aligned_cols=183  Identities=21%  Similarity=0.259  Sum_probs=138.6

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC---CCCeeeeeeecCCCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT---HENIVKVKDIIPPMD  107 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~  107 (339)
                      .+.+.-+-|-+.||.|+||+||+|.+.. |+.+|+|+=+.+..-.     ++--..++.+|+   -+.|..+...+    
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~----  763 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAH----  763 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHH----
Confidence            3333333338899999999999999887 9999999866542221     222223333333   34555565555    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-------CCCeEE
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-------NCDLKI  179 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-------~~~ikL  179 (339)
                       .-.+.-++|+||.+ |+|.+++...+.+++..+..+..|++..|+.||.+|||||||||+|++|..       +--++|
T Consensus       764 -~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  764 -VFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             -ccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence             33455699999999 999999999999999999999999999999999999999999999999942       335999


Q ss_pred             eeccccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCC
Q 042681          180 CDFGLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGS  224 (339)
Q Consensus       180 ~Dfg~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~  224 (339)
                      +|||.+.-+             .+..+-+.+...+.+.....|.|.+..+++.|+.|.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            999998422             122344556666667778899999999999999885

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.9e-18  Score=142.49  Aligned_cols=138  Identities=20%  Similarity=0.190  Sum_probs=105.2

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh--------------------HhHHHHHHHHHHHhhCCCCC
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR--------------------IDAKRILREIKLLCHMTHEN   95 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~h~~   95 (339)
                      |.. .+.||+|++|.||++... +|+.+|+|++.......                    .......+|+.++..+.|++
T Consensus        17 ~~~-~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          17 ESL-GNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhc-CCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            555 889999999999999875 79999999876432110                    01123567888888887764


Q ss_pred             --eeeeeeecCCCCcCCcCeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec
Q 042681           96 --IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN  172 (339)
Q Consensus        96 --I~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~  172 (339)
                        ++..++.         ...+++|||++| +|.....      ......++.+++.++.++|+.|++|+||+|+||+++
T Consensus        95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~  159 (198)
T cd05144          95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD  159 (198)
T ss_pred             CCCCceeec---------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence              4444332         234899999985 5544322      134567889999999999999999999999999999


Q ss_pred             cCCCeEEeecccccccCC
Q 042681          173 ANCDLKICDFGLARTTSE  190 (339)
Q Consensus       173 ~~~~ikL~Dfg~~~~~~~  190 (339)
                      .++.++|+|||.+.....
T Consensus       160 ~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         160 DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcEEEEECCccccCCC
Confidence            999999999999976654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=2.1e-18  Score=142.51  Aligned_cols=132  Identities=23%  Similarity=0.300  Sum_probs=101.3

Q ss_pred             ccccccceEEEEEEeCCCCceEEEEEecccccC------hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEE
Q 042681           42 PIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN------RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        42 ~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      .||+|++|.||++..  +|..+++|+.......      .....++.+|+.++..+.|+++.....+.     ......+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~-----~~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYD-----VDPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEE-----EECCCCE
Confidence            489999999999984  5788999986533211      11235677899999999877544333332     2233458


Q ss_pred             EEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          116 IVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       116 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ++|||++ ++|.+.+.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+...
T Consensus        74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999997 588877654321       7899999999999999999999999999999 889999999998664

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=4.2e-18  Score=139.26  Aligned_cols=138  Identities=22%  Similarity=0.254  Sum_probs=99.2

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHH----------------------HHHHHHHHhhCCCC--C
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR----------------------ILREIKLLCHMTHE--N   95 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~h~--~   95 (339)
                      .+.||+|+||.||+|.+. +|+.||+|++............                      ...|...+..+.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999976 7999999998754222111111                      13456666665433  3


Q ss_pred             eeeeeeecCCCCcCCcCeEEEEEecCcc-cHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeec
Q 042681           96 IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLH-QIIRSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLN  172 (339)
Q Consensus        96 I~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~-~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~  172 (339)
                      +++.+++.         ..+++|||++| .+. ..+... ... ..+..++.+++.++.++|+ .|++|+||||+||+++
T Consensus        81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD  149 (187)
T ss_pred             CCceEecC---------CCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence            44444432         24899999986 221 111111 111 6788899999999999999 9999999999999999


Q ss_pred             cCCCeEEeecccccccCC
Q 042681          173 ANCDLKICDFGLARTTSE  190 (339)
Q Consensus       173 ~~~~ikL~Dfg~~~~~~~  190 (339)
                       ++.++|+|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             89999999999977655

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1.4e-17  Score=157.44  Aligned_cols=137  Identities=21%  Similarity=0.317  Sum_probs=106.4

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-cc-----ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FD-----NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~-----~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      .|.. .+.||+|+||.||++....  ..+++|+.... ..     .....+++.+|+.++..++|++++....+.     
T Consensus       334 ~~~~-~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~-----  405 (535)
T PRK09605        334 RKIP-DHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYD-----  405 (535)
T ss_pred             ccCc-cceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEE-----
Confidence            3344 7899999999999998654  34444443221 11     112345688999999999999998876665     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ......++||||++ ++|.+++.        ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||+++.
T Consensus       406 ~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        406 VDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            33345689999998 58888775        356789999999999999999999999999999 678999999999976


Q ss_pred             c
Q 042681          188 T  188 (339)
Q Consensus       188 ~  188 (339)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            4

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.73  E-value=6.4e-18  Score=138.30  Aligned_cols=232  Identities=13%  Similarity=0.172  Sum_probs=175.7

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      +.+|.....|..|++++.  |..+++|++....-+....+.|..|.-.|+.+.||||+.+++.+     ..+..+.++..
T Consensus       195 ~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv~isq  267 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLVIISQ  267 (448)
T ss_pred             hhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCceEeee
Confidence            567888999999999986  45678887765544444456788899999999999999999999     77788999999


Q ss_pred             cCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeeeccCCCeEEe--ecccc----ccc
Q 042681          120 LMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKIC--DFGLA----RTT  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dikp~NIli~~~~~ikL~--Dfg~~----~~~  188 (339)
                      |++ |+|+..+....  -++..++.+.+.+++.|+.|||+..  |----|....++||.+.+.+|+  |--++    .+.
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~gr~  347 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRA  347 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeeccccc
Confidence            999 89999986543  4778899999999999999999874  3333588899999988776654  42222    333


Q ss_pred             CCCCccccccccccc---cCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          189 SETDFMTEYVVTRWD---TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       189 ~~~~~~~~~~~~~~~---~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                      ..+.+++|+...+.+   ...+.|.|++.+.++++.+...||.+++.+.-.- +..++.+  ...     ..|++|....
T Consensus       348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-kialegl--rv~-----ippgis~hm~  419 (448)
T KOG0195|consen  348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-KIALEGL--RVH-----IPPGISRHMN  419 (448)
T ss_pred             cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-hhhhccc--ccc-----CCCCccHHHH
Confidence            445667777665543   3446788999999999999999998876543221 1111111  111     1267899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHh
Q 042681          266 DLAERMLVFDPAKRITVEEAL  286 (339)
Q Consensus       266 ~li~~~L~~dP~~Rps~~ell  286 (339)
                      .|++-|+..||.+||.+..++
T Consensus       420 klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  420 KLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999988765

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=8.9e-17  Score=135.83  Aligned_cols=142  Identities=16%  Similarity=0.251  Sum_probs=106.2

Q ss_pred             ccccc-cccceEEEEEEeCCCCceEEEEEeccccc-----------ChHhHHHHHHHHHHHhhCCCCCe--eeeeeecCC
Q 042681           40 LQPIG-RGAYGIVCSAVNSETKEEVAIKKITNAFD-----------NRIDAKRILREIKLLCHMTHENI--VKVKDIIPP  105 (339)
Q Consensus        40 ~~~lg-~G~~~~v~~~~~~~~~~~~avK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~I--~~~~~~~~~  105 (339)
                      ...|| .||.|+||.+...  +..+++|.+.....           +.....++.+|+.++..+.|++|  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45677 8999999999764  77899998853210           11234678899999999988775  666666421


Q ss_pred             CCcCCcCeEEEEEecCcc--cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          106 MDKEKFNDVYIVYELMDT--DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~g--~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                      .. ......++|||+++|  +|.+++.. .++++..    +.+++.+|.+||+.||+|+||||.||+++.++.++|+|||
T Consensus       114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg  187 (239)
T PRK01723        114 RH-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD  187 (239)
T ss_pred             ec-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence            11 111223699999985  78777754 4556543    5789999999999999999999999999999999999999


Q ss_pred             cccccC
Q 042681          184 LARTTS  189 (339)
Q Consensus       184 ~~~~~~  189 (339)
                      .+....
T Consensus       188 ~~~~~~  193 (239)
T PRK01723        188 RGELRT  193 (239)
T ss_pred             CcccCC
Confidence            987643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=1.1e-17  Score=140.34  Aligned_cols=243  Identities=18%  Similarity=0.178  Sum_probs=171.0

Q ss_pred             EEEEEEeCCCCceEEEEEeccccc-C-hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCc-ccHH
Q 042681           50 IVCSAVNSETKEEVAIKKITNAFD-N-RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLH  126 (339)
Q Consensus        50 ~v~~~~~~~~~~~~avK~~~~~~~-~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~  126 (339)
                      .||++.+...|.+++.-.++-... + .........-...+-++-|.||++++.+|.+...++.....++.||++ |++.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            577777888888777665532211 1 111122222333455556999999999998776556677899999998 8998


Q ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeeeccCCCeEEeecccc---------------
Q 042681          127 QIIRS----KQALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLA---------------  185 (339)
Q Consensus       127 ~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dikp~NIli~~~~~ikL~Dfg~~---------------  185 (339)
                      +++++    .+.+......+|+.||+.||.|||+..  |+|+++..+.|++..+|-+|++--...               
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~  240 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS  240 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence            88864    357899999999999999999999885  999999999999999999998653322               


Q ss_pred             cccCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          186 RTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                      ...+.+.+.+++.+.......+.|+|.+|.+.+++..+......-. . .............          ..-..--+
T Consensus       241 ~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnse-S-~~~~ee~ia~~i~----------~len~lqr  308 (458)
T KOG1266|consen  241 VNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSE-S-KVEVEENIANVII----------GLENGLQR  308 (458)
T ss_pred             ccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCc-c-eeehhhhhhhhee----------eccCcccc
Confidence            1123456778888888888999999999999999998865421100 0 0000000000000          00112246


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCC
Q 042681          266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCP  304 (339)
Q Consensus       266 ~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~  304 (339)
                      +++.+|++..|+.||++.+++.||.+-+++-.+..-...
T Consensus       309 ~~i~kcl~~eP~~rp~ar~llfHpllfeVhslkll~ahc  347 (458)
T KOG1266|consen  309 GSITKCLEGEPNGRPDARLLLFHPLLFEVHSLKLLMAHC  347 (458)
T ss_pred             CcCcccccCCCCCCcchhhhhcCceeeecchHHHHhhHh
Confidence            789999999999999999999999998887655443433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.69  E-value=2.2e-16  Score=142.81  Aligned_cols=195  Identities=21%  Similarity=0.243  Sum_probs=147.1

Q ss_pred             HhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccCCC
Q 042681           88 LCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANV-LHRDL  164 (339)
Q Consensus        88 l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~gi-vH~di  164 (339)
                      |+.+.|.|+.+++|..     -++...++|.+||+ |+|.+.+.. ...++.......+.+|+.||+|||...| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~-----~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGAS-----VDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeE-----ecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence            4567899999999999     55588999999998 999999987 4678899999999999999999997765 99999


Q ss_pred             CCCCeeeccCCCeEEeecccccccCC-------------CCcccccccccc-------ccCCCCccHHHHHHHHHHHhCC
Q 042681          165 KPSNLLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRW-------DTLFPGKDYVQQLTMITELLGS  224 (339)
Q Consensus       165 kp~NIli~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~-------~~~~~~d~~~~g~~~~~~l~g~  224 (339)
                      +..|.+++....+||+|||+......             .-+.+|+.....       .....+|+|++|++++++++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999876631             114455554432       1355699999999999999998


Q ss_pred             CCCCcccccccc-hHHHHHhh-CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          225 PDDSDLGFLRSD-NARRYVKQ-LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       225 ~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .++......... .....+.. ......+..... ....+++..++.+||..+|..||+++++...
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~  220 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQIRSK  220 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCCCcCcchhhh-hhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence            887654322221 11111111 111122222111 1456689999999999999999999998754

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=3.4e-16  Score=123.12  Aligned_cols=130  Identities=21%  Similarity=0.231  Sum_probs=107.7

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCC--CCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      ++.||+|.++.||++....  ..+++|.......    ...+.+|...+..+++  .++++++.+.     ...+..+++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v   71 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLL   71 (155)
T ss_pred             ceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEE
Confidence            6789999999999998754  7899998865422    4567889999999976  5899998887     444678999


Q ss_pred             EecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          118 YELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       118 ~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      +||++| .+..+       +......++.+++.+|..+|..   +++|+|++|+||+++..+.++++|||.+..
T Consensus        72 ~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          72 MEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999985 44322       5566778899999999999985   799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=9e-18  Score=158.47  Aligned_cols=247  Identities=23%  Similarity=0.270  Sum_probs=191.6

Q ss_pred             cCCCccccccccceEEEEEEeCCC-CceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCe
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSET-KEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      |.. .+.||+|+++.|-.+....+ ...+|+|.+...........+...|..+-..+. |+|++.+++..     .....
T Consensus        22 ~~~-~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~~   95 (601)
T KOG0590|consen   22 YKL-SRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPRS   95 (601)
T ss_pred             ccc-cccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCcc
Confidence            444 88899999999999887544 345677777655434444556667888888886 99999999988     77788


Q ss_pred             EEEEEecCc-ccHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCeeeccCC-CeEEeeccccccc
Q 042681          114 VYIVYELMD-TDLHQII-RSKQ-ALTDDHCQYFLYQLLRGLKYIH-SANVLHRDLKPSNLLLNANC-DLKICDFGLARTT  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l-~~~~-~~~~~~~~~i~~qi~~aL~~LH-~~givH~dikp~NIli~~~~-~ikL~Dfg~~~~~  188 (339)
                      .+++++|.. +++...+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++.++ .+++.|||+|...
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            999999986 5888887 5544 7888899999999999999999 99999999999999999999 9999999998643


Q ss_pred             --------------C-CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          189 --------------S-ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       189 --------------~-~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                                    + ...|.++|.... .......|.|+.|+++..+++|..++......... ...+....    ...
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~----~~~  250 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK----GRF  250 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc----ccc
Confidence                          3 345666766665 35677799999999999999999886543322211 11111111    111


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                      ....+...+....+++.+++..+|+.|.+.+++..+||+..
T Consensus       251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            12234568889999999999999999999999999999999

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.56  E-value=3.7e-15  Score=132.87  Aligned_cols=165  Identities=21%  Similarity=0.283  Sum_probs=124.4

Q ss_pred             eEEEEEecCc-ccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc-
Q 042681          113 DVYIVYELMD-TDLHQIIRSK---QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-  187 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~-  187 (339)
                      +++|.|+.|. .+|.+++..+   ...+....+.++.|++.|+.|   +|.+|+|+||.||++..+..+||.|||+... 
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            5899999998 7999999754   346777889999999999999   9999999999999999999999999998743 


Q ss_pred             ----------------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          188 ----------------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       188 ----------------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                                      .++..|++|+......+....|+|++|+++++++.-.....    .    .......+.....+
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~----e----r~~t~~d~r~g~ip  478 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF----E----RIATLTDIRDGIIP  478 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH----H----HHHhhhhhhcCCCC
Confidence                            33446889999888899999999999999999986322200    0    00111111111111


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                         +.+..--++-.+|+.+||...|.+||++.+.--|+|.
T Consensus       479 ---~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  479 ---PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ---hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence               0001112446799999999999999988887778775

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.56  E-value=8.3e-14  Score=112.69  Aligned_cols=142  Identities=20%  Similarity=0.223  Sum_probs=104.0

Q ss_pred             ccccccccceEEEEEEeCC------CCceEEEEEeccccc---C-----------------hHhHHH----HHHHHHHHh
Q 042681           40 LQPIGRGAYGIVCSAVNSE------TKEEVAIKKITNAFD---N-----------------RIDAKR----ILREIKLLC   89 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~------~~~~~avK~~~~~~~---~-----------------~~~~~~----~~~e~~~l~   89 (339)
                      ...||.|.=+.||.|....      .+..+|+|+.+....   .                 ....+.    ..+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4678999999999998654      357999998853210   0                 011222    338999999


Q ss_pred             hCC--CCCeeeeeeecCCCCcCCcCeEEEEEecCccc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCC
Q 042681           90 HMT--HENIVKVKDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQALTDDHCQYFLYQLLRGLKYI-HSANVLHRDLK  165 (339)
Q Consensus        90 ~l~--h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~g~-L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~givH~dik  165 (339)
                      ++.  .-++++.+++.         ..+|||||++++ +..-..+...+++..+..+..+++.+|..| |+.|+|||||+
T Consensus        82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            985  45677777643         249999999853 322222233566667788899999999998 89999999999


Q ss_pred             CCCeeeccCCCeEEeecccccccCCC
Q 042681          166 PSNLLLNANCDLKICDFGLARTTSET  191 (339)
Q Consensus       166 p~NIli~~~~~ikL~Dfg~~~~~~~~  191 (339)
                      +.||+++ ++.+.|+|||.+.....+
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCCCC
Confidence            9999997 468999999999776643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=6.7e-14  Score=128.33  Aligned_cols=143  Identities=21%  Similarity=0.283  Sum_probs=96.2

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHh--------------------------------H------HHH
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID--------------------------------A------KRI   81 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~--------------------------------~------~~~   81 (339)
                      .+.||+|++|+||+|+.+ +|+.||||+.+........                                .      -.+
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            467999999999999865 6899999998644211100                                0      013


Q ss_pred             HHHHHHHhhC----CCCCeeeeeeecCCCCcCCcCeEEEEEecCcc-cHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHH
Q 042681           82 LREIKLLCHM----THENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK-QALTDDHCQYFLYQLLR-GLKYI  154 (339)
Q Consensus        82 ~~e~~~l~~l----~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~-aL~~L  154 (339)
                      .+|...+.++    ++.+-+.+-.++.    +.....++||||++| +|.+..... ...+   ...++.+++. .+..+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~----~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYW----DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQV  273 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEeh----hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence            4455555554    2333334434432    223346999999985 666655321 1222   2345555555 46789


Q ss_pred             HhCCcccCCCCCCCeeeccCCCeEEeecccccccCC
Q 042681          155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  190 (339)
Q Consensus       155 H~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~  190 (339)
                      |..|++|+|++|.||+++.+++++|+|||++...+.
T Consensus       274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            999999999999999999999999999999987753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=1.7e-14  Score=130.83  Aligned_cols=243  Identities=24%  Similarity=0.260  Sum_probs=184.9

Q ss_pred             cccccc--ccceEEEEEEe--CCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCeE
Q 042681           40 LQPIGR--GAYGIVCSAVN--SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        40 ~~~lg~--G~~~~v~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      .+-+|.  |.+|.+|.+..  ..++..+|+|+-+..........+=++|+...+.++ |++.++.+..+     +..+..
T Consensus       119 ~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e~~~~l  193 (524)
T KOG0601|consen  119 SSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----EGSGIL  193 (524)
T ss_pred             ccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----ccCCcc
Confidence            666898  99999999998  889999999986655554444455567887777774 99999977776     788899


Q ss_pred             EEEEecCcccHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCcccCCCCCCCeeeccC-CCeEEeeccccccc
Q 042681          115 YIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLR----GLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTT  188 (339)
Q Consensus       115 ~iv~e~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~----aL~~LH~~givH~dikp~NIli~~~-~~ikL~Dfg~~~~~  188 (339)
                      ++-+|+++.+|..+...... +++..++..+.+..+    ||.++|+.+++|.|+||.||+...+ ...+++|||.....
T Consensus       194 fiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i  273 (524)
T KOG0601|consen  194 FIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI  273 (524)
T ss_pred             eeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEc
Confidence            99999999999988876544 899999999999999    9999999999999999999999999 78999999998776


Q ss_pred             CCCC----------------ccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          189 SETD----------------FMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       189 ~~~~----------------~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      +...                |+.++... .-+.+..|++++|.+..+..++......-....+.....      ..   .
T Consensus       274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~------~~---i  343 (524)
T KOG0601|consen  274 SDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ------GY---I  343 (524)
T ss_pred             cCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc------cc---C
Confidence            6554                22222221 236777999999999999888865432111111111000      00   0


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      -.+.....+.+++..+.+|++.+|..|+++..++.|+++..-...
T Consensus       344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~  388 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFV  388 (524)
T ss_pred             chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhh
Confidence            111223456777889999999999999999999999998755443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.52  E-value=2.2e-14  Score=133.13  Aligned_cols=140  Identities=17%  Similarity=0.304  Sum_probs=94.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccCh--------------------------------HhHHH------H
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR--------------------------------IDAKR------I   81 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~--------------------------------~~~~~------~   81 (339)
                      .+.||+|++|+||+|+.+.+|+.||||+.++.....                                .-.+.      +
T Consensus       124 ~~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~  203 (537)
T PRK04750        124 IKPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDL  203 (537)
T ss_pred             hhhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCH
Confidence            478999999999999999889999999997542110                                00111      3


Q ss_pred             HHHHHHHhhCC----CCCeeeeeeecCCCCcCCcCeEEEEEecCcc-cHHHH--HHhcC----CCCHHHHHHHHHHHHHH
Q 042681           82 LREIKLLCHMT----HENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQI--IRSKQ----ALTDDHCQYFLYQLLRG  150 (339)
Q Consensus        82 ~~e~~~l~~l~----h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~--l~~~~----~~~~~~~~~i~~qi~~a  150 (339)
                      .+|...+.++.    +...+.+-.++.    +-....++||||+.| .+.+.  +...+    .+.+..+..++.|++  
T Consensus       204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~----d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        204 MREAANASQLRRNFEDSDMLYVPEVYW----DYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             HHHHHHHHHHHHHccCCCCeecceeec----ccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence            34444444442    444444444442    223456899999985 66653  23322    244444555555554  


Q ss_pred             HHHHHhCCcccCCCCCCCeeeccCC----CeEEeecccccccCC
Q 042681          151 LKYIHSANVLHRDLKPSNLLLNANC----DLKICDFGLARTTSE  190 (339)
Q Consensus       151 L~~LH~~givH~dikp~NIli~~~~----~ikL~Dfg~~~~~~~  190 (339)
                           ..|++|+|++|.||+++.+|    +++++|||++.....
T Consensus       278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 59999999999999999888    999999999977654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.47  E-value=1.6e-12  Score=119.54  Aligned_cols=161  Identities=16%  Similarity=0.227  Sum_probs=120.0

Q ss_pred             EEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCcccHHHHHHhc
Q 042681           53 SAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK  132 (339)
Q Consensus        53 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~  132 (339)
                      .+..+.++.++.+.+.+....  .......+-++.|+.++||||+++++.+     +..+..|||+|.+.. |..++++ 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~P-l~~~lk~-  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVTERVRP-LETVLKE-  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEeecccc-HHHHHHH-
Confidence            355566788898888865433  4456677888999999999999999998     777899999999852 1222332 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCeeeccCCCeEEeecccccccCCCCccccccccccc-----cC-
Q 042681          133 QALTDDHCQYFLYQLLRGLKYIH-SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWD-----TL-  205 (339)
Q Consensus       133 ~~~~~~~~~~i~~qi~~aL~~LH-~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~~~~~~~~~~~~~-----~~-  205 (339)
                        +....+...+.||+.||.||| +++++|++|....|+++..|.+||++|..+.........+.....-+.     .. 
T Consensus       101 --l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  101 --LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID  178 (690)
T ss_pred             --hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence              226677778999999999997 788999999999999999999999999988765543311111111111     11 


Q ss_pred             ---CCCccHHHHHHHHHHHhCC
Q 042681          206 ---FPGKDYVQQLTMITELLGS  224 (339)
Q Consensus       206 ---~~~d~~~~g~~~~~~l~g~  224 (339)
                         ...|.|.+|+++++.+-|.
T Consensus       179 ~s~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  179 PSEWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccccchhhhhHHHHHHHHhCcc
Confidence               2348899999999999883

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=3e-13  Score=108.67  Aligned_cols=127  Identities=18%  Similarity=0.155  Sum_probs=93.3

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCC-eeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN-IVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ++.|+.|.++.||++...  ++.|++|.......   ......+|+.+++.+.+.+ +++++...     ..  ..++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~--~~~lv~   70 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD-----PE--TGVLIT   70 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe-----CC--CCeEEE
Confidence            678999999999999864  77899998754421   1223467888888875433 45566544     22  237999


Q ss_pred             ecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          119 ELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV-----LHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       119 e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~gi-----vH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      |+++| ++.+.        .......+.+++.+|..||+.++     +|+|++|.||+++ ++.++++||+.+..
T Consensus        71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99986 44322        11123457899999999999985     9999999999999 67899999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.46  E-value=2.5e-12  Score=114.79  Aligned_cols=224  Identities=12%  Similarity=0.168  Sum_probs=161.9

Q ss_pred             cceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCc--cc
Q 042681           47 AYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD--TD  124 (339)
Q Consensus        47 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~--g~  124 (339)
                      -..+.|++....+|..|++|+++......  ...-..-++.++++.|+|++++.++|.... -....+++|++|++  ++
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCch
Confidence            34589999999999999999994332211  112235677899999999999999996332 34456999999997  58


Q ss_pred             HHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          125 LHQIIR---------------SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       125 L~~~l~---------------~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      |.++.-               ++...+|..+|.++.||..||.++|+.|+.-+-|.|.+|+++.+.+++|+..|......
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            888762               12458899999999999999999999999999999999999999999999888765554


Q ss_pred             CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHH
Q 042681          190 ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAE  269 (339)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  269 (339)
                      ...      ....+.....|.-.+|.+++.+.+|.-.-+.-     +...+.          ......+.+|.+++++|.
T Consensus       445 ~d~------~~~le~~Qq~D~~~lG~ll~aLAt~~~ns~~~-----d~~~~s----------~~~~I~~~yS~D~rn~v~  503 (655)
T KOG3741|consen  445 EDP------TEPLESQQQNDLRDLGLLLLALATGTENSNRT-----DSTQSS----------HLTRITTTYSTDLRNVVE  503 (655)
T ss_pred             CCC------CcchhHHhhhhHHHHHHHHHHHhhcccccccc-----cchHHH----------HHHHhhhhhhHHHHHHHH
Confidence            332      11112223456678999999999986432211     111111          001112468999999999


Q ss_pred             HhcccCCCCCCCHHHHhcC---CCCCCCc
Q 042681          270 RMLVFDPAKRITVEEALNH---PYLSSLH  295 (339)
Q Consensus       270 ~~L~~dP~~Rps~~ell~h---p~f~~~~  295 (339)
                      -+...++++ -++.+++.|   -||....
T Consensus       504 yl~s~~~~~-ksI~~llp~~~~~ff~vme  531 (655)
T KOG3741|consen  504 YLESLNFRE-KSIQDLLPMIGSRFFTVME  531 (655)
T ss_pred             HHHhcCccc-ccHHHHHHHHHHHHHHHHH
Confidence            999999987 788888876   4554443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.41  E-value=3.4e-13  Score=122.50  Aligned_cols=246  Identities=20%  Similarity=0.176  Sum_probs=183.6

Q ss_pred             cccccCccCCCccccccccceEEEEEEeC-CCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCC
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNS-ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPM  106 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~  106 (339)
                      ......++-. +..||.|.|+.|+.+.-. .++..|++|.+.+......+...-+.|+.+...+ .|.+++.++..|   
T Consensus       260 ~s~~~~df~~-v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W---  335 (524)
T KOG0601|consen  260 TSCKLTDFGL-VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW---  335 (524)
T ss_pred             ceeecCCcce-eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc---
Confidence            5555667777 899999999999998755 6788999998877655554444556777777777 488888888877   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC-CCeEEeeccc
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGL  184 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~-~~ikL~Dfg~  184 (339)
                        ......++=.|||+ +++.........+++...+++..|++.|+.++|++.++|+|++|+||++.++ +..+++|||.
T Consensus       336 --~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  336 --SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             --cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccc
Confidence              55556679999997 5555555555678999999999999999999999999999999999999986 7789999998


Q ss_pred             ccccCC--------CCcc--ccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          185 ARTTSE--------TDFM--TEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       185 ~~~~~~--------~~~~--~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      ...+.-        ..+.  ++............++++++..+.+.+++.+.-+........             .....
T Consensus       414 ~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i-------------~~~~~  480 (524)
T KOG0601|consen  414 WTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI-------------RSGDT  480 (524)
T ss_pred             ccccceecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceee-------------ecccc
Confidence            864221        1222  444445566788899999999999999988764432111000             00001


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                      ...+..+.++..+.+.++..++..||.+.++..|+-|..
T Consensus       481 p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  481 PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            111344577889999999999999999999999876654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=2e-11  Score=95.71  Aligned_cols=132  Identities=22%  Similarity=0.273  Sum_probs=94.6

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEecccccC------hHhHHHHHHHHHHHhhCC--CCCeeeeeeecCCCCcCCcC
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN------RIDAKRILREIKLLCHMT--HENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~e~~~l~~l~--h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ..+++|+-+.++.+...  |..+++|.--++...      .....+-.+|..++..+.  .-+.+.++++.       ..
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-------~~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-------PD   72 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-------CC
Confidence            45789999999999663  445666643222221      223456778999988885  44555666654       34


Q ss_pred             eEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          113 DVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       113 ~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      .-.|+|||.+| .|.+.+...       ...++..+-.-+.-||..||+|+||+++||++.+.+ +.++|||++....
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            45899999997 555566653       245566666677889999999999999999998765 9999999997544

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.32  E-value=2.5e-11  Score=94.71  Aligned_cols=143  Identities=24%  Similarity=0.305  Sum_probs=101.1

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEec-cc-----ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKIT-NA-----FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~-~~-----~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ...|-+|+-+.|+++..  .|+..++|.-. +.     ...+...++..+|.+.+.++.--.|.--.-++     .+...
T Consensus        12 l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~-----~D~~~   84 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF-----IDTYG   84 (229)
T ss_pred             ceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE-----EecCC
Confidence            67788999999988865  57777777432 11     12233456788899998887533332222222     22334


Q ss_pred             EEEEEecCcc--cHHHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC---eEEeeccccc
Q 042681          114 VYIVYELMDT--DLHQIIRSK-Q-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLAR  186 (339)
Q Consensus       114 ~~iv~e~~~g--~L~~~l~~~-~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~---ikL~Dfg~~~  186 (339)
                      -+|+|||.+|  ++.+++... . ..........+..|-..+.-||..+|+||||+.+||++.+++.   +.|+|||++.
T Consensus        85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            5899999997  888888653 2 2333333678888889999999999999999999999976553   5899999986


Q ss_pred             ccC
Q 042681          187 TTS  189 (339)
Q Consensus       187 ~~~  189 (339)
                      ...
T Consensus       165 ~s~  167 (229)
T KOG3087|consen  165 VSR  167 (229)
T ss_pred             ccc
Confidence            543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.32  E-value=1.3e-12  Score=125.15  Aligned_cols=247  Identities=18%  Similarity=0.217  Sum_probs=178.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ++.+.+|.+++++.+.-..+|...+.|+.... .......+....+-.++....+|-+++..--+     .-....++++
T Consensus       809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rsP~~L~~  883 (1205)
T KOG0606|consen  809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRSPLPLVG  883 (1205)
T ss_pred             cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCCCcchhh
Confidence            67899999999999998888877777765433 11222233333333333333344444333322     3345689999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc----------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----------  187 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~----------  187 (339)
                      +|++ ++|...+.+.+..+.+.++..+..+.+++++||+..+.|+|++|.|+++..++..++.+|+....          
T Consensus       884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~  963 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL  963 (1205)
T ss_pred             HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence            9997 68998888888899999999999999999999999999999999999999999999999974321          


Q ss_pred             --------------------------------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc
Q 042681          188 --------------------------------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS  235 (339)
Q Consensus       188 --------------------------------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~  235 (339)
                                                      .+.+.|.+|+.........+.|.|..|.++++.++|.+++..-.    
T Consensus       964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t---- 1039 (1205)
T KOG0606|consen  964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET---- 1039 (1205)
T ss_pred             ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc----
Confidence                                            12223555666655667888999999999999999999975432    


Q ss_pred             chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCCCCCCccCC
Q 042681          236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVE---EALNHPYLSSLHEIN  298 (339)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~---ell~hp~f~~~~~~~  298 (339)
                        ..+.+..+.... .+........+++.++++..++..+|.+|..+.   ++-.||||+.+.|..
T Consensus      1040 --pq~~f~ni~~~~-~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1040 --PQQIFENILNRD-IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             --hhhhhhccccCC-CCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence              122222222221 222222235788999999999999999999887   888999999998754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.27  E-value=3.6e-11  Score=100.84  Aligned_cols=143  Identities=16%  Similarity=0.219  Sum_probs=100.3

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCC--CCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      .+.|+.|..+.+|++.... |+.+++|........ .....+.+|..++..+.+  ..+++++.+....  ...+..++|
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v   78 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYV   78 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEE
Confidence            4678999999999998643 688999987654221 124567889999999865  4467777776321  112356899


Q ss_pred             EecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 042681          118 YELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS----------------------------------------  156 (339)
Q Consensus       118 ~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~----------------------------------------  156 (339)
                      |||++| ++.+.+.. ..+++.....++.+++.+|..||+                                        
T Consensus        79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            999986 44433221 345556666666666666666663                                        


Q ss_pred             ----------------CCcccCCCCCCCeeecc--CCCeEEeecccccc
Q 042681          157 ----------------ANVLHRDLKPSNLLLNA--NCDLKICDFGLART  187 (339)
Q Consensus       157 ----------------~givH~dikp~NIli~~--~~~ikL~Dfg~~~~  187 (339)
                                      ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            24699999999999998  56689999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.26  E-value=8.2e-11  Score=94.96  Aligned_cols=129  Identities=23%  Similarity=0.295  Sum_probs=84.5

Q ss_pred             EEEEEeCCCCceEEEEEecccccC------------------------hHhHHHHHHHHHHHhhCCCC--CeeeeeeecC
Q 042681           51 VCSAVNSETKEEVAIKKITNAFDN------------------------RIDAKRILREIKLLCHMTHE--NIVKVKDIIP  104 (339)
Q Consensus        51 v~~~~~~~~~~~~avK~~~~~~~~------------------------~~~~~~~~~e~~~l~~l~h~--~I~~~~~~~~  104 (339)
                      ||.|... +|..+|+|+.+.....                        ........+|.+.|..+..-  ++++++++. 
T Consensus         2 Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    2 VYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             EEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            7888764 5779999987532100                        11234567899999999754  677777654 


Q ss_pred             CCCcCCcCeEEEEEecCc--ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCcccCCCCCCCeeeccCCCeEEee
Q 042681          105 PMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY-IHSANVLHRDLKPSNLLLNANCDLKICD  181 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~-LH~~givH~dikp~NIli~~~~~ikL~D  181 (339)
                          .    .+|||||++  |.....+... .++......++.+++..+.. +|+.||+||||++.||+++.+ .+.++|
T Consensus        80 ----~----~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ----R----NVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ----T----TEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ----C----CEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEe
Confidence                1    289999998  6433333331 22245567778888885555 589999999999999999887 999999


Q ss_pred             cccccccCCC
Q 042681          182 FGLARTTSET  191 (339)
Q Consensus       182 fg~~~~~~~~  191 (339)
                      ||.+.....+
T Consensus       150 f~qav~~~~p  159 (188)
T PF01163_consen  150 FGQAVDSSHP  159 (188)
T ss_dssp             GTTEEETTST
T ss_pred             cCcceecCCc
Confidence            9998776643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.23  E-value=2.6e-10  Score=97.53  Aligned_cols=139  Identities=12%  Similarity=0.058  Sum_probs=95.0

Q ss_pred             cceEEEEEEeCCCCceEEEEEecccccCh---------HhHHHHHHHHHHHhhCCCCC--eeeeeeecCCCCcCCcCeEE
Q 042681           47 AYGIVCSAVNSETKEEVAIKKITNAFDNR---------IDAKRILREIKLLCHMTHEN--IVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        47 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~--I~~~~~~~~~~~~~~~~~~~  115 (339)
                      ....|.++..  .|+.|.+|......-..         .....+.+|...+..+..-+  .++.+++...........-+
T Consensus        34 ~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~  111 (268)
T PRK15123         34 EGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF  111 (268)
T ss_pred             CCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence            3344556543  46789999764322100         11124678888887774322  23334444211111133568


Q ss_pred             EEEecCcc--cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-------CCCeEEeeccc
Q 042681          116 IVYELMDT--DLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-------NCDLKICDFGL  184 (339)
Q Consensus       116 iv~e~~~g--~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-------~~~ikL~Dfg~  184 (339)
                      +|+|++++  +|.+++..  ..+.+......++.+++..+.-||..|++|+|+++.||+++.       ++.+.|+||+.
T Consensus       112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            99999986  78888754  345667788899999999999999999999999999999985       46799999998


Q ss_pred             ccc
Q 042681          185 ART  187 (339)
Q Consensus       185 ~~~  187 (339)
                      +..
T Consensus       192 ~~~  194 (268)
T PRK15123        192 AQI  194 (268)
T ss_pred             ccc
Confidence            854

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.14  E-value=8.6e-10  Score=91.29  Aligned_cols=111  Identities=21%  Similarity=0.259  Sum_probs=85.0

Q ss_pred             HHHHHHHHHHHhhCC--CCCeeeeeeecCCCCcCCcCeEEEEEecCcc--cHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 042681           78 AKRILREIKLLCHMT--HENIVKVKDIIPPMDKEKFNDVYIVYELMDT--DLHQIIRSKQALTDDHCQYFLYQLLRGLKY  153 (339)
Q Consensus        78 ~~~~~~e~~~l~~l~--h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~g--~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~  153 (339)
                      ..+..+|...+..+.  .-..++.+++..... ......++|+|++++  +|.+++......+......++.+++..+.-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence            345677888777774  333445555543211 111346899999985  789988875557888889999999999999


Q ss_pred             HHhCCcccCCCCCCCeeeccCC---CeEEeecccccccC
Q 042681          154 IHSANVLHRDLKPSNLLLNANC---DLKICDFGLARTTS  189 (339)
Q Consensus       154 LH~~givH~dikp~NIli~~~~---~ikL~Dfg~~~~~~  189 (339)
                      ||..|++|+|++|.|||++.++   .+.|+||+.++...
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            9999999999999999999887   89999999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.09  E-value=1.1e-09  Score=91.03  Aligned_cols=147  Identities=20%  Similarity=0.186  Sum_probs=106.9

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC--------------------hHhHHHHHHHHHHHh
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN--------------------RIDAKRILREIKLLC   89 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~--------------------~~~~~~~~~e~~~l~   89 (339)
                      +...+....+...||-|.-|.||.|.+. .|.++|+|.=+.....                    ..+.....+|.++|+
T Consensus        86 l~~r~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~  164 (304)
T COG0478          86 LVKRGIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQ  164 (304)
T ss_pred             HHHcChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHH
Confidence            3344444555889999999999999877 5889999953211000                    112345678999999


Q ss_pred             hCCCC--CeeeeeeecCCCCcCCcCeEEEEEecCccc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 042681           90 HMTHE--NIVKVKDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKP  166 (339)
Q Consensus        90 ~l~h~--~I~~~~~~~~~~~~~~~~~~~iv~e~~~g~-L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp  166 (339)
                      .|...  .+++.+++         +...+|||+.+|. |..     .+++.+....++..|+.-+.-+-..|+||||+++
T Consensus       165 ~L~~~G~~VP~P~~~---------nRHaVvMe~ieG~eL~~-----~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSe  230 (304)
T COG0478         165 RLYPEGVKVPKPIAW---------NRHAVVMEYIEGVELYR-----LRLDVENPDEILDKILEEVRKAYRRGIVHGDLSE  230 (304)
T ss_pred             HhhhcCCCCCCcccc---------ccceeeeehcccceeec-----ccCcccCHHHHHHHHHHHHHHHHHcCccccCCch
Confidence            99644  67776664         4569999999983 321     1224555666667777777766699999999999


Q ss_pred             CCeeeccCCCeEEeecccccccCCC
Q 042681          167 SNLLLNANCDLKICDFGLARTTSET  191 (339)
Q Consensus       167 ~NIli~~~~~ikL~Dfg~~~~~~~~  191 (339)
                      -||+++.+|.+.++||-.+...+.+
T Consensus       231 fNIlV~~dg~~~vIDwPQ~v~~~hp  255 (304)
T COG0478         231 FNILVTEDGDIVVIDWPQAVPISHP  255 (304)
T ss_pred             heEEEecCCCEEEEeCcccccCCCC
Confidence            9999999999999999988776654

>PRK09902 hypothetical protein; Provisional

Probab=99.08  E-value=4.1e-09  Score=85.68  Aligned_cols=142  Identities=15%  Similarity=0.169  Sum_probs=102.5

Q ss_pred             ccccceEEEEEEeCCCCceEEEEEecccc----cChHhHHHHHHHHHHHhhCCCC--CeeeeeeecCCCCcCCcCeEEEE
Q 042681           44 GRGAYGIVCSAVNSETKEEVAIKKITNAF----DNRIDAKRILREIKLLCHMTHE--NIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        44 g~G~~~~v~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~~e~~~l~~l~h~--~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      |+||-|.|+.....  |+.|=+|.-....    ..+.....+.+|+..++.+..-  .+++++ ++..........-+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            67899999998654  3356677664211    1122456788999998888532  244444 2211111122346899


Q ss_pred             EecCc--ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC--eEEeeccccccc
Q 042681          118 YELMD--TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTT  188 (339)
Q Consensus       118 ~e~~~--g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~--ikL~Dfg~~~~~  188 (339)
                      +|-++  .+|.+++.+.  .+.++.....++.+++.++.-||+.|+.|+|+-+.||+++.++.  ++++||.-++..
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            99887  4898888653  45678888899999999999999999999999999999987777  999999988654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.90  E-value=1.7e-08  Score=83.24  Aligned_cols=140  Identities=16%  Similarity=0.134  Sum_probs=99.7

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChH----------------------hHHHHHHHHHHHhhCC--CCC
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI----------------------DAKRILREIKLLCHMT--HEN   95 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~--h~~   95 (339)
                      ...|.+|.-+.||+|.. .++..+|+|+++.....-.                      ......+|+..|.++.  +=.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            44677788889999975 4688999999864321100                      1122457888888874  445


Q ss_pred             eeeeeeecCCCCcCCcCeEEEEEecCcccH--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeec
Q 042681           96 IVKVKDIIPPMDKEKFNDVYIVYELMDTDL--HQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLN  172 (339)
Q Consensus        96 I~~~~~~~~~~~~~~~~~~~iv~e~~~g~L--~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~  172 (339)
                      +++-+++.         ...+||||++...  .-.++ ..++....+..+..++++.+.-|-. .|+||+||+.-|||+.
T Consensus       132 vP~Pi~~~---------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         132 VPEPIAFR---------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             CCCceeec---------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence            55555554         3489999998431  11111 1234444788889999999998876 9999999999999999


Q ss_pred             cCCCeEEeecccccccCCC
Q 042681          173 ANCDLKICDFGLARTTSET  191 (339)
Q Consensus       173 ~~~~ikL~Dfg~~~~~~~~  191 (339)
                       ++.+.++|||.+.....+
T Consensus       202 -~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         202 -DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             -CCeEEEEECccccccCCC
Confidence             889999999999877654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.90  E-value=2e-08  Score=81.98  Aligned_cols=142  Identities=14%  Similarity=0.136  Sum_probs=82.6

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHh-HH------HHHHHHHHHhhC---CCCCeeeeeeec
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID-AK------RILREIKLLCHM---THENIVKVKDII  103 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~-~~------~~~~e~~~l~~l---~h~~I~~~~~~~  103 (339)
                      ++|.. .+.+-......|.++.  -+|+.+++|..+........ ..      ...+++..+..+   .-.....++.+.
T Consensus        31 ~~~~~-~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   31 NNYKI-IKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             CCceE-EEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            34444 5566665555565554  46789999987653221110 00      112333333333   222333322222


Q ss_pred             CCCCcCCcCeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeec
Q 042681          104 PPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF  182 (339)
Q Consensus       104 ~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Df  182 (339)
                      .-....-....+++|||++| .|.+...    +++    .+...+.+++.-||+.|++|+|..|.|++++.+ .++++||
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~  178 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT  178 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence            11111223446789999997 4543321    232    244567788999999999999999999999865 4999999


Q ss_pred             ccccc
Q 042681          183 GLART  187 (339)
Q Consensus       183 g~~~~  187 (339)
                      +..+.
T Consensus       179 ~~k~~  183 (229)
T PF06176_consen  179 QGKRM  183 (229)
T ss_pred             ccccc
Confidence            87654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.82  E-value=4.8e-07  Score=79.85  Aligned_cols=238  Identities=12%  Similarity=0.128  Sum_probs=151.7

Q ss_pred             CCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCC--CCcCCcCeE
Q 042681           38 PPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPP--MDKEKFNDV  114 (339)
Q Consensus        38 ~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~--~~~~~~~~~  114 (339)
                      ...+.||+|+-+.+|.+-.-   ..-+.|++.++.....     .+-+..|... .||-+..-+.+=..  .........
T Consensus        14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~-----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQ-----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CCCccccCCccceeeecchh---hchhheeecCCCchHH-----HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            34788999999999987543   2346788876533221     1223334444 45543321111000  000233337


Q ss_pred             EEEEecCcc--cHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEee---cc
Q 042681          115 YIVYELMDT--DLHQIIRS------KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD---FG  183 (339)
Q Consensus       115 ~iv~e~~~g--~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~D---fg  183 (339)
                      .++|+...|  .+..++..      .....+..+.+....++.|...||..|.+-||+.++|+++++++.+.|.|   |.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence            889999875  45555532      24588899999999999999999999999999999999999999999986   33


Q ss_pred             cc-------cccCCCCccccccccc-----cccCCCCccHHHHHHHHHHHhC-CCCCCcccccccc--hHH-HH------
Q 042681          184 LA-------RTTSETDFMTEYVVTR-----WDTLFPGKDYVQQLTMITELLG-SPDDSDLGFLRSD--NAR-RY------  241 (339)
Q Consensus       184 ~~-------~~~~~~~~~~~~~~~~-----~~~~~~~d~~~~g~~~~~~l~g-~~~~~~~~~~~~~--~~~-~~------  241 (339)
                      ++       +.++.+.|.+||...-     .+.....|.+.+++.++.++.| +.|+...+.....  ..+ .+      
T Consensus       166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            22       4556667778876652     2455668889999999999887 7777655422110  000 00      


Q ss_pred             --HhhCCCCCCCCccccCCCCCHHHHHHHHHhcccC--CCCCCCHH
Q 042681          242 --VKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFD--PAKRITVE  283 (339)
Q Consensus       242 --~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d--P~~Rps~~  283 (339)
                        ..........+....+.-+++++..|..+|+..-  +.-|||++
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence              0111112222223334457899999999998753  56899874

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.78  E-value=2.9e-09  Score=98.80  Aligned_cols=148  Identities=20%  Similarity=0.217  Sum_probs=107.7

Q ss_pred             HHHHHHHHHHH-hCCcccCCCCCCCeeeccCCCeEEeecccccccCC--------------------CCccccccccccc
Q 042681          145 YQLLRGLKYIH-SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--------------------TDFMTEYVVTRWD  203 (339)
Q Consensus       145 ~qi~~aL~~LH-~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~--------------------~~~~~~~~~~~~~  203 (339)
                      .+++.|+.|+| +.++||++|.|++|.++.++.+||+.|+.+.....                    ..|.+||......
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            33448999999 55899999999999999999999999988754322                    2366677777777


Q ss_pred             cCCCCccHHHHHHHHHHH-hCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 042681          204 TLFPGKDYVQQLTMITEL-LGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITV  282 (339)
Q Consensus       204 ~~~~~d~~~~g~~~~~~l-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  282 (339)
                      ..++.|.+++|+.+|+.. .|.+-+.................      ........++++++++-+.+++..++.-||++
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~------~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~  259 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN------AGAFGYSNNLPSELRESLKKLLNGDSAVRPTL  259 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc------cccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence            788899999999999988 44444333222221111111111      11111225689999999999999999999999


Q ss_pred             HHHhcCCCCCCCccCC
Q 042681          283 EEALNHPYLSSLHEIN  298 (339)
Q Consensus       283 ~ell~hp~f~~~~~~~  298 (339)
                      ..++..|||.+..-..
T Consensus       260 ~~l~~~~ff~D~~~~a  275 (700)
T KOG2137|consen  260 DLLLSIPFFSDPGLKA  275 (700)
T ss_pred             hhhhcccccCCchhhh
Confidence            9999999999876543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.72  E-value=1.5e-07  Score=87.45  Aligned_cols=143  Identities=22%  Similarity=0.307  Sum_probs=92.5

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHh----------------------------H----H------HH
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID----------------------------A----K------RI   81 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~----------------------------~----~------~~   81 (339)
                      .+.||+++-|+||+|+.+. |+.||||+.++.......                            .    +      .+
T Consensus       130 ~~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy  208 (517)
T COG0661         130 PEPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY  208 (517)
T ss_pred             CCchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence            4789999999999999875 999999988643221110                            0    0      13


Q ss_pred             HHHHHHHhhCC----CCCeeeeeeecCCCCcCCcCeEEEEEecCcc-cHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHH
Q 042681           82 LREIKLLCHMT----HENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSKQALTDDHCQYFLYQLLRGLKYI  154 (339)
Q Consensus        82 ~~e~~~l~~l~----h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l--~~~~~~~~~~~~~i~~qi~~aL~~L  154 (339)
                      .+|...+.+++    ..-=+++-.++.    +-.+.-.++|||++| .+.+..  .. ..++.+.+...+.++.  ++.+
T Consensus       209 ~~EA~n~~~~~~nf~~~~~v~VP~V~w----e~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~  281 (517)
T COG0661         209 RREAANAERFRENFKDDPDVYVPKVYW----EYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQL  281 (517)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEeceeeh----hccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHH
Confidence            44555555542    222223334432    334556999999987 455553  33 4455333333222221  2334


Q ss_pred             HhCCcccCCCCCCCeeeccCCCeEEeecccccccCC
Q 042681          155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  190 (339)
Q Consensus       155 H~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~  190 (339)
                      =..|+.|+|..|.||+++.+|++.+.|||+....+.
T Consensus       282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            458999999999999999999999999999877654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.64  E-value=4.2e-07  Score=76.26  Aligned_cols=133  Identities=18%  Similarity=0.211  Sum_probs=80.6

Q ss_pred             cccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCC--CeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE--NIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ..||+|..+.||+.    .|..+++|......    ....+.+|.+++..+..-  .+++++++.     +..+...+||
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~   73 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIY   73 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeee
Confidence            46899999999984    25568899875432    234568899998888532  356777776     4455578899


Q ss_pred             ecCccc--HH--------------HHHHh------c---CCCCHHHH-HHHHH----------HHHHH-HHHHH----hC
Q 042681          119 ELMDTD--LH--------------QIIRS------K---QALTDDHC-QYFLY----------QLLRG-LKYIH----SA  157 (339)
Q Consensus       119 e~~~g~--L~--------------~~l~~------~---~~~~~~~~-~~i~~----------qi~~a-L~~LH----~~  157 (339)
                      |+++|.  +.              ..+..      .   ...+.... ..+..          .+... .++|.    ..
T Consensus        74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~  153 (226)
T TIGR02172        74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS  153 (226)
T ss_pred             eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence            999873  11              11100      0   01111100 00100          01111 11222    12


Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          158 NVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       158 givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .++|+|+.|.||+++.++ +.++||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            478999999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.54  E-value=9.9e-07  Score=74.43  Aligned_cols=140  Identities=20%  Similarity=0.266  Sum_probs=79.7

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCC--CeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE--NIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      ++.|+.|..+.||++....  ..+++|.....    .....+.+|..+++.+...  .+++++......  ......+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence            5778999999999998765  48999986543    3456677888888887422  356666533111  233457999


Q ss_pred             EecCcc-cHHH----------------HHH---hc----CCCCHHH------HHHH---------------HHHHHH-HH
Q 042681          118 YELMDT-DLHQ----------------IIR---SK----QALTDDH------CQYF---------------LYQLLR-GL  151 (339)
Q Consensus       118 ~e~~~g-~L~~----------------~l~---~~----~~~~~~~------~~~i---------------~~qi~~-aL  151 (339)
                      |++++| .+..                .+.   +.    .+.....      ....               ...+.. .+
T Consensus        74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (239)
T PF01636_consen   74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL  153 (239)
T ss_dssp             EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred             EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence            999986 4444                111   10    0111100      0000               111222 23


Q ss_pred             HHHH-------hCCcccCCCCCCCeeec-cCCCeEEeecccccc
Q 042681          152 KYIH-------SANVLHRDLKPSNLLLN-ANCDLKICDFGLART  187 (339)
Q Consensus       152 ~~LH-------~~givH~dikp~NIli~-~~~~ikL~Dfg~~~~  187 (339)
                      +.++       ...++|+|+.|.||+++ .++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            3333       24599999999999999 666678999988754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.41  E-value=2.8e-06  Score=66.60  Aligned_cols=128  Identities=20%  Similarity=0.226  Sum_probs=90.3

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCe-eeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI-VKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I-~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      .+.||+|.+|.||++.+.  |..+|+|+-+.+    .....+..|.++|+.++..++ ++++.+-         .-++.|
T Consensus        27 ~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg---------~~~i~m   91 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR--GGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYG---------EDFIRM   91 (201)
T ss_pred             hhhhhcccccEEEEeecc--CceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEec---------hhhhhh
Confidence            678999999999999885  568999976543    234567889999999875555 3445443         235669


Q ss_pred             ecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-CCCeeeccCCCeEEeecccccccC
Q 042681          119 ELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLK-PSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       119 e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dik-p~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ||..| .|.+.....   +    ..-+..++.+---|-..||-|+.|. |...++-+++.+.|+||..|+...
T Consensus        92 e~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~  157 (201)
T COG2112          92 EYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK  157 (201)
T ss_pred             hhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence            99987 665544321   1    2224445555555778899999997 666666666699999999997443

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.38  E-value=9.2e-06  Score=66.27  Aligned_cols=133  Identities=18%  Similarity=0.264  Sum_probs=92.4

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccc--------------cChHhHHHHHHHHHHHhhCC------CCCeeee
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF--------------DNRIDAKRILREIKLLCHMT------HENIVKV   99 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~~I~~~   99 (339)
                      ...||+|+.-.||.--   .....++|+.....              ..........+|+.....+.      +.+|+++
T Consensus         6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4578999999998753   34567899887654              01112455666777666665      8899999


Q ss_pred             eeecCCCCcCCcCeEEEEEecCc---c----cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec
Q 042681          100 KDIIPPMDKEKFNDVYIVYELMD---T----DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN  172 (339)
Q Consensus       100 ~~~~~~~~~~~~~~~~iv~e~~~---g----~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~  172 (339)
                      +|+.     ++.....+|+|...   |    +|.+++++ +.++. .....+.+   -.++|-+.+|+.+|++|.||++.
T Consensus        83 ~G~v-----eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~~---f~~~l~~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFV-----ETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALDE---FKRYLLDHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEE-----ecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHHH---HHHHHHHcCCeecCCCcccEEEE
Confidence            9999     66666788888862   2    68888855 45666 44444443   35678899999999999999996


Q ss_pred             cCC----CeEEee-cccc
Q 042681          173 ANC----DLKICD-FGLA  185 (339)
Q Consensus       173 ~~~----~ikL~D-fg~~  185 (339)
                      .+.    .+.|+| ||..
T Consensus       153 ~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ecCCCceEEEEEeCCCCc
Confidence            432    477776 4443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.37  E-value=4.8e-06  Score=70.93  Aligned_cols=135  Identities=11%  Similarity=0.053  Sum_probs=79.1

Q ss_pred             cccccccc-eEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAY-GIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~-~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.|..|.+ +.||++...  +..+++|......     ...+.+|++++..+. +--+++++++.     ...+..++||
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~lv~   71 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYG-----SDDGRAWLLT   71 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEE-----ecCCccEEEE
Confidence            34566666 789999653  4678888764331     234567888877773 44566777776     3335578999


Q ss_pred             ecCcc-cHHHHH----------------Hh--cC-----CCCHH---HHHH---HHH----------------HHHHHHH
Q 042681          119 ELMDT-DLHQII----------------RS--KQ-----ALTDD---HCQY---FLY----------------QLLRGLK  152 (339)
Q Consensus       119 e~~~g-~L~~~l----------------~~--~~-----~~~~~---~~~~---i~~----------------qi~~aL~  152 (339)
                      ++++| ++.+..                ..  ..     +....   ....   .+.                .+...+.
T Consensus        72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (244)
T cd05150          72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA  151 (244)
T ss_pred             EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence            99986 333221                10  00     11100   0000   000                0111122


Q ss_pred             HHH-------hCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          153 YIH-------SANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       153 ~LH-------~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .|-       ...++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            221       23489999999999999987788999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.34  E-value=6.5e-06  Score=76.47  Aligned_cols=139  Identities=23%  Similarity=0.280  Sum_probs=89.1

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHh-----------------------------HHH------HHHH
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID-----------------------------AKR------ILRE   84 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~-----------------------------~~~------~~~e   84 (339)
                      -+.||..+.|+|++|+.+. |+.||||+-++.......                             .+.      +.+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            4789999999999999886 999999987644322110                             011      3334


Q ss_pred             HHHHhhC----CCCC------eeeeeeecCCCCcCCcCeEEEEEecCcc----cHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 042681           85 IKLLCHM----THEN------IVKVKDIIPPMDKEKFNDVYIVYELMDT----DLHQIIRSKQALTDDHCQYFLYQLLRG  150 (339)
Q Consensus        85 ~~~l~~l----~h~~------I~~~~~~~~~~~~~~~~~~~iv~e~~~g----~L~~~l~~~~~~~~~~~~~i~~qi~~a  150 (339)
                      .+...+.    .|-+      |++++-       +-.....++|||++|    ++ +.+.+ ..++...+...+.+..  
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~-------~~st~RVLtME~~~G~~i~Dl-~~i~~-~gi~~~~i~~~l~~~~--  313 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYW-------DLSTKRVLTMEYVDGIKINDL-DAIDK-RGISPHDILNKLVEAY--  313 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehh-------hcCcceEEEEEecCCccCCCH-HHHHH-cCCCHHHHHHHHHHHH--
Confidence            4433333    3545      444443       333456999999986    44 34444 3455553333333222  


Q ss_pred             HHHHHhCCcccCCCCCCCeeecc----CCCeEEeecccccccCC
Q 042681          151 LKYIHSANVLHRDLKPSNLLLNA----NCDLKICDFGLARTTSE  190 (339)
Q Consensus       151 L~~LH~~givH~dikp~NIli~~----~~~ikL~Dfg~~~~~~~  190 (339)
                      ++-+=..|.+|+|=.|.||++.+    ++.+.+-|||+......
T Consensus       314 ~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  314 LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            12333578999999999999984    56899999999876654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.27  E-value=7.5e-06  Score=69.30  Aligned_cols=73  Identities=14%  Similarity=0.222  Sum_probs=45.1

Q ss_pred             ccccccccce-EEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCC---CeeeeeeecCCCCcCCcCeEE
Q 042681           40 LQPIGRGAYG-IVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE---NIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        40 ~~~lg~G~~~-~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      ++.|+.||.. .||++     +..+++|.....    .....+.+|.+++..+...   .++++++.....  +.....+
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~--~~~~~~~   70 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPG--EGYPWPW   70 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCc--cCCCcce
Confidence            5678877777 59987     245788865432    1234688899998887532   345555543211  1122458


Q ss_pred             EEEecCcc
Q 042681          116 IVYELMDT  123 (339)
Q Consensus       116 iv~e~~~g  123 (339)
                      ++|++++|
T Consensus        71 ~l~~~i~G   78 (235)
T cd05155          71 SVYRWLEG   78 (235)
T ss_pred             EEEEeecC
Confidence            89999876

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=1.6e-05  Score=79.43  Aligned_cols=82  Identities=13%  Similarity=0.171  Sum_probs=56.3

Q ss_pred             ccccccccceEEEEEEeCCCC--ceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCe--eeeeeecCCCCcCCcCeE
Q 042681           40 LQPIGRGAYGIVCSAVNSETK--EEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENI--VKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I--~~~~~~~~~~~~~~~~~~  114 (339)
                      ++.|+.|.+..+|++.....+  ..+++|+...... ......+.+|..+++.+. |+++  ++++.++.+.  ...+..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCc
Confidence            778899999999999765433  4678887543211 112346779999999985 6654  7778776432  223457


Q ss_pred             EEEEecCccc
Q 042681          115 YIVYELMDTD  124 (339)
Q Consensus       115 ~iv~e~~~g~  124 (339)
                      |+||||++|.
T Consensus       120 flVME~v~G~  129 (822)
T PLN02876        120 FYIMEYLEGR  129 (822)
T ss_pred             eEEEEecCCc
Confidence            8999999863

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.12  E-value=1.9e-05  Score=78.15  Aligned_cols=196  Identities=17%  Similarity=0.173  Sum_probs=131.1

Q ss_pred             HHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC-eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 042681           81 ILREIKLLCHMTHENIVKVKDIIPPMDKEKFN-DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN  158 (339)
Q Consensus        81 ~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~-~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g  158 (339)
                      .--|+..+..+.|+|+..++.+-...  ...+ ...+..+++. .++...+...+.++...++.+..++..||.++|+..
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~--~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLER--LFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehh--hcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            34566677788999999999887322  1112 2334557777 488888888899999999999999999999999996


Q ss_pred             cccCCCCCC---CeeeccCCCeEEe--ecccccccCCCCccc----------ccccccc--ccCCCCccHHHHHHHHHHH
Q 042681          159 VLHRDLKPS---NLLLNANCDLKIC--DFGLARTTSETDFMT----------EYVVTRW--DTLFPGKDYVQQLTMITEL  221 (339)
Q Consensus       159 ivH~dikp~---NIli~~~~~ikL~--Dfg~~~~~~~~~~~~----------~~~~~~~--~~~~~~d~~~~g~~~~~~l  221 (339)
                      ..|.-+...   +--.+..+.+..+  ||+.+.......+..          ++.....  ......|.|.+|.....+.
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence            666555544   3344555666666  888887766543222          1111111  1222357888888888777


Q ss_pred             hCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH-HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          222 LGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP-VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       222 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      .|.....-..        .....            .+..+. ...+.+.+|+.-++++|+++.+++.|||.+......
T Consensus       387 ~~~~i~~~~~--------~~~~~------------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~  444 (1351)
T KOG1035|consen  387 QGEDISEKSA--------VPVSL------------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNE  444 (1351)
T ss_pred             hcCccccccc--------chhhh------------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccccc
Confidence            7754421110        00000            011122 688899999999999999999999999998776554

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.96  E-value=0.00023  Score=64.43  Aligned_cols=77  Identities=19%  Similarity=0.178  Sum_probs=54.9

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccccc---C--hHhHHHHHHHHHHHhhCC---CCCeeeeeeecCCCCcCCc
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD---N--RIDAKRILREIKLLCHMT---HENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~---~--~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~~~~~  111 (339)
                      .+.||.|.+..||++.....++.++||.-.....   .  .....+...|.+.|+.+.   ..++++++.+-     .  
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~--  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----E--  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----C--
Confidence            6789999999999999865446899998542111   1  234567778888888863   35678888764     2  


Q ss_pred             CeEEEEEecCcc
Q 042681          112 NDVYIVYELMDT  123 (339)
Q Consensus       112 ~~~~iv~e~~~g  123 (339)
                      ...++|||++++
T Consensus       104 ~~~~lVME~L~~  115 (401)
T PRK09550        104 ELAVTVMEDLSD  115 (401)
T ss_pred             CCCEEEEecCCC
Confidence            335899999874

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.94  E-value=0.00016  Score=61.16  Aligned_cols=72  Identities=15%  Similarity=0.223  Sum_probs=45.3

Q ss_pred             ccccccccceEEEEEEeCC-CCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSE-TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      ++.|..|-...+|++.... .++.|++|.........   -...+|..++..+. +.-.+++++..     ..    .++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~---~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l   70 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI---IDRERELRIHKLLSKHGLAPKLYATF-----QN----GLI   70 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce---ecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEE
Confidence            5678888889999997543 35788899765331111   12236777777774 33345555543     21    479


Q ss_pred             EecCcc
Q 042681          118 YELMDT  123 (339)
Q Consensus       118 ~e~~~g  123 (339)
                      |||++|
T Consensus        71 ~e~i~G   76 (235)
T cd05157          71 YEFIPG   76 (235)
T ss_pred             EEeeCC
Confidence            999875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.87  E-value=4.6e-05  Score=61.87  Aligned_cols=96  Identities=21%  Similarity=0.162  Sum_probs=76.9

Q ss_pred             HHHHHHhhCCC-CCeeeeeeecCCCCcCCcCeEEEEEecCc-ccHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh-
Q 042681           83 REIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQI---IRSKQALTDDHCQYFLYQLLRGLKYIHS-  156 (339)
Q Consensus        83 ~e~~~l~~l~h-~~I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~---l~~~~~~~~~~~~~i~~qi~~aL~~LH~-  156 (339)
                      .|.-+++.+++ +++++++|.+        + .+++.||.+ +++...   +.+-...++.....++.+++..+.+|+. 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C--------G-~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC--------G-RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC--------C-CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            57888888865 6999999998        2 277899998 555422   1222346899999999999999999986 


Q ss_pred             --CCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          157 --ANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       157 --~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                        ..+.-.|++|+|+-+++++++|++|......
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence              3477789999999999999999999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.84  E-value=0.00012  Score=62.86  Aligned_cols=132  Identities=17%  Similarity=0.200  Sum_probs=74.3

Q ss_pred             ccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCC-eeeeeeecCCCCcCCcCeEEEEEec
Q 042681           42 PIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN-IVKVKDIIPPMDKEKFNDVYIVYEL  120 (339)
Q Consensus        42 ~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-I~~~~~~~~~~~~~~~~~~~iv~e~  120 (339)
                      .+..|-.+.+|++.  .+++.+++|........- . -...+|..+++.+.... .++++...     .    -++|+||
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~-~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~   69 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-G-VDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEW   69 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc-c-CcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEe
Confidence            46778888999986  456788999754321110 0 12356888888775322 34455443     2    2689999


Q ss_pred             Cccc-HH--------------HHHHh--c-----CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcc
Q 042681          121 MDTD-LH--------------QIIRS--K-----QALTDD-HCQYFLYQL---------LRGLKYIHS--------ANVL  160 (339)
Q Consensus       121 ~~g~-L~--------------~~l~~--~-----~~~~~~-~~~~i~~qi---------~~aL~~LH~--------~giv  160 (339)
                      ++|. +.              +.+.+  .     .+++.. .+..+..++         ...+..+-.        ..++
T Consensus        70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            8762 21              11111  1     111211 111221111         111222211        2589


Q ss_pred             cCCCCCCCeeeccCCCeEEeecccccc
Q 042681          161 HRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       161 H~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      |+|+.|.||+++.++ +.|+||+.+..
T Consensus       150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       150 HMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            999999999999877 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.82  E-value=0.00028  Score=62.32  Aligned_cols=142  Identities=15%  Similarity=0.142  Sum_probs=79.4

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCC--eeeeeeecCCC-CcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN--IVKVKDIIPPM-DKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--I~~~~~~~~~~-~~~~~~~~~i  116 (339)
                      ++.++.|....+|++...  +..+++|+.....    ....+..|..++..|....  +++++...... .....+..++
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~  100 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC  100 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence            667788888899998642  4468889765421    1234456667776664222  34444321000 0012355789


Q ss_pred             EEecCccc------HH------HHHHh----cCCC--------CHHH-----HH----------HHHHHHHHHHHHHH--
Q 042681          117 VYELMDTD------LH------QIIRS----KQAL--------TDDH-----CQ----------YFLYQLLRGLKYIH--  155 (339)
Q Consensus       117 v~e~~~g~------L~------~~l~~----~~~~--------~~~~-----~~----------~i~~qi~~aL~~LH--  155 (339)
                      ++++++|.      ..      ..+.+    ...+        ....     ..          .....+..+++++.  
T Consensus       101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~  180 (307)
T TIGR00938       101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF  180 (307)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence            99998762      11      11110    0000        0000     00          00112233455553  


Q ss_pred             -----hCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          156 -----SANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       156 -----~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                           ..++||+|+.+.||+++.++...|+||+.+..
T Consensus       181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence                 25899999999999999888778999998744

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK10593 hypothetical protein; Provisional

Probab=97.80  E-value=0.0005  Score=60.27  Aligned_cols=76  Identities=11%  Similarity=0.084  Sum_probs=52.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCC---CCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH---ENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      .+.||.|..+.||...... + .+++|..+. .   .....+..|...++.|..   -.++++++++...  ...+..++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~L   90 (297)
T PRK10593         19 VECISEQPYAALWALYDSQ-G-NPMPLMARS-F---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVL   90 (297)
T ss_pred             eeecCCccceeEEEEEcCC-C-CEEEEEecc-c---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEE
Confidence            6789999999999996432 3 566776432 1   122467889999888842   4688888876322  23456899


Q ss_pred             EEecCcc
Q 042681          117 VYELMDT  123 (339)
Q Consensus       117 v~e~~~g  123 (339)
                      |||+++|
T Consensus        91 VmE~i~G   97 (297)
T PRK10593         91 LLERLRG   97 (297)
T ss_pred             EEeccCC
Confidence            9999875

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.77  E-value=0.00035  Score=61.98  Aligned_cols=81  Identities=12%  Similarity=0.061  Sum_probs=54.5

Q ss_pred             ccccccceEEEEEEeCCCCceEEEEEeccc-----ccChHhHHHHHHHHHHHhhCC--CC-CeeeeeeecCCCCcCCcCe
Q 042681           42 PIGRGAYGIVCSAVNSETKEEVAIKKITNA-----FDNRIDAKRILREIKLLCHMT--HE-NIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        42 ~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~~~~e~~~l~~l~--h~-~I~~~~~~~~~~~~~~~~~  113 (339)
                      .||.|...-||++.....++.++||.-...     ........+..-|...|+...  .| .+++++.+-       ...
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-------~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-------TEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-------ccc
Confidence            579999999999998654468999976422     112344566777888887763  33 577777653       344


Q ss_pred             EEEEEecCcc--cHHHHH
Q 042681          114 VYIVYELMDT--DLHQII  129 (339)
Q Consensus       114 ~~iv~e~~~g--~L~~~l  129 (339)
                      ..+|||+++.  .+.+.+
T Consensus        75 ~~~vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        75 AVTVMEDLSHHKIARKGL   92 (370)
T ss_pred             ceehHhhCccchHHHHHH
Confidence            5799999862  454444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK05231 homoserine kinase; Provisional

Probab=97.72  E-value=0.0014  Score=58.08  Aligned_cols=31  Identities=29%  Similarity=0.351  Sum_probs=26.6

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          157 ANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       157 ~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .|+||+|+.|.||+++.+...-++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4899999999999999765568999998854

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.70  E-value=0.00024  Score=57.66  Aligned_cols=127  Identities=24%  Similarity=0.280  Sum_probs=85.4

Q ss_pred             ccccccccc-eEEEEEEeCCCCceEEEEEecc---ccc-------Ch---------HhHHHHHHHHHHHhhCC---CCCe
Q 042681           40 LQPIGRGAY-GIVCSAVNSETKEEVAIKKITN---AFD-------NR---------IDAKRILREIKLLCHMT---HENI   96 (339)
Q Consensus        40 ~~~lg~G~~-~~v~~~~~~~~~~~~avK~~~~---~~~-------~~---------~~~~~~~~e~~~l~~l~---h~~I   96 (339)
                      ++.||.|.- |.||+++.  .|+.||+|.+..   ...       ..         .....|..|-+..-+|+   +.++
T Consensus        42 lefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~  119 (207)
T PF13095_consen   42 LEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGL  119 (207)
T ss_pred             eeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCc
Confidence            899999999 99999977  478999999421   100       00         11234667777766664   5566


Q ss_pred             --eeeeeecCCCCc-------------CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 042681           97 --VKVKDIIPPMDK-------------EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH  161 (339)
Q Consensus        97 --~~~~~~~~~~~~-------------~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH  161 (339)
                        ++++|+......             .......||-||+...-        .++...    +.++.+-+..+|+.||+-
T Consensus       120 ~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~----~~~~~~dl~~~~k~gI~~  187 (207)
T PF13095_consen  120 WAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD----IPQMLRDLKILHKLGIVP  187 (207)
T ss_pred             eEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH----HHHHHHHHHHHHHCCeee
Confidence              899998843210             11123567888776422        223333    556667788999999999


Q ss_pred             CCCCCCCeeeccCCCeEEeecccc
Q 042681          162 RDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       162 ~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                      +|+++.|..     .=+|+|||.+
T Consensus       188 ~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  188 RDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ccCcccccc-----CCEEEecccC
Confidence            999999987     2488999864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.66  E-value=0.0005  Score=60.49  Aligned_cols=143  Identities=20%  Similarity=0.227  Sum_probs=98.5

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccccc---ChH-----------------h---H-HHHHHHHHHHhhCCCCC
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD---NRI-----------------D---A-KRILREIKLLCHMTHEN   95 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~-----------------~---~-~~~~~e~~~l~~l~h~~   95 (339)
                      -.+|..|.-+-||.|... +|..+|+|+++.+..   ++.                 .   . -..-.|++.|.+++...
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            567888888899998754 578899998864321   100                 0   1 12346888888887555


Q ss_pred             eeeeeeecCCCCcCCcCeEEEEEecCcccHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCCeeecc
Q 042681           96 IVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQI-IRSKQALTDDHCQYFLYQLLRGLKYI-HSANVLHRDLKPSNLLLNA  173 (339)
Q Consensus        96 I~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~-l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~givH~dikp~NIli~~  173 (339)
                      |+-.--+.       -....|||++++++-+-. ..+.-.++...+..+-.|++.-+.-| |.+++||.||.--|+|+- 
T Consensus       228 IP~PePIl-------Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  228 IPCPEPIL-------LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-  299 (520)
T ss_pred             CCCCCcee-------eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-
Confidence            43221111       123489999998432211 12335678888888888888888877 578999999999999885 


Q ss_pred             CCCeEEeecccccccCCC
Q 042681          174 NCDLKICDFGLARTTSET  191 (339)
Q Consensus       174 ~~~ikL~Dfg~~~~~~~~  191 (339)
                      +|.+.++|.+.+.....+
T Consensus       300 dG~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             CCEEEEEEccccccCCCh
Confidence            568999999988765544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.62  E-value=1.3e-05  Score=74.44  Aligned_cols=230  Identities=17%  Similarity=0.119  Sum_probs=144.0

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCC-eeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN-IVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      -+-+++|+++++++.+...+.... .+.+...       ....-++++|.+++||| .+..++-+     +......+.+
T Consensus       247 fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~  313 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPM  313 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhh
Confidence            567889999999999877655444 6766543       33456888899999999 44444433     5556688999


Q ss_pred             ecCc-c-cHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC------
Q 042681          119 ELMD-T-DLHQII-RSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS------  189 (339)
Q Consensus       119 e~~~-g-~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~------  189 (339)
                      ++++ + +....+ ...-.+.+.+...+...-+.+++++|+..-+|+|    ||+..+ +..++.+|+....+.      
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~  388 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPR  388 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccc
Confidence            9998 3 222221 1112344444556667777889999998889998    666654 678999998875443      


Q ss_pred             ----CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCC-CCCccccCCCCCHHH
Q 042681          190 ----ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP-KQPFSQKFPNMSPVA  264 (339)
Q Consensus       190 ----~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~  264 (339)
                          .+...+|+...........+.|+.+.....+--|.+|-...+..        .......+ ...+... ...++..
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--------~~~~g~~p~s~~L~~~-~aw~~~~  459 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--------LPMIGNGPNSPMLTDK-SAWSPVF  459 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc--------cCCCCCCCCccccchh-hhcCccc
Confidence                23445566555555666677787777666666665553321100        00000000 0000000 0011112


Q ss_pred             -HHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          265 -IDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       265 -~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                       +++...|+...|..|+....++.|.+|....-
T Consensus       460 ~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl  492 (829)
T KOG0576|consen  460 HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL  492 (829)
T ss_pred             ccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence             25788999999999999999999999987653

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.61  E-value=0.00089  Score=58.73  Aligned_cols=141  Identities=15%  Similarity=0.072  Sum_probs=80.2

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCC--eeeeeeecCCC-CcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN--IVKVKDIIPPM-DKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--I~~~~~~~~~~-~~~~~~~~~i  116 (339)
                      ++.|..|....+|++..  ++..+++|+...  .   ....+..|+.++..+.+.+  +++++...... .....+..++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC--C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            66788888889999864  345789998753  1   2345566777777774322  44444321000 0012345689


Q ss_pred             EEecCcccHH------------HHHHh----cCCC----------CHHHH----------HHHHHHHHHHHHHHHh----
Q 042681          117 VYELMDTDLH------------QIIRS----KQAL----------TDDHC----------QYFLYQLLRGLKYIHS----  156 (339)
Q Consensus       117 v~e~~~g~L~------------~~l~~----~~~~----------~~~~~----------~~i~~qi~~aL~~LH~----  156 (339)
                      |+++++|...            ..+.+    ...+          .+...          ......+..++.++.+    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9999976211            11100    0000          00000          0011112333444442    


Q ss_pred             ---CCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          157 ---ANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       157 ---~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                         .++||+|+.|.||+++.++.+.|+||+.+..
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence               4799999999999999887778999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.54  E-value=0.0011  Score=58.41  Aligned_cols=72  Identities=13%  Similarity=0.140  Sum_probs=44.8

Q ss_pred             ccccccccceEEEEEEeCC------CCceEEEEEecccccChHhHHHHHHHHHHHhhCCC-CCeeeeeeecCCCCcCCcC
Q 042681           40 LQPIGRGAYGIVCSAVNSE------TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++.|..|-...+|++....      +++.+++|........   .....+|..++..+.. --.++++..+     ..  
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~~--   72 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIF-----PN--   72 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEe-----CC--
Confidence            4567777788999997543      2578999987543211   1234567777777742 2244566654     21  


Q ss_pred             eEEEEEecCcc
Q 042681          113 DVYIVYELMDT  123 (339)
Q Consensus       113 ~~~iv~e~~~g  123 (339)
                        .+|++|++|
T Consensus        73 --~~v~e~i~G   81 (302)
T cd05156          73 --GRIEEFIPS   81 (302)
T ss_pred             --CchhheeCC
Confidence              347888765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.47  E-value=0.0022  Score=58.06  Aligned_cols=75  Identities=16%  Similarity=0.209  Sum_probs=51.9

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccccc---C--hHhHHHHHHHHHHHhhCC---CCCeeeeeeecCCCCcCCc
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD---N--RIDAKRILREIKLLCHMT---HENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~---~--~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~~~~~  111 (339)
                      .+.||.|....||++.+.  +..++||.-.....   .  .....+...|...|+.+.   ...+++++.+.     .  
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----e--  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----R--  107 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----C--
Confidence            678999999999999873  45688997652211   1  123455666777777664   35888899887     3  


Q ss_pred             CeEEEEEecCcc
Q 042681          112 NDVYIVYELMDT  123 (339)
Q Consensus       112 ~~~~iv~e~~~g  123 (339)
                      ...+++||++++
T Consensus       108 d~~vlvME~L~~  119 (418)
T PLN02756        108 TMALIGMRYLEP  119 (418)
T ss_pred             CCCEEEEeecCC
Confidence            234788999965

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.45  E-value=0.0021  Score=56.36  Aligned_cols=143  Identities=13%  Similarity=0.182  Sum_probs=81.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC--CCCeeeeeeecCCCCcCCcCeEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT--HENIVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      ++.+..|-...+|.....  ++.++++ ...............+|+.++..+.  ---+...++++...  . -+..+.|
T Consensus        30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~--~-~g~pf~v  103 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEG--Y-LGTPFYV  103 (321)
T ss_pred             eeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccC--C-CCCceEE
Confidence            344444545566666554  7889998 3222333445566778888888874  33455556665221  1 2467999


Q ss_pred             EecCcc-cH------------------HHHHHh--c------------CCCCHHHHHHHHHHH--------------HHH
Q 042681          118 YELMDT-DL------------------HQIIRS--K------------QALTDDHCQYFLYQL--------------LRG  150 (339)
Q Consensus       118 ~e~~~g-~L------------------~~~l~~--~------------~~~~~~~~~~i~~qi--------------~~a  150 (339)
                      |++++| .+                  .+.+..  +            ......++..+..+.              ..-
T Consensus       104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            999876 11                  111110  0            000111111111111              112


Q ss_pred             HHHHHhC--------CcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          151 LKYIHSA--------NVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       151 L~~LH~~--------givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ..+|+.+        .++|||+.+.||+++.++.+-++||+.+...
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            2334322        3899999999999999999999999998653

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.28  E-value=0.0026  Score=57.31  Aligned_cols=83  Identities=18%  Similarity=0.121  Sum_probs=57.4

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccc----ccChHhHHHHHHHHHHHhhCC--CC-CeeeeeeecCCCCcCCcC
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNA----FDNRIDAKRILREIKLLCHMT--HE-NIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~----~~~~~~~~~~~~e~~~l~~l~--h~-~I~~~~~~~~~~~~~~~~  112 (339)
                      .+.||.|...-||++.+...++.++||.-...    ..-.....+..-|...|+.+.  .| .+++++.+-       ..
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D-------~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD-------SV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-------cH
Confidence            67899999999999998544567999976422    122445677788888888773  33 577777753       34


Q ss_pred             eEEEEEecCcc--cHHHHH
Q 042681          113 DVYIVYELMDT--DLHQII  129 (339)
Q Consensus       113 ~~~iv~e~~~g--~L~~~l  129 (339)
                      ...+|||+++.  .|.+.+
T Consensus       107 ~~~~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        107 MNCCVMEDLSDHTILRTAL  125 (409)
T ss_pred             HhhHHHHhCcccHHHHHHH
Confidence            45889999863  444444

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.24  E-value=0.00036  Score=60.33  Aligned_cols=132  Identities=16%  Similarity=0.181  Sum_probs=87.9

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccccc------ChH--------------hHHHHHHHHHHHhhCCC--CCee
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD------NRI--------------DAKRILREIKLLCHMTH--ENIV   97 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~--------------~~~~~~~e~~~l~~l~h--~~I~   97 (339)
                      +..||-|.-+-||++.+. .|+++++|.=+....      ...              +.-...+|...|..|..  =-++
T Consensus        97 GnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVP  175 (465)
T KOG2268|consen   97 GNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVP  175 (465)
T ss_pred             ccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCC
Confidence            888999999999999875 478888884321100      000              11234578888888842  2344


Q ss_pred             eeeeecCCCCcCCcCeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC
Q 042681           98 KVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD  176 (339)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~  176 (339)
                      +.+++         ...|+|||++.| .|.+...   -.   .+..+...+..-+--|...|++|+|..-=||+++.++.
T Consensus       176 kpiD~---------~RH~Vvmelv~g~Pl~~v~~---v~---d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  176 KPIDH---------NRHCVVMELVDGYPLRQVRH---VE---DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             Ccccc---------cceeeHHHhhcccceeeeee---cC---ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence            44443         456999999886 4432211   11   12333444444466788899999999999999999999


Q ss_pred             eEEeecccccc
Q 042681          177 LKICDFGLART  187 (339)
Q Consensus       177 ikL~Dfg~~~~  187 (339)
                      ++++||-.+..
T Consensus       241 i~vIDFPQmvS  251 (465)
T KOG2268|consen  241 IVVIDFPQMVS  251 (465)
T ss_pred             EEEeechHhhc
Confidence            99999976543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.24  E-value=0.0069  Score=53.51  Aligned_cols=29  Identities=24%  Similarity=0.423  Sum_probs=25.7

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       157 ~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      .+++|||+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57999999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02236 choline kinase

Probab=97.23  E-value=0.0047  Score=55.39  Aligned_cols=136  Identities=16%  Similarity=0.189  Sum_probs=76.3

Q ss_pred             ccccccccceEEEEEEeCC----CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCC-CeeeeeeecCCCCcCCcCeE
Q 042681           40 LQPIGRGAYGIVCSAVNSE----TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE-NIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +..|..|-...+|++....    +++.+++|......  .....+ .+|..+++.+... --+++++.+     ..+   
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~idR-~~E~~~~~~l~~~gl~P~~~~~~-----~~g---  109 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFDR-DDEIRTFECMSRHGQGPRLLGRF-----PNG---  109 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeech-HHHHHHHHHHHHcCCCCceEEEE-----CCc---
Confidence            6677778888999987432    34689999876432  111222 5677777777432 233555655     222   


Q ss_pred             EEEEecCcc-cHH-----------HH---HHh--cC-------CCCHHHHHHHHHHH-----------------HHHHHH
Q 042681          115 YIVYELMDT-DLH-----------QI---IRS--KQ-------ALTDDHCQYFLYQL-----------------LRGLKY  153 (339)
Q Consensus       115 ~iv~e~~~g-~L~-----------~~---l~~--~~-------~~~~~~~~~i~~qi-----------------~~aL~~  153 (339)
                       .|.+|++| ++.           ..   +++  ..       ......+..+..++                 ...+..
T Consensus       110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~  188 (344)
T PLN02236        110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL  188 (344)
T ss_pred             -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence             46777754 221           11   110  00       11112222222111                 111112


Q ss_pred             H----H----hCCcccCCCCCCCeeecc-CCCeEEeecccccc
Q 042681          154 I----H----SANVLHRDLKPSNLLLNA-NCDLKICDFGLART  187 (339)
Q Consensus       154 L----H----~~givH~dikp~NIli~~-~~~ikL~Dfg~~~~  187 (339)
                      |    .    ...++|+|+++.||+++. ++.+.|+||..+..
T Consensus       189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2    1    235899999999999986 46899999998853

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.05  E-value=0.0082  Score=53.51  Aligned_cols=29  Identities=34%  Similarity=0.478  Sum_probs=25.6

Q ss_pred             cccCCCCCCCeeecc-CCCeEEeecccccc
Q 042681          159 VLHRDLKPSNLLLNA-NCDLKICDFGLART  187 (339)
Q Consensus       159 ivH~dikp~NIli~~-~~~ikL~Dfg~~~~  187 (339)
                      +||+|+.+.||+++. ++.++|+||+.|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            899999999999975 57899999998854

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.98  E-value=0.01  Score=52.38  Aligned_cols=30  Identities=20%  Similarity=0.206  Sum_probs=27.8

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          158 NVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       158 givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ++||+|+.+.|++++.++.+.++||..++.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.93  E-value=0.0071  Score=52.41  Aligned_cols=31  Identities=23%  Similarity=0.504  Sum_probs=25.9

Q ss_pred             CcccCCCCCCCeeeccCCC-eEEeeccccccc
Q 042681          158 NVLHRDLKPSNLLLNANCD-LKICDFGLARTT  188 (339)
Q Consensus       158 givH~dikp~NIli~~~~~-ikL~Dfg~~~~~  188 (339)
                      .++|+|++|.||+++++++ .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997565 569999988653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.85  E-value=0.008  Score=52.25  Aligned_cols=71  Identities=14%  Similarity=0.155  Sum_probs=43.3

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC---CCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM---THENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      .+.++.|....+|++.  .+++.+.+|.-...     ....+..|.+-|+.|   ..-.+++++++.     ...+.-++
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G-----~~~~~~fL   89 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWG-----EYDDDAFL   89 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEE-----E-SSCCEE
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----eecCCceE
Confidence            5678889999999997  56788999976522     223466677777766   345677888776     33334499


Q ss_pred             EEecCc
Q 042681          117 VYELMD  122 (339)
Q Consensus       117 v~e~~~  122 (339)
                      ||||.+
T Consensus        90 lle~l~   95 (288)
T PF03881_consen   90 LLEFLE   95 (288)
T ss_dssp             EEE---
T ss_pred             EEEeec
Confidence            999985

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.83  E-value=0.0041  Score=54.83  Aligned_cols=74  Identities=20%  Similarity=0.354  Sum_probs=59.2

Q ss_pred             CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          109 EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       109 ~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ......|++|++.++.+.-.    +....+++..++.+.+..+.-+..+ ..=||++...||+|+ +|+|.|+||-+++.
T Consensus       296 de~~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             CCceEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            34456789999998766422    3456778888899888877777644 689999999999999 99999999999984

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.42  E-value=0.019  Score=47.23  Aligned_cols=86  Identities=19%  Similarity=0.270  Sum_probs=59.6

Q ss_pred             HHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 042681           78 AKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS  156 (339)
Q Consensus        78 ~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  156 (339)
                      .+.+.++.++++++.  .|+++..       .+...+.++.|+|-. ..         ...    .++..=+.+|.-.|+
T Consensus       102 ~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i---------~~~----N~i~agi~~L~~fH~  159 (308)
T PF07387_consen  102 DALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKI---------NFS----NFITAGIKDLMDFHS  159 (308)
T ss_pred             hhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCccc---------chh----HHHHHhHHHHHHhhc
Confidence            355678888888763  3666652       455668899999852 11         000    111222456777884


Q ss_pred             --CCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          157 --ANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       157 --~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                        .+.+|||..|+||+-|+.|.+||.|-+.-
T Consensus       160 ~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  160 ENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             cCCCeecCCCChhheeecCCCCEEecChhhh
Confidence              47999999999999999999999997654

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=96.34  E-value=0.056  Score=49.11  Aligned_cols=29  Identities=28%  Similarity=0.252  Sum_probs=24.5

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       157 ~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      ...||.|+-+.||+.+. +.+.++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence            46899999999998754 469999998874

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.26  E-value=0.0056  Score=56.36  Aligned_cols=171  Identities=16%  Similarity=0.172  Sum_probs=102.7

Q ss_pred             hHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 042681           77 DAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS  156 (339)
Q Consensus        77 ~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  156 (339)
                      ...+++....+++.+.|++...++++..    .......+|||+++.++.+.+..+. +......               
T Consensus        25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r----~~~~r~IVV~e~~~~Sled~~~~~~-l~~~s~~---------------   84 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQHDNLCQYLDFSR----GKHERVIVVMEHYTMSLEDILKTGN-LKDESLL---------------   84 (725)
T ss_pred             cHHHHhhhhHHHHhhcCccceeeEeeec----CccceEEEEehhhccchHHHHHhcc-cchhhhc---------------
Confidence            3467788899999999999999998874    2334489999999999999987644 2211111               


Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecccccccCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc
Q 042681          157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD  236 (339)
Q Consensus       157 ~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~  236 (339)
                         +|+=+ +-|+       ++.+| .+....       +     .+...++|+|++|.++.+...|...+....   ..
T Consensus        85 ---~~~~~-~~~~-------~~~td-~~~t~~-------~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~~---~s  137 (725)
T KOG1093|consen   85 ---AHGVL-HLNI-------IYITD-HFLTKY-------P-----SPIGPKSDVWSLGFIILELYLGISLEAELT---ES  137 (725)
T ss_pred             ---ccccc-eehh-------hhccc-cccccC-------C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHHH---HH
Confidence               22211 1111       22222 111110       1     111138999999999999998865432111   00


Q ss_pred             hHHHHHhhCCCCCCCCcc-----ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          237 NARRYVKQLPHVPKQPFS-----QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      .....+......+.....     ...-.++....++..+|+...|..||...++.+++-|..+
T Consensus       138 ~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  138 EYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            001111111111110000     0012356668899999999999999999999999999876

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.84  E-value=0.34  Score=43.12  Aligned_cols=29  Identities=31%  Similarity=0.412  Sum_probs=24.8

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          157 ANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       157 ~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .++||+|+.+.||+++ + .+.++||+.+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            4799999999999995 4 588999999854

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.43  E-value=0.025  Score=58.88  Aligned_cols=202  Identities=15%  Similarity=0.043  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHH
Q 042681           79 KRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK----QALTDDHCQYFLYQLLRGLKY  153 (339)
Q Consensus        79 ~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~  153 (339)
                      +....|..-++...|+++...+.-.+.   ......+..++|+. |.+++.+.++    .+.....+.....+.+.+..-
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccch
Confidence            334455555666789999888877654   33445689999998 8999998654    344445555555555777777


Q ss_pred             HHhCC-----cccCCCCCCCeeeccCCCeEEeeccccc-ccCCCCccc----------cccccccccCCCCccHHHHHHH
Q 042681          154 IHSAN-----VLHRDLKPSNLLLNANCDLKICDFGLAR-TTSETDFMT----------EYVVTRWDTLFPGKDYVQQLTM  217 (339)
Q Consensus       154 LH~~g-----ivH~dikp~NIli~~~~~ikL~Dfg~~~-~~~~~~~~~----------~~~~~~~~~~~~~d~~~~g~~~  217 (339)
                      +|+..     -+|+++|+-|.+|..+.+++++++|+.+ +.....+..          +.+........++|+|..++.+
T Consensus      1351 ~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred             hhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence            77542     7889999999999999999999999998 333222221          2222233455567788778888


Q ss_pred             HHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          218 ITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       218 ~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                      |..--|..++-..         ...................-.|.+.-.....+|-+.-..||.-...+.-+.|-
T Consensus      1431 y~rs~~n~~fi~f---------lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFF---------LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHhcccHHHHHH---------HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            7766555442111         00111111111111111111234444455556666667788777777665553

>PTZ00296 choline kinase; Provisional

Probab=95.39  E-value=0.25  Score=45.90  Aligned_cols=29  Identities=24%  Similarity=0.403  Sum_probs=24.4

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          158 NVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       158 givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .+||+|+-+.||+.+.+ .+.|+||..|..
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg~  313 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSGY  313 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeeccccc
Confidence            48999999999987654 499999988743

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.89  E-value=0.049  Score=46.93  Aligned_cols=45  Identities=33%  Similarity=0.407  Sum_probs=34.8

Q ss_pred             HHHHHHHHHHHHHhC--CcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          143 FLYQLLRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       143 i~~qi~~aL~~LH~~--givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .+..+-.++.-.+..  -.||+|+.|+|++.++.+.+.|+||..|..
T Consensus       137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            444444555555433  599999999999999999999999988754

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.85  E-value=0.024  Score=45.72  Aligned_cols=29  Identities=31%  Similarity=0.475  Sum_probs=25.4

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          158 NVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       158 givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      -.+|+|+.|.||+++.++ ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            379999999999998777 99999998854

>PRK06148 hypothetical protein; Provisional

Probab=94.85  E-value=0.4  Score=49.51  Aligned_cols=31  Identities=35%  Similarity=0.560  Sum_probs=26.3

Q ss_pred             CCcccCCCCCCCeeeccCC--CeE-Eeecccccc
Q 042681          157 ANVLHRDLKPSNLLLNANC--DLK-ICDFGLART  187 (339)
Q Consensus       157 ~givH~dikp~NIli~~~~--~ik-L~Dfg~~~~  187 (339)
                      .++||+|+.+.||+++.++  ++. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999875  555 999998754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.51  E-value=0.02  Score=47.50  Aligned_cols=30  Identities=37%  Similarity=0.634  Sum_probs=21.6

Q ss_pred             CcccCCCCCCCeee-ccCCCeEEeecccccc
Q 042681          158 NVLHRDLKPSNLLL-NANCDLKICDFGLART  187 (339)
Q Consensus       158 givH~dikp~NIli-~~~~~ikL~Dfg~~~~  187 (339)
                      .++|+|+.|.||++ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            59999999999999 8889999999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	339
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-79
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-79
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-79
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-79
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-79
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-79
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-79
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-79
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-79
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-79
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-79
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-79
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-79
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-79
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-78
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-78
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-78
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-78
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-78
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-78
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-78
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-78
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-78
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-78
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-77
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-77
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-77
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-77
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-76
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-73
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-72
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-72
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-72
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-72
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-72
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-72
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-72
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-72
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-72
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-72
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-72
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-72
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-72
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-72
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-72
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-72
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-72
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-72
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-72
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-72
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-72
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-72
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-72
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-72
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-72
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-72
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-72
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-72
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-72
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-72
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-72
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-72
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-72
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-72
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-72
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-71
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-71
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-71
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-71
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-71
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-71
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-71
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-71
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-71
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-71
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-71
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-71
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-71
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-71
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-71
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-71
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-71
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-71
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-71
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-71
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-71
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-71
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-71
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-70
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-70
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-69
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-66
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-66
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-64
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-54
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-54
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-54
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-54
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-54
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-54
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-54
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-54
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-54
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-54
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-54
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-54
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-54
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-54
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-53
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-53
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-53
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-53
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-53
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-52
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-52
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-52
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-52
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-52
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-52
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-52
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-52
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-52
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-51
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-51
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-51
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-51
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-51
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-50
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-48
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-48
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-48
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-46
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-45
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-33
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-33
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-32
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-32
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-32
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-32
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-32
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-32
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-32
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-32
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-32
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-32
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-32
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-32
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-32
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-32
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-32
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-31
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-31
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-31
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-31
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-31
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-31
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-31
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-31
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-31
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-31
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-31
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-31
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-31
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-31
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-31
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-31
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-31
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-31
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-31
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-31
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-31
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-31
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-31
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-30
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-29
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-28
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-28
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-28
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-28
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-27
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-27
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-27
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-27
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-27
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-27
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-27
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-27
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-27
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-27
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-26
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-26
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-26
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-26
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-26
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-26
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-26
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-26
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-26
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-26
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-26
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-26
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-25
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-25
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-25
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-25
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-24
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-23
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-23
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-23
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-23
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-23
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-23
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-23
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-23
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-22
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-22
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-22
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-22
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-22
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-21
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-21
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-21
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-21
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-21
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-20
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-20
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		6e-20
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-20
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-20
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-20
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-20
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-20
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-20
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-19
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-19
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-19
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-19
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-19
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-19
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-19
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-19
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-19
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-19
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-19
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-19
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-19
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-19
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-19
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-19
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-18
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-18
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-18
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-18
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-18
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-18
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-18
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-18
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-18
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-18
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-18
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-18
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-18
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-18
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-18
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-18
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-18
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-17
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-17
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-17
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-17
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-16
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-16
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-16
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-16
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-16
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-16
3soa_A	444	Full-Length Human Camkii Length = 444		2e-16
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-16
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-16
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-16
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-16
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-16
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-16
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-15
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-15
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-15
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-15
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-15
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-15
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		4e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-15
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-15
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-15
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-14
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-14
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-14
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-14
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-14
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-13
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-13
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-13
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-13
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-13
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-13
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-13
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-13
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-13
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-13
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-13
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-13
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-12
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-12
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-12
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-12
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-12
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-12
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-12
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-12
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-12
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-12
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		5e-12
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		5e-12
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		6e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-12
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-11
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-11
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-11
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-11
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-10
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-10
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-08
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-08
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-07
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-07
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-07
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-07
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		7e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		7e-07
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-06
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-06
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-06
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-06
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-06
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-06
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		1e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-05
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-05
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-05
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-05
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-05
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-05

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  292 bits (748), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 211/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 12  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLRE 69
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 70  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 128
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP+  
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQE 248
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 249 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 308
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 309 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 356

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  292 bits (748), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 211/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 16  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLRE 73
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 74  IKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 132
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 252
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 253 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 312
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL+  ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 313 PYLAQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 360

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  292 bits (747), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 210/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 22  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLRE 79
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 80  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 138
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 139 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 258
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 259 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 318
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 319 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 366

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  292 bits (747), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 210/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLRE 71
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 250
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 251 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 310
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 311 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 358

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  292 bits (747), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 210/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 34  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLRE 91
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 92  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 150
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 270
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 271 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 330
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 331 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 378

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  292 bits (747), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 210/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 16  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLRE 73
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 74  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 132
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 252
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 253 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 312
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 313 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 360

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  291 bits (746), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 210/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLRE 71
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 250
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 251 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 310
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 311 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 358

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  291 bits (746), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 210/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 12  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLRE 69
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 70  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 128
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 248
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 249 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 308
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 309 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 356

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  291 bits (746), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 210/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 19  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLRE 76
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 77  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 135
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 255
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 256 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 315
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 316 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 363

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  291 bits (746), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 210/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 20  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLRE 77
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 78  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 136
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 137 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 256
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 257 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 316
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 317 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 364

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  291 bits (746), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 210/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 11  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLRE 68
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 69  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 127
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 128 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 247
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 248 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 307
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 308 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 355

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  291 bits (746), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 210/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLRE 75
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 315 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 362

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  290 bits (743), Expect = 6e-79,   Method: Compositional matrix adjust.
 Identities = 160/348 (45%), Positives = 210/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAI+KI+  F+++   +R LRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIRKIS-PFEHQTYCQRTLRE 75
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 315 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 362

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  290 bits (743), Expect = 6e-79,   Method: Compositional matrix adjust.
 Identities = 161/348 (46%), Positives = 209/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLRE 75
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL+++++  Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKC-QHLSNDHICYFL 134
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 315 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 362

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  289 bits (740), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 165/361 (45%), Positives = 214/361 (59%), Gaps = 58/361 (16%)
Query: 19  KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA 78
           K + YNI  + FQ+ S        +G GAYG+VCSA +  T E VAIKKI   FD  + A
Sbjct: 3   KRIVYNISSD-FQLKSL-------LGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFA 53
Query: 79  KRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDD 138
            R LREIK+L H  HENI+ + +I  P   E FN+VYI+ ELM TDLH++I S Q L+DD
Sbjct: 54  LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDD 112
Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----------- 187
           H QYF+YQ LR +K +H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR            
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 188 TSETDFMTEYVVTRW--------------------------------DTLFPGKDYVQQL 215
           T +   MTEYV TRW                                  +FPG+DY  QL
Sbjct: 173 TGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232
Query: 216 TMITELLGSP-DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVF 274
            +I  ++G+P  D+DL  + S  AR Y+K LP  P  P  + FP ++P  IDL +RMLVF
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292
Query: 275 DPAKRITVEEALNHPYLSSLHEINEEPTC-PYP---FNFDFEQTSMNEEDIKELILRECL 330
           DPAKRIT +EAL HPYL + H+ N+EP   P P   F FD  + ++  +D+K+LI  E  
Sbjct: 293 DPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
Query: 331 N 331
           +
Sbjct: 353 S 353

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  288 bits (738), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 160/348 (45%), Positives = 209/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLRE 71
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN   DLKICDFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 250
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 251 DLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 310
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 311 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 358

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  288 bits (736), Expect = 4e-78,   Method: Compositional matrix adjust.
 Identities = 160/348 (45%), Positives = 209/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLRE 71
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN   DLKICDFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 250
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 251 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 310
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 311 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 358

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  288 bits (736), Expect = 4e-78,   Method: Compositional matrix adjust.
 Identities = 160/348 (45%), Positives = 209/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYXQRTLRE 75
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN   DLKICDFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 315 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 362

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  288 bits (736), Expect = 4e-78,   Method: Compositional matrix adjust.
 Identities = 160/348 (45%), Positives = 209/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLRE 75
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN   DLKICDFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 315 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 362

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  287 bits (735), Expect = 6e-78,   Method: Compositional matrix adjust.
 Identities = 160/348 (45%), Positives = 209/348 (60%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 16  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLRE 73
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 74  IKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 132
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN   DLKICDFGLAR        T F+TEYV T
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 252
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL    +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 253 DLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 312
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL+  ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 313 PYLAQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 360

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  287 bits (734), Expect = 7e-78,   Method: Compositional matrix adjust.
 Identities = 150/332 (45%), Positives = 205/332 (61%), Gaps = 38/332 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG GAYG+V SA    T ++VAIKKI NAFD   +AKR LRE+K+L H  H+NI+ +
Sbjct: 59  IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI 118
Query: 100 KDII-PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           KDI+ P +   +F  VY+V +LM++DLHQII S Q LT +H +YFLYQLLRGLKY+HSA 
Sbjct: 119 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ 178
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLART--TSETD---FMTEYVVTRW----------- 202
           V+HRDLKPSNLL+N NC+LKI DFG+AR   TS  +   FMTEYV TRW           
Sbjct: 179 VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH 238
Query: 203 ---------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRY 241
                                  LFPGK+YV QL +I  +LG+P  + +  + ++  R Y
Sbjct: 239 EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAY 298
Query: 242 VKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
           ++ LP     P+   +P     A+ L  RML F+P+ RI+   AL HP+L+  H+ ++EP
Sbjct: 299 IQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEP 358
Query: 302 TCPYPFNFDFEQTSMNEEDIKELILRECLNFH 333
            C  PF+F F++ ++  E IKE I+ E  +FH
Sbjct: 359 DCAPPFDFAFDREALTRERIKEAIVAEIEDFH 390

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  286 bits (733), Expect = 9e-78,   Method: Compositional matrix adjust.
 Identities = 150/332 (45%), Positives = 205/332 (61%), Gaps = 38/332 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG GAYG+V SA    T ++VAIKKI NAFD   +AKR LRE+K+L H  H+NI+ +
Sbjct: 60  IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI 119
Query: 100 KDII-PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           KDI+ P +   +F  VY+V +LM++DLHQII S Q LT +H +YFLYQLLRGLKY+HSA 
Sbjct: 120 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ 179
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLART--TSETD---FMTEYVVTRW----------- 202
           V+HRDLKPSNLL+N NC+LKI DFG+AR   TS  +   FMTEYV TRW           
Sbjct: 180 VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH 239
Query: 203 ---------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRY 241
                                  LFPGK+YV QL +I  +LG+P  + +  + ++  R Y
Sbjct: 240 EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAY 299
Query: 242 VKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
           ++ LP     P+   +P     A+ L  RML F+P+ RI+   AL HP+L+  H+ ++EP
Sbjct: 300 IQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEP 359
Query: 302 TCPYPFNFDFEQTSMNEEDIKELILRECLNFH 333
            C  PF+F F++ ++  E IKE I+ E  +FH
Sbjct: 360 DCAPPFDFAFDREALTRERIKEAIVAEIEDFH 391

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  286 bits (733), Expect = 9e-78,   Method: Compositional matrix adjust.
 Identities = 159/348 (45%), Positives = 208/348 (59%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLRE 75
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+ E V T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 315 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 362

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  286 bits (733), Expect = 9e-78,   Method: Compositional matrix adjust.
 Identities = 159/348 (45%), Positives = 208/348 (59%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 19  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLRE 76
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 77  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 135
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+ E V T
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 255
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 256 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 315
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 316 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 363

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  286 bits (733), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 164/361 (45%), Positives = 213/361 (59%), Gaps = 58/361 (16%)
Query: 19  KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA 78
           K + YNI  + FQ+ S        +G GAYG+VCSA +  T E VAIKKI   FD  + A
Sbjct: 3   KRIVYNISSD-FQLKSL-------LGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFA 53
Query: 79  KRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDD 138
            R LREIK+L H  HENI+ + +I  P   E FN+VYI+ ELM TDLH++I S Q L+DD
Sbjct: 54  LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDD 112
Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----------- 187
           H QYF+YQ LR +K +H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR            
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 188 TSETDFMTEYVVTRW--------------------------------DTLFPGKDYVQQL 215
           T +   MTE V TRW                                  +FPG+DY  QL
Sbjct: 173 TGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232
Query: 216 TMITELLGSP-DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVF 274
            +I  ++G+P  D+DL  + S  AR Y+K LP  P  P  + FP ++P  IDL +RMLVF
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292
Query: 275 DPAKRITVEEALNHPYLSSLHEINEEPTC-PYP---FNFDFEQTSMNEEDIKELILRECL 330
           DPAKRIT +EAL HPYL + H+ N+EP   P P   F FD  + ++  +D+K+LI  E  
Sbjct: 293 DPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
Query: 331 N 331
           +
Sbjct: 353 S 353

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  286 bits (732), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 163/361 (45%), Positives = 213/361 (59%), Gaps = 58/361 (16%)
Query: 19  KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA 78
           K + YNI  + FQ+ S        +G GAYG+VCSA +  T E VAIKKI   FD  + A
Sbjct: 3   KRIVYNISSD-FQLKSL-------LGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFA 53
Query: 79  KRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDD 138
            R LREIK+L H  HENI+ + +I  P   E FN+VYI+ ELM TDLH++I S Q L+DD
Sbjct: 54  LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDD 112
Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----------- 187
           H QYF+YQ LR +K +H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR            
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 188 TSETDFMTEYVVTRW--------------------------------DTLFPGKDYVQQL 215
           T +   M E+V TRW                                  +FPG+DY  QL
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232
Query: 216 TMITELLGSP-DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVF 274
            +I  ++G+P  D+DL  + S  AR Y+K LP  P  P  + FP ++P  IDL +RMLVF
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292
Query: 275 DPAKRITVEEALNHPYLSSLHEINEEPTC-PYP---FNFDFEQTSMNEEDIKELILRECL 330
           DPAKRIT +EAL HPYL + H+ N+EP   P P   F FD  + ++  +D+K+LI  E  
Sbjct: 293 DPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
Query: 331 N 331
           +
Sbjct: 353 S 353

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  285 bits (728), Expect = 3e-77,   Method: Compositional matrix adjust.
 Identities = 159/348 (45%), Positives = 208/348 (59%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLRE 71
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN   DLKI DFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 250
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 251 DLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 310
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 311 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 358

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  284 bits (727), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 158/348 (45%), Positives = 206/348 (59%), Gaps = 39/348 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI+  F+++   +R LRE
Sbjct: 34  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLRE 91
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           IK+L    HENI+ + DII     E+  DVY+V  LM  DL++++++ Q L++DH  YFL
Sbjct: 92  IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFL 150
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLLLN   DLKICDFGLAR        T F+TEYV T
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 270
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL H
Sbjct: 271 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 330
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           PYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 331 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 378

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  281 bits (719), Expect = 4e-76,   Method: Compositional matrix adjust.
 Identities = 156/346 (45%), Positives = 205/346 (59%), Gaps = 39/346 (11%)
Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           + G  F V  +Y   LQ IG GAYG+V SA +   K  VAIKKI+  F+++   +R LRE
Sbjct: 34  VKGQPFDVGPRYTQ-LQYIGEGAYGMVSSAYDHVRKTRVAIKKIS-PFEHQTYCQRTLRE 91
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           I++L    HEN++ ++DI+     E   DVYIV +LM+TDL+++++S+Q L++DH  YFL
Sbjct: 92  IQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ-LSNDHICYFL 150
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----SETDFMTEYVVT 200
           YQ+LRGLKYIHSANVLHRDLKPSNLL+N  CDLKICDFGLAR        T F+TE V T
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVAT 210
Query: 201 RW--------------------------------DTLFPGKDYVQQLTMITELLGSPDDS 228
           RW                                  +FPGK Y+ QL  I  +LGSP   
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 270
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           DL  + +  AR Y++ LP   K  +++ FP     A+DL +RML F+P KRITVEEAL H
Sbjct: 271 DLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAH 330
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           PYL   ++  +EP    PF F  E   + +E +KELI +E   F P
Sbjct: 331 PYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQP 376

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  271 bits (693), Expect = 4e-73,   Method: Compositional matrix adjust.
 Identities = 145/338 (42%), Positives = 201/338 (59%), Gaps = 38/338 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VCS+ + ++  ++A+KK++  F + I AKR  RE++L
Sbjct: 45  TIWEVPERY-QTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 162
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 163 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 220
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL  I  L G+P  S +  + 
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMP 280
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S  AR Y+  LP +PK+ F+  F   +P+A+DL E+MLV D  KRIT  EAL HPY S  
Sbjct: 281 SHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQY 340
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           H+ ++EP    P++  FE   +  E+ K L   E  +F
Sbjct: 341 HDPDDEPESE-PYDQSFESRQLEIEEWKRLTYEEVCSF 377

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  269 bits (687), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  269 bits (687), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 144/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    PF+  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PFDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  269 bits (687), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 35  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 152
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 210
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 270
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 271 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 331 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 369

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  269 bits (687), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 36  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 153
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 211
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 271
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 272 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 332 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 370

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  269 bits (687), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 22  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 258 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 318 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  268 bits (686), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 205/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 23  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRW    
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAP 198
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 319 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  268 bits (686), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 26  TIWEVPERY-QNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 143
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 144 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 201
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 261
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 262 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 321
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 322 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 360

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  268 bits (686), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 12  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 129
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 187
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 308 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  268 bits (685), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  268 bits (684), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 28  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 145
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 203
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 324 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 362

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  268 bits (684), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 23  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 198
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 319 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  268 bits (684), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 18  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 314 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 39  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 156
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 214
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 274
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 335 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 373

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 27  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 144
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 202
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 262
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 323 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 361

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 22  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 318 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 21  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 196
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 317 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 22  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 318 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 28  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 145
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 203
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 324 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 362

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 28  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 145
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 203
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 324 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 362

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 35  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 152
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 210
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 270
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 271 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 331 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 369

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 18  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 314 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 36  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 153
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 211
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 271
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 272 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 332 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 370

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  267 bits (683), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 21  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 196
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 317 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  267 bits (683), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 15  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 132
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 133 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 190
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 250
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 251 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 310
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 311 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 349

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  267 bits (683), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 12  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 129
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 187
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 308 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  267 bits (683), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 13  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 130
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 188
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 248
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 309 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 347

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  267 bits (682), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 14  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 131
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 132 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 189
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 249
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 250 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 309
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 310 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 348

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  267 bits (682), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 12  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  + LTDDH Q+ +YQ
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK-LTDDHVQFLIYQ 129
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 187
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 308 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  267 bits (682), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 18  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 314 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  267 bits (682), Expect = 7e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 13  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 130
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 188
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 248
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 309 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 347

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  267 bits (682), Expect = 7e-72,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  266 bits (681), Expect = 9e-72,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 23  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRW    
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAP 198
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++   E   +  ++ K L   E ++F P
Sbjct: 319 HDPDDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  266 bits (680), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI D+GLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  266 bits (679), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 39  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 156
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  YV TRW    
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGYVATRWYRAP 214
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 274
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 335 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 373

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  266 bits (679), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 141/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  +V TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  266 bits (679), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P +  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PTDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  265 bits (678), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 141/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  +V TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  265 bits (678), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 204/340 (60%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 23  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRW    
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAP 198
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++   E   +  ++ K L   E ++F P
Sbjct: 319 HDPDDEPVAD-PYDQSSESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  265 bits (678), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P +  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PRDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  265 bits (677), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 141/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 12  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 129
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  +V TRW    
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAP 187
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 308 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  265 bits (677), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI  FGLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  265 bits (677), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P +  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PQDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  265 bits (676), Expect = 4e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 22  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRW    
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 318 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  264 bits (675), Expect = 4e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DF LAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  264 bits (675), Expect = 5e-71,   Method: Compositional matrix adjust.
 Identities = 136/328 (41%), Positives = 196/328 (59%), Gaps = 37/328 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+P+G GAYG VCSA ++  +++VA+KK++  F + I A+R  RE++LL H+ HEN++ +
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D+  P    E F++VY+V  LM  DL+ I++  QAL+D+H Q+ +YQLLRGLKYIHSA 
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAG 143
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+ +N +C+L+I DFGLAR   E   MT YV TRW                
Sbjct: 144 IIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 203 ----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP 246
                             LFPG DY+ QL  I E++G+P    L  + S++AR Y++ LP
Sbjct: 202 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 261
Query: 247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYP 306
            +P++  S  F   +P+AIDL  RMLV D  +R++  EAL H Y S  H+  +EP    P
Sbjct: 262 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEAE-P 320
Query: 307 FNFDFEQTSMNEEDIKELILRECLNFHP 334
           ++   E      E+ KEL  +E L+F P
Sbjct: 321 YDESVEAKERTLEEWKELTYQEVLSFKP 348

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  264 bits (675), Expect = 5e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI D GLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  264 bits (675), Expect = 5e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  264 bits (674), Expect = 5e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 18  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRW    
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 314 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  264 bits (674), Expect = 6e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI D GLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  264 bits (674), Expect = 6e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT  V TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGXVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  264 bits (674), Expect = 6e-71,   Method: Compositional matrix adjust.
 Identities = 143/340 (42%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L PIG GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 21  TIWEVPERY-QNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRW    
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAP 196
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 317 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  264 bits (674), Expect = 7e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI D GLAR T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  264 bits (674), Expect = 7e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 27  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 144
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRW    
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAP 202
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 262
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 323 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 361

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  263 bits (673), Expect = 8e-71,   Method: Compositional matrix adjust.
 Identities = 141/340 (41%), Positives = 202/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 36  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 153
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M   V TRW    
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGXVATRWYRAP 211
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 271
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 272 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 332 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 370

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  263 bits (673), Expect = 9e-71,   Method: Compositional matrix adjust.
 Identities = 142/340 (41%), Positives = 203/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 21  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTDDH Q+ +YQ
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRW    
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAP 196
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++  FE   +  ++ K L   E ++F P
Sbjct: 317 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  262 bits (669), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 141/340 (41%), Positives = 202/340 (59%), Gaps = 38/340 (11%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
            +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I AKR  RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 88  LCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           L HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++S Q LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
           +LRGLKYIHSA+++HRDLKPSNL +N + +LKI DFGL R T   D MT YV TRW    
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD--DEMTGYVATRWYRAP 191
Query: 203 ----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR 234
                                        TLFPG D++ QL +I  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL H Y +  
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           H+ ++EP    P++   E   +  ++ K L   E ++F P
Sbjct: 312 HDPDDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  261 bits (667), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 135/326 (41%), Positives = 195/326 (59%), Gaps = 37/326 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+P+G GAYG VCSA ++  +++VA+KK++  F + I A+R  RE++LL H+ HEN++ +
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D+  P    E F++VY+V  LM  DL+ I++S QAL+D+H Q+ +YQLLRGLKYIHSA 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+ +N + +L+I DFGLAR   E   MT YV TRW                
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 203 ----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP 246
                             LFPG DY+ QL  I E++G+P    L  + S++AR Y++ LP
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYP 306
            +P++  S  F   +P+AIDL  RMLV D  +R++  EAL H Y S  H+  +EP    P
Sbjct: 270 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEAE-P 328
Query: 307 FNFDFEQTSMNEEDIKELILRECLNF 332
           ++   E      E+ KEL  +E L+F
Sbjct: 329 YDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 134/326 (41%), Positives = 194/326 (59%), Gaps = 37/326 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+P+G GAYG VCSA ++  +++VA+KK++  F + I A+R  RE++LL H+ HEN++ +
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D+  P    E F++VY+V  LM  DL+ I++  QAL+D+H Q+ +YQLLRGLKYIHSA 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+ +N + +L+I DFGLAR   E   MT YV TRW                
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 203 ----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP 246
                             LFPG DY+ QL  I E++G+P    L  + S++AR Y++ LP
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYP 306
            +P++  S  F   +P+AIDL  RMLV D  +R++  EAL H Y S  H+  +EP    P
Sbjct: 270 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEAE-P 328
Query: 307 FNFDFEQTSMNEEDIKELILRECLNF 332
           ++   E      E+ KEL  +E L+F
Sbjct: 329 YDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  248 bits (633), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 135/338 (39%), Positives = 186/338 (55%), Gaps = 38/338 (11%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           +++   YV P   +G GAYG VCSA++  + E+VAIKK++  F + I AKR  RE+ LL 
Sbjct: 20  WELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78
Query: 90  HMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL 148
           HM HEN++ + D+  P      F D Y+V   M TDL +I+  K   +++  QY +YQ+L
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQML 136
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW------ 202
           +GLKYIHSA V+HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRW      
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEV 194
Query: 203 --------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD 236
                                      TLF GKDY+ QLT I ++ G P    +  L   
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 237 NARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
            A+ Y++ LP  P++ F+Q FP  SP A DL E+ML  D  KR+T  +AL HP+     +
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314
Query: 297 INEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
             EE     PF+   E   +  ++ K+ I +E +NF P
Sbjct: 315 PEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  247 bits (630), Expect = 8e-66,   Method: Compositional matrix adjust.
 Identities = 134/338 (39%), Positives = 186/338 (55%), Gaps = 38/338 (11%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           +++   YV P   +G GAYG VCSA++  + E+VAIKK++  F + I AKR  RE+ LL 
Sbjct: 38  WELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 96
Query: 90  HMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL 148
           HM HEN++ + D+  P      F D Y+V   M TDL +I+  +   +++  QY +YQ+L
Sbjct: 97  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGME--FSEEKIQYLVYQML 154
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW------ 202
           +GLKYIHSA V+HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRW      
Sbjct: 155 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEV 212
Query: 203 --------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD 236
                                      TLF GKDY+ QLT I ++ G P    +  L   
Sbjct: 213 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272
Query: 237 NARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
            A+ Y++ LP  P++ F+Q FP  SP A DL E+ML  D  KR+T  +AL HP+     +
Sbjct: 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332
Query: 297 INEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
             EE     PF+   E   +  ++ K+ I +E +NF P
Sbjct: 333 PEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 370

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 135/358 (37%), Positives = 200/358 (55%), Gaps = 39/358 (10%)
Query: 14  PLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD 73
           P   G Y Q  +    ++V + Y   LQP+G GAYG VCSAV+  T  +VAIKK+   F 
Sbjct: 6   PARSGFYRQ-EVTKTAWEVRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 63
Query: 74  NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSK 132
           + + AKR  RE++LL HM HEN++ + D+  P +  + F D Y+V   M TDL ++++ +
Sbjct: 64  SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE 123
Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           + L +D  Q+ +YQ+L+GL+YIH+A ++HRDLKP NL +N +C+LKI DFGLAR      
Sbjct: 124 K-LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 181
Query: 193 FMTEYVVTRW--------------------------------DTLFPGKDYVQQLTMITE 220
            M   VVTRW                                 TLF G D++ QL  I +
Sbjct: 182 -MXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240
Query: 221 LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRI 280
           + G+P    +  L+SD A+ Y+K LP + K+ F+    N SP+A++L E+MLV D  +R+
Sbjct: 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300
Query: 281 TVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDHML 338
           T  EAL HPY  SLH+  +EP     ++  F+      ++ K +  +E L+F P   L
Sbjct: 301 TAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQL 357

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  209 bits (532), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 126/337 (37%), Positives = 185/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 30  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 147
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR                 
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 207
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 208 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 266
Query: 248 VPKQPFSQKFPN------------MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 267 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 326
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 327 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 363

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  209 bits (532), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 126/337 (37%), Positives = 185/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 184
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR                 
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 244
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 245 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 303
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 304 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 364 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 400

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  209 bits (532), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 126/337 (37%), Positives = 185/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 30  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 147
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR                 
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 207
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 208 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 266
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 267 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 326
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 327 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 363

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  209 bits (532), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 126/337 (37%), Positives = 185/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR                 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 326 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 362

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  209 bits (532), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 126/337 (37%), Positives = 185/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR                 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 326 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 362

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 126/337 (37%), Positives = 185/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 28  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 87
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 145
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR                 
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 205
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 206 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 264
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 265 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 324
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 325 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 361

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 126/337 (37%), Positives = 185/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 23  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 140
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR                 
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 200
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 201 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 259
Query: 248 VPKQPFSQKFPN------------MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 260 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 319
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 320 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 356

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 126/337 (37%), Positives = 185/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 22  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 139
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR                 
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 199
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 200 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 258
Query: 248 VPKQPFSQKFPN------------MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 319 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 355

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 126/337 (37%), Positives = 185/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 184
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR                 
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 244
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 245 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 303
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 304 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 364 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 400

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  209 bits (531), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 126/337 (37%), Positives = 185/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 23  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 140
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR                 
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 200
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 201 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 259
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 260 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 319
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 320 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 356

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  208 bits (530), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 127/359 (35%), Positives = 190/359 (52%), Gaps = 49/359 (13%)
Query: 18  GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID 77
            ++    +  + F V  +Y   L+PIG GA GIVC+A ++     VA+KK++  F N+  
Sbjct: 6   SQFYSVQVADSTFTVLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 64
Query: 78  AKRILREIKLLCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALT 136
           AKR  RE+ LL  + H+NI+ + ++  P    E+F DVY+V ELMD +L Q+I  +  L 
Sbjct: 65  AKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME--LD 122
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE 196
            +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART S    MT 
Sbjct: 123 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTP 182
Query: 197 YVVTRW-------------------------------DTLFPGKDYVQQLTMITELLGSP 225
           YVVTR+                                 +F G D++ Q   + E LG+P
Sbjct: 183 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 242
Query: 226 DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM------------SPVAIDLAERMLV 273
               +  L+    R YV+  P  P   F + FP+             +  A DL  +MLV
Sbjct: 243 SAEFMAALQP-TVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLV 301
Query: 274 FDPAKRITVEEALNHPYLSSLHEINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
            DP KRI+V+EAL HPY++  ++  E E   P  ++   E+     E+ KELI +E ++
Sbjct: 302 IDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMD 360

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  208 bits (529), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 125/337 (37%), Positives = 184/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME--LDHERMSYLLYQMLXGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++  LKI DFGLART   +  MT YVVTR                 
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 265
Query: 248 VPKQPFSQKFPN------------MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 326 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 362

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  207 bits (527), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 125/337 (37%), Positives = 184/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME--LDHERMSYLLYQMLXGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++  LKI DFGLART   +  MT YVVTR                 
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 265
Query: 248 VPKQPFSQKFPN------------MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 326 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 362

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  207 bits (527), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 125/337 (37%), Positives = 184/337 (54%), Gaps = 48/337 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 22  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME--LDHERMSYLLYQMLXGIKHLHSAG 139
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++  LKI DFGLART   +  MT YVVTR                 
Sbjct: 140 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 199
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 200 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 258
Query: 248 VPKQPFSQKFPN------------MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 319 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 355

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  207 bits (526), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 127/359 (35%), Positives = 190/359 (52%), Gaps = 49/359 (13%)
Query: 19  KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA 78
           ++    +  + F V  +Y   L+PIG GA GIVC+A ++     VA+KK++  F N+  A
Sbjct: 9   QFYSVEVADSTFTVLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 67
Query: 79  KRILREIKLLCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTD 137
           KR  RE+ LL  + H+NI+ + ++  P    E+F DVY+V ELMD +L Q+I  +  L  
Sbjct: 68  KRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME--LDH 125
Query: 138 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEY 197
           +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART      MT Y
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY 185
Query: 198 VVTR-------------------WD------------TLFPGKDYVQQLTMITELLGSPD 226
           VVTR                   W              +F G D++ Q   + E LG+P 
Sbjct: 186 VVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPS 245
Query: 227 DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM------------SPVAIDLAERMLVF 274
              +  L+    R YV+  P  P   F + FP+             +  A DL  +MLV 
Sbjct: 246 AEFMAALQP-TVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVI 304
Query: 275 DPAKRITVEEALNHPYLSSLHEINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           DP KRI+V+EAL HPY++  ++  E E   P  ++   E+     E+ KELI +E +++
Sbjct: 305 DPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMDW 363

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 125/338 (36%), Positives = 186/338 (55%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 34  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 93
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 151
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR                 
Sbjct: 152 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 211
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 212 DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPK 270
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 271 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 330
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 331 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 368

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  205 bits (521), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 123/338 (36%), Positives = 185/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR+                
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 203 ---------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
                            LFPG D++ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 326 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  205 bits (521), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 125/338 (36%), Positives = 186/338 (55%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 23  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 82
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 140
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR                 
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 200
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 201 DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPK 259
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 260 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 319
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 320 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 357

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  204 bits (518), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 123/338 (36%), Positives = 185/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR+                
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 203 ---------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
                            LFPG D++ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 326 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 122/338 (36%), Positives = 184/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME--LDHERMSYLLYQMLVGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+++ ++  LKI DFGLART   +  MT YVVTR+                
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 203 ---------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
                            LFPG D++ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 326 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  203 bits (516), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 122/338 (36%), Positives = 184/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME--LDHERMSYLLYQMLVGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+++ ++  LKI DFGLART   +  MT YVVTR+                
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 203 ---------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
                            LFPG D++ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 326 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 123/338 (36%), Positives = 185/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 30  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 147
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR+                
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 207
Query: 203 ---------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
                            LFPG D++ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 208 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPK 266
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 267 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 327 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 364

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 123/338 (36%), Positives = 185/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT YVVTR+                
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 203 ---------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
                            LFPG D++ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 326 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  202 bits (514), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 122/338 (36%), Positives = 184/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+++ ++  LKI DFGLART   +  MT YVVTR+                
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 203 ---------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
                            LFPG D++ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 326 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  201 bits (512), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 122/338 (36%), Positives = 184/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+++ ++  LKI DFGLART   +  MT YVVTR+                
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 203 ---------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
                            LFPG D++ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 326 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  201 bits (510), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 129/388 (33%), Positives = 187/388 (48%), Gaps = 98/388 (25%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G+YG VC A +   K  VAIKKI   F++ ID KRILREI +L  + H+++VKV DI
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHR 162
           + P D EKF+++Y+V E+ D+D  ++ R+   LT+ H +  LY LL G+KY+HSA +LHR
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHR 180
Query: 163 DLKPSNLLLNANCDLKICDFGLARTTS--------------ETDF--------------M 194
           DLKP+N L+N +C +K+CDFGLART                E D               +
Sbjct: 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 195 TEYVVTRW-----------------DTLFPGKDYVQQLTMITELLG-------------- 223
           T +VVTRW                 D    G  + + L MI E +               
Sbjct: 241 TGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSC 300
Query: 224 ---SPD-----------------------------DSDLGFLRSDNARRYVKQLPHVPKQ 251
              SPD                             + D+  L  ++A+RY++  P     
Sbjct: 301 FPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360
Query: 252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH----EINEEPTCPYPF 307
             +++FP  S  AI L +RMLVF+P KRIT+ E L HP+   +     E N       PF
Sbjct: 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPF 420
Query: 308 NFDFEQTSMNEEDIKELILRECLNFHPD 335
           N   +  +M+E  ++   ++E   +HP+
Sbjct: 421 N---DWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  200 bits (509), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 121/338 (35%), Positives = 183/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIV +A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME--LDHERMSYLLYQMLVGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+++ ++  LKI DFGLART   +  MT YVVTR+                
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 203 ---------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
                            LFPG D++ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 326 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  200 bits (509), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 123/338 (36%), Positives = 185/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  M   VVTR                 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENV 206
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P  + +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQP-TVRNYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 326 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  199 bits (507), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 121/338 (35%), Positives = 184/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 31  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 90
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 148
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+++ ++C LKI DFGLART   +  M  +VVTR+                
Sbjct: 149 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENV 208
Query: 203 ---------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
                            LFPG D++ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 209 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPK 267
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 268 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 327
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 328 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 365

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  199 bits (507), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 126/346 (36%), Positives = 182/346 (52%), Gaps = 58/346 (16%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           F V  +Y   L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+ 
Sbjct: 20  FTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 90  HMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL 148
            + H+NI+ + ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQML 136
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR------- 201
            G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLART   +  MT YVVTR       
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 202 ------------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN 237
                       W              LFPG+DY+ Q   + E LG+P    +  L+   
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 255
Query: 238 ARRYVKQLPHVPKQPFSQKFPN------------MSPVAIDLAERMLVFDPAKRITVEEA 285
            R YV+  P      F + FP+             +  A DL  +MLV DPAKRI+V++A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 286 LNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           L HPY++            Y      ++     E+ KELI +E +N
Sbjct: 316 LQHPYINVW----------YXXXXXXDEREHTIEEWKELIYKEVMN 351

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  199 bits (506), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 123/338 (36%), Positives = 184/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++C LKI DFGLART   +  M   VVTR                 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENV 206
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 326 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  199 bits (506), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 125/336 (37%), Positives = 180/336 (53%), Gaps = 55/336 (16%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++     VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVY+V ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR----------------- 201
           ++HRDLKPSN+++ ++  LKI DFGLART   +  MT YVVTR                 
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 202 --WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
             W              LFPG+DY+ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPK 265
Query: 248 VPKQPFSQKFPN------------MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP+             +  A DL  +MLV DPAKRI+V++AL HPY++  +
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 296 EINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           +       P       E+    EE  KELI +E +N
Sbjct: 326 D-------PAXXXXXDEREHTIEE-WKELIYKEVMN 353

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  199 bits (505), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 122/338 (36%), Positives = 184/338 (54%), Gaps = 48/338 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+PIG GA GIVC+A ++  +  VAIKK++  F N+  AKR  RE+ L+  + H+NI+ +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 100 KDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++  P    E+F DVYIV ELMD +L Q+I+ +  L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---------------- 202
           ++HRDLKPSN+++ ++C LKI DFGLART   +  MT  VVTR+                
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENV 206
Query: 203 ---------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH 247
                            LFPG D++ Q   + E LG+P    +  L+    R YV+  P 
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPK 265
Query: 248 VPKQPFSQKFPNM------------SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
                F + FP++            +  A DL  +MLV D +KRI+V+EAL HPY++  +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 296 EINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNF 332
           + +E E   P   +   ++     E+ KELI +E ++ 
Sbjct: 326 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  195 bits (496), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 125/378 (33%), Positives = 189/378 (50%), Gaps = 86/378 (22%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IGRG+YG V  A +  T++ VAIKK+   F++ ID KRILREI +L  +  + I+++ D+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHR 162
           I P D  KF+++YIV E+ D+DL ++ ++   LT++H +  LY LL G  +IH + ++HR
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHR 153
Query: 163 DLKPSNLLLNANCDLKICDFGLART-TSETDF----------------------MTEYVV 199
           DLKP+N LLN +C +K+CDFGLART  SE D                       +T +VV
Sbjct: 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV 213
Query: 200 TRWDT-------------------------------------------LFPG-------- 208
           TRW                                             LFPG        
Sbjct: 214 TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSP 273
Query: 209 ---------KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
                    K    QL +I  ++G+P + DL  +      +Y+K  PH       QK+P+
Sbjct: 274 DRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE--PTCPYPFNFDFEQTSMN 317
           +S   I+L E ML F+P KRIT+++AL+HPYL  + +   E   T      FD +   ++
Sbjct: 334 ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLS 392
Query: 318 EEDIKELILRECLNFHPD 335
           E  ++ + L+E  +FHP+
Sbjct: 393 ETQLRYIFLKEVQSFHPE 410

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 112/320 (35%), Positives = 164/320 (51%), Gaps = 45/320 (14%)
Query: 18  GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI--------- 68
           G+    +++  L  + S Y    + I  G+YG VC+ V+SE    VAIK++         
Sbjct: 6   GEAAMRDLIAELHAMQSPYTVQ-RFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRT 63
Query: 69  TNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQI 128
            N   +    KR+LREI+LL H  H NI+ ++DI    ++   + +Y+V ELM TDL Q+
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123
Query: 129 IRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
           I  ++  ++  H QYF+Y +L GL  +H A V+HRDL P N+LL  N D+ ICDF LAR 
Sbjct: 124 IHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 188 TSETDFMTEYVVTRW--------------------------------DTLFPGKDYVQQL 215
            +     T YV  RW                                  LF G  +  QL
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 216 TMITELLGSPDDSDLGFLRSDNARRYVK-QLPHVPKQPFSQKFPNMSPVAIDLAERMLVF 274
             I E++G+P   D+    S +AR Y++  L +VP + ++   P   PVA+DL  +ML F
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303
Query: 275 DPAKRITVEEALNHPYLSSL 294
           +P +RI+ E+AL HPY  SL
Sbjct: 304 NPQRRISTEQALRHPYFESL 323

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 112/320 (35%), Positives = 164/320 (51%), Gaps = 45/320 (14%)
Query: 18  GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI--------- 68
           G+    +++  L  + S Y    + I  G+YG VC+ V+SE    VAIK++         
Sbjct: 6   GEAAMRDLIAELHAMQSPYTVQ-RFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRT 63
Query: 69  TNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQI 128
            N   +    KR+LREI+LL H  H NI+ ++DI    ++   + +Y+V ELM TDL Q+
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123
Query: 129 IRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
           I  ++  ++  H QYF+Y +L GL  +H A V+HRDL P N+LL  N D+ ICDF LAR 
Sbjct: 124 IHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 188 TSETDFMTEYVVTRW--------------------------------DTLFPGKDYVQQL 215
            +     T YV  RW                                  LF G  +  QL
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 216 TMITELLGSPDDSDLGFLRSDNARRYVK-QLPHVPKQPFSQKFPNMSPVAIDLAERMLVF 274
             I E++G+P   D+    S +AR Y++  L +VP + ++   P   PVA+DL  +ML F
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303
Query: 275 DPAKRITVEEALNHPYLSSL 294
           +P +RI+ E+AL HPY  SL
Sbjct: 304 NPQRRISTEQALRHPYFESL 323

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  188 bits (477), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 122/380 (32%), Positives = 183/380 (48%), Gaps = 87/380 (22%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IGRG+YG V  A +    + VAIKK+   F++ ID KRILREI +L  +  + I+++ D+
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDL 95
Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHR 162
           I P D  KF+++YIV E+ D+DL ++ ++   LT+ H +  LY LL G K+IH + ++HR
Sbjct: 96  IIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHR 155
Query: 163 DLKPSNLLLNANCDLKICDFGLART-TSETDF-------------------------MTE 196
           DLKP+N LLN +C +KICDFGLART  S+ D                          +T 
Sbjct: 156 DLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTS 215
Query: 197 YVVTRWDT-------------------------------------------LFPG----- 208
           +VVTRW                                             LFPG     
Sbjct: 216 HVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFP 275
Query: 209 ------------KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK 256
                       K    QL +I  ++G+P + DL  +      +Y+K  P       S+K
Sbjct: 276 LSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDLSKK 335
Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQ-TS 315
           + ++S   IDL E ML F+  KRIT+++AL+HPYL  + + N E          F+    
Sbjct: 336 YSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFSTEKIILPFDDWMV 395
Query: 316 MNEEDIKELILRECLNFHPD 335
           ++E  ++ + L+E  +FH D
Sbjct: 396 LSETQLRYIFLKEIQSFHAD 415

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 113/337 (33%), Positives = 177/337 (52%), Gaps = 75/337 (22%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVK 98
           ++ +G+GAYGIV  +++  T E VA+KKI +AF N  DA+R  REI +L  ++ HENIV 
Sbjct: 14  VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           + +++   D ++  DVY+V++ M+TDLH +IR+   L   H QY +YQL++ +KY+HS  
Sbjct: 74  LLNVLRA-DNDR--DVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLART------------------TSETD----FMTE 196
           +LHRD+KPSN+LLNA C +K+ DFGL+R+                  T   D     +T+
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 197 YVVTRW--------------------------------DTLFPGKDYVQQLTMITELLGS 224
           YV TRW                                  +FPG   + QL  I  ++  
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDF 249
Query: 225 PDDSDLGFLRSDNARRYVKQLP------HVPKQPFSQKFPNM----------SPVAIDLA 268
           P + D+  ++S  A+  ++ L          K+    K+ N+          +  A+DL 
Sbjct: 250 PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309
Query: 269 ERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPY 305
           +++L F+P KRI+  +AL HP++S  H  NEEP C +
Sbjct: 310 DKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDH 346

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  177 bits (449), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 119/315 (37%), Positives = 170/315 (53%), Gaps = 53/315 (16%)
Query: 24  NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR 83
           NI G  F + S+Y+  L+P+G G  G+V SAV+++  + VAIKKI     +    K  LR
Sbjct: 3   NIHG--FDLGSRYMD-LKPLGCGGNGLVFSAVDNDCDKRVAIKKIV--LTDPQSVKHALR 57
Query: 84  EIKLLCHMTHENIVKVKDIIPPMDKE---------KFNDVYIVYELMDTDLHQIIRSKQA 134
           EIK++  + H+NIVKV +I+ P   +         + N VYIV E M+TDL  ++  +  
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE-QGP 116
Query: 135 LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARTT----S 189
           L ++H + F+YQLLRGLKYIHSANVLHRDLKP+NL +N  +  LKI DFGLAR      S
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 190 ETDFMTEYVVTRW--------------------------------DTLFPGKDYVQQLTM 217
               ++E +VT+W                                 TLF G   ++Q+ +
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236
Query: 218 ITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPA 277
           I E +    + D   L S     Y++     P +P +Q  P +S  A+D  E++L F P 
Sbjct: 237 ILESIPVVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPM 295
Query: 278 KRITVEEALNHPYLS 292
            R+T EEAL+HPY+S
Sbjct: 296 DRLTAEEALSHPYMS 310

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 105/289 (36%), Positives = 145/289 (50%), Gaps = 41/289 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G G YG+V  A +S+ +  VA+K+I  +A D  I +  I REI LL  + H NIV 
Sbjct: 26  LEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAI-REISLLKELHHPNIVS 83
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQII-RSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           + D+I          + +V+E M+ DL +++  +K  L D   + +LYQLLRG+ + H  
Sbjct: 84  LIDVI-----HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW----DTLFPGKDYV 212
            +LHRDLKP NLL+N++  LK+ DFGLAR         T  VVT W    D L   K Y 
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 213 QQL----------TMITE---LLGSPDDSDL----GFLRSDNARRY--VKQLPH------ 247
             +           MIT      G  DD  L      L + N R +  V++LP       
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258
Query: 248 --VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
               K+P+S   P      IDL   ML FDP KRI+  +A+NHPY   L
Sbjct: 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 103/289 (35%), Positives = 146/289 (50%), Gaps = 41/289 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G G YG+V  A +S+ +  VA+K+I  +A D  I +  I REI LL  + H NIV 
Sbjct: 26  LEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAI-REISLLKELHHPNIVS 83
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQII-RSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           + D+I          + +V+E M+ DL +++  +K  L D   + +LYQLLRG+ + H  
Sbjct: 84  LIDVI-----HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW----DTLFPGKDYV 212
            +LHRDLKP NLL+N++  LK+ DFGLAR         T  VVT W    D L   K Y 
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 213 QQL------TMITELL-------GSPDDSDL----GFLRSDNARRY--VKQLPH------ 247
             +       +  E++       G  DD  L      L + N R +  V++LP       
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258
Query: 248 --VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
               K+P+S   P      IDL   ML FDP KRI+  +A+NHPY   L
Sbjct: 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 101/301 (33%), Positives = 138/301 (45%), Gaps = 68/301 (22%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG G YG V  A N ET E VA+K++    D+       LREI LL  + H+NIV++
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSAN 158
            D++    K     + +V+E  D DL +   S    L  +  + FL+QLL+GL + HS N
Sbjct: 67  HDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW--------------- 202
           VLHRDLKP NLL+N N +LK+ DFGLAR         +  VVT W               
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 203 ------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ 244
                               LFPG D   QL  I  LLG+P +               +Q
Sbjct: 182 SIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTE---------------EQ 226
Query: 245 LPHVPKQPFSQKF-------------PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            P + K P  + +             P ++    DL + +L  +P +RI+ EEAL HPY 
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
Query: 292 S 292
           S
Sbjct: 287 S 287

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 75  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 188
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 246
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 247 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 75  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 188
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 246
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 247 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 68  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 181
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 239
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 68  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 239
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 68  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 239
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 68  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 239
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 67  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 238
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 72  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 185
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 243
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 244 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 67  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 238
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 69  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 182
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 240
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  134 bits (338), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 100/301 (33%), Positives = 138/301 (45%), Gaps = 68/301 (22%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG G YG V  A N ET E VA+K++    D+       LREI LL  + H+NIV++
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSAN 158
            D++    K     + +V+E  D DL +   S    L  +  + FL+QLL+GL + HS N
Sbjct: 67  HDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW--------------- 202
           VLHRDLKP NLL+N N +LK+ +FGLAR         +  VVT W               
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 203 ------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ 244
                               LFPG D   QL  I  LLG+P +               +Q
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE---------------EQ 226
Query: 245 LPHVPKQPFSQKF-------------PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            P + K P  + +             P ++    DL + +L  +P +RI+ EEAL HPY 
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
Query: 292 S 292
           S
Sbjct: 287 S 287

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  134 bits (337), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +D DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 71  LDVI-----HTENKLYLVFEHVDQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 242
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  134 bits (337), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 71  LDVI-----HTENKLYLVFEFLSMDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 242
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 69  LDVI-----HTENKLYLVFEFLSMDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 240
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 71  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 242
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 70  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 241
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 69  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 240
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 71  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 242
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 68  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 239
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 70  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 241
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 70  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 241
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 69  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 240
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 68  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 239
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 68  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 239
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 67  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 238
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 69  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 240
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+ KI    +        +REI LL  + H NIVK+
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 68  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 239
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+ KI    +        +REI LL  + H NIVK+
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 67  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 238
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 72  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 185
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 243
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 244 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 67  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 238
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL + + +  ALT       + +L+QLL+GL + HS
Sbjct: 68  LDVI-----HTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 239
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 132/288 (45%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL   + +  ALT       + +L+QLL+GL + HS
Sbjct: 70  LDVI-----HTENKLYLVFEFLSMDLKDFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 241
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 144/291 (49%), Gaps = 39/291 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G+YG+V    N +T + VAIKK   + D+ +  K  LREI++L  + H N+V + ++
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
                  +   +++V+E  D T LH++ R ++ + +   +   +Q L+ + + H  N +H
Sbjct: 71  F-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIH 125
Query: 162 RDLKPSNLLLNANCDLKICDFGLAR-TTSETDFMTEYVVTRW---------DT------- 204
           RD+KP N+L+  +  +K+CDFG AR  T  +D+  + V TRW         DT       
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVD 185
Query: 205 ----------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHV 248
                           L+PGK  V QL +I + LG           ++     VK     
Sbjct: 186 VWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPE 245
Query: 249 PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
             +P   KFPN+S  A+ L +  L  DP +R+T E+ L+HPY  ++ EI +
Sbjct: 246 DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 132/288 (45%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL   + +  ALT       + +L+QLL+GL + HS
Sbjct: 71  LDVI-----HTENKLYLVFEFLSMDLKDFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 242
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL   + +  ALT       + +L+QLL+GL + HS
Sbjct: 67  LDVI-----HTENKLYLVFEHVHQDLKTFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W             
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 238
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 132/288 (45%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL   + +  ALT       + +L+QLL+GL + HS
Sbjct: 71  LDVI-----HTENKLYLVFEFLHQDLKTFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 242
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 132/288 (45%), Gaps = 44/288 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIHS 156
            D+I        N +Y+V+E +  DL   + +  ALT       + +L+QLL+GL + HS
Sbjct: 68  LDVI-----HTENKLYLVFEFLHQDLKDFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW------------- 202
             VLHRDLKP NLL+N    +K+ DFGLAR            VVT W             
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                LFPG   + QL  I   LG+PD+     + S     Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 239
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+ 
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 93/300 (31%), Positives = 147/300 (49%), Gaps = 46/300 (15%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           FQ   KY   L  +G G+YG+V    N +T   VAIKK   + D+++  K  +REIKLL 
Sbjct: 21  FQSMEKY-ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLK 79
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLL 148
            + HEN+V + ++      +K    Y+V+E +D T L  +      L     Q +L+Q++
Sbjct: 80  QLRHENLVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQII 134
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW----- 202
            G+ + HS N++HRD+KP N+L++ +  +K+CDFG ART  +  +   + V TRW     
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
Query: 203 ---------------------------DTLFPGKDYVQQLTMITELLGS--PDDSDLGFL 233
                                      + LFPG   + QL  I   LG+  P   +   L
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE---L 251
Query: 234 RSDNARRYVKQLPHVP-KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
            + N      +LP +  ++P  +++P +S V IDLA++ L  DP KR    E L+H +  
Sbjct: 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 94/292 (32%), Positives = 133/292 (45%), Gaps = 43/292 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  +G G Y  V    +  T   VA+K+I    +       I RE+ LL  + H NIV +
Sbjct: 7   LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTL 65
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDH-CQYFLYQLLRGLKYIHSAN 158
            DII     EK   + +V+E +D DL Q +     + + H  + FL+QLLRGL Y H   
Sbjct: 66  HDII---HTEK--SLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTS-----------------------ETDFMT 195
           VLHRDLKP NLL+N   +LK+ DFGLAR  S                        TD+ T
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYST 180
Query: 196 E----------YVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDL-GFLRSDNARRYVKQ 244
           +          Y +     LFPG    +QL  I  +LG+P +    G L ++  + Y   
Sbjct: 181 QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY--N 238
Query: 245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
            P    +      P +     DL  ++L F+   RI+ E+A+ HP+  SL E
Sbjct: 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 91/286 (31%), Positives = 127/286 (44%), Gaps = 42/286 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG G YG+V  A N+   E  A+KKI    ++       +REI +L  + H NIVK+
Sbjct: 7   LEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D+I    +     + +V+E +D DL +++   +  L     + FL QLL G+ Y H   
Sbjct: 66  YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW--------------- 202
           VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT W               
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 203 -----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL 245
                              LFPG     QL  I  +LG+P+  +  +       +Y    
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN--WPNVTELPKYDPNF 238
Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                 P+      +    IDL  +ML  DP +RIT ++AL H Y 
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 91/286 (31%), Positives = 127/286 (44%), Gaps = 42/286 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG G YG+V  A N+   E  A+KKI    ++       +REI +L  + H NIVK+
Sbjct: 7   LEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D+I    +     + +V+E +D DL +++   +  L     + FL QLL G+ Y H   
Sbjct: 66  YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW--------------- 202
           VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT W               
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 203 -----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL 245
                              LFPG     QL  I  +LG+P+  +  +       +Y    
Sbjct: 181 TIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKN--WPNVTELPKYDPNF 238
Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                 P+      +    IDL  +ML  DP +RIT ++AL H Y 
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 127/286 (44%), Gaps = 42/286 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG G YG+V  A N+   E  A+KKI    ++       +REI +L  + H NIVK+
Sbjct: 7   LEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D+I    +     + +V+E +D DL +++   +  L     + FL QLL G+ Y H   
Sbjct: 66  YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW--------------- 202
           VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT W               
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 203 -----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL 245
                              LFPG     QL  I  +LG+P+  +  +       +Y    
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN--WPNVTELPKYDPNF 238
Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                 P+      +    IDL  +ML  DP +RIT ++AL H Y 
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 96/303 (31%), Positives = 139/303 (45%), Gaps = 51/303 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-----RILREIKLLCHMTHENIV 97
           +G G +  V  A +  T + VAIKKI     +R +AK       LREIKLL  ++H NI+
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIK--LGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHS 156
            + D          +++ +V++ M+TDL  II+     LT  H + ++   L+GL+Y+H 
Sbjct: 76  GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW----DTLF----- 206
             +LHRDLKP+NLLL+ N  LK+ DFGLA++  S        VVTRW    + LF     
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMY 190
Query: 207 -----------------------PGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                                  PG   + QLT I E LG+P +     + S       K
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 250
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTC 303
             P +   P    F       +DL + + +F+P  RIT  +AL   Y S+       P C
Sbjct: 251 SFPGI---PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN--RPGPTPGC 305
Query: 304 PYP 306
             P
Sbjct: 306 QLP 308

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 150/321 (46%), Gaps = 58/321 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI--TNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           IG G++G+V  A   ++ E VAIKK+    AF NR        E++++  + H NIV+++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHCNIVRLR 79
Query: 101 DIIPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYI 154
                   EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YI
Sbjct: 80  YFFY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 155 HSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR------------ 201
           HS  + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R            
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198
Query: 202 --------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRY 241
                   W              +FPG   V QL  I ++LG+P       +R  N    
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 255
Query: 242 VKQLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE 300
             + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N +
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 315
Query: 301 -PT---CPYPFNFDFEQTSMN 317
            P     P  FNF  ++ S N
Sbjct: 316 LPNGRDTPALFNFTTQELSSN 336

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 149/321 (46%), Gaps = 58/321 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI--TNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           IG G++G+V  A   ++ E VAIKK+    AF NR        E++++  + H NIV+++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHCNIVRLR 79
Query: 101 DIIPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYI 154
                   EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YI
Sbjct: 80  YFFY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 155 HSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR------------ 201
           HS  + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R            
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198
Query: 202 --------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRY 241
                   W              +FPG   V QL  I ++LG+P       +R  N    
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 255
Query: 242 VKQLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE 300
               P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N +
Sbjct: 256 EFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 315
Query: 301 -PT---CPYPFNFDFEQTSMN 317
            P     P  FNF  ++ S N
Sbjct: 316 LPNGRDTPALFNFTTQELSSN 336

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 94/319 (29%), Positives = 149/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 81
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 82  FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R              
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 200
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 257
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 317
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 318 NGRDTPALFNFTTQELSSN 336

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  117 bits (294), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 94/319 (29%), Positives = 149/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 94
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 95  FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 153
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R              
Sbjct: 154 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 213
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 214 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 270
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 271 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 330
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 331 NGRDTPALFNFTTQELSSN 349

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 94/319 (29%), Positives = 149/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 86
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 87  FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 145
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R              
Sbjct: 146 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 205
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 206 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 262
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 263 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 322
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 323 NGRDTPALFNFTTQELSSN 341

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 94/319 (29%), Positives = 149/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 160
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 161 FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 219
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R              
Sbjct: 220 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 279
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 280 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 336
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 337 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 396
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 397 NGRDTPALFNFTTQELSSN 415

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 94/319 (29%), Positives = 149/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 109
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 110 FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 168
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R              
Sbjct: 169 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 228
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 229 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 285
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 286 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 345
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 346 NGRDTPALFNFTTQELSSN 364

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 94/319 (29%), Positives = 149/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 119
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 120 FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 178
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R              
Sbjct: 179 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 238
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 239 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 295
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 296 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 355
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 356 NGRDTPALFNFTTQELSSN 374

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 94/319 (29%), Positives = 149/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 115
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 116 FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R              
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 234
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 291
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 292 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 351
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 352 NGRDTPALFNFTTQELSSN 370

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 94/319 (29%), Positives = 149/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 117
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 118 FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 176
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R              
Sbjct: 177 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 236
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 237 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 293
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 294 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 353
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 354 NGRDTPALFNFTTQELSSN 372

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 142/307 (46%), Gaps = 58/307 (18%)
Query: 33  SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT 92
           SS     L+ +G G Y  V   +N  T   VA+K++    +    +  I REI L+  + 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKELK 61
Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK------QALTDDHCQYFLYQ 146
           HENIV++ D+I        N + +V+E MD DL + + S+      + L  +  +YF +Q
Sbjct: 62  HENIVRLYDVI-----HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTRW--- 202
           LL+GL + H   +LHRDLKP NLL+N    LK+ DFGLAR      +  +  VVT W   
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176
Query: 203 -----------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFL 233
                                          LFPG +  +QL +I +++G+P++S     
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES----- 231
Query: 234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVA--------IDLAERMLVFDPAKRITVEEA 285
              +  +  K  P++ ++P       + P          +D    +L  +P  R++ ++A
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291
Query: 286 LNHPYLS 292
           L+HP+ +
Sbjct: 292 LHHPWFA 298

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 94/321 (29%), Positives = 148/321 (46%), Gaps = 58/321 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI--TNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           IG G++G+V  A   ++ E VAIKK+    AF NR        E++++  + H NIV+++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHCNIVRLR 79
Query: 101 DIIPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYI 154
                   EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YI
Sbjct: 80  YFFY-SSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 155 HSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR------------ 201
           HS  + HRD+KP NLLL+ +   LK+CDFG A+     +     + +R            
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 198
Query: 202 --------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRY 241
                   W              +FPG   V QL  I ++LG+P       +R  N    
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 255
Query: 242 VKQLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE 300
               P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N +
Sbjct: 256 EFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 315
Query: 301 -PT---CPYPFNFDFEQTSMN 317
            P     P  FNF  ++ S N
Sbjct: 316 LPNGRDTPALFNFTTQELSSN 336

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 93/319 (29%), Positives = 148/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 85
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 86  FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 144
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +     + +R              
Sbjct: 145 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 204
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 205 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 261
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 262 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 321
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 322 NGRDTPALFNFTTQELSSN 340

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 93/319 (29%), Positives = 148/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 81
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 82  FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +     + +R              
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 200
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 257
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 317
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 318 NGRDTPALFNFTTQELSSN 336

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 93/319 (29%), Positives = 148/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 81
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 82  FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +     + +R              
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 200
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 257
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 317
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 318 NGRDTPALFNFTTQELSSN 336

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 93/319 (29%), Positives = 148/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 89
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 90  FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +     + +R              
Sbjct: 149 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 208
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 209 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 265
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 266 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 325
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 326 NGRDTPALFNFTTQELSSN 344

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 93/319 (29%), Positives = 148/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 100
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 101 FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +     + +R              
Sbjct: 160 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 219
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 220 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 276
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 277 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 336
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 337 NGRDTPALFNFTTQELSSN 355

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 93/319 (29%), Positives = 148/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 82
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 83  FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +     + +R              
Sbjct: 142 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 201
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 202 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 258
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 259 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 318
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 319 NGRDTPALFNFTTQELSSN 337

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 93/319 (29%), Positives = 148/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 93
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 94  FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +     + +R              
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 212
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 213 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 269
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 270 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 329
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 330 NGRDTPALFNFTTQELSSN 348

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 93/319 (29%), Positives = 148/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 93
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 94  FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +     + +R              
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 212
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 213 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 269
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 270 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 329
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 330 NGRDTPALFNFTTQELSSN 348

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 96/327 (29%), Positives = 153/327 (46%), Gaps = 55/327 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   E+ +EVAIKK+    D R       RE++++  + H N+V +K  
Sbjct: 48  IGNGSFGVVFQAKLVES-DEVAIKKVLQ--DKRFKN----RELQIMRIVKHPNVVDLKAF 100
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHS 156
               + +K ++V++  V E +   +++  R     KQ +     + ++YQLLR L YIHS
Sbjct: 101 FY-SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+     LK+ DFG A+     +     + +R              
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNY 219
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W T            LFPG+  + QL  I ++LG+P       +++ N      
Sbjct: 220 TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ---IKTMNPNYMEH 276
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH----EIN 298
           + P +   PFS+ F P   P AIDL  R+L + P+ R+T  EAL HP+   L      + 
Sbjct: 277 KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMP 336
Query: 299 EEPTCPYPFNFDFEQTSMNEEDIKELI 325
                P  FN+  E+ S+  + I  L+
Sbjct: 337 NGRELPPLFNWTKEELSVRPDLISRLV 363

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 93/319 (29%), Positives = 148/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 115
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK ++VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 116 FY-SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +     + +R              
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 234
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 291
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 292 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 351
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 352 NGRDTPALFNFTTQELSSN 370

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/319 (29%), Positives = 147/319 (46%), Gaps = 54/319 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G++G+V  A   ++ E VAIKK+    D R       RE++++  + H NIV+++  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKN----RELQIMRKLDHCNIVRLRYF 81
Query: 103 IPPMDKEKFNDVYI--VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHS 156
                 EK + VY+  V + +   ++++ R    +KQ L   + + ++YQL R L YIHS
Sbjct: 82  FY-SSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 157 ANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTR-------------- 201
             + HRD+KP NLLL+ +   LK+CDFG A+     +     + +R              
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 200
Query: 202 ------WDT------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
                 W              +FPG   V QL  I ++LG+P       +R  N      
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 257
Query: 244 QLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE-P 301
           + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N + P
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 317
Query: 302 T---CPYPFNFDFEQTSMN 317
                P  FNF  ++ S N
Sbjct: 318 NGRDTPALFNFTTQELSSN 336

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 128/302 (42%), Gaps = 72/302 (23%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V  A+++ T E VAIK+I    +        +RE+ LL  + H NI+++K +
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHR 162
           I        + +++++E  + DL + +     ++    + FLYQL+ G+ + HS   LHR
Sbjct: 102 I-----HHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHR 156
Query: 163 DLKPSNLLLNANCD-----LKICDFGLARTTS-ETDFMTEYVVTRW-------------- 202
           DLKP NLLL+ +       LKI DFGLAR         T  ++T W              
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYS 216
Query: 203 ------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ 244
                               LFPG   + QL  I E+LG PDD+                
Sbjct: 217 TSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT---------------T 261
Query: 245 LPHVPKQP-FSQKFPNMSPVAID-------------LAERMLVFDPAKRITVEEALNHPY 290
            P V   P + Q FP      +              L   ML  DP KRI+ + AL HPY
Sbjct: 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
Query: 291 LS 292
            S
Sbjct: 322 FS 323

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 134/294 (45%), Gaps = 41/294 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEE-VAIKKITNAFDNRIDAKRILREIKLLCHMT---HENIVK 98
           IG GAYG V  A + +     VA+K++             +RE+ +L H+    H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHS 156
           + D+      ++   + +V+E +D DL   +    +  +  +  +  ++QLLRGL ++HS
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW-------------- 202
             V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  VVT W              
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 203 -----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL 245
                              LF G   V QL  I +++G P + D  + R     R  +  
Sbjct: 199 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED--WPRDVALPR--QAF 254
Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
                QP  +   ++  +  DL  + L F+PAKRI+   AL+HPY   L    E
Sbjct: 255 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 134/294 (45%), Gaps = 41/294 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEE-VAIKKITNAFDNRIDAKRILREIKLLCHMT---HENIVK 98
           IG GAYG V  A + +     VA+K++             +RE+ +L H+    H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHS 156
           + D+      ++   + +V+E +D DL   +    +  +  +  +  ++QLLRGL ++HS
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW-------------- 202
             V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  VVT W              
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 203 -----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL 245
                              LF G   V QL  I +++G P + D  + R     R  +  
Sbjct: 199 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED--WPRDVALPR--QAF 254
Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
                QP  +   ++  +  DL  + L F+PAKRI+   AL+HPY   L    E
Sbjct: 255 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 132/286 (46%), Gaps = 41/286 (14%)
Query: 43  IGRGAYGIVCSAVNSETKEE-VAIKKITNAFDNRIDAKRILREIKLLCHMT---HENIVK 98
           IG GAYG V  A + +     VA+K++             +RE+ +L H+    H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHS 156
           + D+      ++   + +V+E +D DL   +    +  +  +  +  ++QLLRGL ++HS
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW-------------- 202
             V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  VVT W              
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 203 -----------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL 245
                              LF G   V QL  I +++G P + D  + R     R  +  
Sbjct: 199 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED--WPRDVALPR--QAF 254
Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                QP  +   ++  +  DL  + L F+PAKRI+   AL+HPY 
Sbjct: 255 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 134/276 (48%), Gaps = 32/276 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G++G V    +  T++E A+K I  A     D   ILRE++LL  + H NI+K+ +I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 103 IPPMDKEKFNDVYIVYEL-MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           +     E  +  YIV EL    +L   I  ++  ++      + Q+  G+ Y+H  N++H
Sbjct: 90  L-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 162 RDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRW----DTLFPGKD---- 210
           RDLKP N+LL +   +CD+KI DFGL+    +   M + + T +    + L    D    
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCD 204
Query: 211 -YVQQLTMITELLGSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
            +   + +   L G+P     ++   L+     +Y   LP         ++  +S  A D
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP---------QWRTISDDAKD 255
Query: 267 LAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
           L  +ML F P+ RIT  + L HP++      +E PT
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYS--SETPT 289

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 130/265 (49%), Gaps = 30/265 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G++G V    +  T++E A+K I  A     D   ILRE++LL  + H NI+K+ +I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 103 IPPMDKEKFNDVYIVYEL-MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           +     E  +  YIV EL    +L   I  ++  ++      + Q+  G+ Y+H  N++H
Sbjct: 90  L-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 162 RDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRW----DTLFPGKD---- 210
           RDLKP N+LL +   +CD+KI DFGL+    +   M + + T +    + L    D    
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCD 204
Query: 211 -YVQQLTMITELLGSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
            +   + +   L G+P     ++   L+     +Y   LP         ++  +S  A D
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP---------QWRTISDDAKD 255
Query: 267 LAERMLVFDPAKRITVEEALNHPYL 291
           L  +ML F P+ RIT  + L HP++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 130/265 (49%), Gaps = 30/265 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G++G V    +  T++E A+K I  A     D   ILRE++LL  + H NI+K+ +I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 103 IPPMDKEKFNDVYIVYEL-MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           +     E  +  YIV EL    +L   I  ++  ++      + Q+  G+ Y+H  N++H
Sbjct: 90  L-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 162 RDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRW----DTLFPGKD---- 210
           RDLKP N+LL +   +CD+KI DFGL+    +   M + + T +    + L    D    
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCD 204
Query: 211 -YVQQLTMITELLGSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
            +   + +   L G+P     ++   L+     +Y   LP         ++  +S  A D
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP---------QWRTISDDAKD 255
Query: 267 LAERMLVFDPAKRITVEEALNHPYL 291
           L  +ML F P+ RIT  + L HP++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 126/296 (42%), Gaps = 41/296 (13%)
Query: 32  VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM 91
            +S+Y  P+  IG GAYG V  A +  +   VA+K +             +RE+ LL  +
Sbjct: 2   ATSRY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 92  T---HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQII--RSKQALTDDHCQYFLYQ 146
               H N+V++ D+      ++   V +V+E +D DL   +       L  +  +  + Q
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
            LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +   VVT W    
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAP 180
Query: 203 ---------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS 235
                                        LF G     QL  I +L+G P + D  + R 
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD--WPRD 238
Query: 236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            +  R     P    +P     P M      L   ML F+P KRI+   AL H YL
Sbjct: 239 VSLPR--GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 137/281 (48%), Gaps = 40/281 (14%)
Query: 32  VSSKYVPPL---QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKL 87
           +S +++ P    + +G G++G V  A + +T+++VA+K I+     + D   R+ REI  
Sbjct: 3   ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 88  LCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQL 147
           L  + H +I+K+ D+I         D+ +V E    +L   I  K+ +T+D  + F  Q+
Sbjct: 63  LKLLRHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
           +  ++Y H   ++HRDLKP NLLL+ N ++KI DFGL+   ++ +F+         T   
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK--------TSCG 169
Query: 208 GKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF-PN------- 259
             +Y     +  +L   P+      + S     YV     V + PF  +F PN       
Sbjct: 170 SPNYAAPEVINGKLYAGPEVD----VWSCGIVLYVML---VGRLPFDDEFIPNLFKKVNS 222
Query: 260 --------MSPVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
                   +SP A  L  RM+V DP +RIT++E    P+ +
Sbjct: 223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 130/304 (42%), Gaps = 43/304 (14%)
Query: 27  GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIK--KITNAFDNRIDAK-RILR 83
           G L  +++    P+  IG GAYG V  A +  +   VA+K  ++ N            +R
Sbjct: 1   GPLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR 60
Query: 84  EIKLLCHMT---HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQII--RSKQALTDD 138
           E+ LL  +    H N+V++ D+      ++   V +V+E +D DL   +       L  +
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYV 198
             +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T  V
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 199 VTRW-------------------------------DTLFPGKDYVQQLTMITELLGSPDD 227
           VT W                                 LF G     QL  I +L+G P +
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240
Query: 228 SDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN 287
            D  + R  +  R     P    +P     P M      L   ML F+P KRI+   AL 
Sbjct: 241 DD--WPRDVSLPR--GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296
Query: 288 HPYL 291
           H YL
Sbjct: 297 HSYL 300

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 126/296 (42%), Gaps = 41/296 (13%)
Query: 32  VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM 91
            +S+Y  P+  IG GAYG V  A +  +   VA+K +             +RE+ LL  +
Sbjct: 2   ATSRY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 92  T---HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQII--RSKQALTDDHCQYFLYQ 146
               H N+V++ D+      ++   V +V+E +D DL   +       L  +  +  + Q
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
            LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +   VVT W    
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAP 180
Query: 203 ---------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS 235
                                        LF G     QL  I +L+G P + D  + R 
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD--WPRD 238
Query: 236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            +  R     P    +P     P M      L   ML F+P KRI+   AL H YL
Sbjct: 239 VSLPR--GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 126/296 (42%), Gaps = 41/296 (13%)
Query: 32  VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM 91
            +S+Y  P+  IG GAYG V  A +  +   VA+K +             +RE+ LL  +
Sbjct: 2   ATSRY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 92  T---HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ--ALTDDHCQYFLYQ 146
               H N+V++ D+      ++   V +V+E +D DL   +       L  +  +  + Q
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW---- 202
            LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +   VVT W    
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAP 180
Query: 203 ---------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS 235
                                        LF G     QL  I +L+G P + D  + R 
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD--WPRD 238
Query: 236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            +  R     P    +P     P M      L   ML F+P KRI+   AL H YL
Sbjct: 239 VSLPR--GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 143/305 (46%), Gaps = 49/305 (16%)
Query: 34  SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH 93
           SKY   L  IG+G +G V  A + +T ++VA+KK+    +        LREIK+L  + H
Sbjct: 17  SKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 94  ENIVKVKDII----PPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLL 148
           EN+V + +I      P ++ K   +Y+V++  + DL  ++ +     T    +  +  LL
Sbjct: 76  ENVVNLIEICRTKASPYNRCK-GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----TSETDFMTEYVVTRW- 202
            GL YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +     VVT W 
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 203 ---DTLFPGKDY----------------------------VQQLTMITELLGSPDDSDLG 231
              + L   +DY                              QL +I++L GS       
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE--V 252
Query: 232 FLRSDNARRYVK-QLPHVPKQPFSQKFPNM--SPVAIDLAERMLVFDPAKRITVEEALNH 288
           +   DN   Y K +L    K+    +       P A+DL +++LV DPA+RI  ++ALNH
Sbjct: 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312
Query: 289 PYLSS 293
            +  S
Sbjct: 313 DFFWS 317

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 143/305 (46%), Gaps = 49/305 (16%)
Query: 34  SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH 93
           SKY   L  IG+G +G V  A + +T ++VA+KK+    +        LREIK+L  + H
Sbjct: 18  SKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 94  ENIVKVKDII----PPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLL 148
           EN+V + +I      P ++ K   +Y+V++  + DL  ++ +     T    +  +  LL
Sbjct: 77  ENVVNLIEICRTKASPYNRCK-GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----TSETDFMTEYVVTRW- 202
            GL YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +     VVT W 
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 203 ---DTLFPGKDYV----------------------------QQLTMITELLGSPDDSDLG 231
              + L   +DY                              QL +I++L GS       
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE--V 253
Query: 232 FLRSDNARRYVK-QLPHVPKQPFSQKFPNM--SPVAIDLAERMLVFDPAKRITVEEALNH 288
           +   DN   Y K +L    K+    +       P A+DL +++LV DPA+RI  ++ALNH
Sbjct: 254 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 313
Query: 289 PYLSS 293
            +  S
Sbjct: 314 DFFWS 318

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 143/305 (46%), Gaps = 49/305 (16%)
Query: 34  SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH 93
           SKY   L  IG+G +G V  A + +T ++VA+KK+    +        LREIK+L  + H
Sbjct: 18  SKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 94  ENIVKVKDI----IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLL 148
           EN+V + +I      P ++ K   +Y+V++  + DL  ++ +     T    +  +  LL
Sbjct: 77  ENVVNLIEICRTKASPYNRCK-GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----TSETDFMTEYVVTRW- 202
            GL YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +     VVT W 
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 203 ---DTLFPGKDY----------------------------VQQLTMITELLGSPDDSDLG 231
              + L   +DY                              QL +I++L GS       
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE--V 253
Query: 232 FLRSDNARRYVK-QLPHVPKQPFSQKFPN--MSPVAIDLAERMLVFDPAKRITVEEALNH 288
           +   DN   Y K +L    K+    +       P A+DL +++LV DPA+RI  ++ALNH
Sbjct: 254 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 313
Query: 289 PYLSS 293
            +  S
Sbjct: 314 DFFWS 318

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 144/305 (47%), Gaps = 49/305 (16%)
Query: 34  SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH 93
           SKY   L  IG+G +G V  A + +T ++VA+KK+    +        LREIK+L  + H
Sbjct: 18  SKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 94  ENIVKVKDII----PPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLL 148
           EN+V + +I      P ++ K + +Y+V++  + DL  ++ +     T    +  +  LL
Sbjct: 77  ENVVNLIEICRTKASPYNRCKAS-IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----TSETDFMTEYVVTRW- 202
            GL YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +     VVT W 
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 203 ---DTLFPGKDYV----------------------------QQLTMITELLGSPDDSDLG 231
              + L   +DY                              QL +I++L GS       
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE--V 253
Query: 232 FLRSDNARRYVK-QLPHVPKQPFSQKFPNM--SPVAIDLAERMLVFDPAKRITVEEALNH 288
           +   DN   Y K +L    K+    +       P A+DL +++LV DPA+RI  ++ALNH
Sbjct: 254 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 313
Query: 289 PYLSS 293
            +  S
Sbjct: 314 DFFWS 318

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 95/393 (24%), Positives = 168/393 (42%), Gaps = 99/393 (25%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
            + SSK     + +G G++GIVC   + E+ +  A+KK+        D +   RE+ ++ 
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMK 55
Query: 90  HMTHENIVKVKDII------------PPMDKEKFND---------------------VYI 116
            + H NI+K+ D              PP D  K                        + +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 117 VYELMDTDLHQI----IRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN 172
           + E +   LH++    IRS +++  +    ++YQL R + +IHS  + HRD+KP NLL+N
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175
Query: 173 A-NCDLKICDFGLARTTSETDFMTEYVVTR--------------------WDT------- 204
           + +  LK+CDFG A+    ++     + +R                    W         
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 205 -----LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
                LF G+  + QL  I +++G+P    +  +R +     V+  P +  + + +  P 
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQM--IRMNPHYTEVR-FPTLKAKDWRKILPE 292
Query: 260 MSP-VAIDLAERMLVFDPAKRITVEEALNHPYLSSL---------------HEINEEPTC 303
            +P +AIDL E++L ++P  RI   EA+ HP+   L               H +N+    
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQ--NI 350
Query: 304 PYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           P  FNF   + S+   ++   IL +  NF P++
Sbjct: 351 PQLFNFSPYELSIIPGNVLNRILPK--NFSPNY 381

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 135/279 (48%), Gaps = 44/279 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITN---AFDNRIDAKRILR---EIKLLCHMTHE 94
           + +G GA G V  A   +T ++VAIK I+    A  +  +A   L    EI++L  + H 
Sbjct: 15  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 74
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            I+K+K+     D E   D YIV ELM+  +L   +   + L +  C+ + YQ+L  ++Y
Sbjct: 75  CIIKIKNF---FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 128
Query: 154 IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKD 210
           +H   ++HRDLKP N+LL++   +C +KI DFG ++   ET  M         TL     
Sbjct: 129 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGTPT 180
Query: 211 YVQQLTMITELLGSP------DDSDLGFLRSDNARRYVKQLPH-----VPKQPFSQKF-- 257
           Y+    +++  +G+       D   LG +       Y     H     +  Q  S K+  
Sbjct: 181 YLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 238
Query: 258 -----PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                  +S  A+DL +++LV DP  R T EEAL HP+L
Sbjct: 239 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 135/279 (48%), Gaps = 44/279 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITN---AFDNRIDAKRILR---EIKLLCHMTHE 94
           + +G GA G V  A   +T ++VAIK I+    A  +  +A   L    EI++L  + H 
Sbjct: 22  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 81
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            I+K+K+     D E   D YIV ELM+  +L   +   + L +  C+ + YQ+L  ++Y
Sbjct: 82  CIIKIKNF---FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 135
Query: 154 IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKD 210
           +H   ++HRDLKP N+LL++   +C +KI DFG ++   ET  M         TL     
Sbjct: 136 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGTPT 187
Query: 211 YVQQLTMITELLGSP------DDSDLGFLRSDNARRYVKQLPH-----VPKQPFSQKF-- 257
           Y+    +++  +G+       D   LG +       Y     H     +  Q  S K+  
Sbjct: 188 YLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 245
Query: 258 -----PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                  +S  A+DL +++LV DP  R T EEAL HP+L
Sbjct: 246 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 135/279 (48%), Gaps = 44/279 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITN---AFDNRIDAKRILR---EIKLLCHMTHE 94
           + +G GA G V  A   +T ++VAIK I+    A  +  +A   L    EI++L  + H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            I+K+K+     D E   D YIV ELM+  +L   +   + L +  C+ + YQ+L  ++Y
Sbjct: 76  CIIKIKNF---FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 154 IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKD 210
           +H   ++HRDLKP N+LL++   +C +KI DFG ++   ET  M         TL     
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGTPT 181
Query: 211 YVQQLTMITELLGSP------DDSDLGFLR---------SDNARRYVKQLPHVPKQPFS- 254
           Y+    +++  +G+       D   LG +              R  V     +    ++ 
Sbjct: 182 YLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 255 --QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             + +  +S  A+DL +++LV DP  R T EEAL HP+L
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 135/279 (48%), Gaps = 44/279 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITN---AFDNRIDAKRILR---EIKLLCHMTHE 94
           + +G GA G V  A   +T ++VAIK I+    A  +  +A   L    EI++L  + H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            I+K+K+     D E   D YIV ELM+  +L   +   + L +  C+ + YQ+L  ++Y
Sbjct: 76  CIIKIKNF---FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 154 IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKD 210
           +H   ++HRDLKP N+LL++   +C +KI DFG ++   ET  M         TL     
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGTPT 181
Query: 211 YVQQLTMITELLGSP------DDSDLGFLR---------SDNARRYVKQLPHVPKQPFS- 254
           Y+    +++  +G+       D   LG +              R  V     +    ++ 
Sbjct: 182 YLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 255 --QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             + +  +S  A+DL +++LV DP  R T EEAL HP+L
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 135/279 (48%), Gaps = 44/279 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITN---AFDNRIDAKRILR---EIKLLCHMTHE 94
           + +G GA G V  A   +T ++VAIK I+    A  +  +A   L    EI++L  + H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            I+K+K+     D E   D YIV ELM+  +L   +   + L +  C+ + YQ+L  ++Y
Sbjct: 76  CIIKIKNF---FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 154 IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKD 210
           +H   ++HRDLKP N+LL++   +C +KI DFG ++   ET  M         TL     
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGTPT 181
Query: 211 YVQQLTMITELLGSP------DDSDLGFLRSDNARRYVKQLPH-----VPKQPFSQKF-- 257
           Y+    +++  +G+       D   LG +       Y     H     +  Q  S K+  
Sbjct: 182 YLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 258 -----PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                  +S  A+DL +++LV DP  R T EEAL HP+L
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 135/279 (48%), Gaps = 44/279 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITN---AFDNRIDAKRILR---EIKLLCHMTHE 94
           + +G GA G V  A   +T ++VAI+ I+    A  +  +A   L    EI++L  + H 
Sbjct: 155 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 214
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            I+K+K+     D E   D YIV ELM+  +L   +   + L +  C+ + YQ+L  ++Y
Sbjct: 215 CIIKIKNF---FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 268
Query: 154 IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKD 210
           +H   ++HRDLKP N+LL++   +C +KI DFG ++   ET  M         TL     
Sbjct: 269 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGTPT 320
Query: 211 YVQQLTMITELLGSP------DDSDLGFLRSDNARRYVKQLPH-----VPKQPFSQKF-- 257
           Y+    +++  +G+       D   LG +       Y     H     +  Q  S K+  
Sbjct: 321 YLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 378
Query: 258 -----PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                  +S  A+DL +++LV DP  R T EEAL HP+L
Sbjct: 379 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 44/279 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITN---AFDNRIDAKRILR---EIKLLCHMTHE 94
           + +G GA G V  A   +T ++VAI+ I+    A  +  +A   L    EI++L  + H 
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            I+K+K+     D E   D YIV ELM+  +L   +   + L +  C+ + YQ+L  ++Y
Sbjct: 201 CIIKIKNF---FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 154 IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKD 210
           +H   ++HRDLKP N+LL++   +C +KI DFG ++   ET  M         TL     
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGTPT 306
Query: 211 YVQQLTMITELLGSP------DDSDLG------------FLRSDNARRYVKQLPHVPKQP 252
           Y+    +++  +G+       D   LG            F           Q+       
Sbjct: 307 YLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364
Query: 253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             + +  +S  A+DL +++LV DP  R T EEAL HP+L
Sbjct: 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 137/302 (45%), Gaps = 63/302 (20%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE-NIVK 98
           ++ +GRG Y  V  A+N    E+V +K +     N+I      REIK+L ++    NI+ 
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK-----REIKILENLRGGPNIIT 96
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           + DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 97  LADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 159 VLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF-MTEY 197
           ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ M +Y
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 198 VVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DSDLGF 232
            +  W             +  F G D   QL  I ++LG+ D            D     
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 233 LRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
           +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ HPY  
Sbjct: 272 ILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 293 SL 294
           ++
Sbjct: 326 TV 327

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 34/272 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + +V       T  + A K I    T +    +  + I RE+ +L  + H N+
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           S  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F   ++
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIFGTPEF 183
Query: 212 VQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFSQKFPN 259
           V    +  E LG   D   +G +             D  +  +  +  V  +   + F N
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            S +A D   R+LV DP KR+T++++L HP++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 34/277 (12%)
Query: 36  YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHM 91
           Y    + +G G + +V       T  + A K I    T +    +  + I RE+ +L  +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
            H N++ + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G
Sbjct: 72  QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 151 LKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLF 206
           + Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIF 178
Query: 207 PGKDYVQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFS 254
              ++V    +  E LG   D   +G +             D  +  +  +  V  +   
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           + F N S +A D   R+LV DP KR+T++++L HP++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 34/272 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + +V       T  + A K I    T +    +  + I RE+ +L  + H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G+ Y+H
Sbjct: 76  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           S  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F   ++
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIFGTPEF 182
Query: 212 VQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFSQKFPN 259
           V    +  E LG   D   +G +             D  +  +  +  V  +   + F N
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            S +A D   R+LV DP KR+T++++L HP++
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 34/272 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + +V       T  + A K I    T +    +  + I RE+ +L  + H N+
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           S  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F   ++
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIFGTPEF 183
Query: 212 VQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFSQKFPN 259
           V    +  E LG   D   +G +             D  +  +  +  V  +   + F N
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            S +A D   R+LV DP KR+T++++L HP++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 34/272 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + +V       T  + A K I    T +    +  + I RE+ +L  + H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G+ Y+H
Sbjct: 76  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           S  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F   ++
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIFGTPEF 182
Query: 212 VQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFSQKFPN 259
           V    +  E LG   D   +G +             D  +  +  +  V  +   + F N
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            S +A D   R+LV DP KR+T++++L HP++
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 34/272 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + +V       T  + A K I    T +    +  + I RE+ +L  + H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           S  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F   ++
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIFGTPEF 183
Query: 212 VQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFSQKFPN 259
           V    +  E LG   D   +G +             D  +  +  +  V  +   + F N
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            S +A D   R+LV DP KR+T++++L HP++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 34/277 (12%)
Query: 36  YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHM 91
           Y    + +G G + +V       T  + A K I    T +    +  + I RE+ +L  +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
            H N++ + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G
Sbjct: 72  QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 151 LKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLF 206
           + Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIF 178
Query: 207 PGKDYVQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFS 254
              ++V    +  E LG   D   +G +             D  +  +  +  V  +   
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           + F N S +A D   R+LV DP KR+T++++L HP++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 34/272 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + +V       T  + A K I    T +    +  + I RE+ +L  + H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           S  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F   ++
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIFGTPEF 183
Query: 212 VQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFSQKFPN 259
           V    +  E LG   D   +G +             D  +  +  +  V  +   + F N
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            S +A D   R+LV DP KR+T++++L HP++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 129/276 (46%), Gaps = 32/276 (11%)
Query: 36  YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHM 91
           Y    + +G G + +V       T  + A K I    T +    +  + I RE+ +L  +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
            H N++ + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G
Sbjct: 72  QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 151 LKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLF 206
           + Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+        F
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPAF 183
Query: 207 PGKDYVQ-----------QLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ 255
              + V             + +IT +L S     LG    D  +  +  +  V  +   +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFEDE 239
Query: 256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            F N S +A D   R+LV DP KR+T++++L HP++
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 34/277 (12%)
Query: 36  YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHM 91
           Y    + +G G + +V       T  + A K I    T +    +  + I RE+ +L  +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
            H N++ + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G
Sbjct: 72  QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 151 LKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLF 206
           + Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIF 178
Query: 207 PGKDYVQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFS 254
              ++V    +  E LG   D   +G +             D  +  +  +  V  +   
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           + F N S +A D   R+LV DP KR+T++++L HP++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 34/272 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + +V       T  + A K I    T +    +  + I RE+ +L  + H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           S  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F   ++
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIFGTPEF 183
Query: 212 VQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFSQKFPN 259
           V    +  E LG   D   +G +             D  +  +  +  V  +   + F N
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            S +A D   R+LV DP KR+T++++L HP++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 141/290 (48%), Gaps = 32/290 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + +G+GA+ +V   V     +E A K I     +  D +++ RE ++   + H NIV++
Sbjct: 36  FEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 95
Query: 100 KDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D I    +E F+  Y+V++L+   +L + I +++  ++    + ++Q+L  + +IH  +
Sbjct: 96  HDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD 150
Query: 159 VLHRDLKPSNLLLNANCD---LKICDFGLA-----------RTTSETDFMTEYVVTRWDT 204
           ++HRDLKP NLLL + C    +K+ DFGLA                  +++  V+ +   
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPY 210
Query: 205 LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
             P   +   + +   L+G P      F   D  + Y +Q+        S ++  ++P A
Sbjct: 211 GKPVDIWACGVILYILLVGYPP-----FWDEDQHKLY-QQIKAGAYDFPSPEWDTVTPEA 264
Query: 265 IDLAERMLVFDPAKRITVEEALNHPY------LSSLHEINEEPTCPYPFN 308
            +L  +ML  +PAKRIT ++AL HP+      ++S+    E   C   FN
Sbjct: 265 KNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFN 314

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 34/277 (12%)
Query: 36  YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHM 91
           Y    + +G G + +V       T  + A K I    T +    +  + I RE+ +L  +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
            H N++ + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G
Sbjct: 72  QHPNVITLHEVY-----ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 151 LKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLF 206
           + Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIF 178
Query: 207 PGKDYVQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFS 254
              ++V    +  E LG   D   +G +             D  +  +  +  V  +   
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           + F N S +A D   R+LV DP KR+T++++L HP++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 34/277 (12%)
Query: 36  YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHM 91
           Y    + +G G + +V       T  + A K I    T +    +  + I RE+ +L  +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
            H N++ + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G
Sbjct: 72  QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 151 LKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLF 206
           + Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIF 178
Query: 207 PGKDYVQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFS 254
              ++V    +  E LG   D   +G +             D  +  +  +  V  +   
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           + F N S +A D   R+LV DP KR+T++++L HP++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 34/277 (12%)
Query: 36  YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHM 91
           Y    + +G G + +V       T  + A K I    T +    +  + I RE+ +L  +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
            H N++ + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G
Sbjct: 72  QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 151 LKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSETDFMTEYVVTRWDTLF 206
           + Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+       +F
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF-----KNIF 178
Query: 207 PGKDYVQQLTMITELLG-SPDDSDLGFLR-----------SDNARRYVKQLPHVPKQPFS 254
              ++V    +  E LG   D   +G +             D  +  +  +  V  +   
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           + F N S +A D   R+LV DP KR+T++++L HP++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 136/287 (47%), Gaps = 32/287 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG+GA+ +V   V   T  E A K I     +  D +++ RE ++   + H NIV++ D 
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 103 IPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           I    +E F+  Y+V++L+   +L + I +++  ++    + + Q+L  + + H   V+H
Sbjct: 72  I---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVH 126
Query: 162 RDLKPSNLLLNANCD---LKICDFGLA-----------RTTSETDFMTEYVVTRWDTLFP 207
           RDLKP NLLL + C    +K+ DFGLA                  +++  V+ +     P
Sbjct: 127 RDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKP 186
Query: 208 GKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
              +   + +   L+G P      F   D  + Y +Q+        S ++  ++P A +L
Sbjct: 187 VDIWACGVILYILLVGYPP-----FWDEDQHKLY-QQIKAGAYDFPSPEWDTVTPEAKNL 240
Query: 268 AERMLVFDPAKRITVEEALNHPY------LSSLHEINEEPTCPYPFN 308
             +ML  +PAKRIT  EAL HP+      ++S+    E   C   FN
Sbjct: 241 INQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECLKKFN 287

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 132/276 (47%), Gaps = 28/276 (10%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT----NAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + IV       T +E A K I     ++    +  + I RE+ +L  + H NI
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + DI      E   DV ++ EL+   +L   +  K++LT+D    FL Q+L G+ Y+H
Sbjct: 71  ITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 156 SANVLHRDLKPSNLLL----NANCDLKICDFGLARTTSETD-----FMT-EYV---VTRW 202
           S  + H DLKP N++L      N  +K+ DFG+A      +     F T E+V   +  +
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 185
Query: 203 DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + L    D +  + +IT +L S     LG    +  +  +  +  V      + F N S 
Sbjct: 186 EPLGLEAD-MWSIGVITYILLSGASPFLG----ETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN 298
           +A D   R+LV DP +R+T+ ++L H ++ ++   N
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 136/272 (50%), Gaps = 36/272 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNR--IDAKRILREIKLLCHM-THENIVK 98
           IG+GA+ +V   +N ET ++ A+K +  A F +   +  + + RE  + CHM  H +IV+
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI-CHMLKHPHIVE 90
Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDL-HQIIRSKQA---LTDDHCQYFLYQLLRGLKY 153
           + +            +Y+V+E MD  DL  +I++   A    ++    +++ Q+L  L+Y
Sbjct: 91  LLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 154 IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETD-----------FMTEYVV 199
            H  N++HRD+KP N+LL +   +  +K+ DFG+A    E+            FM   VV
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 200 TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
            R     P   +   + +   L G      L F  +    R  + +     +   +++ +
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGC-----LPFYGTKE--RLFEGIIKGKYKMNPRQWSH 258
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           +S  A DL  RML+ DPA+RITV EALNHP+L
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 31/266 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVK 98
           ++ +G G++G V  A ++ T ++VA+K I      + D + RI REI  L  + H +I+K
Sbjct: 19  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 78
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           + D+I   D     ++ +V E    +L   I  +  +++   + F  Q++  ++Y H   
Sbjct: 79  LYDVIKSKD-----EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 133
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMI 218
           ++HRDLKP NLLL+ + ++KI DFGL+   ++ +F+         T     +Y     + 
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK--------TSCGSPNYAAPEVIS 185
Query: 219 TELLGSPDDSDLGFLRSDNARRYVKQLPHVP--KQPFSQKFPN-----------MSPVAI 265
            +L   P+      + S     YV     +P   +     F N           +SP A 
Sbjct: 186 GKLYAGPEVD----VWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAA 241
Query: 266 DLAERMLVFDPAKRITVEEALNHPYL 291
            L +RML+ +P  RI++ E +   + 
Sbjct: 242 GLIKRMLIVNPLNRISIHEIMQDDWF 267

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 31/266 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVK 98
           ++ +G G++G V  A ++ T ++VA+K I      + D + RI REI  L  + H +I+K
Sbjct: 18  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 77
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           + D+I   D     ++ +V E    +L   I  +  +++   + F  Q++  ++Y H   
Sbjct: 78  LYDVIKSKD-----EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 132
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMI 218
           ++HRDLKP NLLL+ + ++KI DFGL+   ++ +F+         T     +Y     + 
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK--------TSCGSPNYAAPEVIS 184
Query: 219 TELLGSPDDSDLGFLRSDNARRYVKQLPHVP--KQPFSQKFPN-----------MSPVAI 265
            +L   P+      + S     YV     +P   +     F N           +SP A 
Sbjct: 185 GKLYAGPEVD----VWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAA 240
Query: 266 DLAERMLVFDPAKRITVEEALNHPYL 291
            L +RML+ +P  RI++ E +   + 
Sbjct: 241 GLIKRMLIVNPLNRISIHEIMQDDWF 266

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 136/315 (43%), Gaps = 55/315 (17%)
Query: 44  GRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDII 103
           G+G +G V       T   VAIKK+      R    +I++++ +L    H NIV+++   
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL---HHPNIVQLQSYF 88
Query: 104 PPMDKEKFNDVY--IVYELMDTDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIH-- 155
             + +    D+Y  +V E +   LH+  R+    + A      + FL+QL+R +  +H  
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP 148
Query: 156 SANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSETDFMTEYVVTRW------------ 202
           S NV HRD+KP N+L+N A+  LK+CDFG A+  S ++    Y+ +R+            
Sbjct: 149 SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQH 208
Query: 203 --------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV 242
                               + +F G +   QL  I  +LG P       LR  N     
Sbjct: 209 YTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE---VLRKLNPSHTD 265
Query: 243 KQLPHVPKQPFSQKFPNMS----PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN 298
             L +    P+S  F + S      A DL   +L + P +R+   EAL HPY   LH   
Sbjct: 266 VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH--- 322
Query: 299 EEPTCPYPFNFDFEQ 313
            +P    P N D  +
Sbjct: 323 -DPATKLPNNKDLPE 336

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 31/266 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVK 98
           ++ +G G++G V  A ++ T ++VA+K I      + D + RI REI  L  + H +I+K
Sbjct: 9   VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           + D+I   D     ++ +V E    +L   I  +  +++   + F  Q++  ++Y H   
Sbjct: 69  LYDVIKSKD-----EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMI 218
           ++HRDLKP NLLL+ + ++KI DFGL+   ++ +F+         T     +Y     + 
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK--------TSCGSPNYAAPEVIS 175
Query: 219 TELLGSPDDSDLGFLRSDNARRYVKQLPHVP--KQPFSQKFPN-----------MSPVAI 265
            +L   P+      + S     YV     +P   +     F N           +SP A 
Sbjct: 176 GKLYAGPEVD----VWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAA 231
Query: 266 DLAERMLVFDPAKRITVEEALNHPYL 291
            L +RML+ +P  RI++ E +   + 
Sbjct: 232 GLIKRMLIVNPLNRISIHEIMQDDWF 257

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 31/266 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVK 98
           ++ +G G++G V  A ++ T ++VA+K I      + D + RI REI  L  + H +I+K
Sbjct: 13  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 72
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           + D+I   D     ++ +V E    +L   I  +  +++   + F  Q++  ++Y H   
Sbjct: 73  LYDVIKSKD-----EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 127
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMI 218
           ++HRDLKP NLLL+ + ++KI DFGL+   ++ +F+         T     +Y     + 
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK--------TSCGSPNYAAPEVIS 179
Query: 219 TELLGSPDDSDLGFLRSDNARRYVKQLPHVP--KQPFSQKFPN-----------MSPVAI 265
            +L   P+      + S     YV     +P   +     F N           +SP A 
Sbjct: 180 GKLYAGPEVD----VWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAA 235
Query: 266 DLAERMLVFDPAKRITVEEALNHPYL 291
            L +RML+ +P  RI++ E +   + 
Sbjct: 236 GLIKRMLIVNPLNRISIHEIMQDDWF 261

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 35/270 (12%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G++G V    +  T +E A+K I+      + D + +LRE++LL  + H NI+K+ +
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 102 IIPPMDKEKF---NDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                DK  F    +VY   EL D      I S++  ++      + Q+L G+ Y+H   
Sbjct: 100 FFE--DKGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 159 VLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRW----DTLFPGKD- 210
           ++HRDLKP NLLL +   + +++I DFGL+     +  M + + T +    + L    D 
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 212
Query: 211 ----YVQQLTMITELLGSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
               +   + +   L G P     ++   L+     +Y  +LP   K         +S  
Sbjct: 213 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK---------VSES 263
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  +ML + P+ RI+  +AL+H ++ +
Sbjct: 264 AKDLIRKMLTYVPSMRISARDALDHEWIQT 293

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITN----AFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + IV       T +E A K I      +    +  + I RE+ +L  + H NI
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + DI      E   DV ++ EL+   +L   +  K++LT+D    FL Q+L G+ Y+H
Sbjct: 92  ITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 146
Query: 156 SANVLHRDLKPSNLLL----NANCDLKICDFGLARTTSETD-----FMT-EYV---VTRW 202
           S  + H DLKP N++L      N  +K+ DFG+A      +     F T E+V   +  +
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 206
Query: 203 DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + L    D +  + +IT +L S     LG    +  +  +  +  V      + F N S 
Sbjct: 207 EPLGLEAD-MWSIGVITYILLSGASPFLG----ETKQETLTNISAVNYDFDEEYFSNTSE 261
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN 298
           +A D   R+LV DP +R+ + ++L H ++ ++   N
Sbjct: 262 LAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRN 297

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 137/290 (47%), Gaps = 32/290 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + +G+GA+ +V   +   T +E A K I     +  D +++ RE ++   + H NIV++
Sbjct: 9   FEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 68
Query: 100 KDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D I    +E F+  Y+V++L+   +L + I +++  ++    + + Q+L  + + H   
Sbjct: 69  HDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 159 VLHRDLKPSNLLLNA---NCDLKICDFGLA-----------RTTSETDFMTEYVVTRWDT 204
           ++HRDLKP NLLL +      +K+ DFGLA                  +++  V+ +   
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 205 LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
             P   +   + +   L+G P      F   D  R Y +Q+        S ++  ++P A
Sbjct: 184 GKPVDMWACGVILYILLVGYPP-----FWDEDQHRLY-QQIKAGAYDFPSPEWDTVTPEA 237
Query: 265 IDLAERMLVFDPAKRITVEEALNHPYL------SSLHEINEEPTCPYPFN 308
            DL  +ML  +PAKRIT  EAL HP++      +S+    E   C   FN
Sbjct: 238 KDLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFN 287

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 35/270 (12%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G++G V    +  T +E A+K I+      + D + +LRE++LL  + H NI+K+ +
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 102 IIPPMDKEKF---NDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                DK  F    +VY   EL D      I S++  ++      + Q+L G+ Y+H   
Sbjct: 117 FFE--DKGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 159 VLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRW----DTLFPGKD- 210
           ++HRDLKP NLLL +   + +++I DFGL+     +  M + + T +    + L    D 
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 229
Query: 211 ----YVQQLTMITELLGSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
               +   + +   L G P     ++   L+     +Y  +LP   K         +S  
Sbjct: 230 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK---------VSES 280
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  +ML + P+ RI+  +AL+H ++ +
Sbjct: 281 AKDLIRKMLTYVPSMRISARDALDHEWIQT 310

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 35/270 (12%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G++G V    +  T +E A+K I+      + D + +LRE++LL  + H NI+K+ +
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 102 IIPPMDKEKF---NDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                DK  F    +VY   EL D      I S++  ++      + Q+L G+ Y+H   
Sbjct: 94  FFE--DKGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 159 VLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRW----DTLFPGKD- 210
           ++HRDLKP NLLL +   + +++I DFGL+     +  M + + T +    + L    D 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206
Query: 211 ----YVQQLTMITELLGSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
               +   + +   L G P     ++   L+     +Y  +LP   K         +S  
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK---------VSES 257
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  +ML + P+ RI+  +AL+H ++ +
Sbjct: 258 AKDLIRKMLTYVPSMRISARDALDHEWIQT 287

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 35/270 (12%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G++G V    +  T +E A+K I+      + D + +LRE++LL  + H NI+K+ +
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 102 IIPPMDKEKF---NDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                DK  F    +VY   EL D      I S++  ++      + Q+L G+ Y+H   
Sbjct: 118 FFE--DKGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 159 VLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRW----DTLFPGKD- 210
           ++HRDLKP NLLL +   + +++I DFGL+     +  M + + T +    + L    D 
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 230
Query: 211 ----YVQQLTMITELLGSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
               +   + +   L G P     ++   L+     +Y  +LP   K         +S  
Sbjct: 231 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK---------VSES 281
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  +ML + P+ RI+  +AL+H ++ +
Sbjct: 282 AKDLIRKMLTYVPSMRISARDALDHEWIQT 311

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 34/279 (12%)
Query: 34  SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH 93
           S+    ++ +G GAYG V    +  T  E AIK I     +     ++L E+ +L  + H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVY---ELMDTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
            NI+K+ D     DK  +  V   Y   EL D  +H++        +      + Q+L G
Sbjct: 96  PNIMKLYDFFE--DKRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSG 148
Query: 151 LKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRW----D 203
           + Y+H  N++HRDLKP NLLL +   +  +KI DFGL+        M E + T +    +
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE 208
Query: 204 TLFPGKD-----YVQQLTMITELLGSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQ 255
            L    D     +   + +   L G P     +D   LR     +Y    P         
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP--------- 259
Query: 256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           ++ N+S  A DL ++ML FD  +RI+ ++AL HP++  +
Sbjct: 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 137/290 (47%), Gaps = 32/290 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + +G+GA+ +V   +   T +E A K I     +  D +++ RE ++   + H NIV++
Sbjct: 9   FEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 68
Query: 100 KDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D I    +E F+  Y+V++L+   +L + I +++  ++    + + Q+L  + + H   
Sbjct: 69  HDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 159 VLHRDLKPSNLLLNA---NCDLKICDFGLA-----------RTTSETDFMTEYVVTRWDT 204
           ++HRDLKP NLLL +      +K+ DFGLA                  +++  V+ +   
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 205 LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
             P   +   + +   L+G P      F   D  R Y +Q+        S ++  ++P A
Sbjct: 184 GKPVDMWACGVILYILLVGYPP-----FWDEDQHRLY-QQIKAGAYDFPSPEWDTVTPEA 237
Query: 265 IDLAERMLVFDPAKRITVEEALNHPYL------SSLHEINEEPTCPYPFN 308
            DL  +ML  +PAKRIT  EAL HP++      +S+    E   C   FN
Sbjct: 238 KDLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFN 287

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 129/271 (47%), Gaps = 28/271 (10%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT----NAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + IV       T +E A K I     ++    +  + I RE+ +L  + H NI
Sbjct: 18  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 77
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + DI      E   DV ++ EL+   +L   +  K++LT+D    FL Q+L G+ Y+H
Sbjct: 78  ITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 132
Query: 156 SANVLHRDLKPSNLLL----NANCDLKICDFGLARTTSETD-----FMT-EYV---VTRW 202
           S  + H DLKP N++L      N  +K+ DFG+A      +     F T E+V   +  +
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 192
Query: 203 DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + L    D +  + +IT +L S     LG    +  +  +  +  V      + F N S 
Sbjct: 193 EPLGLEAD-MWSIGVITYILLSGASPFLG----ETKQETLTNISAVNYDFDEEYFSNTSE 247
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           +A D   R+LV DP +R+ + ++L H ++ +
Sbjct: 248 LAKDFIRRLLVKDPKRRMXIAQSLEHSWIKA 278

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 132/265 (49%), Gaps = 25/265 (9%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + +G+GA+ +V   V+  T  E A K I     +  D +++ RE ++   + H NIV++ 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 101 DIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           D I    +E F+  Y+V++L+   +L + I +++  ++    + + Q+L  + Y HS  +
Sbjct: 72  DSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 160 LHRDLKPSNLLLNA---NCDLKICDFGLARTTSETD----------FMTEYVVTRWDTLF 206
           +HR+LKP NLLL +      +K+ DFGLA   ++++          +++  V+ +     
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186
Query: 207 PGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
           P   +   + +   L+G P      F   D  R Y +        P S ++  ++P A  
Sbjct: 187 PVDIWACGVILYILLVGYPP-----FWDEDQHRLYAQIKAGAYDYP-SPEWDTVTPEAKS 240
Query: 267 LAERMLVFDPAKRITVEEALNHPYL 291
           L + ML  +P KRIT ++AL  P++
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 127/283 (44%), Gaps = 39/283 (13%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLL 88
           FQ  S     ++ +G GAYG V    +  T  E AIK I  ++     ++  +L E+ +L
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL 148
             + H NI+K+ +     DK  +  V  VY     +L   I  +Q  ++      + Q+L
Sbjct: 76  KQLDHPNIMKLYEFFE--DKRNYYLVMEVYR--GGELFDEIILRQKFSEVDAAVIMKQVL 131
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARTTSETDFMTEYVVTRW--- 202
            G  Y+H  N++HRDLKP NLLL +      +KI DFGL+        M E + T +   
Sbjct: 132 SGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIA 191
Query: 203 ----DTLFPGKDYVQQLTMITELL-------GSPDDSDLGFLRSDNARRYVKQLPHVPKQ 251
                  +  K  V    +I  +L       G   D ++              L  V K 
Sbjct: 192 PEVLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEI--------------LKRVEKG 237
Query: 252 PFSQKFPNMSPV---AIDLAERMLVFDPAKRITVEEALNHPYL 291
            FS   P+ + V   A  L + ML ++P+KRI+ EEALNHP++
Sbjct: 238 KFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 132/265 (49%), Gaps = 25/265 (9%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + +G+GA+ +V   V+  T  E A K I     +  D +++ RE ++   + H NIV++ 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 101 DIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           D I    +E F+  Y+V++L+   +L + I +++  ++    + + Q+L  + Y HS  +
Sbjct: 72  DSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 160 LHRDLKPSNLLLNA---NCDLKICDFGLARTTSETD----------FMTEYVVTRWDTLF 206
           +HR+LKP NLLL +      +K+ DFGLA   ++++          +++  V+ +     
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186
Query: 207 PGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
           P   +   + +   L+G P      F   D  R Y +        P S ++  ++P A  
Sbjct: 187 PVDIWACGVILYILLVGYPP-----FWDEDQHRLYAQIKAGAYDYP-SPEWDTVTPEAKS 240
Query: 267 LAERMLVFDPAKRITVEEALNHPYL 291
           L + ML  +P KRIT ++AL  P++
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 132/265 (49%), Gaps = 25/265 (9%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + +G+GA+ +V   V+  T  E A K I     +  D +++ RE ++   + H NIV++ 
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 70
Query: 101 DIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           D I    +E F+  Y+V++L+   +L + I +++  ++    + + Q+L  + Y HS  +
Sbjct: 71  DSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 125
Query: 160 LHRDLKPSNLLLNA---NCDLKICDFGLARTTSETD----------FMTEYVVTRWDTLF 206
           +HR+LKP NLLL +      +K+ DFGLA   ++++          +++  V+ +     
Sbjct: 126 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 185
Query: 207 PGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
           P   +   + +   L+G P      F   D  R Y +        P S ++  ++P A  
Sbjct: 186 PVDIWACGVILYILLVGYPP-----FWDEDQHRLYAQIKAGAYDYP-SPEWDTVTPEAKS 239
Query: 267 LAERMLVFDPAKRITVEEALNHPYL 291
           L + ML  +P KRIT ++AL  P++
Sbjct: 240 LIDSMLTVNPKKRITADQALKVPWI 264

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 132/265 (49%), Gaps = 25/265 (9%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + +G+GA+ +V   V+  T  E A K I     +  D +++ RE ++   + H NIV++ 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 101 DIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           D I    +E F+  Y+V++L+   +L + I +++  ++    + + Q+L  + Y HS  +
Sbjct: 95  DSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149
Query: 160 LHRDLKPSNLLLNA---NCDLKICDFGLARTTSETD----------FMTEYVVTRWDTLF 206
           +HR+LKP NLLL +      +K+ DFGLA   ++++          +++  V+ +     
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 209
Query: 207 PGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
           P   +   + +   L+G P      F   D  R Y +        P S ++  ++P A  
Sbjct: 210 PVDIWACGVILYILLVGYPP-----FWDEDQHRLYAQIKAGAYDYP-SPEWDTVTPEAKS 263
Query: 267 LAERMLVFDPAKRITVEEALNHPYL 291
           L + ML  +P KRIT ++AL  P++
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWI 288

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 133/265 (50%), Gaps = 31/265 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G++  V  A +  T  EVAIK I   A       +R+  E+K+ C + H +I+++ +
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 102 IIPPMDKEKFNDVYIVYELM-DTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANV 159
                  E  N VY+V E+  + ++++ ++++ +  +++  ++F++Q++ G+ Y+HS  +
Sbjct: 79  YF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGI 133
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLART-----------TSETDFMTEYVVTRWDTLFPG 208
           LHRDL  SNLLL  N ++KI DFGLA                 ++++  + TR       
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLES 193
Query: 209 KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPVAIDL 267
             +       T L+G P         +D  +  + ++     +      P+ +S  A DL
Sbjct: 194 DVWSLGCMFYTLLIGRPP------FDTDTVKNTLNKVVLADYE-----MPSFLSIEAKDL 242
Query: 268 AERMLVFDPAKRITVEEALNHPYLS 292
             ++L  +PA R+++   L+HP++S
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMS 267

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + IV       T  E A K I    + A    +  + I RE+ +L  + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + D+      E   DV ++ EL+   +L   +  K++L+++    F+ Q+L G+ Y+H
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSE-TDFMT-----EYV---VTRW 202
           +  + H DLKP N +LL+ N     +K+ DFGLA    +  +F       E+V   +  +
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 203 DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + L    D +  + +IT +L S     LG    D  +  +  +  V      + F + S 
Sbjct: 193 EPLGLEAD-MWSIGVITYILLSGASPFLG----DTKQETLANITSVSYDFDEEFFSHTSE 247
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLS 292
           +A D   ++LV +  KR+T++EAL HP+++
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + IV       T  E A K I    + A    +  + I RE+ +L  + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + D+      E   DV ++ EL+   +L   +  K++L+++    F+ Q+L G+ Y+H
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSE-TDFMT-----EYV---VTRW 202
           +  + H DLKP N +LL+ N     +K+ DFGLA    +  +F       E+V   +  +
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 203 DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + L    D +  + +IT +L S     LG    D  +  +  +  V      + F + S 
Sbjct: 193 EPLGLEAD-MWSIGVITYILLSGASPFLG----DTKQETLANITSVSYDFDEEFFSHTSE 247
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLS 292
           +A D   ++LV +  KR+T++EAL HP+++
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + IV       T  E A K I    + A    +  + I RE+ +L  + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + D+      E   DV ++ EL+   +L   +  K++L+++    F+ Q+L G+ Y+H
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSE-TDFMT-----EYV---VTRW 202
           +  + H DLKP N +LL+ N     +K+ DFGLA    +  +F       E+V   +  +
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 203 DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + L    D +  + +IT +L S     LG    D  +  +  +  V      + F + S 
Sbjct: 193 EPLGLEAD-MWSIGVITYILLSGASPFLG----DTKQETLANITSVSYDFDEEFFSHTSE 247
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLS 292
           +A D   ++LV +  KR+T++EAL HP+++
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 126/268 (47%), Gaps = 26/268 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + +G+GA+ +V   V     +E A K I     +  D +++ RE ++   + H NIV++
Sbjct: 27  FEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 86
Query: 100 KDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D I           Y++++L+   +L + I +++  ++    + + Q+L  + + H   
Sbjct: 87  HDSISEEGHH-----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 141
Query: 159 VLHRDLKPSNLLLNA---NCDLKICDFGLA-----------RTTSETDFMTEYVVTRWDT 204
           V+HRDLKP NLLL +      +K+ DFGLA                  +++  V+ +   
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 201
Query: 205 LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
             P   +   + +   L+G P      F   D  R Y +Q+        S ++  ++P A
Sbjct: 202 GKPVDLWACGVILYILLVGYPP-----FWDEDQHRLY-QQIKAGAYDFPSPEWDTVTPEA 255
Query: 265 IDLAERMLVFDPAKRITVEEALNHPYLS 292
            DL  +ML  +P+KRIT  EAL HP++S
Sbjct: 256 KDLINKMLTINPSKRITAAEALKHPWIS 283

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + IV       T  E A K I    + A    +  + I RE+ +L  + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + D+      E   DV ++ EL+   +L   +  K++L+++    F+ Q+L G+ Y+H
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSE-TDFMT-----EYV---VTRW 202
           +  + H DLKP N +LL+ N     +K+ DFGLA    +  +F       E+V   +  +
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 203 DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + L    D +  + +IT +L S     LG    D  +  +  +  V      + F   S 
Sbjct: 193 EPLGLEAD-MWSIGVITYILLSGASPFLG----DTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLS 292
           +A D   ++LV +  KR+T++EAL HP+++
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + IV       T  E A K I    + A    +  + I RE+ +L  + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + D+      E   DV ++ EL+   +L   +  K++L+++    F+ Q+L G+ Y+H
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSE-TDFMT-----EYV---VTRW 202
           +  + H DLKP N +LL+ N     +K+ DFGLA    +  +F       E+V   +  +
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 203 DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + L    D +  + +IT +L S     LG    D  +  +  +  V      + F   S 
Sbjct: 193 EPLGLEAD-MWSIGVITYILLSGASPFLG----DTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLS 292
           +A D   ++LV +  KR+T++EAL HP+++
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 124/273 (45%), Gaps = 39/273 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVK 98
           ++ +G GAYG V    +  T  E AIK I  ++     ++  +L E+ +L  + H NI+K
Sbjct: 9   VKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           + +     DK  +  V  VY     +L   I  +Q  ++      + Q+L G  Y+H  N
Sbjct: 69  LYEFFE--DKRNYYLVMEVYR--GGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 124
Query: 159 VLHRDLKPSNLLLNANCD---LKICDFGLARTTSETDFMTEYVVTRW-------DTLFPG 208
           ++HRDLKP NLLL +      +KI DFGL+        M E + T +          +  
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKYDE 184
Query: 209 KDYVQQLTMITELL-------GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
           K  V    +I  +L       G   D ++              L  V K  FS   P+ +
Sbjct: 185 KCDVWSCGVILYILLCGYPPFGGQTDQEI--------------LKRVEKGKFSFDPPDWT 230
Query: 262 PV---AIDLAERMLVFDPAKRITVEEALNHPYL 291
            V   A  L + ML ++P+KRI+ EEALNHP++
Sbjct: 231 QVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 130/290 (44%), Gaps = 53/290 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKIT------------------------NAFDNRIDA 78
           IG+G+YG+V  A N       A+K ++                             R   
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 79  KRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDD 138
           +++ +EI +L  + H N+VK+ ++   +D    + +Y+V+EL++      + + + L++D
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-----------LART 187
             +++   L++G++Y+H   ++HRD+KPSNLL+  +  +KI DFG           L+ T
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT 197
Query: 188 TSETDFMTEYVVTRWDTLFPGKD---YVQQLTMITELLGSPD--DSDLGFLRSDNARRYV 242
                FM    ++    +F GK    +   +T+   + G     D  +  L S    +  
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS----KIK 253
Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
            Q    P Q      P+++    DL  RML  +P  RI V E   HP+++
Sbjct: 254 SQALEFPDQ------PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 36/272 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNR--IDAKRILREIKLLCHM-THENIVK 98
           IG+G + +V   +N ET ++ A+K +  A F +   +  + + RE  + CHM  H +IV+
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI-CHMLKHPHIVE 92
Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDL-HQIIRSKQA---LTDDHCQYFLYQLLRGLKY 153
           + +            +Y+V+E MD  DL  +I++   A    ++    +++ Q+L  L+Y
Sbjct: 93  LLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 154 IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETD-----------FMTEYVV 199
            H  N++HRD+KP  +LL +   +  +K+  FG+A    E+            FM   VV
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 200 TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
            R     P   +   + +   L G      L F  +    R  + +     +   +++ +
Sbjct: 208 KREPYGKPVDVWGCGVILFILLSGC-----LPFYGTKE--RLFEGIIKGKYKMNPRQWSH 260
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           +S  A DL  RML+ DPA+RITV EALNHP+L
Sbjct: 261 ISESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G + IV       T  E A K I    + A    +  + I RE+ +L  + H NI
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + D+      E   DV ++ EL+   +L   +  K++L+++    F+ Q+L G+ Y+H
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 156 SANVLHRDLKPSN-LLLNANC---DLKICDFGLARTTSE-TDFMT-----EYV---VTRW 202
           +  + H DLKP N +LL+ N     +K+ DFGLA    +  +F       E+V   +  +
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 203 DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + L    D +  + +IT +L S     LG    D  +  +  +  V      + F   S 
Sbjct: 193 EPLGLEAD-MWSIGVITYILLSGASPFLG----DTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLS 292
           +A D   ++LV +  KR+T++EAL HP+++
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 36/272 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNR--IDAKRILREIKLLCHM-THENIVK 98
           IG+G + +V   +N ET ++ A+K +  A F +   +  + + RE  + CHM  H +IV+
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI-CHMLKHPHIVE 90
Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDL-HQIIRSKQA---LTDDHCQYFLYQLLRGLKY 153
           + +            +Y+V+E MD  DL  +I++   A    ++    +++ Q+L  L+Y
Sbjct: 91  LLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 154 IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETD-----------FMTEYVV 199
            H  N++HRD+KP  +LL +   +  +K+  FG+A    E+            FM   VV
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 200 TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
            R     P   +   + +   L G      L F  +    R  + +     +   +++ +
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGC-----LPFYGTKE--RLFEGIIKGKYKMNPRQWSH 258
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           +S  A DL  RML+ DPA+RITV EALNHP+L
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 126/270 (46%), Gaps = 35/270 (12%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G++G V    +  T +E A+K I+      + D + +LRE++LL  + H NI K+ +
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 102 IIPPMDKEKF---NDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                DK  F    +VY   EL D      I S++  ++      + Q+L G+ Y H   
Sbjct: 94  FFE--DKGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 159 VLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRW----DTLFPGKD- 210
           ++HRDLKP NLLL +   + +++I DFGL+     +    + + T +    + L    D 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTYDE 206
Query: 211 ----YVQQLTMITELLGSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
               +   + +   L G P     ++   L+     +Y  +LP   K         +S  
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK---------VSES 257
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  + L + P+ RI+  +AL+H ++ +
Sbjct: 258 AKDLIRKXLTYVPSXRISARDALDHEWIQT 287

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 142/301 (47%), Gaps = 34/301 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVKVKD 101
           +G+G +       +++TKE  A K +  +   +   + ++  EI +   + H+++V    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                  E  + V++V EL     L ++ + ++ALT+   +Y+L Q++ G +Y+H   V+
Sbjct: 89  FF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 143
Query: 161 HRDLKPSNLLLNANCDLKICDFGLA----------RTTSET-DFMTEYVVTRWDTLFPGK 209
           HRDLK  NL LN + ++KI DFGLA          +T   T +++   V+++    F   
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVD 203
Query: 210 DYVQQLTMITELLGSP--DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
            +     M T L+G P  + S L     +   R  K    +PK        +++PVA  L
Sbjct: 204 VWSIGCIMYTLLVGKPPFETSCL----KETYLRIKKNEYSIPK--------HINPVAASL 251
Query: 268 AERMLVFDPAKRITVEEALNHPYLSSLHEINEEP-TC-PYPFNFDFEQTSMNEEDIKELI 325
            ++ML  DP  R T+ E LN  + +S +     P TC   P  F    +S++  + K L 
Sbjct: 252 IQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLT 311
Query: 326 L 326
           +
Sbjct: 312 V 312

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 141/302 (46%), Gaps = 36/302 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVKVKD 101
           +G+G +       +++TKE  A K +  +   +   + ++  EI +   + H+++V    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                  E  + V++V EL     L ++ + ++ALT+   +Y+L Q++ G +Y+H   V+
Sbjct: 109 FF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 163
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETD------------FMTEYVVTRWDTLFPG 208
           HRDLK  NL LN + ++KI DFGLA T  E D            ++   V+++    F  
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222
Query: 209 KDYVQQLTMITELLGSP--DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
             +     M T L+G P  + S L     +   R  K    +PK        +++PVA  
Sbjct: 223 DVWSIGCIMYTLLVGKPPFETSCL----KETYLRIKKNEYSIPK--------HINPVAAS 270
Query: 267 LAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP-TC-PYPFNFDFEQTSMNEEDIKEL 324
           L ++ML  DP  R T+ E LN  + +S +     P TC   P  F    +S++  + K L
Sbjct: 271 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
Query: 325 IL 326
            +
Sbjct: 331 TV 332

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 142/301 (47%), Gaps = 34/301 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVKVKD 101
           +G+G +       +++TKE  A K +  +   +   + ++  EI +   + H+++V    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                  E  + V++V EL     L ++ + ++ALT+   +Y+L Q++ G +Y+H   V+
Sbjct: 85  FF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 161 HRDLKPSNLLLNANCDLKICDFGLA----------RTTSET-DFMTEYVVTRWDTLFPGK 209
           HRDLK  NL LN + ++KI DFGLA          +T   T +++   V+++    F   
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVD 199
Query: 210 DYVQQLTMITELLGSP--DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
            +     M T L+G P  + S L     +   R  K    +PK        +++PVA  L
Sbjct: 200 VWSIGCIMYTLLVGKPPFETSCL----KETYLRIKKNEYSIPK--------HINPVAASL 247
Query: 268 AERMLVFDPAKRITVEEALNHPYLSSLHEINEEP-TC-PYPFNFDFEQTSMNEEDIKELI 325
            ++ML  DP  R T+ E LN  + +S +     P TC   P  F    +S++  + K L 
Sbjct: 248 IQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLT 307
Query: 326 L 326
           +
Sbjct: 308 V 308

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 141/302 (46%), Gaps = 36/302 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVKVKD 101
           +G+G +       +++TKE  A K +  +   +   + ++  EI +   + H+++V    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                  E  + V++V EL     L ++ + ++ALT+   +Y+L Q++ G +Y+H   V+
Sbjct: 107 FF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 161
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETD------------FMTEYVVTRWDTLFPG 208
           HRDLK  NL LN + ++KI DFGLA T  E D            ++   V+++    F  
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 220
Query: 209 KDYVQQLTMITELLGSP--DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
             +     M T L+G P  + S L     +   R  K    +PK        +++PVA  
Sbjct: 221 DVWSIGCIMYTLLVGKPPFETSCL----KETYLRIKKNEYSIPK--------HINPVAAS 268
Query: 267 LAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP-TC-PYPFNFDFEQTSMNEEDIKEL 324
           L ++ML  DP  R T+ E LN  + +S +     P TC   P  F    +S++  + K L
Sbjct: 269 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 328
Query: 325 IL 326
            +
Sbjct: 329 TV 330

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 142/301 (47%), Gaps = 34/301 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVKVKD 101
           +G+G +       +++TKE  A K +  +   +   + ++  EI +   + H+++V    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                  E  + V++V EL     L ++ + ++ALT+   +Y+L Q++ G +Y+H   V+
Sbjct: 85  FF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 161 HRDLKPSNLLLNANCDLKICDFGLA----------RTTSET-DFMTEYVVTRWDTLFPGK 209
           HRDLK  NL LN + ++KI DFGLA          +T   T +++   V+++    F   
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVD 199
Query: 210 DYVQQLTMITELLGSP--DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
            +     M T L+G P  + S L     +   R  K    +PK        +++PVA  L
Sbjct: 200 VWSIGCIMYTLLVGKPPFETSCL----KETYLRIKKNEYSIPK--------HINPVAASL 247
Query: 268 AERMLVFDPAKRITVEEALNHPYLSSLHEINEEP-TC-PYPFNFDFEQTSMNEEDIKELI 325
            ++ML  DP  R T+ E LN  + +S +     P TC   P  F    +S++  + K L 
Sbjct: 248 IQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPXFSIAPSSLDPSNRKPLT 307
Query: 326 L 326
           +
Sbjct: 308 V 308

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 51/284 (17%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G +  V  A +  T  EVAIK I     N    +++ RE++++  + H NIVK+
Sbjct: 17  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 76
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++I     E    +Y++ E     ++   + +   + +   +    Q++  ++Y H   
Sbjct: 77  FEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVV-TRWDT-----------LF 206
           ++HRDLK  NLLL+A+ ++KI DFG         F  E+ V  + DT           LF
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFG---------FSNEFTVGGKLDTFCGSPPYAAPELF 182
Query: 207 PGKDY------VQQLTMITELLGSP----DDSDLGFLRSDNAR-RYVKQLPHVPKQPFSQ 255
            GK Y      V  L +I   L S     D  +L  LR    R +Y        + PF  
Sbjct: 183 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--------RIPFY- 233
Query: 256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
               MS    +L +R LV +P KR T+E+ +   ++++ HE +E
Sbjct: 234 ----MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 273

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 33/274 (12%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G G+YG V  A++ ET + VAIK++        D + I++EI ++      ++VK 
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQVPV----ESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSA 157
                     K  D++IV E      +  IIR + + LT+D     L   L+GL+Y+H  
Sbjct: 90  YG-----SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQ--- 214
             +HRD+K  N+LLN     K+ DFG+A     TD M +         +   + +Q+   
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 215 ----------LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
                     +T I    G P  +D+  +R+      +  +P  P   F +K    S   
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIPTNPPPTF-RKPELWSDNF 255
Query: 265 IDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN 298
            D  ++ LV  P +R T  + L HP++ S   ++
Sbjct: 256 TDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + +G+GA+ +V   V     +E A   I     +  D +++ RE ++   + H NIV++
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 100 KDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            D I           Y++++L+   +L + I +++  ++    + + Q+L  + + H   
Sbjct: 76  HDSISEEGHH-----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 159 VLHRDLKPSNLLLNA---NCDLKICDFGLA-----------RTTSETDFMTEYVVTRWDT 204
           V+HR+LKP NLLL +      +K+ DFGLA                  +++  V+ +   
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 205 LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
             P   +   + +   L+G P      F   D  R Y +Q+        S ++  ++P A
Sbjct: 191 GKPVDLWACGVILYILLVGYPP-----FWDEDQHRLY-QQIKAGAYDFPSPEWDTVTPEA 244
Query: 265 IDLAERMLVFDPAKRITVEEALNHPYLS 292
            DL  +ML  +P+KRIT  EAL HP++S
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWIS 272

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 116/267 (43%), Gaps = 36/267 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IGRG++G V  AV   T+   A KKI   F   +D  R  +EI+++  + H NI+++ + 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD--RFKQEIEIMKSLDHPNIIRLYET 74
Query: 103 IPPMDKEKFNDVYIVYEL-MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
                 E   D+Y+V EL    +L + +  K+   +      +  +L  + Y H  NV H
Sbjct: 75  F-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAH 129
Query: 162 RDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRW-------DTLF-PGKD 210
           RDLKP N L    + +  LK+ DFGLA        M   V T +       + L+ P  D
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECD 189
Query: 211 YVQQLTMITELL------GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
                 M+  LL       +P D ++        R      P        + + N+SP A
Sbjct: 190 EWSAGVMMYVLLCGYPPFSAPTDXEVML----KIREGTFTFPE-------KDWLNVSPQA 238
Query: 265 IDLAERMLVFDPAKRITVEEALNHPYL 291
             L  R+L   P +RIT  +AL H + 
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWF 265

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 116/267 (43%), Gaps = 36/267 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IGRG++G V  AV   T+   A KKI   F   +D  R  +EI+++  + H NI+++ + 
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD--RFKQEIEIMKSLDHPNIIRLYET 91
Query: 103 IPPMDKEKFNDVYIVYEL-MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
                 E   D+Y+V EL    +L + +  K+   +      +  +L  + Y H  NV H
Sbjct: 92  F-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAH 146
Query: 162 RDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRW-------DTLF-PGKD 210
           RDLKP N L    + +  LK+ DFGLA        M   V T +       + L+ P  D
Sbjct: 147 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECD 206
Query: 211 YVQQLTMITELL------GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
                 M+  LL       +P D ++        R      P        + + N+SP A
Sbjct: 207 EWSAGVMMYVLLCGYPPFSAPTDXEVML----KIREGTFTFPE-------KDWLNVSPQA 255
Query: 265 IDLAERMLVFDPAKRITVEEALNHPYL 291
             L  R+L   P +RIT  +AL H + 
Sbjct: 256 ESLIRRLLTKSPKQRITSLQALEHEWF 282

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 34/268 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +      +   +  LR E+++  H+ H NI+++
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 78  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           S  V+HRD+KP NLLL +N +LKI DFG         +      +R DTL    DY+   
Sbjct: 130 SKRVIHRDIKPENLLLGSNGELKIADFG---------WSVHAPSSRRDTLCGTLDYLPPE 180
Query: 216 TMITELLGSPDD-SDLGFLRSD--------NARRYVKQLPHVPKQPFSQKFPN-MSPVAI 265
            +   +     D   LG L  +         A  Y +    + +  F+  FP+ ++  A 
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT--FPDFVTEGAR 238
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           DL  R+L  + ++R+T+ E L HP++ +
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEHPWIKA 266

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 127/267 (47%), Gaps = 34/267 (12%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVKVKD 101
           +G+G +       +++TKE  A K +  +   +   + ++  EI +   + H+++V    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                  E  + V++V EL     L ++ + ++ALT+   +Y+L Q++ G +Y+H   V+
Sbjct: 83  FF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 137
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETD------------FMTEYVVTRWDTLFPG 208
           HRDLK  NL LN + ++KI DFGLA T  E D            ++   V+++    F  
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 209 KDYVQQLTMITELLGSP--DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
             +     M T L+G P  + S L     +   R  K    +PK        +++PVA  
Sbjct: 197 DVWSIGCIMYTLLVGKPPFETSCL----KETYLRIKKNEYSIPK--------HINPVAAS 244
Query: 267 LAERMLVFDPAKRITVEEALNHPYLSS 293
           L ++ML  DP  R T+ E LN  + +S
Sbjct: 245 LIQKMLQTDPTARPTINELLNDEFFTS 271

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 132/274 (48%), Gaps = 31/274 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G +  V  A +  T +EVA++ I     N    +++ RE++++  + H NIVK+
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++I     E    +Y+V E     ++   + +   + +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT---RWDTLFPGKDY---- 211
           ++HRDLK  NLLL+A+ ++KI DFG +   +  + + E+  +       LF GK Y    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 212 --VQQLTMITELLGSP----DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             V  L +I   L S     D  +L  LR        + L    + PF      MS    
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRE-------RVLRGKYRIPFY-----MSTDCE 241
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
           +L ++ L+ +P+KR T+E+ +   +++  HE +E
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDE 275

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 128/274 (46%), Gaps = 31/274 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G +  V  A +  T  EVAIK I     N    +++ RE++++  + H NIVK+
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++I     E    +Y++ E     ++   + +   + +   +    Q++  ++Y H   
Sbjct: 80  FEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT---RWDTLFPGKDY---- 211
           ++HRDLK  NLLL+A+ ++KI DFG +   +    +  +          LF GK Y    
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 212 --VQQLTMITELLGSP----DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             V  L +I   L S     D  +L  LR        + L    + PF      MS    
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRE-------RVLRGKYRIPFY-----MSTDCE 242
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
           +L +R LV +P KR T+E+ +   ++++ HE +E
Sbjct: 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 47/290 (16%)
Query: 24  NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR 83
           + L + F+V S+       +GRGA  IV       T++  A+K +    D +I    +  
Sbjct: 49  DALSDFFEVESE-------LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI----VRT 97
Query: 84  EIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQY 142
           EI +L  ++H NI+K+K+I      E   ++ +V EL+   +L   I  K   ++     
Sbjct: 98  EIGVLLRLSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD 152
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVV 199
            + Q+L  + Y+H   ++HRDLKP NLL      +  LKI DFGL++       M     
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212
Query: 200 T---------RWDTLFPGKDYVQQLTMITELL---GSPDDSDLG----FLRSDNARRYVK 243
           T         R     P  D +  + +IT +L     P   + G    F R  N   Y  
Sbjct: 213 TPGYCAPEILRGCAYGPEVD-MWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF- 270
Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
                     S  +  +S  A DL  +++V DP KR+T  +AL HP+++ 
Sbjct: 271 ---------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 34/268 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 75  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           S  V+HRD+KP NLLL +  +LKI DFG         +      +R DTL    DY+   
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFG---------WSVHAPSSRRDTLCGTLDYLPPE 177
Query: 216 TMITELLGSPDD-SDLGFLRSD--------NARRYVKQLPHVPKQPFSQKFPN-MSPVAI 265
            +   +     D   LG L  +         A  Y +    + +  F+  FP+ ++  A 
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGAR 235
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           DL  R+L  +P++R  + E L HP++++
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 130/286 (45%), Gaps = 33/286 (11%)
Query: 35  KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--ILREIKLLCHMT 92
           +Y+     IG G+ GIVC A    T ++VA+KK+    D R   +R  +  E+ ++    
Sbjct: 45  EYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRDYH 100
Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
           H+N+V +       D     ++++V E ++      I +   + ++        +LR L 
Sbjct: 101 HDNVVDMYSSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALS 155
Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTR 201
           Y+H+  V+HRD+K  ++LL ++  +K+ DFG  A+ + E            +M   V++R
Sbjct: 156 YLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISR 215
Query: 202 WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
                    +   + +I  + G P   +   L++   RR    LP     P  +    +S
Sbjct: 216 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--MRRIRDSLP-----PRVKDLHKVS 268
Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPF 307
            V     + MLV +P++R T +E L HP+L    ++   P+C  P 
Sbjct: 269 SVLRGFLDLMLVREPSQRATAQELLGHPFL----KLAGPPSCIVPL 310

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 126/266 (47%), Gaps = 37/266 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--ILREIKLLCHMTHENIVKVK 100
           IG G+ GIVC A    +  +VA+K +    D R   +R  +  E+ ++    H N+V+  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM----DLRKQQRRELLFNEVVIMRDYQHFNVVE-- 106
Query: 101 DIIPPMDKEKF--NDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                M K      +++++ E +       I S+  L ++        +L+ L Y+H+  
Sbjct: 107 -----MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETD-----------FMTEYVVTRWDTLFP 207
           V+HRD+K  ++LL  +  +K+ DFG     S+             +M   V++R  +L+ 
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISR--SLYA 219
Query: 208 GKDYVQQL-TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
            +  +  L  M+ E++ G P         SD+  + +K+L   P  P  +    +SPV  
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPP------YFSDSPVQAMKRLRDSPP-PKLKNSHKVSPVLR 272
Query: 266 DLAERMLVFDPAKRITVEEALNHPYL 291
           D  ERMLV DP +R T +E L+HP+L
Sbjct: 273 DFLERMLVRDPQERATAQELLDHPFL 298

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 129/263 (49%), Gaps = 24/263 (9%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +      +   +  LR E+++  H+ H NI+++
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 78  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +N +LKI DFG +     +   T  +    D L P    G+ +
Sbjct: 130 SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTT--LCGTLDYLPPEMIEGRMH 187
Query: 212 VQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPVAIDLAER 270
            +++ + +  LG      L  +    A  Y +    + +  F+  FP+ ++  A DL  R
Sbjct: 188 DEKVDLWS--LGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT--FPDFVTEGARDLISR 243
Query: 271 MLVFDPAKRITVEEALNHPYLSS 293
           +L  + ++R+T+ E L HP++ +
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKA 266

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 42/281 (14%)
Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI-------LREIKLLCHM 91
           P + +GRG   +V   ++  T +E A+K I         A+ +       L+E+ +L  +
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 92  T-HENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLR 149
           + H NI+++KD       E     ++V++LM   +L   +  K  L++   +  +  LL 
Sbjct: 81  SGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---------RTTSETD--FMTEYV 198
            +  +H  N++HRDLKP N+LL+ + ++K+ DFG +         R+   T      E +
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEII 195
Query: 199 VTRWDTLFPGKD-----YVQQLTMITELLGSP---DDSDLGFLRSDNARRYVKQLPHVPK 250
               +   PG       +   + M T L GSP       +  LR   +  Y         
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY--------- 246
Query: 251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           Q  S ++ + S    DL  R LV  P KR T EEAL HP+ 
Sbjct: 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G +  V  A +  T +EVA+K I     N    +++ RE++++  + H NIVK+
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++I     E    +Y+V E     ++   + +   + +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT---RWDTLFPGKDY---- 211
           ++HRDLK  NLLL+A+ ++KI DFG +   +  + +  +  +       LF GK Y    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 212 --VQQLTMITELLGSP----DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             V  L +I   L S     D  +L  LR        + L    + PF      MS    
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRE-------RVLRGKYRIPFY-----MSTDCE 241
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
           +L ++ L+ +P+KR T+E+ +   +++  HE +E
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDE 275

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 43/281 (15%)
Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI-------LREIKLLCHM 91
           P   IGRG   +V   V+  T  E A+K I      R+  +++        RE  +L  +
Sbjct: 98  PKDVIGRGVSSVVRRCVHRATGHEFAVK-IMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 92  T-HENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLR 149
             H +I+ + D       E  + +++V++LM   +L   +  K AL++   +  +  LL 
Sbjct: 157 AGHPHIITLID-----SYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT--------- 200
            + ++H+ N++HRDLKP N+LL+ N  +++ DFG +      + + E   T         
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 201 --RWDTLFPGKD-----YVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF 253
               D   PG       +   + + T L GSP      F      RR +  L  + +  +
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPP-----FWH----RRQILMLRMIMEGQY 322
Query: 254 ---SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
              S ++ + S    DL  R+L  DP  R+T E+AL HP+ 
Sbjct: 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G +  V  A +  T +EVA+K I     N    +++ RE++++  + H NIVK+
Sbjct: 12  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 71
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++I     E    +Y+V E     ++   + +   + +   +    Q++  ++Y H   
Sbjct: 72  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT---RWDTLFPGKDY---- 211
           ++HRDLK  NLLL+A+ ++KI DFG +   +  + +  +  +       LF GK Y    
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 212 --VQQLTMITELLGSP----DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             V  L +I   L S     D  +L  LR        + L    + PF      MS    
Sbjct: 187 VDVWSLGVILYTLVSGSLPFDGQNLKELRE-------RVLRGKYRIPFY-----MSTDCE 234
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
           +L ++ L+ +P+KR T+E+ +   +++  HE +E
Sbjct: 235 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDE 268

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G +  V  A +  T +EVA+K I     N    +++ RE++++  + H NIVK+
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++I     E    +Y+V E     ++   + +   + +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT---RWDTLFPGKDY---- 211
           ++HRDLK  NLLL+A+ ++KI DFG +   +  + +  +  +       LF GK Y    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 212 --VQQLTMITELLGSP----DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             V  L +I   L S     D  +L  LR        + L    + PF      MS    
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRE-------RVLRGKYRIPFY-----MSTDCE 241
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
           +L ++ L+ +P+KR T+E+ +   +++  HE +E
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDE 275

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 122/273 (44%), Gaps = 45/273 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G+Y +    ++  T  E A+K I  +  +  +   IL     L +  H NI+ +KD+
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL-----LRYGQHPNIITLKDV 84
Query: 103 IPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
               D  K+  VY+V ELM     L +I+R K   ++      L+ + + ++Y+H+  V+
Sbjct: 85  ---YDDGKY--VYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 161 HRDLKPSNLLL---NANCD-LKICDFGLARTTSE-----------TDFMTEYVVTRW--- 202
           HRDLKPSN+L    + N + ++ICDFG A+                +F+   V+ R    
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD 198
Query: 203 ---DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
              D    G      LT  T     PDD+    L    + ++            S  + N
Sbjct: 199 AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF----------SLSGGYWN 248
Query: 260 -MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            +S  A DL  +ML  DP +R+T    L HP++
Sbjct: 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 122/276 (44%), Gaps = 45/276 (16%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + IG G+Y      V+  T  E A+K I  +   R  ++ I  EI LL +  H NI+ +K
Sbjct: 33  ETIGVGSYSECKRCVHKATNMEYAVKVIDKS--KRDPSEEI--EI-LLRYGQHPNIITLK 87
Query: 101 DIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           D+      +    VY+V ELM     L +I+R K   ++    + L+ + + ++Y+HS  
Sbjct: 88  DVY-----DDGKHVYLVTELMRGGELLDKILRQK-FFSEREASFVLHTIGKTVEYLHSQG 141
Query: 159 VLHRDLKPSNLLL-----NANCDLKICDFGLARTTSE-----------TDFMTEYVVTRW 202
           V+HRDLKPSN+L      N  C L+ICDFG A+                +F+   V+ R 
Sbjct: 142 VVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQ 200
Query: 203 ------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK 256
                 D    G      L   T     P D+    L    + ++               
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLS---------GGN 251
Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
           +  +S  A DL  +ML  DP +R+T ++ L HP+++
Sbjct: 252 WNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVT 287

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 141/293 (48%), Gaps = 37/293 (12%)
Query: 26  LGNL-FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           +GN  F+V +  + P+  +GRGAYG+V    +  + + +A+K+I  A  N  + KR+L +
Sbjct: 41  IGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMD 99
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDL----HQIIRSKQALTDDHC 140
           + +   M   +          + +E   DV+I  ELMDT L     Q+I   Q + +D  
Sbjct: 100 LDI--SMRTVDCPFTVTFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDIL 155
Query: 141 QYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVV 199
                 +++ L+++HS  +V+HRD+KPSN+L+NA   +K+CDFG+      + ++ + V 
Sbjct: 156 GKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI------SGYLVDSVA 209
Query: 200 TRWDTLFPGKDYVQQLTMITEL--LGSPDDSD----------LGFLR--SDNARRYVKQL 245
              D     K Y+    +  EL   G    SD          L  LR   D+     +QL
Sbjct: 210 KTIDA--GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 267
Query: 246 PHVPKQPFSQKFP--NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
             V ++P S + P    S   +D   + L  +  +R T  E + HP+  +LHE
Sbjct: 268 KQVVEEP-SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF-TLHE 318

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 122/276 (44%), Gaps = 45/276 (16%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + IG G+Y      V+  T  E A+K I  +   R  ++ I  EI LL +  H NI+ +K
Sbjct: 33  ETIGVGSYSECKRCVHKATNMEYAVKVIDKS--KRDPSEEI--EI-LLRYGQHPNIITLK 87
Query: 101 DIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           D+      +    VY+V ELM     L +I+R K   ++    + L+ + + ++Y+HS  
Sbjct: 88  DVY-----DDGKHVYLVTELMRGGELLDKILRQK-FFSEREASFVLHTIGKTVEYLHSQG 141
Query: 159 VLHRDLKPSNLLL-----NANCDLKICDFGLARTTSE-----------TDFMTEYVVTRW 202
           V+HRDLKPSN+L      N  C L+ICDFG A+                +F+   V+ R 
Sbjct: 142 VVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQ 200
Query: 203 ------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK 256
                 D    G      L   T     P D+    L    + ++               
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLS---------GGN 251
Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
           +  +S  A DL  +ML  DP +R+T ++ L HP+++
Sbjct: 252 WNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVT 287

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 44/282 (15%)
Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI-------LREIKLLCHM 91
           P + +GRG   +V   ++  T +E A+K I         A+ +       L+E+ +L  +
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 92  T-HENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLR 149
           + H NI+++KD       E     ++V++LM   +L   +  K  L++   +  +  LL 
Sbjct: 81  SGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP-- 207
            +  +H  N++HRDLKP N+LL+ + ++K+ DFG +      + + E   T    L P  
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP-SYLAPEI 194
Query: 208 ------------GKD---YVQQLTMITELLGSP---DDSDLGFLRSDNARRYVKQLPHVP 249
                       GK+   +   + M T L GSP       +  LR   +  Y        
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY-------- 246
Query: 250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            Q  S ++ + S    DL  R LV  P KR T EEAL HP+ 
Sbjct: 247 -QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 130/274 (47%), Gaps = 31/274 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G +  V  A +  T +EVA+K I     N    +++ RE++++  + H NIVK+
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++I     E    +Y+V E     ++   + +   + +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT---RWDTLFPGKDY---- 211
           ++HRDLK  NLLL+A+ ++KI DFG +   +  + +  +          LF GK Y    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 212 --VQQLTMITELLGSP----DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             V  L +I   L S     D  +L  LR        + L    + PF      MS    
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRE-------RVLRGKYRIPFY-----MSTDCE 241
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
           +L ++ L+ +P+KR T+E+ +   +++  HE +E
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDE 275

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 128/266 (48%), Gaps = 30/266 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G V       +  E  IK I N   +++  ++I  EI++L  + H NI+K+ ++
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 103 IPPMDKEKFNDVYIVYELMDTD--LHQIIRSK---QALTDDHCQYFLYQLLRGLKYIHSA 157
                 E ++++YIV E  +    L +I+ ++   +AL++ +    + Q++  L Y HS 
Sbjct: 89  F-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 158 NVLHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVT---------RWDTL 205
           +V+H+DLKP N+L    + +  +KI DFGLA      +  T    T         + D  
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVT 203
Query: 206 FPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
           F    +   + M   L G      L F  +  +   V+Q     +  ++ +   ++P A+
Sbjct: 204 FKCDIWSAGVVMYFLLTGC-----LPF--TGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256
Query: 266 DLAERMLVFDPAKRITVEEALNHPYL 291
           DL ++ML  DP +R +  + L+H + 
Sbjct: 257 DLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 44/282 (15%)
Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI-------LREIKLLCHM 91
           P + +GRG   +V   ++  T +E A+K I         A+ +       L+E+ +L  +
Sbjct: 8   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 67
Query: 92  T-HENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLR 149
           + H NI+++KD       E     ++V++LM   +L   +  K  L++   +  +  LL 
Sbjct: 68  SGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 122
Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP-- 207
            +  +H  N++HRDLKP N+LL+ + ++K+ DFG +      + + E   T    L P  
Sbjct: 123 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP-SYLAPEI 181
Query: 208 ------------GKD---YVQQLTMITELLGSP---DDSDLGFLRSDNARRYVKQLPHVP 249
                       GK+   +   + M T L GSP       +  LR   +  Y        
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY-------- 233
Query: 250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            Q  S ++ + S    DL  R LV  P KR T EEAL HP+ 
Sbjct: 234 -QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 129/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 79  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +   T  +    D L P    G+ +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--LCGTLDYLPPEXIEGRXH 188
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 237
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 238 ARDLISRLLKHNPSQRPXLREVLEHPWITA 267

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 125/268 (46%), Gaps = 34/268 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 100 YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 151
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           S  V+HRD+KP NLLL +  +LKI DFG         +      +R D L    DY+   
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFG---------WSVHAPSSRRDDLCGTLDYLPPE 202
Query: 216 TMITELLGSPDD-SDLGFLRSD--------NARRYVKQLPHVPKQPFSQKFPN-MSPVAI 265
            +   +     D   LG L  +         A  Y +    + +  F+  FP+ ++  A 
Sbjct: 203 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGAR 260
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           DL  R+L  +P++R  + E L HP++++
Sbjct: 261 DLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 129/301 (42%), Gaps = 61/301 (20%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +GRG Y  V  A+N    E+VA+K +          K       L       NI+ +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVAVKILKPV----KKKKIKREIKILENLRGGPNIITL 97
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  +
Sbjct: 98  ADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGI 152
Query: 160 LHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF-MTEYV 198
           +HRD+KP N+L++  +  L++ D+GLA           R  S          D+ M +Y 
Sbjct: 153 MHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 212
Query: 199 VTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DSDLGFL 233
           +  W             +  F G D   QL  I ++LG+ D            D     +
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 272
Query: 234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
              ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ HPY  +
Sbjct: 273 LGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 326
Query: 294 L 294
           +
Sbjct: 327 V 327

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 131/270 (48%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +   + +   TE   T  D L P    G+ +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGT-LDYLPPEMIEGRMH 183
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 232
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 233 ARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G +  V  A +  T +EVA++ I     N    +++ RE++++  + H NIVK+
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++I     E    +Y+V E     ++   + +   + +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT---RWDTLFPGKDY---- 211
           ++HRDLK  NLLL+A+ ++KI DFG +   +  + +  +  +       LF GK Y    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 212 --VQQLTMITELLGSP----DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             V  L +I   L S     D  +L  LR        + L    + PF      MS    
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRE-------RVLRGKYRIPFY-----MSTDCE 241
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
           +L ++ L+ +P+KR T+E+ +   +++  HE +E
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDE 275

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 129/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 100 YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 151
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +   T  +    D L P    G+ +
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--LCGTLDYLPPEMIEGRMH 209
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 258
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 259 ARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 44/273 (16%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGL---ARTTSETDFMTEYVVTRWDTLFP----G 208
           S  V+HRD+KP NLLL +  +LKI DFG    A ++  TD          D L P    G
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL-----DYLPPEMIEG 180
Query: 209 KDYVQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-M 260
           + + +++ + +        L+G P            A  Y +    + +  F+  FP+ +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFV 229
Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           +  A DL  R+L  +P++R  + E L HP++++
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHENVVK 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 70  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 44/273 (16%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 79  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGL---ARTTSETDFMTEYVVTRWDTLFP----G 208
           S  V+HRD+KP NLLL +  +LKI DFG    A ++  TD          D L P    G
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL-----DYLPPEMIEG 185
Query: 209 KDYVQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-M 260
           + + +++ + +        L+G P            A  Y +    + +  F+  FP+ +
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFV 234
Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           +  A DL  R+L  +P++R  + E L HP++++
Sbjct: 235 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHENVVK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 69  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 125/268 (46%), Gaps = 34/268 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 91  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 142
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           S  V+HRD+KP NLLL +  +LKI DFG         +      +R  TL    DY+   
Sbjct: 143 SKRVIHRDIKPENLLLGSAGELKIADFG---------WSVHAPSSRRTTLCGTLDYLPPE 193
Query: 216 TMITELLGSPDD-SDLGFLRSD--------NARRYVKQLPHVPKQPFSQKFPN-MSPVAI 265
            +   +     D   LG L  +         A  Y +    + +  F+  FP+ ++  A 
Sbjct: 194 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGAR 251
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           DL  R+L  +P++R  + E L HP++++
Sbjct: 252 DLISRLLKHNPSQRPMLREVLEHPWITA 279

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 129/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +   T  +    D L P    G+ +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--LCGTLDYLPPEMIEGRMH 186
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 235
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 236 ARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 125/268 (46%), Gaps = 34/268 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 79  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           S  V+HRD+KP NLLL +  +LKI DFG         +      +R  TL    DY+   
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFG---------WSVHAPSSRRTTLCGTLDYLPPE 181
Query: 216 TMITELLGSPDD-SDLGFLRSD--------NARRYVKQLPHVPKQPFSQKFPN-MSPVAI 265
            +   +     D   LG L  +         A  Y +    + +  F+  FP+ ++  A 
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGAR 239
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           DL  R+L  +P++R  + E L HP++++
Sbjct: 240 DLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 44/273 (16%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 75  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGL---ARTTSETDFMTEYVVTRWDTLFP----G 208
           S  V+HRD+KP NLLL +  +LKI DFG    A ++  TD          D L P    G
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL-----DYLPPEMIEG 181
Query: 209 KDYVQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-M 260
           + + +++ + +        L+G P            A  Y +    + +  F+  FP+ +
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFV 230
Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           +  A DL  R+L  +P++R  + E L HP++++
Sbjct: 231 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 129/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 78  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 129
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +   T  +    D L P    G+ +
Sbjct: 130 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--LCGTLDYLPPEMIEGRMH 187
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 236
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 237 ARDLISRLLKHNPSQRPMLREVLEHPWITA 266

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 44/273 (16%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGL---ARTTSETDFMTEYVVTRWDTLFP----G 208
           S  V+HRD+KP NLLL +  +LKI DFG    A ++  TD          D L P    G
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL-----DYLPPEMIEG 180
Query: 209 KDYVQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-M 260
           + + +++ + +        L+G P            A  Y +    + +  F+  FP+ +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFV 229
Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           +  A DL  R+L  +P++R  + E L HP++++
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 125/268 (46%), Gaps = 34/268 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           S  V+HRD+KP NLLL +  +LKI DFG         +      +R  TL    DY+   
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFG---------WSVHAPSSRRTTLCGTLDYLPPE 179
Query: 216 TMITELLGSPDD-SDLGFLRSD--------NARRYVKQLPHVPKQPFSQKFPN-MSPVAI 265
            +   +     D   LG L  +         A  Y +    + +  F+  FP+ ++  A 
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGAR 237
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           DL  R+L  +P++R  + E L HP++++
Sbjct: 238 DLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 129/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 73  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 124
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +   T  +    D L P    G+ +
Sbjct: 125 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--LCGTLDYLPPEMIEGRMH 182
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 231
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 232 ARDLISRLLKHNPSQRPMLREVLEHPWITA 261

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 129/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +   T  +    D L P    G+ +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--LCGTLDYLPPEMIEGRMH 183
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 232
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 233 ARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINAMLNHENVVK 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 70  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHENVVK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 69  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 125/268 (46%), Gaps = 34/268 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           S  V+HRD+KP NLLL +  +LKI DFG         +      +R D L    DY+   
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFG---------WSVHAPSSRRDDLCGTLDYLPPE 179
Query: 216 TMITELLGSPDD-SDLGFLRSD--------NARRYVKQLPHVPKQPFSQKFPN-MSPVAI 265
            +   +     D   LG L  +         A  Y +    + +  F+  FP+ ++  A 
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGAR 237
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           DL  R+L  +P++R  + E L HP++++
Sbjct: 238 DLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 138/308 (44%), Gaps = 48/308 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVKVKD 101
           +G G +G V    +  T  +VA+K +       +D   +I REI+ L    H +I+K+  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +I        +D+++V E +   +L   I     L +   +    Q+L G+ Y H   V+
Sbjct: 84  VI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVV 138
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT-----------EYVVTRWDTLFPGK 209
           HRDLKP N+LL+A+ + KI DFGL+   S+ +F+            E +  R   L+ G 
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGR---LYAGP 195
Query: 210 D---YVQQLTMITELLGS-PDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN---MSP 262
           +   +   + +   L G+ P D D               +P + K+     F     ++P
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDDD--------------HVPTLFKKICDGIFYTPQYLNP 241
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIK 322
             I L + ML  DP KR T+++   H +        + P   +P +  +  T +++E +K
Sbjct: 242 SVISLLKHMLQVDPMKRATIKDIREHEWFK-----QDLPKYLFPEDPSYSSTMIDDEALK 296
Query: 323 ELILR-EC 329
           E+  + EC
Sbjct: 297 EVCEKFEC 304

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 125/268 (46%), Gaps = 34/268 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 75  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           S  V+HRD+KP NLLL +  +LKI DFG         +      +R  TL    DY+   
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFG---------WSCHAPSSRRTTLSGTLDYLPPE 177
Query: 216 TMITELLGSPDD-SDLGFLRSD--------NARRYVKQLPHVPKQPFSQKFPN-MSPVAI 265
            +   +     D   LG L  +         A  Y +    + +  F+  FP+ ++  A 
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGAR 235
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           DL  R+L  +P++R  + E L HP++++
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 70  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 69  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 125/257 (48%), Gaps = 61/257 (23%)
Query: 95  NIVKVKDIIP-PMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
           NI+K+ D +  P+ K       +V+E ++ TD  Q+    Q LTD   ++++Y+LL+ L 
Sbjct: 94  NIIKLIDTVKDPVSKTPA----LVFEYINNTDFKQLY---QILTDFDIRFYMYELLKALD 146
Query: 153 YIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TD 192
           Y HS  ++HRD+KP N++++     L++ D+GLA           R  S          D
Sbjct: 147 YCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVD 206
Query: 193 F-MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNA 238
           + M +Y +  W             +  F G+D   QL  I ++LG+  +   G+L+    
Sbjct: 207 YQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLK---- 260
Query: 239 RRYVKQLPH---VPKQPFSQKFPN---------MSPVAIDLAERMLVFDPAKRITVEEAL 286
           + ++   PH   +  Q   +++ N         +SP A+DL +++L +D  +R+T +EA+
Sbjct: 261 KYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAM 320
Query: 287 NHPYLSSLHEINEEPTC 303
            HPY   + +   +P+ 
Sbjct: 321 EHPYFYPVVKEQSQPSA 337

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 69  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 70  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 70  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 70  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 35/284 (12%)
Query: 43  IGRGAYGIVCSAVNSET--KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +G G+YG V   ++SET  +  V I K             + +EI+LL  + H+N++++ 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY--QLLRGLKYIHSAN 158
           D++   +K+K   +Y+V E     + +++ S        CQ   Y  QL+ GL+Y+HS  
Sbjct: 73  DVLYNEEKQK---MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLA------------RTTSET-DFMTEYVVTRWDTL 205
           ++H+D+KP NLLL     LKI   G+A            RT+  +  F    +    DT 
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189
Query: 206 --FPGKDYVQQLTMITELLG-SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
             F    +   +T+     G  P + D  +   +N  +    +P     P S        
Sbjct: 190 SGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS-------- 241
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYP 306
              DL + ML ++PAKR ++ +   H +    H   E P  P P
Sbjct: 242 ---DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV-PIP 281

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 128/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   + K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 71  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 122
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +   T  +    D L P    G+ +
Sbjct: 123 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--LCGTLDYLPPEMIEGRMH 180
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 229
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 230 ARDLISRLLKHNPSQRPMLREVLEHPWITA 259

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 69  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 69  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 68  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLA 150

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 70  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 70  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 69  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 69  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 69  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 69  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 129/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI +FG +     +   T  +    D L P    G+ +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT--LCGTLDYLPPEMIEGRMH 186
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 235
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 236 ARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GAYG V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 69  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 90/161 (55%), Gaps = 10/161 (6%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
            +V +  + P+  +GRGAYG+V    +  + + +A+K+I  A  N  + KR+L ++ +  
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDI-- 58
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDL----HQIIRSKQALTDDHCQYFLY 145
            M   +          + +E   DV+I  ELMDT L     Q+I   Q + +D       
Sbjct: 59  SMRTVDCPFTVTFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 146 QLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            +++ L+++HS  +V+HRD+KPSN+L+NA   +K+CDFG++
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 128/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +      +    D L P    G+ +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEMIEGRMH 183
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 232
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 233 ARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 130/270 (48%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +   + +   T    T  D L P    G+ +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGT-LDYLPPEMIEGRMH 183
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 232
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 233 ARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 125/268 (46%), Gaps = 34/268 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 76  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 127
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           S  V+HRD+KP NLLL +  +LKI +FG         +      +R  TL    DY+   
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIANFG---------WSVHAPSSRRTTLCGTLDYLPPE 178
Query: 216 TMITELLGSPDD-SDLGFLRSD--------NARRYVKQLPHVPKQPFSQKFPN-MSPVAI 265
            +   +     D   LG L  +         A  Y +    + +  F+  FP+ ++  A 
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGAR 236
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           DL  R+L  +P++R  + E L HP++++
Sbjct: 237 DLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 128/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +      +    D L P    G+ +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA--LCGTLDYLPPEMIEGRMH 183
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 232
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 233 ARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 128/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 76  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 127
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +      +    D L P    G+ +
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEMIEGRMH 185
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 234
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 235 ARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 128/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +      +    D L P    G+ +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA--LCGTLDYLPPEMIEGRMH 186
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 235
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 236 ARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 133/278 (47%), Gaps = 37/278 (13%)
Query: 39  PLQPIGRGAYG--IVCSAVNSETKEEVAIKKITN------AFDNRIDAK---RILREIKL 87
            ++ +G GAYG  ++C   N  +++ + + K +       + DN+   K    I  EI L
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 88  LCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQ 146
           L  + H NI+K+ D+    DK+ F   Y+V E  +  +L + I ++    +      + Q
Sbjct: 100 LKSLDHPNIIKLFDVFE--DKKYF---YLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRWD 203
           +L G+ Y+H  N++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T + 
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY- 213
Query: 204 TLFP---GKDYVQQ-------LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF 253
            + P    K Y ++       + M   L G P           N +  +K++        
Sbjct: 214 YIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPP------FGGQNDQDIIKKVEKGKYYFD 267
Query: 254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
              + N+S  A +L + ML +D  KR T EEALN  ++
Sbjct: 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 125/268 (46%), Gaps = 34/268 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 100 KDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++     ++++ ++      +     ++ +L   L Y H
Sbjct: 79  YGY--------FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH 130
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           S  V+HRD+KP NLLL +  +LKI DFG         +      +R  TL    DY+   
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFG---------WSVHAPSSRRTTLCGTLDYLPPE 181
Query: 216 TMITELLGSPDD-SDLGFLRSD--------NARRYVKQLPHVPKQPFSQKFPN-MSPVAI 265
            +   +     D   LG L  +         A  Y +    + +  F+  FP+ ++  A 
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGAR 239
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           DL  R+L  +P++R  + E L HP++++
Sbjct: 240 DLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 38/272 (13%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G +G+     +  TKE VA+K I       ID + + REI     + H NIV+ 
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERG--AAID-ENVQREIINHRSLRHPNIVRF 81
Query: 100 KDII-PPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           K++I  P        + I+ E     +L++ I +    ++D  ++F  QLL G+ Y HS 
Sbjct: 82  KEVILTP------THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135
Query: 158 NVLHRDLKPSNLLLNANCD--LKICDFGLAR----------TTSETDFMTEYVVTRWDTL 205
            + HRDLK  N LL+ +    LKICDFG ++          T     ++   V+ R +  
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQE-- 193
Query: 206 FPGK---DYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN--- 259
           + GK    +   +T+   L+G+       F   +  R Y K +  +    +S   P+   
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGA-----YPFEDPEEPRDYRKTIQRILSVKYS--IPDDIR 246
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           +SP    L  R+ V DPA RI++ E   H + 
Sbjct: 247 ISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 128/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +      +    D L P    G+ +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RXXLCGTLDYLPPEMIEGRMH 186
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y +    + +  F+  FP+ ++  
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQETYKRISRVEFT--FPDFVTEG 235
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 236 ARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 121/268 (45%), Gaps = 32/268 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G GA+  V  A +  T++ VAIK I   A + +     +  EI +L  + H NIV + D
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           I      E    +Y++ +L+   +L   I  K   T+      ++Q+L  +KY+H   ++
Sbjct: 84  IY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 161 HRDLKPSNLL---LNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTM 217
           HRDLKP NLL   L+ +  + I DFGL++       ++    T      PG  YV    +
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT------PG--YVAPEVL 190
Query: 218 ITELLGSPDDS-DLGFLR-----------SDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             +      D   +G +             +N  +  +Q+     +  S  + ++S  A 
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           D    ++  DP KR T E+AL HP+++ 
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 136/300 (45%), Gaps = 65/300 (21%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +GRG Y  V  A+N    E    + +          K       L       NI+K+
Sbjct: 48  VRKLGRGKYSEVFEAINITNNE----RVVVKILKPVKKKKIKREVKILENLRGGTNIIKL 103
Query: 100 KDIIP-PMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
            D +  P+ K       +V+E ++ TD  Q+    Q LTD   ++++Y+LL+ L Y HS 
Sbjct: 104 IDTVKDPVSKTPA----LVFEYINNTDFKQLY---QILTDFDIRFYMYELLKALDYCHSK 156
Query: 158 NVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF-MTE 196
            ++HRD+KP N++++     L++ D+GLA           R  S          D+ M +
Sbjct: 157 GIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYD 216
Query: 197 YVVTRW-------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
           Y +  W             +  F G+D   QL  I ++LG+  +   G+L+    + ++ 
Sbjct: 217 YSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLK----KYHID 270
Query: 244 QLPH---VPKQPFSQKFPN---------MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
             PH   +  Q   +++ N         +SP A+DL +++L +D  +R+T +EA+ HPY 
Sbjct: 271 LDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 121/268 (45%), Gaps = 32/268 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G GA+  V  A +  T++ VAIK I   A + +     +  EI +L  + H NIV + D
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           I      E    +Y++ +L+   +L   I  K   T+      ++Q+L  +KY+H   ++
Sbjct: 84  IY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 161 HRDLKPSNLL---LNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTM 217
           HRDLKP NLL   L+ +  + I DFGL++       ++    T      PG  YV    +
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT------PG--YVAPEVL 190
Query: 218 ITELLGSPDDS-DLGFLR-----------SDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             +      D   +G +             +N  +  +Q+     +  S  + ++S  A 
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           D    ++  DP KR T E+AL HP+++ 
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 116/264 (43%), Gaps = 31/264 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--ILREIKLLCHMTHENIVKVK 100
           IG G+ GIVC A    + + VA+KK+    D R   +R  +  E+ ++    HEN+V++ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 137
Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +     D     ++++V E ++      I +   + ++        +L+ L  +H+  V+
Sbjct: 138 NSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 192
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITE 220
           HRD+K  ++LL  +  +K+ DFG     S+        V R   L  G  Y     +I+ 
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-------VPRRKXLV-GTPYWMAPELISR 244
Query: 221 LLGSP--DDSDLGFL---RSDNARRYVKQLPHVPKQPFSQKFP-------NMSPVAIDLA 268
           L   P  D   LG +     D    Y  + P    +      P        +SP      
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 304
Query: 269 ERMLVFDPAKRITVEEALNHPYLS 292
           +R+LV DPA+R T  E L HP+L+
Sbjct: 305 DRLLVRDPAQRATAAELLKHPFLA 328

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 116/264 (43%), Gaps = 31/264 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--ILREIKLLCHMTHENIVKVK 100
           IG G+ GIVC A    + + VA+KK+    D R   +R  +  E+ ++    HEN+V++ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 92
Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +     D     ++++V E ++      I +   + ++        +L+ L  +H+  V+
Sbjct: 93  NSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 147
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITE 220
           HRD+K  ++LL  +  +K+ DFG     S+        V R   L  G  Y     +I+ 
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-------VPRRKXLV-GTPYWMAPELISR 199
Query: 221 LLGSP--DDSDLGFL---RSDNARRYVKQLPHVPKQPFSQKFP-------NMSPVAIDLA 268
           L   P  D   LG +     D    Y  + P    +      P        +SP      
Sbjct: 200 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 259
Query: 269 ERMLVFDPAKRITVEEALNHPYLS 292
           +R+LV DPA+R T  E L HP+L+
Sbjct: 260 DRLLVRDPAQRATAAELLKHPFLA 283

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 116/264 (43%), Gaps = 31/264 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--ILREIKLLCHMTHENIVKVK 100
           IG G+ GIVC A    + + VA+KK+    D R   +R  +  E+ ++    HEN+V++ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 87
Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +     D     ++++V E ++      I +   + ++        +L+ L  +H+  V+
Sbjct: 88  NSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 142
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITE 220
           HRD+K  ++LL  +  +K+ DFG     S+        V R   L  G  Y     +I+ 
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-------VPRRKXLV-GTPYWMAPELISR 194
Query: 221 LLGSP--DDSDLGFL---RSDNARRYVKQLPHVPKQPFSQKFP-------NMSPVAIDLA 268
           L   P  D   LG +     D    Y  + P    +      P        +SP      
Sbjct: 195 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 254
Query: 269 ERMLVFDPAKRITVEEALNHPYLS 292
           +R+LV DPA+R T  E L HP+L+
Sbjct: 255 DRLLVRDPAQRATAAELLKHPFLA 278

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 121/268 (45%), Gaps = 32/268 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G GA+  V  A +  T++ VAIK I   A + +     +  EI +L  + H NIV + D
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           I      E    +Y++ +L+   +L   I  K   T+      ++Q+L  +KY+H   ++
Sbjct: 84  IY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 161 HRDLKPSNLL---LNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTM 217
           HRDLKP NLL   L+ +  + I DFGL++       ++    T      PG  YV    +
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT------PG--YVAPEVL 190
Query: 218 ITELLGSPDDS-DLGFLR-----------SDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             +      D   +G +             +N  +  +Q+     +  S  + ++S  A 
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           D    ++  DP KR T E+AL HP+++ 
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 86/167 (51%), Gaps = 21/167 (12%)
Query: 27  GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           G+L  +  K +   + +GRGA+G+VC A      ++VAIK+I    ++  + K  + E++
Sbjct: 1   GSLHMIDYKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQI----ESESERKAFIVELR 54
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQAL---TDDHCQY 142
            L  + H NIVK+            N V +V E  +   L+ ++   + L   T  H   
Sbjct: 55  QLSRVNHPNIVKLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 107
Query: 143 FLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCD-LKICDFGLA 185
           +  Q  +G+ Y+HS     ++HRDLKP NLLL A    LKICDFG A
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 116/264 (43%), Gaps = 31/264 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--ILREIKLLCHMTHENIVKVK 100
           IG G+ GIVC A    + + VA+KK+    D R   +R  +  E+ ++    HEN+V++ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +     D     ++++V E ++      I +   + ++        +L+ L  +H+  V+
Sbjct: 84  NSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 138
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITE 220
           HRD+K  ++LL  +  +K+ DFG     S+        V R   L  G  Y     +I+ 
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-------VPRRKXLV-GTPYWMAPELISR 190
Query: 221 LLGSP--DDSDLGFL---RSDNARRYVKQLPHVPKQPFSQKFP-------NMSPVAIDLA 268
           L   P  D   LG +     D    Y  + P    +      P        +SP      
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 250
Query: 269 ERMLVFDPAKRITVEEALNHPYLS 292
           +R+LV DPA+R T  E L HP+L+
Sbjct: 251 DRLLVRDPAQRATAAELLKHPFLA 274

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 121/268 (45%), Gaps = 32/268 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G GA+  V  A +  T++ VAIK I   A + +     +  EI +L  + H NIV + D
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           I      E    +Y++ +L+   +L   I  K   T+      ++Q+L  +KY+H   ++
Sbjct: 84  IY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 161 HRDLKPSNLL---LNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTM 217
           HRDLKP NLL   L+ +  + I DFGL++       ++    T      PG  YV    +
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT------PG--YVAPEVL 190
Query: 218 ITELLGSPDDS-DLGFLR-----------SDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             +      D   +G +             +N  +  +Q+     +  S  + ++S  A 
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           D    ++  DP KR T E+AL HP+++ 
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 116/264 (43%), Gaps = 31/264 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--ILREIKLLCHMTHENIVKVK 100
           IG G+ GIVC A    + + VA+KK+    D R   +R  +  E+ ++    HEN+V++ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 94
Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +     D     ++++V E ++      I +   + ++        +L+ L  +H+  V+
Sbjct: 95  NSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 149
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITE 220
           HRD+K  ++LL  +  +K+ DFG     S+        V R   L  G  Y     +I+ 
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-------VPRRKXLV-GTPYWMAPELISR 201
Query: 221 LLGSP--DDSDLGFL---RSDNARRYVKQLPHVPKQPFSQKFP-------NMSPVAIDLA 268
           L   P  D   LG +     D    Y  + P    +      P        +SP      
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 261
Query: 269 ERMLVFDPAKRITVEEALNHPYLS 292
           +R+LV DPA+R T  E L HP+L+
Sbjct: 262 DRLLVRDPAQRATAAELLKHPFLA 285

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 110/246 (44%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NI+ + DI+   D        +   + +TD  Q+   +Q LTD   ++++Y++L+ L Y 
Sbjct: 93  NIITLADIVK--DPVSRTPALVFEHVNNTDFKQL---RQTLTDYDIRFYMYEILKALDYC 147
Query: 155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF- 193
           HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 194 MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DS 228
           M +Y +  W             +  F G D   QL  I ++LG+ D            D 
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
               +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ H
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 289 PYLSSL 294
           PY  ++
Sbjct: 322 PYFYTV 327

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 116/264 (43%), Gaps = 31/264 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--ILREIKLLCHMTHENIVKVK 100
           IG G+ GIVC A    + + VA+KK+    D R   +R  +  E+ ++    HEN+V++ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 214
Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +     D     ++++V E ++      I +   + ++        +L+ L  +H+  V+
Sbjct: 215 NSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 269
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITE 220
           HRD+K  ++LL  +  +K+ DFG     S+        V R   L  G  Y     +I+ 
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-------VPRRKXLV-GTPYWMAPELISR 321
Query: 221 LLGSP--DDSDLGFL---RSDNARRYVKQLPHVPKQPFSQKFP-------NMSPVAIDLA 268
           L   P  D   LG +     D    Y  + P    +      P        +SP      
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 381
Query: 269 ERMLVFDPAKRITVEEALNHPYLS 292
           +R+LV DPA+R T  E L HP+L+
Sbjct: 382 DRLLVRDPAQRATAAELLKHPFLA 405

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 120/273 (43%), Gaps = 45/273 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G+Y +    ++  T  E A+K I  +  +  +   IL     L +  H NI+ +KD+
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEIL-----LRYGQHPNIITLKDV 84
Query: 103 IPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
               D  K+  VY+V EL      L +I+R K   ++      L+ + + ++Y+H+  V+
Sbjct: 85  ---YDDGKY--VYVVTELXKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 161 HRDLKPSNLLL---NANCD-LKICDFGLARTTSE-----------TDFMTEYVVTRW--- 202
           HRDLKPSN+L    + N + ++ICDFG A+                +F+   V+ R    
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYD 198
Query: 203 ---DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
              D    G      LT  T     PDD+    L    + ++            S  + N
Sbjct: 199 AACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKF----------SLSGGYWN 248
Query: 260 -MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            +S  A DL  + L  DP +R+T    L HP++
Sbjct: 249 SVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 32/269 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G +G+     + ++ E VA+K I      +ID + + REI     + H NIV+ 
Sbjct: 23  VKDIGSGNFGVARLMRDKQSNELVAVKYIERG--EKID-ENVKREIINHRSLRHPNIVRF 79
Query: 100 KDII-PPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           K++I  P        + IV E     +L + I +    ++D  ++F  QL+ G+ Y H+ 
Sbjct: 80  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 133
Query: 158 NVLHRDLKPSNLLLNANCD--LKICDFGLAR----------TTSETDFMTEYVVTRWDTL 205
            V HRDLK  N LL+ +    LKICDFG ++          T     ++   V+ + +  
Sbjct: 134 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-- 191
Query: 206 FPGK---DYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + GK    +   +T+   L+G+    D       N R+ + ++ +V  Q     + ++SP
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFEDPE--EPKNFRKTIHRILNV--QYAIPDYVHISP 247
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYL 291
               L  R+ V DPAKRI++ E  NH + 
Sbjct: 248 ECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 124/268 (46%), Gaps = 34/268 (12%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   ++K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 100 KDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++     ++++ ++      +     ++ +L   L Y H
Sbjct: 79  YGY--------FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH 130
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           S  V+HRD+KP NLLL +  +LKI DFG         +      +R   L    DY+   
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFG---------WSVHAPSSRRXXLXGTLDYLPPE 181
Query: 216 TMITELLGSPDD-SDLGFLRSD--------NARRYVKQLPHVPKQPFSQKFPN-MSPVAI 265
            +   +     D   LG L  +         A  Y +    + +  F+  FP+ ++  A 
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGAR 239
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSS 293
           DL  R+L  +P++R  + E L HP++++
Sbjct: 240 DLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 119/269 (44%), Gaps = 25/269 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G GA+G+V   V   T      K I   +   +D   +  EI ++  + H  ++ +
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINL 113
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSAN 158
            D      ++K+  V I+  L   +L   I ++   +++     ++ Q   GLK++H  +
Sbjct: 114 HDAF----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 159 VLHRDLKPSNLLLNAN--CDLKICDFGLAR----------TTSETDFMTEYVVTRWDTLF 206
           ++H D+KP N++        +KI DFGLA           TT+  +F    +V R    F
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229
Query: 207 PGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
               Y     +   +LG    S L     ++    ++ +     +     F ++SP A D
Sbjct: 230 ----YTDMWAI--GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283
Query: 267 LAERMLVFDPAKRITVEEALNHPYLSSLH 295
             + +L  +P KR+TV +AL HP+L   H
Sbjct: 284 FIKNLLQKEPRKRLTVHDALEHPWLKGDH 312

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 133/314 (42%), Gaps = 65/314 (20%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G++G V  A + +  + VA+K + N  + R   ++   EI++L H+  ++    
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRN--EKRFH-RQAAEEIRILEHLRKQDKDNT 158
Query: 100 KDIIPPMDKEKF-NDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHS 156
            ++I  ++   F N + + +EL+  +L+++I+    Q  +    + F + +L+ L  +H 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 157 ANVLHRDLKPSNLLL--NANCDLKICDFGLA---------------RTTSETDFMTEYV- 198
             ++H DLKP N+LL       +K+ DFG +                   E      Y  
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGARYGM 278
Query: 199 -VTRWDT------------LFPGKDYVQQLTMITELLGSPDDSDL-------GFLRSDNA 238
            +  W              L PG+D   QL  + ELLG P    L        F+     
Sbjct: 279 PIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGY 338
Query: 239 RRYV----------------KQLPHVPKQPFSQKFPNM-----SPVAIDLAERMLVFDPA 277
            RY                  +   +   P S+++ N       P+ +D  ++ L +DPA
Sbjct: 339 PRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398
Query: 278 KRITVEEALNHPYL 291
            R+T  +AL HP+L
Sbjct: 399 VRMTPGQALRHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 137/314 (43%), Gaps = 65/314 (20%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G++G V  A + +  + VA+K + N  + R   ++   EI++L H+  ++    
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRN--EKRFH-RQAAEEIRILEHLRKQDKDNT 158
Query: 100 KDIIPPMDKEKF-NDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHS 156
            ++I  ++   F N + + +EL+  +L+++I+    Q  +    + F + +L+ L  +H 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 157 ANVLHRDLKPSNLLL--NANCDLKICDFGLA-------RTTSETDFMT--EYV------- 198
             ++H DLKP N+LL       +K+ DFG +        T  ++ F    E +       
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGARYGM 278
Query: 199 -VTRWDT------------LFPGKDYVQQLTMITELLGSPDDSDL-------GFLRSDNA 238
            +  W              L PG+D   QL  + ELLG P    L        F+     
Sbjct: 279 PIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGY 338
Query: 239 RRYV----------------KQLPHVPKQPFSQKFPNM-----SPVAIDLAERMLVFDPA 277
            RY                  +   +   P S+++ N       P+ +D  ++ L +DPA
Sbjct: 339 PRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398
Query: 278 KRITVEEALNHPYL 291
            R+T  +AL HP+L
Sbjct: 399 VRMTPGQALRHPWL 412

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NI+ + DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y 
Sbjct: 93  NIITLADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF- 193
           HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 194 MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DS 228
           M +Y +  W             +  F G D   QL  I ++LG+ D            D 
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
               +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ H
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 289 PYLSSL 294
           PY  ++
Sbjct: 322 PYFYTV 327

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 130/281 (46%), Gaps = 33/281 (11%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +P+G G++ I    V+ ++ +  A+K I+   +   + ++ +  +KL C   H NIVK+ 
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME--ANTQKEITALKL-CE-GHPNIVKLH 72
Query: 101 DIIPPMDKEKFND---VYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           ++        F+D    ++V EL++  +L + I+ K+  ++    Y + +L+  + ++H 
Sbjct: 73  EV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 157 ANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSETD-------FMTEYVVTRWDTLF 206
             V+HRDLKP NLL    N N ++KI DFG AR     +       F   Y         
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ- 183
Query: 207 PGKDYVQQLTMITELLGSPDDSDLGFL---RSDNARRYVKQLPHVPKQPFS---QKFPNM 260
            G D    L  +  +L +     + F    RS      V+ +  + K  FS   + + N+
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243
Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
           S  A DL + +L  DP KR+ +     + +L    +++  P
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NI+ + DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y 
Sbjct: 93  NIITLADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF- 193
           HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 194 MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DS 228
           M +Y +  W             +  F G D   QL  I ++LG+ D            D 
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
               +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ H
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 289 PYLSSL 294
           PY  ++
Sbjct: 322 PYFYTV 327

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NI+ + DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y 
Sbjct: 98  NIITLADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 152
Query: 155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF- 193
           HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ 
Sbjct: 153 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 194 MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DS 228
           M +Y +  W             +  F G D   QL  I ++LG+ D            D 
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 272
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
               +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ H
Sbjct: 273 RFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEH 326
Query: 289 PYLSSL 294
           PY  ++
Sbjct: 327 PYFYTV 332

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NI+ + DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y 
Sbjct: 93  NIITLADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF- 193
           HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 194 MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DS 228
           M +Y +  W             +  F G D   QL  I ++LG+ D            D 
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
               +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ H
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 289 PYLSSL 294
           PY  ++
Sbjct: 322 PYFYTV 327

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NI+ + DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y 
Sbjct: 93  NIITLADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF- 193
           HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 194 MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DS 228
           M +Y +  W             +  F G D   QL  I ++LG+ D            D 
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
               +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ H
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 289 PYLSSL 294
           PY  ++
Sbjct: 322 PYFYTV 327

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NI+ + DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y 
Sbjct: 93  NIITLADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF- 193
           HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 194 MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DS 228
           M +Y +  W             +  F G D   QL  I ++LG+ D            D 
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
               +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ H
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 289 PYLSSL 294
           PY  ++
Sbjct: 322 PYFYTV 327

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NI+ + DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y 
Sbjct: 93  NIITLADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF- 193
           HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 194 MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DS 228
           M +Y +  W             +  F G D   QL  I ++LG+ D            D 
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
               +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ H
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 289 PYLSSL 294
           PY  ++
Sbjct: 322 PYFYTV 327

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NI+ + DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y 
Sbjct: 92  NIITLADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 146
Query: 155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF- 193
           HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ 
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 194 MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DS 228
           M +Y +  W             +  F G D   QL  I ++LG+ D            D 
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
               +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ H
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 289 PYLSSL 294
           PY  ++
Sbjct: 321 PYFYTV 326

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NI+ + DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y 
Sbjct: 93  NIITLADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF- 193
           HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 194 MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DS 228
           M +Y +  W             +  F G D   QL  I ++LG+ D            D 
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
               +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ H
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 289 PYLSSL 294
           PY  ++
Sbjct: 322 PYFYTV 327

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +GRGA+G+VC A      ++VAIK+I    ++  + K  + E++ L  + H NIVK+   
Sbjct: 16  VGRGAFGVVCKA--KWRAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQAL---TDDHCQYFLYQLLRGLKYIHSAN 158
                    N V +V E  +   L+ ++   + L   T  H   +  Q  +G+ Y+HS  
Sbjct: 70  C-------LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 159 ---VLHRDLKPSNLLLNANCD-LKICDFGLA 185
              ++HRDLKP NLLL A    LKICDFG A
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 61/248 (24%)
Query: 95  NIVKVKDIIP-PMDKEKFNDVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
           NI+ + DI+  P+ +       +V+E + +TD  Q+    Q LTD   ++++Y++L+ L 
Sbjct: 91  NIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALD 143
Query: 153 YIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TD 192
           Y HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 193 F-MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------ 226
           + M +Y +  W             +  F G D   QL  I ++LG+ D            
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 227 DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEAL 286
           D     +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAM 317
Query: 287 NHPYLSSL 294
            HPY  ++
Sbjct: 318 EHPYFYTV 325

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NI+ + DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y 
Sbjct: 92  NIITLADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 146
Query: 155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF- 193
           HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ 
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 194 MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DS 228
           M +Y +  W             +  F G D   QL  I ++LG+ D            D 
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
               +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ H
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 289 PYLSSL 294
           PY  ++
Sbjct: 321 PYFYTV 326

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 126/270 (46%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR-EIKLLCHMTHENIVKV 99
           +P+G+G +G V  A    +K  +A+K +  A   +   +  LR E+++  H+ H NI+++
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT---DDHCQYFLYQLLRGLKYIH 155
                      F+D   VY +++   L  + R  Q L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
           S  V+HRD+KP NLLL +  +LKI DFG +     +      +    D L P    G+ +
Sbjct: 126 SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA--LCGTLDYLPPEMIEGRMH 183
Query: 212 VQQLTMITE-------LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN-MSPV 263
            +++ + +        L+G P            A  Y      + +  F+  FP+ ++  
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKP---------PFEANTYQDTYKRISRVEFT--FPDFVTEG 232
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  R+L  +P++R  + E L HP++++
Sbjct: 233 ARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 111/255 (43%), Gaps = 57/255 (22%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NI+ + DI+   D        +   + +TD  Q+    Q LTD   ++++Y++L+ L Y 
Sbjct: 93  NIITLADIVK--DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLA-----------RTTSE--------TDF- 193
           HS  ++HRD+KP N++++  +  L++ D+GLA           R  S          D+ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 194 MTEYVVTRW-------------DTLFPGKDYVQQLTMITELLGSPD------------DS 228
           M +Y +  W             +  F G D   QL  I ++LG+ D            D 
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
               +   ++R+  ++  H   Q        +SP A+D  +++L +D   R+T  EA+ H
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 289 PYLSSLHEINEEPTC 303
           PY   + +   +P  
Sbjct: 322 PYFYPVVKEQSQPCA 336

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 127/269 (47%), Gaps = 32/269 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G +G+     + ++ E VA+K I      +I A  + REI     + H NIV+ 
Sbjct: 24  VKDIGSGNFGVARLMRDKQSNELVAVKYIERG--EKI-AANVKREIINHRSLRHPNIVRF 80
Query: 100 KDII-PPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           K++I  P        + IV E     +L + I +    ++D  ++F  QL+ G+ Y H+ 
Sbjct: 81  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 158 NVLHRDLKPSNLLLNANCD--LKICDFGLAR----------TTSETDFMTEYVVTRWDTL 205
            V HRDLK  N LL+ +    LKICDFG ++          T     ++   V+ + +  
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-- 192
Query: 206 FPGK---DYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + GK    +   +T+   L+G+    D       N R+ + ++ +V  Q     + ++SP
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPE--EPKNFRKTIHRILNV--QYAIPDYVHISP 248
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYL 291
               L  R+ V DPAKRI++ E  NH + 
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 77/148 (52%), Gaps = 9/148 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           +Q +G GA G V  AVN  T+E VA+K +       +D  + I +EI +   + HEN+VK
Sbjct: 11  VQTLGEGAAGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    + + N  Y+  E     +L   I     + +   Q F +QL+ G+ Y+H  
Sbjct: 69  FYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            + HRD+KP NLLL+   +LKI DFGLA
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 32/276 (11%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           + +G GA+  V  A    T +  A+K I   A   +  +  I  EI +L  + HENIV +
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS--IENEIAVLRKIKHENIVAL 85
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           +DI      E  N +Y+V +L+   +L   I  K   T+      + Q+L  + Y+H   
Sbjct: 86  EDIY-----ESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMG 140
Query: 159 VLHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           ++HRDLKP NLL    +    + I DFGL++   + D M+    T      PG  YV   
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGT------PG--YVAPE 192
Query: 216 TMITELLGSPDDS-DLGFLR-----------SDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
            +  +      D   +G +             +N  +  +Q+     +  S  + ++S  
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDS 252
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
           A D    ++  DP KR T E+A  HP+++    +N+
Sbjct: 253 AKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNK 288

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 86/161 (53%), Gaps = 10/161 (6%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           F+V +  + P+  +GRGAYG+V    +  + +  A+K+I  A  N  + KR+L ++ +  
Sbjct: 29  FEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI-RATVNSQEQKRLLXDLDISX 87
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDL----HQIIRSKQALTDDHCQYFLY 145
                           + +E   DV+I  EL DT L     Q+I   Q + +D       
Sbjct: 88  RTVDCPFTVT--FYGALFRE--GDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAV 143
Query: 146 QLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            +++ L+++HS  +V+HRD+KPSN+L+NA   +K CDFG++
Sbjct: 144 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGIS 184

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 147/330 (44%), Gaps = 48/330 (14%)
Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI 76
            G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +        
Sbjct: 4   SGLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKMLQ------- 50
Query: 77  DAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSK 132
           D  +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I  R  
Sbjct: 51  DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD 109
Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTS 189
           QA T+      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+
Sbjct: 110 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 169
Query: 190 ETDFMTEYVVTRW----DTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNA 238
             + +TE   T +    + L P K       +   + M   L G P   S+ G   S   
Sbjct: 170 SHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 229
Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV-----FDPAKRITVEEALNHPYLSS 293
           +  ++   +        +FPN     +    +ML+      +P +R+T+ E +NHP++  
Sbjct: 230 KTRIRMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 281
Query: 294 LHEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
             ++   P  P   +   ++     ED+KE
Sbjct: 282 STKV---PQTPLHTSRVLKEDKERWEDVKE 308

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 128/273 (46%), Gaps = 28/273 (10%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVKVKD 101
           +G+G +       + +TKE  A K +  +   +   K ++  EI +   + + ++V    
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                  E  + VY+V E+     L ++ + ++A+T+   +YF+ Q ++G++Y+H+  V+
Sbjct: 110 FF-----EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVI 164
Query: 161 HRDLKPSNLLLNANCDLKICDFGLA----------RTTSET-DFMTEYVVTRWDTLFPGK 209
           HRDLK  NL LN + D+KI DFGLA          +T   T +++   V+ +    F   
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVD 224
Query: 210 DYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAE 269
            +     + T L+G P      F  S     Y++    + K  +S    +++PVA  L  
Sbjct: 225 IWSLGCILYTLLVGKPP-----FETSCLKETYIR----IKKNEYSVPR-HINPVASALIR 274
Query: 270 RMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
           RML  DP  R +V E L   + +S +     PT
Sbjct: 275 RMLHADPTLRPSVAELLTDEFFTSGYAPMRLPT 307

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 115/265 (43%), Gaps = 29/265 (10%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G+V       T    A K +    ++  D + + +EI+ +  + H  +V + D 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 103 IPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                 E  N++ ++YE M       ++      +++D    ++ Q+ +GL ++H  N +
Sbjct: 223 F-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 161 HRDLKPSNLLLNA--NCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQ----- 213
           H DLKP N++     + +LK+ DFGL   T+  D      VT     F   +  +     
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGL---TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 214 ------QLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
                  + +++ +L S   S  G    D   R VK             F  +S    D 
Sbjct: 335 YYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDW---NMDDSAFSGISEDGKDF 390
Query: 268 AERMLVFDPAKRITVEEALNHPYLS 292
             ++L+ DP  R+T+ +AL HP+L+
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLT 415

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + +G GA+G+V       T    A K +    ++  D + + +EI+ +  + H  +V + 
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLH 114
Query: 101 DIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           D       E  N++ ++YE M       ++      +++D    ++ Q+ +GL ++H  N
Sbjct: 115 DAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 159 VLHRDLKPSNLLLNA--NCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQ--- 213
            +H DLKP N++     + +LK+ DFGL   T+  D      VT     F   +  +   
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGL---TAHLDPKQSVKVTTGTAEFAAPEVAEGKP 226
Query: 214 --------QLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
                    + +++ +L S   S  G    D   R VK             F  +S    
Sbjct: 227 VGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDW---NMDDSAFSGISEDGK 282
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLS 292
           D   ++L+ DP  R+T+ +AL HP+L+
Sbjct: 283 DFIRKLLLADPNTRMTIHQALEHPWLT 309

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 30/274 (10%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVKVKD 101
           +G+G +       + +TKE  A K +  +   +   K ++  EI +   + + ++V    
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                  E  + VY+V E+     L ++ + ++A+T+   +YF+ Q ++G++Y+H+  V+
Sbjct: 110 FF-----EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVI 164
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETD------------FMTEYVVTRWDTLFPG 208
           HRDLK  NL LN + D+KI DFGLA T  E D            ++   V+ +    F  
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEV 223
Query: 209 KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA 268
             +     + T L+G P      F  S     Y++    + K  +S    +++PVA  L 
Sbjct: 224 DIWSLGCILYTLLVGKPP-----FETSCLKETYIR----IKKNEYSVPR-HINPVASALI 273
Query: 269 ERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
            RML  DP  R +V E L   + +S +     PT
Sbjct: 274 RRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPT 307

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 132/314 (42%), Gaps = 65/314 (20%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G +G V  A + +  + VA+K + N  + R   ++   EI++L H+  ++    
Sbjct: 102 LKVIGKGXFGQVVKAYDHKVHQHVALKMVRN--EKRFH-RQAAEEIRILEHLRKQDKDNT 158
Query: 100 KDIIPPMDKEKF-NDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHS 156
            ++I  ++   F N + + +EL+  +L+++I+    Q  +    + F + +L+ L  +H 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 157 ANVLHRDLKPSNLLL--NANCDLKICDFGLA---------------RTTSETDFMTEYV- 198
             ++H DLKP N+LL       +K+ DFG +                   E      Y  
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRFYRAPEVILGARYGM 278
Query: 199 -VTRWDT------------LFPGKDYVQQLTMITELLGSPDDSDL-------GFLRSDNA 238
            +  W              L PG+D   QL  + ELLG P    L        F+     
Sbjct: 279 PIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVSXKGY 338
Query: 239 RRYV----------------KQLPHVPKQPFSQKFPNM-----SPVAIDLAERMLVFDPA 277
            RY                  +   +   P S+++ N       P+ +D  ++ L +DPA
Sbjct: 339 PRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398
Query: 278 KRITVEEALNHPYL 291
            R+T  +AL HP+L
Sbjct: 399 VRMTPGQALRHPWL 412

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 30/274 (10%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVKVKD 101
           +G+G +       + +TKE  A K +  +   +   K ++  EI +   + + ++V    
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                  E  + VY+V E+     L ++ + ++A+T+   +YF+ Q ++G++Y+H+  V+
Sbjct: 94  FF-----EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVI 148
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETD------------FMTEYVVTRWDTLFPG 208
           HRDLK  NL LN + D+KI DFGLA T  E D            ++   V+ +    F  
Sbjct: 149 HRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEV 207
Query: 209 KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA 268
             +     + T L+G P      F  S     Y++    + K  +S    +++PVA  L 
Sbjct: 208 DIWSLGCILYTLLVGKPP-----FETSCLKETYIR----IKKNEYSVP-RHINPVASALI 257
Query: 269 ERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
            RML  DP  R +V E L   + +S +     PT
Sbjct: 258 RRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPT 291

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 122/270 (45%), Gaps = 27/270 (10%)
Query: 37  VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
           V   + +G G +G V     + T  ++A K I        D + +  EI ++  + H N+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANL 148
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           +++ D       E  ND+ +V E +D      +II     LT+     F+ Q+  G++++
Sbjct: 149 IQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 155 HSANVLHRDLKPSNLL-LNANC-DLKICDFGLAR----------TTSETDFMTEYVVTRW 202
           H   +LH DLKP N+L +N +   +KI DFGLAR               +F+   VV   
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD 263
Query: 203 DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
              FP   +   + +I  +L S     LG    DN    +  +         ++F ++S 
Sbjct: 264 FVSFPTDMW--SVGVIAYMLLSGLSPFLG----DNDAETLNNILACRWDLEDEEFQDISE 317
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLS 292
            A +   ++L+ + + RI+  EAL HP+LS
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLS 347

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 30/274 (10%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVKVKD 101
           +G+G +       + +TKE  A K +  +   +   K ++  EI +   + + ++V    
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                  E  + VY+V E+     L ++ + ++A+T+   +YF+ Q ++G++Y+H+  V+
Sbjct: 110 FF-----EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVI 164
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETD------------FMTEYVVTRWDTLFPG 208
           HRDLK  NL LN + D+KI DFGLA T  E D            ++   V+ +    F  
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEV 223
Query: 209 KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA 268
             +     + T L+G P      F  S     Y++    + K  +S    +++PVA  L 
Sbjct: 224 DIWSLGCILYTLLVGKPP-----FETSCLKETYIR----IKKNEYSVPR-HINPVASALI 273
Query: 269 ERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
            RML  DP  R +V E L   + +S +     PT
Sbjct: 274 RRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPT 307

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 7/153 (4%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G    V  A ++    +VAIK I     +     KR  RE+     ++H+NIV + D
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +      E+ +  Y+V E ++   L + I S   L+ D    F  Q+L G+K+ H   ++
Sbjct: 79  V-----DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIV 133
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           HRD+KP N+L+++N  LKI DFG+A+  SET  
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 87/165 (52%), Gaps = 9/165 (5%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           FQ   KYV  LQ IG G++G      ++E   +  IK+I  +  +  + +   RE+ +L 
Sbjct: 20  FQSMEKYVR-LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLA 78
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQAL--TDDHCQYFLYQ 146
           +M H NIV+ ++       E+   +YIV +  +  DL + I +++ +   +D    +  Q
Sbjct: 79  NMKHPNIVQYRESF-----EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ 133
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           +   LK++H   +LHRD+K  N+ L  +  +++ DFG+AR  + T
Sbjct: 134 ICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 126/267 (47%), Gaps = 28/267 (10%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G +G+     + ++ E VA+K I      +ID + + REI     + H NIV+ 
Sbjct: 24  VKDIGSGNFGVARLMRDKQSNELVAVKYIERG--EKID-ENVKREIINHRSLRHPNIVRF 80
Query: 100 KDII-PPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           K++I  P        + IV E     +L + I +    ++D  ++F  QL+ G+ Y H+ 
Sbjct: 81  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 158 NVLHRDLKPSNLLLNANCD--LKICDFGLARTT------SETDFMTEYVVTR--WDTLFP 207
            V HRDLK  N LL+ +    LKIC FG ++++       +T     Y+         + 
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYD 194
Query: 208 GK---DYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
           GK    +   +T+   L+G+    D       N R+ + ++ +V  Q     + ++SP  
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPE--EPKNFRKTIHRILNV--QYAIPDYVHISPEC 250
Query: 265 IDLAERMLVFDPAKRITVEEALNHPYL 291
             L  R+ V DPAKRI++ E  NH + 
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 127/269 (47%), Gaps = 32/269 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G +G+     + ++ E VA+K I      +ID + + REI     + H NIV+ 
Sbjct: 24  VKDIGSGNFGVARLMRDKQSNELVAVKYIERG--EKID-ENVKREIINHRSLRHPNIVRF 80
Query: 100 KDII-PPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           K++I  P        + IV E     +L + I +    ++D  ++F  QL+ G+ Y H+ 
Sbjct: 81  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 158 NVLHRDLKPSNLLLNANCD--LKICDFGLAR----------TTSETDFMTEYVVTRWDTL 205
            V HRDLK  N LL+ +    LKIC FG ++          T     ++   V+ + +  
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-- 192
Query: 206 FPGK---DYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + GK    +   +T+   L+G+    D       N R+ + ++ +V  Q     + ++SP
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPE--EPKNFRKTIHRILNV--QYAIPDYVHISP 248
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYL 291
               L  R+ V DPAKRI++ E  NH + 
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 15/160 (9%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV--- 99
           +G+GA+G V  A N+      AIKKI +  +       IL E+ LL  + H+ +V+    
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEK---LSTILSEVMLLASLNHQYVVRYYAA 70
Query: 100 ----KDIIPPMDK-EKFNDVYIVYELMDTD-LHQIIRSKQALTDDHCQYF--LYQLLRGL 151
               ++ + PM   +K + ++I  E  +   L+ +I S+  L     +Y+    Q+L  L
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEAL 129
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
            YIHS  ++HRDLKP N+ ++ + ++KI DFGLA+    +
Sbjct: 130 SYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 15/160 (9%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV--- 99
           +G+GA+G V  A N+      AIKKI +  +       IL E+ LL  + H+ +V+    
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEK---LSTILSEVMLLASLNHQYVVRYYAA 70
Query: 100 ----KDIIPPMDK-EKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYF--LYQLLRGL 151
               ++ + PM   +K + ++I  E  +   L+ +I S+  L     +Y+    Q+L  L
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSEN-LNQQRDEYWRLFRQILEAL 129
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
            YIHS  ++HRDLKP N+ ++ + ++KI DFGLA+    +
Sbjct: 130 SYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/335 (24%), Positives = 148/335 (44%), Gaps = 48/335 (14%)
Query: 12  GIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA 71
           G  +  G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +   
Sbjct: 1   GSHVKSGLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKMLQ-- 52
Query: 72  FDNRIDAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII 129
                D  +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I
Sbjct: 53  -----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRI 106
Query: 130 --RSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGL 184
             R  QA T+      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 185 ARTTSETDFMTEYVVTRW----DTLFPGK------DYVQQLTMITELLGSPD-DSDLGFL 233
           A+ T+  + +T    T +    + L P K       +   + M   L G P   S+ G  
Sbjct: 167 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 226
Query: 234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV-----FDPAKRITVEEALNH 288
            S   +  ++   +        +FPN     +    +ML+      +P +R+T+ E +NH
Sbjct: 227 ISPGMKTRIRMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 278
Query: 289 PYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
           P++    ++   P  P   +   ++     ED+KE
Sbjct: 279 PWIMQSTKV---PQTPLHTSRVLKEDKERWEDVKE 310

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 125/274 (45%), Gaps = 31/274 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G +  V  A +  T +EVA+K I     N    +++ RE+++   + H NIVK+
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKL 78
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            ++I     E    +Y+V E     ++   + +     +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT---RWDTLFPGKDY---- 211
           ++HRDLK  NLLL+A+ ++KI DFG +   +  + +  +          LF GK Y    
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 212 --VQQLTMITELLGSP----DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             V  L +I   L S     D  +L  LR        + L    + PF       S    
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRE-------RVLRGKYRIPFY-----XSTDCE 241
Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
           +L ++ L+ +P+KR T+E+     + +  HE +E
Sbjct: 242 NLLKKFLILNPSKRGTLEQIXKDRWXNVGHEDDE 275

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/330 (24%), Positives = 146/330 (44%), Gaps = 48/330 (14%)
Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI 76
            G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +        
Sbjct: 11  SGLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKMLQ------- 57
Query: 77  DAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSK 132
           D  +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I  R  
Sbjct: 58  DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD 116
Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTS 189
           QA T+      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+
Sbjct: 117 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 176
Query: 190 ETDFMTEYVVTRW----DTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNA 238
             + +T    T +    + L P K       +   + M   L G P   S+ G   S   
Sbjct: 177 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 236
Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV-----FDPAKRITVEEALNHPYLSS 293
           +  ++   +        +FPN     +    +ML+      +P +R+T+ E +NHP++  
Sbjct: 237 KTRIRMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 288
Query: 294 LHEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
             ++   P  P   +   ++     ED+KE
Sbjct: 289 STKV---PQTPLHTSRVLKEDKERWEDVKE 315

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/330 (24%), Positives = 146/330 (44%), Gaps = 48/330 (14%)
Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI 76
            G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +        
Sbjct: 5   SGLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKMLQ------- 51
Query: 77  DAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSK 132
           D  +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I  R  
Sbjct: 52  DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD 110
Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTS 189
           QA T+      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+
Sbjct: 111 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 170
Query: 190 ETDFMTEYVVTRW----DTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNA 238
             + +T    T +    + L P K       +   + M   L G P   S+ G   S   
Sbjct: 171 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 230
Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV-----FDPAKRITVEEALNHPYLSS 293
           +  ++   +        +FPN     +    +ML+      +P +R+T+ E +NHP++  
Sbjct: 231 KTRIRMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 282
Query: 294 LHEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
             ++   P  P   +   ++     ED+KE
Sbjct: 283 STKV---PQTPLHTSRVLKEDKERWEDVKE 309

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/329 (24%), Positives = 146/329 (44%), Gaps = 48/329 (14%)
Query: 18  GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID 77
           G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +        D
Sbjct: 13  GLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------D 59
Query: 78  AKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSKQ 133
             +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I  R  Q
Sbjct: 60  CPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQ 118
Query: 134 ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSE 190
           A T+      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+ 
Sbjct: 119 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 178
Query: 191 TDFMTEYVVTRW----DTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNAR 239
            + +T    T +    + L P K       +   + M   L G P   S+ G   S   +
Sbjct: 179 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 238
Query: 240 RYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV-----FDPAKRITVEEALNHPYLSSL 294
             ++   +        +FPN     +    +ML+      +P +R+T+ E +NHP++   
Sbjct: 239 TRIRMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 290
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
            ++   P  P   +   ++     ED+KE
Sbjct: 291 TKV---PQTPLHTSRVLKEDKERWEDVKE 316

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/329 (24%), Positives = 146/329 (44%), Gaps = 48/329 (14%)
Query: 18  GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID 77
           G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +        D
Sbjct: 21  GLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------D 67
Query: 78  AKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSKQ 133
             +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I  R  Q
Sbjct: 68  CPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQ 126
Query: 134 ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSE 190
           A T+      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+ 
Sbjct: 127 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 186
Query: 191 TDFMTEYVVTRW----DTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNAR 239
            + +T    T +    + L P K       +   + M   L G P   S+ G   S   +
Sbjct: 187 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 246
Query: 240 RYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV-----FDPAKRITVEEALNHPYLSSL 294
             ++   +        +FPN     +    +ML+      +P +R+T+ E +NHP++   
Sbjct: 247 TRIRMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 298
Query: 295 HEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
            ++   P  P   +   ++     ED+KE
Sbjct: 299 TKV---PQTPLHTSRVLKEDKERWEDVKE 324

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/330 (24%), Positives = 146/330 (44%), Gaps = 48/330 (14%)
Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI 76
            G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +        
Sbjct: 10  SGLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKMLQ------- 56
Query: 77  DAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSK 132
           D  +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I  R  
Sbjct: 57  DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD 115
Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTS 189
           QA T+      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+
Sbjct: 116 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 175
Query: 190 ETDFMTEYVVTRW----DTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNA 238
             + +T    T +    + L P K       +   + M   L G P   S+ G   S   
Sbjct: 176 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 235
Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV-----FDPAKRITVEEALNHPYLSS 293
           +  ++   +        +FPN     +    +ML+      +P +R+T+ E +NHP++  
Sbjct: 236 KTRIRMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 287
Query: 294 LHEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
             ++   P  P   +   ++     ED+KE
Sbjct: 288 STKV---PQTPLHTSRVLKEDKERWEDVKE 314

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/330 (24%), Positives = 146/330 (44%), Gaps = 48/330 (14%)
Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI 76
            G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +        
Sbjct: 4   SGLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKMLQ------- 50
Query: 77  DAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSK 132
           D  +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I  R  
Sbjct: 51  DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD 109
Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTS 189
           QA T+      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+
Sbjct: 110 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 169
Query: 190 ETDFMTEYVVTRW----DTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNA 238
             + +T    T +    + L P K       +   + M   L G P   S+ G   S   
Sbjct: 170 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 229
Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV-----FDPAKRITVEEALNHPYLSS 293
           +  ++   +        +FPN     +    +ML+      +P +R+T+ E +NHP++  
Sbjct: 230 KTRIRMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 281
Query: 294 LHEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
             ++   P  P   +   ++     ED+KE
Sbjct: 282 STKV---PQTPLHTSRVLKEDKERWEDVKE 308

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/330 (24%), Positives = 146/330 (44%), Gaps = 48/330 (14%)
Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI 76
            G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +        
Sbjct: 6   SGLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKMLQ------- 52
Query: 77  DAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSK 132
           D  +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I  R  
Sbjct: 53  DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD 111
Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTS 189
           QA T+      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171
Query: 190 ETDFMTEYVVTRW----DTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNA 238
             + +T    T +    + L P K       +   + M   L G P   S+ G   S   
Sbjct: 172 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 231
Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV-----FDPAKRITVEEALNHPYLSS 293
           +  ++   +        +FPN     +    +ML+      +P +R+T+ E +NHP++  
Sbjct: 232 KTRIRMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 283
Query: 294 LHEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
             ++   P  P   +   ++     ED+KE
Sbjct: 284 STKV---PQTPLHTSRVLKEDKERWEDVKE 310

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 81/330 (24%), Positives = 146/330 (44%), Gaps = 48/330 (14%)
Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI 76
            G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +        
Sbjct: 50  SGLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKMLQ------- 96
Query: 77  DAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSK 132
           D  +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I  R  
Sbjct: 97  DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD 155
Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTS 189
           QA T+      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+
Sbjct: 156 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 190 ETDFMTEYVVTRW----DTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNA 238
             + +T    T +    + L P K       +   + M   L G P   S+ G   S   
Sbjct: 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 275
Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV-----FDPAKRITVEEALNHPYLSS 293
           +  ++   +        +FPN     +    +ML+      +P +R+T+ E +NHP++  
Sbjct: 276 KTRIRMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327
Query: 294 LHEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
             ++   P  P   +   ++     ED+KE
Sbjct: 328 STKV---PQTPLHTSRVLKEDKERWEDVKE 354

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 81/330 (24%), Positives = 146/330 (44%), Gaps = 48/330 (14%)
Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI 76
            G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +        
Sbjct: 56  SGLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKMLQ------- 102
Query: 77  DAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSK 132
           D  +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I  R  
Sbjct: 103 DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD 161
Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTS 189
           QA T+      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+
Sbjct: 162 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 221
Query: 190 ETDFMTEYVVTRW----DTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNA 238
             + +T    T +    + L P K       +   + M   L G P   S+ G   S   
Sbjct: 222 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 281
Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV-----FDPAKRITVEEALNHPYLSS 293
           +  ++   +        +FPN     +    +ML+      +P +R+T+ E +NHP++  
Sbjct: 282 KTRIRMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 333
Query: 294 LHEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
             ++   P  P   +   ++     ED+KE
Sbjct: 334 STKV---PQTPLHTSRVLKEDKERWEDVKE 360

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 122/319 (38%), Gaps = 72/319 (22%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G V   ++ +        KI    D   +A R   EI++L H+   +       
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR--SEIQVLEHLNTTDPNSTFRC 79
Query: 103 IPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQAL--TDDHCQYFLYQLLRGLKYIHSANV 159
           +  ++  E    + IV+EL+    +  I+    L    DH +   YQ+ + + ++HS  +
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKL 139
Query: 160 LHRDLKPSNLLLNA-------------------NCDLKICDFGLARTTSETDFMTEYVVT 200
            H DLKP N+L                      N D+K+ DFG A  T + +  +  V T
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVST 197
Query: 201 R------------WD-------------------TLFPGKDYVQQLTMITELLGSP---- 225
           R            W                    T+FP  D  + L M+  +LG      
Sbjct: 198 RHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHM 257
Query: 226 ----------DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFD 275
                         L +    +A RYV +    P + F            DL ++ML +D
Sbjct: 258 IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYD 316
Query: 276 PAKRITVEEALNHPYLSSL 294
           PAKRIT+ EAL HP+   L
Sbjct: 317 PAKRITLREALKHPFFDLL 335

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 124/282 (43%), Gaps = 46/282 (16%)
Query: 36  YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLL------- 88
           Y+   + +GRG + +V   ++  T +E A K +      +     IL EI +L       
Sbjct: 30  YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 89  ----CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
                H  +EN     +II  ++     +++    L   +L +++     +        +
Sbjct: 90  RVINLHEVYEN---TSEIILILEYAAGGEIF---SLCLPELAEMVSENDVIR------LI 137
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARTTSETDFMTEYVVT- 200
            Q+L G+ Y+H  N++H DLKP N+LL++     D+KI DFG++R       + E + T 
Sbjct: 138 KQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 201 --------RWDTLFPGKDYVQQLTMITELL---GSPDDSDLGFLRSDNARRYVKQLPHVP 249
                    +D +    D +  + +I  +L    SP      F+  DN   Y+  +  V 
Sbjct: 198 EYLAPEILNYDPITTATD-MWNIGIIAYMLLTHTSP------FVGEDNQETYLN-ISQVN 249
Query: 250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                + F ++S +A D  + +LV +P KR T E  L+H +L
Sbjct: 250 VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 86/158 (54%), Gaps = 10/158 (6%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G YGIV +  +   +  +AIK+I    D+R  ++ +  EI L  H+ H+NIV+    
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRY-SQPLHEEIALHKHLKHKNIVQY--- 70
Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQ---YFLYQLLRGLKYIHSANV 159
           +    +  F  +++  ++    L  ++RSK     D+ Q   ++  Q+L GLKY+H   +
Sbjct: 71  LGSFSENGFIKIFME-QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 160 LHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTE 196
           +HRD+K  N+L+N     LKI DFG ++  +  +  TE
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 167

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 88/169 (52%), Gaps = 10/169 (5%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G YGIV +  +   +  +AIK+I    D+R  ++ +  EI L  H+ H+NIV+    
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRY-SQPLHEEIALHKHLKHKNIVQY--- 84
Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQ---YFLYQLLRGLKYIHSANV 159
           +    +  F  +++  ++    L  ++RSK     D+ Q   ++  Q+L GLKY+H   +
Sbjct: 85  LGSFSENGFIKIFME-QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 160 LHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
           +HRD+K  N+L+N     LKI DFG ++  +  +  TE        + P
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 121/273 (44%), Gaps = 40/273 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G +G+     + +  E VA+K I      +ID + + REI     + H NIV+ 
Sbjct: 24  VKDIGAGNFGVARLMRDKQANELVAVKYIERG--EKID-ENVKREIINHRSLRHPNIVRF 80
Query: 100 KDII-PPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           K++I  P        + IV E     +L + I +    ++D  ++F  QL+ G+ Y H+ 
Sbjct: 81  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAM 134
Query: 158 NVLHRDLKPSNLLLNANCD--LKICDFGLARTT-----------------SETDFMTEYV 198
            V HRDLK  N LL+ +    LKI DFG ++ +                  E     EY 
Sbjct: 135 QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYD 194
Query: 199 VTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP 258
               D    G      +T+   L+G+    D       N R+ + ++ +V  Q     + 
Sbjct: 195 GKVADVWSCG------VTLYVMLVGAYPFEDPE--EPKNFRKTIHRILNV--QYAIPDYV 244
Query: 259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           ++SP    L  R+ V DPAKRI++ E  NH + 
Sbjct: 245 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKIT------NAFDNRIDAKRILRE 84
           + S KY   + P+G GA+G V +AV+ E  +EV +K I       + +       ++  E
Sbjct: 21  EYSQKY-STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFL 144
           I +L  + H NI+KV DI    + + F  + +       DL   I     L +    Y  
Sbjct: 80  IAILSRVEHANIIKVLDI---FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
            QL+  + Y+   +++HRD+K  N+++  +  +K+ DFG A
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 123/271 (45%), Gaps = 38/271 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           ++P+G+G +G V  A   + K  +A+K +  +  +      ++ REI++  H+ H NI++
Sbjct: 19  VRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 99  VKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           + +         F+D   +Y +++     +L++ ++      +     F+ +L   L Y 
Sbjct: 79  MYNY--------FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKD 210
           H   V+HRD+KP NLL+    +LKI DFG   +          +    D L P    GK 
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRXMCGTLDYLPPEMIEGKT 188
Query: 211 YVQQLTMITE-------LLGSPD-DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           + +++ +          L+G P  DS      ++  RR V      P        P +S 
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSP---SHTETHRRIVNVDLKFP--------PFLSD 237
Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
            + DL  ++L + P +R+ ++  + HP++ +
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 121/319 (37%), Gaps = 72/319 (22%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G V   ++ +        KI    D   +A R   EI++L H+   +       
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR--SEIQVLEHLNTTDPNSTFRC 79
Query: 103 IPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQAL--TDDHCQYFLYQLLRGLKYIHSANV 159
           +  ++  E    + IV+EL+    +  I+    L    DH +   YQ+ + + ++HS  +
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKL 139
Query: 160 LHRDLKPSNLLLNA-------------------NCDLKICDFGLARTTSETDFMTEYVVT 200
            H DLKP N+L                      N D+K+ DFG A  T + +  +  V  
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVXX 197
Query: 201 R------------WD-------------------TLFPGKDYVQQLTMITELLGSP---- 225
           R            W                    T+FP  D  + L M+  +LG      
Sbjct: 198 RHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHM 257
Query: 226 ----------DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFD 275
                         L +    +A RYV +    P + F            DL ++ML +D
Sbjct: 258 IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYD 316
Query: 276 PAKRITVEEALNHPYLSSL 294
           PAKRIT+ EAL HP+   L
Sbjct: 317 PAKRITLREALKHPFFDLL 335

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 82
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 142
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R ++      Y
Sbjct: 143 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANSFVGTAQY 197
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 254
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 255 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 123/267 (46%), Gaps = 32/267 (11%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +P+G+G +G V  A   + K  +A+K +  +  +      ++ REI++  H+ H NI+++
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 100 KDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            +     D+++   +Y++ E     +L++ ++      +     F+ +L   L Y H   
Sbjct: 81  YNYF--HDRKR---IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 135
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDYVQQ 214
           V+HRD+KP NLL+    +LKI DFG   +          +    D L P    GK + ++
Sbjct: 136 VIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEK 193
Query: 215 LTMITE-------LLGSPD-DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
           + +          L+G P  DS      ++  RR V      P        P +S  + D
Sbjct: 194 VDLWCAGVLCYEFLVGMPPFDSP---SHTETHRRIVNVDLKFP--------PFLSDGSKD 242
Query: 267 LAERMLVFDPAKRITVEEALNHPYLSS 293
           L  ++L + P +R+ ++  + HP++ +
Sbjct: 243 LISKLLRYHPPQRLPLKGVMEHPWVKA 269

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 86
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 146
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R ++      Y
Sbjct: 147 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANSFVGTAQY 201
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 258
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 259 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 124/264 (46%), Gaps = 26/264 (9%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + +GRG +GIV   V + +K+    K +     +++  K+   EI +L    H NI+ + 
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHLH 67
Query: 101 DIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSAN 158
           +    M+     ++ +++E +   D+ + I +    L +     +++Q+   L+++HS N
Sbjct: 68  ESFESME-----ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 159 VLHRDLKPSNLLLNA--NCDLKICDFGLARTTSETD-----FMT-EYV---VTRWDTLFP 207
           + H D++P N++     +  +KI +FG AR     D     F   EY    V + D +  
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 208 GKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
             D     T++  LL   +     FL   N ++ ++ + +       + F  +S  A+D 
Sbjct: 183 ATDMWSLGTLVYVLLSGINP----FLAETN-QQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 268 AERMLVFDPAKRITVEEALNHPYL 291
            +R+LV +   R+T  EAL HP+L
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWL 261

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 139/319 (43%), Gaps = 49/319 (15%)
Query: 18  GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID 77
           G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +        D
Sbjct: 7   GLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------D 53
Query: 78  AKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSKQ 133
             +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I  R  Q
Sbjct: 54  CPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 134 ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSE 190
           A T+      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+ 
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG 172
Query: 191 TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD-DSDLGFLRSDNARRYVKQLPHVP 249
             +  +     W            + M   L G P   S+ G   S   +  ++   +  
Sbjct: 173 EKY--DKSCDMWSL---------GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-- 219
Query: 250 KQPFSQKFPNMSPVAIDLAERMLV-----FDPAKRITVEEALNHPYLSSLHEINEEPTCP 304
                 +FPN     +    +ML+      +P +R+T+ E +NHP++    ++   P  P
Sbjct: 220 ------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV---PQTP 270
Query: 305 YPFNFDFEQTSMNEEDIKE 323
              +   ++     ED+KE
Sbjct: 271 LHTSRVLKEDKERWEDVKE 289

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 119/265 (44%), Gaps = 28/265 (10%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  IG+G++G V   +++ TKE VAIK I +  +   + + I +EI +L       I + 
Sbjct: 24  LDRIGKGSFGEVYKGIDNHTKEVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 82
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                     K   ++I+ E +       +     L + +    L ++L+GL Y+HS   
Sbjct: 83  FG-----SYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK 137
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETD-----------FMTEYVVTRWDTLFPG 208
           +HRD+K +N+LL+   D+K+ DFG+A   ++T            +M   V+ +    F  
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKA 197
Query: 209 KDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK-QPFSQKFPNMSPVAIDL 267
             +   +T I    G P +SDL  +R          L  +PK  P + +  +  P   + 
Sbjct: 198 DIWSLGITAIELAKGEPPNSDLHPMRV---------LFLIPKNSPPTLEGQHSKPFK-EF 247
Query: 268 AERMLVFDPAKRITVEEALNHPYLS 292
            E  L  DP  R T +E L H +++
Sbjct: 248 VEACLNKDPRFRPTAKELLKHKFIT 272

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 82
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 142
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 143 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 197
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 254
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 255 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 84/160 (52%), Gaps = 15/160 (9%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV--- 99
           +G+GA+G V  A N+      AIKKI +  +       IL E+ LL  + H+ +V+    
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEK---LSTILSEVXLLASLNHQYVVRYYAA 70
Query: 100 ----KDIIPPMDK-EKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYF--LYQLLRGL 151
               ++ + P    +K + ++I  E  +   L+ +I S+  L     +Y+    Q+L  L
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSEN-LNQQRDEYWRLFRQILEAL 129
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
            YIHS  ++HR+LKP N+ ++ + ++KI DFGLA+    +
Sbjct: 130 SYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRS 169

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 83
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANAFVGTAQY 198
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 255
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 256 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 67
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 68  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 127
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 128 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 182
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 239
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 240 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 279

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 83
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 198
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 255
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 256 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 36/273 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G++  V  A    T  E AIK +       +N++    + RE  ++  + H   VK+
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY--VTRERDVMSRLDHPFFVKL 75
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                  +K  F   Y      + +L + IR   +  +   +++  +++  L+Y+H   +
Sbjct: 76  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 131
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQ-QLTMI 218
           +HRDLKP N+LLN +  ++I DFG A+  S      E    R +       YV  +L   
Sbjct: 132 IHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQYVSPELLTE 186
Query: 219 TELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
                S D   LG +           R+ N     +++  + +  F +KF    P A DL
Sbjct: 187 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF---FPKARDL 242
Query: 268 AERMLVFDPAKRITVEEALN------HPYLSSL 294
            E++LV D  KR+  EE         HP+  S+
Sbjct: 243 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 275

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 83
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 198
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 255
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 256 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 85
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 200
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 257
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 258 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 85
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 200
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 257
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 258 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 85
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 200
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 257
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 258 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 132/301 (43%), Gaps = 61/301 (20%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +GRG Y  V   +N    E+  IK +      +   KR ++ ++ LC     NIVK+
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV--KKKKIKREIKILQNLC--GGPNIVKL 91
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            DI+   D+       I   + +TD   +  +   LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIV--RDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGI 146
Query: 160 LHRDLKPSNLLLNANC-DLKICDFGLA-----------RTTS-------------ETDF- 193
           +HRD+KP N++++     L++ D+GLA           R  S             + D+ 
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 194 --------MTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD------------DSDLGFL 233
                   M   ++ R +  F G D   QL  I ++LG+              D  L  L
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 266
Query: 234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
              ++R+   +  +   Q        +SP AID  +++L +D  +R+T  EA+ HPY   
Sbjct: 267 VGRHSRKPWLKFMNADNQHL------VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 294 L 294
           +
Sbjct: 321 V 321

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 77/146 (52%), Gaps = 6/146 (4%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + IG+G +  V  A +  T  EVA+K I     N    +++ RE++++  + H NIVK+ 
Sbjct: 21  KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 101 DIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           ++I     E    +Y+V E     ++   + +   + +   +    Q++  ++Y H   +
Sbjct: 81  EVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYI 135
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLA 185
           +HRDLK  NLLL+ + ++KI DFG +
Sbjct: 136 VHRDLKAENLLLDGDMNIKIADFGFS 161

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 36/273 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G++  V  A    T  E AIK +       +N++    + RE  ++  + H   VK+
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY--VTRERDVMSRLDHPFFVKL 74
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                  +K  F   Y      + +L + IR   +  +   +++  +++  L+Y+H   +
Sbjct: 75  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 130
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQ-QLTMI 218
           +HRDLKP N+LLN +  ++I DFG A+  S      E    R +       YV  +L   
Sbjct: 131 IHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQYVSPELLTE 185
Query: 219 TELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
                S D   LG +           R+ N     +++  + +  F +KF    P A DL
Sbjct: 186 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF---FPKARDL 241
Query: 268 AERMLVFDPAKRITVEEALN------HPYLSSL 294
            E++LV D  KR+  EE         HP+  S+
Sbjct: 242 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 274

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 86
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 146
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 147 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 201
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 258
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 259 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 90
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 91  MSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 150
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 151 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 205
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 262
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 263 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 302

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 36/273 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G++  V  A    T  E AIK +       +N++    + RE  ++  + H   VK+
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY--VTRERDVMSRLDHPFFVKL 72
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                  +K  F   Y      + +L + IR   +  +   +++  +++  L+Y+H   +
Sbjct: 73  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 128
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQ-QLTMI 218
           +HRDLKP N+LLN +  ++I DFG A+  S      E    R +       YV  +L   
Sbjct: 129 IHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQYVSPELLTE 183
Query: 219 TELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
                S D   LG +           R+ N     +++  + +  F +KF    P A DL
Sbjct: 184 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF---FPKARDL 239
Query: 268 AERMLVFDPAKRITVEEALN------HPYLSSL 294
            E++LV D  KR+  EE         HP+  S+
Sbjct: 240 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 272

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 132/301 (43%), Gaps = 61/301 (20%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +GRG Y  V   +N    E+  IK +      +   KR ++ ++ LC     NIVK+
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV--KKKKIKREIKILQNLC--GGPNIVKL 91
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            DI+   D+       I   + +TD   +  +   LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIV--RDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGI 146
Query: 160 LHRDLKPSNLLLNANC-DLKICDFGLA-----------RTTS-------------ETDF- 193
           +HRD+KP N++++     L++ D+GLA           R  S             + D+ 
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 194 --------MTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD------------DSDLGFL 233
                   M   ++ R +  F G D   QL  I ++LG+              D  L  L
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 266
Query: 234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
              ++R+   +  +   Q        +SP AID  +++L +D  +R+T  EA+ HPY   
Sbjct: 267 VGRHSRKPWLKFMNADNQHL------VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 294 L 294
           +
Sbjct: 321 V 321

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 132/301 (43%), Gaps = 61/301 (20%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +GRG Y  V   +N    E+  IK +      +   KR ++ ++ LC     NIVK+
Sbjct: 38  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV--KKKKIKREIKILQNLC--GGPNIVKL 93
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            DI+   D+       I   + +TD   +  +   LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 94  LDIV--RDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGI 148
Query: 160 LHRDLKPSNLLLNANC-DLKICDFGLA-----------RTTS-------------ETDF- 193
           +HRD+KP N++++     L++ D+GLA           R  S             + D+ 
Sbjct: 149 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 208
Query: 194 --------MTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD------------DSDLGFL 233
                   M   ++ R +  F G D   QL  I ++LG+              D  L  L
Sbjct: 209 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 268
Query: 234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
              ++R+   +  +   Q        +SP AID  +++L +D  +R+T  EA+ HPY   
Sbjct: 269 VGRHSRKPWLKFMNADNQHL------VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 322
Query: 294 L 294
           +
Sbjct: 323 V 323

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 36/273 (13%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G++  V  A    T  E AIK +       +N++    + RE  ++  + H   VK+
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY--VTRERDVMSRLDHPFFVKL 73
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                  +K  F   Y      + +L + IR   +  +   +++  +++  L+Y+H   +
Sbjct: 74  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQ-QLTMI 218
           +HRDLKP N+LLN +  ++I DFG A+  S      E    R +       YV  +L   
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQYVSPELLTE 184
Query: 219 TELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
                S D   LG +           R+ N     +++  + +  F +KF    P A DL
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF---FPKARDL 240
Query: 268 AERMLVFDPAKRITVEEALN------HPYLSSL 294
            E++LV D  KR+  EE         HP+  S+
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 132/301 (43%), Gaps = 61/301 (20%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +GRG Y  V   +N    E+  IK +      +   KR ++ ++ LC     NIVK+
Sbjct: 37  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV--KKKKIKREIKILQNLC--GGPNIVKL 92
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            DI+   D+       I   + +TD   +  +   LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 93  LDIV--RDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGI 147
Query: 160 LHRDLKPSNLLLNANC-DLKICDFGLA-----------RTTS-------------ETDF- 193
           +HRD+KP N++++     L++ D+GLA           R  S             + D+ 
Sbjct: 148 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 207
Query: 194 --------MTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD------------DSDLGFL 233
                   M   ++ R +  F G D   QL  I ++LG+              D  L  L
Sbjct: 208 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 267
Query: 234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
              ++R+   +  +   Q        +SP AID  +++L +D  +R+T  EA+ HPY   
Sbjct: 268 VGRHSRKPWLKFMNADNQHL------VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321
Query: 294 L 294
           +
Sbjct: 322 V 322

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 126/301 (41%), Gaps = 61/301 (20%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +GRG Y  V   +N    E+  IK +          K       L   M   NIVK+
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLMGGPNIVKL 91
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            DI+   D+       I   + +TD   +  +   LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIV--RDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGI 146
Query: 160 LHRDLKPSNLLLNANC-DLKICDFGLA-----------RTTS-------------ETDF- 193
           +HRD+KP N++++     L++ D+GLA           R  S             + D+ 
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 194 --------MTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD------------DSDLGFL 233
                   M   ++ R +  F G D   QL  I ++LG+              D  L  L
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 266
Query: 234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
              ++R+   +  +   Q        +SP AID  +++L +D  +R+T  EA+ HPY   
Sbjct: 267 VGRHSRKPWLKFMNADNQHL------VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 294 L 294
           +
Sbjct: 321 V 321

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/325 (24%), Positives = 141/325 (43%), Gaps = 38/325 (11%)
Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI 76
            G  ++ N + + ++V+S      Q +G G  G V    N  T+E+ A+K +        
Sbjct: 50  SGLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKXLQ------- 96
Query: 77  DAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSK 132
           D  +  RE++L    +   +IV++ D+   +   +   + IV E +D  +L   I  R  
Sbjct: 97  DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVXECLDGGELFSRIQDRGD 155
Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTS 189
           QA T+         +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+
Sbjct: 156 QAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 190 ETDFMTEYVVTRW----DTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNA 238
             + +T    T +    + L P K       +   +     L G P   S+ G   S   
Sbjct: 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGX 275
Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN 298
           +  ++   +    P   ++  +S     L   +L  +P +R T+ E  NHP++    ++ 
Sbjct: 276 KTRIRXGQYEFPNP---EWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKV- 331
Query: 299 EEPTCPYPFNFDFEQTSMNEEDIKE 323
             P  P   +   ++     ED+KE
Sbjct: 332 --PQTPLHTSRVLKEDKERWEDVKE 354

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 119/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 85
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 200
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N      ++  + +  F +KF  
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-EYDFPEKF-- 257
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 258 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 119/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 85
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 200
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N      ++  + +  F +KF  
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-EYDFPEKF-- 257
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 258 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 122/283 (43%), Gaps = 56/283 (19%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 85
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             +  L + IR   +  +   +++  +++  L
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R ++      Y
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANSFVGTAQY 200
Query: 212 VQQLTMITELLGSPDDSDLGFL--------------RSDNARRYVKQLPHVPKQPFSQKF 257
           V    ++TE   S   SDL  L              R+ N     +++  + +  F +KF
Sbjct: 201 VSP-ELLTEKSAS-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF 257
Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
               P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 258 ---FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 124/274 (45%), Gaps = 33/274 (12%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G GA+  V       T +  A+K I  +   R  +  +  EI +L  + HENIV +
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS--LENEIAVLKKIKHENIVTL 71
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           +DI      E     Y+V +L+   +L   I  +   T+      + Q+L  +KY+H   
Sbjct: 72  EDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 159 VLHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTE-----YVVTRWDTLFPGKD 210
           ++HRDLKP NLL      N  + I DFGL++        T      YV        P   
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSK 186
Query: 211 YV--QQLTMITELL--GSPDDSDLGFLRSDNARRY--VKQLPHVPKQPFSQKFPNMSPVA 264
            V    + +IT +L  G P      F     ++ +  +K+  +  + PF   + ++S  A
Sbjct: 187 AVDCWSIGVITYILLCGYPP-----FYEETESKLFEKIKEGYYEFESPF---WDDISESA 238
Query: 265 IDLAERMLVFDPAKRITVEEALNHPYL---SSLH 295
            D    +L  DP +R T E+AL+HP++   ++LH
Sbjct: 239 KDFICHLLEKDPNERYTCEKALSHPWIDGNTALH 272

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 91/351 (25%), Positives = 147/351 (41%), Gaps = 98/351 (27%)
Query: 18  GKYVQ--YNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVN-SETKEEVAIKKITNAFDN 74
           G ++Q  Y I+GNL              G G +G V   ++ +  K +VA+K I N    
Sbjct: 46  GDWLQERYEIVGNL--------------GEGTFGKVVECLDHARGKSQVALKIIRNVGKY 91
Query: 75  RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN---DVYIVYELMDTDLHQIIRS 131
           R +A R+  EI +L  +  ++  K    +  +  + FN    + I +EL+  +  + ++ 
Sbjct: 92  R-EAARL--EINVLKKIKEKD--KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKE 146
Query: 132 K--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLL-LNA--------------- 173
              Q     H ++  YQL   L+++H   + H DLKP N+L +N+               
Sbjct: 147 NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 206
Query: 174 ---NCDLKICDFGLARTTSETDFMTEYVVTR-------------------WD-------- 203
              N  +++ DFG A  T + +  T  V TR                   W         
Sbjct: 207 SVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 264
Query: 204 ----TLFPGKDYVQQLTMITELLGSPDDSDL-------------GFLRSDNAR--RYVKQ 244
               TLF   +  + L M+ ++LG P  S +             G +  +N+   RYVK+
Sbjct: 265 YRGFTLFQTHENREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 323
Query: 245 LPHVPKQPFSQKFPNMSPVAI-DLAERMLVFDPAKRITVEEALNHPYLSSL 294
                K    Q   ++  V + DL  RML FDPA+RIT+ EAL HP+ + L
Sbjct: 324 NCKPLKSYMLQD--SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 372

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 91/351 (25%), Positives = 147/351 (41%), Gaps = 98/351 (27%)
Query: 18  GKYVQ--YNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVN-SETKEEVAIKKITNAFDN 74
           G ++Q  Y I+GNL              G G +G V   ++ +  K +VA+K I N    
Sbjct: 23  GDWLQERYEIVGNL--------------GEGTFGKVVECLDHARGKSQVALKIIRNVGKY 68
Query: 75  RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN---DVYIVYELMDTDLHQIIRS 131
           R +A R+  EI +L  +  ++  K    +  +  + FN    + I +EL+  +  + ++ 
Sbjct: 69  R-EAARL--EINVLKKIKEKD--KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKE 123
Query: 132 K--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLL-LNA--------------- 173
              Q     H ++  YQL   L+++H   + H DLKP N+L +N+               
Sbjct: 124 NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 183
Query: 174 ---NCDLKICDFGLARTTSETDFMTEYVVTR-------------------WD-------- 203
              N  +++ DFG A  T + +  T  V TR                   W         
Sbjct: 184 SVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 241
Query: 204 ----TLFPGKDYVQQLTMITELLGSPDDSDL-------------GFLRSDNAR--RYVKQ 244
               TLF   +  + L M+ ++LG P  S +             G +  +N+   RYVK+
Sbjct: 242 YRGFTLFQTHENREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 300
Query: 245 LPHVPKQPFSQKFPNMSPVAI-DLAERMLVFDPAKRITVEEALNHPYLSSL 294
                K    Q   ++  V + DL  RML FDPA+RIT+ EAL HP+ + L
Sbjct: 301 NCKPLKSYMLQD--SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 349

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 91/351 (25%), Positives = 147/351 (41%), Gaps = 98/351 (27%)
Query: 18  GKYVQ--YNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVN-SETKEEVAIKKITNAFDN 74
           G ++Q  Y I+GNL              G G +G V   ++ +  K +VA+K I N    
Sbjct: 14  GDWLQERYEIVGNL--------------GEGTFGKVVECLDHARGKSQVALKIIRNVGKY 59
Query: 75  RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN---DVYIVYELMDTDLHQIIRS 131
           R +A R+  EI +L  +  ++  K    +  +  + FN    + I +EL+  +  + ++ 
Sbjct: 60  R-EAARL--EINVLKKIKEKD--KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKE 114
Query: 132 K--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLL-LNA--------------- 173
              Q     H ++  YQL   L+++H   + H DLKP N+L +N+               
Sbjct: 115 NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174
Query: 174 ---NCDLKICDFGLARTTSETDFMTEYVVTR-------------------WD-------- 203
              N  +++ DFG A  T + +  T  V TR                   W         
Sbjct: 175 SVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232
Query: 204 ----TLFPGKDYVQQLTMITELLGSPDDSDL-------------GFLRSDNAR--RYVKQ 244
               TLF   +  + L M+ ++LG P  S +             G +  +N+   RYVK+
Sbjct: 233 YRGFTLFQTHENREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 291
Query: 245 LPHVPKQPFSQKFPNMSPVAI-DLAERMLVFDPAKRITVEEALNHPYLSSL 294
                K    Q   ++  V + DL  RML FDPA+RIT+ EAL HP+ + L
Sbjct: 292 NCKPLKSYMLQD--SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 119/281 (42%), Gaps = 52/281 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++     A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 83
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 198
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFPN 259
           V  +L        S D   LG +           R+ N     +++  + +  F +KF  
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKF-- 255
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
             P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 256 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 47/241 (19%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NIVK+ DI+   D+       I   + +TD   +  +   LTD   +Y++Y+LL+ L Y 
Sbjct: 108 NIVKLLDIV--RDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYC 162
Query: 155 HSANVLHRDLKPSNLLLNANC-DLKICDFGLA-----------RTTS------------- 189
           HS  ++HRD+KP N++++     L++ D+GLA           R  S             
Sbjct: 163 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 190 ETDF---------MTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD-DSDLGFLRSDNAR 239
           + D+         M   ++ R +  F G D   QL  I ++LG+   ++ L   R +   
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDP 282
Query: 240 RYVKQLPHVPKQPFSQKFPN------MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           +    +    ++P+  KF N      +SP AID  +++L +D  +R+T  EA+ HPY   
Sbjct: 283 QLEALVGRHSRKPWL-KFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 341
Query: 294 L 294
           +
Sbjct: 342 V 342

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 33/180 (18%)
Query: 23  YNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR-- 80
           YN L N F++  K       IGRG +  V  A        VA+KK+   FD  +DAK   
Sbjct: 28  YNTLAN-FRIEKK-------IGRGQFSEVYRAACLLDGVPVALKKV-QIFD-LMDAKARA 77
Query: 81  -ILREIKLLCHMTHENIVK-----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIR--- 130
             ++EI LL  + H N++K     ++D          N++ IV EL D  DL ++I+   
Sbjct: 78  DCIKEIDLLKQLNHPNVIKYYASFIED----------NELNIVLELADAGDLSRMIKHFK 127
Query: 131 -SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
             K+ + +     +  QL   L+++HS  V+HRD+KP+N+ + A   +K+ D GL R  S
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 90/173 (52%), Gaps = 16/173 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAI-KKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L  IG G+YG  C  +  ++  ++ + K++        + + ++ E+ LL  + H NIV+
Sbjct: 11  LYTIGTGSYG-RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQII----RSKQALTDDHCQYFLYQLLRGLKY 153
             D I  +D+     +YIV E  +  DL  +I    + +Q L ++     + QL   LK 
Sbjct: 70  YYDRI--IDRTN-TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 154 IHSAN-----VLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVT 200
            H  +     VLHRDLKP+N+ L+   ++K+ DFGLAR  + + DF  E+V T
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGT 179

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 117/282 (41%), Gaps = 54/282 (19%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G++  V  A    T  E AIK +        + + I++E K+        + + +D+
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKIL--------EKRHIIKENKV------PYVTRERDV 88
Query: 103 IPPMDKEKFNDVYIVYE-----------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           +  +D   F  +Y  ++             + +L + IR   +  +   +++  +++  L
Sbjct: 89  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 148
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+H   ++HRDLKP N+LLN +  ++I DFG A+  S      E    R +       Y
Sbjct: 149 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-----PESKQARANXFVGTAQY 203
Query: 212 VQ-QLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFP- 258
           V  +L        S D   LG +           R+ N     +++  +        FP 
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-----EYDFPA 258
Query: 259 NMSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSSL 294
              P A DL E++LV D  KR+  EE         HP+  S+
Sbjct: 259 AFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 300

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 125/301 (41%), Gaps = 61/301 (20%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +GRG Y  V   +N    E+  IK +          K       L       NIVK+
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLXGGPNIVKL 91
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            DI+   D+       I   + +TD   +  +   LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIV--RDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGI 146
Query: 160 LHRDLKPSNLLLNANC-DLKICDFGLA-----------RTTS-------------ETDF- 193
           +HRD+KP N++++     L++ D+GLA           R  S             + D+ 
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 194 --------MTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD------------DSDLGFL 233
                   M   ++ R +  F G D   QL  I ++LG+              D  L  L
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 266
Query: 234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
              ++R+   +  +   Q        +SP AID  +++L +D  +R+T  EA+ HPY   
Sbjct: 267 VGRHSRKPWLKFMNADNQHL------VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 294 L 294
           +
Sbjct: 321 V 321

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 115/264 (43%), Gaps = 27/264 (10%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+GA G V +A++  T +EVAI+++      +   + I+ EI ++    + NIV  
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            D     D     ++++V E +       + ++  + +        + L+ L+++HS  V
Sbjct: 83  LDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 160 LHRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTRWDTLFPG 208
           +HRD+K  N+LL  +  +K+ DFG  A+ T E            +M   VVTR     P 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-KAYGPK 196
Query: 209 KDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
            D      M  E++ G P      +L  +  R     L      P  Q    +S +  D 
Sbjct: 197 VDIWSLGIMAIEMIEGEPP-----YLNENPLRALY--LIATNGTPELQNPEKLSAIFRDF 249
Query: 268 AERMLVFDPAKRITVEEALNHPYL 291
             R L  D  KR + +E L H +L
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 108/246 (43%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NIVK+ DI+   D+       I   + +TD   +  +   LTD   +Y++Y+LL+ L Y 
Sbjct: 88  NIVKLLDIV--RDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYC 142
Query: 155 HSANVLHRDLKPSNLLLNANC-DLKICDFGLA-----------RTTS------------- 189
           HS  ++HRD+KP N++++     L++ D+GLA           R  S             
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 190 ETDF---------MTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD------------DS 228
           + D+         M   ++ R +  F G D   QL  I ++LG+              D 
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 262
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
            L  L   ++R+   +  +   Q        +SP AID  +++L +D  +R+T  EA+ H
Sbjct: 263 QLEALVGRHSRKPWLKFMNADNQHL------VSPEAIDFLDKLLRYDHQERLTALEAMTH 316
Query: 289 PYLSSL 294
           PY   +
Sbjct: 317 PYFQQV 322

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/317 (25%), Positives = 132/317 (41%), Gaps = 76/317 (23%)
Query: 43  IGRGAYGIV--CSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +GRG YG V      + +  ++ A+K+I    +    +    REI LL  + H N++ ++
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 84
Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA---------LTDDHCQYFLYQLLRGL 151
            +       K   V+++++  + DL  II+  +A         L     +  LYQ+L G+
Sbjct: 85  KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 152 KYIHSANVLHRDLKPSNLLLNA----NCDLKICDFGLARTTSET----DFMTEYVVTRW- 202
            Y+H+  VLHRDLKP+N+L+         +KI D G AR  +        +   VVT W 
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 203 ---DTLFPGKDYVQQL------TMITELLGS---------------PDDSD--------L 230
              + L   + Y + +       +  ELL S               P   D        +
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261
Query: 231 GFLRSDNARRYVKQLPH---VPKQPFSQKFPNMSPV-------------AIDLAERMLVF 274
           GF  +D     +K++P    + K      + N S +             A  L +++L  
Sbjct: 262 GF-PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM 320
Query: 275 DPAKRITVEEALNHPYL 291
           DP KRIT E+A+  PY 
Sbjct: 321 DPIKRITSEQAMQDPYF 337

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 108/246 (43%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NIVK+ DI+   D+       I   + +TD   +  +   LTD   +Y++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIV--RDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYC 141
Query: 155 HSANVLHRDLKPSNLLLNANC-DLKICDFGLA-----------RTTS------------- 189
           HS  ++HRD+KP N++++     L++ D+GLA           R  S             
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 190 ETDF---------MTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD------------DS 228
           + D+         M   ++ R +  F G D   QL  I ++LG+              D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
            L  L   ++R+   +  +   Q        +SP AID  +++L +D  +R+T  EA+ H
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHL------VSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 289 PYLSSL 294
           PY   +
Sbjct: 316 PYFQQV 321

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 108/246 (43%), Gaps = 57/246 (23%)
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           NIVK+ DI+   D+       I   + +TD   +  +   LTD   +Y++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIV--RDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYC 141
Query: 155 HSANVLHRDLKPSNLLLNANC-DLKICDFGLA-----------RTTS------------- 189
           HS  ++HRD+KP N++++     L++ D+GLA           R  S             
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 190 ETDF---------MTEYVVTRWDTLFPGKDYVQQLTMITELLGSPD------------DS 228
           + D+         M   ++ R +  F G D   QL  I ++LG+              D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
            L  L   ++R+   +  +   Q        +SP AID  +++L +D  +R+T  EA+ H
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHL------VSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 289 PYLSSL 294
           PY   +
Sbjct: 316 PYFQQV 321

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 15/174 (8%)
Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIV 97
           P+Q +GRG +G+V  A N       AIK+I     NR  A+ +++RE+K L  + H  IV
Sbjct: 9   PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR--LPNRELAREKVMREVKALAKLEHPGIV 66
Query: 98  K-VKDIIPPMDKEKFN----DVYIVYELM---DTDLHQIIRSKQALTDDH---CQYFLYQ 146
           +     +     EK       VY+  ++      +L   +  +  + +     C +   Q
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT 200
           +   ++++HS  ++HRDLKPSN+    +  +K+ DFGL  T  + D   + V+T
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV-TAMDQDEEEQTVLT 179

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G V  A N ET    A K I    +  ++   +  EI +L    H NIVK+ D 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV--EIDILASCDHPNIVKLLDA 102
Query: 103 IPPMDKEKFNDVYIVYELMDTDL--HQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                    N+++I+ E          ++  ++ LT+   Q    Q L  L Y+H   ++
Sbjct: 103 F-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 157
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           HRDLK  N+L   + D+K+ DFG++   + T
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRT 188

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 115/264 (43%), Gaps = 27/264 (10%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+GA G V +A++  T +EVAI+++      +   + I+ EI ++    + NIV  
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            D     D     ++++V E +       + ++  + +        + L+ L+++HS  V
Sbjct: 83  LDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 160 LHRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTRWDTLFPG 208
           +HRD+K  N+LL  +  +K+ DFG  A+ T E            +M   VVTR     P 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTR-KAYGPK 196
Query: 209 KDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
            D      M  E++ G P      +L  +  R     L      P  Q    +S +  D 
Sbjct: 197 VDIWSLGIMAIEMIEGEPP-----YLNENPLRALY--LIATNGTPELQNPEKLSAIFRDF 249
Query: 268 AERMLVFDPAKRITVEEALNHPYL 291
             R L  D  KR + +E L H +L
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 115/264 (43%), Gaps = 27/264 (10%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+GA G V +A++  T +EVAI+++      +   + I+ EI ++    + NIV  
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            D     D     ++++V E +       + ++  + +        + L+ L+++HS  V
Sbjct: 83  LDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 160 LHRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTRWDTLFPG 208
           +HRD+K  N+LL  +  +K+ DFG  A+ T E            +M   VVTR     P 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPK 196
Query: 209 KDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
            D      M  E++ G P      +L  +  R     L      P  Q    +S +  D 
Sbjct: 197 VDIWSLGIMAIEMIEGEPP-----YLNENPLRALY--LIATNGTPELQNPEKLSAIFRDF 249
Query: 268 AERMLVFDPAKRITVEEALNHPYL 291
             R L  D  KR + +E L H +L
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 82/166 (49%), Gaps = 9/166 (5%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G +G V   ++ +T E+VAIK+       + + +R   EI+++  + H N+V  +++
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 103 IPPMDKEKFNDV-YIVYELMDT-DLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKYIHSA 157
              + K   ND+  +  E  +  DL + +   +    L +   +  L  +   L+Y+H  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 158 NVLHRDLKPSNLLLNANCDL---KICDFGLARTTSETDFMTEYVVT 200
            ++HRDLKP N++L         KI D G A+   + +  TE+V T
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 82/166 (49%), Gaps = 9/166 (5%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G +G V   ++ +T E+VAIK+       + + +R   EI+++  + H N+V  +++
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 103 IPPMDKEKFNDV-YIVYELMDT-DLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKYIHSA 157
              + K   ND+  +  E  +  DL + +   +    L +   +  L  +   L+Y+H  
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 158 NVLHRDLKPSNLLLNANCDL---KICDFGLARTTSETDFMTEYVVT 200
            ++HRDLKP N++L         KI D G A+   + +  TE+V T
Sbjct: 142 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 187

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 20/163 (12%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHH- 90
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA------------LTDDHCQYF 143
            + V +++    K     + IV      +L   +RSK+             LT +H   +
Sbjct: 91  -LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 144 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 22/165 (13%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHH- 92
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA--------------LTDDHCQ 141
            + V +++    K     + IV      +L   +RSK+               LT +H  
Sbjct: 93  -LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 152 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 115/264 (43%), Gaps = 27/264 (10%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+GA G V +A++  T +EVAI+++      +   + I+ EI ++    + NIV  
Sbjct: 26  FEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNY 83
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            D     D     ++++V E +       + ++  + +        + L+ L+++HS  V
Sbjct: 84  LDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 138
Query: 160 LHRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTRWDTLFPG 208
           +HRD+K  N+LL  +  +K+ DFG  A+ T E            +M   VVTR     P 
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-KAYGPK 197
Query: 209 KDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
            D      M  E++ G P      +L  +  R     L      P  Q    +S +  D 
Sbjct: 198 VDIWSLGIMAIEMIEGEPP-----YLNENPLRALY--LIATNGTPELQNPEKLSAIFRDF 250
Query: 268 AERMLVFDPAKRITVEEALNHPYL 291
             R L  D  KR + +E + H +L
Sbjct: 251 LNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 78/156 (50%), Gaps = 7/156 (4%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVKVKD 101
           +G G +G V    +  T  +VA+K +       +D   +I REI+ L    H +I+K+  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +I         D ++V E +   +L   I     + +   +    Q+L  + Y H   V+
Sbjct: 79  VISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE 196
           HRDLKP N+LL+A+ + KI DFGL+   S+ +F+ +
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRD 169

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 16/173 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAI-KKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L  IG G+YG  C  +  ++  ++ + K++        + + ++ E+ LL  + H NIV+
Sbjct: 11  LYTIGTGSYG-RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQII----RSKQALTDDHCQYFLYQLLRGLKY 153
             D I  +D+     +YIV E  +  DL  +I    + +Q L ++     + QL   LK 
Sbjct: 70  YYDRI--IDRTN-TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 154 IHSAN-----VLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVT 200
            H  +     VLHRDLKP+N+ L+   ++K+ DFGLAR  + +T F   +V T
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT 179

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 7/154 (4%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVKVKD 101
           +G G +G V    +  T  +VA+K +       +D   +I REI+ L    H +I+K+  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +I         D ++V E +   +L   I     + +   +    Q+L  + Y H   V+
Sbjct: 79  VISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFM 194
           HRDLKP N+LL+A+ + KI DFGL+   S+ +F+
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 16/173 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAI-KKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L  IG G+YG  C  +  ++  ++ + K++        + + ++ E+ LL  + H NIV+
Sbjct: 11  LYTIGTGSYG-RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQII----RSKQALTDDHCQYFLYQLLRGLKY 153
             D I  +D+     +YIV E  +  DL  +I    + +Q L ++     + QL   LK 
Sbjct: 70  YYDRI--IDRTN-TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 154 IHSAN-----VLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVT 200
            H  +     VLHRDLKP+N+ L+   ++K+ DFGLAR  + +T F   +V T
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 46/298 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLL--CHMTHENIVKVK 100
           +G GA+  V + +N  T +E A+K I     +     R+ RE+++L  C   H N++++ 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--RSRVFREVEMLYQCQ-GHRNVLELI 77
Query: 101 DIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           +     D+      Y+V+E M    +   I  ++   +      +  +   L ++H+  +
Sbjct: 78  EFFEEEDR-----FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 160 LHRDLKPSNLLL---NANCDLKICDFGLART------------------TSETDFMTEYV 198
            HRDLKP N+L    N    +KICDFGL                         ++M   V
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 199 VTRWD---TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ 255
           V  +    +++  +  +  L +I  +L S     +G   SD      +  P      F  
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252
Query: 256 ------KFPN-----MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
                 +FP+     +S  A DL  ++LV D  +R++  + L HP++      N  PT
Sbjct: 253 IQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 9/145 (6%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G V  A N ET    A K I    +  ++   +  EI +L    H NIVK+ D 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV--EIDILASCDHPNIVKLLDA 102
Query: 103 IPPMDKEKFNDVYIVYELMDTDL--HQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                    N+++I+ E          ++  ++ LT+   Q    Q L  L Y+H   ++
Sbjct: 103 F-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 157
Query: 161 HRDLKPSNLLLNANCDLKICDFGLA 185
           HRDLK  N+L   + D+K+ DFG++
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 9/145 (6%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G V  A N ET    A K I    +  ++   +  EI +L    H NIVK+ D 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV--EIDILASCDHPNIVKLLDA 102
Query: 103 IPPMDKEKFNDVYIVYELMDTDL--HQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                    N+++I+ E          ++  ++ LT+   Q    Q L  L Y+H   ++
Sbjct: 103 F-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 157
Query: 161 HRDLKPSNLLLNANCDLKICDFGLA 185
           HRDLK  N+L   + D+K+ DFG++
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 14/145 (9%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +GRG++G V    + +T  + A+KK+      R++  R   E+     +T   IV +   
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRA-EELMACAGLTSPRIVPLYGA 153
Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           +      +   V I  EL++   L Q+++ +  L +D   Y+L Q L GL+Y+HS  +LH
Sbjct: 154 V-----REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILH 208
Query: 162 RDLKPSNLLLNANCD-LKICDFGLA 185
            D+K  N+LL+++     +CDFG A
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHA 233

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 43  IGRGAYGIVCSAV--NSETKEEV--AIKKITNAF--DNRIDAKRILREIKLLCHMTHENI 96
           IG G +G V   +   S  K+EV  AIK +   +    R+D    L E  ++   +H NI
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD---FLGEAGIMGQFSHHNI 108
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQA-LTDDHCQYFLYQLLRGLKYI 154
           ++++ +I      K+  + I+ E M+   L + +R K    +       L  +  G+KY+
Sbjct: 109 IRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            + N +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 42/275 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK---- 98
           +G G YG V    + +T +  AIK +    D   + K+ +  +K   H  H NI      
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATYYGA 89
Query: 99  -VKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            +K   P MD    + +++V E       TDL +  +    L ++   Y   ++LRGL +
Sbjct: 90  FIKKNPPGMD----DQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSH 144
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RTTSETD-------FMTEYVVT-- 200
           +H   V+HRD+K  N+LL  N ++K+ DFG++    RT    +       +M   V+   
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 201 -RWDTLFPGKDYVQQL--TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ-K 256
              D  +  K  +  L  T I    G+P   D+  +R+         L  +P+ P  + K
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---------LFLIPRNPAPRLK 255
Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
               S       E  LV + ++R   E+ + HP++
Sbjct: 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 14/145 (9%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +GRG++G V    + +T  + A+KK+      R++  R   E+     +T   IV +   
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRA-EELMACAGLTSPRIVPLYGA 134
Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           +      +   V I  EL++   L Q+++ +  L +D   Y+L Q L GL+Y+HS  +LH
Sbjct: 135 V-----REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILH 189
Query: 162 RDLKPSNLLLNANCD-LKICDFGLA 185
            D+K  N+LL+++     +CDFG A
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHA 214

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 112 EGVV-----TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGLAR
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLAR 195

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 42/223 (18%)
Query: 40  LQPIGRGAYG---IVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
           L+ +G+G++G   +V     S+ ++  A+K +  A     D  R   E  +L  + H  I
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 97  VKVKDIIPPMDKEKFNDVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           VK+        K     +Y++ + L   DL   +  +   T++  +++L +L   L ++H
Sbjct: 89  VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTT-----------SETDFMTEYVVTR--- 201
           S  +++RDLKP N+LL+    +K+ DFGL++ +              ++M   VV R   
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 202 -----WDTL-------------FPGKDYVQQLTMITEL-LGSP 225
                W +              F GKD  + +TMI +  LG P
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 41  QPIGRGAYGIVCSA-VNSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           Q IG G +G VCS  +    K E  VAIK + + +  +   +  L E  ++    H N++
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVI 97
Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIH 155
            ++ ++      K   V I+ E M+   L   +R      T       L  +  G+KY+ 
Sbjct: 98  HLEGVV-----TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 152
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             N +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 183

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 11/166 (6%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIV--CS--AVNSETKEEVAIKKITNAFDNRIDAKRILR 83
           N+ Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   R
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFER 78
Query: 84  EIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYF 143
           EI++L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +  
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 135
Query: 144 LY--QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Y  Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 136 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 181

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 42/223 (18%)
Query: 40  LQPIGRGAYG---IVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
           L+ +G+G++G   +V     S+ ++  A+K +  A     D  R   E  +L  + H  I
Sbjct: 30  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 89
Query: 97  VKVKDIIPPMDKEKFNDVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           VK+        K     +Y++ + L   DL   +  +   T++  +++L +L   L ++H
Sbjct: 90  VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 144
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTT-----------SETDFMTEYVVTR--- 201
           S  +++RDLKP N+LL+    +K+ DFGL++ +              ++M   VV R   
Sbjct: 145 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 204
Query: 202 -----WDTL-------------FPGKDYVQQLTMITEL-LGSP 225
                W +              F GKD  + +TMI +  LG P
Sbjct: 205 TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 11/166 (6%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIV--CS--AVNSETKEEVAIKKITNAFDNRIDAKRILR 83
           N+ Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   R
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFER 78
Query: 84  EIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYF 143
           EI++L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +  
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 135
Query: 144 LY--QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Y  Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 136 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 181

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 30/170 (17%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE- 94
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 82
Query: 95  NIVKV-----KDIIPPMDKEKF-------------NDVYIVYELMDTDLHQIIRSKQALT 136
           N+V +     K   P M   +F              + ++ Y++   DL+     K  LT
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY-----KDFLT 137
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 30/170 (17%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE- 94
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 82
Query: 95  NIVKV-----KDIIPPMDKEKF-------------NDVYIVYELMDTDLHQIIRSKQALT 136
           N+V +     K   P M   +F              + ++ Y++   DL+     K  LT
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY-----KDFLT 137
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 42/223 (18%)
Query: 40  LQPIGRGAYG---IVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
           L+ +G+G++G   +V     S+ ++  A+K +  A     D  R   E  +L  + H  I
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 97  VKVKDIIPPMDKEKFNDVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           VK+        K     +Y++ + L   DL   +  +   T++  +++L +L   L ++H
Sbjct: 89  VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTT-----------SETDFMTEYVVTR--- 201
           S  +++RDLKP N+LL+    +K+ DFGL++ +              ++M   VV R   
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 202 -----WDTL-------------FPGKDYVQQLTMITEL-LGSP 225
                W +              F GKD  + +TMI +  LG P
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 112 EGVV-----TKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 30/170 (17%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE- 94
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 82
Query: 95  NIVKV-----KDIIPPMDKEKF-------------NDVYIVYELMDTDLHQIIRSKQALT 136
           N+V +     K   P M   +F              + ++ Y++   DL+     K  LT
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY-----KDFLT 137
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 115/264 (43%), Gaps = 27/264 (10%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+GA G V +A++  T +EVAI+++      +   + I+ EI ++    + NIV  
Sbjct: 26  FEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNY 83
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            D     D     ++++V E +       + ++  + +        + L+ L+++HS  V
Sbjct: 84  LDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 138
Query: 160 LHRDLKPSNLLLNANCDLKICDFGL-ARTTSETD----------FMTEYVVTRWDTLFPG 208
           +HR++K  N+LL  +  +K+ DFG  A+ T E            +M   VVTR     P 
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPK 197
Query: 209 KDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
            D      M  E++ G P      +L  +  R     L      P  Q    +S +  D 
Sbjct: 198 VDIWSLGIMAIEMIEGEPP-----YLNENPLRALY--LIATNGTPELQNPEKLSAIFRDF 250
Query: 268 AERMLVFDPAKRITVEEALNHPYL 291
             R L  D  KR + +E + H +L
Sbjct: 251 LNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 23/166 (13%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 34  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHH- 91
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA---------------LTDDHC 140
            + V +++    K     + IV      +L   +RSK+                LT +H 
Sbjct: 92  -LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 141 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 30/170 (17%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE- 94
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 82
Query: 95  NIVKV-----KDIIPPM---DKEKFNDV----------YIVYELMDTDLHQIIRSKQALT 136
           N+V +     K   P M   +  KF ++          ++ Y++   DL+     K  LT
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY-----KDFLT 137
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 30/170 (17%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE- 94
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 70  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 128
Query: 95  NIVKV-----KDIIPPM---DKEKFNDV----------YIVYELMDTDLHQIIRSKQALT 136
           N+V +     K   P M   +  KF ++          ++ Y++   DL+     K  LT
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY-----KDFLT 183
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 184 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 233

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 26  LGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREI 85
           LG+ + ++ K +  LQ IG+G +G V   +      +VA+K I N       A+  L E 
Sbjct: 3   LGSGWALNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKN----DATAQAFLAEA 56
Query: 86  KLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSK--QALTDDHCQY 142
            ++  + H N+V++  +I     E+   +YIV E M    L   +RS+    L  D    
Sbjct: 57  SVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 112
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           F   +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S T
Sbjct: 113 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 161

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 30/170 (17%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE- 94
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 95  NIVKV-----KDIIPPM---DKEKFNDV----------YIVYELMDTDLHQIIRSKQALT 136
           N+V +     K   P M   +  KF ++          ++ Y++   DL+     K  LT
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY-----KDFLT 146
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 30/170 (17%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE- 94
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 95  NIVKV-----KDIIPPM---DKEKFNDV----------YIVYELMDTDLHQIIRSKQALT 136
           N+V +     K   P M   +  KF ++          ++ Y++   DL+     K  LT
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY-----KDFLT 146
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 30/170 (17%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE- 94
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 95  NIVKV-----KDIIPPM---DKEKFNDV----------YIVYELMDTDLHQIIRSKQALT 136
           N+V +     K   P M   +  KF ++          ++ Y++   DL+     K  LT
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY-----KDFLT 146
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 24/167 (14%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHH- 92
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA----------------LTDDH 139
            + V +++    K     + IV      +L   +RSK+                 LT +H
Sbjct: 93  -LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 140 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
              + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 152 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 112 EGVV-----TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 89/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 6   LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E M+   DL   I  + AL ++  + 
Sbjct: 64  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERMEPVQDLFDFITERGALQEELARS 118
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 119 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 173

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 112 EGVV-----TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 112 EGVV-----TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGL R
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGR 195

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 112 EGVV-----TKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 99
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 100 EGVV-----TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSR 183

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 82/148 (55%), Gaps = 7/148 (4%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ IG+G++G VC    ++TK+  A+K +       R + + + +E++++  + H  +V 
Sbjct: 20  LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 99  VKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           +       D+E   D+++V +L+   DL   ++      ++  + F+ +L+  L Y+ + 
Sbjct: 80  L--WYSFQDEE---DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            ++HRD+KP N+LL+ +  + I DF +A
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIA 162

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 109
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 110 EGVV-----TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 164
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSR 193

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 112 EGVV-----TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 112 EGVV-----TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 82
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 83  EGVVT-----KSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSR 166

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 112 EGVV-----TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E M   D+   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +K+ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK 189

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG GA  +V +A  +  KE+VAIK+I N    +     +L+EI+ +    H NIV     
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 103 IPPMDKEKFNDVYIVYELM------DTDLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKY 153
               D     ++++V +L+      D   H + + +     L +      L ++L GL+Y
Sbjct: 82  FVVKD-----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           +H    +HRD+K  N+LL  +  ++I DFG++
Sbjct: 137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 18/184 (9%)
Query: 31  QVSSKYVPPLQPIGRGAYGIVCSA-VNSETKEE--VAIKKITNAFDNRIDAKRILREIKL 87
           ++   YV   + IG G +G VC   + +  K+E  VAIK +   +  R   +  L E  +
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER-QRREFLSEASI 70
Query: 88  LCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTD-LHQIIR-SKQALTDDHCQYFLY 145
           +    H NI++++ ++          V I+ E M+   L   +R +    T       L 
Sbjct: 71  MGQFEHPNIIRLEGVV-----TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-------TTSETDFMTEYV 198
            +  G++Y+   + +HRDL   N+L+N+N   K+ DFGL+R         +ET  +   +
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 199 VTRW 202
             RW
Sbjct: 186 PIRW 189

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS    + S+ +  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 82
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V IV E M+   L   +R   A  T       L  +  G+KY+   
Sbjct: 83  EGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRDL   N+L+N+N   K+ DFGL+R
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSR 166

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E M   D+   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +K+ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK 189

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 30/265 (11%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G++G V   +++ T++ VAIK I +  +   + + I +EI +L       + K 
Sbjct: 28  LERIGKGSFGEVFKGIDNRTQQVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSSYVTKY 86
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                     K + ++I+ E +       +       +      L ++L+GL Y+HS   
Sbjct: 87  YG-----SYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK 141
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQ----- 214
           +HRD+K +N+LL+   D+K+ DFG+A   ++T       V     + P  + +QQ     
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP--EVIQQSAYDS 199
Query: 215 --------LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
                   +T I    G P +SD+  +R          L  +PK        + +    +
Sbjct: 200 KADIWSLGITAIELAKGEPPNSDMHPMRV---------LFLIPKNNPPTLVGDFTKSFKE 250
Query: 267 LAERMLVFDPAKRITVEEALNHPYL 291
             +  L  DP+ R T +E L H ++
Sbjct: 251 FIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 78/148 (52%), Gaps = 15/148 (10%)
Query: 41  QP-IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           QP +GRG++G V    + +T  + A+KK+      R++  R+  E+     ++   IV +
Sbjct: 79  QPRVGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRV-EELVACAGLSSPRIVPL 131
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
              +      +   V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  
Sbjct: 132 YGAV-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 186
Query: 159 VLHRDLKPSNLLLNANCD-LKICDFGLA 185
           +LH D+K  N+LL+++     +CDFG A
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHA 214

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 78/148 (52%), Gaps = 15/148 (10%)
Query: 41  QP-IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           QP +GRG++G V    + +T  + A+KK+      R++  R+  E+     ++   IV +
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRV-EELVACAGLSSPRIVPL 115
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
              +      +   V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  
Sbjct: 116 YGAV-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 159 VLHRDLKPSNLLLNANCD-LKICDFGLA 185
           +LH D+K  N+LL+++     +CDFG A
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHA 198

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG GA  +V +A  +  KE+VAIK+I N    +     +L+EI+ +    H NIV     
Sbjct: 18  IGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 76
Query: 103 IPPMDKEKFNDVYIVYELM------DTDLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKY 153
               D     ++++V +L+      D   H + + +     L +      L ++L GL+Y
Sbjct: 77  FVVKD-----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           +H    +HRD+K  N+LL  +  ++I DFG++
Sbjct: 132 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 163

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 124/294 (42%), Gaps = 49/294 (16%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  IGRGAYG V   V+  + + +A+K+I +  D + + K++L ++ ++  M   +   +
Sbjct: 27  LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVV--MRSSDCPYI 83
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHC-----QYFLYQLLRGLKYI 154
                 + +E   D +I  ELM T   +  +   ++ DD              ++ L ++
Sbjct: 84  VQFYGALFRE--GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 155 -HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQ 213
             +  ++HRD+KPSN+LL+ + ++K+CDFG++                 D++   +D   
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-------------DSIAKTRDAGC 188
Query: 214 QLTMITELLGSPDDSDLGF-LRSD-------------------NARRYVKQLPHV----P 249
           +  M  E +  P  S  G+ +RSD                          QL  V    P
Sbjct: 189 RPYMAPERI-DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP 247
Query: 250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTC 303
            Q  + +    SP  I+     L  D +KR   +E L HP++    E   E  C
Sbjct: 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVAC 301

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 78/148 (52%), Gaps = 15/148 (10%)
Query: 41  QP-IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           QP +GRG++G V    + +T  + A+KK+      R++  R+  E+     ++   IV +
Sbjct: 77  QPRLGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRV-EELVACAGLSSPRIVPL 129
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
              +      +   V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  
Sbjct: 130 YGAV-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 184
Query: 159 VLHRDLKPSNLLLNANCD-LKICDFGLA 185
           +LH D+K  N+LL+++     +CDFG A
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHA 212

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 20/163 (12%)
Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHH- 90
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA------------LTDDHCQYF 143
            + V +++    K     + IV      +L   +RSK+             LT +H   +
Sbjct: 91  -LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 144 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 117/272 (43%), Gaps = 34/272 (12%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVK 98
           L+ +G G++G V    +       A+K +      R+       + +L+  + TH  I++
Sbjct: 11  LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 99  VKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           +           F D   ++ +MD     +L  ++R  Q   +   +++  ++   L+Y+
Sbjct: 71  MWGT--------FQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT----EYVVTRWDTLFP--- 207
           HS ++++RDLKP N+LL+ N  +KI DFG A+   +  +      +Y+     +  P   
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPYNK 182
Query: 208 GKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
             D+     +I E+L         F  S+  + Y K L    + P     P  +    DL
Sbjct: 183 SIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKILNAELRFP-----PFFNEDVKDL 233
Query: 268 AERMLVFDPAKRI-----TVEEALNHPYLSSL 294
             R++  D ++R+       E+  NHP+   +
Sbjct: 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 26/170 (15%)
Query: 43  IGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           +G GA+G V  A        + K  VA+K + +A DN    K   RE +LL ++ HE+IV
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA--RKDFHREAELLTNLQHEHIV 78
Query: 98  KVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK-------------QALTDDHCQYF 143
           K   +    D      + +V+E M   DL++ +R+                LT     + 
Sbjct: 79  KFYGVCVEGDP-----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 144 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             Q+  G+ Y+ S + +HRDL   N L+  N  +KI DFG++R    TD+
Sbjct: 134 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 183

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 63
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 94
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 68
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 69  ILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 125
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 126 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 168

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 11/165 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIVCSA-VNSETKEE--VAIKKITNAFDNRIDAKRILREIKL 87
           ++   YV   + IG G +G VC   + +  K+E  VAIK +   +  R   +  L E  +
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER-QRREFLSEASI 68
Query: 88  LCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTD-LHQIIR-SKQALTDDHCQYFLY 145
           +    H NI++++ ++          V I+ E M+   L   +R +    T       L 
Sbjct: 69  MGQFEHPNIIRLEGVV-----TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 123
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            +  G++Y+   + +HRDL   N+L+N+N   K+ DFGL+R   E
Sbjct: 124 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEE 168

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 66
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +      A   DH +   Y 
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYT 123
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 166

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 66
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 123
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 166

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 69
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 70  ILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 126
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 127 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 169

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 70
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 71  ILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 127
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 128 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 170

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 28/289 (9%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           + V+  Y    Q +G G  G V    +  T ++ A+K +        D+ +  +E+    
Sbjct: 24  YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHW 76
Query: 90  HMTHE-NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQII--RSKQALTDDHCQYFLYQ 146
             +   +IV + D+   M   K   + I+  +   +L   I  R  QA T+      +  
Sbjct: 77  QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD 136
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTS----ETDFMTEYVV 199
           +   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+ T+    +T   T Y V
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYV 196
Query: 200 TRWDTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNARRYVKQLPHVPKQP 252
              + L P K       +   + M   L G P   S+ G   S   +R ++   +    P
Sbjct: 197 AP-EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
              ++  +S  A  L   +L  DP +R+T+ + +NHP+++    + + P
Sbjct: 256 ---EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ IG G++G V  A +    E VAIKK++ +   +    + I++E++ L  + H N ++
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 99  VKDIIPPMDKEKFNDVYIVYEL---MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
            +         + +  ++V E      +DL ++   K+ L +       +  L+GL Y+H
Sbjct: 119 YRGCY-----LREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           S N++HRD+K  N+LL+    +K+ DFG A
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 63
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--CS--AVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 63
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 67
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 68  ILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 124
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 125 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 167

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 61
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 62  ILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 118
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 119 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 161

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 28/289 (9%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           + V+  Y    Q +G G  G V    +  T ++ A+K +        D+ +  +E+    
Sbjct: 5   YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHW 57
Query: 90  HMTHE-NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQII--RSKQALTDDHCQYFLYQ 146
             +   +IV + D+   M   K   + I+  +   +L   I  R  QA T+      +  
Sbjct: 58  QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD 117
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTS----ETDFMTEYVV 199
           +   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+ T+    +T   T Y V
Sbjct: 118 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYV 177
Query: 200 TRWDTLFPGK------DYVQQLTMITELLGSPD-DSDLGFLRSDNARRYVKQLPHVPKQP 252
              + L P K       +   + M   L G P   S+ G   S   +R ++   +    P
Sbjct: 178 AP-EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 236
Query: 253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
              ++  +S  A  L   +L  DP +R+T+ + +NHP+++    + + P
Sbjct: 237 ---EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 282

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 19/151 (12%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G      + ET E + +K++   FD     +  L+E+K++  + H N++K   +
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQ-RTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQY-------FLYQLLRGLKYIH 155
           +    +  F   YI        L  II+S  +      QY       F   +  G+ Y+H
Sbjct: 76  LYKDKRLNFITEYI----KGGTLRGIIKSMDS------QYPWSQRVSFAKDIASGMAYLH 125
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           S N++HRDL   N L+  N ++ + DFGLAR
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLAR 156

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--CS--AVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 62
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 63  ILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 119
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 120 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 162

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK- 98
           L+ IG+G++G V   +++ T++ VAIK I +  +   + + I +EI +L       + K 
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 99  ----VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
               +KD            ++I+ E +       +     L +      L ++L+GL Y+
Sbjct: 86  YGSYLKD----------TKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYL 135
Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T
Sbjct: 136 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK- 98
           L+ IG+G++G V   +++ T++ VAIK I +  +   + + I +EI +L       + K 
Sbjct: 32  LEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 90
Query: 99  ----VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
               +KD            ++I+ E +       +     L +      L ++L+GL Y+
Sbjct: 91  YGSYLKD----------TKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYL 140
Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T
Sbjct: 141 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK- 98
           L+ IG+G++G V   +++ T++ VAIK I +  +   + + I +EI +L       + K 
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 99  ----VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
               +KD            ++I+ E +       +     L +      L ++L+GL Y+
Sbjct: 71  YGSYLKD----------TKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYL 120
Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T
Sbjct: 121 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK- 98
           L+ IG+G++G V   +++ T++ VAIK I +  +   + + I +EI +L       + K 
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 99  ----VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
               +KD            ++I+ E +       +     L +      L ++L+GL Y+
Sbjct: 71  YGSYLKD----------TKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYL 120
Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T
Sbjct: 121 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/298 (22%), Positives = 122/298 (40%), Gaps = 46/298 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLL--CHMTHENIVKVK 100
           +G GA+  V + +N  T +E A+K I     +     R+ RE+++L  C   H N++++ 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--RSRVFREVEMLYQCQ-GHRNVLELI 77
Query: 101 DIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           +     D+      Y+V+E M    +   I  ++   +      +  +   L ++H+  +
Sbjct: 78  EFFEEEDR-----FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 160 LHRDLKPSNLLL---NANCDLKICDFGLART------------------TSETDFMTEYV 198
            HRDLKP N+L    N    +KICDF L                         ++M   V
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 199 VTRWD---TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ 255
           V  +    +++  +  +  L +I  +L S     +G   SD      +  P      F  
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252
Query: 256 ------KFPN-----MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
                 +FP+     +S  A DL  ++LV D  +R++  + L HP++      N  PT
Sbjct: 253 IQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ IG G++G V  A +    E VAIKK++ +   +    + I++E++ L  + H N ++
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 99  VKDIIPPMDKEKFNDVYIVYEL---MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
            +         + +  ++V E      +DL ++   K+ L +       +  L+GL Y+H
Sbjct: 80  YRGCYL-----REHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           S N++HRD+K  N+LL+    +K+ DFG A
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--CS--AVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  L+ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 66
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGR---RNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYT 123
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HRDL   N+L+     +KI DFGL + 
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 166

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 95/195 (48%), Gaps = 23/195 (11%)
Query: 8   MKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKK 67
           M D  IP     Y Q  + G+   +    +   + IG G++G V  A       +VA+K 
Sbjct: 10  MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRA--EWHGSDVAVKI 67
Query: 68  ITNAFDNRIDAKRI---LREIKLLCHMTHENIVKVKDII--PPMDKEKFNDVYIVYE-LM 121
           +    +    A+R+   LRE+ ++  + H NIV     +  PP       ++ IV E L 
Sbjct: 68  L---MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-------NLSIVTEYLS 117
Query: 122 DTDLHQIIR---SKQALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCD 176
              L++++    +++ L +       Y + +G+ Y+H+ N  ++HR+LK  NLL++    
Sbjct: 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT 177
Query: 177 LKICDFGLARTTSET 191
           +K+CDFGL+R  + T
Sbjct: 178 VKVCDFGLSRLKAST 192

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 40  LQPIGRGAYG---IVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
           L+ +G+G++G   +V      ++    A+K +  A     D  R   E  +L  + H  +
Sbjct: 33  LKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFV 92
Query: 97  VKVKDIIPPMDKEKFNDVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           VK+        K     +Y++ + L   DL   +  +   T++  +++L +L  GL ++H
Sbjct: 93  VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           S  +++RDLKP N+LL+    +K+ DFGL++
Sbjct: 148 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 178

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCH-MTHENIVKVKD 101
           +G GAY  V  AV+ +  +E A+K I     +     R+ RE++ L     ++NI+++ +
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGH--SRSRVFREVETLYQCQGNKNILELIE 78
Query: 102 IIPPMDKEKFNDVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                D  +F   Y+V+E L    +   I+ ++   +      +  +   L ++H+  + 
Sbjct: 79  FFE--DDTRF---YLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIA 133
Query: 161 HRDLKPSNLLLNAN---CDLKICDFGLAR-----------TTSE-------TDFMTEYVV 199
           HRDLKP N+L  +      +KICDF L             TT E        ++M   VV
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 200 ---TRWDTLFPGKDYVQQLTMITELL--GSPD-----DSDLGFLRSDNARRYVKQL---P 246
              T   T +  +  +  L ++  ++  G P       +D G+ R +  R    +L    
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 253
Query: 247 HVPKQPFSQK-FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
              K  F  K + ++S  A DL  ++LV D  +R++  + L HP++  
Sbjct: 254 QEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 71/151 (47%), Gaps = 11/151 (7%)
Query: 41  QPIGRGAYGIVCSA-VNSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           Q IG G +G VCS  +    K E  VAIK + + +  +   +  L E  ++    H N++
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVI 71
Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIH 155
            ++ ++      K   V I+ E M+   L   +R      T       L  +  G+KY+ 
Sbjct: 72  HLEGVV-----TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 126
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             N +HR L   N+L+N+N   K+ DFGL+R
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSR 157

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 93/190 (48%), Gaps = 23/190 (12%)
Query: 8   MKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKK 67
           M D  IP     Y Q  + G+   +    +   + IG G++G V  A       +VA+K 
Sbjct: 10  MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRA--EWHGSDVAVKI 67
Query: 68  ITNAFDNRIDAKRI---LREIKLLCHMTHENIVKVKDII--PPMDKEKFNDVYIVYE-LM 121
           +    +    A+R+   LRE+ ++  + H NIV     +  PP       ++ IV E L 
Sbjct: 68  L---MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-------NLSIVTEYLS 117
Query: 122 DTDLHQIIR---SKQALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCD 176
              L++++    +++ L +       Y + +G+ Y+H+ N  ++HRDLK  NLL++    
Sbjct: 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYT 177
Query: 177 LKICDFGLAR 186
           +K+CDFGL+R
Sbjct: 178 VKVCDFGLSR 187

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           + ++ K +  LQ IG+G +G V   +      +VA+K I N       A+  L E  ++ 
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVM--LGDYRGNKVAVKCIKN----DATAQAFLAEASVMT 69
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSK--QALTDDHCQYFLYQ 146
            + H N+V++  +I     E+   +YIV E M    L   +RS+    L  D    F   
Sbjct: 70  QLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S T
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 31  QVSSKYVPPLQPIGRGAYGIV--CS--AVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           Q   +++  LQ +G+G +G V  C    +   T E VA+KK+ ++ +  +  +   REI+
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 64
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY- 145
           +L  + H+NIVK K +     +    ++ ++ E +     +    K     DH +   Y 
Sbjct: 65  ILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 121
Query: 146 -QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
            Q+ +G++Y+ +   +HR+L   N+L+     +KI DFGL + 
Sbjct: 122 SQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKV 164

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 7   LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 65  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 119
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 174

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG+G +G+V        ++ + + AIK ++   + +   +  LRE  L+  + H N++ +
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ-QVEAFLREGLLMRGLNHPNVLAL 87
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSAN 158
             I+ P   E    V + Y +   DL Q IRS Q   T      F  Q+ RG++Y+    
Sbjct: 88  IGIMLP--PEGLPHVLLPY-MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
            +HRDL   N +L+ +  +K+ DFGLAR   + ++ +
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 46/277 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G V  A N ET    A K I    +  ++    + EI++L    H  IVK+   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE--DYIVEIEILATCDHPYIVKLLGA 84
Query: 103 IPPMDKEKFND--VYIVYEL-----MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
                   ++D  ++I+ E      +D  + ++ R    LT+   Q    Q+L  L ++H
Sbjct: 85  Y-------YHDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLH 134
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLA----RTTSETD-------FMTEYVV---TR 201
           S  ++HRDLK  N+L+    D+++ DFG++    +T  + D       +M   VV   T 
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 202 WDTLFPGKDYVQQL--TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP--FSQKF 257
            DT +  K  +  L  T+I      P   +L  +R     +  K  P     P  +S +F
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSDPPTLLTPSKWSVEF 252
Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
            +   +A+D        +P  R +  + L HP++SS+
Sbjct: 253 RDFLKIALDK-------NPETRPSAAQLLEHPFVSSI 282

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 46/277 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G V  A N ET    A K I    +  ++    + EI++L    H  IVK+   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE--DYIVEIEILATCDHPYIVKLLGA 76
Query: 103 IPPMDKEKFND--VYIVYEL-----MDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
                   ++D  ++I+ E      +D  + ++ R    LT+   Q    Q+L  L ++H
Sbjct: 77  Y-------YHDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLH 126
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLA----RTTSETD-------FMTEYVV---TR 201
           S  ++HRDLK  N+L+    D+++ DFG++    +T  + D       +M   VV   T 
Sbjct: 127 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 202 WDTLFPGKDYVQQL--TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP--FSQKF 257
            DT +  K  +  L  T+I      P   +L  +R     +  K  P     P  +S +F
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSDPPTLLTPSKWSVEF 244
Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
            +   +A+D        +P  R +  + L HP++SS+
Sbjct: 245 RDFLKIALDK-------NPETRPSAAQLLEHPFVSSI 274

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 29  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 86
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 87  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 141
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 142 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 196

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           + ++ K +  LQ IG+G +G V   +      +VA+K I N       A+  L E  ++ 
Sbjct: 1   WALNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKN----DATAQAFLAEASVMT 54
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSK--QALTDDHCQYFLYQ 146
            + H N+V++  +I     E+   +YIV E M    L   +RS+    L  D    F   
Sbjct: 55  QLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 110
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S T
Sbjct: 111 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 7   LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 65  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 119
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 174

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 7   LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 65  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 119
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 174

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 41  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 99  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 153
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 208

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 34  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 92  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 146
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 147 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 201

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           + ++ K +  LQ IG+G +G V   +      +VA+K I     N   A+  L E  ++ 
Sbjct: 188 WALNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMT 241
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSK--QALTDDHCQYFLYQ 146
            + H N+V++  +I     E+   +YIV E M    L   +RS+    L  D    F   
Sbjct: 242 QLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 297
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S T
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 49  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 107 LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 161
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 162 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 216

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 35  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 93  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 147
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 148 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 202

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 34  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 92  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 146
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 147 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 201

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 6   LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 64  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 118
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 119 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 173

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 22  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 80  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 134
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 135 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 189

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 54  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 111
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 112 LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 166
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 167 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 221

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 5   LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 62
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 63  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 117
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 118 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 172

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 34  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 92  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 146
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 147 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 201

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K +        D +++++ +K + H  +E  ++ 
Sbjct: 47  IRTLGTGSFGRVMLVKHKETGNHYAMKIL--------DKQKVVK-LKQIEHTLNEKRIQQ 97
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E     ++   +R     ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +K+ DFG A+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK 190

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 35  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 93  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 147
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 148 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 202

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 21  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 79  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 133
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 134 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 188

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 35  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 93  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 147
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 148 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 202

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 22  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 80  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 134
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 135 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 189

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 2   LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 59
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 60  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 114
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 169

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 21  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 79  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 133
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 134 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 188

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 2   LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 59
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 60  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 114
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 115 FFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 169

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 34  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 92  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 146
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 147 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 201

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 35  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 93  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 147
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 148 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 202

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 49  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 107 LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 161
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 162 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 216

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 2   LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 59
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 60  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 114
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 169

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32  VSSKY-VPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIK 86
           + S+Y V PL  +G G +G V S +       VAIK +     + +    +  R+  E+ 
Sbjct: 22  LESQYQVGPL--LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 87  LLCHMTH--ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQY 142
           LL  ++     ++++ D       E+ +   ++ E  +   DL   I  + AL ++  + 
Sbjct: 80  LLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARS 134
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG---LARTTSETDF 193
           F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   L + T  TDF
Sbjct: 135 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 189

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +K+ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK 189

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 15/155 (9%)
Query: 43  IGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G +G V  A  N  TK  VA+K +       +  +  L E  ++  + H+ +VK+  
Sbjct: 23  LGAGQFGEVWMATYNKHTK--VAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHA 77
Query: 102 IIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQY--FLYQLLRGLKYIHSAN 158
           ++    KE    +YI+ E M    L   ++S +       +   F  Q+  G+ +I   N
Sbjct: 78  VV---TKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 131
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
            +HRDL+ +N+L++A+   KI DFGLAR   + ++
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 166

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 53/208 (25%)
Query: 43  IGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENI 96
           +G GA+G V +A       +    +VA+K +    D+  + + ++ E+K++  + +HENI
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQLGSHENI 111
Query: 97  VKVKDIIPPMDKEKFNDVYIVYE-LMDTDLHQIIRSK-QALTDDHCQY------------ 142
           V +              +Y+++E     DL   +RSK +  ++D  +Y            
Sbjct: 112 VNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 143 ----------FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
                     F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR     D
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----D 221
Query: 193 FMTE--YVV-------TRW---DTLFPG 208
            M++  YVV        +W   ++LF G
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEG 249

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G VCS    V  + +  VAIK +   + ++   +  L E  ++    H NI+ +
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHL 95
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V I+ E M+   L   +R      T       L  +  G+KY+   
Sbjct: 96  EGVV-----TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLART 187
           + +HRDL   N+L+N+N   K+ DFG++R 
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRV 180

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 130/278 (46%), Gaps = 18/278 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIK-LLCHMTHENIV 97
           L+ IG+G++G V  A +   +   A+K +   A   + + K I+ E   LL ++ H  +V
Sbjct: 43  LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
            +       DK     +Y V + ++  +L   ++ ++   +   +++  ++   L Y+HS
Sbjct: 103 GLHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS 157
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL- 215
            N+++RDLKP N+LL++   + + DFGL +   E +  T       + L P   + Q   
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 216 -TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVF 274
            T+    LG+     L  L    +R   +   ++  +P   K PN++  A  L E +L  
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK-PNITNSARHLLEGLLQK 276
Query: 275 DPAKRITVE----EALNHPYLSSLHE---INEEPTCPY 305
           D  KR+  +    E  +H + S ++    IN++ T P+
Sbjct: 277 DRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPF 314

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 15/155 (9%)
Query: 43  IGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G +G V  A  N  TK  VA+K +       +  +  L E  ++  + H+ +VK+  
Sbjct: 196 LGAGQFGEVWMATYNKHTK--VAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 102 IIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQY--FLYQLLRGLKYIHSAN 158
           ++    KE    +YI+ E M    L   ++S +       +   F  Q+  G+ +I   N
Sbjct: 251 VV---TKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
            +HRDL+ +N+L++A+   KI DFGLAR   + ++
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 130/287 (45%), Gaps = 50/287 (17%)
Query: 24  NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR 83
           N+ G+  +V  +    L+ +G GAYG V             ++KI+     ++ A ++L+
Sbjct: 43  NLTGHAEKVGIENFELLKVLGTGAYGKV-----------FLVRKISGHDTGKLYAMKVLK 91
Query: 84  EIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQII------------ 129
           +  ++    T E+    + ++  + +  F  V + Y    +T LH I+            
Sbjct: 92  KATIVQKAKTTEHTRTERQVLEHIRQSPFL-VTLHYAFQTETKLHLILDYINGGELFTHL 150
Query: 130 RSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--T 187
             ++  T+   Q ++ +++  L+++H   +++RD+K  N+LL++N  + + DFGL++   
Sbjct: 151 SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210
Query: 188 TSET----------DFMTEYVVTRWDTLF-PGKDYVQQLTMITELLGSPDDSDLGFLRSD 236
             ET          ++M   +V   D+      D+     ++ ELL       +   ++ 
Sbjct: 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 270
Query: 237 NA---RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRI 280
            A   RR +K  P  P++        MS +A DL +R+L+ DP KR+
Sbjct: 271 QAEISRRILKSEPPYPQE--------MSALAKDLIQRLLMKDPKKRL 309

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 127/270 (47%), Gaps = 38/270 (14%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK----RILREIKLLCHMTHENI 96
           +P+G+G +G V  A   ++   VA+K +   F ++I+ +    ++ REI++  H+ H NI
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVL---FKSQIEKEGVEHQLRREIEIQAHLHHPNI 85
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           +++ +     D+ +   +Y++ E     +L++ ++      +      + +L   L Y H
Sbjct: 86  LRLYNYF--YDRRR---IYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDY 211
              V+HRD+KP NLLL    +LKI DFG   +        + +    D L P    G+ +
Sbjct: 141 GKKVIHRDIKPENLLLGLKGELKIADFGW--SVHAPSLRRKTMCGTLDYLPPEMIEGRMH 198
Query: 212 VQQL------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV- 263
            +++       +  ELL G+P         ++  RR VK            KFP   P  
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESAS--HNETYRRIVK---------VDLKFPASVPTG 247
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           A DL  ++L  +P++R+ + +   HP++ +
Sbjct: 248 AQDLISKLLRHNPSERLPLAQVSAHPWVRA 277

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 65/229 (28%)
Query: 33  SSKYVP---PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-RILREIKLL 88
           +S+Y+    P+Q +GRG +G+V  A N       AIK+I     NR  A+ +++RE+K L
Sbjct: 1   ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIR--LPNRELAREKVMREVKAL 58
Query: 89  CHMTHENIVKVKDII----PPMDKEKFNDVYIVYELMDTDLH------------------ 126
             + H  IV+  +      P   +E+ +++++  E  D  L                   
Sbjct: 59  AKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF 118
Query: 127 ----------------------QIIRSKQALTD-----------DH--CQYFLYQLLRGL 151
                                 Q+ R K+ L D           +H  C +   Q+   +
Sbjct: 119 STKNTVGQLQPSSPKVYLYIQMQLCR-KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAV 177
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT 200
           +++HS  ++HRDLKPSN+    +  +K+ DFGL  T  + D   + V+T
Sbjct: 178 EFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV-TAMDQDEEEQTVLT 225

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 83/173 (47%), Gaps = 24/173 (13%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           +++  + +  ++ +G G +G V     N+ TK  VA+K +       +  +  L E  L+
Sbjct: 7   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLK---PGTMSVQAFLEEANLM 61
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQA-------LTDDHC 140
             + H+ +V++  ++      K   +YI+ E M    L   ++S +        L D   
Sbjct: 62  KTLQHDKLVRLYAVVT-----KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLID--- 113
Query: 141 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             F  Q+  G+ YI   N +HRDL+ +N+L++ +   KI DFGLAR   + ++
Sbjct: 114 --FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 164

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G VCS    V  + +  VAIK +   + ++   +  L E  ++    H NI+ +
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHL 74
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V I+ E M+   L   +R      T       L  +  G+KY+   
Sbjct: 75  EGVV-----TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLART 187
           + +HRDL   N+L+N+N   K+ DFG++R 
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRV 159

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G VCS    V  + +  VAIK +   + ++   +  L E  ++    H NI+ +
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHL 80
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V I+ E M+   L   +R      T       L  +  G+KY+   
Sbjct: 81  EGVV-----TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLART 187
           + +HRDL   N+L+N+N   K+ DFG++R 
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRV 165

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G VCS    +  + +  VAIK +   +  +   +  L E  ++    H NI+ +
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIHL 88
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL-------RGLK 152
           + ++      K   V IV E M+            L  +  Q+ + QL+        G+K
Sbjct: 89  EGVV-----TKSKPVMIVTEYMENGSLDTF-----LKKNDGQFTVIQLVGMLRGISAGMK 138
Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 187
           Y+     +HRDL   N+L+N+N   K+ DFGL+R 
Sbjct: 139 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 173

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E     ++   +R     ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NL+++    +K+ DFG A+
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK 190

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 43  IGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G +G V  A  N  TK  VA+K +       +  +  L E  ++  + H+ +VK+  
Sbjct: 190 LGAGQFGEVWMATYNKHTK--VAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHA 244
Query: 102 IIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQY--FLYQLLRGLKYIHSAN 158
           ++    KE    +YI+ E M    L   ++S +       +   F  Q+  G+ +I   N
Sbjct: 245 VV---TKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 298
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            +HRDL+ +N+L++A+   KI DFGLAR  ++
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLARVGAK 330

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E     ++   +R     ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NL+++    +K+ DFG A+
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK 190

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKEIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E     ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NL+++    +K+ DFGLA+
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAK 189

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 31/174 (17%)
Query: 43  IGRGAYGIVCSAVN---SETKEE--VAIKKITNAFDNRIDAKR-ILREIKLLCHMTHENI 96
           +G GA+G V  A     S TK++  VA+K +    D  + A++   RE +LL ++ HE+I
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK---DPTLAARKDFQREAELLTNLQHEHI 79
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRS----------------KQALTDDH 139
           VK   +    D      + +V+E M   DL++ +R+                K  L    
Sbjct: 80  VKFYGVCGDGDP-----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 140 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             +   Q+  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R    TD+
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q ++     Y   Q+   ++Y+  
Sbjct: 76  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
            N +HRDL   N L+  N  +K+ DFGL+R  +   F
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF 164

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E     ++   +R     ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NL+++    +K+ DFG A+
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK 190

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K +        D +++++ +K + H  +E  +  
Sbjct: 39  IKTLGTGSFGRVMLVKHKETGNHYAMKIL--------DKQKVVK-LKQIEHTLNEKRILQ 89
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 149
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 182

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 190

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 8/160 (5%)
Query: 35  KYVPPLQPIGRGAYGIVC----SAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCH 90
           +Y+  ++ +G G +G V        N  T E VA+K +      ++ +    REI++L  
Sbjct: 9   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG-WQREIEILRT 67
Query: 91  MTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
           + HE+IVK K      + +    V +V E +     +    +  +       F  Q+  G
Sbjct: 68  LYHEHIVKYKGCC---EDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEG 124
Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
           + Y+H+ + +HR L   N+LL+ +  +KI DFGLA+   E
Sbjct: 125 MAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 164

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 8/160 (5%)
Query: 35  KYVPPLQPIGRGAYGIVC----SAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCH 90
           +Y+  ++ +G G +G V        N  T E VA+K +      ++ +    REI++L  
Sbjct: 8   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG-WQREIEILRT 66
Query: 91  MTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
           + HE+IVK K      + +    V +V E +     +    +  +       F  Q+  G
Sbjct: 67  LYHEHIVKYKGCC---EDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEG 123
Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
           + Y+H+ + +HR L   N+LL+ +  +KI DFGLA+   E
Sbjct: 124 MAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 163

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 190

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 67  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 117
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 177
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 210

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 190

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q ++     Y   Q+   ++Y+  
Sbjct: 83  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 134
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSR 164

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q ++     Y   Q+   ++Y+  
Sbjct: 78  CTREPPF--------YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSR 159

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 34/274 (12%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI-LREIKLLCHMTHENIVKVKD 101
           +G+G +G VC+     T +  A KK+      +   + + L E ++L  +    +V +  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 102 IIPPMDKEKFNDVYIVYELM---DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                D      + +V  LM   D   H     +    +    ++  ++  GL+ +H   
Sbjct: 252 AYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSE----------TDFMTEYVVTRWDTLFPG 208
           +++RDLKP N+LL+ +  ++I D GLA    E            +M   VV      F  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF-S 365
Query: 209 KDYVQQLTMITELLG--SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
            D+     ++ E++   SP       ++ +   R VK++P    + +S++F   SP A  
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP----EEYSERF---SPQARS 418
Query: 267 LAERMLVFDPAKRI-----TVEEALNHPYLSSLH 295
           L  ++L  DPA+R+     +  E   HP    L+
Sbjct: 419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q ++     Y   Q+   ++Y+  
Sbjct: 78  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSR 159

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q ++     Y   Q+   ++Y+  
Sbjct: 78  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSR 159

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 126/284 (44%), Gaps = 40/284 (14%)
Query: 27  GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           G  +++  K +  L+ +G G +G+V        + +VAIK I    +  +     + E K
Sbjct: 1   GGSWEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAK 56
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT--------DLHQIIRSKQALTDD 138
           ++ +++HE +V++  +       K   ++I+ E M          ++    +++Q L  +
Sbjct: 57  VMMNLSHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--E 109
Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYV 198
            C+     +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   +     EY 
Sbjct: 110 MCK----DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYT 161
Query: 199 VTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP 258
            +R  + FP +    ++ M ++     D    G L        + ++  + K P+ ++F 
Sbjct: 162 SSR-GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL--------MWEIYSLGKMPY-ERFT 211
Query: 259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
           N S  A  +A+ + ++ P   +  E+     Y     + +E PT
Sbjct: 212 N-SETAEHIAQGLRLYRP--HLASEKVYTIMYSCWHEKADERPT 252

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q ++     Y   Q+   ++Y+  
Sbjct: 76  CTREPPF--------YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSR 157

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q ++     Y   Q+   ++Y+  
Sbjct: 78  CTREPPF--------YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSR 159

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E     ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NL+++    +K+ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK 189

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K +        D +++++ +K + H  +E  +  
Sbjct: 32  IKTLGTGSFGRVMLVKHMETGNHYAMKIL--------DKQKVVK-LKQIEHTLNEKRILQ 82
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 83  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 142
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 143 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 175

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 190

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 190

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 117/274 (42%), Gaps = 34/274 (12%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI-LREIKLLCHMTHENIVKVKD 101
           +G+G +G VC+     T +  A KK+      +   + + L E ++L  +    +V +  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 102 IIPPMDKEKFNDVYIVYELM---DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                  E  + + +V  LM   D   H     +    +    ++  ++  GL+ +H   
Sbjct: 251 ----YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSE----------TDFMTEYVVTRWDTLFPG 208
           +++RDLKP N+LL+ +  ++I D GLA    E            +M   VV      F  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF-S 365
Query: 209 KDYVQQLTMITELLG--SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
            D+     ++ E++   SP       ++ +   R VK++P    + +S++F   SP A  
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP----EEYSERF---SPQARS 418
Query: 267 LAERMLVFDPAKRI-----TVEEALNHPYLSSLH 295
           L  ++L  DPA+R+     +  E   HP    L+
Sbjct: 419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 80/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E     ++   +R      + H +++  Q++   +Y
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NL+++    +K+ DFG A+
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK 190

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 11/153 (7%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G VCS    +  +    VAIK +   +  +   +  L E  ++    H N+V +
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEK-QRRDFLCEASIMGQFDHPNVVHL 109
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      +   V IV E M+   L   +R      T       L  +  G++Y+   
Sbjct: 110 EGVV-----TRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
             +HRDL   N+L+N+N   K+ DFGL+R   +
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRVIED 197

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G +G V  A +    +   IK++      + + ++  RE+K L  + H NIV  
Sbjct: 16  IELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAEREVKALAKLDHVNIVHY 69
Query: 100 KDIIPPMD-----------KEKFNDVYIVYELMDTD-LHQIIRSKQALTDDH--CQYFLY 145
                  D           + K   ++I  E  D   L Q I  ++    D         
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 184
           Q+ +G+ YIHS  +++RDLKPSN+ L     +KI DFGL
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGL 168

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 86/165 (52%), Gaps = 13/165 (7%)
Query: 35  KYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLC 89
           +++  ++ +G G +G V  C        T E+VA+K +   +  N I    + +EI++L 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILR 78
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII-RSKQALTDDHCQYFLYQL 147
           ++ HENIVK K I     ++  N + ++ E + +  L + + ++K  +       +  Q+
Sbjct: 79  NLYHENIVKYKGICT---EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +   ETD
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETD 179

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 86/165 (52%), Gaps = 13/165 (7%)
Query: 35  KYVPPLQPIGRGAYGIV--C--SAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLC 89
           +++  ++ +G G +G V  C        T E+VA+K +   +  N I    + +EI++L 
Sbjct: 9   RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILR 66
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII-RSKQALTDDHCQYFLYQL 147
           ++ HENIVK K I     ++  N + ++ E + +  L + + ++K  +       +  Q+
Sbjct: 67  NLYHENIVKYKGICT---EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 123
Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +   ETD
Sbjct: 124 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETD 167

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 15/168 (8%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E  L+
Sbjct: 18  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEANLM 72
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLY 145
             + H+ +V++  ++          +YI+ E M+   L   +++     LT +       
Sbjct: 73  KQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 126
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR   + ++
Sbjct: 127 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 174

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 103 IPPMDKEKFNDVYIVYELMD---------TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +          +YIV E M           ++ + +R  Q L D        Q+  G+ Y
Sbjct: 82  VSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAY 129
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 103 IPPMDKEKFNDVYIVYELMD---------TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +          +YIV E M           ++ + +R  Q L D        Q+  G+ Y
Sbjct: 82  VSE------EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAY 129
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 15  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 103 IPPMDKEKFNDVYIVYELMD---------TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +          +YIV E M           ++ + +R  Q L D        Q+  G+ Y
Sbjct: 71  VSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAY 118
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 119 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 158

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K +        D +++++ +K + H  +E  +  
Sbjct: 39  IKTLGTGSFGRVMLVKHKETGNHYAMKIL--------DKQKVVK-LKQIEHTLNEKRILQ 89
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R      + H +++  Q++   +Y
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 149
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 182

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 15/168 (8%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E  L+
Sbjct: 13  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEANLM 67
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLY 145
             + H+ +V++  ++          +YI+ E M+   L   +++     LT +       
Sbjct: 68  KQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 121
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR   + ++
Sbjct: 122 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 169

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 30/203 (14%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 103 IPPMDKEKFNDVYIVYELMD---------TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +          +YIV E M           ++ + +R  Q L D        Q+  G+ Y
Sbjct: 82  VSE------EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAY 129
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQ 213
           +   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++       R    FP K    
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-----TARQGAKFPIKWTAP 184
Query: 214 QLTMITELLGSPDDSDLGFLRSD 236
           +  +        D    G L ++
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTE 207

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 17  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 103 IPPMDKEKFNDVYIVYELMD---------TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +          +YIV E M           ++ + +R  Q L D        Q+  G+ Y
Sbjct: 73  VSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAY 120
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 121 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 160

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 15/168 (8%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E  L+
Sbjct: 14  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEANLM 68
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLY 145
             + H+ +V++  ++          +YI+ E M+   L   +++     LT +       
Sbjct: 69  KQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 122
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR   + ++
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 170

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 117/282 (41%), Gaps = 51/282 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G++G V  A   +T +  AIK +            +L +  + C M  + ++ +   
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDV--------VLMDDDVECTMVEKRVLSLAWE 76
Query: 103 IPPMD------KEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
            P +       + K N  +++  L   DL   I+S          ++  +++ GL+++HS
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDYV 212
             +++RDLK  N+LL+ +  +KI DFG+ +     D  T       D + P    G+ Y 
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYN 196
Query: 213 QQL------TMITELL-------GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
             +       ++ E+L       G  ++     +R DN        P  P+         
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--------PFYPRW-------- 240
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEAL-NHPYLSSLHEINEE 300
           +   A DL  ++ V +P KR+ V   +  HP      EIN E
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL---FREINWE 279

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 15/168 (8%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E  L+
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEANLM 62
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLY 145
             + H+ +V++  ++          +YI+ E M+   L   +++     LT +       
Sbjct: 63  KQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR   + ++
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 83  CTREPPF--------YIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSR 164

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 91  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 142
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 143 KNFIHRDLAARNCLVGENHLVKVADFGLSR 172

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 79  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSR 160

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKEIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E     ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NL+++    +++ DFGLA+
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAK 189

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 79  CTREPPF--------YIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSR 160

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 83  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSR 164

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 82  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 133
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSR 163

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 103 IPPMDKEKFNDVYIVYELMD---------TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +          +YIV E M           ++ + +R  Q L D        Q+  G+ Y
Sbjct: 82  VSE------EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAY 129
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +++     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 83  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSR 164

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 83  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSR 164

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 33  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 83
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 84  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 143
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 144 LHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK 176

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 80  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSR 161

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 15/168 (8%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E  L+
Sbjct: 3   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEANLM 57
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLY 145
             + H+ +V++  ++          +YI+ E M+   L   +++     LT +       
Sbjct: 58  KQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 111
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR   + ++
Sbjct: 112 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 159

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 103 IPPMDKEKFNDVYIVYELMD---------TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +          +YIV E M           ++ + +R  Q L D        Q+  G+ Y
Sbjct: 82  VSE------EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAY 129
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +++     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +++     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 8/150 (5%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IGRG +G V S         VA+K         + AK  L+E ++L   +H NIV++  +
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 180
Query: 103 IPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSANVL 160
                  +   +YIV EL+   D    +R++ A L        +     G++Y+ S   +
Sbjct: 181 C-----TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSE 190
           HRDL   N L+     LKI DFG++R  ++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEAD 265

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 67  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 117
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 177
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 210

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 103 IPPMDKEKFNDVYIVYELMD---------TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +          +YIV E M           ++ + +R  Q L D        Q+  G+ Y
Sbjct: 82  VSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAY 129
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 47  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 190

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 8/150 (5%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IGRG +G V S         VA+K         + AK  L+E ++L   +H NIV++  +
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 180
Query: 103 IPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSANVL 160
                  +   +YIV EL+   D    +R++ A L        +     G++Y+ S   +
Sbjct: 181 C-----TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSE 190
           HRDL   N L+     LKI DFG++R  ++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEAD 265

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 78  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSR 159

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 78  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSR 159

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 80  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSR 161

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YIV E M   +L   +R  +++ +T     Y   Q+   ++Y+  
Sbjct: 97  CTLEPPF--------YIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEK 148
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 149 KNFIHRDLAARNCLVGENHVVKVADFGLSR 178

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 80  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSR 161

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           + +++  + +  ++ +G G +G V     N+ TK  VA+K +       +  +  L E  
Sbjct: 6   DAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTK--VAVKTLK---PGTMSVQAFLEEAN 60
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQA-------LTDD 138
           L+  + H+ +V++  ++      +   +YI+ E M    L   ++S +        L D 
Sbjct: 61  LMKTLQHDKLVRLYAVVT-----REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID- 114
Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
               F  Q+  G+ YI   N +HRDL+ +N+L++ +   KI DFGLAR   + ++
Sbjct: 115 ----FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 165

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 117/282 (41%), Gaps = 51/282 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G++G V  A   +T +  AIK +            +L +  + C M  + ++ +   
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDV--------VLMDDDVECTMVEKRVLSLAWE 77
Query: 103 IPPMD------KEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
            P +       + K N  +++  L   DL   I+S          ++  +++ GL+++HS
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 137
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDYV 212
             +++RDLK  N+LL+ +  +KI DFG+ +     D  T       D + P    G+ Y 
Sbjct: 138 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYN 197
Query: 213 QQL------TMITELL-------GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
             +       ++ E+L       G  ++     +R DN        P  P+         
Sbjct: 198 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--------PFYPRW-------- 241
Query: 260 MSPVAIDLAERMLVFDPAKRITVEEAL-NHPYLSSLHEINEE 300
           +   A DL  ++ V +P KR+ V   +  HP      EIN E
Sbjct: 242 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL---FREINWE 280

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 26/156 (16%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IGRGA+G            EVA+ K+ N    RI A +IL + ++L         + 
Sbjct: 79  IKVIGRGAFG------------EVAVVKMKNT--ERIYAMKILNKWEMLKRAETACFREE 124
Query: 100 KDIIPPMDKE-------KFNDVYIVYELMD----TDLHQII-RSKQALTDDHCQYFLYQL 147
           +D++   D +        F D   +Y +MD     DL  ++ + +  L +D  ++++ ++
Sbjct: 125 RDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEM 184
Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 183
           +  +  IH  + +HRD+KP N+LL+ N  +++ DFG
Sbjct: 185 VLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG 220

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R      + H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 190

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 26/156 (16%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IGRGA+G            EVA+ K+ N    RI A +IL + ++L         + 
Sbjct: 95  IKVIGRGAFG------------EVAVVKMKNT--ERIYAMKILNKWEMLKRAETACFREE 140
Query: 100 KDIIPPMDKE-------KFNDVYIVYELMD----TDLHQII-RSKQALTDDHCQYFLYQL 147
           +D++   D +        F D   +Y +MD     DL  ++ + +  L +D  ++++ ++
Sbjct: 141 RDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEM 200
Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 183
           +  +  IH  + +HRD+KP N+LL+ N  +++ DFG
Sbjct: 201 VLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG 236

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 80/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E     ++   +R      + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NL+++    +K+ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK 189

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R      + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R      + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E  L+
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEANLM 62
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLY 145
             + H+ +V++  ++          +YI+ E M+   L   +++     LT +       
Sbjct: 63  KQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 20/173 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA--KRILREIKLLCHMTHENIVKVK 100
           IG G +G V  A      +EVA+K   +  D  I    + + +E KL   + H NI+ ++
Sbjct: 15  IGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV- 159
            +       K  ++ +V E         + S + +  D    +  Q+ RG+ Y+H   + 
Sbjct: 73  GVC-----LKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 160 --LHRDLKPSNLLL--------NANCDLKICDFGLARTTSETDFMTEYVVTRW 202
             +HRDLK SN+L+         +N  LKI DFGLAR    T  M+      W
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW 180

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 13/154 (8%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQA--LTDDHCQYFLYQLLRGLKYIHSANV 159
           +          +YIV E M+   L   ++ +    L          Q+  G+ Y+   N 
Sbjct: 79  VSE------EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEY 166

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 13/154 (8%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 19  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQA--LTDDHCQYFLYQLLRGLKYIHSANV 159
           +          +YIV E M    L   ++ +    L          Q+  G+ Y+   N 
Sbjct: 75  VSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 128
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEY 162

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E  L+
Sbjct: 17  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEANLM 71
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLY 145
             + H+ +V++  ++          +YI+ E M+   L   +++     LT +       
Sbjct: 72  KQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 125
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR
Sbjct: 126 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 166

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E  L+
Sbjct: 14  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEANLM 68
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLY 145
             + H+ +V++  ++          +YI+ E M+   L   +++     LT +       
Sbjct: 69  KQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 122
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 163

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E  L+
Sbjct: 16  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEANLM 70
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLY 145
             + H+ +V++  ++          +YI+ E M+   L   +++     LT +       
Sbjct: 71  KQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 124
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR
Sbjct: 125 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 165

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 56/113 (49%), Gaps = 2/113 (1%)
Query: 80  RILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDD 138
           R  RE +    + H  IV V D     +       YIV E +D   L  I+ ++  +T  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDT-GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
                +    + L + H   ++HRD+KP+N+L++A   +K+ DFG+AR  +++
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADS 169

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 75/323 (23%), Positives = 135/323 (41%), Gaps = 82/323 (25%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN--AFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           IG+G++G V  A +   +E VAIK I N  AF N+        E++LL  + +++  ++K
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-----EVRLL-ELMNKHDTEMK 115
Query: 101 DIIPPMDKEKF--NDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHS 156
             I  + +     N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++ +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 157 A--NVLHRDLKPSNLLLN--ANCDLKICDFGLARTTSETDFMT----------------- 195
              +++H DLKP N+LL       +KI DFG +    +  +                   
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPEVLLGMPY 235
Query: 196 EYVVTRW------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
           +  +  W            + LF G + V Q+  I E+LG P    L   ++  AR++ +
Sbjct: 236 DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKFFE 293
Query: 244 QLPHVP-------------KQPFSQKFPNMSPVAI----------------------DLA 268
           +LP                K P ++K  N+  V                        DL 
Sbjct: 294 KLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 353
Query: 269 ERMLVFDPAKRITVEEALNHPYL 291
            RML +DP  RI    AL H + 
Sbjct: 354 LRMLDYDPKTRIQPYYALQHSFF 376

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 107/255 (41%), Gaps = 42/255 (16%)
Query: 72  FDNR-IDAKRIL--------REIKLLCHM-THENIVKVKDIIPPMDKEKFNDVYIVYELM 121
           FDNR +  KRIL        RE++LL     H N+++        D++ F   YI  EL 
Sbjct: 46  FDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRY--FCTEKDRQ-FQ--YIAIELC 100
Query: 122 DTDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDL 177
              L + +  K  A         L Q   GL ++HS N++HRDLKP N+L+   NA+  +
Sbjct: 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKI 160
Query: 178 K--ICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS 235
           K  I DFGL +  +    +  +  +R   + PG +      M++E         +    +
Sbjct: 161 KAMISDFGLCKKLA----VGRHSFSRRSGV-PGTEGWIAPEMLSEDCKENPTYTVDIFSA 215
Query: 236 DNARRYVKQLPHVPKQPFSQKFPNM----------------SPVAIDLAERMLVFDPAKR 279
                YV      P     Q+  N+                  +A +L E+M+  DP KR
Sbjct: 216 GCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKR 275
Query: 280 ITVEEALNHPYLSSL 294
            + +  L HP+  SL
Sbjct: 276 PSAKHVLKHPFFWSL 290

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 13/154 (8%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQA--LTDDHCQYFLYQLLRGLKYIHSANV 159
           +          +YIV E M+   L   ++ +    L          Q+  G+ Y+   N 
Sbjct: 79  VSE------EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEW 166

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E  L+
Sbjct: 10  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEANLM 64
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLY 145
             + H+ +V++  ++          +YI+ E M+   L   +++     LT +       
Sbjct: 65  KQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 118
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR
Sbjct: 119 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 159

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/180 (22%), Positives = 84/180 (46%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++VS + +  L+ +G+G++G+V        +  E +  VA+K +  +   R +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNE 70
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQ-- 141
             ++   T  ++V++  ++      K     +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 142 --------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMTHENIV 97
           ++ IGRGA+G V   V  +  ++V   K+ + F+   R D+     E  ++       +V
Sbjct: 80  VKVIGRGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 138
Query: 98  KVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           +   +      +K+  +Y+V E M   DL  ++ S   + +   +++  +++  L  IHS
Sbjct: 139 Q---LFCAFQDDKY--LYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAIHS 192
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
             ++HRD+KP N+LL+ +  LK+ DFG      ET
Sbjct: 193 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 227

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + ET    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E     ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NL+++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAK 189

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E  L+
Sbjct: 9   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEANLM 63
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLY 145
             + H+ +V++  ++          +YI+ E M+   L   +++     LT +       
Sbjct: 64  KQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 117
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR
Sbjct: 118 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 158

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G +G V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q ++     Y   Q+   ++Y+  
Sbjct: 76  CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSR 157

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R      + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 25/160 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 103 IPPMDKEKFNDVYIVYELMD---------TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +          +YIV E M           ++ + +R  Q L D        Q+  G+ Y
Sbjct: 82  VSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAY 129
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +   N +HRDL  +N+L+  N   K+ DFGLAR   + ++
Sbjct: 130 VERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLL 88
           ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E  L+
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEANLM 62
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYFLY 145
             + H+ +V++  ++          +YI+ E M+   L   +++     LT +       
Sbjct: 63  KQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 25/153 (16%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 103 IPPMDKEKFNDVYIVYELMD---------TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +          +YIV E M           ++ + +R  Q L D        Q+  G+ Y
Sbjct: 82  VSE------EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAY 129
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +   N +HRDL+ +N+L+  N   K+ DFGLAR
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 3/146 (2%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IGRG++  V   +++ET  EVA  ++ +    + + +R   E + L  + H NIV+  D 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN--VL 160
                K K   V +        L   ++  +       + +  Q+L+GL+++H+    ++
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 161 HRDLKPSNLLLNA-NCDLKICDFGLA 185
           HRDLK  N+ +      +KI D GLA
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLA 179

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 41  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 91
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R      + H +++  Q++   +Y
Sbjct: 92  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 151
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 152 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 184

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 76/326 (23%), Positives = 137/326 (42%), Gaps = 88/326 (26%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN--AFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           IG+G++G V  A +   +E VAIK I N  AF N+        E++LL  + +++  ++K
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-----EVRLL-ELMNKHDTEMK 115
Query: 101 DIIPPMDKEKF--NDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHS 156
             I  + +     N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++ +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 157 --ANVLHRDLKPSNLLLNANCD-----LKICDFGLARTTSETDFMT-------------- 195
              +++H DLKP N+LL   C+     +KI DFG +    +  +                
Sbjct: 176 PELSIIHCDLKPENILL---CNPKRXAIKIVDFGSSCQLGQRIYQXIQSRFYRSPEVLLG 232
Query: 196 ---EYVVTRW------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARR 240
              +  +  W            + LF G + V Q+  I E+LG P    L   ++  AR+
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKARK 290
Query: 241 YVKQLPHVP-------------KQPFSQKFPNMSPVAI---------------------- 265
           + ++LP                K P ++K  N+  V                        
Sbjct: 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350
Query: 266 DLAERMLVFDPAKRITVEEALNHPYL 291
           DL  RML +DP  RI    AL H + 
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFF 376

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 67  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 117
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R      + H +++  Q++   +Y
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 177
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 210

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R      + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q ++     Y   Q+   ++Y+  
Sbjct: 285 CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HR+L   N L+  N  +K+ DFGL+R
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSR 366

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R      + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R     ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NL+++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAK 189

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G++G V    + E+    A+K         +D +++++ +K + H  +E  +  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 100 KDIIPPMDKEKFN-----DVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + K +F+     ++Y+V E +   ++   +R      + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HS ++++RDLKP NLL++    +++ DFG A+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 31/163 (19%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD----DHCQYF--------LYQLLRG 150
           +          +YIV E M         SK +L D    +  +Y           Q+  G
Sbjct: 331 VSE------EPIYIVTEYM---------SKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           + Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 75/323 (23%), Positives = 135/323 (41%), Gaps = 82/323 (25%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN--AFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           IG+G++G V  A +   +E VAIK I N  AF N+        E++LL  + +++  ++K
Sbjct: 43  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-----EVRLL-ELMNKHDTEMK 96
Query: 101 DIIPPMDKEKF--NDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHS 156
             I  + +     N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++ +
Sbjct: 97  YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 156
Query: 157 A--NVLHRDLKPSNLLLN--ANCDLKICDFGLARTTSETDFMT----------------- 195
              +++H DLKP N+LL       +KI DFG +    +  +                   
Sbjct: 157 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPEVLLGMPY 216
Query: 196 EYVVTRW------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK 243
           +  +  W            + LF G + V Q+  I E+LG P    L   ++  AR++ +
Sbjct: 217 DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKFFE 274
Query: 244 QLPHVP-------------KQPFSQKFPNMSPVAI----------------------DLA 268
           +LP                K P ++K  N+  V                        DL 
Sbjct: 275 KLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 334
Query: 269 ERMLVFDPAKRITVEEALNHPYL 291
            RML +DP  RI    AL H + 
Sbjct: 335 LRMLDYDPKTRIQPYYALQHSFF 357

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++VS + +  L+ +G+G++G+V        +  E +  VA+K +  +   R +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNE 70
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQ-- 141
             ++   T  ++V++  ++      K     +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 142 --------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 184

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++VS + +  L+ +G+G++G+V        +  E +  VA+K +  +   R +    L E
Sbjct: 9   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNE 67
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQ-- 141
             ++   T  ++V++  ++      K     +V ELM   DL   +RS +   +++    
Sbjct: 68  ASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 122
Query: 142 --------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD
Sbjct: 123 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 181

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++VS + +  L+ +G+G++G+V        +  E +  VA+K +  +   R +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNE 70
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQ-- 141
             ++   T  ++V++  ++      K     +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 142 --------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 184

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 31/163 (19%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD----DHCQYF--------LYQLLRG 150
           +          +YIV E M         SK +L D    +  +Y           Q+  G
Sbjct: 248 VSE------EPIYIVTEYM---------SKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           + Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 31/163 (19%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD----DHCQYF--------LYQLLRG 150
           +          +YIV E M         SK +L D    +  +Y           Q+  G
Sbjct: 248 VSE------EPIYIVTEYM---------SKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           + Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 81/156 (51%), Gaps = 26/156 (16%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IGRGA+G            EVA+ K+ NA  +++ A +IL + ++L         + 
Sbjct: 79  LKVIGRGAFG------------EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREE 124
Query: 100 KDIIPPMDKE-------KFNDVYIVYELMD----TDLHQII-RSKQALTDDHCQYFLYQL 147
           +D++   D +        F D   +Y +MD     DL  ++ + +  L ++  +++L ++
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 183
           +  +  +H  + +HRD+KP N+L++ N  +++ DFG
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG 220

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 12/162 (7%)
Query: 35  KYVPPLQPIGRGAYGIVC----SAVNSETKEEVAIK--KITNAFDNRIDAKRILREIKLL 88
           +Y+  ++ +G G +G V        N  T E VA+K  K      +R   K+   EI +L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDIL 87
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL 148
             + HE+I+K K      +      + +V E +     +    + ++       F  Q+ 
Sbjct: 88  RTLYHEHIIKYKGCC---EDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC 144
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            G+ Y+H+ + +HRDL   N+LL+ +  +KI DFGLA+   E
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 20/177 (11%)
Query: 18  GKYVQY-NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI 76
           GK   Y  I G  +Q     +  L  +G G  G V      +T   +A+K++  +  N+ 
Sbjct: 7   GKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKE 65
Query: 77  DAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN------DVYIVYELMDTDLHQIIR 130
           + KRIL ++ +        ++K  D   P   + F       DV+I  ELM T   ++ +
Sbjct: 66  ENKRILMDLDV--------VLKSHDC--PYIVQCFGTFITNTDVFIAMELMGTCAEKLKK 115
Query: 131 SKQA-LTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLA 185
             Q  + +         +++ L Y+     V+HRD+KPSN+LL+    +K+CDFG++
Sbjct: 116 RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 112 NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNL 169
            ++ I  E MD   L Q+++  + + ++        +LRGL Y+   + ++HRD+KPSN+
Sbjct: 87  GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 146
Query: 170 LLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
           L+N+  ++K+CDFG++    ++     +V TR
Sbjct: 147 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTR 177

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 31/163 (19%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD----DHCQYF--------LYQLLRG 150
           +          +YIV E M         SK +L D    +  +Y           Q+  G
Sbjct: 248 VSE------EPIYIVGEYM---------SKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           + Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 117/288 (40%), Gaps = 47/288 (16%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           +++++  + +  ++ +G G +G V     N  TK  VAIK +       +  +  L E +
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTK--VAIKTLK---PGTMSPESFLEEAQ 56
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYF 143
           ++  + H+ +V++  ++          +YIV E M+   L   ++  +  AL   +    
Sbjct: 57  IMKKLKHDKLVQLYAVVSE------EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDM 110
Query: 144 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWD 203
             Q+  G+ YI   N +HRDL+ +N+L+      KI DFGLAR   + +        R  
Sbjct: 111 AAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNE-----XTARQG 165
Query: 204 TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD------------NARRYVKQLPHVPKQ 251
             FP K    +  +        D    G L ++            N R  ++Q+    + 
Sbjct: 166 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 225
Query: 252 PFSQKFPNMSPVAIDLAERML---VFDPAKRITVEEALNHPYLSSLHE 296
           P  Q  P      I L E M+     DP +R T E      YL S  E
Sbjct: 226 PCPQDCP------ISLHELMIHCWKKDPEERPTFE------YLQSFLE 261

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 80/171 (46%), Gaps = 15/171 (8%)
Query: 27  GNLFQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREI 85
           G  ++V  + +  ++ +G G +G V     N  TK  VA+K +       +     L E 
Sbjct: 1   GPEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEA 55
Query: 86  KLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQY 142
            L+  + H+ +V++  ++          +YI+ E M+   L   +++     LT +    
Sbjct: 56  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 109
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
              Q+  G+ +I   N +HR+L+ +N+L++     KI DFGLAR   + ++
Sbjct: 110 MAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEY 160

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 90/196 (45%), Gaps = 25/196 (12%)
Query: 112 NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNL 169
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 96  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 155
Query: 170 LLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDYVQQ-------LTMI 218
           L+N+  ++K+CDFG++      D M    V     + P    G  Y  Q       L+++
Sbjct: 156 LVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 213
Query: 219 TELLGS-PDDSDLGFLRSDNARRYV--KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFD 275
              +G  P  S  G +       Y+  +  P +P   FS +F        D   + L+ +
Sbjct: 214 EMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQ-------DFVNKCLIKN 266
Query: 276 PAKRITVEEALNHPYL 291
           PA+R  +++ + H ++
Sbjct: 267 PAERADLKQLMVHAFI 282

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 25/160 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 193 LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGNMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 103 IPPMDKEKFNDVYIVYELMD---------TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +          +YIV E M           ++ + +R  Q L D        Q+  G+ Y
Sbjct: 249 VSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAY 296
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           +   N +HRDL+ +N+L+  N   K+ DFGL R   + ++
Sbjct: 297 VERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEY 336

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 27/163 (16%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRIL------REIKLLCHMTH 93
           L+ +G+G YG V             ++K+T A   +I A ++L      R  K   H   
Sbjct: 22  LRVLGKGGYGKV-----------FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 94  E-NIVK------VKDIIPPMDKEKFNDVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLY 145
           E NI++      + D+I     +    +Y++ E L   +L   +  +    +D   ++L 
Sbjct: 71  ERNILEEVKHPFIVDLIYAF--QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 188
           ++   L ++H   +++RDLKP N++LN    +K+ DFGL + +
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 27/163 (16%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRIL------REIKLLCHMTH 93
           L+ +G+G YG V             ++K+T A   +I A ++L      R  K   H   
Sbjct: 22  LRVLGKGGYGKV-----------FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 94  E-NIVK------VKDIIPPMDKEKFNDVYIVYE-LMDTDLHQIIRSKQALTDDHCQYFLY 145
           E NI++      + D+I     +    +Y++ E L   +L   +  +    +D   ++L 
Sbjct: 71  ERNILEEVKHPFIVDLIYAF--QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 188
           ++   L ++H   +++RDLKP N++LN    +K+ DFGL + +
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 56/113 (49%), Gaps = 2/113 (1%)
Query: 80  RILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDD 138
           R  RE +    + H  IV V D     +       YIV E +D   L  I+ ++  +T  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDT-GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
                +    + L + H   ++HRD+KP+N++++A   +K+ DFG+AR  +++
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 56/113 (49%), Gaps = 2/113 (1%)
Query: 80  RILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDD 138
           R  RE +    + H  IV V D     +       YIV E +D   L  I+ ++  +T  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDT-GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
                +    + L + H   ++HRD+KP+N++++A   +K+ DFG+AR  +++
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 56/113 (49%), Gaps = 2/113 (1%)
Query: 80  RILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDD 138
           R  RE +    + H  IV V D     +       YIV E +D   L  I+ ++  +T  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDT-GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
                +    + L + H   ++HRD+KP+N++++A   +K+ DFG+AR  +++
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 31  QVSSKYVPPLQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREI 85
           +VS + +  L+ +G+G++G+V        +  E +  VA+K +  +   R +    L E 
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEA 70
Query: 86  KLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQ--- 141
            ++   T  ++V++  ++      K     +V ELM   DL   +RS +   +++     
Sbjct: 71  SVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 125
Query: 142 -------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                      ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 126 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 184

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++  +
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 103 I---PPMDKEKFNDVYIVYELMD-TDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHS 156
               PP         YI+ E M   +L   +R  ++Q +      Y   Q+   ++Y+  
Sbjct: 324 CTREPPF--------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 375
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            N +HR+L   N L+  N  +K+ DFGL+R
Sbjct: 376 KNFIHRNLAARNCLVGENHLVKVADFGLSR 405

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 65/147 (44%), Gaps = 7/147 (4%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  +G G+YG V    + E     A+K+  + F    D  R L E+      +HE + + 
Sbjct: 62  LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG-----SHEKVGQH 116
Query: 100 KDIIP-PMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
              +      E+   +Y+  EL    L Q   +  A L +     +L   L  L ++HS 
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGL 184
            ++H D+KP+N+ L      K+ DFGL
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGL 203

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 56/113 (49%), Gaps = 2/113 (1%)
Query: 80  RILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDD 138
           R  RE +    + H  IV V D     +       YIV E +D   L  I+ ++  +T  
Sbjct: 75  RFRREAQNAAALNHPAIVAVYDT-GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 133
Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
                +    + L + H   ++HRD+KP+N++++A   +K+ DFG+AR  +++
Sbjct: 134 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 186

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 43  IGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G V   +    +     VAIK   N   + +  K  L+E   +    H +IVK+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 104
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSA 157
             +I        N V+I+ EL    +L   ++  K +L       + YQL   L Y+ S 
Sbjct: 105 IGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 158
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             +HRD+   N+L+++N  +K+ DFGL+R   ++ +
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 194

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 35  KYVPPLQPIGRGAYGIVC----SAVNSETKEEVAIK--KITNAFDNRIDAKRILREIKLL 88
           +Y+  ++ +G G +G V        N  T E VA+K  K      +R   K+   EI +L
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---EIDIL 70
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL 148
             + HE+I+K K       ++      +V E +     +    + ++       F  Q+ 
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC 127
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
            G+ Y+HS + +HR+L   N+LL+ +  +KI DFGLA+   E     EY   R D   P
Sbjct: 128 EGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSP 183

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 43  IGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G V   +    +     VAIK   N   + +  K  L+E   +    H +IVK+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 73
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSA 157
             +I        N V+I+ EL    +L   ++  K +L       + YQL   L Y+ S 
Sbjct: 74  IGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 127
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             +HRD+   N+L+++N  +K+ DFGL+R   ++ +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 43  IGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G V   +    +     VAIK   N   + +  K  L+E   +    H +IVK+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 79
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSA 157
             +I        N V+I+ EL    +L   ++  K +L       + YQL   L Y+ S 
Sbjct: 80  IGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 133
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             +HRD+   N+L+++N  +K+ DFGL+R   ++ +
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 169

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 84/180 (46%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++VS + +  L+ +G+G++G+V        +  E +  VA+K +  +   R +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNE 70
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQ-- 141
             ++   T  ++V++  ++      K     +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 142 --------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HR+L   N ++  +  +KI DFG+ R   ETD+
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 84/180 (46%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++VS + +  L+ +G+G++G+V        +  E +  VA+K +  +   R +    L E
Sbjct: 13  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNE 71
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQ-- 141
             ++   T  ++V++  ++      K     +V ELM   DL   +RS +   +++    
Sbjct: 72  ASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 126
Query: 142 --------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HR+L   N ++  +  +KI DFG+ R   ETD+
Sbjct: 127 PPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 186

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 43  IGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G V   +    +     VAIK   N   + +  K  L+E   +    H +IVK+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 76
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSA 157
             +I        N V+I+ EL    +L   ++  K +L       + YQL   L Y+ S 
Sbjct: 77  IGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 130
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             +HRD+   N+L+++N  +K+ DFGL+R   ++ +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 166

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 43  IGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G V   +    +     VAIK   N   + +  K  L+E   +    H +IVK+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 78
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSA 157
             +I        N V+I+ EL    +L   ++  K +L       + YQL   L Y+ S 
Sbjct: 79  IGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 132
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             +HRD+   N+L+++N  +K+ DFGL+R   ++ +
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 168

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 43  IGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G V   +    +     VAIK   N   + +  K  L+E   +    H +IVK+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 76
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSA 157
             +I        N V+I+ EL    +L   ++  K +L       + YQL   L Y+ S 
Sbjct: 77  IGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 130
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             +HRD+   N+L+++N  +K+ DFGL+R   ++ +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 166

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 17/162 (10%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT----NAFDNRIDAKRILREIKLLCHMT-HEN 95
           + +G GA+G V  A      +E A+ K+      +  +  + + ++ E+K++ H+  HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 96  IVKVKDIIPPMDKEKFNDVYIVY-----------ELMDTDLHQIIRSKQALTDDHCQYFL 144
           IV +               Y  Y            +++TD    I +  A T D   +F 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD-LLHFS 170
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 15/169 (8%)
Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           + ++V  + +  ++ +G G  G V     N  TK  VA+K +       +     L E  
Sbjct: 6   DAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTK--VAVKSLKQG---SMSPDAFLAEAN 60
Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA--LTDDHCQYF 143
           L+  + H+ +V++  ++          +YI+ E M+   L   +++     LT +     
Sbjct: 61  LMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 144 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
             Q+  G+ +I   N +HRDL+ +N+L++     KI DFGLAR   + +
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAE 163

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 43  IGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G V   +    +     VAIK   N   + +  K  L+E   +    H +IVK+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 81
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSA 157
             +I        N V+I+ EL    +L   ++  K +L       + YQL   L Y+ S 
Sbjct: 82  IGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             +HRD+   N+L+++N  +K+ DFGL+R   ++ +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 12/156 (7%)
Query: 43  IGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G V   +    +     VAIK   N   + +  K  L+E   +    H +IVK+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 456
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSA 157
             +I        N V+I+ EL    +L   ++ ++ +L       + YQL   L Y+ S 
Sbjct: 457 IGVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             +HRD+   N+L+++N  +K+ DFGL+R   ++ +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 71/173 (41%), Gaps = 33/173 (19%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G +G V  A +    +   I+++      + + ++  RE+K L  + H NIV  
Sbjct: 17  IELIGSGGFGQVFKAKHRIDGKTYVIRRV------KYNNEKAEREVKALAKLDHVNIVHY 70
Query: 100 KDIIPPMD------------------------KEKFNDVYIVYELMDTD-LHQIIRSKQA 134
                  D                        + K   ++I  E  D   L Q I  ++ 
Sbjct: 71  NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 130
Query: 135 LTDDH--CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
              D         Q+ +G+ YIHS  ++HRDLKPSN+ L     +KI DFGL 
Sbjct: 131 EKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLV 183

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/281 (21%), Positives = 126/281 (44%), Gaps = 40/281 (14%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           +++  K +  L+ +G G +G+V        + +VAIK I    +  +     + E K++ 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMM 59
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT--------DLHQIIRSKQALTDDHCQ 141
           +++HE +V++  +       K   ++I+ E M          ++    +++Q L  + C+
Sbjct: 60  NLSHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK 112
Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
                +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ T  V ++
Sbjct: 113 ----DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSK 167
Query: 202 WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
               FP +    ++ M ++     D    G L        + ++  + K P+ ++F N S
Sbjct: 168 ----FPVRWSPPEVLMYSKFSSKSDIWAFGVL--------MWEIYSLGKMPY-ERFTN-S 213
Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
             A  +A+ + ++ P   +  E+     Y     + +E PT
Sbjct: 214 ETAEHIAQGLRLYRP--HLASEKVYTIMYSCWHEKADERPT 252

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 23/155 (14%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G  G VC     V  +    VAIK +   +  R   +  L E  ++    H NI+++
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-QRRDFLSEASIMGQFDHPNIIRL 115
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLL-------RGL 151
           + ++      +     IV E M+   L   +R+         Q+ + QL+        G+
Sbjct: 116 EGVV-----TRGRLAMIVTEYMENGSLDTFLRTHDG------QFTIMQLVGMLRGVGAGM 164
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +Y+     +HRDL   N+L+++N   K+ DFGL+R
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 85/178 (47%), Gaps = 31/178 (17%)
Query: 41  QPIGRGAYGIVCSA----VNSETKEE---VAIKKITNAFDNRIDAKRILREIKLLCHMT- 92
           +P+G GA+G V  A    ++ +  +E   VA+K + +    + D   ++ E++++  +  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99
Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK----------------QAL 135
           H+NI+ +          +   +Y++ E     +L + +R++                + +
Sbjct: 100 HKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 136 TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           T        YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 23/155 (14%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G  G VC     V  +    VAIK +   +  R   +  L E  ++    H NI+++
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-QRRDFLSEASIMGQFDHPNIIRL 115
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLL-------RGL 151
           + ++      +     IV E M+   L   +R+         Q+ + QL+        G+
Sbjct: 116 EGVV-----TRGRLAMIVTEYMENGSLDTFLRTHDG------QFTIMQLVGMLRGVGAGM 164
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +Y+     +HRDL   N+L+++N   K+ DFGL+R
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 85/178 (47%), Gaps = 31/178 (17%)
Query: 41  QPIGRGAYGIVCSA----VNSETKEE---VAIKKITNAFDNRIDAKRILREIKLLCHMT- 92
           +P+G GA+G V  A    ++ +  +E   VA+K + +    + D   ++ E++++  +  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99
Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK----------------QAL 135
           H+NI+ +          +   +Y++ E     +L + +R++                + +
Sbjct: 100 HKNIITLLGAC-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 136 TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           T        YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 124/281 (44%), Gaps = 40/281 (14%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           +++  K +  L+ +G G +G+V        + +VAIK I    +  +     + E K++ 
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMM 58
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT--------DLHQIIRSKQALTDDHCQ 141
           +++HE +V++  +       K   ++I+ E M          ++    +++Q L  + C+
Sbjct: 59  NLSHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK 111
Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
                +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +      
Sbjct: 112 ----DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---- 163
Query: 202 WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
             + FP +    ++ M ++     D    G L        + ++  + K P+ ++F N S
Sbjct: 164 -GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL--------MWEIYSLGKMPY-ERFTN-S 212
Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
             A  +A+ + ++ P   +  E+     Y     + +E PT
Sbjct: 213 ETAEHIAQGLRLYRP--HLASEKVYTIMYSCWHEKADERPT 251

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 87/178 (48%), Gaps = 13/178 (7%)
Query: 22  QYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI 81
           Q + +G   ++    +   + +  G +  V  A +  +  E A+K++ +  + +  A  I
Sbjct: 15  QSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA--I 72
Query: 82  LREIKLLCHMT-HENIVKVKDIIPPMDKEKFN----DVYIVYELMDTDLHQIIR---SKQ 133
           ++E+  +  ++ H NIV+       + KE+ +    +  ++ EL    L + ++   S+ 
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSA-ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131
Query: 134 ALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
            L+ D      YQ  R ++++H     ++HRDLK  NLLL+    +K+CDFG A T S
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 124/281 (44%), Gaps = 40/281 (14%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           +++  K +  L+ +G G +G+V        + +VAIK I    +  +     + E K++ 
Sbjct: 10  WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMM 65
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT--------DLHQIIRSKQALTDDHCQ 141
           +++HE +V++  +       K   ++I+ E M          ++    +++Q L  + C+
Sbjct: 66  NLSHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK 118
Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
                +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +      
Sbjct: 119 ----DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---- 170
Query: 202 WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
             + FP +    ++ M ++     D    G L        + ++  + K P+ ++F N S
Sbjct: 171 -GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL--------MWEIYSLGKMPY-ERFTN-S 219
Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
             A  +A+ + ++ P   +  E+     Y     + +E PT
Sbjct: 220 ETAEHIAQGLRLYRP--HLASEKVYTIMYSCWHEKADERPT 258

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 85/178 (47%), Gaps = 31/178 (17%)
Query: 41  QPIGRGAYGIVCSA----VNSETKEE---VAIKKITNAFDNRIDAKRILREIKLLCHMT- 92
           +P+G GA+G V  A    ++ +  +E   VA+K + +    + D   ++ E++++  +  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99
Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK----------------QAL 135
           H+NI+ +          +   +Y++ E     +L + +R++                + +
Sbjct: 100 HKNIIHLLGAC-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 136 TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           T        YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 124/281 (44%), Gaps = 40/281 (14%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           +++  K +  L+ +G G +G+V        + +VAIK I    +  +     + E K++ 
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMM 74
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT--------DLHQIIRSKQALTDDHCQ 141
           +++HE +V++  +       K   ++I+ E M          ++    +++Q L  + C+
Sbjct: 75  NLSHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK 127
Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
                +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +      
Sbjct: 128 ----DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---- 179
Query: 202 WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
             + FP +    ++ M ++     D    G L        + ++  + K P+ ++F N S
Sbjct: 180 -GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL--------MWEIYSLGKMPY-ERFTN-S 228
Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
             A  +A+ + ++ P   +  E+     Y     + +E PT
Sbjct: 229 ETAEHIAQGLRLYRP--HLASEKVYTIMYSCWHEKADERPT 267

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 139/336 (41%), Gaps = 81/336 (24%)
Query: 27  GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI---DAKRILR 83
           G+L ++  KY      IG+G+YG+V  A+ ++T+   AIK +      +I   D +RI  
Sbjct: 19  GSLLELQKKYHLK-GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT 77
Query: 84  EIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYEL----------------------M 121
           E++L+  + H NI ++ ++    + E++  + +V EL                      M
Sbjct: 78  EVRLMKKLHHPNIARLYEV---YEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 122 DTDLHQIIR----SKQALTD---------DHCQY------FLYQLLRGLKYIHSANVLHR 162
           D    QI      +++A+           D  Q        + Q+   L Y+H+  + HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 163 DLKPSNLLLNAN--CDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYV---QQLTM 217
           D+KP N L + N   ++K+ DFGL++   + +    Y +T       G  Y    + L  
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK----AGTPYFVAPEVLNT 248
Query: 218 ITELLGSPDDSDLGFLRSDNARRYVKQLPHVP----------KQPFSQKF----PN---M 260
             E  G   D+      S     ++  +  VP           Q  ++K     PN   +
Sbjct: 249 TNESYGPKCDA-----WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL 303
Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
           SP+A DL   +L  +  +R     AL HP++S   +
Sbjct: 304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 43  IGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G V   +    +     VAIK   N   + +  K  L+E   +    H +IVK+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 76
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSA 157
             +I        N V+I+ EL    +L   ++ ++ +L       + YQL   L Y+ S 
Sbjct: 77  IGVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             +HRD+   N+L+++N  +K+ DFGL+R
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMTHENIV 97
           ++ IGRGA+G V   V  ++  +V   K+ + F+   R D+     E  ++       +V
Sbjct: 79  VKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 137
Query: 98  KVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           +   +      +++  +Y+V E M   DL  ++ S   + +   +++  +++  L  IHS
Sbjct: 138 Q---LFYAFQDDRY--LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHS 191
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQ 213
              +HRD+KP N+LL+ +  LK+ DFG          M +  + R DT     DY+ 
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK------MNKEGMVRCDTAVGTPDYIS 242

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 35  KYVPPLQPIGRGAYGIVC----SAVNSETKEEVAIK--KITNAFDNRIDAKRILREIKLL 88
           +Y+  ++ +G G +G V        N  T E VA+K  K      +R   K+   EI +L
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---EIDIL 70
Query: 89  CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL 148
             + HE+I+K K       ++      +V E +     +    + ++       F  Q+ 
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC 127
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
            G+ Y+H+ + +HR+L   N+LL+ +  +KI DFGLA+   E     EY   R D   P
Sbjct: 128 EGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSP 183

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 83/180 (46%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++VS + +  L+ +G+G++G+V        +  E +  VA+K +  +   R +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNE 70
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQ-- 141
             ++   T  ++V++  ++      K     +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 142 --------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ET +
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAY 185

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 43  IGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G V   +    +     VAIK   N   + +  K  L+E   +    H +IVK+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 456
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSA 157
             +I        N V+I+ EL    +L   ++ ++ +L       + YQL   L Y+ S 
Sbjct: 457 IGVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             +HRD+   N+L++A   +K+ DFGL+R   ++ +
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTY 546

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 43  IGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G V   +    +     VAIK   N   + +  K  L+E   +    H +IVK+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 76
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSA 157
             +I        N V+I+ EL    +L   ++ ++ +L       + YQL   L Y+ S 
Sbjct: 77  IGVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
             +HRD+   N+L++A   +K+ DFGL+R   ++ +
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTY 166

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 23/49 (46%), Positives = 32/49 (65%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/271 (21%), Positives = 119/271 (43%), Gaps = 40/271 (14%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G G +G+V        + +VAIK I    +  +     + E K++ +++HE +V++
Sbjct: 9   LKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT--------DLHQIIRSKQALTDDHCQYFLYQLLRGL 151
             +       K   ++I+ E M          ++    +++Q L  + C+     +   +
Sbjct: 65  YGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK----DVCEAM 113
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY 211
           +Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        + FP +  
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-----GSKFPVRWS 168
Query: 212 VQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERM 271
             ++ M ++     D    G L        + ++  + K P+ ++F N S  A  +A+ +
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVL--------MWEIYSLGKMPY-ERFTN-SETAEHIAQGL 218
Query: 272 LVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
            ++ P   +  E+     Y     + +E PT
Sbjct: 219 RLYRP--HLASEKVYTIMYSCWHEKADERPT 247

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 23/49 (46%), Positives = 32/49 (65%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMTHENIV 97
           ++ IGRGA+G V   V  ++  +V   K+ + F+   R D+     E  ++       +V
Sbjct: 79  VKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 137
Query: 98  KVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           +   +      +++  +Y+V E M   DL  ++ S   + +   +++  +++  L  IHS
Sbjct: 138 Q---LFYAFQDDRY--LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHS 191
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQ 213
              +HRD+KP N+LL+ +  LK+ DFG          M +  + R DT     DY+ 
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK------MNKEGMVRCDTAVGTPDYIS 242

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 23/49 (46%), Positives = 32/49 (65%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMTHENIV 97
           ++ IGRGA+G V   V  ++  +V   K+ + F+   R D+     E  ++       +V
Sbjct: 74  VKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 98  KVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           +   +      +++  +Y+V E M   DL  ++ S   + +   +++  +++  L  IHS
Sbjct: 133 Q---LFYAFQDDRY--LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHS 186
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQ 213
              +HRD+KP N+LL+ +  LK+ DFG          M +  + R DT     DY+ 
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK------MNKEGMVRCDTAVGTPDYIS 237

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 23/78 (29%), Positives = 45/78 (57%), Gaps = 1/78 (1%)
Query: 115 YIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA 173
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 174 NCDLKICDFGLARTTSET 191
              +K+ DFG+AR  +++
Sbjct: 152 TNAVKVMDFGIARAIADS 169

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 85/178 (47%), Gaps = 31/178 (17%)
Query: 41  QPIGRGAYGIVCSA----VNSETKEE---VAIKKITNAFDNRIDAKRILREIKLLCHMT- 92
           +P+G GA+G V  A    ++ +  +E   VA+K + +    + D   ++ E++++  +  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99
Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK----------------QAL 135
           H+NI+ +          +   +Y++ E     +L + +R++                + +
Sbjct: 100 HKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 136 TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           T        YQL RG++Y+ S   +HRDL   N+L+  N  ++I DFGLAR  +  D+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDY 212

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 23/49 (46%), Positives = 32/49 (65%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+
Sbjct: 156 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 204

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 23/49 (46%), Positives = 32/49 (65%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+
Sbjct: 153 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 201

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 23/49 (46%), Positives = 32/49 (65%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 31/177 (17%)
Query: 41  QPIGRGAYGIVCSA----VNSETKEE---VAIKKITNAFDNRIDAKRILREIKLLCHMT- 92
           +P+G GA+G V  A    ++ +  +E   VA+K + +    + D   ++ E++++  +  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99
Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK----------------QAL 135
           H+NI+ +          +   +Y++ E     +L + +R++                + +
Sbjct: 100 HKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 136 TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           T        YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 43  IGRGAYGIVCSAVNSETKEE---VAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVK 98
           +G G +G V   V +  K E   VA+K  T   D  +D K + + E  ++ ++ H +IVK
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVK--TCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           +  II         ++Y   EL     H + R+K +L       +  Q+ + + Y+ S N
Sbjct: 90  LIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 145
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
            +HRD+   N+L+ +   +K+ DFGL+R   + D+
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 180

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 31/177 (17%)
Query: 41  QPIGRGAYGIVCSA----VNSETKEE---VAIKKITNAFDNRIDAKRILREIKLLCHMT- 92
           +P+G GA+G V  A    ++ +  +E   VA+K + +    + D   ++ E++++  +  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99
Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK----------------QAL 135
           H+NI+ +          +   +Y++ E     +L + +R++                + +
Sbjct: 100 HKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 136 TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           T        YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 23/49 (46%), Positives = 32/49 (65%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+
Sbjct: 151 YQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDY 199

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 4/74 (5%)
Query: 124 DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 182
           DL   I  + AL ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 183 G---LARTTSETDF 193
           G   L + T  TDF
Sbjct: 203 GSGALLKDTVYTDF 216

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 71/147 (48%), Gaps = 13/147 (8%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++  +
Sbjct: 16  LGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 103 I---PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           +   P     ++     + + +  +  + +R  Q L D        Q+  G+ Y+   N 
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQ-LVD-----MAAQIASGMAYVERMNY 125
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLAR 186
           +HRDL+ +N+L+  N   K+ DFGLAR
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLAR 152

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 43  IGRGAYGIVCSAVNSETKEE---VAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVK 98
           +G G +G V   V +  K E   VA+K  T   D  +D K + + E  ++ ++ H +IVK
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVK--TCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           +  II         ++Y   EL     H + R+K +L       +  Q+ + + Y+ S N
Sbjct: 78  LIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
            +HRD+   N+L+ +   +K+ DFGL+R   + D+
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 43  IGRGAYGIVCSAVNSETKEE---VAIKKITNAFDNRIDAK-RILREIKLLCHMTHENIVK 98
           +G G +G V   V +  K E   VA+K  T   D  +D K + + E  ++ ++ H +IVK
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVK--TCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           +  II         ++Y   EL     H + R+K +L       +  Q+ + + Y+ S N
Sbjct: 74  LIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 129
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
            +HRD+   N+L+ +   +K+ DFGL+R   + D+
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 164

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIK-KITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G +G V   V    K+++ +  K+      + D + ++RE +++  + +  IV++  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 102 IIPPMDKEKFNDVYIVYELMDTD-LHQ-IIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           +       +   + +V E+     LH+ ++  ++ +   +    L+Q+  G+KY+   N 
Sbjct: 78  VC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETD-FMTEYVVTRW 202
           +HRDL   N+LL      KI DFGL++     D + T     +W
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 23/55 (41%), Positives = 37/55 (67%)
Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           K+ +T +    + +Q+ RG++++ S   +HRDL   N+LL+ N  +KICDFGLAR
Sbjct: 193 KEPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLAR 247

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 112 NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNL 169
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 80  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 139
Query: 170 LLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
           L+N+  ++K+CDFG++    + +   E+V TR
Sbjct: 140 LVNSRGEIKLCDFGVSGQLID-EMANEFVGTR 170

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 29/170 (17%)
Query: 41  QPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THE 94
           + +G GA+G V  A     + S+    VA+K +  +  +  + + ++ E+K+L ++  H 
Sbjct: 45  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHM 103
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ------------------ALT 136
           NIV +               Y  Y     DL   +R K+                  AL 
Sbjct: 104 NIVNLLGACTIGGPTLVITEYCCY----GDLLNFLRRKRDSFICSKTSPAIMEDDELALD 159
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +    F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR
Sbjct: 160 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 209

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 29/170 (17%)
Query: 41  QPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THE 94
           + +G GA+G V  A     + S+    VA+K +  +  +  + + ++ E+K+L ++  H 
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHM 110
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ------------------ALT 136
           NIV +               Y  Y     DL   +R K+                  AL 
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCY----GDLLNFLRRKRDSFICSKTSPAIMEDDELALD 166
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +    F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR
Sbjct: 167 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 216

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 29/170 (17%)
Query: 41  QPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THE 94
           + +G GA+G V  A     + S+    VA+K +  +  +  + + ++ E+K+L ++  H 
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHM 110
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ------------------ALT 136
           NIV +               Y  Y     DL   +R K+                  AL 
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCY----GDLLNFLRRKRDSFICSKTSPAIMEDDELALD 166
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +    F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR
Sbjct: 167 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 216

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 29/170 (17%)
Query: 41  QPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THE 94
           + +G GA+G V  A     + S+    VA+K +  +  +  + + ++ E+K+L ++  H 
Sbjct: 47  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHM 105
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ------------------ALT 136
           NIV +               Y  Y     DL   +R K+                  AL 
Sbjct: 106 NIVNLLGACTIGGPTLVITEYCCY----GDLLNFLRRKRDSFICSKTSPAIMEDDELALD 161
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +    F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR
Sbjct: 162 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 211

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 14  QRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +    + +Y    +++T    I      L D        Q  +G+
Sbjct: 71  GYSTAPQLAIVTQWCEG---SSLYHHLHIIETKFEMI-----KLID-----IARQTAQGM 117
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S 
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 29/170 (17%)
Query: 41  QPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THE 94
           + +G GA+G V  A     + S+    VA+K +  +  +  + + ++ E+K+L ++  H 
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHM 87
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ------------------ALT 136
           NIV +               Y  Y     DL   +R K+                  AL 
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCY----GDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            +    F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIK-KITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G +G V   V    K+++ +  K+      + D + ++RE +++  + +  IV++  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 102 IIPPMDKEKFNDVYIVYELMDTD-LHQ-IIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           +       +   + +V E+     LH+ ++  ++ +   +    L+Q+  G+KY+   N 
Sbjct: 404 VC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETD-FMTEYVVTRW 202
           +HR+L   N+LL      KI DFGL++     D + T     +W
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 15/146 (10%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD- 101
           IG+G +G V    +     EVAI+ I    DN    K   RE+       HEN+V     
Sbjct: 41  IGKGRFGQV---YHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 102 -IIPPMDKEKFNDVYIVYEL-MDTDLHQIIRSKQALTD-DHCQYFLYQLLRGLKYIHSAN 158
            + PP        + I+  L     L+ ++R  + + D +  +    ++++G+ Y+H+  
Sbjct: 98  CMSPP-------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGL 184
           +LH+DLK  N+  + N  + I DFGL
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGL 175

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 40  LQPIGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHEN 95
           L+ +G G++G+V        S     VA+K +     ++ +A    +RE+  +  + H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 96  IVKVKDII--PPMDKEKFNDVYIVYEL--MDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           ++++  ++  PPM         +V EL  + + L ++ + +          +  Q+  G+
Sbjct: 83  LIRLYGVVLTPPMK--------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            Y+ S   +HRDL   NLLL     +KI DFGL R   + D
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 84/185 (45%), Gaps = 26/185 (14%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           +++  K +  L+ +G G +G+V        + +VAIK I    +  +     + E K++ 
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMM 74
Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT--------DLHQIIRSKQALTDDHCQ 141
           +++HE +V++  +       K   ++I+ E M          ++    +++Q L  + C+
Sbjct: 75  NLSHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK 127
Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---SETDFMTEYV 198
                +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R      ET  +    
Sbjct: 128 ----DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKF 183
Query: 199 VTRWD 203
             RW 
Sbjct: 184 PVRWS 188

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 40  LQPIGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHEN 95
           L+ +G G++G+V        S     VA+K +     ++ +A    +RE+  +  + H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 96  IVKVKDII--PPMDKEKFNDVYIVYEL--MDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           ++++  ++  PPM         +V EL  + + L ++ + +          +  Q+  G+
Sbjct: 83  LIRLYGVVLTPPMK--------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            Y+ S   +HRDL   NLLL     +KI DFGL R   + D
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 40  LQPIGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHEN 95
           L+ +G G++G+V        S     VA+K +     ++ +A    +RE+  +  + H N
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 96  IVKVKDII--PPMDKEKFNDVYIVYEL--MDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           ++++  ++  PPM         +V EL  + + L ++ + +          +  Q+  G+
Sbjct: 77  LIRLYGVVLTPPMK--------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 128
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            Y+ S   +HRDL   NLLL     +KI DFGL R   + D
Sbjct: 129 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 169

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/258 (22%), Positives = 113/258 (43%), Gaps = 35/258 (13%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  +G+G++G V  A    T+E  AIK +            ++++  + C M  + ++ +
Sbjct: 24  LMVLGKGSFGKVMLADRKGTEELYAIKILKKDV--------VIQDDDVECTMVEKRVLAL 75
Query: 100 KDIIPPMDK-----EKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            D  P + +     +  + +Y V E ++  DL   I+      +    ++  ++  GL +
Sbjct: 76  LDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFF 135
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-------TTSETDFMTEYVVTRWDTLF 206
           +H   +++RDLK  N++L++   +KI DFG+ +       TT E     +Y+        
Sbjct: 136 LHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQ 195
Query: 207 P-GK--DYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           P GK  D+     ++ E+L G P      F   D    +   + H    P S     +S 
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPP-----FDGEDEDELFQSIMEHNVSYPKS-----LSK 245
Query: 263 VAIDLAERMLVFDPAKRI 280
            A+ + + ++   PAKR+
Sbjct: 246 EAVSICKGLMTKHPAKRL 263

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 84/179 (46%), Gaps = 12/179 (6%)
Query: 21  VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRID 77
           VQ+ ++G     SS  V   + IGRG +G V       N   K   A+K + N   +  +
Sbjct: 18  VQHVVIGP----SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGE 72
Query: 78  AKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALT 136
             + L E  ++   +H N++ +  I     + + + + ++  +   DL   IR++    T
Sbjct: 73  VSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 129
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
                 F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ +
Sbjct: 130 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 188

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IGRG +G V       N   K   A+K + N   +  +  + L E  ++   +H N++ +
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSAN 158
             I     + + + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 92  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
            +HRDL   N +L+    +K+ DFGLAR   + ++ +
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IGRG +G V       N   K   A+K + N   +  +  + L E  ++   +H N++ +
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSAN 158
             I     + + + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 115 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 171
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
            +HRDL   N +L+    +K+ DFGLAR   + ++ +
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 208

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IGRG +G V       N   K   A+K + N   +  +  + L E  ++   +H N++ +
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSAN 158
             I     + + + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 89  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 145
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
            +HRDL   N +L+    +K+ DFGLAR   + ++ +
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 182

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IGRG +G V       N   K   A+K + N   +  +  + L E  ++   +H N++ +
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSAN 158
             I     + + + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 96  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
            +HRDL   N +L+    +K+ DFGLAR   + ++ +
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 189

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IGRG +G V       N   K   A+K + N   +  +  + L E  ++   +H N++ +
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSAN 158
             I     + + + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 116 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 172
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
            +HRDL   N +L+    +K+ DFGLAR   + ++ +
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 209

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 12/177 (6%)
Query: 21  VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRID 77
           VQ+ ++G     SS  V   + IGRG +G V       N   K   A+K + N   +  +
Sbjct: 20  VQHVVIGP----SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGE 74
Query: 78  AKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALT 136
             + L E  ++   +H N++ +  I     + + + + ++  +   DL   IR++    T
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 131
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                 F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F
Sbjct: 132 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 188

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IGRG +G V       N   K   A+K + N   +  +  + L E  ++   +H N++ +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSAN 158
             I     + + + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
            +HRDL   N +L+    +K+ DFGLAR   + ++ +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 190

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 44/284 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVK 98
           L+ IG G +G V   V        AIK+        +D +  LRE+     +  H ++V+
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                   D     + Y     +   + +  R      +   +  L Q+ RGL+YIHS +
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135
Query: 159 VLHRDLKPSNLLL------NANCD-------------LKICDFG-LARTTS------ETD 192
           ++H D+KPSN+ +      NA  +              KI D G + R +S      ++ 
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSR 195
Query: 193 FMTEYVVTRWDTLFPGKD-YVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ--LPHVP 249
           F+   V+    T  P  D +   LT++      P        R+ +    ++Q  LP +P
Sbjct: 196 FLANEVLQENYTHLPKADIFALALTVVCAAGAEP------LPRNGDQWHEIRQGRLPRIP 249
Query: 250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
            Q  SQ+F  +  V       M+  DP +R +    + H  L S
Sbjct: 250 -QVLSQEFTELLKV-------MIHPDPERRPSAMALVKHSVLLS 285

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IGRG +G V       N   K   A+K + N   +  +  + L E  ++   +H N++ +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSAN 158
             I     + + + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
            +HRDL   N +L+    +K+ DFGLAR   + ++ +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 190

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 43  IGRGAYGIVCSA-VNSETKEEVAIKKITNAFDNRID--AKRILREIKLLCHMTHENIVKV 99
           +G G +G+V    VN+ T   VA+KK+    D   +   ++  +EIK++    HEN+V++
Sbjct: 39  MGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT----DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
                  D     D+ +VY  M      D    +     L+             G+ ++H
Sbjct: 96  LGFSSDGD-----DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 188
             + +HRD+K +N+LL+     KI DFGLAR +
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 19  QRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +    + +Y    +++T    I      L D        Q  +G+
Sbjct: 76  GYSTKPQLAIVTQWCEG---SSLYHHLHIIETKFEMI-----KLID-----IARQTAQGM 122
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S 
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 161

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 19  QRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +    + +Y    +++T    I      L D        Q  +G+
Sbjct: 76  GYSTKPQLAIVTQWCEG---SSLYHHLHIIETKFEMI-----KLID-----IARQTAQGM 122
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S 
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 161

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 43  IGRGAYGIVCSA-VNSETKEEVAIKKITNAFDNRID--AKRILREIKLLCHMTHENIVKV 99
           +G G +G+V    VN+ T   VA+KK+    D   +   ++  +EIK++    HEN+V++
Sbjct: 39  MGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT----DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
                  D     D+ +VY  M      D    +     L+             G+ ++H
Sbjct: 96  LGFSSDGD-----DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 188
             + +HRD+K +N+LL+     KI DFGLAR +
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 78/169 (46%), Gaps = 16/169 (9%)
Query: 32  VSSKYVPPLQPIGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDA-KRILREIKL 87
           +  K +  L+ +G G++G+V        S     VA+K +     ++ +A    +RE+  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 88  LCHMTHENIVKVKDII--PPMDKEKFNDVYIVYEL--MDTDLHQIIRSKQALTDDHCQYF 143
           +  + H N++++  ++  PPM         +V EL  + + L ++ + +          +
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMK--------MVTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
Query: 144 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
             Q+  G+ Y+ S   +HRDL   NLLL     +KI DFGL R   + D
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IGRG +G V       N   K   A+K + N   +  +  + L E  ++   +H N++ +
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSAN 158
             I     + + + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 94  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 150
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
            +HRDL   N +L+    +K+ DFGLAR   + ++ +
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 187

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 40  LQPIGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHEN 95
           L+ +G G++G+V        S     VA+K +     ++ +A    +RE+  +  + H N
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 96  IVKVKDII--PPMDKEKFNDVYIVYEL--MDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           ++++  ++  PPM         +V EL  + + L ++ + +          +  Q+  G+
Sbjct: 73  LIRLYGVVLTPPMK--------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            Y+ S   +HRDL   NLLL     +KI DFGL R   + D
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 14  QRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +    + +Y    +++T    I      L D        Q  +G+
Sbjct: 71  GYSTKPQLAIVTQWCEG---SSLYHHLHIIETKFEMI-----KLID-----IARQTAQGM 117
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S 
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 40  LQPIGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHEN 95
           L+ +G G++G+V        S     VA+K +     ++ +A    +RE+  +  + H N
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 96  IVKVKDII--PPMDKEKFNDVYIVYEL--MDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           ++++  ++  PPM         +V EL  + + L ++ + +          +  Q+  G+
Sbjct: 77  LIRLYGVVLTPPMK--------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 128
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            Y+ S   +HRDL   NLLL     +KI DFGL R   + D
Sbjct: 129 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 169

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 40  LQPIGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHEN 95
           L+ +G G++G+V        S     VA+K +     ++ +A    +RE+  +  + H N
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 96  IVKVKDII--PPMDKEKFNDVYIVYEL--MDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           ++++  ++  PPM         +V EL  + + L ++ + +          +  Q+  G+
Sbjct: 73  LIRLYGVVLTPPMK--------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            Y+ S   +HRDL   NLLL     +KI DFGL R   + D
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IGRG +G V       N   K   A+K + N   +  +  + L E  ++   +H N++ +
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSAN 158
             I     + + + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 156 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
            +HRDL   N +L+    +K+ DFGLAR   + +F
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 16  QRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +    + +Y    +++T    I      L D        Q  +G+
Sbjct: 73  GYSTKPQLAIVTQWCEG---SSLYHHLHIIETKFEMI-----KLID-----IARQTAQGM 119
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S 
Sbjct: 120 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 158

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 12/177 (6%)
Query: 21  VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRID 77
           VQ+ ++G     SS  V   + IGRG +G V       N   K   A+K + N   +  +
Sbjct: 25  VQHVVIGP----SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGE 79
Query: 78  AKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALT 136
             + L E  ++   +H N++ +  I     + + + + ++  +   DL   IR++    T
Sbjct: 80  VSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 136
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                 F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F
Sbjct: 137 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 193

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +Q IG G +G+V        K++VAIK I    +  +  +  + E +++  ++H  +V++
Sbjct: 12  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQAL-TDDHCQYFLYQLLRGLKYIHSA 157
             +           + +V+E M+   L   +R+++ L   +        +  G+ Y+  A
Sbjct: 68  YGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +V+HRDL   N L+  N  +K+ DFG+ R
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTR 151

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 41  QRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +    + +Y    +++T    I      L D        Q  +G+
Sbjct: 98  GYSTKPQLAIVTQWCEG---SSLYHHLHIIETKFEMI-----KLID-----IARQTAQGM 144
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S 
Sbjct: 145 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 183

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 21  VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRID 77
           VQ+ ++G     SS  V   + IGRG +G V       N   K   A+K + N   +  +
Sbjct: 19  VQHVVIGP----SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGE 73
Query: 78  AKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALT 136
             + L E  ++   +H N++ +  I     + + + + ++  +   DL   IR++    T
Sbjct: 74  VSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 130
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
                 F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR
Sbjct: 131 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 75/150 (50%), Gaps = 11/150 (7%)
Query: 43  IGRGAYGIV--CS--AVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           +G+G +G V  C    +   T   VA+K++ ++  ++   +   REI++L  +  + IVK
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIVK 76
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY--QLLRGLKYIHS 156
            + +     ++      +V E + +   +    +     D  +  LY  Q+ +G++Y+ S
Sbjct: 77  YRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 133
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
              +HRDL   N+L+ +   +KI DFGLA+
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAK 163

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 44/284 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVK 98
           L+ IG G +G V   V        AIK+        +D +  LRE+     +  H ++V+
Sbjct: 14  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 73
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                   D     + Y     +   + +  R      +   +  L Q+ RGL+YIHS +
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 133
Query: 159 VLHRDLKPSNLLL------NANCD-------------LKICDFG-LARTTS------ETD 192
           ++H D+KPSN+ +      NA  +              KI D G + R +S      ++ 
Sbjct: 134 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSR 193
Query: 193 FMTEYVVTRWDTLFPGKD-YVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ--LPHVP 249
           F+   V+    T  P  D +   LT++      P        R+ +    ++Q  LP +P
Sbjct: 194 FLANEVLQENYTHLPKADIFALALTVVCAAGAEP------LPRNGDQWHEIRQGRLPRIP 247
Query: 250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
            Q  SQ+F  +  V       M+  DP +R +    + H  L S
Sbjct: 248 -QVLSQEFTELLKV-------MIHPDPERRPSAMALVKHSVLLS 283

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 43  IGRGAYGIVCSA-VNSETKEEVAIKKITNAFDNRID--AKRILREIKLLCHMTHENIVKV 99
           +G G +G+V    VN+ T   VA+KK+    D   +   ++  +EIK++    HEN+V++
Sbjct: 33  MGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 100 KDIIPPMDKEKFNDVYIVYELMDT----DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
                  D     D+ +VY  M      D    +     L+             G+ ++H
Sbjct: 90  LGFSSDGD-----DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 144
Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 188
             + +HRD+K +N+LL+     KI DFGLAR +
Sbjct: 145 ENHHIHRDIKSANILLDEAFTAKISDFGLARAS 177

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 44/284 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVK 98
           L+ IG G +G V   V        AIK+        +D +  LRE+     +  H ++V+
Sbjct: 14  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 73
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                   D     + Y     +   + +  R      +   +  L Q+ RGL+YIHS +
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 133
Query: 159 VLHRDLKPSNLLL------NANCD-------------LKICDFG-LARTTS------ETD 192
           ++H D+KPSN+ +      NA  +              KI D G + R +S      ++ 
Sbjct: 134 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSR 193
Query: 193 FMTEYVVTRWDTLFPGKD-YVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ--LPHVP 249
           F+   V+    T  P  D +   LT++      P        R+ +    ++Q  LP +P
Sbjct: 194 FLANEVLQENYTHLPKADIFALALTVVCAAGAEP------LPRNGDQWHEIRQGRLPRIP 247
Query: 250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
            Q  SQ+F  +  V       M+  DP +R +    + H  L S
Sbjct: 248 -QVLSQEFTELLKV-------MIHPDPERRPSAMALVKHSVLLS 283

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 42  QRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +    + +Y    +++T    I      L D        Q  +G+
Sbjct: 99  GYSTKPQLAIVTQWCEG---SSLYHHLHIIETKFEMI-----KLID-----IARQTAQGM 145
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S 
Sbjct: 146 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 184

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 44/284 (15%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVK 98
           L+ IG G +G V   V        AIK+        +D +  LRE+     +  H ++V+
Sbjct: 12  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 71
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                   D     + Y     +   + +  R      +   +  L Q+ RGL+YIHS +
Sbjct: 72  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 131
Query: 159 VLHRDLKPSNLLL------NANCD-------------LKICDFG-LARTTS------ETD 192
           ++H D+KPSN+ +      NA  +              KI D G + R +S      ++ 
Sbjct: 132 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSR 191
Query: 193 FMTEYVVTRWDTLFPGKD-YVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ--LPHVP 249
           F+   V+    T  P  D +   LT++      P        R+ +    ++Q  LP +P
Sbjct: 192 FLANEVLQENYTHLPKADIFALALTVVXAAGAEP------LPRNGDQWHEIRQGRLPRIP 245
Query: 250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
            Q  SQ+F  +  V       M+  DP +R +    + H  L S
Sbjct: 246 -QVLSQEFTELLKV-------MIHPDPERRPSAMALVKHSVLLS 281

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 12/177 (6%)
Query: 21  VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRID 77
           VQ+ ++G     SS  V   + IGRG +G V       N   K   A+K + N   +  +
Sbjct: 21  VQHVVIGP----SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGE 75
Query: 78  AKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALT 136
             + L E  ++   +H N++ +  I     + + + + ++  +   DL   IR++    T
Sbjct: 76  VSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 132
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                 F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F
Sbjct: 133 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 189

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT----NAFDNRIDAKRILREIKLLCHMT-HEN 95
           + +G GA+G V  A      +E A+ K+      +  +  + + ++ E+K++ H+  HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 96  IVKVKDIIPPMDKEKFNDVYIVY-----------ELMDTDLHQIIRSKQALTDDHCQYFL 144
           IV +               Y  Y            +++TD    I +    T D   +F 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD-LLHFS 170
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 12/177 (6%)
Query: 21  VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRID 77
           VQ+ ++G     SS  V   + IGRG +G V       N   K   A+K + N   +  +
Sbjct: 20  VQHVVIGP----SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGE 74
Query: 78  AKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALT 136
             + L E  ++   +H N++ +  I     + + + + ++  +   DL   IR++    T
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 131
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                 F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F
Sbjct: 132 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 188

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR----ILREIKLLCHMTHEN--- 95
           IGRG +G V     ++T +  A+K +      RI  K+     L E  +L  ++  +   
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           IV +       DK  F     + +LM+  DLH  +      ++   +++  +++ GL+++
Sbjct: 254 IVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           H+  V++RDLKP+N+LL+ +  ++I D GLA
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 75/150 (50%), Gaps = 11/150 (7%)
Query: 43  IGRGAYGIV--CS--AVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           +G+G +G V  C    +   T   VA+K++ ++  ++   +   REI++L  +  + IVK
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIVK 75
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY--QLLRGLKYIHS 156
            + +     ++      +V E + +   +    +     D  +  LY  Q+ +G++Y+ S
Sbjct: 76  YRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
              +HRDL   N+L+ +   +KI DFGLA+
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAK 162

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 112 NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNL 169
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 139 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 198
Query: 170 LLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
           L+N+  ++K+CDFG++    ++     +V TR
Sbjct: 199 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTR 229

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR----ILREIKLLCHMTHEN--- 95
           IGRG +G V     ++T +  A+K +      RI  K+     L E  +L  ++  +   
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 252
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           IV +       DK  F     + +LM+  DLH  +      ++   +++  +++ GL+++
Sbjct: 253 IVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 307
Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           H+  V++RDLKP+N+LL+ +  ++I D GLA
Sbjct: 308 HNRFVVYRDLKPANILLDEHGHVRISDLGLA 338

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 75/150 (50%), Gaps = 11/150 (7%)
Query: 43  IGRGAYGIV--CS--AVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           +G+G +G V  C    +   T   VA+K++ ++  ++   +   REI++L  +  + IVK
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIVK 88
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY--QLLRGLKYIHS 156
            + +     ++      +V E + +   +    +     D  +  LY  Q+ +G++Y+ S
Sbjct: 89  YRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
              +HRDL   N+L+ +   +KI DFGLA+
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAK 175

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR----ILREIKLLCHMTHEN--- 95
           IGRG +G V     ++T +  A+K +      RI  K+     L E  +L  ++  +   
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           IV +       DK  F     + +LM+  DLH  +      ++   +++  +++ GL+++
Sbjct: 254 IVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           H+  V++RDLKP+N+LL+ +  ++I D GLA
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR----ILREIKLLCHMTHEN--- 95
           IGRG +G V     ++T +  A+K +      RI  K+     L E  +L  ++  +   
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           IV +       DK  F     + +LM+  DLH  +      ++   +++  +++ GL+++
Sbjct: 254 IVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           H+  V++RDLKP+N+LL+ +  ++I D GLA
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 12/177 (6%)
Query: 21  VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRID 77
           VQ+ ++G     SS  V   + IGRG +G V       N   K   A+K + N   +  +
Sbjct: 18  VQHVVIGP----SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGE 72
Query: 78  AKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALT 136
             + L E  ++   +H N++ +  I     + + + + ++  +   DL   IR++    T
Sbjct: 73  VSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 129
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                 F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F
Sbjct: 130 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 186

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 12/177 (6%)
Query: 21  VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRID 77
           VQ+ ++G     SS  V   + IGRG +G V       N   K   A+K + N   +  +
Sbjct: 21  VQHVVIGP----SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGE 75
Query: 78  AKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALT 136
             + L E  ++   +H N++ +  I     + + + + ++  +   DL   IR++    T
Sbjct: 76  VSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 132
Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                 F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F
Sbjct: 133 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEF 189

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 42  QRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +    + +Y    +++T    I      L D        Q  +G+
Sbjct: 99  GYSTKPQLAIVTQWCEG---SSLYHHLHIIETKFEMI-----KLID-----IARQTAQGM 145
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S 
Sbjct: 146 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSR 184

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 14  QRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +    + +Y    +++T    I      L D        Q  +G+
Sbjct: 71  GYSTKPQLAIVTQWCEG---SSLYHHLHIIETKFEMI-----KLID-----IARQTAQGM 117
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S 
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSR 156

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 112 NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNL 169
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163
Query: 170 LLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
           L+N+  ++K+CDFG++    ++     +V TR
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTR 194

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 25/165 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKIT----NAFDNRIDAKRILREIKLLCHMT-HENIV 97
           +G GA+G V  A      +E A+ K+      +  +  + + ++ E+K++ H+  HENIV
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK----------------QALTDDHCQ 141
            +               Y  Y     DL   +R K                + L+     
Sbjct: 114 NLLGACTHGGPVLVITEYCCY----GDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR
Sbjct: 170 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 214

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 34  QRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +    + +Y    +++T    I      L D        Q  +G+
Sbjct: 91  GYSTKPQLAIVTQWCEG---SSLYHHLHIIETKFEMI-----KLID-----IARQTAQGM 137
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S 
Sbjct: 138 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSR 176

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 25/158 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 30  QRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +                  H +  S+             Q  RG+
Sbjct: 87  GYSTAPQLAIVTQWCEGSSL-------------YHHLHASETKFEMKKLIDIARQTARGM 133
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 25/158 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 18  QRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +                  H +  S+             Q  RG+
Sbjct: 75  GYSTKPQLAIVTQWCEGSSL-------------YHHLHASETKFEMKKLIDIARQTARGM 121
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S
Sbjct: 122 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKS 159

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT----NAFDNRIDAKRILREIKLLCHMT-HEN 95
           + +G GA+G V  A      +E A+ K+      +  +  + + ++ E+K++ H+  HEN
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDH----------CQYFLY 145
           IV +               Y  Y     DL   +R K     D             +F  
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCY----GDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR
Sbjct: 160 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 200

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 112 NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNL 169
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 170 LLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
           L+N+  ++K+CDFG++    ++     +V TR
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTR 167

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 112 NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNL 169
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 170 LLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
           L+N+  ++K+CDFG++    ++     +V TR
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTR 167

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/55 (41%), Positives = 36/55 (65%)
Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           K  LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 194 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 248

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 112 NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNL 169
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 170 LLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
           L+N+  ++K+CDFG++    ++     +V TR
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTR 167

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/55 (41%), Positives = 36/55 (65%)
Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           K  LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 185 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 239

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 83/180 (46%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V   V       E +  VAIK +  A   R +    L E
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 78
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRS-KQALTDD---- 138
             ++      ++V++  ++      +     ++ ELM   DL   +RS + A+ ++    
Sbjct: 79  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 139 -----HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/55 (41%), Positives = 36/55 (65%)
Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           K  LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/55 (41%), Positives = 36/55 (65%)
Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           K  LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR
Sbjct: 192 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 246

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT----NAFDNRIDAKRILREIKLLCHMT-HEN 95
           + +G GA+G V  A      +E A+ K+      +  +  + + ++ E+K++ H+  HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDH----------CQYFLY 145
           IV +               Y  Y     DL   +R K     D             +F  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCY----GDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR
Sbjct: 168 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 208

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 112 NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNL 169
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 170 LLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
           L+N+  ++K+CDFG++    ++     +V TR
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTR 167

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 112 NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNL 169
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 170 LLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
           L+N+  ++K+CDFG++    ++     +V TR
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTR 167

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +Q IG G +G+V        K++VAIK I    +  +  +  + E +++  ++H  +V++
Sbjct: 15  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQL 70
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQAL-TDDHCQYFLYQLLRGLKYIHSA 157
             +           + +V+E M+   L   +R+++ L   +        +  G+ Y+  A
Sbjct: 71  YGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 125
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            V+HRDL   N L+  N  +K+ DFG+ R
Sbjct: 126 CVIHRDLAARNCLVGENQVIKVSDFGMTR 154

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +Q IG G +G+V        K++VAIK I    +  +  +  + E +++  ++H  +V++
Sbjct: 10  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQAL-TDDHCQYFLYQLLRGLKYIHSA 157
             +           + +V+E M+   L   +R+++ L   +        +  G+ Y+  A
Sbjct: 66  YGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            V+HRDL   N L+  N  +K+ DFG+ R
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTR 149

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +Q IG G +G+V        K++VAIK I    +  +  +  + E +++  ++H  +V++
Sbjct: 12  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQAL-TDDHCQYFLYQLLRGLKYIHSA 157
             +           + +V+E M+   L   +R+++ L   +        +  G+ Y+  A
Sbjct: 68  YGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            V+HRDL   N L+  N  +K+ DFG+ R
Sbjct: 123 CVIHRDLAARNCLVGENQVIKVSDFGMTR 151

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 75/150 (50%), Gaps = 11/150 (7%)
Query: 43  IGRGAYGIV--CS--AVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           +G+G +G V  C    +   T   VA+K++ ++  ++   +   REI++L  +  + IVK
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIVK 72
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY--QLLRGLKYIHS 156
            + +     + +     +V E + +   +    +     D  +  LY  Q+ +G++Y+ S
Sbjct: 73  YRGVSYGPGRPELR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
              +HRDL   N+L+ +   +KI DFGLA+
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAK 159

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/148 (22%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G+G +G V       T    A+K +       + +    + E ++L +  H  +  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           +K      D+  F    ++      +L   +  ++  T++  +++  +++  L+Y+HS +
Sbjct: 70  LKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
           V++RD+K  NL+L+ +  +KI DFGL +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/148 (22%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G+G +G V       T    A+K +       + +    + E ++L +  H  +  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           +K      D+  F    ++      +L   +  ++  T++  +++  +++  L+Y+HS +
Sbjct: 70  LKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
           V++RD+K  NL+L+ +  +KI DFGL +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/148 (22%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G+G +G V       T    A+K +       + +    + E ++L +  H  +  
Sbjct: 15  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 74
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           +K      D+  F    ++      +L   +  ++  T++  +++  +++  L+Y+HS +
Sbjct: 75  LKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 130
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
           V++RD+K  NL+L+ +  +KI DFGL +
Sbjct: 131 VVYRDIKLENLMLDKDGHIKITDFGLCK 158

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/148 (22%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G+G +G V       T    A+K +       + +    + E ++L +  H  +  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           +K      D+  F    ++      +L   +  ++  T++  +++  +++  L+Y+HS +
Sbjct: 70  LKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
           V++RD+K  NL+L+ +  +KI DFGL +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/148 (22%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G+G +G V       T    A+K +       + +    + E ++L +  H  +  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           +K      D+  F    ++      +L   +  ++  T++  +++  +++  L+Y+HS +
Sbjct: 70  LKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
           V++RD+K  NL+L+ +  +KI DFGL +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/148 (22%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G+G +G V       T    A+K +       + +    + E ++L +  H  +  
Sbjct: 13  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 72
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           +K      D+  F    ++      +L   +  ++  T++  +++  +++  L+Y+HS +
Sbjct: 73  LKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 128
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
           V++RD+K  NL+L+ +  +KI DFGL +
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCK 156

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 83/180 (46%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V   V       E +  VAIK +  A   R +    L E
Sbjct: 10  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 68
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRS-KQALTDD---- 138
             ++      ++V++  ++      +     ++ ELM   DL   +RS + A+ ++    
Sbjct: 69  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 139 -----HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 183

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 25/158 (15%)
Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLCHM 91
           Q IG G++G V      +   +VA+K +           AF N +   R  R + +L  M
Sbjct: 30  QRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +    ++  +    +                  H +  S+             Q  RG+
Sbjct: 87  GYSTKPQLAIVTQWCEGSSL-------------YHHLHASETKFEMKKLIDIARQTARGM 133
Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
            Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA   S
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/148 (22%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G+G +G V       T    A+K +       + +    + E ++L +  H  +  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           +K      D+  F    ++      +L   +  ++  T++  +++  +++  L+Y+HS +
Sbjct: 70  LKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR 186
           V++RD+K  NL+L+ +  +KI DFGL +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 71/163 (43%), Gaps = 39/163 (23%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKIT---------NAFDNRIDAKRILREIKLLC---H 90
           IG G++G V      +   +VA+K +           AF N +   R  R + +L    +
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 91  MTHENIVKVKDIIPPMDKEKFNDV----YIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           MT +N+  V          K   V    + +++L+D     I R               Q
Sbjct: 101 MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLID-----IAR---------------Q 140
Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
             +G+ Y+H+ N++HRD+K +N+ L+    +KI DFGLA   S
Sbjct: 141 TAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V   V       E +  VAIK +  A   R +    L E
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 78
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDH---- 139
             ++      ++V++  ++      +     ++ ELM   DL   +RS +   +++    
Sbjct: 79  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 140 ------CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +Q IG G +G+V        K++VAIK I    +  +     + E +++  ++H  +V++
Sbjct: 32  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIK---EGSMSEDDFIEEAEVMMKLSHPKLVQL 87
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQAL-TDDHCQYFLYQLLRGLKYIHSA 157
             +           + +V+E M+   L   +R+++ L   +        +  G+ Y+  A
Sbjct: 88  YGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 142
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            V+HRDL   N L+  N  +K+ DFG+ R
Sbjct: 143 CVIHRDLAARNCLVGENQVIKVSDFGMTR 171

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V   V       E +  VAIK +  A   R +    L E
Sbjct: 13  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 71
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDH---- 139
             ++      ++V++  ++      +     ++ ELM   DL   +RS +   +++    
Sbjct: 72  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 140 ------CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V   V       E +  VAIK +  A   R +    L E
Sbjct: 7   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 65
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDH---- 139
             ++      ++V++  ++      +     ++ ELM   DL   +RS +   +++    
Sbjct: 66  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 140 ------CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 180

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V   V       E +  VAIK +  A   R +    L E
Sbjct: 14  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 72
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDH---- 139
             ++      ++V++  ++      +     ++ ELM   DL   +RS +   +++    
Sbjct: 73  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 140 ------CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 187

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V   V       E +  VAIK +  A   R +    L E
Sbjct: 11  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 69
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDH---- 139
             ++      ++V++  ++      +     ++ ELM   DL   +RS +   +++    
Sbjct: 70  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 140 ------CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 184

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V   V       E +  VAIK +  A   R +    L E
Sbjct: 13  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 71
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDH---- 139
             ++      ++V++  ++      +     ++ ELM   DL   +RS +   +++    
Sbjct: 72  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 140 ------CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 114/294 (38%), Gaps = 47/294 (15%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITN----AFDNRIDAKRILREIKLLCHMT----HE 94
           +G+G +G V +      + +VAIK I       +    D+     E+ LL  +     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYE--LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
            ++++ D       E      +V E  L   DL   I  K  L +   + F  Q++  ++
Sbjct: 99  GVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 153 YIHSANVLHRDLKPSNLL--LNANCDLKICDFG---LARTTSETDF--MTEYVVTRWDT- 204
           + HS  V+HRD+K  N+L  L   C  K+ DFG   L      TDF     Y    W + 
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGC-AKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISR 212
Query: 205 ----LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM 260
                 P   +   + +   + G     D+ F R    +  ++   H P         ++
Sbjct: 213 HQYHALPATVWSLGILLYDMVCG-----DIPFERD---QEILEAELHFPA--------HV 256
Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE---INEEPTCPYPFNFDF 311
           SP    L  R L   P+ R ++EE L  P++ +  E   +N     P P  +  
Sbjct: 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSL 310

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 76/153 (49%), Gaps = 14/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G+G++G V  A   ET +  A+K +            IL++  + C MT + I+ +
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV--------ILQDDDVECTMTEKRILSL 79
Query: 100 KDIIPPMDK-----EKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + +     +  + ++ V E ++  DL   I+  +   +   +++  +++  L +
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +H   +++RDLK  N+LL+     K+ DFG+ +
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 77/162 (47%), Gaps = 6/162 (3%)
Query: 27  GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREI 85
           G + +V+      L+ +G+G +G V       T    A+K +       + +    L E 
Sbjct: 1   GAMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 60
Query: 86  KLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLY 145
           ++L +  H  +  +K      D+  F    ++      +L   +  ++  ++D  +++  
Sbjct: 61  RVLQNSRHPFLTALKYSFQTHDRLCF----VMEYANGGELFFHLSRERVFSEDRARFYGA 116
Query: 146 QLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +
Sbjct: 117 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 158

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V   V       E +  VAIK +  A   R +    L E
Sbjct: 42  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 100
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDH---- 139
             ++      ++V++  ++      +     ++ ELM   DL   +RS +   +++    
Sbjct: 101 ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 140 ------CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 215

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/179 (21%), Positives = 81/179 (45%), Gaps = 22/179 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V   V       E +  VAIK +  A   R +    L E
Sbjct: 14  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 72
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDH---- 139
             ++      ++V++  ++      +     ++ ELM   DL   +RS +   +++    
Sbjct: 73  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 140 ------CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETD 186

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/179 (21%), Positives = 81/179 (45%), Gaps = 22/179 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V   V       E +  VAIK +  A   R +    L E
Sbjct: 5   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 63
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDH---- 139
             ++      ++V++  ++      +     ++ ELM   DL   +RS +   +++    
Sbjct: 64  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 140 ------CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
                       ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETD 177

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/153 (21%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  +G+G++G V  +    T E  A+K +            ++++  + C M  + ++ +
Sbjct: 25  LMVLGKGSFGKVMLSERKGTDELYAVKILKKDV--------VIQDDDVECTMVEKRVLAL 76
Query: 100 KDIIPPMDK-----EKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + +     +  + +Y V E ++  DL   I+      + H  ++  ++  GL +
Sbjct: 77  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           + S  +++RDLK  N++L++   +KI DFG+ +
Sbjct: 137 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 31/49 (63%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+
Sbjct: 157 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 31/49 (63%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+
Sbjct: 150 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 198

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 31/49 (63%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+
Sbjct: 157 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 31/49 (63%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+
Sbjct: 149 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 197

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 31/49 (63%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+
Sbjct: 146 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 194

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/178 (21%), Positives = 85/178 (47%), Gaps = 31/178 (17%)
Query: 41  QPIGRGAYG--IVCSAVNSETKE-----EVAIKKITNAFDNRIDAKRILREIKLLCHMT- 92
           +P+G GA+G  ++  A+  +  +     +VA+K + +    + D   ++ E++++  +  
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 92
Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQ---------- 141
           H+NI+ +          +   +Y++ E     +L + +++++    ++C           
Sbjct: 93  HKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 142 ------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                    YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 79/338 (23%), Positives = 136/338 (40%), Gaps = 79/338 (23%)
Query: 26  LGNLFQVSSKYVPPLQPIGRGAYGIVCSAVN-SETKEEVAIKKITNAFDNRIDAKRILRE 84
           +G+  Q   + V  L   G G +G V   V+       VA+K I N  +   +A R+  E
Sbjct: 27  VGDWLQERYEIVSTL---GEGTFGRVVQCVDHRRGGARVALKIIKNV-EKYKEAARL--E 80
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFND-VYIVYELMDTDLHQIIRSKQALTD--DHCQ 141
           I +L  +  ++       +   D   ++  + I +EL+       ++    L       +
Sbjct: 81  INVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVR 140
Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLL-LNANCDL------------------KICDF 182
           +  +QL + +K++H   + H DLKP N+L +N++ +L                  ++ DF
Sbjct: 141 HMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDF 200
Query: 183 GLARTTSETDFMTEYVVTR-------------------WD------------TLFPGKDY 211
           G A  T + +  +  V TR                   W             TLF   D 
Sbjct: 201 GSA--TFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDN 258
Query: 212 VQQLTMITELLGSPDDSDL------------GFLRSD---NARRYVKQLPHVPKQPFSQK 256
            + L M+  +LG P  S +            G L  D   +A RYV++     ++  + +
Sbjct: 259 REHLAMMERILG-PIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSE 317
Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
                 +  DL E ML ++PAKR+T+ EAL HP+ + L
Sbjct: 318 AEEHHQL-FDLIESMLEYEPAKRLTLGEALQHPFFARL 354

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 31/49 (63%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+
Sbjct: 198 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 31/49 (63%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+
Sbjct: 142 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 37/61 (60%)
Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           ++ALT      F +Q+ +G++Y+   +++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 192 D 192
           D
Sbjct: 204 D 204

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 19/154 (12%)
Query: 44  GRGAYGIVCSA-VNSETKEEVAIKKITNAFDNRID--AKRILREIKLLCHMTHENIVKVK 100
           G G +G+V    VN+ T   VA+KK+    D   +   ++  +EIK+     HEN+V++ 
Sbjct: 31  GEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELL 87
Query: 101 DIIPPMDKEKFNDVYIVY------ELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
                 D     D+ +VY       L+D  L  +  +        C+        G+ ++
Sbjct: 88  GFSSDGD-----DLCLVYVYXPNGSLLDR-LSCLDGTPPLSWHXRCK-IAQGAANGINFL 140
Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 188
           H  + +HRD+K +N+LL+     KI DFGLAR +
Sbjct: 141 HENHHIHRDIKSANILLDEAFTAKISDFGLARAS 174

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G+G +G V       T    A+K +       + +    L E ++L +  H  +  
Sbjct: 15  LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 74
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-A 157
           +K      D+  F    ++      +L   +  ++  ++D  +++  +++  L Y+HS  
Sbjct: 75  LKYSFQTHDRLCF----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 130
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           NV++RDLK  NL+L+ +  +KI DFGL +
Sbjct: 131 NVVYRDLKLENLMLDKDGHIKITDFGLCK 159

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 81/180 (45%), Gaps = 22/180 (12%)
Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILRE 84
           ++V+ + +   + +G+G++G+V   V       E +  VAIK +  A   R +    L E
Sbjct: 7   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 65
Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDH---- 139
             ++      ++V++  ++      +     ++ ELM   DL   +RS +   +++    
Sbjct: 66  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 140 ------CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                       ++  G+ Y+++   +HRDL   N  +  +  +KI DFG+ R   ETD+
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDY 180

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 24  NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKIT--NAFDNRIDAKRI 81
           N+      V  +    L+ IG G    V   +N E K+  AIK +    A +  +D+ R 
Sbjct: 17  NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR- 74
Query: 82  LREIKLLCHMTHENIVKVKDIIPPMDKEKFND-VYIVYELMDTDLHQIIRSKQALTDDHC 140
             EI  L  +   +      II   D E  +  +Y+V E  + DL+  ++ K+++     
Sbjct: 75  -NEIAYLNKLQQHS----DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWER 129
Query: 141 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           + +   +L  +  IH   ++H DLKP+N L+  +  LK+ DFG+A
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 173

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +Q IG G +G+V        K++VAIK I    +  +  +  + E +++  ++H  +V++
Sbjct: 13  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQAL-TDDHCQYFLYQLLRGLKYIHSA 157
             +           + +V E M+   L   +R+++ L   +        +  G+ Y+  A
Sbjct: 69  YGVCLEQ-----APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
            V+HRDL   N L+  N  +K+ DFG+ R
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTR 152

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G+G +G V       T    A+K +       + +    L E ++L +  H  +  
Sbjct: 13  LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 72
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-A 157
           +K      D+  F    ++      +L   +  ++  ++D  +++  +++  L Y+HS  
Sbjct: 73  LKYSFQTHDRLCF----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 128
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           NV++RDLK  NL+L+ +  +KI DFGL +
Sbjct: 129 NVVYRDLKLENLMLDKDGHIKITDFGLCK 157

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/153 (21%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  +G+G++G V  +    T E  A+K +            ++++  + C M  + ++ +
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDV--------VIQDDDVECTMVEKRVLAL 397
Query: 100 KDIIPPMDK-----EKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
               P + +     +  + +Y V E ++  DL   I+      + H  ++  ++  GL +
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           + S  +++RDLK  N++L++   +KI DFG+ +
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT--NAFDNRIDAKRILREIKLLCHMTHENIV 97
           L+ IG G    V   +N E K+  AIK +    A +  +D+ R   EI  L  +   +  
Sbjct: 33  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR--NEIAYLNKLQQHS-- 87
Query: 98  KVKDIIPPMDKEKFND-VYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
               II   D E  +  +Y+V E  + DL+  ++ K+++     + +   +L  +  IH 
Sbjct: 88  --DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLA 185
             ++H DLKP+N L+  +  LK+ DFG+A
Sbjct: 146 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 173

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G+G +G V       T    A+K +       + +    L E ++L +  H  +  
Sbjct: 156 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-A 157
           +K      D+  F    ++      +L   +  ++  ++D  +++  +++  L Y+HS  
Sbjct: 216 LKYSFQTHDRLCF----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 271
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           NV++RDLK  NL+L+ +  +KI DFGL +
Sbjct: 272 NVVYRDLKLENLMLDKDGHIKITDFGLCK 300

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 36/61 (59%)
Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           ++ALT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 192 D 192
           D
Sbjct: 204 D 204

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 36/61 (59%)
Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           ++ALT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 192 D 192
           D
Sbjct: 204 D 204

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITN-AFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G+G +G V       T    A+K +       + +    L E ++L +  H  +  
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-A 157
           +K      D+  F    ++      +L   +  ++  ++D  +++  +++  L Y+HS  
Sbjct: 213 LKYSFQTHDRLCF----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           NV++RDLK  NL+L+ +  +KI DFGL +
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCK 297

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVKVKD 101
           +GRG +G V +     T +  A KK+      +    +  + E K+L  +    IV +  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 102 IIPPMDKEKFNDVYIVYELMDTD-----LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
                  E   D+ +V  +M+       ++ +        +    ++  Q++ GL+++H 
Sbjct: 253 AF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLA 185
            N+++RDLKP N+LL+ + +++I D GLA
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 22/162 (13%)
Query: 43  IGRGAYGIVCSA--VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE-NIVKV 99
           IG G +G V  A       + + AIK++   + ++ D +    E+++LC + H  NI+  
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII-- 89
Query: 100 KDIIPPMDKEKFNDVYIVY-------------ELMDTDLHQIIRSKQA--LTDDHCQYFL 144
            +++   +   +  + I Y              +++TD    I +  A  L+     +F 
Sbjct: 90  -NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVKVKD 101
           +GRG +G V +     T +  A KK+      +    +  + E K+L  +    IV +  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 102 IIPPMDKEKFNDVYIVYELMDTD-----LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
                  E   D+ +V  +M+       ++ +        +    ++  Q++ GL+++H 
Sbjct: 253 AF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLA 185
            N+++RDLKP N+LL+ + +++I D GLA
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVKVKD 101
           +GRG +G V +     T +  A KK+      +    +  + E K+L  +    IV +  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 102 IIPPMDKEKFNDVYIVYELMDTD-----LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
                  E   D+ +V  +M+       ++ +        +    ++  Q++ GL+++H 
Sbjct: 253 AF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLA 185
            N+++RDLKP N+LL+ + +++I D GLA
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT--NAFDNRIDAKRILREIKLLCHMTHENIV 97
           L+ IG G    V   +N E K+  AIK +    A +  +D+ R   EI  L  +   +  
Sbjct: 14  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR--NEIAYLNKLQQHS-- 68
Query: 98  KVKDIIPPMDKEKFND-VYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
               II   D E  +  +Y+V E  + DL+  ++ K+++     + +   +L  +  IH 
Sbjct: 69  --DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLA 185
             ++H DLKP+N L+  +  LK+ DFG+A
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 154

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 22/162 (13%)
Query: 43  IGRGAYGIVCSA--VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE-NIVKV 99
           IG G +G V  A       + + AIK++   + ++ D +    E+++LC + H  NI+  
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII-- 79
Query: 100 KDIIPPMDKEKFNDVYIVY-------------ELMDTDLHQIIRSKQA--LTDDHCQYFL 144
            +++   +   +  + I Y              +++TD    I +  A  L+     +F 
Sbjct: 80  -NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R
Sbjct: 139 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT--NAFDNRIDAKRILREIKLLCHMTHENIV 97
           L+ IG G    V   +N E K+  AIK +    A +  +D+ R   EI  L  +   +  
Sbjct: 61  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR--NEIAYLNKLQQHS-- 115
Query: 98  KVKDIIPPMDKEKFND-VYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
               II   D E  +  +Y+V E  + DL+  ++ K+++     + +   +L  +  IH 
Sbjct: 116 --DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLA 185
             ++H DLKP+N L+  +  LK+ DFG+A
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 201

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT--NAFDNRIDAKRILREIKLLCHMTHENIV 97
           L+ IG G    V   +N E K+  AIK +    A +  +D+ R   EI  L  +   +  
Sbjct: 61  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR--NEIAYLNKLQQHS-- 115
Query: 98  KVKDIIPPMDKEKFND-VYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
               II   D E  +  +Y+V E  + DL+  ++ K+++     + +   +L  +  IH 
Sbjct: 116 --DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLA 185
             ++H DLKP+N L+  +  LK+ DFG+A
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 201

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT--NAFDNRIDAKRILREIKLLCHMTHENIV 97
           L+ IG G    V   +N E K+  AIK +    A +  +D+ R   EI  L  +   +  
Sbjct: 17  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR--NEIAYLNKLQQHS-- 71
Query: 98  KVKDIIPPMDKEKFND-VYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
               II   D E  +  +Y+V E  + DL+  ++ K+++     + +   +L  +  IH 
Sbjct: 72  --DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLA 185
             ++H DLKP+N L+  +  LK+ DFG+A
Sbjct: 130 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 157

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT--NAFDNRIDAKRILREIKLLCHMTHENIV 97
           L+ IG G    V   +N E K+  AIK +    A +  +D+ R   EI  L  +   +  
Sbjct: 61  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR--NEIAYLNKLQQHS-- 115
Query: 98  KVKDIIPPMDKEKFND-VYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
               II   D E  +  +Y+V E  + DL+  ++ K+++     + +   +L  +  IH 
Sbjct: 116 --DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLA 185
             ++H DLKP+N L+  +  LK+ DFG+A
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 201

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 11/158 (6%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G G +G+V      + + +VA+K I    +  +      +E + +  ++H  +VK 
Sbjct: 13  LKELGSGQFGVV-KLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSA 157
             +       K   +YIV E +    L   +RS  + L         Y +  G+ ++ S 
Sbjct: 69  YGVC-----SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
             +HRDL   N L++ +  +K+ DFG+ R   +  +++
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT--NAFDNRIDAKRILREIKLLCHMTHENIV 97
           L+ IG G    V   +N E K+  AIK +    A +  +D+ R   EI  L  +   +  
Sbjct: 13  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR--NEIAYLNKLQQHS-- 67
Query: 98  KVKDIIPPMDKEKFND-VYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
               II   D E  +  +Y+V E  + DL+  ++ K+++     + +   +L  +  IH 
Sbjct: 68  --DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLA 185
             ++H DLKP+N L+  +  LK+ DFG+A
Sbjct: 126 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 153

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 18/44 (40%), Positives = 34/44 (77%)
Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           ++  Q++ GL+++H  N+++RDLKP N+LL+ + +++I D GLA
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 117/295 (39%), Gaps = 68/295 (23%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKD 101
           +G G+ G V     S     VA+K++   F         L EIKLL     H N+++   
Sbjct: 23  LGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRY-- 74
Query: 102 IIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQY--------FLYQLLRGLKY 153
                  ++F  +YI  EL + +L  ++ SK  ++D++ +          L Q+  G+ +
Sbjct: 75  -YCSETTDRF--LYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 154 IHSANVLHRDLKPSNLLLNA-------------NCDLKICDFGLART--TSETDFMTEYV 198
           +HS  ++HRDLKP N+L++              N  + I DFGL +   + ++ F T   
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 199 VTRWDTLFPGKDYVQQ---LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ 255
                + +   + +++   L     L  S D   +G +           +    K PF  
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV--------FYYILSKGKHPFGD 242
Query: 256 KFPNMSPV---------------------AIDLAERMLVFDPAKRITVEEALNHP 289
           K+   S +                     A DL  +M+  DP KR T  + L HP
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 21/48 (43%), Positives = 30/48 (62%)
Query: 145 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 157 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 111/269 (41%), Gaps = 57/269 (21%)
Query: 61  EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYEL 120
           ++++IK   + F N +   +I+ +IK    +T E I+             +++VYI+YE 
Sbjct: 79  DKISIKSKYDDFKNEL---QIITDIKNEYCLTCEGII-----------TNYDEVYIIYEY 124
Query: 121 MDTDLHQIIRSKQALTDDHCQYFL---------YQLLRGLKYIHS-ANVLHRDLKPSNLL 170
           M+ D          + D +   F+           +L    YIH+  N+ HRD+KPSN+L
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184
Query: 171 LNANCDLKICDFG---------LARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTM---- 217
           ++ N  +K+ DFG         +  +    +FM     +   +    K  +  L +    
Sbjct: 185 MDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244
Query: 218 -------------ITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF-SQKFPNMSPV 263
                        + EL  +    ++ +    N   Y    P   K+   S  F  +S  
Sbjct: 245 MFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLY----PLTNKKSTCSNNF--LSNE 298
Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLS 292
            ID  +  L  +PA+RIT E+AL H +L+
Sbjct: 299 DIDFLKLFLRKNPAERITSEDALKHEWLA 327

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 74/175 (42%), Gaps = 39/175 (22%)
Query: 26  LGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIK-----------KITNAFDN 74
           +GN +++  K       IG G++G +    N  + EEVAIK            I + F  
Sbjct: 7   VGNKYRLGRK-------IGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYK 59
Query: 75  RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA 134
            +     +  IK  C    +  V V +++ P  ++ FN     + L    L         
Sbjct: 60  MMQGGVGIPSIKW-CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL--------- 109
Query: 135 LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLAR 186
           L D        Q++  ++YIHS N +HRD+KP N L+        + I DFGLA+
Sbjct: 110 LAD--------QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 25/173 (14%)
Query: 26  LGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREI 85
           +GN F++  K       IG G++G +    N +T EEVAIK + N    +    ++L E 
Sbjct: 5   VGNKFRLGRK-------IGSGSFGEIYLGTNIQTNEEVAIK-LENV---KTKHPQLLYES 53
Query: 86  KLLCHMTHENIVKVKDIIPPMDKEKFNDVY--IVYELMDTDLHQIIR-SKQALTDDHCQY 142
           K+        I++    IP +        Y  +V +L+   L  +     + L+      
Sbjct: 54  KIY------RILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDFGLARTTSET 191
              Q++  ++++HS + LHRD+KP N L+     AN  + I DFGLA+   +T
Sbjct: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDT 159

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 24  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 82
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 83  VCRLLGIC------LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 137 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 169

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 31/44 (70%)
Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           RGL Y+H+  ++HRD+K  N+LL+ N   KI DFG+++  +E D
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 21  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 79
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 80  VCRLLGIC------LTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 134 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 166

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 81
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 82  VCRLLGIC------LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 168

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 45  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 103
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 104 VCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 158 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 190

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 70/161 (43%), Gaps = 10/161 (6%)
Query: 43  IGRGAYGIVCSA---VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G V          T  +VA+K +     ++ + +  L E   +   +H N++++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQ-IIRSKQALTDDHCQY-----FLYQLLRGLK 152
             +   M  +      ++   M   DLH  ++ S+      H        F+  +  G++
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
           Y+ + N LHRDL   N +L  +  + + DFGL++     D+
Sbjct: 162 YLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 80
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 81  VCRLLGIC------LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 167

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 21  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 79
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 80  VCRLLGIC------LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 134 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 166

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 23/161 (14%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI------LREIKLLCHMTHENI 96
           IG+G +G+V      + K  VAIK +    D+  + + I       RE+ ++ ++ H NI
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILG-DSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 97  VKVKDII--PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           VK+  ++  PP    +F     +Y  +    H I  S +          +  +  G++Y+
Sbjct: 86  VKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL-------RLMLDIALGIEYM 138
Query: 155 HSAN--VLHRDLKPSNLLL-----NANCDLKICDFGLARTT 188
            + N  ++HRDL+  N+ L     NA    K+ DFGL++ +
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 81
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 82  VCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 168

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 78
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 79  VCRLLGIC------LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 78
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 79  VCRLLGIC------LTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 76/321 (23%), Positives = 129/321 (40%), Gaps = 69/321 (21%)
Query: 17  GGKYVQYNILGNL--FQVSSK-YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD 73
           GGK  + + + N+  F+ S K  V   + +G G+ G V     S     VA+K++   F 
Sbjct: 12  GGKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF- 69
Query: 74  NRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK 132
                   L EIKLL     H N+++          ++F  +YI  EL + +L  ++ SK
Sbjct: 70  ----CDIALMEIKLLTESDDHPNVIRY---YCSETTDRF--LYIALELCNLNLQDLVESK 120
Query: 133 QALTDDHCQY--------FLYQLLRGLKYIHSANVLHRDLKPSNLLLNA----------- 173
             ++D++ +          L Q+  G+ ++HS  ++HRDLKP N+L++            
Sbjct: 121 N-VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 179
Query: 174 --NCDLKICDFGLART--TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSD 229
             N  + I DFGL +   + +  F          + +   + +++ T    L  S D   
Sbjct: 180 AENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTK-RRLTRSIDIFS 238
Query: 230 LGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV---------------------AIDLA 268
           +G +           +    K PF  K+   S +                     A DL 
Sbjct: 239 MGCV--------FYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLI 290
Query: 269 ERMLVFDPAKRITVEEALNHP 289
            +M+  DP KR T  + L HP
Sbjct: 291 SQMIDHDPLKRPTAMKVLRHP 311

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 30/173 (17%)
Query: 43  IGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTHENI 96
           +G GA+G V  A     +  + K  VA+K +  A ++ R D +R   E +LL  + H++I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTMLQHQHI 105
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQA---------------LTDDHC 140
           V+   +       +   + +V+E M   DL++ +RS                  L     
Sbjct: 106 VRFFGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 141 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                Q+  G+ Y+   + +HRDL   N L+     +KI DFG++R    TD+
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 76/321 (23%), Positives = 129/321 (40%), Gaps = 69/321 (21%)
Query: 17  GGKYVQYNILGNL--FQVSSK-YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD 73
           GGK  + + + N+  F+ S K  V   + +G G+ G V     S     VA+K++   F 
Sbjct: 12  GGKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF- 69
Query: 74  NRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK 132
                   L EIKLL     H N+++          ++F  +YI  EL + +L  ++ SK
Sbjct: 70  ----CDIALMEIKLLTESDDHPNVIRY---YCSETTDRF--LYIALELCNLNLQDLVESK 120
Query: 133 QALTDDHCQY--------FLYQLLRGLKYIHSANVLHRDLKPSNLLLNA----------- 173
             ++D++ +          L Q+  G+ ++HS  ++HRDLKP N+L++            
Sbjct: 121 N-VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 179
Query: 174 --NCDLKICDFGLART--TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSD 229
             N  + I DFGL +   + +  F          + +   + +++ T    L  S D   
Sbjct: 180 AENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTK-RRLTRSIDIFS 238
Query: 230 LGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV---------------------AIDLA 268
           +G +           +    K PF  K+   S +                     A DL 
Sbjct: 239 MGCV--------FYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLI 290
Query: 269 ERMLVFDPAKRITVEEALNHP 289
            +M+  DP KR T  + L HP
Sbjct: 291 SQMIDHDPLKRPTAMKVLRHP 311

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 81
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 82  VCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 168

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 80
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 81  VCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 167

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 13/150 (8%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIK---KITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G GA+G V   +     E V I    KI N           + E  ++  M H ++V++
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 100 KDI-IPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
             + + P        + +V +LM     L  +   K  +       +  Q+ +G+ Y+  
Sbjct: 106 LGVCLSP-------TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE 158
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             ++HRDL   N+L+ +   +KI DFGLAR
Sbjct: 159 RRLVHRDLAARNVLVKSPNHVKITDFGLAR 188

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 81
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 82  VCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 168

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 78
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 79  VCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 26  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 84
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 85  VCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 139 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 171

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 27  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 85
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 86  VCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 172

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 13/150 (8%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIK---KITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G GA+G V   +     E V I    KI N           + E  ++  M H ++V++
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 100 KDI-IPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
             + + P        + +V +LM     L  +   K  +       +  Q+ +G+ Y+  
Sbjct: 83  LGVCLSPT-------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE 135
Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
             ++HRDL   N+L+ +   +KI DFGLAR
Sbjct: 136 RRLVHRDLAARNVLVKSPNHVKITDFGLAR 165

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 30  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 88
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 89  VCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 143 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 175

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 30/173 (17%)
Query: 43  IGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTHENI 96
           +G GA+G V  A     +  + K  VA+K +  A ++ R D +R   E +LL  + H++I
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTMLQHQHI 82
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQA---------------LTDDHC 140
           V+   +       +   + +V+E M   DL++ +RS                  L     
Sbjct: 83  VRFFGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 137
Query: 141 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                Q+  G+ Y+   + +HRDL   N L+     +KI DFG++R    TD+
Sbjct: 138 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 190

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 30/173 (17%)
Query: 43  IGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTHENI 96
           +G GA+G V  A     +  + K  VA+K +  A ++ R D +R   E +LL  + H++I
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTMLQHQHI 76
Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSKQA---------------LTDDHC 140
           V+   +       +   + +V+E M   DL++ +RS                  L     
Sbjct: 77  VRFFGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 131
Query: 141 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDF 193
                Q+  G+ Y+   + +HRDL   N L+     +KI DFG++R    TD+
Sbjct: 132 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 184

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   + + K IL E  ++  + + +
Sbjct: 14  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 72
Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 73  VCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +    ++HRDL   N+L+     +KI DFGLA+
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 32/172 (18%)
Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKIT----NAFDNRIDAKRILREIKLLCHMT-HENIV 97
           +G GA+G V  A      +E A+ K+      +  +  + + ++ E+K++ H+  HENIV
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK---------------QALTDDHCQ- 141
            +               Y  Y     DL   +R K               + L  +  + 
Sbjct: 99  NLLGACTHGGPVLVITEYCCY----GDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 142 -------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
                  +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR
Sbjct: 155 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 206
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	339
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	0.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	0.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	0.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	0.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	0.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	0.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	0.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-180
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-173
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-173
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-172
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-164
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-148
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-141
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-140
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-136
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-134
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-106
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-81
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-81
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-80
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-80
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-80
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-79
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-79
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-79
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-78
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-76
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-75
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-61
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-51
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-51
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-50
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-49
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-48
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-47
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-47
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-46
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-46
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-46
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-46
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-46
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-45
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-45
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-44
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-44
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-44
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-44
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-44
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-44
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-44
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-44
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-44
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-43
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-43
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-43
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-43
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-43
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-43
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-43
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-43
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-42
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-41
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-41
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-41
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-41
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-41
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-41
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-40
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-40
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-40
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-40
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-39
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-39
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-39
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-39
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-39
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-39
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-39
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-39
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-38
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-38
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-38
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-38
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-38
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-38
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-38
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-38
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-37
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-37
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-36
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-36
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-36
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-36
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-36
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-35
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-35
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-35
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-34
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-05
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-33
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-33
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-06
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-33
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-33
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-06
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-32
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-32
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-07
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-31
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-31
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-07
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-31
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-07
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-28
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-28
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-27
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-27
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-27
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-27
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-06
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-26
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-26
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-23
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-22
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-21
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-21
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-20
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-20
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-20
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-19
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-19
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-19
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-19
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-18
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-18
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-18
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-18
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-18
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-18
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-15
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-12
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-11
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-10
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-10
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-05

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  524 bits (1351), Expect = 0.0
 Identities = 162/355 (45%), Positives = 211/355 (59%), Gaps = 39/355 (10%)

Query: 18  GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID 77
                  + G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI + F+++  
Sbjct: 11  AAAGPEMVRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTY 68

Query: 78  AKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD 137
            +R LREIK+L    HENI+ + DII     E+  DVYIV +LM+TDL++++++ Q L++
Sbjct: 69  CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSN 127

Query: 138 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS----ETDF 193
           DH  YFLYQ+LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 194 MTEYVVTRW-----------------D---------------TLFPGKDYVQQLTMITEL 221
           +TEYV TRW                 D                +FPGK Y+ QL  I  +
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247

Query: 222 LGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRIT 281
           LGSP   DL  + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI 
Sbjct: 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307

Query: 282 VEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           VE+AL HPYL   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 308 VEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 362

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  517 bits (1334), Expect = 0.0
 Identities = 116/360 (32%), Positives = 178/360 (49%), Gaps = 46/360 (12%)

Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI-------- 68
            G+    +++  L  + S Y    + I  G+YG VC+ V+S     VAIK++        
Sbjct: 5   KGEAAMRDLIAELHAMQSPYTV-QRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGR 62

Query: 69  -TNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQ 127
             N   +    KR+LREI+LL H  H NI+ ++DI    ++   + +Y+V ELM TDL Q
Sbjct: 63  TVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ 122

Query: 128 IIRSKQA-LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +I  ++  ++  H QYF+Y +L GL  +H A V+HRDL P N+LL  N D+ ICDF LAR
Sbjct: 123 VIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182

Query: 187 TTSETDFMTEYVVTRW--------------------------------DTLFPGKDYVQQ 214
             +     T YV  RW                                  LF G  +  Q
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242

Query: 215 LTMITELLGSPDDSDLGFLRSDNARRYVKQ-LPHVPKQPFSQKFPNMSPVAIDLAERMLV 273
           L  I E++G+P   D+    S +AR Y++  L +VP + ++   P   PVA+DL  +ML 
Sbjct: 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLE 302

Query: 274 FDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFH 333
           F+P +RI+ E+AL HPY  SL +  +         F F+++  +  D+ ++   E   F+
Sbjct: 303 FNPQRRISTEQALRHPYFESLFDPLDLTEGL-SERFHFDESVTDVYDMHKIFTAEVERFN 361

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  517 bits (1334), Expect = 0.0
 Identities = 124/403 (30%), Positives = 191/403 (47%), Gaps = 85/403 (21%)

Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI 76
            G+   Y        V   Y+     IGRG+YG V  A +  T++ VAIKK+   F++ I
Sbjct: 9   SGRENLYFQGIKNVHVPDNYII-KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI 67

Query: 77  DAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALT 136
           D KRILREI +L  +  + I+++ D+I P D  KF+++YIV E+ D+DL ++ ++   LT
Sbjct: 68  DCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT 127

Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS------- 189
           ++H +  LY LL G  +IH + ++HRDLKP+N LLN +C +K+CDFGLART +       
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 190 ----------------ETDFMTEYVVTRW------------------------------- 202
                               +T +VVTRW                               
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

Query: 203 ------------DTLFPG-----------------KDYVQQLTMITELLGSPDDSDLGFL 233
                         LFPG                 K    QL +I  ++G+P + DL  +
Sbjct: 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI 307

Query: 234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
                 +Y+K  PH       QK+P++S   I+L E ML F+P KRIT+++AL+HPYL  
Sbjct: 308 NKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

Query: 294 LHEINEEPTCPYPFNFDFEQ-TSMNEEDIKELILRECLNFHPD 335
           + +   E          F+    ++E  ++ + L+E  +FHP+
Sbjct: 368 VRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPE 410

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  513 bits (1323), Expect = 0.0
 Identities = 133/350 (38%), Positives = 188/350 (53%), Gaps = 38/350 (10%)

Query: 18  GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID 77
             + + ++    +++   YV     +G GAYG VCSA++  + E+VAIKK++  F + I 
Sbjct: 8   KGFYKQDVNKTAWELPKTYVS-PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF 66

Query: 78  AKRILREIKLLCHMTHENIVKVKDII-PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALT 136
           AKR  RE+ LL HM HEN++ + D+  P      F D Y+V   M TDL +I+      +
Sbjct: 67  AKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFS 124

Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE 196
           ++  QY +YQ+L+GLKYIHSA V+HRDLKP NL +N +C+LKI DFGLAR       MT 
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTG 182

Query: 197 YVVTRW--------------------------------DTLFPGKDYVQQLTMITELLGS 224
           YVVTRW                                 TLF GKDY+ QLT I ++ G 
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242

Query: 225 PDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEE 284
           P    +  L    A+ Y++ LP  P++ F+Q FP  SP A DL E+ML  D  KR+T  +
Sbjct: 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302

Query: 285 ALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
           AL HP+     +  EE     PF+   E   +  ++ K+ I +E +NF P
Sbjct: 303 ALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  511 bits (1319), Expect = 0.0
 Identities = 133/354 (37%), Positives = 198/354 (55%), Gaps = 38/354 (10%)

Query: 18  GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID 77
             + +  +    ++V + Y   LQP+G GAYG VCSAV+  T  +VAIKK+   F + + 
Sbjct: 9   SGFYRQEVTKTAWEVRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 67

Query: 78  AKRILREIKLLCHMTHENIVKVKDII-PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALT 136
           AKR  RE++LL HM HEN++ + D+  P    + F D Y+V   M TDL ++++  + L 
Sbjct: 68  AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLG 126

Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE 196
           +D  Q+ +YQ+L+GL+YIH+A ++HRDLKP NL +N +C+LKI DFGLAR       MT 
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTG 184

Query: 197 YVVTRW--------------------------------DTLFPGKDYVQQLTMITELLGS 224
           YVVTRW                                 TLF G D++ QL  I ++ G+
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244

Query: 225 PDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEE 284
           P    +  L+SD A+ Y+K LP + K+ F+    N SP+A++L E+MLV D  +R+T  E
Sbjct: 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304

Query: 285 ALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDHML 338
           AL HPY  SLH+  +EP     ++  F+      ++ K +  +E L+F P   L
Sbjct: 305 ALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQL 357

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  510 bits (1316), Expect = 0.0
 Identities = 142/354 (40%), Positives = 209/354 (59%), Gaps = 38/354 (10%)

Query: 19  KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA 78
            + +  +   +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I A
Sbjct: 14  TFYRQELNKTIWEVPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72

Query: 79  KRILREIKLLCHMTHENIVKVKDII-PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD 137
           KR  RE++LL HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTD
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTD 131

Query: 138 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEY 197
           DH Q+ +YQ+LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT Y
Sbjct: 132 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGY 189

Query: 198 VVTRW--------------------------------DTLFPGKDYVQQLTMITELLGSP 225
           V TRW                                 TLFPG D++ QL +I  L+G+P
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

Query: 226 DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEA 285
               L  + S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +A
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 309

Query: 286 LNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDHMLE 339
           L H Y +  H+ ++EP    P++   E   +  ++ K L   E ++F P  + +
Sbjct: 310 LAHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPPPLDQ 362

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  508 bits (1311), Expect = 0.0
 Identities = 156/350 (44%), Positives = 207/350 (59%), Gaps = 51/350 (14%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           + +SS +      +G GAYG+VCSA +  T E VAIKKI   FD  + A R LREIK+L 
Sbjct: 7   YNISSDFQL-KSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILK 64

Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLR 149
           H  HENI+ + +I  P   E FN+VYI+ ELM TDLH++I + Q L+DDH QYF+YQ LR
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLR 123

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----------TSETDFMTEYV 198
            +K +H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR            T +   M E+V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 199 VTRW--------------------------------DTLFPGKDYVQQLTMITELLGSP- 225
            TRW                                  +FPG+DY  QL +I  ++G+P 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243

Query: 226 DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEA 285
            D+DL  + S  AR Y+K LP  P  P  + FP ++P  IDL +RMLVFDPAKRIT +EA
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303

Query: 286 LNHPYLSSLHEINEEPTC----PYPFNFDFEQTSMNEEDIKELILRECLN 331
           L HPYL + H+ N+EP      P  F FD  + ++  +D+K+LI  E  +
Sbjct: 304 LEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  505 bits (1302), Expect = e-180
 Identities = 128/419 (30%), Positives = 191/419 (45%), Gaps = 93/419 (22%)

Query: 9   KDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI 68
           + R                + +Q+  +Y      IG G+YG VC A +   K  VAIKKI
Sbjct: 28  QQRKQHHSSKPTASMPRPHSDWQIPDRYEI-RHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86

Query: 69  TNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQI 128
              F++ ID KRILREI +L  + H+++VKV DI+ P D EKF+++Y+V E+ D+D  ++
Sbjct: 87  LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKL 146

Query: 129 IRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 188
            R+   LT+ H +  LY LL G+KY+HSA +LHRDLKP+N L+N +C +K+CDFGLART 
Sbjct: 147 FRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206

Query: 189 SETD----------------------------FMTEYVVTRW------------------ 202
              +                             +T +VVTRW                  
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAID 266

Query: 203 -------------------------DTLFPGKDYVQ--------------------QLTM 217
                                      LFPG                         QL +
Sbjct: 267 VWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNV 326

Query: 218 ITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPA 277
           I  +LG+P + D+  L  ++A+RY++  P       +++FP  S  AI L +RMLVF+P 
Sbjct: 327 IFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPN 386

Query: 278 KRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFE-QTSMNEEDIKELILRECLNFHPD 335
           KRIT+ E L HP+   +     E          F    +M+E  ++   ++E   +HP+
Sbjct: 387 KRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  485 bits (1251), Expect = e-173
 Identities = 127/363 (34%), Positives = 190/363 (52%), Gaps = 49/363 (13%)

Query: 19  KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA 78
            +    I  + F V  +Y   L+PIG GA GIVC+A ++  +  VAIKK++  F N+  A
Sbjct: 10  NFYSVEIGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA 68

Query: 79  KRILREIKLLCHMTHENIVKVKDII-PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD 137
           KR  RE+ L+  + H+NI+ + ++  P    E+F DVYIV ELMD +L Q+I+    L  
Sbjct: 69  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDH 126

Query: 138 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEY 197
           +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART   +  MT Y
Sbjct: 127 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186

Query: 198 VVTRW-------------------------------DTLFPGKDYVQQLTMITELLGSPD 226
           VVTR+                                 LFPG D++ Q   + E LG+P 
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246

Query: 227 DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM------------SPVAIDLAERMLVF 274
              +  L     R YV+  P      F + FP++            +  A DL  +MLV 
Sbjct: 247 PEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305

Query: 275 DPAKRITVEEALNHPYLSSLHEINEEPTC-PYPFNFDFEQTSMNEEDIKELILRECLNFH 333
           D +KRI+V+EAL HPY++  ++ +E     P   +   ++     E+ KELI +E ++  
Sbjct: 306 DASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE 365

Query: 334 PDH 336
             H
Sbjct: 366 HHH 368

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  484 bits (1248), Expect = e-173
 Identities = 116/380 (30%), Positives = 185/380 (48%), Gaps = 77/380 (20%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
             V  KY   ++ +G+GAYGIV  +++  T E VA+KKI +AF N  DA+R  REI +L 
Sbjct: 5   RHVLRKYEL-VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63

Query: 90  HM-THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLL 148
            +  HENIV + +++     +   DVY+V++ M+TDLH +IR+   L   H QY +YQL+
Sbjct: 64  ELSGHENIVNLLNVLRA---DNDRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLI 119

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--------------------- 187
           + +KY+HS  +LHRD+KPSN+LLNA C +K+ DFGL+R+                     
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 188 -TSETDFMTEYVVTRW-----------------D---------------TLFPGKDYVQQ 214
              +   +T+YV TRW                 D                +FPG   + Q
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239

Query: 215 LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF----------------P 258
           L  I  ++  P + D+  ++S  A+  ++ L    +   S K                  
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299

Query: 259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDF-EQTSMN 317
           + +  A+DL +++L F+P KRI+  +AL HP++S  H  NEEP C +       +    +
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHS 359

Query: 318 EEDIKELILRECLNFHPDHM 337
            +D + L+  E      + +
Sbjct: 360 IDDYRNLVYSEISRRKRELI 379

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  485 bits (1251), Expect = e-172
 Identities = 127/365 (34%), Positives = 190/365 (52%), Gaps = 49/365 (13%)

Query: 18  GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID 77
            ++    +  + F V  +Y   L+PIG GA GIVC+A ++     VAIKK++  F N+  
Sbjct: 46  NQFYSVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104

Query: 78  AKRILREIKLLCHMTHENIVKVKDII-PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALT 136
           AKR  RE+ L+  + H+NI+ + ++  P    E+F DVY+V ELMD +L Q+I+    L 
Sbjct: 105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELD 162

Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE 196
            +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART   +  MT 
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222

Query: 197 YVVTRW-------------------------------DTLFPGKDYVQQLTMITELLGSP 225
           YVVTR+                                 LFPG+DY+ Q   + E LG+P
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282

Query: 226 DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN------------MSPVAIDLAERMLV 273
               +  L     R YV+  P      F + FP+             +  A DL  +MLV
Sbjct: 283 CPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341

Query: 274 FDPAKRITVEEALNHPYLSSLHEINEEPT-CPYPFNFDFEQTSMNEEDIKELILRECLNF 332
            DPAKRI+V++AL HPY++  ++  E     P  ++   ++     E+ KELI +E +N 
Sbjct: 342 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNS 401

Query: 333 HPDHM 337
                
Sbjct: 402 EEKTK 406

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  458 bits (1181), Expect = e-164
 Identities = 117/321 (36%), Positives = 168/321 (52%), Gaps = 51/321 (15%)

Query: 27  GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
            + F + S+Y+  L+P+G G  G+V SAV+++  + VAIKKI     +    K  LREIK
Sbjct: 4   IHGFDLGSRYMD-LKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIK 60

Query: 87  LLCHMTHENIVKVKDIIPPMDK---------EKFNDVYIVYELMDTDLHQIIRSKQALTD 137
           ++  + H+NIVKV +I+ P             + N VYIV E M+TDL  ++     L +
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLE 119

Query: 138 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARTTS----ETD 192
           +H + F+YQLLRGLKYIHSANVLHRDLKP+NL +N  +  LKI DFGLAR          
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 193 FMTEYVVTRW--------------------------------DTLFPGKDYVQQLTMITE 220
            ++E +VT+W                                 TLF G   ++Q+ +I E
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239

Query: 221 LLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRI 280
            +    + D   L S     Y++     P +P +Q  P +S  A+D  E++L F P  R+
Sbjct: 240 SIPVVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298

Query: 281 TVEEALNHPYLSSLHEINEEP 301
           T EEAL+HPY+S      +EP
Sbjct: 299 TAEEALSHPYMSIYSFPMDEP 319

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  420 bits (1083), Expect = e-148
 Identities = 90/362 (24%), Positives = 147/362 (40%), Gaps = 53/362 (14%)

Query: 17  GGKYVQYNILGNLFQVSSKYVP---PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD 73
            G  +  N      + S K +      +  G+G +G V       T   VAIKK+     
Sbjct: 2   PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQ 58

Query: 74  NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY--IVYELMDTDLHQIIRS 131
           +     R L+ ++ L  + H NIV+++     + +    D+Y  +V E +   LH+  R+
Sbjct: 59  DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN 118

Query: 132 ----KQALTDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLN-ANCDLKICDFGL 184
               + A      + FL+QL+R +  +H  S NV HRD+KP N+L+N A+  LK+CDFG 
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178

Query: 185 ARTTSETDFMTEYVVTRW-----------------DT---------------LFPGKDYV 212
           A+  S ++    Y+ +R+                 D                +F G +  
Sbjct: 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238

Query: 213 QQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP-KQPFSQKFPNMSPVAIDLAERM 271
            QL  I  +LG P    L  L   +    +     +P    FS      +  A DL   +
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298

Query: 272 LVFDPAKRITVEEALNHPYLSSLHEINEE-----PTCPYPFNFDFEQTSMNEEDIKELIL 326
           L + P +R+   EAL HPY   LH+   +           F F   +  +  E  K  ++
Sbjct: 299 LQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV 358

Query: 327 RE 328
           R+
Sbjct: 359 RK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  403 bits (1038), Expect = e-141
 Identities = 84/391 (21%), Positives = 159/391 (40%), Gaps = 93/391 (23%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
            + SSK     + +G G++GIVC   + E+ +  A+KK+        D +   RE+ ++ 
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMK 55

Query: 90  HMTHENIVKVKDII---------------------------------PPMDKEKFNDVYI 116
            + H NI+K+ D                                     ++  +   + +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 117 VYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN 172
           + E +   LH++++    S +++  +    ++YQL R + +IHS  + HRD+KP NLL+N
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175

Query: 173 ANCD-LKICDFGLARTTSETDFMTEYVVTRW----------------------------- 202
           +  + LK+CDFG A+    ++    Y+ +R+                             
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235

Query: 203 ---DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
                LF G+  + QL  I +++G+P    +  +            P +  + + +  P 
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVR---FPTLKAKDWRKILPE 292

Query: 260 MSP-VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTC-------------PY 305
            +P +AIDL E++L ++P  RI   EA+ HP+   L    E                 P 
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQ 352

Query: 306 PFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
            FNF   + S+   ++   IL +  + +  H
Sbjct: 353 LFNFSPYELSIIPGNVLNRILPKNFSPNYKH 383

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  402 bits (1036), Expect = e-140
 Identities = 96/367 (26%), Positives = 156/367 (42%), Gaps = 53/367 (14%)

Query: 2   ENESMVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKE 61
              SM +            V     G        Y    + IG G++G+V  A   ++ E
Sbjct: 22  AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTD-TKVIGNGSFGVVYQAKLCDSGE 80

Query: 62  EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDII-PPMDKEKFNDVYIVYEL 120
            VAIKK+        D +   RE++++  + H NIV+++       +K+    + +V + 
Sbjct: 81  LVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134

Query: 121 MDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD 176
           +   ++++ R    +KQ L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +  
Sbjct: 135 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 194

Query: 177 -LKICDFGLARTTSETDFMTEYVVTRW-----------------DT-------------- 204
            LK+CDFG A+     +    Y+ +R+                 D               
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

Query: 205 -LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF-PNMSP 262
            +FPG   V QL  I ++LG+P       +R  N      + P +   P+++ F P   P
Sbjct: 255 PIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 311

Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP----TCPYPFNFDFEQTSMNE 318
            AI L  R+L + P  R+T  EA  H +   L + N +       P  FNF  ++ S N 
Sbjct: 312 EAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP 371

Query: 319 EDIKELI 325
                LI
Sbjct: 372 PLATILI 378

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  391 bits (1006), Expect = e-136
 Identities = 98/351 (27%), Positives = 156/351 (44%), Gaps = 54/351 (15%)

Query: 21  VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR 80
           V  +      Q    Y    + IG G++G+V  A   E+ +EVAIKK+        D + 
Sbjct: 27  VLASDGKTGEQREIAYTN-CKVIGNGSFGVVFQAKLVES-DEVAIKKV------LQDKRF 78

Query: 81  ILREIKLLCHMTHENIVKVKDII-PPMDKEKFNDVYIVYELMDTDLHQIIRS----KQAL 135
             RE++++  + H N+V +K       DK+    + +V E +   +++  R     KQ +
Sbjct: 79  KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTM 138

Query: 136 TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFM 194
                + ++YQLLR L YIHS  + HRD+KP NLLL+     LK+ DFG A+     +  
Sbjct: 139 PMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198

Query: 195 TEYVVTRW-----------------DT---------------LFPGKDYVQQLTMITELL 222
             Y+ +R+                 D                LFPG+  + QL  I ++L
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258

Query: 223 GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRIT 281
           G+P       +++ N      + P +   PFS+ F P   P AIDL  R+L + P+ R+T
Sbjct: 259 GTPSREQ---IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315

Query: 282 VEEALNHPYLSSLHEINEE----PTCPYPFNFDFEQTSMNEEDIKELILRE 328
             EAL HP+   L             P  FN+  E+ S+  + I  L+ + 
Sbjct: 316 AIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQH 366

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  384 bits (989), Expect = e-134
 Identities = 77/319 (24%), Positives = 140/319 (43%), Gaps = 52/319 (16%)

Query: 19  KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA 78
           +Y  Y      +     Y   ++ +GRG Y  V  A+N    E+V +K +       +  
Sbjct: 21  EYWDYESHVVEWGNQDDYQL-VRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKK 74

Query: 79  KRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD 137
           K+I REIK+L ++    NI+ + DI+   D        +   + +TD  Q+    Q LTD
Sbjct: 75  KKIKREIKILENLRGGPNIITLADIV--KDPVSRTPALVFEHVNNTDFKQLY---QTLTD 129

Query: 138 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSETDFMTE 196
              ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ D+GLA           
Sbjct: 130 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189

Query: 197 YVVTRW-------------DT--------------------LFPGKDYVQQLTMITELLG 223
            V +R+             D                      F G D   QL  I ++LG
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249

Query: 224 SPDDSD-LGFLRSDNARRYVKQLPHVPKQPFSQKFPN-----MSPVAIDLAERMLVFDPA 277
           + D  D +     +   R+   L    ++ + +   +     +SP A+D  +++L +D  
Sbjct: 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 309

Query: 278 KRITVEEALNHPYLSSLHE 296
            R+T  EA+ HPY  ++ +
Sbjct: 310 SRLTAREAMEHPYFYTVVK 328

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  312 bits (803), Expect = e-106
 Identities = 88/314 (28%), Positives = 147/314 (46%), Gaps = 41/314 (13%)

Query: 35  KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE 94
           KY   +  IG G+YG+V    N +T + VAIKK   + D+ +  K  LREI++L  + H 
Sbjct: 4   KYEK-IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDL-HQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           N+V + ++       +   +++V+E  D  + H++ R ++ + +   +   +Q L+ + +
Sbjct: 63  NLVNLLEVFR-----RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW---------- 202
            H  N +HRD+KP N+L+  +  +K+CDFG AR  T  +D+  + V TRW          
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177

Query: 203 ----------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARR 240
                                   L+PGK  V QL +I + LG           ++    
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237

Query: 241 YVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE 300
            VK       +P   KFPN+S  A+ L +  L  DP +R+T E+ L+HPY  ++ EI + 
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297

Query: 301 PTCP-YPFNFDFEQ 313
                 P    + Q
Sbjct: 298 AKEHDKPAENLYFQ 311

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  280 bits (719), Expect = 2e-93
 Identities = 87/299 (29%), Positives = 139/299 (46%), Gaps = 40/299 (13%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
           FQ   KY   L  +G G+YG+V    N +T   VAIKK   + D+++  K  +REIKLL 
Sbjct: 21  FQSMEKYEN-LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLK 79

Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLL 148
            + HEN+V + ++       K    Y+V+E +D  +   +      L     Q +L+Q++
Sbjct: 80  QLRHENLVNLLEVCK-----KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQII 134

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW----- 202
            G+ + HS N++HRD+KP N+L++ +  +K+CDFG ART  +  +   + V TRW     
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194

Query: 203 ---------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS 235
                                      + LFPG   + QL  I   LG+           
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254

Query: 236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           +     V+      ++P  +++P +S V IDLA++ L  DP KR    E L+H +    
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  247 bits (633), Expect = 8e-81
 Identities = 82/302 (27%), Positives = 119/302 (39%), Gaps = 59/302 (19%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI-----LREIKLL---CHM 91
           +  IG GAYG V  A +  +   VA+K +     N            +RE+ LL      
Sbjct: 14  VAEIGVGAYGTVYKARDPHSGHFVALKSV--RVPNGGGGGGGLPISTVREVALLRRLEAF 71

Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA--LTDDHCQYFLYQLLR 149
            H N+V++ D+      ++   V +V+E +D DL   +       L  +  +  + Q LR
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW------- 202
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T  VVT W       
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191

Query: 203 ------------------------DTLFPGKDYVQQLTMITELLGSPDDSDL-GFLRSDN 237
                                     LF G     QL  I +L+G P + D         
Sbjct: 192 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR------ 245

Query: 238 ARRYVKQLPHV-----PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
                  LP         +P     P M      L   ML F+P KRI+   AL H YL 
Sbjct: 246 ----DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301

Query: 293 SL 294
             
Sbjct: 302 KD 303

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  247 bits (633), Expect = 1e-80
 Identities = 90/295 (30%), Positives = 130/295 (44%), Gaps = 53/295 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-----RILREIKLLCHMTHE 94
           L  +G G Y  V    +  T   VA+K+I      R++ +       +RE+ LL  + H 
Sbjct: 7   LDKLGEGTYATVYKGKSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLKDLKHA 60

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKY 153
           NIV + DII          + +V+E +D DL Q +      +   + + FL+QLLRGL Y
Sbjct: 61  NIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW---------- 202
            H   VLHRDLKP NLL+N   +LK+ DFGLAR  +  T      VVT W          
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175

Query: 203 ----------------------DTLFPGKDYVQQLTMITELLGSPDDSDL-GFLRSDNAR 239
                                   LFPG    +QL  I  +LG+P +    G L ++  +
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235

Query: 240 RYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
            Y    P    +      P +     DL  ++L F+   RI+ E+A+ HP+  SL
Sbjct: 236 TY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  247 bits (632), Expect = 3e-80
 Identities = 91/295 (30%), Positives = 130/295 (44%), Gaps = 51/295 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR-----ILREIKLLCHMTHE 94
           L  +G G +  V  A +  T + VAIKKI     +R +AK       LREIKLL  ++H 
Sbjct: 15  LDFLGEGQFATVYKARDKNTNQIVAIKKI--KLGHRSEAKDGINRTALREIKLLQELSHP 72

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKY 153
           NI+ + D            + +V++ M+TDL  II+     LT  H + ++   L+GL+Y
Sbjct: 73  NIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW---------- 202
           +H   +LHRDLKP+NLLL+ N  LK+ DFGLA++  S     T  VVTRW          
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 187

Query: 203 ---DT-------------------LFPGKDYVQQLTMITELLGSPDDSDL-GFLRSDNAR 239
                                     PG   + QLT I E LG+P +          +  
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY- 246

Query: 240 RYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
                    P  P    F       +DL + + +F+P  RIT  +AL   Y S+ 
Sbjct: 247 ---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  244 bits (626), Expect = 5e-80
 Identities = 91/296 (30%), Positives = 127/296 (42%), Gaps = 56/296 (18%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR------ILREIKLLCHMTH 93
           L+ IG G YG+V  A N    E  A+KKI      R++ +        +REI +L  + H
Sbjct: 7   LEKIGEGTYGVVYKAQN-NYGETFALKKI------RLEKEDEGIPSTTIREISILKELKH 59

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLK 152
            NIVK+ D+I    +     + +V+E +D DL +++   +  L     + FL QLL G+ 
Sbjct: 60  SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW--------- 202
           Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT W         
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 203 -----------------------DTLFPGKDYVQQLTMITELLGSPDDSDL-GFLRSDNA 238
                                    LFPG     QL  I  +LG+P+  +          
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV---TEL 231

Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
            +Y          P+      +    IDL  +ML  DP +RIT ++AL H Y    
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  244 bits (626), Expect = 1e-79
 Identities = 97/296 (32%), Positives = 137/296 (46%), Gaps = 55/296 (18%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR------ILREIKLLCHMTH 93
           L+ +G G YG+V  A +S     VA+K+I      R+DA+        +REI LL  + H
Sbjct: 26  LEKVGEGTYGVVYKAKDS-QGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHH 78

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLK 152
            NIV + D+I    +     + +V+E M+ DL +++   K  L D   + +LYQLLRG+ 
Sbjct: 79  PNIVSLIDVI--HSERC---LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW--------- 202
           + H   +LHRDLKP NLL+N++  LK+ DFGLAR         T  VVT W         
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193

Query: 203 -----------------------DTLFPGKDYVQQLTMITELLGSPDDSDL-GFLRSDNA 238
                                    LFPG     QL  I  +LG+P+  +          
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253

Query: 239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
           ++         K+P+S   P      IDL   ML FDP KRI+  +A+NHPY   L
Sbjct: 254 KQR--TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  243 bits (624), Expect = 1e-79
 Identities = 100/304 (32%), Positives = 137/304 (45%), Gaps = 70/304 (23%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR------ILREIKLLCHMTH 93
           L+ IG G YG V  A N ET E VA+K++      R+D          LREI LL  + H
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKH 60

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLK 152
           +NIV++ D++     +K   + +V+E  D DL +   S    L  +  + FL+QLL+GL 
Sbjct: 61  KNIVRLHDVL--HSDKK---LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW--------- 202
           + HS NVLHRDLKP NLL+N N +LK+ +FGLAR         +  VVT W         
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 203 ----DT--------------------LFPGKDYVQQLTMITELLGSPDDSDL-GFLRSDN 237
                T                    LFPG D   QL  I  LLG+P +           
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS------ 229

Query: 238 ARRYVKQLPHV-------PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
               + +LP                  P ++    DL + +L  +P +RI+ EEAL HPY
Sbjct: 230 ----MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

Query: 291 LSSL 294
            S  
Sbjct: 286 FSDF 289

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  243 bits (623), Expect = 5e-79
 Identities = 85/316 (26%), Positives = 133/316 (42%), Gaps = 65/316 (20%)

Query: 40  LQPIGRGAYGIVCSAVNS-ETKEEVAIKKITNAFDNRIDAKR------ILREIKLL---C 89
           +  IG GAYG V  A +       VA+K++      R+           +RE+ +L    
Sbjct: 16  VAEIGEGAYGKVFKARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLE 69

Query: 90  HMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS--KQALTDDHCQYFLYQL 147
              H N+V++ D+      ++   + +V+E +D DL   +    +  +  +  +  ++QL
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129

Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW----- 202
           LRGL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  VVT W     
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 189

Query: 203 --------------------------DTLFPGKDYVQQLTMITELLGSPDDSDL-GFLRS 235
                                       LF G   V QL  I +++G P + D       
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR---- 245

Query: 236 DNARRYVKQLPHV-----PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
                    LP         QP  +   ++  +  DL  + L F+PAKRI+   AL+HPY
Sbjct: 246 ------DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

Query: 291 LSSLHEINEEPTCPYP 306
              L    E      P
Sbjct: 300 FQDLERCKENLDSHLP 315

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  242 bits (619), Expect = 2e-78
 Identities = 87/301 (28%), Positives = 134/301 (44%), Gaps = 60/301 (19%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR------ILREIKLLCHMTH 93
           +  +G G YG V  A+++ T E VAIK+I      R++ +        +RE+ LL  + H
Sbjct: 39  ITKLGEGTYGEVYKAIDTVTNETVAIKRI------RLEHEEEGVPGTAIREVSLLKELQH 92

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            NI+++K +I    +     +++++E  + DL + +     ++    + FLYQL+ G+ +
Sbjct: 93  RNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147

Query: 154 IHSANVLHRDLKPSNLLLNANCD-----LKICDFGLART-TSETDFMTEYVVTRW----- 202
            HS   LHRDLKP NLLL+ +       LKI DFGLAR         T  ++T W     
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPE 207

Query: 203 ---------------------------DTLFPGKDYVQQLTMITELLGSPDDSDL-GFLR 234
                                        LFPG   + QL  I E+LG PDD+   G   
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267

Query: 235 SDNARRYVKQLPHVPKQPFSQKFPN-MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
             +   + +  P    +   +     +    +DL   ML  DP KRI+ + AL HPY S 
Sbjct: 268 LPD---WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324

Query: 294 L 294
            
Sbjct: 325 N 325

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  236 bits (605), Expect = 2e-76
 Identities = 83/310 (26%), Positives = 140/310 (45%), Gaps = 74/310 (23%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR-----ILREIKLLCHMTHE 94
           L+ +G G Y  V   +N  T   VA+K++      ++D++       +REI L+  + HE
Sbjct: 10  LEKLGNGTYATVYKGLNKTTGVYVALKEV------KLDSEEGTPSTAIREISLMKELKHE 63

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS------KQALTDDHCQYFLYQLL 148
           NIV++ D+I   +K     + +V+E MD DL + + S       + L  +  +YF +QLL
Sbjct: 64  NIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW----- 202
           +GL + H   +LHRDLKP NLL+N    LK+ DFGLAR      +  +  VVT W     
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178

Query: 203 ---------------------------DTLFPGKDYVQQLTMITELLGSPDD------SD 229
                                        LFPG +  +QL +I +++G+P++      + 
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238

Query: 230 LGFLRSDNARRYVKQLPHVPKQPFSQKF-----PNMSPVAIDLAERMLVFDPAKRITVEE 284
           L         +Y   +   P +   Q         +    +D    +L  +P  R++ ++
Sbjct: 239 L--------PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290

Query: 285 ALNHPYLSSL 294
           AL+HP+ +  
Sbjct: 291 ALHHPWFAEY 300

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  235 bits (601), Expect = 2e-75
 Identities = 85/322 (26%), Positives = 141/322 (43%), Gaps = 53/322 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI--LREIKLLCHMTHENIV 97
           L  IG+G +G V  A + +T ++VA+KK+    +N  +   I  LREIK+L  + HEN+V
Sbjct: 22  LAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLLKHENVV 79

Query: 98  KVKDII---PPMDKEKFNDVYIVYELMDTDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKY 153
            + +I              +Y+V++  + DL  ++ +     T    +  +  LL GL Y
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-----TTSETDFMTEYVVTRW------ 202
           IH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +  T  VVT W      
Sbjct: 140 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199

Query: 203 -----------DT---------------LFPGKDYVQQLTMITELLGSPDDSDL-GFLRS 235
                      D                +  G     QL +I++L GS            
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259

Query: 236 DNARRYVKQLPHVPKQPFSQKFPN--MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           +   +   +L    K+    +       P A+DL +++LV DPA+RI  ++ALNH +  S
Sbjct: 260 ELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317

Query: 294 L---HEINEEPTCPYPFNFDFE 312
                ++    +      F++ 
Sbjct: 318 DPMPSDLKGMLSTHLTSMFEYL 339

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  199 bits (508), Expect = 6e-61
 Identities = 75/323 (23%), Positives = 123/323 (38%), Gaps = 82/323 (25%)

Query: 43  IGRGAYGIVCSAVN--SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +GRG YG V  A     +  ++ A+K+I       + A    REI LL  + H N++ ++
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSA---CREIALLRELKHPNVISLQ 84

Query: 101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA---------LTDDHCQYFLYQLLRGL 151
            +       K   V+++++  + DL  II+  +A         L     +  LYQ+L G+
Sbjct: 85  KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 152 KYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARTTSE-----TDFMTEYVVTRW 202
            Y+H+  VLHRDLKP+N+L+         +KI D G AR  +       D     VVT W
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV-VVTFW 200

Query: 203 --------------------------------DTLFPGKD---------YVQQLTMITEL 221
                                           + +F  +          +  QL  I  +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260

Query: 222 LGSPDDSDL-GFLRSDNARRYVKQLPHVPKQPFS---------QKFPNMSPVAIDLAERM 271
           +G P D D            +   +    +  ++         +        A  L +++
Sbjct: 261 MGFPADKDWEDI---KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317

Query: 272 LVFDPAKRITVEEALNHPYLSSL 294
           L  DP KRIT E+A+  PY    
Sbjct: 318 LTMDPIKRITSEQAMQDPYFLED 340

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  172 bits (438), Expect = 2e-51
 Identities = 58/320 (18%), Positives = 110/320 (34%), Gaps = 40/320 (12%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH--ENIV 97
           L+ IG G    V   +N E K+  AIK +     +         EI  L  +    + I+
Sbjct: 14  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           ++ D            +Y+V E  + DL+  ++ K+++     + +   +L  +  IH  
Sbjct: 73  RLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTL-----------F 206
            ++H DLKP+N L+  +  LK+ DFG+A                 D+             
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK-----DSQVGTVNYMPPEAI 181

Query: 207 PGKDYVQQLTMITELLGSPDDSDL------------GFLRSDNARRYVKQLPHVPKQPFS 254
                 ++       +     SD+            G          + +L  +      
Sbjct: 182 KDMSSSRENGKSKSKISPK--SDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239

Query: 255 QKFPN-MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQ 313
            +FP+       D+ +  L  DP +RI++ E L HPY+        +          +  
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 299

Query: 314 TSMNEEDIKELILRECLNFH 333
             +   +    IL+     +
Sbjct: 300 GQLVGLNSPNSILKAAKTLY 319

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  170 bits (434), Expect = 4e-51
 Identities = 56/278 (20%), Positives = 102/278 (36%), Gaps = 40/278 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH--ENIV 97
           L+ IG G    V   +N E K+  AIK +     +         EI  L  +    + I+
Sbjct: 33  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           ++ D            +Y+V E  + DL+  ++ K+++     + +   +L  +  IH  
Sbjct: 92  RLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTL-----------F 206
            ++H DLKP+N L+  +  LK+ DFG+A                 D+             
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK-----DSQVGTVNYMPPEAI 200

Query: 207 PGKDYVQQLTMITELLGSPDDSDL------------GFLRSDNARRYVKQLPHVPKQPFS 254
                 ++       +     SD+            G          + +L  +      
Sbjct: 201 KDMSSSRENGKSKSKISPK--SDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258

Query: 255 QKFPN-MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            +FP+       D+ +  L  DP +RI++ E L HPY+
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  169 bits (431), Expect = 9e-50
 Identities = 58/316 (18%), Positives = 111/316 (35%), Gaps = 32/316 (10%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH--ENIV 97
           L+ IG G    V   +N E K+  AIK +     +         EI  L  +    + I+
Sbjct: 61  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           ++ D            +Y+V E  + DL+  ++ K+++     + +   +L  +  IH  
Sbjct: 120 RLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDT-------LFPGKD 210
            ++H DLKP+N L+  +  LK+ DFG+A      D  +    ++                
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP-DTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 211 YVQQLTMITELLGSPDDSDL------------GFLRSDNARRYVKQLPHVPKQPFSQKFP 258
             ++       +     SD+            G          + +L  +       +FP
Sbjct: 233 SSRENGKSKSKISPK--SDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290

Query: 259 -NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMN 317
                   D+ +  L  DP +RI++ E L HPY+        +          +    + 
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 350

Query: 318 EEDIKELILRECLNFH 333
             +    IL+     +
Sbjct: 351 GLNSPNSILKAAKTLY 366

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  167 bits (425), Expect = 4e-49
 Identities = 41/294 (13%), Positives = 78/294 (26%), Gaps = 40/294 (13%)

Query: 42  PIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIV--- 97
           P+  G   +V    + E  E+ A+K  T  A ++R + +R+         +  E+     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 98  ------------------KVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIR-------SK 132
                                 + P  D     +  ++      DL  +          +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
                        QL+R    + S  ++H    P NL +  +  L + D           
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG 248

Query: 193 FM---TEYVVTRWDTLFPGKDYVQQ-------LTMITELLGSPDDSDLGFLRSDNARRYV 242
                      R         +          L++            +      + +R  
Sbjct: 249 PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308

Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
            ++P      F      +      L  R L FD  +R+   EA+  P    L  
Sbjct: 309 LRVPGTDSLAFGSC-TPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  163 bits (415), Expect = 2e-48
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 43/289 (14%)

Query: 31  QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI-------TNAFDNRIDAKRILR 83
                Y P  + +GRG   +V   ++  T +E A+K I        +A + +   +  L+
Sbjct: 14  GFYENYEP-KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72

Query: 84  EIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQ 141
           E+ +L  ++ H NI+++KD       E     ++V++LM   +L   +  K  L++   +
Sbjct: 73  EVDILRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127

Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE----- 196
             +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG +      + + E     
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187

Query: 197 -YV---VTRWDTLFPGKDYVQQLTM-----ITELL--GSP---DDSDLGFLRSDNARRYV 242
            Y+   +           Y +++ M     I   L  GSP       +  LR   +  Y 
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY- 246

Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            Q         S ++ + S    DL  R LV  P KR T EEAL HP+ 
Sbjct: 247 -QFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  162 bits (412), Expect = 3e-47
 Identities = 71/286 (24%), Positives = 124/286 (43%), Gaps = 42/286 (14%)

Query: 31  QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI------TNAFDNRIDAKRILRE 84
           +   KY P    IGRG   +V   V+  T  E A+K +       +        +   RE
Sbjct: 91  EFYQKYDP-KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149

Query: 85  IKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQY 142
             +L  +  H +I+ + D       E  + +++V++LM   +L   +  K AL++   + 
Sbjct: 150 THILRQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS 204

Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE------ 196
            +  LL  + ++H+ N++HRDLKP N+LL+ N  +++ DFG +      + + E      
Sbjct: 205 IMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPG 264

Query: 197 YV---VTRWDTLFPGKDYVQQLTM-----ITELL--GSP---DDSDLGFLRSDNARRYVK 243
           Y+   + +         Y +++ +     I   L  GSP       +  LR     +Y  
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY-- 322

Query: 244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHP 289
           Q         S ++ + S    DL  R+L  DP  R+T E+AL HP
Sbjct: 323 QFS-------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  158 bits (403), Expect = 9e-47
 Identities = 69/274 (25%), Positives = 129/274 (47%), Gaps = 43/274 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+GA+ +V   V+  T  E A K I     +  D +++ RE ++   + H NIV++ D 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           I     ++ +  Y+V++L+   +L + I +++  ++    + + Q+L  + Y HS  ++H
Sbjct: 74  I-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128

Query: 162 RDLKPSNLLLNANCD---LKICDFGLARTTSETDFMTE------YV---VTRWDTLFPGK 209
           R+LKP NLLL +      +K+ DFGLA   ++++          Y+   V +        
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK------KD 182

Query: 210 DYVQQLTM-----ITELL--GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
            Y + + +     I  +L  G P   D+          A  Y    P       S ++  
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY--DYP-------SPEWDT 233

Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           ++P A  L + ML  +P KRIT ++AL  P++ +
Sbjct: 234 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  158 bits (403), Expect = 1e-46
 Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 54/291 (18%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           +G G + IV       T +E A K I     ++    +  + I RE+ +L  + H NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           + DI      E   DV ++ EL+   +L   +  K++LT+D    FL Q+L G+ Y+HS 
Sbjct: 73  LHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127

Query: 158 NVLHRDLKPSNLLL----NANCDLKICDFGLARTTSETDFMT------EYV---VTRWDT 204
            + H DLKP N++L      N  +K+ DFG+A      +         E+V   +  ++ 
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP 187

Query: 205 LFPGKD--------YVQQLTMITELL-GSP---DDSDLGFLRSDNARRYVKQLPHVPKQP 252
           L    D        Y+        LL G+     ++    L + +A  Y           
Sbjct: 188 LGLEADMWSIGVITYI--------LLSGASPFLGETKQETLTNISAVNY----------D 229

Query: 253 F-SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
           F  + F N S +A D   R+LV DP +R+T+ ++L H ++ ++   N    
Sbjct: 230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  159 bits (403), Expect = 1e-46
 Identities = 65/294 (22%), Positives = 113/294 (38%), Gaps = 49/294 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +  +G+GA+G V  A N+      AIKKI +          IL E+ LL  + H+ +V+ 
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 100 KD--------IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTD-DHCQYFLYQLLR 149
                     + P    +K + ++I  E  +   L+ +I S+      D       Q+L 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK 209
            L YIHS  ++HRDLKP N+ ++ + ++KI DFGLA+    +  + +            +
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL---------DSQ 178

Query: 210 DYVQQLTMITELLGSP-------------DD--SDL------------GFLRSDNARRYV 242
           +       +T  +G+               +   D+             F         +
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNIL 238

Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
           K+L  V  +       N   V   +   ++  DP KR      LN  +L   H+
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  159 bits (404), Expect = 2e-46
 Identities = 80/293 (27%), Positives = 122/293 (41%), Gaps = 72/293 (24%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI------TNAFDNRIDAKRILREIKLLCHMTHENI 96
           +G GA G V  A   +T ++VAIK I        +      A  +  EI++L  + H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           +K+K+           D YIV ELM+  +L   +   + L +  C+ + YQ+L  ++Y+H
Sbjct: 78  IKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 156 SANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYV 212
              ++HRDLKP N+LL++   +C +KI DFG ++   ET  M     T      P   Y+
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT------PT--YL 183

Query: 213 QQLTMITELLGSPDDSDLGFLRSDNARRYVKQ-----------------LP----HVPKQ 251
                      +P+      L S     Y +                   P         
Sbjct: 184 -----------APE-----VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227

Query: 252 PFSQ------KFP-----NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
              Q       F       +S  A+DL +++LV DP  R T EEAL HP+L  
Sbjct: 228 LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  157 bits (398), Expect = 5e-46
 Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 48/275 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G++G V    +  T++E A+K I  A     D   ILRE++LL  + H NI+K+ +I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           +     E  +  YIV EL    +L   I  ++  ++      + Q+  G+ Y+H  N++H
Sbjct: 90  L-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144

Query: 162 RDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPG--------KD 210
           RDLKP N+LL     +CD+KI DFGL+    +   M + + T                  
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT------AYYIAPEVLRGT 198

Query: 211 YVQQLTM-----ITELL--GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPF---SQKF 257
           Y ++  +     I  +L  G+P     ++   L+             V    +     ++
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR------------VETGKYAFDLPQW 246

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
             +S  A DL  +ML F P+ RIT  + L HP++ 
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  156 bits (397), Expect = 8e-46
 Identities = 64/278 (23%), Positives = 96/278 (34%), Gaps = 48/278 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G +G V  A +    +   IK++      + + ++  RE+K L  + H NIV  
Sbjct: 16  IELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAEREVKALAKLDHVNIVHY 69

Query: 100 KD-----------IIPPMDKEKFNDVYIVYELMDT-DLHQII--RSKQALTDDHCQYFLY 145
                              + K   ++I  E  D   L Q I  R  + L          
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129

Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTL 205
           Q+ +G+ YIHS  +++RDLKPSN+ L     +KI DFGL  +       T    T     
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLR--- 186

Query: 206 FPGKDYVQQLTMITELL-GSPDD--SD---LG------FLRSDNARRYVKQLPHVPKQPF 253
                Y     M  E +         D   LG          D A    K    +     
Sbjct: 187 -----Y-----MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGII 236

Query: 254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           S  F         L +++L   P  R    E L    +
Sbjct: 237 SDIF---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  161 bits (408), Expect = 1e-45
 Identities = 70/285 (24%), Positives = 131/285 (45%), Gaps = 39/285 (13%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           + +G+G++G V    +  T +E A+K I       + D + +LRE++LL  + H NI+K+
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            +       E     Y+V E+    +L   I S++  ++      + Q+L G+ Y+H   
Sbjct: 92  YEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 159 VLHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP---GKDYV 212
           ++HRDLKP NLLL   + + +++I DFGL+     +  M + + T    + P      Y 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT-AYYIAPEVLHGTYD 205

Query: 213 QQ-----LTMITELL--GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPF---SQKFPN 259
           ++       +I  +L  G P     ++   L+             V K  +     ++  
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKK------------VEKGKYTFELPQWKK 253

Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCP 304
           +S  A DL  +ML + P+ RI+  +AL+H ++ +  +       P
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  158 bits (401), Expect = 1e-45
 Identities = 70/282 (24%), Positives = 130/282 (46%), Gaps = 43/282 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+GA+ +V   V+  T  E A K I     +  D +++ RE ++   + H NIV++ D 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           I     ++ +  Y+V++L+   +L + I +++  ++    + + Q+L  + Y HS  ++H
Sbjct: 97  I-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 151

Query: 162 RDLKPSNLLLNANCD---LKICDFGLARTTSETDFMTEYVVTRWDTLFPG---------K 209
           R+LKP NLLL +      +K+ DFGLA   ++++    +  T      PG          
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT------PGYLSPEVLKKD 205

Query: 210 DYVQQLTM-----ITELL--GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
            Y + + +     I  +L  G P   D+          A  Y    P       S ++  
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY--DYP-------SPEWDT 256

Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
           ++P A  L + ML  +P KRIT ++AL  P++ +   +    
Sbjct: 257 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 298

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  153 bits (389), Expect = 1e-44
 Identities = 72/284 (25%), Positives = 112/284 (39%), Gaps = 50/284 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IGRG++G V  AV   T+   A KKI        D  R  +EI+++  + H NI+++ + 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKY--FVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
                 E   D+Y+V EL    +L + +  K+   +      +  +L  + Y H  NV H
Sbjct: 75  F-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAH 129

Query: 162 RDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPG--------KD 210
           RDLKP N L    + +  LK+ DFGLA        M   V T      P           
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGT------PYYVSPQVLEGL 183

Query: 211 YVQQLTM-----ITELL--GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPF---SQKF 257
           Y  +        +  +L  G P     +D   +              + +  F    + +
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK------------IREGTFTFPEKDW 231

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
            N+SP A  L  R+L   P +RIT  +AL H +       +   
Sbjct: 232 LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRN 275

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  154 bits (392), Expect = 1e-44
 Identities = 58/291 (19%), Positives = 120/291 (41%), Gaps = 52/291 (17%)

Query: 32  VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM 91
            ++ Y+   + +GRG + +V   ++  T +E A K +      +     IL EI +L   
Sbjct: 26  FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELA 85

Query: 92  TH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DL-HQII-RSKQALTDDHCQYFLYQL 147
                ++ + ++      E  +++ ++ E     ++    +    + ++++     + Q+
Sbjct: 86  KSCPRVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQI 140

Query: 148 LRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMT------EYV 198
           L G+ Y+H  N++H DLKP N+LL       D+KI DFG++R       +       EY+
Sbjct: 141 LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL 200

Query: 199 ---VTRWDTLFPGKD--------YVQQLTMITELL-GSP---DDSDLGFLRSDNARRYVK 243
              +  +D +    D        Y+        LL  +     + +     + +      
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYM--------LLTHTSPFVGEDNQETYLNISQVNV-- 250

Query: 244 QLPHVPKQPF-SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
                    +  + F ++S +A D  + +LV +P KR T E  L+H +L  
Sbjct: 251 --------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  154 bits (391), Expect = 1e-44
 Identities = 70/282 (24%), Positives = 124/282 (43%), Gaps = 54/282 (19%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           +G G + IV       T  E A K I    + A    +  + I RE+ +L  + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           + D+      E   DV ++ EL+   +L   +  K++L+++    F+ Q+L G+ Y+H+ 
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 158 NVLHRDLKPSNLLL----NANCDLKICDFGLARTTSETDFMT------EYV---VTRWDT 204
            + H DLKP N++L         +K+ DFGLA    +           E+V   +  ++ 
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194

Query: 205 LFPGKD--------YVQQLTMITELL-GSP---DDSDLGFLRSDNARRYVKQLPHVPKQP 252
           L    D        Y+        LL G+     D+    L +  +  Y           
Sbjct: 195 LGLEADMWSIGVITYI--------LLSGASPFLGDTKQETLANITSVSY----------D 236

Query: 253 F-SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           F  + F + S +A D   ++LV +  KR+T++EAL HP+++ 
Sbjct: 237 FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  153 bits (388), Expect = 1e-44
 Identities = 61/273 (22%), Positives = 115/273 (42%), Gaps = 48/273 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G V       +  E  IK I     +++  ++I  EI++L  + H NI+K+ ++
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 103 IPPMDKEKFNDVYIVYELMD-----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                 E ++++YIV E  +       +       +AL++ +    + Q++  L Y HS 
Sbjct: 89  F-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143

Query: 158 NVLHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPG------ 208
           +V+H+DLKP N+L    + +  +KI DFGLA      +  T    T              
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT------ALYMAPEV 197

Query: 209 --KDYVQQLTM-----ITELL--GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPFSQK 256
             +D   +  +     +   L  G       S     +    +             ++ +
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN----------YAVE 247

Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHP 289
              ++P A+DL ++ML  DP +R +  + L+H 
Sbjct: 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  154 bits (391), Expect = 2e-44
 Identities = 79/307 (25%), Positives = 133/307 (43%), Gaps = 48/307 (15%)

Query: 42  PIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
            +G+G +       +++TKE  A K +  +        +++  EI +   + H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 101 DIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                   E  + V++V EL     L ++ + ++ALT+   +Y+L Q++ G +Y+H   V
Sbjct: 108 GFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 162

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTL-----------FPG 208
           +HRDLK  NL LN + ++KI DFGLA T  E D        R   L              
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYD------GERKKVLCGTPNYIAPEVLSK 215

Query: 209 KDYVQQL-------TMITELLGSP--DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
           K +  ++        M T L+G P  + S L         R  K    +P         +
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEYSIP--------KH 263

Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT--CPYPFNFDFEQTSMN 317
           ++PVA  L ++ML  DP  R T+ E LN  + +S +     P      P  F    +S++
Sbjct: 264 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLD 323

Query: 318 EEDIKEL 324
             + K L
Sbjct: 324 PSNRKPL 330

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  154 bits (392), Expect = 2e-44
 Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 54/290 (18%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           +G G + IV       T  E A K I    + A    +  + I RE+ +L  + H NI+ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           + D+      E   DV ++ EL+   +L   +  K++L+++    F+ Q+L G+ Y+H+ 
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 158 NVLHRDLKPSNLLL----NANCDLKICDFGLARTTSETDFMT------EYV---VTRWDT 204
            + H DLKP N++L         +K+ DFGLA    +           E+V   +  ++ 
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194

Query: 205 LFPGKD--------YVQQLTMITELL-GSP---DDSDLGFLRSDNARRYVKQLPHVPKQP 252
           L    D        Y+        LL G+     D+    L +  A  Y           
Sbjct: 195 LGLEADMWSIGVITYI--------LLSGASPFLGDTKQETLANITAVSY----------D 236

Query: 253 F-SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
           F  + F   S +A D   ++LV +  KR+T++EAL HP+++ +       
Sbjct: 237 FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMV 286

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  153 bits (390), Expect = 2e-44
 Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 54/282 (19%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           +G G + +V       T  + A K I    T +    +  + I RE+ +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      E   DV ++ EL+   +L   +  K++LT++    FL Q+L G+ Y+HS 
Sbjct: 79  LHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133

Query: 158 NVLHRDLKPSNLLL----NANCDLKICDFGLARTTSETDFMT------EYV---VTRWDT 204
            + H DLKP N++L         +KI DFGLA      +         E+V   +  ++ 
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193

Query: 205 LFPGKD--------YVQQLTMITELL-GSP---DDSDLGFLRSDNARRYVKQLPHVPKQP 252
           L    D        Y+        LL G+     D+    L + +A  Y           
Sbjct: 194 LGLEADMWSIGVITYI--------LLSGASPFLGDTKQETLANVSAVNYE---------- 235

Query: 253 F-SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           F  + F N S +A D   R+LV DP KR+T++++L HP++  
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  152 bits (387), Expect = 3e-44
 Identities = 60/291 (20%), Positives = 106/291 (36%), Gaps = 46/291 (15%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           P+Q +GRG +G+V  A N       AIK+I    +  +  ++++RE+K L  + H  IV+
Sbjct: 9   PIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVR 67

Query: 99  VKD-------IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALT---DDHCQYFLYQL 147
             +                   +YI  +L    +L   +  +  +       C +   Q+
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127

Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
              ++++HS  ++HRDLKPSN+    +  +K+ DFGL     + +            L P
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ-------TVLTP 180

Query: 208 GKDYVQQLTMI-T------ELL-GSPDD--SD---LG----------FLRSDNARRYVKQ 244
              Y +    + T      E + G+      D   LG            + +  R     
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTD- 239

Query: 245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
              V    F   F    P    + + ML   P +R      + +     L 
Sbjct: 240 ---VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  152 bits (386), Expect = 7e-44
 Identities = 66/280 (23%), Positives = 117/280 (41%), Gaps = 52/280 (18%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +GRG +GIV   V + +K+    K +        D   + +EI +L    H NI+ + + 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHES 69

Query: 103 IPPMDKEKFNDVYIVYELMD-TDLH-QIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                 E   ++ +++E +   D+  +I  S   L +     +++Q+   L+++HS N+ 
Sbjct: 70  F-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 161 HRDLKPSNLLLNA--NCDLKICDFGLARTTSETDFMT------EYV---VTRWDTLFPGK 209
           H D++P N++     +  +KI +FG AR     D         EY    V + D +    
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 210 D--------YVQQLTMITELL-GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPF-SQK 256
           D        YV        LL G      +++   + +     Y           F  + 
Sbjct: 185 DMWSLGTLVYV--------LLSGINPFLAETNQQIIENIMNAEYT----------FDEEA 226

Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
           F  +S  A+D  +R+LV +   R+T  EAL HP+L    E
Sbjct: 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  152 bits (387), Expect = 2e-43
 Identities = 77/318 (24%), Positives = 135/318 (42%), Gaps = 52/318 (16%)

Query: 2   ENESMVMKDRGIPLYGGKYVQYNILGNLFQVSSKY-VPPLQPIGRGAYGIVCSAVNSETK 60
           +++        IP     +    +      V+S Y V   + +G G +G V     + T 
Sbjct: 55  KSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATG 114

Query: 61  EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYEL 120
            ++A K I        D + +  EI ++  + H N++++ D       E  ND+ +V E 
Sbjct: 115 LKLAAKII--KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEY 167

Query: 121 MDT-DLH-QIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL--NANCD 176
           +D  +L  +II     LT+     F+ Q+  G++++H   +LH DLKP N+L        
Sbjct: 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ 227

Query: 177 LKICDFGLARTTSETDFMT------EYV---VTRWDTLFPGKD--------YVQQLTMIT 219
           +KI DFGLAR     + +       E++   V  +D +    D        Y+       
Sbjct: 228 IKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYM------- 280

Query: 220 ELL-GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPF-SQKFPNMSPVAIDLAERMLVF 274
            LL G      D+D   L +  A R+              ++F ++S  A +   ++L+ 
Sbjct: 281 -LLSGLSPFLGDNDAETLNNILACRW----------DLEDEEFQDISEEAKEFISKLLIK 329

Query: 275 DPAKRITVEEALNHPYLS 292
           + + RI+  EAL HP+LS
Sbjct: 330 EKSWRISASEALKHPWLS 347

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  150 bits (382), Expect = 2e-43
 Identities = 61/273 (22%), Positives = 92/273 (33%), Gaps = 47/273 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVK 98
           L  +G G+YG V    + E     A+K+  + F    D  R L E+     +  H   V+
Sbjct: 62  LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQII-RSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           ++        E+   +Y+  EL    L Q       +L +     +L   L  L ++HS 
Sbjct: 122 LEQAW-----EEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT-RWDTLFPGKDYVQQLT 216
            ++H D+KP+N+ L      K+ DFGL                 R+              
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRY-------------- 222

Query: 217 MITELLGSPDD--SD---LG-------------FLRSDNARRYVKQLPHVPKQPFSQKFP 258
           M  ELL       +D   LG                    +     LP  P+        
Sbjct: 223 MAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--PEFT-----A 275

Query: 259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            +S     +   ML  DP  R T E  L  P L
Sbjct: 276 GLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  152 bits (387), Expect = 2e-43
 Identities = 63/285 (22%), Positives = 114/285 (40%), Gaps = 51/285 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G+V   V   T      K I       +D   +  EI ++  + H  ++ + D 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDA 116

Query: 103 IPPMDKEKFNDVYIVYELMD-TDLH-QIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                 E   ++ ++ E +   +L  +I      +++     ++ Q   GLK++H  +++
Sbjct: 117 F-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171

Query: 161 HRDLKPSNLLL--NANCDLKICDFGLARTTSETDFMT------EYV---VTRWDTLFPGK 209
           H D+KP N++        +KI DFGLA   +  + +       E+    +   + +    
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 231

Query: 210 D--------YVQQLTMITELL-GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPF-SQK 256
           D        YV        LL G      + DL  L++     +           F    
Sbjct: 232 DMWAIGVLGYV--------LLSGLSPFAGEDDLETLQNVKRCDWE----------FDEDA 273

Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
           F ++SP A D  + +L  +P KR+TV +AL HP+L   H      
Sbjct: 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  154 bits (392), Expect = 3e-43
 Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 48/283 (16%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G++G V    +  T++E A+K I  A     D   ILRE++LL  + H NI+K+ +I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           +     E  +  YIV EL    +L   I  ++  ++      + Q+  G+ Y+H  N++H
Sbjct: 90  L-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144

Query: 162 RDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPG--------KD 210
           RDLKP N+LL     +CD+KI DFGL+    +   M + + T                  
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT------AYYIAPEVLRGT 198

Query: 211 YVQQ-----LTMIT-ELL-GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPF---SQKF 257
           Y ++       +I   LL G+P     ++   L+             V    +     ++
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR------------VETGKYAFDLPQW 246

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE 300
             +S  A DL  +ML F P+ RIT  + L HP++         
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  150 bits (381), Expect = 3e-43
 Identities = 71/273 (26%), Positives = 114/273 (41%), Gaps = 40/273 (14%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + +G GA+  V       T +  A+K I  +         +  EI +L  + HENIV ++
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 101 DIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           DI      E     Y+V +L+   +L   I  +   T+      + Q+L  +KY+H   +
Sbjct: 73  DIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127

Query: 160 LHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMT-----EYVVTRWDTLFPGKDY 211
           +HRDLKP NLL      N  + I DFGL++        T      YV      +   K Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVA---PEVLAQKPY 184

Query: 212 VQQLTM-----ITELL--GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPF-SQKFPNM 260
            + +       IT +L  G P   ++++           Y           F S  + ++
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE----------FESPFWDDI 234

Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           S  A D    +L  DP +R T E+AL+HP++  
Sbjct: 235 SESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  150 bits (380), Expect = 5e-43
 Identities = 47/297 (15%), Positives = 95/297 (31%), Gaps = 59/297 (19%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+GA   V    + +T +  AIK   N    R      +RE ++L  + H+NIVK+  I
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKYIHSAN 158
               ++       ++ E      L+ ++        L +      L  ++ G+ ++    
Sbjct: 76  E---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132

Query: 159 VLHRDLKPSNLLLNANCD----LKICDFGLARTTSETDFMT-----------EYVVTRWD 203
           ++HR++KP N++     D     K+ DFG AR   + +              +       
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVL 192

Query: 204 TLFPGKDY------------------------------VQQLTMITELLGSPDDSDLGFL 233
                K Y                                +  M   + G P  +  G  
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252

Query: 234 RSDNAR-RYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHP 289
           +++N    +   +P             +  +   +   +L  D  K    ++     
Sbjct: 253 KAENGPIDWSGDMPVSCSLS-----RGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  153 bits (389), Expect = 7e-43
 Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 34/279 (12%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           + +G GAYG V    +  T  E AIK I     +     ++L E+ +L  + H NI+K+ 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 101 DIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           D       E   + Y+V E     +L   I  +    +      + Q+L G+ Y+H  N+
Sbjct: 103 DFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157

Query: 160 LHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP---GKDYVQ 213
           +HRDLKP NLLL     +  +KI DFGL+        M E + T    + P    K Y +
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT-AYYIAPEVLRKKYDE 216

Query: 214 Q-----LTMITELL--GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPF-SQKFPNMSP 262
           +     + +I  +L  G P     +D   LR     +Y           F S ++ N+S 
Sbjct: 217 KCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY----------TFDSPEWKNVSE 266

Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
            A DL ++ML FD  +RI+ ++AL HP++  +    E  
Sbjct: 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESG 305

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  148 bits (377), Expect = 9e-43
 Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 46/270 (17%)

Query: 42  PIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
            +G+G +       +++TKE  A K +  +        +++  EI +   + H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 101 DIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
                   E  + V++V EL     L ++ + ++ALT+   +Y+L Q++ G +Y+H   V
Sbjct: 82  GFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 136

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTL-----------FPG 208
           +HRDLK  NL LN + ++KI DFGLA T  E D        R   L              
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYD------GERKKVLCGTPNYIAPEVLSK 189

Query: 209 KDYVQQL-------TMITELLGSP--DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
           K +  ++        M T L+G P  + S L         R  K    +P         +
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEYSIP--------KH 237

Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNHP 289
           ++PVA  L ++ML  DP  R T+ E LN  
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLNDE 267

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  153 bits (389), Expect = 2e-42
 Identities = 61/276 (22%), Positives = 114/276 (41%), Gaps = 51/276 (18%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G GA+G+V       T    A K +     +  D + + +EI+ +  + H  +V + D 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFV--MTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222

Query: 103 IPPMDKEKFNDVYIVYELMD-TDL-HQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
                 E  N++ ++YE M   +L  ++      +++D    ++ Q+ +GL ++H  N +
Sbjct: 223 F-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277

Query: 161 HRDLKPSNLLL--NANCDLKICDFGLARTTSETDFMT------EYV---VTRWDTLFPGK 209
           H DLKP N++     + +LK+ DFGL         +       E+    V     +    
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 337

Query: 210 D--------YVQQLTMITELL-GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPF-SQK 256
           D        Y+        LL G      ++D   LR+  +  +                
Sbjct: 338 DMWSVGVLSYI--------LLSGLSPFGGENDDETLRNVKSCDWN----------MDDSA 379

Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
           F  +S    D   ++L+ DP  R+T+ +AL HP+L+
Sbjct: 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  147 bits (372), Expect = 1e-41
 Identities = 76/278 (27%), Positives = 120/278 (43%), Gaps = 50/278 (17%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
             +GRGA  IV       T++  A+K +       +D K +  EI +L  ++H NI+K+K
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 101 DIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
           +I      E   ++ +V EL+   +L   I  K   ++      + Q+L  + Y+H   +
Sbjct: 115 EIF-----ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169

Query: 160 LHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTE------YV---VTRWDTLFP 207
           +HRDLKP NLL      +  LKI DFGL++       M        Y    + R      
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR------ 223

Query: 208 GKDYVQQLTM-----ITELL--GSP----DDSDLGFLRSDNARRYVKQLPHVPKQPF-SQ 255
           G  Y  ++ M     IT +L  G      +  D    R      Y           F S 
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY----------FISP 273

Query: 256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
            +  +S  A DL  +++V DP KR+T  +AL HP+++ 
Sbjct: 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  147 bits (372), Expect = 2e-41
 Identities = 71/290 (24%), Positives = 127/290 (43%), Gaps = 52/290 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNR--IDAKRILREIKLLCHMTHENIVKV 99
           IG+G + +V   +N ET ++ A+K +    F +   +  + + RE  +   + H +IV++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDL-HQIIRSKQA---LTDDHCQYFLYQLLRGLKYI 154
            +            +Y+V+E MD  DL  +I++   A    ++    +++ Q+L  L+Y 
Sbjct: 92  LETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 155 HSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSETD-FMTEYVVTRWDTLFPG-- 208
           H  N++HRD+KP  +LL     +  +K+  FG+A    E+       V T      P   
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT------PHFM 200

Query: 209 -------KDYVQQLTM-----ITELL--GSP--DDSDLGFLRSDNARRYVKQLPHVPKQP 252
                  + Y + + +     I  +L  G      +           +Y           
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY----------K 250

Query: 253 F-SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
              +++ ++S  A DL  RML+ DPA+RITV EALNHP+L        + 
Sbjct: 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKI 300

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  150 bits (380), Expect = 2e-41
 Identities = 75/296 (25%), Positives = 121/296 (40%), Gaps = 55/296 (18%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI-----------TNAFDNRIDAKRILREIKLLCHM 91
           +G GAYG V          E AIK I            +  +     + I  EI LL  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRG 150
            H NI+K+ D+      E     Y+V E  +  +L + I ++    +      + Q+L G
Sbjct: 104 DHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158

Query: 151 LKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
           + Y+H  N++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T       
Sbjct: 159 ICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT------A 212

Query: 208 G--------KDYVQQ-----LTMIT-ELL-GSP---DDSDLGFLRSDNARRYVKQLPHVP 249
                    K Y ++       +I   LL G P     +D   ++     +Y        
Sbjct: 213 YYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY-------- 264

Query: 250 KQPF-SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCP 304
              F    + N+S  A +L + ML +D  KR T EEALN  ++        +    
Sbjct: 265 --YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  148 bits (376), Expect = 2e-41
 Identities = 61/294 (20%), Positives = 102/294 (34%), Gaps = 43/294 (14%)

Query: 28  NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL 87
           ++  V      P   +G GA G +          +VA+K+I              RE++L
Sbjct: 17  SVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRI-----LPECFSFADREVQL 70

Query: 88  LCHMT-HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ-ALTDDHCQYFLY 145
           L     H N+++          +     YI  EL    L + +  K  A         L 
Sbjct: 71  LRESDEHPNVIRYFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ 125

Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLL-----NANCDLKICDFGLARTTSETDFMTEYVVT 200
           Q   GL ++HS N++HRDLKP N+L+     +      I DFGL +  +           
Sbjct: 126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185

Query: 201 RWDTLF----------PGKDY-----VQQLTMIT-ELL--GSPDDSDLGFLRSDNARRYV 242
              T              ++      +     +   ++  GS            + +R  
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-------PFGKSLQRQA 238

Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
             L             +   +A +L E+M+  DP KR + +  L HP+  SL +
Sbjct: 239 NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  148 bits (375), Expect = 4e-41
 Identities = 71/284 (25%), Positives = 124/284 (43%), Gaps = 46/284 (16%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+GA+ +V   V     +E A   I     +  D +++ RE ++   + H NIV++ D 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           I      +    Y++++L+   +L + I +++  ++    + + Q+L  + + H   V+H
Sbjct: 79  I-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVH 133

Query: 162 RDLKPSNLLL---NANCDLKICDFGLART-TSETDFMTEYVVTRWDTLFPG--------- 208
           R+LKP NLLL        +K+ DFGLA     E      +  T      PG         
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT------PGYLSPEVLRK 187

Query: 209 KDYVQQLTM-----ITELL--GSP---DDSDLGFLRSDNARRYVKQLPHVPKQPF-SQKF 257
             Y + + +     I  +L  G P   D+      +   A  Y           F S ++
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD----------FPSPEW 237

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
             ++P A DL  +ML  +P+KRIT  EAL HP++S    +    
Sbjct: 238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCM 281

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  146 bits (371), Expect = 8e-41
 Identities = 73/317 (23%), Positives = 131/317 (41%), Gaps = 69/317 (21%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG+G++G V  A + +  + VA+K + N    +   ++   EI++L H+  ++    
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 100 KDIIPPMDKEKF-NDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHS 156
            ++I  ++   F N + + +EL+  +L+++I+    Q  +    + F + +L+ L  +H 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218

Query: 157 ANVLHRDLKPSNLLLN--ANCDLKICDFGLARTTSETDFMTEYVVTR------------W 202
             ++H DLKP N+LL       +K+ DFG +    E   +  Y+ +R            +
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRAPEVILGARY 276

Query: 203 DT-------------------LFPGKDYVQQLTMITELLGSPDDSDL-------GFLRSD 236
                                L PG+D   QL  + ELLG P    L        F+ S 
Sbjct: 277 GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSK 336

Query: 237 NARRYV-----KQLPHVPKQPFSQKFPNMSPVA----------------IDLAERMLVFD 275
              RY           V     S++     P                  +D  ++ L +D
Sbjct: 337 GYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396

Query: 276 PAKRITVEEALNHPYLS 292
           PA R+T  +AL HP+L 
Sbjct: 397 PAVRMTPGQALRHPWLR 413

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  144 bits (365), Expect = 1e-40
 Identities = 74/316 (23%), Positives = 142/316 (44%), Gaps = 49/316 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG+G +  V  A +  T  EVAIK I     N    +++ RE++++  + H NIVK+ ++
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           I     E    +Y++ E     ++   + +   + +   +    Q++  ++Y H   ++H
Sbjct: 83  I-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVH 137

Query: 162 RDLKPSNLLLNANCDLKICDFGLARTTSETDFMT------EYVVTRWDTLFPGKDY---- 211
           RDLK  NLLL+A+ ++KI DFG +   +    +        Y       LF GK Y    
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE---LFQGKKYDGPE 194

Query: 212 -------VQQLTMITELLGSP-DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
                  V   T+++  L  P D  +L  LR     R ++    +P          MS  
Sbjct: 195 VDVWSLGVILYTLVSGSL--PFDGQNLKELR----ERVLRGKYRIP--------FYMSTD 240

Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
             +L +R LV +P KR T+E+ +   ++++ HE +E      P      +  ++++   +
Sbjct: 241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEP------ELDISDQKRID 294

Query: 324 LILRECLNFHPDHMLE 339
           +++   + +  + + E
Sbjct: 295 IMVG--MGYSQEEIQE 308

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  143 bits (362), Expect = 2e-40
 Identities = 65/299 (21%), Positives = 123/299 (41%), Gaps = 77/299 (25%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI------------------------TNAFDNRIDA 78
           IG+G+YG+V  A N       A+K +                              R   
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 79  KRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE------LMDTDLHQIIRSK 132
           +++ +EI +L  + H N+VK+ +++   +++    +Y+V+E      +M+      + + 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVME------VPTL 131

Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           + L++D  +++   L++G++Y+H   ++HRD+KPSNLL+  +  +KI DFG++     +D
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 193 FMTE-------Y----VVTRWDTLFPGKD----------YVQQLTMITELLGSP-DDSDL 230
            +         +     ++    +F GK           Y      +      P  D  +
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC----FVFGQC--PFMDERI 245

Query: 231 GFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHP 289
             L      +   Q    P        P+++    DL  RML  +P  RI V E   HP
Sbjct: 246 MCLH----SKIKSQALEFP------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  143 bits (362), Expect = 3e-40
 Identities = 64/325 (19%), Positives = 114/325 (35%), Gaps = 58/325 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT------NAFDNRIDAKRILREIKLLCHMTH 93
           + P+G GA+G V +AV+ E  +EV +K I       + +       ++  EI +L  + H
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDT--DLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            NI+KV DI      E      +V E   +  DL   I     L +    Y   QL+  +
Sbjct: 89  ANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFM------TEYVVTRWDTL 205
            Y+   +++HRD+K  N+++  +  +K+ DFG A                EY       +
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE---V 200

Query: 206 FPGKDY-----------VQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS 254
             G  Y           V   T++                       V+   H P     
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVF-----------EENPFCELEETVEAAIHPP----- 244

Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQT 314
                +S   + L   +L   P +R T+E+ +  P++       +          +  + 
Sbjct: 245 ---YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV------TQPVNLADYTWEEVFRV 295

Query: 315 SMNEEDIKELILRECLNFHPDHMLE 339
           +  E  +      E  N     + +
Sbjct: 296 NKPESGVLSAASLEMGNRSLSDVAQ 320

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  142 bits (360), Expect = 7e-40
 Identities = 82/313 (26%), Positives = 139/313 (44%), Gaps = 49/313 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G++G V  A + +T+++VA+K I+           R+ REI  L  + H +I+K+ D
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 102 IIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           +I         D+ +V E    +L   I  K+ +T+D  + F  Q++  ++Y H   ++H
Sbjct: 77  VI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH 131

Query: 162 RDLKPSNLLLNANCDLKICDFGLARTTSETDFMT------EYVVTRWDTLFPGKDY---- 211
           RDLKP NLLL+ N ++KI DFGL+   ++ +F+        Y       +  GK Y    
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE---VINGKLYAGPE 188

Query: 212 -------VQQLTMITELLGSP-DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
                  +    M+   L  P DD  +  L     ++    +  +P          +SP 
Sbjct: 189 VDVWSCGIVLYVMLVGRL--PFDDEFIPNLF----KKVNSCVYVMP--------DFLSPG 234

Query: 264 AIDLAERMLVFDPAKRITVEEALNHP--------YLSSLHEINEEPTCPYPFNFDFEQTS 315
           A  L  RM+V DP +RIT++E    P        YL  + E+          +   E   
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMG 294

Query: 316 MNEEDIKELILRE 328
            +E+ I E +  +
Sbjct: 295 FSEDYIVEALRSD 307

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  141 bits (357), Expect = 1e-39
 Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 53/297 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKIT----NAFDNRIDAKRILREIKLL----CHMTHE 94
           +G+G +G V +      + +VAIK I       +    D+     E+ LL        H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT--DLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
            ++++ D       E      +V E      DL   I  K  L +   + F  Q++  ++
Sbjct: 99  GVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153

Query: 153 YIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSETDFMT-----EYVVTRWDTLF 206
           + HS  V+HRD+K  N+L++      K+ DFG      +  +        Y    W    
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEW---I 210

Query: 207 PGKDYVQQLTMITELLGSPDDS--------DL--GFLRSDNARRYVKQLPHVPKQPFSQK 256
               Y             P           D+  G +  +  +  ++   H P       
Sbjct: 211 SRHQY----------HALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFP------- 253

Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL-SSLHEINEEPTCPYPFNFDFE 312
             ++SP    L  R L   P+ R ++EE L  P++ +   ++   P+   P    + 
Sbjct: 254 -AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWS 309

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  141 bits (358), Expect = 1e-39
 Identities = 70/353 (19%), Positives = 125/353 (35%), Gaps = 95/353 (26%)

Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA---FD 73
            G+   Y   G+L ++  KY      IG+G+YG+V  A+ ++T+   AIK +        
Sbjct: 9   SGRENLYFQGGSLLELQKKYHL-KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI 67

Query: 74  NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELM------------ 121
           N  D +RI  E++L+  + H NI ++ ++      E    + +V EL             
Sbjct: 68  NPKDVERIKTEVRLMKKLHHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVF 122

Query: 122 -----------------------------DTDLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
                                         +             +      + Q+   L 
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182

Query: 153 YIHSANVLHRDLKPSNLLL--NANCDLKICDFGLAR-----TTSETDFMTE------YV- 198
           Y+H+  + HRD+KP N L   N + ++K+ DFGL++        E   MT       +V 
Sbjct: 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

Query: 199 --VTRWDTLFPGKDYVQQLTM-----IT-ELL-GSP---DDSDLGFLRSDNARRYVKQLP 246
             V         + Y  +        +   LL G+      +D   +             
Sbjct: 243 PEVLN----TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ----------- 287

Query: 247 HVPKQPF---SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
            V  +     +  +  +SP+A DL   +L  +  +R     AL HP++S   +
Sbjct: 288 -VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  141 bits (357), Expect = 1e-39
 Identities = 61/294 (20%), Positives = 110/294 (37%), Gaps = 56/294 (19%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHE--NI 96
           +G G +G V S +       VAIK +     + +    +  R+  E+ LL  ++     +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT--DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           +++ D       E+ +   ++ E  +   DL   I  + AL ++  + F +Q+L  +++ 
Sbjct: 111 IRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 165

Query: 155 HSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTSETDFMT-----EYVVTRWDTLFPG 208
           H+  VLHRD+K  N+L++ N  +LK+ DFG      +T +        Y    W      
Sbjct: 166 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW---IRY 222

Query: 209 KDYVQQLTMITELLGSPDDS--------DL--GFLRSDNARRYVKQLPHVPKQPFSQKFP 258
             Y           G             D+  G +  ++    ++               
Sbjct: 223 HRY----------HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--------Q 264

Query: 259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYL------SSLHEINEEPTCPYP 306
            +S     L    L   P+ R T EE  NHP++          EI+     P P
Sbjct: 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGP 318

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  140 bits (355), Expect = 2e-39
 Identities = 56/290 (19%), Positives = 99/290 (34%), Gaps = 36/290 (12%)

Query: 27  GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           G++  + +K+   +Q +G G +  V            A+K+I      + D +   RE  
Sbjct: 21  GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREAD 78

Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII----RSKQALTDDHCQ 141
           +     H NI+++       ++   ++ +++        L   I         LT+D   
Sbjct: 79  MHRLFNHPNILRLVAYCL-RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
           + L  + RGL+ IH+    HRDLKP+N+LL       + D G              V   
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH------VEGS 191

Query: 202 WDTLFPGKDYVQQLT-------MITELLGSPDD--SD---LG-------FLRS--DNARR 240
              L       Q+ T       + +       D  +D   LG       F     D   +
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251

Query: 241 YVKQLPHVPKQPFSQ-KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHP 289
               +    +   S  + P  S     L   M+  DP +R  +   L+  
Sbjct: 252 KGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  140 bits (356), Expect = 3e-39
 Identities = 73/318 (22%), Positives = 128/318 (40%), Gaps = 64/318 (20%)

Query: 17  GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI 76
           G   +   +  N  Q +  Y    + IG G+Y +    ++  T  E A+K I     ++ 
Sbjct: 5   GVHSIVQQLHRNSIQFTDGYEV-KEDIGVGSYSVCKRCIHKATNMEFAVKIID---KSKR 60

Query: 77  DAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA 134
           D      EI++L     H NI+ +KD+      +    VY+V ELM   +L   I  ++ 
Sbjct: 61  DPTE---EIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKF 112

Query: 135 LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLAR-TTS 189
            ++      L+ + + ++Y+H+  V+HRDLKPSN+L          ++ICDFG A+   +
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172

Query: 190 ETDFMTEYVVTRWDTLFPGKDYV------QQ-------------LTMITELL-------G 223
           E   +     T          +V      +Q             L     +L        
Sbjct: 173 ENGLLMTPCYT------AN--FVAPEVLERQGYDAACDIWSLGVLLYT--MLTGYTPFAN 222

Query: 224 SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVE 283
            PDD+    L    + ++   L           + ++S  A DL  +ML  DP +R+T  
Sbjct: 223 GPDDTPEEILARIGSGKF--SLS-------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273

Query: 284 EALNHPYLSSLHEINEEP 301
             L HP++    ++ +  
Sbjct: 274 LVLRHPWIVHWDQLPQYQ 291

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  138 bits (349), Expect = 7e-39
 Identities = 62/274 (22%), Positives = 118/274 (43%), Gaps = 52/274 (18%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI--TNAFDNRIDAKRILREIKLLCHMTHENIV 97
            +P+G+G +G V  A   ++K  +A+K +         +   ++ RE+++  H+ H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRHPNIL 72

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           ++       D  +   VY++ E      +++ ++      +     ++ +L   L Y HS
Sbjct: 73  RLYGYF--HDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTL----------- 205
             V+HRD+KP NLLL +  +LKI DFG +              +R   L           
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---------SRRTDLCGTLDYLPPEM 178

Query: 206 FPGKDYVQQL------TMITELL-GSP--DDSDLGFLRSDNARRYVKQLPHVPKQPFSQK 256
             G+ + +++       +  E L G P  + +            Y +    + +  F   
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKR----ISRVEF--T 225

Query: 257 FPN-MSPVAIDLAERMLVFDPAKRITVEEALNHP 289
           FP+ ++  A DL  R+L  +P++R  + E L HP
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  137 bits (348), Expect = 9e-39
 Identities = 71/281 (25%), Positives = 112/281 (39%), Gaps = 66/281 (23%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIK-----KITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           +G GAYG V  AVN  T+E VA+K     +  +        + I +EI +   + HEN+V
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD------CPENIKKEICINKMLNHENVV 68

Query: 98  KVKDIIPPMDKEKFNDVYIV--Y----ELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           K           + N  Y+   Y    EL D      I     + +   Q F +QL+ G+
Sbjct: 69  KFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLMAGV 118

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDT------- 204
            Y+H   + HRD+KP NLLL+   +LKI DFGLA T    +     +     T       
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 205 LFPGKDYVQQLTMITELLGSPDDSDL------------GFL----RSDNARRYVKQLPHV 248
           L   +++             P   D+            G L     SD+ + Y       
Sbjct: 178 LLKRREFH----------AEP--VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---K 222

Query: 249 PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHP 289
            K+ +   +  +    + L  ++LV +P+ RIT+ +     
Sbjct: 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  140 bits (354), Expect = 1e-38
 Identities = 70/324 (21%), Positives = 111/324 (34%), Gaps = 80/324 (24%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLL----------- 88
           ++ +G G +  V  A +      VA+K +     +++  +    EIKLL           
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 89  CHMTHENIVKVKD---IIPPMDKEKFNDVYIVYELMDTDLHQIIRS--KQALTDDHCQYF 143
             M   +I+K+ D      P        V +V+E++  +L  +I+    + +   + +  
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVH----VVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136

Query: 144 LYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCD------LKICDFGLARTTSETDFMTE 196
             QLL GL Y+H    ++H D+KP N+L+           +KI D G A    E    T 
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTN 194

Query: 197 YVVTR------------WDT-------------------LFPGKDY------VQQLTMIT 219
            + TR            W                     LF   +          +  I 
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254

Query: 220 ELLGSPDDSDL-------GFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA----IDLA 268
           ELLG      L        F  S    R + +L   P +    +    S        D  
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 269 ERMLVFDPAKRITVEEALNHPYLS 292
             ML  DP KR      +NHP+L 
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLK 338

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  137 bits (347), Expect = 1e-38
 Identities = 64/272 (23%), Positives = 110/272 (40%), Gaps = 52/272 (19%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G +G V    +  T  +VA+K +      +     +I REI+ L    H +I+K+  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +I         D ++V E +   +L   I     + +   +    Q+L  + Y H   V+
Sbjct: 79  VI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133

Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDT-----------LFPGK 209
           HRDLKP N+LL+A+ + KI DFGL+   S+ +F+         T           +  G+
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--------RTSCGSPNYAAPEVISGR 185

Query: 210 DY-----------VQQLTMITELLGSP-DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF 257
            Y           V    ++   L  P DD  +  L     ++    + ++P        
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTL--PFDDEHVPTLF----KKIRGGVFYIP-------- 231

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHP 289
             ++     L   ML  DP KR T+++   H 
Sbjct: 232 EYLNRSVATLLMHMLQVDPLKRATIKDIREHE 263

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  141 bits (356), Expect = 2e-38
 Identities = 64/308 (20%), Positives = 108/308 (35%), Gaps = 67/308 (21%)

Query: 31  QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCH 90
            + +  V   + +G G+ G V     S     VA+K++   F +         EIKLL  
Sbjct: 12  SLKNLVVSE-KILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL-----MEIKLLTE 64

Query: 91  MT-HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ-------ALTDDHCQY 142
              H N+++               +YI  EL + +L  ++ SK           + +   
Sbjct: 65  SDDHPNVIRYYCSE-----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119

Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLL-------------NANCDLKICDFGLARTTS 189
            L Q+  G+ ++HS  ++HRDLKP N+L+               N  + I DFGL +   
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 190 ETDFM----------TEY-----VVTRWDTLFPGKDY-----VQQLTMIT-ELL--GSP- 225
                          T       ++   + L   +       +  +  +   +L  G   
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

Query: 226 --DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVE 283
             D       R  N  R +  L  +          ++   A DL  +M+  DP KR T  
Sbjct: 240 FGDKYS----RESNIIRGIFSLDEMKCLH----DRSLIAEATDLISQMIDHDPLKRPTAM 291

Query: 284 EALNHPYL 291
           + L HP  
Sbjct: 292 KVLRHPLF 299

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  138 bits (349), Expect = 2e-38
 Identities = 72/316 (22%), Positives = 120/316 (37%), Gaps = 66/316 (20%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIK-----KITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           +G GAYG V  AVN  T+E VA+K     +  +        + I +EI +   + HEN+V
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD------CPENIKKEICINKMLNHENVV 68

Query: 98  KVKDIIPPMDKEKFNDVYIV--Y----ELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
           K           + N  Y+   Y    EL D      I     + +   Q F +QL+ G+
Sbjct: 69  KFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLMAGV 118

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDT------- 204
            Y+H   + HRD+KP NLLL+   +LKI DFGLA T    +     +     T       
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 205 LFPGKDYVQQLTMITELLGSPDDSDL------------GFL----RSDNARRYVKQLPHV 248
           L   +++             P   D+            G L     SD+ + Y       
Sbjct: 178 LLKRREFH----------AEP--VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---K 222

Query: 249 PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFN 308
            K+ +   +  +    + L  ++LV +P+ RIT+ +     + +   +   +        
Sbjct: 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGG 282

Query: 309 FDFEQTSMNEEDIKEL 324
                +  ++     L
Sbjct: 283 VSESPSGFSKHIQSNL 298

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  139 bits (352), Expect = 2e-38
 Identities = 47/296 (15%), Positives = 95/296 (32%), Gaps = 59/296 (19%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+GA   V    + +T +  AIK   N    R      +RE ++L  + H+NIVK+  I
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKYIHSAN 158
               ++       ++ E      L+ ++        L +      L  ++ G+ ++    
Sbjct: 76  E---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132

Query: 159 VLHRDLKPSNLLLNANCD----LKICDFGLARTTSETDFMT-----------EYVVTRWD 203
           ++HR++KP N++     D     K+ DFG AR   + +              +       
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVL 192

Query: 204 TLFPGKDY------------------------------VQQLTMITELLGSPDDSDLGFL 233
                K Y                                +  M   + G P  +  G  
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252

Query: 234 RSDNAR-RYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           +++N    +   +P             +  +   +   +L  D  K    ++    
Sbjct: 253 KAENGPIDWSGDMPVSCSLS-----RGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  142 bits (360), Expect = 3e-38
 Identities = 56/291 (19%), Positives = 112/291 (38%), Gaps = 43/291 (14%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G G +G V   ++ +T E+VAIK+       + + +R   EI+++  + H N+V  +++
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 103 IPPMDKEKFND-VYIVYELMDT-DLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKYIHSA 157
              + K   ND   +  E  +  DL + +   +    L +   +  L  +   L+Y+H  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 158 NVLHRDLKPSNLLLNANCD---LKICDFGLARTTSETDFMT------EYV---------- 198
            ++HRDLKP N++L         KI D G A+   + +  T      +Y+          
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKY 200

Query: 199 ---VTRWD---TLF-------PGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL 245
              V  W      F       P     Q +    ++    ++  + +     A ++   L
Sbjct: 201 TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVL 260

Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
           P       +     ++       + ML++   +R T  +  N     +L  
Sbjct: 261 P-----TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  137 bits (348), Expect = 5e-38
 Identities = 75/305 (24%), Positives = 128/305 (41%), Gaps = 41/305 (13%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG G +G+     +  TKE VA+K I          + + REI     + H NIV+ K++
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           I          + I+ E     +L++ I +    ++D  ++F  QLL G+ Y HS  + H
Sbjct: 85  I-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query: 162 RDLKPSNLLL--NANCDLKICDFGLARTTSETDFMTEYVVTRWDT-------LFPGKDYV 212
           RDLK  N LL  +    LKICDFG ++++           +   T       +   ++Y 
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEVLLRQEYD 195

Query: 213 QQLTMI--------TELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN---MS 261
            ++  +          L+G+       F   +  R Y K +  +    +    P+   +S
Sbjct: 196 GKIADVWSCGVTLYVMLVGA-----YPFEDPEEPRDYRKTIQRILSVKY--SIPDDIRIS 248

Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHP-YLSSLHEINEEPTCPYPFNFDFEQTSMNEED 320
           P    L  R+ V DPA RI++ E   H  +L +L       +       + EQ   + + 
Sbjct: 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDT 308

Query: 321 IKELI 325
           I ++I
Sbjct: 309 IMQII 313

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  138 bits (350), Expect = 8e-38
 Identities = 55/170 (32%), Positives = 89/170 (52%), Gaps = 16/170 (9%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI------TNAFDNRIDAKRILREIKLLCHMTHE 94
           + +G GA G V  A   +T ++VAI+ I        +      A  +  EI++L  + H 
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            I+K+K+     D E   D YIV ELM+  +L   +   + L +  C+ + YQ+L  ++Y
Sbjct: 201 CIIKIKNFF---DAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 154 IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVT 200
           +H   ++HRDLKP N+LL++   +C +KI DFG ++   ET  M     T
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 17/40 (42%), Positives = 25/40 (62%)

Query: 254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
            + +  +S  A+DL +++LV DP  R T EEAL HP+L  
Sbjct: 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  137 bits (347), Expect = 1e-37
 Identities = 75/347 (21%), Positives = 134/347 (38%), Gaps = 87/347 (25%)

Query: 19  KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA 78
                    + +++          IG+G++G V  A +   +E VAIK I N    +   
Sbjct: 45  IVKNGEKWMDRYEI-------DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFL 94

Query: 79  KRILREIKLLCHMTHENIVKVKDIIPPMDKEKF-NDVYIVYELMDTDLHQIIR--SKQAL 135
            +   E++LL  M   +      I+       F N + +V+E++  +L+ ++R  + + +
Sbjct: 95  NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV 154

Query: 136 TDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLL--NANCDLKICDFGLARTTSET 191
           + +  + F  Q+   L ++ +   +++H DLKP N+LL       +KI DFG +      
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLG 212

Query: 192 DFMTEYVVTR------------WDT-------------------LFPGKDYVQQLTMITE 220
             + +Y+ +R            +D                    LF G + V Q+  I E
Sbjct: 213 QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272

Query: 221 LLGSPDDSDLGFLRSDNARRYVKQLPH-------------VPKQPFSQKFPNMSPVA--- 264
           +LG P    L   ++  AR++ ++LP                K P ++K  N+  V    
Sbjct: 273 VLGIPPAHIL--DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG 330

Query: 265 -------------------IDLAERMLVFDPAKRITVEEALNHPYLS 292
                               DL  RML +DP  RI    AL H +  
Sbjct: 331 PGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  136 bits (344), Expect = 1e-37
 Identities = 57/277 (20%), Positives = 106/277 (38%), Gaps = 43/277 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +GRG++G V    + +T  + A+KK+      R++  R + E+     ++   IV +   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 118

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLH 161
           +      +   V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH
Sbjct: 119 V-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173

Query: 162 RDLKPSNLLLNAN-CDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY------VQQ 214
            D+K  N+LL+++     +CDFG A            +        PG +       V  
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD---YIPGTETHMAPEVVMG 230

Query: 215 LT------------MITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
                         M+  +L G    +           +   + P + + P     P+ +
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLKIASEPPPIREIP-----PSCA 283

Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN 298
           P+     +  L  +P  R +  E       +      
Sbjct: 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  135 bits (343), Expect = 2e-37
 Identities = 43/163 (26%), Positives = 81/163 (49%), Gaps = 8/163 (4%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           LQ IG G++G      ++E   +  IK+I  +  +  + +   RE+ +L +M H NIV+ 
Sbjct: 29  LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQII--RSKQALTDDHCQYFLYQLLRGLKYIHS 156
           ++       E+   +YIV +  +  DL + I  +      +D    +  Q+   LK++H 
Sbjct: 89  RESF-----EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVV 199
             +LHRD+K  N+ L  +  +++ DFG+AR  + T  +    +
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI 186

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  134 bits (339), Expect = 2e-37
 Identities = 64/288 (22%), Positives = 125/288 (43%), Gaps = 50/288 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA----KRILREIKLLCHMTHEN 95
            +P+G+G +G V  A   + K  +A+K +   F ++++      ++ REI++  H+ H N
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKVL---FKSQLEKEGVEHQLRREIEIQSHLRHPN 75

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           I+++ +     D+++   +Y++ E     +L++ ++      +     F+ +L   L Y 
Sbjct: 76  ILRMYNYF--HDRKR---IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT-----EY----VVTRWDTL 205
           H   V+HRD+KP NLL+    +LKI DFG +         T     +Y    ++      
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIE----- 185

Query: 206 FPGKDYVQQL------TMITELL-GSP--DDSDLGFLRSDNARRYVKQLPHVPKQPFSQK 256
             GK + +++       +  E L G P  D            RR V      P       
Sbjct: 186 --GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH----RRIVNVDLKFP------- 232

Query: 257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCP 304
            P +S  + DL  ++L + P +R+ ++  + HP++ +       P   
Sbjct: 233 -PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQ 279

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  132 bits (333), Expect = 3e-36
 Identities = 68/299 (22%), Positives = 119/299 (39%), Gaps = 51/299 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI--TNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +G G+YG V   ++SET    A+K +              + +EI+LL  + H+N++++ 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 101 DIIPPMDKEKFNDVYIVYELM---DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           D++   +K+K   +Y+V E       ++   +  K+         +  QL+ GL+Y+HS 
Sbjct: 73  DVLYNEEKQK---MYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEYLHSQ 128

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFG---LARTTSETDFMT------EYV---VTRWDTL 205
            ++H+D+KP NLLL     LKI   G        +  D          +    +      
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT 188

Query: 206 FPGKD----------YVQQLTMITELLGSP-DDSDLGFLRSDNARRYVKQLPHVPKQPFS 254
           F G            Y     + T L   P +  ++  L         K    +P     
Sbjct: 189 FSGFKVDIWSAGVTLYN----ITTGLY--PFEGDNIYKLF----ENIGKGSYAIP----- 233

Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQ 313
               +  P   DL + ML ++PAKR ++ +   H +    H   E P  P P + D + 
Sbjct: 234 ---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV-PIPPSPDTKD 288

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  133 bits (336), Expect = 3e-36
 Identities = 42/306 (13%), Positives = 84/306 (27%), Gaps = 68/306 (22%)

Query: 42  PIGRGAYGIVCSAVNSETKEEVAIK-----------------------KITNAFDNRIDA 78
            +G+        A + ET E   +                        ++     N+  A
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 79  KRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTD-------LHQIIRS 131
           K  LR I     +      K+  +            + +Y  M ++       L     +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR----- 186
            ++L          Q++R L  +H   ++H  L+P +++L+    + +  F         
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR 259

Query: 187 -TTSET-DFMTEYVVTRWDTLFPGKDYVQQLTMIT----------ELL-GSP---DDSDL 230
             +S +  F    +  R  T+   +D    +T              +         D+ L
Sbjct: 260 VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL 319

Query: 231 GFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
           G                           N+      L E  L +    R+   +A+  P 
Sbjct: 320 GGSEWIFRSC-----------------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362

Query: 291 LSSLHE 296
              L  
Sbjct: 363 YEQLRT 368

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  132 bits (333), Expect = 5e-36
 Identities = 74/330 (22%), Positives = 124/330 (37%), Gaps = 84/330 (25%)

Query: 40  LQPIGRGAYGIVCSAVNSETK-EEVAIKKITNAFDNRIDAK---RILREIKLLCHMTHEN 95
           +  +G GA+G V   ++ +     VA+K + N       A+   ++L  +      +   
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 96  IVKVKDIIPPMDKEKF---NDVYIVYELMDTDLHQIIR--SKQALTDDHCQYFLYQLLRG 150
            V++ +         F     + IV+EL+    +  I+         DH +   YQ+ + 
Sbjct: 79  CVQMLE--------WFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130

Query: 151 LKYIHSANVLHRDLKPSNLLLN-------------------ANCDLKICDFGLARTTSET 191
           + ++HS  + H DLKP N+L                      N D+K+ DFG A  T + 
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDD 188

Query: 192 DFMTEYVVTR------------WD-------------------TLFPGKDYVQQLTMITE 220
           +  +  V TR            W                    T+FP  D  + L M+  
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248

Query: 221 LLGSP--------------DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
           +LG                    L +    +A RYV +     K+    +      +  D
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL-FD 307

Query: 267 LAERMLVFDPAKRITVEEALNHPYLSSLHE 296
           L ++ML +DPAKRIT+ EAL HP+   L +
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFFDLLKK 337

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  134 bits (340), Expect = 5e-36
 Identities = 74/307 (24%), Positives = 131/307 (42%), Gaps = 57/307 (18%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G +G V    +  T  +VA+K +      +     +I REI+ L    H +I+K+  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVL 160
           +I        +D+++V E +   +L   I     L +   +    Q+L G+ Y H   V+
Sbjct: 84  VI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVV 138

Query: 161 HRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDT-----------LFPGK 209
           HRDLKP N+LL+A+ + KI DFGL+   S+ +F+         T           +  G+
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--------RTSCGSPNYAAPEVISGR 190

Query: 210 DY-----------VQQLTMITELLGSP-DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF 257
            Y           V    ++   L  P DD  +  L     ++    + + P        
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTL--PFDDDHVPTLF----KKICDGIFYTP-------- 236

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMN 317
             ++P  I L + ML  DP KR T+++   H +        + P   +P +  +  T ++
Sbjct: 237 QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ-----DLPKYLFPEDPSYSSTMID 291

Query: 318 EEDIKEL 324
           +E +KE+
Sbjct: 292 DEALKEV 298

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  130 bits (329), Expect = 8e-36
 Identities = 58/300 (19%), Positives = 100/300 (33%), Gaps = 70/300 (23%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVK 98
           L+ IG G +G V   V        AIK+        +D +  LRE+     +  H ++V+
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQII----RSKQALTDDHCQYFLYQLLRGLKY 153
                      + + + I  E  +   L   I    R      +   +  L Q+ RGL+Y
Sbjct: 76  YFSAW-----AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 154 IHSANVLHRDLKPSNLLLNAN-------------------CDLKICDFGLARTTSETDFM 194
           IHS +++H D+KPSN+ ++                        KI D G     S     
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190

Query: 195 T--------EYVVTRWDTLFPGKDYVQQ-------LTMITELLGS---PDDSDLGFLRSD 236
                    E  V + +       ++ +       LT++    G+   P + D       
Sbjct: 191 EGDSRFLANE--VLQEN-----YTHLPKADIFALALTVV-CAAGAEPLPRNGDQ------ 236

Query: 237 NARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
                  ++         Q     S    +L + M+  DP +R +    + H  L S   
Sbjct: 237 -----WHEIRQGRLPRIPQVL---SQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  131 bits (332), Expect = 1e-35
 Identities = 61/334 (18%), Positives = 115/334 (34%), Gaps = 96/334 (28%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE----- 94
           ++ +G G +G V    + + K+  A+K + N       AK    E  +L  + ++     
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNN 96

Query: 95  NIVKVKDIIPPMDKEKF---NDVYIVYELMDTDLHQIIR--SKQALTDDHCQYFLYQLLR 149
           NIVK           KF   + + +++E +   L++II   +      +  + +  ++L+
Sbjct: 97  NIVKYHG--------KFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILK 148

Query: 150 GLKYIHSANVLHRDLKPSNLLLN-------------------------ANCDLKICDFGL 184
            L Y+   ++ H DLKP N+LL+                          +  +K+ DFG 
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 185 ARTTSETDFMTEYVVTR-------------------W------------DTLFPGKDYVQ 213
           A  T ++D+    + TR                   W              LF   ++++
Sbjct: 209 A--TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266

Query: 214 QLTMITELLGSPD----------------DSDLGFLRSDNARRYVKQLPHVPKQPFSQKF 257
            L M+  ++                    + D   L        +  + HV K       
Sbjct: 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL-PLYK 325

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                +  D    +L  DP  R +  E L H +L
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  131 bits (331), Expect = 3e-35
 Identities = 39/304 (12%), Positives = 74/304 (24%), Gaps = 69/304 (22%)

Query: 42  PIGRGAYGIVCSAVNSETKEEVAIKKIT----------NAFDNRIDAKRILREIK----- 86
            +G+        A + ET E   +                    +   R+LR IK     
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 87  --------LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS------- 131
                       +      K+  +            + +Y  M ++L             
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 132 KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR----- 186
            ++L          Q++R L  +H   ++H  L+P +++L+    + +  F         
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264

Query: 187 --TTSETDFMT-EYVVTRWDTLFPGKDYVQQLTMITELLGSPDDS-DLG----------- 231
             +     F   E    R                   L+    D+  LG           
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHH---------PTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 232 -FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
                                       N+      L E  L +    R+   +A+  P 
Sbjct: 316 PNTDDAALGGSEWIFRSC---------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366

Query: 291 LSSL 294
              L
Sbjct: 367 YEQL 370

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  130 bits (329), Expect = 3e-35
 Identities = 78/350 (22%), Positives = 129/350 (36%), Gaps = 91/350 (26%)

Query: 19  KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRID 77
                + L   +++       +  +G G +G V   + ++  K +VA+K I N    R  
Sbjct: 10  VCRIGDWLQERYEI-------VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 62

Query: 78  AK---RILREIKLLCHMTHENIVKVKDIIPPMDKEKF---NDVYIVYELMDTDLHQIIR- 130
           A+    +L++IK          V + D         F     + I +EL+  +  + ++ 
Sbjct: 63  ARLEINVLKKIKEKDKENKFLCVLMSD--------WFNFHGHMCIAFELLGKNTFEFLKE 114

Query: 131 -SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN----------------- 172
            + Q     H ++  YQL   L+++H   + H DLKP N+L                   
Sbjct: 115 NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174

Query: 173 --ANCDLKICDFGLARTTSETDFMTEYVVTR------------WDT-------------- 204
              N  +++ DFG A  T + +  T  V TR            W                
Sbjct: 175 SVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232

Query: 205 -----LFPGKDYVQQLTMITELLGSPD--------------DSDLGFLRSDNARRYVKQL 245
                LF   +  + L M+ ++LG                    L +  + +  RYVK+ 
Sbjct: 233 YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKEN 292

Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
               K    Q       +  DL  RML FDPA+RIT+ EAL HP+ + L 
Sbjct: 293 CKPLKSYMLQDSLEHVQL-FDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  129 bits (327), Expect = 4e-35
 Identities = 58/301 (19%), Positives = 110/301 (36%), Gaps = 45/301 (14%)

Query: 22  QYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRI 81
           Q + +G   ++    +   + +  G +  V  A +  +  E A+K++    +     + I
Sbjct: 15  QSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAI 72

Query: 82  LREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVYELMD----TDLHQII--RSKQA 134
           ++E+  +  ++ H NIV+         +E          L +      +  +    S+  
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132

Query: 135 LTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           L+ D      YQ  R ++++H     ++HRDLK  NLLL+    +K+CDFG A T S   
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192

Query: 193 FMTEYVVTRWDTLFPGKDYVQQLT--------MITELLGSPDD--SD---LG-------F 232
             +     R       ++ + + T        +I      P     D   LG       F
Sbjct: 193 DYSWSAQRRALV----EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF 248

Query: 233 LRS----DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
            +         R V     +P             V   L   ML  +P +R+++ E ++ 
Sbjct: 249 RQHPFEDGAKLRIVNGKYSIP------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302

Query: 289 P 289
            
Sbjct: 303 L 303

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  127 bits (321), Expect = 8e-35
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 13/170 (7%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  IG G+YG           + +  K++        + + ++ E+ LL  + H NIV+ 
Sbjct: 11  LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQII----RSKQALTDDHCQYFLYQLLRGLKYI 154
            D I          +YIV E  +  DL  +I    + +Q L ++     + QL   LK  
Sbjct: 71  YDRI---IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 155 HSAN-----VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVV 199
           H  +     VLHRDLKP+N+ L+   ++K+ DFGLAR  +      +  V
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV 177

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  127 bits (321), Expect = 1e-34
 Identities = 61/265 (23%), Positives = 117/265 (44%), Gaps = 28/265 (10%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IGRG++  V   +++ET  EVA  ++ +    + + +R   E ++L  + H NIV+  D 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN--V 159
                K K   + +V ELM +  L   ++  + +     + +  Q+L+GL+++H+    +
Sbjct: 94  WESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152

Query: 160 LHRDLKPSNLLLNA-NCDLKICDFGLARTTSETD---------FMT-EYVVTRWDTLFPG 208
           +HRDLK  N+ +      +KI D GLA     +          FM  E    ++D     
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESV-- 210

Query: 209 KD-YVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
            D Y   + M+ E+       S+      + A+ Y +    V    F +      P   +
Sbjct: 211 -DVYAFGMCML-EMATSEYPYSEC----QNAAQIYRRVTSGVKPASFDK---VAIPEVKE 261

Query: 267 LAERMLVFDPAKRITVEEALNHPYL 291
           + E  +  +  +R ++++ LNH + 
Sbjct: 262 IIEGCIRQNKDERYSIKDLLNHAFF 286

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  127 bits (321), Expect = 2e-34
 Identities = 48/173 (27%), Positives = 82/173 (47%), Gaps = 14/173 (8%)

Query: 34  SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKI--TNAFDNRIDAKRILREIKLLCHM 91
           + +    + IGRG +  V  A        VA+KK+   +  D +      ++EI LL  +
Sbjct: 32  ANFRI-EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQL 89

Query: 92  THENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQII----RSKQALTDDHCQYFLYQ 146
            H N++K           + N++ IV EL D  DL ++I    + K+ + +     +  Q
Sbjct: 90  NHPNVIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144

Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVV 199
           L   L+++HS  V+HRD+KP+N+ + A   +K+ D GL R  S        +V
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 197

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (320), Expect = 2e-34
 Identities = 72/291 (24%), Positives = 128/291 (43%), Gaps = 51/291 (17%)

Query: 30  FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLC 89
            +V +  + P+  +GRGAYG+V    +  + + +A+K+I    +++ + KR+L ++ +  
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISM 60

Query: 90  HMT-HENIVK-----VKDIIPPMDKEKFNDVYIVYELMDT----DLHQIIRSKQALTDDH 139
                   V       ++           DV+I  ELMDT       Q+I   Q + +D 
Sbjct: 61  RTVDCPFTVTFYGALFRE----------GDVWICMELMDTSLDKFYKQVIDKGQTIPEDI 110

Query: 140 CQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYV 198
                  +++ L+++HS  +V+HRD+KPSN+L+NA   +K+CDFG++    +        
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170

Query: 199 VT-------RWDTLFPGKDYVQQ-------LTMITEL-LGS-PDDSDLGFLRSDNARRYV 242
                    R +     K Y  +       +TMI EL +   P DS     +        
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMI-ELAILRFPYDSWGTPFQ-------- 221

Query: 243 KQLPHVPKQPFSQKFP--NMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            QL  V ++P S + P    S   +D   + L  +  +R T  E + HP+ 
Sbjct: 222 -QLKQVVEEP-SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  127 bits (320), Expect = 2e-34
 Identities = 65/282 (23%), Positives = 111/282 (39%), Gaps = 52/282 (18%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +G+G YGIV +  +   +  +AIK+I     +   ++ +  EI L  H+ H+NIV+    
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 103 IPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQA---LTDDHCQYFLYQLLRGLKYIHSAN 158
                  +   + I  E +    L  ++RSK       +    ++  Q+L GLKY+H   
Sbjct: 88  F-----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142

Query: 159 VLHRDLKPSNLLLNA-NCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY------ 211
           ++HRD+K  N+L+N  +  LKI DFG ++  +  +  TE           G         
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--------GTLQYMAPEI 194

Query: 212 VQQL---------------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ 255
           + +                T+I E+  G P   +LG             +  V       
Sbjct: 195 IDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELG--------EPQAAMFKVGMFKVHP 245

Query: 256 KFP-NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
           + P +MS  A     +    DP KR    + L   +L    +
Sbjct: 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  125 bits (316), Expect = 5e-34
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 16/151 (10%)

Query: 42  PIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
            +G+G++  V  A +  T  EVAIK I   A       +R+  E+K+ C + H +I+++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 101 DIIPPMDKEKFNDVYIV--Y----ELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           +       E  N VY+V       E+       +    +  +++  ++F++Q++ G+ Y+
Sbjct: 78  NYF-----EDSNYVYLVLEMCHNGEMNR----YLKNRVKPFSENEARHFMHQIITGMLYL 128

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           HS  +LHRDL  SNLLL  N ++KI DFGLA
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 45.2 bits (108), Expect = 1e-05
 Identities = 12/35 (34%), Positives = 22/35 (62%), Gaps = 1/35 (2%)

Query: 256 KFPN-MSPVAIDLAERMLVFDPAKRITVEEALNHP 289
           + P+ +S  A DL  ++L  +PA R+++   L+HP
Sbjct: 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  124 bits (314), Expect = 2e-33
 Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 15/171 (8%)

Query: 32  VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM 91
           V+  Y    Q +G G  G V    +  T ++ A+K +        D+ +  +E+      
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQA 78

Query: 92  T-HENIVKVKDIIPPMDKEKFNDVYIVYELMDTD--LHQII-RSKQALTDDHCQYFLYQL 147
           +   +IV + D+   M   K   + I+ E M+      +I  R  QA T+      +  +
Sbjct: 79  SGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137

Query: 148 LRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMT 195
              ++++HS N+ HRD+KP NLL      +  LK+ DFG A+ T++    T
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT 188

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 12/44 (27%), Positives = 24/44 (54%)

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
             +S  A  L   +L  DP +R+T+ + +NHP+++    + + P
Sbjct: 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  123 bits (311), Expect = 6e-33
 Identities = 56/291 (19%), Positives = 107/291 (36%), Gaps = 46/291 (15%)

Query: 27  GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           G  +Q     +  L  +G G  G V      +T   +A+K++  + +   + KRIL ++ 
Sbjct: 17  GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLD 75

Query: 87  LLCHMT-HENIVK-----VKDIIPPMDKEKFNDVYIVYELMDTDLHQII-RSKQALTDDH 139
           ++        IV+     + +           DV+I  ELM T   ++  R +  + +  
Sbjct: 76  VVLKSHDCPYIVQCFGTFITN----------TDVFIAMELMGTCAEKLKKRMQGPIPERI 125

Query: 140 CQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYV 198
                  +++ L Y+     V+HRD+KPSN+LL+    +K+CDFG++    +        
Sbjct: 126 LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185

Query: 199 VTR-W-------DTLFPGKDYVQQ-------LTMITEL-LGSPDDSDLGFLRSDNARRYV 242
               +              DY  +       ++++ EL  G     +            +
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV-ELATGQFPYKNC-----KTDFEVL 239

Query: 243 KQLPH--VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            ++     P  P    F   S       +  L  D  KR    + L H ++
Sbjct: 240 TKVLQEEPPLLPGHMGF---SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  123 bits (311), Expect = 6e-33
 Identities = 41/179 (22%), Positives = 74/179 (41%), Gaps = 12/179 (6%)

Query: 31  QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCH 90
           +    Y      +G GA+  V + +N  T +E A+K I           R+ RE+++L  
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQ 66

Query: 91  MT-HENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLL 148
              H N++++ +       E+ +  Y+V+E M    +   I  ++   +      +  + 
Sbjct: 67  CQGHRNVLELIEFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVA 121

Query: 149 RGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRWDT 204
             L ++H+  + HRDLKP N+L    N    +KICDF L          +        T
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 11/35 (31%), Positives = 21/35 (60%)

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
            ++S  A DL  ++LV D  +R++  + L HP++ 
Sbjct: 266 AHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  122 bits (309), Expect = 1e-32
 Identities = 61/296 (20%), Positives = 120/296 (40%), Gaps = 51/296 (17%)

Query: 27  GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
              +  +++ +  L  IGRGAYG V   V+  + + +A+K+I  +  +  + K++L ++ 
Sbjct: 14  EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLD 72

Query: 87  LLCHMT-HENIVK-----VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-----KQAL 135
           ++   +    IV+      ++           D +I  ELM T   +  +         +
Sbjct: 73  VVMRSSDCPYIVQFYGALFRE----------GDCWICMELMSTSFDKFYKYVYSVLDDVI 122

Query: 136 TDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFM 194
            ++         ++ L ++     ++HRD+KPSN+LL+ + ++K+CDFG++    ++   
Sbjct: 123 PEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182

Query: 195 TEYVVT-------RWDTLFPGKDYVQQ-------LTMITEL-LGSPDDSDLGFLRSDNAR 239
           T            R D     + Y  +       +T+  EL  G         +      
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY-ELATGRFPYPKWNSV------ 235

Query: 240 RYVKQLPHVPKQP----FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
               QL  V K       + +    SP  I+     L  D +KR   +E L HP++
Sbjct: 236 --FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  121 bits (306), Expect = 2e-32
 Identities = 63/276 (22%), Positives = 114/276 (41%), Gaps = 47/276 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+GA G V +A++  T +EVAI+++      + +   I+ EI ++    + NIV  
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNY 82

Query: 100 KDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
            D          +++++V E +     TD    + ++  + +        + L+ L+++H
Sbjct: 83  LDSY-----LVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLH 133

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD-----------FMTEYVVTRWDT 204
           S  V+HRD+K  N+LL  +  +K+ DFG     +              +M   VVTR   
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--- 190

Query: 205 LFPGKDYVQQL------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF 257
               K Y  ++       M  E++ G P   +       N  R +  +            
Sbjct: 191 ----KAYGPKVDIWSLGIMAIEMIEGEPPYLNE------NPLRALYLIATNGTPELQNP- 239

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
             +S +  D   R L  D  KR + +E L H +L  
Sbjct: 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  123 bits (310), Expect = 3e-32
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 15/167 (8%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKV 99
           Q +G G  G V    N  T+E+ A+K +        D  +  RE++L    +   +IV++
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRI 120

Query: 100 KDIIPPMDKEKFNDVYIVYELMD--TDLHQII-RSKQALTDDHCQYFLYQLLRGLKYIHS 156
            D+   +   +   + IV E +D      +I  R  QA T+      +  +   ++Y+HS
Sbjct: 121 VDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179

Query: 157 ANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVT 200
            N+ HRD+KP NLL      N  LK+ DFG A+ T+  + +T    T
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 11/44 (25%), Positives = 23/44 (52%)

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
             +S     L   +L  +P +R+T+ E +NHP++    ++ + P
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  121 bits (306), Expect = 4e-32
 Identities = 70/280 (25%), Positives = 119/280 (42%), Gaps = 42/280 (15%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLL---CHMTHENI 96
           ++ +G G YG V    + +T +  AIK +    D   +   I +EI +L    H  H NI
Sbjct: 29  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---IKQEINMLKKYSH--HRNI 83

Query: 97  VKVKDI-IPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
                  I        + +++V E       TDL +  +    L ++   Y   ++LRGL
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGL 142

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD-----FM-TEY-----VVT 200
            ++H   V+HRD+K  N+LL  N ++K+ DFG++     T      F+ T Y     V+ 
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202

Query: 201 RWDTLFPGKDYVQQL-----TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS 254
             +      D+   L     T I E+  G+P   D+  +R+         L  +P+ P  
Sbjct: 203 CDENPDATYDFKSDLWSLGITAI-EMAEGAPPLCDMHPMRA---------LFLIPRNPAP 252

Query: 255 Q-KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           + K    S       E  LV + ++R   E+ + HP++  
Sbjct: 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  120 bits (304), Expect = 4e-32
 Identities = 65/275 (23%), Positives = 108/275 (39%), Gaps = 38/275 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +  +G GA+G V  A N ET    A K I    +  ++    + EI++L    H  IVK+
Sbjct: 24  VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED--YIVEIEILATCDHPYIVKL 81

Query: 100 KDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
                         ++I+ E         +  ++   + LT+   Q    Q+L  L ++H
Sbjct: 82  LGAY-----YHDGKLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLEALNFLH 134

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFG----LARTTSETDFM--TEY-----VVTRWDT 204
           S  ++HRDLK  N+L+    D+++ DFG      +T  + D    T Y     VV     
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194

Query: 205 LFPGKDYVQQL-----TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP 258
                DY   +     T+I E+    P   +L      N  R + ++             
Sbjct: 195 KDTPYDYKADIWSLGITLI-EMAQIEPPHHEL------NPMRVLLKIAKSDPPTLLTP-S 246

Query: 259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
             S    D  +  L  +P  R +  + L HP++SS
Sbjct: 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (301), Expect = 2e-31
 Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 47/276 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
              IG G+ GIVC A    +  +VA+K +      R +   +  E+ ++    H N+V++
Sbjct: 50  YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE--LLFNEVVIMRDYQHFNVVEM 107

Query: 100 KDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
                        +++++ E +     TD+   +R    L ++        +L+ L Y+H
Sbjct: 108 YKSY-----LVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLH 158

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD-----------FMTEYVVTRWDT 204
           +  V+HRD+K  ++LL  +  +K+ DFG     S+             +M   V++R   
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR--- 215

Query: 205 LFPGKDYVQQL------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF 257
                 Y  ++       M+ E++ G P           +  + +K+L   P        
Sbjct: 216 ----SLYATEVDIWSLGIMVIEMVDGEPPYFSD------SPVQAMKRLRDSPPPKLKNS- 264

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
             +SPV  D  ERMLV DP +R T +E L+HP+L  
Sbjct: 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  120 bits (302), Expect = 2e-31
 Identities = 61/272 (22%), Positives = 112/272 (41%), Gaps = 37/272 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ IG G++G V  A +    E VAIKK+  +   +    + I++E++ L  + H N ++
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSA 157
            +         + +  ++V E        ++   K+ L +       +  L+GL Y+HS 
Sbjct: 119 YRGCY-----LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFM--TEY-----VVTRWDTLFPGKD 210
           N++HRD+K  N+LL+    +K+ DFG A   +  +    T Y     V+   D       
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMD----EGQ 229

Query: 211 YVQQ-------LTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ-KFPNMS 261
           Y  +       +T I EL    P   ++  + +         L H+ +      +  + S
Sbjct: 230 YDGKVDVWSLGITCI-ELAERKPPLFNMNAMSA---------LYHIAQNESPALQSGHWS 279

Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
               +  +  L   P  R T E  L H ++  
Sbjct: 280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  118 bits (298), Expect = 3e-31
 Identities = 72/279 (25%), Positives = 122/279 (43%), Gaps = 53/279 (18%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G G+YG V  A++ ET + VAIK++        D + I++EI ++      ++VK 
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQEIIKEISIMQQCDSPHVVKY 89

Query: 100 KDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
                     K  D++IV E       +D+ ++    + LT+D     L   L+GL+Y+H
Sbjct: 90  YGSY-----FKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLH 142

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFG----LARTTSETDFM--TEY-----VVTRWDT 204
               +HRD+K  N+LLN     K+ DFG    L  T ++ + +  T +     V+     
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--- 199

Query: 205 LFPGKDYVQQ-------LTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ--PFS 254
                 Y          +T I E+  G P  +D+  +R          +  +P    P  
Sbjct: 200 ----IGYNCVADIWSLGITAI-EMAEGKPPYADIHPMR---------AIFMIPTNPPPTF 245

Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
           +K    S    D  ++ LV  P +R T  + L HP++ S
Sbjct: 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  118 bits (298), Expect = 4e-31
 Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 16/172 (9%)

Query: 35  KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-H 93
                 +P+G G++ I    V+ ++ +  A+K I     ++       +EI  L     H
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII-----SKRMEANTQKEITALKLCEGH 65

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
            NIVK+ ++            ++V EL++  +L + I+ K+  ++    Y + +L+  + 
Sbjct: 66  PNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS 120

Query: 153 YIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR-TTSETDFMTEYVVT 200
           ++H   V+HRDLKP NLL    N N ++KI DFG AR    +   +     T
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 12/44 (27%), Positives = 22/44 (50%)

Query: 258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
            N+S  A DL + +L  DP KR+ +     + +L    +++  P
Sbjct: 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  117 bits (296), Expect = 5e-31
 Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 15/152 (9%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKV 99
           Q +G G  G V    N  T+E+ A+K +        D  +  RE++L    +   +IV++
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRI 76

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD--LHQII-RSKQALTDDHCQYFLYQLLRGLKYIHS 156
            D+   +   +   + IV E +D      +I  R  QA T+      +  +   ++Y+HS
Sbjct: 77  VDVYENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135

Query: 157 ANVLHRDLKPSNLLL---NANCDLKICDFGLA 185
            N+ HRD+KP NLL      N  LK+ DFG A
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 11/48 (22%), Positives = 26/48 (54%)

Query: 254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
           + ++  +S     L   +L  +P +R+T+ E +NHP++    ++ + P
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  116 bits (292), Expect = 4e-30
 Identities = 37/172 (21%), Positives = 76/172 (44%), Gaps = 18/172 (10%)

Query: 27  GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
             + ++       +  +G G  G+V    +  +   +A K I +         +I+RE++
Sbjct: 25  QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQ 83

Query: 87  LLCHMTHENIVK-----VKDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQALTDDHC 140
           +L       IV        D           ++ I  E MD   L Q+++    + +   
Sbjct: 84  VLHECNSPYIVGFYGAFYSD----------GEISICMEHMDGGSLDQVLKKAGRIPEQIL 133

Query: 141 QYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
                 +++GL Y+     ++HRD+KPSN+L+N+  ++K+CDFG++    ++
Sbjct: 134 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  111 bits (280), Expect = 1e-28
 Identities = 62/295 (21%), Positives = 106/295 (35%), Gaps = 66/295 (22%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK- 98
            + IG GA  +V +A  +  KE+VAIK+I N    +     +L+EI+ +    H NIV  
Sbjct: 20  QEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78

Query: 99  ----VKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQA-----LTDDHCQYFLY 145
               V            +++++V +L+      D+ + I +K       L +      L 
Sbjct: 79  YTSFVVK----------DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128

Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTL 205
           ++L GL+Y+H    +HRD+K  N+LL  +  ++I DFG++                  T 
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS--AFLATGGDITRNKVRKT- 185

Query: 206 FPGKDY------VQQLT-------------MITELL-GSPDDSDLGFLRSDNARRYVKQL 245
           F G         ++Q+                 EL  G+        ++          L
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---------L 236

Query: 246 PHVPKQP---------FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
               +             +           +    L  DP KR T  E L H + 
Sbjct: 237 MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (278), Expect = 2e-28
 Identities = 68/282 (24%), Positives = 118/282 (41%), Gaps = 60/282 (21%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI--TNAFDNRIDAKRILREIKLLCHMTHENIV 97
           L+ IG+G++G V   +++ T++ VAIK I    A D   D   I +EI +L       + 
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED---IQQEITVLSQCDSPYVT 83

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           K           K   ++I+ E +      DL +       L +      L ++L+GL Y
Sbjct: 84  KYYGSY-----LKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDY 134

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDY-- 211
           +HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T         + +T F G  +  
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-------QIKRNT-FVGTPFWM 186

Query: 212 ----VQQLT------------MITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQP-- 252
               ++Q                 EL  G P  S+L  ++          L  +PK    
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---------LFLIPKNNPP 237

Query: 253 -FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS 293
                +   S    +  E  L  +P+ R T +E L H ++  
Sbjct: 238 TLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  109 bits (274), Expect = 5e-28
 Identities = 41/179 (22%), Positives = 79/179 (44%), Gaps = 32/179 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRIL----REIKLLCHMTHENIV 97
           IG+G +G+V      + K  VAIK +     +   +         RE+ ++ ++ H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 98  K----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK-QALTDDHCQYFLYQLLRGL 151
           K    + +  PP          +V E +   DL+  +  K   +        +  +  G+
Sbjct: 87  KLYGLMHN--PPR---------MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135

Query: 152 KYIHSAN--VLHRDLKPSNLLL-----NANCDLKICDFGLARTTSETDFMTEYVVT-RW 202
           +Y+ + N  ++HRDL+  N+ L     NA    K+ DFGL++ +  +  ++  +   +W
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQW 192

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  108 bits (272), Expect = 2e-27
 Identities = 40/162 (24%), Positives = 71/162 (43%), Gaps = 19/162 (11%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK---- 98
           +G+G +G      + ET E + +K++    +     +  L+E+K++  + H N++K    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ--RTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 99  -VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIH 155
             KD            +  + E +    L  II+S            F   +  G+ Y+H
Sbjct: 76  LYKD--KR--------LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEY 197
           S N++HRDL   N L+  N ++ + DFGLAR   +     E 
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  108 bits (271), Expect = 3e-27
 Identities = 44/163 (26%), Positives = 81/163 (49%), Gaps = 21/163 (12%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK---- 98
           IG G++G V  A    +  +VA+K +     +       LRE+ ++  + H NIV     
Sbjct: 45  IGAGSFGTVHRAEWHGS--DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR---SKQALTDDHCQYFLYQLLRGLKYI 154
           V    PP       ++ IV E +    L++++    +++ L +       Y + +G+ Y+
Sbjct: 103 VTQ--PP-------NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 155 HSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
           H+ N  ++HR+LK  NLL++    +K+CDFGL+R  + T   +
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS 196

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  108 bits (272), Expect = 4e-27
 Identities = 33/163 (20%), Positives = 60/163 (36%), Gaps = 22/163 (13%)

Query: 40  LQPIGRGA--YGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           L  IG+G      V  A    T E V +++I     +      +  E+ +     H NIV
Sbjct: 30  LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 98  K-----VKDIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLL 148
                 + D          N++++V   M      DL         + +    Y L  +L
Sbjct: 90  PYRATFIAD----------NELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVL 138

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
           + L YIH    +HR +K S++L++ +  + +       +    
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  106 bits (267), Expect = 5e-27
 Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 26/170 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA--KRILREIKLLCHMTHENIVKVK 100
           IG G +G V  A       EVA+K   +  D  I    + + +E KL   + H NI+ ++
Sbjct: 15  IGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 101 D--IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
              +  P       ++ +V E      L++++  K+ +  D    +  Q+ RG+ Y+H  
Sbjct: 73  GVCLKEP-------NLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDE 124

Query: 158 N---VLHRDLKPSNLLLN--------ANCDLKICDFGLARTTSETDFMTE 196
               ++HRDLK SN+L+         +N  LKI DFGLAR    T  M+ 
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA 174

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  107 bits (269), Expect = 5e-27
 Identities = 42/163 (25%), Positives = 68/163 (41%), Gaps = 19/163 (11%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK- 98
            + IG+G +G V          EVAI+ I    DN    K   RE+       HEN+V  
Sbjct: 38  GELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 99  ---VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKY 153
                   PP        + I+  L     L+ ++R  K  L  +  +    ++++G+ Y
Sbjct: 95  MGACMS--PP-------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE 196
           +H+  +LH+DLK  N+  + N  + I DFGL   +        
Sbjct: 146 LHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  106 bits (267), Expect = 7e-27
 Identities = 55/169 (32%), Positives = 80/169 (47%), Gaps = 24/169 (14%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +GRGA+G+VC A       +VAIK+I +  +     K  + E++ L  + H NIVK+   
Sbjct: 16  VGRGAFGVVCKAKWRAK--DVAIKQIESESER----KAFIVELRQLSRVNHPNIVKLYGA 69

Query: 103 IPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKYIHSAN 158
                    N V +V E  +   L+ ++   +     T  H   +  Q  +G+ Y+HS  
Sbjct: 70  C-------LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 159 ---VLHRDLKPSNLLLNANCD-LKICDFGLARTTSETDFMTEYVVT-RW 202
              ++HRDLKP NLLL A    LKICDFG A        MT    +  W
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAW 169

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  106 bits (267), Expect = 1e-26
 Identities = 31/181 (17%), Positives = 71/181 (39%), Gaps = 32/181 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI---------------TNAFDNRIDAKRILRE 84
           ++ + +G +  +      +  +  A+KK                 +    +        E
Sbjct: 36  IRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93

Query: 85  IKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIV--Y----ELMDTDLHQ---IIRSKQAL 135
           ++++  + +E  +  + II       +++VYI+  Y     ++  D +           +
Sbjct: 94  LQIITDIKNEYCLTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 136 TDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFM 194
                +  +  +L    YIH+  N+ HRD+KPSN+L++ N  +K+ DFG +    +    
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208

Query: 195 T 195
            
Sbjct: 209 G 209

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 17/74 (22%), Positives = 32/74 (43%), Gaps = 3/74 (4%)

Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
             L  +  +  +     +S   ID  +  L  +PA+RIT E+AL H +L+   + N E  
Sbjct: 278 HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA---DTNIEDL 334

Query: 303 CPYPFNFDFEQTSM 316
             +      ++  +
Sbjct: 335 REFSKELYKKRKKL 348

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  105 bits (264), Expect = 1e-26
 Identities = 38/164 (23%), Positives = 67/164 (40%), Gaps = 19/164 (11%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK- 98
            Q IG G++G V          +VA+K +          +    E+ +L    H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85

Query: 99  ---VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKY 153
                   P +         IV +  +   L+  + + +             Q  RG+ Y
Sbjct: 86  MGYSTA--PQL--------AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEY 197
           +H+ +++HRDLK +N+ L+ +  +KI DFGLA   S      ++
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (265), Expect = 2e-26
 Identities = 44/281 (15%), Positives = 88/281 (31%), Gaps = 41/281 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++                  +  +  +       +         +I+ +   + +N V  
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV-- 124

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTD---DHCQYFLYQLLRGLKYIH 155
                         +YI  +L    +L   +  + +L D     C +   Q+   ++++H
Sbjct: 125 ---GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
           S  ++HRDLKPSN+    +  +K+ DFGL     + +           T+          
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE--------QTVLTPMPAYATH 233

Query: 216 TMIT--------ELL-GSPDD--SD---LG--------FLRSDNARRYVKQLPHVPKQPF 253
           T           E + G+      D   LG           +   R  V+ +  V    F
Sbjct: 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKF 291

Query: 254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
              F    P    + + ML   P +R    + + +    +L
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  103 bits (258), Expect = 7e-26
 Identities = 20/159 (12%), Positives = 52/159 (32%), Gaps = 14/159 (8%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           +     G +          ++ +K +     +   ++    E   L   +H N++ V   
Sbjct: 18  LNENHSGELWKGRWQGN--DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 103 I--PPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQY--FLYQLLRGLKYIHSA 157
              PP          ++   M    L+ ++        D  Q   F   + RG+ ++H+ 
Sbjct: 76  CQSPPAPH-----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 158 N--VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFM 194
              +    L   +++++ +   +I    +  +      M
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM 169

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =   99 bits (249), Expect = 2e-23
 Identities = 36/154 (23%), Positives = 65/154 (42%), Gaps = 6/154 (3%)

Query: 40  LQPIGRGAYGIVCSAVNSE-TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
              I  G  G +  A++       V +K + ++ D        + E + L  + H +IV+
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           + + +   D+      YIV E +    L +     Q L       +L ++L  L Y+HS 
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSI 201

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
            +++ DLKP N++L     LK+ D G     +  
Sbjct: 202 GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 95.8 bits (239), Expect = 5e-23
 Identities = 52/159 (32%), Positives = 85/159 (53%), Gaps = 8/159 (5%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVK 98
           +  +G G    V  A ++    +VAIK I     +     KR  RE+     ++H+NIV 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           + D+      E+ +  Y+V E ++   L + I S   L+ D    F  Q+L G+K+ H  
Sbjct: 76  MIDV-----DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE 196
            ++HRD+KP N+L+++N  LKI DFG+A+  SET  +T+
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQ 168

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 95.1 bits (237), Expect = 1e-22
 Identities = 40/182 (21%), Positives = 69/182 (37%), Gaps = 30/182 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE--IKLLCHMTHENIV 97
           L+ +G+G YG V         E VA+K  ++      D K   RE  +     + HENI+
Sbjct: 13  LECVGKGRYGEVWRGSWQG--ENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENIL 65

Query: 98  KVK--DIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
                D+       +    +++    +   L+  ++    L    C   +  +  GL ++
Sbjct: 66  GFIASDMTSRHSSTQL---WLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHL 121

Query: 155 HSA--------NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT------ 200
           H           + HRDLK  N+L+  N    I D GLA   S++    +          
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 201 RW 202
           R+
Sbjct: 182 RY 183

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 94.4 bits (235), Expect = 3e-22
 Identities = 41/180 (22%), Positives = 66/180 (36%), Gaps = 26/180 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG+G YG V         E+VA+K      +     +    EI     M HENI+  
Sbjct: 42  VKQIGKGRYGEVWMGKWRG--EKVAVKVFFTT-EEASWFRE--TEIYQTVLMRHENILGF 96

Query: 100 K--DIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
              DI       +    Y++ +  +   L+  ++S   L         Y  + GL ++H+
Sbjct: 97  IAADIKGTGSWTQL---YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152

Query: 157 AN--------VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT------RW 202
                     + HRDLK  N+L+  N    I D GLA          +          R+
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 93.5 bits (233), Expect = 4e-22
 Identities = 46/176 (26%), Positives = 83/176 (47%), Gaps = 17/176 (9%)

Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHMTH 93
           ++ +G G +G V           T E+VA+K  K  +  ++  D   + +EI++L ++ H
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYH 82

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGL 151
           ENIVK K I     ++  N + ++ E + +  L + +   K  +       +  Q+ +G+
Sbjct: 83  ENIVKYKGICT---EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
            Y+ S   +HRDL   N+L+ +   +KI DFGL +         EY   + D   P
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK---EYYTVKDDRDSP 192

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 94.3 bits (234), Expect = 5e-22
 Identities = 29/166 (17%), Positives = 57/166 (34%), Gaps = 29/166 (17%)

Query: 43  IGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           +G GA+  V  A      +++ K++  +K    A  N  +     + ++ L        +
Sbjct: 73  LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFM 130

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK-----QALTDDHCQYFLYQLLRGL 151
           K             N   +V EL     L   I        + +       F  ++L  +
Sbjct: 131 KFYSAH-----LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 152 KYIHSANVLHRDLKPSNLLLN-----------ANCDLKICDFGLAR 186
           + +H   ++H D+KP N +L             +  L + D G + 
Sbjct: 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 94.2 bits (235), Expect = 7e-22
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 18/173 (10%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IGRG +G V S         VA+K             + L+E ++L   +H NIV++
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIVRL 177

Query: 100 KDII---PPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKYI 154
             +     P        +YIV EL+   D    +R+    L        +     G++Y+
Sbjct: 178 IGVCTQKQP--------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
            S   +HRDL   N L+     LKI DFG++R  ++      Y  +      P
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGLRQVP 278

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 91.9 bits (229), Expect = 1e-21
 Identities = 38/174 (21%), Positives = 77/174 (44%), Gaps = 16/174 (9%)

Query: 41  QPIGRGAYGIVCSAV--NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           + +G G +G V        +  + VA+K + N  ++      +L E  ++  + +  IV+
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 99  VKDII--PPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           +  I               +V E+ +   L++ ++  + + D +    ++Q+  G+KY+ 
Sbjct: 83  MIGICEAESW--------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK 209
            +N +HRDL   N+LL      KI DFGL++     +    Y   +    +P K
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE---NYYKAQTHGKWPVK 185

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 38/154 (24%), Positives = 73/154 (47%), Gaps = 7/154 (4%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVK 98
            + +GRG  G V  A ++  +  VA+K ++     + +   R+ RE +    +   ++V 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           + D       E    +Y+   L++  DL  ++R +  L        + Q+   L   H+A
Sbjct: 99  IHDF-----GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
              HRD+KP N+L++A+    + DFG+A  T++ 
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 36/178 (20%), Positives = 60/178 (33%), Gaps = 22/178 (12%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+G +G V         EEVA+K           +     EI     + HENI+  
Sbjct: 47  QESIGKGRFGEVWRGKWRG--EEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 101

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA- 157
                  +      +++V +  +   L   +  +  +T +           GL ++H   
Sbjct: 102 IAADNKDNGTWTQ-LWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 158 -------NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT------RW 202
                   + HRDLK  N+L+  N    I D GLA          +          R+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 90.4 bits (225), Expect = 5e-21
 Identities = 43/175 (24%), Positives = 81/175 (46%), Gaps = 16/175 (9%)

Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHE 94
           LQ +G+G +G V           T E VA+KK+  +  ++  D     REI++L  + H+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---FEREIEILKSLQHD 71

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLK 152
           NIVK K +     +    ++ ++ E +    L   ++  K+ +       +  Q+ +G++
Sbjct: 72  NIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
           Y+ +   +HRDL   N+L+     +KI DFGL +   +     E+   +     P
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK---EFFKVKEPGESP 180

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 90.9 bits (226), Expect = 5e-21
 Identities = 43/174 (24%), Positives = 81/174 (46%), Gaps = 14/174 (8%)

Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           LQ +G+G +G V           T E VA+KK+ ++ +     +   REI++L  + H+N
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDN 103

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKY 153
           IVK K +     +    ++ ++ E +    L   ++  K+ +       +  Q+ +G++Y
Sbjct: 104 IVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
           + +   +HRDL   N+L+     +KI DFGL +   +     EY   +     P
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK---EYYKVKEPGESP 211

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 90.8 bits (226), Expect = 5e-21
 Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 3/154 (1%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVK 98
            + +G G    V  A +     +VA+K +      +     R  RE +    + H  IV 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           V D     +       YIV E +D   L  I+ ++  +T       +    + L + H  
Sbjct: 77  VYDT-GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
            ++HRD+KP+N++++A   +K+ DFG+AR  +++
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 89.7 bits (223), Expect = 1e-20
 Identities = 42/175 (24%), Positives = 79/175 (45%), Gaps = 16/175 (9%)

Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHE 94
           +  +G+G +G V           T   VA+K++  +  D + D     REI++L  +  +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD---FQREIQILKALHSD 84

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLK 152
            IVK + +     ++    + +V E + +  L   ++  +  L       +  Q+ +G++
Sbjct: 85  FIVKYRGVSYGPGRQ---SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
           Y+ S   +HRDL   N+L+ +   +KI DFGLA+         +Y V R     P
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPGQSP 193

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 48/175 (27%), Positives = 77/175 (44%), Gaps = 17/175 (9%)

Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHMTH 93
           ++ +G G +G V        N  T E VA+K  K      +R       +EI +L  + H
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTLYH 92

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
           E+I+K K             + +V E +    L   +  + ++       F  Q+  G+ 
Sbjct: 93  EHIIKYKGCCEDAGAA---SLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMA 148

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
           Y+H+ + +HRDL   N+LL+ +  +KI DFGLA+   E     EY   R D   P
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSP 200

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 87.3 bits (217), Expect = 7e-20
 Identities = 42/175 (24%), Positives = 72/175 (41%), Gaps = 19/175 (10%)

Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           +G G++G+V        S     VA+K +  +           +RE+  +  + H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 99  VKDII--PPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKYI 154
           +  ++  PPM         +V EL     L   +R  +          +  Q+  G+ Y+
Sbjct: 86  LYGVVLTPPM--------KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK 209
            S   +HRDL   NLLL     +KI DFGL R   + D   ++ V +     P  
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND---DHYVMQEHRKVPFA 189

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 87.7 bits (218), Expect = 8e-20
 Identities = 37/161 (22%), Positives = 73/161 (45%), Gaps = 17/161 (10%)

Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   +   K IL E  ++  + + +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVDNPH 78

Query: 96  IVKVKDII--PPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGL 151
           + ++  I     +         ++ +LM    L   +R  K  +   +   +  Q+ +G+
Sbjct: 79  VCRLLGICLTSTV--------QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            Y+    ++HRDL   N+L+     +KI DFGLA+     +
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 87.5 bits (217), Expect = 9e-20
 Identities = 37/165 (22%), Positives = 60/165 (36%), Gaps = 22/165 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+   RG +G V  A      E VA+K            +    E+  L  M HENI++ 
Sbjct: 29  LEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEY---EVYSLPGMKHENILQF 83

Query: 100 --KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
              +             +++    +   L   ++    ++ +   +    + RGL Y+H 
Sbjct: 84  IGAEKRGTSVDVDL---WLITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGLAYLHE 139

Query: 157 A----------NVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
                       + HRD+K  N+LL  N    I DFGLA      
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 19/154 (12%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK- 98
              +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V+ 
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQL 281

Query: 99  ---VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS--KQALTDDHCQYFLYQLLRGLK 152
                   P          YI+ E M   +L   +R   +Q ++     Y   Q+   ++
Sbjct: 282 LGVCTREPP---------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Y+   N +HR+L   N L+  N  +K+ DFGL+R
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR 366

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 21/154 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK- 98
           LQ IG+G +G V        K  VA+K I N       A+  L E  ++  + H N+V+ 
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNK--VAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQL 79

Query: 99  ---VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS--KQALTDDHCQYFLYQLLRGLK 152
              + +            +YIV E M    L   +RS  +  L  D    F   +   ++
Sbjct: 80  LGVIVEEKGG--------LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Y+   N +HRDL   N+L++ +   K+ DFGL +
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 17/153 (11%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
              +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQL 74

Query: 100 KDII---PPMDKEKFNDVYIVYELMDT-DLHQIIRS--KQALTDDHCQYFLYQLLRGLKY 153
             +    PP         YI+ E M   +L   +R   +Q ++     Y   Q+   ++Y
Sbjct: 75  LGVCTREPP--------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           +   N +HRDL   N L+  N  +K+ DFGL+R
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 40/172 (23%), Positives = 62/172 (36%), Gaps = 28/172 (16%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKIT----NAFDNRIDAKRILREIKLLCHMTHENI 96
           + IGRG YG V      E    VA+K  +      F N        + I  +  M H+NI
Sbjct: 19  ELIGRGRYGAVYKGSLDE--RPVAVKVFSFANRQNFINE-------KNIYRVPLMEHDNI 69

Query: 97  VK--VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
            +  V D     D     +  +V E      L + +               + + RGL Y
Sbjct: 70  ARFIVGDERVTADGR--MEYLLVMEYYPNGSLXKYLS-LHTSDWVSSCRLAHSVTRGLAY 126

Query: 154 IHSA---------NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE 196
           +H+           + HRDL   N+L+  +    I DFGL+   +    +  
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 86.1 bits (214), Expect = 2e-19
 Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 18/171 (10%)

Query: 43  IGRGAYGIVCSAV-NSETKE-EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +G G +G V   V     K+ +VAIK +    +   D + ++RE +++  + +  IV++ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLI 76

Query: 101 DII--PPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHS 156
            +     +         +V E+     LH+ +   ++ +   +    L+Q+  G+KY+  
Sbjct: 77  GVCQAEAL--------MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
            N +HRDL   N+LL      KI DFGL++     D    Y   R    +P
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD---SYYTARSAGKWP 176

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 21/154 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK- 98
           LQ IG+G +G V        K  VA+K I N       A+  L E  ++  + H N+V+ 
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNK--VAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQL 251

Query: 99  ---VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS--KQALTDDHCQYFLYQLLRGLK 152
              + +            +YIV E M    L   +RS  +  L  D    F   +   ++
Sbjct: 252 LGVIVEEKGG--------LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 186
           Y+   N +HRDL   N+L++ +   K+ DFGL +
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 41/162 (25%), Positives = 65/162 (40%), Gaps = 18/162 (11%)

Query: 40  LQPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
            + IGRG +G V       N   K   A+K +    D   +  + L E  ++   +H N+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNV 88

Query: 97  VK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRG 150
           +                      +V   M   DL   IR+     T      F  Q+ +G
Sbjct: 89  LSLLGICLRSEGS--------PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 140

Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           +KY+ S   +HRDL   N +L+    +K+ DFGLAR   + +
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 85.3 bits (212), Expect = 2e-19
 Identities = 37/159 (23%), Positives = 71/159 (44%), Gaps = 19/159 (11%)

Query: 40  LQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           +Q IG G +G+V      ++ K  VAIK I    +  +  +  + E +++  ++H  +V+
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK--VAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQ 67

Query: 99  VKDII---PPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKY 153
           +  +     P+         +V E M+   L   +R+ +     +        +  G+ Y
Sbjct: 68  LYGVCLEQAPI--------CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           +  A V+HRDL   N L+  N  +K+ DFG+ R   +  
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.0 bits (211), Expect = 5e-19
 Identities = 36/178 (20%), Positives = 71/178 (39%), Gaps = 14/178 (7%)

Query: 40  LQPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
            + +G G +G V          T  +VA+K +     ++ + +  L E   +   +H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS------KQALTDDHCQYFLYQLLR 149
           +++  +   M  +      ++   M   DLH  +         + +       F+  +  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
           G++Y+ + N LHRDL   N +L  +  + + DFGL++     D    Y   R     P
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YYRQGR-IAKMP 212

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 86.5 bits (214), Expect = 6e-19
 Identities = 41/173 (23%), Positives = 78/173 (45%), Gaps = 18/173 (10%)

Query: 43  IGRGAYGIVCSAV--NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +G G +G V   V    + + +VAIK +    +   D + ++RE +++  + +  IV++ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLI 402

Query: 101 DII--PPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHS 156
            +     +         +V E+     LH+ +   ++ +   +    L+Q+  G+KY+  
Sbjct: 403 GVCQAEAL--------MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK 209
            N +HR+L   N+LL      KI DFGL++     D    Y   R    +P K
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 504

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 84.2 bits (209), Expect = 7e-19
 Identities = 37/156 (23%), Positives = 69/156 (44%), Gaps = 13/156 (8%)

Query: 40  LQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G G +G+V       +    VAIK I    +  +     + E K++ +++HE +V+
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD--VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQ 83

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHS 156
           +  +       K   ++I+ E M    L   +R  +              +   ++Y+ S
Sbjct: 84  LYGVC-----TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
              LHRDL   N L+N    +K+ DFGL+R   + +
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 83.8 bits (208), Expect = 8e-19
 Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 21/160 (13%)

Query: 40  LQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G G +G+V       +    VA+K I    +  +      +E + +  ++H  +VK
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD--VAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVK 67

Query: 99  ----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLK 152
                    P         +YIV E +    L   +RS  + L         Y +  G+ 
Sbjct: 68  FYGVCSKEYP---------IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           ++ S   +HRDL   N L++ +  +K+ DFG+ R   +  
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 36/167 (21%), Positives = 63/167 (37%), Gaps = 17/167 (10%)

Query: 40  LQPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
            + +G+G +G V  A       +  +VA+K +        D +  LRE   +    H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 97  VK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS------KQALTDDHCQYFLY 145
            K                     ++   M   DLH  + +         L       F+ 
Sbjct: 88  AKLVGVSLRSRAKGRLPIP---MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            +  G++Y+ S N +HRDL   N +L  +  + + DFGL+R     D
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 41/167 (24%), Positives = 68/167 (40%), Gaps = 18/167 (10%)

Query: 40  LQPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
            + IGRG +G V       N   K   A+K +    D   +  + L E  ++   +H N+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNV 152

Query: 97  VK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRG 150
           +                      +V   M   DL   IR+     T      F  Q+ +G
Sbjct: 153 LSLLGICLRSEGS--------PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 204

Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEY 197
           +K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 251

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 83.4 bits (207), Expect = 1e-18
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 20/162 (12%)

Query: 40  LQPIGRGAYGIVCSAV---NSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHMTHE 94
            + +G G +G V   V   +   K  VA+K  K     DN+      + E  ++ ++ H 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK---FMSEAVIMKNLDHP 73

Query: 95  NIVKVKDII--PPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRG 150
           +IVK+  II   P         +I+ EL    +L   +   K +L       +  Q+ + 
Sbjct: 74  HIVKLIGIIEEEPT--------WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125

Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           + Y+ S N +HRD+   N+L+ +   +K+ DFGL+R   + D
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 41/173 (23%), Positives = 69/173 (39%), Gaps = 20/173 (11%)

Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G  G VC        +    VAIK +   +  R   +  L E  ++    H NI+++
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-QRRDFLSEASIMGQFDHPNIIRL 115

Query: 100 KDII---PPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKYI 154
           + ++               IV E M+   L   +R+     T       L  +  G++Y+
Sbjct: 116 EGVVTRGRLA--------MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
                +HRDL   N+L+++N   K+ DFGL+R   +     +   T      P
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP---DAAYTTTGGKIP 217

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 65/361 (18%), Positives = 117/361 (32%), Gaps = 112/361 (31%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI--V 97
           ++ +G G +  V  + + + K+ VA+K + +A      A     EI+LL  + + +    
Sbjct: 42  IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDP 98

Query: 98  KVKDIIPPMDKEKFNDVY-----IVYELMDTDLHQIIRS--KQALTDDHCQYFLYQLLRG 150
             + ++  +D  K + V      +V+E++   L + I     Q L     +  + Q+L+G
Sbjct: 99  NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158

Query: 151 LKYIHS-ANVLHRDLKPSNLLLNAN----------------------------------- 174
           L Y+H+   ++H D+KP N+LL+ N                                   
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 175 --------------CDLKICDFGLARTTSE---TDFMTEYV------------------- 198
                           +KI D G A    +    D  T                      
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWS 278

Query: 199 --VTRWD-----TLFPGKD------YVQQLTMITELLGSPDDSDLGFLRSDNARRY---- 241
                ++      LF              + +I ELLG      +  +    ++ +    
Sbjct: 279 TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYSKEFFTKK 336

Query: 242 -----VKQLPHVPKQPFSQKFPNMSP----VAIDLAERMLVFDPAKRITVEEALNHPYLS 292
                + +L          +    S        D    ML   P KR T  E L HP+L+
Sbjct: 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

Query: 293 S 293
           S
Sbjct: 397 S 397

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 20/174 (11%)

Query: 40  LQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
              +G+G +G V     N  T+  VAIK +       +  +  L+E +++  + HE +V+
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQ 243

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIH 155
           +  ++          +YIV E M    L   ++ +  + L          Q+  G+ Y+ 
Sbjct: 244 LYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK 209
             N +HRDL+ +N+L+  N   K+ DFGLAR   + ++       R    FP K
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-----TARQGAKFPIK 346

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 20/165 (12%)

Query: 40  LQPIGRGAYGIVCSAV---NSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHMTHE 94
            + IG G +G V   +          VAIK  K   +   R      L+E   +    H 
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK---FLQEALTMRQFDHP 76

Query: 95  NIVKVKDII--PPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRG 150
           +IVK+  +I   P+        +I+ EL    +L   ++  K +L       + YQL   
Sbjct: 77  HIVKLIGVITENPV--------WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128

Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
           L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +  
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 37/161 (22%), Positives = 73/161 (45%), Gaps = 17/161 (10%)

Query: 40  LQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +      + K  VAIK++  A   +   K IL E  ++  + + +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVDNPH 78

Query: 96  IVKVKDII--PPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGL 151
           + ++  I     +         ++ +LM    L   +R  K  +   +   +  Q+ +G+
Sbjct: 79  VCRLLGICLTSTV--------QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            Y+    ++HRDL   N+L+     +KI DFGLA+     +
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 18/161 (11%)

Query: 41  QPIGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV 97
           + IG+G +G+V        ++ + + AIK ++   + +   +  LRE  L+  + H N++
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ-QVEAFLREGLLMRGLNHPNVL 85

Query: 98  K----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGL 151
                +               +++   M   DL Q IRS ++  T      F  Q+ RG+
Sbjct: 86  ALIGIMLPPEGL--------PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
           +Y+     +HRDL   N +L+ +  +K+ DFGLAR   + +
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 24/176 (13%)

Query: 40  LQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
              +G+G +G V     N  T+  VAIK +       +  +  L+E +++  + HE +V+
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQ 326

Query: 99  VKDIIP--PMDKEKFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKY 153
           +  ++   P+        YIV E M    L   ++ +  + L          Q+  G+ Y
Sbjct: 327 LYAVVSEEPI--------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK 209
           +   N +HRDL+ +N+L+  N   K+ DFGLAR   + ++       R    FP K
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-----TARQGAKFPIK 429

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 82.3 bits (204), Expect = 3e-18
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 24/176 (13%)

Query: 40  LQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           ++ +G G +G V     N  TK  VA+K +       +     L E  L+  + H+ +V+
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK--VAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 99  VKDII--PPMDKEKFNDVYIVYELMDT-DLHQIIRSK--QALTDDHCQYFLYQLLRGLKY 153
           +  ++   P        +YI+ E M+   L   +++     LT +       Q+  G+ +
Sbjct: 73  LYAVVTQEP--------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK 209
           I   N +HRDL+ +N+L++     KI DFGLAR   + ++       R    FP K
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-----TAREGAKFPIK 175

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.5 bits (204), Expect = 3e-18
 Identities = 31/249 (12%), Positives = 68/249 (27%), Gaps = 42/249 (16%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L   G         A+++    +VA+  +           +  L     L  +    + +
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           V D++            +V E +    L ++  +  + +       +  L       H A
Sbjct: 96  VLDVV-----HTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRA 148

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFG-LARTTSETDF------MTEYVVTRWDTLFPGKD 210
            V      PS + ++ + D+ +     +     + D       +   +V RW    P   
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQDDIRGIGASLYALLVNRWP--LPEAG 206

Query: 211 YVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAER 270
               L                           +     P +P +    ++      +A R
Sbjct: 207 VRSGLAPA-----------------------ERDTAGQPIEP-ADIDRDIPFQISAVAAR 242

Query: 271 MLVFDPAKR 279
            +  D   R
Sbjct: 243 SVQGDGGIR 251

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 62/316 (19%), Positives = 121/316 (38%), Gaps = 62/316 (19%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR-ILREIKLLCHMTHENIVKVK- 100
           IG+G++G VC    ++TK+  A+K +        +  R + +E++++  + H  +V +  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 101 ---DIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
              D           D+++V +L+   DL   ++      ++  + F+ +L+  L Y+ +
Sbjct: 83  SFQDE---------EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT------EY----VVTRWDTLF 206
             ++HRD+KP N+LL+ +  + I DF +A        +T       Y    + +      
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS----R 189

Query: 207 PGKDYVQQL------TMITELL--GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP 258
            G  Y   +          ELL    P          +    +   +   P         
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP--------S 241

Query: 259 NMSPVAIDLAERMLVFDPAKRI-TVEEALNHPYLSSLHEIN----EEPTCPYPF------ 307
             S   + L +++L  +P +R   + +  N PY++    IN     +      F      
Sbjct: 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND---INWDAVFQKRLIPGFIPNKGR 298

Query: 308 -NFD--FEQTSMNEED 320
            N D  FE   M  E 
Sbjct: 299 LNCDPTFELEEMILES 314

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 24/176 (13%)

Query: 40  LQPIGRGAYGIVCSAV-NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
            + +G G +G V  A  N  TK  VA+K +       +  +  L E  ++  + H+ +VK
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK--VAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVK 247

Query: 99  VKDII--PPMDKEKFNDVYIVYELMDT-DLHQIIRS--KQALTDDHCQYFLYQLLRGLKY 153
           +  ++   P+        YI+ E M    L   ++S             F  Q+  G+ +
Sbjct: 248 LHAVVTKEPI--------YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK 209
           I   N +HRDL+ +N+L++A+   KI DFGLAR   + ++       R    FP K
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-----TAREGAKFPIK 350

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.4 bits (204), Expect = 5e-18
 Identities = 34/177 (19%), Positives = 72/177 (40%), Gaps = 21/177 (11%)

Query: 41  QPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
           + +G G +G V   V        K  V IK I +    +   + +   +  +  + H +I
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ-SFQAVTDHMLAIGSLDHAHI 77

Query: 97  VKVKDII--PPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLK 152
           V++  +     +         +V + +    L   +R  + AL       +  Q+ +G+ 
Sbjct: 78  VRLLGLCPGSSL--------QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK 209
           Y+    ++HR+L   N+LL +   +++ DFG+A      D   + ++   +   P K
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD---KQLLYS-EAKTPIK 182

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 82.8 bits (205), Expect = 6e-18
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 20/175 (11%)

Query: 43  IGRGAYGIVCSAV-NSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G G +G VCS      +K+E  VAIK +   +  +   +  L E  ++    H NI+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111

Query: 100 KDII---PPMDKEKFNDVYIVYELMDT-DLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYI 154
           + ++    P+         IV E M+   L   +R   A  T       L  +  G+KY+
Sbjct: 112 EGVVTKSKPV--------MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK 209
                +HRDL   N+L+N+N   K+ DFGL R   +     E   T      P +
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP---EAAYTTRGGKIPIR 215

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 82.4 bits (204), Expect = 7e-18
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 15/171 (8%)

Query: 43  IGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           IG G +G V   +    + + +  VAIK +   +  +      L E  ++   +H NI++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIR 110

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHS 156
           ++ +I      K+  + I+ E M+   L + +R      +       L  +  G+KY+ +
Sbjct: 111 LEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP 207
            N +HRDL   N+L+N+N   K+ DFGL+R   +     E   T      P
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP---EATYTTSGGKIP 213

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 20/165 (12%)

Query: 40  LQPIGRGAYGIVCSAV---NSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHMTHE 94
            + IG G +G V   +          VAIK  K   +   R      L+E   +    H 
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK---FLQEALTMRQFDHP 451

Query: 95  NIVKVKDII--PPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQLLRG 150
           +IVK+  +I   P+        +I+ EL    +L   ++  K +L       + YQL   
Sbjct: 452 HIVKLIGVITENPV--------WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503

Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT 195
           L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +  
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 44/198 (22%), Positives = 75/198 (37%), Gaps = 45/198 (22%)

Query: 28  NLFQVSSKYVPP-----------LQPIGRGAYGIVCSAV-----NSETKEEVAIK--KIT 69
             F  +  YVP             + +G+G++G+V   V       E +  VAIK     
Sbjct: 7   EYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 66

Query: 70  NAFDNRIDAKRILREIKLLCHMTHENIVK----VKDIIPPMDKEKFNDVYIVYELMDT-D 124
            +   RI+    L E  ++      ++V+    V    P           ++ ELM   D
Sbjct: 67  ASMRERIE---FLNEASVMKEFNCHHVVRLLGVVSQGQPT---------LVIMELMTRGD 114

Query: 125 LHQIIRSK----------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN 174
           L   +RS              +         ++  G+ Y+++   +HRDL   N ++  +
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174

Query: 175 CDLKICDFGLARTTSETD 192
             +KI DFG+ R   ETD
Sbjct: 175 FTVKIGDFGMTRDIYETD 192

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.1 bits (198), Expect = 5e-17
 Identities = 56/325 (17%), Positives = 110/325 (33%), Gaps = 64/325 (19%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVK 98
           L+ IGRGA+  V      +T +  A+K +       R +      E  +L +     I +
Sbjct: 66  LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD----TDL-HQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +           F D   +Y +M+     DL   + +  + +  +  +++L +++  +  
Sbjct: 126 LH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RTTSETDFMT-------EY----VVTR 201
           +H    +HRD+KP N+LL+    +++ DFG   +  ++    +       +Y    ++  
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237

Query: 202 WDTLFPGKDYVQQL------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS 254
                    Y  +           E+  G        F     A  Y K + +       
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP-----FYADSTAETYGKIVHYKEHLSLP 292

Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRIT---VEEALNHPYLSS-----LHEINEEPTCPYP 306
                +   A D  +R+L   P  R+      +   HP+        L +    P    P
Sbjct: 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDS--VP----P 345

Query: 307 F-----------NFDFEQTSMNEED 320
           F           NFD  +  +    
Sbjct: 346 FTPDFEGATDTCNFDLVEDGLTAMV 370

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 60/325 (18%), Positives = 120/325 (36%), Gaps = 66/325 (20%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ IGRGA+G V         +  A+K +       R +      E  +L +   + I  
Sbjct: 79  LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD----TDL-HQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +           F D   +Y +MD     DL   + + +  L ++  +++L +++  +  
Sbjct: 139 LH--------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RTTSETDFMT-------EY----VVTR 201
           +H  + +HRD+KP N+L++ N  +++ DFG   +   +    +       +Y    ++  
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250

Query: 202 WDTLFPGKDYVQQL------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS 254
            +       Y  +         + E+L G        F        Y K + H  +  F 
Sbjct: 251 MEGGKGR--YGPECDWWSLGVCMYEMLYGETP-----FYAESLVETYGKIMNHKERFQFP 303

Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRIT---VEEALNHPYLSS-----LHEINEEPTCPYP 306
            +  ++S  A DL  R++      R+    +E+   HP+ S      +     E     P
Sbjct: 304 TQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSGIDWDNIRNC--EA----P 356

Query: 307 F-----------NFDFEQTSMNEED 320
           +           NFD +   +   +
Sbjct: 357 YIPEVSSPTDTSNFDVDDDCLKNSE 381

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 40/195 (20%)

Query: 40  LQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-TH 93
            +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+  H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHH 90

Query: 94  ENIVK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS----------------K 132
            N+V           P+         ++ E     +L   +RS                K
Sbjct: 91  LNVVNLLGACTKPGGPL--------MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
             LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR   +  
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202

Query: 193 FMTEYVVTRWDTLFP 207
              +YV    D   P
Sbjct: 203 ---DYVRKG-DARLP 213

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 43/195 (22%)

Query: 40  LQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTH 93
            + +G GA+G V  A       ++ K  VA+K + +     R D     RE +LL ++ H
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD---FQREAELLTNLQH 76

Query: 94  ENIVK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS----------------K 132
           E+IVK      D  P         + +V+E M   DL++ +R+                K
Sbjct: 77  EHIVKFYGVCGDGDP---------LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
             L      +   Q+  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R    TD
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

Query: 193 FMTEYVVTRWDTLFP 207
               Y      T+ P
Sbjct: 188 ----YYRVGGHTMLP 198

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 77.0 bits (190), Expect = 4e-16
 Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 38/179 (21%)

Query: 40  LQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTH 93
              +G GA+G V  A     +  + K  VA+K +  A ++ R D     RE +LL  + H
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD---FQREAELLTMLQH 102

Query: 94  ENIVK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS---------------KQ 133
           ++IV+      +  P         + +V+E M   DL++ +RS                 
Sbjct: 103 QHIVRFFGVCTEGRP---------LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 134 ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
            L          Q+  G+ Y+   + +HRDL   N L+     +KI DFG++R    TD
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 76.2 bits (188), Expect = 7e-16
 Identities = 43/190 (22%), Positives = 72/190 (37%), Gaps = 39/190 (20%)

Query: 41  QPIGRGAYGIVCSAV--NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIV 97
             IG G +G V  A       + + AIK++   + ++ D +    E+++LC +  H NI+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 98  K---VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQ------------ 141
                 +    +        Y+  E     +L   +R  + L  D               
Sbjct: 90  NLLGACEHRGYL--------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 142 ----YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEY 197
               +F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R         E 
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-------QEV 194

Query: 198 VVTRWDTLFP 207
            V +     P
Sbjct: 195 YVKKTMGRLP 204

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 76.2 bits (188), Expect = 8e-16
 Identities = 58/286 (20%), Positives = 115/286 (40%), Gaps = 62/286 (21%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-------TNAFDNRIDAKRILREIKLLCHMT 92
           ++ +G G++G V    + E+    A+K +           ++ ++ KRIL+ +       
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN------ 99

Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMDT----DLHQIIRSKQALTDDHCQYFLYQLL 148
              +VK++          F D   +Y +M+     ++   +R     ++ H +++  Q++
Sbjct: 100 FPFLVKLEF--------SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 149 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFM----TEYVVTRWDT 204
              +Y+HS ++++RDLKP NLL++    +++ DFG A+      +      E        
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEA------- 204

Query: 205 LFP----GKDYVQQL------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPF 253
           L P     K Y + +       +I E+  G P      F      + Y K +    + P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP-----FFADQPIQIYEKIVSGKVRFP- 258

Query: 254 SQKFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSL 294
                + S    DL   +L  D  KR       V +  NH + ++ 
Sbjct: 259 ----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 75.3 bits (186), Expect = 1e-15
 Identities = 38/181 (20%), Positives = 67/181 (37%), Gaps = 40/181 (22%)

Query: 40  LQPIGRGAYGIVCSAV-----NSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHMT 92
           ++ +G   +G V           E  + VAIK  K       R +      E  L   + 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE---FRHEAMLRARLQ 70

Query: 93  HENIVK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQ------ 141
           H N+V     V    P         + +++      DLH+ +  +   +D          
Sbjct: 71  HPNVVCLLGVVTKDQP---------LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 142 ----------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
                     + + Q+  G++Y+ S +V+H+DL   N+L+    ++KI D GL R     
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181

Query: 192 D 192
           D
Sbjct: 182 D 182

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 75.3 bits (186), Expect = 1e-15
 Identities = 38/148 (25%), Positives = 67/148 (45%), Gaps = 13/148 (8%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G G++  V  A    T  E AIK +             + RE  ++  + H   VK+  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 102 IIPPMDKEKFNDVYIVYELMDT----DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    F D   +Y  +      +L + IR   +  +   +++  +++  L+Y+H  
Sbjct: 98  --------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
            ++HRDLKP N+LLN +  ++I DFG A
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTA 177

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 61/285 (21%), Positives = 111/285 (38%), Gaps = 58/285 (20%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI-VKVKD 101
           IGRG +G V     ++T +  A+K +        D KRI  +      +    +   V  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVST 248

Query: 102 IIPPM---------DKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGL 151
              P            +K   +  + +LM+  DLH  +      ++   +++  +++ GL
Sbjct: 249 GDCPFIVCMSYAFHTPDK---LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT-----EY----VVTRW 202
           +++H+  V++RDLKP+N+LL+ +  ++I D GLA   S+           Y    V+ + 
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK- 364

Query: 203 DTLFPGKDYVQQL------TMITELLG--SPDDSDLGFLRSDNARRYVKQLPHVPKQPFS 254
                G  Y           M+ +LL   SP        + +  R  +     +P     
Sbjct: 365 -----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----- 414

Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSL 294
               + SP    L E +L  D  +R+       +E    P+  SL
Sbjct: 415 ---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 66/310 (21%), Positives = 112/310 (36%), Gaps = 48/310 (15%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G +G VC+     T +  A KK+       R      L E ++L  +    +V +  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 102 IIPPMDKEKFNDVYIVYELMDT-DL-HQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSAN 158
                D      + +V  LM+  DL   I    +    +    ++  ++  GL+ +H   
Sbjct: 252 AYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDYVQQ 214
           +++RDLKP N+LL+ +  ++I D GLA    E   +   V T    + P     + Y   
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV-GYMAPEVVKNERYTFS 365

Query: 215 L------TMITELL-GSP--DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
                   ++ E++ G            R +  R   +                 SP A 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--------ERFSPQAR 417

Query: 266 DLAERMLVFDPAKRI-----TVEEALNHPYLSS------LHEINEEPTCPYPF------N 308
            L  ++L  DPA+R+     +  E   HP             + E P  P P        
Sbjct: 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDV 477

Query: 309 FDFEQTSMNE 318
            D EQ S  +
Sbjct: 478 LDIEQFSTVK 487

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 49/195 (25%), Positives = 77/195 (39%), Gaps = 43/195 (22%)

Query: 40  LQPIGRGAYGIVCSA-----VNSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHM- 91
            + +G GA+G V  A        +   +VA+K  K T   D +     ++ E+K++ H+ 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---LMSELKIMSHLG 107

Query: 92  THENIVK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK-------------- 132
            HENIV          P         V ++ E     DL   +R K              
Sbjct: 108 QHENIVNLLGACTHGGP---------VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 133 QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD 192
              +     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR      
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218

Query: 193 FMTEYVVTRWDTLFP 207
               Y+V   +   P
Sbjct: 219 ---NYIVKG-NARLP 229

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 44/192 (22%), Positives = 71/192 (36%), Gaps = 38/192 (19%)

Query: 40  LQPIGRGAYGIVCSAV-----NSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHMT 92
           ++ +G GA+G V         N  +  +VA+K      +  + +D    L E  ++    
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD---FLMEALIISKFN 91

Query: 93  HENIVK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQL 147
           H+NIV+        +P          +I+ ELM   DL   +R  +          +  L
Sbjct: 92  HQNIVRCIGVSLQSLP---------RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 148 L-------RGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARTTSETDFMTEY 197
           L        G +Y+   + +HRD+   N LL         KI DFG+AR          Y
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----Y 198

Query: 198 VVTRWDTLFPGK 209
                  + P K
Sbjct: 199 YRKGGCAMLPVK 210

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 73.5 bits (181), Expect = 4e-15
 Identities = 27/173 (15%), Positives = 60/173 (34%), Gaps = 30/173 (17%)

Query: 40  LQPIGRGAYGIVCSAV-------NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT 92
            + +G+G +  +   V           + EV +K +  A  N   ++       ++  ++
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN--YSESFFEAASMMSKLS 70

Query: 93  HENIVK---VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRS-KQALTDDHCQYFLYQL 147
           H+++V    V                +V E +    L   ++  K  +          QL
Sbjct: 71  HKHLVLNYGVCVCGDEN--------ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQL 122

Query: 148 LRGLKYIHSANVLHRDLKPSNLLLNANCDL--------KICDFGLARTTSETD 192
              + ++    ++H ++   N+LL    D         K+ D G++ T    D
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 42/202 (20%), Positives = 71/202 (35%), Gaps = 48/202 (23%)

Query: 40  LQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE 94
            + +G G +G V  A             VA+K +        + + +L E  +L  + H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-ELRDLLSEFNVLKQVNHP 86

Query: 95  NIVK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK----------------- 132
           +++K         P           ++ E      L   +R                   
Sbjct: 87  HVIKLYGACSQDGPL---------LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137

Query: 133 -------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
                  +ALT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197

Query: 186 RTTSETDFMTEYVVTRWDTLFP 207
           R   E D    YV        P
Sbjct: 198 RDVYEED---SYVKRS-QGRIP 215

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 51/197 (25%), Positives = 79/197 (40%), Gaps = 43/197 (21%)

Query: 40  LQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-TH 93
            + +G GA+G V  A     + S+    VA+K +     +  + + ++ E+K+L ++  H
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNH 86

Query: 94  ENIVK----VKDIIPPMDKEKFNDVYIVYELM-DTDLHQIIRSK---------------- 132
            NIV          P           ++ E     DL   +R K                
Sbjct: 87  MNIVNLLGACTIGGP---------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 133 --QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
              AL  +    F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR    
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 191 TDFMTEYVVTRWDTLFP 207
                 YVV   +   P
Sbjct: 198 DS---NYVVKG-NARLP 210

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 44/192 (22%), Positives = 71/192 (36%), Gaps = 38/192 (19%)

Query: 40  LQPIGRGAYGIVCSA-----VNSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHMT 92
           ++ +G GA+G V         N  +  +VA+K      +  + +D    L E  ++    
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD---FLMEALIISKFN 132

Query: 93  HENIVK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQL 147
           H+NIV+        +P          +I+ ELM   DL   +R  +          +  L
Sbjct: 133 HQNIVRCIGVSLQSLP---------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 148 L-------RGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARTTSETDFMTEY 197
           L        G +Y+   + +HRD+   N LL         KI DFG+AR          Y
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----Y 239

Query: 198 VVTRWDTLFPGK 209
                  + P K
Sbjct: 240 YRKGGCAMLPVK 251

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 73.5 bits (181), Expect = 7e-15
 Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 43/197 (21%)

Query: 40  LQPIGRGAYGIVCSAV-------NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM- 91
            +P+G G +G V  A          +    VA+K +        D   ++ E++++  + 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIG 144

Query: 92  THENIVK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK-------------- 132
            H+NI+          P          Y++ E     +L + +R++              
Sbjct: 145 KHKNIINLLGACTQDGPL---------YVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195

Query: 133 --QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
             + +T        YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  + 
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 191 TDFMTEYVVTRWDTLFP 207
            D    Y  T  +   P
Sbjct: 256 ID---YYKKTT-NGRLP 268

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 73.1 bits (180), Expect = 8e-15
 Identities = 47/197 (23%), Positives = 80/197 (40%), Gaps = 43/197 (21%)

Query: 40  LQPIGRGAYGIVCSAV-------NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM- 91
            +P+G GA+G V  A          +    VA+K +        D   ++ E++++  + 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIG 98

Query: 92  THENIVK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK-------------- 132
            H+NI+          P          Y++ E     +L + +R++              
Sbjct: 99  KHKNIINLLGACTQDGPL---------YVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149

Query: 133 --QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
             + +T        YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  + 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 191 TDFMTEYVVTRWDTLFP 207
            D    Y  T  +   P
Sbjct: 210 ID---YYKKTT-NGRLP 222

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 37/148 (25%), Positives = 69/148 (46%), Gaps = 14/148 (9%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVKVKD 101
           IGRGA+G V    +  T++  A+K ++      R D+     E  ++       +V++  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135

Query: 102 IIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
                    F D   +Y +M+     DL  ++     + +   +++  +++  L  IHS 
Sbjct: 136 -------YAFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIHSM 187

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLA 185
             +HRD+KP N+LL+ +  LK+ DFG  
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTC 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 25/170 (14%)

Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRIL-R 83
           ++G  F+V  K       IG G +G +    N  T E VAIK      +        L  
Sbjct: 6   MVGPNFRVGKK-------IGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHL 53

Query: 84  EIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQ 141
           E +    +   + I +V    P     K+N   +V EL+   L  +     +  +     
Sbjct: 54  EYRFYKQLGSGDGIPQVYYFGP---CGKYN--AMVLELLGPSLEDLFDLCDRTFSLKTVL 108

Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLL--NANCDLKIC---DFGLAR 186
               QL+  ++Y+HS N+++RD+KP N L+    N   ++    DF LA+
Sbjct: 109 MIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 47/189 (24%), Positives = 70/189 (37%), Gaps = 48/189 (25%)

Query: 40  LQPIGRGAYGIVCSA-----VNSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHMT 92
           ++ IG GA+G V  A     +  E    VA+K  K   + D + D     RE  L+    
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD---FQREAALMAEFD 108

Query: 93  HENIVK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK--------------- 132
           + NIVK         P           +++E M   DL++ +RS                
Sbjct: 109 NPNIVKLLGVCAVGKPM---------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159

Query: 133 ---------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 183
                      L+         Q+  G+ Y+     +HRDL   N L+  N  +KI DFG
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 219

Query: 184 LARTTSETD 192
           L+R     D
Sbjct: 220 LSRNIYSAD 228

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 43/196 (21%), Positives = 82/196 (41%), Gaps = 41/196 (20%)

Query: 40  LQPIGRGAYGIVCSAV-------NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM- 91
            +P+G GA+G V  A              +VA+K + +    + D   ++ E++++  + 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIG 132

Query: 92  THENIVK---VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQ------ 141
            H+NI+          P+        Y++ E     +L + +++++    ++        
Sbjct: 133 KHKNIINLLGACTQDGPL--------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 142 ----------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET 191
                        YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244

Query: 192 DFMTEYVVTRWDTLFP 207
           D    Y  T  +   P
Sbjct: 245 D---YYKKTT-NGRLP 256

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 53/283 (18%), Positives = 106/283 (37%), Gaps = 51/283 (18%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +GRG +G V +     T +  A KK+       R   +  + E K+L  +    IV +  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252

Query: 102 IIPPMDKEKFNDVYIVYELMD-----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
                       + +V  +M+       ++ +        +    ++  Q++ GL+++H 
Sbjct: 253 AFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT-------EY----VVTRWDTL 205
            N+++RDLKP N+LL+ + +++I D GLA         T        +    ++      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL----- 362

Query: 206 FPGKDYVQQL------TMITELL-GSP--DDSDLGFLRSDNARRYVKQLPHVPKQPFSQK 256
             G++Y   +        + E++                +  +R ++Q    P       
Sbjct: 363 --GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP------- 413

Query: 257 FPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSL 294
               SP + D  E +L  DP KR+     + +    HP    +
Sbjct: 414 -DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 70.4 bits (173), Expect = 7e-14
 Identities = 50/202 (24%), Positives = 85/202 (42%), Gaps = 48/202 (23%)

Query: 40  LQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-TH 93
            + +G GA+G V +A       +    +VA+K +    D+  + + ++ E+K++  + +H
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQLGSH 108

Query: 94  ENIVK----VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSK---------------- 132
           ENIV          P          Y+++E     DL   +RSK                
Sbjct: 109 ENIVNLLGACTLSGPI---------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159

Query: 133 -------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
                    LT +    F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLA
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219

Query: 186 RTTSETDFMTEYVVTRWDTLFP 207
           R          YVV   +   P
Sbjct: 220 RDIMSDS---NYVVRG-NARLP 237

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.7 bits (169), Expect = 3e-13
 Identities = 62/278 (22%), Positives = 116/278 (41%), Gaps = 52/278 (18%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIK--KITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +G G++G V    +       A+K  K       +   +    E  +L  +TH  I+++ 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTNDERLMLSIVTHPFIIRMW 72

Query: 101 DIIPPMDKEKFNDVYIVYELMD----TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
                     F D   ++ +MD     +L  ++R  Q   +   +++  ++   L+Y+HS
Sbjct: 73  G--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFM----TEYVVTRWDTLFP----G 208
            ++++RDLKP N+LL+ N  +KI DFG A+   +  +      +Y       + P     
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDY-------IAPEVVST 177

Query: 209 KDYVQQL------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
           K Y + +       +I E+L G        F  S+  + Y K L    + P     P  +
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTP-----FYDSNTMKTYEKILNAELRFP-----PFFN 227

Query: 262 PVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSL 294
               DL  R++  D ++R+       E+  NHP+   +
Sbjct: 228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 42/169 (24%), Positives = 71/169 (42%), Gaps = 25/169 (14%)

Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--IL 82
            +GN +++  K       IG G++G +    +    EEVAIK         +  K   + 
Sbjct: 6   RVGNRYRLGRK-------IGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTKHPQLH 52

Query: 83  REIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHC 140
            E K+   M     I  ++       +  +N   +V EL+   L  +     +  +    
Sbjct: 53  IESKIYKMMQGGVGIPTIRWCGA---EGDYN--VMVMELLGPSLEDLFNFCSRKFSLKTV 107

Query: 141 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLAR 186
                Q++  ++YIHS N +HRD+KP N L+        + I DFGLA+
Sbjct: 108 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 67.0 bits (164), Expect = 8e-13
 Identities = 32/172 (18%), Positives = 67/172 (38%), Gaps = 27/172 (15%)

Query: 24  NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR--I 81
           N++G  ++V  +       IG G++G++    N    ++VAIK           +    +
Sbjct: 6   NVVGVHYKVGRR-------IGEGSFGVIFEGTNLLNNQQVAIK------FEPRRSDAPQL 52

Query: 82  LREIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDH 139
             E +    +     I  V        +   N   +V +L+   L  ++    +  +   
Sbjct: 53  RDEYRTYKLLAGCTGIPNVYYFGQ---EGLHN--VLVIDLLGPSLEDLLDLCGRKFSVKT 107

Query: 140 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK-----ICDFGLAR 186
                 Q+L  ++ IH  ++++RD+KP N L+            + DFG+ +
Sbjct: 108 VAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 39/183 (21%), Positives = 68/183 (37%), Gaps = 34/183 (18%)

Query: 24  NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIK--KITNAFDNRIDAKRI 81
           ++ GN + +  K       IG G +G++  A  +   E+ A    K+        +   +
Sbjct: 33  DMEGNQWVLGKK-------IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQ-----ENGPL 80

Query: 82  LREIKLL------CHMTHENIVKVKDI--IP--------PMDKEKFNDVYIVYELMDTDL 125
             E+K          +      K  D   IP              +   ++V E +  DL
Sbjct: 81  FSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYR--FMVMERLGIDL 138

Query: 126 HQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN-ANCD-LKICDFG 183
            +I                 ++L  L+YIH    +H D+K +NLLL   N D + + D+G
Sbjct: 139 QKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYG 198

Query: 184 LAR 186
           L+ 
Sbjct: 199 LSY 201

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 21/167 (12%)

Query: 25  ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILRE 84
            +GN F++  K       IG G++G +    N +T EEVAIK      + +    ++L E
Sbjct: 4   RVGNKFRLGRK-------IGSGSFGEIYLGTNIQTNEEVAIKLE----NVKTKHPQLLYE 52

Query: 85  IKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQY 142
            K+   +     I  V+       +  +N   +V +L+   L  +     + L+      
Sbjct: 53  SKIYRILQGGTGIPNVRWFGV---EGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107

Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLAR 186
              Q++  ++++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.1 bits (155), Expect = 9e-12
 Identities = 47/314 (14%), Positives = 87/314 (27%), Gaps = 71/314 (22%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKR------ILREIKLLCHMT- 92
            + IG G +G V   +       VAIK I     + ++         IL EI +   ++ 
Sbjct: 25  CEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSL 82

Query: 93  --------HENIVKVKDII-------------------------PPMDKEKFNDVYIVYE 119
                    E  + +  +                             D  K + ++IV E
Sbjct: 83  LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142

Query: 120 LMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLK 178
                +       +  +    +  L+QL   L    ++    HRDL   N+LL      K
Sbjct: 143 FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKK 202

Query: 179 ICDFGLAR----------------TTSETDFMTEYVVTRWDT---LFPGKDYVQQLTMIT 219
           +      +                T S  +     V         LF G    Q    I 
Sbjct: 203 LHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQ--FDIY 260

Query: 220 ELLGSPDDSDL-GFLRSDNA------RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERML 272
            L+   +++    +    N          + +      +  +     +     +    ML
Sbjct: 261 RLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML 320

Query: 273 VFDPAKRITVEEAL 286
            F  A  +  + +L
Sbjct: 321 NFSSATDLLCQHSL 334

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 63.3 bits (155), Expect = 1e-11
 Identities = 41/183 (22%), Positives = 73/183 (39%), Gaps = 51/183 (27%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID--AKRILREIKLLCHMTHENIVKV- 99
           +G G +G+V     + T   VA+KK+    D   +   ++  +EIK++    HEN+V++ 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96

Query: 100 ---KDIIPPMDKEKFNDVYIVYELM-----DTDLHQIIRSKQ-------------ALTDD 138
               D       +      +VY  M        L  +  +               A    
Sbjct: 97  GFSSD-----GDDLC----LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA---- 143

Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYV 198
                      G+ ++H  + +HRD+K +N+LL+     KI DFGLAR + +       +
Sbjct: 144 ----------NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVM 191

Query: 199 VTR 201
            +R
Sbjct: 192 TSR 194

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 34/147 (23%), Positives = 59/147 (40%), Gaps = 6/147 (4%)

Query: 65  IKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVY--IVYELMD 122
           ++   N F          R+ K        ++ +  D I        +          ++
Sbjct: 118 LRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

Query: 123 TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 182
            +       K  LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDF
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 237

Query: 183 GLARTTSETDFMTEYVVTRWDTLFPGK 209
           GLAR   +     +YV    D   P K
Sbjct: 238 GLARDIYKDP---DYVRKG-DARLPLK 260

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 40.7 bits (95), Expect = 5e-04
 Identities = 33/172 (19%), Positives = 67/172 (38%), Gaps = 16/172 (9%)

Query: 41  QPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THE 94
           +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+  H 
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 86

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           N+V +              + ++ E     +L   +RSK+     +      +  +G  Y
Sbjct: 87  NVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG-ARFRQGKDY 141

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTL 205
           +     +  DLK     + ++       F   ++ S+ +          D L
Sbjct: 142 V---GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFL 190

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 62.6 bits (153), Expect = 3e-11
 Identities = 71/324 (21%), Positives = 126/324 (38%), Gaps = 83/324 (25%)

Query: 43  IGRGAYG---IVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G+G++G   +V     S+ ++  A+K +  A     D  R   E  +L  + H  IVK+
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 100 KDIIPPMDKEKFNDVYIV--Y----ELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
                   K     +Y++  +    +L      ++ +     T++  +++L +L   L +
Sbjct: 92  HYAFQTEGK-----LYLILDFLRGGDLF----TRLSKEVM-FTEEDVKFYLAELALALDH 141

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT-------EY----VVTRW 202
           +HS  +++RDLKP N+LL+    +K+ DFGL++ + + +          EY    VV   
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN-- 199

Query: 203 DTLFPGKDYVQQL------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ 255
                 + + Q         ++ E+L G+       F   D        L      P   
Sbjct: 200 -----RRGHTQSADWWSFGVLMFEMLTGTLP-----FQGKDRKETMTMILKAKLGMP--- 246

Query: 256 KFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSL-------HEINEEPTC 303
               +SP A  L   +   +PA R+      VEE   H + S++        EI   P  
Sbjct: 247 --QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREI--HP-- 300

Query: 304 PYPF-----------NFDFEQTSM 316
             PF            FD E T+ 
Sbjct: 301 --PFKPATGRPEDTFYFDPEFTAK 322

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 62.2 bits (152), Expect = 4e-11
 Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 53/183 (28%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNA-------FDNRIDAKRILREIKLLCHMTHEN 95
           IG G +G V   V  +  + VA+K+ T         F+          EI+ L    H +
Sbjct: 47  IGHGVFGKVYKGVLRDGAK-VALKRRTPESSQGIEEFET---------EIETLSFCRHPH 96

Query: 96  IVK-----VKDIIPPMDKEKFNDVYIVYELMDTD-----LHQIIRSKQALTDDHCQYFLY 145
           +V       +           N++ ++Y+ M+       L+       +++ +       
Sbjct: 97  LVSLIGFCDER----------NEMILIYKYMENGNLKRHLYGSDLPTMSMSWE------- 139

Query: 146 QLL-------RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYV 198
           Q L       RGL Y+H+  ++HRD+K  N+LL+ N   KI DFG+++  +E D    ++
Sbjct: 140 QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD--QTHL 197

Query: 199 VTR 201
            T 
Sbjct: 198 STV 200

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 35/150 (23%), Positives = 71/150 (47%), Gaps = 17/150 (11%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G +G V       T    A+K +       + +    + E ++L +  H  +  +K 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 102 IIPPMDKEKFNDVYIV--Y----ELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
                D+     +  V  Y    EL     H  +  ++  T++  +++  +++  L+Y+H
Sbjct: 73  AFQTHDR-----LCFVMEYANGGELF---FH--LSRERVFTEERARFYGAEIVSALEYLH 122

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           S +V++RD+K  NL+L+ +  +KI DFGL 
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLC 152

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 61.4 bits (150), Expect = 6e-11
 Identities = 60/286 (20%), Positives = 111/286 (38%), Gaps = 61/286 (21%)

Query: 43  IGRGAYG---IVCSAVNSETKEEVAIKKITNAF--DNRIDAKRILREIKLLCHMTHENIV 97
           +G+G YG    V     + T +  A+K +  A    N  D      E  +L  + H  IV
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 98  KVKDIIPPMDKEKFNDVYIV--Y----ELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
            +        K     +Y++  Y    EL      Q+ R      +D   ++L ++   L
Sbjct: 85  DLIYAFQTGGK-----LYLILEYLSGGELF----MQLEREGI-FMEDTACFYLAEISMAL 134

Query: 152 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT-------EY----VVT 200
            ++H   +++RDLKP N++LN    +K+ DFGL + +     +T       EY    ++ 
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194

Query: 201 RWDTLFPGKDYVQQL------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPF 253
                     + + +       ++ ++L G+P      F   +  +   K L      P 
Sbjct: 195 -------RSGHNRAVDWWSLGALMYDMLTGAPP-----FTGENRKKTIDKILKCKLNLP- 241

Query: 254 SQKFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSL 294
               P ++  A DL +++L  + A R+        E   HP+   +
Sbjct: 242 ----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 34/155 (21%), Positives = 71/155 (45%), Gaps = 20/155 (12%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDAKRILREIKLLCHMTHENI 96
           L  +G+G++G V  +    T E  A+K +       D+ ++   + + + L        +
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFL 404

Query: 97  VKVKDIIPPMDKEKFNDVYIVYE------LMDTDLHQIIRSKQALTDDHCQYFLYQLLRG 150
            ++      MD+     +Y V E      LM    + I +  +   + H  ++  ++  G
Sbjct: 405 TQLHSCFQTMDR-----LYFVMEYVNGGDLM----YHIQQVGR-FKEPHAVFYAAEIAIG 454

Query: 151 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           L ++ S  +++RDLK  N++L++   +KI DFG+ 
Sbjct: 455 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 38/172 (22%), Positives = 71/172 (41%), Gaps = 28/172 (16%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK---- 98
           +GRG +G V     ++    VA+K++        +  +   E++++    H N+++    
Sbjct: 38  LGRGGFGKVYKGRLADGTL-VAVKRLKEERTQGGE-LQFQTEVEMISMAVHRNLLRLRGF 95

Query: 99  -VKDIIPPMDKEKFNDVYIVYELM-----DTDLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
            +             +  +VY  M      + L +   S+  L     Q       RGL 
Sbjct: 96  CMTP----------TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLA 145

Query: 153 YIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR 201
           Y+H      ++HRD+K +N+LL+   +  + DFGLA+     D    +V T 
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---THVTTA 194

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 34/156 (21%), Positives = 71/156 (45%), Gaps = 28/156 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDA----KRILREIKLLCHMTHEN 95
           +G+G++G V  A   ET +  A+K +       D+ ++     KRIL          H  
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-----RNHPF 85

Query: 96  IVKVKDIIPPMDKEKFNDVYIV--Y----ELMDTDLHQIIRSKQALTDDHCQYFLYQLLR 149
           + ++       D+     ++ V  +    +LM      I +S++   +   +++  +++ 
Sbjct: 86  LTQLFCCFQTPDR-----LFFVMEFVNGGDLM----FHIQKSRR-FDEARARFYAAEIIS 135

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
            L ++H   +++RDLK  N+LL+     K+ DFG+ 
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 27/183 (14%), Positives = 62/183 (33%), Gaps = 31/183 (16%)

Query: 24  NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSET--------KEEVAIK--------K 67
           +  G  +++ S          R   GI+  A  + T        K++ ++K         
Sbjct: 38  DKSGRQWKLKSF-------QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLF 90

Query: 68  ITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQ 127
               F  R      + + K L       I         + ++K+   ++V   +   L  
Sbjct: 91  NEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGF--GVHQDKYR--FLVLPSLGRSLQS 146

Query: 128 IIR--SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI--CDFG 183
            +    K  L++        +LL  L+++H    +H ++   N+ ++     ++    +G
Sbjct: 147 ALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206

Query: 184 LAR 186
            A 
Sbjct: 207 FAF 209

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 57/276 (20%), Positives = 110/276 (39%), Gaps = 48/276 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDAKRILREIKLLCHMTHENIVKV 99
           +G+G++G V  A   +T +  AIK +       D+ ++   + + + L     H  +  +
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTHM 83

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                  +      ++ V E ++  DL   I+S          ++  +++ GL+++HS  
Sbjct: 84  FCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT-------EYVVTRWDTLFP---- 207
           +++RDLK  N+LL+ +  +KI DFG+ +     D  T       +Y       + P    
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY-------IAPEILL 191

Query: 208 GKDYVQQL------TMITELL--GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
           G+ Y   +       ++ E+L   SP      F   D    +       P  P       
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSP------FHGQDEEELFHSIRMDNPFYP-----RW 240

Query: 260 MSPVAIDLAERMLVFDPAKRI-TVEEALNHPYLSSL 294
           +   A DL  ++ V +P KR+    +   HP    +
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 34/151 (22%), Positives = 69/151 (45%), Gaps = 18/151 (11%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDA----KRILREIKLLCHMTHEN 95
           IGRG+Y  V      +T    A+K +       D  ID     K +  +        H  
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-----SNHPF 71

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           +V +        +     ++ V E ++  DL   ++ ++ L ++H +++  ++   L Y+
Sbjct: 72  LVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           H   +++RDLK  N+LL++   +K+ D+G+ 
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 55/274 (20%), Positives = 112/274 (40%), Gaps = 40/274 (14%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKD 101
           +G+G +G V       T    A+K +       + +    L E ++L +  H  +  +K 
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215

Query: 102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA-NV 159
                D+     +  V E  +  +L   +  ++  ++D  +++  +++  L Y+HS  NV
Sbjct: 216 SFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 270

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT-------EYVVTRWDTLFPGKDYV 212
           ++RDLK  NL+L+ +  +KI DFGL +   +            EY+      +    DY 
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE---VLEDNDYG 327

Query: 213 QQL------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
           + +       ++ E++ G        F   D+ + +   L    + P       + P A 
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLP-----FYNQDHEKLFELILMEEIRFP-----RTLGPEAK 377

Query: 266 DLAERMLVFDPAKRI-----TVEEALNHPYLSSL 294
            L   +L  DP +R+       +E + H + + +
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 59.9 bits (146), Expect = 3e-10
 Identities = 35/156 (22%), Positives = 71/156 (45%), Gaps = 28/156 (17%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDA----KRILREIKLLCHMTHEN 95
           +G+G++G V  +    T E  A+K +       D+ ++     KR+L             
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPPF 82

Query: 96  IVKVKDIIPPMDKEKFNDVYIV--Y----ELMDTDLHQIIRSKQALTDDHCQYFLYQLLR 149
           + ++      MD+     +Y V  Y    +LM    + I +  +   + H  ++  ++  
Sbjct: 83  LTQLHSCFQTMDR-----LYFVMEYVNGGDLM----YHIQQVGR-FKEPHAVFYAAEIAI 132

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           GL ++ S  +++RDLK  N++L++   +KI DFG+ 
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 34/187 (18%), Positives = 70/187 (37%), Gaps = 39/187 (20%)

Query: 24  NILGNLFQVSSKYVPPLQPIGRGAYGIV-----CSAVNSETKEEVAIKKITNAFDNRIDA 78
           ++    ++V          IG+G +G +      S+ +  +     +K          D 
Sbjct: 31  DMAAAAWKVGLP-------IGQGGFGCIYLADMNSSESVGSDAPCVVKV------EPSDN 77

Query: 79  KRILREIKLLCHMTHENIVKVKDI--------IPPM--------DKEKFNDVYIVYELMD 122
             +  E+K          ++            +P          + + +   +++ +   
Sbjct: 78  GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR--FMIMDRFG 135

Query: 123 TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN-ANCD-LKI 179
           +DL +I  +  +  +         ++L  L+YIH    +H D+K SNLLLN  N D + +
Sbjct: 136 SDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYL 195

Query: 180 CDFGLAR 186
            D+GLA 
Sbjct: 196 VDYGLAY 202

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 33/151 (21%), Positives = 69/151 (45%), Gaps = 18/151 (11%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDA----KRILREIKLLCHMTHEN 95
           IGRG+Y  V      +T    A++ +       D  ID     K +  +        H  
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-----SNHPF 114

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           +V +        +     ++ V E ++  DL   ++ ++ L ++H +++  ++   L Y+
Sbjct: 115 LVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           H   +++RDLK  N+LL++   +K+ D+G+ 
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 67/291 (23%), Positives = 117/291 (40%), Gaps = 75/291 (25%)

Query: 43  IGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDI 102
           IG+G++G V  A +   +   A+K +          K+ + + K   H+  E  V +K++
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQ---------KKAILKKKEEKHIMSERNVLLKNV 96

Query: 103 IPP-----------MDKEKFNDVYIV--Y----ELMDTDLHQIIRSKQALTDDHCQYFLY 145
             P            DK     +Y V  Y    EL     H  ++ ++   +   +++  
Sbjct: 97  KHPFLVGLHFSFQTADK-----LYFVLDYINGGELF---YH--LQRERCFLEPRARFYAA 146

Query: 146 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT-------EYV 198
           ++   L Y+HS N+++RDLKP N+LL++   + + DFGL +   E +  T       EY 
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEY- 205

Query: 199 VTRWDTLFP----GKDYVQQL------TMITE-LLGSPDDSDLGFLRSDNARRYVKQLPH 247
                 L P     + Y + +       ++ E L G P      F   + A  Y   L  
Sbjct: 206 ------LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP-----FYSRNTAEMYDNILNK 254

Query: 248 VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRI----TVEEALNHPYLSSL 294
             +       PN++  A  L E +L  D  KR+       E  +H + S +
Sbjct: 255 PLQLK-----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 58.5 bits (142), Expect = 7e-10
 Identities = 33/163 (20%), Positives = 74/163 (45%), Gaps = 38/163 (23%)

Query: 43  IGRGAYG---IVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +G GAYG   +V      +T +  A+K +  A         I+++ K   H   E     
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT--------IVQKAKTTEHTRTE----- 108

Query: 100 KDIIPPMDKEKF-----------NDVYIV--Y----ELMDTDLHQIIRSKQALTDDHCQY 142
           + ++  + +  F             ++++  Y    EL       + + ++  T+   Q 
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF----THLSQRER-FTEHEVQI 163

Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 185
           ++ +++  L+++H   +++RD+K  N+LL++N  + + DFGL+
Sbjct: 164 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 34/164 (20%), Positives = 57/164 (34%), Gaps = 22/164 (13%)

Query: 33  SSKYVPPLQPIGRGAYGIVCSAVNSE----TKEEVAIKKITNAFDNRIDAKRILREIKLL 88
             K   P   IG+GA   +      +     KE V         D  I   R  RE + L
Sbjct: 334 GKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYL 393

Query: 89  CHMTHENIVKVKDIIPPM--DKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
                  +VK   I  P   D +  N   ++  +       +I               Y+
Sbjct: 394 ------ALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLD--------IAYK 439

Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
           +   +  +H  +V+H DL  SN + + +  +   DFGL + ++ 
Sbjct: 440 IGEIVGKLHKNDVIHNDLTTSNFIFDKDLYI--IDFGLGKISNL 481

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	339
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.2
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.83
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.83
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.73
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.71
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.47
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.26
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.09
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.08
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.02
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.92
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.84
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.8
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.67
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.53
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.52
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.46
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.37
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.37
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.33
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.2
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.16
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.12
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.19
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.01
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	88.66
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.76

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-60  Score=425.57  Aligned_cols=309  Identities=42%  Similarity=0.710  Sum_probs=259.8

Q ss_pred             EccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecC
Q 042681           25 ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIP  104 (339)
Q Consensus        25 ~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~  104 (339)
                      .....+.++++|.+ ++.||+|+||+||+|+++.+|+.||+|++.+........+++.+|+.+|+.++||||+++++++.
T Consensus        45 ~~~~~~~i~~~Y~~-~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  123 (398)
T 4b99_A           45 SFDVTFDVGDEYEI-IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR  123 (398)
T ss_dssp             ---CCCCCCSSEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             ccCCCCCCCCCeEE-EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence            34455678889998 99999999999999999999999999999877666667788999999999999999999999985


Q ss_pred             CCC-cCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          105 PMD-KEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       105 ~~~-~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                      ... ....+.+||||||++|+|.+++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus       124 ~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          124 PTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             CSSCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             cccccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecc
Confidence            432 1345679999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccc---------------cCCCCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccc-------------
Q 042681          184 LART---------------TSETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR-------------  234 (339)
Q Consensus       184 ~~~~---------------~~~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~-------------  234 (339)
                      +|+.               .++..|++||+.... ++..+.|+|++|+++|++++|.+||.......             
T Consensus       204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~  283 (398)
T 4b99_A          204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS  283 (398)
T ss_dssp             TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9863               355678999986654 56788999999999999999999985432110             


Q ss_pred             --------cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCC
Q 042681          235 --------SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYP  306 (339)
Q Consensus       235 --------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~  306 (339)
                              ...........+.....++...++.+|+++++||.+||+.||++|||+.|+|+||||+...++...+.+..+
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~~  363 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPP  363 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSSC
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCCC
Confidence                    011112222233333333444567789999999999999999999999999999999999988888888889


Q ss_pred             CCCChhhccCCHHHHHHHHHHHHHhcCC
Q 042681          307 FNFDFEQTSMNEEDIKELILRECLNFHP  334 (339)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (339)
                      +++++....++.+++++.+.+|+.+|++
T Consensus       364 ~~~~~~~~~~~~~~~k~~i~~ei~~~~~  391 (398)
T 4b99_A          364 FDFAFDREALTRERIKEAIVAEIEDFHA  391 (398)
T ss_dssp             CCCHHHHSCCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCccchhhcCHHHHHHHHHHHHHHHHH
Confidence            9999998899999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-57  Score=396.37  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=215.1

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      +++|.+ ++.||+|+||+||+|+++.+|+.||+|++.+.. ......+.+.+|+.+++.++||||+++++++     ++.
T Consensus        31 ~~dy~i-~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~  104 (311)
T 4aw0_A           31 PEDFKF-GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDD  104 (311)
T ss_dssp             GGGEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             ccccEE-EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence            466777 999999999999999999999999999997642 2233467899999999999999999999999     677


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      +.+|+|||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..  
T Consensus       105 ~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          105 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            88999999998 699999999899999999999999999999999999999999999999999999999999999643  


Q ss_pred             -----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          189 -----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       189 -----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                 |++.|++||+.....+..+.|+|++|+++|++++|..||....  .......+.......        .
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~--------p  254 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EGLIFAKIIKLEYDF--------P  254 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCC--------C
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCC--------C
Confidence                       4567999999888888899999999999999999999986432  111222222221111        1


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCccCCC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEE------ALNHPYLSSLHEINE  299 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~e------ll~hp~f~~~~~~~~  299 (339)
                      ..+|+++++||.+||+.||++|||++|      +++||||+++.|...
T Consensus       255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          255 EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence            358999999999999999999999988      589999999987653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.4e-57  Score=385.95  Aligned_cols=244  Identities=25%  Similarity=0.389  Sum_probs=201.2

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.+ ++.||+|+||+||+|+++.+|+.||+|++.+... .....+++.+|+.+++.++||||+++++++     .+.+
T Consensus        13 g~Y~i-~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~   86 (275)
T 3hyh_A           13 GNYQI-VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD   86 (275)
T ss_dssp             -CCEE-EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             eCeEE-EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence            57877 9999999999999999999999999999976533 333456789999999999999999999999     6678


Q ss_pred             eEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc-----
Q 042681          113 DVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----  187 (339)
Q Consensus       113 ~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~-----  187 (339)
                      .+|+||||++|+|.+++.+++++++..++.++.||+.||+|||++||+||||||+||+++.++++||+|||+|+.     
T Consensus        87 ~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           87 EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            899999999999999999999999999999999999999999999999999999999999999999999999864     


Q ss_pred             -----cCCCCcccccccccccc-CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          188 -----TSETDFMTEYVVTRWDT-LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       188 -----~~~~~~~~~~~~~~~~~-~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                           .|++.|++||+.....+ ..+.|+|++|+++|++++|..||......  .............        ...+|
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--~~~~~i~~~~~~~--------p~~~s  236 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--VLFKNISNGVYTL--------PKFLS  236 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCC--------CTTSC
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCCC--------CCCCC
Confidence                 35567999998876654 56899999999999999999998643211  1112222211111        13589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                      +++++||.+||+.||++|||++|+++||||+.
T Consensus       237 ~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          237 PGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            99999999999999999999999999999963

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.3e-56  Score=382.35  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=209.4

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ..++|....+.||+|+||.||+|.++.+++.||+|++..........+++.+|+.++++++||||+++++++.+.. ...
T Consensus        23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~  101 (290)
T 3fpq_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK  101 (290)
T ss_dssp             TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTE
T ss_pred             CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCC
Confidence            3456655467899999999999999999999999999877666667788999999999999999999999984321 234


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeeecc-CCCeEEeecccccc
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNA-NCDLKICDFGLART  187 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dikp~NIli~~-~~~ikL~Dfg~~~~  187 (339)
                      ..+++|||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||+++ +|.+||+|||+|+.
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            56899999998 799999999899999999999999999999999998  999999999999985 78999999999853


Q ss_pred             ---------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          188 ---------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       188 ---------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                               .|++.|++||+... .+..+.|+|++|+++|++++|..||.....     .............+..  ...
T Consensus       182 ~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~i~~~~~~~~--~~~  253 (290)
T 3fpq_A          182 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVKPAS--FDK  253 (290)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTCCCGG--GGG
T ss_pred             CCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHHHHcCCCCCC--CCc
Confidence                     35678999998764 578899999999999999999999754321     1111111111111111  113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                      .+++++++||.+||+.||++|||++|+++||||+.
T Consensus       254 ~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            47899999999999999999999999999999974

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.6e-56  Score=393.91  Aligned_cols=247  Identities=21%  Similarity=0.309  Sum_probs=207.6

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      -++|.+ ++.||+|+||+||+|+++.+|+.||+|++.+........+.+.+|+.++++++||||+++++++     .+.+
T Consensus        23 me~Y~~-~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~   96 (350)
T 4b9d_A           23 MEKYVR-LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENG   96 (350)
T ss_dssp             CCCEEE-EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred             ccceEE-eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECC
Confidence            468888 9999999999999999999999999999987766666778899999999999999999999999     6778


Q ss_pred             eEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc--
Q 042681          113 DVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--  187 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~--  187 (339)
                      .+|||||||+ |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.  
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            8999999998 7999999754  4579999999999999999999999999999999999999999999999999964  


Q ss_pred             ---------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          188 ---------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       188 ---------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                               .|++.|++||+.....+..+.|+|++|+++|++++|..||.....  ......+...  ..  .   ....
T Consensus       177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~--~~--~---~~~~  247 (350)
T 4b9d_A          177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--KNLVLKIISG--SF--P---PVSL  247 (350)
T ss_dssp             HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHT--CC--C---CCCT
T ss_pred             CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcC--CC--C---CCCc
Confidence                     367789999999888888999999999999999999999864321  1111222211  11  1   1224


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      .+|+++++||.+||+.||++|||++|+++||||+.-
T Consensus       248 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          248 HYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            689999999999999999999999999999999753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-55  Score=388.37  Aligned_cols=246  Identities=24%  Similarity=0.404  Sum_probs=207.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ..|.. .+.||+|+||+||+|+++.+|+.||+|++......  ..+.+.+|+.+++.++||||+++++++     .+.+.
T Consensus        74 ~~y~~-~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~  145 (346)
T 4fih_A           74 SYLDN-FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDE  145 (346)
T ss_dssp             GTEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             HhcEE-eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence            34666 89999999999999999999999999999754322  235688999999999999999999999     67788


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +|||||||+ |+|.+++.+ +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..    
T Consensus       146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            999999998 699998875 67999999999999999999999999999999999999999999999999998643    


Q ss_pred             -------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          189 -------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                             |++.|++||+.....+..+.|+|++|+++|++++|.+||......  .....+.....     +....+..+|
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~-----~~~~~~~~~s  297 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLP-----PRLKNLHKVS  297 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSSC-----CCCSCGGGSC
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCC-----CCCCccccCC
Confidence                   455799999998888999999999999999999999998653211  11122222111     1112234689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      +++++||.+||+.||++|||++|+++||||+...
T Consensus       298 ~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          298 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999999999998654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.8e-56  Score=386.61  Aligned_cols=249  Identities=24%  Similarity=0.365  Sum_probs=206.9

Q ss_pred             cCccCCCccccccccceEEEEEEeC---CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNS---ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      +++|.+ ++.||+|+||+||+|++.   .+++.||+|++++.........++.+|+.++++++||||+++++++     .
T Consensus        23 p~~Y~i-~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~   96 (304)
T 3ubd_A           23 PSQFEL-LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----Q   96 (304)
T ss_dssp             GGGEEE-EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----E
T ss_pred             ccccEE-EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----E
Confidence            467877 999999999999999874   4688999999976544333445688999999999999999999999     6


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc-
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~-  187 (339)
                      +.+.+|+|||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+. 
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            7788999999998 79999999989999999999999999999999999999999999999999999999999999863 


Q ss_pred             ----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          188 ----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       188 ----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                .|++.|++||+.....+..+.|+|++|+++|++++|..||.....  ......+......        ..
T Consensus       177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~~--------~p  246 (304)
T 3ubd_A          177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KETMTMILKAKLG--------MP  246 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCC--------CC
T ss_pred             cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--HHHHHHHHcCCCC--------CC
Confidence                      345679999999888889999999999999999999999864321  1112222221111        11


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCccC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRIT-----VEEALNHPYLSSLHEI  297 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~~  297 (339)
                      ..+|+++++||.+||+.||++|||     ++|+++||||+++.|.
T Consensus       247 ~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          247 QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence            358999999999999999999998     5799999999998764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.9e-54  Score=389.31  Aligned_cols=246  Identities=24%  Similarity=0.404  Sum_probs=208.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +.|.. ++.||+|+||.||+|+++.+|+.||+|++......  ..+.+.+|+.+|+.++||||++++++|     ...+.
T Consensus       151 ~~y~~-~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~  222 (423)
T 4fie_A          151 SYLDN-FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDE  222 (423)
T ss_dssp             GTEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             HhcEe-eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCE
Confidence            34666 99999999999999999999999999999754322  245688999999999999999999999     67788


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +|||||||+ |+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..    
T Consensus       223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            999999998 699988865 67999999999999999999999999999999999999999999999999998643    


Q ss_pred             -------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          189 -------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                             |++.|++||+.....+..+.|+|++|+++|++++|..||......  .....+.....     +....+..+|
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~-----~~~~~~~~~s  374 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLP-----PRLKNLHKVS  374 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCC-----CCCSCTTSSC
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCC-----CCCcccccCC
Confidence                   455799999998888999999999999999999999998643211  11122222111     1122335689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      +++++||.+||+.||++|||+.|+|+||||+...
T Consensus       375 ~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          375 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            9999999999999999999999999999998654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.1e-54  Score=380.04  Aligned_cols=240  Identities=24%  Similarity=0.325  Sum_probs=206.3

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||+|+||.||+|+++.+|+.||+|+++....       ..+|+.+++.++||||+++++++     .+.+.+|||||
T Consensus        63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ivmE  130 (336)
T 4g3f_A           63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFME  130 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEE-----EETTEEEEEEC
T ss_pred             CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEEEEe
Confidence            7789999999999999999999999999975422       24699999999999999999999     67788999999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC-CeEEeecccccc----------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLART----------  187 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~-~ikL~Dfg~~~~----------  187 (339)
                      ||+ |+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.+| ++||+|||+|+.          
T Consensus       131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~  210 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL  210 (336)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence            998 79999999989999999999999999999999999999999999999999988 699999999863          


Q ss_pred             ------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          188 ------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       188 ------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                            .|++.|++||+.....+..+.|+|++|+++|++++|..||......  .....+...     ..+.....+.+|
T Consensus       211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~~~-----~~~~~~~~~~~s  283 (336)
T 4g3f_A          211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--PLCLKIASE-----PPPIREIPPSCA  283 (336)
T ss_dssp             ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--CCHHHHHHS-----CCGGGGSCTTSC
T ss_pred             ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHcC-----CCCchhcCccCC
Confidence                  2566799999998888899999999999999999999998653221  222222221     112233446799


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHH-------------hcCCCCCCCccCC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEA-------------LNHPYLSSLHEIN  298 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~el-------------l~hp~f~~~~~~~  298 (339)
                      +++++||.+||+.||++|||+.|+             ++|||+....++.
T Consensus       284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence            999999999999999999999997             5799999887664

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.9e-52  Score=384.38  Aligned_cols=311  Identities=36%  Similarity=0.625  Sum_probs=246.8

Q ss_pred             cccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           27 GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        27 ~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      ...+.+.++|.. ++.||+|+||.||+|++..+|+.||+|++..........+++.+|+.+++.++||||+++++++...
T Consensus        46 ~~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           46 HSDWQIPDRYEI-RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK  124 (458)
T ss_dssp             CSSCCSCTTEEE-CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             CCcCccCCCeEE-eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            455778899999 9999999999999999999999999999987666677778899999999999999999999999654


Q ss_pred             CcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          107 DKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      .......+|+||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       125 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          125 DVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             CTTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             CcccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence            43455679999999999999999998899999999999999999999999999999999999999999999999999997


Q ss_pred             ccC--------------------------------------CCCccccccc-cccccCCCCccHHHHHHHHHHHhC----
Q 042681          187 TTS--------------------------------------ETDFMTEYVV-TRWDTLFPGKDYVQQLTMITELLG----  223 (339)
Q Consensus       187 ~~~--------------------------------------~~~~~~~~~~-~~~~~~~~~d~~~~g~~~~~~l~g----  223 (339)
                      ...                                      +..|.+||+. ....+..+.|+|++|++++++++|    
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            543                                      4458889864 445678889999999999999984    


Q ss_pred             -------CCCCCcccccc-----------------------------------------cchHHHHHhhCCCCCCCCccc
Q 042681          224 -------SPDDSDLGFLR-----------------------------------------SDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       224 -------~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~~~~~~  255 (339)
                             .+++......+                                         ......+..............
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                   44432211100                                         001112222333344445555


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCChhh-ccCCHHHHHHHHHHHHHhcCC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQ-TSMNEEDIKELILRECLNFHP  334 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  334 (339)
                      .++..++++.+||.+||+.||++|||++|+|+||||+.+++...++.+..+....+.. .+++.++++..+.+|++.|++
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~  444 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHP  444 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHTTTCT
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhCc
Confidence            6678899999999999999999999999999999999999887766665555554443 578889999999999999999


Q ss_pred             CCCC
Q 042681          335 DHML  338 (339)
Q Consensus       335 ~~~~  338 (339)
                      +..+
T Consensus       445 ~~~~  448 (458)
T 3rp9_A          445 EIQL  448 (458)
T ss_dssp             TCCC
T ss_pred             cccC
Confidence            8653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.1e-51  Score=378.03  Aligned_cols=309  Identities=34%  Similarity=0.600  Sum_probs=253.2

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      ..+.+.++|.. ++.||+|+||.||+|.+..+|+.||+|++..........+++.+|+.+++.++||||+++++++....
T Consensus        20 ~~~~i~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           20 KNVHVPDNYII-KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             GGCCCCTTEEE-EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             CcceecCCEEE-EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            36778999999 99999999999999999999999999999876666677788999999999999999999999995443


Q ss_pred             cCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          108 KEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ......+|+||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        99 ~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A           99 LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             TTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            33336799999999999999999888999999999999999999999999999999999999999999999999999865


Q ss_pred             cC---------------------------------CCCccccccc-cccccCCCCccHHHHHHHHHHHhCCCCCCccc--
Q 042681          188 TS---------------------------------ETDFMTEYVV-TRWDTLFPGKDYVQQLTMITELLGSPDDSDLG--  231 (339)
Q Consensus       188 ~~---------------------------------~~~~~~~~~~-~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~--  231 (339)
                      ..                                 +..|.+||+. ....+..+.|+|++|++++++++|..++...+  
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            32                                 3458888874 45567888999999999999998654443211  


Q ss_pred             ---ccc--------------------------------------------cchHHHHHhhCCCCCCCCccccCCCCCHHH
Q 042681          232 ---FLR--------------------------------------------SDNARRYVKQLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       232 ---~~~--------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  264 (339)
                         .+.                                            ......................++.+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence               110                                            111222233333334444444567799999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCChhh-ccCCHHHHHHHHHHHHHhcCCCCC
Q 042681          265 IDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQ-TSMNEEDIKELILRECLNFHPDHM  337 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  337 (339)
                      ++||.+||+.||++|||++|+|+||||+.+++...++.+..++..+|.. ..++.++++..+.+|+..|+++..
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~  412 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPELV  412 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHHhCcccc
Confidence            9999999999999999999999999999999988777666665555554 578889999999999999999764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-53  Score=371.88  Aligned_cols=251  Identities=21%  Similarity=0.333  Sum_probs=194.7

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc------
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK------  108 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~------  108 (339)
                      +|.+ ++.||+|+||+||+|+++.+|+.||+|+++... .....+++.+|+.++++++||||+++++++.....      
T Consensus         6 dy~~-~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            6 DFEP-IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HEEE-EEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hCEE-eeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            4555 899999999999999999999999999997542 34456789999999999999999999999843211      


Q ss_pred             -CCcCeEEEEEecCc-ccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          109 -EKFNDVYIVYELMD-TDLHQIIRSKQA---LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       109 -~~~~~~~iv~e~~~-g~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                       .....+|+|||||+ |+|.+++.....   .++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence             12235799999997 799999987654   4456788999999999999999999999999999999999999999999


Q ss_pred             cccc-----------------------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHH
Q 042681          184 LART-----------------------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARR  240 (339)
Q Consensus       184 ~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~  240 (339)
                      +|+.                       .|++.|++||+.....+..+.|+|++|+++|++++   |+...     .....
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~~~  235 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MERVR  235 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHHHH
Confidence            9864                       36677999999888888999999999999999995   33211     11111


Q ss_pred             HHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          241 YVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      ..........+   ..++..++.+++||.+||+.||++|||+.|+++||||+++.++.
T Consensus       236 ~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          236 TLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            11111111111   12234567889999999999999999999999999999887643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-51  Score=368.05  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=199.9

Q ss_pred             cccCccCCCccccccccceEEEEEEeC---CCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNS---ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPM  106 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~  106 (339)
                      .+.++|.+ ++.||+|+||+||+|+++   .+++.||+|++.+.    ....++.+|+.+++.+ +||||+++++++   
T Consensus        18 ~l~~~Y~i-~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~---   89 (361)
T 4f9c_A           18 QLSNVFKI-EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCF---   89 (361)
T ss_dssp             GGGGTCEE-EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEE---
T ss_pred             CccCcEEE-EEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEE---
Confidence            46788888 999999999999999875   46789999998653    2245678999999998 699999999999   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC-CCeEEeeccc
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGL  184 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~-~~ikL~Dfg~  184 (339)
                        ...+.+|+||||++ |+|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus        90 --~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           90 --RKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             --EETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             --EECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence              67788999999997 79999884   59999999999999999999999999999999999999877 7999999999


Q ss_pred             ccc---------------------------------------cCCCCcccccccccc-ccCCCCccHHHHHHHHHHHhCC
Q 042681          185 ART---------------------------------------TSETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGS  224 (339)
Q Consensus       185 ~~~---------------------------------------~~~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~  224 (339)
                      |+.                                       .|++.|++||+.... .+..+.|+|++|+++|++++|.
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            853                                       356679999987654 4778889999999999999999


Q ss_pred             CCCCcccccc---------------------------------cchHHHHHhhCCC------------CCCCCccccCCC
Q 042681          225 PDDSDLGFLR---------------------------------SDNARRYVKQLPH------------VPKQPFSQKFPN  259 (339)
Q Consensus       225 ~~~~~~~~~~---------------------------------~~~~~~~~~~~~~------------~~~~~~~~~~~~  259 (339)
                      .|+..-....                                 .............            .........++.
T Consensus       245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            9975322100                                 0000000000000            000111123466


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      +|++++|||++||+.||++|||++|+|+||||+++.
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            899999999999999999999999999999999863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-50  Score=361.64  Aligned_cols=316  Identities=37%  Similarity=0.668  Sum_probs=248.5

Q ss_pred             CCceEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCe
Q 042681           17 GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI   96 (339)
Q Consensus        17 ~~~~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I   96 (339)
                      ......+...+..+.+.++|.. ++.||+|+||.||+|.+..+|+.||+|++..........+++.+|+.+++.++||||
T Consensus         8 ~~~~~~~~~~~~~~~~~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI   86 (367)
T 1cm8_A            8 RSGFYRQEVTKTAWEVRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV   86 (367)
T ss_dssp             CCSBCCEECSSSEECCBSSEEE-EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTB
T ss_pred             cCCceEEEecCceeeecceEEE-eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCC
Confidence            3445566778889999999999 999999999999999999999999999997765566667889999999999999999


Q ss_pred             eeeeeecCCCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC
Q 042681           97 VKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC  175 (339)
Q Consensus        97 ~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~  175 (339)
                      +++++++..... .....+++||||++++|.+++.. +.+++..++.++.||+.||+|||++|++||||||+||+++.++
T Consensus        87 v~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~  165 (367)
T 1cm8_A           87 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC  165 (367)
T ss_dssp             CCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred             CCceeeEecCCccccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC
Confidence            999999954311 12245799999999899999876 6799999999999999999999999999999999999999999


Q ss_pred             CeEEeecccccccC--------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccc------------
Q 042681          176 DLKICDFGLARTTS--------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR------------  234 (339)
Q Consensus       176 ~ikL~Dfg~~~~~~--------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~------------  234 (339)
                      .+||+|||+++...        +..|.+||.... ..+..+.|+|++|++++++++|..++.......            
T Consensus       166 ~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~  245 (367)
T 1cm8_A          166 ELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP  245 (367)
T ss_dssp             CEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             CEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999999987543        345788887655 567888999999999999999999976432111            


Q ss_pred             ---------cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCC
Q 042681          235 ---------SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPY  305 (339)
Q Consensus       235 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~  305 (339)
                               ......+....+......+...++.+++++++||.+||+.||++|||+.++++||||+.+.+....+.+. 
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~-  324 (367)
T 1cm8_A          246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-  324 (367)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-
T ss_pred             CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC-
Confidence                     1111223334444455555566678899999999999999999999999999999999998887665554 


Q ss_pred             CCCCChhhccCCHHHHHHHHHHHHHhcCCC
Q 042681          306 PFNFDFEQTSMNEEDIKELILRECLNFHPD  335 (339)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (339)
                      +++.++.....+.++.+..+.++.++|.+.
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (367)
T 1cm8_A          325 KYDDSFDDVDRTLDEWKRVTYKEVLSFKPP  354 (367)
T ss_dssp             CCCCC-----CCHHHHHHHHHHHHHTCCC-
T ss_pred             CCCCChhhhcCCHHHHHHHHHHHHHHhccc
Confidence            677888887888899999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.9e-50  Score=361.68  Aligned_cols=315  Identities=39%  Similarity=0.694  Sum_probs=249.0

Q ss_pred             ceEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeee
Q 042681           19 KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK   98 (339)
Q Consensus        19 ~~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~   98 (339)
                      +...+.+.+..+.++++|.. ++.||+|+||.||+|.+..+|+.||+|++..........+++.+|+.+++.++||||++
T Consensus        14 ~~~~~~~~~~~~~~~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~   92 (367)
T 2fst_X           14 TFYRQELNKTIWEVPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG   92 (367)
T ss_dssp             CEEEEEETTEEEEEETTEEE-EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcceEeecCcccCCCCceEE-eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            34456788899999999999 99999999999999999999999999999776556666788999999999999999999


Q ss_pred             eeeecCCCC-cCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCe
Q 042681           99 VKDIIPPMD-KEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL  177 (339)
Q Consensus        99 ~~~~~~~~~-~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~i  177 (339)
                      +++++.... ......+++++|+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~  171 (367)
T 2fst_X           93 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL  171 (367)
T ss_dssp             CSEEECSCSSGGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             EEEEEecCCccccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCE
Confidence            999985421 122356899999999999988876 679999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccc--------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccc--------------
Q 042681          178 KICDFGLARTT--------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR--------------  234 (339)
Q Consensus       178 kL~Dfg~~~~~--------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~--------------  234 (339)
                      ||+|||+++..        ++..|.+||.... ..+..+.|+|++|++++++++|..++.......              
T Consensus       172 kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          172 KILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  251 (367)
T ss_dssp             EECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99999998653        3456888887665 567788999999999999999999876432211              


Q ss_pred             -------cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCC
Q 042681          235 -------SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPF  307 (339)
Q Consensus       235 -------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~  307 (339)
                             ......+.......+...+...++..++++++||.+||+.||++|||+.++++||||+...++...+.+. |+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~-~~  330 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PY  330 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCC-CC
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCC-CC
Confidence                   1111222333344444444455677899999999999999999999999999999999998887665554 78


Q ss_pred             CCChhhccCCHHHHHHHHHHHHHhcCCCC
Q 042681          308 NFDFEQTSMNEEDIKELILRECLNFHPDH  336 (339)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (339)
                      +.++.......++.+..+.+|...|.++.
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  359 (367)
T 2fst_X          331 DQSLESRDLLIDEWKSLTYDEVISFVPPP  359 (367)
T ss_dssp             CGGGSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred             CcchhhccCCHHHHHHHHHHHHHHhccCc
Confidence            88888888889999999999999998874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1e-50  Score=382.14  Aligned_cols=251  Identities=21%  Similarity=0.289  Sum_probs=206.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHH---HHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRIL---REIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~---~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ++|.+ ++.||+|+||+||+|+++.+|+.||+|++.+... .......+.   .++.++..++||||++++++|     .
T Consensus       189 ddf~i-~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~  262 (689)
T 3v5w_A          189 NDFSV-HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H  262 (689)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred             HHeEE-EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence            34666 9999999999999999999999999999975421 111223333   446677788999999999999     6


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc-
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~-  187 (339)
                      +...+|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+. 
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            7788999999998 79999999999999999999999999999999999999999999999999999999999999864 


Q ss_pred             --------cCCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          188 --------TSETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       188 --------~~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                              .|++.|++||+... ..+..+.|+|++|+++|+|++|.+||................... ..      ...
T Consensus       343 ~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~-~~------~p~  415 (689)
T 3v5w_A          343 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-VE------LPD  415 (689)
T ss_dssp             SSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-CC------CCT
T ss_pred             CCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-CC------CCc
Confidence                    45668999998854 568889999999999999999999986543222111111111111 11      114


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCccC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRIT-----VEEALNHPYLSSLHEI  297 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~~  297 (339)
                      .+|+++++||.+||+.||++|++     ++|+++||||+++.|.
T Consensus       416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence            58999999999999999999998     7999999999999874

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.5e-49  Score=357.41  Aligned_cols=315  Identities=37%  Similarity=0.645  Sum_probs=261.9

Q ss_pred             CCceEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCe
Q 042681           17 GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI   96 (339)
Q Consensus        17 ~~~~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I   96 (339)
                      .+.+++....+..+.++++|.. ++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||
T Consensus        25 ~~g~~~~~~~~~~~~l~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  103 (371)
T 4exu_A           25 KKGFYKQDVNKTAWELPKTYVS-PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV  103 (371)
T ss_dssp             CTTEEEEEETTEEEEEETTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             cccceeeeeccceecccccEEE-EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCc
Confidence            5566888899999999999999 999999999999999999999999999998766666667889999999999999999


Q ss_pred             eeeeeecCCCCcC-CcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC
Q 042681           97 VKVKDIIPPMDKE-KFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC  175 (339)
Q Consensus        97 ~~~~~~~~~~~~~-~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~  175 (339)
                      +++++++...... ....+++||||++++|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus       104 v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~  181 (371)
T 4exu_A          104 IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC  181 (371)
T ss_dssp             CCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred             hhhhhheeccCCcccceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC
Confidence            9999999432211 111349999999999988874  4599999999999999999999999999999999999999999


Q ss_pred             CeEEeeccccccc--------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccc------------
Q 042681          176 DLKICDFGLARTT--------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR------------  234 (339)
Q Consensus       176 ~ikL~Dfg~~~~~--------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~------------  234 (339)
                      .++|+|||.+...        ++..|.+|+.... .....+.|+|++|++++++++|..|+.......            
T Consensus       182 ~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  261 (371)
T 4exu_A          182 ELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  261 (371)
T ss_dssp             CEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             CEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999999998643        3456888887765 567888999999999999999999986532111            


Q ss_pred             ---------cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCC
Q 042681          235 ---------SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPY  305 (339)
Q Consensus       235 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~  305 (339)
                               .......................+.+++++++||.+||+.||++|||+.|+++||||+.+.+.........
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~  341 (371)
T 4exu_A          262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ  341 (371)
T ss_dssp             CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS
T ss_pred             cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccccccc
Confidence                     01112222333344444444455678999999999999999999999999999999999988877777788


Q ss_pred             CCCCChhhccCCHHHHHHHHHHHHHhcCC
Q 042681          306 PFNFDFEQTSMNEEDIKELILRECLNFHP  334 (339)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (339)
                      +++........+.++.++.+.++..+|.|
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T 4exu_A          342 PFDDSLEHEKLTVDEWKQHIYKEIVNFSP  370 (371)
T ss_dssp             CCCCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             CcCcchhhcccchHHHHHHHHHHHHhccc
Confidence            88888888889999999999999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=346.42  Aligned_cols=247  Identities=20%  Similarity=0.264  Sum_probs=200.0

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      ..|.|..+...+.+.||+|+||+||+|++..   .+|||+++.........+.+.+|+.++.+++||||+++++++    
T Consensus        29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~----  101 (307)
T 3omv_A           29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM----  101 (307)
T ss_dssp             CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            3466666666668999999999999998653   589999976656666778899999999999999999999987    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                       .. +.++||||||+ |+|.+++.. ..++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus       102 -~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  179 (307)
T 3omv_A          102 -TK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA  179 (307)
T ss_dssp             -CS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred             -EC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence             33 35799999998 799999975 467999999999999999999999999999999999999999999999999998


Q ss_pred             cc-------------cCCCCcccccccccc---ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCC
Q 042681          186 RT-------------TSETDFMTEYVVTRW---DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP  249 (339)
Q Consensus       186 ~~-------------~~~~~~~~~~~~~~~---~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (339)
                      +.             .|++.|++||+....   .++.++|+|++|+++|++++|..|+......  .........  ...
T Consensus       180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~--~~~  255 (307)
T 3omv_A          180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGR--GYA  255 (307)
T ss_dssp             BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHT--TCC
T ss_pred             eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhc--CCC
Confidence            53             345679999987532   4677899999999999999999998643211  111122221  112


Q ss_pred             CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       250 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .+......+.+|+++.+||.+||+.||++|||+.|+++
T Consensus       256 ~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          256 SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            22223344678999999999999999999999998753

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.4e-50  Score=378.65  Aligned_cols=254  Identities=23%  Similarity=0.387  Sum_probs=214.2

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      +-++|.+ ++.||+|+||.||+|+++.+|+.||+|++...  .....+.+.+|+.+|+.++||||++++++|     .+.
T Consensus       155 il~~Y~i-~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~  226 (573)
T 3uto_A          155 VLDHYDI-HEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDD  226 (573)
T ss_dssp             GGGTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECS
T ss_pred             CccccEE-EEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence            3467877 99999999999999999999999999999754  334457789999999999999999999999     677


Q ss_pred             CeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC--CCeEEeecccccc
Q 042681          112 NDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGLART  187 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~--~~ikL~Dfg~~~~  187 (339)
                      ..+++|||||+ |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+|+.
T Consensus       227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            88999999997 799999965 4689999999999999999999999999999999999999854  8999999999975


Q ss_pred             c----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          188 T----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       188 ~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                      .          |++.|++||+.....+..+.|+|++|+++|++++|.+||.....  ......+..    .........+
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--~~~~~~i~~----~~~~~~~~~~  380 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKS----CDWNMDDSAF  380 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHT----TCCCCCSGGG
T ss_pred             ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHh----CCCCCCcccc
Confidence            4          45678999998888888999999999999999999999764321  111112211    1111122334


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE  299 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~  299 (339)
                      +.+|+++++||.+||+.||++|||+.|+|+||||+...++..
T Consensus       381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~  422 (573)
T 3uto_A          381 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR  422 (573)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence            678999999999999999999999999999999998877543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1e-48  Score=352.58  Aligned_cols=309  Identities=45%  Similarity=0.738  Sum_probs=249.2

Q ss_pred             ccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCC
Q 042681           26 LGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPP  105 (339)
Q Consensus        26 ~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~  105 (339)
                      .|..+.++++|.. ++.||+|+||.||+|.+..+++.||+|++... ......+.+.+|+.++.+++||||+++++++..
T Consensus        19 ~g~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   96 (364)
T 3qyz_A           19 RGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRA   96 (364)
T ss_dssp             C-CBCCCTTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred             ccEeccccccEEE-EEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence            4677888999999 99999999999999999999999999998743 334455788999999999999999999999965


Q ss_pred             CCcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          106 MDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                      .........++||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||.+
T Consensus        97 ~~~~~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A           97 PTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             SSTTTCCCEEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CCccccceEEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence            44344467999999999999998876 57999999999999999999999999999999999999999999999999998


Q ss_pred             ccc--------------CCCCcccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc--------------
Q 042681          186 RTT--------------SETDFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD--------------  236 (339)
Q Consensus       186 ~~~--------------~~~~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~--------------  236 (339)
                      ...              ++..|.+||... ......+.|+|++|++++++++|..|+.........              
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            643              334577888643 344678899999999999999999998654322110              


Q ss_pred             -------hHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCC
Q 042681          237 -------NARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNF  309 (339)
Q Consensus       237 -------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~  309 (339)
                             .....................+.+++++++||.+||+.||++|||+.|+++||||+........+....|+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~  335 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKF  335 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCCCC
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCcCCc
Confidence                   0111122222223333344456789999999999999999999999999999999999888777788888999


Q ss_pred             ChhhccCCHHHHHHHHHHHHHhcCCCCC
Q 042681          310 DFEQTSMNEEDIKELILRECLNFHPDHM  337 (339)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (339)
                      +.....+..+++++++.++..+|.++-.
T Consensus       336 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~  363 (364)
T 3qyz_A          336 DMELDDLPKEKLKELIFEETARFQPGYR  363 (364)
T ss_dssp             C-----CCHHHHHHHHHHHTGGGCC---
T ss_pred             ccccccCCHHHHHHHHHHHHHHhhhhcC
Confidence            9888899999999999999999998753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.4e-50  Score=347.45  Aligned_cols=239  Identities=23%  Similarity=0.299  Sum_probs=195.8

Q ss_pred             CccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           39 PLQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        39 ~~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +.+.||+|+||+||+|++.     .++..||+|+++..  .....+.+.+|+.++.+++||||+++++++     .+.+.
T Consensus        17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~~~~   89 (299)
T 4asz_A           17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEGDP   89 (299)
T ss_dssp             EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSSSS
T ss_pred             EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeCCE
Confidence            3899999999999999865     35788999999753  344567899999999999999999999999     66778


Q ss_pred             EEEEEecCc-ccHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEE
Q 042681          114 VYIVYELMD-TDLHQIIRSK-------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI  179 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL  179 (339)
                      +++|||||+ |+|.+++.+.             ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence            999999998 7999999753             36999999999999999999999999999999999999999999999


Q ss_pred             eeccccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhC
Q 042681          180 CDFGLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQL  245 (339)
Q Consensus       180 ~Dfg~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~  245 (339)
                      +|||+|+..             ++..|++||......+..++|+|++|+++|++++ |..|+.....   ......+...
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~~~  246 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECITQG  246 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHHT
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcC
Confidence            999998632             3345899998888888999999999999999998 8998765432   1112222221


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       246 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      ...+.      ...+|+++.+|+.+||+.||++|||+.+++  +|++++.
T Consensus       247 ~~~~~------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~~  288 (299)
T 4asz_A          247 RVLQR------PRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNLA  288 (299)
T ss_dssp             CCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHHH
T ss_pred             CCCCC------CccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHHH
Confidence            11111      146899999999999999999999999994  5666554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.4e-49  Score=348.18  Aligned_cols=243  Identities=20%  Similarity=0.272  Sum_probs=196.5

Q ss_pred             ccccCccCCCccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIP  104 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~  104 (339)
                      ..+..+...+.+.||+|+||+||+|+++     .+++.||||+++..  .....+.+.+|+.++.+++||||+++++++ 
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-  112 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVC-  112 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-
Confidence            3444444444789999999999999865     46889999999753  445567899999999999999999999999 


Q ss_pred             CCCcCCcCeEEEEEecCc-ccHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 042681          105 PMDKEKFNDVYIVYELMD-TDLHQIIRSK---------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN  168 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~N  168 (339)
                          .+...++||||||+ |+|.+++.+.               +++++..+..++.||+.||.|||+++|+||||||+|
T Consensus       113 ----~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~N  188 (329)
T 4aoj_A          113 ----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN  188 (329)
T ss_dssp             ----CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             ----EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhh
Confidence                66778999999998 7999998653               359999999999999999999999999999999999


Q ss_pred             eeeccCCCeEEeeccccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccc
Q 042681          169 LLLNANCDLKICDFGLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLR  234 (339)
Q Consensus       169 Ili~~~~~ikL~Dfg~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~  234 (339)
                      ||++.++.+||+|||+++..             ++..|++||......+..++|+|++|+++|++++ |..|+...... 
T Consensus       189 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-  267 (329)
T 4aoj_A          189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-  267 (329)
T ss_dssp             EEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-
T ss_pred             EEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-
Confidence            99999999999999998643             3345899999888888999999999999999998 89887654321 


Q ss_pred             cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                        .....+......+.      ...+++++.+|+.+||+.||++|||+.|++++
T Consensus       268 --~~~~~i~~g~~~~~------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          268 --EAIDCITQGRELER------PRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             --HHHHHHHHTCCCCC------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             --HHHHHHHcCCCCCC------cccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence              11122222111111      14689999999999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.1e-49  Score=359.01  Aligned_cols=300  Identities=33%  Similarity=0.568  Sum_probs=232.7

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~  109 (339)
                      .+.++|.. ++.||+|+||.||+|.+..+|+.||+|++...........++.+|+.++..+. ||||+++++++..   .
T Consensus         6 ~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~   81 (388)
T 3oz6_A            6 HVLRKYEL-VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---D   81 (388)
T ss_dssp             HHHTTEEE-EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---T
T ss_pred             cccCceEE-EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---C
Confidence            35677888 99999999999999999999999999999876666777788999999999997 9999999999843   3


Q ss_pred             CcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-
Q 042681          110 KFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-  188 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-  188 (339)
                      ....+|+||||++++|.+++.. +.+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.. 
T Consensus        82 ~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           82 NDRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             TSSCEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             CCCEEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            3457999999999999999876 68999999999999999999999999999999999999999999999999998643 


Q ss_pred             -------------------------------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccc
Q 042681          189 -------------------------------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD  236 (339)
Q Consensus       189 -------------------------------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~  236 (339)
                                                     ++..|.+||+... ..+..+.|+|++|++++++++|.+|+......  .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~  238 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM--N  238 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH--H
Confidence                                           3345788887654 45778899999999999999999998643211  1


Q ss_pred             hHHHHHhhCCCCC--------------------------CCCcccc-------------CCCCCHHHHHHHHHhcccCCC
Q 042681          237 NARRYVKQLPHVP--------------------------KQPFSQK-------------FPNMSPVAIDLAERMLVFDPA  277 (339)
Q Consensus       237 ~~~~~~~~~~~~~--------------------------~~~~~~~-------------~~~~s~~~~~li~~~L~~dP~  277 (339)
                      ....+........                          .......             ...+++++++||.+||+.||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            1111111111000                          0001111             126789999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCChhh-ccCCHHHHHHHHHHHHHhcCCCCC
Q 042681          278 KRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQ-TSMNEEDIKELILRECLNFHPDHM  337 (339)
Q Consensus       278 ~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  337 (339)
                      +|||++|+++||||+.+......+.+..++..++.. ...+.++.++.+.+++..|.++.+
T Consensus       319 ~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (388)
T 3oz6_A          319 KRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKRELI  379 (388)
T ss_dssp             GSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHHHHHHHT
T ss_pred             cCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhhhhhh
Confidence            999999999999999998888888888777777764 356778999999999998877543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.5e-49  Score=363.08  Aligned_cols=315  Identities=35%  Similarity=0.586  Sum_probs=237.5

Q ss_pred             CCceEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCe
Q 042681           17 GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI   96 (339)
Q Consensus        17 ~~~~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I   96 (339)
                      .+....+...+..+.+.++|.. ++.||+|+||.||+|.+..+|+.||+|++..........+++.+|+.+++.++||||
T Consensus        45 ~~~~~~~~~~~~~~~~~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  123 (464)
T 3ttj_A           45 DNQFYSVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI  123 (464)
T ss_dssp             -CCEEEEEC--CEEEEETTEEE-EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             cccceeeecCCcceeecCCeEE-EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCC
Confidence            3455667777788899999999 999999999999999999999999999998776666677889999999999999999


Q ss_pred             eeeeeecCCCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC
Q 042681           97 VKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC  175 (339)
Q Consensus        97 ~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~  175 (339)
                      +++++++..... .....+++||||++++|.+.+..  .+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus       124 v~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~  201 (464)
T 3ttj_A          124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC  201 (464)
T ss_dssp             CCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred             CcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC
Confidence            999999954321 23356899999999988888754  599999999999999999999999999999999999999999


Q ss_pred             CeEEeeccccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc----------
Q 042681          176 DLKICDFGLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS----------  235 (339)
Q Consensus       176 ~ikL~Dfg~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~----------  235 (339)
                      .+||+|||+++..          ++..|.+||+.....+..+.|+|++|++++++++|..++........          
T Consensus       202 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~  281 (464)
T 3ttj_A          202 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  281 (464)
T ss_dssp             CEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             CEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999999998653          34458889988877888999999999999999999999865321100          


Q ss_pred             ----------chHHHHHhhCCCCCCCCccccCCC------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          236 ----------DNARRYVKQLPHVPKQPFSQKFPN------------MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       236 ----------~~~~~~~~~~~~~~~~~~~~~~~~------------~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                                .....+...........+...++.            .++++++||.+||+.||++|||++|+++||||+.
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                      001111111111111111111111            1567999999999999999999999999999998


Q ss_pred             CccCCC-CCCCCCCCCCChhhccCCHHHHHHHHHHHHHhcCC
Q 042681          294 LHEINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP  334 (339)
Q Consensus       294 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (339)
                      ..++.. ....+..++..+.....+.++.++.+.++.+++..
T Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~  403 (464)
T 3ttj_A          362 WYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEE  403 (464)
T ss_dssp             GCCHHHHSCCC-----------CCCHHHHHHHHHHHHHC---
T ss_pred             ccCcccccCCCCccCCcchhhccCCHHHHHHHHHHHHHHhhh
Confidence            765432 22334456667777778889999999999888754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=349.04  Aligned_cols=314  Identities=37%  Similarity=0.647  Sum_probs=257.8

Q ss_pred             CceEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCee
Q 042681           18 GKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIV   97 (339)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~   97 (339)
                      +.+.+.......+.++++|.. .+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+
T Consensus         8 ~~~~~~~~~~~~~~l~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   86 (353)
T 3coi_A            8 KGFYKQDVNKTAWELPKTYVS-PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI   86 (353)
T ss_dssp             HHEEEEEETTEEEEEETTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCcEEEeecCcccccCceEEE-eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcc
Confidence            345566677788889999999 9999999999999999999999999999987655566677889999999999999999


Q ss_pred             eeeeecCCCCcC-CcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC
Q 042681           98 KVKDIIPPMDKE-KFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD  176 (339)
Q Consensus        98 ~~~~~~~~~~~~-~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~  176 (339)
                      ++++++...... ....+++||||++++|.+.+.  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~  164 (353)
T 3coi_A           87 GLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE  164 (353)
T ss_dssp             CCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC
T ss_pred             cHhheEecccccccceeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc
Confidence            999999432110 112469999999999887764  35999999999999999999999999999999999999999999


Q ss_pred             eEEeeccccccc--------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccccccc------------
Q 042681          177 LKICDFGLARTT--------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS------------  235 (339)
Q Consensus       177 ikL~Dfg~~~~~--------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~------------  235 (339)
                      ++|+|||.+...        ++..|.+||.... .....+.|+|++|++++++++|..|+........            
T Consensus       165 ~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  244 (353)
T 3coi_A          165 LKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  244 (353)
T ss_dssp             EEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred             EEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999998653        3456888887655 5677889999999999999999999765331110            


Q ss_pred             ---------chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCC
Q 042681          236 ---------DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYP  306 (339)
Q Consensus       236 ---------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~  306 (339)
                               .................+....+.+++++++||.+||+.||++|||+.++++||||+.............+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~  324 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQP  324 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSC
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCC
Confidence                     00112222233333344444556789999999999999999999999999999999999887777777778


Q ss_pred             CCCChhhccCCHHHHHHHHHHHHHhcCC
Q 042681          307 FNFDFEQTSMNEEDIKELILRECLNFHP  334 (339)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (339)
                      ++........+.++.+..+.++..+|.+
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 3coi_A          325 FDDSLEHEKLTVDEWKQHIYKEIVNFSP  352 (353)
T ss_dssp             CCCTTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred             CccchhhccCCHHHHHHHHHHHHHhhcc
Confidence            8888888889999999999999999986

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-48  Score=340.12  Aligned_cols=234  Identities=18%  Similarity=0.252  Sum_probs=192.7

Q ss_pred             ccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           40 LQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      ++.||+|+||+||+|+..     .+++.||||+++... .....+.+.+|+.++.+++||||++++|++     .....+
T Consensus        31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~-----~~~~~~  104 (308)
T 4gt4_A           31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVV-----TKDQPL  104 (308)
T ss_dssp             EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred             eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEE-----EECCEE
Confidence            788999999999999864     467899999987542 333457899999999999999999999999     666788


Q ss_pred             EEEEecCc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCe
Q 042681          115 YIVYELMD-TDLHQIIRSK----------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL  177 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~i  177 (339)
                      ++|||||+ |+|.+++..+                ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCE
Confidence            99999998 8999999643                358999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHh
Q 042681          178 KICDFGLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVK  243 (339)
Q Consensus       178 kL~Dfg~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~  243 (339)
                      ||+|||+++..             ++..|++||......++.++|+|++|+++|++++ |..|+.....   ......+.
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~i~  261 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEMIR  261 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHHHH
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH
Confidence            99999998643             2335889998888888999999999999999998 8888765432   11222222


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       244 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ....   .+   ..+.+|+++.+|+.+||+.||++|||+.|++++
T Consensus       262 ~~~~---~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          262 NRQV---LP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             TTCC---CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCC---CC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2111   11   124689999999999999999999999999876

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.6e-47  Score=338.07  Aligned_cols=250  Identities=24%  Similarity=0.362  Sum_probs=212.0

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      .-++|.. ++.||+|+||.||+|.+..+|+.||+|++.+........+++.+|+.+++.++||||+++++++     ...
T Consensus        13 ~~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~   86 (328)
T 3fe3_A           13 HIGNYRL-LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETE   86 (328)
T ss_dssp             EETTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             ccCCEEE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence            4567777 9999999999999999999999999999987766666778899999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      +.+++||||++ |+|.+++...+++++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...  
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            88999999997 799999988899999999999999999999999999999999999999999999999999998643  


Q ss_pred             --------CCCCccccccccccccC-CCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          189 --------SETDFMTEYVVTRWDTL-FPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       189 --------~~~~~~~~~~~~~~~~~-~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                              ++..|.+||........ .+.|+|++|++++++++|..|+......  ............  .+      ..
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~--~p------~~  236 (328)
T 3fe3_A          167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRERVLRGKYR--IP------FY  236 (328)
T ss_dssp             SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCC--CC------TT
T ss_pred             CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC--CC------CC
Confidence                    34457888877655543 6799999999999999999997643211  111112111111  11      24


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      +++++.+||++||+.||.+|||++|+++||||+...+.
T Consensus       237 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence            78999999999999999999999999999999987654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.4e-47  Score=343.42  Aligned_cols=316  Identities=35%  Similarity=0.565  Sum_probs=242.1

Q ss_pred             CCceEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCe
Q 042681           17 GGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI   96 (339)
Q Consensus        17 ~~~~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I   96 (339)
                      .+...++...+..+.+.++|.. ++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||
T Consensus         8 ~~~~~~~~~~~~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni   86 (371)
T 2xrw_A            8 DNNFYSVEIGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI   86 (371)
T ss_dssp             GGGEEEEEETTEEEEEETTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             cCcceEeecCCcccchhhheeE-eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCc
Confidence            3456677777778888999999 999999999999999999999999999998765566667788999999999999999


Q ss_pred             eeeeeecCCCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC
Q 042681           97 VKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC  175 (339)
Q Consensus        97 ~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~  175 (339)
                      +++++++..... ......++||||++++|.+.+.  ..+++..++.++.||+.||.|||++|++||||||+||+++.++
T Consensus        87 v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~  164 (371)
T 2xrw_A           87 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC  164 (371)
T ss_dssp             CCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred             cceEEeeccccccccccceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC
Confidence            999999853221 1234789999999999998886  4699999999999999999999999999999999999999999


Q ss_pred             CeEEeecccccccC----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHh--
Q 042681          176 DLKICDFGLARTTS----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK--  243 (339)
Q Consensus       176 ~ikL~Dfg~~~~~~----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~--  243 (339)
                      .+||+|||++...+          +..|.+||......+..+.|+|++|++++++++|..|+......  ........  
T Consensus       165 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~  242 (371)
T 2xrw_A          165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQL  242 (371)
T ss_dssp             CEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHC-C
T ss_pred             CEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHh
Confidence            99999999986543          34588898887777888999999999999999999987543211  11111111  


Q ss_pred             --------------------hCCCCCCCCccccC-----C-------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          244 --------------------QLPHVPKQPFSQKF-----P-------NMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       244 --------------------~~~~~~~~~~~~~~-----~-------~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                                          .............+     +       ..++++++||.+||+.||++|||++|+++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  322 (371)
T 2xrw_A          243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  322 (371)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             CCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence                                11111110000000     1       015679999999999999999999999999999


Q ss_pred             CCCccCCCC-CCCCCCCCCChhhccCCHHHHHHHHHHHHHhcCCCCC
Q 042681          292 SSLHEINEE-PTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDHM  337 (339)
Q Consensus       292 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (339)
                      +...++... ...+............+.++.++.+..+..+|+--||
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (371)
T 2xrw_A          323 NVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEHHHH  369 (371)
T ss_dssp             HTTCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHHHHCC---
T ss_pred             hhhcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHHHHHhhhcc
Confidence            877654321 1122223344555567889999999999999998776

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5e-47  Score=334.33  Aligned_cols=259  Identities=33%  Similarity=0.515  Sum_probs=208.4

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      ...+.++|.. ++.||+|+||.||+|.+. +|+.+|+|++............+.+|+.+++.++||||+++++++     
T Consensus        16 ~q~l~~~y~~-~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   88 (311)
T 3niz_A           16 FQGLMEKYQK-LEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----   88 (311)
T ss_dssp             EECSSCEEEE-EEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             ecchHhhhHh-hhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----
Confidence            3456788888 999999999999999985 589999999976644444567788999999999999999999999     


Q ss_pred             CCcCeEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          109 EKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       109 ~~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ......++||||++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+..
T Consensus        89 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  168 (311)
T 3niz_A           89 HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA  168 (311)
T ss_dssp             CCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence            667789999999999999988765 4699999999999999999999999999999999999999999999999999865


Q ss_pred             cC-----------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC--------
Q 042681          188 TS-----------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH--------  247 (339)
Q Consensus       188 ~~-----------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~--------  247 (339)
                      .+           +..|.+||.... ..+..+.|+|++|++++++++|..|+......  ............        
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--DQLPKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--THHHHHHHHHCCCCTTTSGG
T ss_pred             cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHHCCCChHHhhh
Confidence            43           345788887654 45678899999999999999999988643322  111111111111        


Q ss_pred             --------------CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          248 --------------VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       248 --------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                                    ..........+.+++++++||.+||+.||++|||+.|+++||||+++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                          1111122234568899999999999999999999999999999998754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1e-47  Score=341.36  Aligned_cols=247  Identities=22%  Similarity=0.349  Sum_probs=199.0

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCC-----CceEEEEEecccccChHhHHHHHHHHHHHhhCCC-CCeeeeeee
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSET-----KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH-ENIVKVKDI  102 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~I~~~~~~  102 (339)
                      .|.|+.+.+.+++.||+|+||+||+|.+..+     ++.||+|++... ......+.+.+|+.++.+++| |||++++++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            3555544444499999999999999997654     367999998654 334456789999999999975 899999998


Q ss_pred             cCCCCcCCcCeEEEEEecCc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 042681          103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSK----------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLK  165 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dik  165 (339)
                      +.    .....++||||||+ |+|.+++.+.                ..+++..+..++.||+.||+|||+++|+|||||
T Consensus       137 ~~----~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK  212 (353)
T 4ase_A          137 CT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA  212 (353)
T ss_dssp             EC----CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EE----ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccC
Confidence            83    33456899999998 7999999753                348999999999999999999999999999999


Q ss_pred             CCCeeeccCCCeEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCccc
Q 042681          166 PSNLLLNANCDLKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLG  231 (339)
Q Consensus       166 p~NIli~~~~~ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~  231 (339)
                      |+|||++.++.+||+|||+|+...             +..|++||......++.++|+|++|+++|++++ |..|+....
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999997532             235889998888888999999999999999997 899876543


Q ss_pred             ccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          232 FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..  ...............+      ..+++++.+|+.+||+.||++|||+.++++|
T Consensus       293 ~~--~~~~~~i~~g~~~~~p------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          293 ID--EEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             CS--HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH--HHHHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            21  1122222222222211      3589999999999999999999999999987

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.3e-47  Score=329.68  Aligned_cols=255  Identities=33%  Similarity=0.482  Sum_probs=207.0

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||.||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++     .....
T Consensus         2 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~   75 (292)
T 3o0g_A            2 QKYEK-LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKK   75 (292)
T ss_dssp             CSEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTE
T ss_pred             CCcee-eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCE
Confidence            45666 9999999999999999999999999999987665565667889999999999999999999999     66788


Q ss_pred             EEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          114 VYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      .++||||+++++.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+...+   
T Consensus        76 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            999999999988887765 5789999999999999999999999999999999999999999999999999996543   


Q ss_pred             --------CCCccccccccccc-cCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCC-----------
Q 042681          190 --------ETDFMTEYVVTRWD-TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP-----------  249 (339)
Q Consensus       190 --------~~~~~~~~~~~~~~-~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  249 (339)
                              +..|.+||...... ...+.|+|++|++++++++|..|+....... ..............           
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhhhhhhcccc
Confidence                    33478888765544 6788999999999999998887754322111 11111111111100           


Q ss_pred             ----------CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          250 ----------KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       250 ----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                                ........+.+++++++||.+||+.||++|||++|+++||||+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                      0111122346889999999999999999999999999999999763

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.7e-47  Score=341.10  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=212.3

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh----HhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR----IDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      .+.++|.. ++.||+|+||.||+|.+..+|+.||+|++.+.....    ...+.+.+|+.+++.++||||+++++++   
T Consensus         9 ~~~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~---   84 (361)
T 2yab_A            9 KVEDFYDI-GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY---   84 (361)
T ss_dssp             CGGGTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             ChhhceEE-eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE---
Confidence            46677887 999999999999999999999999999997653322    2356789999999999999999999999   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC----CeEEee
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC----DLKICD  181 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~----~ikL~D  181 (339)
                        .....+++||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|
T Consensus        85 --~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           85 --ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             --ECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             --EeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence              66788999999996 79999998888999999999999999999999999999999999999998877    799999


Q ss_pred             ccccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          182 FGLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       182 fg~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ||++...          +++.|.+||+.....+..+.|+|++|+++|++++|..|+.....  ......+..    ....
T Consensus       163 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~~~~~~i~~----~~~~  236 (361)
T 2yab_A          163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANITA----VSYD  236 (361)
T ss_dssp             CSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHT----TCCC
T ss_pred             cCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh----cCCC
Confidence            9998653          34468889988777788899999999999999999999764321  111111111    1111


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      .....++.+|+++++||.+||+.||++|||+.|+++||||+...+
T Consensus       237 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          237 FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            112233568999999999999999999999999999999997654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.3e-46  Score=334.10  Aligned_cols=299  Identities=46%  Similarity=0.758  Sum_probs=236.4

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      ...+.++|.. .+.||+|+||.||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++.....
T Consensus         6 ~~~i~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            6 VYNISSDFQL-KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CCCSCTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             ccccccceEE-eeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            3456788888 99999999999999999999999999998643 334456678899999999999999999999854333


Q ss_pred             CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          109 EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       109 ~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ......++||||++++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+...
T Consensus        84 ~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           84 ENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             TTCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            44577999999999999998876 67999999999999999999999999999999999999999999999999998653


Q ss_pred             C---------------------CCCcccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCccccccc-----------
Q 042681          189 S---------------------ETDFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS-----------  235 (339)
Q Consensus       189 ~---------------------~~~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~-----------  235 (339)
                      .                     +..|.+||... ......+.|+|++|++++++++|..|+........           
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            2                     33477888653 35567789999999999999999998765431110           


Q ss_pred             -----------chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCC-
Q 042681          236 -----------DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTC-  303 (339)
Q Consensus       236 -----------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~-  303 (339)
                                 .............+........+.+++++++||.+||+.||++|||+.++++||||+...+....+.. 
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~  322 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGE  322 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCC
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccC
Confidence                       01112222222223333334456789999999999999999999999999999999998876533221 


Q ss_pred             CCC---CCCChhhccCCHHHHHHHHHHHHH
Q 042681          304 PYP---FNFDFEQTSMNEEDIKELILRECL  330 (339)
Q Consensus       304 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~  330 (339)
                      +.|   +.++......+.++++..+.+|+.
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 2b9h_A          323 PIPPSFFEFDHYKEALTTKDLKKLIWNEIF  352 (353)
T ss_dssp             CCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred             CCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence            111   445555667888999999988864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.2e-46  Score=332.08  Aligned_cols=248  Identities=19%  Similarity=0.306  Sum_probs=209.8

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.. ++.||+|+||.||+|+++.+|+.||+|++++... .......+.+|+.+++.++||||+++++++     ....
T Consensus         5 ~~y~~-~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~   78 (337)
T 1o6l_A            5 NDFDY-LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             HHeEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence            45666 8999999999999999999999999999976421 233456788999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .+++||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++..   
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            8999999997 699999998889999999999999999999999999999999999999999999999999998642   


Q ss_pred             --------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          189 --------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       189 --------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                              ++..|++||+.....+..+.|+|++|+++|++++|..|+.....  ..............        ...+
T Consensus       159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~--------p~~~  228 (337)
T 1o6l_A          159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILMEEIRF--------PRTL  228 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCC--------CTTS
T ss_pred             CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCC--------CCCC
Confidence                    34468899988877888999999999999999999999754321  11112222211111        1357


Q ss_pred             CHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          261 SPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      ++++++||.+||+.||++||     ++.++++||||..+.|.
T Consensus       229 s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence            99999999999999999999     89999999999998763

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=343.73  Aligned_cols=253  Identities=26%  Similarity=0.415  Sum_probs=211.9

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .+.++|.. ++.||+|+||.||+|.+..+|+.+|+|++..........+.+.+|+.+++.++||||+++++++     ..
T Consensus         8 ~~~~~Y~i-~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~   81 (444)
T 3soa_A            8 RFTEEYQL-FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SE   81 (444)
T ss_dssp             HHHHHEEE-EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----EC
T ss_pred             cccCCeEE-EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EE
Confidence            35567777 9999999999999999999999999999987655555677899999999999999999999999     67


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec---cCCCeEEeeccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDFGLAR  186 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~---~~~~ikL~Dfg~~~  186 (339)
                      .+..++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.
T Consensus        82 ~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           82 EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             SSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             CCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            788999999997 69999999989999999999999999999999999999999999999998   45789999999986


Q ss_pred             cc-----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          187 TT-----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       187 ~~-----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                      ..           +++.|.+||......+..+.|+|++|+++|++++|.+|+.....  ..............+    ..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~~~----~~  235 (444)
T 3soa_A          162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQIKAGAYDFP----SP  235 (444)
T ss_dssp             CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCCCC----TT
T ss_pred             EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhCCCCCC----cc
Confidence            43           34468889988777788899999999999999999999764321  111222222222111    22


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      .++.+++++++||.+||+.||++|||+.|+++||||+...
T Consensus       236 ~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~  275 (444)
T 3soa_A          236 EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS  275 (444)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHH
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCc
Confidence            3457899999999999999999999999999999997543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.4e-46  Score=332.51  Aligned_cols=258  Identities=29%  Similarity=0.439  Sum_probs=204.3

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ...++|.. ++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++     ..
T Consensus        31 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~  104 (329)
T 3gbz_A           31 TSIDRYRR-ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HH  104 (329)
T ss_dssp             -CGGGEEE-EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EE
T ss_pred             cchhhEEE-EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ec
Confidence            44567888 9999999999999999999999999999976654444556788999999999999999999999     66


Q ss_pred             cCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec-----cCCCeEEeecccc
Q 042681          111 FNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN-----ANCDLKICDFGLA  185 (339)
Q Consensus       111 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~-----~~~~ikL~Dfg~~  185 (339)
                      ...+++||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++     .++.+||+|||.+
T Consensus       105 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          105 NHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             CCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            78899999999999999999988999999999999999999999999999999999999995     4455999999998


Q ss_pred             cccC-----------CCCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          186 RTTS-----------ETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       186 ~~~~-----------~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      ...+           +..|.+||..... .+..+.|+|++|++++++++|..++......  ..................
T Consensus       185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTS
T ss_pred             cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHHhCCCchhhh
Confidence            6433           4458888877653 4688899999999999999999997643221  111122211111111000


Q ss_pred             ---------cccC-------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          254 ---------SQKF-------------PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       254 ---------~~~~-------------~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                               ...+             ..+++++++||.+||+.||++|||+.|+++||||++..+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence                     0000             116899999999999999999999999999999998865

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.4e-46  Score=337.89  Aligned_cols=250  Identities=18%  Similarity=0.327  Sum_probs=207.2

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++|.. ++.||+|+||.||+|+++.+++.||+|++++... .....+.+.+|..++.++ +||||+++++++     ...
T Consensus        52 ~~y~~-~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~  125 (396)
T 4dc2_A           52 QDFDL-LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE  125 (396)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred             hHcEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EEC
Confidence            45666 9999999999999999999999999999986533 233345678899999887 899999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc---
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART---  187 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~---  187 (339)
                      ..+++||||++ |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.   
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            88999999997 69999999889999999999999999999999999999999999999999999999999999864   


Q ss_pred             --------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc------c-hHHHHHhhCCCCCCCC
Q 042681          188 --------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS------D-NARRYVKQLPHVPKQP  252 (339)
Q Consensus       188 --------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~------~-~~~~~~~~~~~~~~~~  252 (339)
                              .++..|++||+.....+..+.|+|++|+++|++++|..|+........      . ............    
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~----  281 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI----  281 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC----
T ss_pred             CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC----
Confidence                    234568899988888888999999999999999999999854321110      0 111111111111    


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCccC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITV------EEALNHPYLSSLHEI  297 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~------~ell~hp~f~~~~~~  297 (339)
                          ...+++++++||++||+.||++||++      +++++||||+++.|.
T Consensus       282 ----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          282 ----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             ----CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence                13589999999999999999999985      899999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=335.73  Aligned_cols=248  Identities=17%  Similarity=0.293  Sum_probs=210.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++|.. ++.||+|+||.||+|+++.+|+.||+|++++.. ........+.+|..++..+ +||||+++++++     ...
T Consensus        23 ~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~   96 (353)
T 3txo_A           23 DNFEF-IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP   96 (353)
T ss_dssp             CCEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hheEE-EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence            56666 999999999999999999999999999997642 2233456788999999988 799999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ..+++||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..  
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            78999999998 699999998899999999999999999999999999999999999999999999999999998642  


Q ss_pred             ---------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          189 ---------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       189 ---------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                               ++..|++||+.....+..+.|+|++|+++|++++|..|+.....  ......+.......+        ..
T Consensus       177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~~~~~p--------~~  246 (353)
T 3txo_A          177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--DDLFEAILNDEVVYP--------TW  246 (353)
T ss_dssp             ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCCC--------TT
T ss_pred             CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCCCC--------CC
Confidence                     45568899988877788899999999999999999999764321  112222222211111        34


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCccC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITV------EEALNHPYLSSLHEI  297 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~------~ell~hp~f~~~~~~  297 (339)
                      +++++++||++||+.||++||++      .++++||||+.+.|.
T Consensus       247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence            78999999999999999999998      899999999998764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.6e-46  Score=333.63  Aligned_cols=246  Identities=28%  Similarity=0.401  Sum_probs=205.0

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC-hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      -++|.+ ++.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++     ...
T Consensus         8 i~~Y~i-~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~   81 (336)
T 3h4j_B            8 IGPYII-RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTP   81 (336)
T ss_dssp             ETTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             cCCEEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence            467777 99999999999999999999999999998754221 12235788999999999999999999999     667


Q ss_pred             CeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          112 NDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       112 ~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      ...++||||++|+|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...   
T Consensus        82 ~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           82 TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             SEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             CEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            78999999999999999988899999999999999999999999999999999999999999999999999998643   


Q ss_pred             -------CCCCcccccccccccc-CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          189 -------SETDFMTEYVVTRWDT-LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~-~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                             +++.|.+||......+ ..+.|+|++|++++++++|..|+........      ....    ..........+
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------~~~i----~~~~~~~p~~~  231 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------FKKV----NSCVYVMPDFL  231 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC------BCCC----CSSCCCCCTTS
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH------HHHH----HcCCCCCcccC
Confidence                   3456888887765544 5679999999999999999999754321110      0000    00111112357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      |+++++||++||+.||.+|||+.|+++||||+..
T Consensus       232 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          232 SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.4e-46  Score=324.22  Aligned_cols=252  Identities=33%  Similarity=0.478  Sum_probs=204.0

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||.||+|++ .+|+.+|+|++............+.+|+.+++.++||||+++++++     .....
T Consensus         2 ~~y~~-~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~   74 (288)
T 1ob3_A            2 EKYHG-LEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKR   74 (288)
T ss_dssp             CSEEE-EEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSC
T ss_pred             ccchh-hhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCe
Confidence            45666 89999999999999998 6789999999976544433456788999999999999999999999     56678


Q ss_pred             EEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      .++||||++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+...    
T Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             EEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            9999999999999998764 67999999999999999999999999999999999999999999999999998643    


Q ss_pred             -------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC-------------
Q 042681          189 -------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH-------------  247 (339)
Q Consensus       189 -------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~-------------  247 (339)
                             ++..|.+||.... ..+..+.|+|++|++++++++|..|+......  ............             
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHCCCChhhchhhhccc
Confidence                   3445888887654 34678899999999999999999987653211  111111111000             


Q ss_pred             --------CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          248 --------VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       248 --------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                              ....+.......+++++++||.+||+.||++|||+.|+++||||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                    01111122335689999999999999999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-45  Score=329.89  Aligned_cols=250  Identities=19%  Similarity=0.331  Sum_probs=209.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++|.. ++.||+|+||.||+|+++.+++.||+|++.+.. ......+.+.+|..++..+ +||||+++++++     ...
T Consensus         9 ~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~   82 (345)
T 3a8x_A            9 QDFDL-LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE   82 (345)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hheEE-EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence            45666 899999999999999999999999999998653 3444567788999999988 899999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc---
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART---  187 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~---  187 (339)
                      ..+++||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.   
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            78999999997 69999998888999999999999999999999999999999999999999999999999999864   


Q ss_pred             --------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc------c-hHHHHHhhCCCCCCCC
Q 042681          188 --------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS------D-NARRYVKQLPHVPKQP  252 (339)
Q Consensus       188 --------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~------~-~~~~~~~~~~~~~~~~  252 (339)
                              .++..|.+||......+..+.|+|++|+++|++++|..|+........      . ...........     
T Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-----  237 (345)
T 3a8x_A          163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-----  237 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-----
T ss_pred             CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-----
Confidence                    234568889988877788899999999999999999999864321110      1 11111111111     


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCccC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITV------EEALNHPYLSSLHEI  297 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~------~ell~hp~f~~~~~~  297 (339)
                      .   ...+++++++||.+||+.||++||++      .++++||||+++.|.
T Consensus       238 ~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~  285 (345)
T 3a8x_A          238 I---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  285 (345)
T ss_dssp             C---CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred             C---CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence            1   13579999999999999999999995      899999999998763

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.3e-46  Score=330.41  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=210.8

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh----HhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR----IDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      .+.++|.. .+.||+|+||.||+|.+..+|+.||+|++.......    ...+.+.+|+.+++.++||||+++++++   
T Consensus         8 ~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---   83 (326)
T 2y0a_A            8 NVDDYYDT-GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY---   83 (326)
T ss_dssp             CHHHHEEE-EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             CcccceEe-ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE---
Confidence            35566777 999999999999999999999999999997653221    2357789999999999999999999999   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC----CeEEee
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC----DLKICD  181 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~----~ikL~D  181 (339)
                        ......++||||++ ++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++    .+||+|
T Consensus        84 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           84 --ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             --ECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             --EeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence              66778999999997 79999998888999999999999999999999999999999999999999877    799999


Q ss_pred             ccccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          182 FGLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       182 fg~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ||++...          ++..|.+||......+..+.|+|++|++++++++|..|+......  ...........    .
T Consensus       162 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~----~  235 (326)
T 2y0a_A          162 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSAVNY----E  235 (326)
T ss_dssp             CTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHTCC----C
T ss_pred             CCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHhcCC----C
Confidence            9998654          344688899887777888999999999999999999997543211  11111111111    1


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      .....++.+++.+++||.+||+.||++|||+.++++||||+....
T Consensus       236 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence            111223568999999999999999999999999999999987643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.9e-45  Score=329.36  Aligned_cols=249  Identities=29%  Similarity=0.411  Sum_probs=200.2

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ...++|.. ++.||+|+||.||++++..+++.||+|++......   .+.+.+|+.+++.++||||+++++++     ..
T Consensus        17 ~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   87 (361)
T 3uc3_A           17 HDSDRYDF-VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVI-----LT   87 (361)
T ss_dssp             CCTTTEEE-EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             CCCCcEEE-EEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEE-----ee
Confidence            34577877 99999999999999999999999999999754322   25678999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC--eEEeecccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLART  187 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~--ikL~Dfg~~~~  187 (339)
                      ...+++||||++ |+|.+++...+++++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++.
T Consensus        88 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            778999999997 799999988889999999999999999999999999999999999999987765  99999998863


Q ss_pred             ----------cCCCCccccccccccccCCC-CccHHHHHHHHHHHhCCCCCCcccccccch--HHHHHhhCCCCCCCCcc
Q 042681          188 ----------TSETDFMTEYVVTRWDTLFP-GKDYVQQLTMITELLGSPDDSDLGFLRSDN--ARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       188 ----------~~~~~~~~~~~~~~~~~~~~-~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  254 (339)
                                .++..|.+||.......... .|+|++|++++++++|..|+..........  ...........+     
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-----  242 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP-----  242 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC-----
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC-----
Confidence                      24456888887765555444 899999999999999999986543221111  111111111111     


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                       ....+++++++||.+||+.||++|||+.++++||||...
T Consensus       243 -~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          243 -DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             -TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             -CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence             113579999999999999999999999999999999544

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=325.92  Aligned_cols=248  Identities=20%  Similarity=0.336  Sum_probs=210.6

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.. ++.||+|+||.||+|++..+|+.||+|++.+... .....+.+.+|+.++..++||||+++++++     ....
T Consensus         6 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   79 (318)
T 1fot_A            6 QDFQI-LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ   79 (318)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred             HHcEE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence            45666 8999999999999999999999999999975422 223456788999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .+++||||++ |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++..   
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            8999999997 699999998889999999999999999999999999999999999999999999999999998643   


Q ss_pred             -----CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          189 -----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       189 -----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                           ++..|.+||......+..+.|+|++|++++++++|..|+.....  ..............        .+.++++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~--------p~~~~~~  229 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYEKILNAELRF--------PPFFNED  229 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHCCCCC--------CTTSCHH
T ss_pred             cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCC--------CCCCCHH
Confidence                 45568899988877888999999999999999999999764321  11122222221111        1357899


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          264 AIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      +++||.+||+.||++||     +++++++||||+.+.|.
T Consensus       230 ~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence            99999999999999999     89999999999998764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=324.51  Aligned_cols=258  Identities=30%  Similarity=0.495  Sum_probs=207.8

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      -++|.. ++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++     ....
T Consensus         2 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~   75 (311)
T 4agu_A            2 MEKYEK-IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-----RRKR   75 (311)
T ss_dssp             -CCEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred             cccceE-eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-----ecCC
Confidence            356777 9999999999999999999999999999977655565667888999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC--
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--  189 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~--  189 (339)
                      ..++||||++ ++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+....  
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            8999999999 5677777777889999999999999999999999999999999999999999999999999986543  


Q ss_pred             ---------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhC--------------
Q 042681          190 ---------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL--------------  245 (339)
Q Consensus       190 ---------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~--------------  245 (339)
                               +..|.+||.... .....+.|+|++|++++++++|..|+........  ........              
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHTC
T ss_pred             ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhcccccccccccccc
Confidence                     334778887654 4567889999999999999999998765432111  01000000              


Q ss_pred             -----CCCC----CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          246 -----PHVP----KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       246 -----~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                           ...+    .......++.+++++.+||.+||+.||++|||++|+++||||+++.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence                 0000    0111122357899999999999999999999999999999999998764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-46  Score=330.65  Aligned_cols=251  Identities=23%  Similarity=0.362  Sum_probs=209.8

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .+.++|.. ++.||+|+||.||+|.+..+++.+|+|.+...   ......+.+|+.+++.++||||+++++++     ..
T Consensus         2 ~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~   72 (321)
T 1tki_A            2 ELYEKYMI-AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESF-----ES   72 (321)
T ss_dssp             CCTTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EE
T ss_pred             chhhceEe-eeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ec
Confidence            35678888 99999999999999999999999999998643   33456788999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc--CCCeEEeeccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLAR  186 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~--~~~ikL~Dfg~~~  186 (339)
                      ...+++||||++ ++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.  ++.++|+|||++.
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            778999999998 6999999765 47999999999999999999999999999999999999987  7899999999986


Q ss_pred             cc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          187 TT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       187 ~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      ..          +++.|.+||.........+.|+|++|++++++++|..|+.....  ............    ......
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~----~~~~~~  226 (321)
T 1tki_A          153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAEY----TFDEEA  226 (321)
T ss_dssp             ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTCC----CCCHHH
T ss_pred             ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHcCCC----CCChhh
Confidence            54          34468888888777778899999999999999999999764321  111122222111    111223


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ++.+|+++++||.+||+.||.+|||+.|+++||||+....
T Consensus       227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  266 (321)
T 1tki_A          227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence            3568999999999999999999999999999999987644

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-45  Score=320.37  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=216.6

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .+.++|.. .+.||+|+||.||+|.+..+|+.+|+|++..........+.+.+|+.+++.++||||+++++++     ..
T Consensus         3 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   76 (284)
T 3kk8_A            3 KFSDNYDV-KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QE   76 (284)
T ss_dssp             TTTTTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             hhhhhhhh-hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----Ec
Confidence            46788888 9999999999999999999999999999987766666678889999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC---eEEeeccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLAR  186 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~---ikL~Dfg~~~  186 (339)
                      ....++||||++ ++|.+.+.....+++..++.++.|++.||.|||++|++||||||+||+++.++.   ++|+|||.+.
T Consensus        77 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           77 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            778999999997 699999988889999999999999999999999999999999999999987665   9999999985


Q ss_pred             cc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          187 TT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       187 ~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      ..          ++..|.+||.........+.|+|++|++++++++|..|+......  .............+    ...
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~----~~~  230 (284)
T 3kk8_A          157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGAYDYP----SPE  230 (284)
T ss_dssp             ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCCC----TTT
T ss_pred             EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHhccccCC----chh
Confidence            43          334578888887777888999999999999999999997653211  11122222222111    122


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE  299 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~  299 (339)
                      +..+++++++||.+||+.||++|||+.|+++||||++..+...
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          231 WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence            3568999999999999999999999999999999998876543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.7e-45  Score=325.48  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=192.7

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. ++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++     ...+
T Consensus         4 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   76 (317)
T 2pmi_A            4 SSQFKQ-LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVI-----HTEN   76 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTT
T ss_pred             ccceeE-eeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECC
Confidence            467777 999999999999999999999999999997543 222346788999999999999999999999     6677


Q ss_pred             eEEEEEecCcccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          113 DVYIVYELMDTDLHQIIRSK------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       113 ~~~iv~e~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      .+++||||++|+|.+++...      ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+.
T Consensus        77 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           77 KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             eEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence            89999999999999998653      469999999999999999999999999999999999999999999999999986


Q ss_pred             ccC-----------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC----
Q 042681          187 TTS-----------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK----  250 (339)
Q Consensus       187 ~~~-----------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~----  250 (339)
                      ..+           +..|.+||.... ..+..+.|+|++|++++++++|..|+......  ...............    
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--EQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCTTTCG
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhHhh
Confidence            532           345888887754 35678899999999999999999987543211  111111111110000    


Q ss_pred             -----------------CCc-----cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          251 -----------------QPF-----SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       251 -----------------~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                                       ...     ......+++++++||.+||+.||++|||+.|+++||||+.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                             000     00112578999999999999999999999999999999987664

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=323.79  Aligned_cols=262  Identities=27%  Similarity=0.413  Sum_probs=201.8

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC---hHhHHHHHHHHHHHhhC---CCCCeeeeeeecCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN---RIDAKRILREIKLLCHM---THENIVKVKDIIPP  105 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~e~~~l~~l---~h~~I~~~~~~~~~  105 (339)
                      +.++|.. ++.||+|+||.||+|++..+|+.||+|++......   ......+.+|+.+++.+   +||||+++++++..
T Consensus         7 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            7 ATSRYEP-VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ---CCEE-EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             cccceEE-EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4678888 99999999999999999999999999998754321   11123456677776666   49999999999854


Q ss_pred             CCcCCcCeEEEEEecCcccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          106 MDKEKFNDVYIVYELMDTDLHQIIRSKQA--LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                      .........+++|||++++|.+++.....  +++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  165 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG  165 (308)
T ss_dssp             CCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred             cCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence            33222336899999999999999987654  9999999999999999999999999999999999999999999999999


Q ss_pred             ccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC---
Q 042681          184 LARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK---  250 (339)
Q Consensus       184 ~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~---  250 (339)
                      .+...          ++..|.+||......+..+.|+|++|++++++++|..|+......  .............+.   
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--HHHHHHHHHHCCCCTTTS
T ss_pred             cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhhc
Confidence            98643          344688898887777888999999999999999999997643221  111222221111111   


Q ss_pred             ----------------CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          251 ----------------QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       251 ----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                                      .......+.+++++.+||.+||+.||++|||+.|+++||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence                            1111233568999999999999999999999999999999987543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.1e-45  Score=330.75  Aligned_cols=302  Identities=33%  Similarity=0.563  Sum_probs=232.4

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC---------hHhHHHHHHHHHHHhhCCCCCeee
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN---------RIDAKRILREIKLLCHMTHENIVK   98 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~I~~   98 (339)
                      +...+.++|.. ++.||+|+||.||+|.+.. |+.||+|++......         ....+.+.+|+.+++.++||||++
T Consensus        16 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           16 ELHAMQSPYTV-QRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHTTCSCEE-EEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHhccceEE-eEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            34567788888 9999999999999999865 899999999654322         223478899999999999999999


Q ss_pred             eeeecCCCCcCCcCeEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCe
Q 042681           99 VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL  177 (339)
Q Consensus        99 ~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~i  177 (339)
                      +++++..........+++||||++|+|.+.+... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~  173 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI  173 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             eeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCE
Confidence            9999855433445579999999999999998764 479999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccc----------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHH----
Q 042681          178 KICDFGLARTT----------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV----  242 (339)
Q Consensus       178 kL~Dfg~~~~~----------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~----  242 (339)
                      +|+|||.+...          ++..|.+||.... .....+.|+|++|++++++++|..|+.......  ......    
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~  251 (362)
T 3pg1_A          174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN--QLNKIVEVVG  251 (362)
T ss_dssp             EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHC
T ss_pred             EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcC
Confidence            99999998642          2345788887654 557778999999999999999999976532111  111111    


Q ss_pred             --------------------hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCC
Q 042681          243 --------------------KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT  302 (339)
Q Consensus       243 --------------------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~  302 (339)
                                          ......+........+.+++.+.+||.+||+.||++|||+.++++||||+.+....... 
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~-  330 (362)
T 3pg1_A          252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT-  330 (362)
T ss_dssp             CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGT-
T ss_pred             CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccc-
Confidence                                11111122222233456789999999999999999999999999999999987654322 


Q ss_pred             CCCCCCCChhhccCCHHHHHHHHHHHHHhcCC
Q 042681          303 CPYPFNFDFEQTSMNEEDIKELILRECLNFHP  334 (339)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (339)
                      ....-.+++........++...+.+|...|+.
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~  362 (362)
T 3pg1_A          331 EGLSERFHFDESVTDVYDMHKIFTAEVERFND  362 (362)
T ss_dssp             TTCCCCCCCCTTCCCHHHHHHHHHHHHHHHC-
T ss_pred             cccccccChhhhhhhHHHHHHHHHHHHHHhcC
Confidence            22223345555666778999999999988763

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.5e-46  Score=335.39  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=214.8

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      .-.+.++|.. .+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++     
T Consensus        24 ~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----   97 (362)
T 2bdw_A           24 STKFSDNYDV-KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----   97 (362)
T ss_dssp             CCHHHHHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             CCCcccCeEE-eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence            3456678888 9999999999999999999999999999987655666678899999999999999999999999     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC---CeEEeeccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC---DLKICDFGL  184 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~---~ikL~Dfg~  184 (339)
                      ......++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||+
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A           98 QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            66788999999998 69999998888999999999999999999999999999999999999998654   599999999


Q ss_pred             cccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          185 ARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       185 ~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      +...          ++..|.+||+.....+..+.|+|++|+++|++++|..|+.....  ..............+    .
T Consensus       178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~~~----~  251 (362)
T 2bdw_A          178 AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYP----S  251 (362)
T ss_dssp             CBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCCC----T
T ss_pred             ceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCCCCC----c
Confidence            8643          34468889988777788899999999999999999999764321  111122222211111    1


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ..+..+++++++||.+||+.||++|||+.++++||||.....
T Consensus       252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  293 (362)
T 2bdw_A          252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  293 (362)
T ss_dssp             TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHH
T ss_pred             ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCcc
Confidence            223457999999999999999999999999999999986543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.8e-45  Score=321.08  Aligned_cols=249  Identities=24%  Similarity=0.349  Sum_probs=206.5

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ..++|.. ++.||+|+||.||+|.+..+|+.||+|++......  ..+.+.+|+.+++.++||||+++++++     ...
T Consensus        18 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~   89 (297)
T 3fxz_A           18 PKKKYTR-FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSY-----LVG   89 (297)
T ss_dssp             GGGTBCC-CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEE-----EET
T ss_pred             hhhceee-eeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEE-----EEC
Confidence            3467877 99999999999999999999999999998754332  246788999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ...++||||++ |+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...  
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            78999999996 799998876 47999999999999999999999999999999999999999999999999987543  


Q ss_pred             ---------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          189 ---------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       189 ---------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                               ++..|.+||......+..+.|+|++|++++++++|..|+......  ...........  ....   ....
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~--~~~~---~~~~  241 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGT--PELQ---NPEK  241 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHHCS--CCCS---CGGG
T ss_pred             cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC--CCCC---Cccc
Confidence                     344588888887777888999999999999999999997543211  11111111111  1111   1135


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      +++.+++||.+||+.||++|||+.++++||||+....
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence            7899999999999999999999999999999987643

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=331.94  Aligned_cols=250  Identities=20%  Similarity=0.377  Sum_probs=208.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.+ ++.||+|+||.||+|++..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++     ....
T Consensus        15 ~~y~i-~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   88 (384)
T 4fr4_A           15 DHFEI-LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE   88 (384)
T ss_dssp             GGEEE-EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             HHeEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence            55666 999999999999999999999999999997542 2233457788999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .+++||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++...   
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            8999999997 799999998889999999999999999999999999999999999999999999999999998643   


Q ss_pred             -------CCCCccccccccc---cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          189 -------SETDFMTEYVVTR---WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       189 -------~~~~~~~~~~~~~---~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                             ++..|.+||+...   ..+..+.|+|++|+++|++++|..|+................... ..      ...
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~~------~p~  241 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-VT------YPS  241 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC-CC------CCT
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc-cC------CCC
Confidence                   3446888888753   346788999999999999999999986433222222222211111 11      113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCCCcc
Q 042681          259 NMSPVAIDLAERMLVFDPAKRIT-VEEALNHPYLSSLHE  296 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps-~~ell~hp~f~~~~~  296 (339)
                      .+++++++||.+||+.||.+||+ +.++++||||+.+.|
T Consensus       242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence            57999999999999999999998 899999999999876

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.3e-45  Score=333.64  Aligned_cols=263  Identities=19%  Similarity=0.230  Sum_probs=208.2

Q ss_pred             cccccCccCCCccccccc--cceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           29 LFQVSSKYVPPLQPIGRG--AYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      ...-.++|.+ ++.||+|  +||.||+|++..+|+.||+|++..........+.+.+|+.+++.++||||+++++++   
T Consensus        20 ~~~~~~~y~~-~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~---   95 (389)
T 3gni_B           20 FLPEGGCYEL-LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF---   95 (389)
T ss_dssp             CCCCGGGEEE-EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             ccCCCCcEEE-EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE---
Confidence            3344667777 9999999  999999999999999999999987766666678889999999999999999999999   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                        ...+.+++||||++ |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||
T Consensus        96 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg  173 (389)
T 3gni_B           96 --IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR  173 (389)
T ss_dssp             --EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGG
T ss_pred             --EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccc
Confidence              66778999999998 7999999775  779999999999999999999999999999999999999999999999999


Q ss_pred             cccc------------------cCCCCccccccccc--cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHH--HH
Q 042681          184 LART------------------TSETDFMTEYVVTR--WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNAR--RY  241 (339)
Q Consensus       184 ~~~~------------------~~~~~~~~~~~~~~--~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~--~~  241 (339)
                      .+..                  .+...|.+||....  ..+..+.|+|++|++++++++|..|+............  ..
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  253 (389)
T 3gni_B          174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT  253 (389)
T ss_dssp             GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred             cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            8743                  23334788887765  46778899999999999999999998653322110000  00


Q ss_pred             Hhh----------------------------------CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          242 VKQ----------------------------------LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       242 ~~~----------------------------------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ...                                  ...............+++++++||.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            000                                  0000000011123457899999999999999999999999999


Q ss_pred             CCCCCCCccC
Q 042681          288 HPYLSSLHEI  297 (339)
Q Consensus       288 hp~f~~~~~~  297 (339)
                      ||||+.+.+.
T Consensus       334 hp~f~~~~~~  343 (389)
T 3gni_B          334 HSFFKQIKRR  343 (389)
T ss_dssp             SGGGGGC---
T ss_pred             CHHHHHHhhc
Confidence            9999988754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.7e-46  Score=330.88  Aligned_cols=249  Identities=20%  Similarity=0.308  Sum_probs=208.7

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~  110 (339)
                      .++|.. .+.||+|+||.||+|+++.+|+.||+|++++... .......+..|..++..+ +||||+++++++     ..
T Consensus        16 ~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~   89 (345)
T 1xjd_A           16 IEDFIL-HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT   89 (345)
T ss_dssp             CTTEEE-EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred             hHHeEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence            356666 9999999999999999999999999999976421 123356678899998876 899999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-  188 (339)
                      ...+++||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++.. 
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            778999999997 799999998889999999999999999999999999999999999999999999999999998642 


Q ss_pred             ----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          189 ----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       189 ----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                ++..|.+||+.....+..+.|+|++|+++|++++|..|+.....  ......+.......        ..
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~--------p~  239 (345)
T 1xjd_A          170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNPFY--------PR  239 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCC--------CT
T ss_pred             cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHhCCCCC--------Cc
Confidence                      34468889988777788899999999999999999999764321  11112222211111        13


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCccC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVE-EALNHPYLSSLHEI  297 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~-ell~hp~f~~~~~~  297 (339)
                      .+++++++||.+||+.||++||++. ++++||||+.+.|.
T Consensus       240 ~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          240 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             ccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence            4799999999999999999999998 99999999998753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.2e-45  Score=328.44  Aligned_cols=248  Identities=19%  Similarity=0.291  Sum_probs=210.8

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      .++|.. ++.||+|+||.||+|++..+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++     ...
T Consensus        40 ~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~  113 (350)
T 1rdq_E           40 LDQFDR-IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN  113 (350)
T ss_dssp             GGGEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             HHHCEE-EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence            466777 9999999999999999999999999999975421 223456788999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ..+++||||++ |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..  
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence            78999999997 799999998889999999999999999999999999999999999999999999999999998754  


Q ss_pred             ------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          189 ------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       189 ------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                            ++..|.+||+.....+..+.|+|++|++++++++|..|+.....  ......+.......        ...+++
T Consensus       194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~--------p~~~~~  263 (350)
T 1rdq_E          194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSGKVRF--------PSHFSS  263 (350)
T ss_dssp             CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCC--------CTTCCH
T ss_pred             CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHHHHHHHcCCCCC--------CCCCCH
Confidence                  34568889988777788899999999999999999999764321  11112222211111        135799


Q ss_pred             HHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCcc
Q 042681          263 VAIDLAERMLVFDPAKRIT-----VEEALNHPYLSSLHE  296 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~  296 (339)
                      ++++||.+||+.||++||+     ++++++||||+.+.|
T Consensus       264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             HHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence            9999999999999999998     999999999998876

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.5e-45  Score=323.22  Aligned_cols=255  Identities=22%  Similarity=0.313  Sum_probs=203.2

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~  110 (339)
                      +.++|.+..+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.++.++ +||||+++++++     ..
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~   82 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EE   82 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ee
Confidence            56778775588999999999999999999999999997542  23356788999999985 799999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC---eEEeeccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLAR  186 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~---ikL~Dfg~~~  186 (339)
                      .+.+++||||++ ++|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.   +||+|||++.
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            778999999997 799999988889999999999999999999999999999999999999998776   9999999875


Q ss_pred             cc------------------CCCCccccccccc-----cccCCCCccHHHHHHHHHHHhCCCCCCcccccc---------
Q 042681          187 TT------------------SETDFMTEYVVTR-----WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR---------  234 (339)
Q Consensus       187 ~~------------------~~~~~~~~~~~~~-----~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~---------  234 (339)
                      ..                  ++..|.+||....     ..+..+.|+|++|++++++++|..|+.......         
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            43                  3446888887653     446788999999999999999999986532111         


Q ss_pred             ----cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          235 ----SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       235 ----~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                          .............    .....+..+++++++||.+||+.||++|||+.++++||||+.....
T Consensus       243 ~~~~~~~~~~i~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          243 PACQNMLFESIQEGKYE----FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHHHHHHHHHCCCC----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred             hhHHHHHHHHHhccCcc----cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence                0011111111111    1111224578999999999999999999999999999999987543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.2e-46  Score=328.10  Aligned_cols=259  Identities=30%  Similarity=0.449  Sum_probs=205.5

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++     .....
T Consensus         2 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~   74 (324)
T 3mtl_A            2 ETYIK-LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKS   74 (324)
T ss_dssp             CSEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSC
T ss_pred             CceEE-EEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCE
Confidence            45666 99999999999999999999999999998654221 1112355799999999999999999999     66778


Q ss_pred             EEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC---
Q 042681          114 VYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS---  189 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~---  189 (339)
                      .++||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||.+....   
T Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           75 LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             EEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            9999999999999998765 469999999999999999999999999999999999999999999999999986432   


Q ss_pred             --------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC--------------
Q 042681          190 --------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP--------------  246 (339)
Q Consensus       190 --------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~--------------  246 (339)
                              +..|.+||.... ..+..+.|+|++|++++++++|..|+......  ...........              
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHhchhhhcch
Confidence                    445788887654 45678899999999999999999987653211  11111111111              


Q ss_pred             --------CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCC
Q 042681          247 --------HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP  301 (339)
Q Consensus       247 --------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~  301 (339)
                              ...........+.+++++++||.+||+.||++|||++|+++||||.++.+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~  295 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKL  295 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSS
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccC
Confidence                    1111111223356899999999999999999999999999999999987764433

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-45  Score=322.41  Aligned_cols=247  Identities=18%  Similarity=0.189  Sum_probs=181.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      .+|.. .+.||+|+||+||+|++  +|+.||||+++...   ........|+..+.+++||||+++++++.... .....
T Consensus         3 r~i~L-~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~   75 (303)
T 3hmm_A            3 RTIVL-QESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ   75 (303)
T ss_dssp             GGEEE-EEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred             cEEEE-EEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceE
Confidence            34444 88999999999999987  58899999986431   11122234666667889999999999984211 12236


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA--------NVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                      ++|||||++ |+|.+++.+ .++++..+..++.|++.||.|||++        ||+||||||+|||++.++++||+|||+
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            899999998 799999976 5799999999999999999999987        999999999999999999999999999


Q ss_pred             ccc---------------cCCCCcccccccccc------ccCCCCccHHHHHHHHHHHhCCCCCCcccccc---------
Q 042681          185 ART---------------TSETDFMTEYVVTRW------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR---------  234 (339)
Q Consensus       185 ~~~---------------~~~~~~~~~~~~~~~------~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~---------  234 (339)
                      |+.               .++..|++||+....      .++.++|+|++|+++|++++|.+++.......         
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence            853               245568899876532      35567999999999999999977653221110         


Q ss_pred             cchHHHHHh-hCCCCCCCCccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          235 SDNARRYVK-QLPHVPKQPFSQKF--PNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       235 ~~~~~~~~~-~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ......... .......+..+...  ...++.+.+|+.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            001111111 11111111111111  1234578999999999999999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.5e-45  Score=327.29  Aligned_cols=248  Identities=17%  Similarity=0.286  Sum_probs=209.0

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++|.. ++.||+|+||.||+|++..+|+.||+|++++... .....+.+.+|..++..+ +||+|+++++++     ...
T Consensus        20 ~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~   93 (353)
T 2i0e_A           20 TDFNF-LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM   93 (353)
T ss_dssp             TTEEE-EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----ECS
T ss_pred             HHcEE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----EcC
Confidence            55666 9999999999999999999999999999976422 223456788999999988 799999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ..+++||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++..  
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            78999999997 699999998889999999999999999999999999999999999999999999999999998642  


Q ss_pred             ---------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          189 ---------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       189 ---------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                               +++.|++||+.....+..+.|+|++|+++|++++|..|+.....  ......+.......        ...
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~~~~~--------p~~  243 (353)
T 2i0e_A          174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEHNVAY--------PKS  243 (353)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCC--------CTT
T ss_pred             CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHHHHHhCCCCC--------CCC
Confidence                     34568899988877788899999999999999999999764321  11122222221111        135


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          260 MSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      +|+++++||.+||+.||++||     ++.++++||||+.+.|.
T Consensus       244 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence            899999999999999999999     47999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.1e-45  Score=323.66  Aligned_cols=252  Identities=25%  Similarity=0.347  Sum_probs=204.9

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      +.++|.. ++.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++     ...
T Consensus         5 ~~~~y~i-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~   77 (323)
T 3tki_A            5 FVEDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHR-----REG   77 (323)
T ss_dssp             TTTCEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             Hhhhcee-eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecC
Confidence            4567777 9999999999999999999999999999865422 22235688999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ...++||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...  
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            88999999997 699999988888999999999999999999999999999999999999999999999999998642  


Q ss_pred             -----------CCCCcccccccccccc-CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          189 -----------SETDFMTEYVVTRWDT-LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       189 -----------~~~~~~~~~~~~~~~~-~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                                 ++..|.+||....... ..+.|+|++|++++++++|..|+........ ..........  ..    ..
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~--~~----~~  230 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKT--YL----NP  230 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTCT--TS----TT
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcccc--cC----Cc
Confidence                       3445788887765544 5679999999999999999999865432211 1111111111  11    11


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      +..+++++.+||.+||+.||++|||+.|+++||||+.....
T Consensus       231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  271 (323)
T 3tki_A          231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (323)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccccc
Confidence            24578999999999999999999999999999999876543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-45  Score=335.03  Aligned_cols=252  Identities=20%  Similarity=0.274  Sum_probs=205.0

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      .++|.. ++.||+|+||.||+|+++.+++.||+|++.+... .....+.+.+|+.++..++||||+++++++     .+.
T Consensus        68 ~~~y~~-~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~  141 (410)
T 3v8s_A           68 AEDYEV-VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  141 (410)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             ccccEE-EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence            456666 9999999999999999999999999999975311 112234578999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ..+++||||++ |+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..  
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~  220 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  220 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence            88999999996 799998875 57999999999999999999999999999999999999999999999999998543  


Q ss_pred             ----------CCCCccccccccccc----cCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 ----------SETDFMTEYVVTRWD----TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 ----------~~~~~~~~~~~~~~~----~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                                +++.|++||+.....    +..+.|+|++|+++|++++|..|+.....  ......+.........+   
T Consensus       221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~~~~p---  295 (410)
T 3v8s_A          221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKIMNHKNSLTFP---  295 (410)
T ss_dssp             TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTHHHHCCCC---
T ss_pred             CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--hhHHHHHHhccccccCC---
Confidence                      445688888776544    66789999999999999999999764321  11112222111001111   


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCccC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAK--RITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~--Rps~~ell~hp~f~~~~~~  297 (339)
                       ....+|+++++||.+||+.+|.+  ||+++|+++||||+++.|.
T Consensus       296 -~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          296 -DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             -TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             -CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence             11358999999999999999998  9999999999999998763

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-45  Score=338.81  Aligned_cols=255  Identities=19%  Similarity=0.330  Sum_probs=208.1

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      .++|.. ++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.++..++||||+++++++     ...
T Consensus        73 ~~~y~~-~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  146 (437)
T 4aw2_A           73 REDFEI-LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDD  146 (437)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             hhheEE-EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeC
Confidence            456666 9999999999999999999999999999975311 112233478999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--  187 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~--  187 (339)
                      ..+++||||++ |+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.  
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  226 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence            88999999996 799999987 57899999999999999999999999999999999999999999999999999853  


Q ss_pred             ----------cCCCCcccccccc-----ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          188 ----------TSETDFMTEYVVT-----RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       188 ----------~~~~~~~~~~~~~-----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                                .++..|++||+..     ...+..+.|+|++|+++|++++|..|+......  .....+.....   ...
T Consensus       227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~---~~~  301 (437)
T 4aw2_A          227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNHKE---RFQ  301 (437)
T ss_dssp             TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHHH---HCC
T ss_pred             cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--HHHHhhhhccc---ccc
Confidence                      3455688888775     345778899999999999999999998643211  11122211100   011


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCccCC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAK--RITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~--Rps~~ell~hp~f~~~~~~~  298 (339)
                      .....+.+|+++++||++||+.+|++  ||+++|+++||||+++.|..
T Consensus       302 ~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~  349 (437)
T 4aw2_A          302 FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN  349 (437)
T ss_dssp             CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred             CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence            12223458999999999999998888  99999999999999998764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5e-45  Score=322.98  Aligned_cols=255  Identities=25%  Similarity=0.406  Sum_probs=211.0

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh----HhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR----IDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      .+.++|.. .+.||+|+||.||+|.+..+|+.+|+|++.......    ...+.+.+|+.++..++||||+++++++   
T Consensus         9 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---   84 (321)
T 2a2a_A            9 KVEDFYDI-GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY---   84 (321)
T ss_dssp             CHHHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             hhhccEEE-eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE---
Confidence            35567777 999999999999999999999999999997653222    2357789999999999999999999999   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC----CeEEee
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC----DLKICD  181 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~----~ikL~D  181 (339)
                        ......++||||++ ++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++    .++|+|
T Consensus        85 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           85 --ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             --ECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             --ecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence              66778999999997 79999999888999999999999999999999999999999999999999888    799999


Q ss_pred             ccccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          182 FGLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       182 fg~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ||.+...          +...|.+||.........+.|+|++|++++++++|..|+......  ........    ....
T Consensus       163 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~----~~~~  236 (321)
T 2a2a_A          163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITS----VSYD  236 (321)
T ss_dssp             CTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHT----TCCC
T ss_pred             CccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHh----cccc
Confidence            9998654          334588888887777788899999999999999999987543211  11111111    1111


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ......+.+++.+++||.+||+.||++|||+.++++||||+.+.+.
T Consensus       237 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~  282 (321)
T 2a2a_A          237 FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ  282 (321)
T ss_dssp             CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred             cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence            1112234688999999999999999999999999999999987653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=322.13  Aligned_cols=243  Identities=22%  Similarity=0.264  Sum_probs=200.7

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~  111 (339)
                      .++|.. ++.||+|+||+||+|++..+|+.||+|++...............|+..+..+ +||||+++++++     ...
T Consensus        56 ~~~y~~-~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~  129 (311)
T 3p1a_A           56 QQSFQR-LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEG  129 (311)
T ss_dssp             HHHEEE-EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EET
T ss_pred             hhheee-eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeC
Confidence            366777 8999999999999999999999999999877655555566666777666665 899999999999     677


Q ss_pred             CeEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      +.+++||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...  
T Consensus       130 ~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          130 GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             TEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             CEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            889999999999999988764 56999999999999999999999999999999999999999999999999998654  


Q ss_pred             --------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          189 --------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       189 --------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                              ++..|.+||.... ....+.|+|++|++++++++|..++...     ......   ......   ......+
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~~~~~---~~~~~~---~~~~~~~  277 (311)
T 3p1a_A          210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQQL---RQGYLP---PEFTAGL  277 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HHHHHH---TTTCCC---HHHHTTS
T ss_pred             CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHH---hccCCC---cccccCC
Confidence                    3446888887765 5778899999999999999997654321     111111   111111   1122458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                      ++++.+||.+||+.||++|||+.++++||||+.
T Consensus       278 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          278 SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            999999999999999999999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=327.12  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=208.5

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .+.++|.. ++.||+|+||.||+|.+..+|+.+|+|++...  .......+.+|+.++..++||||+++++++     ..
T Consensus        48 ~~~~~y~i-~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~  119 (387)
T 1kob_A           48 SVYDYYDI-LEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAF-----ED  119 (387)
T ss_dssp             CGGGTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----EC
T ss_pred             ccccceEE-EEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----Ee
Confidence            34567777 99999999999999999999999999998754  233456788999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc--CCCeEEeeccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLAR  186 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~--~~~ikL~Dfg~~~  186 (339)
                      ....++||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.  ++.+||+|||++.
T Consensus       120 ~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccce
Confidence            788999999997 6999998765 47999999999999999999999999999999999999974  4679999999987


Q ss_pred             cc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          187 TT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       187 ~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      ..          ++..|.+||.........+.|+|++|++++++++|..|+......  ...........    ......
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~i~~~~~----~~~~~~  273 (387)
T 1kob_A          200 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCDW----EFDEDA  273 (387)
T ss_dssp             ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHCCC----CCCSST
T ss_pred             ecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC----CCCccc
Confidence            54          344688898887777888899999999999999999997643211  11111211111    111223


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      +..+++++++||.+||+.||++|||+.++++||||+....
T Consensus       274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            3568999999999999999999999999999999987643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=323.71  Aligned_cols=253  Identities=27%  Similarity=0.361  Sum_probs=200.9

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      .-.+.++|.. .+.||+|+||.||+|.+..+++.||+|++....    ..+.+.+|+.++..++||||+++++++     
T Consensus        48 ~~~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~-----  117 (349)
T 2w4o_A           48 RDALSDFFEV-ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIF-----  117 (349)
T ss_dssp             CSCGGGTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEE-----
T ss_pred             cccccCcEEE-eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeE-----
Confidence            3456677777 999999999999999999999999999987542    345678999999999999999999999     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc---CCCeEEeeccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGL  184 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~---~~~ikL~Dfg~  184 (339)
                      ......++||||++ ++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.   ++.+||+|||+
T Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~  197 (349)
T 2w4o_A          118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGL  197 (349)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred             ecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence            66778999999997 799999998889999999999999999999999999999999999999975   88999999999


Q ss_pred             cccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          185 ARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       185 ~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      +...          ++..|.+||......+..+.|+|++|++++++++|..|+....... .........    ......
T Consensus       198 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~i~~~----~~~~~~  272 (349)
T 2w4o_A          198 SKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-FMFRRILNC----EYYFIS  272 (349)
T ss_dssp             ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-HHHHHHHTT----CCCCCT
T ss_pred             ccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-HHHHHHHhC----CCccCC
Confidence            8643          3446888988877778889999999999999999999875432111 011112111    111112


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ..++.++.++++||.+||+.||++|||+.++++||||.....
T Consensus       273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence            233568999999999999999999999999999999987654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-45  Score=330.17  Aligned_cols=257  Identities=28%  Similarity=0.403  Sum_probs=208.1

Q ss_pred             cccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc---cChHhHHHHHHHHHHHhhCCCCCeeeeeeec
Q 042681           27 GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDAKRILREIKLLCHMTHENIVKVKDII  103 (339)
Q Consensus        27 ~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~  103 (339)
                      .....+.++|.. .+.||+|+||.||+|.+..+|+.||+|++....   ......+.+.+|+.+++.++||||+++++++
T Consensus        17 ~~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   95 (351)
T 3c0i_A           17 DDDVLFEDVYEL-CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY   95 (351)
T ss_dssp             ---CCHHHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCccccceEE-eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            444566788888 999999999999999999999999999986432   1122357789999999999999999999999


Q ss_pred             CCCCcCCcCeEEEEEecCc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC--
Q 042681          104 PPMDKEKFNDVYIVYELMD-TDLHQIIRSK----QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--  176 (339)
Q Consensus       104 ~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~--  176 (339)
                           ...+.+++||||++ ++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  
T Consensus        96 -----~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~  170 (351)
T 3c0i_A           96 -----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSA  170 (351)
T ss_dssp             -----EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTC
T ss_pred             -----EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCC
Confidence                 66788999999998 6998877542    35899999999999999999999999999999999999987655  


Q ss_pred             -eEEeeccccccc-----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh
Q 042681          177 -LKICDFGLARTT-----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ  244 (339)
Q Consensus       177 -ikL~Dfg~~~~~-----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~  244 (339)
                       +||+|||++...           ++..|.+||......+..+.|+|++|+++|++++|..|+....   ..........
T Consensus       171 ~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~i~~~  247 (351)
T 3c0i_A          171 PVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERLFEGIIKG  247 (351)
T ss_dssp             CEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHHHHHHHHT
T ss_pred             cEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHHHHHHHcC
Confidence             999999998653           3445888888877778889999999999999999999976532   1111112111


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       245 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ..    ......++.+++++++||.+||+.||++|||+.++++||||+....
T Consensus       248 ~~----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~  295 (351)
T 3c0i_A          248 KY----KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR  295 (351)
T ss_dssp             CC----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHH
T ss_pred             CC----CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCcc
Confidence            11    1111223568999999999999999999999999999999987643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=331.70  Aligned_cols=255  Identities=18%  Similarity=0.246  Sum_probs=205.8

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      .++|.. ++.||+|+||.||+|+++.+|+.||+|++.+.. ......+.+.+|..++..++||||+++++++     .+.
T Consensus        60 ~~~f~~-~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  133 (412)
T 2vd5_A           60 RDDFEI-LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE  133 (412)
T ss_dssp             GGGEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             hhhEEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence            456666 999999999999999999999999999997532 1222345578999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-
Q 042681          112 NDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-  188 (339)
                      ..+|+||||++ |+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||+++.++++||+|||+++.. 
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence            88999999996 7999999875 48999999999999999999999999999999999999999999999999998543 


Q ss_pred             -----------CCCCcccccccc-------ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          189 -----------SETDFMTEYVVT-------RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       189 -----------~~~~~~~~~~~~-------~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                                 ++..|++||+..       ...+..+.|+|++|+++|++++|..|+......  .....+........ 
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~~~~-  290 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--ETYGKIVHYKEHLS-  290 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHHHHCC-
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--HHHHHHHhcccCcC-
Confidence                       345688888775       245678899999999999999999997643211  11112211100001 


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCCccCCC
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKR---ITVEEALNHPYLSSLHEINE  299 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~ell~hp~f~~~~~~~~  299 (339)
                        .......+|+++++||++||+ +|.+|   |+++++++||||+++.|...
T Consensus       291 --~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          291 --LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             --CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             --CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence              111124589999999999999 99998   59999999999999988654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.7e-44  Score=318.99  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=201.8

Q ss_pred             cCccCCCccccccccceEEEEEEeC---CCCceEEEEEeccccc--ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNS---ETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~---~~~~~~avK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      .++|.. ++.||+|+||.||+|++.   .+|+.+|+|++.+...  .......+.+|+.+++.++||||+++++++    
T Consensus        16 ~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----   90 (327)
T 3a62_A           16 PECFEL-LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF----   90 (327)
T ss_dssp             GGGEEE-EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE----
T ss_pred             HHHeEE-EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE----
Confidence            466777 999999999999999985   6899999999976532  223456678999999999999999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                       ...+.+++||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus        91 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           91 -QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             -ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             -EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence             66778999999997 7999999988899999999999999999999999999999999999999999999999999885


Q ss_pred             c-----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          187 T-----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       187 ~-----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                      .           .++..|.+||.........+.|+|++|++++++++|..|+.....  .............        
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~--------  239 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--KKTIDKILKCKLN--------  239 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCC--------
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCCC--------
Confidence            3           244568889988777788899999999999999999999764321  1111222222111        


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      ..+.+++++++||.+||+.||++||     ++.++++||||+.+.+.
T Consensus       240 ~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          240 LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence            1135789999999999999999999     89999999999988753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.5e-44  Score=320.36  Aligned_cols=248  Identities=23%  Similarity=0.371  Sum_probs=192.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      .+.||+|+||.||+|.+..+|+.||+|++.+.     ....+.+|+.+++.+. ||||+++++++     ......++||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~lv~   85 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFLVM   85 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEEEEE
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEEEEE
Confidence            47899999999999999999999999998643     3456778999999996 99999999999     6678899999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC---CeEEeecccccccC-----
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC---DLKICDFGLARTTS-----  189 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~---~ikL~Dfg~~~~~~-----  189 (339)
                      ||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++   .++|+|||++....     
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9997 69999999989999999999999999999999999999999999999998766   79999999986432     


Q ss_pred             ------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccc-cchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          190 ------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR-SDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       190 ------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                            +..|.+||......+..+.|+|++|++++++++|..|+....... ......................+..+++
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ  245 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCH
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCH
Confidence                  345888888877777888999999999999999999986533211 1111222222222222222222345899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ++++||.+||+.||++|||+.++++||||+.....
T Consensus       246 ~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~  280 (325)
T 3kn6_A          246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL  280 (325)
T ss_dssp             HHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred             HHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence            99999999999999999999999999999986554

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.5e-45  Score=324.55  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=205.6

Q ss_pred             EccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeec
Q 042681           25 ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDII  103 (339)
Q Consensus        25 ~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~  103 (339)
                      ...+...+.++|.. .+.||+|+||.||+|.++.+|+.||+|++.+....      ..+|+.++.++ +||||+++++++
T Consensus        13 ~~~~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~   85 (342)
T 2qr7_A           13 LHRNSIQFTDGYEV-KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVY   85 (342)
T ss_dssp             ------CHHHHEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             hcccccCccccEEE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEE
Confidence            33455677888888 99999999999999999999999999999765322      34678888877 799999999999


Q ss_pred             CCCCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC-C---CeE
Q 042681          104 PPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-C---DLK  178 (339)
Q Consensus       104 ~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~-~---~ik  178 (339)
                           .....+++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||++..+ +   .+|
T Consensus        86 -----~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~k  160 (342)
T 2qr7_A           86 -----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIR  160 (342)
T ss_dssp             -----ECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEE
T ss_pred             -----EcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEE
Confidence                 66788999999997 6999999988899999999999999999999999999999999999998543 3   499


Q ss_pred             Eeeccccccc-----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC
Q 042681          179 ICDFGLARTT-----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH  247 (339)
Q Consensus       179 L~Dfg~~~~~-----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  247 (339)
                      |+|||++...           ++..|.+||......+..+.|+|++|+++|++++|..|+..............+...  
T Consensus       161 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--  238 (342)
T 2qr7_A          161 ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--  238 (342)
T ss_dssp             ECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC--
T ss_pred             EEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC--
Confidence            9999998643           234578888877666778899999999999999999998653322221111111111  


Q ss_pred             CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          248 VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       248 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                       ........++.+|+++++||.+||+.||++|||+.++++||||......
T Consensus       239 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  287 (342)
T 2qr7_A          239 -KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL  287 (342)
T ss_dssp             -CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGS
T ss_pred             -CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccc
Confidence             1111122345689999999999999999999999999999999776543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.7e-44  Score=323.58  Aligned_cols=262  Identities=29%  Similarity=0.390  Sum_probs=204.5

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc---C
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK---E  109 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~---~  109 (339)
                      .++|.. ++.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++.....   .
T Consensus        16 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEK-LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEE-EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             ccceeE-EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            367777 999999999999999999999999999997664444445678899999999999999999999843210   1


Q ss_pred             CcCeEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          110 KFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ..+.+++||||++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence            14568999999999998888764 67999999999999999999999999999999999999999999999999998643


Q ss_pred             C---------------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          189 S---------------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       189 ~---------------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      .               +..|.+||.... ..+..+.|+|++|++++++++|..++......  .............+...
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSITPEV  252 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhh
Confidence            2               334788886654 45678899999999999999999987643211  11111111111111111


Q ss_pred             cccc-----CC-------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          253 FSQK-----FP-------------------NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       253 ~~~~-----~~-------------------~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ....     ..                   ..++++++||.+||+.||++|||++|+++||||++...+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            0000     00                   027789999999999999999999999999999876543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-44  Score=325.52  Aligned_cols=251  Identities=21%  Similarity=0.326  Sum_probs=201.8

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHH-HhhCCCCCeeeeeeecCCCCc
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKL-LCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~-l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      ...++|.. ++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|..+ ++.++||||+++++++     
T Consensus        35 ~~~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----  108 (373)
T 2r5t_A           35 AKPSDFHF-LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----  108 (373)
T ss_dssp             CCGGGEEE-EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----
T ss_pred             CChhheEE-EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----
Confidence            34466777 9999999999999999999999999999976533 23345567778777 5678999999999999     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .....+|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+|++||+|||+++.
T Consensus       109 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          109 QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            66778999999997 69999999888999999999999999999999999999999999999999999999999999864


Q ss_pred             -----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          188 -----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       188 -----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                                 .++..|.+||+.....+..+.|+|++|+++|++++|..|+.....  ......+......        .
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~~~~--------~  258 (373)
T 2r5t_A          189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDNILNKPLQ--------L  258 (373)
T ss_dssp             GBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--HHHHHHHHHSCCC--------C
T ss_pred             cccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhcccC--------C
Confidence                       234568899988877888899999999999999999999764321  1112222221111        1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCccC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITV----EEALNHPYLSSLHEI  297 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~----~ell~hp~f~~~~~~  297 (339)
                      .+.++.++++||.+||+.||.+||++    .++++||||+.+.|.
T Consensus       259 ~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          259 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence            14589999999999999999999986    699999999998764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6e-45  Score=340.64  Aligned_cols=252  Identities=29%  Similarity=0.415  Sum_probs=204.6

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .+.++|.. ++.||+|+||.||+|++..++..+|+|++.+..........+.+|+.+++.++||||+++++++     ..
T Consensus        34 ~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~  107 (494)
T 3lij_A           34 HLSEMYQR-VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----ED  107 (494)
T ss_dssp             CHHHHEEE-EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             chhcCeEE-eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ee
Confidence            45567888 9999999999999999999999999999986644444457789999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC---CCeEEeeccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLAR  186 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~---~~ikL~Dfg~~~  186 (339)
                      ...+++||||++ |+|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++.
T Consensus       108 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            788999999997 6999999888899999999999999999999999999999999999999764   459999999986


Q ss_pred             cc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          187 TT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       187 ~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      ..          ++..|.+||+.. ..+..+.|+|++|+++|++++|..|+.....  ............    ......
T Consensus       188 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~----~~~~~~  260 (494)
T 3lij_A          188 VFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEILRKVEKGKY----TFDSPE  260 (494)
T ss_dssp             ECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCC----CCCSGG
T ss_pred             ECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC----CCCchh
Confidence            43          445688888765 3577889999999999999999999765321  111122222111    111223


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      ++.+|+++++||.+||+.||++|||+.++++||||+...
T Consensus       261 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          261 WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence            456899999999999999999999999999999998753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=322.07  Aligned_cols=253  Identities=21%  Similarity=0.264  Sum_probs=204.2

Q ss_pred             cccccC-ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCC--CCeeeeeeecCC
Q 042681           29 LFQVSS-KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH--ENIVKVKDIIPP  105 (339)
Q Consensus        29 ~~~~~~-~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~I~~~~~~~~~  105 (339)
                      .+.+.+ +|.+ ++.||+|+||.||++.+. +++.||+|++..........+.+.+|+.++..++|  |||+++++++  
T Consensus         3 ~i~~~~~~y~i-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~--   78 (343)
T 3dbq_A            3 CISVKGRIYSI-LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE--   78 (343)
T ss_dssp             CEESSSCEEEE-EEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE--
T ss_pred             eeeeecCEEEE-EEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE--
Confidence            334444 4555 999999999999999884 68999999998766666667889999999999976  9999999999  


Q ss_pred             CCcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          106 MDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                         ......++|||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++
T Consensus        79 ---~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           79 ---ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             ---ECSSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             ---eeCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence               6677899999988899999999989999999999999999999999999999999999999997 678999999998


Q ss_pred             ccc-------------CCCCccccccccc-----------cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHH
Q 042681          186 RTT-------------SETDFMTEYVVTR-----------WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRY  241 (339)
Q Consensus       186 ~~~-------------~~~~~~~~~~~~~-----------~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~  241 (339)
                      ...             ++..|.+||....           ..+..+.|+|++|++++++++|..|+......    ....
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~  230 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISKL  230 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----HHHH
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----HHHH
Confidence            543             4556888887643           45667899999999999999999997643211    1111


Q ss_pred             HhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          242 VKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ...........   .....++++.+||.+||+.||.+|||+.++++||||+....
T Consensus       231 ~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          231 HAIIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             HHHHCTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             HHHhcCCcccC---CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            11111111111   11345789999999999999999999999999999986543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.9e-45  Score=341.31  Aligned_cols=253  Identities=29%  Similarity=0.458  Sum_probs=210.3

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .+.++|.+ ++.||+|+||.||+|.+..+++.||+|++.+..........+.+|+.++++++||||+++++++     ..
T Consensus        19 ~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   92 (486)
T 3mwu_A           19 TFAERYNI-VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----ED   92 (486)
T ss_dssp             HHHHHEEE-EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             ChhcceEE-eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----Ec
Confidence            46778888 9999999999999999999999999999976544444567889999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec---cCCCeEEeeccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDFGLAR  186 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~---~~~~ikL~Dfg~~~  186 (339)
                      ...+++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.
T Consensus        93 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            788999999997 69999998888999999999999999999999999999999999999995   45679999999986


Q ss_pred             cc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          187 TT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       187 ~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      ..          +++.|.+||+... .+..+.|+|++|+++|++++|..|+.....  .............    .....
T Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~----~~~~~  245 (486)
T 3mwu_A          173 CFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYA----FDLPQ  245 (486)
T ss_dssp             TBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCC----SCSGG
T ss_pred             ECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC----CCCcc
Confidence            43          3456888887764 467789999999999999999999764321  1111222221111    11223


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      +..+|+++++||.+||+.||++|||+.++++||||+....
T Consensus       246 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            3568999999999999999999999999999999987643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.2e-44  Score=311.02  Aligned_cols=257  Identities=20%  Similarity=0.285  Sum_probs=208.4

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      .+...++|+.+.+.||+|+||.||+|.+..++..+|+|++..........+.+.+|+.+++.++||||+++++++.... 
T Consensus        20 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-   98 (290)
T 1t4h_A           20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-   98 (290)
T ss_dssp             EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-
T ss_pred             hcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-
Confidence            3444555555588899999999999999999999999999877666777788999999999999999999999884322 


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeeec-cCCCeEEeeccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGL  184 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dikp~NIli~-~~~~ikL~Dfg~  184 (339)
                      .....+++||||++ ++|.+++...+.+++..++.++.||+.||.|||+.|  ++||||||+||+++ .++.++|+|||+
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A           99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             CCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            23466899999997 699999998889999999999999999999999999  99999999999998 788999999999


Q ss_pred             cccc---------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          185 ARTT---------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       185 ~~~~---------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                      +...         +...|.+|+.... ....+.|+|++|++++++++|..|+......     ..............  .
T Consensus       179 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~--~  250 (290)
T 1t4h_A          179 ATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGVKPA--S  250 (290)
T ss_dssp             GGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTCCCG--G
T ss_pred             cccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhccCCcc--c
Confidence            8533         4456888887653 4778899999999999999999997543211     11111111111111  1


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      .....++++.+||.+||+.||++|||+.++++||||++-
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            113467899999999999999999999999999999863

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.2e-45  Score=336.20  Aligned_cols=246  Identities=25%  Similarity=0.355  Sum_probs=205.1

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      .++|.. ++.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++     ...
T Consensus        15 ~~~Y~l-~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~   88 (476)
T 2y94_A           15 IGHYIL-GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STP   88 (476)
T ss_dssp             ETTEEE-EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             ecCEEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EEC
Confidence            467777 9999999999999999999999999999975422 122356788999999999999999999999     666


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ..+++||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...  
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            78999999996 799999988889999999999999999999999999999999999999999999999999998653  


Q ss_pred             --------CCCCcccccccccccc-CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          189 --------SETDFMTEYVVTRWDT-LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       189 --------~~~~~~~~~~~~~~~~-~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                              +++.|.+||......+ ..+.|+|++|++++++++|..|+......  ...........  .      ....
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~--~------~p~~  238 (476)
T 2y94_A          169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFKKICDGIF--Y------TPQY  238 (476)
T ss_dssp             TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHHHHHTTCC--C------CCTT
T ss_pred             cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhcCCc--C------CCcc
Confidence                    3445788887765443 56799999999999999999997643211  11122221111  1      1134


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      +++++++||.+||+.||++|||+.++++||||+..
T Consensus       239 ~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          239 LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            78999999999999999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2e-44  Score=338.26  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=209.6

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ..++|.. ++.||+|+||.||+|++..+|+.||+|++.+.. ........+.+|+.++..++||||+++++++     ..
T Consensus       182 ~~~~f~~-~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  255 (576)
T 2acx_A          182 TKNTFRQ-YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET  255 (576)
T ss_dssp             CGGGEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             cccceEE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence            3455666 999999999999999999999999999997542 1223356788999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ...+++||||++ |+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..
T Consensus       256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence            778999999997 79999997754  499999999999999999999999999999999999999999999999999864


Q ss_pred             c----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc-chHHHHHhhCCCCCCCCcccc
Q 042681          188 T----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS-DNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       188 ~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      .          ++..|++||+.....+..+.|+|++|+++|++++|..|+........ ............    .   .
T Consensus       336 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~----~---~  408 (576)
T 2acx_A          336 VPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE----E---Y  408 (576)
T ss_dssp             CCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC----C---C
T ss_pred             cccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc----c---C
Confidence            3          34468889988877788899999999999999999999865432111 111122221111    1   1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      ...+|+++++||.+||+.||++||     ++.|+++||||+++.|.
T Consensus       409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence            145899999999999999999999     89999999999998763

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1e-44  Score=321.83  Aligned_cols=258  Identities=21%  Similarity=0.333  Sum_probs=213.6

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCc
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDK  108 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~  108 (339)
                      -.+.++|.+..+.||+|+||.||+|.+..+|+.||+|++............+.+|+.++..+. ||||+++++++     
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----   98 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----   98 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----
Confidence            345677777348999999999999999999999999999876555555678899999999994 79999999999     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc---CCCeEEeec
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDF  182 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~---~~~ikL~Df  182 (339)
                      ......++||||+. |+|.+++...  +.+++..++.++.||+.||.|||++|++||||||+||+++.   ++.++|+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            66778999999998 6998888553  67999999999999999999999999999999999999987   789999999


Q ss_pred             cccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          183 GLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       183 g~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      |++...          ++..|.+||......+..+.|+|++|++++++++|..|+......  ............    .
T Consensus       179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~----~  252 (327)
T 3lm5_A          179 GMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--ETYLNISQVNVD----Y  252 (327)
T ss_dssp             GGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC----C
T ss_pred             ccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHHHhcccc----c
Confidence            998653          344688888887777888999999999999999999987543211  111112221111    1


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      ....+..+++.+++||.+||+.||++|||++++++||||+.+.+..
T Consensus       253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          253 SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence            1223356899999999999999999999999999999999887643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.6e-44  Score=333.58  Aligned_cols=248  Identities=20%  Similarity=0.305  Sum_probs=201.2

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.. ++.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++     ...+
T Consensus       148 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-----~~~~  221 (446)
T 4ejn_A          148 NEFEY-LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHD  221 (446)
T ss_dssp             GGEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-----EETT
T ss_pred             HHcEE-eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-----eeCC
Confidence            56776 999999999999999999999999999997542 2333456778999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      .+++||||++ |+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+||+++.++.+||+|||+++..  
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            8999999998 6999999888899999999999999999999998 99999999999999999999999999998642  


Q ss_pred             ---------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          189 ---------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       189 ---------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                               ++..|++||......+..+.|+|++|++++++++|..|+......  .............        ...
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~~~~--------p~~  371 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMEEIRF--------PRT  371 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCC--------CTT
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHHhCCCCC--------Ccc
Confidence                     345688899887778888999999999999999999997643211  1112222211111        135


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          260 MSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      +++++++||.+||+.||++||     ++.++++||||+++.+.
T Consensus       372 ~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence            789999999999999999999     99999999999998764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.4e-44  Score=320.03  Aligned_cols=265  Identities=29%  Similarity=0.465  Sum_probs=209.5

Q ss_pred             EEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeee
Q 042681           22 QYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD  101 (339)
Q Consensus        22 ~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~  101 (339)
                      ++....-.+..-++|.. ++.||+|+||.||+|++..+|+.||+|++..........+.+.+|+.+++.++||||+++++
T Consensus        13 ~~~~~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   91 (331)
T 4aaa_A           13 DLGTENLYFQSMEKYEN-LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE   91 (331)
T ss_dssp             ------CCCBCGGGEEE-EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccchhhhhhhhhhee-eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence            34444455666788888 99999999999999999999999999999776666666677889999999999999999999


Q ss_pred             ecCCCCcCCcCeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEe
Q 042681          102 IIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC  180 (339)
Q Consensus       102 ~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~  180 (339)
                      ++     ......++||||+++ +|.++....+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+
T Consensus        92 ~~-----~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~  166 (331)
T 4aaa_A           92 VC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLC  166 (331)
T ss_dssp             EE-----EETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             Ee-----ecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEE
Confidence            99     667889999999995 566666667889999999999999999999999999999999999999999999999


Q ss_pred             eccccccc-----------CCCCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHh-----
Q 042681          181 DFGLARTT-----------SETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK-----  243 (339)
Q Consensus       181 Dfg~~~~~-----------~~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~-----  243 (339)
                      |||.+...           +...|.+||..... ....+.|+|++|++++++++|..|+.......  .......     
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~  244 (331)
T 4aaa_A          167 DFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNL  244 (331)
T ss_dssp             CCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSC
T ss_pred             eCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCC
Confidence            99998643           33457888876543 56778999999999999999998876433211  1111100     


Q ss_pred             ---------hCC-----C----CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          244 ---------QLP-----H----VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       244 ---------~~~-----~----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                               ...     .    ..........+.+++++.+||.+||+.||++|||+.|+++||||+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                     000     0    01111122335689999999999999999999999999999999765

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.5e-44  Score=313.76  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=195.5

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. ++.||+|+||.||+|.+..+|+.||+|++..........+.+.++...++.++||||+++++++     ...+
T Consensus         6 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----~~~~   79 (290)
T 3fme_A            6 ADDLEP-IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL-----FREG   79 (290)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             HHhhhh-HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee-----eccC
Confidence            355666 9999999999999999999999999999976544444444455566668888999999999999     5667


Q ss_pred             eEEEEEecCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          113 DVYIVYELMDTDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       113 ~~~iv~e~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ..++||||++|+|.+++..    ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.++|+|||.+..
T Consensus        80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            8999999999998777653    57899999999999999999999998 999999999999999999999999999864


Q ss_pred             ----------cCCCCccccccc----cccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          188 ----------TSETDFMTEYVV----TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       188 ----------~~~~~~~~~~~~----~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                                .++..|.+||..    .......+.|+|++|++++++++|..|+......... ......... .. .  
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~-~~-~--  234 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-LKQVVEEPS-PQ-L--  234 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-HHHHHHSCC-CC-C--
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-HHHHhccCC-CC-c--
Confidence                      344568888874    4445677899999999999999999997643322111 111111111 11 1  


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                        ....+++++.+||.+||+.||++|||+.++++||||+....
T Consensus       235 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~  275 (290)
T 3fme_A          235 --PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES  275 (290)
T ss_dssp             --CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             --ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence              11357999999999999999999999999999999986544

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-44  Score=317.99  Aligned_cols=259  Identities=30%  Similarity=0.435  Sum_probs=200.6

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh---HhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR---IDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      ..++|.. ++.||+|+||.||+|.+..+|+.||+|++.......   .....+.+|+.+++.++||||+++++++     
T Consensus         8 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----   81 (346)
T 1ua2_A            8 RAKRYEK-LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----   81 (346)
T ss_dssp             -----CE-EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HhcccEE-EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----
Confidence            3567777 999999999999999999999999999987542221   1124678999999999999999999999     


Q ss_pred             CCcCeEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          109 EKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       109 ~~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ......++||||++++|.+.+... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus        82 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           82 GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             eeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            566788999999999999988764 4799999999999999999999999999999999999999999999999999865


Q ss_pred             cC-----------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCC------
Q 042681          188 TS-----------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVP------  249 (339)
Q Consensus       188 ~~-----------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~------  249 (339)
                      ..           +..|.+||.... ..+..+.|+|++|++++++++|.+++......  ..............      
T Consensus       162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSSS
T ss_pred             ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCCCChhhhhh
Confidence            42           334788887643 34567789999999999999999886543211  11122222111110      


Q ss_pred             --------------CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          250 --------------KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       250 --------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                                    ..+....+..+++++++||.+||+.||++|||+.|+++||||++...+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence                          0111112356789999999999999999999999999999999876654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.5e-45  Score=322.83  Aligned_cols=242  Identities=24%  Similarity=0.348  Sum_probs=204.1

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh------HhHHHHHHHHHHHhhCCCCCeeeeeeecCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR------IDAKRILREIKLLCHMTHENIVKVKDIIPP  105 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~  105 (339)
                      +.++|.. ++.||+|+||.||+|++..+++.||+|++.......      .....+.+|+.+++.++||||+++++++  
T Consensus        22 ~~~~y~~-~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~--   98 (335)
T 3dls_A           22 YSQKYST-MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--   98 (335)
T ss_dssp             HHHHEEE-EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE--
T ss_pred             cccceEE-EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence            4567777 999999999999999999999999999997653221      1334577899999999999999999999  


Q ss_pred             CCcCCcCeEEEEEecCc-c-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          106 MDKEKFNDVYIVYELMD-T-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~-g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                         ...+..++||||++ | +|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus        99 ---~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A           99 ---ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             ---ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             ---eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence               67788999999986 5 999999998899999999999999999999999999999999999999999999999999


Q ss_pred             ccccc----------CCCCcccccccccccc-CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          184 LARTT----------SETDFMTEYVVTRWDT-LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       184 ~~~~~----------~~~~~~~~~~~~~~~~-~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      ++...          ++..|.+||....... ..+.|+|++|++++++++|..|+......           ......  
T Consensus       176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~~~~~~--  242 (335)
T 3dls_A          176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------VEAAIH--  242 (335)
T ss_dssp             TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------TTTCCC--
T ss_pred             cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------HhhccC--
Confidence            98654          3446788887765554 56789999999999999999997643211           011111  


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                         ....+++++++||.+||+.||++|||+.++++||||+...
T Consensus       243 ---~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          243 ---PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             ---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             ---CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence               1134799999999999999999999999999999998753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.8e-44  Score=338.23  Aligned_cols=253  Identities=28%  Similarity=0.400  Sum_probs=206.6

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh-----------HhHHHHHHHHHHHhhCCCCCeeee
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR-----------IDAKRILREIKLLCHMTHENIVKV   99 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~I~~~   99 (339)
                      .+.++|.. ++.||+|+||.||+|.+..+++.+|+|++.+.....           ...+.+.+|+.+++.++||||+++
T Consensus        33 ~i~~~Y~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           33 KIGESYFK-VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             CGGGTEEE-EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CcccceEE-EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            46788888 999999999999999999999999999997653221           235678899999999999999999


Q ss_pred             eeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC---
Q 042681          100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC---  175 (339)
Q Consensus       100 ~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~---  175 (339)
                      ++++     .....+++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++   
T Consensus       112 ~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          112 FDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEE-----ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred             EEEE-----EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence            9999     67788999999997 69999998889999999999999999999999999999999999999998776   


Q ss_pred             CeEEeeccccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhC
Q 042681          176 DLKICDFGLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL  245 (339)
Q Consensus       176 ~ikL~Dfg~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~  245 (339)
                      .+||+|||++...          +++.|.+||+... .+..+.|+|++|+++|++++|..|+......  ......... 
T Consensus       187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~-  262 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEKG-  262 (504)
T ss_dssp             SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC-
T ss_pred             cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC-
Confidence            6999999998643          3456888887663 5778899999999999999999997643211  111111111 


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       246 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                         ........++.+|+++++||.+||+.||++|||+.|+++||||+....
T Consensus       263 ---~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          263 ---KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             ---CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             ---CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence               111112233568999999999999999999999999999999987644

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.5e-44  Score=321.03  Aligned_cols=249  Identities=21%  Similarity=0.353  Sum_probs=197.3

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc----
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK----  108 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~----  108 (339)
                      .++|.. ++.||+|+||.||+|++..+|+.||+|++.... .....+.+.+|+.++++++||||+++++++.....    
T Consensus         5 ~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEP-IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEE-EEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCce-eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            356666 899999999999999999999999999997543 33456789999999999999999999998743211    


Q ss_pred             ------------------------------------------------CCcCeEEEEEecCc-ccHHHHHHhcC---CCC
Q 042681          109 ------------------------------------------------EKFNDVYIVYELMD-TDLHQIIRSKQ---ALT  136 (339)
Q Consensus       109 ------------------------------------------------~~~~~~~iv~e~~~-g~L~~~l~~~~---~~~  136 (339)
                                                                      ......++||||++ ++|.+++....   ..+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                            11224899999998 69999998754   356


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-----------------------CCCCc
Q 042681          137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-----------------------SETDF  193 (339)
Q Consensus       137 ~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-----------------------~~~~~  193 (339)
                      +..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++...                       ++..|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            6678999999999999999999999999999999999999999999998653                       34457


Q ss_pred             cccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcc
Q 042681          194 MTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLV  273 (339)
Q Consensus       194 ~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  273 (339)
                      .+||......+..+.|+|++|++++++++|..+...     ..   ...........   .......++++++||.+||+
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~---~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~  311 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RV---RIITDVRNLKF---PLLFTQKYPQEHMMVQDMLS  311 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HH---HHHHHHHTTCC---CHHHHHHCHHHHHHHHHHHC
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HH---HHHHHhhccCC---CcccccCChhHHHHHHHHcc
Confidence            888888777788899999999999999998665211     11   11111111111   11123457889999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCC
Q 042681          274 FDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       274 ~dP~~Rps~~ell~hp~f~~~  294 (339)
                      .||++|||+.++++||||+++
T Consensus       312 ~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          312 PSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             SSGGGSCCHHHHHHSTTCCCC
T ss_pred             CCCCcCCCHHHHhhchhhhcC
Confidence            999999999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5e-44  Score=311.30  Aligned_cols=248  Identities=26%  Similarity=0.439  Sum_probs=201.8

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ++.++|.. .+.||+|+||.||+|.+..+++.+|+|++..... ....+.+.+|+.+++.++||||+++++++     ..
T Consensus        19 ~i~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~   91 (285)
T 3is5_A           19 TIDDLFIF-KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----ED   91 (285)
T ss_dssp             CHHHHEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             Chhhheee-cceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHhe-----ec
Confidence            45677877 9999999999999999999999999999876532 23457789999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee---ccCCCeEEeec
Q 042681          111 FNDVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDF  182 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli---~~~~~ikL~Df  182 (339)
                      ....++||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++|++||||||+||++   +.++.++|+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            778999999998 699988854    3789999999999999999999999999999999999999   45678999999


Q ss_pred             cccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          183 GLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       183 g~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      |.+...          +...|.+||... .....+.|+|++|++++++++|..|+......   ............    
T Consensus       172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~----  243 (285)
T 3is5_A          172 GLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQKATYKEPN----  243 (285)
T ss_dssp             CCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCC----
T ss_pred             ecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHhhhccCCcc----
Confidence            998643          234577888765 35677899999999999999999997653211   111111111111    


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                      .......+++++++||.+||+.||++|||+.|+++||||+.
T Consensus       244 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          244 YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            11112347899999999999999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.3e-45  Score=339.45  Aligned_cols=255  Identities=26%  Similarity=0.420  Sum_probs=211.7

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      -.+.++|.. .+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.++++++||||+++++++     
T Consensus        22 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----   95 (484)
T 3nyv_A           22 AIFSDRYKG-QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----   95 (484)
T ss_dssp             CCHHHHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             CcccCceEE-eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            456778888 9999999999999999999999999999976532 234567889999999999999999999999     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee---ccCCCeEEeeccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGL  184 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli---~~~~~ikL~Dfg~  184 (339)
                      ...+..++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||+
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A           96 EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            66788999999997 7999999998999999999999999999999999999999999999999   4678999999999


Q ss_pred             cccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          185 ARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       185 ~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      +...          +++.|.+||.... .+..+.|+|++|+++|++++|.+|+......  .............    ..
T Consensus       176 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~----~~  248 (484)
T 3nyv_A          176 STHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVEKGKYTF----EL  248 (484)
T ss_dssp             HHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCC----CS
T ss_pred             eEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCCC----CC
Confidence            8643          3456888887655 5778899999999999999999997653211  1112222211111    11


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ..+..+|+++++||.+||+.||++|||+.++++||||+.....
T Consensus       249 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE  291 (484)
T ss_dssp             GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence            2335689999999999999999999999999999999876553

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=315.60  Aligned_cols=247  Identities=26%  Similarity=0.452  Sum_probs=194.3

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh------------------------HhHHHHHHHHHHH
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR------------------------IDAKRILREIKLL   88 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~------------------------~~~~~~~~e~~~l   88 (339)
                      .++|.. .+.||+|+||.||+|.+..+++.||+|++.......                        ...+.+.+|+.++
T Consensus        12 ~~~y~~-~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           12 LNQYTL-KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             ETTEEE-EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             ecceEE-EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            467777 999999999999999999999999999997543211                        1235688999999


Q ss_pred             hhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 042681           89 CHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPS  167 (339)
Q Consensus        89 ~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~  167 (339)
                      +.++||||+++++++..   .....+++||||++ ++|.+++ ..+++++..++.++.||+.||.|||++|++||||||+
T Consensus        91 ~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  166 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS  166 (298)
T ss_dssp             HTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence            99999999999999843   23567999999998 5776643 4468999999999999999999999999999999999


Q ss_pred             CeeeccCCCeEEeeccccccc-----------CCCCccccccccccc---cCCCCccHHHHHHHHHHHhCCCCCCccccc
Q 042681          168 NLLLNANCDLKICDFGLARTT-----------SETDFMTEYVVTRWD---TLFPGKDYVQQLTMITELLGSPDDSDLGFL  233 (339)
Q Consensus       168 NIli~~~~~ikL~Dfg~~~~~-----------~~~~~~~~~~~~~~~---~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~  233 (339)
                      ||+++.++.+||+|||++...           ++..|.+||......   ...+.|+|++|++++++++|..|+......
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            999999999999999998653           234577888765443   255679999999999999999997643211


Q ss_pred             ccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                        .............+      ..+.+++++++||.+||+.||++|||+.|+++||||+
T Consensus       247 --~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          247 --CLHSKIKSQALEFP------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             --HHHHHHHHCCCCCC------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             --HHHHHHhcccCCCC------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence              11111111111111      1246899999999999999999999999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.7e-44  Score=311.96  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=207.1

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.. ++.||+|+||.||+|.+..+++.+|+|++..... .......+.+|+.++..++||||+++++++     ....
T Consensus         9 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   82 (279)
T 3fdn_A            9 EDFEI-GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT   82 (279)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccEEE-eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecCC
Confidence            56666 9999999999999999999999999999865422 222346788999999999999999999999     6667


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      ..++||||++ ++|.+.+.....+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+...   
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            8999999998 699999988889999999999999999999999999999999999999999999999999987543   


Q ss_pred             ------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          189 ------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       189 ------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                            +...|.+|+.........+.|+|++|++++++++|..|+......  .............        ...+++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~--------~~~~~~  232 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISRVEFTF--------PDFVTE  232 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCCC--------CTTSCH
T ss_pred             cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHHHHhCCCCC--------CCcCCH
Confidence                  345688898887777888999999999999999999997643211  1111111111111        134789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ++++||.+||+.||++|||+.++++||||+....
T Consensus       233 ~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          233 GARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             HHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence            9999999999999999999999999999987654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-43  Score=312.18  Aligned_cols=273  Identities=22%  Similarity=0.317  Sum_probs=203.0

Q ss_pred             ccccCCCccccCCceEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHH
Q 042681            6 MVMKDRGIPLYGGKYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREI   85 (339)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~   85 (339)
                      -.|+|++++..++..++-.+.+..+.++...+.+.+.||+|+||.||+|++  +|+.+|+|++..........+.+.+|+
T Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~   85 (309)
T 3p86_A            8 HPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREV   85 (309)
T ss_dssp             ------------------------CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHH
T ss_pred             CCccccCCCCcccceeccCCCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHH
Confidence            368899999999998888899999998876666699999999999999987  578999999987766666678899999


Q ss_pred             HHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--c
Q 042681           86 KLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQA---LTDDHCQYFLYQLLRGLKYIHSAN--V  159 (339)
Q Consensus        86 ~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~g--i  159 (339)
                      .++++++||||+++++++     ......++||||++ |+|.+++...+.   +++..++.++.|++.||+|||++|  +
T Consensus        86 ~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~i  160 (309)
T 3p86_A           86 AIMKRLRHPNIVLFMGAV-----TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI  160 (309)
T ss_dssp             HHHHHCCCTTBCCEEEEE-----CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred             HHHHhCCCCCEeeEEEEE-----EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCE
Confidence            999999999999999999     66677899999997 699999987543   999999999999999999999999  9


Q ss_pred             ccCCCCCCCeeeccCCCeEEeecccccc-----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCC
Q 042681          160 LHRDLKPSNLLLNANCDLKICDFGLART-----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDS  228 (339)
Q Consensus       160 vH~dikp~NIli~~~~~ikL~Dfg~~~~-----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~  228 (339)
                      +||||||+||+++.++.+||+|||+++.           .++..|.+||.........+.|+|++|++++++++|..|+.
T Consensus       161 vH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~  240 (309)
T 3p86_A          161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG  240 (309)
T ss_dssp             CCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred             ECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999999853           23456889998887778889999999999999999999976


Q ss_pred             cccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q 042681          229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN--HPYLSS  293 (339)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~~  293 (339)
                      .....  ..............      ....+++++.+||.+||+.||.+|||+.++++  .++++.
T Consensus       241 ~~~~~--~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          241 NLNPA--QVVAAVGFKCKRLE------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             TSCHH--HHHHHHHHSCCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCCHH--HHHHHHHhcCCCCC------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            43211  11111111111111      11468999999999999999999999999997  455443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.8e-44  Score=310.73  Aligned_cols=251  Identities=28%  Similarity=0.411  Sum_probs=207.2

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .+.++|.. .+.||+|+||.||++.+..++..+|+|++......  ..+.+.+|+.+++.++||||+++++++     ..
T Consensus         6 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~   77 (277)
T 3f3z_A            6 DINQYYTL-ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETF-----ED   77 (277)
T ss_dssp             CHHHHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             hhhhhEEe-eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEE-----ec
Confidence            45667777 99999999999999999999999999998765332  356788999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee---ccCCCeEEeeccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR  186 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli---~~~~~ikL~Dfg~~~  186 (339)
                      ....++||||++ ++|.+.+...+.+++..++.++.|++.||+|||++|++||||||+||++   +.++.++|+|||.+.
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           78 NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             CCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            778999999997 6999999888899999999999999999999999999999999999999   788899999999986


Q ss_pred             cc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          187 TT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       187 ~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      ..          ++..|.+||..... ...+.|+|++|++++++++|..|+.....  ............    ......
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~----~~~~~~  230 (277)
T 3f3z_A          158 RFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--SEVMLKIREGTF----TFPEKD  230 (277)
T ss_dssp             ECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC----CCCHHH
T ss_pred             eccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCC----CCCchh
Confidence            43          33457788876543 77889999999999999999999764321  111111111111    111112


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      +..+++++.+||.+||+.||++|||+.++++||||+....
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          231 WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence            2358999999999999999999999999999999976543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.7e-45  Score=333.00  Aligned_cols=249  Identities=16%  Similarity=0.155  Sum_probs=195.6

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHH---HHhhCCCCCeeeee-------e
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIK---LLCHMTHENIVKVK-------D  101 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~---~l~~l~h~~I~~~~-------~  101 (339)
                      .++|.. .+.||+|+||.||+|.+..+|+.||+|++... .......+.+.+|+.   .+..++||||++++       +
T Consensus        72 ~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           72 PRTLVR-GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CEEEEE-EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CceEEE-cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            355666 99999999999999999999999999999754 233445678889995   55555799999998       4


Q ss_pred             ecCCCCc-------CCcC-----eEEEEEecCcccHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCcccC
Q 042681          102 IIPPMDK-------EKFN-----DVYIVYELMDTDLHQIIRSKQALTD-------DHCQYFLYQLLRGLKYIHSANVLHR  162 (339)
Q Consensus       102 ~~~~~~~-------~~~~-----~~~iv~e~~~g~L~~~l~~~~~~~~-------~~~~~i~~qi~~aL~~LH~~givH~  162 (339)
                      ++.....       ....     ..+++|||++|+|.+++...+.+++       ..++.++.||+.||+|||++||+||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            4421100       0011     3789999999999999987655665       7888899999999999999999999


Q ss_pred             CCCCCCeeeccCCCeEEeecccccccCC-------CCcccccccccc-----------ccCCCCccHHHHHHHHHHHhCC
Q 042681          163 DLKPSNLLLNANCDLKICDFGLARTTSE-------TDFMTEYVVTRW-----------DTLFPGKDYVQQLTMITELLGS  224 (339)
Q Consensus       163 dikp~NIli~~~~~ikL~Dfg~~~~~~~-------~~~~~~~~~~~~-----------~~~~~~d~~~~g~~~~~~l~g~  224 (339)
                      ||||+||+++.++.+||+|||+++..+.       ..|.+||.....           .+..+.|+|++|++++++++|.
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~  310 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD  310 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence            9999999999999999999999864322       678899988766           7788999999999999999999


Q ss_pred             CCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          225 PDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      .|+........              ........+.+++++++||.+||+.||++|||+.++++||||+.+..
T Consensus       311 ~Pf~~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          311 LPITKDAALGG--------------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             CCC------CC--------------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred             CCCcccccccc--------------hhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence            99754321110              00111122568999999999999999999999999999999987654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.6e-44  Score=321.77  Aligned_cols=257  Identities=19%  Similarity=0.314  Sum_probs=206.6

Q ss_pred             EccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-----CCCeeee
Q 042681           25 ILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-----HENIVKV   99 (339)
Q Consensus        25 ~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~I~~~   99 (339)
                      .......+.++|.. ++.||+|+||.||+|++..+++.||+|++...   ......+..|+.+++.++     ||||+++
T Consensus        26 ~~~~g~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           26 SWKKGMLLNNAFLV-IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             CCCTTCEETTTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeecceEecCEEEE-EEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            35566677889988 99999999999999999999999999998643   334466778999999986     9999999


Q ss_pred             eeecCCCCcCCcCeEEEEEecCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc----
Q 042681          100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA----  173 (339)
Q Consensus       100 ~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~----  173 (339)
                      ++++     ......++||||++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+||+++.    
T Consensus       102 ~~~~-----~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          102 HGKF-----MYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEE-----EETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred             ccee-----eECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence            9999     6667899999999999999998754  5999999999999999999999999999999999999975    


Q ss_pred             ---------------------CCCeEEeeccccccc--------CCCCccccccccccccCCCCccHHHHHHHHHHHhCC
Q 042681          174 ---------------------NCDLKICDFGLARTT--------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGS  224 (339)
Q Consensus       174 ---------------------~~~ikL~Dfg~~~~~--------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~  224 (339)
                                           ++.+||+|||++...        ++..|.+||......+..+.|+|++|++++++++|.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  256 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS  256 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence                                 789999999998643        344688999888878889999999999999999999


Q ss_pred             CCCCcccccccchHHHHHhhCCCCCC-----------------CCccccC---------------------CCCCHHHHH
Q 042681          225 PDDSDLGFLRSDNARRYVKQLPHVPK-----------------QPFSQKF---------------------PNMSPVAID  266 (339)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~---------------------~~~s~~~~~  266 (339)
                      .|+......  .............+.                 ......+                     ...++.+.+
T Consensus       257 ~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  334 (360)
T 3llt_A          257 LLFRTHEHM--EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD  334 (360)
T ss_dssp             CSCCCSSHH--HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred             CCCCCCcHH--HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence            997643211  111111111111000                 0000000                     113477889


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          267 LAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       267 li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                      ||.+||+.||++|||+.|+|+||||+
T Consensus       335 li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          335 FLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHhcCChhhCCCHHHHhcCcccC
Confidence            99999999999999999999999996

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.9e-44  Score=315.63  Aligned_cols=265  Identities=39%  Similarity=0.614  Sum_probs=204.9

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC-
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD-  107 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-  107 (339)
                      .+.+.++|.. ++.||+|+||.||+|.+..+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++.... 
T Consensus         6 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            6 GFDLGSRYMD-LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             CEEETTTEEE-EEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             cCccCCceeE-EEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            4567788888 99999999999999999999999999998643  4455678899999999999999999999874321 


Q ss_pred             --------cCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec-cCCCeE
Q 042681          108 --------KEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN-ANCDLK  178 (339)
Q Consensus       108 --------~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~-~~~~ik  178 (339)
                              .......++||||++|+|.+++.+ +++++..++.++.|++.||+|||++|++||||||+||+++ .++.+|
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence                    123467899999999999998865 6799999999999999999999999999999999999997 567899


Q ss_pred             EeecccccccC--------------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHh
Q 042681          179 ICDFGLARTTS--------------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK  243 (339)
Q Consensus       179 L~Dfg~~~~~~--------------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~  243 (339)
                      |+|||.+....              ...|.+|+.... .....+.|+|++|++++++++|..|+......  ........
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~  239 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILE  239 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence            99999987542              334777776543 45677889999999999999999997654321  11111111


Q ss_pred             hC----------------------CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCC
Q 042681          244 QL----------------------PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE  299 (339)
Q Consensus       244 ~~----------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~  299 (339)
                      ..                      ...+..+.....+.+++++++||.+||+.||++|||+.++++||||+....+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~  317 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD  317 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence            11                      111122222334568999999999999999999999999999999998876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.8e-44  Score=313.66  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=210.5

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh----HhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR----IDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      +.++|.. ++.||+|+||.||++.+..+|+.+|+|++.......    ...+.+.+|+.+++.++||||+++++++    
T Consensus         3 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----   77 (283)
T 3bhy_A            3 VEDHYEM-GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF----   77 (283)
T ss_dssp             HHHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             hhhhhhh-HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee----
Confidence            3456777 999999999999999999999999999987653221    2357789999999999999999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC----CeEEeec
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC----DLKICDF  182 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~----~ikL~Df  182 (339)
                       ......++||||++ ++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++    .++|+||
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           78 -ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             -cCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEec
Confidence             66678999999997 79999998888999999999999999999999999999999999999998877    8999999


Q ss_pred             cccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          183 GLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       183 g~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      |.+...          +...|.+||.........+.|+|++|++++++++|..|+......  ........    .....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~----~~~~~  230 (283)
T 3bhy_A          157 GIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLTNISA----VNYDF  230 (283)
T ss_dssp             TTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHT----TCCCC
T ss_pred             ccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHHHhHh----cccCC
Confidence            998654          334588888877777788899999999999999999987543211  11111111    11111


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      .....+.+++.+++||.+||+.||++|||+.++++||||+.+....
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          231 DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            1222356889999999999999999999999999999999886653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.3e-43  Score=308.71  Aligned_cols=246  Identities=23%  Similarity=0.344  Sum_probs=200.7

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~  109 (339)
                      .+.++|.. ++.||+|+||.||+|.+..+++.+|+|++............+.+|+..+..+ +||||+++++++     .
T Consensus         8 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-----~   81 (289)
T 1x8b_A            8 RYTTEFHE-LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----A   81 (289)
T ss_dssp             HHHHHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-----E
T ss_pred             cccchhhh-hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-----e
Confidence            34567777 9999999999999999999999999999987655666677889999999999 899999999999     6


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC----------
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK----QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN----------  174 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~----------  174 (339)
                      .....++||||++ ++|.+++...    ..+++..++.++.||+.||.|||++|++||||||+||+++.+          
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred             cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence            6778999999997 5999999764    679999999999999999999999999999999999999844          


Q ss_pred             ---------CCeEEeecccccccC-------CCCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccch
Q 042681          175 ---------CDLKICDFGLARTTS-------ETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN  237 (339)
Q Consensus       175 ---------~~ikL~Dfg~~~~~~-------~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~  237 (339)
                               ..++|+|||.+....       +..|.+||..... ....+.|+|++|++++++++|.+++...     ..
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~  236 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----DQ  236 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----HH
T ss_pred             ccccccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----hH
Confidence                     479999999987543       3457788876544 4446899999999999999988764322     11


Q ss_pred             HHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          238 ARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      .......  ..+     .....+++++++||.+||+.||++|||+.++++||||.+.
T Consensus       237 ~~~~~~~--~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 WHEIRQG--RLP-----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHHTT--CCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHHcC--CCC-----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            1111111  111     1124589999999999999999999999999999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.8e-43  Score=313.55  Aligned_cols=267  Identities=27%  Similarity=0.430  Sum_probs=208.6

Q ss_pred             ccccCccCCCccccccccceEEEEEEeC-CCCceEEEEEecccccChHhHHHHHHHHHHHhhC---CCCCeeeeeeecCC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNS-ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM---THENIVKVKDIIPP  105 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~I~~~~~~~~~  105 (339)
                      ....++|.. ++.||+|+||.||+|++. .+|+.||+|++............+.+|+.+++.+   +||||+++++++..
T Consensus         7 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            7 CRADQQYEC-VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             CCGGGTEEE-EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             cCchhceee-eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            344567777 999999999999999995 6789999999875533322223455677666655   89999999999842


Q ss_pred             CCcCCcCeEEEEEecCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          106 MDKEKFNDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                      .........++||||++|+|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence            211256779999999999999999764  349999999999999999999999999999999999999999999999999


Q ss_pred             cccccC----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhC--------
Q 042681          184 LARTTS----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL--------  245 (339)
Q Consensus       184 ~~~~~~----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~--------  245 (339)
                      .+....          ...|.+||.........+.|+|++|++++++++|..|+......  ..........        
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          166 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCGGGS
T ss_pred             ccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCcccC
Confidence            986432          34578888877777888899999999999999999987643221  1111111110        


Q ss_pred             -----------CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCC
Q 042681          246 -----------PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE  299 (339)
Q Consensus       246 -----------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~  299 (339)
                                 ............+.+++.+++||.+||+.||++|||+.++++||||+.+.+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~  308 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE  308 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence                       011111222334568999999999999999999999999999999999877543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-44  Score=324.02  Aligned_cols=260  Identities=24%  Similarity=0.393  Sum_probs=208.6

Q ss_pred             ccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc---cChHhHHHHHHHHHHHhhCCCCCeeeeeee
Q 042681           26 LGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF---DNRIDAKRILREIKLLCHMTHENIVKVKDI  102 (339)
Q Consensus        26 ~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~  102 (339)
                      .|....+.++|.. ++.||+|+||.||+|.+..+++.+|+|++.+..   ......+.+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   96 (345)
T 3hko_A           18 GGSLLELQKKYHL-KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV   96 (345)
T ss_dssp             CBCHHHHHHHEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             Cchhhhhhhheee-cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence            3556678888988 999999999999999999999999999986542   133456789999999999999999999999


Q ss_pred             cCCCCcCCcCeEEEEEecCc-ccHHHHHHh----------------------------------------cCCCCHHHHH
Q 042681          103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRS----------------------------------------KQALTDDHCQ  141 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----------------------------------------~~~~~~~~~~  141 (339)
                      +     ......++||||++ |+|.+++..                                        ...+++..++
T Consensus        97 ~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (345)
T 3hko_A           97 Y-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS  171 (345)
T ss_dssp             E-----ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred             h-----ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence            9     66778999999997 799988842                                        1124678899


Q ss_pred             HHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC--CeEEeeccccccc---------------CCCCccccccccc--c
Q 042681          142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARTT---------------SETDFMTEYVVTR--W  202 (339)
Q Consensus       142 ~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~--~ikL~Dfg~~~~~---------------~~~~~~~~~~~~~--~  202 (339)
                      .++.||+.||.|||++|++||||||+||+++.++  .++|+|||.+...               +...|.+||....  .
T Consensus       172 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  251 (345)
T 3hko_A          172 NIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE  251 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred             HHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence            9999999999999999999999999999998776  8999999998643               2335788887643  4


Q ss_pred             ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 042681          203 DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITV  282 (339)
Q Consensus       203 ~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  282 (339)
                      .+..+.|+|++|++++++++|..|+......  ...............    ..+..+++++++||.+||+.||.+|||+
T Consensus       252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA--DTISQVLNKKLCFEN----PNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCTTS----GGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcccccCC----cccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            5677899999999999999999997644321  122222222211111    1223478999999999999999999999


Q ss_pred             HHHhcCCCCCCCccC
Q 042681          283 EEALNHPYLSSLHEI  297 (339)
Q Consensus       283 ~ell~hp~f~~~~~~  297 (339)
                      .++++||||+...+.
T Consensus       326 ~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          326 MRALQHPWISQFSDK  340 (345)
T ss_dssp             HHHHHSHHHHTTSSC
T ss_pred             HHHhcChhhccChHh
Confidence            999999999988654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.3e-43  Score=308.50  Aligned_cols=251  Identities=27%  Similarity=0.421  Sum_probs=210.3

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ..++|.. .+.||+|+||.||+|.+..+++.+|+|++.... ......+.+.+|+.+++.++||||+++++++     ..
T Consensus        13 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~   86 (294)
T 2rku_A           13 SRRRYVR-GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----ED   86 (294)
T ss_dssp             TTEEEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             cccceEE-EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----cc
Confidence            3456666 999999999999999999999999999987653 3344567788999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-  188 (339)
                      .+..++||||++ ++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+... 
T Consensus        87 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            778999999998 799999988889999999999999999999999999999999999999999999999999998653 


Q ss_pred             ----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          189 ----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       189 ----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                +...|.+||.........+.|+|++|++++++++|..|+......  ........  ....      ...
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~--~~~~------~~~  236 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLRIKK--NEYS------IPK  236 (294)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHT--TCCC------CCT
T ss_pred             cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhh--ccCC------Ccc
Confidence                      233578888877777788999999999999999999987643211  11111111  1111      113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      .+++.+.+||.+||+.||++|||+.++++||||.+...+.
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             ccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence            5789999999999999999999999999999998776544

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.9e-44  Score=333.04  Aligned_cols=251  Identities=23%  Similarity=0.342  Sum_probs=208.3

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      .++|.. ++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++     ...
T Consensus       184 ~~~f~~-~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~  257 (543)
T 3c4z_A          184 EDWFLD-FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETK  257 (543)
T ss_dssp             GGGEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             hhheEE-EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeC
Confidence            355666 8999999999999999999999999999975422 223356788999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          112 NDVYIVYELMD-TDLHQIIRSK----QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      ..+|+||||++ |+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++
T Consensus       258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV  337 (543)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence            78999999998 7999998763    469999999999999999999999999999999999999999999999999985


Q ss_pred             c-----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccc--cchHHHHHhhCCCCCCCCc
Q 042681          187 T-----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR--SDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       187 ~-----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  253 (339)
                      .           .++..|++||+.....+..+.|+|++|+++|++++|..|+.......  ..............     
T Consensus       338 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~-----  412 (543)
T 3c4z_A          338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY-----  412 (543)
T ss_dssp             ECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC-----
T ss_pred             eccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC-----
Confidence            4           34456889998887788899999999999999999999986542111  11111222211111     


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCccC
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRIT-----VEEALNHPYLSSLHEI  297 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~~  297 (339)
                         ...+|+++++||.+||+.||++||+     +.++++||||+++.|.
T Consensus       413 ---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          413 ---PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             ---CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             ---CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence               1458999999999999999999995     5899999999998763

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-43  Score=311.92  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=207.6

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .+.++|.. .+.||+|+||.||+|.+..+|+.+|+|++.....  .....+.+|+.++..++||||+++++++     ..
T Consensus         6 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   77 (304)
T 2jam_A            6 NIRKTFIF-MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIY-----ES   77 (304)
T ss_dssp             CHHHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             chhcccee-eeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhc-----cc
Confidence            45677777 9999999999999999999999999999975422  2345688999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee---ccCCCeEEeeccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR  186 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli---~~~~~ikL~Dfg~~~  186 (339)
                      ....++||||++ ++|.+.+...+.+++..++.++.|++.||.|||++|++||||||+||++   +.++.++|+|||.+.
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           78 TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             CCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            778999999997 6999999888899999999999999999999999999999999999999   778899999999986


Q ss_pred             cc---------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          187 TT---------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       187 ~~---------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                      ..         +...|.+||......+..+.|+|++|++++++++|..|+.....  ...............    ....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~----~~~~  231 (304)
T 2jam_A          158 MEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKEGYYEFE----SPFW  231 (304)
T ss_dssp             CCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHCCCCCC----TTTT
T ss_pred             ecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCCCCC----cccc
Confidence            43         34568889988777778889999999999999999998754321  111122222111111    1223


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      +.+++++++||.+||+.||++|||+.++++||||+....
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          232 DDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence            568999999999999999999999999999999987543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=305.83  Aligned_cols=247  Identities=26%  Similarity=0.436  Sum_probs=189.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.. .+.||+|+||.||+|.+..+|+.+|+|++..... .....+.+.+|+.++..++||||+++++++     ....
T Consensus        11 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   84 (278)
T 3cok_A           11 EDFKV-GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN   84 (278)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred             cccee-eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence            45666 8999999999999999999999999999865421 122346788999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-
Q 042681          113 DVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-  189 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-  189 (339)
                      ..++||||++ ++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+.... 
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            8999999997 6999998875 679999999999999999999999999999999999999999999999999986543 


Q ss_pred             ----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          190 ----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       190 ----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                ...|.+||.........+.|+|++|++++++++|..|+.......      .........    ......
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~----~~~~~~  234 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN------TLNKVVLAD----YEMPSF  234 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSSC----CCCCTT
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH------HHHHHhhcc----cCCccc
Confidence                      345788888877778889999999999999999999875432111      011111100    011235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ++.++++||.+||+.||++|||+.++++||||.....
T Consensus       235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          235 LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence            7899999999999999999999999999999987543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.6e-43  Score=321.16  Aligned_cols=252  Identities=21%  Similarity=0.282  Sum_probs=202.2

Q ss_pred             ccccC-ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC--CCCeeeeeeecCCC
Q 042681           30 FQVSS-KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT--HENIVKVKDIIPPM  106 (339)
Q Consensus        30 ~~~~~-~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~I~~~~~~~~~~  106 (339)
                      +.+.+ +|.. ++.||+|+||.||++.+.. ++.||+|++..........+.+.+|+.++..++  ||||+++++++   
T Consensus        51 ~~~~~~~y~~-~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~---  125 (390)
T 2zmd_A           51 ISVKGRIYSI-LKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE---  125 (390)
T ss_dssp             EEETTEEEEE-EEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE---
T ss_pred             ccccCCceEE-EEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE---
Confidence            33444 3555 9999999999999999875 899999999876556666788999999999996  59999999998   


Q ss_pred             CcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          107 DKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                        .....+++|||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.
T Consensus       126 --~~~~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          126 --ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             --ECSSEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             --ecCCEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence              5667799999977799999999988999999999999999999999999999999999999995 5899999999986


Q ss_pred             cc-------------CCCCccccccccc-----------cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHH
Q 042681          187 TT-------------SETDFMTEYVVTR-----------WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV  242 (339)
Q Consensus       187 ~~-------------~~~~~~~~~~~~~-----------~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~  242 (339)
                      ..             ++..|++||....           ..+..+.|+|++|+++|++++|..|+....... .......
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~~~~  281 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAII  281 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHH
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-HHHHHHh
Confidence            43             3445888887643           246677999999999999999999986432111 1111111


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ....   ....   ....+.++++||.+||+.||++|||+.++++||||+....
T Consensus       282 ~~~~---~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          282 DPNH---EIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             CTTS---CCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             Cccc---cCCC---CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            1111   1111   1235789999999999999999999999999999986544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.5e-43  Score=308.36  Aligned_cols=260  Identities=24%  Similarity=0.349  Sum_probs=208.6

Q ss_pred             EEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeee
Q 042681           22 QYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD  101 (339)
Q Consensus        22 ~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~  101 (339)
                      .|+.....+...++|.+ ++.||+|+||.||+|.+..+++.+|+|++...  .....+.+.+|+.++..++||||+++++
T Consensus         7 ~~~~~~~~~~~~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (302)
T 2j7t_A            7 EYEHVRRDLDPNEVWEI-VGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLG   83 (302)
T ss_dssp             ---CCBSSSCGGGTEEE-EEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhcccccccCCccceee-cceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeee
Confidence            45556667788888888 99999999999999999999999999998654  2234577889999999999999999999


Q ss_pred             ecCCCCcCCcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEE
Q 042681          102 IIPPMDKEKFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI  179 (339)
Q Consensus       102 ~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL  179 (339)
                      ++     ...+..++||||++ ++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|
T Consensus        84 ~~-----~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  158 (302)
T 2j7t_A           84 AY-----YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRL  158 (302)
T ss_dssp             EE-----ECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             ee-----eeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEE
Confidence            99     55678999999997 688888765 567999999999999999999999999999999999999999999999


Q ss_pred             eecccccc-----------cCCCCccccccc-----cccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHh
Q 042681          180 CDFGLART-----------TSETDFMTEYVV-----TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK  243 (339)
Q Consensus       180 ~Dfg~~~~-----------~~~~~~~~~~~~-----~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~  243 (339)
                      +|||.+..           .+...|.+||..     .......+.|+|++|++++++++|..|+......  ........
T Consensus       159 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~  236 (302)
T 2j7t_A          159 ADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAK  236 (302)
T ss_dssp             CCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHH
T ss_pred             EECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHhc
Confidence            99998642           344568888876     2445677899999999999999999987653221  11111111


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       244 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ...  +..   .....++.++.+||.+||+.||++|||+.++++||||+...+
T Consensus       237 ~~~--~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          237 SDP--PTL---LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             SCC--CCC---SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             cCC--ccc---CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            111  111   111357899999999999999999999999999999998765

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-43  Score=316.04  Aligned_cols=248  Identities=22%  Similarity=0.295  Sum_probs=203.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC-hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.. ++.||+|+||.||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++     ....
T Consensus        54 ~~y~~-~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~  127 (348)
T 1u5q_A           54 KLFSD-LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREH  127 (348)
T ss_dssp             HHEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred             hheee-eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence            44666 89999999999999999999999999999765332 33456789999999999999999999999     6667


Q ss_pred             eEEEEEecCcccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMDTDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      ..++||||+.|+|.+.+. ....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...   
T Consensus       128 ~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          128 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             eEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            899999999999988885 4578999999999999999999999999999999999999999999999999998654   


Q ss_pred             ----CCCCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          189 ----SETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       189 ----~~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                          ++..|.+||...   ...+..+.|+|++|++++++++|..|+.......  ........ .. +  ..  ....++
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~~~~~~-~~-~--~~--~~~~~~  279 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQN-ES-P--AL--QSGHWS  279 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHS-CC-C--CC--CCTTSC
T ss_pred             CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhc-CC-C--CC--CCCCCC
Confidence                345688888763   3456778999999999999999999976432211  11111111 11 1  11  114578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      +.+++||.+||+.||++|||+.++++||||....
T Consensus       280 ~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            9999999999999999999999999999997543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.5e-44  Score=321.35  Aligned_cols=244  Identities=26%  Similarity=0.375  Sum_probs=197.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||+|+||.||+|.+..+|+.+|+|++...  .....+.+.+|+.++..++||||+++++++     ......++|||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E  166 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVME  166 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEe
Confidence            45799999999999999999999999998754  234457789999999999999999999999     66778999999


Q ss_pred             cCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee--ccCCCeEEeeccccccc-------
Q 042681          120 LMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARTT-------  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli--~~~~~ikL~Dfg~~~~~-------  188 (339)
                      |++ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||++  +.++.+||+|||++...       
T Consensus       167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~  246 (373)
T 2x4f_A          167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK  246 (373)
T ss_dssp             CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence            997 6998888654 579999999999999999999999999999999999999  56678999999998653       


Q ss_pred             ---CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHH
Q 042681          189 ---SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI  265 (339)
Q Consensus       189 ---~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  265 (339)
                         ++..|.+||.........+.|+|++|++++++++|..|+.....  ............    ......++.++++++
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~----~~~~~~~~~~~~~~~  320 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--AETLNNILACRW----DLEDEEFQDISEEAK  320 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTCC----CSCSGGGTTSCHHHH
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccC----CCChhhhccCCHHHH
Confidence               34568888888777778889999999999999999999754321  111222222211    111223356899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          266 DLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       266 ~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      +||.+||+.||++|||+.++++||||+....
T Consensus       321 ~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~  351 (373)
T 2x4f_A          321 EFISKLLIKEKSWRISASEALKHPWLSDHKL  351 (373)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence            9999999999999999999999999987753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.8e-43  Score=313.55  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=210.6

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ..++|.. ++.||+|+||.||++.+..+++.+|+|++.... ......+.+.+|+.+++.++||||+++++++     ..
T Consensus        39 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~  112 (335)
T 2owb_A           39 SRRRYVR-GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----ED  112 (335)
T ss_dssp             TTEEEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             cCCceEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ec
Confidence            3466777 999999999999999999999999999987653 3344567788999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-  188 (339)
                      .+..++||||++ ++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+... 
T Consensus       113 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          113 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            678999999998 699999988889999999999999999999999999999999999999999999999999998654 


Q ss_pred             ----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          189 ----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       189 ----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                +...|.+||.........+.|+|++|++++++++|..++......  ............        ...
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~--------~~~  262 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLRIKKNEYS--------IPK  262 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCC--------CCT
T ss_pred             cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHhcCCCC--------CCc
Confidence                      233578888877777788999999999999999999987543211  111111111111        113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      .+++.+.+||.+||+.||++|||+.++++||||.+...+.
T Consensus       263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          263 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence            5789999999999999999999999999999998876543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.8e-43  Score=321.30  Aligned_cols=259  Identities=30%  Similarity=0.422  Sum_probs=198.5

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc-C
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK-E  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~-~  109 (339)
                      ....+|.. ++.||+|+||.||+|.+..+++ +|+|++......      ..+|+.+++.++||||+++++++..... .
T Consensus        37 ~~~~~Y~~-~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           37 QREIAYTN-CKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEE-EEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             cccceEEE-eEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            34567877 9999999999999999987776 777777543211      2369999999999999999999843221 2


Q ss_pred             CcCeEEEEEecCcccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec-cCCCeEEeeccc
Q 042681          110 KFNDVYIVYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGL  184 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~-~~~~ikL~Dfg~  184 (339)
                      ....+++||||+++++...+.    ....+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            223488999999987766654    357899999999999999999999999999999999999999 799999999999


Q ss_pred             cccc----------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh---------
Q 042681          185 ARTT----------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ---------  244 (339)
Q Consensus       185 ~~~~----------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~---------  244 (339)
                      ++..          ++..|.+||.... ..+..+.|+|++|++++++++|..|+......  .....+...         
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHH
T ss_pred             cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence            9653          2334788887644 35778899999999999999999998654311  111111110         


Q ss_pred             -----------CCCCCCCCccc-cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCC
Q 042681          245 -----------LPHVPKQPFSQ-KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE  299 (339)
Q Consensus       245 -----------~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~  299 (339)
                                 .......++.. ..+.+++++++||.+||+.||++|||+.++++||||+.+++...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA  333 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence                       00111111111 11348899999999999999999999999999999999887543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-43  Score=321.70  Aligned_cols=254  Identities=25%  Similarity=0.354  Sum_probs=202.0

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhh-CCCCCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCH-MTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~I~~~~~~~~~~~~~  109 (339)
                      .+.++|....+.||+|+||.||++.+..+|+.||+|++...       ..+.+|+.++.+ .+||||+++++++.... .
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-A  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc-c
Confidence            34556666347899999999999999999999999998643       356678888744 58999999999883211 2


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc---CCCeEEeecc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFG  183 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~---~~~ikL~Dfg  183 (339)
                      ....+++||||++ |+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence            3567999999997 69999998753  5999999999999999999999999999999999999997   7889999999


Q ss_pred             cccccC----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc--chHHHHHhhCCCCCCC
Q 042681          184 LARTTS----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS--DNARRYVKQLPHVPKQ  251 (339)
Q Consensus       184 ~~~~~~----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  251 (339)
                      +++...          +..|.+||+.....+..+.|+|++|+++|++++|..|+........  .............+  
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~--  287 (400)
T 1nxk_A          210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP--  287 (400)
T ss_dssp             TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC--
T ss_pred             cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC--
Confidence            986532          4458899988877888899999999999999999999865432211  11112221111111  


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                        ...+..+++++++||.+||+.||++|||+.++++||||.....
T Consensus       288 --~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  330 (400)
T 1nxk_A          288 --NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  330 (400)
T ss_dssp             --TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred             --CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence              1123568999999999999999999999999999999986543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.5e-43  Score=305.29  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=205.9

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. ++.||+|+||.||+|.+..+++.+|+|++..... ....+.+.+|+.+++.++||||+++++++     ....
T Consensus         6 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (276)
T 2yex_A            6 VEDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHR-----REGN   78 (276)
T ss_dssp             HHHEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETT
T ss_pred             ecceEE-EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEE-----EcCC
Confidence            356666 8999999999999999999999999999865432 23457788999999999999999999998     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      ..++||||++ ++|.+++.....+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+...   
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            8999999998 699999888788999999999999999999999999999999999999999999999999998643   


Q ss_pred             ----------CCCCcccccccccccc-CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          189 ----------SETDFMTEYVVTRWDT-LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       189 ----------~~~~~~~~~~~~~~~~-~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                +...|.+||....... ..+.|+|++|++++++++|..|+........ ...........      ....
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~------~~~~  231 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTY------LNPW  231 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTCTT------STTG
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhcccc------cCch
Confidence                      2345788887765443 5679999999999999999999765332111 11111111111      1112


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ..+++.+++||.+||+.||++|||+.++++||||+.....
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence            4578999999999999999999999999999999987554

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-43  Score=319.84  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=197.2

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc---
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK---  108 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~---  108 (339)
                      ..++|.. ++.||+|+||.||+|.+..+|+.||+|++......      ..+|+.+++.++||||+++++++.....   
T Consensus         5 ~~~~y~~-~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSL-GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEE-EEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEE-EEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            3456777 99999999999999999999999999998654221      2379999999999999999999843221   


Q ss_pred             ------------------------------CCcCeEEEEEecCcccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Q 042681          109 ------------------------------EKFNDVYIVYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYI  154 (339)
Q Consensus       109 ------------------------------~~~~~~~iv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~L  154 (339)
                                                    .....+++||||++|+|.+.+.    ..+.+++..++.++.||+.||.||
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                          2234589999999998777764    357899999999999999999999


Q ss_pred             HhCCcccCCCCCCCeeec-cCCCeEEeeccccccc----------CCCCccccccccc-cccCCCCccHHHHHHHHHHHh
Q 042681          155 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTT----------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELL  222 (339)
Q Consensus       155 H~~givH~dikp~NIli~-~~~~ikL~Dfg~~~~~----------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~  222 (339)
                      |++||+||||||+||+++ .++.+||+|||.++..          ++..|.+||.... ..+..+.|+|++|++++++++
T Consensus       158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence            999999999999999998 5889999999999753          2334788887654 347788999999999999999


Q ss_pred             CCCCCCcccccccchHHHHHhh------------CCCCC--------CCCccc-cCCCCCHHHHHHHHHhcccCCCCCCC
Q 042681          223 GSPDDSDLGFLRSDNARRYVKQ------------LPHVP--------KQPFSQ-KFPNMSPVAIDLAERMLVFDPAKRIT  281 (339)
Q Consensus       223 g~~~~~~~~~~~~~~~~~~~~~------------~~~~~--------~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps  281 (339)
                      |..|+......  .........            .....        ...... ....+++++++||.+||+.||++|||
T Consensus       238 g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          238 GKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             SSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             CCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            99997653211  111111111            11100        011111 12347899999999999999999999


Q ss_pred             HHHHhcCCCCCCCcc
Q 042681          282 VEEALNHPYLSSLHE  296 (339)
Q Consensus       282 ~~ell~hp~f~~~~~  296 (339)
                      +.|+++||||+.+++
T Consensus       316 ~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          316 PYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHHHTSGGGHHHHH
T ss_pred             HHHHhcCHHHHHHHh
Confidence            999999999988765

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2e-43  Score=307.34  Aligned_cols=249  Identities=22%  Similarity=0.371  Sum_probs=207.5

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.. .+.||+|+||.||+|.+..+++.+|+|++..... .....+.+.+|+.++..++||||+++++++     ....
T Consensus        14 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   87 (284)
T 2vgo_A           14 DDFDI-GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDRK   87 (284)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hhcee-eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcCC
Confidence            56666 9999999999999999999999999999865422 122346788999999999999999999999     6667


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      ..++||||++ ++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+...   
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            8999999997 699999988889999999999999999999999999999999999999999999999999988543   


Q ss_pred             ------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          189 ------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       189 ------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                            +...|.+||.........+.|+|++|++++++++|..|+......  ...........  .      ..+.++.
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~--~------~~~~~~~  237 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ETHRRIVNVDL--K------FPPFLSD  237 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTTCC--C------CCTTSCH
T ss_pred             ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HHHHHHhcccc--C------CCCcCCH
Confidence                  334578888887777888999999999999999999987543211  11111111111  1      1145789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      ++++||.+||+.||++|||+.++++||||+......
T Consensus       238 ~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~  273 (284)
T 2vgo_A          238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV  273 (284)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred             HHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence            999999999999999999999999999998765543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.8e-44  Score=311.89  Aligned_cols=255  Identities=23%  Similarity=0.327  Sum_probs=183.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. .+.||+|+||.||++.+..+++.||+|++..... ....+.+.+|+.++..++||||+++++++     .....
T Consensus        15 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   87 (303)
T 2vwi_A           15 DDYEL-QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSF-----VVKDE   87 (303)
T ss_dssp             CCCEE-EEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEE-----ESSSC
T ss_pred             hhhhh-hheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEE-----eecCC
Confidence            44555 9999999999999999999999999998865422 23456788999999999999999999999     56677


Q ss_pred             EEEEEecCc-ccHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          114 VYIVYELMD-TDLHQIIRS--------KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                      .++||||++ ++|.+++..        ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            999999997 699998863        45699999999999999999999999999999999999999999999999998


Q ss_pred             cccc----------------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC
Q 042681          185 ARTT----------------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH  247 (339)
Q Consensus       185 ~~~~----------------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  247 (339)
                      +...                ++..|.+||.... .....+.|+|++|++++++++|..|+.......  ...........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~  245 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VLMLTLQNDPP  245 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHHHTSSCC
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HHHHHhccCCC
Confidence            7543                3345788887654 346778999999999999999999986543221  11111111111


Q ss_pred             CCC--CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          248 VPK--QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       248 ~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ...  .........+++++++||.+||+.||++|||+.++++||||+...+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            100  11122335689999999999999999999999999999999987653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-43  Score=319.17  Aligned_cols=256  Identities=18%  Similarity=0.298  Sum_probs=209.4

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. ++.||+|+||.||++.+..+++.+|+|++... ......+.+.+|+.+++.++||||+++++++     ...+
T Consensus        32 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~  104 (360)
T 3eqc_A           32 DDDFEK-ISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDG  104 (360)
T ss_dssp             GGGEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE-----EETT
T ss_pred             ccccee-eeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE-----EECC
Confidence            456777 99999999999999999999999999998754 2344567889999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeeeccCCCeEEeecccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLART---  187 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dikp~NIli~~~~~ikL~Dfg~~~~---  187 (339)
                      ..++||||++ ++|.+++...+.+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||++..   
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            8999999997 69999999888999999999999999999999986 999999999999999999999999998853   


Q ss_pred             ------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccch------------------------
Q 042681          188 ------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN------------------------  237 (339)
Q Consensus       188 ------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~------------------------  237 (339)
                            .++..|.+||......+..+.|+|++|++++++++|..|+..........                        
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence                  34567889998887778888999999999999999999875432110000                        


Q ss_pred             ------------HHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          238 ------------ARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       238 ------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                                  ...............  .....++.++++||.+||+.||++|||+.++++||||+...+.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence                        000000000000000  0113478999999999999999999999999999999887654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.2e-43  Score=320.37  Aligned_cols=264  Identities=24%  Similarity=0.344  Sum_probs=196.8

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeC--CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNS--ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPP  105 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~  105 (339)
                      +...+.+.|....+.||+|+||.||+|+++  .+++.||+|++.....    ...+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (405)
T 3rgf_A           14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLS   89 (405)
T ss_dssp             HCCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred             hhhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence            445666778776778999999999999965  5789999999875422    2457899999999999999999999842


Q ss_pred             CCcCCcCeEEEEEecCcccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee----c
Q 042681          106 MDKEKFNDVYIVYELMDTDLHQIIRSK---------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----N  172 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli----~  172 (339)
                         .....+++||||++++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+||++    +
T Consensus        90 ---~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~  166 (405)
T 3rgf_A           90 ---HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP  166 (405)
T ss_dssp             ---TTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSST
T ss_pred             ---CCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCC
Confidence               345679999999999999888632         259999999999999999999999999999999999999    6


Q ss_pred             cCCCeEEeecccccccC--------------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccccc----
Q 042681          173 ANCDLKICDFGLARTTS--------------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFL----  233 (339)
Q Consensus       173 ~~~~ikL~Dfg~~~~~~--------------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~----  233 (339)
                      .++.+||+|||+++...              +..|.+||+... ..+..+.|+|++|++++++++|..|+......    
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  246 (405)
T 3rgf_A          167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  246 (405)
T ss_dssp             TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred             CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence            77899999999986432              345888887765 34777899999999999999999988533211    


Q ss_pred             ---ccchHHHHHhhCCCCCCCCcc------------------------------ccCCCCCHHHHHHHHHhcccCCCCCC
Q 042681          234 ---RSDNARRYVKQLPHVPKQPFS------------------------------QKFPNMSPVAIDLAERMLVFDPAKRI  280 (339)
Q Consensus       234 ---~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rp  280 (339)
                         .....................                              ......++.+.+||.+||+.||++||
T Consensus       247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~  326 (405)
T 3rgf_A          247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI  326 (405)
T ss_dssp             CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred             ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence               011111111111111110000                              00112378899999999999999999


Q ss_pred             CHHHHhcCCCCCCCccCC
Q 042681          281 TVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       281 s~~ell~hp~f~~~~~~~  298 (339)
                      |++|+|+||||.....+.
T Consensus       327 ta~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          327 TSEQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             CHHHHHTSGGGTSSSCCC
T ss_pred             CHHHHhcChhhccCCCCc
Confidence            999999999999876554

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3e-43  Score=339.25  Aligned_cols=248  Identities=17%  Similarity=0.292  Sum_probs=210.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++|.. ++.||+|+||.||+|++..+++.||+|++++.. ......+.+..|..++..+ +||+|+++++++     ...
T Consensus       341 ~~f~~-~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~~  414 (674)
T 3pfq_A          341 TDFNF-LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM  414 (674)
T ss_dssp             TTEEE-EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BCS
T ss_pred             cceEE-EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----EeC
Confidence            45666 899999999999999999999999999997642 1233456788899999988 799999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc---
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART---  187 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~---  187 (339)
                      ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.   
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            88999999997 79999999888999999999999999999999999999999999999999999999999999864   


Q ss_pred             --------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          188 --------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       188 --------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                              .++..|++||+.....+..+.|+|++|+++|++++|..|+....  .......+.......        ...
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~~~~--------p~~  564 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIMEHNVAY--------PKS  564 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHSSCCCC--------CTT
T ss_pred             CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--HHHHHHHHHhCCCCC--------Ccc
Confidence                    24557899999888888999999999999999999999976432  111222222211111        135


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCccC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITV-----EEALNHPYLSSLHEI  297 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~-----~ell~hp~f~~~~~~  297 (339)
                      +++++++||++||+.||++||++     +++++||||+.+.|.
T Consensus       565 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence            89999999999999999999997     999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.5e-43  Score=308.67  Aligned_cols=255  Identities=26%  Similarity=0.394  Sum_probs=206.3

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC-------hHhHHHHHHHHHHHhhCC-CCCeeeeeee
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-------RIDAKRILREIKLLCHMT-HENIVKVKDI  102 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~~I~~~~~~  102 (339)
                      .+.++|.. .+.||+|++|.||+|.+..+|+.||+|++......       ....+.+.+|+.+++++. ||||++++++
T Consensus        14 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           14 GFYENYEP-KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             -CTTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             chhhccce-eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            34677877 99999999999999999999999999999654311       123466789999999995 9999999999


Q ss_pred             cCCCCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEee
Q 042681          103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD  181 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~D  181 (339)
                      +     ......++||||++ ++|.+++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|
T Consensus        93 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           93 Y-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             E-----ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             e-----ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEec
Confidence            9     66788999999998 69999999888999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC----------CCCcccccccc------ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhC
Q 042681          182 FGLARTTS----------ETDFMTEYVVT------RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL  245 (339)
Q Consensus       182 fg~~~~~~----------~~~~~~~~~~~------~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~  245 (339)
                      ||.+....          ...|.+||...      ......+.|+|++|++++++++|..|+......  ..........
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~  245 (298)
T 1phk_A          168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LMLRMIMSGN  245 (298)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTC
T ss_pred             ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--HHHHHHhcCC
Confidence            99986532          33577777653      234567889999999999999999987543211  1111222211


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       246 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ....    ...++.+++.+++||.+||+.||++|||+.++++||||++....
T Consensus       246 ~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          246 YQFG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             CCCC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             cccC----cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            1111    11224578999999999999999999999999999999987653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.1e-43  Score=306.14  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=202.6

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc--ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      +.++|.. ++.||+|+||.||++.+..+++.+|+|++.....  .....+.+.+|+.+++.++||||+++++++..   .
T Consensus         3 l~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~   78 (305)
T 2wtk_C            3 LIGKYLM-GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---E   78 (305)
T ss_dssp             --CCBCC-CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C
T ss_pred             cccceeE-eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---C
Confidence            5578888 9999999999999999999999999999975422  12345778999999999999999999999832   3


Q ss_pred             CcCeEEEEEecCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          110 KFNDVYIVYELMDTDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .....++||||++++|.+.+..  .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+..
T Consensus        79 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             ---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            4467899999999888888865  46799999999999999999999999999999999999999999999999999865


Q ss_pred             c-------------CCCCccccccccccc--cCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          188 T-------------SETDFMTEYVVTRWD--TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       188 ~-------------~~~~~~~~~~~~~~~--~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      .             +...|.+||......  ...+.|+|++|++++++++|..|+......  ...........  .   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~~~--~---  231 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFENIGKGSY--A---  231 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCCC--C---
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHHhcCCC--C---
Confidence            3             234577787765432  356799999999999999999987643211  11111111111  1   


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                         ....+++.+.+||.+||+.||++|||+.++++||||+......
T Consensus       232 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          232 ---IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             ---CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             ---CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence               1135789999999999999999999999999999998876544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3e-44  Score=316.59  Aligned_cols=260  Identities=20%  Similarity=0.258  Sum_probs=210.3

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      ...+.++|.. ++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.++..++||||+++++++....
T Consensus         7 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            7 PSHLSDRYEL-GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             CSEETTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             cceecCcEEE-EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            3456788888 9999999999999999999999999999976533 3444567899999999999999999999984321


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                       ......++||||++ ++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus        86 -~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           86 -PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             -TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             -CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             12234699999997 7999999888899999999999999999999999999999999999999999999999999986


Q ss_pred             cc--------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          187 TT--------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       187 ~~--------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      ..              ++..|.+||.........+.|+|++|++++++++|..|+......  .........    ...+
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~----~~~~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQHVRE----DPIP  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHC----CCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhcC----CCCC
Confidence            43              355688898887777788899999999999999999997543211  111111111    1111


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      .......+++++.+||.+||+.||.+||++.+++.|+|++....
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            12223568999999999999999999999999999999976543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2e-44  Score=325.36  Aligned_cols=261  Identities=13%  Similarity=0.104  Sum_probs=187.8

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhC--CCCCeeeeeeecC-------
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHM--THENIVKVKDIIP-------  104 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l--~h~~I~~~~~~~~-------  104 (339)
                      +|.. .+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+  +||||++++..+.       
T Consensus        63 ~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKL-VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeee-eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            3555 9999999999999999999999999999987643 334456677885444444  6999888653331       


Q ss_pred             CCCc------------CCcCeEEEEEecCcccHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCcccCCCC
Q 042681          105 PMDK------------EKFNDVYIVYELMDTDLHQIIRSK-QALTDDHC------QYFLYQLLRGLKYIHSANVLHRDLK  165 (339)
Q Consensus       105 ~~~~------------~~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~------~~i~~qi~~aL~~LH~~givH~dik  165 (339)
                      ....            .....+++||||++|+|.+++... ..+++...      ..++.||+.||+|||++||+|||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik  221 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT  221 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence            1000            011458999999999999999763 34555555      6777999999999999999999999


Q ss_pred             CCCeeeccCCCeEEeecccccccC--------CCCccccccccc--cccCCCCccHHHHHHHHHHHhCCCCCCccccccc
Q 042681          166 PSNLLLNANCDLKICDFGLARTTS--------ETDFMTEYVVTR--WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS  235 (339)
Q Consensus       166 p~NIli~~~~~ikL~Dfg~~~~~~--------~~~~~~~~~~~~--~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~  235 (339)
                      |+||+++.++.+||+|||+++..+        +..|++||....  ..+..+.|+|++|++++++++|..|+........
T Consensus       222 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~  301 (371)
T 3q60_A          222 PDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK  301 (371)
T ss_dssp             GGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT
T ss_pred             HHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc
Confidence            999999999999999999986443        346888988866  6678899999999999999999999765421111


Q ss_pred             chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ........ .............+.+++.+++||.+||+.||++|||+.++++||||+++.+.
T Consensus       302 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  362 (371)
T 3q60_A          302 GSWKRPSL-RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE  362 (371)
T ss_dssp             TCCCBCCT-TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred             cchhhhhh-hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence            10000000 00001111112234689999999999999999999999999999999987654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-43  Score=308.48  Aligned_cols=252  Identities=29%  Similarity=0.464  Sum_probs=206.9

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      +.++|.+ ++.||+|++|.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++     ...
T Consensus        20 ~~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   93 (287)
T 2wei_A           20 FAERYNI-VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDS   93 (287)
T ss_dssp             HHHHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             Hhhccee-eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCC
Confidence            4567777 9999999999999999999999999999976655555667899999999999999999999999     666


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC---CCeEEeecccccc
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLART  187 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~---~~ikL~Dfg~~~~  187 (339)
                      ...++||||+. ++|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.+   +.++|+|||.+..
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            78999999997 6999999888899999999999999999999999999999999999999764   4699999999875


Q ss_pred             cCCC----------CccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          188 TSET----------DFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       188 ~~~~----------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                      ....          .|.+||.... ....+.|+|++|++++++++|..|+......  ............    .....+
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~----~~~~~~  246 (287)
T 2wei_A          174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGKYA----FDLPQW  246 (287)
T ss_dssp             BCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCC----CCSGGG
T ss_pred             ecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCC----CCchhh
Confidence            4332          3677776654 3677899999999999999999987653211  111111111111    111223


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ..+++++++||.+||+.||++|||+.++++||||+...+
T Consensus       247 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence            468999999999999999999999999999999986543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7e-43  Score=320.75  Aligned_cols=254  Identities=24%  Similarity=0.374  Sum_probs=200.7

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC------CCCCeeeeeeecC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM------THENIVKVKDIIP  104 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~I~~~~~~~~  104 (339)
                      .+..+|.. ++.||+|+||.||+|.+..+++.||+|++...   ......+.+|+.+++.+      +|+||+++++++ 
T Consensus        94 ~~~~ry~~-~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~-  168 (429)
T 3kvw_A           94 HVAYRYEV-LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF-  168 (429)
T ss_dssp             EETTTEEE-EEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE-
T ss_pred             cccCcEEE-EEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec-
Confidence            45667888 99999999999999999999999999999753   33345667787777776      578999999999 


Q ss_pred             CCCcCCcCeEEEEEecCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC--eEEe
Q 042681          105 PMDKEKFNDVYIVYELMDTDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKIC  180 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~--ikL~  180 (339)
                          .....+++||||++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+
T Consensus       169 ----~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          169 ----TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             ----EETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred             ----ccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEe
Confidence                6678899999999999999997753  5999999999999999999999999999999999999999887  9999


Q ss_pred             eccccccc--------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCC----
Q 042681          181 DFGLARTT--------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHV----  248 (339)
Q Consensus       181 Dfg~~~~~--------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~----  248 (339)
                      |||++...        ++..|++||......+..+.|+|++|++++++++|.+++......  .............    
T Consensus       245 DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~--~~l~~i~~~~~~p~~~~  322 (429)
T 3kvw_A          245 DFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG--DQLACMIELLGMPSQKL  322 (429)
T ss_dssp             CCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred             ecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCHHH
Confidence            99998543        344688999888777889999999999999999999887543211  1111111100000    


Q ss_pred             ----------------CC------------------------------CCccc-cCCCCCHHHHHHHHHhcccCCCCCCC
Q 042681          249 ----------------PK------------------------------QPFSQ-KFPNMSPVAIDLAERMLVFDPAKRIT  281 (339)
Q Consensus       249 ----------------~~------------------------------~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps  281 (339)
                                      +.                              ..... .....++++++||.+||++||++|||
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt  402 (429)
T 3kvw_A          323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT  402 (429)
T ss_dssp             HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence                            00                              00000 01134788999999999999999999


Q ss_pred             HHHHhcCCCCCCCc
Q 042681          282 VEEALNHPYLSSLH  295 (339)
Q Consensus       282 ~~ell~hp~f~~~~  295 (339)
                      +.|+|+||||+...
T Consensus       403 a~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          403 PGQALRHPWLRRRL  416 (429)
T ss_dssp             HHHHHTSTTTC---
T ss_pred             HHHHhCChhhccCC
Confidence            99999999999764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.3e-43  Score=305.67  Aligned_cols=256  Identities=25%  Similarity=0.329  Sum_probs=210.2

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      .+.++|.. ++.||+|+||.||++++..+++.+|+|++.... ......+.+.+|+.++..++||||+++++++     .
T Consensus         8 ~~~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~   81 (294)
T 4eqm_A            8 IINERYKI-VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----E   81 (294)
T ss_dssp             CEETTEEE-EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----E
T ss_pred             HhhccEEE-EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----e
Confidence            34678888 999999999999999999999999999986543 3344567889999999999999999999998     6


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ..+..++||||++ ++|.+++...+++++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus        82 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           82 EDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             eCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            6788999999997 699999998889999999999999999999999999999999999999999999999999998643


Q ss_pred             ------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          189 ------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       189 ------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                                  ++..|.+||.........+.|+|++|++++++++|..|+......     ..................
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~  236 (294)
T 4eqm_A          162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----SIAIKHIQDSVPNVTTDV  236 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----HHHHHHHSSCCCCHHHHS
T ss_pred             ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhhccCCCcchhc
Confidence                        345688898887777888899999999999999999997643211     111111111111111223


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      .+.+++.+.++|.+||+.||++||+..+.+.+.|..-+.+.
T Consensus       237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            35689999999999999999999976666777666555443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8e-44  Score=326.14  Aligned_cols=253  Identities=28%  Similarity=0.455  Sum_probs=201.6

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC------hHhHHHHHHHHHHHhhCCCCCeeeeeeecC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN------RIDAKRILREIKLLCHMTHENIVKVKDIIP  104 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~  104 (339)
                      .+.++|.. .+.||+|+||.||+|.+..+++.||+|++.+....      ......+.+|+.++++++||||+++++++ 
T Consensus       132 ~~~~~y~~-~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-  209 (419)
T 3i6u_A          132 ALRDEYIM-SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-  209 (419)
T ss_dssp             HHHTTEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE-
T ss_pred             hhhccEEE-EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE-
Confidence            34677887 99999999999999999999999999999754321      11223578999999999999999999998 


Q ss_pred             CCCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC---CeEEe
Q 042681          105 PMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC---DLKIC  180 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~---~ikL~  180 (339)
                          .. ...++||||++ |+|.+.+...+.+++..++.++.|++.||+|||++||+||||||+||+++.++   .+||+
T Consensus       210 ----~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          210 ----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             ----ES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             ----ec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEe
Confidence                32 34799999997 69999998888999999999999999999999999999999999999997654   59999


Q ss_pred             ecccccccC----------CCCccccccccc---cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC
Q 042681          181 DFGLARTTS----------ETDFMTEYVVTR---WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH  247 (339)
Q Consensus       181 Dfg~~~~~~----------~~~~~~~~~~~~---~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  247 (339)
                      |||+++..+          +..|++||....   ..+..+.|+|++|++++++++|..|+......  ..........  
T Consensus       285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~i~~~--  360 (419)
T 3i6u_A          285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITSG--  360 (419)
T ss_dssp             CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHHHHTT--
T ss_pred             ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHHHhcC--
Confidence            999996543          446888887642   34566899999999999999999997643221  1111111111  


Q ss_pred             CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          248 VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       248 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                       ........++.+++.+.+||.+||+.||++|||++++++||||+...
T Consensus       361 -~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          361 -KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             -CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             -CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence             11112233356899999999999999999999999999999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.8e-43  Score=311.03  Aligned_cols=253  Identities=28%  Similarity=0.461  Sum_probs=201.4

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc------ChHhHHHHHHHHHHHhhCCCCCeeeeeeecC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD------NRIDAKRILREIKLLCHMTHENIVKVKDIIP  104 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~  104 (339)
                      .+.++|.. .+.||+|+||.||+|.+..+++.||+|++.....      .......+.+|+.+++.++||||+++++++ 
T Consensus         7 ~l~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-   84 (322)
T 2ycf_A            7 ALRDEYIM-SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-   84 (322)
T ss_dssp             HHHHHEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             hhhhceeE-eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE-
Confidence            35567777 9999999999999999999999999999975422      112234578999999999999999999998 


Q ss_pred             CCCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC---eEEe
Q 042681          105 PMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKIC  180 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~---ikL~  180 (339)
                          ... ..++||||++ ++|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.   ++|+
T Consensus        85 ----~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           85 ----DAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             ----ESS-SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             ----cCC-ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence                333 3899999997 699999988889999999999999999999999999999999999999987664   9999


Q ss_pred             eccccccc----------CCCCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC
Q 042681          181 DFGLARTT----------SETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH  247 (339)
Q Consensus       181 Dfg~~~~~----------~~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  247 (339)
                      |||.+...          +...|.+||...   ...+..+.|+|++|++++++++|..|+.......  .......... 
T Consensus       160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~-  236 (322)
T 2ycf_A          160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITSGK-  236 (322)
T ss_dssp             CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHHTC-
T ss_pred             cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHhCc-
Confidence            99998754          345688888752   3456778999999999999999999976432211  1111111111 


Q ss_pred             CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          248 VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       248 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                        .......+..+++++.+||.+||+.||++|||+.++++||||+...
T Consensus       237 --~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          237 --YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             --CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             --cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence              1111222346899999999999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.4e-42  Score=307.21  Aligned_cols=241  Identities=25%  Similarity=0.400  Sum_probs=199.0

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .+.||+|+||.||+|++..+|+.||+|++.....  ...+.+.+|+.++..++||||+++++++     ......++|||
T Consensus        50 ~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv~e  122 (321)
T 2c30_A           50 YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSY-----LVGEELWVLME  122 (321)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEEEEEEC
T ss_pred             cEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEEEEe
Confidence            6689999999999999999999999999875432  2356788999999999999999999999     66678999999


Q ss_pred             cCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----------
Q 042681          120 LMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----------  188 (339)
Q Consensus       120 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----------  188 (339)
                      |++ ++|.+++.+ ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...          
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            997 688887754 67999999999999999999999999999999999999999999999999987643          


Q ss_pred             -CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          189 -SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       189 -~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                       ++..|.+||......+..+.|+|++|++++++++|..|+......  ...... .....   .. ......+++.+++|
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~~~-~~~~~---~~-~~~~~~~~~~l~~l  274 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRL-RDSPP---PK-LKNSHKVSPVLRDF  274 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH-HHSSC---CC-CTTGGGSCHHHHHH
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-hcCCC---CC-cCccccCCHHHHHH
Confidence             334578888887777888899999999999999999997643211  111111 11111   11 11113578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          268 AERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       268 i~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      |.+||+.||++|||+.++++||||....
T Consensus       275 i~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          275 LERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHHccCChhhCcCHHHHhcChhhccCC
Confidence            9999999999999999999999997643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.6e-43  Score=315.62  Aligned_cols=249  Identities=26%  Similarity=0.408  Sum_probs=203.0

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC------hHhHHHHHHHHHHHhhC-CCCCeeeeeeecC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN------RIDAKRILREIKLLCHM-THENIVKVKDIIP  104 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~  104 (339)
                      +.++|.. .+.||+|++|+||+|.+..+|+.||+|++......      ....+.+.+|+.++..+ +||||+++++++ 
T Consensus        92 ~~~~y~~-~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-  169 (365)
T 2y7j_A           92 FYQKYDP-KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-  169 (365)
T ss_dssp             HHHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             hhhhccc-ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE-
Confidence            3456777 89999999999999999999999999998754321      12245678999999999 799999999998 


Q ss_pred             CCCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          105 PMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                          ......++||||++ ++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus       170 ----~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          170 ----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             ----EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ----eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecC
Confidence                66788999999998 5999999888899999999999999999999999999999999999999999999999999


Q ss_pred             ccccc----------CCCCccccccccc------cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC
Q 042681          184 LARTT----------SETDFMTEYVVTR------WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH  247 (339)
Q Consensus       184 ~~~~~----------~~~~~~~~~~~~~------~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  247 (339)
                      ++...          ++..|.+||....      ..+..+.|+|++|++++++++|..|+......  ............
T Consensus       246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~  323 (365)
T 2y7j_A          246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLRMIMEGQYQ  323 (365)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC
T ss_pred             cccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCCCC
Confidence            88643          3345778876642      24677899999999999999999997643211  111111111111


Q ss_pred             CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          248 VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       248 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                          .....+..+++.+.+||.+||+.||++|||+.++++||||+
T Consensus       324 ----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          324 ----FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             ----CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             ----CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence                11122246789999999999999999999999999999997

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-43  Score=309.80  Aligned_cols=257  Identities=16%  Similarity=0.196  Sum_probs=200.2

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      ....+.++|.. .+.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++..  
T Consensus         3 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   78 (319)
T 4euu_A            3 SQSTSNHLWLL-SDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEE--   78 (319)
T ss_dssp             EEECSSEEEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             cccCCCCCEEE-EEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeec--
Confidence            34456677877 9999999999999999999999999999975422 2235677899999999999999999999843  


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee----ccCCCeEE
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKI  179 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli----~~~~~ikL  179 (339)
                       ......++||||++ ++|.+++....   .+++..++.++.||+.||+|||++||+||||||+||++    +.++.+||
T Consensus        79 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL  157 (319)
T 4euu_A           79 -TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL  157 (319)
T ss_dssp             -TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred             -CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEE
Confidence             33447899999997 79999997643   39999999999999999999999999999999999999    77778999


Q ss_pred             eeccccccc----------CCCCcccccccc--------ccccCCCCccHHHHHHHHHHHhCCCCCCccccccc--chHH
Q 042681          180 CDFGLARTT----------SETDFMTEYVVT--------RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS--DNAR  239 (339)
Q Consensus       180 ~Dfg~~~~~----------~~~~~~~~~~~~--------~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~--~~~~  239 (339)
                      +|||++...          ++..|.+||...        ...+..+.|+|++|++++++++|..|+........  ....
T Consensus       158 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  237 (319)
T 4euu_A          158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY  237 (319)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred             ccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence            999999653          334677888764        34677889999999999999999999864432221  1122


Q ss_pred             HHHhhCCCCCC-----------------CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 042681          240 RYVKQLPHVPK-----------------QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHP  289 (339)
Q Consensus       240 ~~~~~~~~~~~-----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  289 (339)
                      ......+....                 .........++..+.+||.+||+.||++|||++|+++||
T Consensus       238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            22222211000                 000011123456789999999999999999999999996

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-43  Score=315.69  Aligned_cols=250  Identities=22%  Similarity=0.326  Sum_probs=202.6

Q ss_pred             CccCCCccccccccceEEEEEEeC---CCCceEEEEEeccccc--ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNS---ETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMD  107 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~---~~~~~~avK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~  107 (339)
                      ++|.. ++.||+|+||.||++++.   .+|+.||+|++++...  .....+.+.+|+.++..+ +||||+++++++    
T Consensus        54 ~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----  128 (355)
T 1vzo_A           54 ENFEL-LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----  128 (355)
T ss_dssp             GGEEE-EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred             cceEE-EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE----
Confidence            56766 999999999999999984   5899999999875421  122234567899999999 699999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                       .....+++||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus       129 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          129 -QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             -EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             -eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence             66778999999997 6999999988899999999999999999999999999999999999999999999999999986


Q ss_pred             cc------------CCCCccccccccc--cccCCCCccHHHHHHHHHHHhCCCCCCcccccccc--hHHHHHhhCCCCCC
Q 042681          187 TT------------SETDFMTEYVVTR--WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD--NARRYVKQLPHVPK  250 (339)
Q Consensus       187 ~~------------~~~~~~~~~~~~~--~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~  250 (339)
                      ..            ++..|.+||....  .....+.|+|++|++++++++|..|+.........  ...........   
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  284 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP---  284 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC---
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC---
Confidence            42            4456888887763  34567899999999999999999997643222111  11111111111   


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                           ....++..+++||.+||+.||++||     ++.++++||||+.+.+.
T Consensus       285 -----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~  331 (355)
T 1vzo_A          285 -----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  331 (355)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             -----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence                 1145789999999999999999999     99999999999988753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.1e-43  Score=312.61  Aligned_cols=256  Identities=24%  Similarity=0.438  Sum_probs=199.3

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCC
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMD  107 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~  107 (339)
                      .+...++|.. ++.||+|+||.||+|.+..+++.||+|++...     ..+.+.+|+.+++.++ ||||+++++++..  
T Consensus        31 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~--  102 (330)
T 3nsz_A           31 EWGNQDDYQL-VRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKD--  102 (330)
T ss_dssp             CCEEGGGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--
T ss_pred             cccCCCceEE-EEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeecc--
Confidence            3445677888 99999999999999999999999999998643     2467889999999997 9999999999943  


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC-CeEEeecccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLA  185 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~-~ikL~Dfg~~  185 (339)
                       ......++||||++ ++|.+++.   .+++..++.++.||+.||+|||++|++||||||+||+++.++ .++|+|||++
T Consensus       103 -~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          103 -PVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA  178 (330)
T ss_dssp             -TTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             -CCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence             23567899999998 68877764   499999999999999999999999999999999999999777 8999999999


Q ss_pred             cccC----------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCccccccc-----------chHHHHHh
Q 042681          186 RTTS----------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS-----------DNARRYVK  243 (339)
Q Consensus       186 ~~~~----------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~-----------~~~~~~~~  243 (339)
                      ....          ...|.+||.... .....+.|+|++|++++++++|..|+........           ........
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            6432          334777777654 4577789999999999999999988743211100           00000011


Q ss_pred             hCC------------CCCCCCcc-----ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          244 QLP------------HVPKQPFS-----QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       244 ~~~------------~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ...            ........     .....+++++++||.+||+.||++|||++|+++||||+++.+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            100            00000000     011237899999999999999999999999999999999865

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.8e-43  Score=315.10  Aligned_cols=267  Identities=26%  Similarity=0.344  Sum_probs=193.0

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc--C
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK--E  109 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~--~  109 (339)
                      .-++|.. .+.||+|+||.||+|.+..+|+.||+|++......   .....+++..+..++||||+++++++.....  .
T Consensus        21 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           21 EMDRFQV-ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHTTEEE-C----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             hccceEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            3456777 99999999999999999999999999998654222   2356677888888899999999999843211  1


Q ss_pred             CcCeEEEEEecCcccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCCeeecc-CCCeEEeec
Q 042681          110 KFNDVYIVYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNA-NCDLKICDF  182 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH--~~givH~dikp~NIli~~-~~~ikL~Df  182 (339)
                      ....+++||||++++|...+.    ....+++..++.++.|++.||.|||  ++||+||||||+||+++. ++.+||+||
T Consensus        97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df  176 (360)
T 3e3p_A           97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF  176 (360)
T ss_dssp             TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred             cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence            223388999999988776554    4578999999999999999999999  999999999999999996 899999999


Q ss_pred             ccccccC----------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCC---
Q 042681          183 GLARTTS----------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHV---  248 (339)
Q Consensus       183 g~~~~~~----------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~---  248 (339)
                      |++....          +..|.+||.... .....+.|+|++|++++++++|..|+......  .............   
T Consensus       177 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          177 GSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             TTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHH
T ss_pred             CCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHHHHcCCCCHH
Confidence            9997543          334788887643 34688899999999999999999997653211  1111111110000   


Q ss_pred             -----------------CCCCc----cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCC
Q 042681          249 -----------------PKQPF----SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCP  304 (339)
Q Consensus       249 -----------------~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~  304 (339)
                                       .....    .......++++++||.+||+.||.+|||+.|+++||||+.+.+........
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~  331 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNN  331 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTS
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCC
Confidence                             00000    011123678999999999999999999999999999999998765543333

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-42  Score=301.32  Aligned_cols=246  Identities=24%  Similarity=0.302  Sum_probs=201.5

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      .++|.+ .+.||+|+||.||++.+..+|+.+|+|++..... .....+.+.+|+.+++.++||||+++++++     ...
T Consensus        10 ~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   83 (276)
T 2h6d_A           10 IGHYVL-GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STP   83 (276)
T ss_dssp             ETTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             eccEEE-EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecC
Confidence            467777 9999999999999999999999999999865421 222356788999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-  189 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-  189 (339)
                      ...++||||++ ++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.... 
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            78999999997 6999999888899999999999999999999999999999999999999999999999999987543 


Q ss_pred             ---------CCCcccccccccccc-CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          190 ---------ETDFMTEYVVTRWDT-LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       190 ---------~~~~~~~~~~~~~~~-~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                               ...|.+||....... ..+.|+|++|++++++++|..|+......  ............        ....
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~--------~~~~  233 (276)
T 2h6d_A          164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGGVFY--------IPEY  233 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCC--------CCTT
T ss_pred             CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcCccc--------Cchh
Confidence                     335778887665443 46799999999999999999887543211  111111111111        1134


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      ++.++.++|.+||+.||++|||+.++++||||+..
T Consensus       234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            78999999999999999999999999999999764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.2e-42  Score=308.38  Aligned_cols=252  Identities=22%  Similarity=0.362  Sum_probs=189.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHH-HHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIK-LLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.. ++.||+|+||.||+|.+..+|+.||+|++..... ......+..|+. +++.++||||+++++++     ...+
T Consensus        22 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~-----~~~~   94 (327)
T 3aln_A           22 EDLKD-LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGAL-----FREG   94 (327)
T ss_dssp             CSEEC--CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEE-----ECSS
T ss_pred             HHhhe-hheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEE-----EeCC
Confidence            45555 9999999999999999999999999999976532 333445556665 67778999999999999     5667


Q ss_pred             eEEEEEecCcccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          113 DVYIVYELMDTDLHQIIRS-----KQALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       113 ~~~iv~e~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      ..++||||++++|.+++..     ...+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++.
T Consensus        95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            8999999999998888763     57899999999999999999999998 99999999999999999999999999986


Q ss_pred             cc----------CCCCccccccc----cccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          187 TT----------SETDFMTEYVV----TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       187 ~~----------~~~~~~~~~~~----~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      ..          +...|.+||..    .......+.|+|++|++++++++|..|+......     ..............
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~  249 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLTQVVKGDPPQ  249 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCSCCCC
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHHHHhcCCCCC
Confidence            53          34458888876    3445677899999999999999999987643211     11111111111111


Q ss_pred             c-cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          253 F-SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       253 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      . ......+++.+.+||.+||+.||++|||+.++++||||....+.
T Consensus       250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER  295 (327)
T ss_dssp             CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence            1 11224589999999999999999999999999999999876543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.9e-42  Score=303.46  Aligned_cols=253  Identities=25%  Similarity=0.329  Sum_probs=197.5

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC---
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD---  107 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~---  107 (339)
                      .+.++|.. ++.||+|+||.||+|++..+|+.||+|++...   ....+.+.+|+.+++.++||||+++++++....   
T Consensus         3 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            3 RYASDFEE-IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred             cccccchh-hheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence            45677777 99999999999999999999999999998643   344577899999999999999999999874311   


Q ss_pred             -----cCCcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEe
Q 042681          108 -----KEKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC  180 (339)
Q Consensus       108 -----~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~  180 (339)
                           .......++||||++ ++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence                 023567899999997 6999999754 468899999999999999999999999999999999999999999999


Q ss_pred             eccccccc-------------------------CCCCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccc
Q 042681          181 DFGLARTT-------------------------SETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR  234 (339)
Q Consensus       181 Dfg~~~~~-------------------------~~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~  234 (339)
                      |||.+...                         +...|.+||..... ....+.|+|++|+++++++++   +...  ..
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p---~~~~--~~  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FSTG--ME  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC---CSSH--HH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc---cCCc--hh
Confidence            99998653                         23357788876543 567789999999999999972   2111  11


Q ss_pred             cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      ............   ...........++.+++||.+||+.||++|||+.++++||||....
T Consensus       234 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          234 RVNILKKLRSVS---IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             HHHHHHHHHSTT---CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             HHHHHHhccccc---cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence            111111111111   1111112245778899999999999999999999999999997643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-43  Score=323.15  Aligned_cols=258  Identities=24%  Similarity=0.309  Sum_probs=202.2

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC--------CCCeeeeeee
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT--------HENIVKVKDI  102 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~I~~~~~~  102 (339)
                      .+.++|.. ++.||+|+||.||+|++..+++.||+|++...   ....+.+.+|+.+++.++        |+||++++++
T Consensus        34 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           34 LFNGRYHV-IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             EETTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             hcCCeEEE-EEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            45688888 99999999999999999999999999999643   344567889999999885        7889999999


Q ss_pred             cCCCCcCCcCeEEEEEecCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeeeccCC----
Q 042681          103 IPPMDKEKFNDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANC----  175 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dikp~NIli~~~~----  175 (339)
                      +.... .....+++||||++++|.+.+...  +.+++..++.++.||+.||.|||++ ||+||||||+||+++.++    
T Consensus       110 ~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          110 FKISG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EEEEE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             eeecC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence            83211 155679999999999888888664  5799999999999999999999998 999999999999998775    


Q ss_pred             ---------------------------------------------CeEEeeccccccc--------CCCCcccccccccc
Q 042681          176 ---------------------------------------------DLKICDFGLARTT--------SETDFMTEYVVTRW  202 (339)
Q Consensus       176 ---------------------------------------------~ikL~Dfg~~~~~--------~~~~~~~~~~~~~~  202 (339)
                                                                   .++|+|||.+...        ++..|++||.....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTS
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCC
Confidence                                                         7999999998643        44568899988777


Q ss_pred             ccCCCCccHHHHHHHHHHHhCCCCCCcccccccc----hHHHHHhhCCCCCC-------------------CCcc-----
Q 042681          203 DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD----NARRYVKQLPHVPK-------------------QPFS-----  254 (339)
Q Consensus       203 ~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~----~~~~~~~~~~~~~~-------------------~~~~-----  254 (339)
                      .+..+.|+|++|++++++++|..|+.........    ............+.                   ....     
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence            7888999999999999999999998654322111    11111111110000                   0000     


Q ss_pred             ----------ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          255 ----------QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       255 ----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                                ......++.+++||.+||+.||++|||+.|+++||||++
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                      000123467889999999999999999999999999974

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.1e-42  Score=314.28  Aligned_cols=258  Identities=29%  Similarity=0.427  Sum_probs=199.3

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc-CCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK-EKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~-~~~  111 (339)
                      ..+|.. ++.||+|+||.||+|.+..+|+.||+|++.....      ...+|+.+++.++||||+++++++..... ...
T Consensus        53 ~~~y~~-~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           53 EVSYTD-TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             cceEEe-eeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            345766 9999999999999999999999999999865421      22479999999999999999998843211 223


Q ss_pred             CeEEEEEecCcccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC-CCeEEeeccccc
Q 042681          112 NDVYIVYELMDTDLHQIIR----SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLAR  186 (339)
Q Consensus       112 ~~~~iv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~-~~ikL~Dfg~~~  186 (339)
                      ..+++||||+++++.+.+.    ....+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||+++
T Consensus       126 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            3478999999988877664    35789999999999999999999999999999999999999965 568999999997


Q ss_pred             cc----------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHh------------
Q 042681          187 TT----------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK------------  243 (339)
Q Consensus       187 ~~----------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~------------  243 (339)
                      ..          +...|.+||+... ..+..+.|+|++|++++++++|..++......  .....+..            
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHHHH
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHh
Confidence            53          2345888887654 36778899999999999999999997653211  11111111            


Q ss_pred             hCCCCCCCCccc---------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCC
Q 042681          244 QLPHVPKQPFSQ---------KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE  299 (339)
Q Consensus       244 ~~~~~~~~~~~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~  299 (339)
                      .........+..         ..+.+++++++||.+||+.||.+|||+.|+++||||..+.+...
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  348 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV  348 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence            111111111100         11357899999999999999999999999999999998876543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.1e-42  Score=298.94  Aligned_cols=251  Identities=25%  Similarity=0.317  Sum_probs=206.6

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. ++.||+|+||.||++.+..+|+.+|+|++..........+.+.+|+.++++++||||+++++++..   ....
T Consensus         5 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   80 (279)
T 2w5a_A            5 AEDYEV-LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNT   80 (279)
T ss_dssp             GGGEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGT
T ss_pred             hhheee-ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCc
Confidence            456777 999999999999999999999999999998765566667889999999999999999999998732   3456


Q ss_pred             eEEEEEecCc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCCeeeccCCCeEEeec
Q 042681          113 DVYIVYELMD-TDLHQIIRSK----QALTDDHCQYFLYQLLRGLKYIHSAN-----VLHRDLKPSNLLLNANCDLKICDF  182 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~g-----ivH~dikp~NIli~~~~~ikL~Df  182 (339)
                      ..++||||++ ++|.+++...    ..+++..++.++.|++.||+|||+.|     ++||||||+||+++.++.++|+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            7999999997 6999998653    35999999999999999999999999     999999999999999999999999


Q ss_pred             cccccc-----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          183 GLARTT-----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       183 g~~~~~-----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      |.+...           +...|.+||.........+.|+|++|++++++++|..|+.....   .............   
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~~~~---  234 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREGKFR---  234 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCC---
T ss_pred             chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHhhcccc---
Confidence            998643           34458888888777777889999999999999999998765421   1111111111111   


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                         .....+++++.++|.+||+.||++|||+.++++|||+..-..
T Consensus       235 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          235 ---RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             ---cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence               111357899999999999999999999999999999986543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.5e-42  Score=301.69  Aligned_cols=247  Identities=24%  Similarity=0.344  Sum_probs=191.1

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHH-hhCCCCCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLL-CHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      .+.++|....+.||+|+||.||+|.+..+++.||+|++...       ..+.+|+.++ +.++||||+++++++.... .
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-A   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhc-C
Confidence            34566766348899999999999999999999999998643       4567888887 5568999999999983211 2


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc---CCCeEEeecc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFG  183 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~---~~~ikL~Dfg  183 (339)
                      .....++||||++ |+|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.   ++.++|+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            2567999999997 69999998754  6999999999999999999999999999999999999998   7889999999


Q ss_pred             cccccCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          184 LARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                      ++......           .+..+.|+|++|++++++++|..|+..........  .................+..++++
T Consensus       166 ~a~~~~~~-----------~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (299)
T 3m2w_A          166 FAKETTGE-----------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKTRIRMGQYEFPNPEWSEVSEE  232 (299)
T ss_dssp             TCEECTTC-----------GGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--CSCCSSCTTCCSSCHHHHTTSCHH
T ss_pred             cccccccc-----------cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--HHHHHHhhccccCCchhcccCCHH
Confidence            99766542           34557899999999999999999975432111000  000000000000001111458999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          264 AIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      +++||.+||+.||++|||+.++++||||+......
T Consensus       233 ~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~  267 (299)
T 3m2w_A          233 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP  267 (299)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence            99999999999999999999999999999876543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7e-43  Score=311.07  Aligned_cols=266  Identities=21%  Similarity=0.261  Sum_probs=188.9

Q ss_pred             EEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeee
Q 042681           22 QYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKD  101 (339)
Q Consensus        22 ~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~  101 (339)
                      +--.....+.+.++|.+..+.||+|+||.||+|.+..+|+.||+|++...   .   ....+....++.++||||+++++
T Consensus        16 ~~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~   89 (336)
T 3fhr_A           16 FQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILD   89 (336)
T ss_dssp             ----CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             ccCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHH
Confidence            33445566788999998455799999999999999999999999998643   1   11122233356678999999999


Q ss_pred             ecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc---CC
Q 042681          102 IIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NC  175 (339)
Q Consensus       102 ~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~---~~  175 (339)
                      ++.... .....+++||||++ |+|.+++....  .+++..++.++.||+.||.|||++|++||||||+||+++.   ++
T Consensus        90 ~~~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~  168 (336)
T 3fhr_A           90 VYENMH-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDA  168 (336)
T ss_dssp             EEEEEE-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTC
T ss_pred             HHhhcc-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCc
Confidence            984321 22456899999997 59999998753  6999999999999999999999999999999999999986   44


Q ss_pred             CeEEeecccccccC---------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC
Q 042681          176 DLKICDFGLARTTS---------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP  246 (339)
Q Consensus       176 ~ikL~Dfg~~~~~~---------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  246 (339)
                      .++|+|||.+....         +..|.+||......+..+.|+|++|++++++++|..|+...........  ......
T Consensus       169 ~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~  246 (336)
T 3fhr_A          169 VLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIR  246 (336)
T ss_dssp             CEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             eEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhh
Confidence            59999999986543         3457888887766777889999999999999999999754332111000  000001


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       247 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ..........+..+++++++||.+||+.||++|||+.++++||||+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  296 (336)
T 3fhr_A          247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV  296 (336)
T ss_dssp             ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred             ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence            11111111223568999999999999999999999999999999987654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.3e-42  Score=304.36  Aligned_cols=259  Identities=19%  Similarity=0.286  Sum_probs=186.9

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCc---eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIP  104 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~  104 (339)
                      ......++|.. ++.||+|+||.||+|.+..++.   .+|+|++..........+.+.+|+.+++.++||||+++++++.
T Consensus        17 ~~~i~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           17 DVLIPEQQFTL-GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             TTBCC---CEE-EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hcccChhHeEE-eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            34445566766 9999999999999999887775   8999999876555666788999999999999999999999984


Q ss_pred             CCCcC-CcCeEEEEEecCc-ccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC
Q 042681          105 PMDKE-KFNDVYIVYELMD-TDLHQIIRSKQ------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD  176 (339)
Q Consensus       105 ~~~~~-~~~~~~iv~e~~~-g~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~  176 (339)
                      ..... .....++||||+. |+|.+++....      .+++..++.++.||+.||.|||++|++||||||+||+++.++.
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence            32110 0112499999998 69999986532      6999999999999999999999999999999999999999999


Q ss_pred             eEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHH
Q 042681          177 LKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYV  242 (339)
Q Consensus       177 ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~  242 (339)
                      ++|+|||.+.....             ..|.+|+......+..+.|+|++|++++++++ |..|+......   ......
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~  252 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNYL  252 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHHH
Confidence            99999999865322             24778887777777888999999999999999 88887643221   111111


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCCCCCCCcc
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRIT-------VEEALNHPYLSSLHE  296 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-------~~ell~hp~f~~~~~  296 (339)
                      .......      ..+.+++++.+||.+||+.||++|||       ++++++|||+.....
T Consensus       253 ~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          253 IGGNRLK------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             HTTCCCC------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             hcCCCCC------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence            1111111      12468899999999999999999999       788889999987644

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=302.30  Aligned_cols=243  Identities=22%  Similarity=0.343  Sum_probs=203.6

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. .+.||+|+||.||+|.+..+++.+|+|++...  .....+.+.+|+.+++.++||||+++++++     ....
T Consensus         9 ~~~~~~-~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   80 (310)
T 3s95_A            9 PSDLIH-GEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVL-----YKDK   80 (310)
T ss_dssp             GGGEEE-EEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETT
T ss_pred             hhHeec-cceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEE-----ecCC
Confidence            566777 99999999999999999999999999988543  455667899999999999999999999999     6678


Q ss_pred             eEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          113 DVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ..++||||++ ++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+...  
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            8999999997 699999987 578999999999999999999999999999999999999999999999999998543  


Q ss_pred             -----------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc---chHHHHH
Q 042681          189 -----------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS---DNARRYV  242 (339)
Q Consensus       189 -----------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~---~~~~~~~  242 (339)
                                             ++..|.+||......+..+.|+|++|++++++++|..++........   .......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~  240 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL  240 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence                                   44458889988877788899999999999999999888654322111   1111111


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      ...          ..+.+++.+.+||.+||+.||++|||+.++++  |++.+.
T Consensus       241 ~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          241 DRY----------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             HHT----------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             ccc----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence            111          11457889999999999999999999999987  455554

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=297.00  Aligned_cols=245  Identities=25%  Similarity=0.349  Sum_probs=194.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ...||+|+||.||+|.+..+++.||+|.+...  .....+.+.+|+.+++.++||||+++++++     ...+..++|||
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e   99 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSF-----SENGFIKIFME   99 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEEEEEE
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEE-----EeCCcEEEEEE
Confidence            56899999999999999999999999998754  233456788999999999999999999999     66778999999


Q ss_pred             cCc-ccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-CCCeEEeecccccccC-----
Q 042681          120 LMD-TDLHQIIRSK---QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARTTS-----  189 (339)
Q Consensus       120 ~~~-g~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-~~~ikL~Dfg~~~~~~-----  189 (339)
                      |++ ++|.+++...   ..+++..++.++.|++.||.|||++|++|+||||+||+++. ++.++|+|||.+....     
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~  179 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC  179 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence            997 7999998764   35678999999999999999999999999999999999987 8999999999986542     


Q ss_pred             ------CCCcccccccccc--ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          190 ------ETDFMTEYVVTRW--DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       190 ------~~~~~~~~~~~~~--~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                            ...|.+||.....  ....+.|+|++|++++++++|..|+.............. .. ...+     .....++
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~-~~~~-----~~~~~~~  252 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MF-KVHP-----EIPESMS  252 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH-HH-CCCC-----CCCTTSC
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc-cc-cccc-----cccccCC
Confidence                  3357778776543  356789999999999999999999764322211111111 11 1111     1124589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      +++++||.+||+.||++|||+.++++||||+.....+
T Consensus       253 ~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  289 (295)
T 2clq_A          253 AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK  289 (295)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-----
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccC
Confidence            9999999999999999999999999999999876543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=304.65  Aligned_cols=258  Identities=23%  Similarity=0.359  Sum_probs=204.7

Q ss_pred             ccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecC
Q 042681           26 LGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIP  104 (339)
Q Consensus        26 ~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~  104 (339)
                      ........++|.. ++.||+|+||.||+|.+..+|+.+|+|++.....   ....+.+|+.+++++ +||||+++++++.
T Consensus        16 ~~~l~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           16 LSALRDPAGIFEL-VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             CCCCCCCTTTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             chhccCCCCcEEE-EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            3455566788888 9999999999999999999999999999865432   236788999999998 7999999999984


Q ss_pred             CCCc-CCcCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEe
Q 042681          105 PMDK-EKFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC  180 (339)
Q Consensus       105 ~~~~-~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~  180 (339)
                      .... ......++||||++ ++|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence            3210 11467899999998 5999999764  579999999999999999999999999999999999999999999999


Q ss_pred             eccccccc-----------CCCCcccccccc-----ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh
Q 042681          181 DFGLARTT-----------SETDFMTEYVVT-----RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ  244 (339)
Q Consensus       181 Dfg~~~~~-----------~~~~~~~~~~~~-----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~  244 (339)
                      |||++...           +...|.+||...     ......+.|+|++|++++++++|..|+......  ..... ...
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~-~~~  248 (326)
T 2x7f_A          172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--RALFL-IPR  248 (326)
T ss_dssp             CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH-HHH
T ss_pred             eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHH-hhc
Confidence            99998643           234578888765     345677899999999999999999987543211  11111 111


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       245 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      ...   ..  .....+++.+++||.+||+.||.+||++.++++||||+...
T Consensus       249 ~~~---~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          249 NPA---PR--LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             SCC---CC--CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             Ccc---cc--CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            111   11  11245799999999999999999999999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=303.25  Aligned_cols=249  Identities=29%  Similarity=0.422  Sum_probs=199.7

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ..++|.. ++.||+|+||.||+|.+..+|+.||+|++....    ..+.+.+|+.+++.++||||+++++++     ...
T Consensus        27 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   96 (314)
T 3com_A           27 PEEVFDV-LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSY-----FKN   96 (314)
T ss_dssp             ---CEEE-EEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEE-----EET
T ss_pred             chhhhhh-heeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEE-----EeC
Confidence            3455666 999999999999999999999999999987542    235688999999999999999999999     666


Q ss_pred             CeEEEEEecCc-ccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          112 NDVYIVYELMD-TDLHQIIR-SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ...++||||++ ++|.+++. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            78999999998 59999986 45789999999999999999999999999999999999999999999999999986432


Q ss_pred             -----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          190 -----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       190 -----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                 ...|.+|+......+..+.|+|++|++++++++|..|+.......  . ......... ...   ....
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~-~~~~~~~~~-~~~---~~~~  249 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--A-IFMIPTNPP-PTF---RKPE  249 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--H-HHHHHHSCC-CCC---SSGG
T ss_pred             hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--H-HHHHhcCCC-ccc---CCcc
Confidence                       335778888777778889999999999999999999876432211  1 111111111 111   1113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      .++..+.+||.+||+.||++|||+.++++||||+.....
T Consensus       250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          250 LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence            478999999999999999999999999999999877543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.5e-42  Score=303.41  Aligned_cols=252  Identities=19%  Similarity=0.283  Sum_probs=190.6

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||.||+|.+..+|+.||+|++..........+.+.++..+++.++||||+++++++     .....
T Consensus        25 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-----~~~~~   98 (318)
T 2dyl_A           25 NDLEN-LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF-----ITNTD   98 (318)
T ss_dssp             GGEEE-EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSE
T ss_pred             ccccc-cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE-----ecCCc
Confidence            45666 8999999999999999999999999999976543333334455555678888999999999999     56678


Q ss_pred             EEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          114 VYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .++||||+++.+..+... ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||.+...   
T Consensus        99 ~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A           99 VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             EEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            999999997666666544 57899999999999999999999995 9999999999999999999999999998543   


Q ss_pred             -------CCCCcccccccc-----ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          189 -------SETDFMTEYVVT-----RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       189 -------~~~~~~~~~~~~-----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                             +...|.+||...     ......+.|+|++|++++++++|..|+...... ............  .   ....
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~--~---~~~~  252 (318)
T 2dyl_A          179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-FEVLTKVLQEEP--P---LLPG  252 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHHHHHHHHSCC--C---CCCS
T ss_pred             ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-HHHHHHHhccCC--C---CCCc
Confidence                   345688888773     345677899999999999999999887643211 111112211111  1   1111


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ...+++++.+||.+||+.||.+||++.++++||||+.....
T Consensus       253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (318)
T 2dyl_A          253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL  293 (318)
T ss_dssp             SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHS
T ss_pred             cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccc
Confidence            23579999999999999999999999999999999876553

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3e-42  Score=307.02  Aligned_cols=255  Identities=27%  Similarity=0.423  Sum_probs=201.7

Q ss_pred             cccCccCCCccccccccceEEEEEEe-CCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCC------Ceeeeeeec
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVN-SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE------NIVKVKDII  103 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~I~~~~~~~  103 (339)
                      .+.++|.+ ++.||+|+||.||+|.+ ..+++.||+|++...   ....+.+.+|+.+++.++|+      +++++++++
T Consensus        11 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           11 VLSARYEI-VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             EETTTEEE-EEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             CccCceEE-EEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            35677888 99999999999999998 567899999998643   33456778899998888655      499999998


Q ss_pred             CCCCcCCcCeEEEEEecCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc--------
Q 042681          104 PPMDKEKFNDVYIVYELMDTDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA--------  173 (339)
Q Consensus       104 ~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~--------  173 (339)
                           ...+..++||||++++|.+++...+  ++++..++.++.||+.||.|||++|++||||||+||+++.        
T Consensus        87 -----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           87 -----EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             -----EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             -----ccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence                 6677899999999999999998765  6899999999999999999999999999999999999987        


Q ss_pred             -----------CCCeEEeeccccccc--------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccc
Q 042681          174 -----------NCDLKICDFGLARTT--------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR  234 (339)
Q Consensus       174 -----------~~~ikL~Dfg~~~~~--------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~  234 (339)
                                 ++.++|+|||.+...        ++..|.+||......+..+.|+|++|++++++++|..|+.......
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             CccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                       678999999998643        3446888988877778889999999999999999999876432111


Q ss_pred             cchHHHHHhhCCCCCC------------------------------------CCccccCCCCCHHHHHHHHHhcccCCCC
Q 042681          235 SDNARRYVKQLPHVPK------------------------------------QPFSQKFPNMSPVAIDLAERMLVFDPAK  278 (339)
Q Consensus       235 ~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~  278 (339)
                        ............+.                                    ..........++++.+||.+||+.||++
T Consensus       242 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          242 --HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             --HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             --HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence              01111000000000                                    0000011224577899999999999999


Q ss_pred             CCCHHHHhcCCCCCCCcc
Q 042681          279 RITVEEALNHPYLSSLHE  296 (339)
Q Consensus       279 Rps~~ell~hp~f~~~~~  296 (339)
                      |||+.|+++||||+.++.
T Consensus       320 Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          320 RITLREALKHPFFDLLKK  337 (339)
T ss_dssp             SCCHHHHTTSGGGGGGGC
T ss_pred             ccCHHHHhcCHHHHHHhc
Confidence            999999999999998754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8.1e-42  Score=301.32  Aligned_cols=250  Identities=20%  Similarity=0.259  Sum_probs=200.9

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC--CCCeeeeeeecCCCCcCC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT--HENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~I~~~~~~~~~~~~~~  110 (339)
                      .++|.. ++.||+|+||.||++.+. +++.+|+|++..........+.+.+|+.++..++  ||||+++++++     ..
T Consensus        27 ~~~y~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~   99 (313)
T 3cek_A           27 GRIYSI-LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----IT   99 (313)
T ss_dssp             TEEEEE-EEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE-----EC
T ss_pred             cceEEE-EEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe-----ec
Confidence            344666 999999999999999986 4889999999776556666788999999999997  59999999998     56


Q ss_pred             cCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          111 FNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       111 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ....++|||+.+++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++ ++.++|+|||.+...  
T Consensus       100 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          100 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            67899999987899999999988999999999999999999999999999999999999996 489999999998643  


Q ss_pred             -----------CCCCccccccccc-----------cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC
Q 042681          189 -----------SETDFMTEYVVTR-----------WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP  246 (339)
Q Consensus       189 -----------~~~~~~~~~~~~~-----------~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  246 (339)
                                 +...|.+||....           .....+.|+|++|++++++++|..|+....... ........   
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~---  254 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIID---  254 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHC---
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-HHHHHHHh---
Confidence                       3445778887653           346667999999999999999999876432111 11111111   


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       247 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      ......   .....++++.+||.+||+.||++|||+.++++||||+....+
T Consensus       255 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          255 PNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             TTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             cccccC---CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            111111   113468899999999999999999999999999999876544

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.2e-42  Score=306.89  Aligned_cols=257  Identities=20%  Similarity=0.304  Sum_probs=202.6

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChH---------------hHHHHHHHHHHHhhCCCCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI---------------DAKRILREIKLLCHMTHEN   95 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~---------------~~~~~~~e~~~l~~l~h~~   95 (339)
                      ...++|.. ++.||+|+||.||+|.+  +|+.||+|++........               ..+.+.+|+.++..++|||
T Consensus        28 ~~~~~y~~-~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           28 KYINDYRI-IRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             EEETTEEE-EEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             cccCceEE-EEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            34578888 99999999999999998  899999999975422211               1277899999999999999


Q ss_pred             eeeeeeecCCCCcCCcCeEEEEEecCc-ccHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCC
Q 042681           96 IVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQI------IRS--KQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLK  165 (339)
Q Consensus        96 I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~------l~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dik  165 (339)
                      |+++++++     ...+..++||||++ ++|.++      +..  ...+++..++.++.|++.||.|||+ +|++|||||
T Consensus       105 i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~  179 (348)
T 2pml_X          105 CLTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK  179 (348)
T ss_dssp             BCCCSEEE-----ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred             cceEEEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence            99999999     66678999999998 599888      655  5789999999999999999999999 999999999


Q ss_pred             CCCeeeccCCCeEEeeccccccc---------CCCCcccccccccc-ccCC-CCccHHHHHHHHHHHhCCCCCCcccccc
Q 042681          166 PSNLLLNANCDLKICDFGLARTT---------SETDFMTEYVVTRW-DTLF-PGKDYVQQLTMITELLGSPDDSDLGFLR  234 (339)
Q Consensus       166 p~NIli~~~~~ikL~Dfg~~~~~---------~~~~~~~~~~~~~~-~~~~-~~d~~~~g~~~~~~l~g~~~~~~~~~~~  234 (339)
                      |+||+++.++.++|+|||.+...         +...|.+||..... .... +.|+|++|++++++++|..|+...... 
T Consensus       180 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-  258 (348)
T 2pml_X          180 PSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-  258 (348)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-
T ss_pred             hHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-
Confidence            99999999999999999998753         33458888877655 3434 899999999999999999987643221 


Q ss_pred             cchHHHHHhhCCCCCCCC-----------ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          235 SDNARRYVKQLPHVPKQP-----------FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ..............+...           .......+++++++||.+||+.||++|||+.++++||||+....
T Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~  331 (348)
T 2pml_X          259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI  331 (348)
T ss_dssp             HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred             HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence            111111111111111000           00011458999999999999999999999999999999988754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.1e-41  Score=296.22  Aligned_cols=247  Identities=23%  Similarity=0.338  Sum_probs=204.4

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ..++|.. ++.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.++..++||||+++++++     ...
T Consensus        20 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   92 (303)
T 3a7i_A           20 PEELFTK-LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKD   92 (303)
T ss_dssp             GGGTEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEE-----EET
T ss_pred             hHHHHHH-hhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecC
Confidence            4455666 9999999999999999999999999999875432 23467889999999999999999999999     566


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-  189 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-  189 (339)
                      ...++||||++ ++|.+++.. +++++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.... 
T Consensus        93 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           93 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            78999999998 588888764 689999999999999999999999999999999999999999999999999986532 


Q ss_pred             ----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          190 ----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       190 ----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                ...|.+||.........+.|+|++|++++++++|..|+......   ...........   .   .....
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~---~---~~~~~  242 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFLIPKNNP---P---TLEGN  242 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCC---C---CCCSS
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHHhhcCCC---C---CCccc
Confidence                      33477888877777788899999999999999999987643211   11111111111   1   11245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      ++..+++||.+||+.||++|||+.++++||||....
T Consensus       243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            789999999999999999999999999999997543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.7e-42  Score=304.39  Aligned_cols=251  Identities=21%  Similarity=0.299  Sum_probs=203.0

Q ss_pred             EEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh----HhHHHHHHHHHHHhhCC--CCCee
Q 042681           24 NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR----IDAKRILREIKLLCHMT--HENIV   97 (339)
Q Consensus        24 ~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~I~   97 (339)
                      ......-.+.++|.. ++.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.+++.++  ||||+
T Consensus        33 ~~~~~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~  111 (320)
T 3a99_A           33 APGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI  111 (320)
T ss_dssp             -------CCTTTEEE-EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             CcccccCCccCceEE-EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence            334445567788888 999999999999999999999999999997653221    12245678999999996  59999


Q ss_pred             eeeeecCCCCcCCcCeEEEEEecCc--ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec-cC
Q 042681           98 KVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN-AN  174 (339)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~iv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~-~~  174 (339)
                      ++++++     ......++|+|++.  ++|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++ .+
T Consensus       112 ~~~~~~-----~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          112 RLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR  186 (320)
T ss_dssp             CEEEEE-----ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred             EEEEEE-----ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCC
Confidence            999999     66778999999996  79999999888999999999999999999999999999999999999999 78


Q ss_pred             CCeEEeecccccccC---------CCCcccccccccccc-CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh
Q 042681          175 CDLKICDFGLARTTS---------ETDFMTEYVVTRWDT-LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ  244 (339)
Q Consensus       175 ~~ikL~Dfg~~~~~~---------~~~~~~~~~~~~~~~-~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~  244 (339)
                      +.+||+|||++....         +..|.+||....... ..+.|+|++|++++++++|..|+....        .....
T Consensus       187 ~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~~~  258 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRG  258 (320)
T ss_dssp             TEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHHC
T ss_pred             CCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hhhcc
Confidence            899999999986543         335777876654443 466799999999999999998865321        11111


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       245 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ...        ....+++++.+||.+||+.||++|||+.++++||||++...
T Consensus       259 ~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          259 QVF--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             CCC--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             ccc--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence            111        11457999999999999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.9e-41  Score=297.75  Aligned_cols=240  Identities=20%  Similarity=0.249  Sum_probs=197.3

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCce---EEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEE---VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~---~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      .++|.+ .+.||+|+||.||++.+..+++.   ||+|++... ......+.+.+|+.++..++||||+++++++     .
T Consensus        48 ~~~y~i-~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~  120 (325)
T 3kul_A           48 ASRIHI-EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T  120 (325)
T ss_dssp             GGGEEE-EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred             hhHeEE-eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            456666 99999999999999999866654   999998754 2344567889999999999999999999999     6


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .....++||||++ ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            6778999999997 6999999754 6899999999999999999999999999999999999999999999999999975


Q ss_pred             cCC--------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          188 TSE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       188 ~~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      ...              ..|.+||......+..+.|+|++|++++++++ |..|+......   ............+   
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~~~~~~~---  274 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISSVEEGYRLP---  274 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHHTTCCCC---
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcCCCCC---
Confidence            432              13788888776777888999999999999998 88887543211   1111112111111   


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                         ....+++++.+||.+||+.||++|||+.++++.
T Consensus       275 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          275 ---APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               114689999999999999999999999999864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1e-41  Score=305.64  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=201.3

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCC-ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCC------eeeeeeecC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETK-EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN------IVKVKDIIP  104 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------I~~~~~~~~  104 (339)
                      +.++|.+ ++.||+|+||.||+|.+..++ +.||+|++...   ....+.+.+|+.+++.++|++      ++.+++++ 
T Consensus        17 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-   91 (355)
T 2eu9_A           17 LQERYEI-VGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-   91 (355)
T ss_dssp             ETTTEEE-EEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-
T ss_pred             ecccEEE-EEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-
Confidence            4678888 999999999999999998877 68999998643   334567788999998887655      89999988 


Q ss_pred             CCCcCCcCeEEEEEecCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee-----------
Q 042681          105 PMDKEKFNDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL-----------  171 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli-----------  171 (339)
                          ...+..++||||+++++.+.+...  ..+++..++.++.||+.||.|||++||+||||||+||++           
T Consensus        92 ----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           92 ----NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             ----EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             ----eeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence                667789999999999998888765  479999999999999999999999999999999999999           


Q ss_pred             --------ccCCCeEEeeccccccc--------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc
Q 042681          172 --------NANCDLKICDFGLARTT--------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS  235 (339)
Q Consensus       172 --------~~~~~ikL~Dfg~~~~~--------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~  235 (339)
                              +.++.++|+|||.+...        ++..|.+||......+..+.|+|++|++++++++|..|+........
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                    56789999999998643        34468889988777788899999999999999999999865332110


Q ss_pred             chHHHHHhhCCCCCC------------------------------------CCccccCCCCCHHHHHHHHHhcccCCCCC
Q 042681          236 DNARRYVKQLPHVPK------------------------------------QPFSQKFPNMSPVAIDLAERMLVFDPAKR  279 (339)
Q Consensus       236 ~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R  279 (339)
                        ...........+.                                    ..........+.++.+||.+||+.||++|
T Consensus       248 --~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          248 --LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             --HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             --HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence              0111110000000                                    00000011234578999999999999999


Q ss_pred             CCHHHHhcCCCCCCCccC
Q 042681          280 ITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       280 ps~~ell~hp~f~~~~~~  297 (339)
                      ||+.|+++||||+.+.+.
T Consensus       326 pt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          326 ITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             CCHHHHTTSGGGGGCCHH
T ss_pred             cCHHHHhcChhhcCCChh
Confidence            999999999999988653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.2e-41  Score=301.74  Aligned_cols=239  Identities=21%  Similarity=0.339  Sum_probs=195.3

Q ss_pred             CccCCCccccccccceEEEEEEeC-------CCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNS-------ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPP  105 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~  105 (339)
                      ++|.. ++.||+|+||.||+|++.       .++..||+|+++.. ......+.+.+|+.+++.+ +||||+++++++  
T Consensus        81 ~~~~~-~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--  156 (370)
T 2psq_A           81 DKLTL-GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--  156 (370)
T ss_dssp             GGEEE-EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE--
T ss_pred             HHCEe-eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence            45555 999999999999999864       34567999998754 3344567899999999999 899999999999  


Q ss_pred             CCcCCcCeEEEEEecCc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 042681          106 MDKEKFNDVYIVYELMD-TDLHQIIRSKQ----------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN  168 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~N  168 (339)
                         ...+.+++||||++ |+|.+++...+                .+++..++.++.||+.||+|||++||+||||||+|
T Consensus       157 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          157 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             ---ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence               66678999999998 69999997643                48999999999999999999999999999999999


Q ss_pred             eeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccc
Q 042681          169 LLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLR  234 (339)
Q Consensus       169 Ili~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~  234 (339)
                      |+++.++.+||+|||+++....             ..|.+||......+..+.|+|++|+++|++++ |..|+.....  
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--  311 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  311 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            9999999999999999874322             24888888777778888999999999999998 8888765432  


Q ss_pred             cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                       ..............      ....+++++.+||.+||+.||++||++.+++++
T Consensus       312 -~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          312 -EELFKLLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             -GGHHHHHHTTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             11122222211111      124588999999999999999999999999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-41  Score=308.63  Aligned_cols=259  Identities=25%  Similarity=0.316  Sum_probs=199.4

Q ss_pred             cccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CC-----Ceeeee
Q 042681           27 GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HE-----NIVKVK  100 (339)
Q Consensus        27 ~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~I~~~~  100 (339)
                      ...-.+.++|.. ++.||+|+||.||+|.+..+++.||+|++...   ......+.+|+.++..++ |+     +|++++
T Consensus        47 ~~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           47 KNGEKWMDRYEI-DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CTTCEETTTEEE-EEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             ecCCEeeeeEEE-EEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            334455678888 99999999999999999999999999999743   333456777888888774 44     499999


Q ss_pred             eecCCCCcCCcCeEEEEEecCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCCeeec--cC
Q 042681          101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLN--AN  174 (339)
Q Consensus       101 ~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~givH~dikp~NIli~--~~  174 (339)
                      +++     ......++||||++++|.+++...  +.+++..++.++.|++.||.|||  +.||+||||||+||+++  .+
T Consensus       123 ~~~-----~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~  197 (382)
T 2vx3_A          123 RHF-----MFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR  197 (382)
T ss_dssp             EEE-----EETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS
T ss_pred             eee-----ccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC
Confidence            998     666889999999999999999765  56999999999999999999999  57999999999999995  47


Q ss_pred             CCeEEeeccccccc--------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC
Q 042681          175 CDLKICDFGLARTT--------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP  246 (339)
Q Consensus       175 ~~ikL~Dfg~~~~~--------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  246 (339)
                      +.+||+|||+++..        ++..|.+||......+..+.|+|++|++++++++|..|+......  ...........
T Consensus       198 ~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~--~~~~~i~~~~~  275 (382)
T 2vx3_A          198 SAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV--DQMNKIVEVLG  275 (382)
T ss_dssp             CCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHC
T ss_pred             CcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC
Confidence            78999999998654        344588899888777888999999999999999999998643211  11111111000


Q ss_pred             CCC------------------CC------------Cccc-cC------------------CC-------CCHHHHHHHHH
Q 042681          247 HVP------------------KQ------------PFSQ-KF------------------PN-------MSPVAIDLAER  270 (339)
Q Consensus       247 ~~~------------------~~------------~~~~-~~------------------~~-------~s~~~~~li~~  270 (339)
                      ..+                  ..            .... ..                  .+       .++++++||.+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  355 (382)
T 2vx3_A          276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR  355 (382)
T ss_dssp             SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence            000                  00            0000 00                  00       01478999999


Q ss_pred             hcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          271 MLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       271 ~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      ||+.||++|||+.|+|+||||+...+
T Consensus       356 mL~~dP~~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          356 MLDYDPKTRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             HTCSCTTTSCCHHHHTTSGGGCC---
T ss_pred             hcCCChhhCCCHHHHhcCcccccCCC
Confidence            99999999999999999999987643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-40  Score=287.14  Aligned_cols=238  Identities=20%  Similarity=0.252  Sum_probs=194.7

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ..++|.. ++.||+|+||.||++.+. ++..+|+|++......   .+.+.+|+.++.+++||||+++++++     ...
T Consensus         6 ~~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~   75 (268)
T 3sxs_A            6 KREEITL-LKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVC-----SKE   75 (268)
T ss_dssp             CGGGEEE-EEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEE-----CSS
T ss_pred             chhheee-eeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEE-----ccC
Confidence            3456666 999999999999999876 5678999999754332   35688999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          112 NDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ...++||||++ ++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+....
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           76 YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL  155 (268)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred             CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecc
Confidence            78999999997 6899999765 459999999999999999999999999999999999999999999999999986543


Q ss_pred             CC------------CccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          190 ET------------DFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       190 ~~------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      ..            .|.+||.........+.|+|++|++++++++ |..|+......   ..............      
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~~~------  226 (268)
T 3sxs_A          156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVVLKVSQGHRLYR------  226 (268)
T ss_dssp             TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTTCCCCC------
T ss_pred             hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHHHHHHcCCCCCC------
Confidence            22            3788888777778889999999999999998 88886543211   11111111111111      


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ...+++.+.++|.+||+.||++|||+.+++++
T Consensus       227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            13468999999999999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=298.79  Aligned_cols=248  Identities=22%  Similarity=0.303  Sum_probs=192.0

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh----HhHHHHHHHHHHHhhC----CCCCeeee
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR----IDAKRILREIKLLCHM----THENIVKV   99 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~~I~~~   99 (339)
                      ..-.+.++|.. .+.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.++.++    +||||+++
T Consensus        25 ~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           25 DREAFEAEYRL-GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             --------CEE-EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             chhhhhhceEE-eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            34556778888 999999999999999999999999999996543221    1223456788888888    89999999


Q ss_pred             eeecCCCCcCCcCeEEEEEec-Cc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec-cCCC
Q 042681          100 KDIIPPMDKEKFNDVYIVYEL-MD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN-ANCD  176 (339)
Q Consensus       100 ~~~~~~~~~~~~~~~~iv~e~-~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~-~~~~  176 (339)
                      ++++     ......++|+|+ +. ++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++ .++.
T Consensus       104 ~~~~-----~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          104 LDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EEEC----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE
T ss_pred             EEEE-----ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe
Confidence            9998     556778999998 55 79999999888999999999999999999999999999999999999999 8899


Q ss_pred             eEEeecccccccC---------CCCcccccccccccc-CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC
Q 042681          177 LKICDFGLARTTS---------ETDFMTEYVVTRWDT-LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP  246 (339)
Q Consensus       177 ikL~Dfg~~~~~~---------~~~~~~~~~~~~~~~-~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  246 (339)
                      ++|+|||.+....         ...|.+||....... ..+.|+|++|++++++++|..++...        ........
T Consensus       179 ~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~  250 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--------QEILEAEL  250 (312)
T ss_dssp             EEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------HHHHHTCC
T ss_pred             EEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh--------HHHhhhcc
Confidence            9999999986543         345777876654443 34789999999999999999886532        11112111


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       247 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                      .        ....++.++++||.+||+.||++|||+.++++||||+...+.
T Consensus       251 ~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~  293 (312)
T 2iwi_A          251 H--------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED  293 (312)
T ss_dssp             C--------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred             C--------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence            1        114578999999999999999999999999999999987653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4e-41  Score=294.38  Aligned_cols=247  Identities=17%  Similarity=0.226  Sum_probs=194.0

Q ss_pred             cCccCCCccccccccceEEEEEE----eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      .++|.. ++.||+|+||.||+|+    +..+++.||+|++...  .....+.+.+|+.++..++||||+++++++..   
T Consensus         9 ~~~~~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   82 (295)
T 3ugc_A            9 ERHLKF-LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---   82 (295)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---
T ss_pred             HHHhhh-hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence            445555 9999999999999998    6778999999998753  44456788999999999999999999998832   


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      .....+++||||++ ++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            23355899999997 6999999775 459999999999999999999999999999999999999999999999999997


Q ss_pred             ccCC--------------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc----------chHHHHH
Q 042681          187 TTSE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS----------DNARRYV  242 (339)
Q Consensus       187 ~~~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~----------~~~~~~~  242 (339)
                      ....              ..|.+||......+..+.|+|++|++++++++|..++...+....          .......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            5432              127888887777788899999999999999999887654321100          0000111


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .........   .....+++++.+||.+||+.||++|||+.++++.
T Consensus       243 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          243 ELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             HHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHhccCcC---CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            111111111   1124689999999999999999999999999863

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-40  Score=287.79  Aligned_cols=237  Identities=19%  Similarity=0.265  Sum_probs=193.9

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. ++.||+|+||.||++.+. +++.+|+|++......   .+.+.+|+.++++++||||+++++++     ....
T Consensus         9 ~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~   78 (269)
T 4hcu_A            9 PSELTF-VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQA   78 (269)
T ss_dssp             GGGEEE-EEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred             hhhcee-eheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCC
Confidence            355666 999999999999999987 4678999999765333   35688999999999999999999999     6667


Q ss_pred             eEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC
Q 042681          113 DVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  190 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~  190 (339)
                      ..++||||++ ++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            7999999997 6999999654 5699999999999999999999999999999999999999999999999999864321


Q ss_pred             ------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          191 ------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       191 ------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                  ..|.+||.........+.|+|++|++++++++ |..|+.....   ..............      ..
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~~~~~------~~  229 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRLY------KP  229 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCC------CC
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcCccCC------CC
Confidence                        24888888777778888999999999999999 8888654321   11111111111111      11


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..+++++.+++.+||+.||++|||+.++++|
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            3478999999999999999999999999976

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3e-40  Score=287.64  Aligned_cols=242  Identities=19%  Similarity=0.280  Sum_probs=194.6

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhH-----HHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-----KRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      ..++|.. .+.||+|+||.||+|.+..+++.||+|++..........     +.+.+|+.+++.++||||+++++++   
T Consensus        17 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---   92 (287)
T 4f0f_A           17 ADNEIEY-EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM---   92 (287)
T ss_dssp             CSTTEEE-EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             hhcccee-hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee---
Confidence            3466666 999999999999999999999999999986543322211     6788999999999999999999998   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeeeccCCC-----e
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCD-----L  177 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dikp~NIli~~~~~-----i  177 (339)
                        ....  ++||||++ ++|.+.+... ..+++..++.++.|++.||.|||++|  ++||||||+||+++.++.     +
T Consensus        93 --~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           93 --HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             --TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             --cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence              3333  69999998 7998888654 57999999999999999999999999  999999999999988776     9


Q ss_pred             EEeeccccccc--------CCCCccccccc--cccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC
Q 042681          178 KICDFGLARTT--------SETDFMTEYVV--TRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH  247 (339)
Q Consensus       178 kL~Dfg~~~~~--------~~~~~~~~~~~--~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  247 (339)
                      +|+|||.+...        ++..|.+||..  ....+..+.|+|++|++++++++|..|+....................
T Consensus       169 kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  248 (287)
T 4f0f_A          169 KVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR  248 (287)
T ss_dssp             EECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred             EeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence            99999998643        34568888876  344566789999999999999999999865443322222222221111


Q ss_pred             CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          248 VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       248 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ..      ....+++++.+||.+||+.||++|||+.++++
T Consensus       249 ~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          249 PT------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            11      12468999999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=305.15  Aligned_cols=244  Identities=19%  Similarity=0.233  Sum_probs=195.0

Q ss_pred             CccCCCccccccccceEEEEEE-----eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      ++|.. ++.||+|+||.||+|.     +..+++.||+|++... ........+.+|+.++..++||||+++++++     
T Consensus        71 ~~~~~-~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----  143 (367)
T 3l9p_A           71 KNITL-IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVS-----  143 (367)
T ss_dssp             GGEEE-EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             hHeEE-eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence            44555 9999999999999999     4557789999998643 3344556788999999999999999999999     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC---Ce
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSK-------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC---DL  177 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~---~i  177 (339)
                      ......++||||++ |+|.+++...       ..+++..++.++.||+.||.|||++||+||||||+||+++.++   .+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            56677899999996 6999999764       3599999999999999999999999999999999999999555   59


Q ss_pred             EEeeccccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHh
Q 042681          178 KICDFGLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVK  243 (339)
Q Consensus       178 kL~Dfg~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~  243 (339)
                      ||+|||+++..             ++..|.+||......+..+.|+|++|++++++++ |..|+.....   ........
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~i~  300 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVT  300 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHH
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH
Confidence            99999998632             2335888888777778889999999999999998 8888654321   11112222


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       244 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                      ......      ....++..+.+||.+||+.||++|||+.+++++.++..
T Consensus       301 ~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          301 SGGRMD------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCC------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            111111      11457899999999999999999999999999976643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5e-41  Score=303.70  Aligned_cols=246  Identities=20%  Similarity=0.316  Sum_probs=200.1

Q ss_pred             cccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           27 GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        27 ~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      ...|.+..+.+.+.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+.+|+.+++.++||||+++++++   
T Consensus       106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~---  181 (377)
T 3cbl_A          106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVC---  181 (377)
T ss_dssp             CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE---
Confidence            445556554445499999999999999999999999999998754 2334456788999999999999999999999   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                        ......++||||++ |+|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus       182 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          182 --TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             --CSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             --ecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence              56677899999997 7999999764 4699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          185 ARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       185 ~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      ++....             ..|.+||......+..+.|+|++|++++++++ |..|+....   ..............+.
T Consensus       260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~  336 (377)
T 3cbl_A          260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---NQQTREFVEKGGRLPC  336 (377)
T ss_dssp             CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC---HHHHHHHHHTTCCCCC
T ss_pred             ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCC
Confidence            865322             23778887766677888999999999999998 888865432   1122222222221111


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                            ...+++++.+||.+||+.||++|||+.++++
T Consensus       337 ------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          337 ------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                  1357899999999999999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-40  Score=293.97  Aligned_cols=243  Identities=19%  Similarity=0.280  Sum_probs=196.6

Q ss_pred             cccCccCCCccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPP  105 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~  105 (339)
                      .+..+.+.+.+.||+|+||.||+|.+.     .+++.+|+|++... ......+.+.+|+.+++.++||||+++++++  
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--   95 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGAC--   95 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEE--
Confidence            333333344999999999999999873     45689999998754 3445567889999999999999999999999  


Q ss_pred             CCcCCcCeEEEEEecCc-ccHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcc
Q 042681          106 MDKEKFNDVYIVYELMD-TDLHQIIRSKQA------------------------LTDDHCQYFLYQLLRGLKYIHSANVL  160 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~aL~~LH~~giv  160 (339)
                         ...+..++||||++ ++|.+++.....                        +++..++.++.||+.||.|||++|++
T Consensus        96 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  172 (314)
T 2ivs_A           96 ---SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV  172 (314)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             ---ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence               66677999999998 799999976543                        89999999999999999999999999


Q ss_pred             cCCCCCCCeeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCC
Q 042681          161 HRDLKPSNLLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPD  226 (339)
Q Consensus       161 H~dikp~NIli~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~  226 (339)
                      ||||||+||+++.++.++|+|||++.....             ..|.+||.........+.|+|++|++++++++ |..|
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999865422             23778887766667888999999999999999 8888


Q ss_pred             CCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          227 DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +.....   .............      .....+++++.+||.+||+.||++|||+.+++++
T Consensus       253 ~~~~~~---~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          253 YPGIPP---ERLFNLLKTGHRM------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             STTCCG---GGHHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCH---HHHHHHhhcCCcC------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            754332   1222222221111      1124689999999999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-41  Score=307.51  Aligned_cols=261  Identities=21%  Similarity=0.295  Sum_probs=199.5

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-----------CCCeeeeee
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-----------HENIVKVKD  101 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~I~~~~~  101 (339)
                      .++|.. ++.||+|+||.||+|.+..+++.||+|++...   ......+.+|+.+++.++           ||||+++++
T Consensus        18 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYIL-VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEE-EEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            467777 99999999999999999999999999998643   334566788999988876           899999999


Q ss_pred             ecCCCCcCCcCeEEEEEecCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeeecc-----
Q 042681          102 IIPPMDKEKFNDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNA-----  173 (339)
Q Consensus       102 ~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dikp~NIli~~-----  173 (339)
                      ++.... .....++++|||++++|.+++...  ..+++..++.++.||+.||+|||++ ||+||||||+||+++.     
T Consensus        94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            984321 123378999999999999999763  5699999999999999999999998 9999999999999953     


Q ss_pred             -CCCeEEeeccccccc--------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc----chHHH
Q 042681          174 -NCDLKICDFGLARTT--------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS----DNARR  240 (339)
Q Consensus       174 -~~~ikL~Dfg~~~~~--------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~----~~~~~  240 (339)
                       .+.++|+|||++...        ++..|.+||......+..+.|+|++|++++++++|..|+........    .....
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  252 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  252 (373)
T ss_dssp             TEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             CcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence             347999999998643        34468889888777788899999999999999999999864331111    01111


Q ss_pred             HHhhCCCCCC------------------------CCc----------cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 042681          241 YVKQLPHVPK------------------------QPF----------SQKFPNMSPVAIDLAERMLVFDPAKRITVEEAL  286 (339)
Q Consensus       241 ~~~~~~~~~~------------------------~~~----------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell  286 (339)
                      ........+.                        ...          ......+++++++||.+||+.||++|||+.|++
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  332 (373)
T 1q8y_A          253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  332 (373)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence            1111110000                        000          000123467789999999999999999999999


Q ss_pred             cCCCCCCCccCC
Q 042681          287 NHPYLSSLHEIN  298 (339)
Q Consensus       287 ~hp~f~~~~~~~  298 (339)
                      +||||++.....
T Consensus       333 ~hp~f~~~~~~~  344 (373)
T 1q8y_A          333 NHPWLKDTLGME  344 (373)
T ss_dssp             TCGGGTTCTTCT
T ss_pred             hChhhhcccCcc
Confidence            999999876544

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.3e-41  Score=301.17  Aligned_cols=245  Identities=23%  Similarity=0.372  Sum_probs=197.0

Q ss_pred             cccc-CccCCCccccccccceEEEEEE-----eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeee
Q 042681           30 FQVS-SKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDI  102 (339)
Q Consensus        30 ~~~~-~~y~~~~~~lg~G~~~~v~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~  102 (339)
                      |.++ ++|.. ++.||+|+||.||+|.     +..+++.||+|++... ......+.+.+|+.++.++ +||||++++++
T Consensus        17 ~~~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           17 WEFPRDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             HBCCGGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccceee-ceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            3443 45555 9999999999999998     5667799999999754 3344457789999999999 79999999999


Q ss_pred             cCCCCcCCcCeEEEEEecCc-ccHHHHHHhcCC-----------------------------------------------
Q 042681          103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQA-----------------------------------------------  134 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~-----------------------------------------------  134 (339)
                      +.    ......++||||++ |+|.+++.....                                               
T Consensus        95 ~~----~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           95 CT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EC----STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             ee----cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            83    33445899999998 699999976533                                               


Q ss_pred             -------------------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-----
Q 042681          135 -------------------LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-----  190 (339)
Q Consensus       135 -------------------~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-----  190 (339)
                                         +++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....     
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                               89999999999999999999999999999999999999999999999999875421     


Q ss_pred             --------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          191 --------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       191 --------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                              ..|++||......+..+.|+|++|++++++++ |..|+......  ...............      ...++
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~~~~------~~~~~  322 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTRMRA------PDYTT  322 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHHHHHHHHTCCCCC------CTTCC
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHHHHHHHcCCCCCC------CCCCC
Confidence                    24788887777777889999999999999998 98887543221  112222222221111      13578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +++.++|.+||+.||++|||+.++++|
T Consensus       323 ~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          323 PEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            999999999999999999999999987

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.2e-41  Score=295.27  Aligned_cols=247  Identities=16%  Similarity=0.155  Sum_probs=200.1

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCC
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMD  107 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~  107 (339)
                      .-.+.++|.. ++.||+|+||.||+|.+..+|+.||+|++....    ....+.+|+.+++.+ +|++++++++++    
T Consensus         5 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~----   75 (298)
T 1csn_A            5 NNVVGVHYKV-GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFG----   75 (298)
T ss_dssp             -CEETTTEEE-EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEE----
T ss_pred             CcccccceEE-EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeec----
Confidence            3456677888 999999999999999999999999999986442    223577899999999 799999999998    


Q ss_pred             cCCcCeEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC-----eEEee
Q 042681          108 KEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-----LKICD  181 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~-----ikL~D  181 (339)
                       ......++||||++++|.+++... .++++..++.++.||+.||+|||++|++||||||+||+++.++.     ++|+|
T Consensus        76 -~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D  154 (298)
T 1csn_A           76 -QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD  154 (298)
T ss_dssp             -EETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             -CCCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence             677889999999988999999865 46999999999999999999999999999999999999987776     99999


Q ss_pred             ccccccc------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchH-HHHH
Q 042681          182 FGLARTT------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNA-RRYV  242 (339)
Q Consensus       182 fg~~~~~------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~-~~~~  242 (339)
                      ||++...                  ++..|.+||.........+.|+|++|++++++++|..|+........... ....
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (298)
T 1csn_A          155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  234 (298)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence            9998643                  33458888887777778889999999999999999999876432221111 1111


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ....   ..+.....+.+++++.+||.+||+.||++||++.++++.
T Consensus       235 ~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          235 EKKQ---STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHHH---HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             hhcc---CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1100   111122234689999999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.1e-40  Score=290.78  Aligned_cols=251  Identities=23%  Similarity=0.268  Sum_probs=196.5

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ...++|.. .+.||+|+||.||+|.+..+|+.+|+|++... .........+.+|+.+++.++||||+++++++     .
T Consensus        29 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~  102 (310)
T 2wqm_A           29 NTLANFRI-EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----I  102 (310)
T ss_dssp             SSGGGEEE-EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----E
T ss_pred             ccccceEE-EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----E
Confidence            34567877 99999999999999999999999999999753 23455567889999999999999999999999     6


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                      ..+..++||||++ ++|.+++..    ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL  182 (310)
T ss_dssp             ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred             cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence            6778999999998 599988864    46799999999999999999999999999999999999999999999999999


Q ss_pred             cccc-----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          185 ARTT-----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       185 ~~~~-----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      +...           +...|.+||.........+.|+|++|++++++++|..|+.......... ........ .+..  
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-~~~~--  258 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-CKKIEQCD-YPPL--  258 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH-HHHHHTTC-SCCC--
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH-HHHhhccc-CCCC--
Confidence            8543           3345788888777777888999999999999999999875432211111 11111111 1111  


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                        ....+++++++||.+||+.||++|||+.+++++  ++.+.
T Consensus       259 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~--l~~l~  296 (310)
T 2wqm_A          259 --PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV--AKRMH  296 (310)
T ss_dssp             --CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             --cccccCHHHHHHHHHHcCCChhhCCCHHHHHHH--HHHHH
Confidence              114578999999999999999999999999975  44443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.8e-40  Score=287.24  Aligned_cols=237  Identities=19%  Similarity=0.235  Sum_probs=192.1

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. ++.||+|+||.||++.+. ++..+|+|++......   .+.+.+|+.++..++||||+++++++     ....
T Consensus        23 ~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~   92 (283)
T 3gen_A           23 PKDLTF-LKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQR   92 (283)
T ss_dssp             GGGEEE-EEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred             HHHHHh-HhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCC
Confidence            345555 999999999999999876 5778999999755333   36688999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC
Q 042681          113 DVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  190 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~  190 (339)
                      ..++||||++ ++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+.....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            8999999997 799999976 56899999999999999999999999999999999999999999999999999864321


Q ss_pred             ------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          191 ------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       191 ------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                  ..|.+||.........+.|+|++|++++++++ |..|+......   ..............      .
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~~~------~  243 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIAQGLRLYR------P  243 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTTCCCCC------C
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHHHhcccCCCC------C
Confidence                        24788888776677888999999999999998 98887654321   11111111111111      1


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..+++.+.+||.+||+.||++|||+.++++|
T Consensus       244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          244 HLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            3468999999999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=292.72  Aligned_cols=245  Identities=20%  Similarity=0.270  Sum_probs=194.8

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. ++.||+|+||.||++.+..+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++.... ....
T Consensus        28 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~  103 (317)
T 2buj_A           28 NKHYLF-IQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH  103 (317)
T ss_dssp             TEEEEE-EEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred             CeEEEE-EEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence            345666 99999999999999999999999999998643  3455678899999999999999999999984211 2345


Q ss_pred             eEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          113 DVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ..++||||+. |+|.+++..    ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+..
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            7899999998 599998875    46799999999999999999999999999999999999999999999999998754


Q ss_pred             c--------------------CCCCcccccccccc---ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh
Q 042681          188 T--------------------SETDFMTEYVVTRW---DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ  244 (339)
Q Consensus       188 ~--------------------~~~~~~~~~~~~~~---~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~  244 (339)
                      .                    +...|.+||.....   ....+.|+|++|++++++++|..|+....... .........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~  262 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALAVQN  262 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHHHHC
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHHhhc
Confidence            3                    24568888876533   25778999999999999999999874321111 111111111


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       245 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ....+      ..+.+++++.+||.+||+.||++|||+.+++++
T Consensus       263 ~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 QLSIP------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             C--CC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCC------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            11111      124678999999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.1e-40  Score=290.64  Aligned_cols=244  Identities=22%  Similarity=0.331  Sum_probs=189.8

Q ss_pred             cCCCccccccccceEEEEEE----eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           36 YVPPLQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      |.. ++.||+|+||.||+|+    +..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++..   ...
T Consensus        23 ~~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   97 (302)
T 4e5w_A           23 LKR-IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG   97 (302)
T ss_dssp             EEE-EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhh-hhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence            444 8999999999999999    67789999999997543 23345778999999999999999999999843   233


Q ss_pred             CeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          112 NDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ..+++||||++ ++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+....
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            66899999997 699999954 4679999999999999999999999999999999999999999999999999986543


Q ss_pred             CC--------------CccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccc---------ccccchHHHHHhhCC
Q 042681          190 ET--------------DFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLG---------FLRSDNARRYVKQLP  246 (339)
Q Consensus       190 ~~--------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~---------~~~~~~~~~~~~~~~  246 (339)
                      ..              .|.+||.........+.|+|++|++++++++|..++....         ...............
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            22              2778887766667788999999999999999987743211         001111111111111


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       247 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ......   ..+.+++++.+||.+||+.||++|||+.++++
T Consensus       258 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          258 EGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             TTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            111111   12468999999999999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-40  Score=298.19  Aligned_cols=239  Identities=20%  Similarity=0.332  Sum_probs=195.5

Q ss_pred             CccCCCccccccccceEEEEEEeCCC-------CceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSET-------KEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPP  105 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~  105 (339)
                      ++|.. .+.||+|+||.||+|.+..+       +..+|+|++... ........+.+|+.+++.+ +||||+++++++  
T Consensus        69 ~~y~i-~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--  144 (382)
T 3tt0_A           69 DRLVL-GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--  144 (382)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             hheEe-eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeee--
Confidence            45555 99999999999999997543       357999998754 3444567889999999999 899999999999  


Q ss_pred             CCcCCcCeEEEEEecCc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 042681          106 MDKEKFNDVYIVYELMD-TDLHQIIRSKQ----------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN  168 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~N  168 (339)
                         ...+..++||||++ |+|.+++....                .+++..++.++.||+.||+|||++||+||||||+|
T Consensus       145 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 ---TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             ---ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence               66677899999997 69999997653                49999999999999999999999999999999999


Q ss_pred             eeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccc
Q 042681          169 LLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLR  234 (339)
Q Consensus       169 Ili~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~  234 (339)
                      |+++.++.+||+|||+++....             ..|.+||.........+.|+|++|++++++++ |..|+.....  
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--  299 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  299 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999875432             23778887777777888999999999999998 8888654321  


Q ss_pred             cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                       ..............      ....+++++.+||.+||+.||++|||+.+++++
T Consensus       300 -~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          300 -EELFKLLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             -HHHHHHHHTTCCCC------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHHHHHHcCCCCC------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             11222222211111      114589999999999999999999999999987

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5e-40  Score=286.34  Aligned_cols=238  Identities=18%  Similarity=0.298  Sum_probs=197.3

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. .+.||+|+||.||++.+..+++.+|+|++...   ....+.+.+|+.+++.++||||+++++++     ....
T Consensus        12 ~~~~~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~   82 (288)
T 3kfa_A           12 RTDITM-KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREP   82 (288)
T ss_dssp             GGGEEE-EEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred             ccceeE-EeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence            445555 89999999999999999999999999998653   33457789999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC
Q 042681          113 DVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  189 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~  189 (339)
                      ..++||||++ ++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+....
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            8999999998 7999999763  459999999999999999999999999999999999999999999999999987544


Q ss_pred             CC------------CccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          190 ET------------DFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       190 ~~------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      ..            .|.+|+.........+.|+|++|++++++++ |..|+.....   ..............      .
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~---~~~~~~~~~~~~~~------~  233 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDYRME------R  233 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHHTTCCCC------C
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhccCCCC------C
Confidence            22            3778887776677788999999999999999 8888654321   12222222221111      1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ...+++.+.+||.+||+.||.+|||+.++++.
T Consensus       234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence            14689999999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6e-40  Score=288.83  Aligned_cols=242  Identities=21%  Similarity=0.285  Sum_probs=196.1

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      -++|.. .+.||+|+||.||++.+..+++.||+|++..... .....+.+.+|+.++..++||||+++++++     ...
T Consensus        33 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~  106 (309)
T 2h34_A           33 FGPYRL-RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EID  106 (309)
T ss_dssp             -CCEEE-EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EET
T ss_pred             eccEEE-EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-----eeC
Confidence            366777 9999999999999999999999999999976533 334457789999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      +..++||||++ ++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+...  
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            78999999998 599999998889999999999999999999999999999999999999999999999999987543  


Q ss_pred             ----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          189 ----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       189 ----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                +...|.+||.........+.|+|++|++++++++|..|+......   ..........    .......+
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~----~~~~~~~~  259 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAI----PRPSTVRP  259 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCC----CCGGGTST
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCC----CCccccCC
Confidence                      334588888887777888999999999999999999987643211   1111111111    11122335


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC-CHHHHhc
Q 042681          259 NMSPVAIDLAERMLVFDPAKRI-TVEEALN  287 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rp-s~~ell~  287 (339)
                      .+++++.++|.+||+.||++|| +++++++
T Consensus       260 ~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          260 GIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             TCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            6899999999999999999999 7888775

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.8e-40  Score=297.26  Aligned_cols=238  Identities=21%  Similarity=0.308  Sum_probs=188.8

Q ss_pred             CccCCCccccccccceEEEEEEeC---CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNS---ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ++|.. .+.||+|+||.||++++.   .++..||+|+++.. ......+.+.+|+.++.+++||||+++++++     ..
T Consensus        45 ~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~  117 (373)
T 2qol_A           45 TNISI-DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TK  117 (373)
T ss_dssp             GGCCC-CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred             hhcee-eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ee
Confidence            45555 999999999999999876   56778999998754 2344567899999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ....++||||++ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            678899999996 7999999765 47999999999999999999999999999999999999999999999999998654


Q ss_pred             CC--------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          189 SE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       189 ~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      ..              ..|.+||......+..+.|+|++|++++++++ |..|+.....   .............+    
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~~----  270 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRLP----  270 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEECC----
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC----
Confidence            22              24788888777777888999999999999997 8888764321   11111111111111    


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                        ....++..+.+||.+||+.||++||++.++++
T Consensus       271 --~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          271 --PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             --CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence              11357899999999999999999999999886

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-40  Score=289.01  Aligned_cols=244  Identities=14%  Similarity=0.246  Sum_probs=195.8

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCC-------ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETK-------EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPP  105 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~  105 (339)
                      .++|.. .+.||+|+||.||+|.+..++       ..+|+|++...  .....+.+.+|+.++..++||||+++++++  
T Consensus         7 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--   81 (289)
T 4fvq_A            7 NEDLIF-NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVC--   81 (289)
T ss_dssp             GGGEEE-EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEE--
T ss_pred             hhHeee-eeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEE--
Confidence            345555 999999999999999998877       46999998654  334457789999999999999999999999  


Q ss_pred             CCcCCcCeEEEEEecCc-ccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC-------
Q 042681          106 MDKEKFNDVYIVYELMD-TDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-------  176 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~-------  176 (339)
                         ......++||||++ ++|.+++...+. +++..++.++.||+.||.|||++|++||||||+||+++.++.       
T Consensus        82 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           82 ---VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             ---CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             ---EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence               55667899999998 799999987654 999999999999999999999999999999999999998887       


Q ss_pred             -eEEeeccccccc-------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC
Q 042681          177 -LKICDFGLARTT-------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH  247 (339)
Q Consensus       177 -ikL~Dfg~~~~~-------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  247 (339)
                       ++|+|||.+...       +...|.+||.... .....+.|+|++|++++++++|..+.....  ..............
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~--~~~~~~~~~~~~~~  236 (289)
T 4fvq_A          159 FIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL--DSQRKLQFYEDRHQ  236 (289)
T ss_dssp             EEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHTTCC
T ss_pred             eeeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc--chHHHHHHhhccCC
Confidence             999999998654       3446888987765 567788999999999999999654433221  11111122221111


Q ss_pred             CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          248 VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       248 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      .+        ...++++.+||.+||+.||++|||+.++++|  ++.+..
T Consensus       237 ~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~  275 (289)
T 4fvq_A          237 LP--------APKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFT  275 (289)
T ss_dssp             CC--------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-
T ss_pred             CC--------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcC
Confidence            11        3457889999999999999999999999988  555544

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=296.00  Aligned_cols=246  Identities=20%  Similarity=0.316  Sum_probs=187.0

Q ss_pred             ccccccC-ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCC
Q 042681           28 NLFQVSS-KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPP  105 (339)
Q Consensus        28 ~~~~~~~-~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~  105 (339)
                      ..+.+.+ +|.. .+.||+|+||.||++++..+++.||+|++...  .....+.+.+|+.++.++. ||||+++++++..
T Consensus        21 ~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           21 QTVELGELRLRV-RRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             CEEEETTEEEEE-EEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ceeeccCceEEE-EEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            3333333 4545 99999999999999999999999999998543  3445677889999999995 9999999998832


Q ss_pred             CC---cCCcCeEEEEEecCcccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeeeccCCCe
Q 042681          106 MD---KEKFNDVYIVYELMDTDLHQIIRS---KQALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDL  177 (339)
Q Consensus       106 ~~---~~~~~~~~iv~e~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dikp~NIli~~~~~i  177 (339)
                      ..   ......++++|||++|+|.+++..   .+++++..++.++.||+.||.|||++|  ++||||||+||+++.++.+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             cccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence            11   134456899999999999998865   567999999999999999999999999  9999999999999999999


Q ss_pred             EEeeccccccc-----------------------CCCCccccccc---cccccCCCCccHHHHHHHHHHHhCCCCCCccc
Q 042681          178 KICDFGLARTT-----------------------SETDFMTEYVV---TRWDTLFPGKDYVQQLTMITELLGSPDDSDLG  231 (339)
Q Consensus       178 kL~Dfg~~~~~-----------------------~~~~~~~~~~~---~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~  231 (339)
                      +|+|||++...                       ++..|.+||..   .......+.|+|++|++++++++|..|+....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99999998654                       33457888876   34456678999999999999999999875322


Q ss_pred             ccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          232 FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..      .........      ......+..+.+||.+||+.||++|||+.++++|
T Consensus       258 ~~------~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          258 KL------RIVNGKYSI------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             --------------CCC------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HH------HhhcCcccC------CcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            11      111111111      1113567889999999999999999999999988

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4e-40  Score=290.26  Aligned_cols=244  Identities=23%  Similarity=0.335  Sum_probs=197.6

Q ss_pred             cccc-CccCCCccccccccceEEEEEEe-----CCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeee
Q 042681           30 FQVS-SKYVPPLQPIGRGAYGIVCSAVN-----SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDI  102 (339)
Q Consensus        30 ~~~~-~~y~~~~~~lg~G~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~  102 (339)
                      +.++ ++|.. .+.||+|+||.||+|.+     ..+++.+|+|++... ......+.+.+|+.++.++ +||||++++++
T Consensus        18 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           18 WEFPRNRLSF-GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GBCCGGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccChhhhhH-HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            4443 45555 99999999999999984     457889999998754 2334567889999999999 89999999999


Q ss_pred             cCCCCcCCcCeEEEEEecCc-ccHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 042681          103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ------------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRD  163 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~------------------~~~~~~~~~i~~qi~~aL~~LH~~givH~d  163 (339)
                      +     ...+..++||||++ |+|.+++....                  .+++..++.++.||+.||.|||++|++|||
T Consensus        96 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  170 (313)
T 1t46_A           96 C-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD  170 (313)
T ss_dssp             E-----CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             E-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            9     66677899999997 69999997653                  489999999999999999999999999999


Q ss_pred             CCCCCeeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCc
Q 042681          164 LKPSNLLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSD  229 (339)
Q Consensus       164 ikp~NIli~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~  229 (339)
                      |||+||+++.++.++|+|||.+.....             ..|.+||.........+.|+|++|++++++++ |..|+..
T Consensus       171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  250 (313)
T 1t46_A          171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG  250 (313)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            999999999999999999999875432             23778887766677888999999999999998 8888765


Q ss_pred             ccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          230 LGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ....  ...............      ...+++++.+||.+||+.||.+|||+.+++++
T Consensus       251 ~~~~--~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          251 MPVD--SKFYKMIKEGFRMLS------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             CCSS--HHHHHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccch--hHHHHHhccCCCCCC------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            4321  111222222211111      14578999999999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.2e-41  Score=307.21  Aligned_cols=246  Identities=23%  Similarity=0.282  Sum_probs=187.5

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~  110 (339)
                      +.+.|.. .+.||+|+||+||.+ ...+|+.||+|++...     ..+.+.+|+.++..+ +||||+++++++     ..
T Consensus        13 l~~~~~~-~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~   80 (434)
T 2rio_A           13 LKNLVVS-EKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSE-----TT   80 (434)
T ss_dssp             CSSCEEE-EEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----EC
T ss_pred             hhheeec-cCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ec
Confidence            4444544 889999999999865 4567999999998643     235578899999876 899999999998     66


Q ss_pred             cCeEEEEEecCcccHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC---------
Q 042681          111 FNDVYIVYELMDTDLHQIIRSKQAL-------TDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---------  174 (339)
Q Consensus       111 ~~~~~iv~e~~~g~L~~~l~~~~~~-------~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~---------  174 (339)
                      ...+++||||++|+|.+++......       ++..++.++.||+.||+|||++||+||||||+||+++.+         
T Consensus        81 ~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             SSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             CCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence            7889999999999999999875433       233457899999999999999999999999999999754         


Q ss_pred             ----CCeEEeeccccccc---------------CCCCccccccccc-------cccCCCCccHHHHHHHHHHHh-CCCCC
Q 042681          175 ----CDLKICDFGLARTT---------------SETDFMTEYVVTR-------WDTLFPGKDYVQQLTMITELL-GSPDD  227 (339)
Q Consensus       175 ----~~ikL~Dfg~~~~~---------------~~~~~~~~~~~~~-------~~~~~~~d~~~~g~~~~~~l~-g~~~~  227 (339)
                          +.+||+|||++...               ++..|.+||+...       .....+.|+|++|++++++++ |..|+
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence                47999999998643               3446888887754       456788999999999999998 88887


Q ss_pred             CcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          228 SDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      ......    ................ .....+++++++||.+||+.||++|||+.++++||||...
T Consensus       241 ~~~~~~----~~~i~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          241 GDKYSR----ESNIIRGIFSLDEMKC-LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             CSTTTH----HHHHHHTCCCCCCCTT-CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             CCchhh----HHHHhcCCCCcccccc-cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            543211    1222222211111110 0112356889999999999999999999999999999754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5e-40  Score=289.83  Aligned_cols=249  Identities=16%  Similarity=0.219  Sum_probs=190.9

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCC---CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSE---TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      ..-.++|.. .+.||+|+||.||+|.+..   ++..+|+|++..........+.+.+|+.++..++||||+++++++...
T Consensus        30 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           30 VIDRNLLIL-GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             BCCGGGEEE-EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             ccCHHHeee-ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            334456666 9999999999999998765   556899999987656666678899999999999999999999998543


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEE
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRS------KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI  179 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL  179 (339)
                      ........++||||++ ++|.+++..      ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence            3222235799999998 699999842      357999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhC
Q 042681          180 CDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQL  245 (339)
Q Consensus       180 ~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~  245 (339)
                      +|||.+.....             ..|.+|+......+..+.|+|++|++++++++ |..|+......   .........
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~~  265 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDYLLHG  265 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHHTT
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHHHcC
Confidence            99999865422             24777887776677788999999999999999 77776543211   111111111


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       246 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ....      ....+++++.+||.+||+.||++|||+.+++++
T Consensus       266 ~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          266 HRLK------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCCC------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCC------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1111      114588999999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.5e-40  Score=292.85  Aligned_cols=252  Identities=19%  Similarity=0.267  Sum_probs=198.6

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      ......++|.. .+.||+|+||.||++.+. +|+.+|+|++...  .....+.+.+|+.++..++||||+++++++    
T Consensus        33 ~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----  104 (321)
T 2qkw_B           33 DLEEATNNFDH-KFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC----  104 (321)
T ss_dssp             CCCCCCCCCSC-CCCSCBCSSSEEEEEECT-TCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEEC----
T ss_pred             HHHHHHhccCc-cceeecCCCeeEEEEEEC-CCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            44456788888 999999999999999964 6899999988654  233457789999999999999999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeec
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSK----QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF  182 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Df  182 (339)
                       ...+..++||||++ |+|.+++...    ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+||
T Consensus       105 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          105 -DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             -CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             -cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeec
Confidence             66678899999997 6999888654    35999999999999999999999999999999999999999999999999


Q ss_pred             cccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHH---HhhCC
Q 042681          183 GLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRY---VKQLP  246 (339)
Q Consensus       183 g~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~---~~~~~  246 (339)
                      |++...             ++..|.+||.........+.|+|++|++++++++|..|+..............   .....
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            998643             23457888877666788899999999999999999988764322211111111   01111


Q ss_pred             CCCC---CCc-cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          247 HVPK---QPF-SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       247 ~~~~---~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ....   ... ....+.++..+.+++.+||+.||++|||+.+++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1110   100 11112346778999999999999999999999976

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-40  Score=294.35  Aligned_cols=240  Identities=21%  Similarity=0.239  Sum_probs=195.8

Q ss_pred             cCccCCCccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      .++|.. ++.||+|+||.||++.+.     .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++    
T Consensus        46 ~~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----  119 (343)
T 1luf_A           46 RNNIEY-VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC----  119 (343)
T ss_dssp             GGGCEE-EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE----
T ss_pred             HHHCee-eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE----
Confidence            355655 999999999999999987     456899999987542 344567889999999999999999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSK------------------------QALTDDHCQYFLYQLLRGLKYIHSANVLHR  162 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~  162 (339)
                       ......++||||++ |+|.+++...                        ..+++..++.++.||+.||.|||++|++||
T Consensus       120 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  198 (343)
T 1luf_A          120 -AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  198 (343)
T ss_dssp             -CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             -ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence             56678899999998 6999999763                        579999999999999999999999999999


Q ss_pred             CCCCCCeeeccCCCeEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCC
Q 042681          163 DLKPSNLLLNANCDLKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDS  228 (339)
Q Consensus       163 dikp~NIli~~~~~ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~  228 (339)
                      ||||+||+++.++.++|+|||++....             ...|.+||.........+.|+|++|++++++++ |..|+.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            999999999999999999999986432             224788887776677888999999999999998 888875


Q ss_pred             cccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          229 DLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ....   ...........   ..   .....+++++.+||.+||+.||++|||+.+++++
T Consensus       279 ~~~~---~~~~~~~~~~~---~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          279 GMAH---EEVIYYVRDGN---IL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TSCH---HHHHHHHHTTC---CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCh---HHHHHHHhCCC---cC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            4321   11111111111   11   1124588999999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.3e-40  Score=292.71  Aligned_cols=256  Identities=20%  Similarity=0.271  Sum_probs=198.5

Q ss_pred             EEccccccccCccCCCccccccccceEEEEEE----eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeee
Q 042681           24 NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV   99 (339)
Q Consensus        24 ~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~   99 (339)
                      ...|....+.++|+.+++.||+|+||.||++.    +..+++.||+|++... ......+.+.+|+.+++.++||||+++
T Consensus        20 ~~pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~   98 (318)
T 3lxp_A           20 QGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKY   98 (318)
T ss_dssp             ----CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cCCCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhE
Confidence            34566677888996669999999999997765    4567899999999754 334456788999999999999999999


Q ss_pred             eeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeE
Q 042681          100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK  178 (339)
Q Consensus       100 ~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ik  178 (339)
                      ++++..   .....+++||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.++
T Consensus        99 ~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~k  174 (318)
T 3lxp_A           99 KGCCED---AGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVK  174 (318)
T ss_dssp             EEEEEE---TTTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEec---CCCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEE
Confidence            999842   23467899999997 699998876 4599999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCC--------------CccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccc--------c-
Q 042681          179 ICDFGLARTTSET--------------DFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR--------S-  235 (339)
Q Consensus       179 L~Dfg~~~~~~~~--------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~--------~-  235 (339)
                      |+|||.+......              .|.+|+.........+.|+|++|++++++++|..|+.......        . 
T Consensus       175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~  254 (318)
T 3lxp_A          175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ  254 (318)
T ss_dssp             ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHH
T ss_pred             ECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccc
Confidence            9999998754322              2778887776667788999999999999999998865432110        0 


Q ss_pred             chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ................   .....+++++.+||.+||+.||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          255 MTVLRLTELLERGERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHHHhcccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            0000111111111111   112468999999999999999999999999985

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.4e-41  Score=297.34  Aligned_cols=244  Identities=18%  Similarity=0.172  Sum_probs=196.1

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCc
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDK  108 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~  108 (339)
                      +.++++|.. ++.||+|+||.||+|.+..+|+.||+|++.....    ...+.+|+.+++.+ +||||+++++++     
T Consensus         5 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~-----   74 (330)
T 2izr_A            5 LMVGPNFRV-GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFG-----   74 (330)
T ss_dssp             CEETTTEEE-EEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEE-----
T ss_pred             EEEcCCeEE-EEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEE-----
Confidence            345677887 9999999999999999999999999999865422    23578899999999 899999999998     


Q ss_pred             CCcCeEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC-----eEEeec
Q 042681          109 EKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-----LKICDF  182 (339)
Q Consensus       109 ~~~~~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~-----ikL~Df  182 (339)
                      ......++||||++++|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+||+++.++.     ++|+||
T Consensus        75 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           75 PCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             EETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             ecCCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence            66778999999998899999986 478999999999999999999999999999999999999998887     999999


Q ss_pred             cccccc------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchH-HHHHh
Q 042681          183 GLARTT------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNA-RRYVK  243 (339)
Q Consensus       183 g~~~~~------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~-~~~~~  243 (339)
                      |++...                  ++..|.+||.........+.|+|++|++++++++|..|+........... .....
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            998643                  33467888888777778889999999999999999999876432211111 11111


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       244 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .....+   .......++ ++.+++.+||+.||.+||++.++++
T Consensus       235 ~~~~~~---~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          235 TKRATP---IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHSC---HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hhccCC---HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            000000   011112244 9999999999999999999988876

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9e-40  Score=285.24  Aligned_cols=239  Identities=18%  Similarity=0.247  Sum_probs=193.0

Q ss_pred             cCccCCCcc-ccccccceEEEEEE--eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           33 SSKYVPPLQ-PIGRGAYGIVCSAV--NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        33 ~~~y~~~~~-~lg~G~~~~v~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      .++|.. .+ .||+|+||.||++.  ...+++.+|+|++..........+.+.+|+.+++.++||||+++++++     .
T Consensus        15 ~~~y~~-~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~   88 (291)
T 1xbb_A           15 RKLLTL-EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-----E   88 (291)
T ss_dssp             GGGEEE-EEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----E
T ss_pred             chhhhh-ccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----C
Confidence            345555 55 89999999999994  566789999999986655555567899999999999999999999998     2


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                       ....++||||++ ++|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+...
T Consensus        89 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           89 -AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             -SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             -CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence             245899999998 799999998888999999999999999999999999999999999999999999999999998654


Q ss_pred             CC--------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          189 SE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       189 ~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      ..              ..|.+||.........+.|+|++|++++++++ |..|+.....   ............   .  
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~---~--  239 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGER---M--  239 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCC---C--
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC---C--
Confidence            32              23777887766667778999999999999998 9988764321   111222222111   1  


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                       .....+++++.++|.+||+.||++||++.++++
T Consensus       240 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          240 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             112468999999999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.5e-40  Score=291.23  Aligned_cols=248  Identities=19%  Similarity=0.283  Sum_probs=198.9

Q ss_pred             cCccCCCccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      .++|.. .+.||+|+||.||+|.+.     .+++.+|+|.+... ........+.+|+.+++.++||||+++++++    
T Consensus        24 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----   97 (322)
T 1p4o_A           24 REKITM-SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV----   97 (322)
T ss_dssp             GGGEEE-EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred             hhheee-eeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE----
Confidence            455666 999999999999999876     46788999998754 2334456789999999999999999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSK----------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD  176 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~  176 (339)
                       ......++||||++ |+|.+++...          ..+++..++.++.||+.||.|||++|++||||||+||+++.++.
T Consensus        98 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A           98 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred             -ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence             56677899999997 6999998652          45799999999999999999999999999999999999999999


Q ss_pred             eEEeecccccccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHH
Q 042681          177 LKICDFGLARTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYV  242 (339)
Q Consensus       177 ikL~Dfg~~~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~  242 (339)
                      ++|+|||++....             ...|.+||.........+.|+|++|++++++++ |..|+.....   .......
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~  253 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFV  253 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHHH
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHHHHH
Confidence            9999999986432             224788887766667788999999999999999 7777654321   1111111


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC------CCCCCCcc
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH------PYLSSLHE  296 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h------p~f~~~~~  296 (339)
                      .....      ......+++.+.+||.+||+.||++|||+.++++|      |+|+.+..
T Consensus       254 ~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~  307 (322)
T 1p4o_A          254 MEGGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF  307 (322)
T ss_dssp             HTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred             HcCCc------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccc
Confidence            11111      11124689999999999999999999999999987      56554443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=305.32  Aligned_cols=242  Identities=24%  Similarity=0.325  Sum_probs=185.5

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcCeE
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      |.. .+.||+|+||+|+. ....+|+.||+|++.....     ..+.+|+.+++.+ +||||+++++++     ......
T Consensus        26 y~~-~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~   93 (432)
T 3p23_A           26 FCP-KDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQ   93 (432)
T ss_dssp             EEE-EEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEE
T ss_pred             Eec-CCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEE
Confidence            444 88999999999763 4456799999999865422     2246799999999 799999999998     667789


Q ss_pred             EEEEecCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-----CCCeEEeeccccccc
Q 042681          115 YIVYELMDTDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-----NCDLKICDFGLARTT  188 (339)
Q Consensus       115 ~iv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-----~~~ikL~Dfg~~~~~  188 (339)
                      ++||||++|+|.+++.... ...+..++.++.||+.||.|||++||+||||||+||+++.     ...++|+|||+++..
T Consensus        94 ~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           94 YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             EEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             EEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            9999999999999998653 4666678899999999999999999999999999999953     235889999998643


Q ss_pred             --------------CCCCcccccccc---ccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          189 --------------SETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       189 --------------~~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                                    ++..|.+||...   ......+.|+|++|++++++++ |..|+.....    .....  .......
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~----~~~~~--~~~~~~~  247 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQANI--LLGACSL  247 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT----HHHHH--HTTCCCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH----HHHHH--HhccCCc
Confidence                          345688898876   3445667999999999999999 7777643211    11111  1111111


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      .. .......+..+++||.+||+.||++|||+.++++||||.++.+
T Consensus       248 ~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          248 DC-LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             TT-SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             cc-cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            11 1111224566899999999999999999999999999988654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-40  Score=295.24  Aligned_cols=245  Identities=21%  Similarity=0.323  Sum_probs=193.6

Q ss_pred             ccccCccCCCccccccccceEEEEEEe-----CCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeec
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVN-----SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDII  103 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~  103 (339)
                      +.++.+.+.+.+.||+|+||.||+|.+     ..++..+|+|++.... .....+.+.+|+.++.++ +||||+++++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            334433333399999999999999997     3466789999997542 233457789999999999 899999999999


Q ss_pred             CCCCcCCcCeEEEEEecCc-ccHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 042681          104 PPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ-----------------------ALTDDHCQYFLYQLLRGLKYIHSANV  159 (339)
Q Consensus       104 ~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~aL~~LH~~gi  159 (339)
                           ...+..++||||++ |+|.+++....                       .+++..++.++.||+.||.|||++|+
T Consensus       119 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  193 (344)
T 1rjb_A          119 -----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC  193 (344)
T ss_dssp             -----CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             -----eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence                 56677999999997 69999997643                       37999999999999999999999999


Q ss_pred             ccCCCCCCCeeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCC
Q 042681          160 LHRDLKPSNLLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSP  225 (339)
Q Consensus       160 vH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~  225 (339)
                      +||||||+||+++.++.++|+|||++.....             ..|.+||......+..+.|+|++|++++++++ |..
T Consensus       194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  273 (344)
T 1rjb_A          194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN  273 (344)
T ss_dssp             EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999864421             24788887766677888999999999999997 988


Q ss_pred             CCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          226 DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      |+......  ..............      ....+++++.+||.+||+.||++|||+.++++|
T Consensus       274 p~~~~~~~--~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          274 PYPGIPVD--ANFYKLIQNGFKMD------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             SSTTCCCS--HHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCCcH--HHHHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            87654322  11122222211111      113578999999999999999999999999987

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.2e-40  Score=283.77  Aligned_cols=239  Identities=23%  Similarity=0.338  Sum_probs=186.7

Q ss_pred             cCccCCCccccccccceEEEEEEeCCC---CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSET---KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      .++|.. .+.||+|+||.||+|.+..+   +..+|+|++... ......+.+.+|+.+++.++||||+++++++     .
T Consensus        14 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~   86 (281)
T 1mp8_A           14 RERIEL-GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVI-----T   86 (281)
T ss_dssp             GGGEEE-EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred             hHHeEE-EeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEE-----c
Confidence            455666 99999999999999998654   456999987653 2344567789999999999999999999998     2


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      . +..++||||++ ++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus        87 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           87 E-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             S-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             c-CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence            2 45789999998 69999997654 799999999999999999999999999999999999999999999999999865


Q ss_pred             cCC------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          188 TSE------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       188 ~~~------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      ...            ..|.+||......+..+.|+|++|++++++++ |..|+......   ............      
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i~~~~~~------  236 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENGERL------  236 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTTCCC------
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHHHcCCCC------
Confidence            432            24788888776677788999999999999996 88887543211   111112111111      


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ...+.+++++.++|.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          237 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1224689999999999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.3e-40  Score=291.82  Aligned_cols=240  Identities=22%  Similarity=0.340  Sum_probs=193.9

Q ss_pred             cCccCCCccccccccceEEEEEEeC-------CCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNS-------ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIP  104 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~  104 (339)
                      .++|.. .+.||+|+||.||+|.+.       .++..||+|++... ......+.+.+|+.+++.+ +||||+++++++ 
T Consensus        34 ~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-  110 (334)
T 2pvf_A           34 RDKLTL-GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-  110 (334)
T ss_dssp             GGGEEE-EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             HhHeEE-eeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-
Confidence            345555 999999999999999975       46778999998754 2344567889999999999 899999999999 


Q ss_pred             CCCcCCcCeEEEEEecCc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 042681          105 PMDKEKFNDVYIVYELMD-TDLHQIIRSKQ----------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPS  167 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~  167 (339)
                          ...+..++||||++ |+|.+++....                .+++..++.++.||+.||.|||++|++||||||+
T Consensus       111 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          111 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             ----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             ----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence                66678899999997 69999997654                3899999999999999999999999999999999


Q ss_pred             CeeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCccccc
Q 042681          168 NLLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFL  233 (339)
Q Consensus       168 NIli~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~  233 (339)
                      ||+++.++.+||+|||++.....             ..|.+||.........+.|+|++|++++++++ |..|+..... 
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-  265 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-  265 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-
Confidence            99999999999999999865432             23778887766667788999999999999998 8888754321 


Q ss_pred             ccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                        ..............      ....++.+++++|.+||+.||++|||+.+++++
T Consensus       266 --~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          266 --EELFKLLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             --HHHHHHHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --HHHHHHHhcCCCCC------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              11111222211111      124588999999999999999999999999976

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.2e-40  Score=289.29  Aligned_cols=248  Identities=21%  Similarity=0.261  Sum_probs=187.7

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhh--CCCCCeeeeeeecCCCCc
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCH--MTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~I~~~~~~~~~~~~  108 (339)
                      .+.++|.. ++.||+|+||.||++.+  +|+.||+|++...     ....+.+|.+++..  ++||||+++++++.... 
T Consensus         5 ~~~~~y~~-~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-   75 (301)
T 3q4u_A            5 TVARDITL-LECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSR-   75 (301)
T ss_dssp             CCGGGCEE-EEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-
T ss_pred             cccCcEEE-EEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-
Confidence            35677777 99999999999999987  6899999998643     23455667777666  78999999999863221 


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCCeeeccCCCeEE
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH--------SANVLHRDLKPSNLLLNANCDLKI  179 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~givH~dikp~NIli~~~~~ikL  179 (339)
                      ......++||||++ |+|.+++.. ..+++..++.++.|++.||+|||        +.|++||||||+||+++.++.+||
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence            33466899999998 699999854 67999999999999999999999        999999999999999999999999


Q ss_pred             eecccccc---------------cCCCCcccccccccc------ccCCCCccHHHHHHHHHHHhC----------CCCCC
Q 042681          180 CDFGLART---------------TSETDFMTEYVVTRW------DTLFPGKDYVQQLTMITELLG----------SPDDS  228 (339)
Q Consensus       180 ~Dfg~~~~---------------~~~~~~~~~~~~~~~------~~~~~~d~~~~g~~~~~~l~g----------~~~~~  228 (339)
                      +|||++..               .++..|.+||.....      ....+.|+|++|++++++++|          ..|+.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            99999843               344567888877654      344678999999999999999          66654


Q ss_pred             cccccccc--hHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          229 DLGFLRSD--NARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       229 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ........  ............+..+.......+++++.+||.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            43221111  1111111111111111111112356789999999999999999999999863

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.9e-40  Score=282.35  Aligned_cols=241  Identities=12%  Similarity=0.147  Sum_probs=195.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. .+.||+|+||.||++.+.  ++.+|+|++..........+.+.+|+.++.+++||||+++++++..   .....
T Consensus        10 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~   83 (271)
T 3kmu_A           10 KQLNF-LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PPAPH   83 (271)
T ss_dssp             GGCEE-EEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT---TTSSS
T ss_pred             HHhHH-HHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc---CCCCC
Confidence            45666 899999999999999985  8899999998776666667889999999999999999999999843   22367


Q ss_pred             EEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeeeccCCCeEEeecccccc-
Q 042681          114 VYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLART-  187 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dikp~NIli~~~~~ikL~Dfg~~~~-  187 (339)
                      .++||||++ |+|.+++....  .+++..++.++.|++.||+|||++|  ++||||||+||+++.++.++|+|||++.. 
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            899999998 69999998765  5899999999999999999999999  99999999999999999999998877643 


Q ss_pred             -----cCCCCccccccccccccCC---CCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          188 -----TSETDFMTEYVVTRWDTLF---PGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       188 -----~~~~~~~~~~~~~~~~~~~---~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                           .++..|.+||.........   +.|+|++|++++++++|..|+......  ............ +.     ....
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~-~~-----~~~~  235 (271)
T 3kmu_A          164 QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM--EIGMKVALEGLR-PT-----IPPG  235 (271)
T ss_dssp             SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH--HHHHHHHHSCCC-CC-----CCTT
T ss_pred             cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH--HHHHHHHhcCCC-CC-----CCCC
Confidence                 3345688888776544444   599999999999999999997643221  111111111111 11     1246


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +++++.++|.+||+.||++|||+.++++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            89999999999999999999999999863

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.5e-40  Score=293.41  Aligned_cols=260  Identities=18%  Similarity=0.248  Sum_probs=199.6

Q ss_pred             EEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeec
Q 042681           24 NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDII  103 (339)
Q Consensus        24 ~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~  103 (339)
                      ....+.....++|.. .+.||+|+||.||++.+. +|+.||+|++...... .....+.+|+.++..++||||+++++++
T Consensus        20 ~~~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           20 FSLRELQVASDNFSN-KNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CCTHHHHTTTTSSCS-TTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             ecHHHHHHHhhcccc-ceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            345566667778888 999999999999999854 6899999998754222 1223688999999999999999999999


Q ss_pred             CCCCcCCcCeEEEEEecCc-ccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCCeeeccCC
Q 042681          104 PPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ----ALTDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANC  175 (339)
Q Consensus       104 ~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~dikp~NIli~~~~  175 (339)
                           ......++||||++ |+|.+++....    .+++..++.++.|++.||.|||++   |++||||||+||+++.++
T Consensus        97 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           97 -----MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             -----CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred             -----ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence                 56677899999997 69999997643    499999999999999999999999   999999999999999999


Q ss_pred             CeEEeeccccccc------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc--hHHHH
Q 042681          176 DLKICDFGLARTT------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD--NARRY  241 (339)
Q Consensus       176 ~ikL~Dfg~~~~~------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~--~~~~~  241 (339)
                      .++|+|||++...            ++..|.+||.........+.|+|++|++++++++|..|+.........  .....
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            9999999998643            344578888877667788899999999999999999997532111111  11111


Q ss_pred             HhhCCCCCC-CCc------cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          242 VKQLPHVPK-QPF------SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       242 ~~~~~~~~~-~~~------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ......... ...      ....+..++.+.+++.+||+.||++|||+.++++|-.-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            111111100 000      00011234679999999999999999999999998543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.4e-40  Score=291.41  Aligned_cols=240  Identities=20%  Similarity=0.299  Sum_probs=189.1

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceE----EEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEV----AIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~----avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      ..++|.. ++.||+|+||.||+|++..+++.+    |+|.+... ......+.+.+|+.++.+++||||+++++++    
T Consensus        13 ~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----   86 (327)
T 3poz_A           13 KETEFKK-IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGIC----   86 (327)
T ss_dssp             CGGGEEE-EEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEE----
T ss_pred             CHHHccc-ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE----
Confidence            3566766 999999999999999998887765    66666432 2233457789999999999999999999998    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                       ... ..+++++|+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        87 -~~~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           87 -LTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             -ESS-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             -ecC-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence             333 3678888887 799999876 467999999999999999999999999999999999999999999999999998


Q ss_pred             cccC-------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          186 RTTS-------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       186 ~~~~-------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      +...             +..|.+||......+..+.|+|++|++++++++ |..|+.....   ............... 
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~~~~-  240 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGERLPQ-  240 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTCCCCC-
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH---HHHHHHHHcCCCCCC-
Confidence            6432             225788888777778888999999999999999 8988765432   222222222222111 


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                           .+.++.++.+++.+||+.||++|||+.+++++
T Consensus       241 -----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          241 -----PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             -----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                 14578999999999999999999999999976

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.8e-40  Score=290.38  Aligned_cols=247  Identities=17%  Similarity=0.222  Sum_probs=196.9

Q ss_pred             cCccCCCccccccccceEEEEEE----eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      .++|.. ++.||+|+||.||+|+    +..+++.||+|++...  .....+.+.+|+.+++.++||||+++++++..   
T Consensus        22 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   95 (327)
T 3lxl_A           22 ERHLKY-ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYG---   95 (327)
T ss_dssp             GGGEEE-EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhh-hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---
Confidence            456666 9999999999999999    5778999999998754  34455778999999999999999999998742   


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      ......++||||++ ++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+.
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence            35567999999996 799999976 4579999999999999999999999999999999999999999999999999997


Q ss_pred             ccCC--------------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccc---------cchHHHHHh
Q 042681          187 TTSE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR---------SDNARRYVK  243 (339)
Q Consensus       187 ~~~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~---------~~~~~~~~~  243 (339)
                      ....              ..|.+||.........+.|+|++|++++++++|..|+.......         .........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            5432              12778887776677888999999999999999988864322110         000011111


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          244 QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       244 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ........   ...+.+++++.+||.+||+.||++|||+.+++++
T Consensus       256 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          256 LLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11111111   1124689999999999999999999999999765

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.1e-40  Score=292.31  Aligned_cols=251  Identities=19%  Similarity=0.191  Sum_probs=188.3

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      +.-.++|.. ++.||+|+||.||+|++.  ++.||+|++...   ........+|+.++.+++||||+++++++.... .
T Consensus        20 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~   92 (322)
T 3soc_A           20 YFQSMPLQL-LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-S   92 (322)
T ss_dssp             EETTEEEEE-EEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-S
T ss_pred             ccchhhchh-hheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-C
Confidence            333456666 999999999999999875  789999998643   233445567999999999999999999984321 1


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccCCCCCCCeeeccCCCeE
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA----------NVLHRDLKPSNLLLNANCDLK  178 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~----------givH~dikp~NIli~~~~~ik  178 (339)
                      ....+++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+.          |++||||||+||+++.++.+|
T Consensus        93 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           93 VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            1345899999997 699999976 5699999999999999999999999          999999999999999999999


Q ss_pred             Eeeccccccc-------------CCCCccccccccc-----cccCCCCccHHHHHHHHHHHhCCCCCCccccccc-----
Q 042681          179 ICDFGLARTT-------------SETDFMTEYVVTR-----WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS-----  235 (339)
Q Consensus       179 L~Dfg~~~~~-------------~~~~~~~~~~~~~-----~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~-----  235 (339)
                      |+|||+++..             ++..|.+||....     .....+.|+|++|++++++++|..|+........     
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            9999998542             3345777877654     2444567999999999999999988754321100     


Q ss_pred             -----chHHHHHh-hCCCCCCCCccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          236 -----DNARRYVK-QLPHVPKQPFSQKF--PNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       236 -----~~~~~~~~-~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                           ........ .......+.....+  ...++++.+||.+||+.||++|||+.++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                 01111111 11111111111111  1234569999999999999999999999863

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=297.85  Aligned_cols=253  Identities=14%  Similarity=0.097  Sum_probs=190.6

Q ss_pred             cCccCCCccccccccceEEEEEEeCC---CCceEEEEEecccccChH---------hHHHHHHHHHHHhhCCCCCeeeee
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSE---TKEEVAIKKITNAFDNRI---------DAKRILREIKLLCHMTHENIVKVK  100 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~I~~~~  100 (339)
                      .++|.. ++.||+|+||.||+|.+..   ++..+|+|++........         ....+.+|+..+..++||||++++
T Consensus        36 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           36 GNQWVL-GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             SCEEEE-EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             CceEEE-EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            456776 9999999999999999987   889999999875422111         112366788899999999999999


Q ss_pred             eecCCCCcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC--CeE
Q 042681          101 DIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC--DLK  178 (339)
Q Consensus       101 ~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~--~ik  178 (339)
                      +++.... ......++||||++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++  .+|
T Consensus       115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            9984311 2257799999999889999998878999999999999999999999999999999999999999887  999


Q ss_pred             Eeeccccccc------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHH
Q 042681          179 ICDFGLARTT------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARR  240 (339)
Q Consensus       179 L~Dfg~~~~~------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~  240 (339)
                      |+|||+++..                  +...|.+||......+..+.|+|++|++++++++|..|+.............
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            9999998543                  3456888888877778889999999999999999999975422111111111


Q ss_pred             HHhhCCCCCCCCccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          241 YVKQLPHVPKQPFSQKF--PNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       241 ~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ........+ .......  ..++++++++|.+||+.||++||++.++++.
T Consensus       274 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          274 KTNLLDELP-QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHTTT-HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHhhccccc-HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            101000000 0000111  1588999999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-39  Score=282.39  Aligned_cols=244  Identities=22%  Similarity=0.309  Sum_probs=193.5

Q ss_pred             cccccc-CccCCCccccccccceEEEEEEeCC---CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeec
Q 042681           28 NLFQVS-SKYVPPLQPIGRGAYGIVCSAVNSE---TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDII  103 (339)
Q Consensus        28 ~~~~~~-~~y~~~~~~lg~G~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~  103 (339)
                      ..+.+. ++|.. .+.||+|+||.||++.+..   ++..+|+|.+... ......+.+.+|+.+++.++||||+++++++
T Consensus         5 ~~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   82 (281)
T 3cc6_A            5 PQYGIAREDVVL-NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGII   82 (281)
T ss_dssp             CCCSCCGGGEEE-EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             ccceecccceEE-EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            334444 34444 9999999999999998653   3456999998754 2344567889999999999999999999998


Q ss_pred             CCCCcCCcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEee
Q 042681          104 PPMDKEKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD  181 (339)
Q Consensus       104 ~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~D  181 (339)
                           .. ...++||||++ ++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|
T Consensus        83 -----~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D  156 (281)
T 3cc6_A           83 -----EE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGD  156 (281)
T ss_dssp             -----CS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECC
T ss_pred             -----cC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCc
Confidence                 32 34589999998 7999999764 5699999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCC
Q 042681          182 FGLARTTSE------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHV  248 (339)
Q Consensus       182 fg~~~~~~~------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~  248 (339)
                      ||.+.....            ..|.+||.........+.|+|++|++++++++ |..|+......   ............
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~~~~~  233 (281)
T 3cc6_A          157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEKGDRL  233 (281)
T ss_dssp             CCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHHTCCC
T ss_pred             cCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhcCCCC
Confidence            999865432            24788887766677788999999999999998 99887543221   112222222211


Q ss_pred             CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          249 PKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       249 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +.      ...+++.+.++|.+||+.||++|||+.+++++
T Consensus       234 ~~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          234 PK------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            11      13578999999999999999999999999876

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=300.90  Aligned_cols=255  Identities=17%  Similarity=0.200  Sum_probs=195.8

Q ss_pred             cccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           29 LFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        29 ~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      ...+.++|.. .+.||+|+||.||+|++..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++..   
T Consensus         4 ~~~~~~~y~i-~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---   78 (396)
T 4eut_A            4 QSTSNHLWLL-SDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---   78 (396)
T ss_dssp             EECSSEEEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             CCCCCCceEE-EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeecc---
Confidence            3455677777 9999999999999999999999999999975422 2235677899999999999999999999843   


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee----ccCCCeEEe
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKIC  180 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli----~~~~~ikL~  180 (339)
                      ......++||||++ |+|.+++....   .+++..++.++.||+.||+|||++||+||||||+||++    +.++.+||+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence            33447899999997 79999987643   39999999999999999999999999999999999999    777789999


Q ss_pred             eccccccc----------CCCCccccccccc--------cccCCCCccHHHHHHHHHHHhCCCCCCcccccccc--hHHH
Q 042681          181 DFGLARTT----------SETDFMTEYVVTR--------WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD--NARR  240 (339)
Q Consensus       181 Dfg~~~~~----------~~~~~~~~~~~~~--------~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~--~~~~  240 (339)
                      |||.++..          ++..|.+||....        ..+..+.|+|++|+++|++++|..|+.........  ....
T Consensus       159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  238 (396)
T 4eut_A          159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK  238 (396)
T ss_dssp             CGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred             cCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence            99999653          3446778887643        34567899999999999999999998644322111  1112


Q ss_pred             HHhhCCCCCC-----------------CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          241 YVKQLPHVPK-----------------QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       241 ~~~~~~~~~~-----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .....+....                 .........++..+.++|.+||+.||++||++.+++++
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            2221111000                 00000112245678899999999999999999998654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.8e-40  Score=290.85  Aligned_cols=242  Identities=23%  Similarity=0.367  Sum_probs=195.0

Q ss_pred             cCccCCCccccccccceEEEEEEe-----CCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVN-----SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPM  106 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~  106 (339)
                      .++|.. ++.||+|+||.||+|.+     ..+++.||+|++... ......+.+.+|+.++.++ +||||+++++++.  
T Consensus        26 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--  101 (316)
T 2xir_A           26 RDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACT--  101 (316)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             hhheee-eeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe--
Confidence            355655 99999999999999984     457789999998754 2344556789999999999 6999999999983  


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCe
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSKQA----------------LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL  169 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~~----------------~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NI  169 (339)
                        .....+++||||++ ++|.+++.....                +++..++.++.|++.||.|||++|++||||||+||
T Consensus       102 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni  179 (316)
T 2xir_A          102 --KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  179 (316)
T ss_dssp             --CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             --cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence              23455899999998 699999987543                89999999999999999999999999999999999


Q ss_pred             eeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCccccccc
Q 042681          170 LLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRS  235 (339)
Q Consensus       170 li~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~  235 (339)
                      +++.++.++|+|||.+.....             ..|.+||.........+.|+|++|++++++++ |..|+......  
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--  257 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--  257 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--
T ss_pred             EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh--
Confidence            999999999999999865421             24788887776677888999999999999998 88887543321  


Q ss_pred             chHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          236 DNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..............      ....+++++.++|.+||+.||.+|||+.++++|
T Consensus       258 ~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          258 EEFCRRLKEGTRMR------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccCccCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11112222211111      113478999999999999999999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.4e-39  Score=283.73  Aligned_cols=242  Identities=21%  Similarity=0.259  Sum_probs=189.1

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. .+.||+|+||.||++.+..   .+|+|+++.........+.+.+|+.+++.++||||++++++.      ...
T Consensus        23 ~~~y~~-~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~~   92 (289)
T 3og7_A           23 DGQITV-GQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TAP   92 (289)
T ss_dssp             TTSCEE-EEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CSS
T ss_pred             ccceee-eeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cCC
Confidence            445555 9999999999999998643   599999987766666778899999999999999999999975      234


Q ss_pred             eEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          113 DVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      ..++||||++ ++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...  
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence            5799999998 799998854 467999999999999999999999999999999999999999999999999998633  


Q ss_pred             -----------CCCCcccccccc---ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          189 -----------SETDFMTEYVVT---RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       189 -----------~~~~~~~~~~~~---~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                                 ++..|.+||...   ......+.|+|++|++++++++|..|+......  ............  .....
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~--~~~~~  248 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRGSL--SPDLS  248 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHHTSC--CCCTT
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhccccc--Ccchh
Confidence                       345678888764   344566799999999999999999997654321  112222222111  11222


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .....+++.+++||.+||+.||++|||+.++++.
T Consensus       249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            2235689999999999999999999999999863

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-39  Score=287.31  Aligned_cols=240  Identities=20%  Similarity=0.321  Sum_probs=190.9

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCC----ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETK----EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      .++|.. .+.||+|+||.||+|.+..++    ..+|+|++.... .......+.+|+.++..++||||+++++++     
T Consensus        43 ~~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----  115 (333)
T 1mqb_A           43 PSCVTR-QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----  115 (333)
T ss_dssp             TTTEEE-EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred             hHHhhc-ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            344544 899999999999999977553    359999987542 344556789999999999999999999999     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      ......++||||++ ++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+.
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            66778999999998 5999999764 679999999999999999999999999999999999999999999999999986


Q ss_pred             ccCC--------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          187 TTSE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       187 ~~~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ....              ..|.+||.........+.|+|++|++++++++ |..|+.....   .............+  
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~~~--  270 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRLP--  270 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCC--
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHCCCcCC--
Confidence            5432              24788888776677788999999999999998 9888754321   11111111111111  


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                          ....+++.+.++|.+||+.||++||++.+++++
T Consensus       271 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          271 ----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                113578999999999999999999999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9e-41  Score=316.75  Aligned_cols=262  Identities=18%  Similarity=0.239  Sum_probs=200.5

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc-CCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK-EKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~-~~~~  112 (339)
                      ++|.. .+.||+|+||.||+|.+..+|+.||+|++... ......+.+.+|+.++..++||||+++++++..... ....
T Consensus        14 grY~i-~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           14 GPWEM-KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ---CC-CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCeEE-EEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            67888 99999999999999999999999999998754 344556788999999999999999999999843211 2256


Q ss_pred             eEEEEEecCc-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC---eEEeecccc
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLA  185 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~---ikL~Dfg~~  185 (339)
                      ..++||||++ |+|.+++....   .+++..++.++.|++.||.|||+.|++||||||+||+++.++.   ++|+|||.+
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            7899999996 79999998754   6999999999999999999999999999999999999997765   999999998


Q ss_pred             ccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc------chHHHHHhhCC-CC
Q 042681          186 RTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS------DNARRYVKQLP-HV  248 (339)
Q Consensus       186 ~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~------~~~~~~~~~~~-~~  248 (339)
                      ...          +...|.+|+......+..+.|+|++|++++++++|..|+........      ........... ..
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~  251 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT  251 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred             cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence            653          33467888888777888899999999999999999998754211000      00000000000 00


Q ss_pred             ------CC-CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          249 ------PK-QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       249 ------~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                            .. .......+.+++.+.+||.+||++||++|||+.++++||||+.+...
T Consensus       252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i  307 (676)
T 3qa8_A          252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI  307 (676)
T ss_dssp             SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred             cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence                  00 00011122367889999999999999999999999999999887654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.4e-39  Score=278.89  Aligned_cols=237  Identities=19%  Similarity=0.255  Sum_probs=193.2

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. ++.||+|+||.||++.+. +++.+|+|++......   .+.+.+|+.+++.++||||+++++++     ...+
T Consensus         7 ~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   76 (267)
T 3t9t_A            7 PSELTF-VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQA   76 (267)
T ss_dssp             GGGEEE-EEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred             hhheee-eeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence            345655 999999999999999986 5778999999765332   36788999999999999999999999     5567


Q ss_pred             eEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC
Q 042681          113 DVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  190 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~  190 (339)
                      ..++||||++ ++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence            7899999997 6999999765 5699999999999999999999999999999999999999999999999999865421


Q ss_pred             ------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          191 ------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       191 ------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                  ..|.+||.........+.|+|++|++++++++ |..|+.....   ..............      ..
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~i~~~~~~~------~~  227 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRLY------KP  227 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCC------CC
T ss_pred             ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHHHHhcCCcCC------CC
Confidence                        24788888776677788999999999999999 7888654321   11111111111111      11


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..+++.+.+++.+||+.||++|||+.+++++
T Consensus       228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3478999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.9e-40  Score=291.44  Aligned_cols=239  Identities=18%  Similarity=0.249  Sum_probs=192.2

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCce----EEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEE----VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      .++|.. ++.||+|+||.||+|.+..+++.    +|+|.+.... .......+.+|+.++..++||||+++++++     
T Consensus        12 ~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----   84 (325)
T 3kex_A           12 ETELRK-LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-----   84 (325)
T ss_dssp             TTTEEE-EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred             HhHcee-eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----
Confidence            456666 99999999999999999888876    6666654321 122234567899999999999999999998     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      . ....++||||+. |+|.+++... +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+++
T Consensus        85 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           85 P-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             C-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             c-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence            3 355899999998 7999999774 689999999999999999999999999999999999999999999999999997


Q ss_pred             ccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          187 TTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       187 ~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      ....             ..|.+|+......+..+.|+|++|++++++++ |..|+.....   ...............  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~--  238 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---AEVPDLLEKGERLAQ--  238 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT---THHHHHHHTTCBCCC--
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH---HHHHHHHHcCCCCCC--
Confidence            5422             25788888776777888999999999999999 9988765322   122222222111111  


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                          ...++.++.++|.+||+.||++|||+.+++++
T Consensus       239 ----~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          239 ----PQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ----CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ----CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                13467889999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=288.60  Aligned_cols=240  Identities=20%  Similarity=0.303  Sum_probs=191.2

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceE----EEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEV----AIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~----avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      ..++|.. ++.||+|+||.||+|.+..+++.+    ++|.+... ......+.+.+|+.+++.++||||+++++++    
T Consensus        13 ~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----   86 (327)
T 3lzb_A           13 KETEFKK-IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGIC----   86 (327)
T ss_dssp             CTTTEEE-EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEE----
T ss_pred             CHhHceE-EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEE----
Confidence            3566777 999999999999999999888866    55555432 2333467889999999999999999999998    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  185 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~  185 (339)
                       ... ..+++++|+. |+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus        87 -~~~-~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           87 -LTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             -ESS-SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             -ecC-CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence             333 3788888887 799999876 467999999999999999999999999999999999999999999999999999


Q ss_pred             cccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          186 RTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       186 ~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      .....             ..|.+|+......+..+.|+|++|++++++++ |..|+.....   .............+. 
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~~~~-  240 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGERLPQ-  240 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTCCCCC-
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCCCC-
Confidence            65421             24788888777777888999999999999999 9988765432   222222222222221 


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                           .+.++.++.+||.+||+.||.+|||+.++++.
T Consensus       241 -----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          241 -----PPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                 14578999999999999999999999999974

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.3e-39  Score=289.03  Aligned_cols=246  Identities=19%  Similarity=0.230  Sum_probs=192.9

Q ss_pred             cCccCCCccccccccceEEEEEE-----eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      .++|.. ++.||+|+||.||++.     +..+++.||+|++... ........+.+|+.+++.++||||+++++++    
T Consensus        29 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----  102 (327)
T 2yfx_A           29 RKNITL-IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVS----  102 (327)
T ss_dssp             GGGCEE-EEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             hhheEE-EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEE----
Confidence            455655 9999999999999999     5567889999998643 3344566788999999999999999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc---CCC
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSK-------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCD  176 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~---~~~  176 (339)
                       ......++||||++ ++|.+++...       ..+++..++.++.||+.||.|||++|++||||||+||+++.   +..
T Consensus       103 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          103 -LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             -CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             -cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence             55667899999996 7999999765       34899999999999999999999999999999999999984   446


Q ss_pred             eEEeeccccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHH
Q 042681          177 LKICDFGLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYV  242 (339)
Q Consensus       177 ikL~Dfg~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~  242 (339)
                      ++|+|||.+...             +...|.+||.........+.|+|++|++++++++ |..|+.....   .......
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~  258 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFV  258 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHH
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHH
Confidence            999999988532             2335888887766677888999999999999998 8887654321   1111112


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      .......      ....+++.+.+||.+||+.||.+||++.++++|.|+..-
T Consensus       259 ~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          259 TSGGRMD------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCCCCC------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            1111111      124688999999999999999999999999999876433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.1e-40  Score=285.74  Aligned_cols=247  Identities=18%  Similarity=0.169  Sum_probs=196.9

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ..+.++|.. ++.||+|+||.||+|++..+|+.||+|++......    ..+.+|+.++..++|++++..+..+.    .
T Consensus         5 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~----~   75 (296)
T 3uzp_A            5 LRVGNRYRL-GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCG----A   75 (296)
T ss_dssp             CEETTTEEE-EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEE----E
T ss_pred             ceeccEEEE-EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCcccccc----C
Confidence            456788888 99999999999999999999999999998654322    35789999999999888766666552    4


Q ss_pred             CcCeEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee---ccCCCeEEeecccc
Q 042681          110 KFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLA  185 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli---~~~~~ikL~Dfg~~  185 (339)
                      .....++||||++++|.+++.. .+.+++..++.++.|++.||+|||++|++||||||+||++   +.++.+||+|||.+
T Consensus        76 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           76 EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             CCCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            5667899999998899999974 5689999999999999999999999999999999999999   48889999999998


Q ss_pred             ccc------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccch-HHHHHhhCC
Q 042681          186 RTT------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN-ARRYVKQLP  246 (339)
Q Consensus       186 ~~~------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~-~~~~~~~~~  246 (339)
                      ...                  ++..|.+||.........++|+|++|++++++++|..|+.......... .........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            643                  2335778888777777888999999999999999999987543222111 111111100


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       247 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..   +.....+.+|+++.+||.+||+.||++|||+.++++.
T Consensus       236 ~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          236 ST---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HS---CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             CC---chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence            00   1111124578999999999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.9e-39  Score=303.14  Aligned_cols=242  Identities=17%  Similarity=0.287  Sum_probs=197.8

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      |.+....+.+.+.||+|+||.||++.+..++..||+|+++....   ..+.+.+|+.++++++||||+++++++     .
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~-----~  286 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVC-----T  286 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEE-----e
Confidence            33433333338999999999999999999999999999875422   357789999999999999999999999     5


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      ....+++||||++ |+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus       287 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccce
Confidence            6677899999998 7999999763  569999999999999999999999999999999999999999999999999987


Q ss_pred             ccCC------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          187 TTSE------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       187 ~~~~------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      ....            ..|.+||......+..+.|+|++|++++++++ |..|+.....   ..............    
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~~----  439 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDYRME----  439 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHHTTCCCC----
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC----
Confidence            5432            24778887776677888999999999999998 8888754322   12222222211111    


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                        ....+++++.+||.+||+.||++|||+.++++.
T Consensus       440 --~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~  472 (495)
T 1opk_A          440 --RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA  472 (495)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence              124689999999999999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4e-40  Score=287.94  Aligned_cols=247  Identities=18%  Similarity=0.169  Sum_probs=191.9

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ..+.++|.. .+.||+|+||.||+|.+..+++.||+|++.....    ...+.+|+.++..++|++++..+..+.    .
T Consensus         5 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~----~   75 (296)
T 4hgt_A            5 LRVGNRYRL-GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCG----A   75 (296)
T ss_dssp             ------CEE-EEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEE----E
T ss_pred             cccCCceEE-eeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeec----C
Confidence            456788888 9999999999999999999999999998754422    234778999999998887777766652    5


Q ss_pred             CcCeEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee---ccCCCeEEeecccc
Q 042681          110 KFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLA  185 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli---~~~~~ikL~Dfg~~  185 (339)
                      .....++||||++++|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+||++   +.++.+||+|||.+
T Consensus        76 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           76 EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             CCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            5677899999999999999975 5679999999999999999999999999999999999999   78999999999998


Q ss_pred             ccc------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchH-HHHHhhCC
Q 042681          186 RTT------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNA-RRYVKQLP  246 (339)
Q Consensus       186 ~~~------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~-~~~~~~~~  246 (339)
                      ...                  ++..|.+||.........+.|+|++|++++++++|..|+........... ........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            643                  23457778877776777889999999999999999999875433222111 11111100


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       247 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .   .+.......+++++.+||.+||+.||++|||+.++++.
T Consensus       236 ~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  274 (296)
T 4hgt_A          236 S---TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             H---SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             c---chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH
Confidence            0   11111224578999999999999999999999999873

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.4e-40  Score=284.92  Aligned_cols=241  Identities=23%  Similarity=0.308  Sum_probs=195.9

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC---
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD---  107 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~---  107 (339)
                      .+.++|.. ++.||+|+||.||+|.+..+|+.||+|++....      ..+.+|+.+++.++||||+++++++....   
T Consensus         8 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B            8 RFGMDFKE-IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHHHEEE-EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             hhccccce-eeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            34566777 999999999999999999999999999986542      34678999999999999999999873210   


Q ss_pred             --------cCCcCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCC
Q 042681          108 --------KEKFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD  176 (339)
Q Consensus       108 --------~~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~  176 (339)
                              ......+++||||++ ++|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence                    012455899999998 5999999754  67999999999999999999999999999999999999999999


Q ss_pred             eEEeeccccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC
Q 042681          177 LKICDFGLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP  246 (339)
Q Consensus       177 ikL~Dfg~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~  246 (339)
                      ++|+|||.+...          +...|.+||.........+.|+|++|++++++++|..++...     ......... .
T Consensus       161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~~~-~  234 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFTDLRD-G  234 (284)
T ss_dssp             EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHHHHHT-T
T ss_pred             EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHHHhhc-c
Confidence            999999988654          334578888877777888999999999999999998774321     111111111 1


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       247 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                        .      ....+++.+++||.+||+.||++|||+.++++|+|.-
T Consensus       235 --~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          235 --I------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             --C------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --c------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              1      1134789999999999999999999999999996643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-39  Score=289.09  Aligned_cols=239  Identities=21%  Similarity=0.310  Sum_probs=193.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceE--EEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEV--AIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~--avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~  110 (339)
                      ++|.. .+.||+|+||.||+|++..+|..+  ++|.+... ......+.+.+|+.+++++ +||||+++++++     ..
T Consensus        25 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~   97 (327)
T 1fvr_A           25 NDIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH   97 (327)
T ss_dssp             GGCEE-EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EE
T ss_pred             HHccc-eeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceee-----ee
Confidence            56666 999999999999999999888866  89988643 2233456788999999999 899999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQ----------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA  173 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~  173 (339)
                      .+..++||||++ ++|.+++...+                .+++..++.++.||+.||.|||++|++||||||+||+++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  177 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence            778999999997 69999997654                7999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHH
Q 042681          174 NCDLKICDFGLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYV  242 (339)
Q Consensus       174 ~~~ikL~Dfg~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~  242 (339)
                      ++.++|+|||++...          +...|.+||.........+.|+|++|++++++++ |..|+......      ...
T Consensus       178 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~  251 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY  251 (327)
T ss_dssp             GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH
T ss_pred             CCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHH
Confidence            999999999998632          1235788888776677888999999999999998 98887543211      111


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .........   .....+++++++||.+||+.||++|||+.+++++
T Consensus       252 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          252 EKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHGGGTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            111111111   1124578999999999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-39  Score=281.65  Aligned_cols=238  Identities=24%  Similarity=0.309  Sum_probs=185.1

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC--hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN--RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++|.. .+.||+|+||.||++.+.  |+.+|+|++......  ....+.+.+|+.+++.++||||+++++++     ...
T Consensus         7 ~~~~~-~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   78 (271)
T 3dtc_A            7 AELTL-EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE   78 (271)
T ss_dssp             TSEEE-EEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred             hheee-eeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence            45555 899999999999999874  789999998754322  23356788999999999999999999999     566


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCCeeecc--------CCCeEE
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNA--------NCDLKI  179 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~dikp~NIli~~--------~~~ikL  179 (339)
                      ...++||||++ ++|.+++. .+++++..++.++.|++.||.|||++|   ++||||||+||+++.        ++.++|
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            77899999997 68877775 578999999999999999999999999   899999999999985        778999


Q ss_pred             eeccccccc---------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          180 CDFGLARTT---------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       180 ~Dfg~~~~~---------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      +|||.+...         ++..|.+||.........+.|+|++|++++++++|..|+......   ........ .... 
T Consensus       158 ~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~-~~~~-  232 (271)
T 3dtc_A          158 TDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---AVAYGVAM-NKLA-  232 (271)
T ss_dssp             CCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHHHT-SCCC-
T ss_pred             ccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHhhhc-CCCC-
Confidence            999998643         344678888777667788899999999999999999997653211   11111111 1111 


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..   ....+++.+.++|.+||+.||++|||+.+++++
T Consensus       233 ~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          233 LP---IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            11   124578999999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=295.62  Aligned_cols=243  Identities=12%  Similarity=0.137  Sum_probs=190.2

Q ss_pred             cCccCCCccccccccceEEEEEEeCCC--------CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeee-----
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSET--------KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV-----   99 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~-----   99 (339)
                      .++|.. ++.||+|+||.||+|++..+        ++.||+|++...       +.+.+|+.++..++||||+++     
T Consensus        41 ~~~y~~-~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKL-KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEE-EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEE-EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            356666 99999999999999999874        889999998654       357889999999999999884     


Q ss_pred             ----------eeecCCCCcCCcCeEEEEEecCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 042681          100 ----------KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPS  167 (339)
Q Consensus       100 ----------~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~  167 (339)
                                ++++.    ......++||||++++|.+++...  ..+++..++.++.||+.||.|||++|++||||||+
T Consensus       113 ~~~~~~i~~~~~~~~----~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~  188 (352)
T 2jii_A          113 STPLLAIPTCMGFGV----HQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE  188 (352)
T ss_dssp             TCTTCSCCCCCEEEE----ETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred             cCCccCccchhhccc----cCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence                      44431    235678999999988999999876  78999999999999999999999999999999999


Q ss_pred             CeeeccCC--CeEEeecccccc------------------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCC
Q 042681          168 NLLLNANC--DLKICDFGLART------------------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDD  227 (339)
Q Consensus       168 NIli~~~~--~ikL~Dfg~~~~------------------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~  227 (339)
                      ||+++.++  .++|+|||+++.                  .++..|.+||......+..+.|+|++|++++++++|..|+
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999998  899999999854                  2344688888877777888999999999999999999997


Q ss_pred             CcccccccchHHHHH--hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          228 SDLGFLRSDNARRYV--KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       228 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ...............  .... .........+..+++++.+||.+||+.||++|||+.++++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             ccCCcCHHHHHHHHHhccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            654311111111111  1111 00000011123578999999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.3e-39  Score=288.05  Aligned_cols=244  Identities=20%  Similarity=0.283  Sum_probs=195.8

Q ss_pred             cccc-CccCCCccccccccceEEEEEEeCCCCc-----eEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeee
Q 042681           30 FQVS-SKYVPPLQPIGRGAYGIVCSAVNSETKE-----EVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDI  102 (339)
Q Consensus        30 ~~~~-~~y~~~~~~lg~G~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~  102 (339)
                      +.+. ++|.. .+.||+|+||.||+|.+..+++     .+|+|.+.... .....+.+.+|+.++..+ +||||++++++
T Consensus        41 ~~~~~~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQF-GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEE-EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHcee-eeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            4443 44555 9999999999999999887665     79999986542 334567789999999999 89999999999


Q ss_pred             cCCCCcCCcCeEEEEEecCc-ccHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 042681          103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSK--------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPS  167 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~  167 (339)
                      +     ...+..++||||++ |+|.+++...              ..+++..++.++.||+.||.|||++|++||||||+
T Consensus       119 ~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  193 (333)
T 2i1m_A          119 C-----THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAAR  193 (333)
T ss_dssp             E-----CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             E-----ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccc
Confidence            9     66677999999997 6999998642              45899999999999999999999999999999999


Q ss_pred             CeeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCccccc
Q 042681          168 NLLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFL  233 (339)
Q Consensus       168 NIli~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~  233 (339)
                      ||+++.++.++|+|||++.....             ..|.+||.........+.|+|++|++++++++ |..|+......
T Consensus       194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            99999999999999999874321             24788887766677888999999999999998 88886543211


Q ss_pred             ccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                        ...............      ...+++.+.+||.+||+.||.+|||+.+++++
T Consensus       274 --~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          274 --SKFYKLVKDGYQMAQ------PAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             --HHHHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --HHHHHHHhcCCCCCC------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence              112222222221111      13478999999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.8e-40  Score=296.63  Aligned_cols=253  Identities=16%  Similarity=0.141  Sum_probs=190.9

Q ss_pred             cCccCCCccccccccceEEEEEEeCCC-----CceEEEEEecccccChHh---------HHHHHHHHHHHhhCCCCCeee
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSET-----KEEVAIKKITNAFDNRID---------AKRILREIKLLCHMTHENIVK   98 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~I~~   98 (339)
                      .++|.+ ++.||+|+||.||+|.+..+     ++.||+|++.........         ......|+..+..++||||++
T Consensus        34 ~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           34 AAAWKV-GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             CCEEEE-EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCeEEE-EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            446666 99999999999999998765     588999998654211110         123445667788889999999


Q ss_pred             eeeecCCCCcCCcCeEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec--cCC
Q 042681           99 VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN--ANC  175 (339)
Q Consensus        99 ~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~--~~~  175 (339)
                      +++++.... ......++||||++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++  .++
T Consensus       113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            999984321 123568999999988999999775 6899999999999999999999999999999999999999  889


Q ss_pred             CeEEeeccccccc------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccch
Q 042681          176 DLKICDFGLARTT------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN  237 (339)
Q Consensus       176 ~ikL~Dfg~~~~~------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~  237 (339)
                      .+||+|||+++..                  ++..|++||......+..+.|+|++|+++|++++|..|+..........
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            9999999998542                  4557888988887778889999999999999999999986432111110


Q ss_pred             HHHHHhhCCCCCCCCccc--cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          238 ARRYVKQLPHVPKQPFSQ--KFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .......... .......  ....+++++.+++.+||+.||.+||++.++++.
T Consensus       272 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~  323 (364)
T 3op5_A          272 RDSKIRYREN-IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI  323 (364)
T ss_dssp             HHHHHHHHHC-HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHhhhh-HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence            0000000000 0000000  014578999999999999999999999998863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-39  Score=280.68  Aligned_cols=242  Identities=19%  Similarity=0.298  Sum_probs=194.8

Q ss_pred             cccCccCCCccccccccceEEEEEEeC--CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNS--ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      .-.++|.+..+.||+|+||.||++.+.  .++..+|+|++... ......+.+.+|+.++..++||||+++++++     
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----   79 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-----   79 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-----
Confidence            345666663349999999999999854  46788999998764 3345567899999999999999999999998     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      .. ...++||||++ ++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+.
T Consensus        80 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           80 QA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             ES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             cC-CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence            22 35899999998 6999998653 569999999999999999999999999999999999999999999999999986


Q ss_pred             ccCC--------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          187 TTSE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       187 ~~~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ....              ..|.+||.........+.|+|++|++++++++ |..|+.....   ............   .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~~~~---~  232 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKR---M  232 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCC---C
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhcCCc---C
Confidence            5421              24778887766677788999999999999998 9988754321   111122221111   1


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                         ...+.+++++.++|.+||+.||++||++.+++++
T Consensus       233 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          233 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               1124689999999999999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-38  Score=279.25  Aligned_cols=236  Identities=21%  Similarity=0.274  Sum_probs=187.9

Q ss_pred             ccccccccceEEEEEEeCCCCc---eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      .+.||+|+||.||+|.+..+++   .+|+|.+... ......+.+.+|+.+++.++||||+++++++.    ......++
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~~  100 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIML----PPEGLPHV  100 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSSCCEE
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe----cCCCCcEE
Confidence            6889999999999999765554   7999988653 34445678899999999999999999999993    22334589


Q ss_pred             EEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC----
Q 042681          117 VYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----  190 (339)
Q Consensus       117 v~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~----  190 (339)
                      +|||+. ++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.....    
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            999996 799999977 46799999999999999999999999999999999999999999999999999864322    


Q ss_pred             -----------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          191 -----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       191 -----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                 ..|.+|+.........+.|+|++|++++++++|..++....  .................      ...
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~------~~~  252 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLTHFLAQGRRLPQ------PEY  252 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CGGGHHHHHHTTCCCCC------CTT
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--CHHHHHHHhhcCCCCCC------Ccc
Confidence                       24677777776677788999999999999999655543221  11222222222221111      135


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +++.+.+||.+||+.||.+|||+.++++.
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            78999999999999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.5e-39  Score=307.08  Aligned_cols=232  Identities=18%  Similarity=0.271  Sum_probs=193.4

Q ss_pred             cccccccceEEEEEE--eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAV--NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||.||++.  ...+++.||+|+++.........+.+.+|+.++..++||||+++++++     .. ...++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~-~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-----EA-ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEE-----ES-SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ec-CCEEEEE
Confidence            479999999999995  456778999999987655566678899999999999999999999998     32 3478999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-------  190 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-------  190 (339)
                      ||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....       
T Consensus       449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            9998 79999999888999999999999999999999999999999999999999999999999999865422       


Q ss_pred             -------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          191 -------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       191 -------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                             ..|.+||......+..+.|+|++|++++++++ |..|+.....   ......+.......      ....+++
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~~------~p~~~~~  599 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERMG------CPAGCPR  599 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCC------CCTTCCH
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC------CCCCCCH
Confidence                   23788888877778889999999999999998 9998764321   11222222211111      1146899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ++.+||.+||+.||++||++.++++
T Consensus       600 ~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          600 EMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=285.60  Aligned_cols=242  Identities=18%  Similarity=0.251  Sum_probs=191.4

Q ss_pred             CccCCCccccccccceEEEEEE----eCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAV----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ++|.. ++.||+|+||.||+++    +..+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++..   .
T Consensus        41 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~  114 (326)
T 2w1i_A           41 RHLKF-LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---A  114 (326)
T ss_dssp             GGEEE-EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHcee-eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---c
Confidence            34555 9999999999999998    5678999999998753  34456788999999999999999999999842   2


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .....++||||++ ++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            3346899999997 6999999875 5699999999999999999999999999999999999999999999999999875


Q ss_pred             cCCC--------------CccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccc--------c-c----hHHH
Q 042681          188 TSET--------------DFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR--------S-D----NARR  240 (339)
Q Consensus       188 ~~~~--------------~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~--------~-~----~~~~  240 (339)
                      ....              .|.+||.........+.|+|++|++++++++|..++.......        . .    ....
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            4321              2677877766667788999999999999999987754321000        0 0    0011


Q ss_pred             HHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          241 YVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ........+      ....+++++.+||.+||+.||++|||+.++++
T Consensus       275 ~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          275 LLKNNGRLP------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHTTCCCC------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhcCCCCC------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            111111111      12468999999999999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8.7e-39  Score=279.89  Aligned_cols=235  Identities=20%  Similarity=0.266  Sum_probs=185.8

Q ss_pred             ccccccccceEEEEEEeCCCC---ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETK---EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      .+.||+|+||.||+|.+..++   ..+|+|.+... ......+.+.+|+.++++++||||+++++++.    ...+..++
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~~  104 (298)
T 3f66_A           30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLV  104 (298)
T ss_dssp             EEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSSCCEE
T ss_pred             cceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cCCCceEE
Confidence            889999999999999965433   35889988653 34445678899999999999999999999863    44567899


Q ss_pred             EEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC----
Q 042681          117 VYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----  190 (339)
Q Consensus       117 v~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~----  190 (339)
                      ||||++ |+|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.....    
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  184 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY  184 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence            999998 599999976 45689999999999999999999999999999999999999999999999999964422    


Q ss_pred             -----------CCccccccccccccCCCCccHHHHHHHHHHHhC-CCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          191 -----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLG-SPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       191 -----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                 ..|.+|+.........+.|+|++|++++++++| .+++....   ................      ..
T Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~------~~  255 (298)
T 3f66_A          185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQ------PE  255 (298)
T ss_dssp             BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC---TTTHHHHHHTTCCCCC------CT
T ss_pred             ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC---HHHHHHHHhcCCCCCC------Cc
Confidence                       237778877666777889999999999999995 44443321   1111111121111111      13


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .+++.+.++|.+||+.||++|||+.++++.
T Consensus       256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            578999999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.9e-39  Score=295.65  Aligned_cols=239  Identities=23%  Similarity=0.314  Sum_probs=193.7

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      |.+..+.+.+++.||+|+||.||++.+.  |+.||+|+++...    ..+.+.+|+.++++++||||+++++++.    .
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~----~  257 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIV----E  257 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEE----C
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEE----c
Confidence            3444333344999999999999999875  7799999997542    3467899999999999999999999973    3


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQA--LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      .....++||||++ |+|.+++...+.  +++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++
T Consensus       258 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  337 (450)
T 1k9a_A          258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  337 (450)
T ss_dssp             TTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence            3347899999997 699999987543  7999999999999999999999999999999999999999999999999986


Q ss_pred             ccC--------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          187 TTS--------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       187 ~~~--------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                      ...        ...|.+||......+..++|+|++|++++++++ |..|+......   .............      ..
T Consensus       338 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~~~~~~------~p  408 (450)
T 1k9a_A          338 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYKMD------AP  408 (450)
T ss_dssp             ECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THHHHHHTTCCCC------CC
T ss_pred             cccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCCC------CC
Confidence            432        235888888877778889999999999999998 98887654322   1222222211111      12


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ..+++++.+||.+||+.||++|||+.++++
T Consensus       409 ~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          409 DGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            468999999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.1e-39  Score=277.82  Aligned_cols=240  Identities=18%  Similarity=0.287  Sum_probs=191.6

Q ss_pred             cccccc-CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           28 NLFQVS-SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        28 ~~~~~~-~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      ..|.++ ++|.. ++.||+|+||.||++.+. +++.+|+|++.....   ..+.+.+|+.+++.++||||+++++++   
T Consensus         6 ~~~~v~~~~y~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~---   77 (279)
T 1qpc_A            6 DEWEVPRETLKL-VERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVV---   77 (279)
T ss_dssp             CTTBCCGGGEEE-EEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             hhcccCHHhhhh-eeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEE---
Confidence            345554 44555 999999999999999975 567899999875432   346788999999999999999999998   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                        . .+..++||||++ ++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||
T Consensus        78 --~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  154 (279)
T 1qpc_A           78 --T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG  154 (279)
T ss_dssp             --C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             --c-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence              3 234799999997 79999987543  79999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          184 LARTTSE------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       184 ~~~~~~~------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      .+.....            ..|.+||.........+.|+|++|++++++++ |..|+.....   .............  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~--  229 (279)
T 1qpc_A          155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRM--  229 (279)
T ss_dssp             TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC--
T ss_pred             ccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhcccCC--
Confidence            9875432            24778887766667778999999999999999 8888654321   1111111111111  


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                          .....+++++.+||.+||+.||++|||+.++++
T Consensus       230 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          230 ----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                111457899999999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.9e-39  Score=296.47  Aligned_cols=242  Identities=20%  Similarity=0.319  Sum_probs=195.4

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      ..+.++.+.+.+.+.||+|+||.||++.+.. +..||+|+++...   ...+.+.+|+.+++.++||||+++++++    
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~----  252 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVV----  252 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEE----
Confidence            3445554444448999999999999999864 6789999997543   2357899999999999999999999998    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                       . ....++||||+. |+|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus       253 -~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~  330 (454)
T 1qcf_A          253 -T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL  330 (454)
T ss_dssp             -C-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred             -e-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence             3 345799999997 7999999754  3789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          185 ARTTSE------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       185 ~~~~~~------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ++....            ..|.+||......+..++|+|++|++++++++ |..|+.....   .............+. 
T Consensus       331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~~-  406 (454)
T 1qcf_A          331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYRMPR-  406 (454)
T ss_dssp             GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCCCC-
T ss_pred             ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCC-
Confidence            975422            24788888776777888999999999999998 8888764321   111122222211111 


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                           ...+++++.+||.+||+.||++|||+.++++.
T Consensus       407 -----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~  438 (454)
T 1qcf_A          407 -----PENCPEELYNIMMRCWKNRPEERPTFEYIQSV  438 (454)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                 14589999999999999999999999999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.7e-39  Score=295.53  Aligned_cols=248  Identities=20%  Similarity=0.291  Sum_probs=195.8

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      ..|.++.+.+.+.+.||+|+||.||++.+.. +..||+|+++....   ..+.+.+|+.++++++||||+++++++    
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~----  248 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVV----  248 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            3455554444448999999999999999875 46799999875432   246789999999999999999999998    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                       .. ...++||||++ |+|.+++..  ...+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus       249 -~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~  326 (452)
T 1fmk_A          249 -SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL  326 (452)
T ss_dssp             -CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             -cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcc
Confidence             33 55799999997 699999964  35699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          185 ARTTSE------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       185 ~~~~~~------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ++....            ..|.+||......+..++|+|++|++++++++ |..|+.....   .............+  
T Consensus       327 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~--  401 (452)
T 1fmk_A          327 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRMP--  401 (452)
T ss_dssp             TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCC--
T ss_pred             ceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence            975432            24778887766677888999999999999999 8888654321   11111122111111  


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC--CCCCCC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH--PYLSSL  294 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h--p~f~~~  294 (339)
                          ..+.+++.+.+||.+||+.||++|||+.++++.  .++...
T Consensus       402 ----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          402 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                114689999999999999999999999999874  555544

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-39  Score=285.08  Aligned_cols=248  Identities=21%  Similarity=0.244  Sum_probs=186.0

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC--CCCCeeeeeeecCCCCc
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM--THENIVKVKDIIPPMDK  108 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~I~~~~~~~~~~~~  108 (339)
                      .+.++|.. ++.||+|+||.||++.+.  |+.||+|++...     ......+|.+++..+  +||||+++++++.... 
T Consensus        34 ~~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-  104 (337)
T 3mdy_A           34 TIAKQIQM-VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGT-  104 (337)
T ss_dssp             THHHHCEE-EEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-
T ss_pred             ccccceEE-EeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-
Confidence            34567877 999999999999999875  889999998543     224445566666554  8999999999984321 


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCeeeccCCCeEE
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA--------NVLHRDLKPSNLLLNANCDLKI  179 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------givH~dikp~NIli~~~~~ikL  179 (339)
                      ......++||||++ |+|.+++.. ..+++..++.++.|++.||.|||++        |++||||||+||+++.++.+||
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence            12267999999997 699999976 5799999999999999999999999        9999999999999999999999


Q ss_pred             eecccccc---------------cCCCCccccccccccccCCC------CccHHHHHHHHHHHhC----------CCCCC
Q 042681          180 CDFGLART---------------TSETDFMTEYVVTRWDTLFP------GKDYVQQLTMITELLG----------SPDDS  228 (339)
Q Consensus       180 ~Dfg~~~~---------------~~~~~~~~~~~~~~~~~~~~------~d~~~~g~~~~~~l~g----------~~~~~  228 (339)
                      +|||++..               .++..|.+||..........      +|+|++|+++|++++|          ..|+.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            99999853               24456888887765544444      8999999999999999          44443


Q ss_pred             cccccccc--hHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          229 DLGFLRSD--NARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       229 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ........  ............+..+.......+++++.+||.+||+.||++|||+.++++|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            32211111  1111111111111111111112466789999999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.2e-38  Score=276.72  Aligned_cols=246  Identities=20%  Similarity=0.284  Sum_probs=189.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccc--cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF--DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ..|.. .+.||+|+||.||++.+  +++.+|+|++....  ......+.+.+|+.+++.++||||+++++++     ...
T Consensus        31 ~~~~~-~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~  102 (307)
T 2nru_A           31 PISVG-GNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-----SDG  102 (307)
T ss_dssp             BTTTT-CCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSS
T ss_pred             ccccc-CCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----ecC
Confidence            33444 68999999999999986  58899999987542  2334467889999999999999999999999     566


Q ss_pred             CeEEEEEecCc-ccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          112 NDVYIVYELMD-TDLHQIIRS---KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      ...++||||++ ++|.+++..   ..++++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+..
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  182 (307)
T 2nru_A          103 DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA  182 (307)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccc
Confidence            77899999996 799999864   35699999999999999999999999999999999999999999999999998764


Q ss_pred             c-------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc-hHHHHHhhCCCC----C
Q 042681          188 T-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD-NARRYVKQLPHV----P  249 (339)
Q Consensus       188 ~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~-~~~~~~~~~~~~----~  249 (339)
                      .             +...|.+|+.... ....+.|+|++|++++++++|..|+......... ............    .
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI  261 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHS
T ss_pred             cccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhc
Confidence            3             2345777776653 4677899999999999999999987654322111 111111110000    0


Q ss_pred             CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          250 KQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       250 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..........+++.+.+++.+||+.||++|||+.+++++
T Consensus       262 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          262 DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            000111112345778999999999999999999999865

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.9e-39  Score=276.80  Aligned_cols=234  Identities=22%  Similarity=0.314  Sum_probs=186.7

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||.||++.+.  |+.+|+|++...    ...+.+.+|+.+++.++||||+++++++.    ...+.
T Consensus        21 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~   89 (278)
T 1byg_A           21 KELKL-LQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGG   89 (278)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--C
T ss_pred             hhceE-EeEEecCCCceEEEEEEc--CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCc
Confidence            55666 999999999999999874  789999998653    24567889999999999999999999863    33456


Q ss_pred             EEEEEecCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-
Q 042681          114 VYIVYELMD-TDLHQIIRSKQ--ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-  189 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-  189 (339)
                      .++||||++ ++|.+++...+  .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+.... 
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            899999998 59999997654  38999999999999999999999999999999999999999999999999986543 


Q ss_pred             -------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          190 -------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       190 -------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                             ...|.+||.........+.|+|++|++++++++ |..|+.....   ..........   ...   .....++
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~---~~~---~~~~~~~  240 (278)
T 1byg_A          170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKG---YKM---DAPDGCP  240 (278)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTTT---CCC---CCCTTCC
T ss_pred             cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcC---CCC---CCcccCC
Confidence                   235888888776677888999999999999998 8888764432   1111111111   111   1124689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      +.+.++|.+||+.||++|||+.++++
T Consensus       241 ~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          241 PAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-38  Score=277.97  Aligned_cols=242  Identities=26%  Similarity=0.375  Sum_probs=191.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. .+.||+|+||.||++.+.  ++.+|+|++...    ...+.+.+|+.++++++||||+++++++     .+  .
T Consensus         8 ~~~~~-~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~--~   73 (307)
T 2eva_A            8 KEIEV-EEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGAC-----LN--P   73 (307)
T ss_dssp             GGEEE-EEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBC-----TT--T
T ss_pred             hHeee-eeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC--C
Confidence            34555 899999999999999874  788999998642    3456789999999999999999999988     32  3


Q ss_pred             EEEEEecCc-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCCCCeeeccCCC-eEEeecccc
Q 042681          114 VYIVYELMD-TDLHQIIRSKQ---ALTDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCD-LKICDFGLA  185 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~givH~dikp~NIli~~~~~-ikL~Dfg~~  185 (339)
                      .++||||++ ++|.+++....   .+++..++.++.|++.||.|||+   +|++||||||+||+++.++. +||+|||.+
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA  153 (307)
T ss_dssp             TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred             cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence            699999997 69999998754   47899999999999999999999   89999999999999998887 799999998


Q ss_pred             ccc--------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          186 RTT--------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       186 ~~~--------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                      ...        +...|.+||.........+.|+|++|++++++++|..|+.............. . ...  ..   ...
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~-~~~--~~---~~~  226 (307)
T 2eva_A          154 CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-H-NGT--RP---PLI  226 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-H-TTC--CC---CCB
T ss_pred             cccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-h-cCC--CC---Ccc
Confidence            543        34568899988877788899999999999999999999765432211111111 1 111  11   112


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC-----CCCCCCcc
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNH-----PYLSSLHE  296 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h-----p~f~~~~~  296 (339)
                      ..+++.+.+||.+||+.||++|||+.+++++     +++....+
T Consensus       227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  270 (307)
T 2eva_A          227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE  270 (307)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence            4689999999999999999999999999974     55554433

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-38  Score=276.01  Aligned_cols=230  Identities=13%  Similarity=0.022  Sum_probs=184.8

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC-hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-RIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      .+.++|.+ .+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+..+..++||||+++++++     .
T Consensus        28 ~~~~~y~i-~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~  101 (286)
T 3uqc_A           28 IANGRYRL-LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----H  101 (286)
T ss_dssp             ETTTTEEE-EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----E
T ss_pred             EecCcEEE-EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----E
Confidence            45678888 89999999999999999999999999999765433 44567889999999999999999999999     6


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ..+..|+||||++ ++|.+++.. + .....+..++.||+.||+|||++||+||||||+||+++.+|.++|++++...  
T Consensus       102 ~~~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~~--  177 (286)
T 3uqc_A          102 TRAGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMP--  177 (286)
T ss_dssp             ETTEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCCT--
T ss_pred             ECCcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccccC--
Confidence            6678999999997 699999854 3 4666788999999999999999999999999999999999999999665431  


Q ss_pred             CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHH
Q 042681          189 SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA  268 (339)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  268 (339)
                                    +...+.|+|++|+++|++++|..|+...........   ................+.+++++.+||
T Consensus       178 --------------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li  240 (286)
T 3uqc_A          178 --------------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTAGQPIEPADIDRDIPFQISAVA  240 (286)
T ss_dssp             --------------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTTSCBCCHHHHCTTSCHHHHHHH
T ss_pred             --------------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhccCCCChhhcccCCCHHHHHHH
Confidence                          245678999999999999999999765322110000   000001111111223356899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcC
Q 042681          269 ERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       269 ~~~L~~dP~~Rps~~ell~h  288 (339)
                      .+||+.||++| |+.++++.
T Consensus       241 ~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          241 ARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHcccCCccC-CHHHHHHH
Confidence            99999999999 99999874

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=286.77  Aligned_cols=235  Identities=20%  Similarity=0.282  Sum_probs=183.4

Q ss_pred             ccccccccceEEEEEEeCCC---CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSET---KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      .+.||+|+||.||+|.+..+   +..+|+|.+... ......+.+.+|+.++++++||||+++++++.    ...+..++
T Consensus        94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~~~~~l  168 (373)
T 3c1x_A           94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLV  168 (373)
T ss_dssp             EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCSSCCEE
T ss_pred             CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCCCCeEE
Confidence            67899999999999987543   246889988643 33445678999999999999999999999863    34456799


Q ss_pred             EEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC----
Q 042681          117 VYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----  190 (339)
Q Consensus       117 v~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~----  190 (339)
                      ||||++ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....    
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            999998 6999999764 4689999999999999999999999999999999999999999999999999864321    


Q ss_pred             -----------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          191 -----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       191 -----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                 ..|.+||......+..+.|+|++|++++++++ |.+|+......   ..............      ..
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~~~~~~~~~------p~  319 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLLQGRRLLQ------PE  319 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHHHTTCCCCC------CT
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHHHcCCCCCC------CC
Confidence                       24788888777777888999999999999999 56665433211   11112222111111      13


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .+++.+.+++.+||+.||++|||+.+++++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            578999999999999999999999999976

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.2e-38  Score=278.00  Aligned_cols=241  Identities=18%  Similarity=0.252  Sum_probs=184.9

Q ss_pred             cCccCCCccccccccceEEEEEEeCC-CCc--eEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSE-TKE--EVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~-~~~--~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      .++|.. ++.||+|+||.||++.+.. +++  .+|+|++.... ......+.+.+|+.+++.++||||+++++++.    
T Consensus        17 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   91 (291)
T 1u46_A           17 EKDLRL-LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL----   91 (291)
T ss_dssp             GGGEEE-EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             hhHeee-eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc----
Confidence            456666 9999999999999998643 333  68999987543 23445678899999999999999999999983    


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                       .. ..++|+||+. ++|.+++... +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.
T Consensus        92 -~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           92 -TP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             -SS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             -cC-CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccc
Confidence             32 3789999998 7999998764 679999999999999999999999999999999999999999999999999986


Q ss_pred             ccCC--------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          187 TTSE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       187 ~~~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ....              ..|.+||.........+.|+|++|++++++++ |..|+......  .............   
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~---  244 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGERL---  244 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCCCC---
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHccCCCC---
Confidence            5432              13778887766667788999999999999999 88887543211  1111111111111   


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                         .....++++++++|.+||+.||++|||+.+++++
T Consensus       245 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          245 ---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence               1124689999999999999999999999999974

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=284.19  Aligned_cols=254  Identities=19%  Similarity=0.206  Sum_probs=182.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHH--HhhCCCCCeeeeeeecCCCCcCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKL--LCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++|.. ++.||+|+||.||++..  +++.||+|++...     ....+..|..+  +..++||||+++++.+........
T Consensus        13 ~~y~~-~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           13 DNLKL-LELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TSEEE-EEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             HHhhe-eeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            55666 99999999999999976  6899999998643     22334444444  445899999999975432222445


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCCeeeccCCCeEEee
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA---------NVLHRDLKPSNLLLNANCDLKICD  181 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------givH~dikp~NIli~~~~~ikL~D  181 (339)
                      ..+++||||++ |+|.+++.. ...++..++.++.||+.||.|||+.         ||+||||||+||+++.++.+||+|
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             ceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            56899999997 699999976 4459999999999999999999999         999999999999999999999999


Q ss_pred             ccccccc-------------------CCCCccccccccc-------cccCCCCccHHHHHHHHHHHhCCCCCCccccccc
Q 042681          182 FGLARTT-------------------SETDFMTEYVVTR-------WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS  235 (339)
Q Consensus       182 fg~~~~~-------------------~~~~~~~~~~~~~-------~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~  235 (339)
                      ||++...                   ++..|.+||....       .....+.|+|++|++++++++|..++........
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            9999643                   3446788887654       3455678999999999999999766533221110


Q ss_pred             c------------hHHHH-HhhCCCCCCCCccccC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCC
Q 042681          236 D------------NARRY-VKQLPHVPKQPFSQKF---PNMSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSS  293 (339)
Q Consensus       236 ~------------~~~~~-~~~~~~~~~~~~~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~ell~------hp~f~~  293 (339)
                      .            ..... ...............+   ..+++++.+||.+||+.||++|||+.++++      ++|-++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence            0            00000 0011111111222211   124567999999999999999999999954      677766


Q ss_pred             Ccc
Q 042681          294 LHE  296 (339)
Q Consensus       294 ~~~  296 (339)
                      -..
T Consensus       324 ~~~  326 (336)
T 3g2f_A          324 KSV  326 (336)
T ss_dssp             ---
T ss_pred             ccC
Confidence            543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-39  Score=295.32  Aligned_cols=242  Identities=14%  Similarity=0.128  Sum_probs=185.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccc-ccChHhHHHHHHHHHHHhhCCC-CCeeee------------------
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTH-ENIVKV------------------   99 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~e~~~l~~l~h-~~I~~~------------------   99 (339)
                      .+.||+|+||.||+|.+..+|+.||+|++... .......+.+.+|+.++..++| ++...+                  
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            78999999999999999999999999998743 2223345778899999999977 322111                  


Q ss_pred             ---eeecCCCCcCCcCeEEEEEecCcccHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCe
Q 042681          100 ---KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRS-------KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL  169 (339)
Q Consensus       100 ---~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NI  169 (339)
                         ..++..........++++|+++.++|.+++..       .+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NI  242 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI  242 (413)
T ss_dssp             --------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             CccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceE
Confidence               11111100011345789999999999988841       34578889999999999999999999999999999999


Q ss_pred             eeccCCCeEEeecccccc--------cCCCCccccccc----------cccccCCCCccHHHHHHHHHHHhCCCCCCccc
Q 042681          170 LLNANCDLKICDFGLART--------TSETDFMTEYVV----------TRWDTLFPGKDYVQQLTMITELLGSPDDSDLG  231 (339)
Q Consensus       170 li~~~~~ikL~Dfg~~~~--------~~~~~~~~~~~~----------~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~  231 (339)
                      +++.++.+||+|||+++.        .+ ..|++||..          ....+..+.|+|++|+++|++++|..|+....
T Consensus       243 Ll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~  321 (413)
T 3dzo_A          243 VLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA  321 (413)
T ss_dssp             EECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTG
T ss_pred             EEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            999999999999999854        34 678889887          44556778999999999999999999976432


Q ss_pred             ccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          232 FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      .....              .........+|+++++||.+||+.||++||++.++++||||+.+.+
T Consensus       322 ~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~  372 (413)
T 3dzo_A          322 ALGGS--------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  372 (413)
T ss_dssp             GGSCS--------------GGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             hhhhH--------------HHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence            11110              0111122467899999999999999999999999999999987754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2e-38  Score=293.98  Aligned_cols=253  Identities=17%  Similarity=0.180  Sum_probs=198.3

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCC-CCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~I~~~~~~~~~~~~~  109 (339)
                      .+.++|.+ ++.||+|+||.||+|.+..+++.||+|++......    ..+.+|+.+++.++| ++|..+..+.     .
T Consensus         4 ~i~~~y~i-~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~-----~   73 (483)
T 3sv0_A            4 RVGNKFRL-GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFG-----V   73 (483)
T ss_dssp             EETTTEEC-CCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEE-----E
T ss_pred             CcCCcEEE-EEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEE-----e
Confidence            45678888 99999999999999999999999999987654222    247789999999986 4555554444     5


Q ss_pred             CcCeEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeee---ccCCCeEEeecccc
Q 042681          110 KFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLA  185 (339)
Q Consensus       110 ~~~~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli---~~~~~ikL~Dfg~~  185 (339)
                      .....++||||++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        74 ~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           74 EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             eCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            5677899999999999999975 5689999999999999999999999999999999999999   68899999999998


Q ss_pred             ccc------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchH-HHHHhhCC
Q 042681          186 RTT------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNA-RRYVKQLP  246 (339)
Q Consensus       186 ~~~------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~-~~~~~~~~  246 (339)
                      +..                  +...|++|+......+..+.|+|++|+++|++++|..|+........... ........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            643                  23357788887777778889999999999999999999876433211111 11111000


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc----------CCCCCCCcc
Q 042681          247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN----------HPYLSSLHE  296 (339)
Q Consensus       247 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~----------hp~f~~~~~  296 (339)
                         ..........+++++.+||.+||+.||.+||++.++++          ++|+..+.|
T Consensus       234 ---~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW  290 (483)
T 3sv0_A          234 ---ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDW  290 (483)
T ss_dssp             ---HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHH
T ss_pred             ---cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCc
Confidence               00111112457899999999999999999999988765          577766655

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.9e-38  Score=296.78  Aligned_cols=248  Identities=20%  Similarity=0.291  Sum_probs=197.2

Q ss_pred             ccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCC
Q 042681           28 NLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMD  107 (339)
Q Consensus        28 ~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~  107 (339)
                      ..|.+..+.+.+.+.||+|+||.||++.+.. +..||+|+++....   ..+.+.+|+.+++.++||||+++++++    
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~----  331 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVV----  331 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            3455554444448999999999999999875 46799999975432   246789999999999999999999998    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  184 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~  184 (339)
                       .. ...++||||++ |+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       332 -~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~  409 (535)
T 2h8h_A          332 -SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL  409 (535)
T ss_dssp             -CS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred             -ee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence             33 55899999997 699999964  35699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          185 ARTTSE------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       185 ~~~~~~------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ++....            ..|.+||......+..+.|+|++|++++++++ |..|+.....   ......+......+  
T Consensus       410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~--  484 (535)
T 2h8h_A          410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRMP--  484 (535)
T ss_dssp             TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTCCCC--
T ss_pred             ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence            975432            24788887776677888999999999999999 8888654321   11111222111111  


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC--CCCCCC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH--PYLSSL  294 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h--p~f~~~  294 (339)
                          ....+++++.+||.+||+.||++|||+.++++.  .+|...
T Consensus       485 ----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          485 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                124689999999999999999999999999874  555444

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.8e-38  Score=298.85  Aligned_cols=230  Identities=20%  Similarity=0.322  Sum_probs=188.2

Q ss_pred             ccccccceEEEEEEeC--CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           42 PIGRGAYGIVCSAVNS--ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        42 ~lg~G~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      .||+|+||.||++.+.  .++..||+|+++.. ......+.+.+|+.++..++||||+++++++     .. ..+++|||
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~-----~~-~~~~lv~E  415 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-----QA-EALMLVME  415 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ES-SSEEEEEE
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEe-----cc-CCeEEEEE
Confidence            7999999999999875  45667999999764 2333567899999999999999999999998     33 45899999


Q ss_pred             cCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-------
Q 042681          120 LMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-------  190 (339)
Q Consensus       120 ~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-------  190 (339)
                      |++ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....       
T Consensus       416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            998 6999998654 5699999999999999999999999999999999999999999999999999975421       


Q ss_pred             -------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          191 -------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       191 -------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                             ..|++||......+..+.|+|++|++++++++ |..|+.....   ......+.......      ..+.+++
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~~------~p~~~~~  566 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRME------CPPECPP  566 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHHHHHHTTCCCC------CCTTCCH
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCCC------CCCcCCH
Confidence                   24788888877778889999999999999998 9988765322   11222222211111      1146899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ++.+||.+||+.||++||++.++++
T Consensus       567 ~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          567 ELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.4e-40  Score=292.52  Aligned_cols=248  Identities=20%  Similarity=0.169  Sum_probs=179.9

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc------ChHhHHHHHHHHHHHhhCC---------CCCee
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD------NRIDAKRILREIKLLCHMT---------HENIV   97 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~~I~   97 (339)
                      .++|.. ++.||+|+||.||+|++  +|+.||+|++.....      .....+.+.+|+.+++.++         ||||+
T Consensus        19 ~~~y~~-~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           19 TEKLQR-CEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             HHHHHT-CEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccchh-eeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            467777 99999999999999998  689999999976532      2223467888888888875         55555


Q ss_pred             ee-----------------eeecCCCC--------cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 042681           98 KV-----------------KDIIPPMD--------KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGL  151 (339)
Q Consensus        98 ~~-----------------~~~~~~~~--------~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL  151 (339)
                      ++                 ++++.+..        ......+++||||+. |++.+.+.+ +.+++..++.++.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence            54                 44442100        012578999999996 666666644 6789999999999999999


Q ss_pred             HHHH-hCCcccCCCCCCCeeeccCC--------------------CeEEeeccccccc------CCCCcccccccccccc
Q 042681          152 KYIH-SANVLHRDLKPSNLLLNANC--------------------DLKICDFGLARTT------SETDFMTEYVVTRWDT  204 (339)
Q Consensus       152 ~~LH-~~givH~dikp~NIli~~~~--------------------~ikL~Dfg~~~~~------~~~~~~~~~~~~~~~~  204 (339)
                      +||| ++||+||||||+|||++.++                    .+||+|||+|+..      ++..|++||+..... 
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~-  253 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG-  253 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCS-
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCC-
Confidence            9999 99999999999999999887                    8999999999754      456789999877555 


Q ss_pred             CCCCccHHHHHH-HHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 042681          205 LFPGKDYVQQLT-MITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVE  283 (339)
Q Consensus       205 ~~~~d~~~~g~~-~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~  283 (339)
                      ..+.|+|+++++ .+.++.|..|+......  ......................+.+|+++++||++||+.|     |++
T Consensus       254 ~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          254 DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             ccceehhhhhCCCCcccccccCCCcchhhh--hHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence            678999998777 44455566664221000  1111111111111222212222357889999999999977     999


Q ss_pred             HHh-cCCCCC
Q 042681          284 EAL-NHPYLS  292 (339)
Q Consensus       284 ell-~hp~f~  292 (339)
                      |++ +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999995

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=281.11  Aligned_cols=256  Identities=19%  Similarity=0.204  Sum_probs=193.5

Q ss_pred             EEEEcccccccc-CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeee
Q 042681           22 QYNILGNLFQVS-SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK  100 (339)
Q Consensus        22 ~~~~~~~~~~~~-~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~  100 (339)
                      +.+.....+.+. ++|.. .+.||+|+||.||++.+..   .+|+|++..........+.+.+|+.+++.++||||++++
T Consensus        20 ~~~~~~~~~~i~~~~~~~-~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   95 (319)
T 2y4i_B           20 QTSIFLQEWDIPFEQLEI-GELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM   95 (319)
T ss_dssp             --CCCGGGSSSCCSCEEC-CCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCC
T ss_pred             ccccccccccCCHHHeEE-eeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEE
Confidence            444555666665 44555 9999999999999998753   599999876544444445677899999999999999999


Q ss_pred             eecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeE
Q 042681          101 DIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK  178 (339)
Q Consensus       101 ~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ik  178 (339)
                      +++     ......++||||++ ++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+||+++ ++.++
T Consensus        96 ~~~-----~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~  169 (319)
T 2y4i_B           96 GAC-----MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVV  169 (319)
T ss_dssp             EEE-----ECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCE
T ss_pred             EEE-----ecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEE
Confidence            999     56677999999997 79999987654 799999999999999999999999999999999999998 67999


Q ss_pred             Eeeccccccc----------------CCCCccccccccc---------cccCCCCccHHHHHHHHHHHhCCCCCCccccc
Q 042681          179 ICDFGLARTT----------------SETDFMTEYVVTR---------WDTLFPGKDYVQQLTMITELLGSPDDSDLGFL  233 (339)
Q Consensus       179 L~Dfg~~~~~----------------~~~~~~~~~~~~~---------~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~  233 (339)
                      |+|||++...                +...|.+||....         .....+.|+|++|++++++++|..|+......
T Consensus       170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  249 (319)
T 2y4i_B          170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE  249 (319)
T ss_dssp             ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred             EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999986532                2234777777653         23566789999999999999999987543211


Q ss_pred             ccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          234 RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                         .........   .....  ....++.++.++|.+||+.||++|||+.++++.  ++.+...
T Consensus       250 ---~~~~~~~~~---~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~--l~~l~~~  303 (319)
T 2y4i_B          250 ---AIIWQMGTG---MKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM--LEKLPKR  303 (319)
T ss_dssp             ---HHHHHHHTT---CCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH--HTTC---
T ss_pred             ---HHHHHhccC---CCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH--HHHHHHh
Confidence               111111111   11111  112578899999999999999999999999975  5555443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.6e-38  Score=280.04  Aligned_cols=247  Identities=19%  Similarity=0.221  Sum_probs=186.4

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhh--CCCCCeeeeeeecCCCCcC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCH--MTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~I~~~~~~~~~~~~~  109 (339)
                      +.++|.. .+.||+|+||.||++.+  +|+.||+|++...     ....+.+|.+++..  ++||||+++++++.... .
T Consensus        40 ~~~~y~~-~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~  110 (342)
T 1b6c_B           40 IARTIVL-QESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-G  110 (342)
T ss_dssp             HHHHCEE-EEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-S
T ss_pred             ccccEEE-EeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-C
Confidence            4567777 99999999999999987  4899999998643     34567788888887  68999999999984321 1


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCCeeeccCCCeEEe
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH--------SANVLHRDLKPSNLLLNANCDLKIC  180 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~givH~dikp~NIli~~~~~ikL~  180 (339)
                      .....++||||++ |+|.+++.+ ..+++..++.++.|++.||.|||        +.|++||||||+||+++.++.++|+
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~  189 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  189 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred             ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence            2237999999998 599999976 57999999999999999999999        8999999999999999999999999


Q ss_pred             eccccccc---------------CCCCcccccccccc------ccCCCCccHHHHHHHHHHHhC----------CCCCCc
Q 042681          181 DFGLARTT---------------SETDFMTEYVVTRW------DTLFPGKDYVQQLTMITELLG----------SPDDSD  229 (339)
Q Consensus       181 Dfg~~~~~---------------~~~~~~~~~~~~~~------~~~~~~d~~~~g~~~~~~l~g----------~~~~~~  229 (339)
                      |||++...               ++..|.+||.....      ....+.|+|++|++++++++|          ..|+..
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~  269 (342)
T 1b6c_B          190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  269 (342)
T ss_dssp             CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence            99998543               23457778776543      223568999999999999999          455443


Q ss_pred             ccccccchHHHHHhhCCCCCCCCcccc--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          230 LGFLRSDNARRYVKQLPHVPKQPFSQK--FPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ...........................  ...+++.+.+||.+||+.||++|||+.++++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            321111111111111111111111111  12344679999999999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=280.17  Aligned_cols=235  Identities=17%  Similarity=0.191  Sum_probs=185.8

Q ss_pred             ccccCc-cCCCccccccccceEEEEE-----EeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC---CCCeeeee
Q 042681           30 FQVSSK-YVPPLQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT---HENIVKVK  100 (339)
Q Consensus        30 ~~~~~~-y~~~~~~lg~G~~~~v~~~-----~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~I~~~~  100 (339)
                      +.+.++ |.. .+.||+|+||.||+|     .+..+++.||+|++...     ....+..|+.++..++   |+||++++
T Consensus        60 ~~~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           60 FQLGSKLVYV-HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             EECSSSEEEE-EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             EEECCEEEEE-EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            334444 544 999999999999999     46778999999998653     2345677777777776   99999999


Q ss_pred             eecCCCCcCCcCeEEEEEecCc-ccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-
Q 042681          101 DIIPPMDKEKFNDVYIVYELMD-TDLHQIIRS-----KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-  173 (339)
Q Consensus       101 ~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-  173 (339)
                      +++     ...+..++||||++ |+|.+++..     .+.+++..++.++.||+.||+|||++||+||||||+||+++. 
T Consensus       134 ~~~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~  208 (365)
T 3e7e_A          134 SAH-----LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG  208 (365)
T ss_dssp             EEE-----ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGG
T ss_pred             eee-----ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccc
Confidence            999     66678899999997 799999973     467999999999999999999999999999999999999998 


Q ss_pred             ----------CCCeEEeeccccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcc
Q 042681          174 ----------NCDLKICDFGLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDL  230 (339)
Q Consensus       174 ----------~~~ikL~Dfg~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~  230 (339)
                                ++.+||+|||+++..             ++..|++||......+..+.|+|++|++++++++|..|+...
T Consensus       209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence                      899999999999532             455789999888877889999999999999999999886432


Q ss_pred             cccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 042681          231 GFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHP  289 (339)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  289 (339)
                      ......       .......       ...++.+.+++.+||+.+|.+|++..+.+.+.
T Consensus       289 ~~~~~~-------~~~~~~~-------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          289 EGGECK-------PEGLFRR-------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             ETTEEE-------ECSCCTT-------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             CCCcee-------echhccc-------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence            211100       0000000       12467899999999999999998665555543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-36  Score=292.59  Aligned_cols=238  Identities=23%  Similarity=0.346  Sum_probs=191.7

Q ss_pred             CccCCCccccccccceEEEEEEeCCC---CceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSET---KEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ++|.. .+.||+|+||.||+|.+..+   +..+|+|.+... ......+.+.+|+.++..++||||+++++++     ..
T Consensus       390 ~~y~i-~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-----~~  462 (656)
T 2j0j_A          390 ERIEL-GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVI-----TE  462 (656)
T ss_dssp             GGEEE-EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CS
T ss_pred             ccEEE-eeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ec
Confidence            44555 89999999999999998654   456899987643 2344557889999999999999999999998     32


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                       +..++||||++ |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence             35799999998 7999999765 47999999999999999999999999999999999999999999999999998754


Q ss_pred             CC------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccc
Q 042681          189 SE------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ  255 (339)
Q Consensus       189 ~~------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (339)
                      ..            ..|++||......+..+.|+|++|++++++++ |..|+......   ............+      
T Consensus       542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~~~~~~~------  612 (656)
T 2j0j_A          542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENGERLP------  612 (656)
T ss_dssp             CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHHTCCCC------
T ss_pred             CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCCCC------
Confidence            32            24888888776677888999999999999997 88886543211   1111122211111      


Q ss_pred             cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       256 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..+.+++.+.+||.+||+.||++|||+.++++.
T Consensus       613 ~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            124689999999999999999999999999853

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-37  Score=298.94  Aligned_cols=242  Identities=21%  Similarity=0.298  Sum_probs=190.5

Q ss_pred             cccCccCCCccccccccceEEEEEEeCC-CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSE-TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      .+.++|.+ ++.||+|+||.||++.+.. +|+.||+|++... ........+.+|+.++..++||||+++++++......
T Consensus        77 ~~~~~y~i-~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           77 IVAGQYEV-KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             EETTTEEE-EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             EeCCceEE-EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            45688888 9999999999999999976 7899999988653 3344556788999999999999999999999432211


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      .....|+||||++ ++|.+.+..  .+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||+++..
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            1112799999998 688877654  79999999999999999999999999999999999999875 8999999998654


Q ss_pred             -------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCC
Q 042681          189 -------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS  261 (339)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  261 (339)
                             ++..|++||..... ...++|+|++|++++++++|.+++......             ..+..   ......+
T Consensus       232 ~~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------~~~~~---~~~~~~~  294 (681)
T 2pzi_A          232 NSFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-------------GLPED---DPVLKTY  294 (681)
T ss_dssp             TCCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-------------SCCTT---CHHHHHC
T ss_pred             ccCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-------------ccccc---ccccccC
Confidence                   44568888876543 367899999999999999998775432100             00000   0001246


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          262 PVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       262 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      +.+.+||.+||+.||++||+..+.+.|+|+..+
T Consensus       295 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            789999999999999999999999998887543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=5.6e-30  Score=241.97  Aligned_cols=170  Identities=17%  Similarity=0.150  Sum_probs=121.8

Q ss_pred             ccccccceEEEEEEeCCCCceEEEEEeccccc--------ChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCCcC
Q 042681           42 PIGRGAYGIVCSAVNSETKEEVAIKKITNAFD--------NRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        42 ~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ..+.|+.|.+..++....|+.+++|++.+...        .....+.+.+|+++|+++ .|+||+++++++     ++.+
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            46678888888888888899999999975421        123346789999999999 699999999999     7788


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-  190 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-  190 (339)
                      ..||||||++ ++|.+++...+++++.   .|+.||+.||+|+|++||+||||||+|||++.+|++||+|||+|+.... 
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999998 5999999998888875   4789999999999999999999999999999999999999999976543 


Q ss_pred             ----------CCccccccccccccCCCCccHHHHHHHHHH
Q 042681          191 ----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITE  220 (339)
Q Consensus       191 ----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~  220 (339)
                                +.|++||+... ......|.|++|+..+.+
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l  431 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNL  431 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCC
T ss_pred             CccccCceechhhccHHHhCC-CCCCcccccccccchhhh
Confidence                      23666776653 344567778777765443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=8.7e-25  Score=205.40  Aligned_cols=170  Identities=20%  Similarity=0.234  Sum_probs=123.4

Q ss_pred             CCccccccccceEEEEEEeCCCCceEEEEEecccccC------hHhHHHHHHHHHHHhhCCCCCee--eeeeecCCCCcC
Q 042681           38 PPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN------RIDAKRILREIKLLCHMTHENIV--KVKDIIPPMDKE  109 (339)
Q Consensus        38 ~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~I~--~~~~~~~~~~~~  109 (339)
                      +..+.||+|+||.||++.  ..++.+++|+.......      ....+++.+|+.++++++||||+  .+++..      
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~------  410 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD------  410 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE------
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe------
Confidence            336789999999999994  35788999987543222      11245689999999999999999  555543      


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                       ....++||||++ ++|.+++..        +..++.|++.||+|||++||+||||||+||+++.  ++||+|||+++..
T Consensus       411 -~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          411 -LDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             -TTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             -CCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence             334599999997 799998875        6689999999999999999999999999999998  9999999999765


Q ss_pred             CC------------------CCccccccccc--cccCCCCccHHHHHHHHHHHhCCCC
Q 042681          189 SE------------------TDFMTEYVVTR--WDTLFPGKDYVQQLTMITELLGSPD  226 (339)
Q Consensus       189 ~~------------------~~~~~~~~~~~--~~~~~~~d~~~~g~~~~~~l~g~~~  226 (339)
                      ..                  +.|++||+...  ..+....|.|+.....+..+-++..
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r  537 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR  537 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence            43                  24556666543  2344445677777666666655443

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=4.7e-24  Score=184.41  Aligned_cols=133  Identities=19%  Similarity=0.250  Sum_probs=107.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccCh----------------HhHHHHHHHHHHHhhCCCCCeeeeeeec
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR----------------IDAKRILREIKLLCHMTHENIVKVKDII  103 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~~I~~~~~~~  103 (339)
                      .+.||+|+||.||+|.+ .+|+.+|+|+++......                .....+.+|+.++..++  | +++.+++
T Consensus        95 ~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             cCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            68999999999999999 889999999996432111                23567889999999998  4 6666655


Q ss_pred             CCCCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeec
Q 042681          104 PPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF  182 (339)
Q Consensus       104 ~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Df  182 (339)
                           .. +..++||||++ ++|.+ +.      ......++.|++.||.|||++||+||||||+||+++ ++.++|+||
T Consensus       171 -----~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          171 -----AW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             -----EE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             -----ec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence                 22 34599999997 58876 31      234557999999999999999999999999999999 999999999


Q ss_pred             ccccccCC
Q 042681          183 GLARTTSE  190 (339)
Q Consensus       183 g~~~~~~~  190 (339)
                      |+++....
T Consensus       237 G~a~~~~~  244 (282)
T 1zar_A          237 PQSVEVGE  244 (282)
T ss_dssp             TTCEETTS
T ss_pred             CCCeECCC
Confidence            99986543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=3.5e-22  Score=170.59  Aligned_cols=137  Identities=16%  Similarity=0.135  Sum_probs=107.3

Q ss_pred             ccccccccceEEEEEEeCCCCce--EEEEEecccccC----------------------hHhHHHHHHHHHHHhhCCCCC
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEE--VAIKKITNAFDN----------------------RIDAKRILREIKLLCHMTHEN   95 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~--~avK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~~   95 (339)
                      .+.||+|+||.||+|.+..+|+.  +|+|+++.....                      ......+.+|+.++..+.|++
T Consensus        52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~  131 (258)
T 1zth_A           52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG  131 (258)
T ss_dssp             EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence            78899999999999998778989  999987543111                      011246789999999998775


Q ss_pred             e--eeeeeecCCCCcCCcCeEEEEEecCcc------cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCC
Q 042681           96 I--VKVKDIIPPMDKEKFNDVYIVYELMDT------DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIH-SANVLHRDLKP  166 (339)
Q Consensus        96 I--~~~~~~~~~~~~~~~~~~~iv~e~~~g------~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH-~~givH~dikp  166 (339)
                      +  +.+++.         ...++||||+++      +|.+....   .++..+..++.|++.||.+|| ++||+||||||
T Consensus       132 i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          132 VSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             CCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             CCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            4  333332         235899999953      66665432   345678899999999999999 99999999999


Q ss_pred             CCeeeccCCCeEEeecccccccCC
Q 042681          167 SNLLLNANCDLKICDFGLARTTSE  190 (339)
Q Consensus       167 ~NIli~~~~~ikL~Dfg~~~~~~~  190 (339)
                      +||+++.  .++|+|||+|.....
T Consensus       200 ~NILl~~--~~~liDFG~a~~~~~  221 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTLRH  221 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEETTS
T ss_pred             HHEEEcC--cEEEEECcccccCCC
Confidence            9999998  999999999977643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=3.9e-19  Score=157.86  Aligned_cols=139  Identities=14%  Similarity=0.132  Sum_probs=98.1

Q ss_pred             cCCCccccccccceEEEEEEeCCCCceEEEEEecccccC------------hHhHH--------HHHHHHHHHhhCCCCC
Q 042681           36 YVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN------------RIDAK--------RILREIKLLCHMTHEN   95 (339)
Q Consensus        36 y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~------------~~~~~--------~~~~e~~~l~~l~h~~   95 (339)
                      |.+ .+.||.|++|.||+|.+. +|+.+|+|+++.....            .....        ...+|...+.++.+.+
T Consensus        97 Y~I-~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           97 YSV-GSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SEE-EEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEe-cCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            666 899999999999999985 6999999987542110            00011        1235666666664433


Q ss_pred             e--eeeeeecCCCCcCCcCeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec
Q 042681           96 I--VKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN  172 (339)
Q Consensus        96 I--~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~  172 (339)
                      +  ...++..         ..+|||||++| .|.++      .....+..++.||+.+|.+||++|||||||||.|||++
T Consensus       175 v~vp~p~~~~---------~~~LVME~i~G~~L~~l------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          175 FPVPEPIAQS---------RHTIVMSLVDALPMRQV------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR  239 (397)
T ss_dssp             CSCCCEEEEE---------TTEEEEECCSCEEGGGC------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred             CCCCeeeecc---------CceEEEEecCCccHhhh------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence            3  2222221         23799999986 55332      12234567889999999999999999999999999998


Q ss_pred             cCC----------CeEEeecccccccCCC
Q 042681          173 ANC----------DLKICDFGLARTTSET  191 (339)
Q Consensus       173 ~~~----------~ikL~Dfg~~~~~~~~  191 (339)
                      .++          .+.|+||+.+.....+
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~hp  268 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSMDHP  268 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEETTST
T ss_pred             CCCCcccccccccceEEEEeCCcccCCCC
Confidence            776          3899999988665443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.40  E-value=9.4e-13  Score=112.31  Aligned_cols=138  Identities=14%  Similarity=0.130  Sum_probs=103.9

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      .|.. ...++.|+.+.||++...  ++.+++|........  ....+.+|+.+++.+. +..+++++++.     ...+.
T Consensus        15 ~~~~-~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~   84 (263)
T 3tm0_A           15 KYRC-VKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGW   84 (263)
T ss_dssp             TSEE-EECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTE
T ss_pred             ccee-EeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEE-----ecCCc
Confidence            3544 667788888999999753  688999988643211  1235778999998884 67788899887     55677


Q ss_pred             EEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 042681          114 VYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS------------------------------------  156 (339)
Q Consensus       114 ~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~------------------------------------  156 (339)
                      .++|||+++| +|.+.+.     +......++.+++.+|..||+                                    
T Consensus        85 ~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             eEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            8999999996 6655421     222345778899999999998                                    


Q ss_pred             -----------------------CCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          157 -----------------------ANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       157 -----------------------~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                                             .+++|+|++|.||+++.++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                   4489999999999998765567999998744

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=1.2e-11  Score=105.14  Aligned_cols=128  Identities=13%  Similarity=0.114  Sum_probs=91.0

Q ss_pred             cccc-cccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCC--eeeeeeecCCCCcCCcCeEEEE
Q 042681           41 QPIG-RGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN--IVKVKDIIPPMDKEKFNDVYIV  117 (339)
Q Consensus        41 ~~lg-~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--I~~~~~~~~~~~~~~~~~~~iv  117 (339)
                      +.++ .|..+.||++.. .+|+.+++|.....     ....+.+|+.+++.+.+.+  +++++++.     ...+..++|
T Consensus        25 ~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~-----~~~~~~~~v   93 (264)
T 1nd4_A           25 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLL   93 (264)
T ss_dssp             EECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEE
T ss_pred             EecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEec-----cCCCCCEEE
Confidence            4454 555689999964 45778999987543     1234678888888885333  56688876     444668999


Q ss_pred             EecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 042681          118 YELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN--------------------------------------  158 (339)
Q Consensus       118 ~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--------------------------------------  158 (339)
                      |||++| ++ . .   ...+   ...++.+++.+|..||+..                                      
T Consensus        94 ~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           94 LGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             EECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             EEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            999986 55 3 1   1112   2356677777777777643                                      


Q ss_pred             --------------------cccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          159 --------------------VLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       159 --------------------ivH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                                          ++|+|++|.||+++.++.+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                99999999999998776667999999754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.20  E-value=4.1e-11  Score=106.90  Aligned_cols=141  Identities=13%  Similarity=0.210  Sum_probs=102.4

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEec--ccccChHhHHHHHHHHHHHhhCC--CCCeeeeeeecCCCCcCCcCeEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKIT--NAFDNRIDAKRILREIKLLCHMT--HENIVKVKDIIPPMDKEKFNDVY  115 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~~I~~~~~~~~~~~~~~~~~~~  115 (339)
                      ++.|+.|.++.||++...  +..+++|+..  ... .......+.+|..+++.+.  +..+++++.++.+.  ...+..+
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~  117 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF  117 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence            678999999999999764  4688899765  221 1122356778999999886  45688888887432  2225579


Q ss_pred             EEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 042681          116 IVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS--------------------------------------  156 (339)
Q Consensus       116 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~--------------------------------------  156 (339)
                      +||||++| .+.+.  .-..++......++.+++.+|..||+                                      
T Consensus       118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99999987 33221  11346788888899999999999997                                      


Q ss_pred             --------------------CCcccCCCCCCCeeeccCCC--eEEeecccccc
Q 042681          157 --------------------ANVLHRDLKPSNLLLNANCD--LKICDFGLART  187 (339)
Q Consensus       157 --------------------~givH~dikp~NIli~~~~~--ikL~Dfg~~~~  187 (339)
                                          .+++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                36999999999999997763  68999998854

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.83  E-value=1.5e-08  Score=88.13  Aligned_cols=135  Identities=19%  Similarity=0.256  Sum_probs=95.1

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCC--eeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THEN--IVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~--I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      ++.++.|....||++.     ..+++|+....    .....+.+|..+++.+ .+..  +++++......  ......++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceE
Confidence            6678999999999983     56899986432    3456788999999887 3332  44555543211  11224588


Q ss_pred             EEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 042681          117 VYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS---------------------------------------  156 (339)
Q Consensus       117 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---------------------------------------  156 (339)
                      ||++++| .+.+...  ..++......++.+++..|..||+                                       
T Consensus        94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            9999986 4543222  346777777778888888888875                                       


Q ss_pred             -------------------CCcccCCCCCCCeeecc--CCCeEEeecccccc
Q 042681          157 -------------------ANVLHRDLKPSNLLLNA--NCDLKICDFGLART  187 (339)
Q Consensus       157 -------------------~givH~dikp~NIli~~--~~~ikL~Dfg~~~~  187 (339)
                                         ..++|+|++|.||+++.  .+.+.|+||+.+..
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                               13799999999999998  45678999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.73  E-value=1.9e-07  Score=79.55  Aligned_cols=131  Identities=18%  Similarity=0.220  Sum_probs=91.3

Q ss_pred             cccccce-EEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCeEEEEEec
Q 042681           43 IGRGAYG-IVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVYEL  120 (339)
Q Consensus        43 lg~G~~~-~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~~~iv~e~  120 (339)
                      +..|..+ .||++.....+..+++|+-...     ....+.+|...|+.+. +--+++++.+.     ...+..++|||+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvme~  101 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLTTA  101 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEEC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEEEe
Confidence            4455554 6999988777888999976432     3456778998888874 33467788777     555778999999


Q ss_pred             Ccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 042681          121 MDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA------------------------------------------  157 (339)
Q Consensus       121 ~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~------------------------------------------  157 (339)
                      ++| ++.+....    .......+..++...|..||+.                                          
T Consensus       102 l~G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          102 IPGKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             CCSEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             eCCccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            986 55544322    1122234455555566666641                                          


Q ss_pred             ----------------CcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          158 ----------------NVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       158 ----------------givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                                      .++|+|+.|.||+++.++.+-|+||+.+..
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                            168999999999999877778999999854

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.71  E-value=2.7e-07  Score=80.19  Aligned_cols=133  Identities=22%  Similarity=0.252  Sum_probs=87.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCC---CeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE---NIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      ++.++.|....||++     |..+++|+...    ......+.+|..++..+.+.   .+++++.+..    ...+..++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEE
Confidence            667888998999998     57789997532    23456788999999998642   3556666552    22355789


Q ss_pred             EEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 042681          117 VYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS---------------------------------------  156 (339)
Q Consensus       117 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---------------------------------------  156 (339)
                      ||++++| .+.+...  ..++......++.++...|..||+                                       
T Consensus        91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            9999986 4443211  122333333444444444444432                                       


Q ss_pred             ---------------------CCcccCCCCCCCeeecc---CCCe-EEeecccccc
Q 042681          157 ---------------------ANVLHRDLKPSNLLLNA---NCDL-KICDFGLART  187 (339)
Q Consensus       157 ---------------------~givH~dikp~NIli~~---~~~i-kL~Dfg~~~~  187 (339)
                                           ..++|+|++|.||+++.   ++.+ .|+||+.+..
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                 24699999999999987   4554 8999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.47  E-value=8.9e-07  Score=79.84  Aligned_cols=77  Identities=18%  Similarity=0.119  Sum_probs=48.6

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEeccccc--C---hHhHHHHHHHHHHHhhCCC---CCeeeeeeecCCCCcCCc
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD--N---RIDAKRILREIKLLCHMTH---ENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h---~~I~~~~~~~~~~~~~~~  111 (339)
                      ++.||.|..+.||++....+++.+++|.......  .   .....++..|..+++.+..   ..+++++.+.     .  
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-----~--  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-----T--  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-----T--
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-----C--
Confidence            6789999999999998766678899998653211  0   1123456778888887632   3455666543     2  


Q ss_pred             CeEEEEEecCcc
Q 042681          112 NDVYIVYELMDT  123 (339)
Q Consensus       112 ~~~~iv~e~~~g  123 (339)
                      ...++|||+++|
T Consensus       108 ~~~~lvmE~l~g  119 (397)
T 2olc_A          108 EMAVTVMEDLSH  119 (397)
T ss_dssp             TTTEEEECCCTT
T ss_pred             CccEEEEEeCCC
Confidence            224799999975

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.26  E-value=9.7e-06  Score=71.24  Aligned_cols=31  Identities=26%  Similarity=0.357  Sum_probs=28.0

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          157 ANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       157 ~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .++||+|+++.||+++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            6799999999999998888999999998743

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.08  E-value=3.4e-05  Score=66.63  Aligned_cols=68  Identities=10%  Similarity=-0.004  Sum_probs=41.1

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ++.|+.|....+|++      +.+++|+.........+   ..+|..+++.+. +.-.++++...     ...  -++++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~---r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~   86 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYIN---RANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVT   86 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCC---HHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeC---HHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEE
Confidence            677899999999999      56889987643111111   234666666553 21225666654     222  26899


Q ss_pred             ecC-cc
Q 042681          119 ELM-DT  123 (339)
Q Consensus       119 e~~-~g  123 (339)
                      ||+ +|
T Consensus        87 e~i~~g   92 (301)
T 3dxq_A           87 RYIAGA   92 (301)
T ss_dssp             ECCTTC
T ss_pred             eecCCC
Confidence            999 65

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.02  E-value=1.3e-05  Score=70.88  Aligned_cols=82  Identities=7%  Similarity=0.101  Sum_probs=50.4

Q ss_pred             cccc-ccccceEEEEEEeC--C----CCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCC-C--CCeeeeeeecCCCCc
Q 042681           40 LQPI-GRGAYGIVCSAVNS--E----TKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMT-H--ENIVKVKDIIPPMDK  108 (339)
Q Consensus        40 ~~~l-g~G~~~~v~~~~~~--~----~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~~I~~~~~~~~~~~~  108 (339)
                      ++.| +.|....+|++...  .    +++.+++|....... .......+.+|..+++.+. +  -.+++++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~--  102 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG--  102 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS--
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC--
Confidence            4567 88888999998653  1    266899997653320 0001134567777777773 2  3577777776321  


Q ss_pred             CCcCeEEEEEecCcc
Q 042681          109 EKFNDVYIVYELMDT  123 (339)
Q Consensus       109 ~~~~~~~iv~e~~~g  123 (339)
                      ...+..++|||+++|
T Consensus       103 ~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          103 DVLGTPFFLMDYVEG  117 (357)
T ss_dssp             TTTSSCEEEEECCCC
T ss_pred             CccCCceEEEEecCC
Confidence            112456899999975

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.92  E-value=9e-05  Score=67.17  Aligned_cols=32  Identities=13%  Similarity=0.322  Sum_probs=28.1

Q ss_pred             HhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          155 HSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       155 H~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      +...++|||++|.||+++.++ +.|+||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            456799999999999998876 99999998854

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.84  E-value=0.00026  Score=57.08  Aligned_cols=134  Identities=11%  Similarity=0.089  Sum_probs=88.1

Q ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCCeeeccCCCeEEeecccccccCCCCccccccccc
Q 042681          124 DLHQIIRS-KQALTDDHCQYFLYQLLRGLKYI-HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR  201 (339)
Q Consensus       124 ~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~L-H~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~~~~~~~~~~~  201 (339)
                      +|.+++.. ..+++|+++|.++.|.+.+|.-+ ++..-..+=+.|..|++..+|.|.+.+ +.+.. ....+.+|+... 
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~~-~~~~~~~pe~~~-  110 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADDA-GEPPPVAGKLGY-  110 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-------------CCSS-
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-ccccc-cccCCCChhhcc-
Confidence            79999875 57999999999999999998876 222212233457999999999998875 22211 122233443321 


Q ss_pred             cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhccc-------
Q 042681          202 WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVF-------  274 (339)
Q Consensus       202 ~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~-------  274 (339)
                      .......-++++|+++|..+--..+...                           -..+|+.+.+||..|..-       
T Consensus       111 ~~~te~~~IysLG~tLY~ALDygL~e~e---------------------------E~eLS~~LE~LL~~Mt~~~~d~~~~  163 (229)
T 2yle_A          111 SQCMETEVIESLGIIIYKALDYGLKENE---------------------------ERELSPPLEQLIDHMANTVEADGSN  163 (229)
T ss_dssp             SSSCHHHHHHHHHHHHHHHHTTTCCTTE---------------------------EECCCHHHHHHHHHHTTCCC-----
T ss_pred             ccchHHHHHHHHHHHHHHHhhcCCCccc---------------------------chhhCHHHHHHHHHHHhcccccccc
Confidence            2334556679999999998854443111                           035899999999999866       


Q ss_pred             ------------------CCCCCCCHHHHhc
Q 042681          275 ------------------DPAKRITVEEALN  287 (339)
Q Consensus       275 ------------------dP~~Rps~~ell~  287 (339)
                                        .+..|++..++++
T Consensus       164 DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          164 DEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             ---------------CCSCCCCCCSHHHHHH
T ss_pred             cccccccccccccccccccccCcCCHHHHHH
Confidence                              2467888888874

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.80  E-value=0.00018  Score=62.27  Aligned_cols=72  Identities=13%  Similarity=0.103  Sum_probs=54.8

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC---CCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT---HENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      ++.|+.|....+|++..  ++..+++|+....     ....+..|...|+.|.   ...+++++.+.     ...+..++
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~-----~~~g~~~l  108 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIG-----NSQGHSFL  108 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEE-----ECSSEEEE
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEe-----ecCCceEE
Confidence            56789999999999975  4678899976532     2456778888888873   35678888776     44467899


Q ss_pred             EEecCcc
Q 042681          117 VYELMDT  123 (339)
Q Consensus       117 v~e~~~g  123 (339)
                      |||+++|
T Consensus       109 vme~l~G  115 (312)
T 3jr1_A          109 LLEALNK  115 (312)
T ss_dssp             EEECCCC
T ss_pred             EEEeccC
Confidence            9999975

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.67  E-value=0.00045  Score=61.46  Aligned_cols=136  Identities=13%  Similarity=0.193  Sum_probs=81.5

Q ss_pred             ccccccccceEEEEEEeCC-------CCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCc
Q 042681           40 LQPIGRGAYGIVCSAVNSE-------TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++.|..|-...+|++....       +++.+++|+.....   .......+|..+++.|. +.-.+++++.+     .+ 
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~-  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVF-----PE-  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT-
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC-
Confidence            7788888899999998642       35789999863321   12345568888888773 33347777776     33 


Q ss_pred             CeEEEEEecCcc-cHH--------------HHHHh--c------CCCC--HHHHHHHHHHHHH-----------------
Q 042681          112 NDVYIVYELMDT-DLH--------------QIIRS--K------QALT--DDHCQYFLYQLLR-----------------  149 (339)
Q Consensus       112 ~~~~iv~e~~~g-~L~--------------~~l~~--~------~~~~--~~~~~~i~~qi~~-----------------  149 (339)
                         .+||||++| .+.              +.+.+  .      +...  +.++..+..++..                 
T Consensus       126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence               289999975 211              11111  1      1111  3455555544422                 


Q ss_pred             --HHHHHH----h----CCcccCCCCCCCeeeccC----CCeEEeecccccc
Q 042681          150 --GLKYIH----S----ANVLHRDLKPSNLLLNAN----CDLKICDFGLART  187 (339)
Q Consensus       150 --aL~~LH----~----~givH~dikp~NIli~~~----~~ikL~Dfg~~~~  187 (339)
                        .+..|.    .    ..++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              223332    2    249999999999999876    7899999998854

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.53  E-value=0.00089  Score=58.25  Aligned_cols=139  Identities=14%  Similarity=0.156  Sum_probs=77.4

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCC--CeeeeeeecCCCC--cCCcCeEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE--NIVKVKDIIPPMD--KEKFNDVY  115 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~I~~~~~~~~~~~--~~~~~~~~  115 (339)
                      ++.|+ |....||++... +|+.+++|.......   ....+..|..++..+...  .+++++..  +..  ....+..+
T Consensus        31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~  103 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYF  103 (328)
T ss_dssp             CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEE
T ss_pred             EEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEE
Confidence            45566 778899988643 466899998863322   234556677777776422  23444432  110  01235568


Q ss_pred             EEEecCccc-H-----H------HHHH------hcC------CCCHHHH----------------------HHHHHHHHH
Q 042681          116 IVYELMDTD-L-----H------QIIR------SKQ------ALTDDHC----------------------QYFLYQLLR  149 (339)
Q Consensus       116 iv~e~~~g~-L-----~------~~l~------~~~------~~~~~~~----------------------~~i~~qi~~  149 (339)
                      +++++++|. +     .      ..+.      ...      ..+....                      ...+..++.
T Consensus       104 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  183 (328)
T 1zyl_A          104 AVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIA  183 (328)
T ss_dssp             EEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHH
T ss_pred             EEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHH
Confidence            899999762 1     1      1110      000      1111110                      111222222


Q ss_pred             HHHHH----HhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          150 GLKYI----HSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       150 aL~~L----H~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .++.+    ....++|||+++.||+++ + .+.|+||+.+..
T Consensus       184 ~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          184 AVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            22222    234689999999999999 4 899999988754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.52  E-value=0.00026  Score=61.88  Aligned_cols=32  Identities=28%  Similarity=0.425  Sum_probs=27.4

Q ss_pred             hCCcccCCCCCCCeeeccC----CCeEEeecccccc
Q 042681          156 SANVLHRDLKPSNLLLNAN----CDLKICDFGLART  187 (339)
Q Consensus       156 ~~givH~dikp~NIli~~~----~~ikL~Dfg~~~~  187 (339)
                      ...++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3479999999999999874    6799999998754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.46  E-value=0.00094  Score=60.57  Aligned_cols=71  Identities=14%  Similarity=0.156  Sum_probs=48.3

Q ss_pred             ccccccccceEEEEEEeCC-------CCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCc
Q 042681           40 LQPIGRGAYGIVCSAVNSE-------TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++.|+.|....+|++....       +++.+++|+.... ..   ...+.+|..+++.+. +.-.+++++.+     .+ 
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~-  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIF-----SG-  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT-
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC-
Confidence            6678888899999998643       3578999987432 11   134557888888874 33346777766     32 


Q ss_pred             CeEEEEEecCcc
Q 042681          112 NDVYIVYELMDT  123 (339)
Q Consensus       112 ~~~~iv~e~~~g  123 (339)
                         .+|+||++|
T Consensus       148 ---g~v~e~l~G  156 (429)
T 1nw1_A          148 ---GRLEEYIPS  156 (429)
T ss_dssp             ---EEEECCCCE
T ss_pred             ---CEEEEEeCC
Confidence               388999875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.37  E-value=0.00049  Score=59.74  Aligned_cols=142  Identities=13%  Similarity=0.127  Sum_probs=74.5

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCC--eeeeeeecCCC-CcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN--IVKVKDIIPPM-DKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--I~~~~~~~~~~-~~~~~~~~~i  116 (339)
                      ++.|+.|....+|++...  +..+++|......    ....+..|..++..+....  +++++...... .....+..++
T Consensus        27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             eeccCCCcccceEEEEeC--CccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence            556778888999999753  3378899886521    1123455666666663212  33443221000 0011245789


Q ss_pred             EEecCccc-H-----H------HHH----HhcCC--------CCHHHHHH---------------HHHHHHHHHHHHHh-
Q 042681          117 VYELMDTD-L-----H------QII----RSKQA--------LTDDHCQY---------------FLYQLLRGLKYIHS-  156 (339)
Q Consensus       117 v~e~~~g~-L-----~------~~l----~~~~~--------~~~~~~~~---------------i~~qi~~aL~~LH~-  156 (339)
                      ++++++|. +     .      ..+    .....        ........               +-..+...++.+.+ 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            99999762 1     0      111    11001        11110000               00113344455542 


Q ss_pred             ------CCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          157 ------ANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       157 ------~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                            .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                  3699999999999999876668999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.33  E-value=0.0045  Score=56.47  Aligned_cols=72  Identities=22%  Similarity=0.249  Sum_probs=45.9

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCC-eeeeeeecCCCCcCCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN-IVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      ++.|+.|-...+|++....+++.+++|+.......-.+   -.+|..+++.|...+ .+++++.+     ..    ..|+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~  180 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFF-----TN----GRIE  180 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEE
Confidence            56788888899999987654578999987543111111   146888888875333 36777776     22    2599


Q ss_pred             ecCcc
Q 042681          119 ELMDT  123 (339)
Q Consensus       119 e~~~g  123 (339)
                      ||++|
T Consensus       181 e~I~G  185 (458)
T 2qg7_A          181 EFMDG  185 (458)
T ss_dssp             ECCCS
T ss_pred             EeeCC
Confidence            99875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.20  E-value=0.0017  Score=57.63  Aligned_cols=72  Identities=11%  Similarity=0.093  Sum_probs=41.4

Q ss_pred             ccccccccceEEEEEEeCC--------CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCC-eeeeeeecCCCCcCC
Q 042681           40 LQPIGRGAYGIVCSAVNSE--------TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHEN-IVKVKDIIPPMDKEK  110 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-I~~~~~~~~~~~~~~  110 (339)
                      ++.|+.|....+|++....        .++.+++|+.......   ......|..+++.+...+ .+++++..     . 
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~-  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---LYNTISEFEVYKTMSKYKIAPQLLNTF-----N-  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---TSCHHHHHHHHHHHHHTTSSCCEEEEE-----T-
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---eecHHHHHHHHHHHHhcCCCCceEEec-----C-
Confidence            5678888888999998643        1368899987542111   111246777777664222 45666554     2 


Q ss_pred             cCeEEEEEecCcc
Q 042681          111 FNDVYIVYELMDT  123 (339)
Q Consensus       111 ~~~~~iv~e~~~g  123 (339)
                       +  ++|++|++|
T Consensus       109 -~--~~v~e~i~G  118 (369)
T 3c5i_A          109 -G--GRIEEWLYG  118 (369)
T ss_dssp             -T--EEEEECCCS
T ss_pred             -C--cEEEEEecC
Confidence             2  689999875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.16  E-value=0.0021  Score=54.80  Aligned_cols=71  Identities=10%  Similarity=-0.002  Sum_probs=48.4

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCC---CCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH---ENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      ++.+|.|..+.||++... +|+.+++|+......  .....+..|...|+.|..   --+++++++-     .    -++
T Consensus        20 v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~----~~l   87 (288)
T 3f7w_A           20 VAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----D----RTL   87 (288)
T ss_dssp             EEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----T----TEE
T ss_pred             EEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc-----C----ceE
Confidence            677899999999999854 688999997643321  112346778888887742   2345555542     1    278


Q ss_pred             EEecCc
Q 042681          117 VYELMD  122 (339)
Q Consensus       117 v~e~~~  122 (339)
                      |||+..
T Consensus        88 v~e~l~   93 (288)
T 3f7w_A           88 AMEWVD   93 (288)
T ss_dssp             EEECCC
T ss_pred             EEEeec
Confidence            999985

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.12  E-value=0.0023  Score=56.02  Aligned_cols=31  Identities=19%  Similarity=0.291  Sum_probs=27.5

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          157 ANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       157 ~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3699999999999999888899999987754

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.19  E-value=0.03  Score=50.10  Aligned_cols=29  Identities=28%  Similarity=0.394  Sum_probs=24.8

Q ss_pred             cccCCCCCCCeeec------cCCCeEEeecccccc
Q 042681          159 VLHRDLKPSNLLLN------ANCDLKICDFGLART  187 (339)
Q Consensus       159 ivH~dikp~NIli~------~~~~ikL~Dfg~~~~  187 (339)
                      +||+|+.+.||++.      .++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            78999999999993      456799999998854

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.01  E-value=0.11  Score=46.87  Aligned_cols=72  Identities=8%  Similarity=0.033  Sum_probs=45.3

Q ss_pred             ccccccccceEEEEEEeCCC-------CceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCc
Q 042681           40 LQPIGRGAYGIVCSAVNSET-------KEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++.|..|-...+|++.....       ++.|++|+.......-.+   ..+|..+++.+. +.-.+++++.+     .  
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~id---R~~E~~~l~~L~~~gi~P~l~~~~-----~--  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYD---SKVELDVFRYLSNINIAPNIIADF-----P--  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCC---HHHHHHHHHHHHHTTSSCCEEEEE-----T--
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcC---HHHHHHHHHHHHhcCCCCCEEEEc-----C--
Confidence            66788888889999986521       578999986442111111   235666666663 33346666654     2  


Q ss_pred             CeEEEEEecCcc
Q 042681          112 NDVYIVYELMDT  123 (339)
Q Consensus       112 ~~~~iv~e~~~g  123 (339)
                      +  +.|++|++|
T Consensus       145 ~--~~I~efI~G  154 (424)
T 3mes_A          145 E--GRIEEFIDG  154 (424)
T ss_dssp             T--EEEEECCCS
T ss_pred             C--CEEEEEeCC
Confidence            2  788999976

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=88.66  E-value=0.051  Score=49.59  Aligned_cols=61  Identities=10%  Similarity=0.063  Sum_probs=16.5

Q ss_pred             ccccccccceEEEEEEeCCCCceEEE------EEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeec
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAI------KKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDII  103 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~av------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~  103 (339)
                      .+.||   ||.||++.......+||+      |..+...........+.++..++..++|||+++.+++.
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            56666   999999988765567888      65543333333445678888999999999999998765

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.76  E-value=4.9  Score=32.24  Aligned_cols=86  Identities=21%  Similarity=0.116  Sum_probs=59.2

Q ss_pred             CCCCeeeeeeecCCCCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCee
Q 042681           92 THENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLL  170 (339)
Q Consensus        92 ~h~~I~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIl  170 (339)
                      .||++..-+.       ...+.+.+.++.-+ +.-+..+   +.++....++++..|+.... -|...-+|--|.|+||+
T Consensus        48 ~~~~f~~~I~-------~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCIVRDID-------VSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLM  116 (219)
T ss_dssp             SCSSSEEEEE-------ECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEE
T ss_pred             cCCCCCeEEE-------EeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEE
Confidence            5788733333       44466677677664 4333344   34788899998988877554 12344567789999999


Q ss_pred             eccCCCeEEeeccccccc
Q 042681          171 LNANCDLKICDFGLARTT  188 (339)
Q Consensus       171 i~~~~~ikL~Dfg~~~~~  188 (339)
                      ++.++.+++.-.|.-..+
T Consensus       117 f~~~~~p~i~hRGi~~~l  134 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESL  134 (219)
T ss_dssp             ECTTCCEEESCCEETTTB
T ss_pred             EeCCCcEEEEEcCCcccC
Confidence            999999999988875433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	339
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-81
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-76
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-76
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-66
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-62
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-57
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-55
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-54
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-54
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-53
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-52
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-52
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-52
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-51
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-51
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-51
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-50
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-50
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-50
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-44
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-41
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-39
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-38
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-37
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-35
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-35
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-35
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-35
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-34
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-34
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-32
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-31
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-31
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-30
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-30
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-29
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-29
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-22

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (637), Expect = 1e-81
 Identities = 158/346 (45%), Positives = 206/346 (59%), Gaps = 39/346 (11%)

Query: 27  GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIK 86
           G +F V  +Y   L  IG GAYG+VCSA ++  K  VAIKKI + F+++   +R LREIK
Sbjct: 1   GQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIK 58

Query: 87  LLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQ 146
           +L    HENI+ + DII     E+  DVY+V  LM  DL+++++++  L++DH  YFLYQ
Sbjct: 59  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117

Query: 147 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR----TTSETDFMTEYVVTRW 202
           +LRGLKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLAR        T F+TEYV TRW
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 203 --------------------------------DTLFPGKDYVQQLTMITELLGSPDDSDL 230
                                             +FPGK Y+ QL  I  +LGSP   DL
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 231 GFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPY 290
             + +  AR Y+  LPH  K P+++ FPN    A+DL ++ML F+P KRI VE+AL HPY
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297

Query: 291 LSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPDH 336
           L   ++ ++EP    PF FD E   + +E +KELI  E   F P +
Sbjct: 298 LEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 343

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (604), Expect = 1e-76
 Identities = 132/348 (37%), Positives = 199/348 (57%), Gaps = 38/348 (10%)

Query: 20  YVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK 79
           + +  +    ++V + Y   LQP+G GAYG VCSAV+  T  +VAIKK+   F + + AK
Sbjct: 4   FYRQEVTKTAWEVRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK 62

Query: 80  RILREIKLLCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDD 138
           R  RE++LL HM HEN++ + D+  P +  + F D Y+V   M TDL ++++ ++ L +D
Sbjct: 63  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGED 121

Query: 139 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYV 198
             Q+ +YQ+L+GL+YIH+A ++HRDLKP NL +N +C+LKI DFGLAR       MT YV
Sbjct: 122 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYV 179

Query: 199 VTRW--------------------------------DTLFPGKDYVQQLTMITELLGSPD 226
           VTRW                                 TLF G D++ QL  I ++ G+P 
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239

Query: 227 DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEAL 286
              +  L+SD A+ Y+K LP + K+ F+    N SP+A++L E+MLV D  +R+T  EAL
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

Query: 287 NHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHP 334
            HPY  SLH+  +EP     ++  F+      ++ K +  +E L+F P
Sbjct: 300 AHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (599), Expect = 7e-76
 Identities = 135/348 (38%), Positives = 201/348 (57%), Gaps = 34/348 (9%)

Query: 19  KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA 78
            + +  +   +++V  +Y   L P+G GAYG VC+A +++T   VA+KK++  F + I A
Sbjct: 3   TFYRQELNKTIWEVPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 79  KRILREIKLLCHMTHENIVKVKDII-PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTD 137
           KR  RE++LL HM HEN++ + D+  P    E+FNDVY+V  LM  DL+ I++  Q LTD
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTD 120

Query: 138 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE- 196
           DH Q+ +YQ+LRGLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T +       
Sbjct: 121 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 180

Query: 197 -----------------------------YVVTRWDTLFPGKDYVQQLTMITELLGSPDD 227
                                          +    TLFPG D++ QL +I  L+G+P  
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240

Query: 228 SDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN 287
             L  + S++AR Y++ L  +PK  F+  F   +P+A+DL E+MLV D  KRIT  +AL 
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

Query: 288 HPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIKELILRECLNFHPD 335
           H Y +  H+ ++EP    P++  FE   +  ++ K L   E ++F P 
Sbjct: 301 HAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPP 347

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 8e-66
 Identities = 127/358 (35%), Positives = 192/358 (53%), Gaps = 49/358 (13%)

Query: 19  KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA 78
           ++    +  + F V  +Y   L+PIG GA GIVC+A ++     VAIKK++  F N+  A
Sbjct: 2   QFYSVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60

Query: 79  KRILREIKLLCHMTHENIVKVKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTD 137
           KR  RE+ L+  + H+NI+ + ++  P    E+F DVY+V ELMD +L Q+I+ +     
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--DH 118

Query: 138 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEY 197
           +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART   +  MT Y
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178

Query: 198 VVTRWDT-------------------------------LFPGKDYVQQLTMITELLGSPD 226
           VVTR+                                 LFPG+DY+ Q   + E LG+P 
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 227 DSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN------------MSPVAIDLAERMLVF 274
              +  L+    R YV+  P      F + FP+             +  A DL  +MLV 
Sbjct: 239 PEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297

Query: 275 DPAKRITVEEALNHPYLSSLHEINE-EPTCPYPFNFDFEQTSMNEEDIKELILRECLN 331
           DPAKRI+V++AL HPY++  ++  E E   P  ++   ++     E+ KELI +E +N
Sbjct: 298 DPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 355

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-62
 Identities = 90/329 (27%), Positives = 149/329 (45%), Gaps = 52/329 (15%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG G++G+V  A   ++ E VAIKK+        D +   RE++++  + H NIV++
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRL 78

Query: 100 KDII-PPMDKEKFNDVYIVYELMDTDLHQII----RSKQALTDDHCQYFLYQLLRGLKYI 154
           +       +K+    + +V + +   ++++     R+KQ L   + + ++YQL R L YI
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 155 HSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSETDFMTEYVVTRW----------- 202
           HS  + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R+           
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198

Query: 203 ---------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRY 241
                                  +FPG   V QL  I ++LG+P       +R  N    
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE---QIREMNPNYT 255

Query: 242 VKQLPHVPKQPFSQKF-PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE 300
             + P +   P+++ F P   P AI L  R+L + P  R+T  EA  H +   L + N +
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 315

Query: 301 ----PTCPYPFNFDFEQTSMNEEDIKELI 325
                  P  FNF  ++ S N      LI
Sbjct: 316 LPNGRDTPALFNFTTQELSSNPPLATILI 344

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 3e-57
 Identities = 90/304 (29%), Positives = 131/304 (43%), Gaps = 45/304 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRID---AKRILREIKLLCHMTHENI 96
           L  +G G +  V  A +  T + VAIKKI     +       +  LREIKLL  ++H NI
Sbjct: 3   LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQALTDDHCQYFLYQLLRGLKYIH 155
           + + D          +++ +V++ M+TD    I  +   LT  H + ++   L+GL+Y+H
Sbjct: 63  IGLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW------------ 202
              +LHRDLKP+NLLL+ N  LK+ DFGLA++  S     T  VVTRW            
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 203 --------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV 242
                                   PG   + QLT I E LG+P +     + S       
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
           K     P  P    F       +DL + + +F+P  RIT  +AL   Y S+         
Sbjct: 238 KSF---PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294

Query: 303 CPYP 306
            P P
Sbjct: 295 LPRP 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (461), Expect = 1e-55
 Identities = 80/298 (26%), Positives = 131/298 (43%), Gaps = 42/298 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  IG+G +G V  A + +T ++VA+KK+    +        LREIK+L  + HEN+V +
Sbjct: 15  LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74

Query: 100 KDIIPPMDKEKF---NDVYIVYELMDTDLHQI-IRSKQALTDDHCQYFLYQLLRGLKYIH 155
            +I              +Y+V++  + DL  +        T    +  +  LL GL YIH
Sbjct: 75  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134

Query: 156 SANVLHRDLKPSNLLLNANCDLKICDFGLAR-----TTSETDFMTEYVVTRW-------- 202
              +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +  T  VVT W        
Sbjct: 135 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194

Query: 203 ------------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNA 238
                                     +  G     QL +I++L GS        + +   
Sbjct: 195 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 254

Query: 239 RRYVKQLPHVPKQPFSQ-KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
              ++ +    ++   + K     P A+DL +++LV DPA+RI  ++ALNH +  S  
Sbjct: 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (452), Expect = 2e-54
 Identities = 63/302 (20%), Positives = 121/302 (40%), Gaps = 26/302 (8%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKIT-NAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ IG G++G V  A +    E VAIKK++ +   +    + I++E++ L  + H N ++
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
            +         + +  ++V E    +    +   K+ L +       +  L+GL Y+HS 
Sbjct: 80  YRGCY-----LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT--------EYVVTRWDTLFPGK 209
           N++HRD+K  N+LL+    +K+ DFG A   +  +           E ++   +  + GK
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 210 DYVQQL--TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
             V  L  T I      P       L + NA   +  +          +  + S    + 
Sbjct: 195 VDVWSLGITCIELAERKP------PLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRNF 246

Query: 268 AERMLVFDPAKRITVEEALNHPYLSSLHEIN-EEPTCPYPFNFDFEQTSMNEEDIKELIL 326
            +  L   P  R T E  L H ++                 +   E  ++    +K+++ 
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILF 306

Query: 327 RE 328
           +E
Sbjct: 307 QE 308

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 4e-54
 Identities = 80/297 (26%), Positives = 131/297 (44%), Gaps = 41/297 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSET-KEEVAIKKITNAFDNRIDAKRILREIKLLCHMT---HEN 95
           +  IG GAYG V  A + +     VA+K++             +RE+ +L H+    H N
Sbjct: 12  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELM--DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           +V++ D+      ++   + +V+E +  D   +     +  +  +  +  ++QLLRGL +
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW----------- 202
           +HS  V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  VVT W           
Sbjct: 132 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 191

Query: 203 --------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV 242
                                 LF G   V QL  I +++G P + D       +     
Sbjct: 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDVALPR 247

Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
           +       QP  +   ++  +  DL  + L F+PAKRI+   AL+HPY   L    E
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 1e-53
 Identities = 94/292 (32%), Positives = 134/292 (45%), Gaps = 42/292 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ IG G YG+V  A N  T E VA+KKI    +        +REI LL  + H NIVK+
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSA 157
            D+I        N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW-------------- 202
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT W              
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 203 ------------------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ 244
                               LFPG   + QL  I   LG+PD+    +    +   Y   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV--WPGVTSMPDYKPS 239

Query: 245 LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
            P   +Q FS+  P +      L  +ML +DP KRI+ + AL HP+   + +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-53
 Identities = 53/298 (17%), Positives = 112/298 (37%), Gaps = 53/298 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +  +G G  G+V    +  +   +A K I           +I+RE+++L       IV  
Sbjct: 11  ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-IRNQIIRELQVLHECNSPYIVGF 69

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                        ++ I  E MD   L Q+++    + +         +++GL Y+   +
Sbjct: 70  YGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 159 -VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW--------------- 202
            ++HRD+KPSN+L+N+  ++K+CDFG++    ++     +V TR                
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ 183

Query: 203 ----------------DTLFPGKDYVQ-QLTMITELLGSPDDSDL-----------GFLR 234
                               P  D  + +L    ++ G   ++               + 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243

Query: 235 SDNARRYVKQLPHVPKQPFSQKFPN-MSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           S       + L ++  +P  +      S    D   + L+ +PA+R  +++ + H ++
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  176 bits (447), Expect = 4e-53
 Identities = 58/295 (19%), Positives = 114/295 (38%), Gaps = 27/295 (9%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + +G GA+G+V       T    A K +    ++  D + + +EI+ +  + H  +V +
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNL 88

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTD--LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
            D       E  N++ ++YE M       ++      +++D    ++ Q+ +GL ++H  
Sbjct: 89  HDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 158 NVLHRDLKPSNLLLNA--NCDLKICDFGLARTTSETDFMTEYVVTRWDT---LFPGKDYV 212
           N +H DLKP N++     + +LK+ DFGL         +     T       +  GK   
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203

Query: 213 QQ-------LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
                    +     L G            +N    ++ +           F  +S    
Sbjct: 204 YYTDMWSVGVLSYILLSGLS------PFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257

Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEED 320
           D   ++L+ DP  R+T+ +AL HP+L+  +    +   P         +   + D
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYD 312

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 6e-53
 Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 28/268 (10%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +Q +G GAYG V  AVN  T+E VA+K + +        + I +EI +   + HEN+VK 
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKF 68

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLH-QIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                     + N  Y+  E          I     + +   Q F +QL+ G+ Y+H   
Sbjct: 69  YGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLAR---TTSETDFMTEYVVTRW----DTLFPGKDY 211
           + HRD+KP NLLL+   +LKI DFGLA      +    + +   T      + L   + +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 212 VQQ-------LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
            +        + +   L G           SD+ + Y        K+ +   +  +    
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQ----PSDSCQEYSDW---KEKKTYLNPWKKIDSAP 236

Query: 265 IDLAERMLVFDPAKRITVEEALNHPYLS 292
           + L  ++LV +P+ RIT+ +     + +
Sbjct: 237 LALLHKILVENPSARITIPDIKKDRWYN 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 1e-52
 Identities = 61/266 (22%), Positives = 117/266 (43%), Gaps = 28/266 (10%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNA-FDNRIDAKRILREIKLLCHMTHENIVK 98
            +P+G+G +G V  A   ++K  +A+K +  A  +      ++ RE+++  H+ H NI++
Sbjct: 11  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 70

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           +              VY++ E      +++ ++      +     ++ +L   L Y HS 
Sbjct: 71  LYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDT---LFPGKDYVQQ 214
            V+HRD+KP NLLL +  +LKI DFG +     +   T    T       +  G+ + ++
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEK 184

Query: 215 L------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
           +       +  E L G P      F  +     Y +        P       ++  A DL
Sbjct: 185 VDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFP-----DFVTEGARDL 234

Query: 268 AERMLVFDPAKRITVEEALNHPYLSS 293
             R+L  +P++R  + E L HP++++
Sbjct: 235 ISRLLKHNPSQRPMLREVLEHPWITA 260

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  172 bits (436), Expect = 3e-52
 Identities = 84/285 (29%), Positives = 116/285 (40%), Gaps = 40/285 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG G YG+V  A N+   E  A+KKI    ++       +REI +L  + H NIVK+
Sbjct: 7   LEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            D+I      K   V +   L       +   +  L     + FL QLL G+ Y H   V
Sbjct: 66  YDVIH----TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR------------------ 201
           LHRDLKP NLL+N   +LKI DFGLAR          + +                    
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181

Query: 202 ---------------WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP 246
                             LFPG     QL  I  +LG+P+  +  +       +Y     
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN--WPNVTELPKYDPNFT 239

Query: 247 HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                P+      +    IDL  +ML  DP +RIT ++AL H Y 
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  173 bits (439), Expect = 7e-52
 Identities = 57/283 (20%), Positives = 112/283 (39%), Gaps = 27/283 (9%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G GA+G+V   V   T      K I       +D   +  EI ++  + H  ++ +
Sbjct: 34  LEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPKLINL 91

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSA 157
            D       E   ++ ++ E +   +L   I ++   +++     ++ Q   GLK++H  
Sbjct: 92  HDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 158 NVLHRDLKPSNLLLNA--NCDLKICDFGLARTTSETDFMTEYVVTRWDT---LFPGKDYV 212
           +++H D+KP N++        +KI DFGLA   +  + +     T       +   +   
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206

Query: 213 QQ-------LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
                    +     L G            ++    ++ +     +     F ++SP A 
Sbjct: 207 FYTDMWAIGVLGYVLLSGLS------PFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260

Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFN 308
           D  + +L  +P KR+TV +AL HP+L   H           +N
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYN 303

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 8e-52
 Identities = 66/271 (24%), Positives = 107/271 (39%), Gaps = 32/271 (11%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +  +G GA+G V  A N ET    A K I     +  + +  + EI +L    H NIVK+
Sbjct: 17  IGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNIVKL 74

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDL--HQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
            D          N+++I+ E          ++  ++ LT+   Q    Q L  L Y+H  
Sbjct: 75  LDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVV--------------TRWD 203
            ++HRDLK  N+L   + D+K+ DFG++   + T    +  +              T  D
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 204 TLFPGKDYVQQL--TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
             +  K  V  L  T+I      P   +L         +  K  P    QP        S
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLKIAKSEPPTLAQP-----SRWS 242

Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYLS 292
               D  ++ L  +   R T  + L HP+++
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 1e-51
 Identities = 90/290 (31%), Positives = 123/290 (42%), Gaps = 40/290 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ IG G YG V  A N ET E VA+K++    D+       LREI LL  + H+NIV++
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            D++            +                  L  +  + FL+QLL+GL + HS NV
Sbjct: 67  HDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLAR-TTSETDFMTEYVVTRWDT-------------- 204
           LHRDLKP NLL+N N +LK+ +FGLAR         +  VVT W                
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

Query: 205 -------------------LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL 245
                              LFPG D   QL  I  LLG+P +     +       Y    
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM--TKLPDYKPYP 240

Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH 295
            +          P ++    DL + +L  +P +RI+ EEAL HPY S   
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-51
 Identities = 57/263 (21%), Positives = 109/263 (41%), Gaps = 25/263 (9%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+GA G V +A++  T +EVAI+++      +   + I+ EI ++    + NIV  
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            D          +++++V E +       + ++  + +        + L+ L+++HS  V
Sbjct: 83  LDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLT--- 216
           +HRD+K  N+LL  +  +K+ DFG     +        +V     + P     +      
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 217 -------MITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA 268
                  M  E++ G P         ++N  R +  +         Q    +S +  D  
Sbjct: 198 DIWSLGIMAIEMIEGEP------PYLNENPLRALYLIATNGTPEL-QNPEKLSAIFRDFL 250

Query: 269 ERMLVFDPAKRITVEEALNHPYL 291
            R L  D  KR + +E L H +L
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFL 273

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  169 bits (428), Expect = 4e-51
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 26/273 (9%)

Query: 39  PLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAK-------RILREIKLLCHM 91
           P + +GRG   +V   ++  T +E A+K I         A+         L+E+ +L  +
Sbjct: 7   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66

Query: 92  -THENIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLR 149
             H NI+++KD       E     ++V++LM   +L   +  K  L++   +  +  LL 
Sbjct: 67  SGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121

Query: 150 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGK 209
            +  +H  N++HRDLKP N+LL+ + ++K+ DFG +      + + E   T    L P  
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY-LAPEI 180

Query: 210 DYVQQLTMITELLGSPDDSDLGFL-----------RSDNARRYVKQLPHVPKQPFSQKFP 258
                           D    G +                   ++ +     Q  S ++ 
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           + S    DL  R LV  P KR T EEAL HP+ 
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  169 bits (429), Expect = 7e-51
 Identities = 68/275 (24%), Positives = 119/275 (43%), Gaps = 26/275 (9%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
              +G GA+  V  A +  T++ VAIK I        +   +  EI +L  + H NIV +
Sbjct: 14  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNIVAL 72

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
            DI      E    +Y++ +L+   +L   I  K   T+      ++Q+L  +KY+H   
Sbjct: 73  DDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 159 VLHRDLKPSNLLL---NANCDLKICDFGLARTTSETDFMTEYVVTRW---DTLFPGKDYV 212
           ++HRDLKP NLL    + +  + I DFGL++       ++    T       +   K Y 
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187

Query: 213 Q-------QLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
           +        +     L G P          +N  +  +Q+     +  S  + ++S  A 
Sbjct: 188 KAVDCWSIGVIAYILLCGYP------PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241

Query: 266 DLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE 300
           D    ++  DP KR T E+AL HP+++    +++ 
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-50
 Identities = 54/266 (20%), Positives = 110/266 (41%), Gaps = 28/266 (10%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + +GRG +GIV   V + +K+    K +        D   + +EI +L    H NI+ +
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHL 66

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSA 157
            +       E   ++ +++E +   D+ + I +    L +     +++Q+   L+++HS 
Sbjct: 67  HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 158 NVLHRDLKPSNLLLNA--NCDLKICDFGLARTTSETDFMTEYVVTR---WDTLFPGKDYV 212
           N+ H D++P N++     +  +KI +FG AR     D               +       
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 213 QQ-------LTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
                      +   L G           ++  ++ ++ + +       + F  +S  A+
Sbjct: 182 TATDMWSLGTLVYVLLSGIN------PFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235

Query: 266 DLAERMLVFDPAKRITVEEALNHPYL 291
           D  +R+LV +   R+T  EAL HP+L
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWL 261

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 3e-50
 Identities = 64/276 (23%), Positives = 104/276 (37%), Gaps = 39/276 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L  IG G+YG           + +  K++        + + ++ E+ LL  + H NIV+ 
Sbjct: 9   LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 68

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQII----RSKQALTDDHCQYFLYQLLRGLKYI 154
            D I          +YIV E  +  DL  +I    + +Q L ++     + QL   LK  
Sbjct: 69  YDRI---IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 155 H-----SANVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRWDT---L 205
           H        VLHRDLKP+N+ L+   ++K+ DFGLAR    +T F   +V T +      
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185

Query: 206 FPGKDY----------VQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQ 255
                Y               +   +      S              +    + +  F +
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------------KELAGKIREGKFRR 233

Query: 256 KFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL 291
                S    ++  RML      R +VEE L +P +
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 4e-50
 Identities = 72/314 (22%), Positives = 136/314 (43%), Gaps = 32/314 (10%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKV 99
           Q +G G  G V    N  T+E+ A+K +        D  +  RE++L    +   +IV++
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRI 70

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHS 156
            D+   +   +   + IV E +D  +L   I+ +  QA T+      +  +   ++Y+HS
Sbjct: 71  VDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 157 ANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSETDFMTEYVVTRW--------DTL 205
            N+ HRD+KP NLL  +   N  LK+ DFG A+ T+  + +T    T +           
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 189

Query: 206 FPGKDYVQQLTMITELLGS---PDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP 262
           +     +  L +I  +L     P  S+ G   S   +  ++   +    P   ++  +S 
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP---EWSEVSE 246

Query: 263 VAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIK 322
               L   +L  +P +R+T+ E +NHP++    ++ + P        + ++     ED+K
Sbjct: 247 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE---RWEDVK 303

Query: 323 ELILRECLNFHPDH 336
           E +         D+
Sbjct: 304 EEMTSALATMRVDY 317

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  167 bits (423), Expect = 6e-50
 Identities = 73/297 (24%), Positives = 136/297 (45%), Gaps = 53/297 (17%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVK 98
           ++ +GRG Y  V  A+N    E+V +K +       +  K+I REIK+L ++    NI+ 
Sbjct: 40  VRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIIT 94

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           + DI+            +V+E ++ TD  Q+ ++   LTD   ++++Y++L+ L Y HS 
Sbjct: 95  LADIVKDPVSRTP---ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSM 148

Query: 158 NVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSETDFMTEYVVTRW-------------- 202
            ++HRD+KP N++++  +  L++ D+GLA            V +R+              
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208

Query: 203 -------------------DTLFPGKDYVQQLTMITELLGSPDDSD-LGFLRSDNARRYV 242
                              +  F G D   QL  I ++LG+ D  D +     +   R+ 
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268

Query: 243 KQLPHVPKQPFSQKFP-----NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL 294
             L    ++ + +         +SP A+D  +++L +D   R+T  EA+ HPY  ++
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 5e-47
 Identities = 56/270 (20%), Positives = 113/270 (41%), Gaps = 22/270 (8%)

Query: 35  KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE 94
           +++     IGRG++  V   +++ET  EVA  ++ +    + + +R   E ++L  + H 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           NIV+  D      K K   + +V ELM +  L   ++  + +     + +  Q+L+GL++
Sbjct: 69  NIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127

Query: 154 IHSAN--VLHRDLKPSNLLLNA-NCDLKICDFGLARTTSETDFMTEYVVTRW-------D 203
           +H+    ++HRDLK  N+ +      +KI D GLA       F    + T         +
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYE 186

Query: 204 TLFPGKDYVQQL--TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
             +     V      M+             +    NA +  +++    K     K     
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVKPASFDK--VAI 239

Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYL 291
           P   ++ E  +  +  +R ++++ LNH + 
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 3e-45
 Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 28/270 (10%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHEN 95
            + +G G + +V       T  + A K I    T +    +  + I RE+ +L  + H N
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           ++ + ++      E   DV ++ EL+    L   +  K++LT++    FL Q+L G+ Y+
Sbjct: 75  VITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 155 HSANVLHRDLKPSNLLLN----ANCDLKICDFGLARTTSETDFMTEYVVTRWDT---LFP 207
           HS  + H DLKP N++L         +KI DFGLA      +       T       +  
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

Query: 208 GKDYVQQLTM------ITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMS 261
            +    +  M         LL     S       D  +  +  +  V  +   + F N S
Sbjct: 190 YEPLGLEADMWSIGVITYILL-----SGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244

Query: 262 PVAIDLAERMLVFDPAKRITVEEALNHPYL 291
            +A D   R+LV DP KR+T++++L HP++
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-44
 Identities = 63/276 (22%), Positives = 108/276 (39%), Gaps = 36/276 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
            + +G G++  V  A    T  E AIK +             + RE  ++  + H   VK
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           +         +    +Y         +L + IR   +  +   +++  +++  L+Y+H  
Sbjct: 73  LYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLART---TSETDFMTEYVVTRWDT---LFPGKDY 211
            ++HRDLKP N+LLN +  ++I DFG A+     S+      +V T       L   K  
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 212 VQQLTM------ITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
            +   +      I +L+ G P      F   +    + K +      P         P A
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKIIKLEYDFP-----EKFFPKA 237

Query: 265 IDLAERMLVFDPAKRITVEEA------LNHPYLSSL 294
            DL E++LV D  KR+  EE         HP+  S+
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 5e-42
 Identities = 62/311 (19%), Positives = 124/311 (39%), Gaps = 45/311 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           L+ +G+G +G V       T    A+K +       + +    + E ++L +  H  +  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTD-LHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           +K      D+     +  V E  +   L   +  ++  T++  +++  +++  L+Y+HS 
Sbjct: 70  LKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLART-TSETDFMTEYVVTRW---DTLFPGKDYVQ 213
           +V++RD+K  NL+L+ +  +KI DFGL +   S+   M  +  T       +    DY +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184

Query: 214 QL-------TMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAID 266
            +        M   + G        F   D+ R +   L    + P       +SP A  
Sbjct: 185 AVDWWGLGVVMYEMMCGRLP-----FYNQDHERLFELILMEEIRFP-----RTLSPEAKS 234

Query: 267 LAERMLVFDPAKRI-----TVEEALNHPYLSSL---HEINEEPTCPY---------PFNF 309
           L   +L  DP +R+       +E + H +  S+     + ++   P+            F
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYF 294

Query: 310 DFEQTSMNEED 320
           D E T+ +   
Sbjct: 295 DDEFTAQSITI 305

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-41
 Identities = 56/281 (19%), Positives = 102/281 (36%), Gaps = 40/281 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLL--CHMTH 93
              +G G +G V S +       VAIK +     + +    +  R+  E+ LL       
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQYFLYQLLRGL 151
             ++++ D     D        ++ E  +   DL   I  + AL ++  + F +Q+L  +
Sbjct: 69  SGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 152 KYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTSETDFMT----------EYVVT 200
           ++ H+  VLHRD+K  N+L++ N  +LK+ DFG      +T +            E++  
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183

Query: 201 RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM 260
                     +   + +   + G        F   +   R                   +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDI-----PFEHDEEIIRGQVFFR-----------QRV 227

Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
           S     L    L   P+ R T EE  NHP++  +    E  
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA 268

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  146 bits (368), Expect = 2e-41
 Identities = 53/275 (19%), Positives = 104/275 (37%), Gaps = 32/275 (11%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI----TNAFDNRIDAKRILREIKLLCHMTHEN 95
            + IGRG +G V     ++T +  A+K +             A      + L+       
Sbjct: 9   HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           IV +            + +  + +LM+  DLH  +      ++   +++  +++ GL+++
Sbjct: 69  IVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQ 214
           H+  V++RDLKP+N+LL+ +  ++I D GLA   S+                 G    + 
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEV 176

Query: 215 LTMITELLGSPDDSDLGFLR----------SDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
           L        S D   LG +             +  +   ++  +      +   + SP  
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236

Query: 265 IDLAERMLVFDPAKRITV-----EEALNHPYLSSL 294
             L E +L  D  +R+       +E    P+  SL
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-40
 Identities = 49/268 (18%), Positives = 93/268 (34%), Gaps = 33/268 (12%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            Q IG G++G V      +   +VA+K +          +    E+ +L    H NI+  
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQA-LTDDHCQYFLYQLLRGLKYIHSA 157
                         + IV +  + + L+  +   +             Q  +G+ Y+H+ 
Sbjct: 70  MGY------STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT--------------EYVVTRWD 203
           +++HRDLK +N+ L+ +  +KI DFGLA   S                    E +  +  
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 204 TLFPGKDYVQQLTMIT-ELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQP-FSQKFPNM 260
             +  +  V    ++  EL+ G        +   +N  + +  +      P  S+   N 
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNH 288
                 L    L     +R    + L  
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 8e-40
 Identities = 64/308 (20%), Positives = 120/308 (38%), Gaps = 42/308 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCH-MTHENIV 97
            + +G+G++G V  A   +T +  AIK +  +      D +  + E ++L     H  + 
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66

Query: 98  KVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
            +         +   +++ V E ++  DL   I+S          ++  +++ GL+++HS
Sbjct: 67  HMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFP----GKDYV 212
             +++RDLK  N+LL+ +  +KI DFG+ +     D  T       D + P    G+ Y 
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181

Query: 213 QQL------TMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAI 265
             +       ++ E+L G        F   D    +       P  P       +   A 
Sbjct: 182 HSVDWWSFGVLLYEMLIGQS-----PFHGQDEEELFHSIRMDNPFYP-----RWLEKEAK 231

Query: 266 DLAERMLVFDPAKRITVE-EALNHPYLSSL---HEINEEPTCPY---------PFNFDFE 312
           DL  ++ V +P KR+ V  +   HP    +       +E   P+           NFD E
Sbjct: 232 DLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKE 291

Query: 313 QTSMNEED 320
             +     
Sbjct: 292 FLNEKPRL 299

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  139 bits (350), Expect = 1e-39
 Identities = 52/266 (19%), Positives = 95/266 (35%), Gaps = 23/266 (8%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
            + +G G    V  A +     +VA+K +  +   +     R  RE +    + H  IV 
Sbjct: 12  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           V D     +       YIV E +D   L  I+ ++  +T       +    + L + H  
Sbjct: 72  VYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 130

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLF----------- 206
            ++HRD+KP+N++++A   +K+ DFG+AR  +++            T             
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190

Query: 207 --PGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
                D      ++ E+L G P          D+      Q       P S +   +S  
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEP------PFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244

Query: 264 AIDLAERMLVFDPAKRITVEEALNHP 289
              +  + L  +P  R      +   
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRAD 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 3e-39
 Identities = 49/272 (18%), Positives = 93/272 (34%), Gaps = 37/272 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G +G V          +VA+K +       +     L E  L+  + H+ +V++
Sbjct: 18  VERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDL---HQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
             ++          +YI+ E M+           S   LT +       Q+  G+ +I  
Sbjct: 74  YAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFM-TEYVVTRWDTLFPGKDYVQQL 215
            N +HRDL+ +N+L++     KI DFGLAR   + ++   E          P        
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187

Query: 216 T----------MITELL--GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
           T          ++TE++  G                  ++ L    +        N    
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRI------PYPGMTNPEVIQNLERGYRMVRP---DNCPEE 238

Query: 264 AIDLAERMLVFDPAKRITVEEALN--HPYLSS 293
              L        P  R T +   +    + ++
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 7e-39
 Identities = 51/274 (18%), Positives = 99/274 (36%), Gaps = 26/274 (9%)

Query: 43  IGRGAYGIVCSAVNSETKE--EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +G G +G V   V    K+  +VAIK +    +   D + ++RE +++  + +  IV++ 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLI 75

Query: 101 DIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSAN 158
            +       +   + +V E+     LH+ +  K + +   +    L+Q+  G+KY+   N
Sbjct: 76  GVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 129

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTMI 218
            +HRDL   N+LL      KI DFGL++     D            L             
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189

Query: 219 TELLGSPDDSDLGFL---------RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAE 269
           +      D    G           +     +  + +  + +    +  P   P    L  
Sbjct: 190 SS---RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS 246

Query: 270 RMLVFDPAKRIT---VEEALNHPYLSSLHEINEE 300
              ++    R     VE+ +   Y S   ++   
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 7e-39
 Identities = 48/275 (17%), Positives = 96/275 (34%), Gaps = 36/275 (13%)

Query: 43  IGRGAYGIVCSAV--NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK 100
           +G G +G V        +  + VA+K + N  ++      +L E  ++  + +  IV++ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 101 DIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANV 159
            I       +     +V E+ +   L++ ++  + + D +    ++Q+  G+KY+  +N 
Sbjct: 75  GIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 160 LHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTL-------FPGKDYV 212
           +HRDL   N+LL      KI DFGL++     +   +        +            + 
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188

Query: 213 QQ------LTMITELL--GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
            +        ++ E    G          R          L    +              
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQK------PYRGMKGSEVTAMLEKGERMGCP---AGCPREM 239

Query: 265 IDLAERMLVFDPAKRIT---VEEALNHPYLSSLHE 296
            DL      +D   R     VE  L + Y   ++E
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  136 bits (344), Expect = 3e-38
 Identities = 60/275 (21%), Positives = 116/275 (42%), Gaps = 40/275 (14%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDA-KRILREIKLLCHMTHENIVK 98
           L+ +G G++G V    +       A+K +      R+   +    E  +L  +TH  I++
Sbjct: 9   LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68

Query: 99  VKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
           +         +    ++++ + ++  +L  ++R  Q   +   +++  ++   L+Y+HS 
Sbjct: 69  MWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTM 217
           ++++RDLKP N+LL+ N  +KI DFG A+          YV     TL    DY+    +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAK----------YVPDVTYTLCGTPDYIAPEVV 173

Query: 218 ITELLGSPDD-SDLG------------FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
            T+      D    G            F  S+  + Y K L    + P     P  +   
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP-----PFFNEDV 228

Query: 265 IDLAERMLVFDPAKRI-----TVEEALNHPYLSSL 294
            DL  R++  D ++R+       E+  NHP+   +
Sbjct: 229 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 3e-38
 Identities = 57/261 (21%), Positives = 97/261 (37%), Gaps = 31/261 (11%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           LQ IG+G +G V          +VA+K I     N   A+  L E  ++  + H N+V++
Sbjct: 12  LQTIGKGEFGDVMLGDY--RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHS 156
             +I     E+   +YIV E M    L   +RS+    L  D    F   +   ++Y+  
Sbjct: 66  LGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDT-LFPGKDYVQQL 215
            N +HRDL   N+L++ +   K+ DFGL +  S T    +  V          K +  + 
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKS 181

Query: 216 ------TMITELL--GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL 267
                  ++ E+   G      +              +P V K           P   ++
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPL---------KDVVPRVEKGYKMDAPDGCPPAVYEV 232

Query: 268 AERMLVFDPAKRITVEEALNH 288
            +     D A R +  +    
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQ 253

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 5e-38
 Identities = 52/294 (17%), Positives = 114/294 (38%), Gaps = 17/294 (5%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           ++ +G G++G V    + E+    A+K +           +  L E ++L  +    +VK
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 99  VKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
           ++       K+  N   ++  +   ++   +R     ++ H +++  Q++   +Y+HS +
Sbjct: 106 LEF----SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 159 VLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWD-TLFPGKDYVQQLTM 217
           +++RDLKP NLL++    +++ DFG A+      +            +   K Y + +  
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDW 221

Query: 218 ITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPA 277
               LG              A + ++    +      +   + S    DL   +L  D  
Sbjct: 222 WA--LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLT 278

Query: 278 KRI-----TVEEALNHPYLSSL---HEINEEPTCPYPFNFDFEQTSMNEEDIKE 323
           KR       V +  NH + ++         +   P+   F     + N +D +E
Sbjct: 279 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEE 332

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 3e-37
 Identities = 55/291 (18%), Positives = 107/291 (36%), Gaps = 54/291 (18%)

Query: 40  LQPIGRGAYGIVCSAVNSETKE-----EVAIKKITNAFDNRIDAKRILREIKLLCHMT-H 93
            + +G GA+G V +A      +     +VA+K +    D+  + + ++ E+K++  +  H
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQLGSH 100

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ------------------- 133
           ENIV +              +Y+++E     DL   +RSK+                   
Sbjct: 101 ENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 134 ----ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
                LT +    F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR   
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 190 ETDFMTEYVVTRWDTLFPGKDYVQQLT------------MITELLGSPDDSDLGFLRSDN 237
                      R    +   + + +              ++ E+     +   G     N
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275

Query: 238 ARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
             + ++       QP        +     + +    FD  KR +     + 
Sbjct: 276 FYKLIQN-GFKMDQP-----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (327), Expect = 3e-36
 Identities = 47/279 (16%), Positives = 99/279 (35%), Gaps = 38/279 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
              +G G YG V   V  +    VA+K +    ++ ++ +  L+E  ++  + H N+V++
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQL 78

Query: 100 KDIIPPMDKEKFNDVYIVYELMD---TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
             +       +    YI+ E M       +    ++Q ++     Y   Q+   ++Y+  
Sbjct: 79  LGVC-----TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
            N +HRDL   N L+  N  +K+ DFGL+R  T +T               P      + 
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193

Query: 216 T----------MITELL--GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
           +          ++ E+   G             +  +  + L    +             
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMS------PYPGIDLSQVYELLEKDYRMERP---EGCPEK 244

Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPT 302
             +L      ++P+ R +  E        +   + +E +
Sbjct: 245 VYELMRACWQWNPSDRPSFAEI-----HQAFETMFQESS 278

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 4e-36
 Identities = 56/273 (20%), Positives = 102/273 (37%), Gaps = 32/273 (11%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEE---VAIKKITNAFDNRIDAKRILREIKLLCHMTHENI 96
            + IG G +G V   +    +     VAIK   N   + +  ++ L+E   +    H +I
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHI 70

Query: 97  VKVKDIIPPMDKEKFNDVYIVYELM--DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYI 154
           VK+  +I        N V+I+ EL         +   K +L       + YQL   L Y+
Sbjct: 71  VKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 155 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVT-----------RWD 203
            S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +                   + 
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 204 TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
                 D       + E+L       +  ++     +    +  +         PN  P 
Sbjct: 185 RFTSASDVWMFGVCMWEIL-------MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237

Query: 264 AIDLAERMLVFDPAKRITVEEALNHPYLSSLHE 296
              L  +   +DP++R    E      LS++ E
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQ--LSTILE 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-35
 Identities = 55/311 (17%), Positives = 120/311 (38%), Gaps = 38/311 (12%)

Query: 24  NILGNLFQVSSKYVPPLQPIGRGAYGIVCSA---VNSETKEEVAIKKI--TNAFDNRIDA 78
           N+ G+  +V  +    L+ +G GAYG V         +T +  A+K +            
Sbjct: 13  NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72

Query: 79  KRILREIKLLCHMTHE-NIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQALT 136
           +    E ++L H+     +V +         +    ++++ + ++  +L   +  ++  T
Sbjct: 73  EHTRTERQVLEHIRQSPFLVTLHYAF-----QTETKLHLILDYINGGELFTHLSQRERFT 127

Query: 137 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTE 196
           +   Q ++ +++  L+++H   +++RD+K  N+LL++N  + + DFGL++          
Sbjct: 128 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK------EFVA 181

Query: 197 YVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFL--------------RSDNARRYV 242
               R        +Y+    +     G     D   L                D  +   
Sbjct: 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 241

Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI 297
            ++     +        MS +A DL +R+L+ DP KR+       +E   H +   ++  
Sbjct: 242 AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301

Query: 298 N-EEPTCPYPF 307
           +      P PF
Sbjct: 302 DLAAKKVPAPF 312

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-35
 Identities = 60/313 (19%), Positives = 119/313 (38%), Gaps = 43/313 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEE----VAIKKITNAFDNRIDAKRILREIKLLCHMTHEN 95
           ++ +G GA+G V   +     E+    VAIK++  A   + + K IL E  ++  + + +
Sbjct: 14  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 72

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           + ++  I         + V ++ +LM     L  +   K  +   +   +  Q+ +G+ Y
Sbjct: 73  VCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSETDFMTEYVVTRWDTLFPGKDY 211
           +    ++HRDL   N+L+     +KI DFGLA+     E ++  E        +      
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 212 VQQLT----------MITELL--GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
            +  T           + EL+  GS             A      L    + P     P 
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSK------PYDGIPASEISSILEKGERLPQP---PI 237

Query: 260 MSPVAIDLAERMLVFDPAKRITVEEALNH-------PYLSSLHEINEEPTCPYPFNFDFE 312
            +     +  +  + D   R    E +         P    + + +E    P P + +F 
Sbjct: 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFY 297

Query: 313 QTSMNEEDIKELI 325
           +  M+EED+ +++
Sbjct: 298 RALMDEEDMDDVV 310

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 3e-35
 Identities = 56/275 (20%), Positives = 99/275 (36%), Gaps = 37/275 (13%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
              +G+G +G V     + T   VAIK +       +  +  L+E +++  + HE +V++
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL 77

Query: 100 KDIIPPMDKEKFNDVYIVYELMD---TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
             ++          +YIV E M            + + L          Q+  G+ Y+  
Sbjct: 78  YAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFM-TEYVVTRWDTLFPGKDYVQQL 215
            N +HRDL+ +N+L+  N   K+ DFGLAR   + ++   +          P      + 
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191

Query: 216 T----------MITELL--GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV 263
           T          ++TEL   G               R  + Q+    + P     P     
Sbjct: 192 TIKSDVWSFGILLTELTTKGRV------PYPGMVNREVLDQVERGYRMPCP---PECPES 242

Query: 264 AIDLAERMLVFDPAKRITVEEALN--HPYLSSLHE 296
             DL  +    +P +R T E        Y +S   
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 3e-35
 Identities = 57/284 (20%), Positives = 100/284 (35%), Gaps = 49/284 (17%)

Query: 40  LQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-H 93
            + +G GA+G V  A     + S+    VA+K +     +  + + ++ E+K+L ++  H
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNH 86

Query: 94  ENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ------------------A 134
            NIV +                ++ E     DL   +R K+                  A
Sbjct: 87  MNIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 135 LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFM 194
           L  +    F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR        
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 195 TEYVVTRWDTLFPGKDYVQQLT------------MITELLGSPDDSDLGFLRSDNARRYV 242
                 R    +   + +                 + EL         G        + +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

Query: 243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEAL 286
           K+   +          +      D+ +     DP KR T ++ +
Sbjct: 262 KEGFRMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (320), Expect = 5e-35
 Identities = 49/260 (18%), Positives = 89/260 (34%), Gaps = 21/260 (8%)

Query: 43  IGRGAYGIVCSAVNSETKEE---VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IG G +G VCS       +    VAIK + + +  +   +  L E  ++    H N++ +
Sbjct: 34  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHL 92

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQA--LTDDHCQYFLYQLLRGLKYIHSA 157
           + ++      K   V I+ E M+         +     T       L  +  G+KY+   
Sbjct: 93  EGVV-----TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 147

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTM 217
           N +HRDL   N+L+N+N   K+ DFGL+R   +      Y       + P +    +   
Sbjct: 148 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI-PIRWTAPEAIQ 206

Query: 218 ITELLGSPDDSDLGFL---------RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA 268
             +   + D    G +         R          +  + +        +       L 
Sbjct: 207 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM 266

Query: 269 ERMLVFDPAKRITVEEALNH 288
                 D   R    + +N 
Sbjct: 267 LDCWQKDRNHRPKFGQIVNT 286

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 1e-34
 Identities = 48/268 (17%), Positives = 97/268 (36%), Gaps = 31/268 (11%)

Query: 40  LQPIGRGAYGIVCSAV---NSETKEEVAIKKI-TNAFDNRIDAKRILREIKLLCHMTHEN 95
           L+ +G G++G+V        S     VA+K +  +           +RE+  +  + H N
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 96  IVKVKDIIPPMDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQYFLYQLLRGLKY 153
           ++++  ++          + +V EL    + L ++ + +          +  Q+  G+ Y
Sbjct: 73  LIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 154 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD---FMTEYVVTRWDTLFPGKD 210
           + S   +HRDL   NLLL     +KI DFGL R   + D    M E+    +    P   
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 211 YVQQLT----------MITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM 260
             +  +           + E+     +  +G   S    +  K+   +P+        + 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP------EDC 240

Query: 261 SPVAIDLAERMLVFDPAKRITVEEALNH 288
                ++  +     P  R T     + 
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 2e-34
 Identities = 48/264 (18%), Positives = 98/264 (37%), Gaps = 33/264 (12%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           L+ +G G +G+V        + +VAIK I    +  +     + E K++ +++HE +V++
Sbjct: 9   LKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 100 KDIIPPMDKEKFNDVYIVYELM--DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA 157
             +       K   ++I+ E M     L+ +   +              +   ++Y+ S 
Sbjct: 65  YGVC-----TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMT-------------EYVVTRWDT 204
             LHRDL   N L+N    +K+ DFGL+R   + ++ +             E ++    +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 205 LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA 264
                D      ++ E+          F  S+ A    + L     +P        S   
Sbjct: 180 --SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--LYRP-----HLASEKV 230

Query: 265 IDLAERMLVFDPAKRITVEEALNH 288
             +          +R T +  L++
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSN 254

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 3e-34
 Identities = 57/310 (18%), Positives = 104/310 (33%), Gaps = 47/310 (15%)

Query: 43  IGRGAYGIVCSAVNSET--KEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKV 99
           IG G +G V  A   +   + + AIK++   + ++ D +    E+++LC +  H NI+ +
Sbjct: 18  IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINL 76

Query: 100 KDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR----------------SKQALTDDHCQY 142
                    E    +Y+  E     +L   +R                +   L+     +
Sbjct: 77  LGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 143 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRW 202
           F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R        T   +   
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 191

Query: 203 DTLFPGKDYVQQLT---------MITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF 253
                  +Y    T         ++ E++                    ++LP   +   
Sbjct: 192 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAELYEKLPQGYRLEK 247

Query: 254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQ 313
                N      DL  +     P +R +  + L       L+ + EE           + 
Sbjct: 248 P---LNCDDEVYDLMRQCWREKPYERPSFAQILVS-----LNRMLEERKTYVNTTLYEKF 299

Query: 314 TSMNEEDIKE 323
           T    +   E
Sbjct: 300 TYAGIDCSAE 309

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-33
 Identities = 60/293 (20%), Positives = 114/293 (38%), Gaps = 46/293 (15%)

Query: 40  LQPIGRGAYGIVCSAV-----NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE 94
            +P+GRGA+G V  A       + T   VA+K +     +  + + ++ E+K+L H+ H 
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHH 76

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSKQ----------------ALTD 137
             V           +    + ++ E     +L   +RSK+                 LT 
Sbjct: 77  LNVVNLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 138 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETD---FM 194
           +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR   +       
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 195 TEYVVTRW--------DTLFPGKDYVQQLTMIT-ELLGSPDDSDLGFLRSDNARRYVKQL 245
            +  +           D ++  +  V    ++  E+         G    +   R +K+ 
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 253

Query: 246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN 298
             +            +P            +P++R T  E + H  L +L + N
Sbjct: 254 TRMR------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQAN 298

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 5e-33
 Identities = 55/271 (20%), Positives = 101/271 (37%), Gaps = 30/271 (11%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           +Q IG G +G+V        K++VAIK I    +  +  +  + E +++  ++H  +V++
Sbjct: 10  VQEIGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTD-DHCQYFLYQLLRGLKYIHSA 157
             +       +   + +V+E M+   L   +R+++ L   +        +  G+ Y+  A
Sbjct: 66  YGVC-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTM 217
            V+HRDL   N L+  N  +K+ DFG+ R   +  +      +   T FP K    ++  
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-----SSTGTKFPVKWASPEVFS 175

Query: 218 ITELLGSPDDSDLGFL--------RSDNARRYVKQLPHVPKQPFSQKFP-NMSPVAIDLA 268
            +      D    G L        +     R   ++       F    P   S     + 
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 235

Query: 269 ERMLVFDPAKRITVEEALNHPYLSSLHEINE 299
                  P  R      L       L EI E
Sbjct: 236 NHCWKERPEDRPAFSRLLRQ-----LAEIAE 261

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  123 bits (309), Expect = 5e-33
 Identities = 58/348 (16%), Positives = 102/348 (29%), Gaps = 68/348 (19%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           ++ +G G +  V  A +      VA+K +     +++  +    EIKLL  +   +  K 
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 100 KDIIPP------------MDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQL 147
             +                       +       +          + +   + +    QL
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 148 LRGLKYI-HSANVLHRDLKPSNLLLNAN------CDLKICDFGLARTTSETDFMTE---- 196
           L GL Y+     ++H D+KP N+L+           +KI D G A    E    +     
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 197 -------------------------YVVTRWDTLFPGKDY------VQQLTMITELLGSP 225
                                    + +   D LF   +          +  I ELLG  
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 226 DDSDL-------GFLRSDNARRYVKQLPHVPKQPFSQK----FPNMSPVAIDLAERMLVF 274
               L        F  S    R + +L   P +    +      + +    D    ML  
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 275 DPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFDFEQTSMNEEDIK 322
           DP KR      +NHP+L     + E                   E+++
Sbjct: 315 DPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVR 362

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (299), Expect = 6e-32
 Identities = 53/286 (18%), Positives = 91/286 (31%), Gaps = 49/286 (17%)

Query: 40  LQPIGRGAYGIVCSA-----VNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE 94
           ++ IG GA+G V  A     +  E    VA+K +       +      RE  L+    + 
Sbjct: 18  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNP 76

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIRS---------------------- 131
           NIVK+  +           + +++E M   DL++ +RS                      
Sbjct: 77  NIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 132 --KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 189
                L+         Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R   
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 190 ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFL---------RSDNARR 240
             D+            +   + +      TE     D    G +         +      
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTES----DVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 241 YVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEAL 286
           + + + +V          N      +L        PA R +     
Sbjct: 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-31
 Identities = 49/271 (18%), Positives = 99/271 (36%), Gaps = 23/271 (8%)

Query: 43  IGRGAYGIVCSAVNSETKEE----VAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK 98
           IG G +G V   +   +  +    VAIK +   +  +      L E  ++   +H NI++
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIR 73

Query: 99  VKDIIPPMDKEKFNDVYIVYELM--DTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS 156
           ++ +I      K+  + I+ E M        +       +       L  +  G+KY+ +
Sbjct: 74  LEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128

Query: 157 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLF---PGKDYVQ 213
            N +HRDL   N+L+N+N   K+ DFGL+R   +    T         +    P     +
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188

Query: 214 QLTMITEL--LGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP-NMSPVAIDLAER 270
           + T  +++   G      + +           ++       F    P +       L  +
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQ 248

Query: 271 MLVFDPAKRITVEEALNHPYLSSLHEINEEP 301
               + A+R    + ++      L ++   P
Sbjct: 249 CWQQERARRPKFADIVSI-----LDKLIRAP 274

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (291), Expect = 7e-31
 Identities = 44/282 (15%), Positives = 81/282 (28%), Gaps = 31/282 (10%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG G++G +    +    EEVAIK        +    ++  E K+   M     +  
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMMQGGVGIPT 67

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQI-IRSKQALTDDHCQYFLYQLLRGLKYIHSAN 158
                     + +   +V EL+   L  +     +  +         Q++  ++YIHS N
Sbjct: 68  IRWC----GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 159 VLHRDLKPSNLL---LNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQL 215
            +HRD+KP N L         + I DFGLA+   +              L     Y    
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 216 TMITELLGSPDD----------------SDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN 259
           T +       DD                   G   +   ++Y +        P       
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243

Query: 260 MSPVAIDLAERMLVFDPAKRIT---VEEALNHPYLSSLHEIN 298
                              +     + +   + +       +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 2e-30
 Identities = 48/311 (15%), Positives = 89/311 (28%), Gaps = 70/311 (22%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
            + IG+G +G V         EEVA+K  ++  +     +    EI     + HENI+  
Sbjct: 8   QESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENILGF 62

Query: 100 KDIIPPMDKEKFNDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSA- 157
                  D   +  +++V +  +   L   +  +  +T +           GL ++H   
Sbjct: 63  IAADN-KDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 158 -------NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTR--------- 201
                   + HRDLK  N+L+  N    I D GLA          +              
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 202 ---------------------WDT-----------LFPGKDYVQQLTMITELLGSPDDSD 229
                                +                G     QL     +   P   +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 230 LGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHP 289
           +  +  +   R        P  P   +      V   +       + A R+T        
Sbjct: 241 MRKVVCEQKLR--------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT- 291

Query: 290 YLSSLHEINEE 300
               L +++++
Sbjct: 292 ----LSQLSQQ 298

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 4e-30
 Identities = 48/274 (17%), Positives = 99/274 (36%), Gaps = 35/274 (12%)

Query: 40  LQPIGRGAYGIVCSAVN-----SETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHE 94
            + +G+G++G+V   V       E +  VAIK +  A   R +    L E  ++      
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCH 83

Query: 95  NIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR----------SKQALTDDHCQYF 143
           ++V++  ++      +     ++ ELM   DL   +R               +       
Sbjct: 84  HVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 144 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWD 203
             ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +       
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 204 TLFPGKDYVQQLTMITELLGSPDDSDLGFL---------RSDNARRYVKQLPHVPKQPFS 254
             +   + ++     T      D    G +         +        + L  V +    
Sbjct: 199 VRWMSPESLKDGVFTTY----SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254

Query: 255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH 288
            K  N   +  +L      ++P  R +  E ++ 
Sbjct: 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-29
 Identities = 45/260 (17%), Positives = 86/260 (33%), Gaps = 21/260 (8%)

Query: 43  IGRGAYGIVCSAV---NSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV 99
           IGRG +G V       N   K   A+K +    D   +  + L E  ++   +H N++ +
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 93

Query: 100 KDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQ--YFLYQLLRGLKYIHSA 157
             I    +        +V   M     +     +           F  Q+ +G+K++ S 
Sbjct: 94  LGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 158 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWDTLFPGKDYVQQLTM 217
             +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      P K    +   
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG--AKLPVKWMALESLQ 207

Query: 218 ITELLGSPDDSDLGFL---------RSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLA 268
             +     D    G L                      ++ +     +         ++ 
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM 267

Query: 269 ERMLVFDPAKRITVEEALNH 288
            +        R +  E ++ 
Sbjct: 268 LKCWHPKAEMRPSFSELVSR 287

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 2e-29
 Identities = 51/279 (18%), Positives = 107/279 (38%), Gaps = 36/279 (12%)

Query: 40  LQPIGRGAYGIVCSAVNSETKEE-------VAIKKITNAFDNRIDAKRILREIKLLCHMT 92
            +P+G GA+G V  A      ++       VA+K + +    + D   ++ E++++  + 
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIG 76

Query: 93  -HENIVKVKDIIPPMDKEKFNDVYIVYELMD-TDLHQIIR----------------SKQA 134
            H+NI+ +          +   +Y++ E     +L + ++                 ++ 
Sbjct: 77  KHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 135 LTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFM 194
           L+        YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+ 
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 195 TEYVVTRWDTLFPGKDYVQQLTMITE----LLGSPDDSDLGFLRSDNARRYVKQLPHVPK 250
            +    R    +   + +       +      G           S      V++L  + K
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 251 QPFSQKFP-NMSPVAIDLAERMLVFDPAKRITVEEALNH 288
           +      P N +     +        P++R T ++ +  
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  112 bits (280), Expect = 2e-29
 Identities = 47/312 (15%), Positives = 96/312 (30%), Gaps = 44/312 (14%)

Query: 24  NILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR 83
           N++G  ++V        + IG G++G++    N    ++VAIK        R DA ++  
Sbjct: 1   NVVGVHYKV-------GRRIGEGSFGVIFEGTNLLNNQQVAIKFE----PRRSDAPQLRD 49

Query: 84  EIKLLCHMTH-ENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSK-QALTDDHCQ 141
           E +    +     I  V         ++     +V +L+   L  ++    +  +     
Sbjct: 50  EYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVA 104

Query: 142 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-----DLKICDFGLARTTSETDFMTE 196
               Q+L  ++ IH  ++++RD+KP N L+          + + DFG+ +   +      
Sbjct: 105 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164

Query: 197 YVVTRWDTLFPGKDYVQQLTMITELLGSPDD----------------SDLGFLRSDNARR 240
                   L     Y+   T +       DD                   G   + N ++
Sbjct: 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 241 YVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEE 300
           Y +        P  +                           +            ++ E 
Sbjct: 225 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG-----LFSKVLER 279

Query: 301 PTCPYPFNFDFE 312
                  NFD+ 
Sbjct: 280 LNTTEDENFDWN 291

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 89.1 bits (220), Expect = 8e-22
 Identities = 23/158 (14%), Positives = 49/158 (31%), Gaps = 17/158 (10%)

Query: 41  QPIGRGAYGIVCSAVNSETKEEVAIKKI--------TNAFDNRIDAKRILREIKLLCHMT 92
           + +G G    V +  + E   E  +K                                  
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 93  HENIVKVKDIIPPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLK 152
              + K++ +  P     +    ++ EL+D      +R       ++    L  +L  + 
Sbjct: 65  FRALQKLQGLAVPKVYA-WEGNAVLMELIDAKELYRVR------VENPDEVLDMILEEVA 117

Query: 153 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 190
             +   ++H DL   N+L++    + I DF  +    E
Sbjct: 118 KFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	339
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.48
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.33
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.99
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.65
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.41
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.85

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-55  Score=389.61  Aligned_cols=311  Identities=38%  Similarity=0.676  Sum_probs=241.3

Q ss_pred             EEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeee
Q 042681           21 VQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVK  100 (339)
Q Consensus        21 ~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~  100 (339)
                      .+..+....|.+.++|.+ ++.||+|+||+||+|.++.+|+.||+|++++........+.+.+|+.+|+.++||||++++
T Consensus         5 ~~~~~~~~~~~~~~~Y~~-i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~   83 (346)
T d1cm8a_           5 YRQEVTKTAWEVRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL   83 (346)
T ss_dssp             CCEECSSSEECCBSSEEE-EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCS
T ss_pred             EEEeccCceeecCCcEEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEE
Confidence            344555566789999998 9999999999999999999999999999987666666778899999999999999999999


Q ss_pred             eecCCCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEE
Q 042681          101 DIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI  179 (339)
Q Consensus       101 ~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL  179 (339)
                      +++..... .....+|+||||++++|..+... +++++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus        84 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl  162 (346)
T d1cm8a_          84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKI  162 (346)
T ss_dssp             EEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred             EEeccCccccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccc
Confidence            99954321 12345899999998888777654 68999999999999999999999999999999999999999999999


Q ss_pred             eecccccccC--------CCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccc----------------
Q 042681          180 CDFGLARTTS--------ETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLR----------------  234 (339)
Q Consensus       180 ~Dfg~~~~~~--------~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~----------------  234 (339)
                      +|||.|+...        +..|++|+.... .....+.|+|++|++++++++|.+|+.......                
T Consensus       163 ~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         163 LDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             CCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            9999997543        445788887654 456789999999999999999999975432110                


Q ss_pred             -----cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCC
Q 042681          235 -----SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNF  309 (339)
Q Consensus       235 -----~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~  309 (339)
                           .......................+.+++++++||.+||+.||++|||+.|+|+||||+++.+...++.+. .++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~-~~~~  321 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDD  321 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-CCCC
T ss_pred             HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC-CCCC
Confidence                 1111222333444455555556678899999999999999999999999999999999998766555443 4566


Q ss_pred             ChhhccCCHHHHHHHHHHHHHhcCC
Q 042681          310 DFEQTSMNEEDIKELILRECLNFHP  334 (339)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~  334 (339)
                      ++...+.+.++.++.+.+|+++|.|
T Consensus       322 ~~~~~~~~~~e~k~~~~~e~~~~~~  346 (346)
T d1cm8a_         322 SFDDVDRTLDEWKRVTYKEVLSFKP  346 (346)
T ss_dssp             C-----CCHHHHHHHHHHHHHTCCC
T ss_pred             chhhhhcCHHHHHHHHHHHhhcCCC
Confidence            6777777889999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-54  Score=382.55  Aligned_cols=307  Identities=45%  Similarity=0.732  Sum_probs=243.5

Q ss_pred             cccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           27 GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        27 ~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      |+.|.++++|.. ++.||+|+||+||+|.++.+|+.||||++.+.. .....+++++|+.+|++++||||+++++++...
T Consensus         1 ~~~~~i~~rY~~-~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~   78 (345)
T d1pmea_           1 GQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAP   78 (345)
T ss_dssp             CCCCCCCTTEEE-EEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             CCccCcCCCeEE-EEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence            567889999988 999999999999999999999999999997542 344567889999999999999999999999654


Q ss_pred             CcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          107 DKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      .......+++++++++|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        79 ~~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          79 TIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             STTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            4334456788888778999999976 579999999999999999999999999999999999999999999999999985


Q ss_pred             cc--------------CCCCcccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccc---------------
Q 042681          187 TT--------------SETDFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSD---------------  236 (339)
Q Consensus       187 ~~--------------~~~~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~---------------  236 (339)
                      ..              +...|.+|++.. ...+..+.|+|++|++++++++|..|+.........               
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            32              334678888764 345567789999999999999999997543211000               


Q ss_pred             ------hHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCCCCC
Q 042681          237 ------NARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPFNFD  310 (339)
Q Consensus       237 ------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~  310 (339)
                            ...............+....++.+|+++++||.+||+.||.+|||+.|+|+||||+........+....+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~~~~~  317 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD  317 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCC---
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCccCCC
Confidence                  11112222333333444445677899999999999999999999999999999999998887777777788888


Q ss_pred             hhhccCCHHHHHHHHHHHHHhcCCCC
Q 042681          311 FEQTSMNEEDIKELILRECLNFHPDH  336 (339)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (339)
                      .+..+...+++++++.+|..+|.|++
T Consensus       318 ~~~~~~~~~~l~~l~~~e~~~~~~~~  343 (345)
T d1pmea_         318 MELDDLPKEKLKELIFEETARFQPGY  343 (345)
T ss_dssp             -----CCHHHHHHHHHHHSGGGSTTT
T ss_pred             hhhhhCCHHHHHHHHHHHHHhcCCCC
Confidence            88888999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-54  Score=383.69  Aligned_cols=314  Identities=40%  Similarity=0.721  Sum_probs=251.4

Q ss_pred             ceEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeee
Q 042681           19 KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK   98 (339)
Q Consensus        19 ~~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~   98 (339)
                      ++.+....+..|.+++||.. ++.||+|+||+||+|++..+|+.||+|++++........+++.+|+.++++++||||++
T Consensus         3 ~~~~~~~~~~~~~~~~rY~i-~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~   81 (348)
T d2gfsa1           3 TFYRQELNKTIWEVPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG   81 (348)
T ss_dssp             CEEEEECSSSEEEEETTEEE-EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcEEEecCCccccCCCCeEE-EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeee
Confidence            45566677778999999998 99999999999999999999999999999877666667788999999999999999999


Q ss_pred             eeeecCCCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCe
Q 042681           99 VKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL  177 (339)
Q Consensus        99 ~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~i  177 (339)
                      +++++..... +.....++++++.+|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+||+++.++.+
T Consensus        82 ~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~  160 (348)
T d2gfsa1          82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL  160 (348)
T ss_dssp             CSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             EEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccc
Confidence            9999854432 22334566666666899998854 679999999999999999999999999999999999999999999


Q ss_pred             EEeecccccccCC--------CCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccc--------------
Q 042681          178 KICDFGLARTTSE--------TDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR--------------  234 (339)
Q Consensus       178 kL~Dfg~~~~~~~--------~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~--------------  234 (339)
                      +++|||.+.....        ..|.+|+..... ....+.|+|++|++++++++|..|+.......              
T Consensus       161 kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         161 KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  240 (348)
T ss_dssp             EECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             cccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9999999865433        246677764443 45778999999999999999999975332110              


Q ss_pred             -------cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCCCCCCCCCC
Q 042681          235 -------SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINEEPTCPYPF  307 (339)
Q Consensus       235 -------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~  307 (339)
                             ......................+..+++++++||.+||+.||++|||+.|+|+||||+....+..++ ...++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~-~~~~~  319 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP-VADPY  319 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC-CCCCC
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC-CCCCC
Confidence                   0111122222333333344444567899999999999999999999999999999999988776554 45588


Q ss_pred             CCChhhccCCHHHHHHHHHHHHHhcCCC
Q 042681          308 NFDFEQTSMNEEDIKELILRECLNFHPD  335 (339)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (339)
                      +.++...+...+++++.+.+|.++|+|.
T Consensus       320 ~~~~~~~~~~~~~~k~~~~~e~~~~~p~  347 (348)
T d2gfsa1         320 DQSFESRDLLIDEWKSLTYDEVISFVPP  347 (348)
T ss_dssp             CCGGGGCCCCHHHHHHHHHHHHHTCCCC
T ss_pred             CCcccchhcCHHHHHHHHHHHhhccCCC
Confidence            8899999999999999999999999984

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-55  Score=375.25  Aligned_cols=248  Identities=26%  Similarity=0.371  Sum_probs=203.8

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.+ ++.||+|+||+||+|+++.+|+.||+|++..... ....+.+.+|+.++++++||||+++++++     .+.+
T Consensus         4 ~~dy~~-~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~   76 (271)
T d1nvra_           4 VEDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHR-----REGN   76 (271)
T ss_dssp             TTEEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEE-----EETT
T ss_pred             CcceEE-EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCc
Confidence            356666 8999999999999999999999999999975432 22345688999999999999999999999     6778


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .+++||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++++||+|||+|+..   
T Consensus        77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            8999999998 699999988889999999999999999999999999999999999999999999999999998632   


Q ss_pred             ----------CCCCcccccccccccc-CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          189 ----------SETDFMTEYVVTRWDT-LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       189 ----------~~~~~~~~~~~~~~~~-~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                |++.|++||+.....+ ..+.|+|++|+++|++++|..|+........ ..... .....     ....+
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~-~~~~~-----~~~~~  229 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-KEKKT-----YLNPW  229 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHH-HTTCT-----TSTTG
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHHH-hcCCC-----CCCcc
Confidence                      4557899998766554 5678999999999999999999864322111 11111 11111     11122


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      +.+|+++++||.+||+.||++|||++|+++||||+..
T Consensus       230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            4689999999999999999999999999999999753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=369.56  Aligned_cols=244  Identities=23%  Similarity=0.401  Sum_probs=207.5

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.+ ++.||+|+||+||+|+++.+|+.||+|++.+.. ......+.+.+|+.+++.++||||+++++++     .+.+
T Consensus         6 ~dy~i-~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~   79 (263)
T d2j4za1           6 EDFEI-GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT   79 (263)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hHeEE-EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECC
Confidence            45776 999999999999999999999999999987542 2233456788999999999999999999999     6678


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .+++||||++ |+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+|...   
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            8999999998 799999998899999999999999999999999999999999999999999999999999999654   


Q ss_pred             ------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          189 ------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       189 ------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                            ++..|++||+.....+..++|+|++|+++|++++|..|+.....  ..........  ...   .   ...+|+
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~--~~~---~---p~~~s~  229 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYKRISRV--EFT---F---PDFVTE  229 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTT--CCC---C---CTTSCH
T ss_pred             cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HHHHHHHHcC--CCC---C---CccCCH
Confidence                  33468999998888888999999999999999999999754321  1111111111  111   1   135899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                      ++++||.+||+.||++|||++|+++||||++
T Consensus       230 ~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         230 GARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            9999999999999999999999999999963

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-54  Score=371.26  Aligned_cols=246  Identities=25%  Similarity=0.358  Sum_probs=206.7

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.. ++.||+|+||+||+|+++.+|+.||+|++......  ..+.+.+|+.+++.++||||+++++++     ...+
T Consensus        19 ~~~Y~~-~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~   90 (293)
T d1yhwa1          19 KKKYTR-FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSY-----LVGD   90 (293)
T ss_dssp             TTTBCS-CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred             ccccEE-EEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECC
Confidence            357888 99999999999999999999999999998754322  346789999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .+++||||++ |+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..   
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            8999999998 688887765 67999999999999999999999999999999999999999999999999998653   


Q ss_pred             --------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          189 --------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       189 --------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                              ++..|++||+.....+..++|+|++|+++|++++|..||......  ...........  +..   ...+.+
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~--~~~---~~~~~~  242 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGT--PEL---QNPEKL  242 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHHCS--CCC---SSGGGS
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHHHHHhCCC--CCC---CCcccC
Confidence                    344688999888888889999999999999999999997643211  11112221111  111   112458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          261 SPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      |+++++||.+||+.||++|||+.|+++||||+..
T Consensus       243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999999999753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-54  Score=367.06  Aligned_cols=252  Identities=21%  Similarity=0.301  Sum_probs=208.0

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ..++|....+.||+|+||+||+|++..+++.||+|++..........+.+.+|++++++++||||+++++++.+.. ...
T Consensus         6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~   84 (270)
T d1t4ha_           6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK   84 (270)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred             CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccC
Confidence            4556655467899999999999999999999999999876666666788999999999999999999999984321 234


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeeec-cCCCeEEeecccccc
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLART  187 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dikp~NIli~-~~~~ikL~Dfg~~~~  187 (339)
                      ..+++||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+.
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            56899999998 699999998899999999999999999999999998  99999999999997 578999999999963


Q ss_pred             ---------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          188 ---------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       188 ---------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                               .|++.|++||+... .+..+.|+|++|+++|++++|..|+.....     .............+.  ....
T Consensus       165 ~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~~~~~i~~~~~~~--~~~~  236 (270)
T d1t4ha_         165 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVKPA--SFDK  236 (270)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTCCCG--GGGG
T ss_pred             ccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHHHHHHHHcCCCCc--ccCc
Confidence                     34567999998765 578899999999999999999999754321     111111111111111  1123


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNHPYLS  292 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  292 (339)
                      .+++++++||.+||+.||++|||++|+++||||+
T Consensus       237 ~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            5789999999999999999999999999999996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=373.65  Aligned_cols=250  Identities=23%  Similarity=0.353  Sum_probs=212.4

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      +++|.+ ++.||+|+||+||+|+++.+|+.||+|++.+.. ......+.+.+|+.++++++||||+++++++     .+.
T Consensus         7 p~dy~i-~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~   80 (288)
T d1uu3a_           7 PEDFKF-GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDD   80 (288)
T ss_dssp             GGGEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECS
T ss_pred             CCCCEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EEC
Confidence            467777 999999999999999999999999999997542 2233457789999999999999999999999     667


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      +.+|+||||++ |+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+|+..  
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            88999999998 699999999899999999999999999999999999999999999999999999999999998643  


Q ss_pred             -----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          189 -----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       189 -----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                                 |+..|++||+.....+..++|+|++|+++|++++|..|+.....  ......+...  ...   +   .
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~~~--~~~---~---p  230 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQKIIKL--EYD---F---P  230 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHTT--CCC---C---C
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHHHHHcC--CCC---C---C
Confidence                       45578999998888888899999999999999999999764321  1111122111  111   1   1


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCccCC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEE------ALNHPYLSSLHEIN  298 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~e------ll~hp~f~~~~~~~  298 (339)
                      ..+|+++++||++||+.||++|||++|      +++||||+++.|..
T Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~  277 (288)
T d1uu3a_         231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  277 (288)
T ss_dssp             TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence            358999999999999999999999988      58899999998654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.4e-54  Score=374.16  Aligned_cols=251  Identities=27%  Similarity=0.381  Sum_probs=202.3

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      .+.++|.. ++.||+|+||+||+|+++.+|+.||+|++.+..... ..+.+.+|+.+++.++||||+++++++     .+
T Consensus         6 di~d~Y~~-~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~   78 (307)
T d1a06a_           6 DIRDIYDF-RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIY-----ES   78 (307)
T ss_dssp             CGGGTEEE-EEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             CCccceEE-EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence            46677887 999999999999999999999999999997653332 245678999999999999999999999     67


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec---cCCCeEEeeccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDFGLAR  186 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~---~~~~ikL~Dfg~~~  186 (339)
                      .+.+++||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||++.   .++.+||+|||+|+
T Consensus        79 ~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          79 GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             CCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            788999999998 79999999989999999999999999999999999999999999999995   47899999999985


Q ss_pred             c----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          187 T----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       187 ~----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      .          .|+..|++||+.....+..++|+|++|+++|++++|..|+......  ........    .........
T Consensus       159 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~----~~~~~~~~~  232 (307)
T d1a06a_         159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQILK----AEYEFDSPY  232 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHT----TCCCCCTTT
T ss_pred             EccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHhc----cCCCCCCcc
Confidence            3          2456799999988888899999999999999999999997643211  11112221    111122223


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      .+.+|+++++||.+||+.||++|||++|+++||||++.
T Consensus       233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            35789999999999999999999999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-54  Score=369.32  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=205.3

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ...+.|.+ ++.||+|+||.||+|+++.+|+.||+|++...  .....+.+.+|+.++++++||||+++++++     .+
T Consensus         9 ~p~d~Y~i-~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~   80 (288)
T d2jfla1           9 NPEDFWEI-IGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAF-----YY   80 (288)
T ss_dssp             CGGGTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred             CcccCeEE-eEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ee
Confidence            33445666 89999999999999999999999999999754  233456788999999999999999999999     67


Q ss_pred             cCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc-
Q 042681          111 FNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-  187 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~-  187 (339)
                      .+.+++||||++ |+|.+++.+ .+++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+|+. 
T Consensus        81 ~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          81 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence            788999999998 699988765 56799999999999999999999999999999999999999999999999999853 


Q ss_pred             ----------cCCCCcccccccc-----ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          188 ----------TSETDFMTEYVVT-----RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       188 ----------~~~~~~~~~~~~~-----~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                                .+++.|++||+..     ...+..++|+|++|+++|++++|..|+......  ...........  +.  
T Consensus       161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~~~~~i~~~~~--~~--  234 (288)
T d2jfla1         161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLLKIAKSEP--PT--  234 (288)
T ss_dssp             HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHHHHSCC--CC--
T ss_pred             CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--HHHHHHHcCCC--CC--
Confidence                      3556799999763     334567899999999999999999998654321  22222222111  11  


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                       ....+.+|+++++||.+||+.||++|||+.|+++||||+.
T Consensus       235 -~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         235 -LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             -CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             -CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence             1112458999999999999999999999999999999974

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=369.44  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=210.9

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC----hHhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN----RIDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      .+.++|.. ++.||+|+||+||+|+++.+|+.||+|++.+....    ....+.+.+|+.++++++||||+++++++   
T Consensus         7 ~i~d~Y~~-~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~---   82 (293)
T d1jksa_           7 NVDDYYDT-GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY---   82 (293)
T ss_dssp             CGGGTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             CcccCEEE-eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE---
Confidence            35677888 99999999999999999999999999999754322    22357899999999999999999999999   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC----CeEEee
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC----DLKICD  181 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~----~ikL~D  181 (339)
                        .+...+++||||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++.++    .+||+|
T Consensus        83 --~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~D  160 (293)
T d1jksa_          83 --ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID  160 (293)
T ss_dssp             --ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred             --EECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecc
Confidence              67788999999998 79999999889999999999999999999999999999999999999998776    599999


Q ss_pred             ccccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          182 FGLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       182 fg~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      ||++...          +++.|++||......+..+.|+|++|+++|++++|..|+......  .......    .....
T Consensus       161 fG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~----~~~~~  234 (293)
T d1jksa_         161 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVS----AVNYE  234 (293)
T ss_dssp             CTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH----TTCCC
T ss_pred             hhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHHHHHH----hcCCC
Confidence            9998653          334588999888778889999999999999999999997643211  1111111    11111


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      ......+.+|+++++||++||+.||++|||++|+++||||+...+..
T Consensus       235 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence            11223356899999999999999999999999999999999876543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-54  Score=376.14  Aligned_cols=256  Identities=18%  Similarity=0.310  Sum_probs=210.3

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      +++|.+ ++.||+|+||+||+|+++.+|+.||+|+++... .....+++.+|+.++++++||||+++++++     .+..
T Consensus         5 ~d~y~~-~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~   77 (322)
T d1s9ja_           5 DDDFEK-ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDG   77 (322)
T ss_dssp             GGGEEE-EEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSS
T ss_pred             ccCCEE-EEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence            566777 899999999999999999999999999997653 333457889999999999999999999999     6677


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCCeEEeecccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLART---  187 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~ikL~Dfg~~~~---  187 (339)
                      .+++||||++ |+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++++||+|||+|+.   
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            8999999998 6999999988899999999999999999999997 5999999999999999999999999999853   


Q ss_pred             ------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchH-----------------------
Q 042681          188 ------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNA-----------------------  238 (339)
Q Consensus       188 ------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~-----------------------  238 (339)
                            .++..|++||+.....+..+.|+|++|++++++++|..|+...........                       
T Consensus       158 ~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence                  456789999999888899999999999999999999999854221100000                       


Q ss_pred             -------------HHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          239 -------------RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       239 -------------~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                                   ............+...  ...+|.++++||.+||+.||++|||++|+|+||||+...+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~  307 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  307 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence                         0000000000000000  12368999999999999999999999999999999876553

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=362.20  Aligned_cols=246  Identities=25%  Similarity=0.326  Sum_probs=200.4

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      .++|.+ ++.||+|+||+||+|+++.+|+.||+|++..........+.+.+|+.++++++||||+++++++.+   ...+
T Consensus         3 ~edy~~-~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~   78 (269)
T d2java1           3 AEDYEV-LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNT   78 (269)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------
T ss_pred             chhCEE-eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCC
Confidence            456766 899999999999999999999999999998776666677889999999999999999999998843   3456


Q ss_pred             eEEEEEecCc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCCeeeccCCCeEEeec
Q 042681          113 DVYIVYELMD-TDLHQIIRS----KQALTDDHCQYFLYQLLRGLKYIHSAN-----VLHRDLKPSNLLLNANCDLKICDF  182 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g-----ivH~dikp~NIli~~~~~ikL~Df  182 (339)
                      .+++||||++ |+|.+++.+    .+.+++..++.++.||+.||+|||++|     |+||||||+||+++.++.+||+||
T Consensus        79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            6899999998 799998854    467999999999999999999999876     999999999999999999999999


Q ss_pred             cccccc-----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          183 GLARTT-----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       183 g~~~~~-----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      |+|+..           +++.|++||+.....+..++|+|++|+++|++++|..|+......  ......... . ..  
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~i~~~-~-~~--  232 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREG-K-FR--  232 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHT-C-CC--
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHHHHHcC-C-CC--
Confidence            998643           345689999988778888999999999999999999997643211  111121111 1 11  


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                         .....+|+++++||.+||+.||++|||++|+++|||+
T Consensus       233 ---~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         233 ---RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence               1124589999999999999999999999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4e-53  Score=374.79  Aligned_cols=253  Identities=23%  Similarity=0.385  Sum_probs=211.8

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      +-++|.+ ++.||+|+||.||+|+++.+|+.||+|++...  .....+.+.+|+.++++++||||+++++++     .+.
T Consensus        24 il~~Y~i-~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~   95 (350)
T d1koaa2          24 VLDHYDI-HEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDD   95 (350)
T ss_dssp             GGGTEEE-EEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EET
T ss_pred             CccCeEE-EEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EEC
Confidence            4467887 99999999999999999999999999999754  334567789999999999999999999999     677


Q ss_pred             CeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc--CCCeEEeecccccc
Q 042681          112 NDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLART  187 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~--~~~ikL~Dfg~~~~  187 (339)
                      +.+++||||++ |+|.+++.. .+++++..++.++.||+.||+|||++||+||||||+||+++.  ++.+||+|||+|+.
T Consensus        96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2          96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            88999999998 799999854 467999999999999999999999999999999999999964  67899999999865


Q ss_pred             c----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          188 T----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       188 ~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                      .          ++..|++||+.....+..+.|+|++|+++|++++|..|+.....  ......+.......    .....
T Consensus       176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~~----~~~~~  249 (350)
T d1koaa2         176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKSCDWNM----DDSAF  249 (350)
T ss_dssp             CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCS----CCGGG
T ss_pred             cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCC----Ccccc
Confidence            3          44578999988877788899999999999999999999754321  11122222221111    12223


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                      +.+|+++++||.+||+.||++|||++|+++||||+......
T Consensus       250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  290 (350)
T d1koaa2         250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  290 (350)
T ss_dssp             GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence            56899999999999999999999999999999999876654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.9e-53  Score=373.99  Aligned_cols=251  Identities=25%  Similarity=0.393  Sum_probs=210.1

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      +.++|.+ ++.||+|+||.||+|+++.+|+.||+|++++.  .....+.+.+|+.++++++||||+++++++     .+.
T Consensus        27 ~~d~Y~i-~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~   98 (352)
T d1koba_          27 VYDYYDI-LEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDK   98 (352)
T ss_dssp             GGGTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECS
T ss_pred             cccceEE-EEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EEC
Confidence            4566777 99999999999999999999999999998754  233456788999999999999999999999     677


Q ss_pred             CeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec--cCCCeEEeecccccc
Q 042681          112 NDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN--ANCDLKICDFGLART  187 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~--~~~~ikL~Dfg~~~~  187 (339)
                      ..+++|||||+ |+|.+.+.+. .++++..++.++.||+.||+|||++||+||||||+|||++  .++.+||+|||+|..
T Consensus        99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_          99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccccee
Confidence            88999999998 7999887664 4799999999999999999999999999999999999998  578999999999975


Q ss_pred             c----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccC
Q 042681          188 T----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKF  257 (339)
Q Consensus       188 ~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (339)
                      .          ++..|++||+.....+..+.|+|++|+++|++++|..|+......  ..........    .......+
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~----~~~~~~~~  252 (352)
T d1koba_         179 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCD----WEFDEDAF  252 (352)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHCC----CCCCSSTT
T ss_pred             cCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC----CCCCcccc
Confidence            4          344588899888888889999999999999999999997643211  1112222211    11122334


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          258 PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       258 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                      +.+|+++++||.+||+.||.+|||+.|+++||||+....
T Consensus       253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~  291 (352)
T d1koba_         253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  291 (352)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence            578999999999999999999999999999999987543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=369.96  Aligned_cols=247  Identities=19%  Similarity=0.309  Sum_probs=211.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.+ ++.||+|+||+||+|+++.+|+.||+|++++... .....+++.+|+.+++.++||||+++++++     .+..
T Consensus         5 ~dy~~-~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   78 (337)
T d1o6la_           5 NDFDY-LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             HhcEE-EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence            34666 9999999999999999999999999999976522 233467889999999999999999999999     6778


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .+|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..   
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            8999999998 799999999999999999999999999999999999999999999999999999999999999643   


Q ss_pred             --------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCC
Q 042681          189 --------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNM  260 (339)
Q Consensus       189 --------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (339)
                              |++.|++||+.....+..+.|+|++|+++|++++|.+|+.....  ..............        ...+
T Consensus       159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~~~i~~~~~~~--------p~~~  228 (337)
T d1o6la_         159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILMEEIRF--------PRTL  228 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCC--------CTTS
T ss_pred             CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--HHHHHHHhcCCCCC--------CccC
Confidence                    34568999999888899999999999999999999998765321  11112222211111        1458


Q ss_pred             CHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCcc
Q 042681          261 SPVAIDLAERMLVFDPAKRIT-----VEEALNHPYLSSLHE  296 (339)
Q Consensus       261 s~~~~~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~  296 (339)
                      |+++++||++||++||++||+     +.|+++||||+.+.+
T Consensus       229 s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             CHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence            999999999999999999994     999999999998864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-52  Score=369.27  Aligned_cols=310  Identities=35%  Similarity=0.569  Sum_probs=238.0

Q ss_pred             ceEEEEEccccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeee
Q 042681           19 KYVQYNILGNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVK   98 (339)
Q Consensus        19 ~~~~~~~~~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~   98 (339)
                      ++.+..+.+..|.+.++|.+ ++.||+|+||+||+|+++.+|+.||||++.+.........++.+|+.++++++||||++
T Consensus         2 ~~~~~~~~~~~f~i~~~Y~i-~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~   80 (355)
T d2b1pa1           2 QFYSVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS   80 (355)
T ss_dssp             CEEEEEETTEEEEEETTEEE-EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCEEEEeCCcceeecCCeEE-EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeE
Confidence            34566666778888999999 99999999999999999999999999999877666767788999999999999999999


Q ss_pred             eeeecCCCCc-CCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCe
Q 042681           99 VKDIIPPMDK-EKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL  177 (339)
Q Consensus        99 ~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~i  177 (339)
                      ++++|..... +....+|+||||+.+++.+.+.  +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+
T Consensus        81 ~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~  158 (355)
T d2b1pa1          81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL  158 (355)
T ss_dssp             CSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred             EEEEEecccccccCceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccce
Confidence            9999954322 2457899999999988887764  579999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCccccccc------------
Q 042681          178 KICDFGLARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRS------------  235 (339)
Q Consensus       178 kL~Dfg~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~------------  235 (339)
                      +++|||.++..          ++..|.+||.........+.|+|++|++++++++|..|+........            
T Consensus       159 kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~  238 (355)
T d2b1pa1         159 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_dssp             EECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence            99999987543          34568889988777888899999999999999999998753321100            


Q ss_pred             --------chHHHHHhhCCCCCCCCcccc------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          236 --------DNARRYVKQLPHVPKQPFSQK------------FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       236 --------~~~~~~~~~~~~~~~~~~~~~------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                              .....................            ....|+++++||++||+.||++||||+|+|+||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                    011111111111111111000            012467789999999999999999999999999999876


Q ss_pred             cC-CCCCCCCCCCCCChhhccCCHHHHHHHHHHHHHh
Q 042681          296 EI-NEEPTCPYPFNFDFEQTSMNEEDIKELILRECLN  331 (339)
Q Consensus       296 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (339)
                      ++ ......+..++.++...+.+-+++++++.+|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (355)
T d2b1pa1         319 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN  355 (355)
T ss_dssp             CHHHHTCCCC-------CCCCCCHHHHHHHHHHHHHC
T ss_pred             CcccccCCCCCCCCcchhhhhcCHHHHHHHHHHHhcC
Confidence            53 2334555667777777888889999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-52  Score=366.12  Aligned_cols=245  Identities=22%  Similarity=0.279  Sum_probs=203.3

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.. ++.||+|+||+||+|++..+|+.||+|++..... .....+.+.+|+.++++++||||+++++++     .+.+.
T Consensus        16 ~y~~-l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~   89 (309)
T d1u5ra_          16 LFSD-LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHT   89 (309)
T ss_dssp             HEEE-EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTE
T ss_pred             hcEe-eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-----EECCE
Confidence            4555 8999999999999999999999999999976543 334457789999999999999999999999     66788


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +++|||||. |+|..++..++++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...    
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN  169 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred             EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCC
Confidence            999999998 566666677789999999999999999999999999999999999999999999999999998653    


Q ss_pred             ---CCCCccccccccc---cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          189 ---SETDFMTEYVVTR---WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       189 ---~~~~~~~~~~~~~---~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                         |++.|++||+...   ..+..+.|+|++|+++|++++|..|+......  ......... ..   ...  ....+|+
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~~~~i~~~-~~---~~~--~~~~~s~  241 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQN-ES---PAL--QSGHWSE  241 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHS-CC---CCC--SCTTSCH
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhC-CC---CCC--CCCCCCH
Confidence               4557899998743   34677899999999999999999997643211  111111111 11   111  1145899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          263 VAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                      ++++||.+||+.||++|||++|+++||||..
T Consensus       242 ~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            9999999999999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=365.21  Aligned_cols=256  Identities=31%  Similarity=0.480  Sum_probs=203.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.+ ++.||+|+||+||+|++..+|+.||+|+++.........+++.+|+.++++++||||+++++++     .....
T Consensus         2 d~Y~~-~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~   75 (298)
T d1gz8a_           2 ENFQK-VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENK   75 (298)
T ss_dssp             TTEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTE
T ss_pred             CCCEe-ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccc
Confidence            46777 8999999999999999999999999999976544444457889999999999999999999999     67788


Q ss_pred             EEEEEecCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          114 VYIVYELMDTDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      +|+||||+++++.+++..  .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.|+..   
T Consensus        76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            999999999887777643  467999999999999999999999999999999999999999999999999998543   


Q ss_pred             --------CCCCccccccccccc-cCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhC--------------
Q 042681          189 --------SETDFMTEYVVTRWD-TLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQL--------------  245 (339)
Q Consensus       189 --------~~~~~~~~~~~~~~~-~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~--------------  245 (339)
                              ++..|.+|+...... ...+.|+|++|+++|++++|..|+......  ..........              
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhccccccc
Confidence                    344677787655444 467899999999999999999997543211  1111111100              


Q ss_pred             -------CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccC
Q 042681          246 -------PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEI  297 (339)
Q Consensus       246 -------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  297 (339)
                             ............+.+|+++++||++||+.||++|||+.|+++||||+++..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence                   0111111112335688999999999999999999999999999999988654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.1e-52  Score=358.89  Aligned_cols=250  Identities=27%  Similarity=0.407  Sum_probs=206.0

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC-------hHhHHHHHHHHHHHhhCC-CCCeeeeeeecC
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-------RIDAKRILREIKLLCHMT-HENIVKVKDIIP  104 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~  104 (339)
                      .++|.. ++.||+|+||+||+|++..+|+.||+|++.+....       ....+++.+|+.++++++ ||||+++++++ 
T Consensus         2 ~~~y~~-~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-   79 (277)
T d1phka_           2 YENYEP-KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-   79 (277)
T ss_dssp             TTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             cccCEE-ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec-
Confidence            467767 99999999999999999999999999999765322       122356889999999997 99999999999 


Q ss_pred             CCCcCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          105 PMDKEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                          .+.+.+|+||||++ |+|.+++..++++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus        80 ----~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          80 ----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             ----ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ----ccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccch
Confidence                67788999999997 6999999998999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC----------CCccccccccc------cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC
Q 042681          184 LARTTSE----------TDFMTEYVVTR------WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH  247 (339)
Q Consensus       184 ~~~~~~~----------~~~~~~~~~~~------~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~  247 (339)
                      +++..+.          ..|.+|+....      ..++.++|+|++|++++++++|..|+....  ..............
T Consensus       156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--~~~~~~~i~~~~~~  233 (277)
T d1phka_         156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMIMSGNYQ  233 (277)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCC
T ss_pred             heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--HHHHHHHHHhCCCC
Confidence            9976432          34566665532      234667899999999999999999986532  11122222222222


Q ss_pred             CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          248 VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       248 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      .+    ....+.+|+++++||.+||+.||++|||++|+++||||+..
T Consensus       234 ~~----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         234 FG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             CC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            11    12234689999999999999999999999999999999853

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4e-52  Score=363.79  Aligned_cols=247  Identities=20%  Similarity=0.330  Sum_probs=211.1

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      +|.+ ++.||+|+||+||+|+++.+|+.||+|++++.. ......+.+.+|+.+++.++||||+++++++     ...+.
T Consensus         5 dy~i-~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   78 (316)
T d1fota_           5 DFQI-LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   78 (316)
T ss_dssp             GEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             HeEE-EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence            4666 999999999999999999999999999997542 2233457889999999999999999999999     67788


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      +++||||++ |+|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+|+..    
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~  158 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  158 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence            999999998 689999999999999999999999999999999999999999999999999999999999999653    


Q ss_pred             ----CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHH
Q 042681          189 ----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVA  264 (339)
Q Consensus       189 ----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  264 (339)
                          |++.|++||+.....+..+.|+|++|+++|++++|..|+.....  ............  .      ..+.+|+++
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~~~~--~------~p~~~s~~~  228 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYEKILNAEL--R------FPPFFNEDV  228 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHCCC--C------CCTTSCHHH
T ss_pred             ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--HHHHHHHHcCCC--C------CCCCCCHHH
Confidence                45679999998888888999999999999999999999764321  111122222111  1      114589999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          265 IDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       265 ~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      +++|.+||+.||.+|+     |++++++||||+++.+.
T Consensus       229 ~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         229 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             HHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence            9999999999999996     89999999999998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.6e-52  Score=367.19  Aligned_cols=248  Identities=19%  Similarity=0.298  Sum_probs=211.8

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFN  112 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~  112 (339)
                      ++|.+ ++.||+|+||.||+|+++.+|+.||+|++.+.. ......+.+.+|+.+++.++||||+++++++     ....
T Consensus        41 d~y~i-~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~  114 (350)
T d1rdqe_          41 DQFDR-IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS  114 (350)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             cCeEE-EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence            57777 999999999999999999999999999997542 2233457789999999999999999999999     6778


Q ss_pred             eEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          113 DVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       113 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .+++||||+. |+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..   
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            8999999998 799999998899999999999999999999999999999999999999999999999999999754   


Q ss_pred             -----CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHH
Q 042681          189 -----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPV  263 (339)
Q Consensus       189 -----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  263 (339)
                           +++.|++||+.....+..+.|+|++|+++|++++|..|+....  .......+......        ....+|++
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~~~--------~p~~~s~~  264 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGKVR--------FPSHFSSD  264 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCC--------CCTTCCHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHHHHHhcCCCC--------CCccCCHH
Confidence                 3456899999888888899999999999999999999976432  11111222221111        11458999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          264 AIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       264 ~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                      +++||++||+.||.+|+     |++++++||||+++.+.
T Consensus       265 ~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             HHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence            99999999999999995     89999999999998753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=363.41  Aligned_cols=252  Identities=31%  Similarity=0.449  Sum_probs=197.4

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChH---hHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRI---DAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      ++.||+|+||+||+|+++.+|+.||+|+++.......   ..+.+.+|+.++++++||||+++++++     ...+.+++
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~i   77 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNISL   77 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCEE
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCceee
Confidence            5789999999999999999999999999975432221   135688999999999999999999999     66778999


Q ss_pred             EEecCcccHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-------
Q 042681          117 VYELMDTDLHQII-RSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-------  188 (339)
Q Consensus       117 v~e~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-------  188 (339)
                      ||||++|++...+ .....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.++..       
T Consensus        78 vmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          78 VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             EEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence            9999996554444 44678999999999999999999999999999999999999999999999999998643       


Q ss_pred             ----CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCC-----------------
Q 042681          189 ----SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLP-----------------  246 (339)
Q Consensus       189 ----~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~-----------------  246 (339)
                          ++..|++||+... ..+..+.|+|++|++++++++|.+++......  .....+.....                 
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--HHHHHHHHhcCCCChhhccchhccchhh
Confidence                3446888887653 34677899999999999999999887543211  11111111111                 


Q ss_pred             ---CCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          247 ---HVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       247 ---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                         ..+..+....++.+++++++||.+||+.||++||||.|+|+||||++...+.
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~  290 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  290 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence               1111111223456789999999999999999999999999999999776543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-52  Score=364.49  Aligned_cols=249  Identities=22%  Similarity=0.364  Sum_probs=207.0

Q ss_pred             cccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           31 QVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        31 ~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ++-++|.+ ++.||+|+||+||+|.++.+|+.||+|+++..   ......+.+|+.+|+.++||||+++++++     .+
T Consensus         2 ~~~~rY~i-~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~   72 (321)
T d1tkia_           2 ELYEKYMI-AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESF-----ES   72 (321)
T ss_dssp             CCTTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EE
T ss_pred             CCccceEE-EEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EE
Confidence            45678888 99999999999999999999999999999764   23345688999999999999999999999     67


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC--CCeEEeeccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQ-ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGLAR  186 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~--~~ikL~Dfg~~~  186 (339)
                      .+.+|+|||||+ |+|.+++...+ ++++..++.++.||+.||+|||++||+||||||+||+++.+  +.++|+|||++.
T Consensus        73 ~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhh
Confidence            788999999998 69999998765 79999999999999999999999999999999999999854  479999999986


Q ss_pred             ccC----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcccc
Q 042681          187 TTS----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQK  256 (339)
Q Consensus       187 ~~~----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (339)
                      ...          .+.|++|+......+..+.|+|++|+++|++++|..|+.....  ......+.....    ......
T Consensus       153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--~~~~~~i~~~~~----~~~~~~  226 (321)
T d1tkia_         153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAEY----TFDEEA  226 (321)
T ss_dssp             ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTCC----CCCHHH
T ss_pred             ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC----CCChhh
Confidence            543          3457777777777788889999999999999999999754321  111122222111    111223


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          257 FPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       257 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      ++.+|+++++||.+||+.||++|||++|+++||||+.-
T Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            35689999999999999999999999999999999753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-51  Score=366.94  Aligned_cols=250  Identities=20%  Similarity=0.265  Sum_probs=204.7

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccC-hHhHH---HHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN-RIDAK---RILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~---~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ++|.+ ++.||+|+||.||+|+++.+|+.||+|++.+.... .....   ...+++.+++.++||||+++++++     .
T Consensus         4 ddy~i-~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~   77 (364)
T d1omwa3           4 NDFSV-HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H   77 (364)
T ss_dssp             TTEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred             HhCee-eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence            35666 89999999999999999999999999998654221 11122   233457778888999999999999     6


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      ..+.+|+||||++ |+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            6788999999998 799999999899999999999999999999999999999999999999999999999999998643


Q ss_pred             ---------CCCCcccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          189 ---------SETDFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       189 ---------~~~~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                               |++.|++||+.. ...+..++|+|++|+++|++++|..||.......   .............    ....
T Consensus       158 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~~~~~~~----~~~~  230 (364)
T d1omwa3         158 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMAV----ELPD  230 (364)
T ss_dssp             SSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHHHHHHSSSCCC----CCCS
T ss_pred             CCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcccCCC----CCCC
Confidence                     455788999875 4457788999999999999999999986543221   1112222211111    1124


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCcc
Q 042681          259 NMSPVAIDLAERMLVFDPAKRIT-----VEEALNHPYLSSLHE  296 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps-----~~ell~hp~f~~~~~  296 (339)
                      .+|+++++||.+||+.||++|||     |+++++||||+++.|
T Consensus       231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence            68999999999999999999999     899999999999865

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-51  Score=354.84  Aligned_cols=264  Identities=27%  Similarity=0.438  Sum_probs=207.5

Q ss_pred             cCccCCCccccccccceEEEEEEeCCC-CceEEEEEecccccChHhHHHHHHHHHHHhhC---CCCCeeeeeeecCCCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSET-KEEVAIKKITNAFDNRIDAKRILREIKLLCHM---THENIVKVKDIIPPMDK  108 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~I~~~~~~~~~~~~  108 (339)
                      .++|.+ ++.||+|+||+||+|++..+ ++.||+|+++...........+.+|+.+++.+   +||||+++++++.....
T Consensus         6 ~~~Y~i-~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYEC-VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEE-EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEE-EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            467877 99999999999999999766 56799999976544333334456777776655   79999999999854333


Q ss_pred             CCcCeEEEEEecCcccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          109 EKFNDVYIVYELMDTDLHQIIR--SKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       109 ~~~~~~~iv~e~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      .....++++|||+++++.....  ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+.
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence            4556799999999976555443  34679999999999999999999999999999999999999999999999999985


Q ss_pred             c----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhh------------
Q 042681          187 T----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQ------------  244 (339)
Q Consensus       187 ~----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~------------  244 (339)
                      .          .++..|++||......+..+.|+|++|+++|++++|..||......  .....+...            
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCchhccccc
Confidence            3          3456799999888888899999999999999999999998643211  111111111            


Q ss_pred             -------CCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCCC
Q 042681          245 -------LPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEINE  299 (339)
Q Consensus       245 -------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~  299 (339)
                             .......+.....+.+++++++||.+||++||++|||++|+++||||++++..++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ke  304 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE  304 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhCC
Confidence                   1111122222334568999999999999999999999999999999999977654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.8e-51  Score=352.52  Aligned_cols=251  Identities=33%  Similarity=0.489  Sum_probs=202.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||+||+|+++ +|+.||+|+++.........+++.+|+.++++++||||+++++++     ...+.
T Consensus         2 ~~Y~~-~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~   74 (286)
T d1ob3a_           2 EKYHG-LEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKR   74 (286)
T ss_dssp             CSEEE-EEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSC
T ss_pred             CCcee-ccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCc
Confidence            57777 999999999999999986 789999999976644444467899999999999999999999999     67788


Q ss_pred             EEEEEecCcccHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc----
Q 042681          114 VYIVYELMDTDLHQII-RSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT----  188 (339)
Q Consensus       114 ~~iv~e~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~----  188 (339)
                      .++++|++.+++...+ ...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+...    
T Consensus        75 ~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            9999999997555555 55688999999999999999999999999999999999999999999999999998543    


Q ss_pred             -------CCCCccccccccc-cccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHh-----------------
Q 042681          189 -------SETDFMTEYVVTR-WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVK-----------------  243 (339)
Q Consensus       189 -------~~~~~~~~~~~~~-~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~-----------------  243 (339)
                             +.+.|.+|+.... .....+.|+|++|++++++++|..|+......  ........                 
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCChhhccchhhhh
Confidence                   3335677776543 45578899999999999999999997543211  11111111                 


Q ss_pred             ----hCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 042681          244 ----QLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSS  293 (339)
Q Consensus       244 ----~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  293 (339)
                          ........+.....+.+++++++||++||+.||++|||+.|+++||||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                01111112222334668999999999999999999999999999999974

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-51  Score=357.73  Aligned_cols=247  Identities=20%  Similarity=0.314  Sum_probs=206.5

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccc-cChHhHHHHHHHHHHHh-hCCCCCeeeeeeecCCCCcCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-DNRIDAKRILREIKLLC-HMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~e~~~l~-~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++|.+ ++.||+|+||+||+|.++.+|+.||+|++++.. ......+.+.+|..++. .++||||+++++++     ...
T Consensus         2 ddy~i-~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~   75 (320)
T d1xjda_           2 EDFIL-HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTK   75 (320)
T ss_dssp             TTEEE-EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred             CCeEE-eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccC
Confidence            35666 899999999999999999999999999997542 12233456677777665 68999999999999     777


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||.++..  
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence            88999999998 799999999899999999999999999999999999999999999999999999999999998643  


Q ss_pred             ---------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          189 ---------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       189 ---------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                               ++..|++||......+..++|+|++|+++|++++|..|+.....  .............        ....
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~~--------~p~~  225 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNPF--------YPRW  225 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCC--------CCTT
T ss_pred             ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCC--------CCcc
Confidence                     34468899988888889999999999999999999999864321  1111122211111        1135


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCcc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVE-EALNHPYLSSLHE  296 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~-ell~hp~f~~~~~  296 (339)
                      +|+++++||++||+.||++|||+. ++++||||+.+.+
T Consensus       226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             CCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence            799999999999999999999995 8999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=349.68  Aligned_cols=242  Identities=22%  Similarity=0.336  Sum_probs=201.1

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccCh----HhHHHHHHHHHHHhhCC--CCCeeeeeeecCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNR----IDAKRILREIKLLCHMT--HENIVKVKDIIPP  105 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~I~~~~~~~~~  105 (339)
                      +.++|.+ .+.||+|+||.||+|++..+|+.||+|++.+.....    ....++.+|+.++++++  ||||+++++++  
T Consensus         2 l~~~Y~i-~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~--   78 (273)
T d1xwsa_           2 LESQYQV-GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--   78 (273)
T ss_dssp             CTTTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE--
T ss_pred             CCCeEEE-eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE--
Confidence            4678877 999999999999999999999999999997543221    12234678999999986  89999999999  


Q ss_pred             CCcCCcCeEEEEEecCc--ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccC-CCeEEeec
Q 042681          106 MDKEKFNDVYIVYELMD--TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF  182 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~-~~ikL~Df  182 (339)
                         ...+..++||||+.  +++.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+||
T Consensus        79 ---~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          79 ---ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             ---ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             ---eeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcc
Confidence               67788999999996  4888888888999999999999999999999999999999999999999854 78999999


Q ss_pred             cccccc---------CCCCcccccccccccc-CCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          183 GLARTT---------SETDFMTEYVVTRWDT-LFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       183 g~~~~~---------~~~~~~~~~~~~~~~~-~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      |+|+..         |+..|++||......+ ..+.|+|++|+++|++++|..|+....        ........     
T Consensus       156 G~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~i~~~~~~-----  222 (273)
T d1xwsa_         156 GSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRGQVF-----  222 (273)
T ss_dssp             TTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHHCCCC-----
T ss_pred             ccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------HHhhcccC-----
Confidence            998643         3446888887655443 456899999999999999999975321        11111111     


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                         ..+.+|+++++||++||+.||++|||++|+++||||+++.
T Consensus       223 ---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         223 ---FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             ---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ---CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence               1145899999999999999999999999999999998764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-51  Score=358.63  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=200.0

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhh-CCCCCeeeeeeecCCCCcCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCH-MTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~I~~~~~~~~~~~~~~  110 (339)
                      +-++|.++.+.||+|+||+||+|++..+|+.||+|+++..       ..+.+|+.++.+ .+||||++++++|.+.. ..
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~   80 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AG   80 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cC
Confidence            3467777346799999999999999999999999998643       456789988665 48999999999984321 23


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc---CCCeEEeeccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGL  184 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~---~~~ikL~Dfg~  184 (339)
                      ...+|+|||||+ |+|.+++.+.  .++++..++.++.||+.||+|||++||+||||||+||+++.   ++.+||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            467999999997 7999999874  47999999999999999999999999999999999999985   55799999999


Q ss_pred             cccc----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCcc
Q 042681          185 ARTT----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFS  254 (339)
Q Consensus       185 ~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (339)
                      |+..          +++.|++||+.....+..+.|+|++|+++|++++|..||........  .................
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSSSCCT
T ss_pred             eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHHHHhcCCCCCCC
Confidence            8643          45578899988888888999999999999999999999754321111  01111111111111111


Q ss_pred             ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          255 QKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       255 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                      ..++.+|+++++||++||+.||++|||+.|+++||||....
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            11235899999999999999999999999999999996543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=343.17  Aligned_cols=255  Identities=32%  Similarity=0.445  Sum_probs=205.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.+ ++.||+|+||+||+|++..+|+.||+|+++..........++.+|+.+++.++||||+++++++     .....
T Consensus         2 ~ry~~-i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~   75 (292)
T d1unla_           2 QKYEK-LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKK   75 (292)
T ss_dssp             CSEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             CCCEe-eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccc
Confidence            46777 9999999999999999999999999999977665666678899999999999999999999999     67788


Q ss_pred             EEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCCC-
Q 042681          114 VYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSET-  191 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~~-  191 (339)
                      .+++++++. +++..++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.++..... 
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999998 467777777889999999999999999999999999999999999999999999999999999764332 


Q ss_pred             ----------Ccccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCC-------------
Q 042681          192 ----------DFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPH-------------  247 (339)
Q Consensus       192 ----------~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~-------------  247 (339)
                                .+.+|+..... ....+.|+|++|++++++++|..|+....... ............             
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH-HHHHHHHhhcCCCChhhhhhhhhcc
Confidence                      24455544433 35677899999999999999998864322111 111111111000             


Q ss_pred             --------CCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 042681          248 --------VPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLH  295 (339)
Q Consensus       248 --------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  295 (339)
                              ..........+.+++++++||++||+.||++||||+|+|+||||+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                    001112223356889999999999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-48  Score=337.90  Aligned_cols=236  Identities=18%  Similarity=0.252  Sum_probs=194.7

Q ss_pred             ccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeE
Q 042681           35 KYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDV  114 (339)
Q Consensus        35 ~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~  114 (339)
                      +|.. .+.||+|+||+||+|.++.+|+.||+|+++....   ..+.+.+|+.++++++||||+++++++     .....+
T Consensus        18 ~~~~-~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~   88 (287)
T d1opja_          18 DITM-KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF   88 (287)
T ss_dssp             GEEE-EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred             HeEE-eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCee
Confidence            4444 8899999999999999999999999999875432   346789999999999999999999999     666788


Q ss_pred             EEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccCC-
Q 042681          115 YIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-  190 (339)
Q Consensus       115 ~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~~-  190 (339)
                      ++||||++ |+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... 
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            99999998 7999998653  6799999999999999999999999999999999999999999999999999975432 


Q ss_pred             -----------CCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          191 -----------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       191 -----------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                 ..|++|+......++.++|+|++|+++|++++|..|+....  ...............      .....
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~~i~~~~~~------~~~~~  240 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRM------ERPEG  240 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTCCC------CCCTT
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHHHHhcCCCC------CCCcc
Confidence                       24678887777778889999999999999999766643221  111122222221111      11246


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      +|+++++||.+||+.||++|||++++++
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            8999999999999999999999999976

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=333.86  Aligned_cols=245  Identities=20%  Similarity=0.240  Sum_probs=197.5

Q ss_pred             cccc-CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           30 FQVS-SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        30 ~~~~-~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      |.++ ++|.. .+.||+|+||.||+|+..   ..||+|+++.........+.+.+|+.++.+++||||+++++++     
T Consensus         3 wei~~~~~~~-~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-----   73 (276)
T d1uwha_           3 WEIPDGQITV-GQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-----   73 (276)
T ss_dssp             CBCCTTCCCC-CSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             cccccccEEE-EEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-----
Confidence            4444 45555 999999999999999764   3599999987665666778899999999999999999999987     


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                      .. ..+++||||++ |+|.+++... .++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus        74 ~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          74 TA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             CS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             ec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence            32 45799999998 7999999654 679999999999999999999999999999999999999999999999999985


Q ss_pred             cc-------------CCCCcccccccccc---ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          187 TT-------------SETDFMTEYVVTRW---DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       187 ~~-------------~~~~~~~~~~~~~~---~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      ..             ++..|++||+....   .++.++|+|++|+++|++++|..|+......  ...........  ..
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~--~~  228 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGY--LS  228 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHTS--CC
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCC--CC
Confidence            32             34468899886532   3566789999999999999999998654322  11122222211  12


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +........+|+++++||.+||+.||++|||+.+++++
T Consensus       229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            22233345789999999999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.9e-49  Score=339.66  Aligned_cols=254  Identities=20%  Similarity=0.269  Sum_probs=205.0

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK  108 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~  108 (339)
                      ..+.++|.+ .+.||+|+||.||+|++..+|+.||+|++++... +....+++.+|+.+++.++||||+++++++.... 
T Consensus         3 ~~l~drY~i-~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-   80 (277)
T d1o6ya_           3 SHLSDRYEL-GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-   80 (277)
T ss_dssp             SEETTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-
T ss_pred             cCccceeEE-eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-
Confidence            356788988 9999999999999999999999999999986543 3445678999999999999999999999984321 


Q ss_pred             CCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          109 EKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       109 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .....+|+||||++ ++|.+.+...+++++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+..
T Consensus        81 ~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          81 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             SSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             CCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence            22345899999998 69999998889999999999999999999999999999999999999999999999999998642


Q ss_pred             --------------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          188 --------------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       188 --------------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                                    .++..|++||+.....+..++|+|++|+++|++++|..|+......  .........    ...+.
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~~~~~----~~~~~  234 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQHVRE----DPIPP  234 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHC----CCCCG
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--HHHHHHHhc----CCCCC
Confidence                          2456799999988777888999999999999999999997543211  111122221    11222


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYL  291 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  291 (339)
                      ....+.+|+++++||.+||++||++||+..+.+.|+|.
T Consensus       235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            23346789999999999999999999954444556554

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-49  Score=336.97  Aligned_cols=238  Identities=18%  Similarity=0.272  Sum_probs=193.3

Q ss_pred             cccccccceEEEEEEeC--CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEE
Q 042681           41 QPIGRGAYGIVCSAVNS--ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVY  118 (339)
Q Consensus        41 ~~lg~G~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~  118 (339)
                      +.||+|+||+||+|.+.  .+++.||+|+++....+....+.+.+|+.++++++||||+++++++     .. ...++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~-----~~-~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-----EA-ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ES-SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEe-----cc-CCEEEEE
Confidence            46999999999999754  4567899999976655555667899999999999999999999998     33 3478999


Q ss_pred             ecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---------
Q 042681          119 ELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---------  188 (339)
Q Consensus       119 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---------  188 (339)
                      ||++ |+|.+++.+..++++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..         
T Consensus        87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            9998 799999999899999999999999999999999999999999999999999999999999998643         


Q ss_pred             -----CCCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCH
Q 042681          189 -----SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSP  262 (339)
Q Consensus       189 -----~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  262 (339)
                           ++..|++||......+..++|+|++|+++|++++ |..|+.....   ......+...   ...+   ....+|+
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~~~---~~~~---~p~~~~~  237 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKG---ERMG---CPAGCPR  237 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTT---CCCC---CCTTCCH
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHHcC---CCCC---CCcccCH
Confidence                 2335888998877778889999999999999997 8888765321   1112222221   1111   1246899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHh---cCCCCCC
Q 042681          263 VAIDLAERMLVFDPAKRITVEEAL---NHPYLSS  293 (339)
Q Consensus       263 ~~~~li~~~L~~dP~~Rps~~ell---~hp~f~~  293 (339)
                      ++++||.+||+.||++|||+++++   +|+|+..
T Consensus       238 ~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence            999999999999999999999984   5666543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-48  Score=342.66  Aligned_cols=251  Identities=28%  Similarity=0.421  Sum_probs=194.7

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc-CCcCeEEEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK-EKFNDVYIVY  118 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~-~~~~~~~iv~  118 (339)
                      ++.||+|+||+||+|++..+|+.||+|++......      ..+|+.++++++||||+++++++..... .+..++++||
T Consensus        25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             eeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            88999999999999999999999999999754222      2479999999999999999999844321 2344689999


Q ss_pred             ecCcccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC-CeEEeeccccccc-----
Q 042681          119 ELMDTDLHQII----RSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTT-----  188 (339)
Q Consensus       119 e~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~-~ikL~Dfg~~~~~-----  188 (339)
                      ||+++++...+    .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...     
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~  178 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  178 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence            99997655554    3456899999999999999999999999999999999999999775 8999999998654     


Q ss_pred             -----CCCCcccccccc-ccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHH------------hhCCCCCC
Q 042681          189 -----SETDFMTEYVVT-RWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYV------------KQLPHVPK  250 (339)
Q Consensus       189 -----~~~~~~~~~~~~-~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~------------~~~~~~~~  250 (339)
                           +...|.+|+... ...+..+.|+|++|++++++++|..||.......  ......            ........
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~~~~~~~~  256 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNPNYTE  256 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred             cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhhhhccchhh
Confidence                 234566676544 4567888999999999999999999975432111  111111            11111000


Q ss_pred             --------CC-ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccCC
Q 042681          251 --------QP-FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHEIN  298 (339)
Q Consensus       251 --------~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  298 (339)
                              .+ .....+.+++++++||.+||+.||++|||+.|+|+||||+.+.+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  313 (350)
T d1q5ka_         257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  313 (350)
T ss_dssp             CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence                    00 1112346899999999999999999999999999999999887654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-48  Score=338.86  Aligned_cols=258  Identities=29%  Similarity=0.387  Sum_probs=196.9

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCc---CC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDK---EK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~---~~  110 (339)
                      ++|.+ ++.||+|+||+||+|++..+|+.||||++...........++.+|+.+++.++||||+++++++.....   ..
T Consensus        10 ~rY~i-~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1          10 SKYEK-LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCEEE-EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            67877 999999999999999999999999999997765555556778999999999999999999999844221   22


Q ss_pred             cCeEEEEEecCcccHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc-
Q 042681          111 FNDVYIVYELMDTDLHQII-RSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-  188 (339)
Q Consensus       111 ~~~~~iv~e~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~-  188 (339)
                      .+..+++|||+++++.... .....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++... 
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            4568999999996655554 44578999999999999999999999999999999999999999999999999998543 


Q ss_pred             --------------CCCCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          189 --------------SETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       189 --------------~~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                                    ++..|.+||..... .+..+.|+|++|++++++++|..|+......  ..................
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSITPEVW  246 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--HHHHHHHHhcCCCChhhc
Confidence                          33457788876543 5677899999999999999999997543211  111111111111111100


Q ss_pred             ccc--------C----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 042681          254 SQK--------F----------------PNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSL  294 (339)
Q Consensus       254 ~~~--------~----------------~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  294 (339)
                      ...        .                ...++++++||.+||++||++|||+.|+++||||++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            000        0                0136788999999999999999999999999999853

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.5e-48  Score=340.61  Aligned_cols=253  Identities=25%  Similarity=0.445  Sum_probs=197.1

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~  110 (339)
                      ..++|.+ ++.||+|+||+||+|+++.+|+.||+|++++.     ..+++.+|+.+|+.++ ||||+++++++..   ..
T Consensus        33 ~~d~y~i-~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~  103 (328)
T d3bqca1          33 NQDDYQL-VRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKD---PV  103 (328)
T ss_dssp             CGGGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TT
T ss_pred             CCcCeEE-EEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cC
Confidence            4567888 99999999999999999999999999998653     2467889999999995 9999999999843   34


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCC-CeEEeeccccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTT  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~-~ikL~Dfg~~~~~  188 (339)
                      ...+++||||++ ++|...   .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||+|+..
T Consensus       104 ~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         104 SRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             TCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             CCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceec
Confidence            467999999998 577554   35799999999999999999999999999999999999999765 5999999999654


Q ss_pred             C----------CCCcccccccccc-ccCCCCccHHHHHHHHHHHhCCCCCCcccccccch-----------HHHHHhhC-
Q 042681          189 S----------ETDFMTEYVVTRW-DTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN-----------ARRYVKQL-  245 (339)
Q Consensus       189 ~----------~~~~~~~~~~~~~-~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~-----------~~~~~~~~-  245 (339)
                      .          +..|.+||..... .+..+.|+|++|++++++++|..|+..........           ........ 
T Consensus       181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             cCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            3          2346777765543 35778899999999999999999875432111000           00000000 


Q ss_pred             -----------CCCCCCCc-----cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 042681          246 -----------PHVPKQPF-----SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNHPYLSSLHE  296 (339)
Q Consensus       246 -----------~~~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  296 (339)
                                 ........     ......+|+++++||++||+.||++|||++|+|+||||+++.+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                       00000000     0111347899999999999999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-47  Score=331.35  Aligned_cols=239  Identities=22%  Similarity=0.286  Sum_probs=188.5

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCc---eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKE---EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~  110 (339)
                      ++|.. .+.||+|+||+||+|.++.+++   .+|+|.+... ......+.+.+|+.++++++||||+++++++     ..
T Consensus        26 ~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~~   98 (299)
T d1jpaa_          26 SCVKI-EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TK   98 (299)
T ss_dssp             GGEEE-EEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred             hhcEE-eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ee
Confidence            44555 8899999999999999987765   4778877543 3344567899999999999999999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  188 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~  188 (339)
                      .+.+++||||++ |+|.+++... +.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++..
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence            678999999998 7899988764 57999999999999999999999999999999999999999999999999998643


Q ss_pred             C----------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          189 S----------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       189 ~----------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      .                +..|++||......+..++|+|++|+++|++++ |..|+......   .....+......+  
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~~~~~~~--  253 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIEQDYRLP--  253 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTTCCCC--
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCCC--
Confidence            2                234788888777778888999999999999997 88887654321   1112222211111  


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                          ....+++++++||.+||+.||++|||+.|++++
T Consensus       254 ----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 ----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                124689999999999999999999999998865

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=326.00  Aligned_cols=237  Identities=19%  Similarity=0.250  Sum_probs=189.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. ++.||+|+||.||+|++. +++.||+|+++....   ..+.+.+|+.++++++||||+++++++     ...+.
T Consensus         5 ~~~~~-~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~-----~~~~~   74 (263)
T d1sm2a_           5 SELTF-VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAP   74 (263)
T ss_dssp             SCEEE-EEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred             HHcEE-EEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCccccccee-----ccCCc
Confidence            45555 899999999999999986 467899999875433   236789999999999999999999999     56677


Q ss_pred             EEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc---
Q 042681          114 VYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~---  188 (339)
                      .++||||++ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..   
T Consensus        75 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          75 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             eEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC
Confidence            899999998 7999988654 67899999999999999999999999999999999999999999999999998643   


Q ss_pred             ---------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          189 ---------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       189 ---------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                               ++..|++||+.....+..++|+|++|+++|+++++..++....  ........+........      ...
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~~~------p~~  226 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYK------PRL  226 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHHTCCCCC------CTT
T ss_pred             CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHhcCCCCC------ccc
Confidence                     2345889998887788889999999999999998544433221  11111222222111111      135


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +++++.+|+.+||+.||++|||++++++|
T Consensus       227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            78999999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-48  Score=330.43  Aligned_cols=249  Identities=17%  Similarity=0.267  Sum_probs=197.2

Q ss_pred             cccccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCC
Q 042681           27 GNLFQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPM  106 (339)
Q Consensus        27 ~~~~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~  106 (339)
                      .+.|.|+.+.+.+++.||+|+||.||+|+++ +++.||||+++....   ..+.+.+|+.++.+++||||+++++++   
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~---   77 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVV---   77 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeee---
Confidence            4556665444444899999999999999976 578899999975432   346789999999999999999999987   


Q ss_pred             CcCCcCeEEEEEecCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          107 DKEKFNDVYIVYELMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       107 ~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                        .. +..++||||++ |+|.+++...  .++++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus        78 --~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          78 --TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             --CS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             --cc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeecccc
Confidence              33 34689999998 7998877543  469999999999999999999999999999999999999999999999999


Q ss_pred             cccccC------------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCC
Q 042681          184 LARTTS------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQ  251 (339)
Q Consensus       184 ~~~~~~------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (339)
                      +|+...            ...|++||+.....+..++|+|++|+++|++++|..++....  ........+....   ..
T Consensus       155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~~~~i~~~~---~~  229 (272)
T d1qpca_         155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNLERGY---RM  229 (272)
T ss_dssp             TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTC---CC
T ss_pred             ceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcC---CC
Confidence            996542            235888988877778889999999999999999655543221  1111111122111   11


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN--HPYLSS  293 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~~  293 (339)
                      .   ....+++++++|+.+||+.||++|||++++++  |+||++
T Consensus       230 ~---~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         230 V---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C---CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            1   11468999999999999999999999999998  787753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-47  Score=321.65  Aligned_cols=236  Identities=19%  Similarity=0.222  Sum_probs=195.3

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.. +++||+|+||.||+|+++ +++.||+|++++....   .+.+.+|+.++.+++||||+++++++     ...+.
T Consensus         4 ~~~~~-~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~~   73 (258)
T d1k2pa_           4 KDLTF-LKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRP   73 (258)
T ss_dssp             CCCCC-CCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSSS
T ss_pred             HHCEE-eEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEE-----eeCCc
Confidence            45555 899999999999999985 6789999999765333   36789999999999999999999999     66678


Q ss_pred             EEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC--
Q 042681          114 VYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--  189 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~--  189 (339)
                      +++||||++ |+|.+++.. ...+++..++.++.|+++||+|||++||+||||||+||+++.++.+||+|||+++...  
T Consensus        74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            999999997 788888654 4679999999999999999999999999999999999999999999999999986432  


Q ss_pred             ----------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          190 ----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       190 ----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                +..|++||......+..++|+|++|+++|++++ |..|+.....   ......+.....   ...   ..
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~~~~~---~~~---p~  224 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLR---LYR---PH  224 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCC---CCC---CT
T ss_pred             CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHHhCCC---CCC---cc
Confidence                      224778888877778889999999999999997 7888754431   112222222111   111   13


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .+++++++||.+||+.||++|||+.++++|
T Consensus       225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         225 LASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            578999999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-48  Score=338.53  Aligned_cols=251  Identities=21%  Similarity=0.317  Sum_probs=200.4

Q ss_pred             CccCCCccccccccceEEEEEEe---CCCCceEEEEEeccccc--ChHhHHHHHHHHHHHhhCCC-CCeeeeeeecCCCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVN---SETKEEVAIKKITNAFD--NRIDAKRILREIKLLCHMTH-ENIVKVKDIIPPMD  107 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~---~~~~~~~avK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~~I~~~~~~~~~~~  107 (339)
                      ++|.+ ++.||+|+||.||+|++   ..+|+.||+|++++...  .....+.+.+|+.++++++| |||+++++++    
T Consensus        24 ~~y~~-~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~----   98 (322)
T d1vzoa_          24 ENFEL-LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----   98 (322)
T ss_dssp             GGEEE-EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred             hceEE-EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence            55777 99999999999999986   44789999999975422  22334668899999999976 8999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccc
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  186 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~  186 (339)
                       .....++++|||+. |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+++
T Consensus        99 -~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_          99 -QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             -EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             -ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence             77788999999998 7999999998999999999999999999999999999999999999999999999999999986


Q ss_pred             ccC------------CCCccccccccc--cccCCCCccHHHHHHHHHHHhCCCCCCcccccccch-HHHHHhhCCCCCCC
Q 042681          187 TTS------------ETDFMTEYVVTR--WDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN-ARRYVKQLPHVPKQ  251 (339)
Q Consensus       187 ~~~------------~~~~~~~~~~~~--~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  251 (339)
                      ...            ...+.+|+....  .....++|+|++|+++|++++|..||.......... ........ ..+  
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-~~~--  254 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPP--  254 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCC--
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-CCC--
Confidence            542            233555555432  245667899999999999999999986543222111 11111111 111  


Q ss_pred             CccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCccC
Q 042681          252 PFSQKFPNMSPVAIDLAERMLVFDPAKRI-----TVEEALNHPYLSSLHEI  297 (339)
Q Consensus       252 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~~~~~  297 (339)
                          ....+|+++++||.+||++||++||     |++|+++||||+.+.+.
T Consensus       255 ----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~  301 (322)
T d1vzoa_         255 ----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  301 (322)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             ----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence                1135899999999999999999999     58999999999998743

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=336.37  Aligned_cols=244  Identities=21%  Similarity=0.318  Sum_probs=194.4

Q ss_pred             ccccC-ccCCCccccccccceEEEEEEeCCCCc-----eEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeee
Q 042681           30 FQVSS-KYVPPLQPIGRGAYGIVCSAVNSETKE-----EVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDI  102 (339)
Q Consensus        30 ~~~~~-~y~~~~~~lg~G~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~  102 (339)
                      |.++. +|.. ++.||+|+||+||+|++..+++     .||+|.+.... .......+.+|+.++.++ +||||++++++
T Consensus        32 wei~~~~~~l-~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~  109 (325)
T d1rjba_          32 WEFPRENLEF-GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA  109 (325)
T ss_dssp             GBCCGGGEEE-EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHeEE-eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence            34443 4444 8999999999999999876554     68899886542 233456788999999998 89999999999


Q ss_pred             cCCCCcCCcCeEEEEEecCc-ccHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 042681          103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSK-----------------------QALTDDHCQYFLYQLLRGLKYIHSAN  158 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~g  158 (339)
                      +     ...+.+++||||++ |+|.+++...                       ..+++..++.++.||+.||+|||++|
T Consensus       110 ~-----~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~  184 (325)
T d1rjba_         110 C-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  184 (325)
T ss_dssp             E-----CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             E-----eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9     66778999999998 7999999754                       24899999999999999999999999


Q ss_pred             cccCCCCCCCeeeccCCCeEEeeccccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHh-CC
Q 042681          159 VLHRDLKPSNLLLNANCDLKICDFGLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GS  224 (339)
Q Consensus       159 ivH~dikp~NIli~~~~~ikL~Dfg~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~  224 (339)
                      |+||||||+||+++.++.+||+|||+|+..             ++..|++||......+..++|+|++|+++|++++ |.
T Consensus       185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~  264 (325)
T d1rjba_         185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV  264 (325)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence            999999999999999999999999998642             2345889998877788889999999999999997 88


Q ss_pred             CCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          225 PDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .|+......  .............+      ....+|+++++||.+||+.||++|||++|+++|
T Consensus       265 ~Pf~~~~~~--~~~~~~~~~~~~~~------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         265 NPYPGIPVD--ANFYKLIQNGFKMD------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSSTTCCCS--HHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHH--HHHHHHHhcCCCCC------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            887654322  11222222221111      124589999999999999999999999999976

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-47  Score=326.90  Aligned_cols=237  Identities=20%  Similarity=0.323  Sum_probs=192.2

Q ss_pred             cc-ccccccceEEEEEEeCC--CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQ-PIGRGAYGIVCSAVNSE--TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~-~lg~G~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      .. .||+|+||+||+|.++.  ++..||||+++.. ......+.+.+|+.++++++||||+++++++     .. +.+++
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~-----~~-~~~~l   85 (285)
T d1u59a_          13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-----QA-EALML   85 (285)
T ss_dssp             EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ES-SSEEE
T ss_pred             CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeee-----cc-CeEEE
Confidence            55 49999999999998754  4457999998754 3445667899999999999999999999998     32 34799


Q ss_pred             EEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-----
Q 042681          117 VYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-----  189 (339)
Q Consensus       117 v~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-----  189 (339)
                      ||||++ |+|.+++.. ++.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..+     
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  165 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  165 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence            999998 699998765 4679999999999999999999999999999999999999999999999999996542     


Q ss_pred             ---------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          190 ---------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       190 ---------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                               +..|++||......+..++|+|++|+++|++++ |..|+......   .....+....   ...   ..+.
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~~~~---~~~---~p~~  236 (285)
T d1u59a_         166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGK---RME---CPPE  236 (285)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHTTC---CCC---CCTT
T ss_pred             cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCC---CCC---CCCc
Confidence                     234778888777778889999999999999997 89987654321   1122222211   111   1246


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHH---hcCCCCC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEA---LNHPYLS  292 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~el---l~hp~f~  292 (339)
                      +|+++.+||.+||+.||++|||+.++   |+|+|++
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            89999999999999999999999888   5678774

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=322.85  Aligned_cols=244  Identities=21%  Similarity=0.266  Sum_probs=195.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCe
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFND  113 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~  113 (339)
                      ++|.+ .+.||+|+||+||+|.++.+ +.||+|+++.....   .+.+.+|+.++++++||||+++++++     .. +.
T Consensus        17 ~~~~i-~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~-----~~-~~   85 (285)
T d1fmka3          17 ESLRL-EVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVV-----SE-EP   85 (285)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEE-----CS-SS
T ss_pred             HHEEE-eeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEE-----ec-CC
Confidence            34444 89999999999999998765 56999999755333   36789999999999999999999998     33 34


Q ss_pred             EEEEEecCc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeeccccccc--
Q 042681          114 VYIVYELMD-TDLHQIIRS--KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--  188 (339)
Q Consensus       114 ~~iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~--  188 (339)
                      .++||||++ |+|..++..  .+.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++..  
T Consensus        86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence            689999998 788888754  367999999999999999999999999999999999999999999999999998643  


Q ss_pred             ----------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCC
Q 042681          189 ----------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFP  258 (339)
Q Consensus       189 ----------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (339)
                                +...|++|+.........++|+|++|+++|++++|..++......     .............+   ..+
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~~~~~i~~~~~~~---~~~  237 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVERGYRMP---CPP  237 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCCCC---CCT
T ss_pred             CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhcCCCC---CCc
Confidence                      233578888887777888999999999999999976554432211     11111111111111   225


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCCCcc
Q 042681          259 NMSPVAIDLAERMLVFDPAKRITVEEALN--HPYLSSLHE  296 (339)
Q Consensus       259 ~~s~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~~~~~  296 (339)
                      .+|+++++||.+||+.||++|||+.++++  ++||++...
T Consensus       238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p  277 (285)
T d1fmka3         238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  277 (285)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence            68999999999999999999999999998  899988643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-46  Score=318.68  Aligned_cols=242  Identities=24%  Similarity=0.353  Sum_probs=189.4

Q ss_pred             cccc-CccCCCccccccccceEEEEEEeCCCC---ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCC
Q 042681           30 FQVS-SKYVPPLQPIGRGAYGIVCSAVNSETK---EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPP  105 (339)
Q Consensus        30 ~~~~-~~y~~~~~~lg~G~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~  105 (339)
                      |.|+ ++|.. ++.||+|+||.||+|.+..++   ..+|+|.++.. ......+.+.+|+.++++++||||+++++++  
T Consensus         2 ~ei~~~~~~l-~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~--   77 (273)
T d1mp8a_           2 YEIQRERIEL-GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVI--   77 (273)
T ss_dssp             CBCCGGGEEE-EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--
T ss_pred             CCcCHHHeEE-EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence            4455 45656 999999999999999987554   45788887543 3444567899999999999999999999998  


Q ss_pred             CCcCCcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          106 MDKEKFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       106 ~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                         .. +.+++||||++ |+|.+++.. ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||
T Consensus        78 ---~~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          78 ---TE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             ---CS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             ---ec-CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence               32 45799999998 788887755 4679999999999999999999999999999999999999999999999999


Q ss_pred             cccccC------------CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCC
Q 042681          184 LARTTS------------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPK  250 (339)
Q Consensus       184 ~~~~~~------------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (339)
                      +|+...            +..|++|+......+..++|+|++|+++|++++ |.+|+......  ..... +......  
T Consensus       154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~-i~~~~~~--  228 (273)
T d1mp8a_         154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR-IENGERL--  228 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH-HHTTCCC--
T ss_pred             hheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHH-HHcCCCC--
Confidence            986532            235788888877788889999999999999997 78887654322  11122 2221111  


Q ss_pred             CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          251 QPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       251 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                          ...+.+|+++++||.+||+.||++|||+.|+++|
T Consensus       229 ----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                1225689999999999999999999999999876

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=316.98  Aligned_cols=239  Identities=20%  Similarity=0.272  Sum_probs=189.2

Q ss_pred             CccCCCccccccccceEEEEEEeCCCC----ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETK----EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      +.|.+ .+.||+|+||.||+|.++.++    ..||+|++... ........+.+|+.++.+++||||+++++++     .
T Consensus         7 ~~~~~-~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~   79 (283)
T d1mqba_           7 SCVTR-QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----S   79 (283)
T ss_dssp             TTEEE-EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred             HHeEe-eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----e
Confidence            34555 889999999999999987654    46999998654 3344556789999999999999999999999     6


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .....++||||+. +++.+.+... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence            6678999999998 6787777654 6799999999999999999999999999999999999999999999999999864


Q ss_pred             c--------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          188 T--------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       188 ~--------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      .              ++..|++||......+..++|+|++|+++|+++++..++....  ..............   .+ 
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~---~~-  233 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFR---LP-  233 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCC---CC-
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHHhccCC---CC-
Confidence            3              2235889998887788889999999999999998655543221  11112222222111   11 


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                        ....+++++++||.+||+.||++|||+.++++
T Consensus       234 --~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         234 --TPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             --CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence              11458899999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-45  Score=320.20  Aligned_cols=238  Identities=20%  Similarity=0.304  Sum_probs=189.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCc----eEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKE----EVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ++|.. ++.||+|+||+||+|.+..+|+    +||+|+++.. ......+.+.+|+.++++++||||+++++++     .
T Consensus         9 ~dy~~-~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~   81 (317)
T d1xkka_           9 TEFKK-IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGIC-----L   81 (317)
T ss_dssp             TTEEE-EEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             HHCEE-eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----e
Confidence            45666 9999999999999999988876    5777877543 2233457899999999999999999999998     3


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      +. ..+++++++. |+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          82 TS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             SS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             cC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence            33 3566777776 788887765 46899999999999999999999999999999999999999999999999999864


Q ss_pred             c-------------CCCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCc
Q 042681          188 T-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPF  253 (339)
Q Consensus       188 ~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (339)
                      .             ++..|++||......++.++|+|++|+++|++++ |.+|+.....   .............+.+  
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---~~~~~~i~~~~~~~~p--  235 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGERLPQP--  235 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---GGHHHHHHHTCCCCCC--
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCCCCC--
Confidence            3             2346888988777778889999999999999998 6777654432   2222233322222211  


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          254 SQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       254 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                          +.+++++++|+.+||+.||++|||+.++++|
T Consensus       236 ----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         236 ----PICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----cccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                4689999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=311.32  Aligned_cols=230  Identities=23%  Similarity=0.321  Sum_probs=184.2

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      ++.||+|+||.||+|+++  |+.||+|++++.    ...+.+.+|++++++++||||+++++++.    ...+.+++|||
T Consensus        12 ~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~lv~e   81 (262)
T d1byga_          12 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTE   81 (262)
T ss_dssp             EEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCEEEEC
T ss_pred             eEEEecCCCeEEEEEEEC--CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcEEEEEe
Confidence            889999999999999984  778999999653    23467899999999999999999999873    23455799999


Q ss_pred             cCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-------
Q 042681          120 LMD-TDLHQIIRSK--QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-------  189 (339)
Q Consensus       120 ~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-------  189 (339)
                      |++ |+|.+++.+.  ..+++..+..++.||+.||.|||+.+++||||||+||+++.++.+||+|||+++...       
T Consensus        82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~  161 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK  161 (262)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCCcccc
Confidence            998 7999998654  359999999999999999999999999999999999999999999999999997533       


Q ss_pred             -CCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHH
Q 042681          190 -ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDL  267 (339)
Q Consensus       190 -~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  267 (339)
                       ...|.+||......++.++|+|++|+++|++++ |.+|+...   ........+..   ....+   ..+.+++++++|
T Consensus       162 ~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i~~---~~~~~---~~~~~~~~~~~l  232 (262)
T d1byga_         162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEK---GYKMD---APDGCPPAVYEV  232 (262)
T ss_dssp             CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHHTT---TCCCC---CCTTCCHHHHHH
T ss_pred             ccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHc---CCCCC---CCccCCHHHHHH
Confidence             335888888877788889999999999999998 56665432   22222222211   11111   224578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcC
Q 042681          268 AERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       268 i~~~L~~dP~~Rps~~ell~h  288 (339)
                      |++||+.||.+|||+.+++++
T Consensus       233 i~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         233 MKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-44  Score=314.44  Aligned_cols=241  Identities=21%  Similarity=0.234  Sum_probs=193.9

Q ss_pred             ccc-CccCCCccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecC
Q 042681           31 QVS-SKYVPPLQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIP  104 (339)
Q Consensus        31 ~~~-~~y~~~~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~  104 (339)
                      .++ ++|.. ++.||+|+||+||+|+++     .+++.||+|+++.. ......+.+.+|+.++++++||||+++++++ 
T Consensus         9 e~p~~~~~~-~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-   85 (301)
T d1lufa_           9 EYPRNNIEY-VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC-   85 (301)
T ss_dssp             BCCGGGCEE-EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             cCCHHHcEE-eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeee-
Confidence            344 34555 999999999999999875     35678999998754 3344567899999999999999999999999 


Q ss_pred             CCCcCCcCeEEEEEecCc-ccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 042681          105 PMDKEKFNDVYIVYELMD-TDLHQIIRSK------------------------QALTDDHCQYFLYQLLRGLKYIHSANV  159 (339)
Q Consensus       105 ~~~~~~~~~~~iv~e~~~-g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~gi  159 (339)
                          ......+++|||++ |+|.+++...                        ..+++..+..++.||+.||+|||++|+
T Consensus        86 ----~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~i  161 (301)
T d1lufa_          86 ----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF  161 (301)
T ss_dssp             ----CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             ----ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCe
Confidence                66678999999998 7999998642                        248999999999999999999999999


Q ss_pred             ccCCCCCCCeeeccCCCeEEeeccccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCC-C
Q 042681          160 LHRDLKPSNLLLNANCDLKICDFGLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGS-P  225 (339)
Q Consensus       160 vH~dikp~NIli~~~~~ikL~Dfg~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~-~  225 (339)
                      +||||||+||+++.++.+||+|||+|+..             +...|++|+......++.++|+|++|+++|++++|. +
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            99999999999999999999999998532             223578888888778888999999999999999985 4


Q ss_pred             CCCcccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          226 DDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      |+.....   ......+....   ..   .....+++++.+||.+||+.||++|||+.|+++
T Consensus       242 p~~~~~~---~e~~~~v~~~~---~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         242 PYYGMAH---EEVIYYVRDGN---IL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTTTSCH---HHHHHHHHTTC---CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCH---HHHHHHHHcCC---CC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            5443221   11111222111   11   112468999999999999999999999999975

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-45  Score=312.10  Aligned_cols=239  Identities=18%  Similarity=0.246  Sum_probs=181.9

Q ss_pred             CccCCCccccccccceEEEEEEeCC-CC--ceEEEEEeccccc-ChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSE-TK--EEVAIKKITNAFD-NRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKE  109 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~-~~--~~~avK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~  109 (339)
                      ++|.. .+.||+|+||.||+|+... ++  ..||+|++.+... .....+.+.+|+.++++++||||+++++++     .
T Consensus         8 ~d~~~-~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~-----~   81 (273)
T d1u46a_           8 KDLRL-LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV-----L   81 (273)
T ss_dssp             GGEEE-EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             HHeEE-EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----e
Confidence            44555 8999999999999998643 33  3689999876533 334457899999999999999999999999     3


Q ss_pred             CcCeEEEEEecCc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          110 KFNDVYIVYELMD-TDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       110 ~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      + ...++||||++ |++.+.+.. .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          82 T-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             e-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhh
Confidence            3 34689999998 788877654 46799999999999999999999999999999999999999999999999999875


Q ss_pred             cCC--------------CCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCcccccccchHHHHHhhCCCCCCCC
Q 042681          188 TSE--------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSDLGFLRSDNARRYVKQLPHVPKQP  252 (339)
Q Consensus       188 ~~~--------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (339)
                      ...              ..|++|+......+...+|+|++|+++|++++ |..|+......  ...........   .. 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~~~~---~~-  234 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGE---RL-  234 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCC---CC-
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHhCCC---CC-
Confidence            422              24667877777777888999999999999997 88886543211  11111111111   11 


Q ss_pred             ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          253 FSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       253 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                        ...+.+|+++++||.+||+.||++|||+.++++
T Consensus       235 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         235 --PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence              122568999999999999999999999999863

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=314.43  Aligned_cols=245  Identities=22%  Similarity=0.342  Sum_probs=186.1

Q ss_pred             cccc-CccCCCccccccccceEEEEEEeCC-----CCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeee
Q 042681           30 FQVS-SKYVPPLQPIGRGAYGIVCSAVNSE-----TKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDI  102 (339)
Q Consensus        30 ~~~~-~~y~~~~~~lg~G~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~  102 (339)
                      |.++ ++|.. ++.||+|+||.||+|.+..     +++.||+|+++.. ......+.+.+|...+.++ +|+||+.++++
T Consensus         8 wei~~~~y~~-~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           8 WEFPRDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HBCCGGGEEE-EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccHHHEEE-eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            3444 45666 9999999999999999654     4568999998654 2334456778888888777 68999999998


Q ss_pred             cCCCCcCCcCeEEEEEecCc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 042681          103 IPPMDKEKFNDVYIVYELMD-TDLHQIIRSK----------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLK  165 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dik  165 (339)
                      +.    .....+++||||++ |+|.+++...                ..+++..++.++.||+.||+|||++||+|||||
T Consensus        86 ~~----~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlK  161 (299)
T d1ywna1          86 CT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA  161 (299)
T ss_dssp             EC----STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             ec----cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCC
Confidence            73    34456899999998 7999999643                348999999999999999999999999999999


Q ss_pred             CCCeeeccCCCeEEeeccccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCC-CCCCccc
Q 042681          166 PSNLLLNANCDLKICDFGLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGS-PDDSDLG  231 (339)
Q Consensus       166 p~NIli~~~~~ikL~Dfg~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~-~~~~~~~  231 (339)
                      |+||+++.++.+||+|||+|+..             ++..|++||......++.++|+|++|+++|++++|. +|+....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999998532             234588898888778888999999999999999875 4554332


Q ss_pred             ccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          232 FLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      ..  ..............      ....+++++++||.+||+.||++|||+.|+++|
T Consensus       242 ~~--~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         242 ID--EEFCRRLKEGTRMR------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             CS--HHHHHHHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH--HHHHHHHhcCCCCC------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            11  11222222222211      114589999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-44  Score=312.66  Aligned_cols=242  Identities=19%  Similarity=0.321  Sum_probs=189.2

Q ss_pred             cccc-CccCCCccccccccceEEEEEEeCCCC-------ceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeee
Q 042681           30 FQVS-SKYVPPLQPIGRGAYGIVCSAVNSETK-------EEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVK  100 (339)
Q Consensus        30 ~~~~-~~y~~~~~~lg~G~~~~v~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~  100 (339)
                      |.++ ++|.+ ++.||+|+||.||+|+...++       ..||+|++++.. .......+.+|...+.++ +||||++++
T Consensus         8 ~~i~~~~~~l-~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           8 WELPRDRLVL-GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TBCCGGGEEE-EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccHHHeEE-eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            4443 45555 899999999999999976554       479999987643 344567788898888888 799999999


Q ss_pred             eecCCCCcCCcCeEEEEEecCc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 042681          101 DIIPPMDKEKFNDVYIVYELMD-TDLHQIIRSK----------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRD  163 (339)
Q Consensus       101 ~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~d  163 (339)
                      +++     ...+.+++||||++ |+|.+++...                ..+++..++.++.||+.||+|||++||+|||
T Consensus        86 ~~~-----~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD  160 (299)
T d1fgka_          86 GAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD  160 (299)
T ss_dssp             EEE-----CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccc-----ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence            999     56678999999998 7999999654                3589999999999999999999999999999


Q ss_pred             CCCCCeeeccCCCeEEeeccccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHh-CCCCCCc
Q 042681          164 LKPSNLLLNANCDLKICDFGLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELL-GSPDDSD  229 (339)
Q Consensus       164 ikp~NIli~~~~~ikL~Dfg~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~-g~~~~~~  229 (339)
                      |||+|||++.++.+||+|||.++..             +...|++|+......+..++|+|++|+++|++++ |.+|+..
T Consensus       161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~  240 (299)
T d1fgka_         161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  240 (299)
T ss_dssp             CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence            9999999999999999999998643             2235778887777778889999999999999997 6777654


Q ss_pred             ccccccchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          230 LGFLRSDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      ...   ............   ...   ...+|+++++||.+||+.||++|||+.|+++
T Consensus       241 ~~~---~~~~~~i~~~~~---~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         241 VPV---EELFKLLKEGHR---MDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             CCH---HHHHHHHHTTCC---CCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCH---HHHHHHHHcCCC---CCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            332   122222222111   111   1458999999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=315.53  Aligned_cols=239  Identities=21%  Similarity=0.291  Sum_probs=190.8

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCce--EEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCCcCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEE--VAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~  110 (339)
                      ++|.. .+.||+|+||.||+|.++.+|..  +|+|+++.. ......+.+.+|+.++.++ +||||+++++++     ..
T Consensus        10 ~~~~~-~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~   82 (309)
T d1fvra_          10 NDIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH   82 (309)
T ss_dssp             GGCEE-EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EE
T ss_pred             HHcEE-EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc-cChHHHHHHHHHHHHHHhccCCCCEeeEEEEE-----ec
Confidence            34555 88999999999999999988875  566766433 2233456789999999999 799999999999     66


Q ss_pred             cCeEEEEEecCc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc
Q 042681          111 FNDVYIVYELMD-TDLHQIIRSK----------------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA  173 (339)
Q Consensus       111 ~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~  173 (339)
                      .+.+++||||++ |+|.+++...                ..+++..+..++.||+.||.|||++|++||||||+|||++.
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  162 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence            788999999998 7999998643                57999999999999999999999999999999999999999


Q ss_pred             CCCeEEeecccccc----------cCCCCccccccccccccCCCCccHHHHHHHHHHHhCCC-CCCcccccccchHHHHH
Q 042681          174 NCDLKICDFGLART----------TSETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSP-DDSDLGFLRSDNARRYV  242 (339)
Q Consensus       174 ~~~ikL~Dfg~~~~----------~~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~-~~~~~~~~~~~~~~~~~  242 (339)
                      ++.+||+|||+++.          .++..|.+|+......+..++|+|++|+++|++++|.. |+....      .....
T Consensus       163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~  236 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELY  236 (309)
T ss_dssp             GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHH
T ss_pred             CCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHH
Confidence            99999999999853          23456888888877778889999999999999999764 443221      11111


Q ss_pred             hhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          243 KQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      .........   .....+++++++||.+||+.||++|||+.++++|
T Consensus       237 ~~i~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         237 EKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HHGGGTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            111111111   1224689999999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-44  Score=311.37  Aligned_cols=248  Identities=19%  Similarity=0.295  Sum_probs=196.7

Q ss_pred             cccc-CccCCCccccccccceEEEEEEeCC-----CCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeec
Q 042681           30 FQVS-SKYVPPLQPIGRGAYGIVCSAVNSE-----TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDII  103 (339)
Q Consensus        30 ~~~~-~~y~~~~~~lg~G~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~  103 (339)
                      |.|. ++|.. .+.||+|+||.||+|.++.     +++.||||+++.. ........+.+|+.++++++||||+++++++
T Consensus        15 ~ei~~~~~~l-~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          15 WEVAREKITM-SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             TBCCGGGEEE-EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             eeecHHHeEE-eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            4444 44554 8999999999999998753     3578999999754 3444566789999999999999999999999


Q ss_pred             CCCCcCCcCeEEEEEecCc-ccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec
Q 042681          104 PPMDKEKFNDVYIVYELMD-TDLHQIIRSK----------QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN  172 (339)
Q Consensus       104 ~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~  172 (339)
                           ......++||||++ |+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus        93 -----~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld  167 (308)
T d1p4oa_          93 -----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA  167 (308)
T ss_dssp             -----CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred             -----ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec
Confidence                 66677899999998 7999888532          3578999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccccccc-------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCC-CCCCcccccccchH
Q 042681          173 ANCDLKICDFGLARTT-------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGS-PDDSDLGFLRSDNA  238 (339)
Q Consensus       173 ~~~~ikL~Dfg~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~-~~~~~~~~~~~~~~  238 (339)
                      .++++||+|||+++..             +...|++|+......+..+.|+|++|++++++++|. +|+....   ....
T Consensus       168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~---~~~~  244 (308)
T d1p4oa_         168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQV  244 (308)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHH
T ss_pred             CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC---HHHH
Confidence            9999999999998643             234577777777667778899999999999999985 5543321   1111


Q ss_pred             HHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCC
Q 042681          239 RRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN------HPYLSS  293 (339)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~------hp~f~~  293 (339)
                      ...+.....   .   ...+.+++.+.+||.+||+.||++|||+.++++      +|+|+.
T Consensus       245 ~~~i~~~~~---~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         245 LRFVMEGGL---L---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             HHHHHTTCC---C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             HHHHHhCCC---C---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            111221111   1   112468899999999999999999999999997      566654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=307.65  Aligned_cols=236  Identities=19%  Similarity=0.220  Sum_probs=187.4

Q ss_pred             ccccccccceEEEEEEeCCCC---ceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeeeeeecCCCCcCCcCeEEE
Q 042681           40 LQPIGRGAYGIVCSAVNSETK---EEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKVKDIIPPMDKEKFNDVYI  116 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~~~~~~i  116 (339)
                      .+.||+|+||+||+|.+..++   ..+|||+++.. ......+++.+|++++.+++||||+++++++.    ...+..++
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~l  106 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLV  106 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE----ETTTEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEE----ecCCceEE
Confidence            356999999999999986543   35899998643 34556688999999999999999999999872    34467899


Q ss_pred             EEecCc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecccccccC-----
Q 042681          117 VYELMD-TDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-----  189 (339)
Q Consensus       117 v~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg~~~~~~-----  189 (339)
                      ||||++ |+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++...     
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999998 7888888754 468888999999999999999999999999999999999999999999999997532     


Q ss_pred             ----------CCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHHHHHhhCCCCCCCCccccCCC
Q 042681          190 ----------ETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNARRYVKQLPHVPKQPFSQKFPN  259 (339)
Q Consensus       190 ----------~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (339)
                                +..|.+|+......++.++|+|++|+++|++++|..|+...... ... ............      .+.
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~-~~~i~~g~~~~~------p~~  258 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDI-TVYLLQGRRLLQ------PEY  258 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------C-HHHHHTTCCCCC------CTT
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHH-HHHHHcCCCCCC------ccc
Confidence                      23467787777777888899999999999999987775543211 111 122221111111      145


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          260 MSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       260 ~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                      +++++.+||.+||+.||++|||+.|+++|
T Consensus       259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         259 CPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            78999999999999999999999999988

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-43  Score=306.18  Aligned_cols=239  Identities=23%  Similarity=0.316  Sum_probs=192.2

Q ss_pred             CccCCCccccccccceEEEEEEeC-----CCCceEEEEEecccccChHhHHHHHHHHHHHhhC-CCCCeeeeeeecCCCC
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNS-----ETKEEVAIKKITNAFDNRIDAKRILREIKLLCHM-THENIVKVKDIIPPMD  107 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~  107 (339)
                      ++|.. .+.||+|+||.||+|.+.     .+++.||||+++.. ........+.+|+.++..+ +||||+++++++    
T Consensus        23 ~~~~l-~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~----   96 (311)
T d1t46a_          23 NRLSF-GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGAC----   96 (311)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             HHeEE-eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence            45555 899999999999999853     46779999999754 3344566789999999999 699999999999    


Q ss_pred             cCCcCeEEEEEecCc-ccHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 042681          108 KEKFNDVYIVYELMD-TDLHQIIRSKQ------------------ALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN  168 (339)
Q Consensus       108 ~~~~~~~~iv~e~~~-g~L~~~l~~~~------------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~N  168 (339)
                       ......++||||++ |+|.+++....                  .+++..+..++.||+.||+|||++|++||||||+|
T Consensus        97 -~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_          97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             -eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence             66677999999998 79999986532                  59999999999999999999999999999999999


Q ss_pred             eeeccCCCeEEeecccccccCC-------------CCccccccccccccCCCCccHHHHHHHHHHHhC-CCCCCcccccc
Q 042681          169 LLLNANCDLKICDFGLARTTSE-------------TDFMTEYVVTRWDTLFPGKDYVQQLTMITELLG-SPDDSDLGFLR  234 (339)
Q Consensus       169 Ili~~~~~ikL~Dfg~~~~~~~-------------~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g-~~~~~~~~~~~  234 (339)
                      |+++.++.++++|||.++....             ..|++|+.......+..+|+|++|+++++++++ .+++...... 
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-  254 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-  254 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999975432             346777877777788889999999999999984 5544332211 


Q ss_pred             cchHHHHHhhCCCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          235 SDNARRYVKQLPHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                       ...............      ...+|+++.+||.+||+.||++|||++++++
T Consensus       255 -~~~~~~i~~~~~~~~------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         255 -SKFYKMIKEGFRMLS------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             -HHHHHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -HHHHHHHhcCCCCCC------cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             112222222221111      1357899999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-43  Score=308.09  Aligned_cols=250  Identities=18%  Similarity=0.181  Sum_probs=195.4

Q ss_pred             ccccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCeeee-eeecCCCCc
Q 042681           30 FQVSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENIVKV-KDIIPPMDK  108 (339)
Q Consensus        30 ~~~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~-~~~~~~~~~  108 (339)
                      +.++++|.+ ++.||+|+||.||+|++..+|+.||+|++......    ..+.+|+++++.++|++++.. .+++     
T Consensus         3 ~~vg~rY~l-~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~-----   72 (299)
T d1ckia_           3 LRVGNRYRL-GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCG-----   72 (299)
T ss_dssp             CEETTTEEE-EEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEE-----
T ss_pred             CeECCEEEE-eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEE-----
Confidence            467889988 99999999999999999999999999988654222    347789999999987665554 5554     


Q ss_pred             CCcCeEEEEEecCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeec---cCCCeEEeeccc
Q 042681          109 EKFNDVYIVYELMDTDLHQIIRS-KQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDFGL  184 (339)
Q Consensus       109 ~~~~~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~---~~~~ikL~Dfg~  184 (339)
                      ......++||||+++++.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+||+++   .+..++|+|||+
T Consensus        73 ~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~  152 (299)
T d1ckia_          73 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  152 (299)
T ss_dssp             EETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred             ecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCc
Confidence            56678899999999888777754 56899999999999999999999999999999999999985   455799999999


Q ss_pred             cccc------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchHH-HHHhhC
Q 042681          185 ARTT------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNAR-RYVKQL  245 (339)
Q Consensus       185 ~~~~------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~~-~~~~~~  245 (339)
                      |+..                  ++..|++||......+..++|+|++|++++++++|..|+............ ......
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ckia_         153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  232 (299)
T ss_dssp             CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred             ceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc
Confidence            8643                  445688899888878889999999999999999999998654432221111 111100


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCCCC
Q 042681          246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVE---EALNHPYLS  292 (339)
Q Consensus       246 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~---ell~hp~f~  292 (339)
                      .   ..+.....+.+|+++.+||.+||+.||++||++.   ++++|+|.+
T Consensus       233 ~---~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         233 M---STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             H---HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             C---CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            0   0111222356899999999999999999999987   556777653

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.3e-43  Score=301.70  Aligned_cols=243  Identities=16%  Similarity=0.169  Sum_probs=196.9

Q ss_pred             ccCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCC-CCeeeeeeecCCCCcCC
Q 042681           32 VSSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTH-ENIVKVKDIIPPMDKEK  110 (339)
Q Consensus        32 ~~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~I~~~~~~~~~~~~~~  110 (339)
                      ++++|.+ ++.||+|+||+||+|++..+|+.||+|++.....    ...+.+|++.++.++| +|++.+++++     ..
T Consensus         3 ig~~Y~i-~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~   72 (293)
T d1csna_           3 VGVHYKV-GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFG-----QE   72 (293)
T ss_dssp             ETTTEEE-EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EE
T ss_pred             CCCceEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEe-----ec
Confidence            4577877 9999999999999999999999999998865422    2346788888999864 8999999998     67


Q ss_pred             cCeEEEEEecCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeecc-----CCCeEEeeccc
Q 042681          111 FNDVYIVYELMDTDLHQIIRSK-QALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-----NCDLKICDFGL  184 (339)
Q Consensus       111 ~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~-----~~~ikL~Dfg~  184 (339)
                      ....++||||++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.     ++.++|+|||+
T Consensus        73 ~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          73 GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             CCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccce
Confidence            7889999999999999998765 57999999999999999999999999999999999999974     57899999999


Q ss_pred             cccc------------------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccchH-HHHHhhC
Q 042681          185 ARTT------------------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDNA-RRYVKQL  245 (339)
Q Consensus       185 ~~~~------------------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~~-~~~~~~~  245 (339)
                      |+..                  |++.|++||......+..++|+|++|++++++++|..|+........... .......
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            8642                  45678999998888888899999999999999999999865433222111 1111110


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 042681          246 PHVPKQPFSQKFPNMSPVAIDLAERMLVFDPAKRITVEEALN  287 (339)
Q Consensus       246 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  287 (339)
                      .   ..+..+..+.+|+++.+++..|+..+|++||+...+.+
T Consensus       233 ~---~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         233 Q---STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             H---HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             C---CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            0   11222333568999999999999999999999877654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-42  Score=299.83  Aligned_cols=245  Identities=19%  Similarity=0.220  Sum_probs=178.8

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHH--HHHHHhhCCCCCeeeeeeecCCCCcCCc
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILR--EIKLLCHMTHENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~--e~~~l~~l~h~~I~~~~~~~~~~~~~~~  111 (339)
                      .+|.. .+.||+|+||.||+|+.  +|+.||+|+++..     ......+  |+..+..++||||+++++++.... ...
T Consensus         3 ~~~~l-~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~   73 (303)
T d1vjya_           3 RTIVL-QESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTW   73 (303)
T ss_dssp             GGEEE-EEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred             cEEEE-EEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Ccc
Confidence            44555 88899999999999986  5889999998643     1233344  445556789999999999984321 223


Q ss_pred             CeEEEEEecCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCCeeeccCCCeEEeec
Q 042681          112 NDVYIVYELMD-TDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS--------ANVLHRDLKPSNLLLNANCDLKICDF  182 (339)
Q Consensus       112 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~--------~givH~dikp~NIli~~~~~ikL~Df  182 (339)
                      ..+++||||++ |+|.+++.+ .++++...+.++.|++.||.|||+        +||+||||||+||+++.++.+||+||
T Consensus        74 ~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          74 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            46899999998 799999976 579999999999999999999996        59999999999999999999999999


Q ss_pred             cccccc---------------CCCCcccccccccc------ccCCCCccHHHHHHHHHHHhCCCCCCcccccc-------
Q 042681          183 GLARTT---------------SETDFMTEYVVTRW------DTLFPGKDYVQQLTMITELLGSPDDSDLGFLR-------  234 (339)
Q Consensus       183 g~~~~~---------------~~~~~~~~~~~~~~------~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~-------  234 (339)
                      |+++..               ++..|++||.....      .+..++|+|++|+++|++++|..++...+...       
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            988543               34567888876543      24556899999999999999977653322111       


Q ss_pred             --cchHHHHHh-hCCCCCCCCcccc--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 042681          235 --SDNARRYVK-QLPHVPKQPFSQK--FPNMSPVAIDLAERMLVFDPAKRITVEEALNH  288 (339)
Q Consensus       235 --~~~~~~~~~-~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  288 (339)
                        ......... .......+.....  .......+.+|+.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              011111111 1111111111111  11233568999999999999999999999864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.2e-41  Score=302.37  Aligned_cols=258  Identities=21%  Similarity=0.271  Sum_probs=188.4

Q ss_pred             CccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-----------CCCeeeeeee
Q 042681           34 SKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-----------HENIVKVKDI  102 (339)
Q Consensus        34 ~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~I~~~~~~  102 (339)
                      +||.+ ++.||+|+||+||+|++..+|+.||||++++.   ....+.+.+|+.+++.++           |+||++++++
T Consensus        13 ~rY~i-~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYIL-VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            46877 99999999999999999999999999999754   233456678888887774           5789999988


Q ss_pred             cCCCCcCCcCeEEEEEecCc--ccHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeeeccCCC-
Q 042681          103 IPPMDKEKFNDVYIVYELMD--TDLHQII--RSKQALTDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCD-  176 (339)
Q Consensus       103 ~~~~~~~~~~~~~iv~e~~~--g~L~~~l--~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dikp~NIli~~~~~-  176 (339)
                      +..   ......++++.++.  ++.....  .....+++..++.++.||+.||+|||+ .||+||||||+||+++.++. 
T Consensus        89 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          89 FNH---KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EEE---EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             eee---ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence            732   23344556666653  3433333  345789999999999999999999997 89999999999999987654 


Q ss_pred             -----eEEeeccccccc--------CCCCccccccccccccCCCCccHHHHHHHHHHHhCCCCCCcccccccch----HH
Q 042681          177 -----LKICDFGLARTT--------SETDFMTEYVVTRWDTLFPGKDYVQQLTMITELLGSPDDSDLGFLRSDN----AR  239 (339)
Q Consensus       177 -----ikL~Dfg~~~~~--------~~~~~~~~~~~~~~~~~~~~d~~~~g~~~~~~l~g~~~~~~~~~~~~~~----~~  239 (339)
                           ++++|||.+...        +...|.+||......+..+.|+|++|++++++++|..|+..........    ..
T Consensus       166 ~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             cccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence                 999999998643        3446888888877778889999999999999999999875432211100    00


Q ss_pred             HHHhhCCC------------------------CCCCCc----------cccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 042681          240 RYVKQLPH------------------------VPKQPF----------SQKFPNMSPVAIDLAERMLVFDPAKRITVEEA  285 (339)
Q Consensus       240 ~~~~~~~~------------------------~~~~~~----------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el  285 (339)
                      ........                        ......          .......++++++||.+||++||.+||||+|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            00000000                        000000          00012246789999999999999999999999


Q ss_pred             hcCCCCCCCccCC
Q 042681          286 LNHPYLSSLHEIN  298 (339)
Q Consensus       286 l~hp~f~~~~~~~  298 (339)
                      |+||||++.....
T Consensus       326 L~Hp~f~~~~~~~  338 (362)
T d1q8ya_         326 VNHPWLKDTLGME  338 (362)
T ss_dssp             HTCGGGTTCTTCT
T ss_pred             hcCcccCCCCCcc
Confidence            9999999775543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.5e-24  Score=174.88  Aligned_cols=135  Identities=17%  Similarity=0.180  Sum_probs=106.7

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccccC----------------hHhHHHHHHHHHHHhhCCCCCeeeeeeec
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDN----------------RIDAKRILREIKLLCHMTHENIVKVKDII  103 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~~I~~~~~~~  103 (339)
                      .+.||+|+||.||+|.+. +|+.||+|+++.....                ........+|...+.++.|++++..+++.
T Consensus         5 g~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           5 GKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             CCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            688999999999999885 6899999987532111                11123455788999999999999988764


Q ss_pred             CCCCcCCcCeEEEEEecCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCeeeccCCCeEEeecc
Q 042681          104 PPMDKEKFNDVYIVYELMDTDLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  183 (339)
Q Consensus       104 ~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dikp~NIli~~~~~ikL~Dfg  183 (339)
                           .    .+++|||+++...      ..++...+..++.|++.||.|||++||+||||||+||+++++ .++|+|||
T Consensus        84 -----~----~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          84 -----G----NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             -----T----TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             -----C----CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence                 2    2799999986321      235666678899999999999999999999999999999865 48999999


Q ss_pred             cccccCCC
Q 042681          184 LARTTSET  191 (339)
Q Consensus       184 ~~~~~~~~  191 (339)
                      .|...+.+
T Consensus       148 ~a~~~~~~  155 (191)
T d1zara2         148 QSVEVGEE  155 (191)
T ss_dssp             TCEETTST
T ss_pred             CcccCCCC
Confidence            99776644

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.48  E-value=1.6e-07  Score=77.61  Aligned_cols=140  Identities=14%  Similarity=0.122  Sum_probs=85.7

Q ss_pred             cCccCCCccccccccceEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCc
Q 042681           33 SSKYVPPLQPIGRGAYGIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        33 ~~~y~~~~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~  111 (339)
                      ..+|.. ++..+.++.+.||++.  .+++.+++|+.......  ....+.+|...+..+. +--+++++.+.     ...
T Consensus        13 ~~~~~~-~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~   82 (263)
T d1j7la_          13 IEKYRC-VKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHD   82 (263)
T ss_dssp             HTTSEE-EECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEE-----EET
T ss_pred             hhceEE-EEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEE-----ecC
Confidence            344444 5544455557899885  35667888887544221  1234566777777663 43466777766     555


Q ss_pred             CeEEEEEecCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------
Q 042681          112 NDVYIVYELMDT-DLHQIIRSKQALTDDHCQYFLYQLLRGLKYIHS----------------------------------  156 (339)
Q Consensus       112 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~----------------------------------  156 (339)
                      +..++||++.+| .+.+....     ......++.++...+..||+                                  
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             CceEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            778999999986 44332211     11112223333333344442                                  


Q ss_pred             -------------------------CCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          157 -------------------------ANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       157 -------------------------~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                                               ..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                     1269999999999999776677999998854

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.33  E-value=9.6e-07  Score=77.26  Aligned_cols=77  Identities=18%  Similarity=0.097  Sum_probs=48.9

Q ss_pred             ccccccccceEEEEEEeCCCCceEEEEEecccc-----cChHhHHHHHHHHHHHhhCC---CCCeeeeeeecCCCCcCCc
Q 042681           40 LQPIGRGAYGIVCSAVNSETKEEVAIKKITNAF-----DNRIDAKRILREIKLLCHMT---HENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~~~~~  111 (339)
                      .+.||.|....||++.+..+++.+++|.-....     .......+...|.+.+..+.   ...+++++.+.     .. 
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-----~~-  104 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-----TE-  104 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-----TT-
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-----CC-
Confidence            567899999999999988888899999754311     11122345567887777662   23566777654     22 


Q ss_pred             CeEEEEEecCcc
Q 042681          112 NDVYIVYELMDT  123 (339)
Q Consensus       112 ~~~~iv~e~~~g  123 (339)
                       ..++|||++++
T Consensus       105 -~~~lvmE~L~~  115 (392)
T d2pula1         105 -MAVTVMEDLSH  115 (392)
T ss_dssp             -TTEEEECCCTT
T ss_pred             -CCEEEEeccCC
Confidence             23789999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.99  E-value=2e-05  Score=64.10  Aligned_cols=70  Identities=10%  Similarity=0.056  Sum_probs=44.7

Q ss_pred             cccccc-eEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCC--CCCeeeeeeecCCCCcCCcCeEEEEEe
Q 042681           43 IGRGAY-GIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT--HENIVKVKDIIPPMDKEKFNDVYIVYE  119 (339)
Q Consensus        43 lg~G~~-~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~I~~~~~~~~~~~~~~~~~~~iv~e  119 (339)
                      +..|.. +.||++... ++..+++|.......     ..+..|...++.+.  .-.+++++.+.     ...+..++||+
T Consensus        18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~   86 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLG   86 (255)
T ss_dssp             CSCTTSSCEEEEEECT-TSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEE
T ss_pred             cCCcccCCeEEEEEeC-CCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEE
Confidence            445543 678988754 466788897654321     23456666666553  33367777766     44567899999


Q ss_pred             cCcc
Q 042681          120 LMDT  123 (339)
Q Consensus       120 ~~~g  123 (339)
                      +++|
T Consensus        87 ~i~G   90 (255)
T d1nd4a_          87 EVPG   90 (255)
T ss_dssp             CCSS
T ss_pred             eeec
Confidence            9975

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.65  E-value=0.0002  Score=60.42  Aligned_cols=133  Identities=13%  Similarity=0.137  Sum_probs=72.8

Q ss_pred             eEEEEEEeCCCCceEEEEEecccccChHhHHHHHHHHHHHhhCCCCCe--eeeeeecCCCCcCCcCeEEEEEecCccc--
Q 042681           49 GIVCSAVNSETKEEVAIKKITNAFDNRIDAKRILREIKLLCHMTHENI--VKVKDIIPPMDKEKFNDVYIVYELMDTD--  124 (339)
Q Consensus        49 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~I--~~~~~~~~~~~~~~~~~~~iv~e~~~g~--  124 (339)
                      -.||++.. .+|+.|++|+.+...   .+.+++..|...+..|....+  +.....-........+..+.++++.+|.  
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            48999976 468899999876432   234567778888777742222  1111111001112345578889988652  


Q ss_pred             ----HH------HHHH-------h-----cCC-------------------CCHH---HHHHHHHHHHHHHHHHH----h
Q 042681          125 ----LH------QIIR-------S-----KQA-------------------LTDD---HCQYFLYQLLRGLKYIH----S  156 (339)
Q Consensus       125 ----L~------~~l~-------~-----~~~-------------------~~~~---~~~~i~~qi~~aL~~LH----~  156 (339)
                          ..      ..+.       .     ...                   ++..   .....+.++...+.-.-    .
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence                11      1110       0     001                   1111   12222333333333321    2


Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          157 ANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       157 ~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .+++|+|+.|.||+++.+  ..++||+-|..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            369999999999999743  46899998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.41  E-value=0.00039  Score=60.25  Aligned_cols=71  Identities=14%  Similarity=0.158  Sum_probs=48.7

Q ss_pred             ccccccccceEEEEEEeCC-------CCceEEEEEecccccChHhHHHHHHHHHHHhhCC-CCCeeeeeeecCCCCcCCc
Q 042681           40 LQPIGRGAYGIVCSAVNSE-------TKEEVAIKKITNAFDNRIDAKRILREIKLLCHMT-HENIVKVKDIIPPMDKEKF  111 (339)
Q Consensus        40 ~~~lg~G~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~~  111 (339)
                      ++.|+.|-.-.+|++....       .++.+++++.... ...   ....+|..+++.+. +.-.+++++++     .+ 
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~---idr~~E~~i~~~ls~~gl~Pkll~~~-----~~-  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETE---SHLVAESVIFTLLSERHLGPKLYGIF-----SG-  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCH---HHHHHHHHHHHHHHHTTSSSCEEEEE-----TT-
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chh---hHHHHHHHHHHHHHhCCCCCeEEEEc-----CC-
Confidence            7789999999999998643       3456778876532 222   23447888888774 44456888877     32 


Q ss_pred             CeEEEEEecCcc
Q 042681          112 NDVYIVYELMDT  123 (339)
Q Consensus       112 ~~~~iv~e~~~g  123 (339)
                         .+|+||.+|
T Consensus       117 ---g~I~efi~g  125 (395)
T d1nw1a_         117 ---GRLEEYIPS  125 (395)
T ss_dssp             ---EEEECCCCE
T ss_pred             ---ceEEEEecc
Confidence               688999875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.85  E-value=0.0045  Score=51.36  Aligned_cols=31  Identities=29%  Similarity=0.338  Sum_probs=27.6

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecccccc
Q 042681          157 ANVLHRDLKPSNLLLNANCDLKICDFGLART  187 (339)
Q Consensus       157 ~givH~dikp~NIli~~~~~ikL~Dfg~~~~  187 (339)
                      .|+||+|+.++||+++.+...-++||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            4799999999999999887778999999854